International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disord	ENTITY
Third	
Edition	
CI	ENTITY
S	ENTITY
ers	ENTITY
D3	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disord	ENTITY
Third	
Edition	
CI	ENTITY
S	ENTITY
ers	ENTITY
D3	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY

Copyright	
©	
2014	
American	
Academy	
of	
Sleep	
Medicine	
,	
2510	
North	ENTITY
Frontage	ENTITY
Road	ENTITY
,	
Darien	ENTITY
,	
IL	ENTITY
60561	
,	
U.S.A.	ENTITY
Copies	ENTITY
of	
the	
manual	ENTITY
are	
available	
from	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
in	
the	
U.S.A.	ENTITY
All	
rights	
reserved	
.	

Unless	
authorized	
in	
writing	
by	
the	
AASM	ENTITY
,	
no	
portion	
of	
this	
book	
may	
be	
reproduced	
or	
used	
in	
a	
manner	
inconsistent	ENTITY
with	
the	
copyright	
.	

This	
applies	
to	
unauthorized	ENTITY
reproductions	ENTITY
in	
any	
form	
,	
including	
computer	ENTITY
programs	ENTITY
.	

Correspondence	ENTITY
regarding	
copyright	
permissions	ENTITY
should	
be	
directed	
to	
the	
Executive	ENTITY
Director	ENTITY
,	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
2510	
North	ENTITY
Frontage	ENTITY
Road	ENTITY
,	
Darien	ENTITY
,	
IL	ENTITY
60561	
,	
U.S.A.	ENTITY
Translations	ENTITY
to	
other	
languages	ENTITY
must	
be	
authorized	
by	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
U.S.A.	ENTITY
Recommended	
Citation	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

International	ENTITY
classification	ENTITY
of	
sleep	ENTITY
disorders	ENTITY
,	
3rd	
ed	
.	

Darien	ENTITY
,	
IL	ENTITY
:	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
2014	
.	

International	ENTITY
classification	ENTITY
of	
sleep	ENTITY
disorders	ENTITY
,	
3rd	
ed	
.	

American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

Includes	ENTITY
bibliographies	ENTITY
and	
index	ENTITY
.	
.	

Sleep	ENTITY
Disorders	ENTITY
–	ENTITY
Classification	ENTITY
.	

2	
.	
Sleep	ENTITY
Disorders	ENTITY
–	
Diagnosis	ENTITY
ISBN	
:	
0991543416	
(	
print	
)	
ISBN	
:	
0991543408	
(	
online	ENTITY
)	

In	
memory	ENTITY
of	
Peter	ENTITY
Hauri	ENTITY
,	
PhD	ENTITY
mentor	ENTITY
,	
colleague	ENTITY
and	
friend	ENTITY
Table	ENTITY
of	
Contents	ENTITY
About	
the	
Editor	ENTITY
8	ENTITY
Editor	ENTITY
’s	ENTITY
Notes	ENTITY
9	ENTITY
Acknowledgments10	ENTITY
Introduction13	ENTITY
Insomnia19	ENTITY
Chronic	ENTITY
Insomnia	ENTITY
Disorder	ENTITY

21	
Short	ENTITY
-	
Term	ENTITY
Insomnia	ENTITY
Disorder41	
Other	
Insomnia	ENTITY
Disorder46	
ISOLATED	ENTITY
SYMPTOMS	ENTITY
AND	
NORMAL	ENTITY
VARIANTS	
Excessive	ENTITY
Time	
in	
Bed47	ENTITY
Short	ENTITY
Sleeper47	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
49	
OBSTRUCTIVE	
SLEEP	
APNEA	
DISORDERS	
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	
Adult	ENTITY

53	
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	
Pediatric	ENTITY

63	
CENTRAL	
SLEEP	

APNEA	ENTITY
SYNDROMES	
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing	
69	
Central	ENTITY
Apnea	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing	

75	
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY

Due	
to	
High	ENTITY
Altitude	ENTITY
Periodic	ENTITY
Breathing79	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance85	ENTITY
Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
89	

Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	ENTITY
Infancy	ENTITY

94	
Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	
Prematurity	ENTITY

98	
Treatment	ENTITY
-	
Emergent	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea102	ENTITY
SLEEP	
RELATED	
HYPOVENTILATION	
DISORDERS	
Obesity	ENTITY
Hypoventilation	ENTITY
Syndrome108	ENTITY
Congenital	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY

113	
Late	ENTITY
-	
Onset	ENTITY
Central	ENTITY
Hypoventilation	ENTITY
with	
Hypothalamic	ENTITY
Dysfunction	ENTITY

118	
Idiopathic	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
121	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
124	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY

128	
SLEEP	
RELATED	
HYPOXEMIA	
DISORDER	
Sleep	
Related	
Hypoxemia	ENTITY

134	
Table	
of	
Contents	ENTITY
ISOLATED	
SYMPTOMS	
AND	
NORMAL	ENTITY
VARIANTS	ENTITY

Snoring	ENTITY
139	
Catathrenia	ENTITY

141	
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence143	ENTITY
Narcolepsy	
Type	
1	

146	
Narcolepsy	ENTITY
Type	ENTITY
2	ENTITY

155	
Idiopathic	ENTITY
Hypersomnia	ENTITY

161	
Kleine	ENTITY
-	
Levin	ENTITY
Syndrome166	
Hypersomnia	
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY

171	
Hypersomnia	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
175	ENTITY
Hypersomnia	ENTITY
Associated	ENTITY
with	ENTITY
a	
Psychiatric	ENTITY
Disorder	ENTITY

179	
Insufficient	ENTITY
Sleep	ENTITY
Syndrome	ENTITY

182	
ISOLATED	
SYMPTOMS	ENTITY
AND	
NORMAL	ENTITY
VARIANTS	ENTITY
Long	ENTITY
Sleeper187	ENTITY
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders189	
Delayed	
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder	ENTITY
191	ENTITY
Advanced	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder198	ENTITY
Irregular	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder	ENTITY

204	
Non-24	ENTITY
-	
Hour	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder209	ENTITY
Shift	ENTITY
Work	
Disorder215	
Jet	
Lag	
Disorder220	
Circadian	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorder	ENTITY
Not	
Otherwise	
Specified	
(	
NOS)224	ENTITY
Parasomnias	
225	
NREM	ENTITY
-	
RELATED	ENTITY
PARASOMNIAS	ENTITY
Disorders	ENTITY
of	
Arousal	ENTITY
(	
From	
NREM	ENTITY
Sleep	ENTITY
)	

228	
Confusional	ENTITY
Arousals	ENTITY

229	
Sleepwalking	ENTITY

229	
Sleep	ENTITY
Terrors	ENTITY
230	ENTITY
Sleep	ENTITY
Related	ENTITY
Eating	ENTITY
Disorder240	
REM	ENTITY
-	
RELATED	ENTITY
PARASOMNIAS	ENTITY
REM	ENTITY
Sleep	ENTITY
Behavior	ENTITY
Disorder246	ENTITY

Recurrent	ENTITY
Isolated	ENTITY
Sleep	ENTITY
Paralysis254	ENTITY
Nightmare	ENTITY
Disorder257	ENTITY
OTHER	
PARASOMNIAS	
Exploding	ENTITY
Head	ENTITY
Syndrome	ENTITY

264	
Sleep	ENTITY
Related	ENTITY
Hallucinations267	ENTITY
Sleep	ENTITY
Enuresis270	

Parasomnia	ENTITY

Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY

276	
Parasomnia	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance276	ENTITY
Parasomnia	ENTITY
,	
Unspecified	
278	
ISOLATED	
SYMPTOMS	
AND	
NORMAL	ENTITY
VARIANTS	ENTITY
Sleep	ENTITY
Talking279	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
281	ENTITY
Restless	ENTITY
Legs	ENTITY
Syndrome282	
Periodic	
Limb	
Movement	
Disorder292	ENTITY
Sleep	ENTITY
Related	
Leg	
Cramps299	
Sleep	
Related	
Bruxism	ENTITY

303	
Sleep	
Related	
Rhythmic	
Movement	
Disorder312	ENTITY
Benign	ENTITY
Sleep	ENTITY
Myoclonus	ENTITY
of	
Infancy317	ENTITY
Propriospinal	ENTITY
Myoclonus	ENTITY
at	
Sleep	ENTITY
Onset321	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY

325	
Sleep	
Related	
Movement	
Disorder	
Due	
to	
a	
Medication	ENTITY
or	
Substance326	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
,	
Unspecified	

327	
ISOLATED	
SYMPTOMS	ENTITY
AND	
NORMAL	ENTITY
VARIANTS	
Excessive	ENTITY
Fragmentary	ENTITY
Myoclonus	ENTITY
328	ENTITY
Hypnagogic	ENTITY
Foot	ENTITY
Tremor	ENTITY
and	
Alternating	ENTITY
Leg	ENTITY
Muscle	ENTITY
Activation	
330	
Sleep	
Starts	
(	
Hypnic	ENTITY
Jerks	ENTITY
)	

335	
Other	
Sleep	ENTITY
Disorder339	
Appendix	
A	
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders341	ENTITY
Fatal	ENTITY
Familial	ENTITY
Insomnia342	ENTITY
Sleep	ENTITY
Related	ENTITY
Epilepsy345	ENTITY
Sleep	ENTITY
Related	ENTITY
Headaches	ENTITY

350	
Sleep	ENTITY
Related	ENTITY
Laryngospasm355	ENTITY
Sleep	ENTITY
Related	ENTITY
Gastroesophageal	ENTITY
Reflux358	ENTITY
Sleep	ENTITY
Related	ENTITY
Myocardial	ENTITY
Ischemia363	
Appendix	
B	
:	
ICD-10	ENTITY
-	
CM	ENTITY
Coding	ENTITY
for	
Substance	ENTITY
-	
Induced	ENTITY
Sleep	ENTITY
Disorders369	
Glossary	
371	
Index	
377	
Table	
of	
Contents	ENTITY
About	
the	
Editor	ENTITY
Michael	ENTITY
Sateia	ENTITY
,	
MD	ENTITY
,	
is	
Professor	ENTITY
of	
Psychiatry	ENTITY
at	
the	
Geisel	ENTITY
School	ENTITY
of	ENTITY
Medicine	ENTITY
at	
Dartmouth	ENTITY
.	

He	
has	
served	
in	
a	
variety	
of	
leadership	ENTITY
capacities	ENTITY
in	
Sleep	ENTITY
Medicine	ENTITY
.	

He	
is	
Past	ENTITY
-	
President	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

Dr.	ENTITY
Sateia	ENTITY
was	
Associate	
Editor	
for	
the	
Journal	ENTITY
of	
Clinical	ENTITY
Sleep	ENTITY
Medicine	ENTITY
and	
chaired	ENTITY
the	
Scientific	ENTITY
Program	ENTITY
Committee	ENTITY
of	
the	
Associated	ENTITY
Professional	ENTITY
Sleep	ENTITY
Societies	ENTITY
.	

He	
was	
a	
member	
of	
the	
Research	ENTITY
Advisory	ENTITY
Board	ENTITY
of	
the	
National	ENTITY
Center	ENTITY
on	ENTITY
Sleep	ENTITY
Disorders	ENTITY
Research	ENTITY
and	
held	
a	
five	
year	ENTITY
Academic	ENTITY
Award	ENTITY
from	
the	
National	ENTITY
Heart	ENTITY
,	ENTITY
Lung	ENTITY
,	ENTITY
and	
Blood	ENTITY
Institute	ENTITY
.	

He	
served	
on	
the	
Accreditation	ENTITY
Council	ENTITY
on	ENTITY
Graduate	ENTITY
Medical	ENTITY
Education	ENTITY
Advisory	ENTITY
Committee	ENTITY
for	ENTITY
Sleep	ENTITY
Medicine	ENTITY
and	
the	
American	ENTITY
Board	ENTITY
of	ENTITY
Internal	ENTITY
Medicine	ENTITY
Policy	ENTITY
and	ENTITY
Test	ENTITY
Committee	ENTITY
for	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

His	ENTITY
editing	ENTITY
respon-	
sibilities	ENTITY
have	
included	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
;	
the	
comprehensive	ENTITY
textbook	
,	
Sleep	ENTITY
Medicine	ENTITY
;	
and	
Insomnia	ENTITY
:	
Diagnosis	ENTITY
and	
Treatment	ENTITY
.	

In	
2009	
he	
received	
the	
Nathaniel	ENTITY
Kleitman	ENTITY
Award	ENTITY
from	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

He	
currently	
serves	
as	
task	ENTITY
force	ENTITY
chair	ENTITY
and	
editor	ENTITY
for	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
,	
and	
chair	ENTITY
of	
the	
task	ENTITY
force	ENTITY
on	
the	
pharmacological	ENTITY
management	ENTITY
of	
insomnia	ENTITY
.	

He	
has	
authored	
numerous	
scientific	ENTITY
articles	ENTITY
in	
sleep	ENTITY
medi-	ENTITY
cine	ENTITY
,	
focused	
primarily	
on	
insomnia	ENTITY
and	
professional	ENTITY
education	ENTITY
in	
sleep	ENTITY
.	

Editor	ENTITY
’s	ENTITY
Notes	ENTITY

Many	
people	ENTITY
contributed	
to	
the	
development	ENTITY
of	
this	
manual	ENTITY
.	

The	
members	ENTITY
of	
the	
Task	ENTITY
Force	ENTITY
on	
ICSD-3	ENTITY
,	
who	
also	
chaired	ENTITY
individual	ENTITY
work	ENTITY
groups	ENTITY
,	
devoted	
countless	
hours	
and	
tireless	
dedication	ENTITY
to	
the	
work	
,	
as	
did	
the	
members	ENTITY
of	
their	
respective	
work	ENTITY
groups	ENTITY
.	

Numerous	ENTITY
reviewers	ENTITY
also	
provided	
thoughtful	
recommendations	ENTITY
which	
served	
to	
improve	ENTITY
the	
text	ENTITY
.	

These	
individuals	ENTITY
are	
acknowledged	
individually	
on	
the	
following	
pages	ENTITY
.	

A	
number	
of	
staff	ENTITY
members	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
contributed	
to	
this	
work	
.	

Our	
field	
owes	
a	
particular	
debt	ENTITY
of	
gratitude	ENTITY
for	
the	
diligence	ENTITY
,	
dedication	ENTITY
and	
determination	ENTITY
of	
Ms.	ENTITY
Carolyn	ENTITY
Winter	ENTITY
-	
Rosenberg	ENTITY
,	
Director	
of	
Coding	ENTITY
and	
Compliance	ENTITY
at	
the	
AASM	ENTITY
,	
who	
oversaw	
all	
facets	
of	
this	
project	ENTITY
.	

Without	
her	
,	
this	
publication	ENTITY
would	
not	
have	
been	
possible	
.	

Special	ENTITY
thanks	
are	
extended	
to	
the	
Board	ENTITY
of	ENTITY
Directors	ENTITY
of	ENTITY
the	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

My	
personal	ENTITY
thanks	
go	
to	
Nancy	ENTITY
Collop	ENTITY
,	
President	ENTITY
of	
the	
AASM	ENTITY
at	
the	
outset	
of	
the	
project	ENTITY
.	

I	
would	
also	
like	
to	
thank	
the	
following	
members	ENTITY
of	
the	
board	ENTITY
during	
the	
revision	ENTITY
process	ENTITY
who	
provided	
their	
expertise	ENTITY
and	
time	ENTITY
in	
reviewing	ENTITY
multiple	ENTITY
drafts	ENTITY
:	
Amy	
Aronsky	
,	
DO	ENTITY
;	
M.	ENTITY
Safwan	ENTITY
Badr	ENTITY
,	
MD	ENTITY
;	
Kelly	
Carden	
,	
MD	ENTITY
;	
Ronald	ENTITY
Chervin	ENTITY
,	ENTITY
MD	ENTITY
,	ENTITY
MS	ENTITY
;	
Nancy	ENTITY
Collop	ENTITY
,	
MD	ENTITY
;	
Samuel	
Fleishman	
,	
MD	ENTITY
;	
Timothy	ENTITY
Morgenthaler	
,	
MD	ENTITY
;	
Susan	ENTITY
Redline	ENTITY
,	
MD	ENTITY
;	
Ilene	ENTITY
Rosen	ENTITY
,	
MD	ENTITY
;	
Steven	
Shea	
,	
PhD	ENTITY
;	
Patrick	
Strollo	
,	
Jr.	
,	
MD	ENTITY
;	
Nathaniel	ENTITY
Watson	ENTITY
,	
MD	ENTITY
,	
MS	ENTITY
;	
Terri	
Weaver	
,	
PhD	ENTITY
,	
RN	ENTITY
;	
and	
Merrill	ENTITY
Wise	ENTITY
,	ENTITY
MD	ENTITY
.	

The	
international	ENTITY
review	ENTITY
effort	ENTITY
was	
coordinated	ENTITY
by	
the	
World	ENTITY
Sleep	ENTITY
Federation	ENTITY
.	

Thanks	
goes	
to	
Clete	ENTITY
Kushida	ENTITY
,	
MD	ENTITY
,	
PhD	ENTITY
,	
President	ENTITY
of	
the	
WSF	ENTITY
for	
his	
assistance	ENTITY
in	
this	
facet	ENTITY
.	

Charles	ENTITY
Reynolds	ENTITY
,	
MD	ENTITY
,	
chair	ENTITY
of	
the	
DSM-5	ENTITY
sleep	ENTITY
disorders	ENTITY
work	ENTITY
group	ENTITY
,	
served	
as	
a	
valuable	
liaison	ENTITY
in	
our	
efforts	
to	
maximize	
concordance	
between	
classification	ENTITY
systems	ENTITY
.	

I	
would	
also	
like	
to	
thank	
David	ENTITY
Neubauer	ENTITY
,	
MD	ENTITY
and	
Ruth	
Benca	
,	
MD	ENTITY
,	
PhD	ENTITY
who	
provided	
expertise	ENTITY
on	
psychiatric	ENTITY
conditions	ENTITY
,	
as	
well	
as	
Maria	ENTITY
Carra	ENTITY
,	
PhD	ENTITY
who	
assisted	ENTITY
with	
the	
development	ENTITY
of	
the	
Movement	ENTITY
Disorders	ENTITY
chapter	ENTITY
.	

Finally	
,	
we	
are	
grateful	
to	
our	
colleagues	ENTITY
and	
families	ENTITY
,	
whose	
patience	ENTITY
,	
support	
and	
understanding	
of	
the	
long	ENTITY
hours	ENTITY
required	
to	
bring	
this	
manual	ENTITY
to	
fruition	
often	
go	
unheralded	ENTITY
,	
but	
are	
deeply	
appreciated	
.	

Michael	ENTITY
Sateia	ENTITY
,	
MD	ENTITY
,	
Editor	ENTITY
Acknowledgments	ENTITY
ICSD	ENTITY
Revision	ENTITY
Task	ENTITY
Force	ENTITY
Michael	ENTITY
Sateia	ENTITY
,	
MD	ENTITY
,	
Chair	ENTITY
Geisel	ENTITY
School	ENTITY
of	ENTITY
Medicine	ENTITY
at	
Dartmouth	ENTITY
,	
Lebanon	ENTITY
,	
NH	ENTITY
Richard	ENTITY
Berry	ENTITY
,	
MD	ENTITY
University	ENTITY
of	ENTITY
Florida	ENTITY
Health	ENTITY
Science	ENTITY
Center	ENTITY
,	
Gainesville	ENTITY
,	
FL	ENTITY
Michel	ENTITY
Cramer	ENTITY
Bornemann	ENTITY
,	
MD	ENTITY
HealthEast	ENTITY
Care	ENTITY
Systems	ENTITY
of	ENTITY
Minnesota	ENTITY
,	
Maplewood	ENTITY
,	
MN	ENTITY
Karl	ENTITY
Doghramji	ENTITY
,	
MD	ENTITY
,	
Psychiatric	ENTITY
Representative	ENTITY
Thomas	ENTITY
Jefferson	ENTITY
University	ENTITY
,	
Philadelphia	ENTITY
,	
PA	
Jack	
Edinger	
,	
PhD	
National	ENTITY
Jewish	ENTITY
Health	ENTITY
,	
Denver	ENTITY
,	
CO	ENTITY
Richard	ENTITY
Ferber	ENTITY
,	
MD	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Harvard	ENTITY
Medical	ENTITY
School	ENTITY
,	
Boston	ENTITY
,	
MA	ENTITY
Gerald	ENTITY
Rosen	ENTITY
,	
MD	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Children	ENTITY
’s	ENTITY
Hospital	ENTITY
of	
Saint	ENTITY
Paul	ENTITY
,	
Saint	ENTITY
Paul	ENTITY
,	
MN	
Michael	
Silber	
,	
MB	
,	
ChB	ENTITY
Mayo	ENTITY
Clinic	ENTITY
,	
Rochester	ENTITY
,	
MN	
Arthur	
Walters	
,	
MD	ENTITY
Vanderbilt	ENTITY
University	ENTITY
Medical	ENTITY
Center	ENTITY
,	
Nashville	ENTITY
,	
TN	ENTITY
Phyllis	
Zee	
,	
MD	ENTITY
,	
PhD	ENTITY
Northwestern	ENTITY
University	ENTITY
Medical	ENTITY
School	ENTITY
,	
Chicago	ENTITY
,	
IL	ENTITY
Acknowledgments	ENTITY
ICSD	ENTITY
Revision	ENTITY
Workgroups	
INSOMNIA	
Jack	
Edinger	
,	
PhD	ENTITY
,	
Chair	ENTITY
National	ENTITY
Jewish	ENTITY
Health	ENTITY
,	
Denver	ENTITY
,	
CO	
Daniel	
Buysse	
,	
MD	ENTITY
University	ENTITY
of	ENTITY
Pittsburg	ENTITY
School	ENTITY
of	ENTITY
Medicine	ENTITY
,	
Pittsburg	ENTITY
,	
PA	ENTITY
Kenneth	ENTITY
Lichstein	ENTITY
,	
PhD	
University	
of	
Alabama	ENTITY
,	
Tuscaloosa	ENTITY
,	
AL	ENTITY
Jodi	ENTITY
Mindell	ENTITY
,	
PhD	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Saint	ENTITY
Joseph	ENTITY
’s	ENTITY
University	ENTITY
,	
Philadelphia	ENTITY
,	
PA	
Charles	
Morin	
,	
PhD	
Universite	
Laval	
,	
Quebec	ENTITY
,	
Canada	ENTITY
CIRCADIAN	
RHYTHM	ENTITY
SLEEP	ENTITY
WAKE	ENTITY
DISORDERS	ENTITY
Phyllis	ENTITY
Zee	ENTITY
,	
MD	ENTITY
,	
PhD	ENTITY
,	
Chair	ENTITY
Northwestern	ENTITY
University	ENTITY
Medical	ENTITY
School	ENTITY
,	
Chicago	ENTITY
,	
IL	ENTITY
Judith	ENTITY
Owens	ENTITY
,	
MD	ENTITY
,	

Pediatric	ENTITY
Representative	ENTITY
Children	
’s	
National	ENTITY
Medical	ENTITY
Center	ENTITY
,	
Washington	ENTITY
,	
DC	ENTITY
Robert	ENTITY
Auger	ENTITY
,	
MD	ENTITY
Mayo	ENTITY
Clinic	ENTITY
,	
Rochester	ENTITY
,	
MN	
Makoto	
Uchiyama	
,	
MD	ENTITY
,	
PhD	ENTITY
Nihon	ENTITY
University	ENTITY
School	ENTITY
of	ENTITY
Medicine	ENTITY
,	
Tokyo	ENTITY
,	
Japan	ENTITY
Kenneth	ENTITY
Wright	ENTITY
,	
PhD	
University	
of	
Colorado	
,	
Boulder	ENTITY
,	
CO	ENTITY
James	ENTITY
Wyatt	ENTITY
,	
PhD	
Rush	
University	
Medical	
Center	
,	
Chicago	ENTITY
,	
IL	ENTITY
Steven	ENTITY
Lockley	ENTITY
,	ENTITY
PhD	ENTITY
,	
Advisor	ENTITY
Harvard	ENTITY
Medical	ENTITY
School	ENTITY
,	
Boston	ENTITY
,	
MA	ENTITY
SLEEP	ENTITY
RELATED	ENTITY
BREATHING	ENTITY
DISORDERS	ENTITY
Richard	ENTITY
Berry	ENTITY
,	
MD	ENTITY
,	
Chair	ENTITY
University	ENTITY
of	ENTITY
Florida	ENTITY
Health	ENTITY
Science	ENTITY
Center	ENTITY
,	
Gainesville	ENTITY
,	
FL	
Teofilo	
Lee	
-	
Chiong	ENTITY
,	
MD	ENTITY
National	ENTITY
Jewish	ENTITY
Health	ENTITY
,	
Denver	ENTITY
,	
CO	
Carole	
Marcus	
,	
MBBCh	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Children	ENTITY
’s	ENTITY
Hospital	ENTITY
of	
Philadelphia	ENTITY
,	
Philadelphia	ENTITY
,	
PA	
Stuart	
Quan	
,	
MD	ENTITY
Harvard	ENTITY
Medical	ENTITY
School	ENTITY
,	
Boston	ENTITY
,	
MA	ENTITY
PARASOMNIAS	ENTITY
Michel	ENTITY
Cramer	ENTITY
Bornemann	ENTITY
,	ENTITY
MD	ENTITY
,	ENTITY
Chair	ENTITY
HealthEast	ENTITY
Care	ENTITY
Systems	ENTITY
of	ENTITY
Minnesota	ENTITY
,	
Maplewood	ENTITY
,	
MN	ENTITY
Carlos	ENTITY
Schenck	ENTITY
,	
MD	ENTITY
Hennepin	ENTITY
County	ENTITY
Medical	ENTITY
Center	ENTITY
,	
Minneapolis	ENTITY
,	
MN	
Gerald	
Rosen	
,	
MD	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Children	ENTITY
’s	ENTITY
Hospital	ENTITY
of	
Saint	ENTITY
Paul	ENTITY
,	
Saint	ENTITY
Paul	ENTITY
,	
MN	
Mark	
Pressman	
,	
PhD	
Lankenau	
Medical	
Center	
,	
Wynnewood	ENTITY
,	
PA	ENTITY
HYPERSOMNOLENCE	ENTITY
Michael	ENTITY
Silber	ENTITY
,	
MB	
,	
ChB	ENTITY
,	
Chair	ENTITY
Mayo	ENTITY
Clinic	ENTITY
,	
Rochester	ENTITY
,	
MN	
Isabelle	
Arnulf	
,	
MD	ENTITY
Hopital	ENTITY
Pitie	ENTITY
Salpetriere	ENTITY
,	
Paris	ENTITY
,	
France	ENTITY
Suresh	ENTITY
Kotagal	ENTITY
,	
MBBS	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Mayo	ENTITY
Clinic	ENTITY
,	
Rochester	ENTITY
,	
MN	
Thomas	
Scammell	
,	
MD	ENTITY
Beth	ENTITY
Israel	ENTITY
Deaconess	ENTITY
Medical	ENTITY
Center	ENTITY
,	
Boston	ENTITY
,	
MA	ENTITY
Sebastiaan	ENTITY
Overeem	ENTITY
,	
MD	ENTITY
,	
PhD	ENTITY
Radboud	ENTITY
University	ENTITY
Nijmegen	
Medical	
Center	
,	
Nijmegen	ENTITY
,	
Netherlands	ENTITY
MOVEMENT	ENTITY
DISORDERS	ENTITY
Arthur	ENTITY
Walters	ENTITY
,	
MD	ENTITY
,	
Chair	ENTITY
Vanderbilt	ENTITY
University	ENTITY
Medical	ENTITY
Center	ENTITY
,	
Nashville	ENTITY
,	
TN	ENTITY
Ronald	
Chervin	
,	
MD	ENTITY
,	
MS	ENTITY
University	ENTITY
of	ENTITY
Michigan	ENTITY
Health	ENTITY
System	ENTITY
,	
Ann	
Arbor	
,	
MI	
Stephen	
Duntley	
,	
MD	ENTITY
Critical	ENTITY
Care	ENTITY
Pulmonary	ENTITY
and	ENTITY
Sleep	ENTITY
Associates	ENTITY
,	
Lakewood	ENTITY
,	
CO	ENTITY
Giles	ENTITY
Lavigne	ENTITY
,	
DMD	ENTITY
,	
PhD	ENTITY
University	ENTITY
of	ENTITY
Montreal	ENTITY
,	
Montreal	ENTITY
,	
Canada	ENTITY
Daniel	ENTITY
Picchietti	ENTITY
,	
MD	ENTITY
,	
Pediatric	ENTITY
Representative	ENTITY
Carle	ENTITY
Foundation	ENTITY
Hospital	ENTITY
,	
Urbana	ENTITY
,	
IL	
Denise	
Sharon	
,	
MD	ENTITY
,	
PhD	ENTITY
Tulane	ENTITY
University	ENTITY
School	ENTITY
of	ENTITY
Medicine	ENTITY
,	
Destrehan	ENTITY
,	
LA	ENTITY
Marco	ENTITY
Zucconi	ENTITY
,	
MD	ENTITY
San	ENTITY
Raffaele	ENTITY
Hospital	ENTITY
,	
Milan	ENTITY
,	
Italy	ENTITY
APPENDIX	ENTITY
A	ENTITY
Members	ENTITY
of	
the	
Movement	ENTITY
Disorders	ENTITY
Work	ENTITY
Group	ENTITY
Sean	ENTITY
Caples	ENTITY
,	
DO	ENTITY
Mayo	ENTITY
Clinic	ENTITY
,	
Rochester	ENTITY
,	
MN	
Susan	
Harding	
,	
MD	ENTITY
University	ENTITY
of	ENTITY
Alabama	ENTITY
,	
Birmingham	ENTITY
,	
AL	ENTITY
Acknowledgments	ENTITY
International	ENTITY
Society	ENTITY
Reviewers	ENTITY
ASIAN	
SLEEP	
RESEARCH	
SOCIETY	
Masako	
Okawa	
,	
MD	ENTITY
,	
PhD	
Makoto	
Honda	
,	
MD	ENTITY
,	
PhD	ENTITY
Yuhei	ENTITY
Kayukawa	ENTITY
,	ENTITY
MD	ENTITY
Yuichi	ENTITY
Inoue	ENTITY
,	ENTITY
MD	ENTITY
,	
PhD	
AUSTRALASIAN	
SLEEP	
ASSOCIATION	
Shantha	
Rajaratnam	
,	
PhD	ENTITY
Leon	ENTITY
Lack	ENTITY
,	
PhD	
Nick	
Antic	
,	
PhD	
CANADIAN	
SLEEP	
SOCIETY	
Charles	
Samuels	
,	
MD	ENTITY
Atul	ENTITY
Khullar	ENTITY
,	
MD	ENTITY
James	ENTITY
MacFarlane	ENTITY
,	
PhD	
Manisha	
Witmans	
,	
MD	ENTITY
EUROPEAN	ENTITY
SLEEP	ENTITY
RESEARCH	ENTITY
SOCIETY	ENTITY
Claudio	ENTITY
Bassetti	ENTITY
,	
MD	ENTITY
Ludger	ENTITY
Grote	ENTITY
,	
MD	ENTITY
,	
PhD	ENTITY
Dieter	ENTITY
Reimann	ENTITY
,	
PhD	
FEDERATION	
OF	
LATIN	
AMERICAN	
SLEEP	
SOCIETIES	
Darwin	
Vizcarra	
,	
MD	ENTITY
Stuart	ENTITY
Franklin	ENTITY
Escobar	ENTITY
-	
Córdoba	ENTITY
,	
MD	ENTITY
,	
MFP	ENTITY
,	
PhD	
Dalva	
Poyares	
,	
MD	ENTITY
,	
PhD	
SLEEP	
RESEARCH	
SOCIETY	
Ronald	
Szymusiak	
,	
PhD	
Kingman	
Strohl	
,	
MD	ENTITY
Phillip	ENTITY
Gehrman	ENTITY
,	
PhD	
Reviewers	
Alon	
Avidan	
,	
MD	ENTITY
Richard	ENTITY
Allen	ENTITY
,	
PhD	
Richard	
Bootzin	
,	
PhD	
Christopher	
Drake	
,	
PhD	
Umakanth	
Khatwa	ENTITY
,	
MD	ENTITY
Sanjeev	ENTITY
Kothare	ENTITY
,	
MD	ENTITY
Lois	ENTITY
Krahn	ENTITY
,	
MD	ENTITY
Leon	ENTITY
Lack	ENTITY
,	
PhD	
Mark	
Mahowald	
,	
MD	ENTITY
Raman	ENTITY
Malhotra	ENTITY
,	
MD	ENTITY
William	ENTITY
Ondo	ENTITY
,	
MD	ENTITY
James	ENTITY
Parish	ENTITY
,	
MD	ENTITY
David	ENTITY
Rapoport	ENTITY
,	
MD	ENTITY
Eve	ENTITY
Rogers	ENTITY
,	
MD	ENTITY
Carol	ENTITY
Rosen	ENTITY
,	
MD	ENTITY
Katherine	ENTITY
Sharkey	ENTITY
,	
PhD	
Arthur	
Spielman	
,	
PhD	
Michael	
Thorpy	
,	
MD	ENTITY
AASM	ENTITY
Staff	
Jerome	ENTITY
Barrett	ENTITY
,	
Executive	ENTITY
Director	ENTITY
Kathleen	ENTITY
McCann	ENTITY
,	ENTITY
Assistant	ENTITY
Executive	ENTITY
Director	ENTITY
Derek	ENTITY
Claussen	
,	
Graphic	ENTITY
Design	ENTITY
Manager	ENTITY
Jon	
Wendling	
,	
Publications	ENTITY
Production	
Editor	ENTITY
Jason	ENTITY
Wilbanks	ENTITY
,	
Programmer	ENTITY
Carolyn	ENTITY
Winter	ENTITY
-	
Rosenberg	ENTITY
,	
Director	
of	
Coding	ENTITY
and	
Compliance	ENTITY
Steve	
Van	
Hout	
,	
Director	
of	
Information	
Technology	
Introduction	
Classification	
of	
disorders	
plays	
several	
key	
roles	
in	
medicine	ENTITY
.	

The	
most	
familiar	
of	
these	
is	
that	
is	
serves	
as	
a	
guide	
to	
clinicians	ENTITY
in	
the	
identification	ENTITY
of	
specific	
disease	ENTITY
states	ENTITY
.	

In	
doing	
so	
,	
classification	ENTITY
systems	ENTITY
provide	
clinicians	ENTITY
with	
important	
informa-	
tion	ENTITY
regarding	
numerous	
related	
factors	ENTITY
including	
pathogenesis	ENTITY
,	
prognosis	ENTITY
,	
course	ENTITY
,	
and	
heritability	ENTITY
.	

Moreover	
,	
therapeutic	ENTITY
interventions	ENTITY
are	
largely	
guided	
by	
the	
nosologi-	
cal	
decisions	ENTITY
made	
by	
clinicians	ENTITY
.	

In	
turn	
,	
information	ENTITY
accrued	
regarding	
therapeutic	ENTITY
response	ENTITY
of	
these	
disease	ENTITY
states	ENTITY
is	
utilized	
to	
further	
refine	
the	
nosology	ENTITY
.	

Classification	ENTITY
systems	ENTITY
also	
serve	
to	
define	
the	
domain	ENTITY
of	
a	
given	
discipline	ENTITY
,	
a	
factor	ENTITY
of	
particular	
importance	
for	
fields	ENTITY
such	
as	
sleep	ENTITY
medicine	ENTITY
which	
cut	
across	
many	
related	
special-	
ties	ENTITY
.	

Finally	
,	
by	
identifying	
areas	
of	
uncertainty	ENTITY
and	
overlap	ENTITY
among	
related	
patholo-	
gies	ENTITY
,	
these	
systems	ENTITY
play	
a	
critical	
role	
in	
guiding	
future	
research	ENTITY
agendas	ENTITY
which	
will	
enhance	ENTITY
our	
knowledge	ENTITY
and	
understanding	
of	
the	
clinical	ENTITY
features	ENTITY
,	
pathophysiology	ENTITY
and	
treatment	ENTITY
response	ENTITY
specific	
to	
each	
disorder	ENTITY
.	

Since	
its	
infancy	ENTITY
35	
years	ENTITY
ago	
,	
the	
field	
of	
sleep	ENTITY
medicine	ENTITY
has	
paid	
particular	
atten-	
tion	ENTITY
to	
the	
issue	ENTITY
of	
classification	ENTITY
,	
beginning	
with	
the	
1979	
American	
Sleep	
Disorders	
Association	
’s	
Diagnostic	
Classification	
of	
Sleep	
and	
Arousal	ENTITY
Disorders	ENTITY
.	

Since	
that	
time	ENTITY
,	
as	
our	
knowledge	ENTITY
and	
understanding	
of	
sleep	ENTITY
disorders	ENTITY
has	
grown	ENTITY
,	
several	
differ-	
ent	
structural	ENTITY
approaches	ENTITY
have	
been	
utilized	
in	
revisions	ENTITY
of	
the	
classification	ENTITY
system	ENTITY
,	
culminating	
in	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
.	

The	
organization	ENTITY
of	
that	
edition	ENTITY
,	
although	
not	
without	
its	
limitations	ENTITY
,	
has	
proven	
effective	ENTITY
and	
user	ENTITY
-	
friendly	ENTITY
and	
has	
been	
maintained	ENTITY
in	
the	
current	ENTITY
revision	ENTITY
.	

Ideally	
,	
classification	ENTITY
systems	ENTITY
are	
based	
largely	
on	
pathophysiology	ENTITY
.	

However	
,	
such	
an	
approach	ENTITY
is	
dependent	
on	
adequate	ENTITY
knowledge	ENTITY
concerning	
the	
various	
pathophysiol-	
ogies	ENTITY
of	
disease	ENTITY
or	
disorder	ENTITY
within	
a	
given	
discipline	ENTITY
.	

As	
is	
the	
case	
with	
many	
diag-	
nostic	ENTITY
systems	ENTITY
,	
our	
current	
knowledge	ENTITY
and	
understanding	
of	
the	
pathophysiology	ENTITY
of	
many	
sleep	ENTITY
disorders	ENTITY
is	
inadequate	ENTITY
.	

As	
a	
result	ENTITY
,	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
,	
not	
unlike	
its	
predecessors	ENTITY
,	
employs	
a	
hybrid	ENTITY
approach	ENTITY
which	
utilizes	
pathophysiology	ENTITY
,	
where	
known	
,	
but	
also	
relies	
heavily	
on	
phenomenology	ENTITY
and	
organ	ENTITY
system	ENTITY
approaches	ENTITY
.	

Despite	
these	
shortcomings	ENTITY
,	
this	
approach	
is	
one	
that	
has	
proven	
familiar	
and	
workable	
for	
sleep	ENTITY
medicine	ENTITY
clinicians	ENTITY
.	

Recognizing	
the	
need	
for	
currency	ENTITY
and	
relevance	ENTITY
in	
a	
rapidly	
evolving	
field	
,	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
Board	ENTITY
of	ENTITY
Directors	ENTITY
approved	
a	
revision	ENTITY
of	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
in	
2011	
.	

Following	
appoint-	
ment	ENTITY
of	
a	
chair	ENTITY
/	
editor	ENTITY
,	
a	
task	ENTITY
force	ENTITY
,	
consisting	
of	
individual	ENTITY
work	ENTITY
group	ENTITY
chairs	ENTITY
for	
each	
Introduction	
major	
division	ENTITY
of	
the	
manual	ENTITY
,	
was	
selected	
,	
along	
with	
two	
pediatric	ENTITY
consultants	ENTITY
.	

A	
focus	ENTITY
group	ENTITY
of	
experts	ENTITY
was	
convened	ENTITY
in	
June	
2011	
to	
obtain	
input	ENTITY
on	
major	
structural	ENTITY
and	
content	ENTITY
issues	ENTITY
.	

Based	
on	
this	
feedback	ENTITY
,	
individual	ENTITY
work	ENTITY
groups	ENTITY
then	
set	
about	
to	
define	
the	
list	
of	
disorders	ENTITY
to	
be	
included	
within	
their	
sections	ENTITY
as	
well	
as	
proposed	
cri-	
teria	ENTITY
for	
each	
diagnosis	ENTITY
.	

This	
process	ENTITY
included	
comprehensive	ENTITY
literature	ENTITY
searches	ENTITY
for	
every	
potential	ENTITY
diagnosis	ENTITY
as	
well	
as	
for	
their	
major	
features	ENTITY
.	

The	
draft	ENTITY
diagnostic	ENTITY
crite-	
ria	ENTITY
which	
emanated	
from	
this	
work	
were	
then	
reviewed	ENTITY
and	
modified	ENTITY
by	
the	
task	ENTITY
force	ENTITY
(	
consisting	
of	
the	
work	ENTITY
group	ENTITY
chairs	ENTITY
and	
pediatric	ENTITY
advisors	ENTITY
)	
,	
as	
well	
as	
by	
the	
board	ENTITY
of	
the	
AASM	ENTITY
.	

The	
edited	
criteria	ENTITY
were	
then	
distributed	
to	
external	ENTITY
peer	ENTITY
reviewers	ENTITY
with	
expertise	ENTITY
in	
the	
respective	
areas	
,	
as	
well	
as	
to	
international	ENTITY
societies	ENTITY
and	
membership	ENTITY
sections	ENTITY
of	
the	
AASM	ENTITY
for	
comment	ENTITY
.	

These	
reviews	ENTITY
were	
carefully	
considered	
and	
revi-	
sions	
made	
based	
on	
this	
input	ENTITY
.	

Subsequent	
to	
this	
,	
text	
revisions	ENTITY
were	
begun	
and	
the	
same	
review	ENTITY
process	ENTITY
and	
modifications	ENTITY
were	
undertaken	
once	
text	
drafts	ENTITY
were	
com-	ENTITY
pleted	ENTITY
.	

Further	
modifications	ENTITY
were	
made	
based	
on	
recommendations	ENTITY
from	
the	
AASM	ENTITY
board	ENTITY
before	
finalization	ENTITY
of	
the	
edition	ENTITY
.	

At	
all	
points	
in	
this	
process	ENTITY
,	
efforts	
were	
made	
to	
rely	
as	
heavily	
as	
possible	
on	
available	
and	
current	
scientific	ENTITY
evidence	ENTITY
.	

However	
,	
due	
to	
the	
paucity	
of	
available	
evidence	ENTITY
in	
many	
areas	ENTITY
,	
decisions	ENTITY
regarding	
the	
nosol-	
ogy	
were	
often	
made	
by	
consensus	ENTITY
of	
the	
work	ENTITY
groups	ENTITY
,	
task	ENTITY
force	ENTITY
,	
and	
reviewers	ENTITY
.	

Using	
ICSD-3	ENTITY
As	
noted	
above	
,	
the	
general	ENTITY
structure	ENTITY
of	
the	
current	
edition	ENTITY
closely	
parallels	
that	
of	
the	
second	
edition	
.	

The	
major	
clinical	ENTITY
divisions	ENTITY
remain	
unchanged	ENTITY
.	

As	
with	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
,	
pediatric	ENTITY
diagnoses	ENTITY
are	
fully	
integrated	
into	
the	
major	
clinical	ENTITY
diagnoses	ENTITY
,	
with	
the	
exception	
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
pediatric	ENTITY
.	

Where	
pediatric	ENTITY
presentations	ENTITY
call	
for	
variation	ENTITY
in	
the	
diagnostic	ENTITY
criteria	ENTITY
,	
those	
variations	ENTITY
are	
noted	
within	
the	
criteria	ENTITY
section	ENTITY
.	

In	
an	
effort	
to	
better	
identify	
those	
clinical	ENTITY
features	ENTITY
of	
a	
disorder	ENTITY
which	
are	
developmentally	ENTITY
-	
specific	ENTITY
,	
a	
text	
heading	
for	
Developmental	ENTITY
Issues	ENTITY
has	
been	
added	
for	
each	
diagnosis	ENTITY
.	

Specific	ENTITY
ICD	ENTITY
codes	ENTITY
(	
9	
-	
CM	ENTITY
and	
10	
-	
CM	ENTITY
)	
are	
listed	
at	
the	
beginning	
of	
each	
diagnosis	ENTITY
.	

Because	
of	
the	
complexities	ENTITY
and	
differences	ENTITY
between	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
diagnoses	ENTITY
and	
the	
ICD	ENTITY
system	ENTITY
,	
assign-	
ment	ENTITY
of	
codes	ENTITY
is	
challenging	
.	

These	
issues	ENTITY
are	
discussed	
further	
under	
Coding	ENTITY
below	
.	

Although	
classification	ENTITY
systems	ENTITY
are	
,	
by	
their	
nature	ENTITY
,	
intended	
to	
define	
disorders	ENTITY
in	
the	
most	
specific	
terms	
possible	
,	
clinicians	ENTITY
must	
recognize	
that	
there	
is	
inevitably	
some	
degree	ENTITY
of	
variability	ENTITY
in	
presentation	ENTITY
which	
may	
result	
in	
clinically	ENTITY
significant	ENTITY
conditions	ENTITY
which	
do	
not	
meet	
all	
specific	
criteria	ENTITY
for	
a	
given	
diagnosis	ENTITY
.	

Therefore	
,	
some	
degree	ENTITY
of	
judgment	ENTITY
is	
necessary	
in	
the	
application	ENTITY
of	
these	
criteria	ENTITY
.	

Bearing	
this	
exception	
in	
mind	
,	
all	
listed	
criteria	ENTITY
should	
generally	
be	
met	
for	
establishment	ENTITY
of	
a	
given	
diagnosis	ENTITY
,	
unless	
otherwise	
specified	
.	

Clinicians	ENTITY
should	
note	
that	
most	
diagnoses	ENTITY
within	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
include	
a	
criterion	ENTITY
,	
or	
cri-	
teria	ENTITY
,	
that	
connote	ENTITY
clinical	ENTITY
significance	ENTITY
(	
i.e.	
,	
disturbing	
symptoms	ENTITY
,	
significant	ENTITY
conse-	
quences	ENTITY
,	
distress	ENTITY
or	
impairment	ENTITY
in	
one	
or	
more	
functional	ENTITY
realms	ENTITY
)	
.	

These	
criteria	ENTITY
are	
particularly	
important	
because	
,	
without	
them	
,	
many	
phenomena	ENTITY
related	
to	
sleep	ENTITY
-	
wake	ENTITY
do	
not	
rise	
to	
a	
level	ENTITY
that	
requires	
clinical	ENTITY
attention	ENTITY
and	
treatment	ENTITY
.	

Users	ENTITY
should	
also	
pay	
particular	
attention	
to	
the	
Notes	ENTITY
section	ENTITY
(	
where	
included	
)	
,	
as	
these	
notes	ENTITY
provide	
essential	
definitions	ENTITY
and	
details	
concerning	
application	ENTITY
of	
the	
criteria	ENTITY
.	

Clinicians	ENTITY
will	
note	
a	
number	
of	
significant	
content	ENTITY
changes	ENTITY
from	
the	
former	ENTITY
edition	ENTITY
.	

The	
most	
apparent	ENTITY
of	
these	
is	
the	
collapse	ENTITY
of	
all	
previous	
chronic	ENTITY
insomnia	ENTITY
diagnoses	ENTITY
into	
a	
single	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
.	

The	
rationale	ENTITY
for	
this	
is	
described	
in	
the	
introductory	ENTITY
section	ENTITY
of	
Insomnia	ENTITY
disorders	ENTITY
.	

A	
separate	
diagnosis	ENTITY
is	
retained	
for	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
.	

Within	
the	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
section	ENTITY
,	
the	
nomenclature	ENTITY
for	
narcolepsy	ENTITY
has	
been	
changed	
to	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
and	
type	
2	
.	

This	
modification	ENTITY
is	
discussed	
in	
the	
introduction	ENTITY
to	
that	
section	ENTITY
.	

Users	ENTITY
will	
also	
find	
several	
new	
diagnoses	ENTITY
within	
the	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

Within	
the	
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Syndromes	ENTITY
,	
a	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
now	
appears	
.	

This	
term	ENTITY
is	
preferred	
to	
the	
widely	
used	
term	
complex	ENTITY
sleep	ENTITY
apnea	ENTITY
because	
it	
describes	
a	
more	
specific	ENTITY
and	
well	
-	
defined	
disorder	ENTITY
in	
which	
the	
central	ENTITY
apnea	ENTITY
arises	
in	
the	
context	ENTITY
of	
positive	ENTITY
airway	
pressure	
treatment	ENTITY
for	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
is	
not	
attributable	
to	
another	
cause	ENTITY
.	

Central	ENTITY
sleep	ENTITY
apnea	ENTITY
associated	ENTITY
with	ENTITY
other	
identi-	
fiable	
etiologies	ENTITY
such	
as	
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	ENTITY
or	
substance	ENTITY
-	
induced	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
are	
not	
classified	
as	
treatment	ENTITY
-	
emergent	ENTITY
.	

Assigning	
a	
diagnosis	ENTITY
of	
a	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorder	ENTITY
requires	
demonstration	
of	
elevated	ENTITY
PaCO2	ENTITY
(	
by	
direct	
measure	ENTITY
of	
arterial	ENTITY
blood	ENTITY
gas	ENTITY
or	
,	
more	
commonly	
,	
by	
proxy	
measures	ENTITY
such	
as	
end	ENTITY
-	
tidal	ENTITY
or	
trans-	
cutaneous	ENTITY
CO2	ENTITY
determination	ENTITY
)	
.	

The	
new	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
disor-	ENTITY
der	ENTITY
should	
be	
employed	
when	
there	
is	
sustained	ENTITY
drop	ENTITY
in	
SaO2	ENTITY
but	
PaCO2	ENTITY
has	
not	
been	
measured	ENTITY
.	

Within	
the	
parasomnia	ENTITY
section	ENTITY
,	
a	
single	
set	
of	
general	ENTITY
criteria	ENTITY
and	
a	
unified	
text	ENTITY
now	
describe	
disorders	ENTITY
of	
arousal	ENTITY
from	
non	ENTITY
-	
rapid	ENTITY
eye	
movement	
sleep	
,	
although	
additional	
,	
specific	
criteria	ENTITY
and	
separate	
coding	ENTITY
are	
maintained	ENTITY
for	
the	
diagnoses	ENTITY
within	
this	
section	ENTITY
(	
i.e.	
,	
confusional	ENTITY
arousal	ENTITY
,	
sleepwalking	ENTITY
and	
sleep	ENTITY
terror	ENTITY
)	
.	

Other	
,	
somewhat	
less	
consequential	
additions	
,	
deletions	ENTITY
and	
reassignment	ENTITY
of	
diagnoses	ENTITY
also	
appear	
in	
this	
edition	ENTITY
.	

International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
contained	
a	
separate	
chapter	
for	
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
.	

A	
small	
number	
of	
these	
were	
felt	
to	
qualify	
as	
formal	
diagnoses	ENTITY
at	
this	
time	ENTITY
and	
have	
been	
moved	
to	
relevant	
sections	ENTITY
.	

Other	
symptoms	ENTITY
and	
variants	ENTITY
appear	
at	
the	
conclusion	
of	
the	
chapter	
to	
which	
they	
are	
most	
applicable	
(	
e.g.	
,	
snoring	ENTITY
to	
the	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
,	
long	ENTITY
sleeper	ENTITY
to	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
,	
and	
movement	ENTITY
related	
variants	ENTITY
to	
the	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
section	ENTITY
)	
.	

Introduction	
Introduction	
A	
wealth	ENTITY
of	
information	ENTITY
regarding	
each	
diagnosis	ENTITY
is	
contained	
within	
the	
separate	
text	
headings	
within	
each	
diagnostic	ENTITY
section	ENTITY
.	

The	
outline	
below	
details	
some	
of	
the	
spe-	
cific	ENTITY
content	ENTITY
to	
be	
found	
within	
each	
text	
heading	ENTITY
.	

These	
terms	
are	
not	
indexed	
in	
the	
hard	
copy	ENTITY
version	ENTITY
of	
this	
manual	ENTITY
because	
they	
appear	
throughout	
the	
document	ENTITY
.	

Users	ENTITY
should	
refer	
to	
the	
relevant	
text	
heading	ENTITY
within	
a	
specific	
diagnosis	ENTITY
for	
information	ENTITY
related	
to	
these	
terms	
:	
Alternate	ENTITY
Names	ENTITY
Diagnostic	ENTITY
Criteria	ENTITY
Essential	ENTITY
Features	ENTITY
Associated	
Features	
Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Demographics	ENTITY
includes	
:	
•	
Prevalence	ENTITY
•	
Gender	ENTITY
bias	ENTITY
•	
Racial	ENTITY
/	
ethnic	ENTITY
bias	ENTITY
•	
Cultural	ENTITY
issues	ENTITY
Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
includes	
:	
•	
Risk	ENTITY
factors	ENTITY
Familial	ENTITY
Pattern	ENTITY
includes	
:	
•	
Genetics	ENTITY
•	
Familial	ENTITY
clusters	ENTITY
Onset	ENTITY
,	
Course	ENTITY
and	
Complications	ENTITY
includes	
:	
•	
Medical	
•	
Neurological	
•	
Psychiatric	ENTITY
/	
social	ENTITY
Developmental	ENTITY
Issues	ENTITY
includes	
:	
•	
Pediatric	ENTITY
•	
Geriatric	
Pathology	
and	
Pathophysiology	ENTITY
Objective	
Findings	ENTITY
includes	
:	
•	
Sleep	ENTITY
logs	
•	
Actigraphy	ENTITY
•	

Questionnaires	ENTITY
•	
Polysomnography	ENTITY
•	
Multiple	ENTITY
sleep	ENTITY
latency	ENTITY
test	ENTITY
•	
Neurological	ENTITY
◦	ENTITY
Electroencephalogram	ENTITY
◦	

Cerebrospinal	ENTITY
fluid	ENTITY
◦	
Neuroimaging	ENTITY
◦	
Electromyogram	ENTITY
◦	

Autonomic	ENTITY
•	
Endocrine	ENTITY
•	
Genetic	ENTITY
testing	ENTITY
•	
Physical	ENTITY
findings	ENTITY
•	
Respiratory	ENTITY
◦	ENTITY
Arterial	ENTITY
blood	ENTITY
gas	ENTITY
◦	
Pulmonary	ENTITY
function	ENTITY
◦	

Ventilatory	ENTITY
response	ENTITY
•	
Cardiac	ENTITY
◦	ENTITY

Electrocardiogram	ENTITY
◦	ENTITY
Echocardiogram	ENTITY
◦	
Cardiac	ENTITY
catheterization	ENTITY
•	
Serum	ENTITY
chemistry	ENTITY
Relationship	ENTITY
to	
Other	
Classification	ENTITY
Systems	ENTITY
Historically	
,	
there	
have	
been	
three	
major	
classifications	ENTITY
systems	ENTITY
for	
sleep	ENTITY
disorders	ENTITY
.	

Although	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
system	ENTITY
has	
,	
for	
many	
years	ENTITY
,	
been	
the	
primary	ENTITY
nosology	ENTITY
for	
sleep	ENTITY
medicine	ENTITY
specialists	ENTITY
,	
both	
the	
Diagnostic	ENTITY
and	ENTITY
Statistical	ENTITY
Manual	ENTITY
of	ENTITY
Mental	ENTITY
Disorders	ENTITY
(	
DSM	ENTITY
)	
of	
the	
American	ENTITY
Psychiatric	ENTITY
Association	ENTITY
and	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Diseases	ENTITY
(	ENTITY
ICD	ENTITY
)	ENTITY
nosology	ENTITY
of	
the	
World	ENTITY
Health	ENTITY
Organization	ENTITY
have	
also	
classified	
sleep	ENTITY
disorders	ENTITY
.	

Unfortunately	
,	
these	
competing	
systems	ENTITY
have	
differed	
significantly	
in	
structure	ENTITY
and	
content	ENTITY
over	
the	
years	ENTITY
.	

Development	ENTITY
of	
DSM-5	ENTITY
was	
ongoing	
during	
the	
development	ENTITY
of	
this	
manual	ENTITY
and	
an	
effort	ENTITY
was	
undertaken	
to	
achieve	
the	
greatest	
degree	ENTITY
of	
concordance	ENTITY
possible	
between	
these	
two	
systems	ENTITY
,	
recognizing	
that	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
will	
inevitably	
contain	
a	
greater	
level	ENTITY
of	
detail	
than	
DSM	ENTITY
due	
to	
differences	
in	
their	
target	ENTITY
users	ENTITY
.	

This	
goal	ENTITY
was	
largely	
achieved	
although	
some	
differences	ENTITY
will	
still	
exist	
.	

The	
major	
change	
to	
the	
Insomnia	ENTITY
section	ENTITY
(	
i.e.	
establishment	ENTITY
of	
a	
single	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
)	
within	
this	
new	
system	ENTITY
is	
paralleled	
in	
DSM-5	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
diagnoses	ENTITY
are	
organized	
somewhat	
differently	
in	
the	
DSM	ENTITY
clas-	
sification	ENTITY
than	
in	
this	
manual	ENTITY
and	
narcolepsy	ENTITY
criteria	ENTITY
differ	
slightly	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorder	ENTITY
diagnoses	ENTITY
are	
identical	ENTITY
within	
the	
two	
systems	ENTITY
with	
the	
exception	
that	
DSM	ENTITY
does	
not	
include	
a	
jet	ENTITY
lag	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
are	
significantly	
more	
detailed	
within	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
than	
DSM-5	ENTITY
,	
although	
the	
organizational	ENTITY
structures	ENTITY
in	
this	
section	ENTITY
are	
quite	
similar	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
and	
Parasomnias	ENTITY
are	
likewise	
similar	
but	
with	
fewer	
overall	
diagnoses	ENTITY
within	
DSM-5	ENTITY
.	

With	
the	
publication	ENTITY
of	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
,	
a	
major	
effort	ENTITY
to	
expand	
and	
reorganize	ENTITY
sleep	ENTITY
related	
diagnoses	ENTITY
within	
ICD-9	ENTITY
-	
CM	ENTITY
was	
undertaken	
.	

This	
effort	
resulted	
in	
the	
inclusion	ENTITY
of	
many	
additional	
sleep	ENTITY
related	
diag-	
noses	ENTITY
in	
ICD-9	ENTITY
-	
CM	ENTITY
(	
primarily	
within	
the	
Diseases	ENTITY
of	
the	
Nervous	ENTITY
System	ENTITY
section	ENTITY
)	
.	

The	
archaic	ENTITY
distinction	
between	
“	
organic	ENTITY
”	
and	
“	
non	ENTITY
-	
organic	ENTITY
”	
disorders	
has	
histori-	
cally	
been	
a	
guiding	
principle	
of	
ICD	ENTITY
,	
resulting	
in	
dissemination	ENTITY
of	
sleep	ENTITY
diagnoses	ENTITY
to	
both	
the	
neurological	ENTITY
and	
mental	ENTITY
disorder	ENTITY
categories	ENTITY
.	

Clinicians	ENTITY
familiar	
with	
the	
ICD-	ENTITY
9	ENTITY
-	
CM	ENTITY
categories	ENTITY
which	
have	
been	
employed	
since	
the	
most	
recent	
changes	ENTITY
will	
find	
general	
concordance	
between	
the	
assigned	
diagnostic	ENTITY
codes	ENTITY
found	
herein	
and	
the	
most	
current	ENTITY
version	ENTITY
of	
ICD-9	ENTITY
-	
CM	ENTITY
.	

These	
ICD-9	ENTITY
-	
CM	ENTITY
codes	ENTITY
for	
sleep	ENTITY
disorders	ENTITY
are	
essen-	
tially	
carried	
over	
to	
ICD-10	ENTITY
-	
CM	ENTITY
.	

However	
,	
certain	
content	
revisions	ENTITY
in	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
(	
e.g.	
,	
chronic	ENTITY
insomnia	ENTITY
)	
necessitates	
a	
significant	
departure	
from	
the	
coding	ENTITY
approach	ENTITY
utilized	
in	
ICD-9	ENTITY
-	
CM	ENTITY
and	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
.	

This	
is	
discussed	
further	
below	
.	

Introduction	
Introduction	
Coding	
Diagnostic	ENTITY
codes	ENTITY
for	
the	
relevant	
ICD-9	ENTITY
-	
CM	ENTITY
and	
ICD-10	ENTITY
-	
CM	ENTITY
diagnoses	ENTITY
can	
be	
found	
at	
the	
beginning	
of	
each	
diagnosis	ENTITY
section	ENTITY
of	
the	
book	ENTITY
.	

In	
the	
United	ENTITY
States	ENTITY
,	
the	
former	ENTITY
codes	ENTITY
(	
ICD-9	ENTITY
-	
CM	ENTITY
)	
should	
be	
employed	
until	
the	
implementation	ENTITY
date	
for	
ICD-10	ENTITY
-	
CM	ENTITY
which	
,	
at	
the	
time	
of	
this	
writing	ENTITY
,	
is	
to	
be	
no	ENTITY
sooner	ENTITY
than	
October	
1	
,	
2015	
.	

Following	
that	
date	
,	
only	
the	
ICD-10	ENTITY
-	
CM	ENTITY
codes	ENTITY
should	
be	
used	
.	

As	
already	
stated	
,	
clinicians	ENTITY
should	
recognize	
that	
there	
is	
not	
precise	
concordance	
between	
the	
assigned	
codes	ENTITY
for	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
diagnoses	ENTITY
and	
the	
diagno-	
ses	
listed	
within	
ICD	ENTITY
.	

Changes	ENTITY
to	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
classification	ENTITY
system	ENTITY
are	
not	
reflected	
in	
the	
ICD	ENTITY
system	ENTITY
for	
many	
years	ENTITY
.	

Moreover	
,	
the	
ICD	ENTITY
classification	ENTITY
of	
sleep	ENTITY
disorders	ENTITY
has	
historically	
been	
significantly	
less	
detailed	
than	
ICSD	ENTITY
(	
particularly	
for	
international	ENTITY
users	ENTITY
not	
employing	
the	
Clinical	ENTITY
Modification	ENTITY
(	
CM	ENTITY
)	
version	ENTITY
used	
in	
the	
United	ENTITY
States	ENTITY
)	
.	

Hence	
,	
clinicians	ENTITY
will	
find	
many	
areas	
in	
which	
assigned	
codes	ENTITY
found	
in	
this	
manual	ENTITY
do	
not	
correspond	
as	
closely	
as	
one	
would	
like	
to	
ICD	ENTITY
codes	ENTITY
.	

Most	
notably	
,	
with	
the	
collapse	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
diagnoses	ENTITY
into	
a	
single	ENTITY
disorder	ENTITY
in	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
,	
the	
assigned	
codes	ENTITY
for	
this	
diagnosis	ENTITY
within	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
are	
307.42	
(	
ICD-9	ENTITY
-	
CM	ENTITY
)	
–	
“	
Nonorganic	ENTITY
persistent	ENTITY
disorder	ENTITY
of	
initiating	
or	
maintaining	
sleep	ENTITY
”	
and	
F51.01	ENTITY
(	
ICD-10	ENTITY
-	
CM	ENTITY
)	
–	
“	
Primary	ENTITY
insomnia	ENTITY
.	
”	

A	
variety	
of	
other	
insomnia	ENTITY
diagnoses	ENTITY
will	
continue	
to	
appear	
in	
the	
ICD	ENTITY
system	ENTITY
but	
,	
with	
the	
classifi-	
cation	ENTITY
and	
coding	ENTITY
changes	ENTITY
recommended	
herein	
,	
these	
become	
essentially	
defunct	ENTITY
for	
sleep	ENTITY
medicine	ENTITY
clinicians	ENTITY
.	

In	
summary	
,	
the	
assigned	
codes	ENTITY
in	
this	
edition	ENTITY
represent	
“	
best	
approximations	ENTITY
”	
to	
the	
corresponding	
ICD	ENTITY
codes	ENTITY
,	
but	
some	
degree	ENTITY
of	
discrep-	
ancy	ENTITY
between	
the	
systems	ENTITY
will	
exist	
in	
a	
number	
of	
areas	
.	

Insomnia	ENTITY
Chronic	ENTITY
Insomnia	ENTITY
Disorder21	ENTITY
Short	ENTITY
-	
Term	ENTITY
Insomnia	ENTITY
Disorder41	
Other	
Insomnia	ENTITY
Disorder	
46	
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Excessive	ENTITY
Time	ENTITY
in	
Bed	ENTITY
47	ENTITY

Short	ENTITY
Sleeper47	ENTITY

This	
section	ENTITY
includes	
sleep	ENTITY
disorders	ENTITY
chiefly	
characterized	ENTITY
by	
the	
complaint	ENTITY
of	
insom-	
nia	ENTITY
.	

For	
the	
purpose	
of	
this	
manual	ENTITY
,	
insomnia	ENTITY
is	
defined	
as	
a	
persistent	ENTITY
difficulty	ENTITY
with	
sleep	ENTITY
initiation	ENTITY
,	
duration	ENTITY
,	
consolidation	ENTITY
,	
or	
quality	ENTITY
that	
occurs	
despite	
adequate	ENTITY
opportunity	ENTITY
and	
circumstances	ENTITY
for	
sleep	ENTITY
,	
and	
results	ENTITY
in	
some	
form	
of	
daytime	ENTITY
impair-	
ment	ENTITY
.	

These	
three	
components	ENTITY
of	
insomnia	ENTITY
—	
persistent	ENTITY
sleep	
difficulty	
,	
adequate	ENTITY
sleep	ENTITY
opportunity	
,	
and	
associated	ENTITY
daytime	ENTITY
dysfunction	ENTITY
—	
are	
collectively	
implied	
by	
text	
references	ENTITY
to	
the	
term	ENTITY
insomnia	ENTITY
.	

Among	
adults	ENTITY
with	
insomnia	ENTITY
,	
sleep	ENTITY
complaints	ENTITY
most	
typically	
include	
difficulties	
initiating	
or	
maintaining	
sleep	ENTITY
.	

Concerns	ENTITY
about	
lengthy	
periods	ENTITY
of	
nocturnal	ENTITY
wakefulness	ENTITY
,	
insufficient	
amounts	
of	
nocturnal	ENTITY
sleep	ENTITY
,	
or	
poor	ENTITY
sleep	ENTITY
quality	ENTITY
often	
accompany	
these	
complaints	ENTITY
.	

Individuals	ENTITY
who	
report	ENTITY
these	
sleep	ENTITY
related	
symptoms	ENTITY
in	
the	
absence	ENTITY
of	
daytime	ENTITY
impairment	ENTITY
are	
not	
regarded	
as	
having	
an	
insomnia	ENTITY
disorder	ENTITY
that	
warrants	
clinical	ENTITY
attention	ENTITY
other	
than	
education	ENTITY
and	
reassurance	ENTITY
.	

Insomnia	ENTITY
among	
children	ENTITY
is	
often	
reported	
by	
their	
caretakers	ENTITY
and	
char-	
acterized	ENTITY
by	
bedtime	ENTITY
resistance	ENTITY
,	
frequent	ENTITY
nighttime	ENTITY
awakenings	ENTITY
and/or	
an	
inability	ENTITY
to	ENTITY
sleep	ENTITY
independently	
.	

Regardless	
of	
the	
exact	
nature	
of	
the	
nocturnal	ENTITY
sleep	ENTITY
concerns	
,	
daytime	ENTITY
impairments	ENTITY
are	
reported	
,	
presumably	
caused	
by	
the	
nighttime	ENTITY
sleep	ENTITY
diffi-	
culties	ENTITY
or	
by	
some	
common	
but	
unidentified	
mechanism	ENTITY
during	
sleep	ENTITY
and	
wakeful-	
ness	ENTITY
.	

Daytime	ENTITY
symptoms	ENTITY
typically	
include	
fatigue	ENTITY
,	
decreased	ENTITY
mood	ENTITY
or	
irritability	ENTITY
,	
general	ENTITY
malaise	ENTITY
,	
and	
cognitive	ENTITY
impairment	ENTITY
.	

Among	
adults	ENTITY
,	
chronic	ENTITY
insomnia	ENTITY
may	
impair	ENTITY
social	ENTITY
or	
vocational	ENTITY
functioning	ENTITY
and	
reduce	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
,	
whereas	
in	
chil-	
dren	
it	
may	
lead	
to	
poor	ENTITY
school	ENTITY
performance	
,	
impaired	ENTITY
attention	ENTITY
,	
and	
behavioral	ENTITY
disturbance	ENTITY
.	

In	
some	
patients	ENTITY
,	
physical	ENTITY
symptoms	ENTITY
such	
as	
muscle	ENTITY
tension	ENTITY
,	
palpita-	
tions	ENTITY
,	
or	
headache	ENTITY
may	
also	
be	
attributed	
to	
the	
insomnia	ENTITY
.	

Others	
with	
more	
severe	ENTITY
forms	
of	
insomnia	ENTITY
may	
be	
at	
increased	ENTITY
risk	ENTITY
for	
motor	ENTITY
vehicle	ENTITY
and	
work	ENTITY
-	
site	ENTITY
acci-	
dents	ENTITY
as	
well	
as	
psychiatric	ENTITY
and	
cardiovascular	ENTITY
disorders	ENTITY
.	

Insomnia	ENTITY
often	
accompa-	
nies	ENTITY
comorbid	ENTITY
medical	ENTITY
illnesses	ENTITY
,	
mental	ENTITY
disorders	ENTITY
,	
and	
other	
sleep	ENTITY
disorders	ENTITY
.	

It	
may	
also	
arise	
in	
association	ENTITY
with	ENTITY
the	
use	
,	
abuse	ENTITY
,	
or	
exposure	ENTITY
to	ENTITY
certain	
substances	ENTITY
.	

When	
insomnia	ENTITY
occurs	
comorbid	ENTITY
to	
these	
conditions	ENTITY
and	
is	
persistent	ENTITY
and	
prominent	ENTITY
,	
a	
sep-	
arate	ENTITY
insomnia	ENTITY
diagnosis	ENTITY
is	
warranted	
.	

Insomnia	ENTITY
The	
insomnia	ENTITY
nosology	ENTITY
presented	
in	
this	
text	
represents	
a	
marked	
departure	
from	
the	
previous	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
insomnia	ENTITY
classification	
system	
in	
terms	
of	
its	
conceptual	ENTITY
framework	ENTITY
and	
relative	
simplicity	
.	

The	
previous	
insomnia	ENTITY
nosology	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
promoted	
the	
concept	ENTITY
that	
insomnia	ENTITY
can	
exist	
as	
a	
primary	ENTITY
sleep	ENTITY
disorder	ENTITY
or	
arise	
as	
a	
secondary	ENTITY
form	ENTITY
of	
sleep	ENTITY
disturbance	ENTITY
related	
to	
an	
underlying	
primary	ENTITY
psychiatric	ENTITY
,	
medical	ENTITY
,	
or	
substance	ENTITY
abuse	ENTITY
disorder	ENTITY
.	

However	
,	
many	
symptoms	ENTITY
and	
associated	ENTITY
fea-	ENTITY
tures	ENTITY
of	
so	
-	
called	
primary	ENTITY
and	
secondary	ENTITY
insomnias	ENTITY
are	
overlapping	
,	
thus	
making	
differentiation	ENTITY
among	
such	
subtypes	ENTITY
difficult	ENTITY
,	
if	
not	
impossible	
.	

There	
is	
increas-	
ing	
recognition	ENTITY
that	
even	
when	
insomnia	ENTITY
arises	
“	
secondary	ENTITY
”	
to	
another	
condition	ENTITY
,	
it	
often	
develops	
an	
independent	
course	ENTITY
over	
time	ENTITY
and	
may	
remain	
as	
a	
clinically	ENTITY
significant	ENTITY
condition	ENTITY
,	
even	
if	
the	
so	
-	
called	
primary	ENTITY
condition	ENTITY
is	
adequately	
treated	ENTITY
.	

Evidence	ENTITY
suggests	
that	
insomnia	ENTITY
,	
if	
left	ENTITY
untreated	ENTITY
,	
may	
adversely	
affect	
the	
outcome	ENTITY
of	
these	
comorbid	ENTITY
conditions	ENTITY
.	

Moreover	
,	
it	
appears	
that	
treatment	ENTITY
of	
the	
insomnia	ENTITY
may	
improve	ENTITY
outcome	ENTITY
of	
both	
the	
sleep	ENTITY
disturbance	ENTITY
and	
the	
comorbid	ENTITY
conditions	ENTITY
.	

Given	
these	
observations	ENTITY
,	
insomnia	ENTITY
seems	
best	
viewed	
as	
a	
comorbid	ENTITY
disorder	ENTITY
that	
warrants	
separate	
treatment	ENTITY
attention	ENTITY
.	

In	
addition	
to	
the	
primary	ENTITY
vs.	
secondary	ENTITY
insomnia	ENTITY
distinction	
,	
prior	
editions	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
delineated	
multiple	
putative	
“	
primary	ENTITY
insomnia	ENTITY
”	
diagnostic	ENTITY
subtypes	ENTITY
.	

Specifically	
,	
both	
the	
original	
1990	
version	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
and	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
described	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
such	
as	
psycho-	
physiological	ENTITY
insomnia	ENTITY
,	
idiopathic	ENTITY
insomnia	ENTITY
,	
inadequate	ENTITY
sleep	ENTITY
hygiene	ENTITY
,	
and	
paradox-	
ical	ENTITY
insomnia	ENTITY
,	
as	
discrete	
diagnostic	ENTITY
entities	ENTITY
.	

Experience	ENTITY
suggests	
that	
,	
in	
practice	ENTITY
,	
it	
is	
rare	
to	
encounter	
patients	ENTITY
who	
meet	
the	
diagnostic	ENTITY
criteria	ENTITY
for	
exclusively	
one	
of	
these	
subtypes	ENTITY
.	

In	
fact	
,	
many	
of	
the	
diagnostic	ENTITY
criteria	ENTITY
delineated	
for	
these	
subtypes	ENTITY
represent	
generic	ENTITY
characteristics	ENTITY
(	
e.g.	
,	
engaging	ENTITY
in	
sleep	ENTITY
-	
disruptive	ENTITY
habits	ENTITY
;	
underesti-	
mation	
of	
sleep	ENTITY
time	ENTITY
,	
evidence	ENTITY
of	
conditioned	ENTITY
arousal	ENTITY
)	
of	
insomnia	ENTITY
,	
per	
se	
,	
and	
do	
not	
facilitate	
discrimination	ENTITY
among	
these	
subtypes	ENTITY
or	
between	
these	
subtypes	ENTITY
and	
those	
presumed	
to	
have	
“	
secondary	ENTITY
”	
forms	
of	
insomnia	ENTITY
.	

Both	
clinical	ENTITY
experience	
and	
a	
growing	ENTITY
body	ENTITY
of	
empirical	ENTITY
findings	ENTITY
have	
shown	
that	
the	
diagnostic	ENTITY
distinctions	
advocated	
by	
previous	
versions	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
are	
difficult	
to	
reliably	
ascertain	
and	
are	
of	
question-	
able	
validity	ENTITY
.	

In	
view	
of	
such	
considerations	ENTITY
,	
the	
current	
manual	ENTITY
abandons	
the	
previ-	
ously	ENTITY
employed	ENTITY
complex	ENTITY
and	
highly	
specific	
insomnia	ENTITY
classification	ENTITY
scheme	
described	
by	
the	
original	ENTITY
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
and	
the	
2nd	
Edition	
in	
favor	
of	
a	
more	
global	ENTITY
and	
defensible	ENTITY
nosology	ENTITY
.	

The	
manual	ENTITY
includes	
three	
diagnostic	ENTITY
categories	ENTITY
for	
insomnia	ENTITY
:	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
and	
other	
insomnia	ENTITY
disorder	ENTITY
.	

These	
diag-	
noses	ENTITY
apply	
to	
patients	ENTITY
with	
and	
without	
comorbidities	ENTITY
regardless	
of	
whether	
those	
comorbidities	ENTITY
are	
viewed	
as	
potentially	
sleep	ENTITY
disruptive	ENTITY
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
characterized	
by	
chronic	ENTITY
sleep	ENTITY
onset	ENTITY
and/or	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
with	
asso-	
ciated	ENTITY
daytime	ENTITY
impairment	ENTITY
,	
and	
is	
reserved	
for	
individuals	ENTITY
whose	
sleep	ENTITY
difficulties	ENTITY
exceed	
minimal	ENTITY
frequency	ENTITY
and	
duration	ENTITY
thresholds	ENTITY
shown	
to	
be	
associated	ENTITY
with	ENTITY
clin-	
ically	ENTITY
significant	
morbidity	ENTITY
outcomes	ENTITY
.	

Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
characterized	
by	
sleep	ENTITY
/	
wake	ENTITY
difficulties	ENTITY
that	
fail	ENTITY
to	
meet	
the	
minimal	ENTITY
frequency	ENTITY
and	
duration	ENTITY
criteria	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Nonetheless	
,	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
associated	ENTITY
with	ENTITY
clinically	ENTITY
significant	ENTITY
sleep	ENTITY
dissatisfaction	ENTITY
or	
waking	ENTITY
impairment	ENTITY
.	

Other	
insomnia	ENTITY
disorders	ENTITY
should	
be	
assigned	
to	
those	
rare	ENTITY
cases	ENTITY
that	
fail	ENTITY
to	
meet	
criteria	ENTITY
for	
short-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
yet	
are	
thought	
to	
have	
sufficient	
symptoms	ENTITY
of	
insomnia	ENTITY
to	
warrant	
clinical	ENTITY
attention	ENTITY
.	

Chronic	ENTITY
Insomnia	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.42	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

F51.01	ENTITY
Alternate	ENTITY
Names	ENTITY
Chronic	ENTITY
insomnia	ENTITY
,	
primary	ENTITY
insomnia	ENTITY
,	
secondary	ENTITY
insomnia	ENTITY
,	
comorbid	ENTITY
insomnia	ENTITY
,	
disor-	
der	
of	
initiating	
and	
maintaining	
sleep	ENTITY
,	
behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
,	
sleep	ENTITY
-	
onset	ENTITY
association	ENTITY
disorder	ENTITY
,	
limit	ENTITY
-	
setting	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
F	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
reports	ENTITY
,	
or	
the	
patient	ENTITY
’s	
parent	ENTITY
or	
caregiver	ENTITY
observes	
,	
one	
or	
more	
of	
the	
following:1	ENTITY
.	

Difficulty	ENTITY
initiating	ENTITY
sleep	
.	
.	

Difficulty	ENTITY
maintaining	
sleep	ENTITY
.	
.	

Waking	ENTITY
up	
earlier	
than	
desired	
.	
.	

Resistance	ENTITY
to	
going	
to	
bed	
on	
appropriate	
schedule	ENTITY
.	
.	

Difficulty	ENTITY
sleeping	ENTITY
without	
parent	ENTITY
or	
caregiver	ENTITY
intervention	ENTITY
.	

B.	ENTITY
The	
patient	ENTITY
reports	ENTITY
,	
or	
the	
patient	ENTITY
’s	
parent	ENTITY
or	
caregiver	ENTITY
observes	
,	
one	
or	
more	
of	
the	
following	
related	
to	
the	
nighttime	ENTITY
sleep	ENTITY
difficulty	ENTITY
:	
.	

Fatigue	ENTITY
/	
malaise	ENTITY
.	
.	

Attention	ENTITY
,	
concentration	ENTITY
,	
or	
memory	ENTITY
impairment	ENTITY
.	
.	

Impaired	ENTITY
social	ENTITY
,	
family	ENTITY
,	
occupational	ENTITY
,	
or	
academic	ENTITY
performance	ENTITY
.	

Insomnia	ENTITY
Insomnia	ENTITY
.	

Mood	ENTITY
disturbance	ENTITY
/	
irritability	ENTITY
.	
.	

Daytime	ENTITY
sleepiness	ENTITY
.	
.	

Behavioral	ENTITY
problems	
(	
e.g.	
,	
hyperactivity	ENTITY
,	
impulsivity	ENTITY
,	
aggression	ENTITY
)	
.	

7	
.	
Reduced	ENTITY
motivation	ENTITY
/	
energy	ENTITY
/	
initiative	ENTITY
.	
.	

Proneness	ENTITY
for	
errors	ENTITY
/	
accidents	ENTITY
.	
.	

Concerns	ENTITY
about	
or	
dissatisfaction	ENTITY
with	ENTITY
sleep	ENTITY
.	

C.	

The	
reported	
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
can	
not	
be	
explained	
purely	
by	
inadequate	ENTITY
opportunity	ENTITY
(	
i.e.	
,	
enough	
time	ENTITY
is	
allotted	
for	
sleep	ENTITY
)	
or	
inadequate	ENTITY
circumstances	
(	
i.e.	
,	
the	
environment	ENTITY
is	
safe	
,	
dark	ENTITY
,	
quiet	ENTITY
,	
and	
comfortable	ENTITY
)	
for	
sleep	ENTITY
.	

D.	
The	
sleep	ENTITY
disturbance	ENTITY
and	
associated	
daytime	ENTITY
symptoms	ENTITY
occur	
at	
least	
three	
times	
per	
week	ENTITY
.	

E.	

The	
sleep	ENTITY
disturbance	ENTITY
and	
associated	
daytime	ENTITY
symptoms	ENTITY
have	
been	
present	
for	
at	
least	
three	
months.2	ENTITY
F.	
The	
sleep	ENTITY
/	
wake	ENTITY
difficulty	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Reports	ENTITY
of	
difficulties	
initiating	
sleep	
,	
difficulties	ENTITY
maintaining	ENTITY
sleep	ENTITY
,	
or	
waking	ENTITY
up	
too	
early	ENTITY
can	
be	
seen	
in	
all	
age	ENTITY
groups	ENTITY
.	

Resistance	ENTITY
going	
to	
bed	ENTITY
on	
an	
appropriate	
schedule	ENTITY
and	
difficulty	ENTITY
sleeping	ENTITY
without	
parent	ENTITY
or	
caregiver	ENTITY
intervention	ENTITY
is	
seen	
most	
commonly	
in	
children	ENTITY
and	
older	ENTITY
adults	ENTITY
who	
require	
the	
supervision	ENTITY
of	
a	
caretaker	ENTITY
due	
to	
a	
significant	
level	ENTITY
of	
functional	ENTITY
impairment	ENTITY
(	
e.g.	
,	
those	
with	
dementia	ENTITY
)	
.	
.	

Some	
patients	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
may	
show	
recurrent	ENTITY
episodes	ENTITY
of	
sleep	ENTITY
/	
wake	ENTITY
difficulties	ENTITY
lasting	
several	
weeks	ENTITY
at	
a	
time	ENTITY
over	
several	
years	ENTITY
,	
yet	
not	
meet	
the	
three	
-	
month	ENTITY
duration	ENTITY
criterion	ENTITY
for	
any	
single	
such	
episode	ENTITY
.	

Nonetheless	
,	
these	
patients	ENTITY
should	
be	
assigned	
a	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
given	
the	
persistence	ENTITY
of	
their	
intermittent	ENTITY
sleep	
difficulties	
over	
time	ENTITY
.	
.	

Some	
patients	ENTITY
who	
use	
hypnotic	ENTITY
medications	ENTITY
regularly	
may	
sleep	ENTITY
well	
and	
not	
meet	
the	
criteria	ENTITY
for	
an	
insomnia	ENTITY
disorder	ENTITY
when	
they	
take	
such	
medications	ENTITY
.	

However	
,	
in	
the	
absence	ENTITY
of	
such	
medications	ENTITY
these	
same	
patients	ENTITY
may	
meet	
the	
above	
criteria	ENTITY
.	

This	
diagnosis	ENTITY
would	
apply	
to	
those	
patients	ENTITY
particularly	
if	
they	
present	
clinically	ENTITY
and	
voice	ENTITY
concerns	ENTITY
about	
their	
inability	
to	
sleep	ENTITY
without	
their	
sleep	ENTITY
medications	ENTITY
.	
.	

Many	
comorbid	ENTITY
conditions	ENTITY
such	
as	
chronic	ENTITY
pain	ENTITY
disorders	ENTITY
or	
gast-	
roesophageal	ENTITY
reflux	ENTITY
disease	ENTITY
(	
GERD	ENTITY
)	
may	
cause	
the	
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
delineated	
here	
.	

When	
such	
conditions	ENTITY
are	
the	
sole	
cause	ENTITY
of	
the	
sleep	ENTITY
difficulty	ENTITY
,	
a	
separate	
insomnia	ENTITY
diagnosis	ENTITY
may	
not	
apply	
.	

However	
,	
in	
many	
patients	ENTITY
such	
conditions	ENTITY
are	
chronic	ENTITY
and	
are	
not	
the	
sole	
cause	ENTITY
of	
sleep	ENTITY
difficulty	ENTITY
.	

Key	
determining	
factors	ENTITY
in	
the	
decision	
to	
invoke	
a	
separate	
insomnia	ENTITY
diagnosis	ENTITY
include	
:	
“	
How	
much	
of	
the	
time	ENTITY
does	
the	
sleep	ENTITY
difficulty	
arise	
as	
a	
result	
of	
factors	ENTITY
directly	
attributable	
to	
the	
comorbid	ENTITY
condition	ENTITY
(	
e.g.	
,	
pain	ENTITY
or	
GERD	ENTITY
)	
?	
”	

or	
“	
Are	
there	
times	
that	
the	
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
occur	
in	
the	
absence	ENTITY
of	
these	
factors	ENTITY
?	
”	

“	
Have	
perpetuating	
cognitive	ENTITY
or	
behavioral	ENTITY
factors	ENTITY
(	
e.g.	
,	
negative	ENTITY
expectations	ENTITY
,	
conditioned	ENTITY
arousal	ENTITY
,	
sleep	ENTITY
-	
disruptive	ENTITY
habits	ENTITY
)	
arisen	
,	
suggesting	
an	
autonomous	
aspect	
to	
the	
ongoing	
insomnia	ENTITY
?	
”	

If	
there	
is	
evidence	ENTITY
that	
the	
patient	ENTITY
’s	
sleep/	ENTITY
wake	ENTITY
complaints	
are	
not	
solely	
caused	
by	
the	
medical	ENTITY
condition	ENTITY
,	
and	
those	
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
seem	
to	
merit	
separate	
treatment	ENTITY
attention	ENTITY
,	
then	
a	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
should	
be	
made	
.	

Essential	ENTITY
Features	ENTITY
The	
essential	
feature	
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
a	
frequent	ENTITY
and	
persistent	ENTITY
difficulty	
initiating	
or	
maintaining	
sleep	ENTITY
that	
results	ENTITY
in	
general	ENTITY
sleep	ENTITY
dissatisfaction	ENTITY
.	

The	
sleep	ENTITY
complaint	ENTITY
is	
accompanied	
by	
distress	ENTITY
about	
poor	ENTITY
sleep	ENTITY
and/or	
impairment	ENTITY
in	
family	ENTITY
,	
social	ENTITY
,	
vocational	ENTITY
,	
academic	ENTITY
,	
or	
other	
important	
areas	
of	
functioning	ENTITY
.	

Furthermore	
,	
the	
sleep	ENTITY
disturbance	ENTITY
and	
associated	
waking	
symptoms	ENTITY
occur	
despite	
having	
adequate	ENTITY
time	ENTITY
and	
circumstances	ENTITY
each	
night	ENTITY
to	
obtain	
necessary	
sleep	ENTITY
.	

Chronic	ENTITY
insomnia	ENTITY
dis-	
order	
can	
occur	
in	
isolation	ENTITY
or	
comorbidly	ENTITY
with	
a	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
condition	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

The	
sleep	ENTITY
complaints	ENTITY
that	
comprise	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
include	
difficul-	
ties	ENTITY
initiating	
sleep	ENTITY
or	
difficulties	ENTITY
maintaining	ENTITY
sleep	ENTITY
.	

The	
latter	
complaint	ENTITY
may	
include	
waking	ENTITY
up	
during	
the	
night	ENTITY
with	
difficulty	ENTITY
returning	
to	
sleep	ENTITY
or	
having	
a	
final	
awaken-	
ing	
occurring	ENTITY
too	
early	ENTITY
,	
well	
before	
the	
desired	
rising	ENTITY
time	ENTITY
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
be	
characterized	ENTITY
solely	
by	
sleep	ENTITY
onset	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
or	
,	
more	
commonly	
,	
by	
both	
types	
of	
complaints	ENTITY
occurring	
together	
.	

Individuals	ENTITY
’	
sleep	ENTITY
com-	ENTITY
plaints	ENTITY
may	
also	
change	
over	
time	ENTITY
such	
that	
those	
with	
solely	ENTITY
sleep	ENTITY
onset	ENTITY
complaints	ENTITY
may	
subsequently	
develop	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
and	
vice	
versa	
.	

Also	
,	
those	
who	
present	
initially	ENTITY
with	
mixed	ENTITY
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
maintenance	ENTITY
difficulties	ENTITY
may	
later	
evidence	ENTITY
one	
or	
the	
other	
of	
these	
difficulties	ENTITY
but	
not	
both	
.	

Complaints	ENTITY
about	
poor	ENTITY
-	
quality	ENTITY
,	
unrefreshing	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
often	
accompany	
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
,	
but	
do	
not	
suffice	
to	
define	
insomnia	ENTITY
disorder	ENTITY
when	
occurring	
as	
the	
sole	ENTITY
sleep	ENTITY
complaint	ENTITY
.	

The	
degree	ENTITY
of	
sleep	ENTITY
disturbance	ENTITY
required	
to	
assign	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diag-	

nosis	ENTITY
is	
somewhat	
arbitrary	ENTITY
in	
that	
it	
relies	
primarily	
on	
individuals	ENTITY
’	
subjective	ENTITY
sleep	ENTITY
Insomnia	ENTITY
Insomnia	ENTITY
complaints	ENTITY
.	

Moreover	
,	
the	
degree	ENTITY
of	
sleep	ENTITY
disturbance	ENTITY
required	
to	
connote	ENTITY
clinical	ENTITY
significance	ENTITY
varies	
across	
age	ENTITY
groups	ENTITY
.	

Nonetheless	
,	
sleep	ENTITY
onset	ENTITY
latencies	ENTITY
and	
periods	ENTITY
of	
wakefulness	ENTITY
after	
sleep	ENTITY
onset	ENTITY
>	
20	
minutes	ENTITY
generally	
connote	ENTITY
clinically	ENTITY
significant	ENTITY
sleep	ENTITY
disturbances	ENTITY
in	
children	ENTITY
and	
young	ENTITY
adults	ENTITY
.	

In	
middle	ENTITY
and	
older	ENTITY
aged	ENTITY
adults	ENTITY
,	
onset	ENTITY
latencies	ENTITY
and	
periods	ENTITY
of	
wakefulness	ENTITY
during	
sleep	ENTITY
>	
30	
minutes	
typically	
connote	ENTITY
clin-	
ical	ENTITY
significance	ENTITY
.	

Complaints	ENTITY
of	
early	ENTITY
morning	ENTITY
awakening	ENTITY
are	
less	
well	
defined	
,	
but	
typically	
entail	
the	
termination	ENTITY
of	ENTITY
sleep	ENTITY
at	
least	
30	
minutes	ENTITY
before	
the	
desired	
rising	ENTITY
time	ENTITY
and	
a	
concomitant	ENTITY
reduced	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
compared	
with	
the	
usual	
premorbid	ENTITY
sleep	
pattern	
.	

The	
exact	
time	
at	
which	
early	
morning	
awakenings	ENTITY
occur	
may	
vary	
con-	
siderably	ENTITY
as	
a	
function	ENTITY
of	
usual	
bedtimes	ENTITY
.	

For	
example	
,	
a	
final	
awakening	ENTITY
at	
4:00	
a.m.	
is	
likely	
to	
connote	ENTITY
clinical	ENTITY
significance	ENTITY
when	
the	
usual	ENTITY
bedtime	ENTITY
is	
11:00	
p.m.	

but	
not	
when	
the	
usual	ENTITY
bedtime	ENTITY
occurs	
at	
9:00	
p.m.	

Symptoms	ENTITY
during	
wakefulness	ENTITY
accompany	
the	
sleep	ENTITY
difficulties	ENTITY
and	
result	
in	
the	
impairment	ENTITY
of	
normal	ENTITY
functioning	ENTITY
.	

Common	
waking	ENTITY
symptoms	ENTITY
include	
fatigue	ENTITY
;	
reduced	ENTITY
motivation	ENTITY
;	
reduced	ENTITY
concentration	ENTITY
,	
attention	ENTITY
,	
and	
memory	ENTITY
functioning	ENTITY
;	
and	
irritability	ENTITY
or	
reduced	ENTITY
mood	ENTITY
.	

Complaints	ENTITY
of	
subjective	ENTITY
daytime	ENTITY
sleepiness	ENTITY
are	
also	
common	
,	
although	
,	
in	
contrast	
to	
patients	ENTITY
with	
hypersomnolence	ENTITY
conditions	ENTITY
,	
many	
with	
this	
complaint	ENTITY
are	
not	
able	
to	
nap	ENTITY
in	
the	
daytime	ENTITY
and	
few	
show	
unintentional	ENTITY
sleep	ENTITY
episodes	ENTITY
.	

Reports	ENTITY
of	
reduced	ENTITY
performance	ENTITY
at	
work	ENTITY
or	
school	ENTITY
or	
impaired	ENTITY
social	ENTITY
functioning	ENTITY
also	
are	
common	
.	

Some	
affected	ENTITY
individuals	ENTITY
attribute	
errors	ENTITY
or	
accidents	ENTITY
at	
work	
to	
their	
sleep	ENTITY
difficulties	ENTITY
.	

Somatic	ENTITY
symptoms	ENTITY
such	
as	
headaches	ENTITY
or	
gastrointes-	
tinal	ENTITY
dysfunction	ENTITY
are	
occasionally	
attributed	
to	
the	
ongoing	
sleep	ENTITY
difficulties	ENTITY
as	
well	
.	

The	
fatigue	ENTITY
of	
insomnia	ENTITY
sufferers	ENTITY
is	
manifest	ENTITY
mainly	
as	
a	
lack	ENTITY
of	
energy	
and	
desire	ENTITY
to	
reduce	ENTITY
or	
limit	
activity	ENTITY
levels	ENTITY
.	

This	
symptom	ENTITY
should	
be	
differentiated	
from	
reports	ENTITY
of	
subjective	ENTITY
sleepiness	ENTITY
as	
well	
as	
from	
unintended	ENTITY
sleep	ENTITY
episodes	ENTITY
.	

Insomnia	ENTITY
sufferers	ENTITY
commonly	
report	
subjective	
sleepiness	ENTITY
characterized	ENTITY
by	
a	
sense	
of	
reduced	ENTITY
alertness	ENTITY
and	
enhanced	ENTITY
need	
or	
desire	ENTITY
to	
sleep	ENTITY
.	

However	
,	
they	
seldom	
fall	ENTITY
asleep	ENTITY
spontaneously	
without	
intending	ENTITY
to	
do	
so	
.	

Despite	
a	
desire	ENTITY
to	
nap	ENTITY
,	
many	
individuals	ENTITY
with	
insomnia	ENTITY
are	
unable	
to	
do	
so	
.	

Frequent	ENTITY
,	
unintentional	ENTITY
daytime	ENTITY
sleep	ENTITY
episodes	
are	
more	
characteristic	
of	
other	
types	
of	
sleep	ENTITY
disorders	ENTITY
such	
as	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
,	
narcolepsy	ENTITY
,	
idio-	
pathic	ENTITY
hypersomnia	ENTITY
,	
and	
the	
like	
.	

In	
young	ENTITY
children	ENTITY
,	
difficulty	ENTITY
falling	ENTITY
asleep	
,	
staying	ENTITY
asleep	ENTITY
,	
or	
both	
are	
often	
the	
result	
of	
inappropriate	ENTITY
sleep	ENTITY
associations	ENTITY
or	
inadequate	ENTITY
limit	ENTITY
setting	ENTITY
.	

Inappropriate	ENTITY
sleep	ENTITY
associ-	

ations	ENTITY
result	
from	
a	
child	ENTITY
’s	
dependency	ENTITY
on	
specific	
stimulation	ENTITY
,	
objects	ENTITY
,	
or	
settings	
for	
initiating	ENTITY
sleep	ENTITY
or	
returning	ENTITY
to	
sleep	ENTITY
following	
an	
awakening	ENTITY
;	
in	
the	
absence	ENTITY
of	
these	
conditions	ENTITY
,	
sleep	ENTITY
onset	ENTITY
is	
significantly	
delayed	ENTITY
.	

This	
manifestation	ENTITY
usually	
presents	
as	
frequent	ENTITY
nighttime	ENTITY
awakenings	ENTITY
and/or	
nighttime	ENTITY
fears	ENTITY
or	
anxiety	ENTITY
about	
sleeping	ENTITY
alone	
.	

The	
process	ENTITY
of	
falling	ENTITY
asleep	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
specific	
form	
of	
stimulation	ENTITY
(	
e.g.	
,	
rocking	ENTITY
,	
watching	ENTITY
television	ENTITY
)	
,	
object	ENTITY
(	
e.g.	
,	
bottle	ENTITY
,	
excessive	ENTITY
feedings	ENTITY
)	
,	
or	
setting	
(	
e.g.	
,	
lighted	ENTITY
room	ENTITY
,	
parents	ENTITY
remaining	
in	
the	
room	ENTITY
,	
or	
child	ENTITY
taken	
to	
parents	ENTITY
’	
bed	ENTITY
)	
.	

When	
such	
conditions	ENTITY
are	
absent	ENTITY
,	
children	ENTITY
with	
this	
disorder	ENTITY
experience	
difficulty	
falling	
asleep	ENTITY
at	
bedtime	ENTITY
and	
following	
normal	ENTITY
nighttime	ENTITY
arousals	ENTITY
.	

If	
the	
conditions	ENTITY
associ-	
ated	ENTITY
with	ENTITY
falling	ENTITY
asleep	ENTITY
are	
reestablished	
,	
the	
child	ENTITY
usually	
resumes	ENTITY
sleep	ENTITY
relatively	
quickly	
.	

Because	
sleep	ENTITY
-	
onset	ENTITY
associations	ENTITY
are	
highly	
prevalent	ENTITY
in	
young	ENTITY
children	ENTITY
,	
the	
phenomenon	ENTITY
is	
defined	
as	
a	
disorder	ENTITY
only	
if	
(	
1	
)	
the	
associations	ENTITY
are	
highly	
problem-	
atic	
or	
demanding	ENTITY
(	
e.g.	
,	
extended	
rocking	ENTITY
,	
car	ENTITY
rides	ENTITY
)	
;	
(	
2	
)	
sleep	ENTITY
onset	ENTITY
is	
significantly	
delayed	ENTITY
or	
sleep	ENTITY
is	
otherwise	
disrupted	ENTITY
in	
the	
absence	ENTITY
of	
the	
associated	ENTITY
conditions	ENTITY
;	
and	
(	
3	
)	
caregiver	ENTITY
intervention	ENTITY
is	
frequently	
required	
to	
aid	
the	
onset	ENTITY
or	
resumption	ENTITY
of	
sleep	ENTITY
.	

Limit	ENTITY
-	
setting	ENTITY
issues	ENTITY
are	
characterized	ENTITY
by	
bedtime	ENTITY
stalling	ENTITY
or	
bedtime	ENTITY
refusal	ENTITY
that	
is	
met	
with	
and	
reinforced	ENTITY
by	
inadequate	ENTITY
limit	ENTITY
setting	ENTITY
by	
a	
caregiver	ENTITY
.	

Sleep	ENTITY
problems	ENTITY
occur	
when	
caregivers	ENTITY
institute	ENTITY
no	ENTITY
or	
few	
limits	ENTITY
or	
when	
limits	ENTITY
are	
instituted	
inconsistently	
or	
in	
an	
unpredictable	ENTITY
manner	
.	

Limit	ENTITY
-	
setting	ENTITY
sleep	ENTITY
problems	ENTITY
may	
also	
result	
in	
prolonged	ENTITY
nocturnal	ENTITY
awakenings	ENTITY
,	
depending	
on	
caregiver	ENTITY
response	ENTITY
during	
the	
night	ENTITY
.	

It	
also	
should	
be	
noted	
that	
some	
children	ENTITY
’s	
needs	
for	
specific	
conditions	ENTITY
for	
sleeping	ENTITY
or	
their	
resistance	ENTITY
to	
go	
to	
bed	ENTITY
may	
reflect	
underlying	
anxiety	ENTITY
or	
fears	ENTITY
.	

Fear	ENTITY
of	ENTITY
sleep-	ENTITY
ing	
alone	
,	
being	
in	
the	
dark	ENTITY
,	
or	
having	
nightmares	ENTITY
may	
lead	
some	
children	ENTITY
to	
demand	
certain	
sleep	ENTITY
promoting	ENTITY
conditions	ENTITY
(	
presence	ENTITY
of	
parent	ENTITY
in	
bedroom	ENTITY
)	
or	
to	
repeatedly	
delay	ENTITY
their	
bedtimes	ENTITY
.	

Although	
transient	ENTITY
and	
episodic	ENTITY
forms	ENTITY
of	
insomnia	ENTITY
occur	
,	
the	
clinically	ENTITY
significant	ENTITY
daytime	ENTITY
consequences	ENTITY
of	
insomnia	ENTITY
and	
the	
longer	ENTITY
term	ENTITY
,	
more	
serious	
morbidity	ENTITY
out-	
comes	
most	
typically	
develop	
when	
the	
sleep	ENTITY
difficulties	ENTITY
occur	
at	
least	
three	
times	
per	
week	ENTITY
and	
persist	
for	
at	
least	
three	
months	ENTITY
.	

For	
this	
reason	
,	
these	
frequency	ENTITY
and	
dura-	
tion	ENTITY
criteria	ENTITY
must	
be	
met	
for	
the	
assignment	ENTITY
of	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
.	

However	
,	
it	
is	
recognized	
that	
more	
acute	ENTITY
and	
episodic	ENTITY
forms	ENTITY
of	
insomnia	ENTITY
may	
cause	
significant	
distress	ENTITY
and	
functional	ENTITY
impairment	ENTITY
and	
require	
clinical	ENTITY
attention	ENTITY
.	

Cases	ENTITY
that	
meet	
all	
criteria	ENTITY
except	
the	
frequency	ENTITY
or	
duration	ENTITY
criteria	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
should	
be	
assigned	
a	
diagnosis	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Individuals	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
typically	
note	
feelings	ENTITY
of	
reduced	ENTITY
well	
-	
being	
and	
general	ENTITY
malaise	ENTITY
during	
the	
day	ENTITY
.	

In	
addition	
,	
excessive	ENTITY
focus	
on	
and	
worry	ENTITY
about	
ongoing	
sleep	ENTITY
difficulties	ENTITY
and	
their	
associated	
daytime	ENTITY
consequences	ENTITY
are	
common	
.	

Thoughts	ENTITY
about	
ongoing	
sleep	ENTITY
difficulties	ENTITY
may	
occur	
through	
the	
day	ENTITY
and	
may	
be	
amplified	ENTITY
as	
bedtime	ENTITY
Insomnia	ENTITY
Insomnia	ENTITY
approaches	ENTITY
.	

Frank	ENTITY
performance	ENTITY
anxiety	ENTITY
about	
sleep	ENTITY
is	
common	
.	

Although	
many	
with	
insomnia	ENTITY
may	
appear	
anxious	ENTITY
and	
worry	ENTITY
-	
prone	ENTITY
,	
their	
anxiety	ENTITY
and	
worry	ENTITY
are	
often	
focused	
mainly	
on	
their	
sleep	ENTITY
difficulties	ENTITY
.	

When	
anxiety	ENTITY
and	
worry	ENTITY
are	
more	
pervasive	ENTITY
and	
not	
solely	
focused	
on	
sleep	ENTITY
problems	ENTITY
,	
a	
comorbid	ENTITY
anxiety	ENTITY
disorder	ENTITY
may	
be	
present	
.	

Many	
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
show	
a	
pattern	ENTITY
of	
conditioned	ENTITY
arousal	ENTITY
in	
response	ENTITY
to	
envi-	
ronmental	ENTITY
cues	ENTITY
in	
their	
bedrooms	ENTITY
or	
conscious	ENTITY
efforts	
to	
initiate	ENTITY
sleep	ENTITY
.	

Such	
individuals	ENTITY
may	
fall	ENTITY
asleep	ENTITY
easily	
in	
settings	
outside	
of	
their	
bedrooms	ENTITY
when	
not	
trying	
to	
sleep	ENTITY
,	
but	
show	
a	
pattern	ENTITY
of	
cognitive	ENTITY
and	
physiological	ENTITY
arousal	ENTITY
when	
lying	
down	
in	
their	
beds	ENTITY
with	
the	
intention	ENTITY
to	
fall	ENTITY
asleep	ENTITY
.	

Some	
patients	ENTITY
with	
this	
pattern	ENTITY
may	
report	ENTITY
sleeping	ENTITY
better	
when	
away	
from	
home	ENTITY
than	
when	
at	
home	ENTITY
.	

Unlike	
noncomplaining	ENTITY
normal	
sleepers	ENTITY
,	
indi-	
viduals	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
often	
express	
conscious	ENTITY
intentions	ENTITY
and	
excessive	ENTITY
effort	
to	
sleep	ENTITY
,	
only	
to	
find	
sleep	ENTITY
difficult	
to	
initiate	ENTITY
under	
such	
circumstances	ENTITY
.	

In	
children	ENTITY
,	
the	
sleep	ENTITY
disturbance	ENTITY
may	
be	
accompanied	
by	
daytime	ENTITY
behavioral	ENTITY
prob-	
lems	ENTITY
and	
limit	ENTITY
-	
setting	ENTITY
difficulties	ENTITY
during	
the	
day	ENTITY
.	

In	
addition	
,	
the	
nighttime	ENTITY
sleep	ENTITY
distur-	
bance	ENTITY
often	
results	ENTITY
in	
poor	ENTITY
parental	ENTITY
sleep	ENTITY
and	
associated	ENTITY
daytime	ENTITY
impairment	ENTITY
.	

Marital	ENTITY
conflicts	ENTITY
regarding	
how	
to	
respond	
to	
or	
intervene	
with	
the	
ongoing	
sleep	ENTITY
problem	ENTITY
may	
arise	
.	

Parents	ENTITY
also	
may	
develop	
negative	ENTITY
feelings	ENTITY
toward	
the	
child	ENTITY
who	
disrupts	ENTITY
their	
sleep	ENTITY
and	
demands	ENTITY
their	
attention	
during	
the	
night	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Various	
clinical	ENTITY
and	
pathophysiological	ENTITY
subtypes	ENTITY
of	
insomnia	ENTITY
have	
been	
described	
in	
previous	
nosologies	ENTITY
.	

Both	
the	
American	ENTITY
Psychiatric	ENTITY
Association	ENTITY
’s	ENTITY
Diagnostic	ENTITY
and	ENTITY
Statistical	ENTITY
Manual	ENTITY
,	
4th	
Edition	
,	
Text	ENTITY
Revision	ENTITY
(	ENTITY
DSM	ENTITY
-	ENTITY
IV	ENTITY
-	
TR	ENTITY
)	
and	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
describe	
independently	
occurring	ENTITY
or	
primary	
forms	
of	
insomnia	ENTITY
.	

Within	
DSM	ENTITY
-	
IV	ENTITY
-	
TR	ENTITY
,	
the	
global	ENTITY
term	ENTITY
,	
primary	ENTITY
insomnia	ENTITY
,	
is	
applied	
to	
all	
forms	
of	
insomnia	ENTITY
that	
are	
not	
better	
explained	
by	
a	
coincident	ENTITY
psychi-	
atric	ENTITY
,	
medical	ENTITY
or	
substance	ENTITY

use	ENTITY
/	
abuse	ENTITY
disorder	ENTITY
.	

Within	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
system	
,	
multiple	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
are	
delin-	
eated	
.	

The	
specific	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
listed	
in	
the	
previous	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
include	
the	
following	
:	
Psychophysiological	ENTITY
insomnia	ENTITY
is	
characterized	ENTITY
primarily	
by	
heightened	ENTITY
arousal	ENTITY
and	
learned	ENTITY
sleep	ENTITY
-	
preventing	ENTITY
associations	ENTITY
that	
result	
in	
a	
complaint	ENTITY
of	
insomnia	ENTITY
.	

Patients	ENTITY
presumed	
to	
have	
this	
type	
of	
insomnia	ENTITY
often	
have	
sleep	ENTITY
difficulty	
when	
trying	
to	
sleep	ENTITY
in	
their	
usual	
sleep	ENTITY
setting	ENTITY
at	
home	ENTITY
but	
may	
fall	ENTITY
asleep	ENTITY
easily	
in	
a	
novel	ENTITY
sleep	ENTITY
setting	ENTITY
or	
when	
not	
trying	
to	
sleep	ENTITY
.	

They	
also	
demonstrate	
excessive	ENTITY
focus	
on	
and	
worry	ENTITY
about	
sleep	ENTITY
and	
suffer	
from	
elevated	ENTITY
levels	ENTITY
of	
cognitive	ENTITY
and	
somatic	ENTITY
arousal	ENTITY
,	
particularly	
at	
bedtime	ENTITY
.	

Idiopathic	ENTITY
insomnia	ENTITY
is	
characterized	ENTITY
by	
a	
longstanding	
complaint	ENTITY
of	
sleep	
difficulties	
with	
insidious	ENTITY
onset	
occurring	
during	
infancy	ENTITY
or	
early	ENTITY
childhood	ENTITY
.	

It	
is	
presumed	
to	
arise	
in	
infancy	ENTITY
or	
early	ENTITY
childhood	ENTITY
without	
discernible	
cause	ENTITY
and	
to	
persist	
over	
time	
without	
sustained	ENTITY
periods	ENTITY
of	
remission	ENTITY
.	

Given	
its	
early	ENTITY
onset	ENTITY
,	
stability	ENTITY
over	
time	ENTITY
,	
and	
lifelong	ENTITY
course	ENTITY
,	
this	
disorder	ENTITY
is	
thought	
to	
arise	
from	
either	
genetically	ENTITY
determined	
or	
congenital	ENTITY
aberrations	ENTITY
in	
the	
sleep	ENTITY
-	
inducing	ENTITY
or	
arousal	ENTITY
systems	ENTITY
in	
the	
brain	ENTITY
,	
or	
both	
.	

No	
consistent	
genetic	ENTITY
markers	ENTITY
or	
neural	ENTITY
pathology	ENTITY
have	
been	
identified	ENTITY
among	
those	
presumed	
to	
suffer	
from	
this	
condition	ENTITY
.	

Paradoxical	ENTITY
insomnia	ENTITY
,	
which	
has	
previously	
been	
called	
sleep	ENTITY
state	ENTITY
misperception	ENTITY
,	
is	
described	
as	
a	
complaint	ENTITY
of	
severe	ENTITY
sleep	ENTITY
disturbance	ENTITY
without	
corroborative	ENTITY
objective	
evidence	ENTITY
of	
the	
degree	ENTITY
of	
sleep	ENTITY
disturbance	ENTITY
claimed	
.	

Those	
presumed	
to	
have	
this	
form	
of	
sleep	ENTITY
difficulty	
have	
a	
marked	
propensity	
to	
underestimate	
the	
amount	ENTITY
of	
sleep	ENTITY
they	
actually	
are	
obtaining	ENTITY
.	

In	
essence	
,	
they	
are	
thought	
to	
perceive	
much	
of	
the	
time	ENTITY
they	
actually	
sleep	ENTITY
as	
wakefulness	ENTITY
.	

Although	
many	
such	
patients	ENTITY
routinely	
obtain	
norma-	
tive	ENTITY
amounts	
of	
sleep	ENTITY
,	
as	
documented	ENTITY
by	
standard	
polysomnographic	ENTITY
measures	ENTITY
,	
they	
complain	ENTITY
of	
the	
common	
sleep	ENTITY
/	
wake	ENTITY
symptoms	ENTITY
of	
other	
insomnia	ENTITY
disorders	ENTITY
.	

Some	
studies	ENTITY
using	
neuroimaging	ENTITY
or	
sleep	ENTITY
electroencephalograph	ENTITY
(	
EEG	
)	
spectral	ENTITY
analysis	ENTITY
techniques	ENTITY
have	
suggested	
that	
an	
altered	ENTITY
sleep	ENTITY
/	
wake	ENTITY
arousal	ENTITY
system	ENTITY
in	
such	
individ-	
uals	ENTITY
may	
explain	
the	
apparent	ENTITY
mismatch	ENTITY
between	
their	
conventional	
objective	ENTITY
sleep	ENTITY
measures	ENTITY
and	
subjective	ENTITY
sleep	ENTITY
reports	ENTITY
.	

Inadequate	ENTITY
sleep	ENTITY
hygiene	ENTITY
is	
presumed	
to	
result	
from	
or	
be	
sustained	ENTITY
by	
daily	ENTITY
living	ENTITY
activities	ENTITY
that	
are	
inconsistent	ENTITY
with	
the	
maintenance	ENTITY
of	
good	ENTITY
-	
quality	ENTITY
sleep	ENTITY
and	
normal	ENTITY
daytime	ENTITY
alertness	ENTITY
.	

Patients	ENTITY
with	
this	
form	
of	
insomnia	ENTITY
have	
ongoing	
sleep/	ENTITY
wake	ENTITY
difficulties	ENTITY
as	
a	
function	ENTITY
of	
practices	ENTITY
such	
as	
daytime	ENTITY
napping	ENTITY
,	
maintaining	
a	
highly	
variable	ENTITY
sleep	ENTITY
/	
wake	ENTITY
schedule	ENTITY
,	
routinely	
using	
sleep	ENTITY
-	
disruptive	ENTITY
products	ENTITY
(	
caf-	
feine	ENTITY
,	
tobacco	ENTITY
,	
alcohol	ENTITY
)	
too	
close	
to	
bedtime	ENTITY
,	
engaging	ENTITY
in	
mentally	ENTITY
or	
physically	ENTITY
acti-	
vating	ENTITY
or	
emotionally	ENTITY
upsetting	ENTITY
activities	
too	
close	
to	
bedtime	ENTITY
,	
routinely	
using	
the	
bed	ENTITY
and	
bedroom	ENTITY
for	
activities	ENTITY
other	
than	
sleep	ENTITY
,	
or	
failing	
to	
maintain	
a	
comfortable	ENTITY
environment	ENTITY
for	
sleep	ENTITY
.	

Behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
is	
presumed	
to	
result	
from	
improper	ENTITY
sleep	ENTITY
train-	
ing	
or	
limit	
setting	
by	
parents	ENTITY
or	
caretakers	ENTITY
.	

Within	
this	
broader	
diagnosis	ENTITY
,	
several	
subtypes	ENTITY
have	
been	
described	
.	

Sleep	ENTITY
-	
onset	ENTITY
association	ENTITY
type	ENTITY
is	
characterized	ENTITY
by	
the	
child	ENTITY
’s	
dependency	ENTITY
on	
specific	
stimulation	ENTITY
,	
objects	ENTITY
,	
or	
settings	
for	
initiating	ENTITY
sleep	ENTITY
or	
returning	ENTITY
to	
sleep	ENTITY
following	
an	
awakening	ENTITY
;	
in	
the	
absence	ENTITY
of	
these	
conditions	ENTITY
,	
sleep	ENTITY
onset	ENTITY
is	
significantly	
delayed	ENTITY
.	

Limit	ENTITY
-	
setting	ENTITY
type	ENTITY
is	
characterized	
by	
bedtime	ENTITY
stalling	ENTITY
or	
bedtime	ENTITY
refusal	ENTITY
that	
is	
the	
result	
of	
inadequate	ENTITY
limit	ENTITY
setting	ENTITY
by	
a	
caregiver	ENTITY
.	

A	
mixed	
type	
Insomnia	
Insomnia	
characterized	ENTITY
by	
features	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
association	ENTITY
difficulties	ENTITY
and	
bedtime	ENTITY
resistance	ENTITY
represents	
a	
third	
subtype	ENTITY
within	
this	
diagnostic	ENTITY
category	ENTITY
.	

The	
DSM	ENTITY
-	
IV	ENTITY
-	
TR	ENTITY
and	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
also	
describe	
several	
so	
-	
called	
secondary	ENTITY
insomnias	ENTITY
,	
arising	
from	
co	ENTITY
-	
occurring	ENTITY
primary	ENTITY
or	
causative	ENTITY
conditions	ENTITY
.	

Among	
these	
are	
the	
following	
:	
Insomnia	ENTITY
due	
to	
(	
another	
)	
mental	ENTITY
disorder	ENTITY
is	
thought	
to	
be	
caused	
by	
or	
secondary	ENTITY
to	
a	
co	ENTITY
-	
occurring	ENTITY
psychiatric	ENTITY
condition	ENTITY
.	

Insomnia	ENTITY
is	
a	
common	
complaint	ENTITY
,	
particularly	
among	
patients	ENTITY
with	
mood	ENTITY
disorders	ENTITY
and	
anxiety	ENTITY
disorders	ENTITY
.	

Likewise	
,	
sleep	ENTITY
distur-	
bance	ENTITY
is	
commonly	
seen	
in	
those	
with	
psychotic	ENTITY
spectrum	ENTITY
disorders	ENTITY
and	
various	
Axis	ENTITY
II	ENTITY
(	
personality	ENTITY
)	
disorders	
.	

Among	
those	
individuals	ENTITY
presumed	
to	
have	
insomnia	ENTITY
due	
to	
a	
mental	ENTITY
disorder	ENTITY
,	
insomnia	ENTITY
has	
historically	
been	
regarded	
as	
a	
secondary	ENTITY
symptom	ENTITY
,	
caused	
by	
the	
mental	ENTITY
disorder	ENTITY
itself	
.	

Insomnia	ENTITY
due	
to	
(	
a	
)	
medical	ENTITY
condition	ENTITY
is	
thought	
to	
be	
caused	
by	
or	
secondary	ENTITY
to	
a	
co	ENTITY
-	
occurring	ENTITY
medical	ENTITY
condition	ENTITY
.	

Like	
the	
mental	ENTITY
disorders	ENTITY
,	
many	
medical	ENTITY
condi-	
tions	ENTITY
may	
have	
an	
ongoing	
insomnia	ENTITY
complaint	ENTITY
associated	ENTITY
with	ENTITY
them	
.	

In	
particular	
,	
those	
conditions	ENTITY
that	
cause	ENTITY
some	
form	
of	
ongoing	
pain	ENTITY
or	
discomfort	ENTITY
,	
mobility	ENTITY
lim-	ENTITY
itation	ENTITY
,	
or	
breathing	ENTITY
disturbance	ENTITY
commonly	
have	
insomnia	ENTITY
complaints	ENTITY
accompanying	
them	
.	

Among	
those	
individuals	ENTITY
presumed	
to	
have	
insomnia	ENTITY
due	
to	
a	
medical	ENTITY
disor-	ENTITY
der	ENTITY
,	
insomnia	ENTITY
has	
historically	
been	
regarded	
as	
a	
secondary	ENTITY
symptom	ENTITY
,	
caused	
by	
the	
medical	ENTITY
disorder	ENTITY
itself	
.	

Insomnia	ENTITY
due	
to	
drug	ENTITY
or	
substance	ENTITY
is	
thought	
to	
be	
caused	
by	
or	
secondary	ENTITY
to	ENTITY
use	
of	
or	
withdrawal	ENTITY
from	
a	
drug	ENTITY
or	
substance	ENTITY
.	

Many	
forms	
of	
prescription	ENTITY
and	
nonprescrip-	
tion	ENTITY
medications	ENTITY
,	
street	ENTITY
drugs	ENTITY
,	
and	
other	
commonly	
used	
substances	ENTITY
may	
produce	
sleep	ENTITY
disturbances	ENTITY
either	
during	
periods	ENTITY
of	
use	
or	
upon	
withdrawal	ENTITY
.	

Given	
these	
effects	ENTITY
,	
insomnia	ENTITY
complaints	ENTITY
may	
arise	
either	
during	
periods	ENTITY
when	
these	
substances	ENTITY
are	
used	
or	
following	
their	
discontinuance	ENTITY
.	

Among	
those	
individuals	ENTITY
presumed	
to	
have	
insom-	
nia	ENTITY
due	
to	
drug	ENTITY
or	
substance	ENTITY
,	
insomnia	ENTITY
has	
historically	
been	
regarded	
as	
a	
secondary	ENTITY
symptom	ENTITY
,	
caused	
by	
the	
drug	ENTITY
or	
substance	ENTITY
itself	ENTITY
.	

Despite	
the	
heuristic	ENTITY
appeal	
of	
these	
various	
subtypes	ENTITY
,	
it	
is	
often	
difficult	
to	
discrim-	
inate	ENTITY
among	
them	
in	
clinical	ENTITY
practice	ENTITY
.	

Many	
of	
the	
defining	
features	ENTITY
of	
the	
so	
-	
called	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
such	
as	
conditioned	ENTITY
arousal	ENTITY
,	
poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
prac-	
tices	ENTITY
,	
and	
underestimation	ENTITY
of	
sleep	ENTITY
time	ENTITY
are	
ubiquitous	
among	
insomnia	ENTITY
sufferers	ENTITY
,	
per	
se	
,	
and	
are	
not	
specific	
to	
one	
subgroup	ENTITY
.	

This	
is	
true	
whether	
the	
so	
-	
called	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
are	
considered	
in	
isolation	ENTITY
or	
if	
all	
of	
the	
primary	ENTITY
and	
secondary	ENTITY
subtypes	ENTITY
mentioned	
are	
considered	
.	

There	
is	
substantial	
symptom	ENTITY
overlap	ENTITY
both	
within	
the	
group	ENTITY
of	
primary	ENTITY
insomnias	ENTITY
as	
well	
as	
among	
the	
primary	ENTITY
and	
secondary	ENTITY
insomnias	ENTITY
.	

Furthermore	
,	
many	
individuals	ENTITY
with	
insomnia	ENTITY
have	
mul-	
tiple	ENTITY
medical	ENTITY
and	
psychiatric	ENTITY
comorbidities	ENTITY
,	
making	
it	
difficult	
to	
assign	
causation	ENTITY
to	
any	
single	ENTITY
factor	ENTITY
.	

As	
a	
result	ENTITY
,	
discrimination	ENTITY
among	
these	
subtypes	ENTITY
has	
proven	
difficult	
given	
their	
current	
definitions	ENTITY
and	
available	
methods	ENTITY
for	
their	
ascertain-	
ment	ENTITY
.	

Furthermore	
,	
it	
is	
not	
clear	
that	
insomnia	ENTITY
is	
always	
the	
result	
of	
co	ENTITY
-	
occur-	
ring	ENTITY
medical	ENTITY
,	
mental	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorders	ENTITY
.	

Often	
insomnia	ENTITY
may	
precede	
the	
onset	
of	
such	
conditions	ENTITY
,	
and	
even	
when	
precipitated	ENTITY
by	
such	
conditions	ENTITY
,	
the	
insom-	
nia	ENTITY
may	
evolve	ENTITY
and	
develop	
partial	ENTITY
or	
total	
independence	ENTITY
over	
time	ENTITY
.	

In	
such	
cir-	ENTITY
cumstances	ENTITY
,	
the	
term	
secondary	ENTITY
insomnia	ENTITY
seems	
inappropriate	ENTITY
.	

Currently	
there	
is	
limited	
understanding	
of	
mechanistic	ENTITY
pathways	ENTITY
in	
chronic	ENTITY
insomnia	ENTITY
,	
so	
it	
is	
not	
possible	
to	
draw	
firm	
conclusions	ENTITY
about	
the	
association	ENTITY
or	
direction	ENTITY
of	
causality	
between	
insomnia	ENTITY
and	
such	
co	ENTITY
-	
occurring	ENTITY
conditions	ENTITY
.	

Furthermore	
,	
other	
than	
the	
differing	
treatments	ENTITY
required	
for	
distinctive	
comorbidities	ENTITY
,	
efficacious	ENTITY
treatments	ENTITY
for	
insomnia	ENTITY
generally	
are	
similar	
across	
the	
range	
of	
insomnia	ENTITY
subtypes	ENTITY
.	

Finally	
,	
research	ENTITY
has	
provided	
very	
limited	
support	
for	
the	
reliability	ENTITY
and	
validity	ENTITY
of	
the	
various	
specific	
subtypes	ENTITY
discussed	
.	

International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
additionally	
delineates	
the	
separate	
pediatric	ENTITY
diagnosis	ENTITY
,	
behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
,	
characterized	ENTITY
by	
sleep	ENTITY
difficulties	ENTITY
resulting	
from	
inappropriate	ENTITY
sleep	ENTITY
associations	ENTITY
or	
inadequate	ENTITY
limit	ENTITY
setting	ENTITY
by	
parents	ENTITY
or	
caretakers	ENTITY
.	

Although	
perhaps	
more	
common	
in	
young	ENTITY
children	ENTITY
,	
inappropriate	ENTITY
sleep	ENTITY
associations	ENTITY
can	
occur	
in	
older	ENTITY
age	ENTITY
groups	
.	

For	
example	
,	
adults	ENTITY
with	
insomnia	ENTITY
may	
report	ENTITY
intolerance	ENTITY
for	
quiet	ENTITY
and	
dark	ENTITY
settings	ENTITY
and	
may	
not	
be	
able	
to	
fall	ENTITY
asleep	ENTITY
unless	
the	
television	ENTITY
is	
on	
.	

Similarly	
,	
it	
is	
not	
clear	
that	
limit	ENTITY
-	
setting	ENTITY
issues	ENTITY
are	
involved	
in	
the	
sleep	ENTITY
difficulties	ENTITY
of	
only	
young	ENTITY
children	ENTITY
.	

Such	
difficulties	ENTITY
also	
can	
manifest	ENTITY
during	
adolescence	ENTITY
as	
a	
function	ENTITY
of	
volitionally	ENTITY
delaying	ENTITY
bedtimes	ENTITY
.	

Similarly	
,	
they	
may	
occur	
in	
older	ENTITY
,	
cognitively	ENTITY
impaired	ENTITY
adults	ENTITY
when	
their	
caretak-	
ers	ENTITY
allow	
liberal	ENTITY
daytime	ENTITY
napping	ENTITY
that	
in	
turn	
results	ENTITY
in	
disruptive	ENTITY
awakenings	ENTITY
and	
night	ENTITY
wandering	
.	

It	
is	
also	
clear	
that	
many	
of	
the	
features	ENTITY
of	
sleep	ENTITY
/	
wake	ENTITY
dysfunc-	
tion	ENTITY
assigned	ENTITY
to	
this	
childhood	ENTITY
insomnia	ENTITY
subtype	ENTITY
overlap	ENTITY
substantially	
with	
the	
global	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Given	
these	
considerations	ENTITY
,	
a	
separate	
childhood	ENTITY
insomnia	ENTITY
diagno-	
sis	ENTITY
is	
of	
questionable	
merit	
.	

In	
addition	
to	
these	
various	
subtypes	ENTITY
,	
a	
distinctive	
subtype	ENTITY
of	
insomnia	ENTITY
with	
objectively	ENTITY
short	ENTITY
sleep	ENTITY
duration	ENTITY
has	
been	
recently	
described	
.	

This	
group	ENTITY
is	
characterized	ENTITY
by	
insom-	
nia	ENTITY
complaints	ENTITY
,	
along	
with	
an	
objectively	ENTITY
documented	ENTITY
average	
sleep	ENTITY
time	ENTITY
less	
than	
six	
hours	
per	
night	ENTITY
and	
elevated	ENTITY
morbidity	ENTITY
risk	ENTITY
.	

Because	
evidence	ENTITY
in	
support	
of	
this	
Insomnia	ENTITY
Insomnia	ENTITY
insomnia	ENTITY
is	
currently	
limited	
,	
it	
is	
premature	ENTITY
to	
delineate	
a	
separate	
insomnia	ENTITY
category	
for	
this	
presentation	ENTITY
at	
this	
juncture	
.	

Given	
all	
of	
these	
considerations	ENTITY
,	
a	
more	
global	ENTITY
and	
defensible	ENTITY
approach	ENTITY
has	
been	
chosen	
for	
the	
diagnosis	ENTITY
of	
those	
with	
chronic	ENTITY
insomnia	ENTITY
complaints	ENTITY
.	

Specifically	
,	
the	
single	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
provided	
for	
all	
patients	ENTITY
who	
have	
per-	ENTITY
sistent	ENTITY
and	
frequent	ENTITY
insomnia	ENTITY
complaints	ENTITY
whether	
they	
occur	
in	
the	
presence	ENTITY
or	
absence	ENTITY
of	
a	
potentially	
sleep	ENTITY
-	
disruptive	ENTITY
comorbid	ENTITY
psychiatric	ENTITY
illness	ENTITY
,	
medical	ENTITY
disorder	ENTITY
,	
or	
pattern	ENTITY
of	
substance	ENTITY
use	ENTITY
.	

Demographics	ENTITY
The	
full	
clinical	ENTITY
syndrome	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
occurs	
in	
about	
10	
%	
of	
the	
population	ENTITY
,	
but	
the	
prevalence	ENTITY
of	
transient	ENTITY
insomnia	ENTITY
symptoms	ENTITY
is	
much	
higher	ENTITY
(	
30	
%	
to	
35	
%	
of	
the	
population	ENTITY
)	
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
more	
common	
in	
women	ENTITY
,	
those	
with	
medical	ENTITY
/	
psychiatric	ENTITY
/	
substance	ENTITY
disorders	ENTITY
,	
and	
in	
people	ENTITY
in	
lower	
socioeco-	
nomic	ENTITY
strata	ENTITY
.	

It	
may	
occur	
at	
any	
age	ENTITY
but	
is	
more	
commonly	
diagnosed	ENTITY
in	
older	ENTITY
adults	ENTITY
,	
most	
likely	
due	
to	
age	ENTITY
-	
related	ENTITY
deterioration	ENTITY
in	
sleep	ENTITY
continuity	ENTITY
and	
increase	ENTITY
in	
medical	ENTITY
comorbidities	ENTITY
and	
medication	ENTITY
use	ENTITY
that	
increase	ENTITY
insomnia	ENTITY
risk	ENTITY
.	

Insomnia	ENTITY
associated	ENTITY
with	ENTITY
requirements	ENTITY
of	
parental	ENTITY
/	
caregiver	ENTITY
presence	ENTITY
at	
bedtime	ENTITY
and/or	
during	
the	
night	ENTITY
,	
along	
with	
insomnia	ENTITY
due	
to	
limit	ENTITY
-	
setting	ENTITY
difficulties	ENTITY
,	
are	
estimated	
to	
occur	
in	
10	
%	
to	
30	
%	
of	
children	ENTITY
,	
depending	
on	
the	
exact	
definitions	ENTITY
used	
.	

Certain	
subgroups	ENTITY
of	
children	ENTITY
,	
such	
as	
those	
suffering	ENTITY
from	
chronic	ENTITY
illnesses	ENTITY
or	
neurodevelopmental	ENTITY
disorders	ENTITY
,	
have	
a	
somewhat	
higher	
prevalence	ENTITY
of	
insomnia	ENTITY
symptoms	ENTITY
.	

Because	
children	ENTITY
are	
not	
expected	
to	
sleep	ENTITY
through	
the	
night	ENTITY
with	
reg-	
ularity	ENTITY
until	
they	
are	
three	
to	
six	
months	ENTITY
of	
age	ENTITY
,	
six	
months	ENTITY
is	
a	
reasonable	
age	ENTITY
to	
first	
consider	
a	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
unless	
the	
sleeplessness	ENTITY
is	
very	
marked	
at	
an	
earlier	
age	ENTITY
.	

Furthermore	
,	
sleep	ENTITY
-	
onset	ENTITY
associations	ENTITY
and	
limit	ENTITY
-	
set-	ENTITY
ting	ENTITY
problems	ENTITY
are	
strongly	
associated	ENTITY
with	ENTITY
caregivers	ENTITY
’	
behaviors	ENTITY
,	
bedtime	ENTITY
interac-	
tions	ENTITY
,	
and	
culture	ENTITY
.	

Thus	
,	
the	
interpretation	ENTITY
of	
the	
nighttime	ENTITY
awakenings	ENTITY
and	
demands	ENTITY
for	
parental	ENTITY
contact	ENTITY
should	
be	
considered	
in	
the	
context	ENTITY
of	
the	
family	ENTITY
and	
culture	ENTITY
.	

Identification	ENTITY
of	
sleep	ENTITY
problems	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
are	
often	
based	
on	
spe-	
cific	ENTITY
cultural	ENTITY
definitions	ENTITY
.	

Studies	ENTITY
on	
adolescents	ENTITY
indicate	
prevalence	ENTITY
rates	ENTITY
of	
3	
%	
to	
12	
%	
,	
depending	
on	
the	
diagnostic	ENTITY
criteria	ENTITY
utilized	
,	
with	
higher	
frequency	ENTITY
in	
girls	ENTITY
than	
boys	ENTITY
after	
puberty	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Individuals	ENTITY
who	
have	
difficulty	ENTITY
sleeping	ENTITY
during	
stressful	ENTITY
times	ENTITY
or	
who	
report	ENTITY
being	
habitual	ENTITY
light	ENTITY
sleepers	ENTITY
appear	
to	
have	
elevated	ENTITY
propensity	
to	
develop	
chronic	ENTITY
insomnia	ENTITY
.	

Prior	
transient	ENTITY
episodes	ENTITY
of	
poor	ENTITY
sleep	ENTITY
elevate	ENTITY
the	
risk	ENTITY
for	
subsequent	
development	ENTITY
of	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Job	ENTITY
-	
related	ENTITY
stress	ENTITY
and	
factors	ENTITY
such	
as	
death	ENTITY
of	
a	
loved	
one	
,	
divorce	ENTITY
,	
a	
marked	
change	
in	
work	ENTITY
schedule	ENTITY
,	
job	ENTITY
loss	ENTITY
,	
and	
other	
major	
life	ENTITY
changes	ENTITY
are	
often	
precipitating	
circumstances	
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Personality	ENTITY
factors	ENTITY
that	
produce	
anxious	ENTITY
overconcern	ENTITY
about	
health	ENTITY
,	
general	
well	
-	
being	
,	
or	
daytime	ENTITY
func-	
tioning	ENTITY
may	
serve	
as	
predisposing	ENTITY
characteristics	ENTITY
because	
individuals	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
often	
display	
excessive	ENTITY
preoccupation	ENTITY
with	
daytime	ENTITY
consequences	ENTITY
of	ENTITY
insomnia	ENTITY
,	
and	
they	
devote	
particular	
effort	ENTITY
to	
what	
they	
presume	
are	
sleep	ENTITY
-	
promot-	ENTITY
ing	
practices	ENTITY
.	

A	
psychological	ENTITY
style	
characterized	ENTITY
by	
the	
repression	ENTITY
and	
internalization	ENTITY
of	
disturbing	
affect	ENTITY
is	
characteristic	ENTITY
of	
those	
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
and	
also	
may	
represent	
a	
predisposing	ENTITY
trait	ENTITY
.	

Parents	ENTITY
who	
have	
unrealistic	ENTITY
sleep	ENTITY
expectations	ENTITY
for	
their	
children	ENTITY
may	
predispose	
them	
to	
insomnia	ENTITY
by	
putting	
them	
in	
bed	
too	
early	ENTITY
or	
assigning	
them	
too	
much	
time	
in	
bed	ENTITY
each	ENTITY
night	ENTITY
.	

Comorbid	ENTITY
psychiatric	ENTITY
conditions	ENTITY
,	
particularly	
mood	ENTITY
and	
anxiety	ENTITY
disorders	ENTITY
,	
are	
asso-	
ciated	ENTITY
with	
increased	ENTITY
risk	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Likewise	
,	
comorbid	ENTITY
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
or	
medical	ENTITY
disorders	ENTITY
such	
as	
GERD	ENTITY
or	
those	
conditions	ENTITY
that	
result	
in	
chronic	ENTITY
pain	ENTITY
,	
breathing	ENTITY
difficulties	ENTITY
,	
or	
immobility	ENTITY
also	
are	
associated	ENTITY
with	ENTITY
increased	ENTITY
risk	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

A	
pattern	ENTITY
of	
alcohol	ENTITY
dependence	ENTITY
/	
abuse	ENTITY
as	
well	
as	
the	
excessive	ENTITY
use	
of	
caffeine	ENTITY
or	
other	
stimulants	ENTITY
may	
raise	
risk	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Insomnia	ENTITY
in	
children	ENTITY
is	
often	
associated	ENTITY
with	ENTITY
difficult	ENTITY
temperament	ENTITY
,	
as	
well	
as	
other	
comorbid	ENTITY
medical	ENTITY
and	
psychiatric	ENTITY
conditions	ENTITY
.	

Unstable	
home	ENTITY
situations	ENTITY
,	
safety	ENTITY
concerns	ENTITY
and	
domestic	ENTITY
abuse	ENTITY
are	
likewise	
significant	
risk	ENTITY
factors	ENTITY
in	
both	
children	ENTITY
and	
adults	ENTITY
.	

Caregiver	ENTITY
and	
relationship	ENTITY
factors	
are	
also	
important	
to	
consider	
.	

Furthermore	
,	
parents	ENTITY
of	
children	ENTITY
with	
a	
current	ENTITY
or	
past	ENTITY
history	ENTITY
of	
medical	ENTITY
problems	ENTITY
may	
have	
dif-	
ficulty	
setting	
limits	ENTITY
,	
whether	
because	
of	
guilt	ENTITY
,	
a	
sense	
that	
the	
child	ENTITY
is	
“	
vulnerable	ENTITY
,	
”	
or	
concerns	ENTITY
about	
doing	
psychological	ENTITY
harm	ENTITY
.	

Environmental	ENTITY
factors	ENTITY
such	
as	
the	
child	ENTITY
sharing	
a	
room	ENTITY
with	
a	
parent	ENTITY
or	
with	
other	
siblings	ENTITY
,	
the	
presence	ENTITY
of	
extended	ENTITY
family	ENTITY
or	
others	
in	
the	
home	ENTITY
,	
and	
cramped	ENTITY
living	ENTITY
accommodations	ENTITY
may	
contribute	
to	
negative	ENTITY
sleep	ENTITY
-	
onset	ENTITY
associations	ENTITY
or	
poor	ENTITY
limit	ENTITY
setting	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

The	
familial	ENTITY
pattern	ENTITY
of	
insomnia	ENTITY
is	
not	
well	
documented	ENTITY
.	

Nonetheless	
,	
the	
preva-	
lence	
of	
insomnia	ENTITY
is	
higher	ENTITY
among	
monozygotic	ENTITY
twins	ENTITY
relative	
to	
dizygotic	ENTITY
twins	ENTITY
;	
it	
is	
also	
higher	
in	
first	
-	
degree	ENTITY
relatives	ENTITY
than	
in	
the	
general	ENTITY
population	ENTITY
.	

The	
association	ENTITY
is	
stronger	
with	
mothers	ENTITY
and	
daughters	ENTITY
.	

The	
extent	
to	
which	
familial	ENTITY
aggregation	ENTITY
represents	
shared	
genetic	ENTITY
predisposition	ENTITY
,	
shared	ENTITY
environment	ENTITY
,	
learned	ENTITY
behavior	ENTITY
(	
e.g.	
,	
by	
observations	ENTITY
of	
parental	ENTITY
behavior	ENTITY
)	
,	
or	
a	
by	
-	
product	ENTITY
of	
psychopathology	ENTITY
remains	
undetermined	
.	

Insomnia	ENTITY
Insomnia	ENTITY
Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
may	
be	
insidious	ENTITY
or	
acute	ENTITY
.	

In	
the	
former	
case	
,	
individuals	ENTITY
often	
report	ENTITY
symptoms	ENTITY
of	
insomnia	ENTITY
in	
early	ENTITY
life	ENTITY
or	
young	ENTITY
adulthood	ENTITY
.	

Onset	ENTITY
of	
insomnia	ENTITY
is	
often	
associated	ENTITY
with	ENTITY
major	ENTITY
life	ENTITY
events	ENTITY
(	
e.g.	
,	
separation	ENTITY
,	
death	ENTITY
of	
a	
loved	
one	
)	
,	
minor	
daily	ENTITY
stressors	ENTITY
,	
or	
changes	ENTITY
in	
sleep	ENTITY
schedule	ENTITY
.	

The	
course	ENTITY
of	
insomnia	ENTITY
can	
be	
situational	ENTITY
,	
recurrent	ENTITY
,	
or	
persistent	ENTITY
.	

The	
specific	
type	
of	
sleep	ENTITY
complaint	ENTITY
may	
also	
change	
over	
time	ENTITY
.	

Individuals	ENTITY
who	
complain	ENTITY
of	
diffi-	
culty	ENTITY
falling	ENTITY
asleep	ENTITY
at	
one	
time	ENTITY
may	
later	
complain	ENTITY
of	
difficulty	ENTITY
maintaining	ENTITY
sleep	ENTITY
,	
and	
vice	
versa	
.	

Although	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
often	
remits	ENTITY
when	
the	
precipitating	ENTITY
event	ENTITY
subsides	ENTITY
or	
the	
individual	ENTITY
adapts	
to	
it	
,	
sleep	ENTITY
difficulties	ENTITY
may	
also	
persist	
over	
time	ENTITY
even	
after	
the	
initial	
triggering	ENTITY
factor	ENTITY
has	
disappeared	
.	

When	
left	ENTITY
untreated	ENTITY
,	
insomnia	ENTITY
may	
persist	
and	
gradually	
lead	
to	
a	
vicious	ENTITY
cycle	ENTITY
of	
poor	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
impairments	ENTITY
,	
apprehension	ENTITY
of	
insomnia	ENTITY
,	
and	
further	
sleep	ENTITY
disturbances	ENTITY
.	

Among	
predisposed	ENTITY
individ-	
uals	ENTITY
,	
insomnia	ENTITY
can	
also	
follow	
an	
intermittent	ENTITY
course	ENTITY
,	
with	
recurrent	ENTITY
episodes	ENTITY
of	
sleep	ENTITY
difficulties	ENTITY
associated	ENTITY
with	ENTITY
stressful	ENTITY
life	ENTITY
events	ENTITY
.	

Even	
in	
persistent	ENTITY
insomnia	ENTITY
,	
there	
is	
extensive	
night	ENTITY
-	
to	
-	
night	ENTITY
variability	ENTITY
,	
with	
an	
occasional	
good	ENTITY
night	ENTITY
’s	ENTITY
sleep	ENTITY
intertwined	
with	
several	
poor	ENTITY
night	ENTITY
’s	ENTITY
sleep	ENTITY
.	

Approximately	
70	
%	
of	
individuals	ENTITY
with	
insomnia	ENTITY
at	
a	
given	
time	
continue	
reporting	
insomnia	ENTITY
a	
year	ENTITY
later	
,	
and	
50	
%	
still	
have	
insomnia	ENTITY
three	
years	ENTITY
later	
.	

Complications	ENTITY
of	
persistent	ENTITY
insomnia	ENTITY
include	
increased	ENTITY
risks	ENTITY
for	
depression	ENTITY
,	
hypertension	ENTITY
,	
work	ENTITY
disability	ENTITY
,	
and	
prolonged	ENTITY
use	ENTITY
of	ENTITY
prescription	ENTITY
or	
over-	
the	
-	
counter	ENTITY
sleep	ENTITY
aids	ENTITY
.	

Among	
children	ENTITY
,	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
have	
its	
onset	
at	
any	
time	
during	
late	ENTITY
infancy	ENTITY
through	
the	
childhood	ENTITY
years	ENTITY
.	

The	
course	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
in	
young	ENTITY
children	ENTITY
varies	
and	
depends	
on	
the	
reasons	ENTITY
for	
the	
sleeplessness	ENTITY
.	

When	
limit	ENTITY
-	
setting	ENTITY
factors	ENTITY
and	
negative	ENTITY
sleep	ENTITY
associations	
resolve	
,	
sleep	ENTITY
often	
improves	ENTITY
.	

With	
age	ENTITY
,	
inde-	
pendence	ENTITY
and	
privacy	ENTITY
become	
more	
important	
,	
and	
sleep	ENTITY
difficulties	ENTITY
may	
decrease	ENTITY
.	

Complications	ENTITY
may	
result	
from	
the	
consequent	ENTITY
sleep	ENTITY
loss	ENTITY
and	
include	
irritability	ENTITY
and	
decreased	ENTITY
attention	ENTITY
and	
school	ENTITY
performance	ENTITY
.	

Increased	ENTITY
family	ENTITY
tensions	ENTITY
and	
caregiver	ENTITY
sleep	ENTITY
loss	ENTITY
may	
also	
result	
.	

Some	
who	
develop	
insomnia	ENTITY
during	
childhood	ENTITY
may	
con-	ENTITY
tinue	ENTITY
to	
suffer	
from	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
into	
adulthood	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Developmental	ENTITY
issues	ENTITY
during	
childhood	ENTITY
,	
such	
as	
separation	ENTITY
anxiety	ENTITY
and	
age	ENTITY
/	
develop-	ENTITY
mental	ENTITY
milestones	ENTITY
,	
may	
predispose	
a	
child	ENTITY
to	
developing	
sleep	ENTITY
problems	ENTITY
.	

For	
example	
,	
limit	ENTITY
-	
setting	ENTITY
issues	ENTITY
are	
often	
more	
common	
after	
the	
child	ENTITY
is	
old	
enough	
to	
climb	ENTITY
out	
of	
the	
crib	ENTITY
or	
is	
moved	
into	
a	
bed	ENTITY
,	
has	
increased	ENTITY
verbal	ENTITY
skills	ENTITY
,	
and	
desires	ENTITY
greater	ENTITY
indepen-	
dence	ENTITY
.	

Because	
children	ENTITY
are	
not	
expected	
to	
sleep	ENTITY
through	
the	
night	ENTITY
with	
regularity	ENTITY
until	
they	
are	
three	
to	
six	
months	ENTITY
of	
age	ENTITY
,	
six	
months	ENTITY
is	
a	
reasonable	
age	ENTITY
to	
first	
consider	
a	
diagnosis	ENTITY
of	
insomnia	ENTITY
disorder	ENTITY
,	
unless	
the	
sleeplessness	ENTITY
is	
very	
marked	
at	
an	
earlier	
age	ENTITY
.	

However	
,	
when	
sleep	ENTITY
difficulties	ENTITY
are	
persistent	ENTITY
and	
pronounced	
in	
infants	ENTITY
,	
underlying	
medical	ENTITY
causes	ENTITY
should	
be	
considered	
(	
e.g.	
,	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
,	
GERD	ENTITY
,	
pain	ENTITY
)	
.	

The	
specific	
symptoms	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
as	
well	
as	
precipitating	ENTITY
and	
per-	
petuating	ENTITY
factors	ENTITY
,	
may	
vary	
across	
the	
adult	ENTITY
age	ENTITY
range	
.	

These	
changes	ENTITY
may	
in	
part	
reflect	
developmental	ENTITY
changes	ENTITY
across	
adulthood	ENTITY
,	
such	
as	
the	
phase	ENTITY
delay	ENTITY
of	
endoge-	
nous	
circadian	ENTITY
rhythms	ENTITY
in	
adolescence	ENTITY
and	
young	ENTITY
adulthood	ENTITY
,	
and	
the	
phase	ENTITY
advance	ENTITY
and	
increased	ENTITY
number	
of	
awakenings	ENTITY
often	
seen	
even	
among	
healthy	ENTITY
older	ENTITY
adults	ENTITY
.	

Epidemiological	ENTITY
studies	ENTITY
confirm	
that	
sleep	ENTITY
onset	ENTITY
difficulties	ENTITY
and	
nonrestorative	ENTITY
sleep	ENTITY
are	
most	
common	
among	
young	ENTITY
adults	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
whereas	
sleep	ENTITY
maintenance	ENTITY
insomnia	ENTITY
and	
early	ENTITY
morning	ENTITY
awakening	ENTITY
are	
more	
common	
in	
middle	ENTITY
-	
aged	ENTITY
and	
older	ENTITY
adults	ENTITY
.	

Objective	ENTITY
daytime	ENTITY
sleepiness	ENTITY
is	
uncommon	
in	
younger	ENTITY
adults	ENTITY
with	
insomnia	ENTITY
,	
but	
more	
common	
in	
older	ENTITY
adults	ENTITY
.	

However	
,	
older	ENTITY
adults	ENTITY
may	
have	
less	
sleep	ENTITY
dissatisfaction	ENTITY
than	
their	
younger	ENTITY
counterparts	
,	
despite	
objectively	ENTITY
worse	
sleep	ENTITY
continuity	ENTITY
.	

Precipitating	ENTITY
factors	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
also	
change	
across	
the	
adult	ENTITY
age	ENTITY
range	
,	
with	
medical	ENTITY
and	
medication	ENTITY
factors	ENTITY
assuming	
a	
larger	
role	
in	
older	ENTITY
adults	ENTITY
.	

Likewise	
,	
perpetuating	
factors	ENTITY
may	
vary	
with	
the	
life	ENTITY
circumstances	ENTITY
of	
adults	ENTITY
of	
different	
ages	ENTITY
.	

One	
common	
example	
is	
the	
option	
of	
older	ENTITY
adults	ENTITY
to	
spend	
large	
amounts	
of	
time	ENTITY
in	
bed	ENTITY
after	
retirement	ENTITY
,	
which	
may	
exacerbate	ENTITY
the	
effects	ENTITY
of	ENTITY
age	ENTITY
on	
sleep	ENTITY
continuity	ENTITY
.	

Finally	
,	
medical	ENTITY
disorders	ENTITY
and	
symptoms	ENTITY
(	
e.g.	
,	
pain	ENTITY
,	
dyspnea	ENTITY
,	
and	
impaired	ENTITY
mobility	ENTITY
)	
and	
medications	ENTITY
often	
play	
a	
larger	
role	
in	
the	
insomnia	ENTITY
of	
older	ENTITY
adults	ENTITY
in	
comparison	ENTITY
with	
younger	ENTITY
adults	ENTITY
.	

Hypnotic	ENTITY
medications	ENTITY
are	
disproportion-	
ately	ENTITY
prescribed	ENTITY
to	
older	ENTITY
adults	ENTITY
,	
often	
with	
limited	
benefit	ENTITY
and	
the	
potential	ENTITY
for	
rebound	ENTITY
and	
withdrawal	ENTITY
insomnia	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Studies	ENTITY
of	
the	
pathophysiology	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
have	
focused	
on	
one	
or	
more	
dimensions	ENTITY
of	
physiological	ENTITY
hyperarousal	ENTITY
during	
sleep	ENTITY
and	
wakefulness	ENTITY
.	

These	
studies	ENTITY
contrast	ENTITY
groups	ENTITY
of	
insomnia	ENTITY
sufferers	ENTITY
,	
typically	
those	
without	
sig-	
nificant	ENTITY
comorbidities	ENTITY
,	
with	
healthy	ENTITY
controls	ENTITY
using	
a	
variety	
of	
physiological	ENTITY
mea-	
sures	ENTITY
.	

Many	
of	
these	
studies	ENTITY
are	
characterized	ENTITY
by	
small	
sample	ENTITY
sizes	ENTITY
and	
lack	ENTITY
of	
replication	ENTITY
.	

Collectively	
these	
studies	ENTITY
suggest	
increased	ENTITY
physiological	ENTITY
arousal	ENTITY
among	
individuals	ENTITY
with	
insomnia	ENTITY
,	
characterized	
by	
measures	ENTITY
such	
as	
increased	ENTITY
heart	ENTITY
rate	ENTITY
,	
altered	
heart	ENTITY
rate	ENTITY
variability	ENTITY
,	
increased	ENTITY
whole	ENTITY
-	
body	ENTITY
metabolic	ENTITY
rate	ENTITY
,	
elevated	ENTITY
corti-	
sol	ENTITY
,	
adrenocorticotropic	ENTITY
hormone	ENTITY
,	
and	
CRF	ENTITY
levels	ENTITY
(	
particularly	
near	ENTITY
sleep	ENTITY
onset	ENTITY
)	
,	
increased	ENTITY
body	ENTITY
temperature	ENTITY
and	
increased	ENTITY
high	ENTITY
-	
frequency	ENTITY
electroencephalographic	ENTITY
(	
EEG	
)	
activity	ENTITY
during	
nonrapid	ENTITY
eye	ENTITY
movement	ENTITY
(	
NREM	
)	
sleep	
.	

These	
studies	ENTITY
imply	
Insomnia	ENTITY
Insomnia	
heightened	ENTITY
activity	ENTITY
of	
the	
sympathetic	ENTITY
nervous	ENTITY
system	ENTITY
and	
hypothalamic	ENTITY
-	
pitu-	
itary	ENTITY
-	
adrenal	ENTITY
axis	
across	
sleep	ENTITY
and	
wakefulness	ENTITY
that	
is	
thought	
to	
perpetuate	
sleep/	ENTITY
wake	ENTITY
dysfunction	ENTITY
.	

Some	
evidence	ENTITY
also	
suggests	
that	
physiological	ENTITY
dysregulation	ENTITY
may	
be	
more	
evident	
in	
certain	
subgroups	ENTITY
of	
individuals	ENTITY
with	
insomnia	ENTITY
(	
e.g.	
,	
those	
with	
extreme	
subjective	ENTITY
-	
objective	ENTITY
sleep	ENTITY
discrepancies	ENTITY
or	
those	
with	
insomnia	ENTITY
and	
short	ENTITY
objective	ENTITY
sleep	ENTITY
duration	ENTITY
)	
.	

There	
is	
also	
some	
evidence	ENTITY
that	
these	
findings	ENTITY
may	
not	
generalize	
to	
insomnia	ENTITY
comorbid	ENTITY
with	
mental	ENTITY
disorders	ENTITY
,	
which	
may	
have	
differ-	
ent	
pathophysiological	ENTITY
findings	ENTITY
.	

No	
discrete	
structural	
brain	
pathology	ENTITY
can	
be	
identified	ENTITY
in	
most	
individuals	ENTITY
with	
insom-	
nia	ENTITY
.	

Patients	ENTITY
with	
insomnia	ENTITY
comorbid	ENTITY
with	
neurological	ENTITY
disorders	ENTITY
such	
as	
stroke	ENTITY
,	
brain	ENTITY
trauma	ENTITY
,	
and	
multiple	ENTITY
sclerosis	ENTITY
may	
have	
identifiable	
brain	ENTITY
lesions	ENTITY
,	
but	
insomnia	ENTITY
is	
rarely	
their	
sole	
neurological	ENTITY
symptom	ENTITY
.	

Recent	
studies	
have	
provided	
conflicting	
evi-	
dence	
regarding	
the	
finding	ENTITY
of	
reduced	ENTITY
hippocampal	ENTITY
or	
anterior	ENTITY
cingulate	ENTITY
volume	ENTITY
,	
with	
most	
studies	ENTITY
reporting	
negative	ENTITY
findings	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

Although	
polysomnography	ENTITY
is	
not	
indicated	
in	
the	
routine	ENTITY
evaluation	ENTITY
of	
insomnia	ENTITY
,	
it	
may	
be	
useful	
to	
rule	
out	
other	
sleep	ENTITY
disorders	ENTITY
(	
e.g.	
,	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
)	
among	
some	
patients	ENTITY
who	
appear	
to	
meet	
criteria	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

In	
the	
absence	ENTITY
of	
other	
sleep	ENTITY
disorders	ENTITY
,	
results	ENTITY
of	
polysomnographic	ENTITY
sleep	ENTITY
monitoring	ENTITY
of	
patients	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
show	
increased	ENTITY
sleep	ENTITY
latency	ENTITY
and/or	
increased	ENTITY
wake	ENTITY
time	ENTITY
after	
sleep	ENTITY
onset	ENTITY
coupled	
with	
reduced	ENTITY
sleep	ENTITY
efficiency	ENTITY
in	
com-	
parison	ENTITY
with	
age	ENTITY
-	
appropriate	ENTITY
norms	ENTITY
.	

Sleep	ENTITY
onset	ENTITY
latency	ENTITY
or	
wake	ENTITY
time	ENTITY
after	
sleep	ENTITY
onset	ENTITY
often	
exceeds	
30	
minutes	ENTITY
,	
although	
one	
-	
hour	ENTITY
to	
two	
-	
hour	ENTITY
periods	ENTITY
of	
wakefulness	ENTITY
in	
bed	ENTITY
are	
not	
uncommon	
.	

A	
subset	
of	
patients	ENTITY
shows	
reduced	ENTITY
sleep	ENTITY
duration	ENTITY
of	
less	
than	
six	
hours	
per	
night	ENTITY
.	

Some	
patients	ENTITY
show	
altered	
sleep	ENTITY
architecture	ENTITY
with	
an	
increase	ENTITY
in	
stage	ENTITY
N1	ENTITY
sleep	ENTITY
and	
a	
decrease	ENTITY
in	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

Patients	ENTITY
with	
a	
pronounced	
condi-	
tioned	ENTITY
sleep	ENTITY
difficulty	ENTITY
in	
the	
home	ENTITY
environment	ENTITY
may	
show	
a	
reverse	ENTITY
first	
-	
night	ENTITY
effect	ENTITY
in	
the	
sleep	ENTITY
laboratory	ENTITY
(	
i.e.	
,	
better	
sleep	ENTITY
on	
the	
first	
vs.	
the	
second	
recording	ENTITY
night	ENTITY
)	
.	

However	
,	
some	
patients	ENTITY
show	
normal	ENTITY
sleep	ENTITY
times	ENTITY
and	
an	
absence	ENTITY
of	
sleep	ENTITY
onset	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
difficulties	ENTITY
on	
standard	ENTITY
polysomnographic	ENTITY
(	
PSG	ENTITY
)	
measures	ENTITY
.	

Some	
insomnia	ENTITY
patients	ENTITY
have	
alterations	ENTITY
in	
power	ENTITY
density	ENTITY
measures	ENTITY
of	
the	
sleep	ENTITY
EEG	ENTITY
when	
compared	ENTITY
with	
individuals	ENTITY
without	
sleep	ENTITY
complaints	ENTITY
.	

Specifically	
,	
these	
patients	ENTITY
often	
show	
relatively	
greater	
power	
in	
the	
high	ENTITY
frequency	ENTITY
(	
beta	ENTITY
and	
gamma	ENTITY
ranges	ENTITY
)	
band-	
widths	ENTITY
.	

Some	
reports	ENTITY
have	
shown	
that	
elevated	ENTITY
high	ENTITY
-	
frequency	ENTITY
power	ENTITY
is	
characteris-	
tic	
of	
insomnia	ENTITY
patients	ENTITY
with	
marked	
subjective	ENTITY
-	
objective	ENTITY
discrepancies	ENTITY
in	
sleep	ENTITY
mea-	
sures	ENTITY
,	
compared	
to	
insomnia	ENTITY
patients	ENTITY
with	
more	
obvious	
objective	ENTITY
sleep	ENTITY
disturbances	ENTITY
or	
individuals	ENTITY
without	
sleep	ENTITY
complaints	ENTITY
.	

Serial	ENTITY
monitoring	ENTITY
with	
PSG	ENTITY
or	
actigraphy	ENTITY
typically	
shows	
marked	
night	ENTITY
-	
to	
-	
night	ENTITY
vari-	
ability	ENTITY
in	
all	
sleep	ENTITY
measures	ENTITY
as	
well	
as	
in	
recorded	
bed	ENTITY
and	
rising	ENTITY
times	ENTITY
.	

This	
variability	ENTITY
is	
typically	
greater	
than	
that	
of	
comparison	ENTITY
groups	ENTITY
of	
good	ENTITY
sleepers	ENTITY
.	

Many	
patients	ENTITY
with	
insomnia	ENTITY
underestimate	
the	
actual	ENTITY
sleep	ENTITY
time	ENTITY
shown	
by	
polysom-	
nography	ENTITY
,	
and	
some	
may	
provide	
sleep	ENTITY
estimates	ENTITY
that	
fall	ENTITY
far	
short	
of	
actual	ENTITY
PSG-	ENTITY
recorded	
sleep	ENTITY
time	ENTITY
.	

This	
latter	
group	ENTITY
has	
previously	
been	
categorized	
as	
having	
subjective	ENTITY
insomnia	ENTITY
,	
sleep	ENTITY
state	ENTITY
misperception	ENTITY
,	
or	
paradoxical	ENTITY
insomnia	ENTITY
.	

In	
general	
,	
patients	ENTITY
with	
insomnia	ENTITY
tend	
to	
underestimate	
sleep	ENTITY
duration	ENTITY
and	
overestimate	ENTITY
sleep	ENTITY
latency	ENTITY
and	
awakenings	ENTITY
,	
whereas	
good	
sleepers	ENTITY
tend	
to	
overestimate	ENTITY
sleep	ENTITY
duration	ENTITY
and	
underestimate	
sleep	ENTITY
latency	ENTITY
and	
awakenings	ENTITY
relative	
to	
PSG	ENTITY
.	

This	
subjective	ENTITY
-	
ob-	
jective	ENTITY
mismatch	ENTITY
may	
be	
related	
to	
physiological	ENTITY
hyperarousal	ENTITY
,	
and	
may	
be	
one	
of	
the	
core	ENTITY
features	ENTITY
of	
insomnia	ENTITY
.	

Results	ENTITY
of	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
(	ENTITY
MSLT	ENTITY
)	
usually	
show	
normal	ENTITY
daytime	ENTITY
alert-	
ness	ENTITY
.	

In	
several	
studies	ENTITY
,	
patients	ENTITY
with	
insomnia	ENTITY
have	
longer	ENTITY
mean	ENTITY
MSLT	ENTITY
values	ENTITY
than	
control	ENTITY
subjects	ENTITY
,	
suggesting	
hyperalertness	ENTITY
or	
hyperarousal	ENTITY
.	

A	
minority	ENTITY
of	
insomnia	ENTITY
patients	ENTITY
,	
particularly	
older	ENTITY
adults	ENTITY
with	
insomnia	ENTITY
,	
have	
reduced	ENTITY
mean	
MSLT	ENTITY
values	
indicating	
increased	ENTITY
sleepiness	ENTITY
.	

Such	
a	
finding	ENTITY
should	
prompt	
consideration	
of	
other	
concurrent	ENTITY
sleep	ENTITY
disorders	ENTITY
such	
as	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Young	ENTITY
children	ENTITY
typically	
show	
essentially	
normal	ENTITY
sleep	ENTITY
during	
PSG	ENTITY
monitoring	ENTITY
when	
the	
caregiver	ENTITY
is	
present	
and	
appropriate	ENTITY
limits	ENTITY
are	
set	
in	
the	
laboratory	ENTITY
.	

Although	
PSG	ENTITY
and	
MSLT	ENTITY
testing	ENTITY
usually	
are	
not	
helpful	
in	
the	
establishment	ENTITY
of	
an	
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
,	
there	
are	
circumstances	
that	
may	
warrant	
such	
testing	ENTITY
with	
selected	
patients	ENTITY
.	

PSG	ENTITY
should	
be	
considered	
when	
there	
are	
reported	
symptoms	ENTITY
or	
bed	ENTITY
partner	ENTITY
observations	ENTITY
of	
sleep	ENTITY
disordered	ENTITY
breathing	
or	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
during	
sleep	ENTITY
.	

Patients	ENTITY
who	
present	
insomnia	ENTITY
symptoms	ENTITY
accompanied	
by	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
may	
warrant	
PSG	ENTITY
and	
MSLT	ENTITY
testing	ENTITY
,	
particularly	
if	
narcolepsy	ENTITY
is	
suspected	ENTITY
.	

Patients	ENTITY
who	
show	
acceptable	
adherence	ENTITY
to	
trials	ENTITY
of	
well	
-	
established	ENTITY
insom-	
nia	ENTITY
therapies	ENTITY
but	
fail	ENTITY
to	
show	
adequate	ENTITY
treatment	ENTITY
response	ENTITY
may	
benefit	
by	
PSG	ENTITY
to	
rule	
out	
a	
comorbid	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

Finally	
,	
a	
small	
number	
of	
functional	ENTITY
imaging	ENTITY
studies	
have	
been	
conducted	
during	
sleep	ENTITY
and	
wakefulness	ENTITY
in	
insomnia	ENTITY
and	
control	ENTITY
groups	ENTITY
.	

These	
studies	ENTITY
suggest	
region-	
ally	
specific	
increases	ENTITY
of	
relative	ENTITY
glucose	ENTITY
metabolism	ENTITY
in	
insomnia	ENTITY
compared	
to	
controls	ENTITY
.	

Specifically	
,	
these	
studies	ENTITY
show	
smaller	
wake	
to	
NREM	ENTITY
decreases	ENTITY
of	
relative	ENTITY
glucose	ENTITY
metabolism	ENTITY
in	
sleep	ENTITY
/	
wake	ENTITY
-	
regulating	ENTITY
regions	ENTITY
including	
thalamus	ENTITY
,	
upper	ENTITY
brainstem	ENTITY
,	
Insomnia	ENTITY
Insomnia	
anterior	ENTITY
cingulate	ENTITY
,	
and	
limbic	ENTITY
cortex	ENTITY
in	
insomnia	ENTITY
patients	ENTITY
.	

Self	ENTITY
-	
reported	ENTITY
and	
objective	ENTITY
sleep	ENTITY
disruptions	ENTITY
are	
related	
to	
increased	ENTITY
relative	ENTITY
metabolism	ENTITY
in	
these	
regions	ENTITY
.	

These	
findings	ENTITY
are	
similar	
to	
regional	ENTITY
activation	
patterns	
during	
sleep	ENTITY
in	
an	
animal	ENTITY
model	ENTITY
of	
stress	ENTITY
-	
induced	ENTITY
insomnia	ENTITY
.	

Other	
studies	ENTITY
using	
nuclear	ENTITY
magnetic	ENTITY
resonance	ENTITY
spectroscopy	ENTITY
have	
identified	ENTITY
reduced	ENTITY
gamma	ENTITY
-	
aminobutyric	ENTITY
acid	ENTITY
(	
GABA	
)	
signaling	
in	
sleep	ENTITY
-	
regu-	ENTITY
lating	ENTITY
regions	ENTITY
in	
insomnia	ENTITY
that	
correlate	
with	
objective	
measure	ENTITY
of	
sleep	ENTITY
continuity	ENTITY
.	

Studies	ENTITY
examining	
task	ENTITY
-	
related	ENTITY
changes	ENTITY
in	
blood	ENTITY
flow	ENTITY
using	
blood	ENTITY
oxygenation	ENTITY
level	ENTITY
dependent	
functional	
magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
(	
BOLD	ENTITY
fMRI	ENTITY
)	
paradigms	ENTITY
have	
shown	
reduced	ENTITY
activation	ENTITY
relative	
to	
baseline	ENTITY
levels	ENTITY
in	
individuals	ENTITY
with	
insomnia	ENTITY
when	
compared	
to	
normal	ENTITY
sleeping	ENTITY
controls	ENTITY
.	

Task	ENTITY
-	
related	ENTITY
activation	ENTITY
changes	
in	
the	
direction	ENTITY
of	
“	
normalization	ENTITY
”	
following	
cognitive	ENTITY
behavioral	ENTITY
treatment	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
that	
presents	
as	
difficulty	
initiating	ENTITY
sleep	ENTITY
should	
be	
differen-	
tiated	
from	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
.	

In	
the	
latter	
condition	ENTITY
,	
sleep	ENTITY
initiation	ENTITY
is	
consistently	
later	
than	
desired	
because	
the	
individual	ENTITY
’s	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
is	
delayed	ENTITY
relative	
to	
the	
desired	
sleep	ENTITY
schedule	ENTITY
.	

Sleep	ENTITY
-	
onset	ENTITY
difficulties	
persist	
,	
and	
sleep	ENTITY
time	ENTITY
is	
reduced	ENTITY
whenever	
the	
individual	ENTITY
chooses	
bedtimes	ENTITY
and	
rising	ENTITY
times	
that	
are	
too	
early	ENTITY
and	
out	
of	
phase	ENTITY
with	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
.	

However	
,	
patients	ENTITY
with	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
are	
able	
to	
fall	ENTITY
asleep	ENTITY
with	
less	
difficulty	ENTITY
,	
and	
sleep	ENTITY
a	
normal	
amount	
of	
time	ENTITY
,	
when	
sleeping	ENTITY
in	
phase	ENTITY
with	
their	
delayed	ENTITY
endogenous	ENTITY
rhythm	ENTITY
by	
selecting	
late	ENTITY
bed	ENTITY
and	
rising	ENTITY
times	ENTITY
.	

By	
comparison	ENTITY
,	
those	
with	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
often	
feel	
sleepy	ENTITY
at	
the	
desired	
bedtime	ENTITY
but	
are	
unable	
to	
sleep	ENTITY
regardless	
of	
the	
timing	ENTITY
of	
their	
bed	ENTITY
and	
rise	
times	
.	

Furthermore	
,	
sleep	ENTITY
problems	ENTITY
tend	
to	
be	
more	
variable	ENTITY
on	
a	
night	ENTITY
-	
to	
-	
night	ENTITY
basis	
in	
insomnia	ENTITY
disorder	ENTITY
.	

Given	
the	
prevalence	ENTITY
of	
delayed	ENTITY
sleep-	
wake	
phase	ENTITY
disorder	ENTITY
in	
teenagers	ENTITY
and	
young	ENTITY
adults	ENTITY
,	
it	
is	
particularly	
important	
to	
con-	
sider	
the	
possibility	
of	
this	
alternate	ENTITY
or	
comorbid	ENTITY
diagnosis	ENTITY
when	
evaluating	ENTITY
individuals	ENTITY
from	
these	
age	ENTITY
groups	ENTITY
presenting	
with	
sleep	ENTITY
onset	ENTITY
insomnia	ENTITY
complaints	ENTITY
.	

A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
that	
presents	
as	
a	
difficulty	ENTITY
maintaining	
sleep	ENTITY
with	
pre-	
mature	ENTITY
morning	ENTITY
rise	
times	
also	
should	
be	
differentiated	
from	
advanced	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
.	

The	
latter	
tends	
to	
be	
more	
common	
in	
older	ENTITY
adults	ENTITY
than	
it	
is	
in	
younger	ENTITY
adults	ENTITY
and	
children	ENTITY
.	

Among	
those	
with	
an	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
pattern	
,	
sleep	ENTITY
initia-	
tion	ENTITY
is	
consistently	
earlier	
than	
desired	
because	
the	
individual	ENTITY
’s	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
is	
advanced	
relative	
to	
the	
desired	
sleep	ENTITY
schedule	ENTITY
.	

However	
,	
total	ENTITY
sleep	ENTITY
time	ENTITY
is	
adequate	ENTITY
when	
the	
individual	ENTITY
chooses	
early	ENTITY
bed	
and	
rise	
times	
that	
coincide	
with	
the	
advanced	ENTITY
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
.	

In	
contrast	
,	
those	
with	
chronic	ENTITY
insomnia	ENTITY
dis-	
order	
may	
display	ENTITY
sleep	ENTITY
maintenance	ENTITY
difficulties	ENTITY
and	
early	ENTITY
morning	ENTITY
rise	
time	
regard-	
less	
of	
the	
sleep	ENTITY
schedule	ENTITY
they	
select	
.	

There	
can	
be	
some	
overlap	ENTITY
between	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
and	
both	
delayed	ENTITY
and	
advanced	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorders	ENTITY
.	

Patients	ENTITY
with	
a	
delayed	ENTITY
sleep	ENTITY
pattern	ENTITY
may	
become	
chronically	ENTITY
frustrated	ENTITY
or	
anxious	ENTITY
about	
their	
inability	
to	
initiate	ENTITY
sleep	ENTITY
at	
their	
desired	
times	ENTITY
,	
and	
this	
frustration	ENTITY
or	
anxiety	ENTITY
may	
continue	
to	
disrupt	ENTITY
sleep	ENTITY
and	
delay	ENTITY
sleep	ENTITY
onset	ENTITY
well	
beyond	
the	
sleep	ENTITY
onset	ENTITY
time	ENTITY
promoted	
by	
the	
endogenous	ENTITY
rhythm	ENTITY
.	

Early	ENTITY
morning	ENTITY
awakenings	ENTITY
may	
similarly	
have	
arousing	ENTITY
sleep	ENTITY
disruptive	ENTITY
effects	ENTITY
in	
the	
setting	
of	
an	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
.	

In	
such	
circumstances	
both	
a	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorder	ENTITY
diagnosis	ENTITY
and	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
may	
apply	
and	
should	
be	
assigned	ENTITY
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
should	
also	
be	
discriminated	
from	
situational	ENTITY
sleep	ENTITY
dif-	
ficulties	ENTITY
arising	
from	
sleep	ENTITY
-	
disruptive	ENTITY
environmental	
circumstances	
.	

A	
variety	
of	
environmental	ENTITY
factors	ENTITY
including	
excessive	ENTITY
noise	ENTITY
or	
light	ENTITY
and	
extreme	ENTITY
temperatures	ENTITY
will	
disrupt	ENTITY
the	
sleep	ENTITY
of	
most	
individuals	ENTITY
.	

Also	
,	
sleeping	ENTITY
in	
an	
area	ENTITY
where	
there	
is	
imminent	ENTITY
threat	ENTITY
or	
danger	ENTITY
to	
one	
’s	
safety	ENTITY
can	
also	
be	
disruptive	ENTITY
to	ENTITY
sleep	ENTITY
.	

Bed	ENTITY
part-	
ners	ENTITY
who	
snore	ENTITY
loudly	ENTITY
,	
move	
excessively	
during	
sleep	ENTITY
,	
or	
have	
parasomnias	ENTITY
may	
also	
disrupt	ENTITY
one	
’s	ENTITY
sleep	ENTITY
.	

When	
an	
individual	ENTITY
reports	ENTITY
environmental	ENTITY
circumstances	
that	
would	
be	
regarded	
as	
disruptive	
to	
the	
sleep	ENTITY
of	
most	
individuals	ENTITY
,	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
should	
not	
be	
assigned	ENTITY
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
applies	
only	
when	
the	
individual	ENTITY
reports	
sleep	ENTITY
difficulty	ENTITY
in	
the	
context	ENTITY
of	
sleep	ENTITY
-	
conducive	ENTITY
envi-	
ronment	ENTITY
circumstances	ENTITY
or	
when	
the	
insomnia	ENTITY
symptoms	ENTITY
show	
some	
independence	ENTITY
from	
the	
environmental	ENTITY
factors	ENTITY
.	

When	
environmental	ENTITY
circumstances	
are	
a	
primary	
cause	
of	
sleep	ENTITY
disturbance	ENTITY
and	
associated	ENTITY
consequences	ENTITY
,	
a	
diagnosis	ENTITY
of	
other	
sleep	ENTITY
disorder	ENTITY
may	
be	
considered	
.	

Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
should	
also	
be	
differentiated	
from	
patterns	ENTITY
of	
chronic	ENTITY
voli-	
tional	ENTITY
sleep	ENTITY
restriction	ENTITY
(	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
)	
.	

Some	
individuals	ENTITY
show	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
fatigue	ENTITY
,	
and	
reduced	ENTITY
sleep	ENTITY
at	
night	ENTITY
as	
a	
result	
of	
electing	ENTITY
overly	
demanding	
daytime	ENTITY
schedules	ENTITY
or	
by	
volitionally	
delaying	
sleep	ENTITY
in	
order	
to	
engage	
in	
desired	
recreational	ENTITY
or	
social	ENTITY
activities	ENTITY
.	

However	
,	
when	
allowing	
themselves	
suffi-	
cient	ENTITY
time	ENTITY
to	
sleep	ENTITY
,	
they	
are	
able	
to	
initiate	ENTITY
and	
maintain	
sleep	ENTITY
easily	
and	
for	
a	
normal	ENTITY
duration	ENTITY
.	

Those	
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
tend	
to	
have	
excessive	ENTITY
wake	ENTITY
time	ENTITY
and	
reduced	ENTITY
sleep	ENTITY
time	ENTITY
despite	
routinely	
allotting	
sufficient	
time	
to	
sleep	ENTITY
.	

Moreover	
,	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
not	
typically	
associated	ENTITY
with	ENTITY
excessive	ENTITY
daytime	ENTITY
sleepi-	
ness	ENTITY
and	
unintentional	ENTITY
daytime	ENTITY
sleep	ENTITY
episodes	ENTITY
,	
which	
are	
often	
observed	
in	
those	
with	
patterns	ENTITY
of	
volitional	ENTITY
sleep	ENTITY
restriction	ENTITY
.	

Insomnia	ENTITY
symptoms	ENTITY
may	
occur	
comorbid	ENTITY
with	
another	
sleep	ENTITY
disorder	ENTITY
,	
such	
as	
sleep	ENTITY
apnea	ENTITY
or	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
.	

A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
would	
apply	
Insomnia	ENTITY
Insomnia	ENTITY
only	
when	
:	
(	
1	
)	
the	
insomnia	ENTITY
symptoms	ENTITY
show	
some	
independence	ENTITY
in	
their	
onset	ENTITY
or	
variation	ENTITY
over	
time	
from	
the	
other	
symptoms	ENTITY
of	
the	
co	ENTITY
-	
occurring	ENTITY
sleep	ENTITY
disorder	ENTITY
;	
or	
(	
2	
)	
when	
insomnia	ENTITY
symptoms	ENTITY
persist	
despite	
adequate	ENTITY
treatment	ENTITY
reflected	
by	
marked	
symptom	ENTITY
improvement	ENTITY
in	
the	
coincident	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
would	
not	
apply	
when	
effective	ENTITY
treatment	ENTITY
of	
the	
coincident	ENTITY
sleep	ENTITY
disorder	ENTITY
resolves	
the	
insomnia	ENTITY
symptoms	ENTITY
.	

Among	
children	ENTITY
,	
sleep	ENTITY
difficulties	ENTITY
may	
be	
present	
when	
the	
child	ENTITY
has	
to	
sleep	ENTITY
alone	
in	
a	
separate	
room	ENTITY
,	
but	
absent	ENTITY
when	
the	
child	ENTITY
is	
allowed	
to	
sleep	ENTITY
with	
parents	ENTITY
or	
when	
a	
parent	ENTITY
is	
present	
in	
the	
child	ENTITY
’s	ENTITY
bedroom	ENTITY
.	

An	
absence	ENTITY
of	
sleep	ENTITY
difficulties	ENTITY
under	
the	
latter	
circumstances	
does	
not	
indicate	
the	
insomnia	ENTITY
is	
resolved	ENTITY
.	

Only	
when	
the	
child	ENTITY
is	
able	
to	
sleep	ENTITY
consistently	
independently	
is	
there	
no	
longer	
an	
insomnia	ENTITY
problem	ENTITY
.	

In	
some	
children	ENTITY
,	
the	
persistence	ENTITY
of	
sleep	ENTITY
difficulties	ENTITY
in	
the	
absence	ENTITY
of	
parents	ENTITY
may	
reflect	
underlying	
conditions	ENTITY
such	
as	
separation	ENTITY
anxiety	ENTITY
or	
an	
anxiety	ENTITY
disorder	ENTITY
.	

In	
young	ENTITY
children	ENTITY
,	
sleep	ENTITY
difficulties	ENTITY
can	
be	
the	
result	
of	
medical	ENTITY
issues	ENTITY
,	
including	
gas-	ENTITY
troesophageal	ENTITY
reflux	ENTITY
,	
as	
well	
as	
developmental	ENTITY
milestones	ENTITY
,	
such	
as	
motoric	ENTITY
,	
language	ENTITY
,	
and	
cognitive	ENTITY
development	ENTITY
.	

Children	ENTITY
,	
adolescents	ENTITY
,	
and	
adults	ENTITY
may	
develop	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
comorbid	ENTITY
with	
a	
medical	ENTITY
or	
psychiatric	ENTITY
disorder	ENTITY
.	

Insomnia	ENTITY
symp-	
toms	ENTITY
may	
arise	
as	
a	
result	
of	
either	
another	
sleep	ENTITY
disorder	ENTITY
,	
a	
medical	ENTITY
condition	ENTITY
,	
or	
a	
psychiatric	ENTITY
disorder	ENTITY
that	
has	
sleep	ENTITY
-	
disruptive	ENTITY
effects	ENTITY
.	

A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
would	
apply	
when	
:	
(	
1	
)	
the	
insomnia	ENTITY
symptoms	ENTITY
show	
some	
independence	ENTITY
in	
their	
onset	ENTITY
or	
variation	ENTITY
over	
time	
from	
the	
other	
symptoms	ENTITY
of	
the	
co	ENTITY
-	
occurring	ENTITY
sleep	ENTITY
,	
medical	ENTITY
,	
or	
psychiatric	ENTITY
disorder	ENTITY
;	
or	
(	
2	
)	
when	
insomnia	ENTITY
symptoms	ENTITY
persist	
despite	
ade-	
quate	ENTITY
treatment	ENTITY
reflected	
by	
marked	
symptom	ENTITY
improvement	ENTITY
in	
the	
coincident	ENTITY
sleep	ENTITY
,	
medical	ENTITY
,	
or	
psychiatric	ENTITY
disorder	ENTITY
.	

Because	
insomnia	ENTITY
symptoms	ENTITY
often	
develop	
some	
independence	ENTITY
over	
time	ENTITY
,	
a	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
usually	
will	
be	
war-	
ranted	
when	
those	
symptoms	ENTITY
are	
persistent	ENTITY
in	
association	ENTITY
with	ENTITY
a	
chronic	ENTITY
medical	ENTITY
or	
psychiatric	ENTITY
disorder	ENTITY
.	

A	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
would	
not	
apply	
when	
effective	ENTITY
treatment	ENTITY
of	
the	
coincident	ENTITY
sleep	ENTITY
,	
medical	ENTITY
,	
or	
psychiatric	ENTITY
disorder	ENTITY
resolves	
the	
insomnia	ENTITY
symptoms	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Much	
remains	
to	
be	
learned	ENTITY
about	
the	
underlying	
pathophysiological	ENTITY
pathways	
leading	
to	
insomnia	ENTITY
and	
whether	
insomnia	ENTITY
should	
be	
classified	
as	
a	
unitary	ENTITY
disorder	ENTITY
or	
sub-	
divided	
into	
several	
subtypes	ENTITY
.	

Clearly	
,	
these	
issues	ENTITY
are	
closely	
linked	
.	

Further	
studies	ENTITY
that	
clarify	
the	
pathophysiological	ENTITY
pathways	
leading	
to	
insomnia	ENTITY
ultimately	
will	
reveal	
whether	
those	
meeting	
current	
criteria	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
suffer	
from	
a	
single	ENTITY
disease	ENTITY
or	
multiple	ENTITY
separate	
diseases	ENTITY
with	
similar	
outward	ENTITY
presentations	ENTITY
.	

A	
related	
unresolved	
issue	ENTITY
is	
whether	
the	
current	
global	
classification	ENTITY
promotes	ENTITY
a	
generic	ENTITY
approach	ENTITY
to	
insomnia	ENTITY
therapy	ENTITY
that	
ultimately	
fails	
to	
benefit	ENTITY
some	
insomnia	ENTITY
subgroups	ENTITY
.	

Perhaps	
this	
global	ENTITY
classification	ENTITY
scheme	
will	
overlook	
distinctive	
insomnia	ENTITY
subtypes	ENTITY
with	
specific	
treatment	ENTITY
needs	
that	
vary	
from	
the	
generic	ENTITY
treatments	ENTITY
typically	
provided	
.	

Previous	
editions	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
allowed	
for	
the	
assignment	ENTITY
of	
an	
insomnia	ENTITY
diagnosis	ENTITY
to	
patients	ENTITY
who	
present	
exclusively	
with	
com-	
plaints	ENTITY
of	
nonrestorative	ENTITY
sleep	ENTITY
;	
that	
is	
,	
patients	ENTITY
who	
complain	ENTITY
only	
of	
sleep	ENTITY
that	
is	
poor	ENTITY
in	
quality	ENTITY
or	
unrefreshing	ENTITY
,	
in	
the	
absence	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
,	
could	
qualify	
for	
an	
insomnia	ENTITY
diagnosis	ENTITY
in	
previous	
versions	ENTITY
of	
this	
nosol-	
ogy	
.	

The	
current	ENTITY
version	ENTITY
of	
this	
nosology	ENTITY
excludes	
such	
patients	ENTITY
from	
the	
insomnia	ENTITY
diagnostic	ENTITY
categories	ENTITY
.	

This	
decision	ENTITY
was	
based	
on	
several	
considerations	ENTITY
.	

Most	
insom-	
nia	ENTITY
patients	ENTITY
present	
with	
complaints	ENTITY
of	
sleep	ENTITY
initiation	ENTITY
or	
maintenance	ENTITY
difficulties	ENTITY
.	

Although	
a	
small	
subset	
of	
patients	ENTITY
present	
with	
isolated	ENTITY
complaints	ENTITY
of	
nonrestorative	ENTITY
sleep	ENTITY
,	
this	
complaint	ENTITY
more	
commonly	
arises	
in	
association	ENTITY
with	ENTITY
other	
symptoms	ENTITY
of	
insomnia	ENTITY
,	
or	
in	
conjunction	ENTITY
with	
sleep	ENTITY
disordered	ENTITY
breathing	
,	
other	
sleep	ENTITY
disorders	ENTITY
or	
certain	
chronic	ENTITY
medical	ENTITY
conditions	ENTITY
(	
e.g.	
,	
fibromyalgia	ENTITY
or	
chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
)	
.	

Although	
various	
epidemiological	ENTITY
studies	ENTITY
have	
identified	ENTITY
subgroups	ENTITY
who	
are	
presumed	
to	
have	
an	
insomnia	ENTITY
disorder	ENTITY
and	
present	
solely	
with	
a	
complaint	ENTITY
that	
their	
sleep	ENTITY
is	
non-	
restorative	ENTITY
or	
unrefreshing	ENTITY
,	
such	
studies	ENTITY
typically	
lack	
polysomnography	ENTITY
that	
would	
be	
needed	
to	
rule	
out	
other	
occult	ENTITY
sleep	ENTITY
disorders	ENTITY
as	
a	
cause	ENTITY
.	

Finally	
,	
nonrestorative	ENTITY
sleep	ENTITY
remains	
a	
poorly	ENTITY
defined	
construct	
that	
may	
reflect	
not	
only	
a	
type	
of	
sleep	ENTITY
disturbance	ENTITY
,	
but	
also	
the	
daytime	ENTITY
consequences	ENTITY
of	
poor	ENTITY
sleep	ENTITY
such	
as	
fatigue	ENTITY
and	
anergia	ENTITY
.	

This	
con-	ENTITY
struct	ENTITY
would	
benefit	ENTITY
from	
further	
definitional	
efforts	
and	
research	ENTITY
to	
explore	
its	
clinical	ENTITY
significance	ENTITY
in	
the	
context	ENTITY
of	
insomnia	ENTITY
.	

Given	
these	
considerations	ENTITY
,	
the	
isolated	ENTITY
com-	ENTITY
plaint	ENTITY
of	
nonrestorative	ENTITY
sleep	ENTITY
was	
not	
retained	
as	
part	
of	
the	
diagnostic	ENTITY
definition	ENTITY
of	
the	
insomnia	ENTITY
disorders	ENTITY
delineated	
in	
this	
manual	ENTITY
.	

Bibliography	ENTITY
Baglioni	ENTITY
C	ENTITY
,	
Battagliese	ENTITY
G	ENTITY
,	
Feige	ENTITY
B	ENTITY
,	
et	
al	
.	

Insomnia	ENTITY
as	
a	
predictor	ENTITY
of	
depression	ENTITY
:	
a	
meta	ENTITY
-	
analytic	ENTITY
evaluation	ENTITY
of	
longitudinal	ENTITY
epidemiological	ENTITY
studies	ENTITY
.	

J	
Affect	
Dis	
2011;135;10–9	
.	

Bastien	ENTITY
CH	ENTITY
,	
St	ENTITY
-	
Jean	ENTITY
G	ENTITY
,	
Morin	ENTITY
CM	ENTITY
,	
Turcotte	ENTITY
I	ENTITY
,	
Carrier	ENTITY
J.	
Chronic	ENTITY
psychophysiological	ENTITY
insomnia	ENTITY
:	
hyperarousal	ENTITY
and/or	
inhibition	ENTITY
deficits	ENTITY
?	

An	
ERPs	ENTITY
investigation	ENTITY
.	

Sleep	ENTITY
2008;31:887–98	
.	

Beaulieu	ENTITY
-	
Bonneau	ENTITY
S	ENTITY
,	
LeBlanc	ENTITY
M	ENTITY
,	
Mérette	ENTITY
C	ENTITY
,	
Dauvilliers	ENTITY
Y	ENTITY
,	
Morin	ENTITY
CM	ENTITY
.	

Family	ENTITY
history	ENTITY
of	
insomnia	ENTITY
in	
a	
population	ENTITY
-	
based	ENTITY
sample	ENTITY
.	

Sleep	ENTITY
2007;30:1739–45	
.	

Billows	ENTITY
M	ENTITY
,	
Gradisar	ENTITY
M	ENTITY
,	
Dohnt	ENTITY
H	ENTITY
,	
Johnston	
A	
,	
McCappin	ENTITY
S	ENTITY
,	
Hudson	ENTITY
J.	ENTITY
Family	ENTITY
disorganization	
,	
sleep	ENTITY
hygiene	ENTITY
,	
and	
adolescent	ENTITY
sleep	ENTITY
disturbance	ENTITY
.	

J	
Clin	
Child	
Adolesc	
Psychol	
2009;38:745–52	
.	

Bonnet	ENTITY
MH	ENTITY
,	
Arand	ENTITY
DL	ENTITY
.	
24	
-	
hour	ENTITY
metabolic	ENTITY
rate	ENTITY
in	
insomniacs	ENTITY
and	
matched	
normal	
sleepers	ENTITY
.	

Sleep	ENTITY
1995;18:581–8	ENTITY
.	

Insomnia	ENTITY
Insomnia	ENTITY
Bonnet	ENTITY
MH	ENTITY
,	
Arand	ENTITY
DL	ENTITY
.	

Heart	ENTITY
rate	ENTITY
variability	ENTITY
in	
insomniacs	ENTITY
and	
matched	
normal	
sleepers	ENTITY
.	

Psychosom	ENTITY
Med	ENTITY
1998;60:610–5	ENTITY
.	

Bonnet	ENTITY
MH	ENTITY
,	
Arand	ENTITY
DL	ENTITY
.	
Hyperarousal	ENTITY
and	
insomnia	ENTITY
:	
State	ENTITY
of	
the	
science	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2010;14:9–15	ENTITY
.	

Buysse	ENTITY
DJ	ENTITY
,	
Angst	
J	
,	
Gamma	ENTITY
A	ENTITY
,	
Ajdacic	ENTITY
V	ENTITY
,	
Eich	ENTITY
D	ENTITY
,	
Rössler	ENTITY
W.	ENTITY
Prevalence	ENTITY
,	
course	ENTITY
,	
and	
comorbidity	ENTITY
of	
insomnia	ENTITY
and	
depression	ENTITY
in	
young	ENTITY
adults	ENTITY
.	

Sleep	ENTITY
2008;31:473–80	
.	

Dohnt	ENTITY
H	ENTITY
,	
Gradisar	ENTITY
M	ENTITY
,	
Short	ENTITY
MA	ENTITY
.	

Insomnia	ENTITY
and	
its	
symptoms	ENTITY
in	
adolescents	ENTITY
:	
comparing	ENTITY
DSM	ENTITY
-	
IV	ENTITY
and	
ICSD	ENTITY
-	
II	ENTITY
diagnostic	ENTITY
criteria	ENTITY
.	

J	
Clin	
Sleep	
Med	
2012;8:295–9	
.	

Edinger	ENTITY
JD	ENTITY
,	
Wyatt	ENTITY
JK	ENTITY
,	
Stepanski	ENTITY
EJ	ENTITY
,	
et	
al	
.	

Testing	ENTITY
the	
reliability	ENTITY
and	
validity	ENTITY
of	
DSM	ENTITY
-	
IV	ENTITY
-	
TR	ENTITY
and	
ICSD-2	ENTITY
insomnia	ENTITY
diagnoses	ENTITY
:	
results	ENTITY
of	
a	
multi	ENTITY
-	
method	ENTITY
/	
multi	ENTITY
-	
trait	ENTITY
analysis	ENTITY
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
2011;68:992–1002	
.	

Krystal	ENTITY
AD	ENTITY
,	
Edinger	ENTITY
JD	ENTITY
,	
Wohlgemuth	ENTITY
WK	ENTITY
,	ENTITY
Marsh	ENTITY
GR	ENTITY
.	

Non	ENTITY
-	
REM	ENTITY
sleep	ENTITY
EEG	ENTITY
frequency	ENTITY
spectral	ENTITY
correlates	
of	
sleep	ENTITY
complaints	ENTITY
in	
primary	ENTITY
insomnia	ENTITY
subtypes	ENTITY
.	

Sleep	ENTITY
2002;25:630–40	ENTITY
.	

Lack	ENTITY
LC	ENTITY
,	
Wright	ENTITY
HR	ENTITY
.	

Treating	ENTITY
chronobiological	ENTITY
components	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2007;8:637–44	ENTITY
.	

Lichstein	ENTITY
KL	ENTITY
.	

Secondary	ENTITY
insomnia	ENTITY
.	

In	
:	
Lichstein	ENTITY
KL	ENTITY
,	ENTITY
Morin	ENTITY
CM	ENTITY
,	
eds	
.	

Treatment	ENTITY
of	
late	ENTITY
-	
life	ENTITY
insomnia	ENTITY
.	

Thousand	ENTITY
Oaks	ENTITY
,	
CA	ENTITY
:	
Sage	ENTITY
,	
2000:297–319	
.	

Mindell	ENTITY
JA	ENTITY
,	
Kuhn	ENTITY
B	ENTITY
,	
Lewin	ENTITY
DS	ENTITY
,	
Meltzer	ENTITY
LJ	ENTITY
,	
Sadeh	ENTITY
A.	ENTITY
Behavioral	ENTITY
treatment	ENTITY
of	
bedtime	ENTITY
problems	ENTITY
and	
night	ENTITY
wakings	ENTITY
in	
infants	ENTITY
and	
young	ENTITY
children	ENTITY
.	

Sleep	ENTITY
2006;29:1263–76	
.	

Mindell	ENTITY
JA	ENTITY
,	
Sadeh	ENTITY
A	ENTITY
,	
Wiegand	ENTITY
B	ENTITY
,	
How	
TH	ENTITY
,	
Goh	ENTITY
DY	ENTITY
.	

Cross	ENTITY
-	
cultural	ENTITY
differences	
in	
infant	ENTITY
and	
toddler	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:274–80	ENTITY
.	

Morgenthaler	ENTITY
TI	ENTITY
,	
Owens	ENTITY
J	ENTITY
,	ENTITY
Alessi	ENTITY
C	ENTITY
,	
et	
al	
.	

Practice	ENTITY
parameters	ENTITY
for	
behavioral	ENTITY
treatment	ENTITY
of	
bedtime	ENTITY
problems	ENTITY
and	
night	ENTITY
wakings	ENTITY
in	
infants	ENTITY
and	
young	ENTITY
children	ENTITY
.	

Sleep	ENTITY
2006;29:1277–81	
.	

Morin	ENTITY
CM	ENTITY
,	
Bélanger	ENTITY
L	ENTITY
,	
LeBlanc	ENTITY
M	ENTITY
,	
et	
al	
.	

The	
natural	ENTITY
history	ENTITY
of	
insomnia	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
3	
-	
year	ENTITY
longitudinal	ENTITY
study	ENTITY
.	

Arch	ENTITY
Intern	ENTITY
Med	ENTITY
2009;169:447–53	ENTITY
.	

Nofzinger	ENTITY
EA	ENTITY
.	

Functional	ENTITY
neuroimaging	ENTITY
evidence	ENTITY
for	
hyperarousal	ENTITY
in	
insomnia	ENTITY
.	

Am	ENTITY
J	ENTITY
Psychiatry	ENTITY
2004;161:2126–31	
.	

Nofzinger	ENTITY
EA	ENTITY
,	
Nissen	ENTITY
C	ENTITY
,	
Germain	ENTITY
A	ENTITY
,	
et	
al	
.	

Regional	ENTITY
cerebral	
metabolic	
correlates	
of	
WASO	ENTITY
during	
sleep	ENTITY
in	
insomnia	ENTITY
.	

J	
Clin	
Sleep	
Med	
2006;2:316–22	
.	

Ohayon	ENTITY
MM	ENTITY
.	

Epidemiology	ENTITY
of	
insomnia	ENTITY
:	
what	
we	
know	
and	
what	
we	
still	
need	
to	
learn	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2002;6:97–111	ENTITY
.	

Ohayon	ENTITY
MM	ENTITY
,	
Caulet	ENTITY
M	ENTITY
,	
Lemoine	ENTITY
P.	ENTITY
Comorbidity	ENTITY
of	ENTITY
mental	ENTITY
and	
insomnia	ENTITY
disorders	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

Compr	ENTITY
Psychiatry	ENTITY
1998;39:185–97	ENTITY
.	

Ohayon	ENTITY
MM	ENTITY
,	
Roberts	ENTITY
RE	ENTITY
.	

Comparability	ENTITY
of	
sleep	ENTITY
disorders	ENTITY
diagnoses	ENTITY
using	
DSM	ENTITY
-	
IV	ENTITY
and	
ICSD	ENTITY
classifications	ENTITY
with	
adolescents	ENTITY
.	

Sleep	ENTITY
2001;24:920–5	
.	

Perlis	ENTITY
ML	ENTITY
,	
Smith	ENTITY
MT	ENTITY
,	
Andrew	ENTITY
PJ	ENTITY
,	
Orff	ENTITY
H	ENTITY
,	
Giles	ENTITY
DE	ENTITY
.	

Beta	ENTITY
/	
gamma	ENTITY
EEG	ENTITY
activity	ENTITY
in	
patients	ENTITY
with	
primary	ENTITY
and	
secondary	ENTITY
insomnia	ENTITY
and	
good	ENTITY
sleeper	ENTITY
controls	
.	

Sleep	ENTITY
2001;24:110–7	
.	

Riemann	ENTITY
D	ENTITY
,	
Voderholzer	ENTITY
U	ENTITY
,	
Spiegelhalder	ENTITY
K	ENTITY
,	
et	
al	
.	

Chronic	ENTITY
insomnia	ENTITY
and	
MRI	ENTITY
-	
measured	ENTITY
hippocampal	ENTITY
volumes	ENTITY
:	

A	
pilot	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2007;30:955–8	
.	

Riemann	ENTITY
D	ENTITY
,	
Spiegelhalder	ENTITY
K	ENTITY
,	
Feige	
B	
,	
et	
al	
.	

The	
hyperarousal	ENTITY
model	ENTITY
of	
insomnia	ENTITY
:	
A	
review	ENTITY
of	
the	
concept	ENTITY
and	
its	
evidence	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2010;14:19–31	
.	

Roberts	ENTITY
RE	ENTITY
,	
Roberts	ENTITY
CR	ENTITY
,	
Chan	
W.	
Persistence	ENTITY
and	
change	ENTITY
in	
symptoms	ENTITY
of	
insomnia	ENTITY
among	
adolescents	ENTITY
.	

Sleep	ENTITY
2008;31:177–84	
.	

Sánchez	ENTITY
-	
Ortuño	
MM	ENTITY
,	
Carney	ENTITY
CE	ENTITY
,	
Edinger	ENTITY
JD	ENTITY
,	
Wyatt	ENTITY
JK	ENTITY
,	
Harris	ENTITY
A.	ENTITY

Moving	ENTITY
beyond	
average	ENTITY
values	ENTITY
:	
assessing	ENTITY
the	
night	ENTITY
-	
to	
-	
night	ENTITY
instability	ENTITY
of	
sleep	ENTITY
and	
arousal	ENTITY
in	
DSM	ENTITY
-	
IV	ENTITY
-	
TR	ENTITY
insomnia	ENTITY
subtypes	ENTITY
.	

Sleep	ENTITY
2011;34:531–9	
.	

Stepanski	ENTITY
E	ENTITY
,	
Zorick	ENTITY
F	ENTITY
,	
Roehrs	ENTITY
T	ENTITY
,	
Young	ENTITY
D	ENTITY
,	
Roth	
T.	ENTITY
Daytime	ENTITY
alertness	ENTITY
in	
patients	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
compared	
with	
asymptomatic	ENTITY
control	ENTITY
subjects	ENTITY
.	

Sleep	ENTITY
1988;11:54–60	
.	

Vgontzas	ENTITY
AN	ENTITY
,	
Liao	
D	
,	
Bixler	ENTITY
EO	ENTITY
,	
Chrousos	ENTITY
GP	ENTITY
,	
Vela	ENTITY
-	
Bueno	
A.	ENTITY
Insomnia	ENTITY
with	
objective	
short	ENTITY
sleep	ENTITY
duration	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
high	ENTITY
risk	ENTITY
for	
hypertension	ENTITY
.	

Sleep	ENTITY
2009;32:491–7	
.	

Winkelman	ENTITY
JW	
,	
Buxton	ENTITY
OM	ENTITY
,	
Jensen	ENTITY
JE	ENTITY
,	
et	
al	
.	

Reduced	ENTITY
brain	ENTITY
GABA	ENTITY
in	
primary	ENTITY
insomnia	ENTITY
:	
preliminary	ENTITY
data	ENTITY
from	
4	
T	ENTITY
proton	ENTITY
magnetic	ENTITY
resonance	ENTITY
spectroscopy	ENTITY
(	
1H	ENTITY
-	
MRS	ENTITY
)	
.	

Sleep	ENTITY
2008;31:1499–506	
.	

Winkelman	ENTITY
JW	
,	
Benson	ENTITY
KL	ENTITY
,	ENTITY
Buxton	ENTITY
OM	ENTITY
,	
et	
al	
.	

Lack	ENTITY
of	
hippocampal	ENTITY
volume	ENTITY
differences	
in	
primary	ENTITY
insomnia	ENTITY
and	
good	ENTITY
sleeper	ENTITY
controls	
:	
an	
MRI	ENTITY
volumetric	ENTITY
study	ENTITY
at	
3	ENTITY
Tesla	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:576–82	ENTITY
.	

Zhang	ENTITY
J	ENTITY
,	
Li	ENTITY
AM	ENTITY
,	
Kong	ENTITY
AP	ENTITY
,	
Lai	ENTITY
KY	ENTITY
,	
Tang	ENTITY
NL	ENTITY
,	
Wing	ENTITY
YK	ENTITY
.	

A	
community	ENTITY
-	
based	ENTITY
study	ENTITY
of	
insomnia	ENTITY
in	
Hong	ENTITY
Kong	ENTITY
Chinese	ENTITY
children	ENTITY
:	
Prevalence	ENTITY
,	
risk	ENTITY
factors	ENTITY
and	
familial	ENTITY
aggregation	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2009;10:1040–6	ENTITY
.	

Short	ENTITY
-	
Term	ENTITY
Insomnia	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.41	
Alternate	ENTITY
Names	ENTITY
Acute	ENTITY
insomnia	ENTITY
,	
adjustment	ENTITY
insomnia	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

F51.02	ENTITY
Insomnia	
A.	
The	
patient	ENTITY
reports	ENTITY
,	
or	
the	
patient	ENTITY
’s	
parent	ENTITY
or	
caregiver	ENTITY
observes	
,	
one	
or	
more	
of	
the	
following:1	ENTITY
.	

Difficulty	ENTITY
initiating	ENTITY
sleep	
.	
.	

Difficulty	ENTITY
maintaining	
sleep	ENTITY
.	
.	

Waking	ENTITY
up	
earlier	
than	
desired	
.	
.	

Resistance	ENTITY
to	
going	
to	
bed	
on	
appropriate	
schedule	ENTITY
.	
.	

Difficulty	ENTITY
sleeping	ENTITY
without	
parent	ENTITY
or	
caregiver	ENTITY
intervention	ENTITY
.	

B.	ENTITY
The	
patient	ENTITY
reports	ENTITY
,	
or	
the	
patient	ENTITY
’s	
parent	ENTITY
or	
caregiver	ENTITY
observes	
,	
one	
or	
more	
of	
the	
following	
related	
to	
the	
nighttime	ENTITY
sleep	ENTITY
difficulty	ENTITY
:	
.	

Fatigue	ENTITY
/	
malaise	ENTITY
.	
.	

Attention	ENTITY
,	
concentration	ENTITY
,	
or	
memory	ENTITY
impairment	ENTITY
.	
.	

Impaired	ENTITY
social	ENTITY
,	
family	ENTITY
,	
vocational	ENTITY
,	
or	
academic	ENTITY
performance	ENTITY
.	
.	

Mood	ENTITY
disturbance	ENTITY
/	
irritability	ENTITY
.	
.	

Daytime	ENTITY
sleepiness	ENTITY
.	
.	

Behavioral	ENTITY
problems	
(	
e.g.	
,	
hyperactivity	ENTITY
,	
impulsivity	ENTITY
,	
aggression	ENTITY
)	
.	

7	
.	
Reduced	ENTITY
motivation	ENTITY
/	
energy	ENTITY
/	
initiative	ENTITY
.	
.	

Proneness	ENTITY
for	
errors	ENTITY
/	
accidents	ENTITY
.	
.	

Concerns	ENTITY
about	
or	
dissatisfaction	ENTITY
with	ENTITY
sleep	ENTITY
.	

Insomnia	ENTITY
C.	

The	
reported	
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
can	
not	
be	
explained	
purely	
by	
inadequate	ENTITY
opportunity	ENTITY
(	
i.e.	
,	
enough	
time	ENTITY
is	
allotted	
for	
sleep	ENTITY
)	
or	
inadequate	ENTITY
circumstances	
(	
i.e.	
,	
the	
environment	ENTITY
is	
safe	
,	
dark	ENTITY
,	
quiet	ENTITY
,	
and	
comfortable	ENTITY
)	
for	
sleep	ENTITY
.	

D.	
The	
sleep	ENTITY
disturbance	ENTITY
and	
associated	
daytime	ENTITY
symptoms	ENTITY
have	
been	
present	
for	
less	
than	
three	
months	ENTITY
.	

E.	

The	
sleep	ENTITY
/	
wake	ENTITY
difficulty	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Reports	ENTITY
of	
difficulties	
initiating	
sleep	
,	
difficulties	ENTITY
maintaining	ENTITY
sleep	ENTITY
,	
or	
waking	ENTITY
up	
too	
early	ENTITY
can	
be	
seen	
in	
all	
age	ENTITY
groups	ENTITY
.	

Resistance	ENTITY
going	
to	
bed	ENTITY
on	
an	
appropriate	
schedule	ENTITY
and	
difficulty	ENTITY
sleeping	ENTITY
without	
parent	ENTITY
or	
caregiver	ENTITY
intervention	ENTITY
is	
seen	
most	
commonly	
in	
children	ENTITY
and	
older	ENTITY
adults	ENTITY
who	
require	
the	
supervision	ENTITY
of	
a	
caretaker	ENTITY
due	
to	
a	
significant	
level	ENTITY
of	
functional	ENTITY
impairment	ENTITY
(	
e.g.	
,	
those	
with	
dementia	ENTITY
)	
.	
.	

Patients	ENTITY
with	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
complain	ENTITY
of	
sleep/	ENTITY
wake	ENTITY
difficulties	ENTITY
fewer	
than	
three	
times	
per	
week	ENTITY
on	
average	ENTITY
,	
yet	
have	
clinically	ENTITY
significant	ENTITY
concerns	ENTITY
about	
their	
symptoms	ENTITY
and	
warrant	
clinical	ENTITY
attention	ENTITY
.	
.	

Many	
conditions	ENTITY
such	
as	
grief	ENTITY
,	
acute	ENTITY
pain	ENTITY
,	
or	
other	
acute	ENTITY
stressors	ENTITY
are	
quite	
often	
associated	ENTITY
with	ENTITY
poor	ENTITY
sleep	ENTITY
.	

When	
such	
conditions	ENTITY
are	
the	
sole	
cause	ENTITY
of	
the	
sleep	ENTITY
difficulty	ENTITY
,	
a	
separate	
insomnia	ENTITY
diagnosis	ENTITY
may	
not	
apply	
.	

The	
primary	ENTITY
factor	ENTITY
in	
determining	
application	ENTITY
of	
a	
short-	ENTITY
term	ENTITY
or	
adjustment	ENTITY
insomnia	ENTITY
diagnosis	ENTITY
is	
the	
extent	
to	
which	
the	
sleep	ENTITY
disturbance	ENTITY
becomes	
a	
significant	
focus	
for	
the	
individual	ENTITY
and/or	
warrants	
independent	
clinical	ENTITY
attention	ENTITY
.	

Essential	ENTITY
Features	ENTITY
The	
essential	
feature	
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
a	
short	ENTITY
-	
term	ENTITY
difficulty	ENTITY
ini-	ENTITY
tiating	ENTITY
or	
maintaining	
sleep	ENTITY
that	
results	ENTITY
in	
general	ENTITY
sleep	ENTITY
dissatisfaction	ENTITY
.	

The	
sleep	ENTITY
complaint	ENTITY
is	
accompanied	
by	
daytime	ENTITY
distress	ENTITY
about	
poor	ENTITY
sleep	ENTITY
or	
impairment	ENTITY
in	
family	ENTITY
,	
social	ENTITY
,	
occupational	ENTITY
,	
academic	ENTITY
,	
or	
other	
important	
areas	
of	
functioning	ENTITY
.	

Furthermore	
,	
the	
sleep	ENTITY
disturbance	ENTITY
and	
associated	
daytime	ENTITY
symptoms	ENTITY
occur	
despite	
having	
adequate	ENTITY
time	ENTITY
and	
circumstances	ENTITY
each	
night	ENTITY
to	
obtain	
necessary	
sleep	ENTITY
.	

Short-	ENTITY
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
can	
occur	
in	
isolation	ENTITY
or	
comorbid	ENTITY
with	
a	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
condition	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

In	
many	
cases	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
lasting	
less	
than	
three	
months	ENTITY
,	
there	
is	
an	
identifiable	
cause	
that	
serves	
as	
the	
precipitant	ENTITY
.	

In	
other	
cases	ENTITY
,	
insomnia	ENTITY
occurs	
episodically	ENTITY
,	
often	
coincident	ENTITY
to	
daytime	ENTITY
stressors	ENTITY
that	
account	
for	
the	
insomnia	ENTITY
.	

As	
is	
the	
case	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
sleep	ENTITY
complaints	ENTITY
that	
compose	
short-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
include	
difficulties	
initiating	
sleep	ENTITY
or	
difficulties	ENTITY
main-	
taining	ENTITY
sleep	ENTITY
.	

The	
latter	
complaint	ENTITY
may	
include	
waking	ENTITY
up	
during	
the	
night	ENTITY
with	
difficulty	ENTITY
returning	
to	
sleep	ENTITY
or	
having	
a	
final	
awakening	ENTITY
occurring	ENTITY
too	
early	ENTITY
,	
well	
before	
the	
desired	
rising	ENTITY
time	ENTITY
.	

Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
may	
be	
character-	
ized	ENTITY
solely	
by	
sleep	ENTITY
onset	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
or	
,	
more	
commonly	
,	
by	
both	
types	
of	
complaints	ENTITY
occurring	
together	
.	

Individuals	ENTITY
’	
sleep	ENTITY
complaints	ENTITY
may	
vary	
such	
that	
sleep	ENTITY
onset	ENTITY
difficulties	ENTITY
are	
apparent	ENTITY
on	
some	
nights	ENTITY
,	
whereas	
sleep	ENTITY
maintenance	ENTITY
difficulties	ENTITY
are	
present	
on	
other	
nights	ENTITY
.	

Complaints	ENTITY
about	
poor	ENTITY
-	
quality	ENTITY
,	
unrefreshing	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
may	
accompany	
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
mainte-	ENTITY
nance	ENTITY
complaints	ENTITY
,	
but	
do	
not	
meet	
the	
definition	ENTITY
of	
this	
condition	ENTITY
when	
they	
occur	
in	
isolation	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Sleep	ENTITY
disturbance	ENTITY
is	
the	
primary	
feature	
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
but	
it	
is	
com-	ENTITY
monly	ENTITY
accompanied	
by	
waking	ENTITY
symptoms	ENTITY
similar	
to	
those	
seen	
in	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Specific	ENTITY
symptoms	ENTITY
such	
as	
fatigue	ENTITY
,	
impaired	ENTITY
attention	ENTITY
and	
concentration	ENTITY
,	
poor	ENTITY
memory	ENTITY
,	
irritability	ENTITY
,	
and	
distress	ENTITY
about	
poor	ENTITY
sleep	ENTITY
are	
common	
.	

When	
the	
insomnia	ENTITY
arises	
in	
reaction	ENTITY
to	
a	
stressful	ENTITY
life	ENTITY
event	ENTITY
,	
such	
as	
the	
loss	ENTITY
of	
a	
loved	
one	
,	
major	ENTITY
illness	ENTITY
,	
or	
divorce	ENTITY
,	
the	
associated	ENTITY
features	ENTITY
may	
include	
anxiety	ENTITY
,	
worry	ENTITY
,	
ruminative	ENTITY
thoughts	ENTITY
,	
sadness	ENTITY
,	
or	
depression	ENTITY
in	
relation	
to	
the	
specific	
stressor	ENTITY
.	

If	
the	
individual	ENTITY
uses	
alcohol	ENTITY
,	
illicit	ENTITY
drugs	ENTITY
,	
or	
medications	ENTITY
for	
self	ENTITY
-	
treatment	ENTITY
,	
additional	
symptoms	ENTITY
related	
to	
these	
substances	ENTITY
may	
be	
seen	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
.	

Demographics	ENTITY
Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
can	
occur	
at	
any	
age	ENTITY
.	

However	
,	
a	
short	ENTITY
-	
term	ENTITY
form	
of	
insomnia	ENTITY
may	
be	
difficult	
to	
establish	
in	
infants	ENTITY
because	
it	
is	
often	
difficult	
to	
link	
stressors	ENTITY
to	
sleep	ENTITY
disturbances	ENTITY
in	
this	
age	ENTITY
group	ENTITY
.	

The	
exact	
prevalence	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
unknown	
.	

The	
one	
-	
year	ENTITY
prevalence	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
dis-	
order	
among	
adults	ENTITY
appears	
to	
be	
in	
the	
range	
of	
15	
%	
to	
20	
%	
.	

Like	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
is	
more	
prevalent	ENTITY
in	
women	ENTITY
than	
in	
men	ENTITY
,	
and	
in	
older	ENTITY
age	ENTITY
groups	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Affected	ENTITY
individuals	ENTITY
may	
note	
a	
lifelong	ENTITY
tendency	
toward	
light	ENTITY
sleep	ENTITY
or	
diffi-	
culty	ENTITY
sleeping	ENTITY
during	
times	
of	
stress	ENTITY
.	

A	
previous	
history	ENTITY
of	
anxiety	ENTITY
or	
depressive	ENTITY
Insomnia	ENTITY
Insomnia	ENTITY
symptoms	ENTITY
and	
disorders	ENTITY
also	
may	
predispose	
an	
individual	ENTITY
to	
develop	
a	
short-	
term	
insomnia	ENTITY
disorder	ENTITY
.	

In	
children	ENTITY
,	
having	
a	
parent	ENTITY
with	
insomnia	ENTITY
or	
living	ENTITY
in	
a	
household	ENTITY
lacking	ENTITY
parental	ENTITY
reinforcement	ENTITY
of	
a	
consistent	
sleep	ENTITY
/	
wake	ENTITY
schedule	ENTITY
may	
be	
predisposing	ENTITY
factors	ENTITY
.	

An	
acute	ENTITY
,	
identifiable	
event	ENTITY
or	
stressor	ENTITY
usually	
precipitates	ENTITY
this	
form	
of	
insomnia	ENTITY
.	

Common	
precipitating	ENTITY
events	ENTITY
include	
changes	ENTITY
or	
disputes	ENTITY
in	
interpersonal	ENTITY
relation-	
ships	ENTITY
,	
occupational	ENTITY
stress	ENTITY
,	
personal	ENTITY
losses	ENTITY
,	
bereavement	ENTITY
,	
diagnosis	ENTITY
or	
onset	
of	
a	
new	
medical	ENTITY
condition	ENTITY
,	
visiting	ENTITY
or	
moving	ENTITY
to	
a	
new	
location	ENTITY
,	
or	
physical	ENTITY
changes	ENTITY
to	
the	
usual	
sleep	ENTITY
environment	ENTITY
or	
schedule	ENTITY
.	

Changes	ENTITY
or	
stresses	ENTITY
with	
a	
positive	ENTITY
emotional	ENTITY
tone	ENTITY
also	
may	
serve	
as	
precipitating	ENTITY
events	ENTITY
.	

In	
children	ENTITY
or	
dependent	ENTITY
adults	ENTITY
,	
such	
insomnia	ENTITY
can	
arise	
when	
the	
caretaker	ENTITY
makes	
abrupt	
changes	ENTITY
in	
the	
child	ENTITY
’s	
or	
adult	ENTITY
’s	ENTITY
sleep	ENTITY
routines	ENTITY
or	
schedule	ENTITY
.	

As	
is	
the	
case	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
environ-	
mental	ENTITY
factors	ENTITY
such	
as	
the	
child	ENTITY
sharing	
a	
room	ENTITY
with	
a	
parent	ENTITY
or	
with	
other	
sib-	ENTITY
lings	ENTITY
,	
the	
presence	ENTITY
of	
extended	ENTITY
family	ENTITY
or	
others	
in	
the	
home	ENTITY
,	
and	
cramped	ENTITY
living	ENTITY
accommodations	ENTITY
may	
contribute	
to	
negative	ENTITY
sleep	ENTITY
-	
onset	ENTITY
associations	ENTITY
or	
poor	ENTITY
limit	ENTITY
setting	ENTITY
in	
children	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
patterns	ENTITY
are	
less	
well	
documented	ENTITY
for	
cases	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disor-	
der	
than	
they	
are	
for	
individuals	ENTITY
meeting	
criteria	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Nonetheless	
,	
the	
familial	ENTITY
aggregation	ENTITY
found	
for	
chronic	ENTITY
insomnia	ENTITY
disorders	ENTITY
is	
expected	
to	
also	
occur	
among	
individuals	ENTITY
with	
more	
transient	ENTITY
forms	
of	
insomnia	ENTITY
.	

Data	ENTITY
support	
a	
greater	
genetic	ENTITY
diathesis	ENTITY
to	
psychophysiologic	ENTITY
arousal	ENTITY
among	
certain	
individuals	ENTITY
in	
response	ENTITY
to	ENTITY
stressors	ENTITY
.	

This	
may	
,	
in	
turn	
,	
suggest	
a	
constitutional	ENTITY
predisposition	ENTITY
to	
short-	
term	
or	
adjustment	ENTITY
insomnia	ENTITY
in	
such	
individuals	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Many	
individuals	ENTITY
who	
develop	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
experience	
remission	ENTITY
of	
their	
insomnia	ENTITY
symptoms	ENTITY
over	
time	ENTITY
.	

This	
occurs	
as	
distress	ENTITY
over	
the	
precipitating	ENTITY
event	ENTITY
diminishes	
over	
time	ENTITY
or	
in	
response	ENTITY
to	
withdrawal	ENTITY
of	
the	
stressor	ENTITY
.	

However	
,	
a	
portion	ENTITY
of	
those	
who	
initially	
experience	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
may	
develop	
a	
more	
chronic	ENTITY
form	ENTITY
of	
insomnia	ENTITY
and	
subsequently	
meet	
criteria	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
dis-	
order	
.	

These	
individuals	ENTITY
will	
then	
have	
the	
course	ENTITY
and	
complications	ENTITY
described	
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
As	
is	
the	
case	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
would	
not	
be	
considered	
until	
after	
a	
child	ENTITY
reaches	
at	
least	
six	
months	ENTITY
of	
age	ENTITY
.	

The	
propensity	
to	
experience	ENTITY
sleep	ENTITY
disturbance	ENTITY
in	
response	ENTITY
to	ENTITY
stress	ENTITY
may	
dispose	
young	ENTITY
and	
older	ENTITY
individuals	ENTITY
toward	
acute	ENTITY
forms	ENTITY
of	
insomnia	ENTITY
.	

As	
is	
the	
case	ENTITY
for	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
sleep	ENTITY
onset	ENTITY
difficulties	ENTITY
are	
most	
common	
among	
young	ENTITY
adults	ENTITY
with	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
,	
whereas	
sleep	ENTITY
maintenance	ENTITY
complaints	ENTITY
and	
early	ENTITY
morning	ENTITY
awakening	ENTITY
are	
more	
common	
in	
middle	ENTITY
-	
aged	ENTITY
and	
older	ENTITY
adults	ENTITY
.	

Objective	ENTITY
daytime	ENTITY
sleepiness	ENTITY
is	
uncommon	
in	
younger	ENTITY
adults	ENTITY
with	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
but	
is	
more	
common	
in	
older	ENTITY
adults	ENTITY
.	

Balancing	ENTITY
job	ENTITY
and	
family	ENTITY
stressors	ENTITY
may	
contribute	
to	
intermittent	ENTITY
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
problems	ENTITY
in	
younger	ENTITY
and	
middle	ENTITY
-	
aged	ENTITY
adults	ENTITY
.	

In	
contrast	
,	
older	ENTITY
,	
retired	ENTITY
adults	ENTITY
may	
have	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
related	
to	
exacerbations	ENTITY
in	
comorbid	ENTITY
chronic	ENTITY
medical	ENTITY
con-	ENTITY
ditions	ENTITY
or	
due	
to	
loss	ENTITY
of	ENTITY
loved	ENTITY
ones	
that	
commonly	
occurs	
with	
advancing	
age	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Research	ENTITY
on	
the	
pathology	ENTITY
and	
pathophysiology	ENTITY
of	
short	ENTITY
-	
term	ENTITY
variants	ENTITY
of	
insomnia	ENTITY
disorder	ENTITY
is	
generally	
lacking	ENTITY
because	
the	
majority	
of	
studies	ENTITY
addressing	
this	
issue	ENTITY
have	
focused	
on	
samples	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorders	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
shares	
many	
features	ENTITY
with	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

The	
primary	ENTITY
difference	ENTITY
between	
the	
two	
conditions	ENTITY
is	
that	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disor-	
der	
does	
not	
meet	
the	
duration	ENTITY
and	
frequency	ENTITY
criteria	ENTITY
required	
for	
the	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
diagnosis	ENTITY
.	

Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
also	
should	
be	
distinguished	
from	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
resulting	
from	
rotating	ENTITY
shift	ENTITY
work	
or	
jet	ENTITY
lag	ENTITY
.	

In	
the	
latter	
case	ENTITY
,	
the	
sleep	ENTITY
disturbance	ENTITY
arises	
from	
a	
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
alteration	ENTITY
that	
results	ENTITY
in	
a	
mismatch	ENTITY
between	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
and	
the	
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
chosen	
—	
for	
example	
,	
having	
to	
sleep	ENTITY
in	
the	
daytime	ENTITY
rather	
than	
during	
the	
nighttime	ENTITY
.	

In	
the	
case	ENTITY
of	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
no	
such	
mismatch	ENTITY
exists	
;	
yet	
,	
the	
individual	
demonstrates	
sleep	ENTITY
onset	ENTITY
or	
maintenance	ENTITY
difficulties	ENTITY
nonetheless	
.	

Bibliography	ENTITY
Agnew	ENTITY
HW	ENTITY
Jr	ENTITY
,	
Webb	
WB	
,	
Williams	
RL	
.	

The	
first	
night	ENTITY
effect	ENTITY
:	
an	
EEG	ENTITY
study	ENTITY
of	
sleep	ENTITY
.	

Psychophysiology	ENTITY
1966;2:263–6	
.	

Angst	ENTITY
J	ENTITY
,	
Vollrath	ENTITY
M	ENTITY
,	
Koch	ENTITY
R	ENTITY
,	ENTITY
Dobler	ENTITY
-	ENTITY
Mikola	ENTITY
A.	ENTITY
The	
Zurich	ENTITY
Study	ENTITY
.	

VII	ENTITY
.	

Insomnia	ENTITY
:	
symptoms	ENTITY
,	
classification	ENTITY
and	
prevalence	ENTITY
.	

Eur	
Arch	
Psychiatry	
Clin	
Neurosci	
1989;238:285–93	
.	

Healey	ENTITY
ES	ENTITY
,	
Kales	ENTITY
A	ENTITY
,	
Monroe	ENTITY
LJ	ENTITY
,	
Bixler	ENTITY
EO	ENTITY
,	
Chamberlin	ENTITY
K	ENTITY
,	
Soldatos	ENTITY
CR	ENTITY
.	

Onset	ENTITY
of	
insomnia	ENTITY
:	
role	
of	
life-	ENTITY
stress	ENTITY
events	ENTITY
.	

Psychosom	ENTITY
Med	ENTITY
1981;43:439–51	ENTITY
.	

Morin	ENTITY
CM	ENTITY
,	
Rodrigue	ENTITY
S	ENTITY
,	
Ivers	
H.	
Role	
of	
stress	ENTITY
,	
arousal	ENTITY
and	
coping	ENTITY
skills	ENTITY
in	
primary	ENTITY
insomnia	ENTITY
.	

Psychosom	ENTITY
Med	ENTITY
2003;65:259–67	ENTITY
.	

Roehrs	ENTITY
T	ENTITY
,	
Zorick	ENTITY
F	ENTITY
,	
Roth	
T.	
Transient	
and	
short	ENTITY
-	
term	ENTITY
insomnias	ENTITY
.	

In	
:	
Krieger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
3rd	
ed	
.	

Philadelphia	ENTITY
:	
WB	ENTITY
Saunders	ENTITY
,	
2000:624–32	
.	

Tachibana	ENTITY
H	ENTITY
,	ENTITY
Izumi	ENTITY
T	ENTITY
,	
Honda	ENTITY
S	ENTITY
,	ENTITY
Takemoto	ENTITY
TI	ENTITY
.	

The	
prevalence	ENTITY
and	
pattern	ENTITY
of	
insomnia	ENTITY
in	
Japanese	ENTITY
industrial	ENTITY
workers	ENTITY
:	
relationship	ENTITY
between	
psychosocial	ENTITY
stress	ENTITY
and	
type	ENTITY
of	
insomnia	ENTITY
.	

Psychiatry	ENTITY
Clin	ENTITY
Neurosci	ENTITY
1998;52:397–402	
.	

Insomnia	ENTITY
Insomnia	ENTITY
Other	
Insomnia	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.49	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F51.09	ENTITY
This	
diagnosis	ENTITY
is	
reserved	
for	
individuals	ENTITY
who	
complain	ENTITY
of	
difficulty	
initiating	
and	
maintaining	
sleep	ENTITY
and	
yet	
do	
not	
meet	
the	
full	
criteria	ENTITY
for	
either	
chronic	ENTITY
insomnia	ENTITY
dis-	
order	
or	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

In	
some	
cases	ENTITY
,	
this	
diagnosis	ENTITY
may	
be	
assigned	
on	
a	
provisional	
basis	
when	
more	
information	ENTITY
is	
needed	
to	
establish	
a	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
or	
short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

It	
is	
expected	
that	
this	
diag-	
nosis	ENTITY
will	
be	
used	
sparingly	ENTITY
,	
given	
its	
nonspecific	ENTITY
nature	ENTITY
.	

Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Excessive	ENTITY
Time	ENTITY
in	
Bed	ENTITY

Some	
individuals	ENTITY
may	
present	
with	
isolated	ENTITY
insomnia	ENTITY
symptoms	ENTITY
such	
as	
prolonged	ENTITY
sleep	ENTITY
latencies	ENTITY
or	
long	ENTITY
periods	ENTITY
of	
wakefulness	ENTITY
during	
the	
night	ENTITY
,	
yet	
not	
complain	
of	
insomnia	ENTITY
nor	
show	
daytime	ENTITY
impairments	ENTITY
.	

In	
children	ENTITY
,	
this	
pattern	ENTITY
may	
emerge	
when	
parents	ENTITY
or	
caregivers	ENTITY
have	
unrealistic	
expectations	ENTITY
for	
the	
child	ENTITY
’s	ENTITY
sleep	ENTITY
needs	
and	
rou-	
tinely	ENTITY
allot	ENTITY
too	
much	
time	
for	
the	
child	ENTITY
to	
be	
in	
bed	ENTITY
each	ENTITY
night	ENTITY
.	

In	
adults	ENTITY
,	
this	
pattern	ENTITY
is	
perhaps	
most	
common	
in	
noncomplaining	ENTITY
groups	ENTITY
who	
routinely	
allot	ENTITY
significantly	
more	
time	ENTITY
in	
bed	ENTITY
than	
needed	
for	
sleep	ENTITY
.	

For	
example	
,	
some	
individuals	ENTITY
who	
are	
retired	ENTITY
from	
work	
or	
not	
currently	
employed	
may	
routinely	
spend	
excessive	
time	
in	
bed	ENTITY
each	ENTITY
night	ENTITY
and	
are	
not	
bothered	
by	
the	
expanded	
periods	ENTITY
of	
wakefulness	ENTITY
they	
routinely	
experience	ENTITY
.	

At	
present	
,	
epidemiological	ENTITY
and	
laboratory	ENTITY
studies	ENTITY
are	
unable	
to	
ascertain	
whether	
adverse	ENTITY
health	ENTITY
outcomes	
are	
more	
strongly	
associated	ENTITY
with	ENTITY
perceived	ENTITY
sleep	ENTITY
difficulties	ENTITY
/	
dissatisfaction	ENTITY
or	
with	
particular	
objective	
indices	ENTITY
of	
sleep	ENTITY
duration	ENTITY
,	
sleep	ENTITY
latency	ENTITY
,	
and	
sleep	ENTITY
continuity	ENTITY
.	

Short	ENTITY
Sleeper	ENTITY
Some	
individuals	ENTITY
routinely	
obtain	
less	
than	
six	
hours	
of	
sleep	ENTITY
per	ENTITY
night	ENTITY
on	
average	ENTITY
yet	
have	
no	ENTITY
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
.	

Such	
individuals	ENTITY
are	
considered	
to	
be	
normal	ENTITY
short	ENTITY
sleepers	ENTITY
if	
they	
have	
no	
complaints	
of	
sleep	ENTITY
difficulties	ENTITY
and	
show	
no	
obvious	
daytime	ENTITY
dysfunction	ENTITY
.	

Among	
these	
individuals	ENTITY
,	
the	
observed	
relatively	
low	
average	ENTITY
sleep	ENTITY
time	ENTITY
does	
not	
result	
from	
chronic	ENTITY
volitional	ENTITY
sleep	ENTITY
restriction	ENTITY
,	
as	
in	
the	
case	ENTITY
of	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
but	
rather	
indicates	
a	
constitutional	ENTITY
disposition	ENTITY
for	
reduced	ENTITY
sleep	ENTITY
requirement	
.	

The	
clinical	ENTITY
significance	ENTITY
of	
chronic	ENTITY
short	ENTITY
sleep	ENTITY
duration	ENTITY
,	
and	
the	
identifi-	
cation	ENTITY
of	
possible	
subtypes	ENTITY
,	
remain	
open	
questions	
.	

Various	
studies	ENTITY
have	
linked	
short	ENTITY
sleep	ENTITY
duration	ENTITY
with	
metabolic	ENTITY
,	
cardiovascular	ENTITY
,	
and	
other	
forms	
of	
medical	ENTITY
morbidity	ENTITY
.	

However	
,	
these	
studies	ENTITY
are	
typically	
unable	
to	
distinguish	
between	
individuals	ENTITY
who	
have	
short	ENTITY
sleep	ENTITY
in	
the	
context	ENTITY
of	
insomnia	ENTITY
or	
another	
sleep	ENTITY
disorder	ENTITY
,	
those	
who	
are	
voluntarily	
restricting	
their	
sleep	ENTITY
,	
and	
those	
who	
may	
have	
naturally	
short	ENTITY
sleep	ENTITY
.	

Short	ENTITY
sleep	ENTITY
resulting	
from	
different	
causes	
may	
have	
different	
pathophysiological	ENTITY
signifi-	
cance	ENTITY
.	

At	
present	
,	
those	
who	
demonstrate	
less	
than	
six	
hours	
of	
sleep	ENTITY
per	ENTITY
night	ENTITY
should	
not	
be	
assigned	
an	
insomnia	ENTITY
diagnosis	ENTITY
unless	
they	
also	
meet	
the	
criteria	ENTITY
for	
one	
of	
the	
insomnia	ENTITY
disorder	ENTITY
subtypes	ENTITY
described	
herein	
.	

Insomnia	ENTITY
Insomnia	ENTITY
Bibliography	
Fernandez	ENTITY
-	
Mendoza	ENTITY
J	ENTITY
,	
Calhoun	ENTITY
S	ENTITY
,	
Bixler	ENTITY
EO	ENTITY
,	
Pejovic	ENTITY
S	ENTITY
,	
Karataraki	ENTITY
M	ENTITY
,	
Liao	
D.	
Insomnia	
with	
objective	ENTITY
short	ENTITY
sleep	ENTITY
duration	ENTITY
is	
associated	ENTITY
with	ENTITY
deficits	ENTITY
in	
neuropsychological	ENTITY
performance	ENTITY
:	
a	
general	ENTITY
population	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2010;33:459–65	
.	

Hartmann	ENTITY
E.	ENTITY
Sleep	ENTITY
requirement	
:	
long	ENTITY
sleepers	ENTITY
,	
short	ENTITY
sleepers	ENTITY
,	
variable	ENTITY
sleepers	ENTITY
,	
and	
insomniacs	ENTITY
.	

Psychosomatics	ENTITY
1973;14:95–103	ENTITY
.	

Ohayon	ENTITY
MM	ENTITY
,	
Caulet	ENTITY
M	ENTITY
,	
Guilleminault	ENTITY
C.	ENTITY
How	
a	
general	ENTITY
population	ENTITY
perceives	
its	
sleep	ENTITY
and	
how	
this	
relates	
to	
the	
complaint	ENTITY
of	
insomnia	ENTITY
.	

Sleep	ENTITY
1997;20:715–23	ENTITY
.	

Roehrs	ENTITY
T	ENTITY
,	
Zorick	ENTITY
F	ENTITY
,	
Roth	
T.	
Transient	
and	
short	ENTITY
-	
term	ENTITY
insomnias	ENTITY
.	

In	
:	
Krieger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
3rd	
ed	
.	

Philadelphia	ENTITY
:	
WB	ENTITY
Saunders	ENTITY
,	
2000:624–32	
.	

Vgontzas	ENTITY
AN	ENTITY
,	
Liao	
D	
,	
Bixler	ENTITY
EO	ENTITY
,	
Chrousos	ENTITY
GP	ENTITY
,	
Vela	ENTITY
-	
Bueno	
A.	ENTITY
Insomnia	ENTITY
with	
objective	
short	ENTITY
sleep	ENTITY
duration	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
high	ENTITY
risk	ENTITY
for	
hypertension	ENTITY
.	

Sleep	ENTITY
2009;32:491–7	
.	

Webb	ENTITY
WB	ENTITY
,	
Friel	
J.	
Characteristics	ENTITY
of	
“	
natural	ENTITY
”	
long	
and	
short	ENTITY
sleepers	ENTITY
:	
a	
preliminary	ENTITY
report	ENTITY
.	

Psychol	ENTITY
Rep	ENTITY
1970;27:63–6	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Disorders	ENTITY
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	
Adult53	ENTITY
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	

Pediatric63	
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Syndromes	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing	
69	
Central	ENTITY
Apnea	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing75	
Central	
Sleep	
Apnea	

Due	
to	
High	ENTITY
Altitude	ENTITY
Periodic	ENTITY
Breathing	ENTITY
79	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
85	ENTITY
Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY

89	
Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	ENTITY
Infancy94	ENTITY
Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	
Prematurity98	
Treatment	ENTITY
-	
Emergent	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
102	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Disorders	ENTITY
Obesity	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY
108	ENTITY
Congenital	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY

113	
Late	ENTITY
-	
Onset	ENTITY
Central	ENTITY
Hypoventilation	ENTITY
with	
Hypothalamic	ENTITY
Dysfunction	ENTITY
118	ENTITY
Idiopathic	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
121	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY

124	
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder128	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoxemia	ENTITY
Disorder	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoxemia134	ENTITY
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY

Snoring	ENTITY
139	
Catathrenia	ENTITY
141	
The	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
are	
characterized	ENTITY
by	
abnormalities	ENTITY
of	
respi-	
ration	ENTITY
during	
sleep	ENTITY
.	

In	
some	
of	
these	
disorders	ENTITY
,	
respiration	ENTITY
is	
also	
abnormal	ENTITY
during	
wakefulness	ENTITY
.	

The	
disorders	ENTITY
are	
grouped	ENTITY
into	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
OSA	
)	
disorders	
,	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
disorders	ENTITY
,	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
,	
and	
sleep	ENTITY
related	
hypoxemia	ENTITY
disorder	ENTITY
.	

However	
,	
many	
patients	ENTITY
will	
meet	
diagnostic	ENTITY
criteria	ENTITY
for	
more	
than	
one	
of	
these	
groups	ENTITY
.	

In	
particular	
,	
many	
patients	ENTITY
have	
a	
combination	ENTITY
of	
obstruc-	
tive	ENTITY
and	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Although	
a	
diagnosis	ENTITY
is	
often	
based	
on	
which	
disorder	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
predominates	
,	
this	
may	
vary	
from	
night	ENTITY
to	
night	ENTITY
as	
well	
as	
over	
time	
in	
individual	ENTITY
patients	ENTITY
.	

There	
is	
also	
overlap	ENTITY
in	
pathophysiology	ENTITY
,	
as	
some	
central	ENTITY
apneas	ENTITY
are	
associ-	
ated	ENTITY
with	
a	
closed	ENTITY
upper	ENTITY
airway	ENTITY
and	
many	
obstructive	ENTITY
apneas	ENTITY
begin	
during	
a	
time	
of	
falling	
ventilatory	ENTITY
drive	
.	

In	
the	
sections	ENTITY
that	
follow	
,	
individual	ENTITY
respiratory	ENTITY
events	ENTITY
(	
e.g.	
,	
apneas	ENTITY
,	
hypopneas	ENTITY
,	
and	
hypoventilation	ENTITY
)	
are	
not	
defined	
;	
rather	
,	
reference	ENTITY
is	
made	
to	
the	
most	
recent	
version	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
(	
AASM	ENTITY
)	
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
for	
these	
definitions	ENTITY
.	

The	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
includes	
different	
scoring	ENTITY
rules	ENTITY
for	
adult	ENTITY
and	
pediatric	ENTITY
individuals	ENTITY
,	
definitions	ENTITY
of	
obstructive	ENTITY
and	
central	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
,	
and	
rules	ENTITY
for	
scoring	ENTITY
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	ENTITY
and	
hypoventilation	ENTITY
.	

The	
OSA	ENTITY
disorders	ENTITY
are	
separated	
into	
adult	ENTITY
and	
pediatric	ENTITY
categories	ENTITY
,	
as	
the	
presenta-	
tion	ENTITY
,	
diagnostic	ENTITY
criteria	ENTITY
,	
course	ENTITY
,	
and	
complications	ENTITY
differ	
significantly	
.	

These	
disorders	ENTITY
are	
characterized	ENTITY
by	
upper	
airway	ENTITY
narrowing	ENTITY
or	
closure	ENTITY
during	
sleep	ENTITY
while	
respiratory	ENTITY
effort	
continues	
(	
at	
least	
during	
some	
portion	ENTITY
of	
the	
event	ENTITY
)	
.	

The	
use	
of	
out	
-	
of	
-	
cen-	
ter	ENTITY
sleep	ENTITY
testing	ENTITY
(	
OCST	ENTITY
)	
with	
limited	ENTITY
channels	ENTITY
(	
electroencephalogram	ENTITY
[	
EEG	ENTITY
]	
is	
not	
usually	
recorded	
)	
is	
now	
included	
in	
the	
diagnostic	ENTITY
criteria	ENTITY
for	
adult	ENTITY
OSA	ENTITY
.	

The	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
syndromes	ENTITY
are	
characterized	ENTITY
by	
reduction	ENTITY
or	
cessation	ENTITY
of	
airflow	ENTITY
due	
to	
absent	ENTITY
or	
reduced	ENTITY
respiratory	ENTITY
effort	ENTITY
.	

Central	ENTITY
apnea	ENTITY
or	
hypopnea	ENTITY
may	
occur	
in	
a	
cyclical	ENTITY
or	
intermittent	ENTITY
fashion	ENTITY
.	

Patients	ENTITY
with	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
of	
various	
etiologies	ENTITY
may	
also	
exhibit	
OSA	ENTITY
.	

In	
primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
the	
cause	
of	
the	
disorder	ENTITY
is	
unknown	
(	
idiopathic	ENTITY
)	
.	

The	
arterial	ENTITY
partial	ENTITY
pressure	ENTITY
of	
carbon	ENTITY
dioxide	ENTITY
(	
PaCO2	ENTITY
)	
during	
wake	ENTITY
in	
these	
patients	ENTITY
is	
normal	ENTITY
or	
low	ENTITY
.	

Patients	ENTITY
do	
not	
meet	
diagnostic	ENTITY
criteria	ENTITY
for	
other	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
dis-	
orders	ENTITY
.	

In	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	
,	
there	
is	
a	
cyclical	ENTITY
pattern	
of	
crescendo	ENTITY
-	
decrescendo	ENTITY
respiration	ENTITY
separated	
by	
central	ENTITY
apneas	ENTITY
or	
central	ENTITY
hypopneas	ENTITY
.	

Most	
patients	ENTITY
with	
this	
disorder	ENTITY
have	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
(	
reduced	ENTITY
or	
preserved	ENTITY
ejection	ENTITY
fraction	ENTITY
)	
,	
although	
,	
less	
commonly	
,	
others	
exhibit	
this	
breathing	ENTITY
pattern	ENTITY
fol-	
lowing	ENTITY
stroke	ENTITY
or	
in	
association	ENTITY
with	ENTITY
other	
neurological	ENTITY
disorders	ENTITY
.	

In	
high	ENTITY
-	
altitude	ENTITY
peri-	
odic	ENTITY
breathing	ENTITY
,	
the	
disorder	ENTITY
is	
associated	ENTITY
with	ENTITY
acute	ENTITY
ascent	ENTITY
to	
high	ENTITY
altitude	ENTITY
.	

Symptoms	ENTITY
must	
be	
present	
to	
establish	
the	
diagnosis	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
,	
as	
this	
breathing	ENTITY
pattern	ENTITY
is	
an	
expected	
finding	ENTITY
after	
ascent	ENTITY
to	
altitude	ENTITY
.	

Central	ENTITY
sleep	ENTITY
apnea	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
(	
not	
Cheyne	ENTITY
-	
Stokes	ENTITY
)	
is	
usually	
due	
to	
a	
struc-	
tural	ENTITY
lesion	ENTITY
in	
the	
central	ENTITY
nervous	ENTITY
system	ENTITY
.	

These	
disorders	ENTITY
should	
be	
excluded	
before	
a	
diagnosis	ENTITY
of	
primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
made	
.	

In	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
due	
to	
drug	ENTITY
or	
substance	ENTITY
,	
the	
patient	ENTITY
demonstrates	
central	ENTITY
apneas	ENTITY
secondary	ENTITY
to	
the	
effects	ENTITY
of	ENTITY
potent	
opioids	ENTITY
or	
other	
respiratory	ENTITY
depressants	ENTITY
on	
respiratory	ENTITY
control	ENTITY
centers	ENTITY
.	

Treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
a	
new	
addition	
to	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
.	

In	
this	
disorder	ENTITY
,	
the	
patient	ENTITY
exhibits	
predominantly	
obstructive	ENTITY
events	ENTITY
during	
diagnostic	ENTITY
sleep	ENTITY
testing	ENTITY
(	
e.g.	
,	
obstructive	ENTITY
or	
mixed	ENTITY
apneas	ENTITY
and	
obstructive	ENTITY
hypopneas	ENTITY
)	
,	
but	
central	ENTITY
apneas	ENTITY
or	
central	ENTITY
hypopneas	ENTITY
emerge	
or	
persist	
on	
positive	ENTITY
airway	
pressure	
treatment	ENTITY
without	
a	
backup	ENTITY
rate	ENTITY
and	
are	
the	
predominant	ENTITY
residual	
breathing	
abnormality	
(	
i.e.	
,	
obstructive	ENTITY
events	ENTITY
have	
resolved	ENTITY
)	
.	

A	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
made	
when	
the	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
component	ENTITY
is	
not	
better	
explained	
by	
another	
diagnosis	ENTITY
(	
i.e.	
,	
another	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
disorder	ENTITY
)	
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
are	
characterized	ENTITY
by	
an	
abnormal	ENTITY
increase	ENTITY
in	
the	
arterial	ENTITY
PCO2	ENTITY
(	
PaCO2	ENTITY
)	
during	
sleep	ENTITY
.	

Adult	ENTITY
and	
pediatric	ENTITY
hypoventilation	ENTITY
disorders	ENTITY
are	
defined	
by	
different	
criteria	ENTITY
.	

For	
adults	ENTITY
,	
an	
increase	ENTITY
in	
the	
arterial	ENTITY
PCO2	ENTITY
(	
or	
sur-	
rogate	ENTITY
)	
to	
greater	
than	
55	
mm	
Hg	
for	
at	
least	
10	
minutes	ENTITY
or	
an	
increase	ENTITY
≥	
10	
mm	

Hg	
above	
the	
awake	ENTITY
value	
to	
a	
value	
of	
50	
mm	
Hg	
or	
greater	
for	
at	
least	
10	
minutes	ENTITY
is	
required	
.	

In	
pediatric	ENTITY
patients	ENTITY
,	
the	
PaCO2	ENTITY
(	
or	
surrogate	ENTITY
)	
must	
be	
greater	
than	
50	
mm	
Hg	
for	
greater	
than	
25	
%	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

In	
this	
edition	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
there	
are	
a	
number	
of	
changes	ENTITY
in	
the	
classification	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
.	

The	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
is	
listed	
as	
a	
separate	
disorder	ENTITY
given	
that	
it	
is	
both	
prevalent	ENTITY
and	
has	
distinct	
clinical	ENTITY
characteristics	ENTITY
.	

In	
contrast	
to	
other	
sleep	ENTITY
related	
hypoventila-	
tion	ENTITY
disorders	ENTITY
,	
a	
diagnosis	ENTITY
of	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
requires	
documenta-	
tion	ENTITY
of	
awake	ENTITY
(	
daytime	
)	
hypoventilation	
(	
PaCO2	ENTITY
>	
45	
mm	
Hg	
)	
.	

For	
the	
other	
disorders	ENTITY
in	
this	
category	
,	
awake	ENTITY
hypoventilation	ENTITY
may	
or	
may	
not	
be	
present	
.	

In	
the	
previous	
version	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
a	
group	ENTITY
of	
disorders	ENTITY
were	
listed	
under	
the	
category	
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
/	
hypoxemia	ENTITY
disorders	ENTITY
.	

In	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
,	
disorders	ENTITY
manifesting	
hypoventilation	ENTITY
are	
separated	
from	
disorders	ENTITY
in	
which	
only	
a	
finding	ENTITY
of	
hypoxemia	ENTITY
(	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
)	
during	
sleep	ENTITY
is	
documented	ENTITY
.	

Demonstrating	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
rather	
than	
simply	
hypoxemia	ENTITY
has	
important	
diagnostic	ENTITY
and	
treatment	ENTITY
consequences	ENTITY
.	

Sleep	ENTITY
related	
hypoxemia	ENTITY
disorders	ENTITY
are	
characterized	ENTITY
by	
sustained	ENTITY
periods	ENTITY
of	
significantly	
reduced	
oxyhemoglobin	ENTITY
saturation	ENTITY
during	
sleep	ENTITY
.	

This	
diagnostic	ENTITY
category	ENTITY
is	
used	
when	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
either	
not	
present	
or	
the	
status	ENTITY
is	
unknown	
.	

Sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY
can	
occur	
due	
to	
hypoventilation	ENTITY
,	
ven-	
tilation	ENTITY
-	
perfusion	ENTITY
mismatch	ENTITY
,	
low	ENTITY
partial	ENTITY
pressure	ENTITY
of	ENTITY
oxygen	ENTITY
,	
shunt	ENTITY
,	
or	
a	
combination	ENTITY
of	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
these	
factors	ENTITY
.	

Many	
diverse	ENTITY
etiologies	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY
.	

There	
are	
no	
longer	
separate	
diagnostic	ENTITY
categories	ENTITY
for	
the	
various	
types	
of	
medical	ENTITY
and	
neurological	ENTITY
pathology	ENTITY
that	
may	
contribute	
to	
hypoventilation	ENTITY
or	
hypoxemia	ENTITY
.	

In	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
,	
these	
included	
lower	ENTITY
airway	ENTITY
obstruction	ENTITY
,	
pulmonary	ENTITY
parenchymal	ENTITY
and	
vascular	ENTITY
pathology	ENTITY
,	
and	
neuromus-	
cular	ENTITY
and	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
.	

In	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
,	
the	
specific	
pulmonary	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
should	
be	
diagnosed	ENTITY
sep-	
arately	ENTITY
,	
in	
association	ENTITY
with	ENTITY
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
or	
sleep	ENTITY
related	
hypoxemia	ENTITY
.	

Bibliography	ENTITY
Badr	ENTITY
MS	ENTITY
,	
Toiber	ENTITY
F	ENTITY
,	
Skatrud	ENTITY
JB	ENTITY
,	ENTITY
Dempsey	
J.	
Pharyngeal	ENTITY
narrowing	ENTITY
/	
occlusion	ENTITY
during	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Appl	
Physiol	
1995;78:1806–15	
.	

Berry	ENTITY
RB	ENTITY
,	
Brooks	ENTITY
R	ENTITY
,	ENTITY
Gamaldo	ENTITY
CE	ENTITY
,	
Harding	
SM	ENTITY
,	
Lloyd	ENTITY
RM	ENTITY
,	
Marcus	ENTITY
CL	ENTITY
and	
Vaughn	ENTITY
BV	ENTITY
for	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

The	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	
Events	
:	
Rules	ENTITY
,	
Terminology	ENTITY
and	
Technical	ENTITY
Specifications	ENTITY
,	
Version	ENTITY
2.0.3	
.	
www.aasmnet.org	ENTITY
.	

Darien	ENTITY
,	
IL	ENTITY
:	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
2014	
Tkacova	ENTITY
R	ENTITY
,	
Niroumand	ENTITY
M	ENTITY
,	
Lorenzi	ENTITY
-	
Filho	ENTITY
G	ENTITY
,	
Bradley	
TD	ENTITY
.	

Overnight	ENTITY
shift	ENTITY
from	
obstructive	ENTITY
to	
central	ENTITY
apneas	ENTITY
in	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
:	
role	
of	
PCO2	ENTITY
and	
circulatory	ENTITY
delay	ENTITY
.	

Circulation	ENTITY
2001;103:238–43	
.	

Tkacova	ENTITY
R	ENTITY
,	
Wang	
H	
,	
Bradley	
TD	ENTITY
.	

Night	ENTITY
-	
to	
-	
night	ENTITY
alterations	ENTITY
in	
sleep	ENTITY
apnea	ENTITY
type	ENTITY
in	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
.	

J	
Sleep	
Res	
2006;15:321–8	
.	

Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Disorders	ENTITY
Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	
Adult	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.23	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.33	
Alternate	ENTITY
Names	ENTITY
OSA	
syndrome	
,	
sleep	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
,	
obstructive	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
disor-	
dered	ENTITY
breathing	ENTITY
,	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
hypopnea	ENTITY
syndrome	ENTITY
.	

The	
term	
upper	
airway	
resistance	
syndrome	
(	
UARS	ENTITY
)	
is	
subsumed	
under	
this	
diagnosis	ENTITY
because	
the	
pathophysiology	ENTITY
does	
not	
significantly	
differ	
from	
that	
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Use	
of	
the	
term	
Pickwickian	ENTITY
syndrome	ENTITY
is	
discouraged	
because	
not	
only	
has	
it	
been	
applied	
to	
those	
with	
OSA	ENTITY
,	
but	
also	
indiscriminately	
used	
to	
describe	
persons	ENTITY
who	
are	
only	
obese	ENTITY
and	
those	
with	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
(	
A	
and	
B	ENTITY
)	
or	
C	ENTITY
satisfy	
the	
criteria	ENTITY
A.	

The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following	
:	
.	

The	
patient	ENTITY
complains	ENTITY
of	
sleepiness	ENTITY
,	
nonrestorative	ENTITY
sleep	ENTITY
,	
fatigue	ENTITY
,	
or	
insomnia	ENTITY
symptoms	ENTITY
.	
.	

The	
patient	ENTITY
wakes	ENTITY
with	
breath	ENTITY
holding	ENTITY
,	
gasping	ENTITY
,	
or	
choking	ENTITY
.	
.	

The	
bed	ENTITY
partner	ENTITY
or	
other	
observer	ENTITY
reports	ENTITY
habitual	ENTITY
snoring	ENTITY
,	
breathing	ENTITY
interruptions	ENTITY
,	
or	
both	
during	
the	
patient	ENTITY
’s	ENTITY
sleep	ENTITY
.	
.	

The	
patient	ENTITY
has	
been	
diagnosed	ENTITY
with	
hypertension	ENTITY
,	
a	
mood	ENTITY
disorder	ENTITY
,	
cognitive	ENTITY
dysfunction	ENTITY
,	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
,	
stroke	ENTITY
,	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
atrial	ENTITY
fibrillation	ENTITY
,	
or	
type	ENTITY
2	ENTITY
diabetes	ENTITY
mellitus	ENTITY
.	

B.	ENTITY
Polysomnography	ENTITY
(	
PSG	ENTITY
)	
or	
OCST1	ENTITY
demonstrates	
:	
.	

Five	
or	
more	
predominantly	
obstructive	ENTITY
respiratory	ENTITY
events2	ENTITY
(	
obstructive	ENTITY
and	
mixed	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
respiratory	ENTITY
effort	ENTITY
related	ENTITY
arousals	ENTITY
[	
RERAs])3	ENTITY
per	
hour	
of	
sleep	ENTITY
during	
a	
PSG	ENTITY
or	
per	
hour	
of	
monitoring	ENTITY
(	
OCST).1	ENTITY
OR	ENTITY
C.	ENTITY
PSG	ENTITY
or	
OCST1	ENTITY
demonstrates	
:	
.	

Fifteen	
or	
more	
predominantly	
obstructive	ENTITY
respiratory	ENTITY
events	ENTITY
(	
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
RERAs)3	ENTITY
per	ENTITY
hour	ENTITY
of	ENTITY
sleep	ENTITY
during	
a	
PSG	ENTITY
or	
per	
hour	
of	
monitoring	ENTITY
(	
OCST).1	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Notes	ENTITY
.	

OCST	ENTITY
commonly	
underestimates	
the	
number	
of	
obstructive	ENTITY
respiratory	ENTITY
events	ENTITY
per	
hour	
as	
compared	
to	
PSG	ENTITY
because	
actual	ENTITY
sleep	ENTITY
time	ENTITY
,	
as	
determined	
primarily	
by	
EEG	ENTITY
,	
is	
often	
not	
recorded	
.	

The	
term	ENTITY
respiratory	ENTITY
event	ENTITY
index	ENTITY
(	
REI	ENTITY
)	
may	
be	
used	
to	
denote	ENTITY
event	ENTITY
frequency	ENTITY
based	
on	
monitoring	ENTITY
time	ENTITY
rather	
than	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	
.	

Respiratory	ENTITY
events	ENTITY
defined	
according	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

RERAs	ENTITY
and	
hypopnea	ENTITY
events	ENTITY
based	
on	
arousals	ENTITY
from	
sleep	ENTITY
can	
not	
be	
scored	ENTITY
using	
OCST	ENTITY
because	
arousals	ENTITY
by	
EEG	ENTITY
criteria	ENTITY
can	
not	
be	
identified	ENTITY
.	

Essential	ENTITY
Features	ENTITY
OSA	ENTITY
is	
characterized	
by	
repetitive	ENTITY
episodes	ENTITY
of	
complete	
(	
apnea	ENTITY
)	
or	
partial	ENTITY
(	ENTITY
hypopnea	ENTITY
)	ENTITY
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
occurring	
during	
sleep	ENTITY
.	

These	
events	ENTITY
often	
result	
in	
reduc-	
tions	ENTITY
in	
blood	ENTITY
oxygen	ENTITY
saturation	ENTITY
and	
are	
usually	
terminated	
by	
brief	ENTITY
arousals	ENTITY
from	
sleep	ENTITY
.	

By	
definition	ENTITY
,	
apneic	ENTITY
and	
hypopneic	ENTITY
events	ENTITY
last	
a	
minimum	
of	
10	
seconds	
.	

Most	
events	ENTITY
are	
10	
to	
30	
seconds	
in	
duration	ENTITY
but	
occasionally	
persist	
for	
one	
minute	ENTITY
or	
longer	ENTITY
.	

Events	ENTITY
can	
occur	
in	
any	
stage	ENTITY
of	ENTITY
sleep	ENTITY
but	
more	
frequently	
occur	
in	
stages	ENTITY
N1	
,	
N2	ENTITY
,	
and	
R	ENTITY
sleep	ENTITY
than	
in	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
.	

Events	ENTITY
are	
usually	
longer	ENTITY
and	
associated	ENTITY
with	ENTITY
more	
severe	ENTITY
decreases	ENTITY
in	
oxygen	ENTITY
saturation	ENTITY
when	
they	
occur	
in	
stage	ENTITY
R	ENTITY
sleep	ENTITY
and	
when	
the	
individual	ENTITY
is	
sleeping	ENTITY
supine	ENTITY
.	

Oxygen	ENTITY
saturation	ENTITY
usually	
returns	
to	
baseline	ENTITY
values	
following	
resumption	ENTITY
of	
normal	ENTITY
breathing	ENTITY
but	
may	
remain	
low	ENTITY
if	
the	
apneic	ENTITY
or	
hypopneic	ENTITY
events	ENTITY
are	
very	
frequent	ENTITY
and	
prolonged	ENTITY
,	
or	
if	
there	
is	
underlying	
pulmonary	ENTITY
pathology	ENTITY
.	

Snoring	ENTITY
between	
apneas	ENTITY
is	
typically	
reported	
by	
bed	ENTITY
partners	ENTITY
,	
as	
are	
wit-	ENTITY
nessed	
episodes	ENTITY
of	
gasping	ENTITY
or	
choking	ENTITY
and	
body	ENTITY
movements	ENTITY
that	
disrupt	ENTITY
sleep	ENTITY
.	

Most	
patients	ENTITY
awaken	
in	
the	
morning	ENTITY
feeling	
tired	ENTITY
and	
unrefreshed	
regardless	
of	
the	
duration	ENTITY
of	
their	
time	ENTITY
in	
bed	ENTITY
.	

Apneas	ENTITY
,	
hypopneas	ENTITY
,	
and	
snoring	ENTITY
may	
be	
exacerbated	ENTITY
following	
the	
ingestion	ENTITY
of	
alcohol	ENTITY
,	
use	
of	
sedating	ENTITY
medications	ENTITY
prior	
to	
sleep	ENTITY
,	
or	
following	
an	
increase	ENTITY
in	
body	ENTITY
weight	ENTITY
.	

Excessive	ENTITY
sleepiness	ENTITY
is	
a	
major	
presenting	
complaint	
in	
many	
but	
not	
all	
cases	ENTITY
.	

The	
sleepiness	ENTITY
is	
most	
evident	
during	
relaxing	ENTITY
or	
inactive	ENTITY
situations	ENTITY
.	

With	
extreme	
sleepi-	
ness	ENTITY
,	
sleep	ENTITY
may	
occur	
while	
actively	
conversing	ENTITY
,	
eating	ENTITY
,	
walking	ENTITY
,	
or	
driving	ENTITY
.	

In	
women	ENTITY
,	
excessive	ENTITY
sleepiness	ENTITY
is	
a	
less	
prominent	ENTITY
complaint	ENTITY
.	

Additionally	
,	
reports	ENTITY
of	
insomnia	ENTITY
,	
poor	ENTITY
sleep	ENTITY
quality	ENTITY
,	
and	
fatigue	ENTITY
are	
common	
,	
particularly	
among	
women	ENTITY
.	

Quality	ENTITY
of	ENTITY
life	ENTITY
generally	
is	
adversely	
affected	ENTITY
by	
unrefreshing	ENTITY
sleep	ENTITY
,	
sleepiness	ENTITY
,	
and	
fatigue	ENTITY
.	

Bed	ENTITY
part-	
ners	ENTITY
may	
also	
report	ENTITY
sleep	ENTITY
disruption	ENTITY
and	
associated	ENTITY
consequences	ENTITY
.	

The	
frequency	ENTITY
of	
apneas	ENTITY
and	
hypopneas	ENTITY
during	
sleep	ENTITY
correlates	
poorly	ENTITY
with	
daytime	ENTITY
symptom	ENTITY
severity	ENTITY
and	
impact	ENTITY
on	
quality	ENTITY
of	ENTITY
life	ENTITY
.	

In	
some	
cases	ENTITY
,	
affected	ENTITY
individuals	ENTITY
will	
not	
endorse	
any	
symptoms	ENTITY
or	
confirm	
any	
bed	ENTITY
partner	ENTITY
observations	ENTITY
.	

Associated	
Features	
Systemic	ENTITY
hypertension	ENTITY
is	
a	
common	
finding	
in	
patients	ENTITY
with	
OSA	ENTITY
.	

There	
is	
substan-	
tial	ENTITY
clinical	ENTITY
and	
epidemiologic	ENTITY
evidence	ENTITY
implicating	
OSA	ENTITY
as	
a	
significant	
risk	ENTITY
factor	ENTITY
for	
development	ENTITY
of	
systemic	ENTITY
hypertension	ENTITY
independent	
of	
other	
conditions	ENTITY
such	
as	
obesity	ENTITY
and	
smoking	ENTITY
.	

Additionally	
,	
OSA	ENTITY
is	
frequently	
observed	
in	
patients	ENTITY
with	
cor-	ENTITY
onary	ENTITY
artery	ENTITY
disease	ENTITY
,	
atrial	ENTITY
fibrillation	ENTITY
,	
and	
stroke	ENTITY
,	
and	
it	
may	
be	
an	
independent	ENTITY
risk	ENTITY
factor	ENTITY
for	
these	
conditions	ENTITY
.	

OSA	ENTITY
is	
also	
associated	ENTITY
with	ENTITY
type	ENTITY
2	ENTITY
diabetes	ENTITY
,	
and	
there	
are	
accumulating	
data	ENTITY
to	
suggest	
that	
it	
is	
a	
risk	ENTITY
factor	ENTITY
for	
the	
development	ENTITY
of	
type	ENTITY
2	ENTITY
diabetes	ENTITY
.	

Patients	ENTITY
with	
severe	ENTITY
disease	ENTITY
may	
be	
at	
risk	ENTITY
for	
developing	
pulmo-	
nary	ENTITY
hypertension	ENTITY
and	
cor	ENTITY
pulmonale	ENTITY
,	
although	
this	
is	
usually	
seen	
only	
in	
patients	ENTITY
with	
daytime	ENTITY
hypercapnia	ENTITY
due	
to	
comorbid	ENTITY
conditions	ENTITY
such	
as	
morbid	ENTITY
obesity	ENTITY
or	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
(	
COPD	ENTITY
)	
.	

When	
OSA	ENTITY
coexists	
with	
dilated	ENTITY
cardiomyopathy	ENTITY
or	
ischemic	ENTITY
heart	ENTITY
disease	ENTITY
,	
there	
may	
be	
worsening	ENTITY
of	
the	
underly-	
ing	
heart	ENTITY
disease	ENTITY
and	
predisposition	ENTITY
to	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
.	

Gastroesophageal	ENTITY
reflux	ENTITY
symptoms	ENTITY
,	
nocturia	ENTITY
,	
mood	ENTITY
disturbance	ENTITY
,	
and	
erectile	ENTITY
dysfunction	ENTITY
are	
some-	
times	
reported	
in	
patients	ENTITY
with	
OSA	ENTITY
.	

The	
disorder	ENTITY
can	
also	
be	
associated	ENTITY
with	ENTITY
the	
following	
motor	ENTITY
parasomnias	ENTITY
:	
OSA	ENTITY
-	
induced	ENTITY
arousals	ENTITY
from	
non	ENTITY
-	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
(	
NREM	
)	
sleep	
mimicking	
a	
primary	ENTITY
disorder	ENTITY
of	
arousal	ENTITY
(	
confusional	ENTITY
arousal	ENTITY
,	
sleep-	ENTITY
walking	ENTITY
,	
or	
sleep	ENTITY
terrors	ENTITY
)	
;	
OSA	ENTITY
-	
induced	ENTITY
arousals	ENTITY
from	
REM	ENTITY
sleep	ENTITY
mimicking	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
;	
disorders	ENTITY
of	
arousal	ENTITY
from	
NREM	ENTITY
associated	ENTITY
with	ENTITY
slow	ENTITY
wave	ENTITY
sleep	ENTITY
rebound	
during	
initiation	ENTITY
of	
nasal	ENTITY
continuous	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
(	
CPAP	ENTITY
)	
therapy	
of	
OSA	ENTITY
;	
OSA	ENTITY
-	
induced	ENTITY
arousals	ENTITY
linked	
with	
sleep	ENTITY
related	
eating	ENTITY
disorder	ENTITY
;	
and	
OSA	ENTITY
-	
induced	ENTITY
nocturnal	ENTITY
seizures	ENTITY
or	
cerebral	ENTITY
anoxic	ENTITY
attacks	ENTITY
with	
prominent	
motor	ENTITY
activity	ENTITY
.	

Severity	ENTITY
of	
OSA	ENTITY
as	
determined	
by	
the	
frequency	ENTITY
of	
apneas	ENTITY
and	
hypopneas	ENTITY
and/or	
degree	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
correlates	
poorly	ENTITY
with	
symptomatic	ENTITY
sleepiness	ENTITY
.	

Different	
measures	ENTITY
of	
sleepiness	ENTITY
,	
including	
self	ENTITY
-	
reported	ENTITY
severity	ENTITY
of	
sleepiness	ENTITY
,	
commonly	
used	
indices	ENTITY
such	
as	
the	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
,	
and	
objective	
measures	ENTITY
such	
as	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
(	ENTITY
MSLT	ENTITY
)	
,	
are	
not	
strongly	
correlated	ENTITY
and	
,	
thus	
,	
assessment	ENTITY
of	
sleepiness	ENTITY
can	
be	
difficult	ENTITY
and	
relatively	
unreliable	ENTITY
.	

In	
addition	
,	
patients	ENTITY
may	
adapt	
to	
any	
level	ENTITY
of	
sleepiness	ENTITY
over	
time	ENTITY
and	
fail	ENTITY
to	
view	
it	
as	
a	
reportable	ENTITY
problem	ENTITY
.	

Bed	ENTITY
partner	ENTITY
-	
observed	ENTITY
breathing	ENTITY
pauses	ENTITY
and	
disruptive	ENTITY
snoring	ENTITY
may	
not	
always	
be	
accompa-	
nied	
by	
patient	ENTITY
complaints	ENTITY
of	
sleepiness	ENTITY
.	

Finally	
,	
it	
is	
important	
to	
note	
that	
sleepiness	ENTITY
is	
a	
condition	ENTITY
with	
a	
number	
of	
possible	
etiologies	ENTITY
and	
a	
range	
of	
manifestations	ENTITY
(	
see	
Differential	ENTITY
Diagnosis	ENTITY
)	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Apneas	ENTITY
and	
hypopneas	ENTITY
are	
believed	
to	
have	
similar	
pathophysiology	ENTITY
and	
consequences	ENTITY
.	

Therefore	
,	
from	
a	
clinical	ENTITY
perspective	ENTITY
,	
there	
is	
little	
importance	
in	
distinguishing	
patients	ENTITY
who	
have	
predominantly	
apnea	ENTITY
from	
those	
who	
have	
predominantly	
hypopnea	ENTITY
.	

Occasionally	
,	
patients	ENTITY
may	
demonstrate	
only	
REM	ENTITY
-	
related	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
,	
but	
there	
is	
no	
consensus	ENTITY
to	
suggest	
that	
this	
is	
a	
distinct	
clinical	ENTITY
or	
pathophysiological	ENTITY
subtype	ENTITY
.	

Some	
patients	ENTITY
have	
relatively	
few	
arterial	ENTITY
oxygen	
desaturations	
but	
a	
significant	
number	
of	
respiratory	ENTITY
events	ENTITY
characterized	ENTITY
by	
narrowing	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
result-	ENTITY
ing	
in	
brief	ENTITY
arousals	ENTITY
from	
sleep	ENTITY
.	

Depending	
on	
the	
definition	ENTITY
of	
hypopnea	ENTITY
employed	ENTITY
,	
these	
events	ENTITY
typically	
meet	
criteria	ENTITY
for	
either	
hypopneas	ENTITY
associated	ENTITY
with	ENTITY
arousal	ENTITY
but	
no	ENTITY
desaturation	ENTITY
,	
or	
for	
RERAs	ENTITY
.	

When	
initially	
described	
,	
this	
latter	
group	ENTITY
was	
said	
to	
have	
UARS	ENTITY
.	

Current	
data	ENTITY
suggest	
that	
this	
condition	ENTITY
represents	
simply	
a	
variant	ENTITY
of	
OSA	ENTITY
in	
which	
obstructive	ENTITY
events	ENTITY
result	
in	
arousal	ENTITY
but	
minimal	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

Patients	ENTITY
with	
this	
condition	ENTITY
commonly	
snore	ENTITY
and	
report	ENTITY
daytime	ENTITY
sleepiness	ENTITY
or	
fatigue	ENTITY
.	

However	
,	
there	
are	
some	
reports	ENTITY
of	
patients	ENTITY
with	
frequent	ENTITY
respiratory	ENTITY
arousals	ENTITY
in	
the	
absence	ENTITY
of	
snoring	ENTITY
.	

They	
tend	
to	
be	
less	
obese	ENTITY
than	
individuals	ENTITY
who	
have	
respiratory	ENTITY
event	ENTITY
-	
associated	ENTITY
arterial	ENTITY
oxygen	
saturation	
.	

The	
prevalence	ENTITY
of	
this	
group	ENTITY
of	
patients	ENTITY
is	
unknown	
.	

When	
advanced	ENTITY
technology	ENTITY
is	
used	
to	
detect	ENTITY
changes	ENTITY
in	
airflow	ENTITY
(	
as	
described	
in	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	
Events	
)	
,	
most	
of	
these	
patients	ENTITY
will	
be	
diagnosed	ENTITY
as	
having	
OSA	ENTITY
,	
as	
defined	
by	
the	
criteria	ENTITY
listed	
above	
.	

COPD	ENTITY
and	
OSA	ENTITY
frequently	
coexist	
,	
but	
there	
is	
no	
common	
pathophysiologic	ENTITY
rela-	
tionship	ENTITY
.	

Nevertheless	
,	
individuals	ENTITY
with	
both	
disorders	ENTITY
have	
greater	
nocturnal	ENTITY
oxygen	ENTITY
desaturation	ENTITY
and	
daytime	ENTITY
hypercapnia	ENTITY
for	
the	
same	
degree	ENTITY
of	
bronchial	ENTITY
airflow	ENTITY
obstruc-	
tion	ENTITY
,	
and	
greater	
risk	ENTITY
of	
developing	
pulmonary	ENTITY
hypertension	ENTITY
and	
right	ENTITY
heart	ENTITY
failure	ENTITY
.	

The	
prevalence	ENTITY
rate	ENTITY
for	
having	
both	
conditions	ENTITY
has	
been	
estimated	
to	
be	
1	
%	
.	

Demographics	ENTITY
OSA	ENTITY
can	
occur	
in	
any	
age	ENTITY
group	ENTITY
.	

Estimates	ENTITY
of	
prevalence	ENTITY
are	
very	
dependent	
on	
how	
sleep	ENTITY
related	
respiratory	ENTITY
events	ENTITY
are	
defined	
,	
as	
well	
as	
their	
frequency	ENTITY
and	
other	
criteria	ENTITY
used	
to	
define	
disease	ENTITY
.	

Nevertheless	
,	
general	ENTITY
population	ENTITY
-	
based	ENTITY
studies	ENTITY
from	
a	
number	
of	
countries	ENTITY
indicate	
that	
OSA	ENTITY
associated	ENTITY
with	ENTITY
daytime	ENTITY
sleepiness	ENTITY
occurs	
in	
3	
%	
to	
7	
%	
of	
adult	ENTITY
men	ENTITY
and	
2	
%	
to	
5	
%	
of	
adult	ENTITY
women	ENTITY
.	

However	
,	
because	
many	
individuals	ENTITY
with	
OSA	ENTITY
do	
not	
endorse	
daytime	ENTITY
sleepiness	ENTITY
,	
the	
prevalence	ENTITY
of	
the	
disease	ENTITY
is	
likely	
much	
higher	
.	

A	
major	
study	ENTITY
yielded	
prevalence	ENTITY
rates	ENTITY
as	
high	
as	
24	
%	
in	
men	ENTITY
and	
9	
%	
in	
women	ENTITY
using	
only	
an	
apnea	ENTITY
-	
hypopnea	ENTITY
index	ENTITY
(	
AHI	ENTITY
)	
criterion	ENTITY
of	
≥	
5	
/	
hour	ENTITY
,	
although	
addition	
of	
a	
daytime	ENTITY
sleepiness	ENTITY
criterion	ENTITY
reduced	ENTITY
these	
estimates	ENTITY
to	
4	
%	
in	
males	ENTITY
and	
2	
%	
in	
females	ENTITY
.	

The	
prevalence	ENTITY
of	
OSA	ENTITY
increases	ENTITY
with	
age	ENTITY
,	
although	
it	
appears	
to	
plateau	ENTITY
in	
the	
elderly	ENTITY
.	

The	
ratio	ENTITY
of	
OSA	ENTITY
in	
men	ENTITY
compared	
to	
women	ENTITY
is	
approximately	
two	
to	
one	
.	

This	
dispar-	
ity	ENTITY
may	
decline	ENTITY
in	
middle	
to	
older	ENTITY
age	ENTITY
as	
a	
result	
of	
a	
greater	
risk	ENTITY
for	
OSA	ENTITY
in	
women	ENTITY
after	
menopause	ENTITY
.	

OSA	ENTITY
occurs	
in	
all	
racial	ENTITY
and	
ethnic	ENTITY
groups	ENTITY
.	

In	
younger	ENTITY
and	
elderly	ENTITY
groups	ENTITY
,	
but	
not	
in	
middle	ENTITY
-	
aged	ENTITY
groups	ENTITY
,	
OSA	ENTITY
has	
been	
reported	
to	
be	
more	
prevalent	ENTITY
in	
blacks	ENTITY
than	
whites	ENTITY
.	

The	
prevalence	ENTITY
of	
OSA	ENTITY
in	
Asian	ENTITY
patients	ENTITY
is	
comparable	
to	
that	
of	
whites	ENTITY
,	
despite	
having	
a	
generally	
lower	ENTITY
body	ENTITY
mass	ENTITY
index	ENTITY
(	
BMI	ENTITY
)	
.	

Differences	ENTITY
in	
craniofacial	ENTITY
features	ENTITY
that	
predispose	
Asians	ENTITY
to	
developing	
OSA	ENTITY
are	
the	
likely	
explanation	
.	

Data	ENTITY
comparing	
OSA	ENTITY
prevalence	ENTITY
rates	ENTITY
among	
Hispanics	ENTITY
and	
Native	ENTITY
Americans	ENTITY
to	
other	
racial	ENTITY
/	
ethnic	ENTITY
groups	ENTITY
are	
sparse	ENTITY
,	
although	
it	
is	
clear	
that	
OSA	ENTITY
occurs	
commonly	
in	
these	
groups	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY

The	
major	
predisposing	ENTITY
factor	ENTITY
for	
OSA	ENTITY
is	
excess	ENTITY
body	ENTITY
weight	ENTITY
.	

It	
has	
been	
estimated	ENTITY
that	
~60	
%	
of	
moderate	ENTITY
to	
severe	ENTITY
OSA	ENTITY
is	
attributable	
to	
obesity	ENTITY
.	

The	
risk	ENTITY
of	
OSA	ENTITY
increases	ENTITY
as	
the	
degree	ENTITY
of	
additional	
weight	ENTITY
increases	ENTITY
,	
with	
an	
extremely	
high	
preva-	
lence	
of	
OSA	ENTITY
in	
people	ENTITY
with	
morbid	ENTITY
obesity	ENTITY
.	

OSA	ENTITY
patients	ENTITY
with	
normal	ENTITY
or	
below	
-	
nor-	ENTITY
mal	ENTITY
body	ENTITY
weight	ENTITY
are	
more	
likely	
to	
have	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
due	
to	
a	
localized	ENTITY
structural	ENTITY
abnormality	ENTITY
such	
as	
a	
maxillomandibular	ENTITY
malformation	ENTITY
or	
adenotonsillar	ENTITY
enlargement	ENTITY
.	

Increasing	ENTITY
neck	ENTITY
circumference	ENTITY
predicts	
higher	
AHIs	ENTITY
;	
it	
is	
not	
,	
however	
,	
independent	
of	
BMI	ENTITY
.	

Instability	ENTITY
in	
ventilatory	ENTITY
control	ENTITY
appears	
to	
increase	ENTITY
risk	ENTITY
of	
OSA	ENTITY
.	

Those	
patients	ENTITY
with	
an	
exaggerated	ENTITY
ventilatory	ENTITY
response	ENTITY
to	
a	
respiratory	ENTITY
disturbance	ENTITY
have	
a	
greater	
propensity	
for	
obstructive	ENTITY
events	ENTITY
.	

Menopause	ENTITY
is	
a	
risk	ENTITY
factor	ENTITY
for	
this	
disorder	ENTITY
in	
women	ENTITY
,	
even	
after	
adjustment	ENTITY
for	
age	ENTITY
and	
BMI	ENTITY
.	

However	
,	
use	
of	
hormone	ENTITY
replacement	ENTITY
therapy	ENTITY
may	
be	
protective	
.	

There	
are	
conflicting	
data	ENTITY
concerning	
smoking	ENTITY
as	
a	
risk	ENTITY
factor	ENTITY
for	
OSA	ENTITY
.	

Various	
abnormalities	ENTITY
of	
the	
bony	ENTITY
and	
soft	ENTITY
tissue	ENTITY
structures	ENTITY
of	
the	
head	ENTITY
and	ENTITY
neck	ENTITY
may	
predispose	
the	
individual	ENTITY
to	
having	
OSA	ENTITY
.	

These	
may	
be	
hereditary	ENTITY
(	
e.g.	
,	
mandibular	ENTITY
size	ENTITY
,	
mandibular	ENTITY
position	ENTITY
,	
palatal	ENTITY
height	ENTITY
)	
or	
acquired	ENTITY
(	
e.g.	
,	
enlarged	ENTITY
adenoids	ENTITY
and	
tonsils	ENTITY
)	
.	

Endocrine	ENTITY
disorders	ENTITY
such	
as	
acromegaly	ENTITY
and	
hypothy-	
roidism	ENTITY
are	
risk	ENTITY
factors	ENTITY
for	
OSA	ENTITY
.	

Adults	ENTITY
and	
children	ENTITY
with	
Down	ENTITY
syndrome	ENTITY
also	
have	
a	
high	
prevalence	ENTITY
of	
OSA	ENTITY
.	

OSA	ENTITY
is	
common	
in	
patients	ENTITY
with	
some	
neurologic	ENTITY
disorders	ENTITY
that	
affect	
peripheral	ENTITY
muscles	ENTITY
,	
such	
as	
myotonic	ENTITY
dystrophy	ENTITY
.	

OSA	ENTITY
is	
likely	
made	
worse	
following	
alcohol	ENTITY
consumption	ENTITY
or	
use	
of	
sedating	ENTITY
medications	ENTITY
before	
sleep	ENTITY
and	
by	
nocturnal	ENTITY
nasal	ENTITY
restriction	ENTITY
or	
congestion	ENTITY
due	
to	
abnormal	ENTITY
morphology	ENTITY
,	
rhinitis	ENTITY
,	
or	
both	
.	

Familial	ENTITY
Patterns	ENTITY
OSA	ENTITY
is	
a	
heritable	ENTITY
condition	ENTITY
as	
demonstrated	
by	
familial	ENTITY
clustering	ENTITY
of	
OSA	ENTITY
patients	ENTITY
.	

First	ENTITY
-	
degree	ENTITY
relatives	ENTITY
of	
OSA	ENTITY
patients	ENTITY
are	
twice	
as	
likely	
to	
have	
OSA	ENTITY
in	
comparison	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
to	
those	
not	
affected	ENTITY
.	

Clustering	ENTITY
of	
symptoms	ENTITY
that	
are	
associated	ENTITY
with	ENTITY
OSA	ENTITY
such	
as	
snoring	ENTITY
,	
daytime	ENTITY
sleepiness	ENTITY
,	
and	
snorting	ENTITY
or	
gasping	ENTITY
also	
occurs	
.	

Heritability	ENTITY
explains	
approximately	
one	
third	
of	
the	
variation	ENTITY
in	
the	
AHI	ENTITY
,	
with	
a	
substantial	
proportion	
of	
the	
heritability	ENTITY
explained	
by	
obesity	ENTITY
.	

Other	
inherited	ENTITY
traits	ENTITY
that	
might	
predispose	
an	
indi-	
vidual	
to	
developing	
OSA	ENTITY
include	
craniofacial	ENTITY
morphology	ENTITY
and	
ventilatory	ENTITY
control	ENTITY
.	

Familial	ENTITY
environmental	ENTITY
factors	ENTITY
such	
as	
physical	ENTITY
activity	ENTITY
and	
eating	ENTITY
habits	ENTITY
may	
play	
a	
role	
as	
well	
.	

Nevertheless	
,	
genetic	ENTITY
studies	ENTITY
to	
date	
have	
not	
identified	
a	
unique	
gene	ENTITY
or	
genes	ENTITY
responsible	
for	
OSA	ENTITY
heritability	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
As	
documented	ENTITY
in	
longitudinal	ENTITY
population	ENTITY
studies	ENTITY
,	
the	
severity	ENTITY
of	
untreated	ENTITY
OSA	ENTITY
mea-	
sured	ENTITY
by	
the	
AHI	ENTITY
tends	
to	
slowly	
progress	ENTITY
over	
time	ENTITY
.	

OSA	ENTITY
becomes	
more	
severe	ENTITY
in	
patients	ENTITY
whose	
BMI	ENTITY
increases	ENTITY
,	
but	
may	
improve	ENTITY
with	
weight	ENTITY
reduction	ENTITY
.	

However	
,	
the	
effect	ENTITY
of	
weight	ENTITY
gain	ENTITY
on	
increasing	ENTITY
OSA	ENTITY
severity	ENTITY
is	
greater	
than	
the	
impact	ENTITY
of	
weight	ENTITY
loss	ENTITY
on	
decreasing	ENTITY
OSA	ENTITY
severity	ENTITY
.	

Moreover	
,	
the	
consequences	ENTITY
of	ENTITY
weight	ENTITY
change	ENTITY
are	
more	
evident	
in	
men	ENTITY
than	
women	ENTITY
.	

Substantial	ENTITY
evidence	ENTITY
implicates	
OSA	ENTITY
as	
a	
risk	ENTITY
factor	ENTITY
for	
incident	ENTITY
systemic	ENTITY
hyper-	
tension	ENTITY
,	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
,	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
stroke	ENTITY
,	
and	
premature	ENTITY
mortality	ENTITY
.	

Data	ENTITY
suggest	
that	
these	
effects	ENTITY
are	
more	
evident	
in	
men	ENTITY
and	
middle	ENTITY
-	
aged	ENTITY
individuals	ENTITY
.	

In	
addition	
,	
there	
is	
accumulating	
evidence	ENTITY
to	
suggest	
that	
OSA	ENTITY
is	
a	
risk	ENTITY
factor	ENTITY
for	
the	
development	ENTITY
of	
type	ENTITY
2	ENTITY
diabetes	ENTITY
mellitus	ENTITY
independent	
of	
obesity	ENTITY
.	

Various	
arrhythmias	ENTITY
are	
commonly	
observed	
in	
association	ENTITY
with	
OSA	ENTITY
.	

Evidence	ENTITY
suggests	
that	
OSA	ENTITY
is	
particularly	
related	
to	
the	
onset	ENTITY
and	
recurrence	ENTITY
of	
atrial	ENTITY
fibrillation	ENTITY
.	

OSA	ENTITY
may	
increase	ENTITY
the	
severity	ENTITY
of	
depression	ENTITY
.	

Because	
of	
daytime	ENTITY
sleepiness	ENTITY
,	
func-	
tional	ENTITY
impairment	ENTITY
occurs	
commonly	
as	
manifested	
by	
poor	ENTITY
job	ENTITY
performance	ENTITY
,	
loss	ENTITY
of	ENTITY
employment	ENTITY
,	
impaired	ENTITY
family	ENTITY
relationships	ENTITY
,	
and	
reduction	ENTITY
in	
overall	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
.	

The	
risk	ENTITY
of	
motor	ENTITY
vehicle	ENTITY
accidents	ENTITY
is	
significantly	
increased	ENTITY
among	
those	
with	
OSA	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
OSA	ENTITY
can	
occur	
in	
any	
age	ENTITY
group	ENTITY
,	
but	
in	
adults	ENTITY
,	
prevalence	ENTITY
accelerates	
between	
young	ENTITY
adulthood	ENTITY
and	
middle	ENTITY
age	ENTITY
,	
with	
a	
plateau	ENTITY
reached	
after	
approximately	
age	ENTITY
65	
years	ENTITY
.	

Although	
OSA	ENTITY
occurs	
in	
the	
elderly	ENTITY
,	
it	
is	
commonly	
observed	
with	
few	
symptoms	ENTITY
.	

In	
addition	
,	
some	
evidence	ENTITY
suggests	
that	
risk	ENTITY
of	
cardiovascular	ENTITY
disease	ENTITY
related	
to	
OSA	ENTITY
may	
be	
less	
important	
in	
the	
elderly	ENTITY
.	

This	
has	
raised	
the	
possibility	
that	
its	
presence	ENTITY
in	
this	
age	ENTITY
group	ENTITY
represents	
a	
distinct	
clinical	ENTITY
variant	ENTITY
.	

Pediatric	ENTITY
OSA	ENTITY
is	
discussed	
in	
a	
separate	ENTITY
section	ENTITY
(	
below	
)	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
pathophysiology	ENTITY
underlying	
upper	ENTITY
airway	ENTITY
narrowing	
during	
sleep	ENTITY
is	
multifactorial	ENTITY
.	

Patients	ENTITY
with	
OSA	ENTITY
commonly	
have	
reduced	ENTITY
cross	ENTITY
-	
sectional	ENTITY
area	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
lumen	ENTITY
due	
to	
either	
excessive	ENTITY
bulk	
of	
soft	ENTITY
tissues	ENTITY
(	
tongue	ENTITY
,	
soft	ENTITY
palate	ENTITY
,	
and	
lateral	ENTITY
pha-	ENTITY
ryngeal	ENTITY
walls	ENTITY
)	
or	
craniofacial	ENTITY
anatomy	ENTITY
,	
or	
both	
.	

During	
inspiration	ENTITY
,	
negative	ENTITY
pressure	ENTITY
is	
generated	
in	
the	
lumen	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
,	
promoting	
closure	ENTITY
.	

However	
,	
pharyngeal	ENTITY
dilating	ENTITY
muscles	ENTITY
act	
to	
maintain	
patency	ENTITY
.	

The	
activity	ENTITY
of	
these	
muscles	ENTITY
decreases	ENTITY
with	
sleep	ENTITY
onset	ENTITY
,	
but	
is	
normally	
adequate	ENTITY
to	
maintain	
an	
open	ENTITY
airway	ENTITY
.	

In	
persons	ENTITY
with	
OSA	ENTITY
,	
the	
activity	ENTITY
of	
the	
pharyngeal	ENTITY
dilating	ENTITY
muscles	ENTITY
becomes	
insufficient	ENTITY
to	
prevent	ENTITY
narrow-	
ing	
and/or	
closure	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
.	

This	
state	ENTITY
-	
dependent	ENTITY
change	
is	
the	
major	
con-	
tributing	
factor	
leading	
to	
an	
obstructed	ENTITY
upper	
airway	ENTITY
.	

There	
is	
a	
further	
reduction	ENTITY
in	
tone	ENTITY
and	
phasic	ENTITY
activity	ENTITY
of	
pharyngeal	ENTITY
dilating	ENTITY
muscles	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
particularly	
in	
phasic	ENTITY
REM	ENTITY
,	
which	
likely	
contributes	
to	
apneas	ENTITY
and	
hypopneas	ENTITY
that	
are	
longer	ENTITY
and	
more	
pronounced	
.	

Decreased	ENTITY
end	ENTITY
-	
expiratory	ENTITY
lung	ENTITY
volume	ENTITY
and	
falling	ENTITY
ventilatory	ENTITY
drive	
associated	ENTITY
with	ENTITY
hypocapnia	ENTITY
also	
predispose	
to	
upper	
airway	ENTITY
narrowing	ENTITY
or	
closure	ENTITY
.	

In	
the	
breaths	ENTITY
leading	
up	
to	
obstructive	ENTITY
apnea	ENTITY
,	
end	ENTITY
-	
expiratory	ENTITY
upper	
airway	
caliber	ENTITY
pro-	ENTITY

gressively	
decreases	ENTITY
.	

Smaller	ENTITY
end	ENTITY
-	
expiratory	ENTITY
lung	ENTITY
volume	ENTITY
may	
result	
in	
smaller	
upper	ENTITY
airway	ENTITY
size	ENTITY
due	
to	
decreased	ENTITY
downward	
traction	
(	
tracheal	ENTITY
tug	ENTITY
)	
.	

Some	
patients	ENTITY
have	
unstable	ENTITY
ventilatory	ENTITY
control	ENTITY
(	
high	
loop	
gain	ENTITY
)	
with	
resulting	
periods	ENTITY
of	
hypocapnia	ENTITY
that	
may	
also	
contribute	
to	
upper	ENTITY
airway	ENTITY
narrowing	
.	

The	
mechanisms	ENTITY
of	
apnea	ENTITY
/	
hypopnea	ENTITY
termination	ENTITY
are	
controversial	
.	

Event	ENTITY
termination	ENTITY
may	
occur	
with	
or	
without	
an	
associated	ENTITY
arousal	ENTITY
.	

Some	
events	ENTITY
may	
resolve	
with	
aug-	
mentation	
of	
upper	ENTITY
airway	ENTITY
muscle	ENTITY
tone	ENTITY
from	
chemical	ENTITY
(	
low	
PaO2	ENTITY
,	
high	
PaCO2	ENTITY
)	
and	
mechanical	ENTITY
(	
upper	ENTITY
airway	ENTITY
mechanoreceptors	ENTITY
)	
stimuli	ENTITY
,	
whereas	
others	
may	
depend	
on	
a	
change	
of	
sleep	ENTITY
state	ENTITY
(	
arousal	ENTITY
)	
at	
either	
a	
cortical	ENTITY
or	
subcortical	ENTITY
level	ENTITY
.	

Cortical	ENTITY
arous-	ENTITY
als	
are	
associated	ENTITY
with	ENTITY
changes	ENTITY
detectable	ENTITY
by	
EEG	ENTITY
,	
whereas	
other	
changes	ENTITY
of	
state	ENTITY
may	
be	
detectable	ENTITY
only	
by	
direct	
or	
indirect	ENTITY
measures	ENTITY
of	
sympathetic	ENTITY
tone	ENTITY
.	

Even	
if	
arousals	ENTITY
are	
not	
required	
for	
termination	ENTITY
of	
all	
obstructive	ENTITY
events	ENTITY
,	
sleep	ENTITY
fragmentation	ENTITY
from	
arousals	ENTITY
is	
nevertheless	
believed	
to	
be	
a	
significant	
cause	ENTITY
of	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
.	

Apneas	ENTITY
and	
hypopneas	ENTITY
typically	
last	
considerably	
longer	
in	
REM	ENTITY
and	
,	
in	
some	
patients	ENTITY
,	
are	
only	
present	
in	
this	
sleep	ENTITY
stage	ENTITY
.	

The	
explanation	
for	
this	
finding	ENTITY
is	
unknown	
.	

As	
an	
apnea	ENTITY
or	
hypopnea	ENTITY
event	ENTITY
progresses	
,	
the	
patient	ENTITY
gradually	
becomes	
more	
hypox-	
emic	ENTITY
;	
the	
degree	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
is	
dependent	
not	
only	
on	
the	
duration	ENTITY
of	
the	
event	ENTITY
,	
but	
also	
on	
the	
patient	ENTITY
’s	
baseline	ENTITY
oxygen	ENTITY
saturation	ENTITY
and	
lung	ENTITY
volume	ENTITY
and	
the	
presence	ENTITY
of	
comorbid	ENTITY
lung	
conditions	
.	

Slight	
hypercarbia	ENTITY
also	
occurs	
during	
apneas	ENTITY
and	
hypopneas	ENTITY
and	
is	
worse	
during	
REM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Accumulating	
evidence	ENTITY
indicates	
that	
persons	ENTITY
with	
OSA	ENTITY
have	
elevated	ENTITY
levels	ENTITY
of	
circu-	
lating	ENTITY
inflammatory	ENTITY
mediators	ENTITY
related	
to	
repetitive	ENTITY
episodes	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
and	
increased	ENTITY
sympathetic	ENTITY
nervous	ENTITY
system	ENTITY
activity	ENTITY
.	

Both	
of	
these	
findings	ENTITY
may	
be	
import-	
ant	ENTITY
in	
the	
pathogenesis	ENTITY
of	
hypertension	ENTITY
and	
cardiovascular	ENTITY
disease	ENTITY
related	
to	
OSA	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Obstructive	ENTITY
apneas	ENTITY
are	
documented	ENTITY
by	
a	
cessation	ENTITY
of	
airflow	ENTITY
with	
ongoing	
respiratory	ENTITY
efforts	ENTITY
during	
PSG	ENTITY
or	
an	
OCST	ENTITY
.	

When	
breathing	ENTITY
effort	ENTITY
is	
recorded	
with	
respiratory	ENTITY
inductance	ENTITY
plethysmography	ENTITY
,	
it	
typically	
shows	
paradoxical	ENTITY
movement	ENTITY
of	
the	
rib	ENTITY
cage	ENTITY
and	
abdomen	ENTITY
.	

If	
esophageal	ENTITY
manometry	ENTITY
is	
used	
,	
increasingly	
large	
swings	ENTITY
between	
inspiratory	ENTITY
and	
expiratory	ENTITY
efforts	
are	
observed	ENTITY
.	

Obstructive	ENTITY
hypopneas	ENTITY
are	
a	
reduction	ENTITY
rather	
than	
a	
cessation	ENTITY
of	
airflow	ENTITY
with	
ongoing	
respiratory	ENTITY
effort	ENTITY
.	

Increasing	ENTITY
respira-	
tory	ENTITY
effort	
with	
constant	ENTITY
or	
reduced	ENTITY
flow	
is	
indicative	
of	
increased	ENTITY
upper	ENTITY
airway	ENTITY
resis-	
tance	ENTITY
.	

This	
state	ENTITY
is	
most	
accurately	
identified	ENTITY
with	
a	
quantitative	ENTITY
measurement	ENTITY
of	
flow	ENTITY
and	
esophageal	ENTITY
manometry	ENTITY
,	
although	
it	
can	
be	
inferred	
when	
there	
is	
obvious	
inspira-	
tory	ENTITY
airflow	ENTITY
limitation	ENTITY
(	
flattening	ENTITY
of	
the	
inspiratory	ENTITY
flow	ENTITY
)	
on	
a	
nasal	ENTITY
pressure	ENTITY
recording	ENTITY
.	

Although	
patients	ENTITY
with	
OSA	ENTITY
have	
predominantly	
obstructive	ENTITY
events	ENTITY
,	
they	
may	
also	
have	
variable	ENTITY
amounts	ENTITY
of	
central	ENTITY
apneas	ENTITY
.	

In	
some	
patients	ENTITY
,	
these	
resolve	
with	
admin-	
istration	ENTITY
of	
positive	ENTITY
airway	ENTITY
pressure	ENTITY
,	
whereas	
in	
others	
frequent	ENTITY
central	ENTITY
apneas	ENTITY
either	
persist	
or	
emerge	
,	
at	
least	
during	
the	
initial	ENTITY
night	ENTITY
of	
positive	ENTITY
airway	
pressure	
treatment	ENTITY
.	

Oxygen	ENTITY
saturation	ENTITY
typically	
declines	
for	
a	
variable	ENTITY
period	ENTITY
of	
time	
following	
the	
onset	
of	
an	
event	ENTITY
(	
apnea	ENTITY
or	
hypopnea	ENTITY
)	
,	
with	
the	
nadir	ENTITY
usually	
occurring	
after	
normal	
breath-	
ing	
resumes	ENTITY
.	

The	
degree	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
may	
range	
from	
as	
little	
as	
1	
%	
to	
2	
%	
,	
up	
to	
30	
%	
to	
40	
%	
or	
greater	ENTITY
.	

If	
the	
baseline	ENTITY
oxygen	ENTITY
saturation	ENTITY
is	
normal	ENTITY
,	
there	
may	
be	
no	
discernible	
drop	ENTITY
in	
oxygen	ENTITY
saturation	ENTITY
despite	
evidence	ENTITY
of	
airflow	ENTITY
limitation	ENTITY
fol-	
lowed	ENTITY
by	
arousal	ENTITY
.	

As	
a	
result	ENTITY
,	
some	
events	ENTITY
associated	ENTITY
with	ENTITY
evidence	ENTITY
of	
increased	ENTITY
respi-	
ratory	ENTITY
effort	ENTITY
(	
and/or	
flattening	ENTITY
of	
inspiratory	ENTITY
flow	ENTITY
)	
and	
an	
arousal	ENTITY
at	
event	ENTITY
termination	ENTITY
may	
not	
meet	
diagnostic	ENTITY
criteria	ENTITY
for	
apnea	ENTITY
or	
hypopnea	ENTITY
.	

These	
events	ENTITY
are	
defined	
as	
RERAs	ENTITY
.	

These	
events	ENTITY
are	
presumed	
to	
have	
the	
same	
underlying	
pathophysiology	ENTITY
as	
obstructive	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
(	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
)	
and	
are	
considered	
to	
be	
as	
much	
of	
a	
risk	ENTITY
factor	ENTITY
for	
symptoms	ENTITY
of	
unrefreshing	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
somnolence	ENTITY
,	
and	
fatigue	ENTITY
as	
frank	ENTITY
apnea	ENTITY
or	
hypopnea	ENTITY
.	

The	
EEG	ENTITY
may	
provide	
evidence	ENTITY
of	
a	
brief	
arousal	ENTITY
from	
sleep	ENTITY
,	
and	
the	
submental	ENTITY
electro-	ENTITY
myogram	ENTITY
may	
demonstrate	
a	
burst	ENTITY
of	
activity	ENTITY
indicating	
upper	ENTITY
airway	ENTITY
dilating	ENTITY
muscle	ENTITY
activation	ENTITY
immediately	
preceding	
the	
resumption	ENTITY
of	
normal	ENTITY
breathing	ENTITY
.	

Microphones	ENTITY
may	
record	ENTITY
a	
sudden	ENTITY
resumption	ENTITY
of	
loud	ENTITY
snoring	ENTITY
.	

Obstructive	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
may	
be	
accompanied	
by	
bradyarrhythmias	ENTITY
,	
tachyarrhythmias	ENTITY
,	
or	
both	
;	
however	
,	
the	
prevalence	ENTITY
of	
this	
finding	ENTITY
in	
patients	ENTITY
varies	
widely	
.	

At	
the	
time	
of	
arousals	ENTITY
,	
there	
is	
often	
a	
surge	ENTITY
in	
both	
sympathetic	ENTITY
nervous	ENTITY
system	ENTITY
activity	ENTITY
and	
systemic	ENTITY
blood	ENTITY
pressure	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

In	
contrast	
to	
patients	ENTITY
with	
OSA	ENTITY
,	
those	
with	
isolated	ENTITY
snoring	ENTITY
will	
not	
exhibit	
obstruc-	
tive	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
RERAs	ENTITY
on	
PSG	ENTITY
or	
OCST	ENTITY
and	
do	
not	
have	
other	
sleep	ENTITY
symp-	
toms	ENTITY
attributable	
to	
breathing	ENTITY
disturbance	ENTITY
.	

However	
,	
because	
arousal	ENTITY
-	
based	ENTITY
hypopneas	ENTITY
and	
RERAs	ENTITY
can	
not	
be	
identified	ENTITY
with	
OCST	ENTITY
,	
OSA	ENTITY
can	
not	
be	
excluded	
if	
the	
OCST	ENTITY
is	
negative	ENTITY
.	

Patients	ENTITY
with	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
have	
predominantly	
central	
rather	
than	
obstruc-	
tive	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
RERAs	ENTITY
as	
the	
primary	
finding	
on	
PSG	ENTITY
or	
OCST	ENTITY
.	

If	
mixed	ENTITY
apneas	ENTITY
are	
predominant	ENTITY
,	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
should	
be	
made	
.	

Patients	ENTITY
with	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
will	
demonstrate	
daytime	ENTITY
hypercap-	
nia	ENTITY
.	

Snoring	ENTITY
may	
not	
be	
a	
prominent	
feature	
,	
although	
daytime	ENTITY
sleepiness	ENTITY
can	
occur	
.	

Patients	ENTITY
with	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
may	
show	
episodes	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
without	
evidence	ENTITY
of	
airflow	ENTITY
obstruction	ENTITY
on	
PSG	ENTITY
or	
OCST	ENTITY
.	

Confirmation	ENTITY
of	
nocturnal	ENTITY
hypercapnia	ENTITY
will	
be	
diagnostic	ENTITY
.	

However	
,	
if	
obstructive	ENTITY
apneas	ENTITY
or	
hypo-	ENTITY
pneas	ENTITY
are	
evident	ENTITY
,	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
should	
be	
made	
instead	
of	
,	
or	
in	
addition	
to	
,	
the	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

OSA	ENTITY
must	
be	
differentiated	
from	
other	
causes	
of	
sleepiness	ENTITY
such	
as	
narcolepsy	ENTITY
,	
idio-	
pathic	ENTITY
hypersomnia	ENTITY
,	
and	
insufficient	ENTITY
sleep	ENTITY
.	

These	
conditions	ENTITY
often	
can	
be	
identified	ENTITY
on	
the	
basis	
of	
history	ENTITY
,	
but	
PSG	ENTITY
and/or	
MSLT	ENTITY
may	
be	
required	
to	
confirm	
the	
diagnosis	ENTITY
.	

OSA	ENTITY
should	
be	
distinguished	
from	
other	
causes	
of	
nocturnal	ENTITY
dyspnea	ENTITY
,	
such	
as	
noc-	
turnal	ENTITY
panic	ENTITY
attacks	ENTITY
,	
nocturnal	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
,	
asthma	ENTITY
,	
paroxysmal	ENTITY
nocturnal	ENTITY
dyspnea	ENTITY
from	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
and	
nocturnal	ENTITY
angina	ENTITY
pectoris	ENTITY
.	

In	
many	
cases	ENTITY
,	
absence	ENTITY
of	
snoring	ENTITY
and	
daytime	ENTITY
sleepiness	ENTITY
will	
be	
highly	
suggestive	
of	
etiologies	ENTITY
other	
than	
OSA	ENTITY
.	

However	
,	
the	
absence	ENTITY
of	
obstructive	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
RERAs	ENTITY
on	
PSG	ENTITY
will	
definitively	
exclude	
OSA	ENTITY
as	
the	
diagnosis	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Although	
substantial	
evidence	
implicates	
OSA	ENTITY
as	
a	
risk	ENTITY
factor	ENTITY
for	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
and	
stroke	ENTITY
,	
it	
has	
not	
been	
clearly	
demonstrated	
that	
treatment	ENTITY
mitigates	ENTITY
this	
risk	ENTITY
.	

This	
is	
especially	
a	
concern	
for	
patients	ENTITY
with	
mild	ENTITY
OSA	ENTITY
who	
are	
not	
hypersom-	
nolent	ENTITY
.	

The	
pathophysiologic	ENTITY
mechanisms	ENTITY
linking	
OSA	ENTITY
to	
increased	ENTITY
risk	ENTITY
of	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
,	
stroke	ENTITY
,	
and	
hypertension	ENTITY
require	
further	
investigation	ENTITY
.	

Although	
there	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
is	
a	
clear	
association	ENTITY
between	
OSA	ENTITY
and	
type	ENTITY
2	ENTITY
diabetes	ENTITY
mellitus	ENTITY
,	
further	
studies	ENTITY
are	
needed	
to	
determine	
whether	
OSA	ENTITY
is	
an	
independent	ENTITY
risk	ENTITY
factor	ENTITY
and	
what	
mechanisms	ENTITY
are	
involved	
.	

Bibliography	ENTITY
Berry	ENTITY
RB	ENTITY
,	
Brooks	ENTITY
R	ENTITY
,	ENTITY
Gamaldo	ENTITY
CE	ENTITY
,	
Harding	
SM	ENTITY
,	
Lloyd	ENTITY
RM	ENTITY
,	
Marcus	ENTITY
CL	ENTITY
and	
Vaughn	ENTITY
BV	ENTITY
for	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

The	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	
Events	
:	
Rules	ENTITY
,	
Terminology	ENTITY
and	
Technical	ENTITY
Specifications	ENTITY
,	
Version	ENTITY
2.0.3	
.	
www.aasmnet.org	ENTITY
.	

Darien	ENTITY
,	
IL	ENTITY
:	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
2014	
Berry	ENTITY
RB	ENTITY
.	

Dreaming	ENTITY
about	
an	
open	
upper	
airway	ENTITY
.	

Sleep	ENTITY
2006;29:429–30	
.	

Budhiraja	ENTITY
R	ENTITY
,	
Budhiraja	ENTITY
P	ENTITY
,	
Quan	
SF	ENTITY
.	

Sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
and	
cardiovascular	ENTITY
disorders	ENTITY
.	

Respir	
Care	
2010;55:1322–32	
.	

Iber	ENTITY
C	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S	ENTITY
,	
Chesson	ENTITY
AL	ENTITY
,	
Quan	
SF	ENTITY
;	
for	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

The	
AASM	ENTITY
manual	ENTITY
for	
the	
scoring	ENTITY
of	
sleep	
and	
associated	ENTITY
events	ENTITY
:	
rules	ENTITY
,	
terminology	ENTITY
and	
technical	ENTITY
specifications	ENTITY
.	

1st	
ed	
.	

Westchester	ENTITY
,	
IL	ENTITY
:	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
,	
2007	
.	

Pamidi	ENTITY
S	ENTITY
,	
Aronsohn	ENTITY
RS	ENTITY
,	
Tasali	
E.	ENTITY
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
role	
in	
the	
risk	ENTITY
and	
severity	ENTITY
of	
diabetes	ENTITY
.	

Best	
Pract	
Res	
Clin	
Endocrinol	
Metab	
2010;24:703–15	
.	

Patel	ENTITY
SR	ENTITY
,	
Larkin	ENTITY
EK	ENTITY
,	
Redline	ENTITY
S.	
Shared	
genetic	ENTITY
basis	ENTITY
for	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
adiposity	ENTITY
measures	ENTITY
.	

Int	ENTITY
J	ENTITY
Obes	ENTITY
(	ENTITY
Lond	ENTITY
)	ENTITY
2008;32:795–800	
.	

Pepin	ENTITY
JL	ENTITY
,	
Guillot	ENTITY
M	ENTITY
,	
Tamisier	ENTITY
R	ENTITY
,	
Levy	
P.	

The	
upper	ENTITY
airway	ENTITY
resistance	ENTITY
syndrome	ENTITY
.	

Respiration	ENTITY
2012;83:559–66	
.	

Peppard	ENTITY
PE	ENTITY
,	
Taheri	ENTITY
S.	ENTITY
Excess	ENTITY
weight	ENTITY
and	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
.	

J	
Appl	
Physiol	
2005;99:1592–9	
.	

Punjabi	ENTITY
NM	ENTITY
.	

The	
epidemiology	ENTITY
of	
adult	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Proc	ENTITY
Am	ENTITY
Thorac	ENTITY
Soc	ENTITY
2008;5:136–43	ENTITY
.	

White	ENTITY
DP	ENTITY
.	

Sleep	ENTITY
apnea	ENTITY
.	

Proc	ENTITY
Am	ENTITY
Thorac	ENTITY
Soc	ENTITY
2006;3:124–8	ENTITY
.	

Younes	ENTITY
M.	
Role	
of	
arousal	ENTITY
in	
the	
pathogenesis	ENTITY
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2004;169:623–33	
.	

Young	ENTITY
T	ENTITY
,	
Palta	ENTITY
M	ENTITY
,	
Dempsey	
J	
,	
Skatrud	ENTITY
J	ENTITY
,	
Weber	ENTITY
S	ENTITY
,	
Badr	
S.	

The	
occurrence	ENTITY
of	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
among	
middle	ENTITY
-	
aged	ENTITY
adults	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
1993;328:1230–5	ENTITY
.	

Young	ENTITY
T	ENTITY
,	
Peppard	ENTITY
PE	ENTITY
,	
Gottlieb	ENTITY
DJ	ENTITY
.	

Epidemiology	ENTITY
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
a	
population	ENTITY
health	
perspective	
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2002;165:1217–39	
.	

Obstructive	ENTITY
Sleep	ENTITY
Apnea	ENTITY
,	
Pediatric	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.23	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.33	
Alternate	ENTITY
Names	ENTITY
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
,	
sleep	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
,	
obstructive	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
,	
sleep	ENTITY
hypopnea	ENTITY
syndrome	ENTITY
,	
obstructive	ENTITY
hypoventila-	
tion	ENTITY
,	
and	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
.	

The	
term	
upper	
airway	
resistance	
syndrome	
(	
UARS	ENTITY
)	
is	
subsumed	
under	
this	
diagnosis	ENTITY
because	
the	
pathophysiology	ENTITY
does	
not	
significantly	
differ	
from	
that	
of	
OSA	ENTITY
.	

Use	
of	
the	
term	
Pickwickian	ENTITY
syndrome	ENTITY
is	
discouraged	
,	
as	
this	
term	ENTITY
has	
been	
used	
loosely	
to	
cover	
a	
constellation	ENTITY
of	
conditions	ENTITY
including	
OSA	ENTITY
and	
central	ENTITY
hypoventilation	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY

The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following	
:	
.	

Snoring	ENTITY
.	
.	

Labored	ENTITY
,	
paradoxical	ENTITY
,	
or	
obstructed	ENTITY
breathing	ENTITY
during	
the	
child	ENTITY
’s	ENTITY
sleep	ENTITY
.	
.	

Sleepiness	ENTITY
,	
hyperactivity	ENTITY
,	
behavioral	ENTITY
problems	ENTITY
,	
or	
learning	ENTITY
problems	ENTITY
.	

B.	ENTITY
PSG	ENTITY
demonstrates	
one	
or	
both	
of	
the	
following	
:	
.	

One	
or	
more	
obstructive	ENTITY
apneas	ENTITY
,	
mixed	ENTITY
apneas	ENTITY
,	
or	
hypopneas	ENTITY
,	
per	
hour	
of	
sleep.1	ENTITY
OR	ENTITY
.	

A	
pattern	ENTITY
of	
obstructive	ENTITY
hypoventilation	ENTITY
,	
defined	
as	
at	
least	
25	
%	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
with	
hypercapnia	ENTITY
(	
PaCO2	ENTITY
>	

50	
mm	
Hg	
)	
in	
association	ENTITY
with	
one	
or	
more	
of	
the	
following	
:	
a.	
Snoring	ENTITY
.	

b.	
Flattening	
of	
the	
inspiratory	ENTITY
nasal	ENTITY
pressure	ENTITY
waveform	ENTITY
.	

c.	
Paradoxical	ENTITY
thoracoabdominal	ENTITY
motion	ENTITY
.	

Notes	ENTITY
.	

Respiratory	ENTITY
events	ENTITY
defined	
according	
to	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Pediatric	ENTITY
criteria	ENTITY
for	
OSA	ENTITY
apply	
to	
patients	ENTITY
younger	ENTITY
than	
18	
years	ENTITY
.	

However	
,	
for	
the	
purpose	
of	
PSG	ENTITY
scoring	ENTITY
,	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	
Events	
states	ENTITY
that	
adult	ENTITY
diagnostic	ENTITY
criteria	ENTITY
may	
be	
used	
for	
patients	ENTITY
aged	ENTITY
13	
to	
18	
years	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Pediatric	ENTITY
OSA	ENTITY
is	
characterized	
by	
intermittent	ENTITY
complete	ENTITY
or	
partial	ENTITY
obstruction	ENTITY
(	
obstruc-	
tive	ENTITY
apnea	ENTITY
or	
hypopnea	ENTITY
)	
;	
prolonged	ENTITY
partial	ENTITY
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
;	
or	
both	
prolonged	ENTITY
and	
intermittent	ENTITY
obstructions	ENTITY
that	
disrupt	ENTITY
normal	ENTITY
ventilation	ENTITY
during	
sleep	ENTITY
,	
normal	ENTITY
sleep	ENTITY
patterns	ENTITY
,	
or	
both	
.	

Children	ENTITY
with	
OSA	ENTITY
may	
demonstrate	
several	
breathing	ENTITY
patterns	ENTITY
during	
sleep	ENTITY
.	

Some	
children	ENTITY
have	
cyclic	ENTITY
episodes	ENTITY
of	
obstructive	ENTITY
apnea	ENTITY
,	
similar	
to	
that	
of	
adults	ENTITY
with	
the	
syndrome	ENTITY
.	

However	
,	
some	
patients	ENTITY
,	
particularly	
younger	ENTITY
children	ENTITY
,	
have	
a	
pattern	ENTITY
of	
obstructive	ENTITY
hypoventilation	ENTITY
,	
which	
consists	
of	
long	ENTITY
periods	ENTITY
of	
persistent	ENTITY
partial	
upper	
airway	
obstruction	
associated	ENTITY
with	ENTITY
hypercapnia	ENTITY
,	
arterial	ENTITY
oxygen	ENTITY
desatu-	ENTITY
ration	ENTITY
,	
or	
both	
.	

Some	
children	ENTITY
may	
manifest	ENTITY
a	
pattern	ENTITY
of	
UARS	ENTITY
similar	
to	
that	
seen	
in	
adults	ENTITY
,	
including	
snoring	ENTITY
without	
identifiable	
airflow	ENTITY
obstruction	ENTITY
and	
increasingly	
negative	ENTITY
esophageal	
pressure	
swings	
and	
cyclic	ENTITY
arousals	ENTITY
.	

In	
children	ENTITY
,	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
occurs	
predominantly	
during	
REM	ENTITY
sleep	ENTITY
.	

Children	ENTITY
often	
do	
not	
have	
cor-	ENTITY
tical	ENTITY
arousals	ENTITY
in	
response	ENTITY
to	
the	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
,	
although	
they	
may	
have	
movement	ENTITY
or	
autonomic	ENTITY
arousals	ENTITY
.	

Perhaps	
as	
a	
result	
of	
this	
higher	ENTITY
arousal	ENTITY
threshold	ENTITY
,	
sleep	ENTITY
architecture	ENTITY
is	
usually	
normal	ENTITY
,	
with	
normal	
amounts	
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

Even	
short	ENTITY
obstructive	ENTITY
apneas	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
severe	ENTITY
hypoxemia	ENTITY
because	
children	ENTITY
have	
a	
lower	
functional	ENTITY
residual	
capacity	ENTITY
and	
a	
higher	ENTITY
metabolic	ENTITY
rate	ENTITY
than	
adults	ENTITY
.	

Most	
children	ENTITY
with	
OSA	ENTITY
present	
with	
a	
history	ENTITY
of	ENTITY
snoring	ENTITY
and	
difficulty	ENTITY
breathing	
during	
sleep	ENTITY
.	

Snoring	ENTITY
is	
usually	
loud	ENTITY
and	
may	
be	
punctuated	ENTITY
by	
pauses	ENTITY
and	
gasps	ENTITY
,	
with	
associated	
movements	ENTITY
or	
arousal	ENTITY
from	
sleep	ENTITY
.	

However	
,	
some	
patients	ENTITY
,	
particu-	
larly	
infants	ENTITY
and	
those	
with	
neuromuscular	ENTITY
weakness	ENTITY
,	
may	
not	
snore	ENTITY
.	

Patients	ENTITY
with	
obstructive	ENTITY
hypoventilation	ENTITY
often	
have	
continuous	ENTITY
snoring	ENTITY
without	
pauses	ENTITY
or	
arous-	
als	
.	

Children	ENTITY
have	
a	
very	
compliant	
rib	ENTITY
cage	ENTITY
.	

As	
a	
result	ENTITY
,	
paradoxical	ENTITY
breathing	
is	
a	
prominent	ENTITY
sign	ENTITY
in	
these	
patients	ENTITY
(	
note	
that	
paradoxical	ENTITY
breathing	
during	
REM	ENTITY
sleep	ENTITY
is	
a	
normal	ENTITY
phenomenon	ENTITY
in	
young	ENTITY
children	ENTITY
up	
to	
at	
least	
age	ENTITY
three	
years	ENTITY
)	
.	

A	
pectus	ENTITY
excavatum	ENTITY
may	
be	
present	
.	

Thoracic	ENTITY
retractions	ENTITY
may	
be	
present	
.	

Children	ENTITY
may	
sleep	ENTITY
in	
unusual	ENTITY
positions	ENTITY
,	
such	
as	
seated	ENTITY
or	
with	
their	
neck	ENTITY
hyperextended	ENTITY
.	

Diaphoresis	ENTITY
may	
be	
observed	ENTITY
.	

Morning	ENTITY
headaches	ENTITY
may	
also	
occur	
.	

Many	
parents	ENTITY
of	
children	ENTITY
with	
OSA	ENTITY
are	
so	
concerned	
about	
their	
child	ENTITY
’s	ENTITY
breathing	ENTITY
that	
they	
sleep	ENTITY
with	
their	
child	ENTITY
or	
stimu-	
late	
their	
child	ENTITY
to	
terminate	ENTITY
the	
apneas	ENTITY
.	

Excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
may	
be	
present	
,	
especially	
in	
older	ENTITY
children	ENTITY
and	
adoles-	
cents	ENTITY
,	
but	
is	
seen	
less	
commonly	
in	
children	ENTITY
than	
in	
adults	ENTITY
with	
OSA	ENTITY
.	

Developmental	ENTITY
,	
behavioral	ENTITY
,	
and	
learning	ENTITY
issues	ENTITY
are	
frequently	
present	
.	

These	
may	
include	
attention	ENTITY
problems	ENTITY
,	
hyperactivity	ENTITY
,	
moodiness	ENTITY
,	
irritability	ENTITY
,	
and	
impaired	ENTITY
academic	ENTITY
performance	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Hypoxemia	ENTITY
and	
hypercapnia	ENTITY
are	
often	
present	
during	
sleep	ENTITY
and	
may	
be	
severe	ENTITY
.	

A	
prom-	
inent	ENTITY
sinus	
arrhythmia	
is	
often	
seen	
,	
although	
other	
arrhythmias	ENTITY
are	
rare	ENTITY
.	

Secondary	ENTITY
enuresis	ENTITY
may	
occur	
.	

Breathing	ENTITY
during	
wakefulness	ENTITY
is	
normal	ENTITY
,	
although	
mouth	ENTITY
breath-	
ing	
secondary	ENTITY
to	ENTITY
adenoidal	ENTITY
hypertrophy	ENTITY
may	
be	
present	
.	

Other	
nonspecific	ENTITY
daytime	ENTITY
symptoms	ENTITY
related	
to	
adenotonsillar	ENTITY
hypertrophy	ENTITY
,	
such	
as	
frequent	ENTITY
upper	ENTITY
respiratory	ENTITY
tract	ENTITY
infections	ENTITY
or	
dysphagia	ENTITY
,	
may	
occur	
.	

Although	
studies	ENTITY
have	
shown	
that	
children	ENTITY
with	
OSA	ENTITY
generally	
have	
larger	
tonsils	ENTITY
and	
adenoidal	ENTITY
tissue	ENTITY
than	
do	
other	
children	ENTITY
,	
the	
size	ENTITY
of	
the	
tonsils	ENTITY
and	
adenoidal	ENTITY
tissue	ENTITY
does	
not	
predict	
disease	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Clinical	ENTITY
presentations	ENTITY
include	
OSA	ENTITY
,	
obstructive	ENTITY
hypoventilation	ENTITY
,	
and	
recurrent	ENTITY
arousal	ENTITY
associated	ENTITY
with	ENTITY
increased	ENTITY
respiratory	ENTITY
effort	ENTITY
(	
RERAs	ENTITY
)	
.	

Demographics	ENTITY
The	
prevalence	ENTITY
in	
children	ENTITY
has	
been	
estimated	ENTITY
at	
1	
%	
to	
4	
%	
,	
but	
the	
prevalence	ENTITY
may	
currently	
be	
higher	ENTITY
due	
to	
the	
pediatric	ENTITY
obesity	ENTITY
epidemic	ENTITY
.	

The	
prevalence	ENTITY
in	
infants	ENTITY
and	
adolescents	ENTITY
is	
unknown	
.	

In	
prepubertal	ENTITY
children	ENTITY
,	
the	
disease	ENTITY
occurs	
equally	
among	
boys	ENTITY
and	
girls	ENTITY
;	
in	
adolescents	ENTITY
,	
data	ENTITY
suggest	
the	
prevalence	ENTITY
may	
be	
higher	ENTITY
in	
males	ENTITY
.	

There	
appears	
to	
be	
a	
higher	
prevalence	ENTITY
in	
black	ENTITY
children	ENTITY
than	
white	ENTITY
children	ENTITY
;	
the	
prev-	
alence	
in	
other	
ethnic	ENTITY
groups	ENTITY
is	
unknown	
.	

The	
disease	ENTITY
can	
occur	
at	
any	
age	ENTITY
,	
from	
the	
neonatal	ENTITY
period	ENTITY
to	
adolescence	ENTITY
,	
but	
in	
otherwise	
healthy	ENTITY
children	ENTITY
it	
is	
most	
common	
in	
the	
preschool	ENTITY
age	ENTITY
(	
in	
association	ENTITY
with	ENTITY
adenotonsillar	ENTITY
hypertrophy	ENTITY
)	
and	
in	
adolescents	ENTITY
(	
in	
association	ENTITY
with	ENTITY
obesity	ENTITY
)	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Adenotonsillar	ENTITY
hypertrophy	ENTITY
and	
obesity	ENTITY
are	
the	
most	
common	
predisposing	ENTITY
/	
precip-	ENTITY
itating	ENTITY
factors	ENTITY
.	

Children	ENTITY
with	
craniofacial	ENTITY
abnormalities	ENTITY
,	
particularly	
micrognathia	ENTITY
or	
midfacial	ENTITY
hypoplasia	ENTITY
,	
are	
at	
risk	ENTITY
.	

Those	
with	
Down	ENTITY
syndrome	ENTITY
are	
particularly	
at	
risk	ENTITY
for	
having	
OSA	ENTITY
.	

Children	ENTITY
with	
neuromuscular	ENTITY
diseases	ENTITY
often	
have	
upper	ENTITY
airway	ENTITY
muscle	ENTITY
weakness	ENTITY
,	
which	
predisposes	
to	
airway	ENTITY
collapse	ENTITY
.	

Children	ENTITY
with	
cerebral	ENTITY
palsy	ENTITY
may	
be	
predisposed	
to	
OSA	ENTITY
because	
of	
spasticity	ENTITY
,	
weakness	ENTITY
,	
or	
incoordination	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
muscles	ENTITY
.	

Infants	ENTITY
with	
gastroesophageal	ENTITY
reflux	ENTITY
may	
develop	
OSA	ENTITY
due	
to	
upper	ENTITY
airway	ENTITY
edema	ENTITY
or	
laryngospasm	ENTITY
.	

Other	
medical	ENTITY
conditions	ENTITY
such	
as	
mucopoly-	
saccharidosis	ENTITY
and	
sickle	ENTITY
cell	ENTITY
disease	ENTITY
may	
predispose	
to	
OSA	ENTITY
.	

Pharyngeal	ENTITY
flap	ENTITY
oper-	
ations	ENTITY
,	
typically	
performed	
to	
improve	ENTITY
speech	ENTITY
quality	ENTITY
in	
patients	ENTITY
with	
cleft	ENTITY
palate	ENTITY
,	
can	
result	
in	
OSA	ENTITY
.	

Environmental	ENTITY
tobacco	ENTITY
smoke	ENTITY
exposure	ENTITY
has	
been	
associated	ENTITY
with	ENTITY
snoring	ENTITY
and	
OSA	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Familial	ENTITY
Patterns	ENTITY

There	
is	
evidence	ENTITY
for	
an	
increased	ENTITY
risk	ENTITY
of	
OSA	ENTITY
in	
children	ENTITY
with	
affected	ENTITY
family	ENTITY
members	ENTITY
.	

Potential	ENTITY
mechanisms	ENTITY
for	
familial	ENTITY
aggregation	ENTITY
include	
heritability	ENTITY
of	
pre-	
disposing	ENTITY
skeletal	ENTITY
,	
soft	ENTITY
tissue	ENTITY
,	
body	ENTITY
habitus	ENTITY
,	
or	
respiratory	ENTITY
control	ENTITY
characteristics	ENTITY
.	

However	
,	
the	
relative	
roles	
of	
genetic	ENTITY
factors	ENTITY
versus	
environmental	ENTITY
factors	ENTITY
have	
not	
been	
determined	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
exact	
course	
of	
pediatric	ENTITY
OSA	ENTITY
has	
not	
been	
well	
studied	
.	

Symptoms	ENTITY
typically	
begin	
within	
the	
first	
few	
years	ENTITY
of	
life	ENTITY
,	
although	
the	
disease	ENTITY
may	
not	
be	
diagnosed	ENTITY
until	
many	
years	ENTITY
later	
.	

The	
natural	ENTITY
course	ENTITY
of	
untreated	ENTITY
OSA	ENTITY
is	
not	
known	
.	

A	
few	
short	ENTITY
-	
term	ENTITY
studies	ENTITY
suggest	
that	
some	
children	ENTITY
with	
mild	ENTITY
disease	ENTITY
may	
improve	ENTITY
,	
or	
conversely	
,	
have	
worsening	ENTITY
of	
the	
condition	ENTITY
;	
long	ENTITY
-	
term	ENTITY
studies	ENTITY
are	
not	
available	
.	

Complications	ENTITY
are	
frequent	ENTITY
and	
may	
be	
severe	ENTITY
.	

In	
early	ENTITY
childhood	ENTITY
,	
OSA	ENTITY
can	
cause	
growth	ENTITY
failure	ENTITY
,	
especially	
when	
associated	ENTITY
with	ENTITY
a	
comorbid	ENTITY
genetic	ENTITY
or	
craniofacial	ENTITY
disorder	ENTITY
.	

Cognitive	ENTITY
and	
behavioral	ENTITY
complications	ENTITY
are	
common	
and	
may	
include	
developmental	ENTITY
delay	ENTITY
,	
poor	ENTITY
school	ENTITY
performance	ENTITY
,	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
dis-	
order	
,	
inattention	ENTITY
and	
impairment	ENTITY
in	
concentration	ENTITY
,	
and	
aggressive	ENTITY
behavior	ENTITY
.	

Rarely	ENTITY
,	
cases	ENTITY
of	
severe	ENTITY
asphyxial	ENTITY
brain	
damage	
,	
seizures	ENTITY
,	
and	
coma	ENTITY
have	
been	
reported	
.	

Cardiovascular	ENTITY
complications	ENTITY
include	
pulmonary	ENTITY
hypertension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
and	
systemic	ENTITY
hypertension	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Developmental	ENTITY
issues	ENTITY
are	
reviewed	ENTITY
within	
individual	ENTITY
sections	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
In	
children	ENTITY
,	
as	
in	
adults	ENTITY
,	
OSA	ENTITY
results	ENTITY
from	
a	
combination	ENTITY
of	
abnormal	ENTITY
neuromuscular	ENTITY
control	ENTITY
and	
anatomical	ENTITY
narrowing	ENTITY
of	
the	
collapsible	ENTITY
(	ENTITY
supracartilaginous	ENTITY
)	ENTITY
portion	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
.	

During	
wakefulness	ENTITY
,	
the	
patient	ENTITY
with	
OSA	ENTITY
compensates	
by	
augmenting	
upper	ENTITY
airway	ENTITY
muscle	ENTITY
tone	ENTITY
to	
dilate	ENTITY
the	
upper	ENTITY
airway	ENTITY
;	
thus	
,	
obstructive	ENTITY
apnea	ENTITY
does	
not	
occur	
.	

During	
sleep	ENTITY
,	
there	
is	
a	
decrease	ENTITY
in	
ventilatory	ENTITY
drive	
and	
in	
neuromuscular	ENTITY
tone	ENTITY
,	
facilitating	
upper	ENTITY
airway	ENTITY
collapse	ENTITY
.	

The	
resultant	ENTITY
recurrent	ENTITY
hypoxemia	ENTITY
,	
hypercapnia	ENTITY
,	
and	
sleep	ENTITY
disruption	ENTITY
may	
lead	
to	
neurobehavioral	ENTITY
,	
cardiovascular	ENTITY
,	
and	
growth	ENTITY
abnor-	ENTITY
malities	ENTITY
.	

Childhood	ENTITY
OSA	ENTITY
has	
also	
been	
associated	ENTITY
with	ENTITY
metabolic	ENTITY
and	
inflammatory	ENTITY
abnormalities	ENTITY
.	

In	
most	
children	ENTITY
who	
are	
otherwise	
healthy	ENTITY
,	
upper	ENTITY
airway	ENTITY
narrowing	ENTITY
is	
primarily	
due	
to	
adenotonsillar	ENTITY
hypertrophy	ENTITY
.	

Pediatric	ENTITY
OSA	ENTITY
also	
occurs	
in	
association	ENTITY
with	ENTITY
obesity	ENTITY
,	
which	
is	
becoming	
increasingly	
prevalent	ENTITY
.	

Other	
causes	
for	
upper	ENTITY
airway	ENTITY
narrowing	ENTITY
include	
craniofacial	ENTITY
anomalies	ENTITY
,	
particularly	
those	
involving	
midface	ENTITY
hypoplasia	ENTITY
or	
micrognathia	ENTITY
/	
retrognathia	ENTITY
.	

In	
addition	
,	
children	ENTITY
with	
decreased	ENTITY
upper	ENTITY
airway	
muscle	
tone	
or	
abnormal	ENTITY
upper	ENTITY
airway	ENTITY
muscle	ENTITY
function	
,	
such	
as	
children	ENTITY
with	
muscular	ENTITY
dys-	ENTITY
trophy	ENTITY
or	
cerebral	ENTITY
palsy	ENTITY
,	
are	
at	
increased	ENTITY
risk	ENTITY
for	
OSA	ENTITY
.	

Objective	
Findings	ENTITY
PSG	ENTITY
demonstrates	
obstructive	ENTITY
and	
mixed	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
,	
or	
periods	ENTITY
of	
obstructive	ENTITY
hypoventilation	ENTITY
.	

In	
children	ENTITY
,	
obstructive	ENTITY
apneas	ENTITY
lasting	
two	
respiratory	ENTITY
cycles	ENTITY
or	
longer	ENTITY
are	
scored	ENTITY
.	

In	
contrast	
to	
adults	ENTITY
with	
OSA	ENTITY
,	
EEG	ENTITY
arousals	ENTITY
may	
or	
may	
not	
be	
present	
fol-	
lowing	ENTITY
apneas	ENTITY
,	
especially	
in	
young	ENTITY
children	ENTITY
,	
although	
subcortical	ENTITY
/	
autonomic	ENTITY
arousals	ENTITY
(	
as	
manifested	
by	
body	ENTITY
movements	ENTITY
,	
tachycardia	ENTITY
,	
or	
measurements	ENTITY
of	
pulse	ENTITY
transit	ENTITY
time	ENTITY
or	
arterial	ENTITY
tonometry	ENTITY
)	
may	
occur	
.	

Possibly	
as	
a	
result	
of	
the	
higher	ENTITY
arousal	ENTITY
threshold	ENTITY
,	
sleep	ENTITY
architecture	ENTITY
is	
usually	
preserved	
.	

Apneas	ENTITY
and	
hypopneas	ENTITY
occur	
primarily	
during	
REM	ENTITY
sleep	ENTITY
,	
and	
breathing	ENTITY
may	
be	
totally	
normal	
during	
NREM	ENTITY
sleep	ENTITY
.	

Obstructive	ENTITY
events	ENTITY
are	
frequently	
associated	ENTITY
with	ENTITY
desaturation	ENTITY
and	
hypercapnia	ENTITY
.	

Evaluation	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
by	
endoscopy	ENTITY
,	
radiography	ENTITY
,	
computed	ENTITY
tomographic	ENTITY
scans	ENTITY
,	
or	
magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
studies	ENTITY
may	
show	
large	
tonsils	ENTITY
and	
adenoidal	ENTITY
tissue	ENTITY
and	
a	
narrow	
upper	
airway	
,	
although	
these	
tests	ENTITY
are	
not	
performed	
routinely	
.	

Echocardiography	ENTITY
may	
show	
evidence	ENTITY
of	
right	ENTITY
,	
left	ENTITY
,	
or	
biventricular	ENTITY
hypertrophy	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Pediatric	ENTITY
OSA	ENTITY
must	
be	
differentiated	
from	
isolated	ENTITY
snoring	ENTITY
.	

Children	ENTITY
with	
snoring	ENTITY
but	
without	
observed	
apnea	ENTITY
,	
labored	ENTITY
breathing	ENTITY
during	
sleep	ENTITY
,	
daytime	ENTITY
behavioral	ENTITY
issues	ENTITY
,	
sleepiness	ENTITY
,	
or	
other	
symptoms	ENTITY
of	
OSA	ENTITY
may	
not	
require	
further	
laboratory	ENTITY
investigation	ENTITY
.	

However	
,	
children	ENTITY
who	
have	
snoring	ENTITY
and	
symptoms	ENTITY
of	
OSA	ENTITY
need	
evaluation	ENTITY
to	
deter-	
mine	ENTITY
whether	
they	
have	
isolated	ENTITY
snoring	ENTITY
or	
OSA	ENTITY
(	
N.B.	
this	
distinction	
can	
not	
reliably	
be	
made	
clinically	ENTITY
but	
should	
be	
based	
on	
PSG	ENTITY
)	
.	

Children	ENTITY
with	
primary	ENTITY
snoring	ENTITY
do	
not	
have	
apneas	ENTITY
,	
gas	ENTITY
exchange	ENTITY
abnormalities	ENTITY
,	
or	
frequent	ENTITY
arousals	ENTITY
on	
PSG	ENTITY
.	

Central	ENTITY
sleep	ENTITY
apnea	ENTITY
can	
be	
differentiated	
from	
OSA	ENTITY
by	
the	
lack	ENTITY
of	ENTITY
chest	ENTITY
or	
abdominal	ENTITY
wall	ENTITY
move-	
ment	ENTITY
associated	ENTITY
with	ENTITY
the	
central	ENTITY
apneas	ENTITY
.	

Mixed	ENTITY
apneas	ENTITY
may	
be	
seen	
and	
are	
included	
in	
the	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

Children	ENTITY
with	
fixed	
upper	
airway	
obstruction	
due	
to	
struc-	
tural	ENTITY
abnormalities	ENTITY
tend	
to	
obstruct	
both	
awake	ENTITY
and	
asleep	ENTITY
,	
and	
have	
stridor	ENTITY
rather	
than	
snoring	ENTITY
.	

OSA	ENTITY
in	
children	ENTITY
must	
be	
distinguished	
from	
nonobstructive	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
.	

Children	ENTITY
with	
lung	ENTITY
or	
chest	ENTITY
wall	ENTITY
disease	ENTITY
may	
have	
desaturation	ENTITY
and	
hypercapnia	ENTITY
during	
sleep	ENTITY
.	

It	
may	
be	
difficult	
to	
separate	
nonobstructive	ENTITY
hypoventila-	
tion	ENTITY
and	
desaturation	ENTITY
from	
OSA	ENTITY
,	
especially	
because	
the	
two	
conditions	ENTITY
may	
coexist	
.	

In	
general	
,	
children	ENTITY
with	
nonobstructive	ENTITY
hypoventilation	ENTITY
will	
not	
snore	ENTITY
and	
will	
not	
have	
paradoxical	ENTITY
inward	ENTITY
rib	ENTITY
cage	ENTITY
motion	ENTITY
during	
inspiration	ENTITY
,	
although	
the	
latter	
may	
be	
present	
in	
children	ENTITY
with	
neuromuscular	ENTITY
disease	ENTITY
.	

OSA	ENTITY
must	
be	
differentiated	
from	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
other	
causes	
of	
sleepiness	ENTITY
such	
as	
narcolepsy	ENTITY
,	
idiopathic	ENTITY
hypersomnia	ENTITY
,	
and	
insufficient	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
may	
mimic	
obstructive	ENTITY
apnea	ENTITY
during	
sleep	ENTITY
and	
may	
be	
indistinguishable	
from	
OSA	ENTITY
without	
the	
appropriate	
EEG	ENTITY
monitoring	ENTITY
,	
especially	
in	
infants	ENTITY
who	
may	
have	
only	
subtle	
motor	ENTITY
components	ENTITY
of	
seizures	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
is	
a	
need	
for	
further	
research	ENTITY
in	
many	
aspects	
of	
pediatric	ENTITY
OSA	ENTITY
.	

Although	
studies	ENTITY
of	
prevalence	ENTITY
have	
been	
performed	
in	
the	
past	
,	
the	
prevalence	ENTITY
has	
probably	
increased	ENTITY
in	
recent	
years	ENTITY
due	
to	
the	
increasing	ENTITY
prevalence	ENTITY
of	
childhood	ENTITY
obesity	ENTITY
.	

Further	
data	ENTITY
regarding	
the	
prevalence	ENTITY
in	
infants	ENTITY
and	
adolescents	ENTITY
is	
needed	
.	

The	
natural	ENTITY
course	ENTITY
of	
the	
disease	ENTITY
,	
the	
optimal	ENTITY
techniques	ENTITY
for	
monitoring	ENTITY
patients	ENTITY
during	
PSG	ENTITY
,	
the	
effects	ENTITY
of	ENTITY
mild	ENTITY
OSA	ENTITY
,	
and	
the	
threshold	ENTITY
necessitating	
treatment	ENTITY
require	
further	
study	ENTITY
.	

The	
role	
of	
genetic	ENTITY
,	
ethnic	ENTITY
,	
and	
anatomic	ENTITY
factors	ENTITY
in	
the	
pathophysiology	ENTITY
of	
childhood	ENTITY
OSA	ENTITY
also	
requires	
further	
study	ENTITY
.	

Bibliography	ENTITY
Arens	ENTITY
R	ENTITY
,	
Marcus	ENTITY
CL	ENTITY
.	

Pathophysiology	ENTITY
of	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
:	
a	
developmental	ENTITY
perspective	ENTITY
.	

Sleep	ENTITY
2004;27:997–1019	
.	

Arens	ENTITY
R	ENTITY
,	
McDonough	ENTITY
JM	ENTITY
,	
Costarino	ENTITY
AT	ENTITY
,	
et	
al	
.	

Magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
structure	ENTITY
in	
children	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2001;164:698–703	
.	

Marcus	ENTITY
CL	ENTITY
,	
Brooks	ENTITY
LJ	ENTITY
,	
Davidson	ENTITY
Ward	ENTITY
S	ENTITY
,	
et	
al	
.	
;	
American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Diagnosis	ENTITY
and	
management	ENTITY
of	
childhood	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
:	
technical	ENTITY
report	ENTITY
.	

American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Pediatrics	ENTITY
2012;130	
:	
e714–55	ENTITY
.	

Marcus	ENTITY
CL	ENTITY
,	
Brooks	ENTITY
LJ	ENTITY
,	
Draper	ENTITY
K	ENTITY
,	
Gozal	ENTITY
D	ENTITY
,	
et	
al	
.	
;	
American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Diagnosis	ENTITY
and	
management	ENTITY
of	
childhood	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
:	
clinical	ENTITY
practice	ENTITY
guideline	ENTITY
.	

American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Pediatrics	ENTITY
2012;130:576–84	
.	

Redline	ENTITY
S	ENTITY
,	
Tishler	ENTITY
PV	ENTITY
,	
Schluchter	ENTITY
M	ENTITY
,	
Aylor	ENTITY
J	ENTITY
,	
Clark	ENTITY
K	ENTITY
,	
Graham	
G.	
Risk	ENTITY
factors	ENTITY
for	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
in	
children	ENTITY
.	

Associations	ENTITY
with	ENTITY
obesity	ENTITY
,	
race	ENTITY
,	
and	
respiratory	ENTITY
problems	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1999;159:1527–32	
.	

Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Syndromes	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
786.04	
Alternate	ENTITY
Names	ENTITY
Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
(	
A	
or	
B	
)	
+	
C	
+	
D	
satisfy	
the	
criteria	ENTITY
A.	

The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following	
:	
1	
.	
Sleepiness	ENTITY
.	

ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
R06.3	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

Difficulty	ENTITY
initiating	
or	
maintaining	
sleep	ENTITY
,	
frequent	ENTITY
awakenings	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
.	
.	

Awakening	ENTITY
short	ENTITY
of	ENTITY
breath	ENTITY
.	
.	

Snoring	ENTITY
.	
.	

Witnessed	ENTITY
apneas	ENTITY
.	

B.	ENTITY
The	
presence	ENTITY
of	
atrial	ENTITY
fibrillation	ENTITY
/	
flutter	ENTITY
,	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
or	
a	
neurological	ENTITY
disorder	ENTITY
.	

C.	ENTITY
PSG	ENTITY
(	
during	
diagnostic	ENTITY
or	
positive	ENTITY
airway	
pressure	
titration	ENTITY
)	
shows	
all	
of	
the	
following	
:	
.	

Five	
or	
more	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
per	
hour	
of	
sleep.1	ENTITY
.	

The	
total	
number	
of	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
is	
>	
50	
%	
of	
the	
total	
number	
of	
apneas	ENTITY
and	
hypopneas.2	ENTITY
.	

The	
pattern	ENTITY
of	
ventilation	ENTITY
meets	
criteria	ENTITY
for	
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	ENTITY
(	
CSB).1	ENTITY
D.	ENTITY
The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
(	
e.g.	
,	
opioids	ENTITY
)	
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

If	
criterion	ENTITY
C2	ENTITY
is	
not	
met	
,	
CSB	ENTITY
can	
be	
listed	
as	
a	
polysomnographic	ENTITY
finding	ENTITY
.	
.	

A	
diagnosis	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
CSA	ENTITY
)	
with	
CSB	ENTITY
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Essential	
Features	
CSA	ENTITY
-	
CSB	ENTITY
is	
characterized	ENTITY
by	
recurrent	ENTITY
central	ENTITY
apneas	ENTITY
or	
central	ENTITY
hypopneas	ENTITY

alternat-	
ing	
with	
a	
respiratory	ENTITY
phase	ENTITY
exhibiting	
a	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	
of	
flow	ENTITY
(	
or	
tidal	ENTITY
volume	ENTITY
)	
.	

The	
longer	ENTITY
cycle	ENTITY
length	ENTITY
(	
>	
40	
seconds	
;	
typically	
45	
to	
60	
seconds	
)	
distinguishes	
CSB	ENTITY
from	
other	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
types	ENTITY
.	

The	
vast	
majority	
of	
patients	ENTITY
with	
CSA	ENTITY
-	
CSB	ENTITY
have	
either	
systolic	ENTITY
or	
diastolic	ENTITY
heart	ENTITY
failure	ENTITY
.	

In	
systolic	ENTITY
heart	ENTITY
failure	ENTITY
the	
cycle	ENTITY
length	ENTITY
is	
longer	ENTITY
(	
longer	ENTITY
respiratory	ENTITY
phase	ENTITY
)	
than	
in	
patients	ENTITY
with	
diastolic	ENTITY
heart	ENTITY
failure	ENTITY
,	
and	
there	
is	
often	
a	
delay	ENTITY
in	
the	
nadir	ENTITY
of	
the	
associated	ENTITY
oxygen	ENTITY
desatu-	ENTITY
ration	ENTITY
.	

Patients	ENTITY
with	
CSA	ENTITY
-	
CSB	ENTITY
have	
normal	ENTITY
or	
low	ENTITY
daytime	ENTITY
arterial	ENTITY
PCO2	ENTITY
(	
PaCO2	ENTITY
)	
.	

Some	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
have	
a	
mixture	
of	
obstructive	ENTITY
and	
central	ENTITY
apneas	ENTITY
with	
more	
central	ENTITY
apneas	ENTITY
in	
the	
later	
part	
of	
the	
night	ENTITY
or	
when	
the	
patient	ENTITY
is	
placed	
on	
posi-	
tive	ENTITY
airway	ENTITY
pressure	ENTITY
(	
PAP	ENTITY
)	
.	

A	
diagnosis	ENTITY
of	
CSA	ENTITY
-	
CSB	ENTITY
requires	
that	
events	ENTITY
be	
predom-	
inantly	
central	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
with	
an	
average	ENTITY
frequency	ENTITY
of	
at	
least	
5	
/	
hour	ENTITY
during	
a	
diagnostic	ENTITY
PSG	ENTITY
or	
either	
the	
diagnostic	ENTITY
or	
therapeutic	ENTITY
portion	ENTITY
of	
a	
split	ENTITY
-	
night	ENTITY
study	ENTITY
.	

For	
patients	ENTITY
with	
a	
mixture	
of	
OSA	ENTITY
and	
CSA	ENTITY
-	
CSB	ENTITY
,	
the	
central	ENTITY
apneas	ENTITY
may	
appear	
only	
after	
elimination	ENTITY
of	
obstruction	ENTITY
on	
positive	ENTITY
airway	
pressure	
.	

In	
patient	ENTITY
with	
CSA	ENTITY
-	
CSB	ENTITY
,	
arousal	ENTITY
from	
sleep	ENTITY
tends	
to	
occur	
at	
the	
zenith	ENTITY
of	
respiratory	ENTITY
effort	ENTITY
between	
contiguous	
central	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
.	

This	
can	
result	
in	
sleep	ENTITY
fragmen-	
tation	ENTITY
.	

However	
,	
patients	ENTITY
may	
complain	ENTITY
of	
disturbed	
nocturnal	ENTITY
sleep	ENTITY
or	
nocturnal	ENTITY
dyspnea	ENTITY
rather	
than	
daytime	ENTITY
sleepiness	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Presenting	
features	
of	
CSB	ENTITY
pattern	ENTITY
during	
sleep	ENTITY
may	
include	
excessive	ENTITY
daytime	ENTITY
sleep-	ENTITY
iness	ENTITY
,	
insomnia	ENTITY
,	
or	
nocturnal	ENTITY
dyspnea	ENTITY
.	

Because	
many	
patients	ENTITY
with	
CSA	ENTITY
-	
CSB	ENTITY
have	
known	
heart	ENTITY
failure	ENTITY
,	
their	
complaints	ENTITY
of	
frequent	ENTITY
awakenings	ENTITY
or	
disturbed	ENTITY
sleep	ENTITY
may	
be	
falsely	
assumed	
to	
be	
entirely	
secondary	ENTITY
to	ENTITY
heart	ENTITY
failure	ENTITY
.	

Because	
studies	ENTITY
have	
shown	
that	
approximately	
60	
%	
of	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
have	
some	
form	
of	
sleep	ENTITY
apnea	ENTITY
,	
a	
high	ENTITY
index	ENTITY
of	
suspicion	ENTITY
is	
indicated	
.	

A	
CSB	ENTITY
pattern	ENTITY
can	
also	
occur	
during	
wakefulness	ENTITY
and	
can	
be	
observed	ENTITY
at	
bedside	ENTITY
or	
in	
the	
clinic	ENTITY
.	

Some	
studies	ENTITY
suggest	
that	
the	
pres-	
ence	ENTITY
of	
CSA	ENTITY
-	
CSB	ENTITY
during	
wakefulness	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
worse	
prognosis	ENTITY
.	

Although	
heart	ENTITY
failure	ENTITY
is	
the	
major	
cause	ENTITY
of	
CSA	ENTITY
-	
CSB	ENTITY
,	
recent	
studies	ENTITY
suggest	
that	
it	
can	
be	
noted	
after	
stroke	ENTITY
.	

CSA	ENTITY
-	
CSB	ENTITY
can	
rarely	
present	
in	
an	
idiopathic	ENTITY
form	ENTITY
or	
be	
associated	ENTITY
with	ENTITY
renal	ENTITY
failure	ENTITY
.	

As	
in	
other	
forms	
of	
CSA	ENTITY
,	
apneas	ENTITY
and	
hypopneas	ENTITY
are	
associated	ENTITY
with	ENTITY
absent	ENTITY
or	
reduced	ENTITY
ventilatory	ENTITY
effort	ENTITY
,	
respectively	
,	
due	
to	
diminished	ENTITY
central	ENTITY
respiratory	ENTITY
drive	
.	

Of	
inter-	
est	
,	
a	
longer	
respiratory	ENTITY
phase	ENTITY
between	
apneas	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
longer	
circulation	ENTITY
time	ENTITY
and	
delay	ENTITY
in	
the	
saturation	ENTITY
nadir	ENTITY
.	

The	
CSB	ENTITY
breathing	ENTITY
pattern	ENTITY
is	
characteristically	
observed	
during	
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
and	
usually	
resolves	
or	
is	
attenuated	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

In	
patients	ENTITY
with	
both	
OSA	ENTITY
and	
CSA	ENTITY
-	
CSB	ENTITY
,	
the	
relative	
amount	
of	
central	ENTITY
and	
obstructive	ENTITY
apnea	ENTITY
can	
vary	
over	
time	ENTITY
or	
even	
within	
the	
same	
night	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY

Some	
patients	ENTITY
have	
combined	
OSA	ENTITY
and	
CSA	ENTITY
,	
and	
the	
CSA	ENTITY
-	
CSB	ENTITY
may	
not	
manifest	ENTITY
until	
the	
patient	ENTITY
is	
placed	
on	
positive	ENTITY
airway	
pressure	
treatment	ENTITY
.	

These	
patients	ENTITY
are	
considered	
to	
have	
both	
OSA	ENTITY
and	
CSA	ENTITY
with	
CSB	ENTITY
.	

Patients	ENTITY
with	
systolic	ENTITY
or	
diastolic	ENTITY
heart	ENTITY
failure	ENTITY
may	
have	
CSB	ENTITY
,	
but	
the	
cycle	ENTITY
length	ENTITY
is	
longer	
in	
those	
with	
systolic	ENTITY
dys-	ENTITY
function	ENTITY
.	

Patients	ENTITY
with	
neurological	ENTITY
disorders	ENTITY
may	
have	
CSB	ENTITY
,	
but	
the	
characteristic	ENTITY
cycle	ENTITY
length	ENTITY
is	
less	
well	
described	
.	

Demographics	ENTITY
CSA	ENTITY
with	
CSB	ENTITY
generally	
is	
seen	
in	
subjects	ENTITY
older	
than	
60	
years	ENTITY
.	

The	
prevalence	ENTITY
of	
this	
breathing	ENTITY
disorder	ENTITY
in	
the	
setting	
of	
chronic	ENTITY
congestive	ENTITY
heart	ENTITY
failure	ENTITY
has	
been	
reported	
to	
be	
25	
%	
to	
40	
%	
,	
depending	
on	
how	
patients	ENTITY
are	
divided	
into	
those	
with	
predomi-	
nant	ENTITY
OSA	ENTITY
and	
those	
with	
CSA	ENTITY
.	

In	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
there	
is	
a	
striking	
male	ENTITY
predominance	ENTITY
in	
the	
occurrence	ENTITY
of	
CSA	ENTITY
-	
CSB	ENTITY
.	

Of	
interest	
,	
the	
use	
of	
β	ENTITY
-	ENTITY
blockers	ENTITY
and	
angiotensin	ENTITY
-	
converting	ENTITY
enzyme	ENTITY
inhibitors	ENTITY
for	
treatment	ENTITY
of	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
has	
not	
decreased	ENTITY
the	
prevalence	ENTITY
of	
CSA	ENTITY
-	
CSB	ENTITY
.	

Some	
form	
of	
sleep	ENTITY
apnea	ENTITY
is	
reported	
in	
50	
%	
to	
70	
%	
of	
patients	ENTITY
following	
stroke	ENTITY
,	
depending	
on	
the	
AHI	ENTITY
cutoff	ENTITY
used	
for	
diagno-	
sis	ENTITY
.	

Although	
OSA	ENTITY
predominates	
,	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
also	
common	
especially	
in	
the	
first	
few	
days	ENTITY
following	
stroke	ENTITY
.	

CSA	ENTITY
-	
CSB	ENTITY
has	
been	
reported	
to	
occur	
in	
26	
%	
to	
50	
%	
of	
patients	ENTITY
in	
the	
acute	ENTITY
period	ENTITY
following	
stroke	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
most	
important	
predisposing	ENTITY
factors	ENTITY
are	
the	
presence	ENTITY
of	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
stroke	ENTITY
,	
and	
possibly	
renal	ENTITY
failure	ENTITY
.	

Within	
the	
heart	ENTITY
failure	ENTITY
population	ENTITY
,	
risk	ENTITY
factors	ENTITY
for	
CSB	ENTITY
pattern	ENTITY
during	
sleep	ENTITY
include	
male	ENTITY
sex	ENTITY
,	
age	ENTITY
older	ENTITY
than	
60	
years	ENTITY
,	
the	
presence	ENTITY
of	
atrial	ENTITY
fibrillation	ENTITY
,	
and	
daytime	ENTITY
hypocapnia	ENTITY
(	
i.e.	
,	
awake	ENTITY
PaCO2	ENTITY
of	
38	
mm	ENTITY
Hg	ENTITY
or	
less	
)	
.	

In	
general	
,	
greater	
pulmonary	ENTITY
congestion	ENTITY
(	
higher	ENTITY
left	ENTITY
ventricular	ENTITY
end	ENTITY
-	
diastolic	ENTITY
pressure	ENTITY
)	
predicts	
lower	ENTITY
PaCO2	ENTITY
.	

Some	
studies	ENTITY
suggest	
that	
CSA	ENTITY
-	
CSB	ENTITY
occurs	
more	
commonly	
in	
the	
supine	ENTITY
position	ENTITY
.	

Although	
renal	ENTITY
failure	ENTITY
is	
often	
listed	
as	
a	
possible	
cause	
of	
CSA-	ENTITY
CSB	ENTITY
,	
there	
is	
scant	
literature	ENTITY
documenting	
this	
association	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
There	
are	
no	
definitive	
data	ENTITY
concerning	
the	
onset	ENTITY
.	

However	
,	
because	
it	
is	
seen	
in	
the	
setting	
of	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
stroke	ENTITY
,	
and	
possibly	
renal	ENTITY
failure	ENTITY
,	
CSA	ENTITY
with	
CSB	ENTITY
most	
likely	
has	
its	
onset	
following	
the	
development	ENTITY
of	
one	
of	
these	
illnesses	ENTITY
.	

In	
the	
setting	
of	
systolic	ENTITY
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
it	
is	
associated	ENTITY
with	ENTITY
a	
poor	ENTITY
prognosis	ENTITY
,	
as	
indicated	
by	
a	
greater	
adjusted	
relative	ENTITY
risk	ENTITY
for	
mortality	ENTITY
-	
cardiac	ENTITY
transplantation	ENTITY
com-	
pared	
to	
patients	ENTITY
without	
CSB	ENTITY
.	

These	
data	ENTITY
suggest	
that	
CSB	ENTITY
pattern	ENTITY
during	
sleep	ENTITY
par-	
ticipates	ENTITY
in	
the	
pathophysiology	ENTITY
and	
progression	ENTITY
of	
heart	ENTITY
failure	ENTITY
.	

Its	
clinical	ENTITY
signifi-	
cance	ENTITY
in	
the	
setting	
of	
stroke	ENTITY
or	
other	
neurological	ENTITY
disorders	ENTITY
remains	
less	
certain	
.	

In	
some	
patients	ENTITY
with	
CSA	ENTITY
after	
stroke	ENTITY
,	
the	
pattern	ENTITY
can	
transition	ENTITY
to	
one	
of	
OSA	ENTITY
.	

The	
presence	ENTITY
of	
obstructive	ENTITY
apnea	ENTITY
following	
stroke	ENTITY
has	
been	
found	
to	
be	
associated	ENTITY
with	ENTITY
a	
worse	
prognosis	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY

Although	
there	
are	
reports	ENTITY
of	
CSB	ENTITY
in	
children	ENTITY
,	
the	
condition	ENTITY
is	
extremely	
rare	
in	
this	
age	ENTITY
group	ENTITY
.	

Of	
interest	
,	
one	
study	ENTITY
of	
patients	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
across	
all	
age	ENTITY
groups	ENTITY
found	
CSB	ENTITY
to	
be	
absent	ENTITY
in	
children	ENTITY
but	
present	
in	
40	
%	
of	
the	
adult	ENTITY
patients	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
.	

A	
limitation	ENTITY
of	
the	
study	ENTITY
was	
that	
only	
ten	
children	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
were	
studied	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
CSA	
with	
CSB	ENTITY
generally	
arises	
because	
of	
instability	ENTITY
in	
the	
respiratory	ENTITY
control	ENTITY
system	ENTITY
.	

A	
high	ENTITY
ventilatory	ENTITY
drive	
and	
delay	ENTITY
in	
chemoreceptor	ENTITY
response	ENTITY
to	
changes	ENTITY
of	
PaCO2	ENTITY
and	
PaO2	ENTITY
(	
due	
to	
increased	ENTITY
circulation	ENTITY
time	ENTITY
)	
are	
likely	
the	
major	
factors	ENTITY
.	

This	
breathing	ENTITY
disorder	ENTITY
tends	
to	
occur	
in	
individuals	ENTITY
with	
a	
chronically	ENTITY
low	ENTITY
PaCO2	ENTITY
when	
awake	ENTITY
and	
asleep	ENTITY
.	

Hyperventilation	ENTITY
occurs	
due	
to	
an	
increase	ENTITY
in	
the	
responsiveness	ENTITY
of	
the	
periph-	
eral	ENTITY
and	
central	ENTITY
chemoreceptors	ENTITY
.	

The	
increased	ENTITY
responsiveness	ENTITY
is	
believed	
to	
be	
due	
to	
both	
increased	ENTITY
sympathetic	ENTITY
tone	ENTITY
and	
stimulation	ENTITY
of	
vagal	ENTITY
irritant	ENTITY
receptors	ENTITY
in	
the	
lungs	ENTITY
by	
pulmonary	ENTITY
congestion	ENTITY
.	

The	
PaCO2	ENTITY
in	
individuals	ENTITY
with	
CSB	ENTITY
pattern	ENTITY
and	
heart	ENTITY
failure	ENTITY
is	
closer	
to	
their	
apneic	ENTITY
threshold	ENTITY
than	
in	
those	
without	
CSB	ENTITY
pattern	ENTITY
(	
primarily	
due	
to	
a	
smaller	ENTITY
sleep	ENTITY
related	
rise	
in	
PaCO2	ENTITY
in	
those	
with	
CSB	ENTITY
)	
,	
so	
that	
even	
modest	
increases	ENTITY
in	
ventilation	ENTITY
can	
drive	
PaCO2	ENTITY
below	
the	
apneic	ENTITY
threshold	ENTITY
.	

The	
most	
common	
trigger	ENTITY
factor	ENTITY
for	
central	ENTITY
apnea	ENTITY
is	
an	
arousal	ENTITY
from	
sleep	ENTITY
,	
which	
abruptly	
augments	
ventilation	ENTITY
and	
drives	
PaCO2	ENTITY
below	
the	
apneic	ENTITY
threshold	ENTITY
.	

The	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	ENTITY
of	
tidal	ENTITY
volume	ENTITY
results	ENTITY
from	
prolonged	ENTITY
lung	ENTITY
-	
to	
-	
che-	
moreceptor	ENTITY
circulatory	ENTITY
delay	
,	
such	
that	
changes	ENTITY
in	
PaCO2	ENTITY
in	
the	
lung	ENTITY
are	
trans-	
mitted	ENTITY
only	
very	
slowly	
to	
the	
chemoreceptors	ENTITY
,	
resulting	
in	
a	
gradual	
buildup	ENTITY
and	
falloff	ENTITY
of	
ventilatory	ENTITY
stimulation	ENTITY
.	

The	
length	ENTITY
of	
the	
cycle	ENTITY
is	
directly	
proportional	
to	
lung	ENTITY
-	
to	
-	
chemoreceptor	ENTITY
circulation	
time	
and	
inversely	ENTITY
proportional	
to	
cardiac	ENTITY
output	ENTITY
.	

Accordingly	
,	
whereas	
the	
length	ENTITY
of	
the	
ventilatory	ENTITY
-	
apneic	ENTITY
cycle	ENTITY
in	
primary	ENTITY
CSA	ENTITY
is	
typically	
shorter	ENTITY
than	
40	
seconds	
,	
in	
CSB	ENTITY
pattern	ENTITY
it	
is	
almost	
invariably	
longer	
than	
40	
seconds	
(	
usually	
45	
-	
90	
seconds	
)	
.	

One	
study	ENTITY
of	
patients	ENTITY
with	
varying	
degrees	
of	
heart	ENTITY
failure	ENTITY
found	
a	
considerably	
shorter	ENTITY
cycle	ENTITY
time	
in	
patients	ENTITY
with	
normal	ENTITY
ejection	ENTITY
frac-	ENTITY
tion	ENTITY
(	
e.g.	
,	
diastolic	ENTITY
heart	ENTITY
failure	ENTITY
)	
.	

The	
pathophysiology	ENTITY
of	
CSB	ENTITY
pattern	ENTITY
in	
the	
setting	
of	
stroke	ENTITY
and	
renal	ENTITY
failure	ENTITY
has	
not	
been	
examined	
in	
any	
detail	
.	

However	
,	
apneas	ENTITY
in	
association	ENTITY
with	ENTITY
these	
medical	ENTITY
disorders	ENTITY
are	
believed	
to	
be	
due	
to	
a	
reduction	ENTITY
in	
PaCO2	ENTITY
below	
the	
apneic	ENTITY
threshold	ENTITY
.	

In	
individuals	ENTITY
with	
renal	ENTITY
failure	ENTITY
,	
pulmonary	ENTITY
congestion	ENTITY
(	
volume	ENTITY
overload	ENTITY
)	
may	
play	
a	
role	
in	
stimulating	ENTITY
hyperventilation	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

The	
polysomnographic	ENTITY
hallmarks	
of	
CSB	ENTITY
pattern	ENTITY
are	
recurrent	ENTITY
central	ENTITY
apneas	ENTITY
and	
central	ENTITY
hypopneas	ENTITY
alternating	
with	
ventilatory	ENTITY
periods	
having	
a	
prolonged	ENTITY
crescen-	
do	
-	
decrescendo	ENTITY
pattern	
of	
airflow	ENTITY
(	
tidal	ENTITY
volume	ENTITY
)	
.	

CSB	ENTITY
pattern	ENTITY
typically	
occurs	
at	
the	
transition	ENTITY
from	
wakefulness	ENTITY
to	
NREM	ENTITY
sleep	ENTITY
and	
during	
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
.	

It	
tends	
to	
dissipate	ENTITY
in	
stages	ENTITY
N3	
and	
R.	

In	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
the	
sleeping	ENTITY
PaCO2	ENTITY
is	
higher	ENTITY
(	
further	
above	
the	
apneic	ENTITY
threshold	ENTITY
)	
.	

During	
REM	ENTITY
sleep	ENTITY
the	
hypoxic	ENTITY
and	
hypercapnic	ENTITY
ventila-	
tory	
responses	ENTITY
are	
lower	ENTITY
,	
thereby	
reducing	ENTITY
the	
tendency	
for	
an	
overshoot	ENTITY
in	
ventilation	ENTITY
which	
may	
drive	
PaCO2	ENTITY
below	
the	
apneic	ENTITY
threshold	ENTITY
.	

Arousals	ENTITY
are	
frequently	
seen	
in	
association	ENTITY
with	
CSB	ENTITY
and	
are	
typically	
noted	
at	
or	
near	
the	
zenith	ENTITY
in	
respiratory	ENTITY
effort	ENTITY
(	
or	
airflow	ENTITY
)	
,	
although	
can	
occur	
at	
or	
near	
the	
onset	
of	
the	
respiratory	ENTITY
phase	ENTITY
pattern	
.	

In	
contrast	
,	
arousals	ENTITY
tend	
to	
occur	
at	
apnea	ENTITY
termination	ENTITY
in	
other	
CSA	ENTITY
disorders	ENTITY
.	

As	
noted	
above	
,	
a	
longer	
respiratory	ENTITY
phase	ENTITY
(	
and	
cycle	ENTITY
length	ENTITY
)	
is	
associated	ENTITY
with	ENTITY
lower	ENTITY
cardiac	ENTITY
output	ENTITY
and	
longer	
circulation	ENTITY
time	
.	

Central	ENTITY
hypopnea	ENTITY
,	
rather	
than	
apnea	ENTITY
,	
can	
occur	
at	
the	
nadir	ENTITY
in	
respiratory	ENTITY
effort	ENTITY
in	
patients	ENTITY
with	
CSB	ENTITY
and	
have	
been	
included	
in	
calculation	ENTITY
of	
the	
central	ENTITY
AHI	ENTITY
in	
a	
sub-	
stantial	ENTITY
number	
of	
investigations	ENTITY
.	

Central	ENTITY
hypopneas	ENTITY
are	
characterized	ENTITY
by	
the	
absence	ENTITY
of	
snoring	ENTITY
,	
flattening	ENTITY
in	
the	
nasal	ENTITY
pressure	ENTITY
or	
PAP	ENTITY
device	ENTITY
flow	ENTITY
signal	ENTITY
,	
and	
thoracoab-	
dominal	ENTITY
paradox	
.	

Central	ENTITY
apneas	ENTITY
and	
central	ENTITY
hypopneas	ENTITY
are	
usually	
accompanied	
by	
modest	
oxyhemo-	
globin	ENTITY
desaturation	ENTITY
;	
arterial	ENTITY
oxygen	ENTITY
saturation	ENTITY
seldom	ENTITY
falls	
below	
80	
%	
to	
85	
%	
.	

The	
combination	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
and	
arousals	ENTITY
from	
sleep	ENTITY
leads	
to	
sleep	ENTITY
fragmenta-	
tion	ENTITY
with	
reduced	ENTITY
amounts	
of	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
.	

Additionally	
,	
PaCO2	ENTITY
less	
than	
40	

mm	ENTITY
Hg	ENTITY
is	
typically	
observed	
during	
wakefulness	ENTITY
.	

In	
patients	ENTITY
with	
both	
obstructive	ENTITY
and	
central	ENTITY
apneas	ENTITY
,	
the	
proportion	ENTITY
of	
central	ENTITY
apneas	ENTITY
tends	
to	
increase	ENTITY
over	
the	
night	ENTITY
,	
and	
this	
is	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
associated	ENTITY
with	ENTITY
a	
fall	ENTITY
in	
the	
sleeping	ENTITY
PaCO2	ENTITY
.	

The	
lower	ENTITY
sleeping	ENTITY
PaCO2	ENTITY
is	
thought	
to	
be	
due	
to	
an	
increase	ENTITY
in	
pulmonary	ENTITY
congestion	ENTITY
during	
the	
night	ENTITY
with	
stimulation	ENTITY
of	
juxta-	ENTITY
capillary	ENTITY
(	ENTITY
J	ENTITY
)	ENTITY
receptors	ENTITY
in	
the	
lung	ENTITY
interstitium	ENTITY
and	
a	
subsequent	
increase	ENTITY
in	
ventilatory	ENTITY
drive	
.	

As	
noted	
above	
,	
some	
patients	ENTITY
have	
more	
CSA	ENTITY
-	
CSB	ENTITY
in	
the	
supine	ENTITY
position	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Primary	ENTITY
CSA	ENTITY
can	
usually	
be	
distinguished	
from	
CSB	ENTITY
pattern	ENTITY
by	
the	
absence	ENTITY
of	
a	
history	ENTITY
of	
heart	ENTITY
failure	ENTITY
,	
stroke	ENTITY
,	
or	
renal	ENTITY
failure	ENTITY
and	
by	
the	
absence	ENTITY
of	
a	
crescendo	ENTITY
-	
decrescendo	ENTITY
breathing	
pattern	
between	
central	ENTITY
apneas	ENTITY
.	

The	
cycle	ENTITY
length	ENTITY
(	ENTITY
apnea	
+	
ventilatory	ENTITY
phase	ENTITY
)	
in	
primary	ENTITY
CSA	ENTITY
is	
typically	
less	
than	
40	
seconds	
.	

High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
only	
occurs	
at	
high	ENTITY
altitude	ENTITY
and	
is	
not	
associated	ENTITY
with	ENTITY
heart	ENTITY
failure	ENTITY
,	
stroke	ENTITY
,	
or	
renal	ENTITY
failure	ENTITY
.	

Patients	ENTITY
with	
CSA	ENTITY
due	
to	
drug	ENTITY
or	
substance	ENTITY
have	
a	
history	ENTITY
of	
use	
of	
this	
type	
of	
medication	ENTITY
,	
and	
an	
ataxic	ENTITY
breathing	
pattern	
may	
be	
present	
.	

If	
patients	ENTITY
with	
CSA	ENTITY
asso-	
ciated	ENTITY
with	
opioids	ENTITY
manifest	
periodic	ENTITY
breathing	ENTITY
,	
the	
respiratory	ENTITY
phase	ENTITY
does	
not	
have	
a	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	
and	
the	
cycle	ENTITY
length	ENTITY
is	
shorter	ENTITY
.	

Patients	ENTITY
with	
CSA	ENTITY
due	
to	
a	
medical	ENTITY
or	
neurological	ENTITY
disease	ENTITY
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
will	
have	
central	ENTITY
apnea	ENTITY
that	
does	
not	
have	
Cheyne	ENTITY
-	
Stokes	ENTITY
morphology	ENTITY
,	
as	
the	
name	
implies	
.	

Sleep	ENTITY
related	
hypoven-	
tilation	ENTITY
and	
hypoxemic	ENTITY
syndromes	ENTITY
can	
be	
readily	
distinguished	
from	
CSA	ENTITY
-	
CSB	ENTITY
by	
documentation	ENTITY
of	
an	
awake	ENTITY
PaCO2	ENTITY
>	

45	
mm	

Hg	ENTITY
and/or	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Patients	ENTITY
with	
CSA	ENTITY
-	
CSB	ENTITY
usually	
have	
an	
awake	ENTITY
PaCO2	ENTITY
<	

40	
mm	
Hg	
.	

In	
patients	ENTITY
with	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
,	
some	
central	ENTITY
apneas	ENTITY
may	
be	
present	
,	
but	
these	
events	ENTITY
do	
not	
have	
a	
Cheyne	ENTITY
-	
Stokes	ENTITY
morphology	ENTITY
.	

Additionally	
,	
oxygen	ENTITY
desaturation	ENTITY
in	
sleep	ENTITY
related	
hypoventilation	ENTITY
syndromes	ENTITY
is	
generally	
more	
pronounced	
during	
REM	ENTITY
sleep	ENTITY
.	

OSA	ENTITY
is	
distinguished	
by	
the	
presence	ENTITY
of	
respiratory	ENTITY
efforts	ENTITY
during	
apneas	ENTITY
.	

A	
few	
central	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
at	
sleep	ENTITY
onset	ENTITY
or	
during	
REM	ENTITY
sleep	ENTITY
are	
normal	ENTITY
,	
especially	
in	
elderly	ENTITY
subjects	ENTITY
.	

These	
cease	ENTITY
once	
sleep	ENTITY
becomes	
stable	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
pathophysiology	ENTITY
and	
clinical	ENTITY
significance	ENTITY
of	
CSB	ENTITY
pattern	ENTITY
have	
not	
yet	
been	
eluci-	
dated	
in	
the	
setting	
of	
stroke	ENTITY
and	
renal	ENTITY
failure	ENTITY
.	

Less	ENTITY
is	
also	
known	
about	
the	
importance	
of	
CSB	ENTITY
in	
patients	ENTITY
with	
heart	ENTITY
failure	ENTITY
with	
a	
normal	ENTITY
ejection	ENTITY
fraction	ENTITY
.	

Bibliography	ENTITY
Dowdell	ENTITY
WT	ENTITY
,	
Javaheri	ENTITY
S	ENTITY
,	
McGinnis	
W.	
Cheyne	
-	
Stokes	ENTITY
respiration	ENTITY
presenting	
as	
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
.	

Clinical	ENTITY
and	
polysomnographic	ENTITY
features	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1990;141:871–9	ENTITY
.	

Hall	ENTITY
M	ENTITY
,	
Xie	ENTITY
A	ENTITY
,	
Rutherford	ENTITY
R	ENTITY
,	
Ando	ENTITY
S	ENTITY
,	
Floras	ENTITY
J	ENTITY
,	ENTITY
Bradley	ENTITY
T.	ENTITY
Cycle	ENTITY
length	
of	
periodic	ENTITY
breathing	ENTITY
in	
patients	ENTITY
with	
and	
without	
heart	ENTITY
failure	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1996;154:376–81	
.	

Lanfranchi	ENTITY
P	ENTITY
,	
Braghiroli	ENTITY
A	ENTITY
,	
Bosimini	ENTITY
E	ENTITY
,	
et	
al	
.	

Prognostic	ENTITY
value	ENTITY
of	
nocturnal	ENTITY
Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
in	
chronic	ENTITY
heart	ENTITY
failure	ENTITY
.	

Circulation	ENTITY
1999;99:1435–40	
.	

MacDonald	ENTITY
M	ENTITY
,	
Fang	
J	
,	
Pittman	ENTITY
SD	ENTITY
,	
White	ENTITY
DP	ENTITY
,	
Malhotra	ENTITY
A.	ENTITY

The	
current	
prevalence	ENTITY
of	
sleep	ENTITY
disordered	
breathing	
in	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
patients	ENTITY
treated	ENTITY
with	ENTITY
beta	ENTITY
-	
blockers	ENTITY
.	

J	
Clin	
Sleep	
Med	
2008;4:38–42	
.	

Naughton	ENTITY
M	ENTITY
,	
Benard	ENTITY
D	ENTITY
,	
Tam	ENTITY
A	ENTITY
,	
Rutherford	ENTITY
R	ENTITY
,	ENTITY
Bradley	ENTITY
T.	ENTITY

The	
role	
of	
hyperventilation	ENTITY
in	
the	
pathogenesis	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
in	
patients	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1993;148:330–8	ENTITY
.	

Peer	ENTITY
A	ENTITY
,	
Lorber	ENTITY
A	ENTITY
,	
Suraiya	ENTITY
S	ENTITY
,	
Malhotra	ENTITY
A	ENTITY
,	
Pillar	ENTITY
G.	
The	
occurrence	ENTITY
of	
Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
in	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
:	
the	
effect	ENTITY
of	
age	ENTITY
.	

Front	ENTITY
Psychiatry	ENTITY
2010;1:133	
.	

Pressman	ENTITY
MR	ENTITY
,	
Benz	
RL	ENTITY
,	
Schleifer	ENTITY
CR	ENTITY
,	
Peterson	ENTITY
DD	ENTITY
.	

Sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
in	
ESRD	ENTITY
:	
acute	ENTITY
beneficial	ENTITY
effects	ENTITY
of	
treatment	ENTITY
with	
nasal	ENTITY
continuous	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
.	

Kidney	ENTITY
Int	ENTITY
1993;43:1134–9	ENTITY
.	

Sahlin	ENTITY
C	ENTITY
,	
Svanborg	ENTITY
E	ENTITY
,	
Stenlund	ENTITY
H	ENTITY
,	ENTITY
Franklin	ENTITY
KA	ENTITY
.	

Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
and	
supine	ENTITY
dependency	ENTITY
.	

Eur	
Respir	
J	
2005;25:829–33	
.	

Sin	ENTITY
D	ENTITY
,	
Fitzgerald	ENTITY
F	ENTITY
,	
Parker	
J	
,	
Newton	ENTITY
G	ENTITY
,	
Floras	ENTITY
J	ENTITY
,	ENTITY
Bradley	ENTITY
T.	ENTITY
Risk	ENTITY
factors	ENTITY
for	
central	ENTITY
and	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
in	
450	
men	ENTITY
and	
women	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1999;160:1101–6	
.	

Sin	ENTITY
DD	ENTITY
,	
Logan	ENTITY
AG	ENTITY
,	
Fitzgerald	ENTITY
FS	ENTITY
,	
et	
al	
.	

Effects	ENTITY
of	ENTITY
continuous	ENTITY
positive	ENTITY
airway	
pressure	
on	
cardiovascular	ENTITY
outcomes	ENTITY
in	
Heart	ENTITY
failure	ENTITY
patients	ENTITY
with	
and	
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
Respiration	ENTITY
.	

Circulation	ENTITY
2000;102:61–6	
.	

Wedewardt	ENTITY
J	ENTITY
,	
Bitter	ENTITY
T	ENTITY
,	
Prinz	
C	
,	
Faber	ENTITY
L	ENTITY
,	
Horstkotte	ENTITY
D	ENTITY
,	
Oldenburg	ENTITY
O.	ENTITY
Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
in	
heart	ENTITY
failure	ENTITY
:	
cycle	ENTITY
length	ENTITY
is	
dependent	
on	
left	ENTITY
ventricular	ENTITY
ejection	ENTITY
fraction	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:137–42	ENTITY
.	

Xie	ENTITY
A	ENTITY
,	
Skatrud	ENTITY
J	ENTITY
,	
Puleo	ENTITY
D	ENTITY
,	
Rahko	ENTITY
P	ENTITY
,	ENTITY
Dempsey	
J.	
Apnea	
-	
hypopnea	ENTITY
threshold	ENTITY
for	
CO2	ENTITY
in	
patients	ENTITY
with	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2002;165:1245–50	
.	

Central	ENTITY
Apnea	ENTITY

Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
Breathing	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.27	
Alternate	ENTITY
Names	ENTITY
Not	
applicable	
or	
known	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following1	ENTITY
:	
1	
.	
Sleepiness	ENTITY
.	

ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.37	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

Difficulty	ENTITY
initiating	
or	
maintaining	
sleep	ENTITY
,	
frequent	ENTITY
awakenings	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
.	
.	

Awakening	ENTITY
short	ENTITY
of	ENTITY
breath	ENTITY
.	
.	

Snoring	ENTITY
.	
.	

Witnessed	ENTITY
apneas	ENTITY
.	

B.	ENTITY
PSG	ENTITY
shows	
all	
of	
the	
following	
:	
.	

Five	
or	
more	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
per	
hour	
of	
sleep.2	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

The	
number	
of	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
is	
>	
50	
%	
of	
the	
total	
number	
of	
apneas	ENTITY
and	
hypopneas	ENTITY
.	
.	

Absence	ENTITY
of	
CSB.2	ENTITY
C.	
The	
disorder	ENTITY
occurs	
as	
a	
consequence	
of	
a	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
but	
is	
not	
due	
to	
medication	ENTITY
use	ENTITY
or	
substance	ENTITY
use	ENTITY
.	

Notes	ENTITY
.	

In	
infants	ENTITY
and	
young	ENTITY
children	ENTITY
,	
symptoms	ENTITY
are	
supportive	ENTITY
but	
not	
required	
.	
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
not	
required	
but	
may	
be	
present	
.	

If	
the	
patient	ENTITY
meets	
criteria	ENTITY
for	
both	
sleep	ENTITY
related	
hypoventilation	ENTITY
and	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
not	
Cheyne	ENTITY
-	
Stokes	ENTITY
,	
both	
diagnoses	ENTITY
can	
be	
made	
.	
.	

In	
some	
patients	ENTITY
other	
abnormalities	ENTITY
of	
breathing	ENTITY
such	
as	
ataxic	ENTITY
breathing	ENTITY
may	
be	
prominent	ENTITY
.	
.	

A	
diagnosis	ENTITY
of	
central	ENTITY
apnea	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
without	
CSB	ENTITY
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

Essential	ENTITY
Features	
CSA	ENTITY
that	
is	
attributed	
to	
a	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
(	
and	
does	
not	
have	
the	
pattern	ENTITY
of	
CSB	ENTITY
)	
is	
classified	
here	
.	

The	
majority	
of	
these	
patients	ENTITY
have	
brainstem	ENTITY
lesions	ENTITY
of	
developmental	ENTITY
,	
vascular	ENTITY
,	
neoplastic	ENTITY
,	
degenerative	ENTITY
,	
demyelinating	ENTITY
,	
or	
traumatic	ENTITY
origin	ENTITY
.	

Associated	
Features	ENTITY
Patients	ENTITY
generally	
present	
with	
sleep	ENTITY
fragmentation	ENTITY
,	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
or	
insomnia	ENTITY
.	

Other	
signs	ENTITY
and	
symptoms	ENTITY
that	
are	
often	
,	
but	
not	
invariably	
,	
present	
include	
snoring	ENTITY
,	
witnessed	ENTITY
apnea	ENTITY
,	
and	
awakening	ENTITY
with	
shortness	ENTITY
of	ENTITY
breath	ENTITY
.	

The	
presentation	ENTITY
varies	
with	
the	
cause	
of	
central	ENTITY
apnea	ENTITY
and	
may	
include	
neurological	ENTITY
findings	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
.	

Some	
of	
the	
common	
medical	ENTITY
and	
neurological	ENTITY
disorders	ENTITY
causing	
central	ENTITY
apnea	ENTITY
not	
associated	ENTITY
with	ENTITY
CSB	ENTITY
are	
listed	
in	
Pathology	ENTITY
and	
Pathophysiology	ENTITY
(	
below	
)	
.	

Demographics	ENTITY
The	
prevalence	ENTITY
and	
demographics	ENTITY
of	
this	
disorder	ENTITY
vary	
with	
the	
underlying	
etiology	ENTITY
.	

Patients	ENTITY
with	
Chiari	ENTITY
malformation	ENTITY
(	
CM	ENTITY
)	
can	
present	
in	
infancy	ENTITY
or	
childhood	ENTITY
,	
but	
the	
most	
common	
age	ENTITY
of	
presentation	ENTITY
is	
20	
to	
40	
years	ENTITY
.	

Patients	ENTITY
with	
stroke	ENTITY
tend	
to	
be	
older	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Because	
of	
the	
heterogeneity	ENTITY
of	
etiologies	ENTITY
in	
this	
type	
of	
CSA	ENTITY
,	
predisposing	ENTITY
and	
pre-	
cipitating	ENTITY
factors	ENTITY
are	
variable	ENTITY
.	

In	
CM	ENTITY
there	
is	
herniation	ENTITY
of	
a	
portion	ENTITY
of	
the	
brainstem	ENTITY
through	
the	
foramen	ENTITY
magnum	ENTITY
.	

In	
CM	ENTITY
type	
1	
,	
a	
portion	ENTITY
of	
the	
cerebellar	ENTITY
tonsils	ENTITY
herni-	
ate	ENTITY
.	

CSA	ENTITY
in	
these	
patients	ENTITY
is	
believed	
to	
occur	
due	
to	
impaired	ENTITY
function	ENTITY
of	
ventilatory	ENTITY
control	ENTITY
centers	ENTITY
in	
the	
brainstem	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
None	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
These	
factors	ENTITY
vary	
as	
well	
with	
the	
different	
etiologies	ENTITY
.	

In	
CM	ENTITY
the	
presentation	ENTITY
is	
typi-	
cally	
age	ENTITY
20	
to	
40	
years	ENTITY
of	
age	ENTITY
but	
can	
occur	
in	
infants	ENTITY
and	
children	ENTITY
.	

With	
the	
increased	ENTITY
use	
of	
magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
(	
MRI	ENTITY
)	
,	
cases	ENTITY
are	
often	
diagnosed	ENTITY
before	
symptoms	ENTITY
are	
severe	ENTITY
.	

The	
CSA	ENTITY
following	
a	
cerebrovascular	ENTITY
accident	ENTITY
(	
CVA	ENTITY
)	
is	
abrupt	
in	
onset	
.	

In	
patients	ENTITY
exhibiting	
both	
central	ENTITY
and	
obstructive	ENTITY
apnea	ENTITY
,	
the	
central	ENTITY
apneas	ENTITY
tend	
to	
resolve	
with	
time	ENTITY
.	

Some	
post	ENTITY
-	
CVA	ENTITY
patients	ENTITY
with	
central	ENTITY
apneas	ENTITY
have	
central	ENTITY
apnea	ENTITY
with	
CSB	ENTITY
,	
whereas	
in	
others	
the	
CSA	ENTITY
does	
not	
have	
a	
pattern	ENTITY
consistent	ENTITY
with	ENTITY
CSB	ENTITY
.	

The	
central	ENTITY
apneas	ENTITY
can	
lead	
to	
sleep	ENTITY
fragmentation	ENTITY
,	
yielding	
either	
hypersomnolence	ENTITY
or	
insomnia	ENTITY
or	
both	
.	

There	
is	
little	
evidence	ENTITY
that	
these	
apneas	ENTITY
or	
their	
associated	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
lead	
to	
pulmonary	ENTITY
hypertension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
or	
other	
adverse	ENTITY
car-	
diovascular	ENTITY
consequences	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
CSA	ENTITY
is	
caused	
by	
failure	ENTITY
of	
the	
ventilatory	ENTITY
control	ENTITY
centers	ENTITY
to	
initiate	ENTITY
ventilatory	ENTITY
effort	ENTITY
.	

The	
abnormality	ENTITY
is	
due	
to	
dysfunction	ENTITY
of	
central	ENTITY
ventilatory	ENTITY
control	ENTITY
centers	ENTITY
.	

The	
pres-	
ence	ENTITY
of	ENTITY
sleep	ENTITY
may	
unmask	
ventilatory	ENTITY
control	ENTITY
abnormalities	ENTITY
with	
the	
loss	ENTITY
of	
the	
wake-	
fulness	ENTITY
stimulus	ENTITY
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
and/or	
daytime	ENTITY
hypoventilation	ENTITY
may	
coexist	
with	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
not	
CSB	ENTITY
,	
in	
which	
case	
both	
diagnoses	ENTITY
can	
be	
made	
.	

A	
number	
of	
causes	
of	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
disorders	ENTITY
–	
not	
Cheyne-	
Stokes	ENTITY
—	
have	
been	
described	
.	

Patients	ENTITY
with	
CM	ENTITY
exhibit	
obstructive	ENTITY
,	
central	ENTITY
,	
or	
a	
mixture	
of	
obstructive	ENTITY
and	
central	ENTITY
apneas	ENTITY
.	

Some	
patient	ENTITY
exhibit	
nocturnal	ENTITY
hypoventi-	
lation	ENTITY
but	
rarely	ENTITY
daytime	ENTITY
hypoventilation	ENTITY
.	

CSA	ENTITY
and/or	
OSA	ENTITY
can	
be	
the	
initial	ENTITY
presenta-	
tion	ENTITY
of	
the	
disorder	ENTITY
.	

Symptoms	ENTITY
include	
headache	ENTITY
(	
especially	
with	
laughter	ENTITY
,	
coughing	ENTITY
,	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
or	
exertion	ENTITY
)	
,	
neck	ENTITY
pain	ENTITY
,	
and	
vertigo	ENTITY
.	

An	
MRI	ENTITY
is	
diagnostic	ENTITY
of	
the	
condition	ENTITY
and	
should	
be	
considered	
as	
part	
of	
the	
evaluation	ENTITY
of	
all	
patients	ENTITY
without	
an	
obvious	
cause	
of	
central	ENTITY
apnea	ENTITY
.	

Brainstem	ENTITY
neoplasm	ENTITY
can	
present	
with	
central	ENTITY
apnea	ENTITY
not	
of	
the	
Cheyne	ENTITY
-	
Stokes	ENTITY
type	
.	

Patients	ENTITY
with	
a	
recent	
cerebrovascular	ENTITY
accident	ENTITY
show	
a	
high	
incidence	ENTITY
of	
sleep	ENTITY
disor-	
dered	ENTITY
breathing	ENTITY
.	

Although	
obstructive	ENTITY
apnea	ENTITY
is	
more	
common	
,	
central	ENTITY
apnea	ENTITY
may	
be	
noted	
initially	
after	
a	
cerebrovascular	ENTITY
accident	ENTITY
.	

Some	
patients	ENTITY
exhibit	
a	
pattern	ENTITY
of	
CSB	ENTITY
,	
whereas	
in	
others	
periodic	ENTITY
breathing	ENTITY
without	
the	
characteristic	ENTITY
CSB	ENTITY
pattern	ENTITY
is	
present	
.	

Patients	ENTITY
with	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
may	
also	
present	
with	
CSA	ENTITY
that	
does	
not	
have	
a	
CSB	ENTITY
pattern	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
The	
polysomnogram	ENTITY
of	
the	
patient	ENTITY
with	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
condi-	
tion	ENTITY
—	
not	
CSB	ENTITY
—	
demonstrate	
recurrent	ENTITY
(	
five	
or	
more	
per	
hour	
)	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
.	

The	
central	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
meet	
criteria	ENTITY
for	
these	
events	ENTITY
as	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Runs	
of	
recurrent	
central	ENTITY
apneas	ENTITY
separated	
by	
periods	ENTITY
of	
ventilation	ENTITY
may	
occur	
.	

The	
interevent	ENTITY
respiratory	ENTITY
phase	ENTITY
is	
typically	
brief	
with	
a	
maximum	ENTITY
of	
five	
breaths	ENTITY
.	

The	
central	ENTITY
apneas	ENTITY
do	
not	
have	
the	
pattern	ENTITY
of	
CSB	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Patients	ENTITY
with	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
—	
not	
CSB	ENTITY
—	
should	
be	
dif-	
ferentiated	ENTITY
from	
primary	ENTITY
CSA	ENTITY
,	
in	
which	
no	
known	
cause	ENTITY
is	
identified	ENTITY
.	

As	
the	
name	
implies	
,	
patients	ENTITY
with	
a	
pattern	ENTITY
of	
CSB	ENTITY
should	
be	
classified	
as	
such	
.	

Patients	ENTITY
with	
central	ENTITY
nervous	ENTITY
system	ENTITY
neoplasms	ENTITY
may	
have	
a	
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
with	
sleep	ENTITY
related	
hypoventilation	ENTITY
with	
or	
without	
an	
increase	ENTITY
in	
daytime	ENTITY
PaCO2	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
With	
the	
possible	
exception	
of	
poststroke	ENTITY
central	ENTITY
apnea	ENTITY
,	
the	
disorders	ENTITY
classified	
here	
are	
thought	
to	
be	
relatively	
rare	
.	

The	
presenting	ENTITY
symptoms	ENTITY
may	
not	
be	
a	
sleep	ENTITY
related	ENTITY
complaint	ENTITY
.	

Except	
for	
those	
associated	ENTITY
with	ENTITY
CM	ENTITY
and	
poststroke	ENTITY
CSA	ENTITY
,	
the	
disorders	ENTITY
are	
not	
well	
characterized	ENTITY
.	

Bibliography	ENTITY
Cormican	ENTITY
LJ	ENTITY
,	
Higgins	ENTITY
AC	ENTITY
,	
Davidson	ENTITY
R	ENTITY
,	
et	
al	
.	

Multi	ENTITY
system	ENTITY
atrophy	ENTITY
presenting	
as	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Eur	
Respir	
J	
2004;24:323–5	
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Stal	ENTITY
V	ENTITY
,	
Abril	ENTITY
B	ENTITY
,	
et	
al	
.	

Chiari	ENTITY
malformation	ENTITY
and	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
.	

J	
Neurol	
Neurosurg	
Psychiatry	
2007;78:1344–8	
.	

Fernández	ENTITY
AA	ENTITY
,	
Guerrero	ENTITY
AI	ENTITY
,	
Martínez	
MI	ENTITY
,	
et	
al	
.	

Malformations	ENTITY
of	
the	
craniocervical	ENTITY
junction	ENTITY
(	
Chiari	ENTITY
type	ENTITY
I	ENTITY
and	
syringomyelia	ENTITY
:	
classification	ENTITY
,	
diagnosis	ENTITY
and	
treatment	ENTITY
)	
.	

BMC	ENTITY
Musculoskelet	ENTITY
Disord	ENTITY
2009	ENTITY

Dec	
17;10	
Suppl	
1	
.	

Parra	ENTITY
O	ENTITY
,	
Arboix	
A	
,	
Bechich	ENTITY
S	ENTITY
,	
et	
al	
.	

Time	ENTITY
course	ENTITY
of	
sleep	ENTITY
-	
related	ENTITY
breathing	ENTITY
disorders	ENTITY
in	
first	
-	
ever	ENTITY
stroke	ENTITY
or	
transient	ENTITY
ischemic	ENTITY
attack	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2000;161:375–80	
.	

Siccoli	ENTITY
MM	ENTITY
,	
Valko	ENTITY
PO	ENTITY
,	
Hermann	ENTITY
DM	ENTITY
,	
Bassetti	ENTITY
CL	ENTITY
.	

Central	ENTITY
periodic	ENTITY
breathing	ENTITY
during	
sleep	ENTITY
in	
74	
patients	ENTITY
with	
acute	ENTITY
ischemic	ENTITY
stroke	ENTITY
—	
neurogenic	ENTITY
and	
cardiogenic	ENTITY
factors	ENTITY
.	

J	
Neurol	
2008;255:1687–92	
.	

Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
Due	
to	
High	ENTITY
Altitude	ENTITY
Periodic	ENTITY
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.32	ENTITY
Breathing	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.22	
Alternate	ENTITY
Names	ENTITY
None	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	
Recent	
ascent	ENTITY
to	
high	
altitude.1	ENTITY

B.	ENTITY
The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following:2	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

Sleepiness	ENTITY
.	
.	

Difficulty	ENTITY
initiating	
or	
maintaining	
sleep	ENTITY
,	
frequent	ENTITY
awakenings	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
.	
.	

Awakening	ENTITY
with	
shortness	ENTITY
of	ENTITY
breath	ENTITY
or	
morning	ENTITY
headache	ENTITY
.	
.	

Witnessed	ENTITY
apnea	ENTITY
.	

C.	

The	
symptoms	ENTITY
are	
clinically	ENTITY
attributable	
to	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
or	
PSG	ENTITY
,	
if	
performed	
,	
demonstrates	
recurrent	ENTITY
central	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
primarily	
during	
NREM	ENTITY
sleep	ENTITY
at	
a	
frequency	ENTITY
of	
≥	
5	
/	
hour	ENTITY
.	

D.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
(	
e.g.	
,	
narcotics	ENTITY
)	
,	
or	
substance	ENTITY
use	ENTITY
disorders	ENTITY
.	

Notes	ENTITY
.	

Typically	
at	
least	
2,500	
meters	ENTITY
(	
8,202	
feet	ENTITY
)	
,	
although	
some	
individuals	ENTITY
may	
exhibit	
the	
disorder	ENTITY
at	
altitudes	ENTITY
as	
low	
as	
1,500	
meters	ENTITY
.	
.	

Periodic	ENTITY
breathing	ENTITY
is	
a	
common	
response	ENTITY
to	
altitude	ENTITY
.	

Associated	ENTITY
symptoms	ENTITY
are	
required	
to	
make	
the	
diagnosis	ENTITY
of	
a	
disorder	ENTITY
.	

There	
is	
no	
level	
of	
the	
central	ENTITY
AHI	ENTITY
separating	
a	
normal	ENTITY
and	
abnormal	ENTITY
response	ENTITY
to	
high	ENTITY
altitude	ENTITY
.	
.	

A	
diagnosis	ENTITY
of	
CSA	ENTITY
due	
to	
high	ENTITY
-	
altitude	ENTITY
period	ENTITY
breathing	ENTITY
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Essential	
Features	
High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	
is	
characterized	
by	
alternating	
periods	ENTITY
of	
central	ENTITY
apnea	ENTITY
and	
hyperpnea	ENTITY
associated	ENTITY
with	ENTITY
recent	
ascent	ENTITY
to	
high	ENTITY
altitude	ENTITY
.	

The	
pattern	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
is	
an	
expected	
response	ENTITY
to	
ascent	ENTITY
to	
elevation	ENTITY
.	

Only	
those	
individuals	ENTITY
who	
manifest	
related	
symptoms	ENTITY
,	
as	
described	
below	
,	
are	
diagnosed	ENTITY
with	
this	
disorder	ENTITY
.	

The	
cycle	ENTITY
length	ENTITY
of	
this	
respiratory	ENTITY
pattern	ENTITY
is	
commonly	
less	
than	
40	
seconds	ENTITY
and	
often	
as	
short	
as	
12	
to	
20	
seconds	
.	

The	
percentage	ENTITY
of	
individuals	ENTITY
exhibiting	
periodic	ENTITY
breathing	ENTITY
during	
sleep	ENTITY
increases	ENTITY
at	
higher	ENTITY
altitudes	ENTITY
.	

Approximately	
25	
%	
exhibit	
periodic	ENTITY
breath-	
ing	
at	
2,500	
meters	ENTITY
(	
8,202	
feet	ENTITY
)	
,	
and	
virtually	
100	
%	
demonstrate	
periodic	ENTITY
breathing	ENTITY
at	
4,000	
m	
(	
13,123	
feet	ENTITY
)	
.	

Periodic	ENTITY
breathing	ENTITY
has	
been	
described	
at	
altitudes	ENTITY
as	
low	
as	
1,500	
meters	ENTITY
(	
4,900	
feet	ENTITY
)	
.	

Chronic	ENTITY
exposure	ENTITY
to	ENTITY
altitude	ENTITY
above	
2,500	
meters	ENTITY
has	
also	
been	
associated	ENTITY
with	ENTITY
periodic	ENTITY
breathing	ENTITY
in	
some	
studies	ENTITY
.	

Associated	ENTITY
Features	ENTITY
At	
altitude	ENTITY
,	
individuals	ENTITY
may	
complain	ENTITY
of	
frequent	ENTITY
awakenings	ENTITY
,	
poor	ENTITY
-	
quality	ENTITY
sleep	ENTITY
,	
and	
a	
sense	ENTITY
of	ENTITY
dyspnea	ENTITY
.	

These	
symptoms	ENTITY
will	
often	
improve	ENTITY
with	
time	ENTITY
at	
moderate	ENTITY
altitude	ENTITY
but	
may	
persist	
at	
extreme	ENTITY
altitude	ENTITY
.	

Alterations	ENTITY
in	
sleep	ENTITY
associated	ENTITY
with	ENTITY
ascent	ENTITY
to	
alti-	
tude	
include	
a	
reduction	ENTITY
in	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
and	
increased	ENTITY
arousal	ENTITY
frequency	ENTITY
.	

Total	ENTITY
sleep	ENTITY
time	ENTITY
and	
the	
amount	ENTITY
of	
REM	ENTITY
sleep	ENTITY
are	
either	
unchanged	ENTITY
or	
decreased	ENTITY
.	

Of	
note	
,	
the	
degree	ENTITY
of	
both	
subjective	ENTITY
and	
objective	
impairment	ENTITY
of	
sleep	ENTITY
quality	ENTITY
was	
not	
correlated	ENTITY
with	
the	
severity	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
in	
a	
number	
of	
studies	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
The	
demographics	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
are	
not	
known	
.	

High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
tends	
to	
occur	
in	
individuals	ENTITY
with	
a	
high	
hypoxic	ENTITY
and	
probably	
hypercapnic	ENTITY
ventilatory	ENTITY
response	ENTITY
.	

Because	
men	ENTITY
generally	
have	
higher	ENTITY
chemorespon-	
siveness	ENTITY
than	
women	ENTITY
,	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
may	
be	
more	
common	
in	
men	ENTITY
than	
in	
women	ENTITY
.	

As	
stated	
above	
,	
periodic	ENTITY
breathing	ENTITY
will	
occur	
in	
virtually	
anyone	
ascending	ENTITY
to	
higher	ENTITY
than	
4,000	
meters	ENTITY
and	
in	
some	
individuals	ENTITY
at	
lower	
altitudes	ENTITY
.	

The	
latter	
group	ENTITY
probably	
comprises	
individuals	ENTITY
with	
increased	ENTITY
hypoxic	ENTITY
chemoresponsive-	

ness	ENTITY
.	

In	
one	
study	ENTITY
,	
individuals	ENTITY
both	
with	
and	
without	
periodic	ENTITY
breathing	ENTITY
at	
altitude	ENTITY
had	
alterations	ENTITY
in	
sleep	ENTITY
architecture	ENTITY
.	

Those	
with	
periodic	ENTITY
breathing	ENTITY
had	
a	
greater	
arousal	ENTITY
index	ENTITY
,	
although	
their	
sleep	ENTITY
architecture	ENTITY
was	
otherwise	
not	
significantly	
different	
from	
individuals	ENTITY
who	
did	
not	
develop	
periodic	ENTITY
breathing	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
only	
known	
predisposing	ENTITY
factor	ENTITY
for	
the	
development	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	
is	
increased	ENTITY
ventilatory	ENTITY
chemoresponsiveness	ENTITY
,	
primarily	
hypoxic	ENTITY
ventila-	
tory	ENTITY
responsiveness	ENTITY
.	

A	
high	
hypoxic	ENTITY
ventilatory	ENTITY
response	ENTITY
will	
lead	
to	
increased	ENTITY
hyper-	
ventilation	ENTITY
on	
ascent	ENTITY
to	
altitude	ENTITY
.	

This	
hyperventilation	ENTITY
leads	
to	
hypocapnic	ENTITY
alkalosis	ENTITY
that	
,	
during	
sleep	ENTITY
,	
inhibits	ENTITY
ventilation	ENTITY
.	

Thus	
,	
repetitive	ENTITY
cycles	ENTITY
of	
apnea	ENTITY
and	
hyperpnea	ENTITY
develop	
during	
NREM	ENTITY
sleep	ENTITY
.	

The	
obvious	
precipitating	ENTITY
factor	ENTITY
for	
the	
development	ENTITY
of	
this	
periodic	ENTITY
breathing	ENTITY
is	
ascent	ENTITY
to	
altitude	ENTITY
.	

The	
more	
rapid	
the	
ascent	ENTITY
,	
the	
more	
likely	
periodic	ENTITY
breathing	ENTITY
is	
to	
develop	
.	

Familial	ENTITY
Patterns	ENTITY

Some	
data	ENTITY
suggest	
that	
ventilatory	ENTITY
chemoresponsiveness	ENTITY
is	
directly	
inherited	ENTITY
.	

Because	
elevated	ENTITY
hypoxic	ENTITY
responsiveness	
is	
a	
predisposing	ENTITY
variable	
in	
the	
development	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
,	
it	
would	
seem	
likely	
that	
there	
would	
be	
a	
familial	ENTITY
pattern	ENTITY
in	
the	
development	ENTITY
of	
this	
respiratory	ENTITY
abnormality	ENTITY
.	

However	
,	
there	
are	
no	
data	ENTITY
addressing	
this	
issue	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
This	
respiratory	ENTITY
pattern	ENTITY
will	
generally	
be	
evident	
during	
sleep	ENTITY
immediately	
after	
ascent	ENTITY
to	
altitude	ENTITY
.	

This	
depends	
to	
some	
extent	
on	
the	
rapidity	ENTITY
of	
the	
ascent	ENTITY
,	
the	
elevation	ENTITY
,	
and	
individual	ENTITY
predisposition	ENTITY
.	

However	
,	
it	
will	
be	
present	
most	
often	
on	
the	
first	
night	ENTITY
at	
altitude	ENTITY
.	

At	
moderate	ENTITY
altitude	ENTITY
,	
the	
breathing	ENTITY
pattern	ENTITY
may	
become	
more	
regular	
over	
time	
,	
although	
at	
extreme	ENTITY
altitude	ENTITY
it	
is	
likely	
to	
persist	
.	

One	
recent	
study	ENTITY
found	
that	
the	
amount	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
continued	
to	
increase	ENTITY
over	
three	
days	ENTITY
to	
two	
weeks	ENTITY
of	
acclimatization	ENTITY
.	

Studies	ENTITY
of	
adaptation	ENTITY
to	
altitude	ENTITY
suggest	
that	
sleep	ENTITY
quality	ENTITY
may	
improve	ENTITY
despite	
further	
increases	ENTITY
in	
periodic	ENTITY
breathing	ENTITY
.	

It	
has	
been	
hypothesized	
that	
hypoxia	ENTITY
itself	
may	
have	
an	
important	
role	
in	
disturbing	
sleep	ENTITY
architecture	ENTITY
.	

Thus	
,	
sleep	ENTITY
and	
symptoms	ENTITY
may	
improve	
during	
acclimatization	ENTITY
to	
altitude	ENTITY
even	
if	
the	
amount	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
actually	
increases	ENTITY
.	

The	
complications	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
,	
which	
are	
generally	
limited	
to	
disrupted	ENTITY
sleep	
on	
the	
initial	
nights	ENTITY
at	
altitude	ENTITY
,	
include	
frequent	ENTITY
awakenings	ENTITY
,	
often	
with	
shortness	ENTITY
of	ENTITY
breath	ENTITY
or	
a	
sensation	ENTITY
of	
suffocation	ENTITY
that	
may	
lead	
to	
fatigue	ENTITY
or	
sleep-	ENTITY
iness	ENTITY
on	
the	
following	
day	ENTITY
.	

There	
is	
no	
clear	
association	ENTITY
between	
periodic	ENTITY
breathing	ENTITY
and	
other	
altitude	ENTITY
syndromes	ENTITY
(	
high	ENTITY
-	
altitude	ENTITY
pulmonary	ENTITY
edema	ENTITY
,	
acute	ENTITY
mountain	ENTITY
sick-	

ness	ENTITY
,	
and	
high	ENTITY
-	
altitude	ENTITY
cerebral	ENTITY
edema	ENTITY
)	
.	

In	
fact	
,	
periodic	ENTITY
breathing	ENTITY
is	
a	
marker	ENTITY
of	
high	ENTITY
hypoxic	ENTITY
responsiveness	
,	
which	
generally	
yields	
improved	ENTITY
oxygenation	ENTITY
at	
altitude	ENTITY
and	
a	
reduced	ENTITY
frequency	ENTITY
of	
the	
maladaptive	ENTITY
syndromes	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Developmental	ENTITY
Issues	ENTITY
Relatively	
little	
is	
known	
about	
differences	
between	
children	ENTITY
and	
adults	ENTITY
concerning	
periodic	ENTITY
breathing	ENTITY
at	
altitude	ENTITY
.	

One	
study	ENTITY
did	
compare	
breathing	ENTITY
in	
children	ENTITY
and	
their	
fathers	ENTITY
.	

The	
children	ENTITY
revealed	
reduced	ENTITY
nocturnal	ENTITY
oxygen	
saturation	
and	
associated	
hyperventilation	ENTITY
at	
high	ENTITY
altitude	ENTITY
similar	
to	
the	
adults	ENTITY
,	
but	
their	
breathing	ENTITY
pattern	ENTITY
was	
more	
stable	ENTITY
.	

The	
investigators	ENTITY
hypothesized	
that	
children	ENTITY
may	
have	
a	
lower	
apnea	ENTITY
threshold	ENTITY
for	
CO2	ENTITY
than	
adults	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
is	
believed	
to	
be	
a	
product	ENTITY
of	
the	
hyperventilation	ENTITY
induced	ENTITY
by	
the	
hypobaric	ENTITY
hypoxia	ENTITY
encountered	
at	
altitude	ENTITY
.	

At	
2,500	
meters	ENTITY
the	
atmo-	
spheric	ENTITY
pressure	ENTITY
is	
approximately	
570	
mm	ENTITY
Hg	ENTITY
and	
the	
ideal	
alveolar	ENTITY
PO2	ENTITY
around	
55	
mm	ENTITY
Hg	ENTITY
(	
depending	
on	
the	
level	ENTITY
of	
PaCO2	ENTITY
)	
.	

Actual	ENTITY
arterial	ENTITY
PO2	ENTITY
values	ENTITY
will	
be	
lower	ENTITY
,	
especially	
during	
sleep	ENTITY
.	

The	
hypoxic	ENTITY
ventilatory	ENTITY
response	ENTITY
shows	
a	
steep	
increase	ENTITY
in	
ventilation	ENTITY
when	
the	
arterial	ENTITY
PO2	ENTITY
level	
drops	ENTITY
below	
55	
mm	
Hg	
.	

The	
increases	ENTITY
in	
venti-	
lation	ENTITY
associated	ENTITY
with	ENTITY
hypoxemia	ENTITY
result	
in	
hypocapnic	ENTITY
alkalosis	ENTITY
.	

Because	
PaCO2	ENTITY
is	
the	
principal	ENTITY
stimulus	ENTITY
to	
respiration	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
,	
a	
low	
PaCO2	ENTITY
can	
yield	
a	
loss	ENTITY
or	
reduction	ENTITY
in	
respiratory	ENTITY
drive	
,	
resulting	
in	
central	ENTITY
apnea	ENTITY
or	
hypopnea	ENTITY
.	

The	
greater	
the	
ventilatory	ENTITY
response	ENTITY
to	
hypoxia	ENTITY
,	
the	
greater	
the	
fall	ENTITY
in	
PaCO2	ENTITY
.	

Thus	
,	
individuals	ENTITY
with	
brisk	ENTITY
hypoxic	ENTITY
responses	ENTITY
more	
commonly	
tend	
to	
demonstrate	
this	
respiratory	ENTITY
pattern	ENTITY
.	

Over	
the	
course	ENTITY
of	
the	
apnea	ENTITY
,	
the	
PaO2	ENTITY
falls	ENTITY
and	
PaCO2	ENTITY
rises	ENTITY
,	
eventually	
stimulating	
a	
resumption	ENTITY
of	
ventilation	ENTITY
.	

However	
,	
after	
several	
large	
breaths	ENTITY
,	
the	
PaCO2	ENTITY
again	
falls	
below	
the	
apnea	ENTITY
threshold	ENTITY
,	
initiating	
another	
pause	ENTITY
in	
breathing	ENTITY
.	

This	
cycle	ENTITY
is	
then	
repeated	
over	
the	
course	ENTITY
of	
the	
night	ENTITY
.	

Of	
note	
,	
the	
respiratory	ENTITY
pattern	ENTITY
is	
often	
improved	
during	
REM	ENTITY
sleep	ENTITY
with	
reduced	ENTITY
cycling	ENTITY
.	

This	
is	
likely	
due	
to	
the	
decreased	ENTITY
hypoxic	ENTITY
and	
hypercapnic	ENTITY
responsiveness	ENTITY
characteristic	
of	
REM	ENTITY
sleep	ENTITY
.	

Of	
interest	
,	
in	
one	
study	ENTITY
the	
hypoxic	ENTITY
ventilatory	ENTITY
response	ENTITY
continued	
to	
increase	ENTITY
up	
to	
seven	
days	ENTITY
after	
ascent	ENTITY
to	
altitude	ENTITY
.	

This	
resulted	
in	
a	
lower	
PaCO2	ENTITY
and	
higher	ENTITY
PaO2	ENTITY
.	

The	
reduction	ENTITY
in	
peri-	
odic	ENTITY
breathing	ENTITY
in	
some	
individuals	ENTITY
with	
adaptation	ENTITY
to	
altitude	ENTITY
despite	
a	
greater	
venti-	
latory	ENTITY
response	ENTITY
to	
hypoxemia	ENTITY
may	
be	
due	
to	
a	
lowering	ENTITY
of	
the	
apneic	ENTITY
threshold	ENTITY
.	

Other	
studies	ENTITY
have	
found	
that	
the	
amount	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
continues	
to	
increase	ENTITY
over	
three	
days	ENTITY
to	
two	
weeks	ENTITY
of	
acclimatization	ENTITY
despite	
improvements	ENTITY
in	
oxygen	ENTITY
saturation	ENTITY
.	

The	
increase	ENTITY
in	
both	
periodic	ENTITY
breathing	ENTITY
and	
oxygen	ENTITY
saturation	ENTITY
is	
thought	
to	
be	
due	
to	
increased	ENTITY
controller	ENTITY
gain	ENTITY
of	
the	
respiratory	ENTITY
system	ENTITY
.	

A	
number	
of	
studies	ENTITY
have	
found	
that	
the	
impairment	ENTITY
of	
sleep	ENTITY
architecture	ENTITY
does	
not	
correlate	
with	
the	
degree	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
.	

One	
study	ENTITY
found	
that	
the	
amount	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
was	
greater	
on	
the	
third	
night	ENTITY
at	
altitude	ENTITY
compared	
to	
the	
first	
night	ENTITY
.	

However	
,	
both	
the	
nocturnal	ENTITY
oxygen	
saturation	
and	
amount	ENTITY
of	
stage	ENTITY
N3	
also	
increased	ENTITY
on	
the	
third	
night	ENTITY
compared	
to	
the	
first	
night	ENTITY
.	

It	
has	
been	
hypothesized	
that	
hypoxia	ENTITY
rather	
than	
periodic	ENTITY
breathing	ENTITY
might	
be	
the	
major	
factor	
disturbing	
sleep	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
The	
PSG	ENTITY
of	
individuals	ENTITY
with	
high	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
demonstrates	
recur-	
rent	ENTITY
central	ENTITY
apneas	ENTITY
with	
a	
cycle	ENTITY
time	ENTITY
of	
less	
than	
40	
seconds	
,	
and	
typically	
around	
20	
seconds	
.	

There	
is	
some	
degree	ENTITY
of	
associated	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

The	
apneas	ENTITY
are	
short	
,	
generally	
8	
to	
10	
seconds	
in	
duration	ENTITY
.	

In	
one	
study	ENTITY
,	
the	
apnea	ENTITY
duration	ENTITY
was	
around	
8	
seconds	
(	
7	
to	
9	
seconds	
)	
in	
children	ENTITY
and	
approximately	
12	
seconds	
(	
10	
-	
14	
seconds	
)	
in	
adults	ENTITY
.	

The	
cycle	ENTITY
length	ENTITY
is	
commonly	
less	
than	
40	
seconds	
.	

This	
breathing	ENTITY
pattern	ENTITY
occurs	
only	
during	
NREM	ENTITY
sleep	ENTITY
with	
more	
rhythmic	ENTITY
respiration	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

Because	
this	
breathing	ENTITY
pattern	ENTITY
is	
a	
physiologic	ENTITY
adaptation	ENTITY
to	
altitude	ENTITY
,	
there	
is	
no	
specific	
number	
of	
apneas	ENTITY
per	
hour	
of	
sleep	ENTITY
that	
is	
considered	
normal	ENTITY
or	
abnormal	ENTITY
.	

The	
apneas	ENTITY
and	
associated	
hyperpnea	ENTITY
can	
lead	
to	
recurrent	ENTITY
arousals	ENTITY
from	
sleep	ENTITY
,	
which	
often	
increase	ENTITY
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
sleep	ENTITY
while	
reducing	ENTITY
stage	ENTITY
N3	ENTITY
sleep	ENTITY
.	

REM	ENTITY
sleep	ENTITY
(	
stage	ENTITY
R	ENTITY
)	ENTITY
duration	ENTITY
is	
generally	
preserved	
,	
as	
is	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

As	
noted	
above	
,	
some	
studies	ENTITY
have	
found	
a	
reduction	ENTITY
in	
total	ENTITY
sleep	ENTITY
time	ENTITY
and	
stage	ENTITY
R	ENTITY
as	
well	
as	
stage	ENTITY
N3	
.	

Of	
interest	
,	
the	
arousal	ENTITY
index	ENTITY
was	
only	
around	
25	
%	
of	
the	
AHI	ENTITY
in	
some	
investigations	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	ENTITY
should	
be	
distinguished	
from	
other	
SRBDs	ENTITY
.	

The	
major	
distinguishing	
factor	ENTITY
is	
,	
of	
course	ENTITY
,	
recent	
ascent	ENTITY
to	
high	ENTITY
altitude	ENTITY
.	

An	
individual	ENTITY
with	ENTITY
OSA	ENTITY
will	
likely	
continue	
to	
have	
this	
nocturnal	ENTITY
respiratory	ENTITY
problem	ENTITY
at	
altitude	ENTITY
.	

Altitude	ENTITY
might	
even	
exacerbate	ENTITY
the	
OSA	ENTITY
.	

Patients	ENTITY
with	
chronic	ENTITY
mountain	ENTITY
sickness	ENTITY
demonstrate	
relative	
hypoventilation	ENTITY
at	
altitude	ENTITY
(	
i.e.	
,	
breathe	ENTITY
less	ENTITY
than	
is	
encoun-	
tered	
in	
normal	ENTITY
individuals	ENTITY
at	
similar	
altitude	ENTITY
)	
such	
that	
they	
are	
more	
hypoxic	ENTITY
than	
normal	ENTITY
individuals	ENTITY
who	
have	
a	
greater	
ventilatory	ENTITY
response	ENTITY
to	
the	
same	
ambient	ENTITY
hypoxia	ENTITY
.	

During	
sleep	ENTITY
,	
these	
individuals	ENTITY
often	
demonstrate	
further	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

Some	
of	
the	
individuals	ENTITY
will	
demonstrate	
apneas	ENTITY
or	
periodic	ENTITY
breathing	ENTITY
.	

A	
diagnosis	ENTITY
of	
chronic	ENTITY
mountain	ENTITY
sickness	ENTITY
does	
not	
imply	
that	
periodic	ENTITY
breathing	ENTITY
is	
present	
.	

However	
,	
periodic	ENTITY
breathing	ENTITY
may	
be	
more	
common	
in	
these	
patients	ENTITY
than	
previously	
appreciated	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Recent	
studies	
suggest	
that	
hypoxemia	ENTITY
rather	
than	
the	
amount	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
may	
be	
the	
major	
factor	
impairing	ENTITY
sleep	ENTITY
quality	ENTITY
.	

Further	
studies	ENTITY
relating	
changes	ENTITY
in	
sleep	ENTITY
and	
periodic	ENTITY
breathing	ENTITY
at	
altitude	ENTITY
are	
needed	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Bibliography	ENTITY
Anholm	
J	
,	
Powles	ENTITY
A	ENTITY
,	
Downey	ENTITY
R	ENTITY
,	
et	
al	
.	

Operation	ENTITY
Everest	ENTITY
II	ENTITY
:	
arterial	ENTITY
oxygen	
saturation	
and	
sleep	ENTITY
at	
extreme	
simulated	ENTITY
altitude	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1992;145:817–26	ENTITY
.	

Bloch	ENTITY
KE	ENTITY
,	
Latshand	
TD	ENTITY
,	
Turk	ENTITY
AJ	ENTITY
,	
et	
al	
.	

Nocturnal	ENTITY
periodic	
breathing	
during	
acclimatization	ENTITY
at	
very	
high	
altitude	ENTITY
at	
Mount	ENTITY
Muztach	ENTITY
Ata	
(	
7,546	
m	
)	
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2010;182:562–8	
.	

Burgess	ENTITY
,	
K.R.	ENTITY
,	
Lucas	
,	
S.J.	
,	
Shepherd	ENTITY
,	
K.L.	ENTITY
,	
et	
al	
.	

Worsening	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
at	
high	ENTITY
altitude	ENTITY
—	
a	
role	
for	
cerebrovascular	ENTITY
function	ENTITY
.	

J	
Appl	
Physiol	
2013	
;	
114	
:	
1021–8	
.	

Coote	ENTITY
JH	ENTITY
,	
Tsang	ENTITY
G	ENTITY
,	
Baker	ENTITY
A	ENTITY
,	
Stone	ENTITY
B.	
Respiratory	ENTITY
changes	ENTITY
and	
structure	ENTITY
of	
sleep	ENTITY
in	
young	ENTITY
high	ENTITY
-	
altitude	ENTITY
dwellers	ENTITY
in	
the	
Andes	ENTITY
of	
Peru	ENTITY
.	

Eur	
J	
Appl	
Physiol	
1993;66:249–53	
.	

Goldberg	ENTITY
S	ENTITY
,	
Schoene	ENTITY
R	ENTITY
,	
Haynor	ENTITY
D	ENTITY
,	
et	
al	
.	

Brain	ENTITY
tissue	ENTITY
pH	ENTITY
and	
ventilatory	ENTITY
acclimatization	ENTITY
to	
high	ENTITY
altitude	ENTITY
.	

J	
Appl	
Physiol	
1992;72:58–63	
.	

Johnson	ENTITY
P	ENTITY
,	
Edwards	ENTITY
N	ENTITY
,	
Burgess	ENTITY
KR	ENTITY
,	
Sullivan	ENTITY
CE	ENTITY
.	

Sleep	ENTITY
architecture	ENTITY
changes	ENTITY
during	
a	
trek	ENTITY
from	
1400	
to	
500	
m	
in	
the	
Nepal	ENTITY
Himalaya	ENTITY
.	

J	
Sleep	
Res	
2010;19:148–56	
.	

Kohler	ENTITY
M	ENTITY
,	
Kriemler	ENTITY
S	ENTITY
,	ENTITY
Wilhelm	ENTITY
EM	ENTITY
,	
Brunner	ENTITY
-	
LaRocca	ENTITY
H	ENTITY
,	
Zehnder	ENTITY
M	ENTITY
,	
Bloch	ENTITY
KE	ENTITY
.	

Children	ENTITY
at	
high	ENTITY
altitude	ENTITY
have	
less	
nocturnal	ENTITY
periodic	ENTITY
breathing	ENTITY
than	
adults	ENTITY
.	

Eur	
Respir	
J	
2008;32:189–97	
.	

Lahiri	ENTITY
S	ENTITY
,	
Barnard	
P.	
Role	
of	
arterial	ENTITY
chemoreflex	ENTITY
in	
breathing	ENTITY
during	
sleep	ENTITY
at	
high	ENTITY
altitude	ENTITY
.	

Prog	ENTITY
Clin	ENTITY
Biol	ENTITY
Res	ENTITY
1983;136:75–85	ENTITY
.	

Lahiri	ENTITY
S	ENTITY
,	
Meret	ENTITY
K	ENTITY
,	
Sherpa	
M.	
Dependence	
of	
high	ENTITY
altitude	ENTITY
sleep	ENTITY
apnea	ENTITY
on	
ventilatory	ENTITY
sensitivity	ENTITY
to	
hypoxia	ENTITY
.	

Respir	
Physiol	
1983;52:281–301	
.	

Lombardi	ENTITY
C	ENTITY
,	
Meriggi	ENTITY
P	ENTITY
,	
Agostoni	
P	
,	
et	
al	
.	

Highcare	ENTITY
Investigators	ENTITY
.	

High	ENTITY
-	
altitude	ENTITY
hypoxia	ENTITY
and	
periodic	ENTITY
breathing	
during	
sleep	ENTITY
:	
gender	ENTITY
-	
related	ENTITY
differences	ENTITY
.	

J	
Sleep	
Res	
2013	
;	
22:322–30	
.	

Nickol	ENTITY
AH	ENTITY
,	
Leverment	ENTITY
J	ENTITY
,	
Richards	
P	
,	
et	
al	
.	

Temazepam	ENTITY
at	
high	ENTITY
altitude	ENTITY
reduces	
periodic	ENTITY
breathing	
without	
impairing	ENTITY
next	ENTITY
-	
day	ENTITY
performance	ENTITY
:	
a	
randomized	ENTITY
cross	ENTITY
-	
over	
double	ENTITY
-	
blind	ENTITY
study	ENTITY
.	

J	
Sleep	
Res	
2006;15:445–54	
.	

Nussbaumer	ENTITY
-	
Ochsner	ENTITY
Y	ENTITY
,	
Ursprung	ENTITY
J	ENTITY
,	
Siebenmann	ENTITY
C	ENTITY
,	
Maggiorini	ENTITY
M	ENTITY
,	
Bloch	ENTITY
KE	ENTITY
.	

Effect	ENTITY
of	
short	ENTITY
-	
term	ENTITY
acclimatization	ENTITY
to	
high	ENTITY
altitude	ENTITY
on	
sleep	ENTITY
and	
nocturnal	ENTITY
breathing	ENTITY
.	

Sleep	ENTITY
2012;35:419–23	
.	

Schoene	ENTITY
R.	ENTITY
Control	ENTITY
of	ENTITY
ventilation	ENTITY
in	
climbers	ENTITY
to	
extreme	ENTITY
altitude	ENTITY
.	

J	
Appl	
Physiol	
1982;53:886–90	
.	

Waggener	ENTITY
TB	ENTITY
,	
Brusil	ENTITY
PJ	ENTITY
,	
Kronauer	ENTITY
RE	ENTITY
,	
Gabel	ENTITY
RA	ENTITY
,	
Inbar	ENTITY
GF	ENTITY
.	

Strength	ENTITY
and	
cycle	ENTITY
time	ENTITY
of	
high	ENTITY
-	
altitude	ENTITY
ventilatory	ENTITY
patterns	ENTITY
in	
unacclimatized	ENTITY
humans	ENTITY
.	

J	
Appl	
Physiol	
1984;56:576–81	
.	

White	ENTITY
D	ENTITY
,	
Gleeson	ENTITY
K	ENTITY
,	
Pickett	ENTITY
C	ENTITY
,	
Rannels	ENTITY
A	ENTITY
,	
Cymerman	ENTITY
A	ENTITY
,	
Weil	ENTITY
J.	ENTITY
Altitude	ENTITY
acclimatization	ENTITY
:	
influence	ENTITY
on	
periodic	ENTITY
breathing	ENTITY
and	
chemoresponsiveness	ENTITY
during	
sleep	ENTITY
.	

J	
Appl	
Physiol	
1987;63:401–12	
.	

Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY

Due	
to	
a	
Medication	ENTITY
or	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.39	ENTITY
Substance	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.29	
Alternate	ENTITY
Names	ENTITY
Narcotic	ENTITY
or	
opioid	ENTITY
induced	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
A.	

The	
patient	ENTITY
is	
taking	
an	
opioid	ENTITY
or	
other	
respiratory	ENTITY
depressant	ENTITY
.	

B.	ENTITY
The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following	
:	
.	

Sleepiness	ENTITY
.	
.	

Difficulty	ENTITY
initiating	
or	
maintaining	
sleep	ENTITY
,	
frequent	ENTITY
awakenings	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
.	
.	

Awakening	ENTITY
short	ENTITY
of	ENTITY
breath	ENTITY
.	
.	

Snoring	ENTITY
.	
.	

Witnessed	ENTITY
apneas	ENTITY
.	

C.	ENTITY
PSG	ENTITY
(	
diagnostic	ENTITY
or	
on	
positive	ENTITY
airway	
pressure	
)	
shows	
all	
of	
the	
following	
:	
.	

Five	
or	
more	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas1	ENTITY
per	ENTITY
hour	ENTITY
of	ENTITY
sleep	ENTITY
(	
PSG	ENTITY
)	
.	
.	

The	
number	
of	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
is	
>	
50	
%	
of	
the	
total	
number	
of	
apneas	ENTITY
and	
hypopneas	ENTITY
.	
.	

Absence	ENTITY
of	
CSB.1	ENTITY
D.	ENTITY
The	
disorder	ENTITY
occurs	
as	
a	
consequence	
of	
an	
opioid	ENTITY
or	
other	
respiratory	ENTITY
depressant	ENTITY
.	

E.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

Ataxic	ENTITY
breathing	ENTITY
(	
irregular	ENTITY
variations	ENTITY
in	
respiratory	ENTITY
cycle	ENTITY
time	ENTITY
and	
tidal	ENTITY
volume	ENTITY
)	
may	
be	
noted	
.	
.	

Nocturnal	ENTITY
and/or	
daytime	ENTITY
hypoventilation	ENTITY
may	
be	
present	
but	
are	
not	
required	
.	

If	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
,	
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
medication	ENTITY
or	
substance	ENTITY
use	ENTITY
can	
be	
made	
as	
well	
as	
a	
diagnosis	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
.	
.	

A	
diagnosis	ENTITY
of	
CSA	ENTITY
due	
to	
a	
medicationor	ENTITY
substance	ENTITY
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Essential	ENTITY
Features	ENTITY
Users	ENTITY
of	
potent	
long	ENTITY
-	
acting	ENTITY
opioids	ENTITY
may	
have	
central	ENTITY
apneas	ENTITY
during	
sleep	ENTITY
.	

The	
most	
common	
offending	ENTITY
drug	ENTITY
is	
methadone	ENTITY
.	

However	
,	
the	
condition	ENTITY
has	
also	
been	
described	
in	
patients	ENTITY
taking	
long	ENTITY
-	
acting	ENTITY
forms	
of	
morphine	ENTITY
or	
oxycodone	ENTITY
as	
well	
as	
individu-	
als	
being	
treated	ENTITY
with	ENTITY
fentanyl	ENTITY
patches	ENTITY
or	
continuous	ENTITY
narcotic	ENTITY
infusions	ENTITY
.	

Suboxone	ENTITY
(	
a	
combination	ENTITY
of	
buprenorphine	ENTITY
and	
naloxone	ENTITY
)	
is	
often	
used	
for	
treatment	ENTITY
of	
patients	ENTITY
with	
narcotic	ENTITY
dependence	ENTITY
and	
pain	ENTITY
and	
can	
also	
cause	
drug	ENTITY
-	
induced	ENTITY
central	ENTITY
apnea	ENTITY
.	

The	
description	ENTITY
of	
this	
population	ENTITY
is	
complicated	
by	
the	
fact	
that	
many	
of	
the	
affected	ENTITY
indi-	
viduals	ENTITY
may	
be	
using	
multiple	ENTITY
drugs	ENTITY
(	
prescribed	ENTITY
or	
illicit	ENTITY
)	
that	
affect	
sleep	ENTITY
and	
breathing	ENTITY
.	

Associated	
Features	
Breathing	ENTITY
abnormalities	ENTITY
associated	ENTITY
with	ENTITY
these	
drugs	ENTITY
are	
not	
restricted	
to	
central	ENTITY
apneas	ENTITY
and	
may	
also	
include	
hypoventilation	ENTITY
and	
OSA	ENTITY
with	
prolonged	ENTITY
respiratory	ENTITY
events	ENTITY
.	

In	
fact	
,	
many	
patients	ENTITY
present	
with	
a	
combination	ENTITY
of	
both	
OSA	ENTITY
and	
CSA	ENTITY
.	

Patients	ENTITY
who	
have	
nocturnal	ENTITY
hypoventilation	ENTITY
may	
have	
normal	ENTITY
or	
increased	ENTITY
daytime	ENTITY
PaCO2	ENTITY
.	

In	
most	
patients	ENTITY
with	
daytime	ENTITY
hypoventilation	ENTITY
,	
the	
PaCO2	ENTITY
is	
only	
mildly	
increased	ENTITY
(	
46	
-	
50	
mm	
Hg	
)	
.	

Patients	ENTITY
with	
drug	ENTITY
-	
induced	ENTITY
central	ENTITY
apnea	ENTITY
who	
are	
being	
treated	ENTITY
for	
chronic	ENTITY
pain	ENTITY
often	
report	
significant	
daytime	ENTITY
sleepiness	ENTITY
.	

Due	
to	
the	
sedating	ENTITY
effects	ENTITY
of	
opioid	ENTITY
medications	ENTITY
,	
the	
sleepiness	ENTITY
may	
not	
substantially	
improve	
even	
if	
the	
central	ENTITY
apnea	ENTITY
is	
treated	ENTITY
successfully	
.	

However	
,	
one	
study	ENTITY
of	
patients	ENTITY
on	
chronic	ENTITY
methadone	ENTITY
mainte-	
nance	ENTITY
found	
the	
average	ENTITY
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
score	ENTITY
to	
be	
within	
normal	
range	
.	

In	
these	
patients	ENTITY
,	
who	
manifested	
only	
mild	ENTITY
to	
moderate	ENTITY
OSA	ENTITY
(	
average	
AHI	ENTITY
about	
18/	
hour	ENTITY
)	
,	
the	
degree	ENTITY
of	
sleepiness	ENTITY
correlated	ENTITY
with	
a	
depression	ENTITY
index	ENTITY
.	

A	
case	ENTITY
series	ENTITY
of	
patients	ENTITY
treated	ENTITY
with	ENTITY
opioids	ENTITY
for	
chronic	ENTITY
pain	ENTITY
found	
AHI	ENTITY
values	ENTITY
above	
30	
/	
hour	ENTITY
(	
up	
to	
100	
/	
hour	ENTITY
)	
and	
moderate	ENTITY
to	
severe	ENTITY
sleepiness	ENTITY
.	

In	
this	
group	ENTITY
,	
50	
%	
to	
80	
%	
of	
respiratory	ENTITY
events	ENTITY
were	
central	ENTITY
apneas	ENTITY
.	

Sleepiness	ENTITY
that	
is	
disproportionately	
high	
in	
comparison	ENTITY
to	
the	
severity	ENTITY
of	
the	
AHI	ENTITY
(	
and	
in	
some	
cases	ENTITY
,	
at	
least	
partially	
unresponsive	
to	
treatment	ENTITY
)	
is	
likely	
due	
to	
the	
direct	
sedative	ENTITY
effects	ENTITY
of	
the	
narcotic	ENTITY
medication	ENTITY
itself	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
There	
are	
no	
known	
sex	ENTITY
,	
racial	ENTITY
,	
or	
ethnic	ENTITY
differences	ENTITY
.	

The	
prevalence	ENTITY
of	
this	
disorder	ENTITY
is	
not	
known	
,	
although	
limited	
data	ENTITY
suggest	
that	
it	
occurs	
commonly	
in	
those	
being	
treated	ENTITY
with	ENTITY
opioids	ENTITY
for	
chronic	ENTITY
pain	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Use	
of	
a	
potent	
long	ENTITY
-	
acting	ENTITY
narcotic	ENTITY
is	
the	
major	
causative	ENTITY
factor	ENTITY
.	

If	
patients	ENTITY
are	
suc-	ENTITY
cessfully	
withdrawn	
from	
the	
offending	ENTITY
medication	ENTITY
,	
the	
central	ENTITY
apnea	ENTITY
may	
resolve	
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
This	
disorder	ENTITY
is	
typically	
seen	
after	
opioids	ENTITY
have	
been	
used	
for	
at	
least	
two	
months	ENTITY
.	

An	
increased	ENTITY
risk	ENTITY
of	
death	ENTITY
has	
been	
reported	
with	
the	
use	
of	
potent	
narcotics	ENTITY
.	

There	
has	
been	
a	
large	
increase	ENTITY
in	
deaths	ENTITY
associated	ENTITY
with	ENTITY
methadone	ENTITY
due	
to	
the	
increasing	ENTITY
use	
of	
this	
medication	ENTITY
for	
chronic	ENTITY
pain	ENTITY
.	

Many	
of	
these	
deaths	ENTITY
occur	
during	
sleep	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Information	ENTITY
regarding	
the	
presentation	ENTITY
of	
this	
disorder	ENTITY
in	
children	ENTITY
is	
limited	
.	

CSA	ENTITY
due	
to	
opioid	ENTITY
medications	ENTITY
has	
been	
described	
in	
children	ENTITY
being	
treated	ENTITY
for	
pain	ENTITY
due	
to	
cancer	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
presumed	
pathophysiology	ENTITY
for	
the	
development	ENTITY
of	
these	
varied	
breathing	ENTITY
abnor-	
malities	ENTITY
during	
sleep	ENTITY
is	
the	
respiratory	ENTITY
depression	ENTITY
that	
occurs	
through	
action	ENTITY
of	
the	
drugs	ENTITY
on	
the	
μ	ENTITY
-	ENTITY
receptors	ENTITY
on	
the	
ventral	ENTITY
surface	ENTITY
of	
the	
medulla	ENTITY
.	

Studies	ENTITY
have	
demon-	
strated	ENTITY
depression	ENTITY
of	
the	
awake	ENTITY
hypercapnic	ENTITY
ventilatory	
drive	
;	
however	
,	
it	
often	
improves	ENTITY
after	
five	
to	
eight	
months	ENTITY
of	
continued	
drug	ENTITY
use	ENTITY
.	

In	
one	
study	ENTITY
the	
hypoxic	ENTITY
ventilatory	ENTITY
drive	
never	
fully	
normalized	ENTITY
.	

Another	
study	ENTITY
of	
patients	ENTITY
on	
chronic	ENTITY
meth-	
adone	
maintenance	ENTITY
found	
that	
the	
hypoxic	ENTITY
ventilatory	ENTITY
drive	
is	
increased	ENTITY
compared	
to	
that	
of	
control	ENTITY
subjects	ENTITY
.	

In	
this	
study	ENTITY
the	
hypercapnic	ENTITY
ventilatory	ENTITY
response	ENTITY
was	
reduced	ENTITY
in	
comparison	ENTITY
with	
that	
of	
controls	ENTITY
who	
were	
not	
taking	
opioids	ENTITY
.	

The	
difference	
was	
not	
due	
to	
a	
lower	
tidal	ENTITY
volume	ENTITY
but	
rather	
reduced	ENTITY
respiratory	ENTITY
rate	ENTITY
.	

Differences	ENTITY
in	
technique	ENTITY
or	
patient	ENTITY
population	ENTITY
may	
explain	
the	
divergent	ENTITY
findings	ENTITY
.	

The	
cause	
of	
the	
ataxic	ENTITY
breathing	ENTITY
in	
patients	ENTITY
on	
opiates	ENTITY
is	
not	
known	
.	

However	
,	
one	
study	ENTITY
of	
patients	ENTITY
on	
chronic	ENTITY
opioids	ENTITY
found	
that	
the	
incidence	ENTITY
of	
ataxic	ENTITY
breathing	ENTITY
increased	ENTITY
with	
the	
total	ENTITY
narcotic	ENTITY
dose	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
The	
drug	ENTITY
-	
induced	ENTITY
central	ENTITY
apneas	ENTITY
may	
occur	
as	
a	
form	
of	
periodic	ENTITY
breathing	ENTITY
with	
runs	
of	
central	ENTITY
apneas	ENTITY
separated	
by	
a	
short	ENTITY
ventilatory	ENTITY
phase	ENTITY
(	
2	
to	
4	
breaths	ENTITY
)	
or	
intermittent	ENTITY
and	
sporadic	ENTITY
central	ENTITY
apneas	ENTITY
.	

The	
underlying	
breathing	ENTITY
pattern	ENTITY
may	
show	
a	
slow	ENTITY
respi-	
ratory	ENTITY
rate	
or	
an	
ataxic	ENTITY
breathing	
pattern	
.	

The	
term	ENTITY
ataxic	ENTITY
breathing	ENTITY
is	
sometimes	
used	
as	
a	
synonym	
of	
Biot	ENTITY
breathing	ENTITY
,	
although	
definitions	ENTITY
of	
the	
latter	
term	
vary	
widely	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Ataxic	ENTITY
breathing	ENTITY
is	
characterized	ENTITY
by	
an	
irregular	ENTITY
breathing	ENTITY
rhythm	ENTITY
as	
well	
as	
irregular	ENTITY
depth	
of	
breathing	ENTITY
(	
tidal	ENTITY
volume	ENTITY
)	
.	

Obstructive	ENTITY
breathing	ENTITY
events	ENTITY
are	
also	
common	
in	
patients	ENTITY
taking	
potent	
opioids	ENTITY
and	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
CSA	ENTITY
is	
often	
appro-	
priate	ENTITY
.	

Prolonged	ENTITY
obstructive	ENTITY
apneas	ENTITY
with	
severe	ENTITY
arterial	ENTITY
desaturation	ENTITY
may	
be	
noted	
.	

The	
drug	ENTITY
-	
induced	ENTITY
central	ENTITY
apneas	ENTITY
occur	
mainly	
during	
NREM	ENTITY
sleep	ENTITY
and	
,	
in	
patients	ENTITY
without	
coexistent	ENTITY
obstructive	ENTITY
apnea	ENTITY
,	
the	
AHI	ENTITY
may	
be	
much	
lower	
during	
REM	ENTITY
than	
during	
NREM	ENTITY
sleep	ENTITY
.	

Patients	ENTITY
also	
tend	
to	
have	
a	
low	ENTITY
arousal	ENTITY
index	ENTITY
and	
increased	ENTITY
stage	
N3	
sleep	
.	

Unlike	
other	
forms	
of	
central	ENTITY
apnea	ENTITY
,	
drug	ENTITY
-	
induced	ENTITY
central	ENTITY
apneas	ENTITY
may	
occur	
during	
stage	ENTITY
N3	
sleep	
.	

Differential	ENTITY
Diagnosis	ENTITY

This	
condition	ENTITY
is	
best	
distinguished	
from	
other	
types	
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
by	
the	
patient	ENTITY
’s	
ongoing	
use	
of	
long	ENTITY
-	
acting	ENTITY
opioids	ENTITY
.	

Other	
SRBDs	ENTITY
may	
be	
present	
and	
may	
complicate	
PSG	ENTITY
findings	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Further	
study	ENTITY
is	
needed	
to	
determine	
risk	ENTITY
factors	ENTITY
and	
pathogenesis	ENTITY
for	
development	ENTITY
of	
these	
sleep	ENTITY
disordered	
breathing	ENTITY
patterns	ENTITY
in	
users	ENTITY
of	
long	ENTITY
-	
acting	ENTITY
opioids	ENTITY
.	

It	
has	
been	
hypothesized	
that	
these	
sleep	ENTITY
disordered	
breathing	ENTITY
patterns	ENTITY
may	
play	
a	
role	
in	
the	
unex-	
plained	ENTITY
increased	ENTITY
mortality	ENTITY
in	
this	
population	ENTITY
.	

This	
also	
requires	
further	
study	ENTITY
.	

Bibliography	ENTITY
Alattar	ENTITY
MA	ENTITY
,	
Scharf	
SM	ENTITY
.	

Opioid	ENTITY
-	
associated	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
a	
case	ENTITY
series	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2009;13:201–6	ENTITY
.	

Centers	ENTITY
for	ENTITY
Disease	ENTITY
Control	ENTITY
and	ENTITY
Prevention	ENTITY
(	ENTITY
CDC	ENTITY
)	
.	

Vital	ENTITY
signs	ENTITY
:	
risk	ENTITY
for	
overdose	ENTITY
from	
methadone	ENTITY
used	
for	
pain	ENTITY
relief	ENTITY
—	
United	ENTITY
States	ENTITY
,	
1999	
-	
2010	
.	

MMWR	ENTITY
Morb	
Mortal	ENTITY
Wkly	ENTITY
Rep	
2012;61:493–7	
.	

Farney	ENTITY
RJ	ENTITY
,	ENTITY
Walker	ENTITY
JM	ENTITY
,	
Cloward	ENTITY
TV	ENTITY
,	
Rhondeau	ENTITY
S.	ENTITY
Sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
associated	ENTITY
with	ENTITY
long	ENTITY
-	
term	ENTITY
opioid	ENTITY
therapy	ENTITY
.	

Chest	ENTITY
2003;123:632–9	ENTITY
.	

Guilleminault	ENTITY
C	ENTITY
,	
Cao	ENTITY
M	ENTITY
,	
Yue	ENTITY
HJ	ENTITY
,	
Chawla	ENTITY
P.	ENTITY
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
chronic	ENTITY
opioid	ENTITY
use	ENTITY
.	

Lung	ENTITY
2010;188:459–68	ENTITY
.	

Ramar	ENTITY
K.	ENTITY
Reversal	
of	
sleep	ENTITY
-	
disordered	ENTITY
breathing	
with	
opioid	ENTITY
withdrawal	ENTITY
.	

Pain	ENTITY
Pract	ENTITY
2009;9:394–8	ENTITY
.	

Santiago	ENTITY
TV	ENTITY
,	
Pugliese	ENTITY
AC	ENTITY
,	
Edelman	ENTITY
NH	ENTITY
.	

Control	ENTITY
of	ENTITY
breathing	ENTITY
during	
methadone	ENTITY
addiction	ENTITY
.	

Am	
J	
Med	
1977;62:347–54	
.	

Shook	ENTITY
JE	ENTITY
,	
Watkins	
WD	
,	
Camporesi	ENTITY
EM	ENTITY
.	

Differential	ENTITY
roles	ENTITY
of	
opioid	ENTITY
receptors	ENTITY
in	
respiration	ENTITY
,	
respiratory	ENTITY
disease	ENTITY
,	
and	
opiate	ENTITY
-	
induced	ENTITY
respiratory	ENTITY
depression	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1990;142:895–909	ENTITY
.	

Teichtahl	ENTITY
H	ENTITY
,	
Prodromidis	ENTITY
A	ENTITY
,	
Miller	ENTITY
B	ENTITY
,	ENTITY
Cherry	ENTITY
G	ENTITY
,	
Kronborg	ENTITY
I.	ENTITY
Sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
in	
stable	ENTITY
methadone	ENTITY
programme	ENTITY
patients	ENTITY
:	
a	
pilot	ENTITY
study	ENTITY
.	

Addiction	ENTITY
2001;96:395–403	
.	

Teichtahl	ENTITY
H	ENTITY
,	
Wang	ENTITY
D	ENTITY
,	
Cunnington	
D.	
Ventilatory	
responses	
to	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
in	
stable	ENTITY
methadone	ENTITY
treatment	ENTITY
patients	ENTITY
.	

Chest	ENTITY
2005;128:1339–47	ENTITY
.	

Walker	ENTITY
JM	ENTITY
,	
Farney	ENTITY
RJ	ENTITY
,	ENTITY
Rhondeau	
SM	ENTITY
.	

Chronic	ENTITY
opioid	ENTITY
use	ENTITY
is	
a	
risk	ENTITY
factor	ENTITY
for	
the	
development	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
ataxic	ENTITY
breathing	ENTITY
.	

J	
Clin	
Sleep	
Med	
2007	
;	
3:455–61	
.	

Wang	ENTITY
D	ENTITY
,	
Teichtahl	ENTITY
H	ENTITY
,	
Goodman	
C	
,	
Drummer	ENTITY
O	ENTITY
,	
Grunstein	ENTITY
RR	ENTITY
,	
Kronborg	ENTITY
I.	ENTITY
Subjective	ENTITY
daytime	ENTITY
sleepiness	ENTITY
and	
daytime	ENTITY
function	ENTITY
in	
patients	ENTITY
on	
stable	ENTITY
methadone	ENTITY
maintenance	ENTITY
treatment	ENTITY
:	
possible	
mechanisms	ENTITY
.	

J	
Clin	
Sleep	
Med	
2008;4:557–62	
.	

Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.21	
Alternate	ENTITY
Names	ENTITY
Idiopathic	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
presence	ENTITY
of	
at	
least	
one	
of	
the	
following1	ENTITY
:	
1	
.	
Sleepiness	ENTITY
.	

ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.31	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
.	

Difficulty	ENTITY
initiating	
or	
maintaining	
sleep	ENTITY
,	
frequent	ENTITY
awakenings	ENTITY
,	
or	
nonrestorative	ENTITY
sleep	ENTITY
.	
.	

Awakening	ENTITY
short	ENTITY
of	ENTITY
breath	ENTITY
.	
.	

Snoring	ENTITY
.	
.	

Witnessed	ENTITY
apneas	ENTITY
.	

B.	ENTITY
PSG	ENTITY
demonstrates	
all	
of	
the	
following	
:	
.	

Five	
or	
more	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas2	ENTITY
per	ENTITY
hour	ENTITY
of	ENTITY
sleep	ENTITY
(	
PSG	ENTITY
)	
.	
.	

The	
number	
of	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
is	
>	
50	
%	
of	
the	
total	
number	
of	
apneas	ENTITY
and	
hypopneas	ENTITY
.	
.	

Absence	ENTITY
of	
CSB.2	ENTITY
C.	
There	
is	
no	
evidence	
of	
daytime	ENTITY
or	
nocturnal	ENTITY
hypoventilation	ENTITY
.	

D.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurologic	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

In	
children	ENTITY
,	
daytime	ENTITY
symptoms	ENTITY
may	
not	
be	
evident	
.	
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Primary	ENTITY
CSA	ENTITY
is	
of	
unknown	
etiology	ENTITY
(	
idiopathic	ENTITY
)	
and	
is	
characterized	ENTITY
by	
recurrent	ENTITY
central	ENTITY
apneas	ENTITY
,	
defined	
as	
a	
cessation	ENTITY
of	
airflow	ENTITY
during	
sleep	ENTITY
associated	ENTITY
with	ENTITY
an	
absence	ENTITY
of	
respiratory	ENTITY
effort	ENTITY
.	

Airflow	ENTITY
and	
respiratory	ENTITY
effort	
cease	
simultaneously	ENTITY
in	
a	
repetitive	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
fashion	
over	
the	
course	ENTITY
of	
the	
night	ENTITY
.	

This	
recurrent	ENTITY
cessation	ENTITY
and	
resumption	ENTITY
of	
venti-	
lation	ENTITY
can	
lead	
to	
sleep	ENTITY
fragmentation	ENTITY
,	
yielding	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
frequent	ENTITY
nocturnal	ENTITY
awakenings	ENTITY
,	
or	
both	
.	

Thus	
,	
patients	ENTITY
may	
present	
with	
symptoms	ENTITY
of	
hyper-	
somnolence	ENTITY
or	
insomnia	ENTITY
.	

Patients	ENTITY
with	
primary	ENTITY
CSA	ENTITY
tend	
to	
have	
low	
normal	
arterial	
PaCO2	ENTITY
during	
wakefulness	ENTITY
(	
less	
than	
40	
mm	
Hg	
)	
.	

Patients	ENTITY
with	
a	
known	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
that	
is	
believed	
to	
cause	
central	ENTITY
apneas	ENTITY
are	
classified	
elsewhere	
.	

Associated	
Features	ENTITY
Patients	ENTITY
generally	
present	
with	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
sleep	ENTITY
fragmentation	ENTITY
,	
or	
insomnia	ENTITY
.	

Other	
signs	ENTITY
and	
symptoms	ENTITY
that	
are	
often	
,	
but	
not	
invariably	
,	
present	
include	
snoring	ENTITY
,	
witnessed	ENTITY
apnea	ENTITY
,	
and	
awakening	ENTITY
with	
shortness	ENTITY
of	ENTITY
breath	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY

The	
disorder	ENTITY
is	
rare	ENTITY
,	
precluding	
identification	ENTITY
of	
any	
definite	
subtypes	ENTITY
.	

Demographics	ENTITY
Not	
known	
.	

Most	
studies	ENTITY
suggest	
this	
disorder	ENTITY
is	
rare	ENTITY
,	
most	
common	
in	
middle	ENTITY
-	
aged	ENTITY
to	
elderly	ENTITY
individuals	ENTITY
,	
and	
more	
frequent	ENTITY
in	
men	ENTITY
than	
women	ENTITY
,	
although	
not	
all	
studies	ENTITY
support	
this	
sex	ENTITY
bias	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
CSA	ENTITY
in	
these	
patients	ENTITY
occurs	
because	
the	
arterial	ENTITY
PCO2	ENTITY
(	
PaCO2	ENTITY
)	
drops	ENTITY
below	
the	
hypo-	
capnic	ENTITY
apnea	ENTITY
threshold	ENTITY
(	
HAT	ENTITY
)	
.	

During	
wakefulness	ENTITY
,	
drops	ENTITY
in	
PaCO2	ENTITY
do	
not	
result	
in	
apnea	ENTITY
.	

However	
,	
during	
sleep	ENTITY
,	
when	
the	
PaCO2	ENTITY
drops	ENTITY
below	
the	
HAT	ENTITY
,	
respiratory	ENTITY
effort	ENTITY
ceases	
.	

For	
most	
patients	ENTITY
,	
the	
HAT	ENTITY
is	
within	
a	
few	
mm	ENTITY
Hg	ENTITY
of	
the	
awake	ENTITY
PaCO2	ENTITY
.	

Any	
factors	ENTITY
that	
narrow	
the	
gap	ENTITY
between	
the	
sleeping	ENTITY
PaCO2	ENTITY
and	
the	
HAT	ENTITY
predispose	
to	
central	ENTITY
apnea	ENTITY
.	

A	
high	
ventilatory	ENTITY
response	ENTITY
to	
CO2	ENTITY
seems	
to	
be	
a	
major	
predisposing	ENTITY
factor	ENTITY
in	
the	
development	ENTITY
of	
primary	ENTITY
CSA	ENTITY
.	

This	
can	
lead	
to	
the	
instability	ENTITY
in	
venti-	
latory	ENTITY
control	ENTITY
that	
characterizes	
the	
disorder	ENTITY
.	

Frequent	ENTITY
arousal	ENTITY
from	
sleep	ENTITY
can	
also	
predispose	
to	
the	
development	ENTITY
of	
central	ENTITY
apneas	ENTITY
,	
as	
ventilatory	ENTITY
control	ENTITY
is	
somewhat	
unstable	ENTITY
at	
sleep	ENTITY
-	
wake	ENTITY
transitions	ENTITY
.	

Increased	ENTITY
ventilation	ENTITY
associated	ENTITY
with	ENTITY
arousal	ENTITY
can	
result	
in	
a	
PaCO2	ENTITY
below	
the	
HAT	ENTITY
after	
the	
return	ENTITY
to	ENTITY
sleep	ENTITY
.	

Because	
ventilatory	ENTITY
drive	
is	
lower	
during	
REM	ENTITY
than	
NREM	ENTITY
sleep	ENTITY
,	
hypocapnic	ENTITY
central	ENTITY
apnea	ENTITY
is	
much	
less	
common	
during	
that	
sleep	ENTITY
stage	ENTITY
.	

Two	
other	
variables	ENTITY
have	
been	
discussed	
as	
possible	
predispos-	
ing	
factors	ENTITY
,	
although	
their	
true	
role	
in	
the	
development	ENTITY
of	
this	
syndrome	ENTITY
is	
uncertain	
.	

First	
,	
frequent	ENTITY
arousal	ENTITY
or	
awakening	ENTITY
due	
to	
low	ENTITY
arousal	ENTITY
threshold	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
insomnia	ENTITY
have	
been	
reported	
to	
lead	
to	
an	
increase	ENTITY
in	
central	ENTITY
apneas	ENTITY
.	

Because	
ventila-	
tory	ENTITY
control	ENTITY
can	
be	
somewhat	
unstable	ENTITY
in	
the	
normal	ENTITY
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
with	
occa-	
sional	ENTITY
central	ENTITY
apneas	ENTITY
being	
observed	
in	
otherwise	
normal	ENTITY
individuals	ENTITY
,	
any	
disorder	ENTITY
that	
interrupts	ENTITY
sleep	ENTITY
may	
worsen	ENTITY
CSA	ENTITY
.	

Some	
studies	ENTITY
have	
suggested	
a	
worsening	ENTITY
of	
primary	ENTITY
CSA	ENTITY
in	
the	
supine	ENTITY
position	ENTITY
,	
but	
this	
has	
been	
more	
clearly	
documented	ENTITY
in	
patients	ENTITY
with	
CSB	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

Some	
data	ENTITY
suggest	
that	
ventilatory	ENTITY
chemoresponsiveness	ENTITY
is	
directly	
inherited	ENTITY
.	

Because	
elevated	ENTITY
CO2	ENTITY
responsiveness	ENTITY
is	
a	
predisposing	ENTITY
variable	
in	
the	
development	ENTITY
of	
idio-	
pathic	ENTITY
CSA	ENTITY
,	
it	
would	
seem	
likely	
that	
there	
would	
be	
a	
familial	ENTITY
pattern	ENTITY
in	
the	
develop-	
ment	ENTITY
of	
this	
respiratory	ENTITY
abnormality	ENTITY
.	

However	
,	
there	
are	
no	
data	ENTITY
addressing	
this	
issue	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Not	
known	
.	

The	
apneas	ENTITY
can	
lead	
to	
sleep	ENTITY
fragmentation	ENTITY
,	
yielding	
either	
hypersomno-	
lence	ENTITY
or	
insomnia	ENTITY
.	

There	
is	
little	
evidence	ENTITY
that	
these	
apneas	ENTITY
or	
their	
associated	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
lead	
to	
pulmonary	ENTITY
hypertension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
or	
other	
adverse	ENTITY
car-	
diovascular	ENTITY
consequences	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Criteria	ENTITY
for	
apnea	ENTITY
of	ENTITY
infancy	ENTITY
and	
apnea	ENTITY
of	
prematurity	ENTITY
are	
detailed	
elsewhere	
and	
it	
should	
be	
noted	
that	
central	ENTITY
apnea	ENTITY
is	
defined	
somewhat	
differently	
in	
infants	ENTITY
and	
chil-	
dren	
than	
in	
adults	ENTITY
.	

Central	ENTITY
apneas	ENTITY
that	
are	
brief	
(	
<	
20	
seconds	
in	
duration	ENTITY
)	
and	
not	
associated	ENTITY
with	ENTITY
desaturation	ENTITY
or	
arousal	ENTITY
are	
commonly	
observed	
in	
both	
premature	ENTITY
and	
term	
infants	ENTITY
.	

In	
adults	ENTITY
,	
population	ENTITY
studies	ENTITY
report	
an	
increase	ENTITY
in	
the	
occurrence	ENTITY
of	
central	ENTITY
apnea	ENTITY
with	
increasing	ENTITY
age	ENTITY
,	
especially	
in	
men	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Primary	ENTITY
CSA	ENTITY
is	
caused	
by	
instability	ENTITY
of	
the	
respiratory	ENTITY
control	ENTITY
system	ENTITY
in	
the	
transition	ENTITY
from	
wakefulness	ENTITY
to	
sleep	ENTITY
and	
less	
commonly	
during	
stable	ENTITY
NREM	ENTITY
sleep	ENTITY
.	

Central	ENTITY
apnea	ENTITY
in	
patients	ENTITY
with	
primary	ENTITY
CSA	ENTITY
most	
often	
occurs	
during	
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
sleep	ENTITY
and	
is	
rare	
during	
stages	ENTITY

N3	ENTITY
and	
R	ENTITY
sleep	ENTITY
.	

Central	ENTITY
apneas	ENTITY
tend	
to	
occur	
in	
individuals	ENTITY
with	
a	
high	ENTITY
or	
increased	ENTITY
ventilatory	ENTITY
responsiveness	ENTITY
to	
CO2	ENTITY
.	

Arterial	ENTITY
PCO2	ENTITY
levels	ENTITY
below	
the	
hypocapnic	ENTITY
apnea	ENTITY
threshold	ENTITY
lead	
to	
a	
cessation	ENTITY
in	
ventilatory	ENTITY
effort	ENTITY
and	
,	
therefore	
,	
a	
central	ENTITY
apnea	ENTITY
.	

Individuals	ENTITY
with	
high	
CO2	ENTITY
ventilatory	ENTITY
responsiveness	ENTITY
tend	
to	
have	
lower	
PaCO2	ENTITY
levels	ENTITY
(	
both	
daytime	ENTITY
and	
sleep	ENTITY
)	
and	
a	
lower	
gradient	ENTITY
between	
the	
sleep-	
ing	
PaCO2	ENTITY
and	
the	
apneic	ENTITY
threshold	ENTITY
.	

Hence	
,	
a	
smaller	
increase	ENTITY
in	
ventilation	ENTITY
is	
required	
to	
reach	
this	
apnea	ENTITY
threshold	ENTITY
and	
inhibit	ENTITY
ventilation	ENTITY
.	

Individuals	ENTITY
with	
high	
chemore-	
sponsiveness	ENTITY
also	
hyperventilate	ENTITY
more	
in	
response	ENTITY
to	
small	
changes	
in	
arterial	ENTITY
PaCO2	ENTITY
.	

This	
again	
often	
drives	
the	
PaCO2	ENTITY
below	
the	
apnea	ENTITY
threshold	ENTITY
,	
yielding	
a	
cessation	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
of	ENTITY
ventilation	ENTITY
.	

However	
,	
not	
all	
factors	ENTITY
that	
cause	
greater	
ventilatory	ENTITY
drive	
have	
the	
same	
effect	ENTITY
.	

Studies	ENTITY
suggest	
that	
although	
hypoxemia	ENTITY
increases	ENTITY
chemoresponsiveness	ENTITY
to	
PaCO2	ENTITY
,	
the	
gap	
between	
the	
PaCO2	ENTITY
and	
the	
apneic	ENTITY
threshold	ENTITY
is	
smaller	ENTITY
(	
predispos-	
ing	
to	
central	ENTITY
apnea	ENTITY
)	
.	

Metabolic	ENTITY
acidosis	ENTITY
and	
nonhypoxic	ENTITY
chemoreceptor	ENTITY
stimulants	ENTITY
tend	
to	
decrease	ENTITY
HAT	ENTITY
more	
than	
they	
decrease	ENTITY
the	
sleeping	ENTITY
PaCO2	ENTITY
,	
resulting	
in	
a	
larger	
gap	ENTITY
between	
the	
HAT	ENTITY
and	
the	
sleeping	ENTITY
PaCO2	ENTITY
and	
lower	
likelihood	ENTITY
of	
central	ENTITY
apnea	ENTITY
.	

Metabolic	ENTITY
alkalosis	ENTITY
tends	
to	
increase	ENTITY
HAT	ENTITY
as	
well	
as	
decrease	ENTITY
ventilatory	ENTITY
responsive-	
ness	ENTITY
,	
yielding	
a	
smaller	
gap	
between	
the	
HAT	ENTITY
and	
sleeping	ENTITY
PaCO2	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
The	
PSG	ENTITY
of	
the	
patient	ENTITY
with	
primary	ENTITY
CSA	ENTITY
demonstrates	
more	
than	
five	
central	ENTITY
apneas	ENTITY
and/or	
central	ENTITY
hypopneas	ENTITY
per	
hour	
of	
sleep	ENTITY
.	

The	
central	ENTITY
apneas	ENTITY
and	
central	ENTITY
hypopneas	ENTITY
meet	
criteria	ENTITY
for	
these	
respiratory	ENTITY
events	ENTITY
in	
adults	ENTITY
or	
children	ENTITY
as	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Published	ENTITY
studies	ENTITY
of	
patients	ENTITY
with	
primary	ENTITY
CSA	ENTITY
have	
required	
that	
>	
50	
%	
to	
85	
%	
of	
respiratory	ENTITY
events	ENTITY
be	
central	ENTITY
apneas	ENTITY
.	

Periodic	ENTITY
breathing	ENTITY
characterized	ENTITY
by	
episodes	ENTITY
of	
recurrent	ENTITY
central	ENTITY
apneas	ENTITY
separated	
by	
periods	ENTITY
of	
ventilation	ENTITY
may	
occur	
.	

The	
inter-	
event	ENTITY
respiratory	ENTITY
phase	ENTITY
is	
typically	
brief	
with	
a	
maximum	ENTITY
of	
five	
breaths	ENTITY
.	

The	
venti-	
latory	ENTITY
phase	
between	
central	ENTITY
apneas	ENTITY
does	
not	
have	
the	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	
of	
CSB	ENTITY
breathing	ENTITY
.	

Central	ENTITY
apneas	ENTITY
commonly	
lead	
to	
mild	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
,	
although	
more	
severe	ENTITY
desaturation	ENTITY
can	
occur	
.	

Central	ENTITY
apneas	ENTITY
may	
also	
lead	
to	
arousal	ENTITY
from	
sleep	ENTITY
,	
causing	
fragmentation	ENTITY
and	
yielding	
increased	ENTITY
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
sleep	ENTITY
at	
the	
expense	
of	
stage	ENTITY
N3	
sleep	
.	

As	
noted	
above	
,	
central	ENTITY
apneas	ENTITY
in	
these	
patients	ENTITY
are	
less	
common	
during	
REM	ENTITY
sleep	ENTITY
.	

In	
summary	
,	
respiration	ENTITY
,	
arterial	ENTITY
oxygenation	ENTITY
,	
and	
sleep	ENTITY
architecture	ENTITY
are	
affected	ENTITY
by	
this	
disorder	ENTITY
.	

Additionally	
,	
an	
arterial	ENTITY
PaCO2	ENTITY

less	
than	
40	
mm	

Hg	ENTITY
is	
typically	
observed	
during	
wakefulness	ENTITY
.	

These	
patients	ENTITY
do	
not	
exhibit	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Normal	ENTITY
individuals	ENTITY
may	
have	
a	
few	
central	ENTITY
apneas	ENTITY
in	
the	
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
.	

However	
,	
once	
stable	ENTITY
sleep	ENTITY
is	
achieved	
,	
these	
apneas	ENTITY
should	
cease	ENTITY
.	

Normal	ENTITY
individuals	ENTITY
should	
not	
have	
more	
than	
five	
central	ENTITY
apneas	ENTITY
per	
hour	
of	
sleep	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
must	
be	
distinguished	
from	
other	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
.	

Some	
patients	ENTITY
with	
predominantly	
OSA	ENTITY
will	
have	
central	ENTITY
apneas	ENTITY
during	
diagnostic	ENTITY
or	
positive	ENTITY
airway	
pressure	
titration	
studies	
.	

These	
apneas	ENTITY
tend	
to	
resolve	
immediately	
or	
over	
time	
on	
positive	ENTITY
airway	
pressure	
treatment	ENTITY
.	

The	
pattern	ENTITY
of	
central	ENTITY
apneas	ENTITY
in	
primary	ENTITY
CSA	ENTITY
differs	
from	
that	
of	
CSA	ENTITY
with	
CSB	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
lacks	
the	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	ENTITY
of	
respiration	ENTITY
between	
contiguous	ENTITY
central	ENTITY
apneas	ENTITY
noted	
in	
patients	ENTITY
with	
CSA	ENTITY
with	
CSB	ENTITY
.	

The	
cycle	ENTITY
length	ENTITY
is	
longer	
in	
CSB	ENTITY
(	
greater	
than	
40	
seconds	ENTITY
and	
typically	
45	
to	
90	
seconds	
)	
.	

The	
longer	ENTITY
cycle	ENTITY
length	
in	
CSB	ENTITY
versus	
primary	ENTITY
CSA	ENTITY
is	
due	
to	
a	
longer	
respiratory	ENTITY
phase	ENTITY
between	
central	ENTITY
apneas	ENTITY
.	

In	
primary	ENTITY
CSA	ENTITY
,	
the	
apnea	ENTITY
is	
often	
terminated	
abruptly	
by	
a	
large	
breath	ENTITY
,	
and	
there	
are	
usually	
no	
more	
that	
4	
to	
5	
breaths	ENTITY
between	
apneas	ENTITY
.	

Furthermore	
,	
most	
patients	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
respiration	ENTITY
will	
have	
a	
history	ENTITY
of	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
or	
a	
neurological	ENTITY
disorder	ENTITY
.	

Patients	ENTITY
with	
central	ENTITY
apnea	ENTITY
due	
to	
substance	ENTITY
use	ENTITY
,	
particularly	
potent	
long	ENTITY
-	
acting	ENTITY
narcotics	ENTITY
,	
may	
exhibit	
periodic	ENTITY
breathing	ENTITY
with	
central	ENTITY
apneas	ENTITY
,	
but	
the	
pattern	ENTITY
of	
ventilation	ENTITY
between	
apneas	ENTITY
does	
not	
have	
a	
crescendo	ENTITY
-	
decrescendo	ENTITY
pattern	
and	
the	
cycle	ENTITY
length	ENTITY
is	
shorter	ENTITY
than	
40	
seconds	
.	

In	
addition	
,	
the	
underlying	
pattern	ENTITY
of	
breathing	ENTITY
is	
often	
ataxic	ENTITY
(	
irregular	ENTITY
varia-	
tions	ENTITY
in	
cycle	ENTITY
length	ENTITY
and	
tidal	ENTITY
volume	ENTITY
)	
and	
a	
low	ENTITY
respiratory	ENTITY
rate	ENTITY
may	
be	
noted	
.	

Unlike	
primary	ENTITY
CSA	ENTITY
,	
central	ENTITY
apneas	ENTITY
can	
occur	
during	
stage	ENTITY
N3	
in	
patients	ENTITY
taking	
opioids	ENTITY
.	

Patients	ENTITY
with	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
conditions	ENTITY
not	
of	
the	
Cheyne	ENTITY
-	
Stokes	ENTITY
pattern	
often	
have	
a	
history	ENTITY
of	
a	
known	
neurological	ENTITY
disorder	ENTITY
(	
recent	
cerebrovascular	
accident	
)	
but	
in	
others	
a	
high	ENTITY
index	ENTITY
of	
suspicion	ENTITY
for	
an	
underlying	
disorder	ENTITY
is	
indi-	
cated	ENTITY
.	

For	
example	
,	
patients	ENTITY
with	
Chiari	ENTITY
malformation	ENTITY
may	
present	
in	ENTITY
adulthood	ENTITY
with	
unexplained	
central	ENTITY
apneas	ENTITY
and	
relatively	
few	
other	
symptoms	ENTITY
.	

Thus	
,	
primary	ENTITY
CSA	ENTITY
is	
a	
diagnosis	ENTITY
based	
on	
careful	
exclusion	ENTITY
of	
other	
causes	
of	
CSA	ENTITY
.	

In	
sleep	ENTITY
related	
hypoventilation	ENTITY
and	
hypoxemic	ENTITY
syndromes	ENTITY
,	
patients	ENTITY
have	
normal	ENTITY
or	
increased	ENTITY
daytime	ENTITY
arterial	ENTITY
PCO2	ENTITY
(	
PaCO2	ENTITY
)	
with	
the	
onset	ENTITY
or	
worsening	ENTITY
of	
hypoven-	
tilation	ENTITY
during	
sleep	ENTITY
.	

Daytime	ENTITY
hypoventilation	ENTITY
is	
defined	
as	
a	
PaCO2	ENTITY
>	
45	
mm	

Hg	ENTITY
.	

Patient	ENTITY
with	
primary	ENTITY
CSA	ENTITY
usually	
have	
an	
awake	ENTITY
PaCO2	ENTITY
<	

40	
mm	
Hg	
.	

The	
causes	
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
include	
abnormalities	ENTITY
in	
ventilatory	ENTITY
control	ENTITY
,	
neuro-	ENTITY
muscular	ENTITY
disease	ENTITY
,	
parenchymal	ENTITY
lung	ENTITY
disease	ENTITY
,	
or	
restrictive	ENTITY
chest	ENTITY
wall	ENTITY
disorders	ENTITY
.	

PSG	ENTITY
in	
these	
patients	ENTITY
may	
reveal	
a	
few	
central	ENTITY
apneas	ENTITY
,	
but	
the	
predominant	ENTITY
pattern	ENTITY
is	
one	
of	
reduced	ENTITY
tidal	
volume	
(	
shallow	ENTITY
pattern	ENTITY
of	
breathing	ENTITY
)	
,	
often	
without	
a	
compensatory	ENTITY
increase	ENTITY
in	
respiratory	ENTITY
rate	ENTITY
.	

There	
is	
usually	
significant	ENTITY
oxygen	ENTITY
desaturation	ENTITY
secondary	ENTITY
to	ENTITY
hypoventilation	ENTITY
and/or	
ventilation	ENTITY
perfusion	ENTITY
mismatch	ENTITY
.	

Patients	ENTITY
with	
parenchymal	ENTITY
lung	ENTITY
disease	ENTITY
,	
neuromuscular	ENTITY
disease	ENTITY
,	
or	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
typically	
have	
abnormal	ENTITY
pulmonary	ENTITY
function	ENTITY
tests	ENTITY
and	
the	
most	
severe	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
typically	
occurs	
during	
REM	ENTITY
sleep	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Although	
primary	ENTITY
CSA	ENTITY
is	
believed	
to	
be	
a	
relatively	
rare	ENTITY
disorder	ENTITY
,	
additional	
prevalence	ENTITY
data	ENTITY
are	
needed	
.	

The	
pathophysiology	ENTITY
of	
this	
disorder	ENTITY
remains	
unclear	ENTITY
.	

Specifically	
,	
the	
relative	
roles	
of	
instability	ENTITY
in	
sleep	ENTITY
state	ENTITY
(	
low	ENTITY
arousal	ENTITY
threshold	ENTITY
,	
delayed	ENTITY
transition	ENTITY
from	
wake	
to	
stable	ENTITY
sleep	ENTITY
)	
and	
respiratory	ENTITY
control	ENTITY
instability	ENTITY
(	
elevated	ENTITY
hypercapnic	ENTITY
ventila-	
tory	
response	
)	
require	
further	
elucidation	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Bibliography	ENTITY
Bixler	ENTITY
EO	ENTITY
,	
Vgontzas	ENTITY
AN	ENTITY
,	ENTITY
Lin	ENTITY
HM	ENTITY
,	
Ten	ENTITY
Have	ENTITY
T	ENTITY
,	
Rein	
J	
,	
Vela	ENTITY
-	
Bueno	
A	
,	
Kales	ENTITY
A.	ENTITY
Prevalence	ENTITY
of	
sleep-	
disordered	ENTITY
breathing	ENTITY
in	
women	ENTITY
:	
effects	ENTITY
of	ENTITY
gender	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2001;163:608–13	
.	

Bradley	ENTITY
T	ENTITY
,	
McNicholas	
W	
,	
Rutherford	ENTITY
R	ENTITY
,	
Popkin	ENTITY
J	ENTITY
,	
Zamel	
N	
,	
Phillipson	
E.	
Clinical	ENTITY
and	
physiological	ENTITY
heterogeneity	ENTITY
of	
the	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1986;134:217–21	ENTITY
.	

Dempsey	ENTITY
JA	ENTITY
,	
Smith	ENTITY
CA	ENTITY
,	
Przybylowski	ENTITY
T	ENTITY
,	
et	
al	
.	

The	
ventilatory	ENTITY
responsiveness	ENTITY
to	
CO(2	ENTITY
)	
below	
eupnoea	ENTITY
as	
a	
determinant	
of	
ventilatory	ENTITY
stability	ENTITY
in	
sleep	ENTITY
.	

J	
Physiol	
2004;560:1–11	
.	

Eckert	ENTITY
DJ	ENTITY
,	
Jordan	ENTITY
AS	ENTITY
,	
Merchia	ENTITY
P	ENTITY
,	
Malhotra	
A.	
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
Pathophysiology	ENTITY
and	
treatment	ENTITY
.	

Chest	ENTITY
2007;131:595–607	
.	

Hall	ENTITY
MJ	ENTITY
,	
Xie	
A	
,	
Rutherford	ENTITY
R	ENTITY
,	
Ando	ENTITY
S	ENTITY
,	
Floras	ENTITY
JS	ENTITY
,	ENTITY
Bradley	
TD	ENTITY
.	

Cycle	ENTITY
length	ENTITY
of	
periodic	ENTITY
breathing	ENTITY
in	
patients	ENTITY
with	
and	
without	
heart	ENTITY
failure	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1996;154:376–81	
.	

White	ENTITY
D	ENTITY
,	
Zwillich	ENTITY
C	ENTITY
,	
Pickett	ENTITY
C	ENTITY
,	
Douglas	ENTITY
N	ENTITY
,	
Findley	
L	
,	
Weil	ENTITY
J.	ENTITY
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
improvement	ENTITY
with	
acetazolamide	ENTITY
therapy	ENTITY
.	

Arch	ENTITY
Intern	ENTITY
Med	ENTITY
1982;142:1816–9	ENTITY
.	

Xie	ENTITY
A	ENTITY
,	
Rankin	ENTITY
F	ENTITY
,	
Rutherford	ENTITY
R	ENTITY
,	ENTITY
Bradley	ENTITY
TD	ENTITY
.	

Effects	ENTITY
of	ENTITY
inhaled	ENTITY
CO2	ENTITY
and	
added	
dead	ENTITY
space	ENTITY
on	
idiopathic	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Appl	
Physiol	
1997;82:918–26	
.	

Xie	ENTITY
A	ENTITY
,	
Rutherford	ENTITY
R	ENTITY
,	
Rankin	ENTITY
F	ENTITY
,	
Wong	ENTITY
B	ENTITY
,	ENTITY
Bradley	ENTITY
T.	ENTITY
Hypocapnia	ENTITY
and	
increased	ENTITY
ventilatory	ENTITY
responsiveness	ENTITY
in	
patients	ENTITY
with	
idiopathic	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1995;152:1950–5	
.	

Xie	ENTITY
A	ENTITY
,	
Wong	ENTITY
B	ENTITY
,	
Phillipson	ENTITY
E	ENTITY
,	
Slutsky	ENTITY
A	ENTITY
,	
Bradley	
T.	
Interaction	ENTITY
of	
hyperventilation	ENTITY
and	
arousal	ENTITY
in	
the	
pathogenesis	ENTITY
of	
idiopathic	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
1994;150:489–95	
.	

Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	ENTITY
Infancy	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
770.81	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

P28.3	
Alternate	ENTITY
Names	ENTITY
Infant	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
apnea	ENTITY
of	ENTITY
infancy	ENTITY
,	
primary	ENTITY
sleep	ENTITY
apnea	ENTITY
of	
the	
newborn	ENTITY
.	

Inappropriate	ENTITY
terms	
for	
primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
of	
the	
newborn	ENTITY
include	
near	ENTITY
-	
miss	ENTITY
sudden	ENTITY
infant	ENTITY
death	ENTITY
syndrome	ENTITY
(	
SIDS	ENTITY
)	
,	

near	ENTITY
-	
SIDS	ENTITY
,	
aborted	ENTITY
SIDS	ENTITY
,	
and	
aborted	ENTITY
crib	
death	
;	
these	
terms	
imply	
a	
causal	
relationship	ENTITY
between	
apnea	ENTITY
and	
SIDS	ENTITY
that	
is	
not	
supported	
by	
extensive	ENTITY
research	ENTITY
.	

Likewise	
,	
the	
term	ENTITY
“	
apparent	ENTITY
life	ENTITY
-	
threatening	ENTITY
event	ENTITY
(	
ALTE	ENTITY
)	
”	
should	
not	
be	
used	
.	

Although	
some	
infants	ENTITY
with	
primary	ENTITY
sleep	ENTITY
apnea	ENTITY
present	
with	
an	
ALTE	ENTITY
,	
there	
are	
many	
other	
causes	
of	
ALTE	ENTITY
,	
and	
some	
children	ENTITY
with	
sleep	ENTITY
apnea	ENTITY
do	
not	
have	
ALTE	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY
Apnea	ENTITY
or	
cyanosis	ENTITY
is	
noted	
by	
an	
observer	ENTITY
or	
an	
episode	ENTITY
of	
sleep	
related	
central	ENTITY
apnea	ENTITY
or	
desaturation	ENTITY
is	
detected	ENTITY
by	
monitoring	ENTITY
.	

B.	ENTITY
The	
infant	ENTITY
has	
a	
conceptional	ENTITY
age	ENTITY
of	
at	
least	
37	
weeks	ENTITY
.	

C.	ENTITY
PSG	ENTITY
or	
alternative	ENTITY
monitoring	ENTITY
such	
as	
hospital	ENTITY
or	
home	ENTITY
apnea	ENTITY
monitoring	ENTITY
shows	
either	
:	
.	

Recurrent	ENTITY
,	
prolonged	ENTITY
(	
>	
20	
seconds	
duration	ENTITY
)	
central	
apneas.1	
.	

Periodic	ENTITY
breathing2	ENTITY
for	
≥	
5	
%	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

D.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
medication	ENTITY
.	

Notes	ENTITY
.	

Normative	ENTITY
data	ENTITY
concerning	
the	
number	
of	
prolonged	ENTITY
central	ENTITY
apneas	ENTITY
per	
hour	
are	
not	
well	
established	
.	
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

Short	ENTITY
(	
<	
20	
seconds	
)	
central	ENTITY
apneas	ENTITY
associated	ENTITY
with	ENTITY
significant	ENTITY
desaturation	ENTITY
are	
more	
likely	
to	
be	
a	
sign	ENTITY
of	
decreased	ENTITY
pulmonary	ENTITY
reserve	ENTITY
than	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
pathology	ENTITY
.	
.	

Definitive	ENTITY
determination	ENTITY
of	
the	
central	
nature	
of	
apneas	ENTITY
requires	
simultaneous	ENTITY
monitoring	ENTITY
of	
airflow	ENTITY
and	
respiratory	ENTITY
effort	ENTITY
.	

Obstructive	ENTITY
and	
mixed	ENTITY
apneas	ENTITY
may	
also	
be	
present	
,	
but	
central	ENTITY
apneas	ENTITY
are	
predominant	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Primary	ENTITY
CSA	ENTITY
of	
infancy	ENTITY
is	
characterized	
by	
prolonged	ENTITY
,	
predominantly	
central	ENTITY
apneas	ENTITY
in	
children	ENTITY
of	
at	
least	
37	
weeks	ENTITY
conceptional	ENTITY
age	ENTITY
.	

These	
events	ENTITY
are	
typically	
associated	ENTITY
with	ENTITY
physiological	ENTITY
compromise	ENTITY
(	
hypoxemia	ENTITY
,	
bradycardia	ENTITY
)	
,	
or	
the	
need	
for	
intervention	ENTITY
such	
as	
stimulation	ENTITY
or	
resuscitation	ENTITY
.	

Obstructive	ENTITY
and/or	
mixed	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
may	
also	
be	
seen	
,	
although	
central	ENTITY
events	ENTITY
are	
the	
predominant	
finding	ENTITY
.	

It	
is	
a	
disorder	ENTITY
of	
respira-	
tory	
control	
that	
can	
be	
either	
a	
developmental	ENTITY
problem	ENTITY
associated	ENTITY
with	ENTITY
immaturity	ENTITY
of	
the	
brainstem	ENTITY
respiratory	ENTITY
centers	ENTITY
or	
secondary	
to	
other	
medical	ENTITY
conditions	ENTITY
that	
produce	
apnea	ENTITY
by	
mechanisms	ENTITY
such	
as	
direct	
depression	ENTITY
of	
central	ENTITY
respiratory	ENTITY
control	ENTITY
.	

Apnea	ENTITY
in	
the	
neonate	ENTITY
or	
infant	ENTITY
may	
be	
exacerbated	ENTITY
or	
precipitated	ENTITY
by	
a	
variety	
of	
medical	ENTITY
condi-	
tions	ENTITY
,	
such	
as	
anemia	ENTITY
,	
infection	ENTITY
,	
hypoxemia	ENTITY
,	
metabolic	ENTITY
disturbances	ENTITY
,	
gastroesophageal	ENTITY
reflux	ENTITY
,	
substances	ENTITY
,	
or	
anesthesia	ENTITY
,	
which	
must	
be	
recognized	
and	
treated	ENTITY
to	
stabilize	ENTITY
the	
apnea	ENTITY
.	

If	
another	
medical	ENTITY
condition	ENTITY
appears	
to	
be	
the	
cause	
rather	
than	
an	
exacerbating	ENTITY
factor	ENTITY
for	
the	
CSA	ENTITY
,	
then	
the	
condition	ENTITY
should	
be	
classified	
as	
CSA	ENTITY
due	
to	
a	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
,	
or	
CSA	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
.	

Despite	
the	
heterogeneity	ENTITY
of	
infant	ENTITY
risk	ENTITY
groups	ENTITY
and	
underlying	
pathophysiology	ENTITY
,	
most	
studies	ENTITY
report	
a	
progressive	ENTITY
decrease	ENTITY
in	
frequency	ENTITY
of	
apneas	ENTITY
and	
risk	ENTITY
of	
symptomatic	ENTITY
apnea	ENTITY
secondary	
to	
other	
medical	ENTITY
conditions	ENTITY
after	
the	
early	ENTITY
weeks	ENTITY
of	
life	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Associated	
Features	ENTITY
Infants	ENTITY
may	
present	
with	
an	
ALTE	ENTITY
(	
defined	
by	
a	
National	ENTITY
Institutes	ENTITY
of	ENTITY
Health	ENTITY
Development	ENTITY
Conference	ENTITY
as	
“	
an	
episode	ENTITY
that	
is	
frightening	
to	
the	
observer	ENTITY
,	
and	
that	
is	
characterized	ENTITY
by	
some	
combination	ENTITY
of	
apnea	ENTITY

[	

central	ENTITY
or	
occasionally	
obstructive	
]	
,	
color	ENTITY
change	ENTITY
,	
marked	
change	
in	
muscle	ENTITY
tone	ENTITY
,	
choking	ENTITY
or	
gagging	ENTITY
.	

In	
some	
cases	ENTITY
,	
the	
observer	ENTITY
fears	ENTITY
that	
the	
infant	ENTITY
has	
died	ENTITY
”	
)	
.	

Many	
infants	ENTITY
with	
primary	ENTITY
CSA	ENTITY
of	
infancy	ENTITY
will	
not	
have	
an	
ALTE	ENTITY
,	
and	
many	
ALTEs	ENTITY
are	
not	
associated	ENTITY
with	ENTITY
apnea	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
of	
infancy	ENTITY
is	
state	
dependent	
,	
and	
the	
frequency	ENTITY
of	
respiratory	ENTITY
events	ENTITY
increases	ENTITY
during	
active	ENTITY
(	
REM	
)	
sleep	
.	

Paradoxical	ENTITY
chest	ENTITY
wall	ENTITY
movements	ENTITY
are	
common	
during	
active	ENTITY
sleep	ENTITY
in	
infants	ENTITY
and	
may	
cause	
a	
fall	ENTITY
in	
arterial	ENTITY
oxygen	
saturation	
because	
of	
ventilation	ENTITY
or	
perfusion	ENTITY
defects	ENTITY
associated	ENTITY
with	ENTITY
a	
decrease	ENTITY
in	
functional	ENTITY
residual	ENTITY
capacity	ENTITY
.	

Underlying	
comorbidities	ENTITY
(	
for	
example	
,	
chronic	ENTITY
lung	ENTITY
disease	ENTITY
or	
abnormal	ENTITY
neurological	ENTITY
status	ENTITY
)	
can	
predispose	ENTITY
the	
infant	ENTITY
to	
having	
a	
more	
severe	ENTITY
or	
prolonged	ENTITY
course	ENTITY
for	
apnea	ENTITY
.	

Note	
that	
a	
small	
upper	
airway	ENTITY
will	
exaggerate	
the	
obstructive	ENTITY
elements	ENTITY
of	
this	
disorder	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Not	
applicable	
.	

Demographics	ENTITY
Less	
than	
0.5	
%	
of	
full	ENTITY
-	
term	ENTITY
newborns	ENTITY
experience	
symptomatic	ENTITY
apnea	ENTITY
.	

Studies	ENTITY
have	
shown	
that	
during	
the	
first	
six	
months	ENTITY
of	
life	ENTITY
,	
2	
%	
of	
healthy	ENTITY
full	
-	
term	ENTITY
infants	ENTITY
will	
experience	ENTITY
at	
least	
one	
apnea	ENTITY
event	ENTITY
lasting	
30	
seconds	
or	
longer	ENTITY
or	
an	
apnea	ENTITY
that	
lasts	
at	
least	
20	
seconds	ENTITY
and	
is	
associated	ENTITY
with	ENTITY
a	
heart	ENTITY
rate	ENTITY
less	
than	
60	
beats	ENTITY
per	
minute	
.	

Apnea	ENTITY
of	
infancy	ENTITY
occurs	
equally	
in	
males	ENTITY
and	
females	ENTITY
,	
and	
in	
infants	ENTITY
of	
all	
races	ENTITY
and	
ethnic	ENTITY
groups	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Many	
factors	ENTITY
may	
precipitate	ENTITY
apneic	ENTITY
episodes	ENTITY
,	
including	
gastroesophageal	ENTITY
reflux	ENTITY
,	
intra-	
cranial	ENTITY
pathology	
,	
substances	ENTITY
,	
anesthesia	ENTITY
,	
metabolic	ENTITY
disorders	ENTITY
,	
impaired	ENTITY
oxygenation	ENTITY
,	
and	
infection	ENTITY
(	
including	
sepsis	ENTITY
,	
meningitis	ENTITY
,	
respiratory	ENTITY
syncytial	ENTITY
virus	ENTITY
infections	ENTITY
,	
and	
pertussis	ENTITY
)	
.	

Infection	ENTITY
with	
respiratory	ENTITY
syncytial	ENTITY
virus	ENTITY
,	
in	
particular	
,	
can	
increase	ENTITY
the	
fre-	
quency	ENTITY
and	
the	
duration	ENTITY
of	
apneas	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
None	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
is	
usually	
in	
the	
first	
weeks	ENTITY
or	
months	ENTITY
of	
life	ENTITY
.	

Some	
infants	ENTITY
may	
be	
diagnosed	ENTITY
by	
nursing	ENTITY
observations	ENTITY
or	
routine	ENTITY
monitoring	ENTITY
soon	
after	
birth	ENTITY
.	

Older	ENTITY
infants	ENTITY
may	
present	
with	
an	
ALTE	ENTITY
or	
may	
have	
failure	ENTITY
to	
thrive	ENTITY
.	

The	
prognosis	ENTITY
is	
generally	
good	
,	
with	
res-	ENTITY
olution	ENTITY
of	
apnea	ENTITY
over	
the	
first	
few	
years	ENTITY
of	
life	ENTITY
and	
no	ENTITY
residual	ENTITY
sequelae	ENTITY
.	

The	
presence	ENTITY
of	
persistent	ENTITY
severe	ENTITY
apnea	ENTITY
may	
be	
an	
indication	ENTITY
of	
an	
underlying	
medical	ENTITY
condition	ENTITY
and	
should	
prompt	
further	
evaluation	ENTITY
.	

Patients	ENTITY
with	
persistent	ENTITY
severe	
apnea	ENTITY
may	
develop	
sequelae	ENTITY
related	
to	
hypoxic	ENTITY
events	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY

This	
is	
a	
condition	ENTITY
of	
infancy	ENTITY
that	
normally	
improves	ENTITY
over	
time	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Physiological	ENTITY
factors	ENTITY
contributing	
to	
apnea	ENTITY
are	
related	
to	
immaturity	ENTITY
of	
respiratory	ENTITY
control	ENTITY
.	

These	
include	
developmental	ENTITY
alterations	ENTITY
in	
central	
drive	
,	
chemoreceptor	ENTITY
or	
mechanoreceptor	ENTITY
responses	ENTITY
,	
and	
upper	ENTITY
airway	ENTITY
reflexes	ENTITY
.	

Precipitating	ENTITY
factors	ENTITY
for	
wors-	
ening	
apnea	ENTITY
include	
gastroesophageal	ENTITY
reflux	ENTITY
,	
intracranial	ENTITY
pathology	ENTITY
,	
substances	ENTITY
,	
anes-	
thesia	ENTITY
,	
metabolic	ENTITY
disturbances	ENTITY
,	
impaired	ENTITY
oxygenation	ENTITY
,	
and	
infection	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Apnea	ENTITY
is	
predominantly	
central	
,	
but	
obstructive	ENTITY
and	
mixed	ENTITY
apneas	ENTITY
may	
occur	
.	

Apneas	ENTITY
are	
seen	
most	
frequently	
during	
REM	ENTITY
sleep	ENTITY
.	

Other	
diagnostic	ENTITY
tests	ENTITY
,	
such	
as	
a	
full	
EEG	ENTITY
or	
evaluation	ENTITY
for	
reflux	ENTITY
,	
may	
be	
appropriate	
in	
individual	ENTITY
cases	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Primary	ENTITY
CSA	ENTITY
of	ENTITY
infancy	ENTITY
should	
be	
distinguished	
from	
the	
normal	ENTITY
respiratory	ENTITY
pauses	
that	
occur	
during	
sleep	ENTITY
.	

Normative	ENTITY
respiratory	
data	ENTITY
from	
several	
large	
studies	ENTITY
show	
that	
healthy	ENTITY
asymptomatic	ENTITY
infants	ENTITY
commonly	
have	
central	ENTITY
respiratory	ENTITY
pauses	ENTITY
,	
either	
as	
isolated	ENTITY
events	ENTITY
(	
particularly	
during	
REM	ENTITY
sleep	ENTITY
)	
or	
after	
sigh	ENTITY
breaths	ENTITY
or	
movements	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
of	ENTITY
infancy	ENTITY
should	
be	
distinguished	
from	
the	
popular	
clinical	ENTITY
term	ENTITY
,	
ALTE	ENTITY
,	
which	
is	
not	
a	
specific	
diagnosis	ENTITY
but	
an	
ill	ENTITY
-	
defined	
constellation	ENTITY
of	
parent	ENTITY
-	
reported	ENTITY
apnea	ENTITY
symptoms	ENTITY
that	
range	
in	
severity	ENTITY
from	
benign	ENTITY
to	ENTITY
life	ENTITY
threatening	ENTITY
.	

Recurrent	ENTITY
,	
severe	ENTITY
infant	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
usually	
due	
to	
other	
comorbid	ENTITY
conditions	ENTITY
,	
such	
as	
gastroesophageal	ENTITY
reflux	ENTITY
,	
metabolic	ENTITY
disease	ENTITY
,	
or	
unrecognized	
neurological	ENTITY
conditions	ENTITY
such	
as	
seizures	ENTITY
,	
brainstem	ENTITY
malformation	ENTITY
,	
or	
neurodegenerative	ENTITY
condi-	
tion	ENTITY
;	
thus	
an	
evaluation	ENTITY
for	
these	
conditions	ENTITY
should	
be	
performed	
.	

Another	
diagnos-	
tic	ENTITY
consideration	
is	
a	
form	
of	
child	ENTITY
abuse	ENTITY
(	
Munchausen	ENTITY
syndrome	ENTITY
by	
proxy	
)	
mani-	
fest	
as	
imposed	
upper	ENTITY
airway	
obstruction	
or	
attempted	
suffocation	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
of	ENTITY
infancy	ENTITY
should	
be	
disassociated	
from	
the	
postmortem	ENTITY
diagnosis	ENTITY
of	
SIDS	ENTITY
.	

Although	
a	
small	
percentage	
of	
SIDS	ENTITY
victims	ENTITY
experience	ENTITY
apnea	ENTITY
symptoms	ENTITY
prior	
to	
death	ENTITY
,	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
primary	ENTITY
apnea	ENTITY
in	
the	
newborn	ENTITY
or	
infant	ENTITY
has	
not	
been	
established	
as	
an	
independent	ENTITY
risk	ENTITY
factor	ENTITY
for	
SIDS	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Infancy	ENTITY
is	
a	
developmental	ENTITY
period	ENTITY
normally	
characterized	ENTITY
by	
instability	ENTITY
of	
control	ENTITY
of	ENTITY
breathing	ENTITY
;	
thus	
,	
defining	
what	
is	
abnormal	ENTITY
is	
a	
diagnostic	ENTITY
challenge	ENTITY
.	

Further	
research	ENTITY
is	
needed	
into	
the	
mechanisms	ENTITY
of	
ventilatory	ENTITY
control	ENTITY
development	ENTITY
in	
the	
infant	ENTITY
and	
the	
pathophysiologic	ENTITY
factors	
resulting	
in	
infant	ENTITY
apnea	ENTITY
.	

Bibliography	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Apnea	ENTITY
,	
sudden	ENTITY
infant	ENTITY
death	ENTITY
syndrome	ENTITY
,	
and	
home	ENTITY
monitoring	ENTITY
.	

Pediatrics	ENTITY
2003;111:914–7	
.	

Hunt	ENTITY
CE	ENTITY
,	
Hufford	ENTITY
DR	ENTITY
,	
Bourguignon	ENTITY
C	ENTITY
,	
Oess	ENTITY
MA	ENTITY
.	

Home	ENTITY
documented	ENTITY
monitoring	ENTITY
of	
cardiorespiratory	ENTITY
pattern	ENTITY
and	
oxygen	ENTITY
saturation	ENTITY
in	
healthy	ENTITY
infants	ENTITY
.	

Pediatr	
Res	
1996;39:216–22	
.	

National	ENTITY
Institutes	ENTITY
of	ENTITY
Health	ENTITY
Consensus	ENTITY
Development	ENTITY
Conference	ENTITY
on	
Infantile	ENTITY
Apnea	ENTITY
and	
Home	ENTITY
Monitoring	ENTITY
,	
Sept	
29	
to	
Oct	
1	
,	
1986	
.	

Pediatrics	ENTITY
1987;79:292–9	
.	

Ramanathan	ENTITY
R	ENTITY
,	
Corwin	ENTITY
MJ	ENTITY
,	
Hunt	ENTITY
CE	ENTITY
,	
et	
al	
.	

Cardiorespiratory	ENTITY
events	ENTITY
recorded	
on	
home	ENTITY
monitors	ENTITY
:	
Comparison	ENTITY
of	
healthy	ENTITY
infants	ENTITY
with	
those	
at	
increased	ENTITY
risk	ENTITY
for	
SIDS	ENTITY
.	

JAMA	ENTITY
2001;285:2199–207	
.	

Southall	ENTITY
DP	ENTITY
,	
Plunkett	
MC	ENTITY
,	
Banks	ENTITY
MW	ENTITY
,	
Falkov	ENTITY
AF	ENTITY
,	
Samuels	ENTITY
MP	ENTITY
.	

Covert	ENTITY
video	ENTITY
recordings	ENTITY
of	
life-	
threatening	ENTITY
child	
abuse	
:	
lessons	ENTITY
for	
child	ENTITY
protection	ENTITY
.	

Pediatrics	ENTITY
1997;100:735–60	
.	

Primary	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
of	
Prematurity	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
770.82	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
P28.4	ENTITY
Alternate	ENTITY
Names	ENTITY
Apnea	ENTITY
of	
prematurity	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY
Apnea	ENTITY
or	
cyanosis	ENTITY
is	
noted	
by	
an	
observer	ENTITY
,	
or	
an	
episode	ENTITY
of	
sleep	
related	
central	ENTITY
apnea	ENTITY
,	
desaturation	ENTITY
,	
or	
bradycardia	ENTITY
is	
detected	ENTITY
by	
hospital	ENTITY
monitoring	ENTITY
in	
the	
postnatal	ENTITY
period	ENTITY
.	

B.	ENTITY
The	
infant	ENTITY
has	
a	
conceptional	ENTITY
age	ENTITY
less	
than	
37	
weeks	ENTITY
at	
the	
time	
of	
onset	ENTITY
of	ENTITY
symptoms	ENTITY
.	

C.	ENTITY
PSG	ENTITY
or	
alternative	ENTITY
monitoring	ENTITY
such	
as	
hospital	ENTITY
or	
home	ENTITY
apnea	ENTITY
monitoring	ENTITY
shows	
either	
:	
.	

Recurrent	ENTITY
prolonged	ENTITY
(	
>	
20	
seconds	
duration	ENTITY
)	
central	
apneas.1	
2	
.	

Periodic	ENTITY
breathing2	ENTITY
for	
≥	
5	
%	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

D.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
medication	ENTITY
.	

Notes	ENTITY
.	

Normative	ENTITY
data	ENTITY
concerning	
the	
number	
of	
prolonged	ENTITY
central	ENTITY
apneas	ENTITY
per	
hour	
are	
not	
well	
established	
.	
.	

As	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

Short	ENTITY
(	
<	
20	
seconds	
)	
central	ENTITY
apneas	ENTITY
associated	ENTITY
with	ENTITY
significant	ENTITY
desaturation	ENTITY
are	
more	
likely	
to	
be	
a	
sign	ENTITY
of	
decreased	ENTITY
pulmonary	ENTITY
reserve	ENTITY
than	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
pathology	ENTITY
.	
.	

Obstructive	ENTITY
and	
mixed	ENTITY
apneas	ENTITY
may	
also	
be	
present	
,	
but	
central	ENTITY
apneas	ENTITY
are	
predominant	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Apnea	ENTITY
is	
very	
common	
in	
preterm	ENTITY
infants	ENTITY
,	
and	
the	
prevalence	ENTITY
varies	
inversely	ENTITY
with	
ges-	ENTITY
tational	ENTITY
age	ENTITY
.	

In	
the	
preterm	ENTITY
infant	ENTITY
,	
sleep	ENTITY
apnea	ENTITY
can	
be	
anticipated	ENTITY
,	
is	
primarily	
related	
to	
immaturity	ENTITY
,	
and	
may	
require	
supportive	ENTITY
ventilatory	ENTITY
and	
pharmacologic	ENTITY
treatment	ENTITY
.	

The	
condition	ENTITY
will	
improve	ENTITY
with	
maturation	ENTITY
unless	
extenuating	ENTITY
conditions	ENTITY
,	
such	
as	
hypoxemia	ENTITY
due	
to	
chronic	ENTITY
lung	ENTITY
disease	ENTITY
or	
gastroesophageal	ENTITY
reflux	ENTITY
,	
are	
present	
.	

Apneas	ENTITY
are	
predominantly	
central	
,	
but	
mixed	
or	
obstructive	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
may	
be	
seen	
.	

The	
events	ENTITY
are	
typically	
associated	ENTITY
with	ENTITY
physiological	ENTITY
compromise	ENTITY
(	
hypoxemia	ENTITY
,	
bra-	
dycardia	ENTITY
)	
or	
the	
need	
for	
intervention	ENTITY
such	
as	
stimulation	ENTITY
or	
resuscitation	ENTITY
.	

Associated	
Features	
Apnea	ENTITY
in	
the	
preterm	ENTITY
infant	ENTITY
is	
commonly	
associated	ENTITY
with	ENTITY
bradycardia	ENTITY
.	

Primary	ENTITY
CSA	ENTITY
of	
prematurity	ENTITY
is	
state	
dependent	
,	
and	
the	
frequency	ENTITY
of	
respiratory	ENTITY
events	ENTITY
increases	ENTITY
during	
active	ENTITY
(	
REM	
)	
sleep	
.	

Paradoxical	ENTITY
chest	ENTITY
wall	ENTITY
movements	ENTITY
are	
common	
during	
active	ENTITY
sleep	ENTITY
in	
neonates	ENTITY
and	
may	
cause	
a	
fall	ENTITY
in	
arterial	ENTITY
oxygen	
saturation	
because	
of	
ventilation	ENTITY
or	
perfusion	ENTITY
defects	ENTITY
associated	ENTITY
with	ENTITY
a	
decrease	ENTITY
in	
functional	ENTITY
residual	ENTITY
capac-	
ity	ENTITY
.	

Underlying	
comorbidities	ENTITY
(	
for	
example	
,	
chronic	ENTITY
lung	ENTITY
disease	ENTITY
or	
abnormal	ENTITY
neuro-	
logical	ENTITY
status	ENTITY
)	
can	
predispose	ENTITY
the	
infant	ENTITY
to	
having	
a	
more	
severe	ENTITY
or	
prolonged	ENTITY
course	ENTITY
for	
apnea	ENTITY
.	

Note	
that	
a	
small	
upper	
airway	ENTITY
will	
exaggerate	
the	
obstructive	ENTITY
elements	ENTITY
of	
this	
disorder	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Demographics	ENTITY

The	
prevalence	ENTITY
of	
apnea	ENTITY
of	
prematurity	ENTITY
varies	
inversely	ENTITY
with	
conceptional	ENTITY
age	ENTITY
.	

In	
studies	ENTITY
,	
approximately	
25	
%	
percent	
of	
infants	ENTITY
who	
weigh	
less	
than	
2,500	
g	
at	
birth	ENTITY
and	
84	
%	
of	
infants	ENTITY
under	
1,000	
g	
may	
experience	
symptomatic	ENTITY
apnea	ENTITY
during	
the	
neo-	
natal	ENTITY
period	ENTITY
.	

Ninety	ENTITY
-	
two	
percent	
of	
preterm	ENTITY
infants	ENTITY
will	
be	
symptom	ENTITY
free	ENTITY
by	
37	
weeks	ENTITY
postconceptional	ENTITY
age	ENTITY
,	
and	
98	
%	
by	
40	
weeks	ENTITY
after	
conception	ENTITY
,	
with	
resolution	ENTITY
in	
most	
infants	ENTITY
by	
43	
weeks	ENTITY
postconception	ENTITY
.	

Apnea	ENTITY
of	
prematurity	ENTITY
occurs	
equally	
in	
males	ENTITY
and	
females	ENTITY
,	
and	
in	
infants	ENTITY
of	
all	
races	ENTITY
and	
ethnic	ENTITY
groups	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Developmental	ENTITY
delay	ENTITY
in	
respiratory	ENTITY
control	ENTITY
associated	ENTITY
with	ENTITY
premature	ENTITY
birth	ENTITY
is	
the	
major	
predisposing	ENTITY
condition	ENTITY
.	

Diverse	ENTITY
factors	ENTITY
are	
known	
to	
precipitate	ENTITY
development	ENTITY
of	
apneic	ENTITY
episodes	ENTITY
in	
predisposed	ENTITY
preterm	ENTITY
infants	ENTITY
.	

These	
include	
thermal	ENTITY
instability	ENTITY
,	
gastroesophageal	ENTITY
reflux	ENTITY
,	
intracranial	ENTITY
pathology	ENTITY
,	
substances	ENTITY
,	
anesthesia	ENTITY
,	
metabolic	ENTITY
disorders	ENTITY
,	
impaired	ENTITY
oxygenation	ENTITY
,	
and	
infection	ENTITY
.	

Infection	ENTITY
with	
respiratory	ENTITY
syncytial	ENTITY
virus	ENTITY
can	
increase	ENTITY
the	
frequency	ENTITY
and	
the	
duration	ENTITY
of	
apneas	
in	
predisposed	ENTITY
infants	ENTITY
.	

OSA	ENTITY
associated	ENTITY
with	ENTITY
upper	ENTITY
airway	ENTITY
abnormalities	ENTITY
can	
present	
as	
apnea	ENTITY
of	
prematurity	ENTITY
.	

Persistence	ENTITY
of	
apnea	ENTITY
after	
43	
weeks	ENTITY
conceptional	ENTITY
age	ENTITY
should	
raise	
suspicion	ENTITY
of	
addi-	
tional	ENTITY
etiologic	ENTITY
factors	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
None	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
In	
preterm	ENTITY
infants	ENTITY
,	
apnea	ENTITY
is	
rare	
on	
day	ENTITY
one	
of	
life	ENTITY
,	
and	
its	
presence	ENTITY
usually	
signals	ENTITY
another	
illness	ENTITY
.	

More	
typical	
onset	
occurs	
between	
the	
second	
and	
seventh	
days	ENTITY
.	

Apnea	ENTITY
of	
prematurity	ENTITY
usually	
ceases	ENTITY
by	
37	
weeks	ENTITY
conceptional	ENTITY
age	ENTITY
but	
may	
persist	
for	
several	
weeks	ENTITY
beyond	
term	ENTITY
,	
especially	
in	
infants	ENTITY
born	ENTITY
before	
28	
weeks	ENTITY
postconception	ENTITY
;	
apnea	ENTITY
beyond	
43	
weeks	ENTITY
postconception	ENTITY
is	
rare	ENTITY
.	

Adverse	ENTITY
outcomes	ENTITY
for	
former	ENTITY
preterm	ENTITY
infants	
are	
more	
closely	
related	
to	
the	
prenatal	ENTITY
or	
neonatal	ENTITY
course	ENTITY
,	
associated	ENTITY
comorbidities	ENTITY
,	
and	
environmental	ENTITY
factors	ENTITY
than	
to	
the	
apnea	ENTITY
of	
prematurity	ENTITY
per	
se	
.	

For	
most	
children	ENTITY
,	
long	ENTITY
-	
term	ENTITY
outcomes	ENTITY
for	
uncomplicated	ENTITY
apnea	ENTITY
of	
prematurity	ENTITY
are	
excellent	ENTITY
.	

However	
,	
the	
prognosis	ENTITY
for	
infants	ENTITY
with	
persistent	ENTITY
recurrent	
apnea	
spells	
requiring	
frequent	ENTITY
resuscitation	ENTITY
is	
more	
guarded	
and	
depends	
on	
the	
cause	
of	
the	
apnea	ENTITY
and	
associated	ENTITY
comorbidities	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY

This	
is	
a	
condition	ENTITY
related	
to	
prematurity	ENTITY
that	
normally	
improves	ENTITY
over	
time	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Physiological	ENTITY
factors	ENTITY
contributing	
to	
apnea	ENTITY
are	
related	
to	
immaturity	ENTITY
of	
respiratory	ENTITY
control	ENTITY
.	

These	
include	
developmental	ENTITY
alterations	ENTITY
in	
central	
drive	
,	
chemoreceptor	ENTITY
or	
mechanoreceptor	ENTITY
responses	ENTITY
,	
and	
upper	ENTITY
airway	ENTITY
reflexes	ENTITY
.	

Precipitating	ENTITY
factors	ENTITY
for	
wors-	
ening	
apnea	ENTITY
in	
preterm	ENTITY
infants	ENTITY
include	
thermal	ENTITY
instability	ENTITY
,	
gastroesophageal	ENTITY
reflux	ENTITY
,	
intracranial	ENTITY
pathology	ENTITY
,	
substances	ENTITY
,	
anesthesia	ENTITY
,	
metabolic	ENTITY
disturbances	ENTITY
,	
impaired	ENTITY
oxy-	ENTITY
genation	ENTITY
,	
and	
infection	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Most	
premature	ENTITY
neonates	ENTITY
are	
diagnosed	ENTITY
with	
apnea	ENTITY
of	ENTITY
prematurity	ENTITY
based	
on	
cardio-	
respiratory	ENTITY
monitoring	ENTITY
in	
the	
neonatal	ENTITY
intensive	ENTITY
care	ENTITY
unit	ENTITY
,	
rather	
than	
by	
PSG	ENTITY
.	

When	
PSG	ENTITY
is	
performed	
,	
central	ENTITY
apneas	ENTITY
are	
often	
shown	
to	
have	
a	
mixed	
component	
,	
with	
mixed	ENTITY
apneas	ENTITY
accounting	
for	
50	
%	
to	
75	
%	
of	
apneas	ENTITY
in	
small	ENTITY
premature	ENTITY
infants	ENTITY
;	
studies	ENTITY
suggest	
that	
obstructive	ENTITY
-	
type	ENTITY
events	ENTITY
account	
for	
10	
%	
to	
20	
%	
of	
events	ENTITY
;	
and	
pure	ENTITY
central	ENTITY
events	ENTITY
,	
10	
%	
to	
25	
%	
.	

Periodic	ENTITY
breathing	ENTITY
may	
be	
present	
.	

Differential	ENTITY
Diagnosis	ENTITY
Apnea	ENTITY
of	
prematurity	ENTITY
should	
be	
distinguished	
from	
normal	ENTITY
,	
physiologic	ENTITY
respiratory	ENTITY
pauses	ENTITY
that	
occur	
during	
sleep	ENTITY
in	
infants	ENTITY
.	

Studies	ENTITY
have	
shown	
that	
healthy	ENTITY
asymptom-	
atic	ENTITY
infants	ENTITY
commonly	
have	
brief	ENTITY
(	
<	
20	
second	
)	
central	ENTITY
respiratory	ENTITY
pauses	ENTITY
,	
either	
as	
isolated	ENTITY
events	ENTITY
(	
particularly	
during	
REM	ENTITY
sleep	ENTITY
)	
or	
after	
sigh	ENTITY
breaths	ENTITY
or	
movements	ENTITY
(	
in	
which	
case	
the	
apneas	ENTITY
may	
be	
longer	
)	
.	

These	
infants	ENTITY
are	
typically	
asymptomatic	ENTITY
,	
with	
no	
changes	
in	
color	ENTITY
or	
muscle	ENTITY
tone	ENTITY
.	

The	
differential	ENTITY
diagnosis	ENTITY
is	
long	ENTITY
and	
includes	
apnea	ENTITY
secondary	
to	
severe	
gastroesoph-	
ageal	
reflux	
,	
central	ENTITY
nervous	ENTITY
system	ENTITY
malformations	ENTITY
or	
hemorrhage	ENTITY
,	
seizures	ENTITY
,	
sepsis	ENTITY
,	
and	
rarely	
primary	
cardiac	ENTITY
arrhythmias	ENTITY
.	

Comorbid	ENTITY
conditions	ENTITY
should	
be	
suspected	ENTITY
whenever	
apneas	ENTITY
are	
severe	ENTITY
or	
continue	
beyond	
43	
weeks	ENTITY
gestation	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
mechanisms	ENTITY
underlying	
physiologic	ENTITY
maturation	ENTITY
of	
ventilatory	ENTITY
control	ENTITY
are	
not	
well	
understood	
.	

Further	
research	ENTITY
is	
required	
to	
determine	
which	
infants	ENTITY
are	
at	
greatest	
risk	ENTITY
for	
severe	ENTITY
apnea	ENTITY
.	

Bibliography	ENTITY
American	ENTITY
Academy	ENTITY
of	ENTITY
Pediatrics	ENTITY
.	

Apnea	ENTITY
,	
sudden	ENTITY
infant	ENTITY
death	ENTITY
syndrome	ENTITY
,	
and	
home	ENTITY
monitoring	ENTITY
.	

Pediatrics	ENTITY
2003;111:914–7	
.	

Hunt	ENTITY
CE	ENTITY
,	
Hufford	ENTITY
DR	ENTITY
,	
Bourguignon	ENTITY
C	ENTITY
,	
Oess	ENTITY
MA	ENTITY
.	

Home	ENTITY
documented	ENTITY
monitoring	ENTITY
of	
cardiorespiratory	ENTITY
pattern	ENTITY
and	
oxygen	ENTITY
saturation	ENTITY
in	
healthy	ENTITY
infants	ENTITY
.	

Pediatr	
Res	
1996;39:216–22	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Kahn	ENTITY
A	ENTITY
,	
Rebuffat	ENTITY
E	ENTITY
,	
Sottiaux	ENTITY
M	ENTITY
,	
Blum	ENTITY
D.	ENTITY
Management	ENTITY
of	
an	
infant	ENTITY
with	
an	
apparent	ENTITY
life	ENTITY
-	
threatening	ENTITY
event	ENTITY
.	

Pediatrician	ENTITY
1988;15:204–11	
.	

National	ENTITY
Institutes	ENTITY
of	ENTITY
Health	ENTITY
Consensus	ENTITY
Development	ENTITY
Conference	ENTITY
on	
Infantile	ENTITY
Apnea	ENTITY
and	
Home	ENTITY
Monitoring	ENTITY
,	
Sept	
29	
to	
Oct	
1	
,	
1986	
.	

Pediatrics	ENTITY
1987;79:292–9	
.	

Ramanathan	ENTITY
R	ENTITY
,	
Corwin	ENTITY
MJ	ENTITY
,	
Hunt	ENTITY
CE	ENTITY
,	
et	
al	
.	

Cardiorespiratory	ENTITY
events	ENTITY
recorded	
on	
home	ENTITY
monitors	ENTITY
:	
Comparison	ENTITY
of	
healthy	ENTITY
infants	ENTITY
with	
those	
at	
increased	ENTITY
risk	ENTITY
for	
SIDS	ENTITY
.	

JAMA	ENTITY
2001;285:2199–207	
.	

Rigatto	ENTITY
H.	ENTITY
Breathing	ENTITY
and	
sleep	ENTITY
in	
preterm	ENTITY
infants	ENTITY
.	

In	
:	
Loughlin	ENTITY
G	ENTITY
,	
Carroll	
J	
,	
Marcus	ENTITY
C	ENTITY
,	
eds	
.	

Sleep	ENTITY
and	
breathing	ENTITY
in	
children	ENTITY
.	

New	ENTITY
York	ENTITY
:	
Marcel	
Dekker	
,	
2000:495–515	
.	

Schmidt	ENTITY
B	ENTITY
,	
Roberts	ENTITY
RS	ENTITY
,	
Davis	
P	
,	
et	
al	
.	

Long	ENTITY
-	
term	ENTITY
effects	ENTITY
of	
caffeine	ENTITY
therapy	ENTITY
for	
apnea	ENTITY
of	ENTITY
prematurity	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2007;357:1893–902	ENTITY
.	

Southall	ENTITY
DP	ENTITY
,	
Plunkett	
MC	ENTITY
,	
Banks	ENTITY
MW	ENTITY
,	
Falkov	ENTITY
AF	ENTITY
,	
Samuels	ENTITY
MP	ENTITY
.	

Covert	ENTITY
video	ENTITY
recordings	ENTITY
of	
life-	
threatening	ENTITY
child	
abuse	
:	
lessons	ENTITY
for	
child	ENTITY
protection	ENTITY
[	
see	
comments	ENTITY
]	
.	

Pediatrics	ENTITY
1997;100:735–60	
.	

Treatment	ENTITY
-	
Emergent	ENTITY
Central	ENTITY
Sleep	ENTITY
Apnea	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.29	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.39	ENTITY
Alternate	ENTITY
names	ENTITY
Complex	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY
Diagnostic	ENTITY
PSG	ENTITY
shows	
five	
or	
more	
predominantly	
obstructive	ENTITY
respiratory	ENTITY
events1	ENTITY
(	
obstructive	ENTITY
or	
mixed	ENTITY
apneas	ENTITY
,	
hypopneas	ENTITY
or	
RERAs	ENTITY
)	
per	
hour	
of	
sleep	
B.	
PSG	
during	
use	
of	
positive	ENTITY
airway	
pressure	
without	
a	
backup	ENTITY
rate	ENTITY
shows	
significant	
resolution	ENTITY
of	
obstructive	ENTITY
events	ENTITY
and	
emergence	ENTITY
or	
persistence	ENTITY
of	
central	ENTITY
apnea	ENTITY
or	
central	ENTITY
hypopnea	ENTITY
with	
all	
of	
the	
following	
:	
.	

Central	ENTITY
apnea	ENTITY
—	
central	ENTITY
hypopnea	ENTITY
index	ENTITY
[	
CAHI	ENTITY
]	
≥	
5	
/	
hour	ENTITY
.	
.	

Number	
of	
central	ENTITY
apneas	ENTITY
and	
central	ENTITY
hypopneas	ENTITY
is	
≥	
50	
%	
of	
total	
number	
of	
apneas	ENTITY
and	
hypopneas	ENTITY
.	

C.	

The	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
is	
not	
better	
explained	
by	
another	
CSA	ENTITY
disorder	ENTITY
(	
e.g.	
,	
CSA	ENTITY
with	
CSB	ENTITY
or	
CSA	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
)	
.	

Notes	ENTITY
.	

Respiratory	ENTITY
events	ENTITY
defined	
according	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

A	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
.	

That	
is	
,	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
can	
be	
made	
based	
on	
the	
diagnostic	ENTITY
sleep	ENTITY
study	ENTITY
.	

Essential	ENTITY
Features	ENTITY
A	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
is	
characterized	ENTITY
by	
predominantly	
obstructive	ENTITY
events	ENTITY
(	
obstructive	ENTITY
or	
mixed	ENTITY
apnea	ENTITY
or	
hypopnea	ENTITY
)	
during	
a	
diagnostic	ENTITY
sleep	ENTITY
study	ENTITY
with	
persistence	ENTITY
or	
emergence	ENTITY
of	
CSA	ENTITY
during	
administration	ENTITY
of	
positive	ENTITY
airway	
pressure	
without	
a	
backup	ENTITY
rate	ENTITY
,	
despite	
significant	
resolution	ENTITY
of	
obstructive	ENTITY
respiratory	ENTITY
events	ENTITY
.	

If	
the	
central	ENTITY
apnea	ENTITY
is	
better	
explained	
by	
another	
CSA	ENTITY
disorder	ENTITY
,	
patients	ENTITY
are	
given	
a	
diagnosis	ENTITY
of	
OSA	ENTITY
and	
that	
CSA	ENTITY
disorder	ENTITY
rather	
than	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
(	
e.g.	
,	
a	
patient	ENTITY
with	
heart	ENTITY
failure	ENTITY
exhibits	
mainly	
obstructive	ENTITY
events	ENTITY
during	
diagnostic	ENTITY
PSG	ENTITY
but	
then	
exhibits	
predominantly	
central	ENTITY
apnea	ENTITY
with	
CSB	ENTITY
on	
positive	ENTITY
airway	
pressure	
)	
.	

Associated	ENTITY
Features	ENTITY
Patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
have	
several	
characteristics	ENTITY
when	
placed	
on	
positive	ENTITY
airway	
pressure	
without	
a	
backup	ENTITY
rate	ENTITY
.	

A	
high	
number	
of	
arousals	ENTITY
persist	
on	
PAP	ENTITY
treatment	ENTITY
,	
and	
the	
AHI	ENTITY
is	
often	
higher	
during	
NREM	ENTITY
than	
REM	ENTITY
sleep	ENTITY
.	

This	
is	
due	
to	
the	
fact	
that	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
almost	
invariably	
occur	
during	
NREM	ENTITY
sleep	ENTITY
.	

Pressures	ENTITY
that	
are	
effective	ENTITY
in	
controlling	ENTITY
obstructive	ENTITY
events	
during	
REM	ENTITY
sleep	ENTITY
prove	
ineffective	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
due	
to	
emergence	ENTITY
of	
central	ENTITY
apneas	ENTITY
.	

If	
patients	ENTITY
can	
attain	
stage	ENTITY
N3	
,	
central	ENTITY
apneas	ENTITY
often	
decrease	ENTITY
until	
interrupted	ENTITY
by	
an	
arousal	ENTITY
or	
transition	ENTITY
to	
a	
lighter	ENTITY
stage	ENTITY
of	
sleep	ENTITY
that	
precipitates	ENTITY
another	
run	
of	
central	ENTITY
apneas	ENTITY
or	
hypopneas	ENTITY
.	

Patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
can	
have	
persistent	ENTITY
sleep	ENTITY
fragmentation	ENTITY
on	
CPAP	ENTITY
treatment	ENTITY
and	
may	
report	
little	
benefit	ENTITY
from	
therapy	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
The	
percentage	ENTITY
of	
patients	ENTITY
with	
persistent	ENTITY
or	
emergent	ENTITY
central	ENTITY
apnea	ENTITY
on	
the	
initial	ENTITY
poly-	
somnographic	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
titration	ENTITY
varies	
from	
2	
%	
to	
20	
%	
depending	
on	
the	
characteristics	ENTITY
of	
the	
group	ENTITY
studied	ENTITY
(	
community	ENTITY
or	
referral	ENTITY
sleep	ENTITY
center	ENTITY
)	
and	
the	
methodology	ENTITY
.	

If	
patients	ENTITY
who	
are	
taking	
opioids	ENTITY
or	
have	
underling	
central	ENTITY
apnea	ENTITY
with	
CSB	ENTITY
are	
included	
,	
the	
percentage	ENTITY
is	
at	
the	
higher	ENTITY
end	
of	
the	
range	ENTITY
.	

The	
percentage	ENTITY
of	
patients	ENTITY
with	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
that	
persists	
on	
chronic	ENTITY
CPAP	ENTITY
treatment	ENTITY
(	
approxi-	
mately	
2	
%	
)	
is	
considerably	
lower	
than	
the	
percentage	ENTITY
identified	ENTITY
on	
the	
first	
or	
second	
night	ENTITY
of	
CPAP	ENTITY
treatment	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY

A	
number	
of	
factors	ENTITY
have	
been	
hypothesized	
to	
cause	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
,	
but	
definitive	
data	ENTITY
are	
not	
available	
.	

The	
patients	ENTITY
presumably	
have	
characteristics	ENTITY
that	
would	
predispose	ENTITY
them	
to	
instability	ENTITY
in	
ventilatory	ENTITY
control	ENTITY
or	
sleep	ENTITY
maintenance	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
These	
include	
a	
low	ENTITY
arousal	ENTITY
threshold	ENTITY
and	
high	ENTITY
ventilatory	ENTITY
controller	
gain	
.	

Studies	ENTITY
have	
found	
that	
often	
a	
small	
increase	ENTITY
in	
end	ENTITY
-	
tidal	ENTITY
PCO2	ENTITY
can	
stabilize	ENTITY
breathing	ENTITY
in	
patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
.	

Therefore	
,	
any	
events	ENTITY
that	
predis-	
pose	
a	
patient	ENTITY
to	
hypocapnia	ENTITY
can	
trigger	ENTITY
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apnea	ENTITY
.	

In	
some	
,	
but	
not	
all	
studies	ENTITY
,	
the	
overall	
AHI	ENTITY
on	
the	
diagnostic	ENTITY
PSG	ENTITY
(	
or	
diagnostic	ENTITY
portion	ENTITY
of	
a	
split	ENTITY
-	
night	ENTITY
PSG	ENTITY
)	
was	
higher	
in	
the	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
group	ENTITY
compared	
to	
the	
patients	ENTITY
without	
this	
diagnosis	ENTITY
.	

In	
other	
studies	ENTITY
,	
patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
had	
more	
central	ENTITY
apneas	ENTITY
during	
the	
diagnostic	ENTITY
PSG	ENTITY
and	
were	
more	
likely	
to	
be	
male	ENTITY
.	

However	
,	
identified	ENTITY
risk	ENTITY
factors	ENTITY
for	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
vary	
considerably	
from	
study	ENTITY
to	
study	ENTITY
.	

Of	
note	
,	
the	
emergence	ENTITY
of	
central	ENTITY
apnea	ENTITY
after	
treatment	ENTITY
of	
obstructive	ENTITY
apnea	ENTITY
with	
tra-	
cheostomy	ENTITY
,	
maxillomandibular	ENTITY
advancement	ENTITY
,	
and	
oral	ENTITY
appliance	ENTITY
treatment	ENTITY
for	
OSA	ENTITY
has	
been	
reported	
.	

A	
case	ENTITY
report	ENTITY
of	
the	
development	ENTITY
of	
central	ENTITY
apnea	ENTITY
following	
nasal	ENTITY
surgery	ENTITY
in	
a	
patient	ENTITY
with	
known	
obstructive	ENTITY
apnea	ENTITY
has	
also	
recently	
been	
published	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
None	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
recognition	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
follows	
PAP	ENTITY
titration	ENTITY
.	

An	
accurate	ENTITY
esti-	
mate	ENTITY
of	
the	
percentage	ENTITY
of	
patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
whose	
central	ENTITY
events	ENTITY
persist	
on	
long	ENTITY
-	
term	ENTITY
PAP	ENTITY
treatment	ENTITY
does	
not	
exist	
,	
as	
most	
published	ENTITY
reports	ENTITY
are	
retrospective	ENTITY
and	
had	
a	
significant	
number	
of	
patients	ENTITY
lost	ENTITY
to	
follow	ENTITY
-	
up	
.	

Of	
interest	
,	
one	
study	ENTITY
comparing	ENTITY
the	
results	ENTITY
of	
an	
initial	
CPAP	ENTITY
titration	
study	
with	
one	
per-	
formed	
after	
six	
months	ENTITY
of	
therapy	ENTITY
found	
patients	ENTITY
who	
did	
not	
meet	
criteria	ENTITY
for	
treat-	
ment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
on	
the	
initial	
study	ENTITY
but	
met	
the	
criteria	ENTITY
on	
the	
second	
study	
.	

Those	
patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
that	
do	
not	
experience	
resolution	ENTITY
of	
central	ENTITY
apneas	ENTITY
on	
chronic	ENTITY
PAP	ENTITY
treatment	ENTITY
are	
found	
to	
have	
a	
high	
number	
of	
residual	ENTITY
events	ENTITY
on	
PAP	ENTITY
machine	ENTITY
interrogation	ENTITY
in	
clinic	ENTITY
follow	ENTITY
-	
up	
.	

Nocturnal	ENTITY
oximetry	ENTITY
at	
home	ENTITY
on	
PAP	ENTITY
treatment	ENTITY
may	
show	
persistent	ENTITY
arterial	ENTITY
oxygen	
desaturation	
.	

Sleep	ENTITY
fragmentation	ENTITY
and	
daytime	ENTITY
sleepiness	ENTITY
may	
persist	
if	
a	
significant	
number	
of	
central	ENTITY
apneas	ENTITY
remain	
.	

There	
is	
the	
potential	ENTITY
for	
poor	ENTITY
adherence	ENTITY
and	
acceptance	ENTITY
of	
PAP	ENTITY
treatment	ENTITY
as	
a	
result	
of	
this	
.	

Developmental	ENTITY
Issues	ENTITY
Treatment	ENTITY
-	
emergent	ENTITY
sleep	ENTITY
apnea	ENTITY
has	
not	
been	
described	
in	
children	ENTITY
but	
this	
may	
be	
due	
to	
the	
relatively	
small	
number	
of	
children	ENTITY
with	
OSA	ENTITY
who	
are	
treated	ENTITY
with	ENTITY
PAP	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Due	
to	
variation	ENTITY
in	
definitions	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
,	
the	
pathophysiology	ENTITY
is	
not	
clearly	
defined	
.	

A	
low	ENTITY
arousal	ENTITY
threshold	ENTITY
and	
difficulty	ENTITY
reaching	
stage	ENTITY
N3	
sleep	
may	
pre-	
dispose	ENTITY
to	
sleep	ENTITY
instability	ENTITY
.	

Arousals	ENTITY
destabilize	ENTITY
breathing	ENTITY
.	

A	
high	
ventilatory	ENTITY
response	ENTITY
to	
PaCO2	ENTITY
and	
a	
small	
difference	
between	
the	
sleeping	ENTITY
PaCO2	ENTITY
and	
the	
apnea	ENTITY
threshold	ENTITY
may	
also	
predispose	
patients	ENTITY
to	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
.	

Treatment	ENTITY
with	
excessive	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
may	
trigger	ENTITY
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
in	
susceptible	ENTITY
individuals	ENTITY
.	

Objective	
Findings	ENTITY
PSG	ENTITY
during	
a	
full	
night	ENTITY
diagnostic	ENTITY
study	ENTITY
(	
or	
diagnostic	ENTITY
portion	ENTITY
of	
a	
split	ENTITY
-	
night	ENTITY
PSG	ENTITY
)	
shows	
predominantly	
obstructive	ENTITY
or	
mixed	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
of	
five	
or	
more	
per	
hour	
of	
sleep	ENTITY
.	

PSG	ENTITY
with	
PAP	ENTITY
(	
either	
a	
full	
night	ENTITY
titration	ENTITY
study	ENTITY
or	
PAP	ENTITY
treatment	ENTITY
portion	ENTITY
of	
a	
split	ENTITY
night	ENTITY
study	
)	
without	
a	
backup	ENTITY
rate	ENTITY
shows	
significant	
resolution	ENTITY
of	
obstructive	ENTITY
events	ENTITY
and	
emergence	ENTITY
or	
persistence	ENTITY
of	
central	ENTITY
apneas	ENTITY
or	
central	ENTITY
hypopneas	ENTITY
.	

The	
CAHI	ENTITY
is	
five	
or	
greater	
per	
hour	ENTITY
,	
and	
more	
than	
50	
%	
of	
the	
respiratory	ENTITY
events	ENTITY
are	
central	
in	
nature	ENTITY
.	

A	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
excludes	
patients	ENTITY
who	
manifest	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
on	
PAP	ENTITY
treatment	ENTITY
when	
the	
CSA	ENTITY
is	
better	
explained	
by	
another	
CSA	ENTITY
dis-	
order	
or	
by	
over	ENTITY
-	
titration	ENTITY
.	

PSG	ENTITY
with	
administration	ENTITY
of	
PAP	ENTITY
often	
reveals	
adequate	ENTITY
treatment	ENTITY
during	
REM	ENTITY
sleep	ENTITY
and	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
but	
repetitive	ENTITY
episodes	ENTITY
of	
central	ENTITY
events	ENTITY
during	
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
.	

In	
some	
patients	ENTITY
,	
progressive	ENTITY
increases	ENTITY
in	
pressure	ENTITY
with	
a	
goal	ENTITY
of	
preventing	ENTITY
airflow	ENTITY
limitation	ENTITY
reach	
a	
“	
break	
point	
”	
at	
which	
central	ENTITY
apneas	ENTITY
appear	
.	

Differential	ENTITY
Diagnosis	ENTITY
Many	
patients	ENTITY
with	
OSA	ENTITY
have	
a	
few	
central	
events	
while	
on	
PAP	ENTITY
.	

However	
,	
in	
the	
majority	
of	
cases	ENTITY
,	
the	
central	ENTITY
AHI	ENTITY
is	
not	
≥	
5	
/	
hour	ENTITY
and	
central	ENTITY
events	ENTITY
are	
not	
≥	
50	
%	
of	
the	
total	
number	
of	
apneas	ENTITY
and	
hypopneas	ENTITY
.	

Other	
patients	ENTITY
with	
OSA	ENTITY
,	
while	
on	
PAP	ENTITY
,	
exhibit	
predominantly	
central	
events	
that	
are	
believed	
to	
be	
secondary	
to	
a	
CSA	ENTITY
disor-	
der	
classified	
elsewhere	
.	

In	
this	
case	ENTITY
,	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
the	
CSA	ENTITY
disorder	ENTITY
is	
appropriate	
,	
rather	
than	
a	
diagnosis	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
.	

For	
example	
,	
a	
patient	ENTITY
taking	
methadone	ENTITY
has	
predominantly	
obstructive	ENTITY
events	ENTITY
during	
the	
diagnostic	ENTITY
portion	ENTITY
of	
a	
split	ENTITY
-	
night	ENTITY
PSG	ENTITY
.	

Once	
obstructive	ENTITY
events	ENTITY
are	
eliminated	
on	
PAP	ENTITY
,	
CSA	ENTITY
with	
ataxic	ENTITY
breathing	ENTITY
is	
noted	
.	

A	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
CSA	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
should	
be	
made	
if	
criteria	ENTITY
for	
that	
disorder	ENTITY
are	
met	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
true	
incidence	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
sleep	ENTITY
apnea	ENTITY
as	
well	
as	
the	
percentage	ENTITY
of	
patients	ENTITY
who	
have	
persistent	ENTITY
central	ENTITY
apnea	ENTITY
on	
chronic	ENTITY
PAP	ENTITY
treatment	ENTITY
remains	
to	
be	
defined	
.	

Further	
prospective	ENTITY
studies	ENTITY
with	
clearly	
defined	
inclusion	ENTITY
and	
exclusion	ENTITY
crite-	
ria	ENTITY
are	
needed	
to	
better	
define	
the	
exact	
percentage	
of	
patients	ENTITY
with	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
who	
have	
persistent	ENTITY
CSA	ENTITY
after	
chronic	ENTITY
PAP	ENTITY
treatment	ENTITY
.	

There	
may	
be	
night	ENTITY
-	
to-	
night	ENTITY
variability	ENTITY
in	
the	
amount	ENTITY
of	
CSA	ENTITY
displayed	
by	
a	
given	
patient	ENTITY
.	

It	
is	
unknown	
,	
for	
example	
,	
whether	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
that	
resolve	
on	
chronic	ENTITY
PAP	ENTITY
treatment	ENTITY
will	
re	
-	
emerge	ENTITY
if	
the	
patient	ENTITY
discontinues	
PAP	ENTITY
treatment	ENTITY
for	
a	
period	ENTITY
of	
time	ENTITY
and	
then	
restarts	ENTITY
treatment	ENTITY
.	

A	
number	
of	
factors	ENTITY
have	
been	
hypothesized	
to	
increase	ENTITY
the	
likelihood	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
including	
overtitration	ENTITY
(	
excessive	ENTITY
pressure	ENTITY
)	
,	
undertitration	ENTITY
(	
respiratory	ENTITY
effort	
arousals	
followed	
by	
central	ENTITY
apnea	ENTITY
)	
,	
the	
use	
of	
bilevel	ENTITY
PAP	ENTITY
rather	
than	
CPAP	ENTITY
,	
arousals	ENTITY
from	
mask	ENTITY
leak	ENTITY
,	
and	
use	
of	
a	
split	
night	
study	
.	

Further	
study	ENTITY
is	
needed	
to	
verify	
that	
these	
factors	ENTITY
do	
indeed	
predispose	
a	
patient	ENTITY
to	
develop	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
.	

The	
evolution	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
apneas	ENTITY
on	
chronic	ENTITY
PAP	ENTITY
treatment	ENTITY
also	
remains	
to	
be	
determined	
;	
that	
is	
,	
to	
what	
extent	
do	
central	ENTITY
events	ENTITY
resolve	
over	
time	ENTITY
and	
what	
is	
the	
time	ENTITY
course	ENTITY
of	
this	
resolu-	
tion	ENTITY
?	

In	
light	
of	
the	
increasing	ENTITY
utilization	ENTITY
of	
auto	ENTITY
-	
titrating	ENTITY
PAP	ENTITY
,	
further	
investigation	ENTITY
of	
the	
incidence	ENTITY
of	
treatment	ENTITY
-	
emergent	ENTITY
CSA	ENTITY
with	
this	
modality	ENTITY
is	
indicated	
.	

Bibliography	ENTITY
Allam	ENTITY
JS	ENTITY
,	
Olson	ENTITY
EJ	ENTITY
,	
Gay	ENTITY
PC	ENTITY
,	
Morgenthaler	ENTITY
TI	ENTITY
.	

Efficacy	ENTITY
of	
adaptive	ENTITY
servoventilation	ENTITY
in	
treatment	ENTITY
of	
complex	ENTITY
and	
central	ENTITY
sleep	ENTITY
apnea	ENTITY
syndromes	ENTITY
.	

Chest	ENTITY
2007;132:1839–46	ENTITY
.	

Dernaika	ENTITY
T	ENTITY
,	
Tawk	ENTITY
M	ENTITY
,	
Nazir	ENTITY
S	ENTITY
,	
Younis	
W	
,	
Kinasewitz	ENTITY
GT	ENTITY
.	

The	
significance	ENTITY
and	
outcome	ENTITY
of	
continuous	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
-	
related	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
during	
split	ENTITY
-	
night	ENTITY
sleep	ENTITY
studies	ENTITY
.	

Chest	ENTITY
2007;132:81–7	
.	

Gay	ENTITY
PC	ENTITY
.	

Complex	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
it	
really	
is	
a	
disease	ENTITY
.	

J	
Clin	
Sleep	
Med	
2008;4:403–5	
.	

Gilmartin	ENTITY
GS	ENTITY
,	
Daly	ENTITY
RW	ENTITY
,	
Thomas	ENTITY
RJ	ENTITY
.	

Recognition	ENTITY
and	
management	ENTITY
of	
complex	ENTITY
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
.	

Curr	
Opin	
Pulm	
Med	
2005;11:485–93	
.	

Javaheri	ENTITY
S	ENTITY
,	
Smith	
J	
,	
Chung	
E.	

The	
prevalence	ENTITY
and	
natural	ENTITY
history	ENTITY
of	
complex	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Clin	
Sleep	
Med	
2009;5:205–11	
.	

Lehman	ENTITY
S	ENTITY
,	
Antic	ENTITY
NA	ENTITY
,	
Thompson	ENTITY
C	ENTITY
,	
Catcheside	ENTITY
PG	ENTITY
,	
Mercer	
J	
,	
McEvoy	
RD	ENTITY
.	

Central	ENTITY
sleep	ENTITY
apnea	ENTITY
on	
commencement	ENTITY
of	
continuous	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
in	
patients	ENTITY
with	
a	
primary	ENTITY
diagnosis	ENTITY
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
-	
hypopnea	ENTITY
.	

J	
Clin	
Sleep	
Med	
2007;3:462–6	
.	

Malhotra	ENTITY
A	ENTITY
,	
Bertisch	ENTITY
S	ENTITY
,	ENTITY
Wellman	ENTITY
A.	ENTITY
Complex	ENTITY
sleep	ENTITY
apnea	ENTITY
:	
it	
is	
n’t	
really	
a	
disease	ENTITY
.	

J	
Clin	
Sleep	
Med	
2008;4:406–8	
.	

Morgenthaler	ENTITY
TI	ENTITY
,	
Kagramanov	ENTITY
V	ENTITY
,	
Hanak	ENTITY
V	ENTITY
,	
et	
al	
.	

Complex	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
:	
is	
it	
a	
unique	
clinical	ENTITY
syndrome	ENTITY
?	

Sleep	ENTITY
2006;29:1203–9	
.	

Thomas	ENTITY
RJ	ENTITY
,	ENTITY
Daly	ENTITY
RW	ENTITY
,	
Weiss	ENTITY
JW	ENTITY
.	

Low	ENTITY
-	
concentration	ENTITY
carbon	ENTITY
dioxide	ENTITY
is	
an	
effective	ENTITY
adjunct	ENTITY
to	
positive	ENTITY
airway	
pressure	
in	
the	
treatment	ENTITY
of	
refractory	ENTITY
mixed	ENTITY
central	ENTITY
and	
obstructive	ENTITY
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
.	

Sleep	ENTITY
2005;28:69–77	
.	

Thomas	ENTITY
RJ	ENTITY
,	
Mietus	ENTITY
JE	ENTITY
,	
Peng	
CK	ENTITY
,	
et	
al	
.	

Differentiating	ENTITY
obstructive	ENTITY
from	
central	ENTITY
and	
complex	ENTITY
sleep	ENTITY
apnea	ENTITY
using	
an	
automated	ENTITY
electrocardiogram	ENTITY
-	
based	ENTITY
method	ENTITY
.	

Sleep	ENTITY
2007;30:1756–69	
.	

Thomas	ENTITY
RJ	ENTITY
,	
Terzano	ENTITY
MG	ENTITY
,	
Parrino	ENTITY
L	ENTITY
,	
Weiss	ENTITY
JW	ENTITY
.	

Obstructive	ENTITY
sleep	ENTITY
-	
disordered	ENTITY
breathing	
with	
a	
dominant	ENTITY
cyclic	ENTITY
alternating	
pattern	ENTITY
--	
a	
recognizable	
polysomnographic	ENTITY
variant	
with	
practical	ENTITY
clinical	ENTITY
implications	
.	

Sleep	ENTITY
2004;27:229–34	
.	

Westhoff	ENTITY
M	ENTITY
,	
Arzt	ENTITY
M	ENTITY
,	
Litterst	ENTITY
P.	ENTITY
Prevalence	ENTITY
and	
treatment	ENTITY
of	
central	ENTITY
sleep	ENTITY
apnoea	ENTITY
emerging	
after	
initiation	ENTITY
of	
continuous	ENTITY
positive	ENTITY
airway	
pressure	
in	
patients	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnoea	ENTITY
without	
evidence	ENTITY
of	
heart	ENTITY
failure	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2012;16:71–8	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Disorders	ENTITY
The	
primary	
feature	
of	
these	
disorders	ENTITY
is	
insufficient	ENTITY
sleep	
related	
ventilation	ENTITY
,	
result-	
ing	
in	
abnormally	
elevated	
arterial	
partial	
pressure	
of	
carbon	ENTITY
dioxide	ENTITY
(	
PaCO2	ENTITY
)	
during	
sleep	ENTITY
.	

In	
addition	
,	
demonstration	
of	
daytime	ENTITY
hypoventilation	ENTITY
is	
required	
for	
a	
diagno-	
sis	ENTITY
of	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
(	
OHS	ENTITY
)	
.	

Awake	ENTITY
hypoventilation	ENTITY
is	
defined	
as	
an	
arterial	ENTITY
partial	
pressure	
of	
carbon	ENTITY
dioxide	ENTITY
(	
PaCO2	ENTITY
)	
greater	
than	
45	
mm	
Hg	
.	

In	
the	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
other	
than	
OHS	ENTITY
,	
daytime	ENTITY
hypoventilation	ENTITY
may	
or	
may	
not	
be	
present	
.	

If	
hypoventilation	ENTITY
is	
present	
during	
wakefulness	ENTITY
,	
it	
worsens	ENTITY
during	
sleep	ENTITY
in	
all	
of	
these	
disorders	ENTITY
.	

General	ENTITY
Criteria	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Criterion	ENTITY
A	
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
,	
as	
defined	
by	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
,	
is	
present.1,2	ENTITY
Notes	
.	

Monitoring	ENTITY
of	
arterial	ENTITY
PCO2	ENTITY
during	
sleep	ENTITY
is	
not	
practical	
.	

Acceptable	ENTITY
surrogates	ENTITY
include	
end	ENTITY
-	
tidal	ENTITY
PCO2	ENTITY
or	
transcutaneous	ENTITY
PCO2	ENTITY
.	
.	

Arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
is	
often	
present	
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Obesity	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
278.03	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
E66.2	ENTITY
Alternate	ENTITY
Names	ENTITY
Hypercapnic	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
related	
hypoventilation	ENTITY
associated	ENTITY
with	ENTITY
obesity	ENTITY
.	

Use	
of	
the	
term	
Pickwickian	ENTITY
syndrome	ENTITY
is	
discouraged	
because	
not	
only	
has	
it	
been	
applied	
to	
those	
with	
OSA	ENTITY
,	
but	
also	
indiscriminately	
used	
to	
describe	
persons	ENTITY
who	
are	
only	
obese	ENTITY
and	
those	
with	
OHS	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	
Presence	ENTITY
of	
hypoventilation	ENTITY
during	
wakefulness	ENTITY
(	
PaCO2	ENTITY
>	
45	
mm	
Hg	
)	
as	
measured	
by	
arterial	ENTITY
PCO2	ENTITY
,	
end	ENTITY
-	
tidal	ENTITY
PCO2	ENTITY
,	
or	
transcutaneous	ENTITY
PCO2	ENTITY
.	

B.	ENTITY
Presence	ENTITY
of	
obesity	ENTITY
(	
BMI	ENTITY
>	
30	
kg	
/	
m2	ENTITY
;	
>	
95th	
percentile	
for	
age	ENTITY
and	
sex	ENTITY
for	
children	ENTITY
)	
.	

C.	ENTITY
Hypoventilation	ENTITY
is	
not	
primarily	
due	
to	
lung	ENTITY
parenchymal	ENTITY
or	
airway	ENTITY
disease	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorder	ENTITY
(	
other	
than	
mass	ENTITY
loading	ENTITY
from	
obesity	ENTITY
)	
,	
medication	ENTITY
use	ENTITY
,	
neurologic	ENTITY
disorder	ENTITY
,	
muscle	ENTITY
weakness	ENTITY
,	
or	
a	
known	
congenital	ENTITY
or	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Notes	ENTITY
.	

PSG	ENTITY
shows	
worsening	ENTITY
of	
hypoventilation	ENTITY
during	
sleep	ENTITY
if	
PaCO2	ENTITY
or	
noninvasive	ENTITY
estimate	ENTITY
of	
the	
PaCO2	ENTITY
is	
measured	ENTITY
.	
.	

OSA	ENTITY
is	
often	
present	
and	
,	
in	
such	
cases	ENTITY
,	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
OHS	ENTITY
should	
be	
made	
.	
.	

Arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
is	
usually	
present	
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Essential	ENTITY
Features	ENTITY
OHS	ENTITY
is	
characterized	
by	
obesity	ENTITY
and	
daytime	ENTITY
hypercapnia	ENTITY
(	
arterial	ENTITY
PaCO2	ENTITY
>	
45	
mm	
Hg	
)	
that	
can	
not	
be	
fully	
attributed	
to	
an	
underlying	
cardiopulmonary	ENTITY
or	
neurologic	ENTITY
disease	ENTITY
.	

Hypercapnia	ENTITY
worsens	ENTITY
during	
sleep	ENTITY
and	
is	
often	
associated	ENTITY
with	ENTITY
severe	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

Hypoventilation	ENTITY
is	
often	
worse	
during	
REM	ENTITY
than	
during	
NREM	ENTITY
sleep	ENTITY
.	

The	
majority	
of	
OHS	ENTITY
patients	ENTITY
have	
comorbid	ENTITY
OSA	ENTITY
(	
80	
%	
to	
90	
%	
)	
.	

In	
these	
patients	ENTITY
,	
daytime	ENTITY
hypercapnia	ENTITY
may	
improve	ENTITY
or	
even	
normalize	ENTITY
with	
adequate	ENTITY
PAP	ENTITY
treatment	ENTITY
and	
sustained	ENTITY
adherence	ENTITY
to	
treatment	ENTITY
.	

Those	
OHS	ENTITY
patients	ENTITY
without	
OSA	ENTITY
exhibit	
sustained	ENTITY
or	
intermittent	ENTITY
episodes	ENTITY
of	
shallow	ENTITY
breathing	ENTITY
during	
sleep	ENTITY
associated	ENTITY
with	ENTITY
worsening	ENTITY
hypoventilation	ENTITY
and	
hypoxemia	ENTITY
.	

Patients	ENTITY
with	
OHS	ENTITY
may	
have	
few	
,	
if	
any	
,	
sleep	ENTITY
com-	ENTITY
plaints	ENTITY
,	
or	
may	
present	
with	
considerable	
sleep	ENTITY
disturbance	ENTITY
including	
reduced	ENTITY
sleep	ENTITY
efficiency	ENTITY
and	
frequent	ENTITY
awakenings	ENTITY
.	

Hypercapnia	ENTITY
and	
hypoxemia	ENTITY
may	
remain	
unno-	
ticed	ENTITY
for	
quite	
some	
time	
until	
sudden	ENTITY
deterioration	ENTITY
with	
cardiopulmonary	ENTITY
arrest	ENTITY
or	
severe	ENTITY
decompensation	ENTITY
(	
acute	ENTITY
or	
chronic	ENTITY
hypercapnic	
respiratory	
failure	
)	
develops	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Patients	ENTITY
with	
OHS	ENTITY
commonly	
complain	ENTITY
of	
hypersomnolence	ENTITY
.	

The	
severity	ENTITY
of	
hyper-	
somnolence	ENTITY
may	
not	
correlate	
closely	
with	
degree	ENTITY
of	
hypercapnia	ENTITY
.	

Other	
symptoms	ENTITY
include	
morning	ENTITY
headaches	ENTITY
,	
fatigue	ENTITY
,	
mood	ENTITY
disturbance	ENTITY
and	
impairments	ENTITY
of	
memory	ENTITY
or	
concentration	ENTITY
.	

Physical	ENTITY
examination	ENTITY
may	
reveal	
features	ENTITY
suggestive	
of	
cor	ENTITY
pul-	ENTITY
monale	ENTITY
or	
circulatory	ENTITY
congestion	ENTITY
,	
such	
as	
plethora	
,	
scleral	ENTITY
injection	ENTITY
,	
and	
peripheral	ENTITY
edema	ENTITY
.	

Laboratory	ENTITY
testing	ENTITY
commonly	
shows	
polycythemia	ENTITY
and	
elevated	ENTITY
serum	ENTITY
CO2	ENTITY
on	
electrolyte	ENTITY
testing	ENTITY
(	
≈	ENTITY
serum	ENTITY
bicarbonate	ENTITY
)	
,	
reduced	ENTITY
forced	ENTITY
vital	
capacity	
during	
pulmo-	
nary	ENTITY
function	ENTITY
testing	ENTITY
,	
right	ENTITY
heart	ENTITY
strain	ENTITY
,	
right	ENTITY
ventricular	ENTITY
hypertrophy	ENTITY
and	
right	ENTITY
atrial	ENTITY
enlargement	ENTITY
on	
electrocardiography	ENTITY
and	
ventricular	ENTITY
dysfunction	ENTITY
on	
echocardiography	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Consequences	ENTITY
of	ENTITY
chronic	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
include	
pulmonary	ENTITY
artery	ENTITY
hyper-	
tension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
and	
neurocognitive	ENTITY
dysfunction	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
OHS	ENTITY
may	
be	
underdiagnosed	ENTITY
if	
CO2	ENTITY
analysis	ENTITY
(	
≈	ENTITY
serum	ENTITY
bicarbonate	ENTITY
)	
is	
not	
performed	
in	
obese	ENTITY
patients	ENTITY
presenting	
with	
complaints	ENTITY
suggestive	
of	
OHS	ENTITY
.	

The	
prevalence	ENTITY
of	
OHS	ENTITY
in	
populations	ENTITY
of	
patients	ENTITY
with	
OSA	ENTITY
varies	
across	
studies	ENTITY
but	
is	
often	
in	
the	
range	
of	
10	
%	
to	
15	
%	
of	
obese	ENTITY
patients	ENTITY
with	
OSA	ENTITY
.	

Although	
the	
prevalence	ENTITY
of	
OHS	ENTITY
is	
higher	ENTITY
in	
men	ENTITY
than	
women	ENTITY
the	
difference	
is	
not	
as	
prominent	
as	
in	
OSA	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Obesity	ENTITY
is	
believed	
to	
be	
the	
primary	
pathophysiologic	ENTITY
factor	ENTITY
responsible	
for	
hypoven-	
tilation	ENTITY
and	
hypoxemia	ENTITY
.	

Greater	ENTITY
degrees	ENTITY
of	
obesity	ENTITY
are	
often	
associated	ENTITY
with	ENTITY
worse	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
,	
but	
individual	ENTITY
variations	ENTITY
in	
the	
severity	ENTITY
of	
hypercap-	
nia	ENTITY
at	
similar	
weights	ENTITY
may	
be	
seen	
.	

The	
use	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
depressants	ENTITY
,	
such	
as	
alcohol	ENTITY
,	
anxiolytics	ENTITY
,	
and	
hypnotics	ENTITY
,	
may	
further	
worsen	ENTITY
respiratory	ENTITY
impair-	ENTITY
ment	ENTITY
.	

Patients	ENTITY
who	
are	
hypercapnic	ENTITY
and	
hypoxemic	ENTITY
during	
wakefulness	ENTITY
will	
invari-	
ably	
become	
even	
more	
so	
during	
sleep	ENTITY
,	
in	
particular	
REM	ENTITY
sleep	ENTITY
,	
but	
the	
relationship	ENTITY
between	
wake	ENTITY
SaO2	ENTITY
/	
PaCO2	ENTITY
and	
sleep	ENTITY
related	ENTITY
desaturation	ENTITY
is	
not	
sufficiently	
strong	
to	
have	
substantial	ENTITY
predictive	ENTITY
value	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Persons	ENTITY
who	
are	
eventually	
diagnosed	ENTITY
with	
OHS	ENTITY
either	
present	
initially	
for	
evalu-	
ation	ENTITY
of	
suspected	ENTITY
OSA	ENTITY
or	
are	
identified	ENTITY
following	
one	
or	
more	
episodes	ENTITY
of	
severe	ENTITY
hypercapnic	ENTITY
respiratory	ENTITY
failure	ENTITY
.	

The	
course	ENTITY
can	
be	
variable	ENTITY
but	
is	
generally	
slowly	
pro-	ENTITY
gressive	ENTITY
.	

Many	
affected	ENTITY
individuals	ENTITY
with	
severe	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
develop	
pulmonary	ENTITY
hypertension	ENTITY
,	
heart	ENTITY
failure	ENTITY
,	
cardiac	ENTITY
arrhythmias	ENTITY
,	
and	
neurocognitive	ENTITY
dys-	ENTITY
function	ENTITY
.	

Polycythemia	ENTITY
is	
common	
in	
those	
with	
chronic	ENTITY
hypoxia	ENTITY
.	

Although	
the	
risk	ENTITY
of	
increased	ENTITY
morbidity	ENTITY
and	
mortality	ENTITY
appears	
to	
increase	ENTITY
with	
worsening	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
/	
hypoxemia	ENTITY
,	
the	
specific	
relationship	ENTITY
between	
sleep	ENTITY
related	
hypoventi-	
lation	ENTITY
/	
hypoxemia	ENTITY
and	
morbidity	ENTITY
and	
mortality	ENTITY
is	
not	
well	
defined	
.	

Obesity	ENTITY
,	
itself	
,	
can	
lead	
to	
other	
respiratory	ENTITY
complaints	ENTITY
,	
including	
shortness	ENTITY
of	ENTITY
breath	ENTITY
,	
dyspnea	ENTITY
on	
exer-	
tion	ENTITY
and	
orthopnea	ENTITY
,	
even	
in	
the	
absence	ENTITY
of	
demonstrable	
elevation	ENTITY
of	
daytime	ENTITY
PaCO2	ENTITY
.	

However	
,	
in	
one	
study	ENTITY
of	
inpatients	ENTITY
with	
obesity	ENTITY
,	
those	
with	
hypoventilation	ENTITY
had	
an	
18	
-	
month	ENTITY
mortality	ENTITY
of	
23	
%	
compared	ENTITY
with	
9	
%	
in	
the	
group	ENTITY
with	
equivalent	ENTITY
obesity	ENTITY
but	
no	
hypoventilation	ENTITY
.	

Many	
patients	ENTITY
with	
OHS	ENTITY
respond	
to	
CPAP	ENTITY
or	
bilevel	ENTITY
PAP	ENTITY
with	
improvement	ENTITY
in	
daytime	ENTITY
PaCO2	ENTITY
.	

However	
,	
normalization	ENTITY
of	
daytime	ENTITY
PaCO2	ENTITY
occurs	
in	
only	
a	
minority	ENTITY
of	
patients	ENTITY
.	

In	
one	
study	ENTITY
,	
34	
%	
of	
OHS	ENTITY
patients	ENTITY
using	
PAP	ENTITY
more	
than	
4.5	
hours	
per	
night	ENTITY
had	
normalization	ENTITY
of	
the	
PaCO2	ENTITY
.	

In	
contrast	ENTITY
hypercapnia	ENTITY
may	
worsen	ENTITY
with	
oxygen	ENTITY
therapy	ENTITY
alone	
for	
the	
associated	
hypoxia	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
etiology	ENTITY
of	
hypoventilation	ENTITY
is	
not	
completely	
understood	
.	

Although	
comorbid	ENTITY
OSA	ENTITY
is	
common	
,	
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
are	
not	
entirely	
a	
function	ENTITY
of	
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
.	

The	
importance	
of	
various	
factors	ENTITY
leading	
to	
hypoventilation	ENTITY
likely	
varies	
among	
patients	ENTITY
.	

It	
has	
been	
postulated	
that	
sustained	ENTITY
nocturnal	ENTITY
hypercapnia	
results	ENTITY
from	
the	
development	ENTITY
of	
short	ENTITY
(	
due	
to	
apnea	ENTITY
-	
hypopnea	ENTITY
)	
or	
longer	ENTITY
(	
secondary	
to	
hypoven-	
tilation	ENTITY
)	
periods	ENTITY
of	
hypercapnia	ENTITY
accompanied	
by	
inadequate	ENTITY
compensation	ENTITY
(	
i.e.	
,	
CO2	ENTITY
unloading	ENTITY
)	
during	
periods	ENTITY
of	
ventilation	ENTITY
between	
obstructive	ENTITY
events	ENTITY
.	

Abnormal	ENTITY
venti-	
latory	
control	
(	
blunted	
hypercapnic	ENTITY
ventilatory	
response	
)	
allows	
hypercapnia	ENTITY
to	
persist	
into	
wakefulness	ENTITY
after	
the	
cause	
of	
acute	ENTITY
hypercapnia	ENTITY
is	
no	
longer	
present	
.	

A	
chronic	ENTITY
hypercapnic	
state	
would	
produce	
an	
elevation	ENTITY
of	
bicarbonate	ENTITY
.	

Although	
this	
blunts	ENTITY
the	
degree	ENTITY
of	
acidosis	ENTITY
due	
to	
an	
elevated	ENTITY
PaCO2	ENTITY
,	
it	
reduces	ENTITY
the	
compensatory	ENTITY
CO2	ENTITY
ventilatory	ENTITY
response	ENTITY
.	

Impaired	ENTITY
renal	ENTITY
bicarbonate	ENTITY
excretion	ENTITY
rate	ENTITY
,	
as	
seen	
in	
hypoxia	ENTITY
,	
heart	ENTITY
failure	ENTITY
,	
or	
diuretic	ENTITY
-	
related	ENTITY
chloride	ENTITY
deficiency	ENTITY
,	
may	
contribute	
to	
the	
persistence	ENTITY
of	
hypercapnia	ENTITY
.	

Obesity	ENTITY
itself	
is	
also	
associated	ENTITY
with	ENTITY
several	
factors	ENTITY
that	
predispose	
to	
CO2	ENTITY
retention	ENTITY
.	

Obesity	ENTITY
itself	
increases	ENTITY
CO2	ENTITY
production	ENTITY
.	

There	
is	
an	
increased	ENTITY
work	
of	
breathing	ENTITY
due	
to	
mass	ENTITY
loading	ENTITY
from	
the	
additional	
weight	
on	
the	
respiratory	ENTITY
pump	ENTITY
as	
well	
as	
resistive	ENTITY
loading	ENTITY
due	
to	
intermittent	ENTITY
upper	ENTITY
airway	ENTITY
obstruction	ENTITY
during	
sleep	ENTITY
.	

Numerous	
factors	ENTITY
impair	ENTITY
CO2	ENTITY
elimination	ENTITY
including	
altered	
lung	ENTITY
volumes	ENTITY
and	
mechan-	
ics	ENTITY
,	
ventilation	ENTITY
-	
perfusion	ENTITY
abnormalities	ENTITY
secondary	ENTITY
to	ENTITY
atelectasis	ENTITY
or	
pulmonary	ENTITY
conges-	ENTITY
tion	ENTITY
,	
reduced	ENTITY
chemosensitivity	ENTITY
and	
load	ENTITY
responsiveness	ENTITY
,	
and	
suppression	ENTITY
of	
respiratory	ENTITY
drive	
due	
to	
obesity	ENTITY
-	
related	ENTITY
humoral	ENTITY
factors	ENTITY
,	
such	
as	
resistance	ENTITY
to	
the	
elevated	ENTITY
leptin	ENTITY
levels	ENTITY
that	
occur	
in	
patients	ENTITY
with	
the	
OHS	ENTITY
(	
leptin	ENTITY
is	
a	
respiratory	ENTITY
stimulant	ENTITY
)	
.	

The	
impor-	
tance	ENTITY
of	
these	
factors	ENTITY
likely	
varies	
from	
patient	ENTITY
to	
patient	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Arterial	ENTITY
blood	ENTITY
gas	ENTITY
testing	ENTITY
during	
wakefulness	ENTITY
shows	
hypercapnia	ENTITY
and	
often	
hypoxemia	ENTITY
in	
untreated	ENTITY
patients	ENTITY
.	

Even	
with	
effective	ENTITY
treatment	ENTITY
most	
OHS	ENTITY
patients	ENTITY
continue	
to	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
exhibit	
some	
degree	ENTITY
of	
daytime	ENTITY
hypoventilation	ENTITY
.	

The	
characteristic	
polysomnographic	ENTITY
finding	ENTITY
is	
sleep	ENTITY
related	
hypoventilation	ENTITY
and	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
during	
sleep	ENTITY
with	
or	
without	
obstructive	ENTITY
apneas	ENTITY
and	
hypopneas	ENTITY
.	

Worsening	ENTITY
hypoventilation	ENTITY
during	
sleep	ENTITY
can	
be	
documented	ENTITY
by	
an	
arterial	ENTITY
blood	
gas	
measurement	ENTITY
of	
PaCO2	ENTITY
during	
sleep	ENTITY
(	
rarely	
performed	
)	
or	
transcutaneous	ENTITY
or	
end	ENTITY
-	
tidal	ENTITY
PCO2	ENTITY
measurements	ENTITY
.	

Periods	ENTITY
of	
decreased	ENTITY
tidal	ENTITY
volume	ENTITY
lasting	
up	
to	
several	
minutes	
with	
sustained	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
are	
usually	
present	
.	

Intermittent	ENTITY
arousals	ENTITY
may	
be	
observed	ENTITY
.	

OSA	ENTITY
is	
present	
in	
the	
majority	
of	
OHS	ENTITY
patients	ENTITY
,	
during	
at	
least	
a	
portion	ENTITY
of	
the	
night	ENTITY
.	

The	
transient	ENTITY
ven-	
tilation	ENTITY
between	
obstructive	ENTITY
events	ENTITY
(	
even	
if	
associated	ENTITY
with	ENTITY
arousal	ENTITY
from	
the	
preceding	
obstructive	ENTITY
event	ENTITY
)	
is	
not	
sufficient	
to	
prevent	ENTITY
worsening	ENTITY
hypoventilation	ENTITY
during	
sleep	ENTITY
.	

Severe	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
is	
usually	
associated	ENTITY
with	ENTITY
the	
obstructive	ENTITY
events	ENTITY
.	

Chronic	ENTITY
hypoxia	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
polycythemia	ENTITY
.	

Electrocardiography	ENTITY
,	
chest	ENTITY
radi-	ENTITY
ography	ENTITY
,	
and	
echocardiography	ENTITY
may	
demonstrate	
evidence	ENTITY
of	
pulmonary	ENTITY
hypertension	ENTITY
.	

The	
serum	ENTITY
bicarbonate	ENTITY
level	ENTITY
is	
usually	
elevated	ENTITY
due	
to	
renal	ENTITY
compensation	ENTITY
for	
chronic	ENTITY
respiratory	ENTITY
acidosis	ENTITY
(	
hypercapnia	ENTITY
)	
.	

In	
one	
study	ENTITY
,	
a	
serum	ENTITY
bicarbonate	ENTITY
level	ENTITY
threshold	ENTITY
>	
27	
mEq	ENTITY
/	
L	ENTITY
had	
a	
sensitivity	ENTITY
of	
92	
%	
and	
a	
specificity	ENTITY
of	
50	
%	
of	
identifying	ENTITY
OHS	ENTITY
in	
obese	ENTITY
patients	ENTITY
suspected	ENTITY
of	
having	
OSA	ENTITY
.	

This	
suggests	
that	
the	
serum	ENTITY
bicarbonate	ENTITY
level	ENTITY
may	
be	
useful	
to	
screen	
patients	ENTITY
for	
possible	
OHS	ENTITY
.	

However	
,	
an	
arterial	ENTITY
blood	
gas	
is	
required	
for	
diagnosis	ENTITY
of	
OHS	ENTITY
,	
as	
the	
serum	ENTITY
bicarbonate	ENTITY
level	ENTITY
may	
be	
elevated	ENTITY
due	
to	
metabolic	ENTITY
alkalosis	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differential	ENTITY
diagnosis	ENTITY
includes	
any	
disorder	ENTITY
that	
can	
give	
rise	
to	
hypoventilation	ENTITY
during	
wakefulness	ENTITY
and	
sleep	ENTITY
.	

This	
includes	
pulmonary	ENTITY
airway	ENTITY
and	
parenchymal	ENTITY
dis-	
orders	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
neuromuscular	ENTITY
and	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
,	
severe	ENTITY
untreated	ENTITY
hypothyroidism	ENTITY
,	
use	
of	
respiratory	ENTITY
suppressants	ENTITY
,	
and	
congenital	ENTITY
or	
idio-	
pathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
syndromes	ENTITY
.	

OSA	ENTITY
and	
CSA	ENTITY
syndromes	ENTITY
can	
be	
distinguished	
from	
sleep	ENTITY
related	
hypoventilation	ENTITY
by	
the	
periodic	ENTITY
alterations	ENTITY
in	
airflow	ENTITY
and	
accompanying	
periodic	ENTITY
fluctuations	ENTITY
in	
SaO2	ENTITY
.	

In	
contrast	
,	
oxygen	ENTITY
desaturation	ENTITY
due	
to	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
generally	
more	
sustained	ENTITY
,	
usually	
several	
minutes	
or	
longer	ENTITY
in	
duration	ENTITY
.	

When	
more	
than	
one	
disorder	ENTITY
is	
believed	
to	
be	
responsible	
for	
the	
ventilatory	ENTITY
insufficiency	ENTITY
during	
sleep	ENTITY
,	
all	
pertinent	
diagnoses	ENTITY
should	
be	
coded	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Future	ENTITY
research	ENTITY
into	
the	
pathogenesis	ENTITY
of	
this	
disorder	ENTITY
,	
including	
renal	ENTITY
bicarbonate	ENTITY
homeostasis	ENTITY
,	
is	
needed	
.	

Because	
it	
is	
clinically	ENTITY
impractical	
to	
routinely	
obtain	
arterial	ENTITY
blood	
samples	
during	
sleep	ENTITY
in	
most	
persons	ENTITY
suspected	ENTITY
of	
this	
disorder	ENTITY
,	
other	
techniques	ENTITY
of	
measuring	ENTITY
CO2	ENTITY
levels	ENTITY
must	
be	
investigated	ENTITY
.	

The	
degree	ENTITY
and	
duration	ENTITY
of	
hypercapnia/	
hypoxemia	ENTITY
necessary	
to	
produce	
adverse	ENTITY
consequences	ENTITY
,	
such	
as	
pulmonary	ENTITY
hyperten-	
sion	ENTITY
,	
in	
individual	ENTITY
patients	ENTITY
is	
not	
well	
defined	
.	

Little	
information	ENTITY
is	
available	
regarding	
the	
effect	ENTITY
of	
oxygen	ENTITY
therapy	ENTITY
or	
noninvasive	ENTITY
ventilation	ENTITY
on	
the	
course	ENTITY
of	
the	
underlying	ENTITY
disease	ENTITY
.	

Studies	ENTITY
are	
needed	
to	
determine	
the	
optimal	ENTITY
time	ENTITY
to	
initiate	ENTITY
these	
interventions	ENTITY
and	
the	
specific	
subpopulations	ENTITY
of	
patients	ENTITY
who	
will	
benefit	ENTITY
most	
from	
these	
therapies	ENTITY
.	

Bibliography	ENTITY
Berger	ENTITY
KI	ENTITY
,	ENTITY
Goldring	ENTITY
RM	ENTITY
,	
Rapoport	ENTITY
DM	ENTITY
.	

Obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:253	
.	

Budweiser	ENTITY
S	ENTITY
,	
Riedl	ENTITY
SG	ENTITY
,	
Jörres	
RA	ENTITY
,	
et	
al	
.	

Mortality	ENTITY
and	
prognostic	ENTITY
factors	ENTITY
in	
patients	ENTITY
with	
obesity-	
hypoventilation	ENTITY
syndrome	ENTITY
undergoing	
noninvasive	ENTITY
ventilation	ENTITY
.	

J	
Intern	
Med	
2007;261:375–83	
.	

Littleton	ENTITY
SW	ENTITY
,	
Mokhlesi	ENTITY
B.	ENTITY
The	
pickwickian	ENTITY
syndrome	ENTITY
-	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Clin	ENTITY
Chest	ENTITY
Med	ENTITY
2009;30:467–78	ENTITY
,	
vii	
-	
viii	
.	

Mokhlesi	ENTITY
B	ENTITY
;	
Tulaimat	ENTITY
A	ENTITY
;	
Evans	ENTITY
AT	ENTITY
et	
al	
.	

Impact	ENTITY
of	
adherence	ENTITY
with	
positive	ENTITY
airway	ENTITY
pressure	ENTITY
therapy	ENTITY
on	
hypercapnia	ENTITY
in	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Clin	
Sleep	
Med	
2006;2:57–62	
.	

Mokhlesi	ENTITY
B.	
Obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
:	
a	
state	ENTITY
-	
of	
-	
the	
-	
art	
review	ENTITY
.	

Respir	
Care	
2010;55:1347–62	
.	

Nowbar	ENTITY
S	
,	
Burkart	ENTITY
KM	ENTITY
,	
Gonzales	ENTITY
R	ENTITY
,	
et	
al	
.	

Obesity	ENTITY
-	
hypoventilation	ENTITY
in	
hospitalized	ENTITY
patients	ENTITY
:	
prevalence	ENTITY
,	
effects	ENTITY
,	
and	
outcome	ENTITY
.	

Am	
J	
Med	
2004;116:1–7	
.	

Piper	ENTITY
AJ	ENTITY
,	
Grunstein	ENTITY
RR	ENTITY
.	

Obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
:	
mechanisms	ENTITY
and	
management	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2011;183:292–8	
.	

Piper	ENTITY
AJ	ENTITY
.	

Obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
--	
the	
big	
and	
the	
breathless	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2011;15:79–89	ENTITY
.	

Congenital	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.25	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.35	
Alternate	ENTITY
Names	ENTITY
Congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

The	
term	
Ondine	ENTITY
’s	ENTITY
curse	ENTITY
is	
no	
longer	
recommended	
due	
to	
its	
negative	ENTITY
connotations	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

B.	ENTITY
Mutation	ENTITY
of	
the	
PHOX2B	ENTITY
gene	ENTITY
is	
present	
.	

Notes	ENTITY
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
either	
daytime	ENTITY
hypoventilation	ENTITY
(	
PaCO2	ENTITY
>	
45	
mm	
Hg	
)	
or	
normal	ENTITY
daytime	ENTITY
PaCO2	ENTITY
levels	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
In	
either	
case	ENTITY
,	
the	
PaCO2	ENTITY
is	
higher	ENTITY
during	
sleep	ENTITY
and	
meets	
criteria	ENTITY
for	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	
.	

PSG	ENTITY
monitoring	ENTITY
demonstrates	
severe	ENTITY
hypercapnia	ENTITY
and	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

Some	
central	ENTITY
apneas	ENTITY
may	
occur	
but	
the	
predominant	ENTITY
pattern	ENTITY
is	
reduced	ENTITY
flow	ENTITY
/	
tidal	ENTITY
volume	ENTITY
.	
.	

Although	
the	
condition	ENTITY
is	
termed	
congenital	ENTITY
,	
some	
patients	ENTITY
with	
a	
PHOX2B	ENTITY
genotype	ENTITY
may	
present	
phenotypically	ENTITY
later	
in	
life	ENTITY
(	
and	
even	
in	ENTITY
adulthood	ENTITY
)	
,	
especially	
in	
the	
presence	ENTITY
of	
a	
stressor	ENTITY
such	
as	
general	ENTITY
anesthesia	ENTITY
or	
a	
severe	ENTITY
respiratory	ENTITY
illness	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Congenital	ENTITY
central	
alveolar	
hypoventilation	
syndrome	
(	
CCHS	ENTITY
)	
is	
a	
syndrome	ENTITY
of	
auto-	
nomic	ENTITY
dysfunction	ENTITY
,	
primarily	
the	
failure	ENTITY
of	
automatic	ENTITY
central	ENTITY
control	ENTITY
of	
breathing	ENTITY
,	
due	
to	
a	
mutation	ENTITY
of	
the	
PHOX2B	ENTITY
gene	ENTITY
.	

CCHS	ENTITY
is	
characterized	ENTITY
by	
the	
onset	
of	
hypoven-	
tilation	ENTITY
,	
usually	
at	
birth	ENTITY
.	

The	
hypoventilation	ENTITY
is	
worse	
during	
sleep	ENTITY
than	
wakefulness	ENTITY
and	
is	
unexplained	
by	
primary	ENTITY
pulmonary	ENTITY
,	
neurological	ENTITY
,	
or	
metabolic	ENTITY
disease	ENTITY
.	

CCHS	ENTITY
typically	
presents	
in	
an	
otherwise	
normal	ENTITY
-	
appearing	ENTITY
infant	ENTITY
who	
is	
noted	
to	
have	
cyano-	
sis	ENTITY
,	
feeding	ENTITY
difficulties	ENTITY
,	
hypotonia	ENTITY
or	
,	
less	
commonly	
,	
central	ENTITY
apnea	ENTITY
.	

Some	
children	ENTITY
are	
diagnosed	ENTITY
following	
cardiovascular	ENTITY
collapse	ENTITY
.	

The	
infant	ENTITY
requires	
intubation	ENTITY
and	
then	
can	
not	
be	
weaned	ENTITY
from	
mechanically	ENTITY
assisted	ENTITY
ventilation	ENTITY
,	
despite	
appearing	
vigorous	ENTITY
and	
having	
a	
normal	ENTITY
chest	ENTITY
radiograph	ENTITY
.	

Some	
infants	ENTITY
may	
appear	
to	
breathe	ENTITY
adequately	
on	
clinical	ENTITY
examination	ENTITY
but	
experience	
episodes	ENTITY
of	
hypoventilation	ENTITY
(	
not	
necessarily	
apnea	ENTITY
)	
characterized	ENTITY
by	
hypoxemia	ENTITY
and	
hypercapnia	ENTITY
.	

Patients	ENTITY
with	
CCHS	ENTITY
may	
occa-	
sionally	
present	
later	
in	
life	ENTITY
with	ENTITY
cyanosis	ENTITY
,	
an	
apparent	ENTITY
life	ENTITY
-	
threatening	ENTITY
event	ENTITY
,	
cor	ENTITY
pul-	ENTITY
monale	ENTITY
,	
or	
hypoxic	ENTITY
neurological	ENTITY
damage	ENTITY
.	

CCHS	ENTITY
has	
been	
diagnosed	ENTITY
in	
adults	ENTITY
who	
present	
with	
respiratory	ENTITY
failure	ENTITY
following	
anesthesia	ENTITY
or	
in	
association	ENTITY
with	
a	
minor	ENTITY
respiratory	ENTITY
illness	ENTITY
;	
these	
patients	ENTITY
usually	
have	
a	
mild	ENTITY
mutation	ENTITY
,	
and	
may	
have	
evidence	ENTITY
of	
longstanding	
hypoxemia	ENTITY
including	
cognitive	ENTITY
deficits	ENTITY
.	

Most	
patients	ENTITY
with	
CCHS	ENTITY
have	
sufficiently	
severe	ENTITY
hypoventilation	ENTITY
during	
sleep	ENTITY
that	
they	
require	
mechanically	ENTITY
assisted	ENTITY
ventilation	ENTITY
,	
although	
this	
state	ENTITY
-	
dependent	ENTITY
difference	
may	
not	
be	
apparent	ENTITY
during	
early	ENTITY
infancy	ENTITY
.	

Some	
patients	ENTITY
(	
~15	
%	
)	
hypoventilate	ENTITY
during	
wakefulness	ENTITY
as	
well	
as	
during	
sleep	ENTITY
and	
require	
continuous	ENTITY
ventilatory	
support	
.	

However	
,	
most	
patients	ENTITY
with	
CCHS	ENTITY
do	
not	
require	
ventilatory	ENTITY
support	
during	
wakefulness	ENTITY
but	
may	
have	
subtle	
abnormali-	
ties	ENTITY
in	
gas	ENTITY
exchange	ENTITY
when	
physically	ENTITY
inactive	ENTITY
or	
during	
vigorous	ENTITY
exercise	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Associated	ENTITY
autonomic	ENTITY
abnormalities	ENTITY
include	
Hirschsprung	ENTITY
disease	ENTITY
in	
approximately	
16	
%	
of	
patients	ENTITY
with	
CCHS	ENTITY
,	
autonomic	ENTITY
dysfunction	ENTITY
(	
e.g.	
,	
decreased	ENTITY
heart	ENTITY
rate	ENTITY
variabil-	
ity	ENTITY
or	
hypotension	ENTITY
)	
,	
neural	ENTITY
tumors	ENTITY
(	
e.g.	
,	
ganglioneuromas	ENTITY
or	
ganglioneuroblastomas	ENTITY
)	
,	
swallowing	ENTITY
dysfunction	ENTITY
during	
the	
early	ENTITY
years	
,	
and	
ocular	ENTITY
abnormalities	ENTITY
(	
e.g.	
,	
stra-	
bismus	ENTITY
)	
.	

Most	
patients	ENTITY
are	
cognitively	ENTITY
normal	ENTITY
,	
although	
developmental	ENTITY
delay	ENTITY
may	
be	
present	
,	
especially	
in	
patients	ENTITY
in	
whom	
the	
hypoventilation	ENTITY
has	
not	
been	
well	
controlled	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Research	ENTITY
suggests	
that	
severity	ENTITY
of	
illness	ENTITY
is	
related	
to	
the	
type	
of	
mutation	ENTITY
present	ENTITY
.	

Most	
patients	ENTITY
have	
a	
polyalanine	ENTITY
expansion	ENTITY
mutation	ENTITY
;	
those	
with	
more	
polyalanine	ENTITY
repeats	
are	
more	
likely	
to	
have	
severe	ENTITY
disease	ENTITY
including	
waking	ENTITY
hypoventilation	ENTITY
.	

Patients	ENTITY
with	
a	
point	ENTITY
mutation	ENTITY
or	
frame	
shift	
mutations	ENTITY
are	
at	
greater	
risk	ENTITY
for	
neural	ENTITY
tumors	ENTITY
.	

Demographics	ENTITY
The	
prevalence	ENTITY
of	
CCHS	ENTITY
is	
not	
known	
,	
but	
the	
disease	ENTITY
is	
rare	ENTITY
.	

The	
condition	ENTITY
occurs	
equally	
among	
both	
sexes	ENTITY
and	
all	
ethnic	ENTITY
/	
racial	ENTITY
groups	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
This	
is	
a	
congenital	ENTITY
genetic	ENTITY
syndrome	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
CCHS	ENTITY
usually	
occurs	
as	
a	
de	ENTITY
novo	ENTITY
mutation	ENTITY
,	
but	
siblings	ENTITY
with	
the	
condition	ENTITY
have	
been	
reported	
.	

As	
the	
gene	ENTITY
is	
dominant	ENTITY
,	
patients	ENTITY
are	
at	
risk	ENTITY
of	
having	
children	ENTITY
with	
CCHS	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY

The	
condition	ENTITY
is	
genetic	ENTITY
and	
is	
therefore	
present	
from	
birth	ENTITY
,	
but	
some	
patients	ENTITY
may	
present	
later	
in	
life	ENTITY
.	

The	
physiological	ENTITY
abnormalities	ENTITY
of	
CCHS	ENTITY
persist	
for	
life	ENTITY
and	
are	
not	
ameliorated	ENTITY
over	
time	ENTITY
.	

However	
,	
the	
clinical	ENTITY
consequences	ENTITY
of	
hypoventilation	ENTITY
can	
be	
prevented	
by	
providing	
adequate	ENTITY
ventilatory	ENTITY
support	ENTITY
.	

If	
untreated	ENTITY
,	
death	ENTITY
usually	
results	ENTITY
from	
cor	ENTITY
pulmonale	ENTITY
or	
complications	ENTITY
of	
apnea	ENTITY
or	
severe	ENTITY
hypoventilation	ENTITY
.	

Patients	ENTITY
with	
poorly	ENTITY
controlled	ENTITY
CCHS	ENTITY
may	
develop	
mental	ENTITY
retardation	ENTITY
,	
growth	ENTITY
failure	ENTITY
,	
seizures	ENTITY
,	
or	
cor	ENTITY
pulmonale	ENTITY
.	

When	
treated	ENTITY
,	
infants	ENTITY
with	
CCHS	ENTITY
may	
improve	ENTITY
over	
the	
first	
six	
to	
12	
months	ENTITY
.	

Some	
patients	ENTITY
who	
initially	
require	
ventilatory	ENTITY
support	
24	
hours	
a	
day	ENTITY
may	
progress	ENTITY
to	
adequate	ENTITY
ventilation	ENTITY
during	
wakefulness	ENTITY
.	

However	
,	
patients	ENTITY
continue	
to	
require	
ventilatory	ENTITY
support	
during	
sleep	ENTITY
.	

Conversely	
,	
some	
patients	ENTITY
may	
develop	
the	
need	
for	
continuous	ENTITY
ventilatory	
support	
.	

It	
is	
unclear	
whether	
these	
patients	ENTITY
had	
condi-	
tions	ENTITY
that	
worsened	ENTITY
,	
were	
not	
adequately	
evaluated	ENTITY
and	
treated	ENTITY
initially	ENTITY
,	
or	
were	
asso-	
ciated	ENTITY
with	
changing	ENTITY
ventilatory	ENTITY
demands	ENTITY
.	

Even	
with	
treatment	ENTITY
,	
patients	ENTITY
with	
CCHS	ENTITY
require	
close	
monitoring	ENTITY
,	
particularly	
during	
infancy	ENTITY
.	

Minor	ENTITY
medical	ENTITY
illnesses	ENTITY
,	
such	
as	
upper	ENTITY
respiratory	ENTITY
tract	ENTITY
illnesses	ENTITY
or	
diarrhea	ENTITY
,	
may	
precipitate	ENTITY
bouts	ENTITY
of	
respiratory	ENTITY
failure	ENTITY
.	

Edema	ENTITY
and	
lethargy	ENTITY
are	
often	
early	
signs	
of	
impending	ENTITY
respiratory	ENTITY
failure	ENTITY
.	

The	
clinical	ENTITY
signs	ENTITY
of	
hypoxemia	ENTITY
and	
hypoventilation	ENTITY
in	
these	
patients	ENTITY
may	
be	
subtle	
,	
as	
the	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
children	ENTITY
do	
not	
show	
signs	
of	
distress	ENTITY
or	
increased	ENTITY
work	
of	
breathing	ENTITY
,	
such	
as	
retrac-	
tions	ENTITY
and	
nasal	ENTITY
flaring	ENTITY
.	

As	
a	
result	ENTITY
,	
gas	ENTITY
exchange	ENTITY
abnormalities	ENTITY
may	
progress	ENTITY
for	
some	
time	ENTITY
without	
notice	
until	
the	
child	ENTITY
appears	
to	
deteriorate	ENTITY
suddenly	
with	
cardiopulmo-	
nary	ENTITY
arrest	ENTITY
or	
severe	ENTITY
decompensation	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
applicable	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
exact	
pathophysiology	ENTITY
of	
CCHS	ENTITY
is	
unknown	
.	

Radiologic	ENTITY
and	
postmortem	ENTITY
studies	ENTITY
have	
not	
shown	
gross	ENTITY
central	ENTITY
nervous	ENTITY
system	ENTITY
abnormalities	ENTITY
.	

The	
PHOX2B	ENTITY
gene	ENTITY
plays	
a	
role	
in	
the	
development	ENTITY
of	
the	
autonomic	ENTITY
system	ENTITY
.	

Functional	ENTITY
MRI	ENTITY
and	
physiologic	ENTITY
studies	ENTITY
have	
shown	
widespread	
cerebral	ENTITY
abnormalities	ENTITY
in	
response	ENTITY
to	ENTITY
stimuli	ENTITY
such	
as	
exogenous	ENTITY
hypercapnia	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Hypoxemia	ENTITY
and	
hypercapnia	ENTITY
are	
present	
on	
PSG	ENTITY
during	
sleep	ENTITY
.	

Central	ENTITY
apneas	ENTITY
may	
be	
present	
,	
but	
hypoventilation	ENTITY
associated	ENTITY
with	ENTITY
decreased	ENTITY
tidal	ENTITY
volume	ENTITY
and	
respiratory	ENTITY
rate	ENTITY
is	
more	
common	
.	

In	
contrast	
to	
most	
types	
of	
sleep	ENTITY
disordered	
breathing	
in	
children	ENTITY
,	
abnormalities	ENTITY
may	
be	
more	
severe	ENTITY
during	
NREM	ENTITY
than	
during	
REM	ENTITY
sleep	ENTITY
.	

Patients	ENTITY
may	
not	
arouse	
from	
sleep	ENTITY
despite	
severe	ENTITY
gas	ENTITY
exchange	ENTITY
abnormalities	ENTITY
.	

Paradoxical	ENTITY
breath-	ENTITY
ing	ENTITY
and	
snoring	ENTITY
do	
not	
typically	
occur	
.	

Patients	ENTITY
with	
CCHS	ENTITY
have	
flat	ENTITY
rebreathing	ENTITY
hypoxic	ENTITY
and	
hypercapnic	ENTITY
responses	ENTITY
,	
although	
they	
may	
respond	
to	
transient	ENTITY
ventilatory	ENTITY
challenges	
of	
the	
peripheral	ENTITY
chemorecep-	
tors	ENTITY
.	

Arterial	ENTITY
blood	ENTITY
gases	ENTITY
may	
be	
normal	
during	
wakefulness	ENTITY
but	
will	
be	
abnormal	ENTITY
if	
obtained	
from	
an	
arterial	ENTITY
line	ENTITY
during	
sleep	ENTITY
.	

In	
patients	ENTITY
with	
chronically	ENTITY
untreated	ENTITY
or	
poorly	ENTITY
controlled	ENTITY
CCHS	ENTITY
,	
a	
compensated	
respiratory	ENTITY
acidosis	ENTITY
may	
be	
present	
.	

In	
these	
patients	ENTITY
,	
polycythemia	ENTITY
may	
be	
present	
and	
the	
serum	ENTITY
bicarbonate	ENTITY
level	ENTITY
may	
be	
elevated	ENTITY
.	

Computed	ENTITY
tomography	ENTITY
and	
MRI	ENTITY
scans	ENTITY
of	
the	
head	ENTITY
are	
normal	
.	

Electrocardiography	ENTITY
,	
echocardiography	ENTITY
,	
or	
cardiac	ENTITY
catheterization	ENTITY
may	
reveal	
evidence	ENTITY
of	
pulmonary	ENTITY
hyper-	
tension	ENTITY
.	

Pulmonary	ENTITY
function	ENTITY
tests	ENTITY
may	
be	
normal	ENTITY
or	
show	
evidence	ENTITY
of	
mild	ENTITY
obstructive	ENTITY
or	
restrictive	ENTITY
lung	ENTITY
disease	ENTITY
resulting	
from	
associated	ENTITY
conditions	ENTITY
such	
as	
tracheitis	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
CCHS	ENTITY
must	
be	
distinguished	
from	
other	
forms	
of	
central	ENTITY
hypoventilation	ENTITY
,	
such	
as	
central	ENTITY
hypoventilation	ENTITY
due	
to	
Chiari	ENTITY
malformation	ENTITY
,	
other	
causes	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
disturbance	ENTITY
such	
as	
trauma	ENTITY
or	
tumors	ENTITY
,	
metabolic	ENTITY
conditions	ENTITY
such	
as	
Leigh	ENTITY
disease	ENTITY
,	
or	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

CCHS	ENTITY
must	
also	
be	
distinguished	
from	
hypoventilation	ENTITY
secondary	
to	
muscle	ENTITY
weakness	ENTITY
due	
to	
conditions	ENTITY
such	
as	
diaphrag-	
matic	ENTITY
paralysis	ENTITY
or	
muscular	ENTITY
dystrophy	ENTITY
.	

Infants	ENTITY
presenting	
with	
apnea	ENTITY
or	
an	
apparent	ENTITY
life	ENTITY
-	
threatening	ENTITY
event	ENTITY
due	
to	
causes	
such	
as	
gastroesophageal	ENTITY
reflux	ENTITY
may	
be	
thought	
to	
have	
CCHS	ENTITY
.	

However	
,	
these	
infants	ENTITY
typically	
have	
intermittent	ENTITY
episodes	ENTITY
of	
apnea	ENTITY
rather	
than	
sustained	ENTITY
hypoventilation	ENTITY
,	
and	
the	
episodes	ENTITY
typically	
resolve	
once	
the	
primary	ENTITY
cause	
has	
been	
treated	ENTITY
.	

CCHS	ENTITY
patients	ENTITY
presenting	
with	
cor	ENTITY
pulmonale	ENTITY
may	
be	
misdiagnosed	ENTITY
as	
having	
congenital	ENTITY
heart	ENTITY
disease	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
are	
many	
unresolved	
issues	ENTITY
regarding	
CCHS	ENTITY
,	
including	
prevalence	ENTITY
data	ENTITY
,	
precise	
genotype	ENTITY
-	
phenotype	ENTITY
correlations	ENTITY
,	
effect	ENTITY
of	
aging	ENTITY
on	
patients	ENTITY
with	
CCHS	ENTITY
,	
long	ENTITY
-	
term	ENTITY
outcome	ENTITY
of	
children	ENTITY
with	
CCHS	ENTITY
born	ENTITY
to	
parents	ENTITY
with	
CCHS	ENTITY
,	
and	
the	
exact	
nature	
of	
the	
gene	ENTITY
-	
encoded	ENTITY
deficit	ENTITY
.	

Bibliography	ENTITY
Amiel	ENTITY
J	ENTITY
,	
Laudier	ENTITY
B	ENTITY
,	
Attie	ENTITY
-	
Bitach	ENTITY
T	ENTITY
,	
et	
al	
.	

Polyalanine	ENTITY
expansion	ENTITY
and	
frameshift	ENTITY
mutations	ENTITY
of	
the	
paired	ENTITY
-	
like	
homeobox	ENTITY
gene	ENTITY
PHOX2B	ENTITY
in	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Nat	
Genet	
2003;33:459–61	
.	

Gozal	ENTITY
D	ENTITY
,	
Marcus	ENTITY
CL	ENTITY
,	
Shoseyov	ENTITY
D	ENTITY
,	
Keens	ENTITY
TG	ENTITY
.	

Peripheral	ENTITY
chemoreceptor	ENTITY
function	ENTITY
in	
children	ENTITY
with	
the	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

J	
Appl	
Physiol	
1993;74:379–87	
.	

Macey	ENTITY
PM	ENTITY
,	
Woo	
MA	
,	
Macey	ENTITY
KE	ENTITY
,	
et	
al	
.	

Hypoxia	ENTITY
reveals	
posterior	ENTITY
thalamic	ENTITY
,	
cerebellar	ENTITY
,	
midbrain	ENTITY
,	
and	
limbic	ENTITY
deficits	ENTITY
in	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

J	
Appl	
Physiol	
2005;98:958–69	
.	

Marcus	ENTITY
CL	ENTITY
,	
Jansen	
MT	
,	
Poulsen	ENTITY
MK	ENTITY
,	
Keens	ENTITY
SE	ENTITY
,	
Nield	ENTITY
TA	ENTITY
,	
Lipsker	ENTITY
LE	ENTITY
et	ENTITY
al	ENTITY
.	

Medical	ENTITY
and	
psychosocial	ENTITY
outcome	ENTITY
of	
children	ENTITY
with	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

J	
Pediatr	
1991;119:888–95	
.	

Paton	ENTITY
JY	ENTITY
,	
Swaminathan	ENTITY
S	ENTITY
,	
Sargent	ENTITY
CW	ENTITY
,	
Hawksworth	ENTITY
A	ENTITY
,	
Keens	ENTITY
TG	ENTITY
.	

Ventilatory	ENTITY
response	ENTITY
to	
exercise	ENTITY
in	
children	ENTITY
with	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1993;147:1185–91	ENTITY
.	

Paton	ENTITY
JY	ENTITY
,	
Swaminathan	ENTITY
S	ENTITY
,	
Sargent	ENTITY
CW	ENTITY
,	
Keens	ENTITY
TG	ENTITY
.	

Hypoxic	ENTITY
and	
hypercapnic	ENTITY
ventilatory	
responses	
in	
awake	ENTITY
children	ENTITY
with	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Am	ENTITY
Rev	ENTITY
Respir	ENTITY
Dis	ENTITY
1989;140:368–72	ENTITY
.	

Weese	
-	
Mayer	ENTITY
DE	ENTITY
,	
Berry	ENTITY
-	
Kravis	ENTITY
EM	ENTITY
,	
Ceccherini	ENTITY
I	ENTITY
,	
Keens	ENTITY
TG	ENTITY
,	
Loghmanee	ENTITY
DA	ENTITY
,	
Trang	ENTITY
H.	
An	
official	
ATS	ENTITY
clinical	ENTITY
policy	ENTITY
statement	ENTITY
:	
Congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
:	
genetic	ENTITY
basis	ENTITY
,	
diagnosis	ENTITY
,	
and	
management	ENTITY
.	

Am	
J	
Respir	
Crit	
Care	
Med	
2010;181:626–44	
.	

Weese	
-	
Mayer	ENTITY
DE	ENTITY
,	
Berry	ENTITY
-	
Kravis	ENTITY
EM	ENTITY
,	
Marazita	ENTITY
ML	ENTITY
.	

In	
pursuit	ENTITY
(	
and	
discovery	ENTITY
)	
of	
a	
genetic	ENTITY
basis	ENTITY
for	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Respir	
Physiol	
Neurobiol	
2005;149:73–82	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Late	ENTITY
-	
Onset	ENTITY
Central	ENTITY
Hypoventilation	ENTITY
with	
Hypothalamic	ENTITY
Dysfunction	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.26	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.36	ENTITY
Alternate	ENTITY
Names	ENTITY
Late	ENTITY
-	
onset	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
;	
rapid	ENTITY
-	
onset	ENTITY
obesity	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
,	
hypoventilation	ENTITY
,	
and	
autonomic	ENTITY
dysregulation	ENTITY
(	
ROHHAD	ENTITY
)	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
E	ENTITY
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

B.	ENTITY
Symptoms	ENTITY
are	
absent	ENTITY
during	
the	
first	
few	
years	ENTITY
of	
life	ENTITY
.	

C.	

The	
patient	ENTITY
has	
at	
least	
two	
of	
the	
following	
:	
.	

Obesity	ENTITY
.	
.	

Endocrine	ENTITY
abnormalities	ENTITY
of	
hypothalamic	ENTITY
origin	ENTITY
.	

3	
.	

Severe	ENTITY
emotional	ENTITY
or	
behavioral	ENTITY
disturbances	ENTITY
.	
.	

Tumor	ENTITY
of	
neural	ENTITY
origin	ENTITY
.	

D.	ENTITY
Mutation	ENTITY
of	
the	
PHOX2B	ENTITY
gene	ENTITY
is	
not	
present	
.	

E.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Central	ENTITY
apneas	ENTITY
may	
occur	
but	
the	
predominant	ENTITY
pattern	ENTITY
is	
reduced	ENTITY
flow	ENTITY
/	
tidal	ENTITY
volume	ENTITY
associated	ENTITY
with	ENTITY
hypoventilation	ENTITY
and	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Late	ENTITY
-	
onset	ENTITY
central	ENTITY
hypoventilation	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
is	
a	
disorder	ENTITY
of	
central	ENTITY
control	ENTITY
of	ENTITY
ventilation	ENTITY
.	

Patients	ENTITY
are	
usually	
healthy	ENTITY
until	
early	ENTITY
childhood	ENTITY
(	
often	
2	
-	
3	
years	ENTITY
of	
age	ENTITY
)	
when	
they	
develop	
hyperphagia	ENTITY
and	
severe	ENTITY
obesity	ENTITY
,	
followed	
by	
central	ENTITY
hypoventilation	ENTITY
,	
which	
often	
presents	
as	
respiratory	ENTITY
failure	ENTITY
.	

The	
respiratory	ENTITY
failure	ENTITY
may	
be	
precipitated	
by	
a	
mild	ENTITY
respiratory	ENTITY
illness	ENTITY
or	
anesthesia	ENTITY
.	

Patients	ENTITY
require	
ventilatory	ENTITY
support	ENTITY
during	
sleep	ENTITY
;	
most	
patients	ENTITY
breathe	ENTITY
adequately	
during	
wakefulness	ENTITY
but	
some	
need	
ventilatory	ENTITY
support	ENTITY
during	
both	
wakefulness	ENTITY
and	
sleep	ENTITY
.	

The	
hypoventila-	
tion	ENTITY
persists	ENTITY
even	
if	
the	
patients	ENTITY
lose	ENTITY
weight	ENTITY
,	
differentiating	
the	
condition	ENTITY
from	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Patients	ENTITY
often	
develop	
hypothalamic	ENTITY
endocrine	ENTITY
dysfunc-	
tion	ENTITY
characterized	ENTITY
by	
increased	ENTITY
or	
decreased	ENTITY
hormone	ENTITY
levels	ENTITY
,	
which	
may	
include	
one	
or	
more	
of	
the	
following	
:	
diabetes	ENTITY
insipidus	ENTITY
,	
inappropriate	
antidiuretic	ENTITY
hormone	ENTITY
hyperse-	
cretion	ENTITY
,	
precocious	ENTITY
puberty	ENTITY
,	
hypogonadism	ENTITY
,	
hyperprolactinemia	ENTITY
,	
hypothyroidism	ENTITY
,	
and	
decreased	ENTITY
growth	ENTITY
hormone	ENTITY
secretion	ENTITY
.	

Mood	ENTITY
and	
behavior	ENTITY
abnormalities	ENTITY
,	
sometimes	
severe	ENTITY
,	
have	
frequently	
been	
reported	
.	

Developmental	ENTITY
delay	ENTITY
or	
autism	ENTITY
may	
be	
present	
,	
but	
many	
patients	ENTITY
are	
cognitively	ENTITY
normal	ENTITY
.	

Other	
symptoms	ENTITY
of	
hypothalamic	ENTITY
dysfunc-	ENTITY
tion	ENTITY
,	
such	
as	
temperature	ENTITY
dysregulation	ENTITY
,	
have	
been	
reported	
.	

Associated	ENTITY
Features	ENTITY
Tumors	
of	
neural	ENTITY
origin	ENTITY
such	
as	
ganglioneuroma	ENTITY
may	
occur	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
There	
are	
no	
prevalence	
data	ENTITY
.	

The	
disorder	ENTITY
seems	
to	
occur	
equally	
among	
males	ENTITY
and	
females	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Unknown	
.	

Patients	ENTITY
do	
not	
have	
the	
PHOX2B	ENTITY
genetic	ENTITY
mutation	ENTITY
of	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
cases	ENTITY
have	
not	
been	
reported	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Patients	ENTITY
are	
typically	
normal	
at	
birth	ENTITY
.	

Obesity	ENTITY
often	
begins	
in	
early	ENTITY
childhood	ENTITY
,	
perhaps	
because	
the	
child	ENTITY
is	
old	
enough	
to	
walk	ENTITY
around	
and	
obtain	
his	
/	
her	
own	
food	ENTITY
.	

Respiratory	ENTITY
failure	ENTITY
typically	
presents	
several	
years	ENTITY
after	
the	
onset	
of	
obesity	ENTITY
,	
and	
requires	
ventila-	
tory	ENTITY
support	ENTITY
via	
face	ENTITY
mask	ENTITY
or	
tracheostomy	ENTITY
.	

The	
respiratory	ENTITY
failure	ENTITY
does	
not	
improve	
over	
time	ENTITY
.	

Death	ENTITY
has	
been	
reported	
from	
respiratory	ENTITY
failure	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
or	
hyper-	
natremia	ENTITY
secondary	ENTITY
to	ENTITY
diabetes	ENTITY
insipidus	ENTITY
;	
case	ENTITY
series	ENTITY
have	
reported	
a	
high	
mortality	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
applicable	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
cause	
of	
the	
disorder	ENTITY
is	
not	
known	
.	

The	
brain	ENTITY
typically	
appears	
normal	
on	
imaging	ENTITY
or	
at	
autopsy	ENTITY
,	
or	
may	
show	
secondary	ENTITY
signs	ENTITY
of	
hypoxemia	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Hypoxemia	ENTITY
and	
hypercapnia	ENTITY
are	
present	
on	
PSG	ENTITY
during	
sleep	ENTITY
.	

Central	ENTITY
apneas	ENTITY
may	
be	
present	
,	
but	
hypoventilation	ENTITY
associated	ENTITY
with	ENTITY
decreased	ENTITY
tidal	ENTITY
volume	ENTITY
and	
respiratory	ENTITY
rate	ENTITY
is	
more	
common	
.	

Obstructive	ENTITY
apneas	ENTITY
may	
occur	
but	
are	
not	
the	
primary	ENTITY
abnormality	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Patients	ENTITY
have	
flat	ENTITY
hypoxic	ENTITY
and	
hypercapnic	ENTITY
responses	ENTITY
.	

Oxygen	ENTITY
and	
carbon	ENTITY
dioxide	ENTITY
determinations	ENTITY
may	
be	
normal	
during	
wakefulness	ENTITY
but	
will	
demonstrate	
hypoxemia	ENTITY
and	
hypercapnia	ENTITY
during	
sleep	ENTITY
.	

In	
patients	ENTITY
with	
chronically	ENTITY
untreated	ENTITY
or	
poorly	ENTITY
con-	ENTITY
trolled	ENTITY
hypoventilation	ENTITY
,	
a	
compensated	
respiratory	ENTITY
acidosis	ENTITY
may	
be	
present	
,	
with	
ele-	ENTITY
vated	ENTITY
serum	ENTITY
bicarbonate	
levels	
.	

In	
these	
patients	ENTITY
,	
polycythemia	ENTITY
may	
be	
present	
.	

Serum	ENTITY
tests	ENTITY
may	
show	
evidence	ENTITY
of	
endocrine	ENTITY
abnormalities	ENTITY
;	
hypernatremia	ENTITY
is	
common	
.	

Computed	ENTITY
tomography	ENTITY
and	
MRI	ENTITY
scans	ENTITY
of	
the	
head	ENTITY
are	
normal	
.	

Electrocardiography	ENTITY
,	
echocardiography	ENTITY
,	
or	
cardiac	ENTITY
catheterization	ENTITY
may	
reveal	
evidence	ENTITY
of	
pulmonary	ENTITY
hyper-	
tension	ENTITY
.	

Pulmonary	ENTITY
function	ENTITY
tests	ENTITY
may	
be	
normal	ENTITY
or	
show	
evidence	ENTITY
of	
mild	ENTITY
obstructive	ENTITY
or	
restrictive	ENTITY
lung	ENTITY
disease	ENTITY
resulting	
from	
associated	ENTITY
conditions	ENTITY
such	
as	
tracheitis	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
disorder	ENTITY
can	
be	
distinguished	
from	
late	
presentation	ENTITY
of	
congenital	ENTITY
central	ENTITY
hypoven-	ENTITY
tilation	ENTITY
syndrome	ENTITY
by	
testing	ENTITY
for	
the	
PHOX2B	ENTITY
gene	ENTITY
.	

Genetic	ENTITY
testing	ENTITY
may	
also	
be	
useful	
in	
distinguishing	
the	
disorder	ENTITY
from	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
,	
which	
is	
characterized	ENTITY
by	
a	
known	
genetic	ENTITY
abnormality	ENTITY
.	

Most	
children	ENTITY
with	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
have	
hypotonia	ENTITY
at	
birth	ENTITY
and	
more	
severe	ENTITY
developmental	ENTITY
delay	ENTITY
.	

The	
disorder	ENTITY
can	
be	
distinguished	
from	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
by	
the	
presence	ENTITY
of	
endocrine	ENTITY
abnormalities	ENTITY
and	
other	
associated	
hypothalamic	ENTITY
abnormalities	ENTITY
,	
and	
by	
the	
persistence	ENTITY
of	
hypoventilation	ENTITY
despite	
weight	ENTITY
loss	ENTITY
.	

In	
addition	
,	
the	
patients	ENTITY
typically	
have	
a	
totally	
flat	
hypercapnic	ENTITY
ventilatory	
response	
rather	
than	
the	
blunted	ENTITY
response	ENTITY
seen	
in	
children	ENTITY
with	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
.	

The	
disorder	ENTITY
should	
be	
distinguished	
from	
isolated	ENTITY
hypopituitarism	ENTITY
or	
other	
hypothalamic	ENTITY
disease	ENTITY
without	
hypoventilation	ENTITY
,	
and	
from	
obesity	ENTITY
-	
related	ENTITY
OSA	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
etiology	ENTITY
of	
the	
disorder	ENTITY
is	
not	
known	
.	

Although	
the	
disorder	ENTITY
shares	
some	
fea-	
tures	ENTITY
of	
congenital	ENTITY
central	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
,	
including	
the	
presence	ENTITY
of	
neural	ENTITY
tumors	ENTITY
,	
it	
does	
not	
share	
the	
same	
gene	ENTITY
.	

Little	
information	ENTITY
is	
available	
on	
prevalence	ENTITY
or	
long	ENTITY
-	
term	ENTITY
prognosis	ENTITY
.	

Bibliography	ENTITY
Ize	ENTITY
-	
Ludlow	ENTITY
D	ENTITY
,	
Gray	ENTITY
JA	ENTITY
,	
Sperling	ENTITY
MA	ENTITY
,	
et	
al	
.	

Rapid	ENTITY
-	
onset	ENTITY
obesity	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
,	
hypoventilation	ENTITY
,	
and	
autonomic	ENTITY
dysregulation	ENTITY
presenting	
in	
childhood	ENTITY
.	

Pediatrics	ENTITY
2007;120	
:	
e179–88	ENTITY
.	

Katz	ENTITY
ES	ENTITY
,	
McGrath	ENTITY
S	ENTITY
,	
Marcus	ENTITY
CL	ENTITY
.	

Late	ENTITY
-	
onset	ENTITY
central	ENTITY
hypoventilation	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
:	
a	
distinct	
clinical	ENTITY
syndrome	ENTITY
.	

Pediatr	
Pulmonol	
2000;29:62–8	
.	

Idiopathic	ENTITY
Central	ENTITY
Alveolar	ENTITY
Hypoventilation	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.24	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.34	ENTITY
Alternate	ENTITY
Names	ENTITY
Alveolar	ENTITY
hypoventilation	ENTITY
,	
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
,	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
,	
nonapneic	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
,	
primary	
alveolar	ENTITY
hypoventilation	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

B.	ENTITY
Hypoventilation	ENTITY
is	
not	
primarily	
due	
to	
lung	ENTITY
parenchymal	ENTITY
or	
airway	ENTITY
disease	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
neurologic	ENTITY
disorder	ENTITY
,	
muscle	ENTITY
weakness	ENTITY
,	
or	
obesity	ENTITY
or	
congenital	ENTITY
hypoventilation	ENTITY
syndromes	ENTITY
.	

Notes	ENTITY
.	

The	
predominant	ENTITY
respiratory	ENTITY
pattern	ENTITY
is	
one	
of	
reduced	ENTITY
tidal	ENTITY
volume	ENTITY
or	
ataxic	ENTITY
breathing	ENTITY
with	
associated	
arterial	ENTITY
oxygen	
desaturation	
.	

Although	
OSA	ENTITY
may	
be	
present	
,	
it	
is	
not	
believed	
to	
be	
the	
major	
cause	ENTITY
of	
hypoventilation	ENTITY
.	

When	
criteria	ENTITY
are	
met	
,	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
may	
be	
made	
.	
.	

Arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
is	
often	
present	
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
is	
defined	
as	
the	
presence	ENTITY
of	
decreased	ENTITY
alve-	
olar	ENTITY
ventilation	ENTITY
resulting	
in	
sleep	ENTITY
related	
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
in	
individuals	ENTITY
with	
presumed	
normal	
mechanical	ENTITY
properties	ENTITY
of	
the	
lung	ENTITY
and	
respiratory	ENTITY
pump	ENTITY
.	

Thus	
,	
chronic	ENTITY
hypoventilation	ENTITY
during	
sleep	ENTITY
exists	
without	
any	
readily	
identifiable	
impairments	ENTITY
of	
res-	ENTITY
piration	ENTITY
,	
such	
as	
pulmonary	ENTITY
airway	ENTITY
or	
parenchymal	ENTITY
conditions	ENTITY
,	
neurologic	ENTITY
,	
neuromus-	
cular	ENTITY
or	
chest	ENTITY
wall	ENTITY
abnormalities	ENTITY
,	
severe	ENTITY
obesity	ENTITY
,	
other	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
,	
or	
use	
of	
respiratory	ENTITY
depressant	ENTITY
medications	ENTITY
or	
substances	ENTITY
.	

Diurnal	ENTITY
as	
well	
as	
nocturnal	ENTITY
hypoventilation	ENTITY
is	
believed	
to	
be	
due	
primarily	
to	
blunted	ENTITY
chemoresponsiveness	ENTITY
to	
CO2	ENTITY
and	
O2	ENTITY
.	

However	
,	
reported	
cases	ENTITY
are	
few	
and	
not	
studied	
in	
enough	
detail	
to	
conclu-	
sively	
establish	
a	
well	
-	
defined	ENTITY
etiology	ENTITY
.	

Alternatively	
,	
these	
cases	ENTITY
may	
represent	
a	
mixed	ENTITY
group	ENTITY
of	
patients	ENTITY
with	
varied	
underlying	
conditions	ENTITY
erroneously	
deemed	
idiopathic	ENTITY
as	
a	
result	
of	
incomplete	ENTITY
diagnostic	ENTITY
work	ENTITY
-	
up	
.	

Patient	ENTITY
may	
complain	ENTITY
of	
morning	ENTITY
headaches	ENTITY
,	
fatigue	ENTITY
,	
neurocognitive	ENTITY
decline	ENTITY
and	
sleep	ENTITY
disturbance	ENTITY
,	
or	
may	
be	
entirely	
asymptomatic	ENTITY
.	

Frequent	ENTITY
episodes	ENTITY
of	
shallow	ENTITY
breathing	ENTITY
may	
be	
noted	
to	
occur	
during	
sleep	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Associated	ENTITY
Features	ENTITY
Consequences	ENTITY
of	
chronic	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
include	
pulmonary	ENTITY
artery	ENTITY
hyper-	
tension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
and	
neurocognitive	ENTITY
dysfunction	ENTITY
.	

Patients	ENTITY
with	
other	
comorbid	ENTITY
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
are	
likely	
to	
experience	
greater	
severity	ENTITY
and	
dura-	
tion	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
than	
are	
patients	ENTITY
with	
isolated	ENTITY
idiopathic	ENTITY
central	ENTITY
hypoventilation	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
Not	
known	
.	

It	
is	
likely	
that	
some	
patients	ENTITY
with	
this	
diagnosis	ENTITY
may	
have	
an	
underlying	
anatomic	ENTITY
or	
functional	ENTITY
defect	ENTITY
affecting	
respiratory	ENTITY
mechanics	ENTITY
and	
ventilatory	ENTITY
drive	
which	
remains	
undiagnosed	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
use	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
depressants	ENTITY
,	
such	
as	
alcohol	ENTITY
,	
anxiolytics	ENTITY
,	
and	
hyp-	ENTITY
notics	ENTITY
,	
may	
further	
worsen	ENTITY
hypercapnia	ENTITY
/	
hypoxemia	ENTITY
.	

Patients	ENTITY
who	
are	
hypercapnic	ENTITY
and	
hypoxemic	ENTITY
during	
wakefulness	ENTITY
will	
generally	
become	
even	
more	
so	
during	
sleep	ENTITY
,	
in	
particular	
REM	ENTITY
sleep	ENTITY
,	
but	
the	
relationship	ENTITY
between	
wake	ENTITY
SaO2	ENTITY
/	
PaCO2	ENTITY
and	
sleep	ENTITY
related	ENTITY
desaturation	ENTITY
is	
not	
sufficiently	
strong	
to	
have	
substantial	ENTITY
predictive	ENTITY
value	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
onset	
of	
the	
condition	ENTITY
is	
variable	ENTITY
,	
often	
presenting	
in	
adolescence	ENTITY
or	
early	ENTITY
adulthood	ENTITY
.	

The	
disorder	ENTITY
is	
generally	
slowly	
progressive	ENTITY
.	

Many	
affected	ENTITY
individuals	ENTITY
with	
severe	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
develop	
respiratory	ENTITY
impairment	ENTITY
,	
pulmonary	ENTITY
hypertension	ENTITY
,	
heart	ENTITY
failure	ENTITY
,	
cardiac	ENTITY
arrhythmias	ENTITY
,	
and	
neurocognitive	ENTITY
dysfunction	ENTITY
.	

Polycythemia	ENTITY
is	
common	
in	
those	
with	
chronic	ENTITY
hypoxia	ENTITY
.	

Although	
the	
risk	ENTITY
of	
increased	ENTITY
morbidity	ENTITY
and	
mortality	ENTITY
appears	
to	
increase	ENTITY
with	
worsening	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
/	
hypoxemia	ENTITY
,	
the	
specific	
relationship	ENTITY
between	
sleep	ENTITY
related	
hypoventilation	ENTITY
/	
hypoxemia	ENTITY
and	
mor-	
bidity	ENTITY
and	
mortality	ENTITY
is	
not	
well	
defined	
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
etiology	ENTITY
of	
hypoventilation	ENTITY
in	
these	
patients	ENTITY
is	
not	
understood	
.	

Chronic	ENTITY
hyper-	
capnia	ENTITY
and	
hypoxemia	ENTITY
in	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
is	
believed	
to	
be	
due	
to	
defective	ENTITY
CO2	ENTITY
and	
O2	ENTITY
homeostasis	ENTITY
,	
with	
impaired	ENTITY
CO2	ENTITY
unloading	ENTITY
,	
reduced	ENTITY
chemoresponsiveness	ENTITY
to	
CO2	ENTITY
and	
O2	ENTITY
,	
and	
suppression	ENTITY
of	
respiratory	ENTITY
drive	
.	

Imaging	ENTITY
of	
the	
central	ENTITY
nervous	ENTITY
system	ENTITY
does	
not	
document	
a	
structural	ENTITY
defect	ENTITY
.	

Hypoventilation	ENTITY
worsens	ENTITY
during	
sleep	ENTITY
compared	
to	
waking	ENTITY
levels	ENTITY
due	
to	
a	
further	
reduction	ENTITY
in	
che-	
mosensitivity	ENTITY
and	
decreased	ENTITY
activity	ENTITY
of	
the	
ventilatory	ENTITY
muscles	ENTITY
.	

Additionally	
,	
daytime	ENTITY
hypoxemia	ENTITY
,	
if	
sufficiently	
severe	ENTITY
,	
may	
place	
the	
patient	ENTITY
near	
or	
on	
the	
steep	ENTITY
portion	ENTITY
of	
the	
oxyhemoglobin	ENTITY
dissociation	ENTITY
curve	ENTITY
where	
even	
relatively	
small	
decrements	ENTITY
in	
arterial	ENTITY
oxygen	ENTITY
tension	ENTITY
result	
in	
large	
decrements	ENTITY
in	
oxyhemoglobin	ENTITY
saturation	ENTITY
.	

Thus	
,	
sleep	ENTITY
related	
hypoventilation	ENTITY
in	
these	
patients	ENTITY
may	
have	
a	
relatively	
great	
impact	ENTITY
on	
oxyhemoglobin	ENTITY
saturation	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

The	
characteristic	
polysomnographic	ENTITY
finding	ENTITY
is	
demonstration	
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
(	
determination	ENTITY
of	
PaCO2	ENTITY
by	
arterial	ENTITY
blood	ENTITY
gas	ENTITY
or	
by	
a	
surrogate	ENTITY
measure	ENTITY
[	
end	ENTITY
-	
tidal	ENTITY
CO2	ENTITY
or	
transcutaneous	ENTITY
CO2	ENTITY
]	
)	
.	

Periods	ENTITY
of	
decreased	ENTITY
tidal	ENTITY
volume	ENTITY
lasting	
up	
to	
several	
minutes	
,	
with	
sustained	ENTITY
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
,	
are	
usually	
present	
.	

Intermittent	ENTITY
arousals	ENTITY
may	
be	
observed	ENTITY
.	

Daytime	ENTITY
arterial	ENTITY
blood	ENTITY
gases	ENTITY
may	
be	
normal	ENTITY
or	
show	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
.	

Chronic	ENTITY
hypoxia	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
polycythemia	ENTITY
.	

Electrocardiography	ENTITY
,	
chest	ENTITY
radiography	ENTITY
,	
and	
echocardiography	ENTITY
may	
demonstrate	
evidence	ENTITY
of	
pulmonary	ENTITY
hypertension	ENTITY
.	

Central	ENTITY
nervous	ENTITY
system	ENTITY
imaging	ENTITY
is	
generally	
unremarkable	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differential	ENTITY
diagnosis	ENTITY
includes	
any	
disorder	ENTITY
that	
can	
cause	ENTITY
hypoventilation	ENTITY
during	
sleep	ENTITY
.	

This	
includes	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
,	
pulmonary	ENTITY
airway	ENTITY
and	
paren-	
chymal	ENTITY
disorders	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
neuromuscular	ENTITY
and	
chest	ENTITY
wall	ENTITY
dis-	
orders	ENTITY
,	
severe	ENTITY
untreated	ENTITY
hypothyroidism	ENTITY
,	
and	
use	
of	
respiratory	ENTITY
suppressants	ENTITY
.	

CCHS	ENTITY
is	
associated	ENTITY
with	ENTITY
an	
abnormal	ENTITY
PHOX2B	ENTITY
gene	ENTITY
.	

Unlike	
patients	ENTITY
with	
late	ENTITY
-	
onset	ENTITY
central	ENTITY
hypoventilation	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
,	
patients	ENTITY
with	
idiopathic	ENTITY
central	ENTITY
hypoventilation	ENTITY
do	
not	
have	
evidence	ENTITY
of	
hypothalamic	ENTITY
dysfunction	ENTITY
.	

It	
is	
essential	
to	
excluded	
medical	ENTITY
and	
neurological	ENTITY
disorders	ENTITY
that	
are	
associated	ENTITY
with	ENTITY
hypoventilation	ENTITY
before	
a	
diagnosis	ENTITY
of	
idiopathic	ENTITY
central	ENTITY
hypoventilation	ENTITY
can	
be	
made	
.	

OSA	ENTITY
and	
CSA	ENTITY
syndromes	ENTITY
can	
be	
distinguished	
from	
sleep	ENTITY
related	
hypoventilation	ENTITY
by	
the	
periodic	ENTITY
alterations	ENTITY
in	
airflow	ENTITY
and	
accompanying	
periodic	ENTITY
fluctuations	ENTITY
in	
SaO2	ENTITY
.	

In	
contrast	
,	
oxygen	ENTITY
desaturation	ENTITY
due	
to	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
generally	
more	
sustained	ENTITY
,	
usually	
several	
minutes	
or	
longer	ENTITY
in	
duration	ENTITY
.	

When	
more	
than	
one	
disorder	ENTITY
is	
believed	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
to	
be	
responsible	
for	
the	
ventilatory	ENTITY
insufficiency	ENTITY
during	
sleep	ENTITY
,	
all	
pertinent	
diagnoses	ENTITY
should	
be	
coded	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

A	
better	
understanding	
of	
the	
etiology	ENTITY
of	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
is	
essential	
to	
guide	
preventive	ENTITY
and	
treatment	ENTITY
measures	ENTITY
.	

Because	
it	
is	
clinically	ENTITY
imprac-	
tical	ENTITY
to	
routinely	
obtain	
arterial	ENTITY
blood	
samples	
during	
sleep	ENTITY
in	
most	
persons	ENTITY
suspected	ENTITY
of	
this	
disorder	ENTITY
,	
other	
techniques	ENTITY
of	
measuring	ENTITY
CO2	ENTITY
levels	ENTITY
must	
be	
investigated	ENTITY
.	

The	
degree	ENTITY
and	
duration	ENTITY
of	
hypercapnia	ENTITY
/	
hypoxemia	ENTITY
necessary	
to	
produce	
adverse	ENTITY
conse-	ENTITY
quences	ENTITY
,	
such	
as	
pulmonary	ENTITY
hypertension	ENTITY
,	
in	
individual	ENTITY
patients	ENTITY
is	
not	
well	
defined	
.	

Little	
information	ENTITY
is	
available	
regarding	
the	
effect	ENTITY
of	
oxygen	ENTITY
therapy	ENTITY
or	
noninvasive	ENTITY
ventilation	ENTITY
on	
the	
course	ENTITY
of	
the	
underlying	ENTITY
disease	ENTITY
.	

Studies	ENTITY
are	
needed	
to	
determine	
the	
optimal	ENTITY
time	ENTITY
to	
initiate	ENTITY
these	
interventions	ENTITY
and	
the	
specific	
subpopulations	ENTITY
of	
patients	ENTITY
who	
will	
benefit	ENTITY
most	
from	
these	
therapies	ENTITY
.	

Bibliography	ENTITY
Brown	ENTITY
LK	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Clin	ENTITY
Chest	ENTITY
Med	ENTITY
2010;31:249–70	ENTITY
.	

Casey	ENTITY
KR	ENTITY
,	
Cantillo	ENTITY
KO	ENTITY
,	
Brown	ENTITY
LK	ENTITY
.	

Sleep	ENTITY
-	
related	ENTITY
hypoventilation	ENTITY
/	
hypoxemic	ENTITY
syndromes	ENTITY
.	

Chest	ENTITY
2007;131:1936–48	ENTITY
.	

Chebbo	ENTITY
A	ENTITY
,	
Tfaili	ENTITY
A	ENTITY
,	
Jones	ENTITY
SF	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Med	ENTITY
Clin	ENTITY
North	ENTITY
Am	ENTITY
2011;95:1189–202	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.26	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.36	ENTITY
Alternate	ENTITY
Names	ENTITY
Alveolar	ENTITY
hypoventilation	ENTITY
,	
nocturnal	ENTITY
hypoventilation	ENTITY
,	
nonapneic	ENTITY
alveolar	
hypoventila-	
tion	ENTITY
,	
secondary	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
,	
sleep	ENTITY
related	ENTITY
hypoventilation	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

B.	ENTITY
A	ENTITY
medication	ENTITY
or	
substance	ENTITY
known	
to	
inhibit	ENTITY
respiration	ENTITY
and/or	
ventilatory	ENTITY
drive	
is	
believed	
to	
be	
the	
primary	
cause	
of	
sleep	
related	
hypoventilation	ENTITY
.	

C.	ENTITY
Hypoventilation	ENTITY
is	
not	
primarily	
due	
to	
lung	ENTITY
parenchymal	ENTITY
or	
airway	ENTITY
disease	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorder	ENTITY
,	
neurologic	ENTITY
disorder	ENTITY
,	
muscle	ENTITY
weakness	ENTITY
,	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
,	
or	
a	
known	
congenital	ENTITY
central	
alveolar	
hypoventilation	
syndrome	
.	

Notes	ENTITY
.	
.	

3	
.	

Although	
OSA	ENTITY
or	
CSA	ENTITY
may	
be	
present	
,	
they	
are	
not	
believed	
to	
be	
the	
major	
cause	ENTITY
of	
hypoventilation	ENTITY
.	

The	
predominant	ENTITY
respiratory	ENTITY
pattern	ENTITY
is	
one	
of	
reduced	ENTITY
tidal	ENTITY
volume	ENTITY
or	
ataxic	ENTITY
breathing	ENTITY
and	
associated	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

When	
criteria	ENTITY
are	
met	
,	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
CSA	ENTITY
due	
to	
medication	ENTITY
or	
substance	ENTITY
as	
well	
as	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
may	
be	
made	
.	

Arterial	ENTITY
desaturation	ENTITY
is	
often	
present	
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Hypoventilation	ENTITY
may	
be	
present	
during	
wakefulness	ENTITY
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Essential	ENTITY
Features	ENTITY

This	
disorder	ENTITY
is	
characterized	ENTITY
primarily	
by	
chronic	ENTITY
hypoventilation	ENTITY
and	
hypercapnia	ENTITY
due	
to	
prolonged	ENTITY
use	ENTITY
of	ENTITY
medications	ENTITY
or	
substances	ENTITY
known	
to	
depress	ENTITY
ventilatory	ENTITY
drive	
and/or	
impair	ENTITY
respiratory	ENTITY
muscle	ENTITY
mechanics	ENTITY
.	

These	
agents	ENTITY
include	
long	ENTITY
-	
acting	ENTITY
nar-	
cotics	ENTITY
,	
anesthetics	ENTITY
,	
sedative	ENTITY
compounds	ENTITY
,	
and	
muscle	ENTITY
relaxants	ENTITY
.	

The	
risk	ENTITY
of	
respiratory	ENTITY
insufficiency	ENTITY
is	
increased	ENTITY
with	
the	
concomitant	ENTITY
use	ENTITY
of	ENTITY
alcohol	ENTITY
or	
with	
polypharmacy	ENTITY
.	

Respiratory	ENTITY
depressants	ENTITY
can	
precipitate	ENTITY
respiratory	ENTITY
failure	ENTITY
in	
patients	ENTITY
with	
limited	
pul-	
monary	ENTITY
reserves	ENTITY
or	
exacerbate	ENTITY
hypoventilation	ENTITY
in	
those	
with	
baseline	ENTITY
hypercapnia	ENTITY
.	

Hypoxemia	ENTITY
is	
commonly	
present	
and	
can	
show	
either	
a	
sustained	ENTITY
reduction	ENTITY
or	
episodic	ENTITY
fluctuations	ENTITY
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

Hypercapnia	ENTITY
may	
also	
be	
present	
during	
wakefulness	ENTITY
in	
some	
patients	ENTITY
.	

Patients	ENTITY
can	
either	
be	
asymptomatic	ENTITY
or	
present	
with	
complaints	ENTITY
of	
dyspnea	ENTITY
,	
chest	ENTITY
tightness	ENTITY
,	
or	
fatigue	ENTITY
.	

Neurocognitive	ENTITY
dysfunction	ENTITY
may	
arise	
following	
use	
of	
narcotics	ENTITY
.	

Associated	
Features	ENTITY
Medications	ENTITY
and	
substances	ENTITY
that	
reduce	ENTITY
respiratory	ENTITY
drive	
may	
also	
alter	
the	
mechanics	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
.	

By	
decreasing	ENTITY
upper	ENTITY
airway	ENTITY
muscle	ENTITY
tone	ENTITY
,	
these	
agents	ENTITY
may	
pre-	
cipitate	ENTITY
or	
exacerbate	ENTITY
OSA	ENTITY
and	
CSA	ENTITY
.	

It	
is	
not	
currently	
known	
whether	
chronic	ENTITY
use	
of	
respiratory	ENTITY
depressants	ENTITY
will	
eventually	
give	
rise	
to	
pulmonary	ENTITY
artery	ENTITY
hypertension	ENTITY
or	
cor	ENTITY
pulmonale	ENTITY
,	
but	
this	
seems	
unlikely	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
The	
demographics	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
use	
of	
respiratory	ENTITY
suppressants	ENTITY
are	
not	
known	
.	

It	
is	
clear	
that	
baseline	ENTITY
hypoventilation	ENTITY
prior	
to	
initiation	ENTITY
of	
respiratory	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
depressant	ENTITY
medication	ENTITY
will	
worsen	ENTITY
following	
initiation	ENTITY
of	
the	
medication	ENTITY
.	

Thus	
,	
preva-	
lence	ENTITY
may	
be	
higher	ENTITY
in	
patients	ENTITY
with	
greater	
perturbations	ENTITY
of	
pulmonary	ENTITY
function	ENTITY
or	
neuro-	ENTITY
muscular	ENTITY
weakness	ENTITY
.	

Individuals	ENTITY
with	
chronic	ENTITY
hypercapnia	ENTITY
during	
wakefulness	ENTITY
will	
expe-	
rience	ENTITY
even	
greater	
decrements	ENTITY
of	
alveolar	ENTITY
ventilation	ENTITY
during	
sleep	ENTITY
.	

Studies	ENTITY
of	
patients	ENTITY
on	
methadone	ENTITY
maintenance	ENTITY
have	
generally	
found	
no	
or	
mild	ENTITY
daytime	ENTITY
hypoventilation	ENTITY
.	

There	
is	
scant	
literature	ENTITY
about	
daytime	ENTITY
or	
nocturnal	ENTITY
PaCO2	ENTITY
in	
patients	ENTITY
on	
potent	
opioids	ENTITY
for	
pain	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
use	
of	
medications	ENTITY
or	
substances	ENTITY
that	
impair	ENTITY
respiration	ENTITY
mechanics	ENTITY
or	
drive	
is	
the	
primary	
pathophysiologic	ENTITY
factor	ENTITY
responsible	
for	
hypoventilation	ENTITY
and	
hypoxemia	ENTITY
.	

There	
are	
significant	
inter	ENTITY
-	
individual	ENTITY
differences	ENTITY
in	
sensitivity	ENTITY
and	
tolerance	ENTITY
to	
respira-	
tory	ENTITY
depressants	ENTITY
.	

Obesity	ENTITY
or	
the	
presence	ENTITY
of	
medical	ENTITY
and	
neurologic	ENTITY
diseases	ENTITY
that	
may	
produce	
hypoventilation	ENTITY
may	
further	
worsen	ENTITY
hypercapnia	ENTITY
/	
hypoxemia	ENTITY
.	

Patients	ENTITY
who	
are	
hypercapnic	ENTITY
and	
hypoxemic	ENTITY
during	
wakefulness	ENTITY
will	
generally	
become	
even	
more	
so	
during	
sleep	ENTITY
,	
in	
particular	
REM	ENTITY
sleep	ENTITY
,	
but	
the	
relationship	ENTITY
between	
wake	ENTITY
SaO2/	ENTITY
PaCO2	ENTITY
and	
sleep	ENTITY
related	ENTITY
desaturation	ENTITY
is	
not	
sufficiently	
strong	
to	
have	
substantial	
pre-	
dictive	ENTITY
value	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
and	
course	ENTITY
of	
the	
hypoventilation	ENTITY
parallel	ENTITY
the	
use	
and	
dosing	ENTITY
of	
medications	ENTITY
or	
substances	ENTITY
that	
can	
impair	ENTITY
respiration	ENTITY
,	
as	
well	
as	
the	
development	ENTITY
of	
tolerance	ENTITY
to	
these	
substances	ENTITY
.	

There	
may	
be	
variability	ENTITY
in	
susceptibility	ENTITY
to	
hypoventilation	ENTITY
in	
dif-	
ferent	ENTITY
individuals	ENTITY
.	

Comorbid	ENTITY
pulmonary	ENTITY
or	
neurologic	ENTITY
disorders	ENTITY
may	
accentuate	
the	
severity	ENTITY
of	
hypoventilation	ENTITY
.	

Patients	ENTITY
may	
present	
for	
evaluation	ENTITY
of	
suspected	ENTITY
OSA	ENTITY
or	
may	
be	
identified	ENTITY
following	
one	
or	
more	
episodes	ENTITY
of	
respiratory	ENTITY
failure	ENTITY
.	

It	
is	
not	
known	
if	
chronic	ENTITY
use	
of	
respiratory	ENTITY
depressants	ENTITY
can	
lead	
to	
the	
development	ENTITY
of	
pulmo-	
nary	ENTITY
hypertension	ENTITY
,	
polycythemia	ENTITY
,	
and	
cardiac	ENTITY
arrhythmias	ENTITY
.	

Neurocognitive	ENTITY
dysfunc-	
tion	ENTITY
may	
develop	
either	
as	
a	
direct	
result	
of	
medication	ENTITY
usage	ENTITY
or	
as	
a	
consequence	
of	
chronic	ENTITY
hypoxia	ENTITY
and	
hypercapnia	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Hypoventilation	ENTITY
is	
a	
direct	
result	
of	
impaired	ENTITY
respiratory	ENTITY
drive	
and	
CO2	ENTITY
and	
O2	ENTITY
chemo-	
sensitivity	ENTITY
.	

Hypoventilation	ENTITY
worsens	ENTITY
during	
sleep	ENTITY
,	
especially	
in	
REM	ENTITY
sleep	ENTITY
,	
compared	
to	
waking	ENTITY
levels	ENTITY
,	
due	
to	
a	
further	
reduction	ENTITY
in	
chemosensitivity	ENTITY
and	
decreased	ENTITY
activity	ENTITY
of	
the	
ventilatory	ENTITY
muscles	ENTITY
.	

In	
addition	
,	
use	
of	
respiratory	ENTITY
suppressants	ENTITY
may	
give	
rise	
to	
OSA	ENTITY
and	
CSA	ENTITY
that	
may	
contribute	
to	
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

The	
characteristic	
PSG	ENTITY
finding	ENTITY
is	
demonstration	
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
by	
monitoring	ENTITY
of	
PaCO2	ENTITY
or	
acceptable	
surrogate	ENTITY
during	
sleep	ENTITY
.	

Sustained	ENTITY
oxygen	ENTITY
desat-	
uration	ENTITY
during	
sleep	ENTITY
that	
is	
unexplained	
by	
discrete	
apnea	ENTITY
and	
hypopnea	ENTITY
events	ENTITY
is	
common	
.	

However	
,	
this	
finding	
alone	
is	
not	
sufficient	
to	
make	
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Medication	ENTITY
use	ENTITY
can	
also	
produce	
obstructive	ENTITY
or	
central	ENTITY
apneas	ENTITY
.	

Intermittent	ENTITY
arousals	ENTITY
associated	ENTITY
with	ENTITY
hypoxemia	ENTITY
may	
be	
observed	ENTITY
.	

An	
ataxic	ENTITY
breathing	
pattern	
may	
be	
present	
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differential	ENTITY
diagnosis	ENTITY
encompasses	
essentially	
all	
disorders	ENTITY
that	
can	
lead	
to	
hypoventilation	ENTITY
during	
sleep	ENTITY
.	

This	
includes	
OHS	ENTITY
,	
pulmonary	ENTITY
airway	ENTITY
and	
parenchy-	
mal	ENTITY
disorders	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
neuromuscular	ENTITY
and	
chest	
wall	
disor-	
ders	ENTITY
,	
severe	ENTITY
untreated	ENTITY
hypothyroidism	ENTITY
,	
and	
congenital	ENTITY
or	
idiopathic	ENTITY
central	ENTITY
alveo-	ENTITY
lar	ENTITY
hypoventilation	ENTITY
syndromes	ENTITY
.	

OSA	ENTITY
and	
CSA	ENTITY
syndromes	ENTITY
can	
be	
distinguished	
from	
sleep	ENTITY
related	
hypoventilation	ENTITY
by	
the	
periodic	ENTITY
alterations	ENTITY
in	
airflow	ENTITY
and	
accompanying	
periodic	ENTITY
fluctuations	ENTITY
in	
SaO2	ENTITY
.	

In	
contrast	
,	
oxygen	ENTITY
desaturation	ENTITY
due	
to	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
generally	
more	
sustained	ENTITY
,	
usually	
several	
minutes	
or	
longer	ENTITY
in	
dura-	
tion	ENTITY
.	

When	
more	
than	
one	
disorder	ENTITY
is	
believed	
to	
be	
responsible	
for	
the	
ventilatory	ENTITY
insufficiency	ENTITY
during	
sleep	ENTITY
,	
all	
pertinent	
diagnoses	ENTITY
should	
be	
coded	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Studies	ENTITY
of	
the	
factors	ENTITY
influencing	
individual	ENTITY
susceptibility	ENTITY
and	
tolerance	ENTITY
to	
hypoven-	
tilation	ENTITY
/	
hypercapnia	ENTITY
due	
to	
medications	ENTITY
or	
substances	ENTITY
are	
needed	
.	

The	
long	ENTITY
-	
term	ENTITY
con-	ENTITY
sequences	ENTITY
of	
chronic	ENTITY
use	
of	
respiratory	ENTITY
depressants	ENTITY
are	
poorly	
understood	
.	

The	
value	
of	
routinely	
measuring	ENTITY
PaCO2	ENTITY
during	
sleep	ENTITY
in	
patients	ENTITY
taking	
respiratory	ENTITY
depressants	ENTITY
is	
not	
clear	
.	

Additionally	
,	
because	
it	
is	
clinically	ENTITY
impractical	
to	
routinely	
obtain	
arterial	ENTITY
blood	
samples	
during	
sleep	ENTITY
in	
most	
persons	ENTITY
suspected	ENTITY
of	
this	
disorder	ENTITY
,	
other	
techniques	ENTITY
of	
measuring	ENTITY
CO2	ENTITY
levels	ENTITY
must	
be	
investigated	ENTITY
.	

Little	
information	ENTITY
is	
available	
regarding	
the	
effect	ENTITY
of	
oxygen	ENTITY
therapy	ENTITY
or	
noninvasive	ENTITY
ventilation	ENTITY
on	
the	
course	ENTITY
of	
the	
underlying	ENTITY
disease	ENTITY
.	

Studies	ENTITY
are	
needed	
to	
determine	
the	
optimal	ENTITY
time	ENTITY
to	
initiate	ENTITY
these	
interventions	ENTITY
and	
the	
specific	
subpopulations	ENTITY
of	
patients	ENTITY
who	
will	
benefit	ENTITY
most	
from	
these	
therapies	ENTITY
.	

Bibliography	ENTITY
Brown	ENTITY
LK	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Clin	ENTITY
Chest	ENTITY
Med	ENTITY
2010;31:249–70	ENTITY
.	

Casey	ENTITY
KR	ENTITY
,	
Cantillo	ENTITY
KO	ENTITY
,	
Brown	ENTITY
LK	ENTITY
.	

Sleep	ENTITY
-	
related	ENTITY
hypoventilation	ENTITY
/	
hypoxemic	ENTITY
syndromes	ENTITY
.	

Chest	ENTITY
2007;131:1936–48	ENTITY
.	

Chebbo	ENTITY
A	ENTITY
,	
Tfaili	ENTITY
A	ENTITY
,	
Jones	ENTITY
SF	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Med	ENTITY
Clin	ENTITY
North	ENTITY
Am	ENTITY
2011;95:1189–202	ENTITY
.	

Macintyre	ENTITY
PE	ENTITY
,	
Loadsman	ENTITY
JA	ENTITY
,	
Scott	ENTITY
DA	ENTITY
.	

Opioids	ENTITY
,	
ventilation	ENTITY
and	
acute	ENTITY
pain	ENTITY
management	ENTITY
.	

Anaesth	ENTITY
Intensive	ENTITY
Care	ENTITY
2011;39:545–58	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Tassinari	
D	
,	
Sartori	ENTITY
S	ENTITY
,	
Tamburini	
E	
,	
et	
al	
.	

Adverse	ENTITY
effects	ENTITY
of	
transdermal	ENTITY
opiates	ENTITY
treating	ENTITY
moderate	ENTITY
-	
severe	ENTITY
cancer	ENTITY
pain	ENTITY
in	
comparison	ENTITY
to	
long	ENTITY
-	
acting	ENTITY
morphine	ENTITY
:	
a	
meta	ENTITY
-	
analysis	ENTITY
and	
systematic	ENTITY
review	ENTITY
of	
the	
literature	ENTITY
.	

J	
Palliat	
Med	
2008;11:492–501	
.	

Sleep	ENTITY
Related	ENTITY
Hypoventilation	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.26	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.36	ENTITY
Alternate	ENTITY
Names	ENTITY
Alveolar	ENTITY
hypoventilation	ENTITY
,	
nonapneic	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
,	
secondary	
alveolar	ENTITY
hypoventilation	ENTITY
,	
sleep	ENTITY
related	ENTITY
hypoventilation	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
.	

B.	ENTITY
A	ENTITY
lung	ENTITY
parenchymal	ENTITY
or	
airway	ENTITY
disease	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorder	ENTITY
,	
neurologic	ENTITY
disorder	ENTITY
,	
or	
muscle	ENTITY
weakness	ENTITY
is	
believed	
to	
be	
the	
primary	
cause	
of	
hypoventilation	ENTITY
.	

C.	ENTITY
Hypoventilation	ENTITY
is	
not	
primarily	
due	
to	
obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
a	
known	
congenital	ENTITY
central	
alveolar	
hypoventilation	
syndrome	
.	

Notes	ENTITY
.	

Arterial	ENTITY
desaturation	ENTITY
is	
often	
present	
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	
.	

Although	
OSA	ENTITY
or	
CSA	ENTITY
may	
be	
present	
,	
they	
are	
not	
believed	
to	
be	
the	
major	
cause	ENTITY
of	
hypoventilation	ENTITY
.	

The	
predominant	ENTITY
respiratory	ENTITY
pattern	ENTITY
is	
one	
of	
reduced	ENTITY
tidal	ENTITY
volume	ENTITY
or	
ataxic	ENTITY
breathing	ENTITY
and	
associated	
arterial	ENTITY
oxygen	ENTITY
desaturation	ENTITY
.	

When	
criteria	ENTITY
are	
met	
,	
a	
diagnosis	ENTITY
of	
both	
OSA	ENTITY
and	
CSA	ENTITY
due	
to	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
as	
well	
as	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
may	
be	
made	
.	
.	

Hypoventilation	ENTITY
may	
be	
present	
during	
wakefulness	ENTITY
but	
is	
not	
required	
for	
the	
diagnosis	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Lung	ENTITY
airway	ENTITY
or	
parenchymal	ENTITY
disease	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
,	
pulmonary	ENTITY
hypertension	ENTITY
,	
neurologic	ENTITY
and	
neuromuscular	ENTITY
disorders	ENTITY
,	
if	
sufficiently	
severe	ENTITY
,	
can	
result	
in	
ventilatory	ENTITY
impairment	ENTITY
and	
chronic	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
.	

Acute	ENTITY
exacerbations	ENTITY
of	
respiratory	ENTITY
disorders	ENTITY
can	
accentuate	ENTITY
the	
severity	ENTITY
of	
hypoventilation	ENTITY
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
present	
and	
is	
usually	
most	
severe	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

In	
some	
patients	ENTITY
,	
hypercap-	
nia	ENTITY
may	
also	
be	
present	
during	
wakefulness	ENTITY
.	

Patients	ENTITY
can	
either	
be	
asymptomatic	ENTITY
or	
present	
with	
complaints	ENTITY
of	
dyspnea	ENTITY
,	
chest	ENTITY
tightness	ENTITY
,	
or	
fatigue	ENTITY
.	

Polycythemia	ENTITY
is	
often	
noted	
with	
severe	ENTITY
chronic	ENTITY
hypoxemia	ENTITY
.	

Specific	ENTITY
respiratory	ENTITY
disorders	ENTITY
are	
associated	ENTITY
with	ENTITY
abnormal	ENTITY
findings	ENTITY
on	
pulmonary	ENTITY
function	ENTITY
testing	ENTITY
,	
radiographic	ENTITY
imaging	ENTITY
,	
echo-	
cardiography	ENTITY
,	
and	
pulmonary	ENTITY
artery	ENTITY
catheter	ENTITY
measurements	
.	

Suspected	ENTITY
neurologic	ENTITY
or	
neuromuscular	ENTITY
causes	ENTITY
of	
hypoventilation	ENTITY
may	
be	
investigated	ENTITY
using	
central	ENTITY
nervous	ENTITY
system	ENTITY
imaging	ENTITY
or	
measures	ENTITY
of	
peripheral	ENTITY
nerve	ENTITY
or	
muscular	ENTITY
function	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Consequences	ENTITY
of	
chronic	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
arising	
as	
a	
result	
of	
medical	ENTITY
and	
neurologic	ENTITY
disorders	ENTITY
include	
pulmonary	ENTITY
artery	ENTITY
hypertension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
and	
neu-	ENTITY
rocognitive	ENTITY
dysfunction	ENTITY
.	

Some	
of	
these	
disorders	ENTITY
are	
prevalent	
diseases	ENTITY
and	
commonly	
overlap	ENTITY
.	

Patients	ENTITY
with	
multiple	ENTITY
disorders	ENTITY
are	
likely	
to	
experience	
greater	
severity	ENTITY
and	
duration	ENTITY
of	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
than	
are	
patients	ENTITY
with	
either	
disorder	ENTITY
alone	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY

The	
clinical	ENTITY
presentation	ENTITY
varies	
with	
the	
underlying	
disorder	ENTITY
responsible	
for	
the	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
is	
characterized	ENTITY
by	
generally	
fixed	ENTITY
and	
not	
fully	
reversible	
lower	
airways	
obstruction	
,	
and	
includes	
chronic	ENTITY
bronchitis	ENTITY
,	
emphysema	ENTITY
,	
cystic	ENTITY
fibrosis	ENTITY
,	
and	
bronchiectasis	ENTITY
.	

Chronic	ENTITY
bron-	
chitis	ENTITY
is	
a	
clinical	ENTITY
entity	ENTITY
defined	
by	
the	
presence	ENTITY
of	
chronic	ENTITY
productive	ENTITY
cough	ENTITY
for	
at	
least	
three	
months	ENTITY
of	
the	
year	ENTITY
,	
for	
at	
least	
two	
consecutive	ENTITY
years	ENTITY
,	
in	
the	
absence	ENTITY
of	
other	
identifiable	
etiologies	ENTITY
.	

Emphysema	ENTITY
is	
characterized	ENTITY
by	
destruction	ENTITY
of	
lung	ENTITY
tissue	ENTITY
and	
the	
dilation	ENTITY
of	
peripheral	ENTITY
airspaces	
without	
evident	
fibrosis	ENTITY
.	

Emphysema	ENTITY
and	
chronic	ENTITY
bronchitis	ENTITY
often	
coexist	
.	

Alpha-1	ENTITY
antitrypsin	ENTITY
deficiency	ENTITY
is	
a	
genetic	ENTITY
cause	ENTITY
of	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
.	

Both	
bronchiectasis	ENTITY
and	
cystic	ENTITY
fibrosis	ENTITY
are	
characterized	ENTITY
by	
lower	ENTITY
airway	ENTITY
inflammation	ENTITY
and	
destruction	ENTITY
of	
airways	ENTITY
and	
lung	ENTITY
parenchyma	ENTITY
.	

Patients	ENTITY
with	
chronic	ENTITY
lower	ENTITY
airways	ENTITY
obstruction	ENTITY
are	
increasingly	
predis-	
posed	
to	
developing	
hypoventilation	ENTITY
as	
the	
severity	ENTITY
of	
the	
underlying	
lower	
airways	ENTITY
obstruction	ENTITY
increases	ENTITY
.	

Parenchymal	ENTITY
lung	ENTITY
disease	ENTITY
associated	ENTITY
with	ENTITY
restrictive	ENTITY
ventilatory	ENTITY
dysfunction	ENTITY
(	
e.g.	
,	
interstitial	ENTITY
lung	ENTITY
disease	ENTITY
)	
can	
also	
be	
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Neurologic	ENTITY
,	
neuromuscular	ENTITY
,	
and	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
can	
produce	
hypoventilation	ENTITY
due	
to	
an	
abnormal	ENTITY
ventilatory	ENTITY
pump	ENTITY
(	
secondary	
to	
reduced	ENTITY
muscle	ENTITY
strength	ENTITY
or	
anatomic	ENTITY
distortion	ENTITY
of	
the	
chest	ENTITY
wall	ENTITY
structures	ENTITY
)	
that	
is	
unable	
to	
meet	
the	
ventilatory	ENTITY
require-	
ments	ENTITY
for	
maintaining	
PaCO2	ENTITY
at	
or	
below	
45	
mm	
Hg	
.	

In	
addition	
,	
some	
of	
these	
patients	ENTITY
have	
reduced	ENTITY
central	
neural	ENTITY
chemoresponsiveness	ENTITY
.	

Last	
,	
hypoxemia	ENTITY
may	
be	
worsened	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
by	
the	
development	ENTITY
of	
atelectasis	ENTITY
or	
aspiration	ENTITY
due	
to	
defective	ENTITY
swallowing	ENTITY
associated	ENTITY
with	ENTITY
some	
neurologic	ENTITY
and	
neuromuscular	ENTITY
conditions	ENTITY
.	

Demographics	ENTITY
The	
demographics	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
are	
a	
function	ENTITY
of	
the	
prevalence	ENTITY
,	
clinical	ENTITY
characteristics	ENTITY
,	
and	
degree	ENTITY
of	
severity	ENTITY
of	
the	
under-	
lying	ENTITY
conditions	ENTITY
.	

Thus	
,	
prevalence	ENTITY
may	
be	
higher	ENTITY
in	
patients	ENTITY
with	
greater	
perturbations	ENTITY
of	
pulmonary	ENTITY
function	ENTITY
or	
neuromuscular	ENTITY
weakness	ENTITY
.	

Individuals	ENTITY
with	
chronic	ENTITY
hyper-	
capnia	ENTITY
during	
wakefulness	ENTITY
will	
experience	ENTITY
even	
greater	
decrements	ENTITY
of	
alveolar	ENTITY
venti-	
lation	ENTITY
during	
sleep	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Greater	ENTITY
impairments	ENTITY
of	
respiratory	ENTITY
function	ENTITY
are	
associated	ENTITY
with	ENTITY
greater	
risk	ENTITY
for	
sleep	ENTITY
related	
hypoventilation	ENTITY
and	
hypoxemia	ENTITY
.	

However	
,	
there	
is	
no	
recognized	
threshold	ENTITY
of	
pulmonary	ENTITY
parenchymal	ENTITY
or	
vascular	ENTITY
disease	ENTITY
severity	ENTITY
that	
adequately	
predicts	
the	
risk	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Reduced	ENTITY
chemosensitivity	ENTITY
may	
be	
present	
in	
some	
neuromuscular	ENTITY
disorders	ENTITY
.	

The	
use	
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
depressants	ENTITY
,	
such	
as	
alcohol	ENTITY
,	
anxiolytics	ENTITY
,	
and	
hypnotics	ENTITY
,	
may	
further	
worsen	ENTITY
respira-	
tory	
impairment	
.	

Patients	ENTITY
who	
are	
hypercapnic	ENTITY
and	
hypoxemic	ENTITY
during	
wakefulness	ENTITY
will	
generally	
become	
even	
more	
so	
during	
sleep	ENTITY
,	
in	
particular	
REM	ENTITY
sleep	ENTITY
,	
but	
the	
rela-	
tionship	ENTITY
between	
wake	
SaO2	ENTITY
/	
PaCO2	ENTITY
and	
sleep	ENTITY
related	ENTITY
desaturation	ENTITY
is	
not	
sufficiently	
strong	
to	
have	
substantial	ENTITY
predictive	ENTITY
value	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Genetic	ENTITY
patterns	ENTITY
for	
many	
of	
the	
disorders	ENTITY
are	
not	
known	
.	

Alpha-1	ENTITY
antitrypsin	ENTITY
defi-	
ciency	ENTITY
is	
a	
genetic	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
defective	ENTITY
production	ENTITY
of	
the	
enzyme	ENTITY
inhib-	ENTITY
itor	ENTITY
;	
severe	
forms	
of	
deficiency	ENTITY
can	
lead	
to	
emphysema	ENTITY
.	

Genetic	ENTITY
causes	ENTITY
of	
bronchi-	
ectasis	ENTITY
include	
primary	ENTITY
ciliary	ENTITY
dyskinesia	ENTITY
and	
cystic	ENTITY
fibrosis	ENTITY
.	

Muscular	ENTITY
dystrophies	ENTITY
are	
genetically	ENTITY
inherited	ENTITY
.	

The	
familial	ENTITY
patterns	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
due	
to	
these	
disorders	ENTITY
reflect	
those	
of	
the	
underlying	
inherited	ENTITY
conditions	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
and	
course	ENTITY
of	
the	
hypoventilation	ENTITY
parallels	
the	
presence	ENTITY
and	
severity	ENTITY
of	
the	
underlying	
medical	ENTITY
or	
neurological	ENTITY
disorders	ENTITY
that	
impair	ENTITY
respiration	ENTITY
although	
substan-	
tial	ENTITY
variability	ENTITY
in	
course	ENTITY
is	
observed	ENTITY
even	
within	
the	
same	
underlying	
condition	ENTITY
.	

Many	
affected	ENTITY
individuals	ENTITY
with	
severe	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
develop	
respiratory	ENTITY
impairment	ENTITY
,	
pulmonary	ENTITY
hypertension	ENTITY
,	
heart	ENTITY
failure	ENTITY
,	
cardiac	ENTITY
arrhythmias	ENTITY
,	
and	
neurocog-	
nitive	ENTITY
dysfunction	ENTITY
.	

Polycythemia	ENTITY
is	
common	
in	
those	
with	
chronic	ENTITY
hypoxia	ENTITY
.	

Although	
the	
risk	ENTITY
of	
increased	ENTITY
morbidity	ENTITY
and	
mortality	ENTITY
appears	
to	
increase	ENTITY
with	
worsening	ENTITY
sleep	
related	
hypoventilation	ENTITY
,	
the	
specific	
relationship	ENTITY
between	
sleep	ENTITY
related	
hypoventilation	ENTITY
and	
morbidity	ENTITY
and	
mortality	ENTITY
is	
not	
well	
defined	
.	

Many	
patients	ENTITY
respond	
to	
assisted	ENTITY
ven-	
tilation	ENTITY
,	
whereas	
hypercapnia	ENTITY
may	
worsen	ENTITY
with	
oxygen	ENTITY
therapy	ENTITY
alone	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Pulmonary	ENTITY
parenchymal	ENTITY
diseases	ENTITY
are	
characterized	ENTITY
by	
altered	
lung	ENTITY
volumes	ENTITY
(	
e.g.	
,	
reduced	ENTITY
functional	
residual	
capacity	ENTITY
)	
and	
abnormal	ENTITY
ventilation	ENTITY
/	
perfusion	ENTITY
relationships	ENTITY
,	
which	
can	
result	
in	
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
during	
wakefulness	ENTITY
.	

Decreased	ENTITY
lung	ENTITY
volume	ENTITY
is	
associated	ENTITY
with	ENTITY
reduced	ENTITY
oxygen	ENTITY
reserves	ENTITY
that	
increase	ENTITY
the	
risk	ENTITY
of	
hypoxemia	ENTITY
.	

In	
addition	
,	
sleep	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
an	
altered	
pattern	ENTITY
of	
ventilatory	ENTITY
-	
muscle	ENTITY
acti-	
vation	ENTITY
,	
particularly	
during	
REM	ENTITY
sleep	ENTITY
when	
,	
due	
to	
reduced	ENTITY
activation	ENTITY
of	
the	
intercos-	
tal	ENTITY
and	
accessory	ENTITY
muscles	ENTITY
,	
there	
is	
a	
disproportionate	ENTITY
ventilatory	ENTITY
burden	ENTITY
placed	
on	
the	
diaphragm	ENTITY
.	

This	
may	
lead	
to	
hypoventilation	ENTITY
in	
patients	ENTITY
with	
chest	ENTITY
wall	ENTITY
abnormalities	ENTITY
or	
in	
those	
with	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
.	

In	
the	
latter	
,	
lung	ENTITY
hyperinfla-	
tion	ENTITY
creates	
a	
mechanical	ENTITY
disadvantage	ENTITY
to	
the	
diaphragm	ENTITY
.	

Many	
neurologic	ENTITY
and	
neu-	ENTITY
romuscular	ENTITY
disorders	ENTITY
are	
associated	ENTITY
with	ENTITY
impaired	ENTITY
respiratory	ENTITY
mechanics	ENTITY
and	
reduced	ENTITY
CO2	ENTITY
chemosensitivity	ENTITY
.	

Finally	
,	
daytime	ENTITY
hypoxemia	ENTITY
,	
if	
sufficiently	
severe	ENTITY
,	
may	
place	
the	
patient	ENTITY
near	
or	
on	
the	
steep	ENTITY
portion	ENTITY
of	
the	
oxyhemoglobin	ENTITY
dissociation	ENTITY
curve	ENTITY
,	
where	
even	
relatively	
small	
decrements	ENTITY
in	
arterial	ENTITY
oxygen	ENTITY
tension	ENTITY
result	
in	
large	
decrements	ENTITY
in	
oxyhemoglobin	ENTITY
saturation	ENTITY
.	

Thus	
,	
sleep	ENTITY
related	
hypoventilation	ENTITY
in	
these	
patients	ENTITY
may	
have	
a	
relatively	
great	
impact	ENTITY
on	
oxyhemoglobin	ENTITY
saturation	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

The	
characteristic	
polysomnographic	ENTITY
finding	ENTITY
is	
demonstration	
of	
sleep	ENTITY
related	
hypoven-	
tilation	ENTITY
(	
by	
arterial	ENTITY
PaCO2	ENTITY
,	
transcutaneous	ENTITY
PCO2	ENTITY
,	
or	
end	ENTITY
-	
tidal	ENTITY
PCO2	ENTITY
)	
.	

Sustained	ENTITY
oxygen	ENTITY
desaturation	ENTITY
during	
sleep	ENTITY
that	
is	
unexplained	
by	
discrete	
apnea	ENTITY
and	
hypopnea	ENTITY
events	ENTITY
is	
common	
but	
is	
not	
sufficient	
to	
establish	
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	

Intermittent	ENTITY
arousals	ENTITY
associated	ENTITY
with	ENTITY
hypoxemia	ENTITY
may	
be	
observed	ENTITY
.	

Many	
medical	ENTITY
and	
neurologic	ENTITY
disorders	ENTITY
are	
associated	ENTITY
with	ENTITY
significant	ENTITY
sleep	ENTITY
disturbances	ENTITY
and	
changes	ENTITY
in	
sleep	ENTITY
architecture	ENTITY
,	
including	
prolonged	ENTITY
sleep	ENTITY
onset	ENTITY
latency	
,	
reduced	ENTITY
sleep	ENTITY
efficiency	ENTITY
,	
and	
decreased	ENTITY
sleep	ENTITY
stages	ENTITY
N3	ENTITY
and	
REM	ENTITY
,	
may	
be	
present	
.	

Obstructive	ENTITY
and	
central	ENTITY
apneas	ENTITY
,	
when	
present	
,	
will	
further	
disturb	ENTITY
sleep	ENTITY
and	
accentuate	ENTITY
sleep	ENTITY
related	
oxyhe-	
moglobin	ENTITY
desaturation	ENTITY
.	

Daytime	ENTITY
arterial	ENTITY
blood	ENTITY
gases	ENTITY
may	
be	
normal	ENTITY
or	
show	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
.	

Chronic	ENTITY
hypoxia	ENTITY
(	
especially	
when	
present	
during	
the	
day	ENTITY
as	
well	
as	
at	
night	ENTITY
)	
can	
be	
associated	ENTITY
with	ENTITY
polycythemia	ENTITY
.	

Electrocardiography	ENTITY
,	
chest	ENTITY
radiography	ENTITY
,	
and	
echocardiography	ENTITY
may	
demonstrate	
evidence	ENTITY
of	
pulmonary	ENTITY
hypertension	ENTITY
.	

In	
patients	ENTITY
with	
neuromuscular	ENTITY
weakness	ENTITY
or	
restrictive	ENTITY
chest	ENTITY
wall	ENTITY
disorders	ENTITY
spirometry	ENTITY
shows	
a	
restrictive	
ventilatory	ENTITY
dysfunction	ENTITY
with	
the	
forced	ENTITY
vital	ENTITY
capacity	ENTITY
(	
FVC	ENTITY
)	
often	
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
less	
than	
50	
%	
of	
predicted	ENTITY
.	

However	
,	
significant	
nocturnal	ENTITY
desaturation	ENTITY
can	
occur	
with	
FVC	ENTITY
values	ENTITY
greater	
than	
50	
%	
of	
predicted	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differential	ENTITY
diagnosis	ENTITY
includes	
all	
disorders	ENTITY
which	
can	
give	
rise	
to	
hypoventila-	
tion	ENTITY
during	
sleep	ENTITY
.	

This	
includes	
OHS	ENTITY
,	
use	
of	
medications	ENTITY
or	
substances	ENTITY
that	
can	
sup-	ENTITY
press	ENTITY
respiratory	ENTITY
drive	
,	
and	
congenital	ENTITY
or	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
syndromes	ENTITY
.	

OSA	ENTITY
and	
CSA	ENTITY
can	
be	
distinguished	
from	
sleep	ENTITY
related	
hypoventilation	ENTITY
by	
the	
periodic	ENTITY
alterations	ENTITY
in	
airflow	ENTITY
and	
accompanying	
periodic	ENTITY
fluctuations	ENTITY
in	
SaO2	ENTITY
.	

In	
contrast	
,	
oxygen	ENTITY
desaturation	ENTITY
due	
to	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
generally	
more	
sustained	ENTITY
,	
usually	
several	
minutes	
or	
longer	ENTITY
in	
duration	ENTITY
.	

When	
more	
than	
one	
disorder	ENTITY
is	
believed	
to	
be	
responsible	
for	
the	
ventilatory	ENTITY
insufficiency	ENTITY
during	
sleep	ENTITY
,	
all	
pertinent	
diagnoses	ENTITY
should	
be	
coded	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Thresholds	ENTITY
of	
impairments	ENTITY
of	
ventilation	ENTITY
and	
respiratory	ENTITY
drive	
producing	
hypercapnia/	
hypoxemia	ENTITY
need	
to	
be	
identified	ENTITY
.	

The	
degree	ENTITY
and	
duration	ENTITY
of	
hypercapnia	ENTITY
/	
hypoxemia	ENTITY
necessary	
to	
produce	
adverse	ENTITY
consequences	ENTITY
,	
such	
as	
pulmonary	ENTITY
hypertension	ENTITY
,	
in	
indi-	
vidual	ENTITY
patients	ENTITY
is	
not	
well	
defined	
.	

The	
value	
of	
routinely	
measuring	ENTITY
PaCO2	ENTITY
during	
sleep	ENTITY
in	
these	
patients	ENTITY
is	
not	
clear	
.	

Additionally	
,	
because	
it	
is	
clinically	ENTITY
impractical	
to	
routinely	
obtain	
arterial	ENTITY
blood	
samples	
during	
sleep	ENTITY
in	
most	
persons	ENTITY
suspected	ENTITY
of	
this	
disorder	ENTITY
,	
other	
techniques	ENTITY
of	
measuring	ENTITY
CO2	ENTITY
levels	ENTITY
must	
be	
investigated	ENTITY
.	

Little	
infor-	
mation	ENTITY
is	
available	
regarding	
the	
effect	ENTITY
of	
oxygen	ENTITY
therapy	ENTITY
or	
noninvasive	ENTITY
ventilation	ENTITY
on	
the	
course	ENTITY
of	
the	
underlying	ENTITY
disease	ENTITY
.	

Studies	ENTITY
are	
needed	
to	
determine	
the	
optimal	ENTITY
time	ENTITY
to	
initiate	ENTITY
these	
interventions	ENTITY
and	
the	
specific	
subpopulations	ENTITY
of	
patients	ENTITY
who	
will	
benefit	ENTITY
most	
from	
these	
therapies	ENTITY
.	

Bibliography	ENTITY
Ambrosino	ENTITY
N	ENTITY
,	
Carpenè	
N	
,	
Gherardi	
M.	
Chronic	ENTITY
respiratory	ENTITY
care	ENTITY
for	
neuromuscular	ENTITY
diseases	ENTITY
in	
adults	ENTITY
.	

Eur	
Respir	
J	
2009;34:444–51	
.	

Beuther	ENTITY
DA	ENTITY
.	

Hypoventilation	ENTITY
in	
asthma	ENTITY
and	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:321–9	
.	

Biering	ENTITY
-	
Sørensen	ENTITY
F	ENTITY
,	
Jennum	ENTITY
P	ENTITY
,	
Laub	
M.	
Sleep	
disordered	ENTITY
breathing	ENTITY
following	
spinal	ENTITY
cord	ENTITY
injury	ENTITY
.	

Respir	
Physiol	
Neurobiol	
2009;169:165–70	
.	

Castriotta	ENTITY
RJ	ENTITY
,	
Murthy	ENTITY
JN	ENTITY
.	

Hypoventilation	ENTITY
after	
spinal	ENTITY
cord	ENTITY
injury	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:330–8	
.	

Dhand	ENTITY
UK	ENTITY
,	
Dhand	ENTITY
R.	ENTITY
Sleep	ENTITY
disorders	ENTITY
in	
neuromuscular	ENTITY
diseases	ENTITY
.	

Curr	ENTITY
Opin	ENTITY
Pulm	ENTITY
Med	ENTITY
2006;12:402–8	ENTITY
.	

Donath	
J	
,	
Miller	
A.	
Restrictive	
chest	
wall	
disorders	
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:275–92	ENTITY
.	

Fathi	ENTITY
M	ENTITY
,	
Lundberg	ENTITY
IE	ENTITY
,	
Tornling	
G.	
Pulmonary	
complications	
of	
polymyositis	ENTITY
and	
dermatomyositis	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2007;28:451–8	ENTITY
.	

Glass	ENTITY
GA	ENTITY
,	
Josephs	
KA	ENTITY
,	
Ahlskog	
JE	ENTITY
.	

Respiratory	ENTITY
insufficiency	ENTITY
as	
the	
primary	
presenting	
symptom	ENTITY
of	
multiple	ENTITY
-	
system	ENTITY
atrophy	ENTITY
.	

Arch	ENTITY
Neurol	ENTITY
2006;63:978–81	ENTITY
.	

Kennedy	ENTITY
JD	ENTITY
,	
Martin	ENTITY
AJ	ENTITY
.	

Chronic	ENTITY
respiratory	ENTITY
failure	ENTITY
and	
neuromuscular	ENTITY
disease	ENTITY
.	

Pediatr	ENTITY
Clin	ENTITY
North	ENTITY
Am	ENTITY
2009;56:261–73	ENTITY
,	ENTITY
xii	
.	

Taylor	ENTITY
-	
Cousar	ENTITY
JL	ENTITY
.	

Hypoventilation	ENTITY
in	
cystic	ENTITY
fibrosis	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:293–302	
.	

Toussaint	ENTITY
M	ENTITY
,	
Chatwin	ENTITY
M	ENTITY
,	
Soudon	ENTITY
P.	ENTITY
Mechanical	ENTITY
ventilation	ENTITY
in	
Duchenne	ENTITY
patients	ENTITY
with	
chronic	ENTITY
respiratory	ENTITY
insufficiency	ENTITY
:	
clinical	ENTITY
implications	
of	
20	
years	ENTITY
published	ENTITY
experience	ENTITY
.	

Chron	ENTITY
Respir	ENTITY
Dis	ENTITY
2007;4:167–77	ENTITY
.	

Vazquez	ENTITY
-	
Sandoval	ENTITY
A	ENTITY
,	
Huang	ENTITY
EJ	ENTITY
,	
Jones	ENTITY
SF	ENTITY
.	

Hypoventilation	ENTITY
in	
neuromuscular	ENTITY
disease	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:348–58	
.	

Wider	ENTITY
C	ENTITY
,	
Wszolek	ENTITY
ZK	ENTITY
.	

Rapidly	
progressive	ENTITY
familial	ENTITY
parkinsonism	ENTITY
with	
central	ENTITY
hypoventilation	ENTITY
,	
depression	ENTITY
and	
weight	ENTITY
loss	ENTITY
(	
Perry	
syndrome)--a	
literature	ENTITY
review	ENTITY
.	

Parkinsonism	ENTITY
Relat	ENTITY
Disord	ENTITY
2008;14:1–7	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoxemia	ENTITY
Disorder	ENTITY
Sleep	ENTITY
Related	ENTITY
Hypoxemia	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.26	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.36	ENTITY
Alternate	ENTITY
Names	ENTITY
Nocturnal	ENTITY
oxygen	ENTITY
(	
or	
oxyhemoglobin	ENTITY
)	
desaturation	
,	
low	ENTITY
nocturnal	ENTITY
oxygen	ENTITY
saturation	ENTITY
,	
nocturnal	ENTITY
hypoxemia	ENTITY
,	
sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY
,	
sleep	ENTITY
related	
oxygen	ENTITY
desaturation	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY
PSG	ENTITY
,	
OCST	ENTITY
or	
nocturnal	ENTITY
oximetry	ENTITY
shows	
the	
arterial	ENTITY
oxygen	ENTITY
saturation	ENTITY
(	
SpO2	ENTITY
)	
during	
sleep	ENTITY
of	
≤	
88	
%	
in	
adults	ENTITY
or	
≤	
90	
%	
in	
children	ENTITY
for	
≥	
5	
minutes	ENTITY
.	

B.	ENTITY
Sleep	ENTITY
related	
hypoventilation	ENTITY
is	
not	
documented.1	ENTITY
Notes	ENTITY
.	

If	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
documented	ENTITY
(	
as	
measured	
by	
arterial	ENTITY
blood	ENTITY
gas	ENTITY
,	
transcutaneous	ENTITY
PCO2	ENTITY
,	
or	
end	ENTITY
-	
tidal	ENTITY
CO2	ENTITY
sensors	ENTITY
)	
,	
the	
disorder	ENTITY
is	
classified	
as	
sleep	ENTITY
related	
hypoventilation	ENTITY
.	
.	

OSA	ENTITY
or	
CSA	ENTITY
may	
be	
present	
,	
but	
these	
are	
not	
believed	
to	
be	
the	
major	
cause	
of	
hypoxemia	ENTITY
.	
.	

Physiological	ENTITY
causes	ENTITY
,	
if	
known	
,	
should	
be	
indicated	
(	
e.g.	
,	
shunt	ENTITY
,	
ventilation	ENTITY
-	
perfusion	ENTITY
[	
V	
/	
Q	ENTITY
]	
mismatch	ENTITY
,	
low	
mixed	ENTITY
venous	ENTITY
oxygen	ENTITY
,	
and/	ENTITY
or	
high	ENTITY
altitude	ENTITY
)	
.	

Essential	ENTITY
Features	ENTITY
Significant	
hypoxemia	ENTITY
during	
sleep	ENTITY
is	
present	
and	
is	
believed	
to	
be	
secondary	
to	
a	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
.	

The	
presence	ENTITY
of	
hypoxemia	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
(	
e.g.	
,	
OSA	ENTITY
)	
.	

Although	
some	
amount	
of	
obstructive	ENTITY
or	
central	ENTITY
apnea	ENTITY
may	
be	
present	
,	
these	
disorders	ENTITY
are	
not	
thought	
to	
be	
pri-	ENTITY
marily	ENTITY
responsible	
for	
the	
hypoxemia	ENTITY
during	
sleep	ENTITY
.	

Some	
patients	ENTITY
with	
sleep	ENTITY
related	
hypoxemia	ENTITY
also	
exhibit	
hypoxemia	ENTITY
during	
wakefulness	ENTITY
.	

Sleep	ENTITY
related	
hypoventilation	ENTITY
has	
not	
been	
documented	ENTITY
(	
if	
so	
,	
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
is	
made	
)	
.	

The	
presentation	ENTITY
of	
patients	ENTITY
with	
sleep	ENTITY
related	
hypoxemia	ENTITY
varies	
with	
the	
underly-	
ing	
medical	ENTITY
or	
neurological	ENTITY
disorders	ENTITY
.	

Chronic	ENTITY
hypoxemia	ENTITY
can	
arise	
from	
airway	ENTITY
or	
parenchymal	ENTITY
pulmonary	ENTITY
disease	ENTITY
,	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
,	
pulmonary	ENTITY
hypertension	ENTITY
,	
or	
neurologic	ENTITY
and	
neuromuscular	ENTITY
disorders	ENTITY
.	

Acute	ENTITY
exacerbations	ENTITY
of	
respiratory	ENTITY
disorders	ENTITY
can	
accentuate	ENTITY
the	
severity	ENTITY
of	
hypoxemia	ENTITY
.	

Hypoxemia	ENTITY
due	
to	
underlying	
lower	ENTITY
airway	
obstructive	
disease	
,	
pulmonary	ENTITY
parenchymal	ENTITY
disease	ENTITY
,	
vascular	ENTITY
pathology	ENTITY
,	
and	
other	
causes	
of	
hypoventilation	ENTITY
is	
generally	
sustained	ENTITY
(	
several	
minutes	
or	
longer	ENTITY
)	
,	
whereas	
sawtooth	
fluctuations	ENTITY
of	
oxygen	ENTITY
saturation	ENTITY
(	
typically	
less	
than	
one	
minute	
)	
characterize	ENTITY
hypoxemia	ENTITY
due	
to	
OSA	ENTITY
or	
CSA	ENTITY
.	

Patients	ENTITY
can	
either	
be	
asymptomatic	ENTITY
or	
present	
with	
complaints	ENTITY
of	
nocturnal	ENTITY
dyspnea	ENTITY
,	
impaired	ENTITY
sleep	ENTITY
quality	ENTITY
,	
chest	ENTITY
tightness	ENTITY
,	
or	
fatigue	ENTITY
.	

Polycythemia	ENTITY
is	
often	
noted	
with	
severe	ENTITY
chronic	ENTITY
hypoxemia	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Consequences	ENTITY
of	
chronic	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
include	
pulmonary	ENTITY
artery	ENTITY
hyper-	
tension	ENTITY
,	
cor	ENTITY
pulmonale	ENTITY
,	
and	
neurocognitive	ENTITY
dysfunction	ENTITY
.	

Some	
of	
the	
disorders	ENTITY
causing	
hypoxemia	ENTITY
are	
prevalent	
diseases	ENTITY
and	
not	
uncommonly	
overlap	ENTITY
.	

Patients	ENTITY
with	
multi-	
ple	ENTITY
breathing	ENTITY
disorders	ENTITY
are	
likely	
to	
experience	
greater	
severity	ENTITY
and	
duration	ENTITY
of	ENTITY
sleep	ENTITY
related	
hypoxemia	ENTITY
than	
are	
patients	ENTITY
with	
a	
single	ENTITY
disorder	ENTITY
.	

Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
Specific	
variations	ENTITY
in	
the	
sleep	ENTITY
related	
findings	ENTITY
have	
not	
been	
described	
for	
the	
various	
etiologies	ENTITY
.	

Demographics	ENTITY
The	
demographics	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
are	
a	
function	ENTITY
of	
the	
prevalence	ENTITY
,	
clinical	ENTITY
characteristics	ENTITY
and	
degree	ENTITY
of	
severity	ENTITY
of	
the	
underlying	
conditions	ENTITY
.	

Thus	
,	
prevalence	ENTITY
may	
be	
higher	ENTITY
in	
patients	ENTITY
with	
greater	
perturbations	ENTITY
of	
pulmonary	ENTITY
function	ENTITY
or	
neu-	ENTITY
romuscular	ENTITY
weakness	ENTITY
.	

Individuals	ENTITY
with	
chronic	ENTITY
hypoxemia	ENTITY
during	
wakefulness	ENTITY
will	
experience	ENTITY
even	
greater	
decrements	ENTITY
of	
oxygenation	ENTITY
during	
sleep	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Greater	ENTITY
impairments	ENTITY
of	
respiratory	ENTITY
function	ENTITY
are	
associated	ENTITY
with	ENTITY
greater	
risk	ENTITY
for	
sleep	ENTITY
related	
hypoxemia	ENTITY
.	

However	
,	
there	
is	
no	
recognized	
threshold	ENTITY
of	
pulmonary	ENTITY
paren-	
chymal	
or	
vascular	ENTITY
disease	ENTITY
severity	ENTITY
or	
extent	
of	
neuromuscular	ENTITY
weakness	ENTITY
that	
ade-	

quately	ENTITY
predicts	
the	
risk	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Patients	ENTITY
who	
are	
hypoxemic	ENTITY
during	
wakefulness	ENTITY
will	
generally	
become	
even	
more	
so	
during	
sleep	ENTITY
,	
especially	
REM	ENTITY
sleep	ENTITY
.	

Among	
the	
best	
predictors	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
are	
reduced	ENTITY
baseline	ENTITY
wake	
SaO2	ENTITY
and	
hypercapnia	ENTITY
.	

Patients	ENTITY
with	
wake	ENTITY
hypercapnia	ENTITY
should	
be	
suspected	ENTITY
of	
sleep	
related	
hypoxemia	ENTITY
.	

However	
,	
the	
relationship	ENTITY
between	
wake	ENTITY
SaO2	ENTITY
/	
PaCO2	ENTITY
and	
sleep	ENTITY
related	ENTITY
desaturation	ENTITY
is	
not	
sufficiently	
strong	
to	
have	
substantial	ENTITY
predictive	ENTITY
value	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Familial	ENTITY
Patterns	ENTITY
Genetic	ENTITY
patterns	ENTITY
for	
many	
of	
the	
disorders	ENTITY
are	
not	
known	
.	

Alpha-1	ENTITY
antitrypsin	ENTITY
defi-	
ciency	ENTITY
is	
a	
genetic	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
defective	ENTITY
production	ENTITY
of	
the	
enzyme	ENTITY
inhib-	ENTITY
itor	ENTITY
;	
severe	
forms	
of	
deficiency	ENTITY
can	
lead	
to	
emphysema	ENTITY
.	

Genetic	ENTITY
causes	ENTITY
of	
bronchiec-	
tasis	ENTITY
include	
primary	ENTITY
ciliary	ENTITY
dyskinesia	ENTITY
and	
cystic	ENTITY
fibrosis	ENTITY
.	

Muscular	ENTITY
dystrophies	ENTITY
are	
genetically	ENTITY
inherited	ENTITY
.	

The	
familial	ENTITY
patterns	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
due	
to	
these	
disorders	ENTITY
reflect	
those	
of	
the	
underlying	
inherited	ENTITY
conditions	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
and	
course	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
parallel	
the	
presence	ENTITY
and	
severity	ENTITY
of	
the	
underlying	
medical	ENTITY
or	
neurological	ENTITY
disorders	ENTITY
that	
impair	ENTITY
respiration	ENTITY
,	
although	
sub-	
stantial	ENTITY
variability	ENTITY
in	
course	ENTITY
is	
observed	ENTITY
even	
within	
the	
same	
underlying	
condition	ENTITY
.	

Many	
affected	ENTITY
individuals	ENTITY
with	
severe	ENTITY
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
develop	
respiratory	ENTITY
impairment	ENTITY
,	
pulmonary	ENTITY
hypertension	ENTITY
,	
heart	ENTITY
failure	ENTITY
,	
cardiac	ENTITY
arrhythmias	ENTITY
,	
and	
neuro-	ENTITY
cognitive	ENTITY
dysfunction	ENTITY
.	

Polycythemia	ENTITY
is	
common	
in	
those	
with	
chronic	ENTITY
hypoxia	ENTITY
.	

Higher	ENTITY
rates	ENTITY
of	
painful	ENTITY
crises	ENTITY
accompany	
hypoxemia	ENTITY
in	
children	ENTITY
with	
sickle	ENTITY
cell	ENTITY
disease	ENTITY
.	

Although	
the	
risk	ENTITY
of	
increased	ENTITY
morbidity	ENTITY
and	
mortality	ENTITY
appears	
to	
increase	ENTITY
with	
wors-	
ening	
sleep	ENTITY
related	
hypoxemia	ENTITY
,	
the	
specific	
relationship	ENTITY
between	
sleep	ENTITY
related	
hypox-	
emia	ENTITY
and	
morbidity	ENTITY
and	
mortality	ENTITY
is	
not	
well	
defined	
.	

Many	
patients	ENTITY
respond	
to	
oxygen	ENTITY
therapy	ENTITY
;	
in	
some	
,	
hypercapnia	ENTITY
may	
worsen	ENTITY
with	
oxygen	ENTITY
therapy	ENTITY
alone	
for	
hypoxia	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Hypoxemia	ENTITY
may	
arise	
from	
a	
shunt	ENTITY
physiology	ENTITY
,	
ventilation	ENTITY
-	
perfusion	ENTITY
[	
V	
/	
Q	ENTITY
]	
mismatch-	
ing	
,	
low	
mixed	ENTITY
venous	ENTITY
oxygen	ENTITY
,	
and/or	
high	ENTITY
altitude	ENTITY
.	

Hypoventilation	ENTITY
also	
gives	
rise	
to	
hypoxemia	ENTITY
;	
however	
,	
when	
hypoventilation	ENTITY
has	
been	
documented	ENTITY
,	
a	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
hypoventilation	ENTITY
should	
be	
assigned	ENTITY
,	
rather	
than	
sleep	ENTITY
related	
hypoxemia	ENTITY
.	

Pulmonary	ENTITY
parenchymal	ENTITY
diseases	ENTITY
are	
characterized	ENTITY
by	
altered	
lung	ENTITY
volumes	ENTITY
(	
e.g.	
,	
reduced	ENTITY
functional	
residual	
capacity	ENTITY
)	
and	
abnormal	ENTITY
ventilation	ENTITY
/	
perfusion	ENTITY
relationships	ENTITY
,	
which	
can	
result	
in	
hypercapnia	ENTITY
and	
hypoxemia	ENTITY
during	
wakefulness	ENTITY
.	

Decreased	ENTITY
lung	ENTITY
volume	ENTITY
is	
associated	ENTITY
with	ENTITY
reduced	ENTITY
oxygen	ENTITY
reserves	ENTITY
that	
increase	ENTITY
the	
risk	ENTITY
of	
hypoxemia	ENTITY
.	

In	
addition	
,	
sleep	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
an	
altered	
pattern	ENTITY
of	
ventilatory	ENTITY
muscle	ENTITY
acti-	
vation	ENTITY
,	
particularly	
during	
REM	ENTITY
sleep	ENTITY
when	
,	
due	
to	
reduced	ENTITY
activation	ENTITY
of	
the	
intercos-	
tal	ENTITY
and	
accessory	ENTITY
muscles	ENTITY
,	
there	
is	
a	
disproportionate	ENTITY
ventilatory	ENTITY
burden	ENTITY
placed	
on	
the	
diaphragm	ENTITY
.	

This	
may	
lead	
to	
hypoventilation	ENTITY
in	
patients	ENTITY
with	
chest	ENTITY
wall	ENTITY
abnormalities	ENTITY
or	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
.	

In	
the	
latter	
,	
lung	ENTITY
hyperinflation	ENTITY
creates	
a	
mechanical	ENTITY
disadvantage	
to	
the	
diaphragm	ENTITY
.	

In	
sickle	ENTITY
cell	ENTITY
anemia	ENTITY
,	
decreased	ENTITY
oxyhemo-	
globin	ENTITY
affinity	ENTITY
may	
partly	
contribute	
to	
hypoxemia	ENTITY
.	

Many	
neurologic	ENTITY
and	
neuromuscu-	
lar	ENTITY
disorders	ENTITY
are	
associated	ENTITY
with	ENTITY
impaired	ENTITY
respiratory	ENTITY
mechanics	ENTITY
and	
reduced	ENTITY
CO2	ENTITY
che-	
mosensitivity	ENTITY
.	

Finally	
,	
daytime	ENTITY
hypoxemia	ENTITY
,	
if	
sufficiently	
severe	ENTITY
,	
may	
place	
the	
patient	ENTITY
near	
or	
on	
the	
steep	ENTITY
portion	ENTITY
of	
the	
oxyhemoglobin	ENTITY
dissociation	ENTITY
curve	ENTITY
where	
even	
rela-	
tively	
small	
decrements	ENTITY
in	
arterial	ENTITY
oxygen	ENTITY
tension	ENTITY
result	
in	
large	
decrements	ENTITY
in	
oxyhe-	
moglobin	ENTITY
saturation	ENTITY
.	

Thus	
,	
sleep	ENTITY
related	
hypoventilation	ENTITY
in	
these	
patients	ENTITY
might	
have	
a	
relatively	
great	
impact	ENTITY
on	
oxyhemoglobin	ENTITY
saturation	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Various	
patterns	ENTITY
of	
oxygen	ENTITY
desaturation	ENTITY
(	
sustained	ENTITY
,	
intermittent	ENTITY
,	
or	
episodic	ENTITY
)	
may	
be	
observed	
during	
sleep	ENTITY
.	

The	
diagnosis	ENTITY
is	
generally	
made	
on	
the	
basis	
of	
overnight	ENTITY
oxim-	
etry	ENTITY
(	
alone	
or	
as	
a	
component	
of	
PSG	ENTITY
or	
OCST	ENTITY
)	
;	
less	
commonly	
,	
arterial	ENTITY
blood	ENTITY
gas	ENTITY
mea-	ENTITY
surements	ENTITY
are	
indicated	
,	
especially	
if	
concomitant	ENTITY
hypoventilation	ENTITY
is	
suspected	ENTITY
.	

PSG	ENTITY
may	
demonstrate	
normal	ENTITY
sleep	ENTITY
architecture	ENTITY
or	
frequent	ENTITY
arousals	ENTITY
,	
increased	ENTITY
wakeful-	
ness	ENTITY
after	
sleep	ENTITY
onset	ENTITY
and	
reduced	ENTITY
sleep	ENTITY
efficiency	ENTITY
;	
however	
,	
the	
contribution	ENTITY
of	
sleep	ENTITY
related	
hypoxemia	ENTITY
to	
the	
altered	ENTITY
sleep	ENTITY
architecture	ENTITY
,	
if	
present	
,	
is	
uncertain	
.	

Daytime	ENTITY
arterial	ENTITY
blood	ENTITY
gases	ENTITY
may	
be	
normal	ENTITY
or	
show	
hypoxia	ENTITY
and	
hypercapnia	ENTITY
.	

Nocturnal	ENTITY
oxim-	ENTITY
etry	ENTITY
usually	
shows	
sustained	ENTITY
periods	ENTITY
of	
reduced	ENTITY
arterial	ENTITY
oxygen	ENTITY
but	
clusters	ENTITY
of	
more	
severe	ENTITY
drops	ENTITY
in	
the	
arterial	ENTITY
oxygen	
saturation	
can	
occur	
every	
one	
to	
two	
hours	
due	
to	
worsening	ENTITY
of	
breathing	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

A	
sawtooth	ENTITY
pattern	ENTITY
of	
briefer	ENTITY
desaturations	ENTITY
(	
typically	
less	
than	
one	
minute	
)	
suggests	
the	
presence	ENTITY
of	
discrete	ENTITY
events	ENTITY
(	
apneas	ENTITY
or	
hypopneas	ENTITY
)	
.	

Some	
sawtooth	ENTITY
changes	ENTITY
may	
be	
superimposed	ENTITY
on	
low	ENTITY
baseline	ENTITY
oxygen	ENTITY
saturation	ENTITY
but	
are	
not	
the	
predominant	ENTITY
pattern	ENTITY
.	

Chronic	ENTITY
hypoxia	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
polycythemia	ENTITY
.	

Electrocardiography	ENTITY
,	
chest	ENTITY
radiography	ENTITY
,	
and	
echocardiography	ENTITY
may	
demonstrate	
evidence	ENTITY
of	
pulmonary	ENTITY
hypertension	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differential	ENTITY
diagnosis	ENTITY
encompasses	
all	
disorders	ENTITY
which	
can	
give	
to	
hypoxemia	ENTITY
during	
sleep	ENTITY
.	

This	
includes	
pulmonary	ENTITY
airway	ENTITY
and	
parenchymal	ENTITY
disorders	ENTITY
,	
pulmonary	ENTITY
vascular	ENTITY
pathology	ENTITY
,	
neuromuscular	ENTITY
and	
chest	ENTITY
wall	ENTITY
disorders	ENTITY
,	
OHS	ENTITY
,	
use	
of	
medications	ENTITY
or	
substances	ENTITY
that	
can	
suppress	ENTITY
respiratory	ENTITY
drive	
,	
and	
congenital	ENTITY
or	
idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
syndromes	ENTITY
.	

OSA	ENTITY
and	
CSA	ENTITY
syndromes	ENTITY
can	
be	
distinguished	
from	
sleep	ENTITY
related	
hypoxemia	ENTITY
by	
the	
periodic	ENTITY
alterations	ENTITY
in	
airflow	ENTITY
and	
accompanying	
periodic	ENTITY
fluctuations	ENTITY
in	
SaO2	ENTITY
.	

In	
contrast	
,	
oxygen	ENTITY
desaturation	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY
is	
generally	
more	
sustained	ENTITY
,	
usually	
several	
minutes	
or	
longer	ENTITY
in	
duration	ENTITY
.	

In	
cases	ENTITY
when	
more	
than	
one	
disorder	ENTITY
is	
believed	
to	
be	
responsible	
for	
the	
ventilatory	ENTITY
insufficiency	ENTITY
during	
sleep	ENTITY
,	
all	
pertinent	
diagnoses	ENTITY
should	
be	
coded	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
The	
degree	ENTITY
and	
duration	ENTITY
of	
hypercapnia	ENTITY
/	
hypoxemia	ENTITY
necessary	
to	
produce	
adverse	ENTITY
consequences	ENTITY
,	
such	
as	
pulmonary	ENTITY
hypertension	ENTITY
,	
in	
individual	ENTITY
patients	ENTITY
is	
not	
well	
defined	
.	

The	
value	
of	
routinely	
measuring	ENTITY
arterial	ENTITY
blood	
gases	
or	
SaO2	ENTITY
during	
sleep	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
is	
not	
clear	
.	

With	
the	
exception	
of	
COPD	ENTITY
,	
little	
information	ENTITY
is	
available	
regarding	
the	
effect	ENTITY
of	
oxygen	ENTITY
therapy	ENTITY
on	
the	
course	ENTITY
of	
the	
underlying	ENTITY
disease	ENTITY
.	

Even	
less	
is	
under-	
stood	
regarding	
the	
consequences	ENTITY
of	
isolated	ENTITY
sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY
and	
the	
need	
for	
oxygen	ENTITY
supplementation	ENTITY
in	
patients	ENTITY
with	
normal	ENTITY
daytime	ENTITY
wake	ENTITY
oxygen	
levels	
.	

Studies	ENTITY
are	
needed	
to	
determine	
the	
optimal	ENTITY
time	
to	
initiate	ENTITY
oxygen	ENTITY
therapy	ENTITY
and	
the	
specific	
subpopulations	ENTITY
of	
patients	ENTITY
who	
will	
benefit	ENTITY
most	
from	
this	
intervention	ENTITY
.	

Bibliography	ENTITY
Berry	ENTITY
RB	ENTITY
,	
Sriram	ENTITY
P.	ENTITY
Evaluation	ENTITY
of	
hypoventilation	ENTITY
.	

Semin	ENTITY
Respir	ENTITY
Crit	ENTITY
Care	ENTITY
Med	ENTITY
2009;30:303–14	
.	

Brown	ENTITY
LK	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Clin	ENTITY
Chest	ENTITY
Med	ENTITY
2010;31:249–70	ENTITY
.	

Casey	ENTITY
KR	ENTITY
,	
Cantillo	ENTITY
KO	ENTITY
,	
Brown	ENTITY
LK	ENTITY
.	

Sleep	ENTITY
-	
related	ENTITY
hypoventilation	ENTITY
/	
hypoxemic	ENTITY
syndromes	ENTITY
.	

Chest	ENTITY
2007;131:1936–48	ENTITY
.	

Chebbo	ENTITY
A	ENTITY
,	
Tfaili	ENTITY
A	ENTITY
,	
Jones	ENTITY
SF	ENTITY
.	

Hypoventilation	ENTITY
syndromes	ENTITY
.	

Med	ENTITY
Clin	ENTITY
North	ENTITY
Am	ENTITY
2011;95:1189–202	ENTITY
.	

Mogri	ENTITY
M	ENTITY
,	
Desai	ENTITY
H	ENTITY
,	
Webster	ENTITY
L	ENTITY
,	ENTITY
Grant	ENTITY
BJ	ENTITY
,	ENTITY
Mador	ENTITY
MJ	ENTITY
.	

Hypoxemia	ENTITY
in	
patients	ENTITY
on	
chronic	ENTITY
opiate	ENTITY
therapy	ENTITY
with	
and	
without	
sleep	ENTITY
apnea	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2009;13:49–57	
.	

Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Snoring	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
786.09	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
R06.83	ENTITY
Snoring	ENTITY
is	
a	
respiratory	ENTITY
sound	ENTITY
generated	
in	
the	
upper	ENTITY
airway	ENTITY
during	
sleep	ENTITY
that	
typically	
occurs	
during	
inspiration	ENTITY
but	
may	
also	
occur	
in	
expiration	ENTITY
;	
the	
snoring	ENTITY
described	
here	
occurs	
without	
episodes	ENTITY
of	
apnea	ENTITY
,	
hypopnea	ENTITY
,	
RERAs	ENTITY
or	
hypoventilation	ENTITY
.	

The	
intensity	ENTITY
of	
snoring	ENTITY
may	
vary	
and	
often	
will	
disturb	
the	
bed	ENTITY
partner	ENTITY
’s	ENTITY
sleep	ENTITY
and	
even	
awaken	
the	
patient	ENTITY
.	

Snoring	ENTITY
in	
this	
context	ENTITY
does	
not	
cause	
symptoms	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
or	
insomnia	ENTITY
in	
the	
patient	ENTITY
.	

This	
type	
of	
snoring	ENTITY
has	
variously	
been	
referred	
to	
as	
habitual	ENTITY
,	
primary	ENTITY
or	
simple	
snoring	
.	

Snoring	ENTITY
is	
a	
cardinal	
symptom	ENTITY
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

A	
designation	ENTITY
of	
habitual	ENTITY
snoring	ENTITY
can	
not	
be	
made	
in	
those	
who	
exhibit	
symptoms	ENTITY
(	
daytime	ENTITY
sleepiness	ENTITY
/	
fatigue	ENTITY
or	
other	
related	
symptoms	ENTITY
)	
or	
report	ENTITY
possible	
breathing	ENTITY
pauses	ENTITY
,	
without	
objective	ENTITY
mea-	
surement	ENTITY
of	
breathing	ENTITY
during	
sleep	ENTITY
.	

In	
addition	
,	
those	
individuals	ENTITY
with	
snoring	ENTITY
and	
comorbid	ENTITY
cardiovascular	ENTITY
disease	ENTITY
(	
especially	
pulmonary	ENTITY
or	
systemic	ENTITY
hypertension	ENTITY
,	
cor-	ENTITY
onary	ENTITY
artery	ENTITY
disease	ENTITY
,	
or	
atrial	ENTITY
fibrillation	ENTITY
)	
are	
at	
increased	ENTITY
risk	ENTITY
for	
the	
presence	ENTITY
of	
OSA	ENTITY
even	
in	
the	
absence	ENTITY
of	
complaints	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
.	

Therefore	
,	
PSG	ENTITY
or	
OCST	ENTITY
is	
required	
in	
order	
to	
effectively	
rule	
out	
OSA	ENTITY
in	
such	
populations	ENTITY
.	

It	
should	
also	
be	
noted	
that	
patients	ENTITY
who	
initially	
have	
isolated	ENTITY
snoring	ENTITY
may	
be	
at	
risk	ENTITY
for	
developing	
OSA	ENTITY
with	
aging	ENTITY
or	
weight	ENTITY
gain	ENTITY
.	

Occasional	ENTITY
snoring	ENTITY
is	
almost	
universal	ENTITY
.	

Estimates	ENTITY
on	
snoring	ENTITY
vary	
widely	
depending	
on	
its	
definition	ENTITY
.	

The	
incidence	ENTITY
of	
snoring	ENTITY
in	
children	ENTITY
is	
reported	
to	
be	
10	
%	
to	
12	
%	
.	

The	
Wisconsin	ENTITY
cohort	ENTITY
study	ENTITY
reports	
habitual	ENTITY
snoring	ENTITY
in	
about	
24	
%	
of	
adult	ENTITY
women	ENTITY
and	
40	
%	
of	
adult	ENTITY
men	ENTITY
.	

Prevalence	ENTITY
of	
snoring	ENTITY
increases	ENTITY
with	
age	ENTITY
in	
both	
sexes	ENTITY
,	
except	
that	
the	
prevalence	ENTITY
of	
reported	
snoring	ENTITY
starts	
to	
decrease	ENTITY
again	
in	
men	ENTITY
after	
70	
years	ENTITY
of	
age	ENTITY
.	

Some	
have	
hypothesized	
that	
his	
may	
be	
due	
to	
decreased	ENTITY
hearing	ENTITY
acuity	ENTITY
in	
older	ENTITY
individuals	ENTITY
.	

Snoring	ENTITY
is	
most	
common	
in	
adult	ENTITY
men	ENTITY
and	
is	
also	
linked	
to	
obesity	ENTITY
.	

Nasal	ENTITY
obstruc-	
tion	ENTITY
increases	ENTITY
the	
risk	ENTITY
of	
snoring	ENTITY
.	

Ingestion	ENTITY
of	
alcohol	ENTITY
,	
muscle	ENTITY
relaxants	ENTITY
,	
narcotics	ENTITY
,	
or	
other	
substances	ENTITY
that	
decrease	ENTITY
upper	ENTITY
airway	ENTITY
muscle	ENTITY
tone	
predisposes	
an	
individual	ENTITY
to	
snoring	ENTITY
.	

Smoking	ENTITY
,	
particularly	
in	
males	ENTITY
,	
has	
also	
been	
shown	
to	
be	
a	
risk	ENTITY
factor	ENTITY
.	

Snoring	ENTITY
has	
also	
been	
shown	
to	
increase	ENTITY
during	
pregnancy	ENTITY
.	

In	
children	ENTITY
,	
an	
association	ENTITY
has	
been	
reported	
between	
snoring	ENTITY
and	
adenotonsillar	ENTITY
hypertrophy	ENTITY
.	

During	
snoring	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
there	
is	
vibration	ENTITY
of	
the	
uvula	ENTITY
and	
soft	ENTITY
palate	ENTITY
,	
although	
it	
may	
also	
involve	
the	
faucial	ENTITY
pillars	ENTITY
,	
pharyngeal	ENTITY
walls	ENTITY
,	
and	
lower	ENTITY
structures	ENTITY
.	

Snorers	ENTITY
have	
been	
shown	
to	
have	
mor-	
phologic	ENTITY
derangements	ENTITY
of	
the	
palate	ENTITY
consistent	ENTITY
with	ENTITY
neurogenic	ENTITY
lesions	ENTITY
.	

These	
are	
thought	
to	
be	
due	
to	
trauma	ENTITY
from	
vibration	ENTITY
.	

If	
PSG	ENTITY
is	
performed	
,	
snoring	ENTITY
tends	
to	
be	
loudest	ENTITY
during	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
or	
REM	ENTITY
sleep	ENTITY
.	

Epidemiologic	ENTITY
studies	ENTITY
are	
difficult	
to	
interpret	
if	
sleep	ENTITY
apnea	ENTITY
was	
not	
excluded	
by	
PSG	ENTITY
.	

Based	
on	
the	
current	
literature	ENTITY
,	
habitual	ENTITY
snoring	ENTITY
in	
children	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
worse	
school	ENTITY
performance	ENTITY
,	
but	
conclusive	
evidence	ENTITY
for	
this	
is	
lacking	ENTITY
.	

Some	
studies	ENTITY
have	
suggested	
that	
adult	ENTITY
snorers	ENTITY
may	
have	
a	
higher	
prevalence	ENTITY
of	
cardiovas-	
cular	ENTITY
disease	ENTITY
,	
including	
hypertension	ENTITY
,	
stroke	ENTITY
,	
and	
ischemic	ENTITY
heart	ENTITY
disease	ENTITY
.	

However	
,	
a	
large	
observational	ENTITY
study	ENTITY
in	
which	
all	
subjects	ENTITY
underwent	
PSG	ENTITY
found	
no	
increased	ENTITY
risk	ENTITY
of	
cardiovascular	ENTITY
morbidity	ENTITY
or	
mortality	ENTITY
with	
habitual	ENTITY
snoring	ENTITY
.	

Of	
interest	
,	
one	
study	ENTITY
found	
that	
snoring	ENTITY
was	
associated	ENTITY
with	ENTITY
atherosclerosis	ENTITY
of	
the	
carotid	ENTITY
artery	ENTITY
,	
but	
this	
has	
not	
been	
confirmed	
by	
other	
studies	ENTITY
.	

As	
snoring	ENTITY
tends	
to	
increase	ENTITY
during	
pregnancy	ENTITY
,	
the	
impact	ENTITY
of	
snoring	ENTITY
on	
maternal	ENTITY
health	
is	
of	
great	
interest	
.	

A	
study	ENTITY
found	
that	
preg-	
nancy	ENTITY
-	
onset	ENTITY
habitual	ENTITY
snoring	ENTITY
(	
but	
not	
chronic	ENTITY
[	
pre	ENTITY
-	
conceptual	ENTITY
]	ENTITY
snoring	ENTITY
)	
was	
associated	ENTITY
with	ENTITY
increased	ENTITY
risk	ENTITY
of	
gestational	ENTITY
hypertension	ENTITY
and	
preeclampsia	ENTITY
.	

Further	
studies	ENTITY
are	
needed	
in	
this	
area	ENTITY
.	

Bibliography	ENTITY
Cho	
JG	
,	
Witting	ENTITY
PK	ENTITY
,	
Verma	ENTITY
M	ENTITY
,	
et	
al	
.	

Tissue	ENTITY
vibration	ENTITY
induces	ENTITY
carotid	ENTITY
artery	ENTITY
endothelial	ENTITY
dysfunction	ENTITY
:	
a	
mechanism	ENTITY
linking	
snoring	ENTITY
and	
carotid	ENTITY
atherosclerosis	ENTITY
?	

Sleep	ENTITY
2011;34:751–7	
.	

Kezirian	ENTITY
EJ	ENTITY
,	ENTITY
Chang	ENTITY
JL	ENTITY
.	

Snoring	ENTITY
without	
OSA	ENTITY
and	
health	ENTITY
consequences	ENTITY
:	
the	
jury	ENTITY
is	
still	
out	
.	

Sleep	ENTITY
2013;36:613	
.	

Lee	ENTITY
SA	ENTITY
,	
Amis	ENTITY
TC	ENTITY
,	
Byth	ENTITY
K	ENTITY
,	
et	
al	
.	

Heavy	ENTITY
snoring	ENTITY
as	
a	
cause	
of	
carotid	ENTITY
artery	ENTITY
atherosclerosis	ENTITY
.	

Sleep	ENTITY
2008;31:1207–13	ENTITY
.	

Marin	ENTITY
JM	ENTITY
,	
Carrizo	ENTITY
SJ	ENTITY
,	
Vicente	ENTITY
E	ENTITY
,	
Agusti	
AG	
.	

Long	ENTITY
-	
term	ENTITY
cardiovascular	ENTITY
outcomes	ENTITY
in	
men	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnoea	ENTITY
-	
hypopnoea	ENTITY
with	
or	
without	
treatment	ENTITY
with	
continuous	ENTITY
positive	ENTITY
airway	ENTITY
pressure	ENTITY
:	
an	
observational	ENTITY
study	ENTITY
.	

Lancet	ENTITY
2005;365:1046–53	
.	

Mason	ENTITY
RH	ENTITY
,	
Mehta	ENTITY
Z	ENTITY
,	
Fonseca	
AC	
,	
Stradling	ENTITY
JR	ENTITY
,	
Rothwell	ENTITY
PM	ENTITY
.	

Snoring	ENTITY
and	
severity	ENTITY
of	
symptomatic	ENTITY
and	
asymptomatic	ENTITY
carotid	ENTITY
stenosis	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2012;35:1147–51	ENTITY
.	

O’Brien	ENTITY
LM	ENTITY
,	
Bullough	ENTITY
AS	ENTITY
,	
Owusu	ENTITY
JT	ENTITY
,	
et	
al	
.	

Pregnancy	ENTITY
-	
onset	ENTITY
habitual	ENTITY
snoring	ENTITY
,	
gestational	ENTITY
hypertension	ENTITY
,	
and	
preeclampsia	ENTITY
:	
prospective	ENTITY
cohort	ENTITY
study	ENTITY
.	

Am	
J	
Obstet	
Gynecol	
2012;207:487.e1–9	
.	

Rich	ENTITY
J	ENTITY
,	ENTITY
Raviv	ENTITY
A	ENTITY
,	
Raviv	ENTITY
N	ENTITY
,	
Brietzke	ENTITY
SE	ENTITY
.	

An	
epidemiologic	ENTITY
study	ENTITY
of	
snoring	ENTITY
and	
all	
-	
cause	ENTITY
mortality	ENTITY
.	

Otolaryngol	ENTITY
Head	ENTITY
Neck	ENTITY
Surg	ENTITY
2011;145:341–46	ENTITY
.	

Catathrenia	ENTITY
Catathrenia	ENTITY
,	
also	
known	
as	
sleep	ENTITY
related	
groaning	ENTITY
,	
is	
included	
in	
the	
SRBD	ENTITY
section	ENTITY
because	
it	
appears	
to	
be	
associated	ENTITY
with	ENTITY
prolonged	ENTITY
expiration	ENTITY
,	
usually	
during	
REM	ENTITY
sleep	ENTITY
.	

However	
,	
some	
studies	ENTITY
have	
documented	ENTITY
catathrenia	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
.	

Typically	
,	
a	
deep	ENTITY
inspiration	ENTITY
is	
followed	
by	
prolonged	ENTITY
expiration	ENTITY
and	
a	
monotonous	ENTITY
vocalization	ENTITY
resembling	
groaning	ENTITY
.	

The	
pattern	ENTITY
is	
sometimes	
called	
bradypnea	ENTITY
(	
low	ENTITY
respiratory	ENTITY
rate	ENTITY
)	
.	

The	
affected	ENTITY
individual	ENTITY
is	
usually	
unaware	
of	
the	
problem	ENTITY
,	
but	
clini-	
cal	
evaluation	ENTITY
is	
sought	
due	
to	
complaints	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
or	
family	ENTITY
members	ENTITY
.	

The	
recurrent	ENTITY
bradypneic	ENTITY
episodes	ENTITY
may	
resemble	
central	ENTITY
apnea	ENTITY
except	
that	
central	ENTITY
apneas	ENTITY
are	
not	
typically	
associated	ENTITY
with	ENTITY
vocalization	ENTITY
.	

Catathrenia	ENTITY
is	
thought	
to	
be	
rare	ENTITY
and	
more	
common	
in	
men	ENTITY
.	

Several	
episodes	ENTITY
may	
occur	
nightly	ENTITY
and	
often	
in	
clusters	ENTITY
.	

The	
long	ENTITY
-	
term	ENTITY
consequences	ENTITY
of	
catathrenia	ENTITY
are	
unknown	
,	
but	
the	
disorder	ENTITY
is	
primarily	
a	
social	ENTITY
problem	ENTITY
for	
the	
affected	ENTITY
individual	ENTITY
.	

The	
episodes	ENTITY
of	
catathrenia	ENTITY
are	
not	
associ-	
ated	ENTITY
with	
sleep	ENTITY
talking	ENTITY
or	
body	ENTITY
movement	ENTITY
.	

No	
association	ENTITY
with	ENTITY
psychiatric	ENTITY
disorders	ENTITY
has	
been	
demonstrated	
.	

The	
onset	
of	
catathrenia	ENTITY
has	
recently	
been	
reported	
in	
patients	ENTITY
taking	
sodium	ENTITY
oxybate	ENTITY
for	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

The	
clinical	ENTITY
significance	ENTITY
of	
this	
finding	ENTITY
is	
unclear	ENTITY
.	

Bibliography	ENTITY
Abbasi	ENTITY
AA	ENTITY
,	
Morgenthaler	ENTITY
TI	ENTITY
,	
Slocumb	ENTITY
NL	ENTITY
,	
et	
al	
.	

Nocturnal	ENTITY
moaning	ENTITY
and	
groaning	ENTITY
-	
catathrenia	ENTITY
or	
nocturnal	ENTITY
vocalizations	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2012;16:367–73	
.	

Pevernagie	ENTITY
DA	ENTITY
,	
Boon	ENTITY
PA	ENTITY
,	
Mariman	ENTITY
ANN	ENTITY
,	
Verhaeghen	
DB	
,	
Pauwels	ENTITY
RA	ENTITY
.	

Vocalization	ENTITY
during	
episodes	ENTITY
of	
prolonged	ENTITY
expiration	ENTITY
:	
a	
parasomnia	ENTITY
related	
to	
REM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2001;2:19–30	
.	

Poli	ENTITY
F	ENTITY
,	
Ricotta	ENTITY
L	ENTITY
,	
Vandi	ENTITY
S	ENTITY
,	
et	
al	
.	

Catathrenia	ENTITY
under	
sodium	ENTITY
oxybate	ENTITY
in	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2012;16:427–34	ENTITY
.	

Vetrugno	ENTITY
R	ENTITY
,	
Lugaresi	ENTITY
E	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
D’Angelo	ENTITY
R	ENTITY
,	
Montagna	
P.	
Catathrenia	
(	
nocturnal	ENTITY
groaning	ENTITY
):	
an	
abnormal	ENTITY
respiratory	ENTITY
pattern	ENTITY
during	
sleep	ENTITY
.	

Eur	
J	
Neurol	
2007;14:1236–43	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Vignatelli	ENTITY
L	
,	
Lugaresi	ENTITY
E	ENTITY
,	
Montagna	
P.	
Catathrenia	
(	
nocturnal	ENTITY
groaning	ENTITY
):	
a	
new	
type	
of	
parasomnia	ENTITY
.	

Neurology	ENTITY
2001;56:681–3	
.	

Sleep	ENTITY
Related	ENTITY
Breathing	ENTITY
Disorders	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
Narcolepsy	ENTITY
Type	ENTITY
1146	ENTITY
Narcolepsy	ENTITY
Type	ENTITY
2155	ENTITY
Idiopathic	ENTITY
Hypersomnia161	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
Syndrome	ENTITY
166	ENTITY
Hypersomnia	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder171	ENTITY
Hypersomnia	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
175	ENTITY
Hypersomnia	ENTITY
Associated	ENTITY
with	ENTITY
a	
Psychiatric	ENTITY
Disorder179	ENTITY
Insufficient	ENTITY
Sleep	ENTITY
Syndrome182	ENTITY
Isolated	
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Long	ENTITY
Sleeper	ENTITY
187	
Adequate	ENTITY
alertness	ENTITY
is	
necessary	
for	
well	
-	
being	
and	
performance	ENTITY
in	
modern	ENTITY
society	ENTITY
.	

Sleepiness	ENTITY
predisposes	
an	
individual	ENTITY
to	
developing	
serious	
performance	ENTITY
decrements	ENTITY
in	
multiple	ENTITY
areas	ENTITY
of	
function	ENTITY
,	
as	
well	
as	
to	
potentially	
life	ENTITY
-	
threatening	ENTITY
domestic	ENTITY
,	
occu-	
pational	ENTITY
,	
and	
vehicular	ENTITY
accidents	ENTITY
.	

This	
section	ENTITY
includes	
a	
group	ENTITY
of	
disorders	ENTITY
in	
which	
the	
primary	ENTITY
complaint	ENTITY
is	
daytime	ENTITY
sleepiness	ENTITY
not	
caused	
by	
disturbed	
nocturnal	ENTITY
sleep	ENTITY
or	
misaligned	ENTITY
circadian	ENTITY
rhythms	ENTITY
.	

Other	
sleep	ENTITY
disorders	ENTITY
may	
be	
present	
,	
but	
they	
must	
be	
adequately	
treated	ENTITY
before	
a	
diagnosis	ENTITY
in	
this	
category	
can	
be	
established	
.	

In	
this	
nosology	ENTITY
,	
the	
term	ENTITY
hypersomnolence	ENTITY
is	
used	
to	
describe	
the	
symptom	ENTITY
of	
exces-	ENTITY
sive	ENTITY
sleepiness	ENTITY
,	
whereas	
hypersomnia	ENTITY
refers	
to	
specific	
disorders	ENTITY
,	
such	
as	
idiopathic	ENTITY
hypersomnia	ENTITY
.	

Daytime	ENTITY
sleepiness	ENTITY
is	
defined	
as	
the	
inability	ENTITY
to	ENTITY
stay	ENTITY
awake	ENTITY
and	
alert	
during	
the	
major	
waking	ENTITY
episodes	ENTITY
of	
the	
day	ENTITY
,	
resulting	
in	
periods	ENTITY
of	
irrepressible	ENTITY
need	
for	
sleep	ENTITY
or	
unin-	
tended	
lapses	ENTITY
into	
drowsiness	ENTITY
or	
sleep	ENTITY
.	

Sleepiness	ENTITY
may	
vary	
in	
severity	ENTITY
and	
is	
more	
likely	
to	
occur	
in	
sedentary	ENTITY
,	
boring	ENTITY
,	
and	
monotonous	ENTITY
situations	ENTITY
that	
require	
little	
active	ENTITY
participation	ENTITY
.	

Some	
patients	ENTITY
are	
aware	
of	
increasing	ENTITY
sleepiness	ENTITY
before	
falling	ENTITY
asleep	ENTITY
,	
whereas	
others	
can	
fall	ENTITY
asleep	ENTITY
with	
little	
or	
no	
prodromal	ENTITY
symptoms	ENTITY
(	
“	
sleep	ENTITY
attacks	ENTITY
”	
)	
.	

This	
group	ENTITY
of	
patients	ENTITY
sometimes	
can	
present	
following	
motor	ENTITY
vehicle	ENTITY
accidents	ENTITY
attrib-	
utable	ENTITY
to	
sleepiness	ENTITY
.	

In	
some	
forms	
of	
hypersomnolence	ENTITY
,	
sleepiness	ENTITY
is	
associated	ENTITY
with	ENTITY
large	
increases	ENTITY
in	
total	ENTITY
daily	ENTITY
amount	ENTITY
of	
sleep	ENTITY
without	
any	
genuine	
feeling	
of	
resto-	
ration	ENTITY
.	

In	
others	
,	
sleepiness	ENTITY
can	
be	
alleviated	
temporarily	
by	
naps	ENTITY
but	
reoccurs	ENTITY
shortly	
thereafter	
.	

In	
young	ENTITY
children	ENTITY
,	
sleepiness	ENTITY
may	
express	ENTITY
itself	
as	
excessively	
long	ENTITY
night	ENTITY
sleep	ENTITY
or	
with	
the	
recurrence	ENTITY
of	
previously	
discontinued	ENTITY
daytime	ENTITY
napping	ENTITY
.	

Children	ENTITY
may	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
paradoxically	
present	
with	
inattentiveness	ENTITY
,	
emotional	ENTITY
lability	ENTITY
,	
hyperactive	ENTITY
behavior	ENTITY
,	
or	
decreased	ENTITY
performance	ENTITY
in	
school	ENTITY
.	

In	
most	
cases	ENTITY
,	
excessive	ENTITY
sleepiness	ENTITY
is	
a	
chronic	ENTITY
symptom	ENTITY
.	

It	
must	
occur	
for	
at	
least	
three	
months	ENTITY
prior	
to	
diagnosis	ENTITY
.	

The	
severity	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
can	
be	
quantified	ENTITY
subjectively	ENTITY
using	
severity	ENTITY
scales	ENTITY
such	
as	
the	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
and	
objectively	ENTITY
using	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
(	ENTITY
MSLT	ENTITY
)	
.	

These	
measures	ENTITY
do	
not	
always	
correlate	ENTITY
with	
each	
other	
and	
must	
be	
used	
with	
appropriate	
clinical	ENTITY
judgment	ENTITY
.	

When	
applied	
in	
clinical	ENTITY
settings	ENTITY
,	
the	
MSLT	ENTITY
is	
sensitive	ENTITY
to	
sleep	ENTITY
deprivation	ENTITY
and	
circadian	ENTITY
effects	ENTITY
.	

It	
has	
not	
been	
validated	
as	
a	
diagnostic	ENTITY
test	ENTITY
in	
people	ENTITY
who	
are	
habitually	ENTITY
awake	ENTITY
throughout	
the	
night	ENTITY
and	
sleep	ENTITY
during	
the	
day	ENTITY
.	

Normal	ENTITY
and	
abnormal	ENTITY
ranges	
of	
sleep	ENTITY
latencies	ENTITY
have	
not	
been	
estab-	
lished	ENTITY
when	
this	
test	ENTITY
is	
administered	ENTITY
at	
times	
other	
than	
the	
hours	
between	
8:00	
a.m.	
and	
6:00	
p.m.	

Normative	ENTITY
data	ENTITY
are	
not	
available	
for	
children	ENTITY
younger	ENTITY
than	
six	
years	ENTITY
.	

The	
MSLT	ENTITY
measures	ENTITY
the	
physiological	ENTITY
tendency	
to	
fall	ENTITY
asleep	ENTITY
in	
quiet	ENTITY
situations	ENTITY
.	

In	
the	
context	
of	
diagnosing	ENTITY
central	ENTITY
disorders	ENTITY
of	
hypersomnolence	ENTITY
,	
the	
MSLT	ENTITY
should	
be	
con-	ENTITY
ducted	ENTITY
according	
to	
standardized	ENTITY
procedures	ENTITY
,	
as	
defined	
in	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
(	
AASM	
)	
practice	
parameters	ENTITY
.	

In	
particular	
,	
patients	ENTITY
should	
be	
encour-	
aged	ENTITY
to	
sleep	ENTITY
as	
much	
as	
possible	
during	
the	
week	ENTITY
and	
,	
especially	
,	
during	
the	
night	ENTITY
prior	
to	
the	
MSLT	ENTITY
.	

Delaying	ENTITY
wake	ENTITY
-	
up	
time	ENTITY
and	
subsequent	
MSLT	ENTITY
start	
time	ENTITY
may	
be	
appropriate	
in	
some	
patients	ENTITY
with	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

It	
is	
strongly	
rec-	
ommended	
that	
adequate	ENTITY
sleep	ENTITY
be	
documented	ENTITY
by	
sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
for	
a	
period	ENTITY
of	
one	
to	
two	
weeks	ENTITY
prior	
to	
the	
MSLT	ENTITY
.	

MSLT	ENTITY
mean	
sleep	ENTITY
latencies	ENTITY
should	
be	
considered	
a	
continuum	
with	
values	ENTITY
below	
five	
minutes	ENTITY
generally	
considered	
as	
indicative	
of	
sleepiness	ENTITY
and	
those	
over	
10	
minutes	ENTITY
generally	
consid-	
ered	
indicative	
of	
normal	
alertness	ENTITY
.	

In	
this	
section	ENTITY
,	
a	
mean	
MSLT	ENTITY
sleep	ENTITY
latency	
of	
less	
than	
eight	
minutes	ENTITY
is	
used	
to	
define	
sleepiness	ENTITY
for	
diagnostic	ENTITY
purposes	ENTITY
.	

This	
value	
has	
been	
shown	
to	
be	
the	
best	
cutoff	ENTITY
in	
the	
context	ENTITY
of	
diagnosing	ENTITY
narcolepsy	ENTITY
,	
with	
approximately	
90	
%	
of	
patients	ENTITY
with	
narcolepsy	ENTITY
having	
a	
latency	ENTITY
below	
this	
level	ENTITY
.	

The	
presence	ENTITY
of	
multiple	ENTITY
sleep	ENTITY
onset	ENTITY
rapid	
eye	
movement	
periods	
(	
SOREMPs	ENTITY
)	
during	
the	
MSLT	ENTITY
is	
a	
more	
specific	
finding	ENTITY
in	
narcolepsy	ENTITY
than	
is	
a	
mean	
sleep	ENTITY
latency	ENTITY
less	
than	
or	
equal	
to	
eight	
minutes	ENTITY
,	
although	
SOREMPs	ENTITY
can	
also	
be	
seen	
in	
the	
presence	ENTITY
of	
insuffi-	
cient	ENTITY
sleep	ENTITY
,	
circadian	ENTITY
rhythm	ENTITY
disorders	ENTITY
(	
including	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
or	
shift	
work	
)	
,	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
or	
,	
occasionally	
,	
normal	ENTITY
subjects	ENTITY
.	

The	
results	ENTITY
of	
an	
MSLT	ENTITY
should	
be	
carefully	
interpreted	ENTITY
in	
the	
context	ENTITY
of	
the	
patient	ENTITY
’s	ENTITY
history	ENTITY
and	
the	
complaint	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
.	

The	
maintenance	ENTITY
of	
wakefulness	ENTITY
test	ENTITY
is	
a	
measure	ENTITY
of	
the	
ability	
to	
remain	
awake	ENTITY
during	
the	
daytime	ENTITY
in	
a	
darkened	ENTITY
,	
quiet	ENTITY
environment	ENTITY
and	
is	
usually	
administered	ENTITY
to	
assess	
response	ENTITY
to	ENTITY
treatment	ENTITY
.	

It	
should	
not	
be	
used	
for	
diagnostic	ENTITY
purposes	ENTITY
.	

A	
24	
-	
hour	ENTITY
continuous	ENTITY
sleep	ENTITY
recording	ENTITY
or	
an	
actigraphic	ENTITY
recording	ENTITY
of	
at	
least	
one	
week	ENTITY
is	
useful	
in	
the	
diagnosis	ENTITY
of	
some	
patients	ENTITY
with	
idiopathic	ENTITY
hypersomnia	ENTITY
.	

In	
all	
cases	ENTITY
in	
which	
a	
diagnosis	ENTITY
of	
hypersomnolence	ENTITY
is	
to	
be	
made	
,	
a	
review	ENTITY
of	
other	
sleep	ENTITY
,	
medical	ENTITY
,	
and	
psychiatric	ENTITY
disorders	ENTITY
,	
as	
well	
as	
substance	ENTITY
and	
medication	ENTITY
use	ENTITY
,	
should	
be	
performed	
.	

In	
this	
edition	
of	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
the	
preferred	
names	ENTITY
of	
certain	
central	ENTITY
disorders	ENTITY
of	
hypersomnolence	ENTITY
have	
been	
changed	
.	

In	
particular	
,	
nar-	
colepsy	ENTITY
has	
been	
divided	
into	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
and	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
rather	
than	
narcolepsy	ENTITY
with	
and	
without	
cataplexy	ENTITY
.	

This	
change	
is	
predicated	
on	
the	
concept	ENTITY
that	
absence	ENTITY
of	
hypocretin	ENTITY
(	
orexin	ENTITY
)	
is	
a	
fundamental	
marker	ENTITY
of	
the	
most	
precisely	
defined	
category	
of	
the	
disorder	ENTITY
.	

Because	
some	
patients	ENTITY
without	
cataplexy	ENTITY
will	
also	
have	
low	ENTITY
cerebrospinal	ENTITY
fluid	ENTITY
(	
CSF	ENTITY
)	
hypocretin-1	
levels	ENTITY
,	
the	
use	
of	
the	
term	ENTITY
“	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
”	
or	
“	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
”	
is	
inappropriate	ENTITY
.	

The	
change	ENTITY
is	
not	
intended	
to	
imply	
that	
the	
presence	ENTITY
or	
absence	ENTITY
of	
cataplexy	ENTITY
is	
unimportant	
clinically	ENTITY
nor	
that	
mea-	
suring	ENTITY
CSF	ENTITY
hypocretin-1	
levels	ENTITY
is	
obligatory	ENTITY
.	

The	
motivation	ENTITY
behind	
the	
decision	
to	
eliminate	
the	
subcategories	ENTITY
of	
idiopathic	ENTITY
hypersomnia	ENTITY
is	
discussed	
in	
the	
appropriate	
section	ENTITY
.	

The	
decision	
to	
use	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
as	
the	
preferred	
name	
in	
place	
of	
recurrent	ENTITY
hypersomnia	ENTITY
is	
based	
on	
data	ENTITY
suggesting	
that	
the	
condition	ENTITY
is	
fairly	
homo-	ENTITY
geneous	ENTITY
,	
as	
well	
as	
the	
lack	ENTITY
of	
definite	
evidence	ENTITY
for	
other	
major	
subcategories	ENTITY
of	
the	
disorder	ENTITY
.	

Bibliography	ENTITY
Arand	ENTITY
D	ENTITY
,	
Bonnet	ENTITY
M	ENTITY
,	
Hurwitz	ENTITY
T	ENTITY
,	
Mitler	ENTITY
M	ENTITY
,	
Rosa	ENTITY
R	ENTITY
,	
Sangal	
RB	
.	

A	
Review	ENTITY
by	
the	
MSLT	ENTITY
and	
MWT	ENTITY
Task	
Force	
of	
the	
Standards	ENTITY
of	ENTITY
Practice	ENTITY
Committee	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

The	
clinical	ENTITY
use	
of	
the	
MSLT	ENTITY
and	
MWT	ENTITY
.	

Sleep	ENTITY
2005;28:123–44	
.	

Aurora	ENTITY
RN	ENTITY
,	
Lamm	ENTITY
CI	ENTITY
,	
Zak	ENTITY
RS	ENTITY
,	
et	
al	
.	

Practice	ENTITY
parameters	ENTITY
for	
the	
non	ENTITY
-	
respiratory	ENTITY
indications	ENTITY
for	
polysomnography	ENTITY
and	
multiple	ENTITY
sleep	ENTITY
latency	ENTITY
testing	ENTITY
for	
children	ENTITY
.	

Sleep	ENTITY
2012;35:1467–73	
.	

Littner	ENTITY
MR	ENTITY
,	
Kushida	ENTITY
C	ENTITY
,	
Wise	ENTITY
M	ENTITY
,	
et	
al	
.	
;	
Standards	ENTITY
of	ENTITY
Practice	ENTITY
Committee	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
.	

Practice	ENTITY
parameters	ENTITY
for	
clinical	ENTITY
use	
of	
the	
multiple	ENTITY
sleep	ENTITY
latency	ENTITY
test	ENTITY
and	
the	
maintenance	ENTITY
of	
wakefulness	ENTITY
test	ENTITY
.	

Sleep	ENTITY
2005;28:113–21	
.	

Mignot	ENTITY
E	ENTITY
,	
Lin	
L	
,	
Finn	ENTITY
L	ENTITY
,	
et	
al	
.	

Correlates	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
REM	ENTITY
periods	ENTITY
during	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
in	
community	ENTITY
adults	ENTITY
.	

Brain	ENTITY
2006;129:1609–23	
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
Narcolepsy	ENTITY
Type	ENTITY
1	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
347.01	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.411	ENTITY
Alternate	ENTITY
Names	ENTITY
Hypocretin	ENTITY
deficiency	ENTITY
syndrome	ENTITY
,	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
,	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
occurring	
for	
at	
least	
three	
months.1	ENTITY

B.	ENTITY
The	
presence	ENTITY
of	
one	
or	
both	
of	
the	
following	
:	
.	

Cataplexy	ENTITY
(	
as	
defined	
under	
Essential	ENTITY
Features	ENTITY
)	
and	
a	
mean	
sleep	ENTITY
latency	ENTITY
of	
≤	
8	
minutes	ENTITY
and	
two	
or	
more	
sleep	ENTITY
onset	
REM	ENTITY
periods	ENTITY
(	
SOREMPs	ENTITY
)	
on	
an	
MSLT	ENTITY
performed	
according	
to	
standard	ENTITY
techniques	ENTITY
.	

A	
SOREMP	ENTITY
(	
within	
15	
minutes	
of	
sleep	ENTITY
onset	ENTITY
)	
on	
the	
preceding	
nocturnal	ENTITY
polysomnogram	ENTITY
may	
replace	
one	
of	
the	
SOREMPs	ENTITY
on	
the	
MSLT.2	ENTITY
.	

CSF	ENTITY
hypocretin-1	ENTITY
concentration	ENTITY
,	
measured	
by	
immunoreactivity	ENTITY
,	
is	
either	
≤	
110	
pg	
/	
mL	
or	
<	
1/3	
of	
mean	ENTITY
values	ENTITY
obtained	
in	
normal	ENTITY
subjects	ENTITY
with	
the	
same	
standardized	ENTITY
assay	ENTITY
.	

Notes	ENTITY
.	

In	
young	ENTITY
children	ENTITY
,	
narcolepsy	ENTITY
may	
sometimes	
present	
as	
excessively	
long	ENTITY
night	ENTITY
sleep	ENTITY
or	
as	
resumption	ENTITY
of	
previously	
discontinued	ENTITY
daytime	ENTITY
napping	ENTITY
.	
.	

If	
narcolepsy	ENTITY
type	ENTITY
I	ENTITY
is	
strongly	
suspected	
clinically	ENTITY
but	
the	
MSLT	ENTITY
criteria	ENTITY
of	
B1	ENTITY
are	
not	
met	
,	
a	
possible	
strategy	
is	
to	
repeat	
the	
MSLT	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Narcolepsy	ENTITY
type	
1	
is	
a	
disorder	ENTITY
primarily	
characterized	
by	
excessive	ENTITY
daytime	ENTITY
sleepi-	
ness	ENTITY
and	
signs	ENTITY
of	
REM	ENTITY
-	
sleep	ENTITY
dissociation	
,	
the	
most	
specific	ENTITY
of	
which	
is	
cataplexy	ENTITY
.	

It	
has	
now	
been	
firmly	
established	
that	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
is	
caused	
by	
a	
deficiency	ENTITY
of	
hypothalamic	ENTITY
hypocretin	ENTITY
(	
orexin	
)	
signaling	
.	

Patients	ENTITY
with	
low	ENTITY
or	
undetectable	ENTITY
concen-	
trations	ENTITY
of	
hypocretin-1	ENTITY
in	
the	
CSF	ENTITY
compose	
a	
specific	
disease	ENTITY
population	ENTITY
with	
a	
single	ENTITY
etiology	ENTITY
and	
relatively	
homogenous	ENTITY
clinical	ENTITY
and	
polysomnographic	ENTITY
features	ENTITY
.	

Patients	ENTITY
with	
sleepiness	ENTITY
and	
low	ENTITY
or	
absent	ENTITY
CSF	ENTITY
hypocretin-1	

levels	ENTITY
are	
classified	
as	
having	
nar-	
colepsy	ENTITY
type	ENTITY
1	ENTITY
,	
even	
if	
they	
do	
not	
manifest	
cataplexy	ENTITY
.	

Excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
is	
the	
cardinal	
symptom	ENTITY
,	
and	
often	
the	
most	
disabling	ENTITY
.	

Patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
experience	
repeated	
daily	ENTITY
episodes	ENTITY
of	
an	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
lapses	ENTITY
into	
sleep	ENTITY
.	

Most	
patients	ENTITY
awaken	
refreshed	
after	
a	
sleep	ENTITY
episode	ENTITY
but	
begin	
to	
feel	
sleepy	ENTITY
again	
after	
variable	ENTITY
times	ENTITY
.	

Sleepiness	ENTITY
is	
most	
likely	
to	
occur	
in	
monotonous	ENTITY
situations	ENTITY
that	
require	
no	
active	
participation	
;	
for	
example	
,	
watching	ENTITY
television	ENTITY
or	
riding	ENTITY
in	
a	
car	ENTITY
.	

Physical	ENTITY
activity	ENTITY
may	
temporarily	
suppress	ENTITY
the	
urge	ENTITY
to	
sleep	ENTITY
.	

In	
some	
cases	ENTITY
sleepiness	ENTITY
manifests	
as	
sudden	ENTITY
irresistible	ENTITY
sleep	ENTITY
“	
attacks	ENTITY
”	
that	
may	
occur	
in	
unusual	ENTITY
situations	ENTITY
such	
as	
eating	ENTITY
or	ENTITY
walking	ENTITY
.	

Often	
,	
such	
sleep	ENTITY
attacks	ENTITY
occur	
on	
a	
background	
of	
overall	
sleepiness	ENTITY
.	

Even	
when	
seemingly	
awake	ENTITY
,	
many	
nar-	
colepsy	ENTITY
patients	ENTITY
have	
lapses	ENTITY
in	
vigilance	ENTITY
,	
sometimes	
in	
combination	ENTITY
with	
automatic	ENTITY
behavior	ENTITY
,	
such	
as	
writing	ENTITY
gibberish	ENTITY
or	
interrupting	ENTITY
a	
conversation	ENTITY
with	
a	
completely	
different	
topic	
.	

Sleepiness	ENTITY
generally	
has	
a	
serious	
impact	ENTITY
on	
the	
ability	
of	
the	
patient	ENTITY
to	
function	ENTITY
in	
educational	ENTITY
,	
social	ENTITY
,	
and	
occupational	ENTITY
situations	ENTITY
.	

Because	
patients	ENTITY
are	
rarely	
examined	
during	
an	
attack	ENTITY
of	
cataplexy	ENTITY
,	
its	
presence	ENTITY
needs	
to	
be	
established	
based	
on	
the	
clinical	ENTITY
interview	ENTITY
alone	
.	

Cataplexy	ENTITY
is	
defined	
as	
more	
than	
one	
episode	ENTITY
of	
generally	
brief	
(	
<	
2	
minutes	ENTITY
)	
,	
usually	
bilaterally	ENTITY
symmetrical	ENTITY
sudden	ENTITY
loss	ENTITY
of	
muscle	ENTITY
tone	ENTITY
with	
retained	
consciousness	ENTITY
.	

The	
episodes	ENTITY
are	
precipitated	ENTITY
by	
strong	
emotions	ENTITY
,	
usually	
positive	ENTITY
,	
with	
almost	
all	
patients	ENTITY
reporting	
some	
episodes	ENTITY
precipitated	ENTITY
by	
emotions	ENTITY
associated	ENTITY
with	ENTITY
laughter	ENTITY
.	

The	
finding	ENTITY
of	
transient	ENTITY
reversible	
loss	
of	
deep	ENTITY
tendon	ENTITY
reflexes	ENTITY
during	
an	
attack	ENTITY
,	
if	
observed	ENTITY
,	
is	
a	
strong	
diagnostic	ENTITY
finding	ENTITY
.	

In	
children	ENTITY
(	
and	
rarely	ENTITY
adults	ENTITY
)	
,	
cataplexy	ENTITY
may	
present	
close	
to	
disease	ENTITY
onset	ENTITY
as	
facial	ENTITY
(	ENTITY
or	ENTITY
generalized	ENTITY
)	ENTITY
hypotonia	ENTITY
with	
droopy	ENTITY
eyelids	ENTITY
,	
mouth	ENTITY
opening	ENTITY
,	
and	
protruded	ENTITY
tongue	ENTITY
,	
or	
gait	ENTITY
unsteadiness	ENTITY
,	
which	
clearly	
are	
not	
related	
to	
emotion	ENTITY
.	

Facial	ENTITY
and	
masticatory	ENTITY
movements	ENTITY
may	
occur	
.	

In	
children	ENTITY
,	
anticipation	ENTITY
of	
a	
reward	ENTITY
is	
a	
common	
precipitant	ENTITY
.	

It	
is	
important	
to	
use	
child	ENTITY
-	
appropriate	ENTITY
contexts	ENTITY
and	
language	ENTITY
when	
trying	
to	
elicit	
a	
history	ENTITY
of	
cataplexy	ENTITY
in	
children	ENTITY
.	

The	
cataplexy	ENTITY
phenotype	ENTITY
differs	
widely	
between	
patients	ENTITY
,	
ranging	
from	
sporadic	ENTITY
partial	ENTITY
attacks	
triggered	ENTITY
by	ENTITY
laughter	ENTITY
,	
to	
frequent	
complete	
attacks	ENTITY
of	
collapse	ENTITY
brought	
about	
by	
a	
variety	
of	
emotions	ENTITY
.	

In	
the	
vast	
majority	
of	
attacks	ENTITY
,	
cataplexy	ENTITY
is	
bilateral	ENTITY
,	
although	
patients	ENTITY
sometimes	
report	ENTITY
one	
side	
of	
the	
body	ENTITY
to	
be	
more	
affected	ENTITY
than	
the	
other	
.	

Partial	ENTITY
attacks	ENTITY
can	
be	
very	
subtle	
and	
sometimes	
only	
recognized	
by	
experi-	
enced	ENTITY
observers	ENTITY
such	
as	
the	
patient	ENTITY
’s	ENTITY
partner	ENTITY
.	

Neck	ENTITY
weakness	ENTITY
,	
producing	
head	ENTITY
drop	
,	
is	
a	
common	
complaint	ENTITY
,	
whereas	
facial	ENTITY
weakness	ENTITY
may	
lead	
to	
sagging	ENTITY
of	
the	
jaw	ENTITY
and	
dysarthria	ENTITY
.	

Respiratory	ENTITY
muscles	ENTITY
are	
not	
involved	
although	
patients	ENTITY
sometimes	
describe	
shortness	ENTITY
of	
breath	ENTITY
when	
symptomatic	ENTITY
.	

Attacks	ENTITY
start	
abruptly	
and	
usually	
build	
up	
over	
several	
seconds	
,	
especially	
in	
attacks	ENTITY
producing	
complete	
peripheral	ENTITY
weakness	ENTITY
and	
collapse	ENTITY
.	

Positive	ENTITY
motor	ENTITY
phenomena	ENTITY
are	
not	
uncommon	
,	
with	
muscle	ENTITY
twitching	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
or	
small	ENTITY
jerks	ENTITY
,	
particularly	
of	
the	
face	ENTITY
.	

Although	
many	
emotions	ENTITY
can	
potentially	
lead	
to	
cataplexy	ENTITY
,	
those	
associated	ENTITY
with	ENTITY
mirth	ENTITY
are	
usually	
the	
most	
potent	
.	

Laughing	ENTITY
out	ENTITY
loud	ENTITY
,	
telling	
a	
joke	ENTITY
,	
and	
making	
a	
witty	
remark	
are	
typical	
examples	
.	

The	
frequency	ENTITY
of	
cataplexy	ENTITY
is	
variable	ENTITY
,	
ranging	
from	
less	
than	
one	
attack	ENTITY
per	
month	ENTITY
to	
more	
than	
20	
attacks	ENTITY
per	
day	ENTITY
.	

Cataplexy	ENTITY
is	
generally	
short	ENTITY
-	
lived	ENTITY
,	
lasting	
a	
matter	
of	
seconds	ENTITY
,	
with	
the	
vast	
majority	
of	
attacks	ENTITY
lasting	
less	
than	
two	
minutes	ENTITY
.	

However	
,	
if	
a	
particular	
trigger	ENTITY
continues	
,	
consecutive	ENTITY
attacks	ENTITY
may	
merge	ENTITY
together	
to	
form	
what	
seems	
to	
be	
one	
long	ENTITY
episode	ENTITY
.	

Sudden	ENTITY
withdrawal	ENTITY
of	
anticataplectic	ENTITY
medication	ENTITY
,	
especially	
anti-	ENTITY
depressants	ENTITY
,	
can	
result	
in	
“	
status	ENTITY
cataplecticus	ENTITY
”	
in	
which	
long	ENTITY
-	
lasting	ENTITY
attacks	ENTITY
happen	
virtually	
continuously	
.	

Associated	ENTITY
Features	ENTITY
In	
addition	
to	
sleepiness	ENTITY
and	
cataplexy	ENTITY
,	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
often	
report	
several	
other	
symptoms	ENTITY
,	
none	
of	
which	
are	
specific	
for	
the	
disorder	ENTITY
.	

Many	
patients	ENTITY
report	
disruption	ENTITY
of	
nocturnal	ENTITY
sleep	ENTITY
,	
which	
can	
sometimes	
be	
of	
major	
concern	
.	

Although	
sleep	ENTITY
onset	ENTITY
is	
rarely	
a	
problem	ENTITY
,	
an	
inability	
to	
maintain	
continuous	ENTITY
sleep	ENTITY
is	
very	
common	
.	

33	
%	
to	
80	
%	
of	
narcolepsy	ENTITY
patients	ENTITY
have	
hypnagogic	ENTITY
hallucinations	ENTITY
and/or	
sleep	ENTITY
paralysis	ENTITY
.	

Hypnagogic	ENTITY
hallucinations	ENTITY
are	
defined	
as	
vivid	
dreamlike	
expe-	
riences	
occurring	
at	
the	
transition	ENTITY
from	
wake	ENTITY
to	ENTITY
sleep	ENTITY
.	

Typically	
,	
hypnagogic	ENTITY
halluci-	
nations	ENTITY
have	
a	
multimodal	ENTITY
or	
“	
holistic	ENTITY
”	
character	
,	
often	
combining	
visual	ENTITY
,	
auditory	ENTITY
,	
and	
tactile	ENTITY
phenomena	ENTITY
.	

Hypnopompic	ENTITY
hallucinations	ENTITY
are	
similar	
but	
occur	
at	
sleep	ENTITY
to	
wake	
transitions	ENTITY
.	

Sleep	ENTITY
paralysis	ENTITY
describes	
the	
disturbing	
temporary	ENTITY
inability	
to	
move	
voluntary	ENTITY
muscles	ENTITY
at	
sleep	ENTITY
-	
wake	ENTITY
transitions	ENTITY
.	

Despite	
being	
awake	ENTITY
and	
conscious	ENTITY
of	
the	
sleeping	ENTITY
environment	ENTITY
,	
it	
is	
impossible	
for	
subjects	ENTITY
to	
move	
their	
limbs	ENTITY
or	
even	
open	
their	
eyes	ENTITY
.	

The	
experience	ENTITY
may	
last	
for	
several	
minutes	ENTITY
and	
can	
be	
very	
distressing	ENTITY
.	

Other	
symptoms	ENTITY
may	
include	
ptosis	ENTITY
,	
blurred	ENTITY
vision	ENTITY
,	
and	
diplopia	ENTITY
,	
presumably	
as	
a	
result	
of	
sleepiness	ENTITY
.	

Epidemiological	ENTITY
studies	ENTITY
have	
shown	
that	
obesity	ENTITY
is	
a	
common	
symptom	ENTITY
of	
narco-	
lepsy	ENTITY
.	

Around	
disease	ENTITY
onset	ENTITY
,	
an	
unexplained	
increase	ENTITY
in	
body	ENTITY
weight	ENTITY
is	
often	
observed	ENTITY
.	

Obesity	ENTITY
(	
defined	
as	
a	
body	ENTITY
mass	ENTITY
index	ENTITY
≥	
30	
kg	
/	
m2	ENTITY
)	
occurs	
more	
than	
twice	
as	
often	
in	
narcoleptic	ENTITY
populations	ENTITY
as	
in	
control	ENTITY
groups	ENTITY
.	

An	
increased	ENTITY
frequency	ENTITY
of	
several	
other	
sleep	ENTITY
abnormalities	ENTITY
has	
been	
described	
in	
narcolepsy	ENTITY
,	
including	
sleep	ENTITY
talking	ENTITY
,	
periodic	ENTITY
limb	ENTITY
movements	
of	
sleep	ENTITY
,	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
,	
and	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disor-	
der	
.	

There	
is	
an	
increased	ENTITY
prevalence	ENTITY
of	
depressive	ENTITY
symptoms	ENTITY
,	
although	
there	
are	
con-	
flicting	ENTITY
reports	
on	
how	
often	
these	
symptoms	ENTITY
qualify	
as	
a	
clinical	ENTITY
depression	ENTITY
.	

Recent	
studies	ENTITY
point	
to	
a	
high	
level	ENTITY
of	
anxiety	ENTITY
disorders	ENTITY
in	
patients	ENTITY
with	
narcolepsy	ENTITY
,	
with	
panic	ENTITY
attacks	ENTITY
or	
social	ENTITY
phobias	ENTITY
in	
about	
20	
%	
.	

More	
than	
half	
of	
patients	ENTITY
report	
severe	
fatigue	ENTITY
,	
which	
can	
be	
distinct	
from	
sleepiness	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Narcolepsy	ENTITY
type	
1	
due	
to	
a	
medical	ENTITY
condition	ENTITY
:	

This	
condition	ENTITY
is	
primarily	
associated	ENTITY
with	ENTITY
central	ENTITY
nervous	ENTITY
system	ENTITY
(	
CNS	
)	
disorders	
,	
including	
autoimmune	ENTITY
or	
paraneoplastic	ENTITY
disorders	ENTITY
associated	ENTITY
with	ENTITY
anti	ENTITY
-	
Ma2	ENTITY
or	
antiaquaporin4	ENTITY
antibodies	ENTITY
,	
and	
tumors	ENTITY
or	
other	
lesions	ENTITY
of	
the	
hypothalamus	ENTITY
.	

In	
addition	
,	
undetectable	
hypocretin-1	ENTITY
levels	ENTITY
have	
been	
reported	
in	
association	ENTITY
with	ENTITY
sleepiness	ENTITY
after	
severe	
head	ENTITY
trauma	ENTITY
.	

The	
condition	ENTITY
must	
fulfill	
criteria	ENTITY
for	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
and	
be	
attributable	
to	
another	
medical	ENTITY
disorder	ENTITY
.	

Narcolepsy	ENTITY
without	
cataplexy	ENTITY
with	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
:	
Narcolepsy	ENTITY
type	ENTITY
1	ENTITY
should	
be	
diagnosed	ENTITY
,	
even	
in	
the	
absence	ENTITY
of	
cataplexy	ENTITY
,	
if	
diagnostic	ENTITY
criteria	ENTITY
A	
and	
B2	ENTITY
are	
fulfilled	
.	

Demographics	ENTITY
Narcolepsy	ENTITY
with	
cataplexy	ENTITY
occurs	
in	
0.02	
%	
to	
0.18	
%	
of	
the	
United	ENTITY
States	ENTITY
and	
western	ENTITY
European	ENTITY
populations	ENTITY
.	

A	
lower	ENTITY
prevalence	ENTITY
has	
been	
reported	
in	
Israel	ENTITY
,	
whereas	
narco-	
lepsy	ENTITY
with	
cataplexy	ENTITY
may	
be	
slightly	
more	
common	
in	
Japan	ENTITY
(	
0.16	
%	
to	
0.18	
%	
)	
.	

Both	
sexes	ENTITY
are	
affected	ENTITY
,	
with	
a	
slight	
preponderance	
of	
males	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Several	
unproven	
precipitating	
factors	
have	
been	
suggested	
in	
case	ENTITY
reports	ENTITY
,	
including	
head	ENTITY
trauma	ENTITY
,	
sustained	ENTITY
sleep	ENTITY
deprivation	ENTITY
,	
unspecified	
viral	ENTITY
illness	ENTITY
,	
and	
sudden	ENTITY
changes	ENTITY
in	
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
.	

Several	
studies	ENTITY
have	
pointed	
to	
seasonal	ENTITY
patterns	ENTITY
in	
the	
onset	
of	
narcolepsy	ENTITY
,	
which	
may	
point	
to	
a	
specific	
environmental	ENTITY
trigger	ENTITY
.	

Recent	
studies	ENTITY
have	
shown	
an	
increase	ENTITY
in	
antibodies	ENTITY
against	
beta	ENTITY
-	
hemolytic	ENTITY
streptococcus	ENTITY
,	
which	
were	
strongest	
around	
onset	
of	
narcolepsy	ENTITY
and	
decreased	ENTITY
with	
disease	ENTITY
duration	ENTITY
,	
suggesting	
that	
streptococcal	ENTITY
infections	ENTITY
may	
constitute	
an	
environmental	ENTITY
trigger	
.	

There	
have	
been	
reports	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
occurring	ENTITY
after	
vaccination	ENTITY
against	
H1N1	ENTITY
associated	ENTITY
influ-	ENTITY
enza	ENTITY
,	
but	
a	
definite	
causal	
association	ENTITY
has	
not	
yet	
been	
established	ENTITY
.	

Tribbles	ENTITY
homolog	ENTITY
2	ENTITY
antibodies	ENTITY
,	
found	
in	
some	
patients	ENTITY
with	
autoimmune	ENTITY
uveitis	ENTITY
,	
have	
been	
described	
in	
14	
%	
to	
26	
%	
of	
narcolepsy	ENTITY
patients	ENTITY
,	
but	
the	
significance	ENTITY
is	
uncertain	
.	

Familial	ENTITY
Patterns	ENTITY
At	
the	
genetic	ENTITY
level	ENTITY
,	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
is	
closely	
associated	ENTITY
with	ENTITY
the	
human	ENTITY
leukocyte	ENTITY
antigen	ENTITY
(	
HLA	ENTITY
)	
subtypes	ENTITY
DR2	ENTITY
/	
DRB1	ENTITY
*	ENTITY
1501	ENTITY
and	
DQB1	ENTITY
*	ENTITY
0602	ENTITY
.	

These	
two	
subtypes	ENTITY
are	
always	
found	
together	
in	
whites	ENTITY
and	
Asians	ENTITY
,	
but	
in	
blacks	ENTITY
,	
DQB1	ENTITY
*	ENTITY
0602	ENTITY
is	
more	
specifically	
associated	ENTITY
with	ENTITY
narcolepsy	ENTITY
.	

Almost	
all	
patients	ENTITY
with	
cataplexy	ENTITY
are	
positive	ENTITY
for	
DQB1	ENTITY
*	ENTITY
0602	ENTITY
,	
compared	
with	
12	
%	
to	
38	
%	
of	
the	
general	ENTITY
population	ENTITY
who	
have	
this	
HLA	ENTITY
subtype	ENTITY
.	

Other	
subtypes	ENTITY
also	
have	
less	
striking	
associations	ENTITY
.	

For	
example	
,	
DQB1	ENTITY
*	ENTITY
0301	ENTITY
is	
associated	ENTITY
with	ENTITY
increased	ENTITY
susceptibility	ENTITY
to	
narcolepsy	ENTITY
,	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
whereas	
subtypes	ENTITY
such	
as	
DQB1	ENTITY
*	ENTITY
0501	ENTITY
and	
DQB1	ENTITY
*	ENTITY
0601	ENTITY
,	
are	
protective	
in	
the	
presence	ENTITY
of	
DQB1	ENTITY
*	ENTITY
0602	ENTITY
.	

Genomewide	ENTITY
studies	ENTITY
have	
found	
associations	ENTITY
between	
narcolepsy	ENTITY
and	
polymorphisms	ENTITY
in	
T	ENTITY
cell	ENTITY
receptor	ENTITY
alpha	ENTITY
,	
tumor	ENTITY
necrosis	ENTITY
factor	ENTITY
(	ENTITY
TNF)-alpha	ENTITY
2	
,	
and	
TNF	ENTITY
receptor	ENTITY
2	ENTITY
as	
well	
as	
the	
purinergic	ENTITY
receptor	ENTITY
P2Y11	ENTITY
genes	ENTITY
.	

There	
is	
a	
low	ENTITY
prevalence	ENTITY
of	
familial	ENTITY
cases	ENTITY
;	
the	
risk	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
in	
first	ENTITY
-	
de-	ENTITY
gree	ENTITY
relatives	ENTITY
of	
affected	ENTITY
individuals	ENTITY
is	
approximately	
1	
%	
to	
2	
%	
.	

When	
compared	ENTITY
to	
the	
population	ENTITY
prevalence	ENTITY
,	
this	
indicates	
a	
tenfold	
to	
fortyfold	
increase	ENTITY
in	
risk	ENTITY
.	

This	
increased	ENTITY
risk	ENTITY
can	
not	
be	
explained	
solely	
by	
HLA	ENTITY
gene	ENTITY
effects	
,	
suggesting	
the	
exis-	
tence	
of	
other	
genetic	ENTITY
factors	ENTITY
.	

Multiplex	ENTITY
families	ENTITY
with	
more	
than	
two	
affected	ENTITY
members	ENTITY
are	
uncommon	ENTITY
.	

In	
most	
cases	ENTITY
,	
normal	
CSF	ENTITY
hypocretin	ENTITY
levels	ENTITY
have	
been	
found	
in	
these	
families	ENTITY
,	
and	
the	
association	ENTITY
with	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
is	
much	
weaker	
compared	
to	
spo-	ENTITY
radic	ENTITY
narcolepsy	ENTITY
.	

So	
far	
,	
only	
a	
single	
case	
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
has	
been	
described	
in	
association	ENTITY
with	ENTITY
a	
preprohypocretin	ENTITY
mutation	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
usually	
occurs	
after	
five	
years	ENTITY
of	
age	ENTITY
and	
most	
typically	
between	
ages	ENTITY
10	
and	
25	
years	ENTITY
.	

However	
,	
a	
bimodal	ENTITY
distribution	ENTITY
in	
the	
age	ENTITY
at	
onset	
has	
been	
described	
in	
some	
populations	ENTITY
with	
a	
first	
peak	
occurring	
at	
adolescence	ENTITY
(	
age	ENTITY
15	
years	ENTITY
)	
and	
a	
second	
at	
the	
age	ENTITY
of	
35	
years	ENTITY
.	

Recent	
studies	ENTITY
highlight	
the	
fact	
that	
narcolepsy	ENTITY
,	
and	
especially	
cataplexy	ENTITY
,	
in	
young	ENTITY
children	ENTITY
may	
present	
somewhat	
differently	
,	
resulting	
in	
delayed	ENTITY
diagnosis	ENTITY
and	
erroneously	
high	
estimates	ENTITY
of	
age	ENTITY
of	
onset	ENTITY
.	

Sleepiness	ENTITY
is	
usually	
the	
first	
symptom	ENTITY
to	
manifest	ENTITY
.	

Cataplexy	ENTITY
most	
often	
occurs	
within	
one	
year	ENTITY
of	
onset	
but	
in	
rare	ENTITY
cases	ENTITY
,	
may	
precede	
the	
onset	ENTITY
of	ENTITY
sleepiness	ENTITY
or	
commence	
up	
to	
40	
years	ENTITY
later	
.	

Hypnagogic	ENTITY
hallucinations	ENTITY
,	
sleep	ENTITY
paralysis	ENTITY
,	
and	
disturbed	
noctur-	
nal	ENTITY
sleep	ENTITY
often	
manifest	ENTITY
later	
in	
the	
course	ENTITY
of	
the	
disease	ENTITY
.	

When	
left	ENTITY
untreated	ENTITY
,	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
is	
often	
socially	ENTITY
disabling	ENTITY
and	
isolating	ENTITY
.	

Patients	ENTITY
have	
a	
tendency	
to	
fail	ENTITY
in	
school	ENTITY
and	
are	
often	
dismissed	
from	
their	
jobs	ENTITY
.	

Driving	ENTITY
may	
be	
avoided	
for	
fear	ENTITY
of	
a	
motor	ENTITY
vehicle	ENTITY
accident	ENTITY
.	

The	
inability	ENTITY
to	ENTITY
sleep	ENTITY
at	
night	ENTITY
may	
further	
contribute	
to	
a	
loss	ENTITY
of	ENTITY
control	ENTITY
these	
patients	ENTITY
have	
over	
their	
schedule	ENTITY
.	

Depression	ENTITY
and	
weight	ENTITY
gain	ENTITY
also	
are	
common	
.	

In	
most	
cases	ENTITY
,	
symptoms	ENTITY
gradually	
develop	
over	
several	
years	ENTITY
.	

When	
the	
clinical	ENTITY
picture	ENTITY
has	
fully	
developed	
,	
there	
are	
usually	
only	
minor	
fluctuations	ENTITY
in	
severity	ENTITY
.	

Cataplexy	ENTITY
may	
lessen	
with	
age	ENTITY
,	
or	
occasionally	
increase	ENTITY
in	
frequency	ENTITY
and	
severity	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
In	
recent	
years	ENTITY
,	
increasing	ENTITY
attention	ENTITY
has	
been	
given	
to	
the	
clinical	ENTITY
presentation	ENTITY
of	
nar-	
colepsy	ENTITY
in	
childhood	ENTITY
.	

Narcolepsy	ENTITY
with	
cataplexy	ENTITY
is	
infrequent	ENTITY
prior	
to	
the	
age	ENTITY
of	
four	
years	ENTITY
.	

In	
addition	
,	
the	
clinical	ENTITY
presentation	ENTITY
in	
children	ENTITY
may	
be	
different	
from	
that	
of	
adults	ENTITY
.	

In	
young	ENTITY
children	ENTITY
,	
sleepiness	ENTITY
may	
be	
difficult	
to	
assess	ENTITY
,	
and	
may	
express	ENTITY
itself	
as	
excessively	
long	ENTITY
night	ENTITY
sleep	ENTITY
,	
or	
the	
recurrence	ENTITY
of	
previously	
discontinued	ENTITY
daytime	ENTITY
napping	ENTITY
.	

Moreover	
,	
children	ENTITY
may	
paradoxically	
present	
with	
hyperactive	ENTITY
behavior	ENTITY
,	
behavioral	ENTITY
problems	ENTITY
or	
decreased	ENTITY
performance	ENTITY
in	
school	ENTITY
.	

Inattentiveness	ENTITY
,	
lack	ENTITY
of	ENTITY
energy	ENTITY
,	
insomnia	ENTITY
,	
bizarre	ENTITY
hallucinations	ENTITY
,	
or	
a	
combination	ENTITY
thereof	
can	
lead	
to	
a	
psy-	ENTITY
chiatric	ENTITY
misdiagnosis	ENTITY
of	
schizophrenia	ENTITY
or	
depression	ENTITY
.	

In	
this	
population	ENTITY
,	
the	
presence	ENTITY
of	
ancillary	ENTITY
symptoms	ENTITY
such	
as	
sleep	ENTITY
paralysis	ENTITY
or	
hypnagogic	ENTITY
hallucinations	ENTITY
may	
also	
be	
difficult	
to	
confirm	ENTITY
,	
depending	
on	
the	
child	ENTITY
’s	
verbal	
ability	
.	

Precocious	ENTITY
puberty	ENTITY
and	
obesity	ENTITY
may	
also	
develop	
around	
the	
time	ENTITY
of	
symptom	ENTITY
onset	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
dis-	
order	
or	
REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
may	
also	
be	
manifest	ENTITY
at	
the	
time	
of	
symptom	ENTITY
onset	ENTITY
.	

Cataplexy	ENTITY
may	
be	
very	
severe	
around	
disease	ENTITY
onset	ENTITY
and	
appear	
phenotypically	ENTITY
differ-	
ent	
from	
typical	
episodes	ENTITY
seen	
in	ENTITY
adulthood	ENTITY
.	

In	
addition	
to	
typical	
attacks	ENTITY
triggered	ENTITY
by	
positive	ENTITY
emotions	ENTITY
,	
children	ENTITY
can	
also	
present	
with	
weakness	ENTITY
involving	
the	
face	ENTITY
,	
eyelids	ENTITY
,	
and	
mouth	ENTITY
not	
clearly	
associated	ENTITY
with	ENTITY
emotion	ENTITY
.	

Together	
with	
tongue	ENTITY
protrusion	ENTITY
,	
this	
characteristic	
pattern	ENTITY
has	
been	
termed	
a	
cataplectic	ENTITY
facies	ENTITY
.	

Children	ENTITY
with	
cataplexy	ENTITY
may	
also	
display	
positive	
motor	ENTITY
phenomena	ENTITY
,	
ranging	
from	
perioral	ENTITY
dyskinetic	ENTITY
or	
dys-	
tonic	ENTITY
movements	ENTITY
to	
frank	ENTITY
stereotypies	ENTITY
.	

In	
children	ENTITY
,	
anticipation	ENTITY
of	
reward	ENTITY
may	
also	
be	
a	
precipitant	ENTITY
.	

The	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
in	
children	ENTITY
may	
be	
complicated	ENTITY
because	
of	
diffi-	
culties	ENTITY
performing	
the	
MSLT	ENTITY
,	
and	
lack	ENTITY
of	
normative	ENTITY
values	ENTITY
in	
children	ENTITY
younger	ENTITY
than	
six	
years	ENTITY
.	

If	
the	
MSLT	ENTITY
shows	
equivocal	ENTITY
results	ENTITY
,	
repeating	
it	
after	
a	
time	ENTITY
interval	ENTITY
may	
be	
helpful	
.	

Given	
these	
difficulties	ENTITY
,	
CSF	ENTITY
hypocretin-1	
measurements	ENTITY
are	
of	
particular	
value	
,	
as	
hypocretin-1	ENTITY
levels	ENTITY
are	
low	ENTITY
or	
undetectable	ENTITY
very	
shortly	
after	
disease	ENTITY
onset	ENTITY
in	
children	ENTITY
as	
well	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
It	
is	
now	
firmly	
established	
that	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
is	
caused	
by	
deficiencies	ENTITY
in	
hypo-	
cretin	ENTITY
signaling	ENTITY
,	
most	
likely	
due	
to	
a	
selective	
loss	
of	
hypothalamic	ENTITY
hypocretin	ENTITY
pro-	
ducing	
neurons	ENTITY
.	

Several	
animal	ENTITY
models	ENTITY
lacking	
hypocretin	ENTITY
neurotransmission	ENTITY
demon-	
strate	ENTITY
narcolepsy	ENTITY
,	
indicating	
a	
causal	
relationship	ENTITY
.	

The	
vast	
majority	
of	
patients	ENTITY
(	
90	
%	
to	
95	
%	
)	
with	
narcolepsy	ENTITY
and	
cataplexy	ENTITY
have	
undetectable	ENTITY
or	
low	ENTITY
(	
<	
110	
pg	
/	
mL	
)	
levels	ENTITY
of	
hypocretin-1	ENTITY
in	
the	
CSF	ENTITY
.	

Patients	ENTITY
without	
cataplexy	ENTITY
can	
be	
hypocretin	ENTITY
deficient	ENTITY
as	
well	
,	
although	
at	
a	
much	
lower	
frequency	ENTITY
,	
and	
are	
thus	
also	
classified	
as	
narcolepsy	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
type	ENTITY
1	ENTITY
.	

The	
strong	
HLA	ENTITY
association	ENTITY
in	
narcolepsy	ENTITY
has	
led	
to	
the	
hypothesis	ENTITY
that	
auto-	
immunity	ENTITY
is	
a	
likely	
etiological	ENTITY
mechanism	ENTITY
,	
potentially	
explaining	
the	
selectivity	ENTITY
of	
neuronal	ENTITY
destruction	ENTITY
in	
the	
hypothalamus	ENTITY
.	

However	
,	
definitive	
proof	
for	
autoimmunity	ENTITY
has	
not	
been	
obtained	
.	

Objective	ENTITY
Findings	ENTITY
Narcolepsy	ENTITY
type	ENTITY
1	ENTITY
is	
essentially	
defined	
as	
a	
hypocretin	ENTITY
deficiency	ENTITY
syndrome	ENTITY
,	
which	
is	
reflected	
in	
the	
need	
for	
objective	
measurements	ENTITY
in	
the	
clinical	ENTITY
criteria	ENTITY
.	

This	
require-	
ment	ENTITY
is	
further	
driven	
by	
the	
fact	
that	
many	
patients	ENTITY
require	
lifelong	ENTITY
treatment	ENTITY
with	
potentially	
addictive	ENTITY
medications	ENTITY
,	
underscoring	
the	
importance	
of	
objective	ENTITY
confirma-	
tion	ENTITY
of	
the	
diagnosis	ENTITY
.	

It	
is	
strongly	
recommended	
that	
the	
MSLT	ENTITY
be	
preceded	
by	
at	
least	
one	
week	ENTITY
of	
acti-	
graphic	ENTITY
recording	ENTITY
with	
a	
sleep	ENTITY
log	ENTITY
to	
establish	
whether	
the	
results	ENTITY
could	
be	
biased	
by	
insufficient	ENTITY
sleep	ENTITY
,	
shift	
work	
,	
or	
another	
circadian	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

In	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
,	
the	
MSLT	ENTITY
demonstrates	
a	
mean	
sleep	ENTITY
latency	ENTITY
of	
less	
than	
eight	
minutes	ENTITY
and	
typically	
less	
than	
five	
minutes	ENTITY
.	

Meta	ENTITY
-	
analysis	ENTITY
shows	
mean	
sleep	ENTITY
latencies	ENTITY
in	
narcoleptic	ENTITY
patients	ENTITY
with	
cataplexy	ENTITY
of	
3.1	
±	
2.9	
minutes	ENTITY
.	

In	
addition	
,	
two	
or	
more	
SOREMPs	ENTITY
must	
be	
present	
.	

Recent	
data	ENTITY
suggest	
that	
a	
SOREMP	ENTITY
within	
15	
minutes	
of	
onset	
of	
nocturnal	ENTITY
sleep	ENTITY
is	
a	
highly	
specific	
finding	ENTITY
in	
the	
absence	ENTITY
of	
another	
sleep	ENTITY
disorder	ENTITY
,	
but	
with	
low	ENTITY
sensitivity	ENTITY
.	

Therefore	
,	
the	
criteria	ENTITY
for	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
allow	
the	
“	
replacement	ENTITY
”	
of	
one	
SOREMP	ENTITY
in	
the	
MSLT	ENTITY
with	
a	
SOREMP	ENTITY
on	
the	
preceding	
poly-	
somnogram	ENTITY
.	

For	
the	
correct	
interpretation	ENTITY
of	
MSLT	ENTITY
findings	ENTITY
,	
the	
recordings	ENTITY
should	
be	
performed	
with	
the	
following	
conditions	ENTITY
:	
(	
1	
)	
the	
patient	ENTITY
must	
be	
free	ENTITY
of	ENTITY
drugs	ENTITY
that	
influence	ENTITY
sleep	ENTITY
for	
at	
least	
14	
days	ENTITY
(	
or	
at	
least	
five	
times	
the	
half	ENTITY
-	
life	ENTITY
of	
the	
drug	ENTITY
and	
longer	ENTITY
-	
acting	ENTITY
metabolite	ENTITY
)	
,	
confirmed	
by	
a	
urine	ENTITY
drug	ENTITY
screen	ENTITY
;	
(	
2	
)	
the	
sleep	ENTITY
-	
wake	ENTITY
sched-	
ule	
must	
have	
been	
standardized	ENTITY
and	
,	
if	
necessary	
,	
extended	
to	
a	
minimum	
of	
seven	
hours	
in	
bed	ENTITY
each	ENTITY
night	ENTITY
(	
longer	
for	
children	ENTITY
)	
for	
at	
least	
seven	
days	ENTITY
before	
polysom-	

nography	ENTITY
(	
preferably	
documented	ENTITY
by	
sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
)	
;	
and	
(	
3	
)	
nocturnal	ENTITY
polysomnography	ENTITY
should	
be	
performed	
on	
the	
night	ENTITY
immediately	
preceding	
the	
MSLT	ENTITY
to	
rule	
out	
other	
sleep	ENTITY
disorders	ENTITY
that	
could	
mimic	
the	
diagnostic	ENTITY
features	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Sleep	ENTITY
time	ENTITY
during	
polysomnography	ENTITY
should	
be	
curtailed	ENTITY
as	
little	
as	
possible	
with	
the	
goal	ENTITY
of	
at	
least	
seven	
hours	
asleep	ENTITY
.	

The	
overnight	ENTITY
poly-	
somnogram	ENTITY
may	
demonstrate	
an	
increase	ENTITY
in	
the	
amount	ENTITY
of	
stage	ENTITY
N1	ENTITY
sleep	ENTITY
,	
and	
there	
may	
be	
a	
disruption	ENTITY
of	
the	
normal	ENTITY
sleep	ENTITY
pattern	ENTITY
,	
with	
frequent	ENTITY
awakenings	ENTITY
.	

REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
may	
be	
present	
.	

Measuring	ENTITY
CSF	ENTITY
levels	ENTITY
of	
hypocretin-1	ENTITY
is	
a	
highly	
specific	ENTITY
and	
sensitive	ENTITY
test	ENTITY
for	
the	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Hypocretin-1	ENTITY
can	
be	
measured	ENTITY
in	
crude	ENTITY
CSF	ENTITY
,	
using	
a	
commercially	
available	
radioimmunoassay	ENTITY
.	

When	
using	
the	
Stanford	ENTITY
reference	ENTITY
sample	ENTITY
,	
values	ENTITY
less	
than	
110	
pg	
/	
mL	
are	
highly	
specific	ENTITY
.	

Alternatively	
,	
a	
laboratory	ENTITY
may	
elect	
to	
obtain	
control	
data	ENTITY
themselves	
,	
in	
which	
case	
a	
level	ENTITY
of	
less	
than	
33	
%	
of	
mean	ENTITY
control	ENTITY
values	ENTITY
is	
considered	
abnormal	ENTITY
.	

Issues	ENTITY
concerning	
the	
standardization	ENTITY
of	
CSF	ENTITY
hypocre-	
tin	ENTITY
measurements	ENTITY
remain	
,	
but	
extensive	
protocols	ENTITY
are	
available	
.	

Low	ENTITY
CSF	ENTITY
hypocre-	
tin	ENTITY
values	ENTITY
are	
occasionally	
observed	
in	
seriously	
ill	ENTITY
patients	ENTITY
with	
other	
disorders	ENTITY
and	
should	
be	
interpreted	ENTITY
within	
the	
clinical	ENTITY
context	ENTITY
.	

HLA	ENTITY
typing	ENTITY
of	
narcoleptic	ENTITY
patients	ENTITY
with	
cataplexy	ENTITY
almost	
always	
shows	
the	
presence	ENTITY
of	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
(	
and	
DR2	ENTITY
or	
DRB1	ENTITY
*	ENTITY
1501	ENTITY
in	
whites	ENTITY
and	
Asians	ENTITY
)	
,	
but	
this	
is	
not	
diagnostic	ENTITY
for	
narcolepsy	ENTITY
.	

Approximately	
25	
%	
of	
the	
normal	ENTITY
Caucasian	ENTITY
population	ENTITY
,	
12	
%	
of	
the	
Japanese	ENTITY
population	ENTITY
,	
and	
38	
%	
of	
the	
black	ENTITY
population	ENTITY
are	
positive	ENTITY
for	
DQB1	ENTITY
*	ENTITY
0602	ENTITY
.	

HLA	ENTITY
typing	ENTITY
could	
be	
considered	
when	
a	
spinal	ENTITY
tap	ENTITY
is	
contemplated	
to	
assess	
hypocretin-1	ENTITY
values	ENTITY
:	
if	
the	
patient	ENTITY
is	
HLA	ENTITY
-	
negative	ENTITY
,	
hypocretin-1	ENTITY
levels	ENTITY
are	
most	
likely	
normal	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
In	
the	
absence	ENTITY
of	
cataplexy	ENTITY
,	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
can	
be	
diagnosed	ENTITY
based	
on	
the	
pres-	
ence	ENTITY
of	
hypersomnolence	ENTITY
and	
low	ENTITY
CSF	ENTITY
hypocretin-1	
levels	ENTITY
.	

When	
cataplexy	ENTITY
is	
absent	ENTITY
and	
CSF	ENTITY
hypocretin-1	ENTITY
levels	ENTITY
are	
normal	ENTITY
or	
unknown	
,	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
should	
be	
diagnosed	ENTITY
.	

Cataplexy	ENTITY
must	
be	
differentiated	
from	
cataplexy	ENTITY
-	
like	
episodes	ENTITY
that	
are	
occasionally	
observed	
in	
normal	ENTITY
individuals	ENTITY
.	

For	
example	
,	
feelings	ENTITY
of	
muscle	ENTITY
weakness	ENTITY
are	
some-	
times	
reported	
when	
healthy	ENTITY
subjects	ENTITY
laugh	
out	
loud	ENTITY
.	

In	
genuine	
cataplexy	ENTITY
,	
episodes	ENTITY
most	
often	
occur	
with	
a	
significant	
frequency	ENTITY
,	
and	
are	
associated	ENTITY
with	ENTITY
loss	ENTITY
of	
muscle	ENTITY
tone	ENTITY
.	

Cataplexy	ENTITY
should	
be	
differentiated	
from	
hypotension	ENTITY
,	
transient	ENTITY
ischemic	ENTITY
attacks	ENTITY
,	
drop	ENTITY
attacks	ENTITY
,	
akinetic	ENTITY
seizures	ENTITY
,	
neuromuscular	ENTITY
disorders	ENTITY
,	
vestibular	ENTITY
disorders	ENTITY
,	
psycho-	
logical	ENTITY
or	
psychiatric	ENTITY
disorders	ENTITY
,	
and	
sleep	ENTITY
paralysis	ENTITY
.	

Clear	ENTITY
improvement	ENTITY
with	
antide-	
pressant	ENTITY
medications	ENTITY
may	
favor	
a	
diagnosis	ENTITY
of	
cataplexy	ENTITY
in	
difficult	
cases	ENTITY
.	

Sleepiness	ENTITY
may	
be	
secondary	ENTITY
to	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
shift	
work	
,	
the	
effects	ENTITY
of	ENTITY
substances	ENTITY
or	
medications	ENTITY
,	
or	
other	
sleep	ENTITY
disorders	ENTITY
.	

Many	
of	
these	
conditions	ENTITY
can	
result	
in	
early	ENTITY
onset	ENTITY
REM	ENTITY
sleep	ENTITY
as	
well	
.	

When	
cataplexy	ENTITY
is	
present	
,	
these	
disorders	ENTITY
do	
not	
preclude	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

When	
there	
is	
a	
questionable	
history	ENTITY
of	
cataplexy	ENTITY
in	
such	
cases	ENTITY
,	
either	
comorbid	ENTITY
conditions	ENTITY
should	
be	
adequately	
treated	ENTITY
before	
performing	
an	
MSLT	ENTITY
or	
CSF	ENTITY
hypocretin-1	ENTITY
should	
be	
measured	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Idiopathic	ENTITY
hypersomnia	ENTITY
is	
differentiated	
from	
narcolepsy	ENTITY
type	
1	
by	
the	
absence	ENTITY
of	
cat-	ENTITY
aplexy	ENTITY
and	
the	
lack	ENTITY
of	
two	
or	
more	
SOREMPs	ENTITY
on	
the	
MSLT	ENTITY
.	

In	
contrast	
with	
patients	ENTITY
who	
have	
narcolepsy	ENTITY
,	
patients	ENTITY
with	
idiopathic	ENTITY
hypersomnia	ENTITY
generally	
have	
high	
sleep	
efficiency	ENTITY
,	
sleep	ENTITY
drunkenness	ENTITY
,	
and	
long	ENTITY
,	
unrefreshing	ENTITY
naps	ENTITY
.	

In	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
there	
is	
no	
cataplexy	ENTITY
,	
and	
normalizing	ENTITY
sleep	ENTITY
time	ENTITY
elim-	

inates	ENTITY
the	
daytime	ENTITY
sleepiness	ENTITY
.	

Chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
and	
depression	ENTITY
may	
mimic	
narcolepsy	ENTITY
but	
do	
not	
show	
the	
typical	
MSLT	ENTITY
findings	ENTITY
.	

Malingering	ENTITY
and	
substance	ENTITY
abuse	ENTITY
disorder	ENTITY
should	
be	
considered	
in	
patients	ENTITY
who	
try	
to	
mislead	
the	
clinician	ENTITY
in	
order	
to	
obtain	
stimulant	ENTITY
medications	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Ten	
percent	
of	
patients	ENTITY
with	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
have	
normal	
hypocretin-1	ENTITY
levels	ENTITY
in	
the	
CSF	ENTITY
,	
which	
suggests	
that	
CSF	ENTITY
levels	ENTITY
either	
do	
not	
perfectly	
reflect	
brain	ENTITY
hypocretin	ENTITY
neurotransmission	ENTITY
or	
that	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
can	
be	
caused	
by	
factors	ENTITY
other	
than	
hypocretin	ENTITY
deficiency	ENTITY
.	

The	
cause	
of	
the	
hypocretin	ENTITY
cell	ENTITY
destruction	ENTITY
remains	
unknown	
,	
although	
an	
autoimmune	ENTITY
-	
mediated	ENTITY
mechanism	ENTITY
is	
suspected	ENTITY
.	

Levels	ENTITY
of	
hypocretin-1	ENTITY
have	
been	
reported	
in	
the	
blood	ENTITY
of	
some	
subjects	ENTITY
.	

The	
development	ENTITY
of	
serum	ENTITY
tests	ENTITY
to	
determine	
hypocretin	ENTITY
deficiency	ENTITY
would	
provide	
a	
less	
invasive	ENTITY
diagnos-	
tic	ENTITY
approach	ENTITY
.	

Bibliography	ENTITY
Andlauer	ENTITY
O	ENTITY
,	
Moore	
H	
,	
Jouhier	ENTITY
L	ENTITY
,	
et	
al	
.	

Nocturnal	ENTITY
REM	ENTITY
sleep	ENTITY
latency	ENTITY
for	
identifying	ENTITY
patients	ENTITY
with	
narcolepsy	ENTITY
/	
hypocretin	ENTITY
deficiency	ENTITY
.	

JAMA	ENTITY
Neurol	
2013;6:1–12	
.	

Aran	ENTITY
A	ENTITY
,	
Einen	ENTITY
M	ENTITY
,	
Lin	ENTITY
L	ENTITY
,	ENTITY
Palazzi	ENTITY
G	ENTITY
,	
Nishino	ENTITY
S	ENTITY
,	
Mignot	ENTITY
E.	ENTITY
Clinical	ENTITY
and	
therapeutic	ENTITY
aspects	ENTITY
of	
childhood	ENTITY
narcolepsy	ENTITY
-	
cataplexy	ENTITY
:	
a	
retrospective	ENTITY
study	ENTITY
of	
51	
children	ENTITY
.	

Sleep	ENTITY
2010;33:1457–64	
.	

Arii	
J	
,	
Kanbayashi	ENTITY
T	ENTITY
,	
Tanabe	ENTITY
Y	ENTITY
,	
et	
al	
.	
CSF	ENTITY
hypocretin-1	ENTITY
(	
orexin	ENTITY
-	
A	ENTITY
)	
levels	ENTITY
in	
childhood	ENTITY
narcolepsy	ENTITY
and	
neurologic	ENTITY
disorders	ENTITY
.	

Neurology	ENTITY
2004;63:2440–2	
.	

Bourgin	ENTITY
P	ENTITY
,	
Zeitzer	ENTITY
JM	
,	
Mignot	ENTITY
E.	ENTITY
CSF	ENTITY
hypocretin-1	ENTITY
assessment	ENTITY
in	
sleep	ENTITY
and	
neurological	ENTITY
disorders	ENTITY
.	

Lancet	ENTITY
Neurol	ENTITY
2008;7:649–62	ENTITY
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Gosselin	
A	
,	
Paquet	
J	
,	
Touchon	ENTITY
J	ENTITY
,	
Billiard	ENTITY
M	ENTITY
,	
Montplaisir	ENTITY
J.	ENTITY
Effect	ENTITY
of	ENTITY
age	ENTITY
on	
MSLT	ENTITY
results	ENTITY
in	
patients	ENTITY
with	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
.	

Neurology	ENTITY
2004;62:46–50	
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Arnulf	ENTITY
I	ENTITY
,	
Mignot	ENTITY
E.	ENTITY
Narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

Lancet	ENTITY
2007;369:499–511	
.	

Kotagal	ENTITY
S	ENTITY
,	
Krahn	ENTITY
LE	ENTITY
,	

Slocumb	ENTITY
N.	ENTITY
A	ENTITY
putative	
link	
between	
childhood	ENTITY
narcolepsy	ENTITY
and	
obesity	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2004;5:147–50	ENTITY
.	

Mignot	ENTITY
E	ENTITY
,	
Lammers	ENTITY
GJ	ENTITY
,	
Ripley	ENTITY
B	ENTITY
,	
et	
al	
.	

The	
role	
of	
cerebrospinal	ENTITY
fluid	ENTITY
hypocretin	ENTITY
measurement	ENTITY
in	
the	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
and	
other	
hypersomnias	ENTITY
.	

Arch	ENTITY
Neurol	ENTITY
2002;59:1553–62	ENTITY
.	

Mignot	ENTITY
E	ENTITY
,	
Lin	
L	
,	
Finn	ENTITY
L	ENTITY
,	
et	
al	
.	

Correlates	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
REM	ENTITY
periods	ENTITY
during	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
in	
community	ENTITY
adults	ENTITY
.	

Brain	ENTITY
2006;129:1609–23	
.	

Nevsimalova	ENTITY
S	ENTITY
,	
Prihodova	ENTITY
I	ENTITY
,	
Kemlink	ENTITY
D	ENTITY
,	
Lin	ENTITY
L	ENTITY
,	ENTITY
Mignot	ENTITY
E.	ENTITY
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
)	
can	
be	
one	
of	
the	
first	
symptoms	ENTITY
of	
childhood	ENTITY
narcolepsy	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2007;8:784–6	ENTITY
.	

Overeem	ENTITY
S	ENTITY
,	
van	
Nues	ENTITY
SJ	ENTITY
,	
van	ENTITY
der	ENTITY
Zande	ENTITY
WL	ENTITY
,	
Donjacour	ENTITY
CE	ENTITY
,	
van	
Mierlo	
P	
,	
Lammers	ENTITY
GJ	ENTITY
.	

The	
clinical	ENTITY
features	ENTITY
of	
cataplexy	ENTITY
:	
a	
questionnaire	ENTITY
study	ENTITY
in	
narcolepsy	ENTITY
patients	ENTITY
with	
and	
without	
hypocretin-1	ENTITY
deficiency	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2011;12:12–8	ENTITY
.	

Pizza	ENTITY
F	ENTITY
,	
Franceschini	ENTITY
C	ENTITY
,	
Peltola	ENTITY
H	ENTITY
,	
et	
al	
.	

Clinical	ENTITY
and	
polysomnographic	ENTITY
course	ENTITY
of	
childhood	ENTITY
narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

Brain	ENTITY
2013	
Oct	
18	
.	

[	
Epub	
ahead	
of	
print	
]	

Plazzi	ENTITY
G	ENTITY
,	
Parmeggiani	ENTITY
A	ENTITY
,	
Mignot	ENTITY
E	ENTITY
,	
et	
al	
.	

Narcolepsy	ENTITY
-	
cataplexy	ENTITY
associated	ENTITY
with	ENTITY
precocious	ENTITY
puberty	ENTITY
.	

Neurology	ENTITY
2006;66:1577–9	
.	

Serra	ENTITY
L	ENTITY
,	
Montagna	
P	
,	
Mignot	ENTITY
E	ENTITY
,	
Lugaresi	ENTITY
E	ENTITY
,	
Plazzi	
G.	
Cataplexy	ENTITY
features	ENTITY
in	
childhood	ENTITY
narcolepsy	ENTITY
.	

Mov	ENTITY
Disord	ENTITY
2008;23:858–65	ENTITY
.	

Narcolepsy	ENTITY
Type	ENTITY
2	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
347.00	
Alternate	ENTITY
Names	ENTITY
Narcolepsy	ENTITY
without	
cataplexy	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.419	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
occurring	
for	
at	
least	
three	
months	ENTITY
.	

B.	ENTITY
A	
mean	
sleep	ENTITY
latency	ENTITY
of	
≤	
8	
minutes	ENTITY
and	
two	
or	
more	
sleep	ENTITY
onset	
REM	ENTITY
periods	ENTITY
(	
SOREMPs	ENTITY
)	
are	
found	
on	
a	
MSLT	ENTITY
performed	
according	
to	
standard	ENTITY
techniques	ENTITY
.	

A	
SOREMP	ENTITY
(	
within	
15	
minutes	
of	
sleep	ENTITY
onset	ENTITY
)	
on	
the	
preceding	
nocturnal	ENTITY
polysomnogram	ENTITY
may	
replace	
one	
of	
the	
SOREMPs	ENTITY
on	
the	
MSLT	ENTITY
.	

C.	ENTITY
Cataplexy	ENTITY
is	
absent.1	ENTITY
D.	
Either	
CSF	ENTITY
hypocretin-1	ENTITY
concentration	ENTITY
has	
not	
been	
measured	ENTITY
or	
CSF	ENTITY
hypocretin-1	ENTITY
concentration	ENTITY
measured	
by	
immunoreactivity	ENTITY
is	
either	
>	
110	
pg	
/	
mL	
or	
>	
1/3	
of	
mean	ENTITY
values	ENTITY
obtained	
in	
normal	ENTITY
subjects	ENTITY
with	
the	
same	
standardized	
assay.2	ENTITY
E.	

The	
hypersomnolence	ENTITY
and/or	
MSLT	ENTITY
findings	ENTITY
are	
not	
better	
explained	
by	
other	
causes	
such	
as	
insufficient	ENTITY
sleep	ENTITY
,	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
,	
or	
the	
effect	ENTITY
of	
medication	ENTITY
or	
substances	ENTITY
or	
their	
withdrawal	ENTITY
.	

Notes	ENTITY
.	

If	
cataplexy	ENTITY
develops	ENTITY
later	
,	
then	
the	
disorder	ENTITY
should	
be	
reclassified	
as	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
.	

If	
the	
CSF	ENTITY
Hcrt-1	ENTITY
concentration	ENTITY
is	
tested	ENTITY
at	
a	
later	
stage	ENTITY
and	
found	
to	
be	
either	
≤	
110	
pg	
/	
mL	
or	
<	
1/3	
of	
mean	ENTITY
values	ENTITY
obtained	
in	
normal	ENTITY
subjects	ENTITY
with	
the	
same	
assay	ENTITY
,	
then	
the	
disorder	ENTITY
should	
be	
reclassified	
as	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Narcolepsy	ENTITY
type	
2	
is	
characterized	ENTITY
by	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
and	
abnormal	ENTITY
man-	
ifestations	ENTITY
of	
REM	ENTITY
sleep	ENTITY
on	
polysomnography	ENTITY
/	
MSLT	ENTITY
.	

Cataplexy	ENTITY
is	
absent	ENTITY
,	
although	
some	
atypical	ENTITY
sensations	ENTITY
of	
weakness	ENTITY
triggered	ENTITY
by	
unusual	ENTITY
emotions	ENTITY
such	
as	
stress	ENTITY
and	
anger	ENTITY
may	
be	
reported	
.	

Refreshing	ENTITY
daytime	ENTITY
naps	ENTITY
are	
characteristic	ENTITY
.	

An	
essential	
feature	
of	
the	
diagnosis	ENTITY
is	
the	
presence	ENTITY
of	
a	
mean	ENTITY
sleep	ENTITY
latency	ENTITY
less	
than	
or	
equal	
to	
eight	
minutes	ENTITY
and	
two	
or	
more	
SOREMPs	ENTITY
on	
an	
MSLT	ENTITY
(	
or	
one	
SOREMP	ENTITY
on	
an	
MSLT	ENTITY
and	
one	
on	
the	
preceding	
nocturnal	ENTITY
polysomnogram	ENTITY
)	
.	

The	
presence	ENTITY
of	
CSF	ENTITY
hypocretin-1	ENTITY
concentrations	ENTITY
≤	
110	
pg	
/	
mL	ENTITY
or	
less	
than	
one	
third	
of	
mean	ENTITY
values	ENTITY
obtained	
in	
normal	ENTITY
subjects	ENTITY
with	
the	
same	
assay	ENTITY
excludes	
the	
diagnosis	ENTITY
,	
but	
most	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
will	
not	
have	
undergone	
CSF	ENTITY
examination	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Sleep	ENTITY
paralysis	ENTITY
,	
hypnagogic	ENTITY
hallucinations	ENTITY
,	
or	
automatic	ENTITY
behavior	ENTITY
may	
be	
present	
.	

Memory	ENTITY
lapses	
,	
automatic	ENTITY
behavior	ENTITY
,	
ptosis	ENTITY
,	
blurred	ENTITY
vision	ENTITY
,	
and	
diplopia	ENTITY
may	
occur	
in	
association	ENTITY
with	ENTITY
sleepiness	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
and	
nonrapid	ENTITY
eye	ENTITY
movement	ENTITY
(	
NREM	
)	
parasomnias	
may	
occur	
.	

Nocturnal	ENTITY
sleep	ENTITY
disruption	ENTITY
with	
frequent	ENTITY
awaken-	
ings	ENTITY
may	
be	
present	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Narcolepsy	ENTITY
type	
2	
due	
to	
a	
medical	ENTITY
condition	ENTITY
:	

This	
condition	ENTITY
fulfills	
criteria	ENTITY
for	
nar-	
colepsy	ENTITY
type	ENTITY
2	ENTITY
and	
is	
attributable	
to	
another	
medical	ENTITY
disorder	ENTITY
.	

Neurologic	ENTITY
disorders	ENTITY
associated	ENTITY
with	ENTITY
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
include	
tumors	ENTITY
or	
sarcoidosis	ENTITY
of	
the	
hypothalamus	ENTITY
,	
autoimmune	ENTITY
or	
paraneoplastic	ENTITY
disorders	ENTITY
associated	ENTITY
with	ENTITY
anti	ENTITY
-	
Ma-2	ENTITY
or	
anti	ENTITY
-	
aquaporin-4	ENTITY
antibodies	ENTITY
,	
multiple	ENTITY
sclerosis	ENTITY
,	
myotonic	ENTITY
dystrophy	ENTITY
,	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
and	
head	ENTITY
trauma	ENTITY
.	

In	
disorders	ENTITY
associated	ENTITY
with	ENTITY
both	
sleep	ENTITY
apnea	ENTITY
and	
narco-	
lepsy	ENTITY
type	ENTITY
2	ENTITY
,	
such	
as	
myotonic	ENTITY
dystrophy	ENTITY
or	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
,	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
should	
only	
be	
made	
if	
abnormal	ENTITY
MSLT	ENTITY
findings	ENTITY
persist	
after	
the	
sleep	ENTITY
apnea	ENTITY
is	
adequately	
treated	ENTITY
.	

In	
all	
cases	ENTITY
,	
especially	
with	
complex	ENTITY
problems	ENTITY
such	
as	
head	ENTITY
trauma	ENTITY
,	
clinical	ENTITY
judgment	ENTITY
should	
be	
used	
to	
determine	
if	
the	
development	ENTITY
of	
narcolepsy	ENTITY
was	
a	
mere	
coincidence	
or	
was	
triggered	
by	
the	
event	ENTITY
or	
disorder	ENTITY
.	

Demographics	ENTITY
The	
exact	
prevalence	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
uncertain	
.	

Cases	ENTITY
of	
narcolepsy	ENTITY
without	
cat-	ENTITY
aplexy	ENTITY
represent	
15	
%	
to	
25	
%	
of	
the	
clinic	ENTITY
narcoleptic	ENTITY
population	ENTITY
.	

A	
population	ENTITY
-	
based	ENTITY
study	ENTITY
suggested	
a	
higher	
percentage	ENTITY
(	
36	
%	
)	
,	
corresponding	
to	
a	
point	
prevalence	ENTITY
of	
20.5/100,000	
.	

Population	ENTITY
-	
based	ENTITY
studies	ENTITY
have	
shown	
that	
approximately	
4	
%	
to	
9.5	
%	
of	
adults	ENTITY
may	
have	
multiple	
SOREMPs	ENTITY
during	
random	ENTITY
MSLTs	ENTITY
,	
but	
shift	ENTITY
workers	ENTITY
and	
subjects	ENTITY
with	
sleep	ENTITY
deprivation	ENTITY
or	
sleep	ENTITY
apnea	ENTITY
were	
included	
in	
the	
studies	ENTITY
.	

Although	
both	
sexes	ENTITY
can	
be	
affected	ENTITY
,	
the	
prevalence	ENTITY
may	
be	
slightly	
higher	
in	
men	ENTITY
.	

The	
age	ENTITY
of	
onset	ENTITY
mirrors	ENTITY
that	
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	
Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
As	
discussed	
below	
,	
about	
24	
%	
of	
patients	ENTITY
with	
narcolepsy	ENTITY
but	
no	
cataplexy	ENTITY
will	
have	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
and	
almost	
all	
of	
these	
will	
be	
positive	ENTITY
for	
the	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
antigen	ENTITY
.	

These	
patients	ENTITY
probably	
share	
a	
common	
pathogenesis	ENTITY
with	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
and	
should	
be	
classified	
as	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Underlying	
genetic	ENTITY
and	
envi-	
ronmental	ENTITY
factors	ENTITY
associated	ENTITY
with	ENTITY
other	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
are	
unknown	
.	

Environmental	ENTITY
precipitating	ENTITY
factors	ENTITY
are	
suspected	ENTITY
from	
case	ENTITY
reports	ENTITY
but	
have	
never	
been	
proven	
to	
trigger	ENTITY
narcolepsy	ENTITY
without	
cataplexy	ENTITY
.	

Among	
the	
most	
commonly	
reported	
triggers	ENTITY
are	
head	ENTITY
trauma	ENTITY
and	
unspecified	
viral	ENTITY
illnesses	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

The	
detailed	
genetic	ENTITY
pattern	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
unknown	
.	

Relatives	ENTITY
of	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
may	
be	
more	
likely	
to	
experience	
partial	ENTITY
narcolepsy	ENTITY
symptoms	ENTITY
compatible	
with	
the	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
typically	
occurs	
during	
adolescence	ENTITY
.	

In	
about	
10	
%	
of	
patients	ENTITY
,	
cataplexy	ENTITY
will	
develop	
later	
in	
the	
course	ENTITY
of	
the	
disease	ENTITY
,	
necessitating	
a	
change	
in	
diagnosis	ENTITY
to	
narco-	
lepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Most	
of	
these	
patients	ENTITY
will	
,	
if	
tested	ENTITY
,	
have	
absent	ENTITY
or	
intermediate	ENTITY
levels	ENTITY
of	
CSF	ENTITY
Hcrt-1	ENTITY
.	

In	
a	
cohort	ENTITY
of	
patients	ENTITY
with	
narcolepsy	ENTITY
without	
cataplexy	ENTITY
in	
whom	
CSF	ENTITY
Hcrt-1	ENTITY
status	ENTITY
was	
known	
,	
33	
%	
of	
those	
with	
low	ENTITY
levels	ENTITY
later	
developed	
cataplexy	ENTITY
,	
compared	
with	
18	
%	
with	
intermediate	ENTITY
levels	ENTITY
and	
only	
1	
%	
with	
normal	ENTITY
levels	ENTITY
.	

When	
left	ENTITY
untreated	ENTITY
,	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
socially	ENTITY
disabling	ENTITY
and	
isolating	ENTITY
.	

Patients	ENTITY
have	
a	
ten-	
dency	ENTITY
to	
fail	ENTITY
in	
school	ENTITY
and	
are	
often	
dismissed	
from	
their	
jobs	ENTITY
.	

Driving	ENTITY
may	
be	
avoided	
for	
fear	ENTITY
of	
a	
motor	ENTITY
vehicle	ENTITY
accident	ENTITY
.	

The	
inability	ENTITY
to	ENTITY
sleep	ENTITY
at	
night	ENTITY
may	
further	
contrib-	
ute	
to	
a	
loss	ENTITY
of	ENTITY
control	ENTITY
these	
patients	ENTITY
have	
over	
their	
schedule	ENTITY
.	

Depression	ENTITY
and	
weight	ENTITY
gain	ENTITY
also	
are	
common	
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Developmental	ENTITY
Issues	ENTITY
Children	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
will	
typically	
present	
with	
a	
reappearance	ENTITY
of	
regular	ENTITY
daytime	ENTITY
napping	ENTITY
after	
naps	ENTITY
had	
been	
discontinued	ENTITY
.	

In	
all	
pediatric	ENTITY
cases	ENTITY
,	
one	
should	
consider	
the	
possibility	
of	
an	
evolving	
disorder	ENTITY
with	
the	
development	ENTITY
of	
cataplexy	ENTITY
over	
time	ENTITY
.	

Once	
the	
patient	ENTITY
develops	
clear	
cataplexy	ENTITY
,	
the	
diagnosis	ENTITY
should	
be	
changed	
to	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Limited	ENTITY
information	ENTITY
is	
available	
on	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
prior	
to	
adolescence	ENTITY
.	

Descriptions	ENTITY
of	
the	
experience	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
or	
hypnagogic	ENTITY
halluci-	
nations	ENTITY
are	
very	
difficult	
to	
evoke	ENTITY
in	
young	ENTITY
patients	ENTITY
,	
and	
normative	ENTITY
data	ENTITY
are	
not	
avail-	
able	
for	
the	
MSLT	ENTITY
in	
children	ENTITY
younger	ENTITY
than	
six	
years	ENTITY
of	
age	ENTITY
.	

In	
peripubertal	ENTITY
children	ENTITY
and	
adolescents	ENTITY
,	
the	
diagnosis	ENTITY
is	
often	
challenging	
.	

The	
most	
common	
causes	
of	
short	ENTITY
sleep	ENTITY
latencies	ENTITY
,	
often	
with	
multiple	
SOREMPs	ENTITY
on	
the	
MSLT	ENTITY
,	
are	
chronic	ENTITY
sleep	ENTITY
depri-	ENTITY
vation	ENTITY
and	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
.	

Behavioral	ENTITY
problems	
may	
be	
associated	ENTITY
with	ENTITY
the	
onset	
of	
the	
disorder	ENTITY
,	
and	
symptoms	ENTITY
may	
be	
hidden	
by	
the	
patient	ENTITY
.	

Inattentiveness	ENTITY
,	
lack	ENTITY
of	ENTITY
energy	ENTITY
,	
insomnia	ENTITY
,	
bizarre	ENTITY
hallucinations	ENTITY
,	
or	
a	
combination	ENTITY
thereof	
can	
lead	
to	
a	
psychiatric	ENTITY
misdiagnosis	ENTITY
of	
schizophrenia	ENTITY
or	
depression	ENTITY
.	

If	
the	
MSLT	ENTITY
shows	
equivocal	ENTITY
results	ENTITY
,	
repeating	
it	
after	
a	
time	ENTITY
interval	ENTITY
may	
be	
helpful	
,	
as	
SOREMPs	ENTITY
often	
emerge	
later	
in	
children	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Narcolepsy	
type	
2	
is	
most	
likely	
a	
heterogeneous	ENTITY
disorder	ENTITY
.	

Approximately	
24	
%	
of	
nar-	

coleptic	ENTITY
patients	ENTITY
without	
cataplexy	ENTITY
have	
a	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
concentration	ENTITY
,	
and	
another	
8	
%	
have	
intermediate	ENTITY
levels	ENTITY
(	
>	
110	
pg	
/	
mL	ENTITY
but	
≤	
200	
pg	
/	
mL	
)	
.	

The	
CSF	ENTITY
Hcrt-1	ENTITY
status	ENTITY
of	
most	
patients	ENTITY
with	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
unknown	
(	
those	
patients	ENTITY
who	
are	
known	
to	
have	
absent	
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
are	
classified	
as	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
)	ENTITY
.	

Therefore	
,	
there	
will	
be	
a	
subgroup	ENTITY
of	
about	
one	
fourth	
to	
one	
third	
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
patients	ENTITY
who	
will	
have	
hypocretin	ENTITY
deficiency	ENTITY
,	
presumably	
from	
loss	ENTITY
of	
the	
hypocretin	ENTITY
-	
producing	ENTITY
neurons	ENTITY
.	

This	
group	ENTITY
of	
patients	ENTITY
can	
not	
be	
accurately	
separated	
clinically	ENTITY
or	
by	
labora-	
tory	ENTITY
tests	ENTITY
(	
other	
than	
CSF	ENTITY
Hcrt-1	ENTITY
level	ENTITY
)	
from	
the	
majority	
of	
patients	ENTITY
without	
cataplexy	ENTITY
who	
have	
normal	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
.	

Although	
those	
with	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
have	
a	
younger	ENTITY
age	ENTITY
of	
onset	
and	
their	
MSLT	ENTITY
shows	
shorter	ENTITY
mean	ENTITY
sleep	ENTITY
latency	ENTITY
with	
more	
SOREMPs	ENTITY
in	
comparison	ENTITY
with	
those	
with	
normal	ENTITY
levels	ENTITY
,	
there	
is	
too	
much	
overlap	ENTITY
between	
the	
groups	ENTITY
for	
these	
differences	
to	
be	
helpful	
diagnostically	
in	
individual	ENTITY
patients	ENTITY
.	

One	
hundred	
percent	
of	
patients	ENTITY
with	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
are	
positive	ENTITY
for	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
.	

About	
26	
%	
of	
patients	ENTITY
with	
normal	ENTITY
levels	ENTITY
are	
also	
HLA	ENTITY
posi-	
tive	ENTITY
,	
a	
percentage	ENTITY
not	
higher	
than	
that	
seen	
in	
the	
normal	ENTITY
population	ENTITY
.	

The	
underlying	
pathophysiology	ENTITY
of	
the	
remainder	
of	
patients	ENTITY
who	
have	
normal	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
is	
unknown	
.	

It	
is	
possible	
some	
may	
have	
partial	
hypocretin	ENTITY
deficiency	ENTITY
severe	
enough	
to	
cause	
sleepiness	ENTITY
but	
not	
severe	
enough	
to	
result	
in	
cataplexy	ENTITY
or	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
.	

However	
,	
support	
for	
this	
hypothesis	ENTITY
is	
lacking	ENTITY
in	
that	
there	
are	
no	
major	
differences	
in	
clinical	ENTITY
or	
polysomnographic	ENTITY
findings	ENTITY
in	
those	
positive	ENTITY
or	
negative	ENTITY
for	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
.	

In	
the	
only	
postmortem	ENTITY
study	ENTITY
of	
a	
case	ENTITY
of	
narcolepsy	ENTITY
without	
cata-	
plexy	ENTITY
(	
CSF	ENTITY
Hcrt-1	ENTITY
status	ENTITY
unknown	
)	
,	
the	
number	
of	
hypocretin	ENTITY
cells	ENTITY
was	
decreased	ENTITY
but	
not	
as	
much	
as	
in	
cases	ENTITY
of	
narcolepsy	ENTITY
with	
cataplexy	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

It	
is	
strongly	
rcommended	
that	
the	
MSLT	ENTITY
be	
preceded	
by	
at	
least	
one	
week	ENTITY
of	
acti-	
graphic	ENTITY
recording	ENTITY
with	
a	
sleep	ENTITY
log	ENTITY
to	
establish	
whether	
the	
results	ENTITY
could	
be	
biased	
by	
insufficient	ENTITY
sleep	ENTITY
,	
shift	
work	
,	
or	
another	
circadian	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

The	
MSLT	ENTITY
demon-	
strates	ENTITY
a	
mean	
latency	ENTITY
of	
less	
than	
eight	
minutes	ENTITY
,	
typically	
less	
than	
five	
minutes	ENTITY
,	
with	
two	
or	
more	
SOREMPs	ENTITY
or	
one	
SOREMP	ENTITY
together	
with	
a	
SOREMP	ENTITY
on	
the	
preceding	
polysomnogram	ENTITY
.	

Meta	ENTITY
-	
analysis	ENTITY
shows	
mean	
sleep	ENTITY
latencies	ENTITY
in	
narcoleptic	ENTITY
patients	ENTITY
with	
cataplexy	ENTITY
of	
3.1	
±	
2.9	
minutes	ENTITY
.	

Recent	
data	ENTITY
suggest	
that	
a	
SOREMP	ENTITY
within	
15	
minutes	
of	
onset	
of	
nocturnal	ENTITY
sleep	ENTITY
is	
a	
highly	
specific	
finding	ENTITY
in	
the	
absence	ENTITY
of	
another	
sleep	ENTITY
disorder	ENTITY
,	
but	
with	
low	ENTITY
sensitivity	ENTITY
.	

Therefore	
,	
the	
criteria	ENTITY
for	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
allow	
the	
“	
replacement	ENTITY
”	
of	
one	
SOREMP	ENTITY
in	
the	
MSLT	ENTITY
with	
a	
SOREMP	ENTITY
on	
the	
preceding	
poly-	
somnogram	ENTITY
.	

For	
the	
correct	
interpretation	ENTITY
of	
MSLT	ENTITY
findings	ENTITY
,	
the	
recordings	ENTITY
should	
be	
performed	
with	
the	
following	
conditions	ENTITY
:	
(	
1	
)	
the	
patient	ENTITY
must	
be	
free	ENTITY
of	ENTITY
drugs	ENTITY
that	
influence	ENTITY
sleep	ENTITY
for	
at	
least	
14	
days	ENTITY
(	
or	
at	
least	
five	
times	
the	
half	ENTITY
-	
life	ENTITY
of	
the	
drug	ENTITY
and	
longer	ENTITY
-	
acting	ENTITY
metabolite	ENTITY
)	
,	
confirmed	
by	
a	
urine	ENTITY
drug	ENTITY
screen	ENTITY
;	
(	
2	
)	
the	
sleep	ENTITY
-	
wake	ENTITY
sched-	
ule	
must	
have	
been	
standardized	ENTITY
and	
,	
if	
necessary	
,	
extended	
to	
a	
minimum	
of	
seven	
hours	
in	
bed	ENTITY
each	ENTITY
night	ENTITY
(	
longer	
for	
children	ENTITY
)	
for	
at	
least	
seven	
days	ENTITY
before	
polysom-	

nography	ENTITY
(	
preferably	
documented	ENTITY
by	
sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
)	
;	
and	
(	
3	
)	
nocturnal	ENTITY
polysomnography	ENTITY
should	
be	
performed	
on	
the	
night	ENTITY
immediately	
preceding	
the	
MSLT	ENTITY
to	
rule	
out	
other	
sleep	ENTITY
disorders	ENTITY
that	
could	
mimic	
the	
diagnostic	ENTITY
features	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
.	

Sleep	ENTITY
time	ENTITY
during	
polysomnography	ENTITY
should	
be	
curtailed	ENTITY
as	
little	
as	
possible	
,	
with	
the	
goal	ENTITY
of	
at	
least	
seven	
hours	
asleep	ENTITY
.	

The	
overnight	ENTITY
poly-	
somnogram	ENTITY
may	
demonstrate	
an	
increase	ENTITY
in	
the	
amount	ENTITY
of	
stage	ENTITY
N1	ENTITY
sleep	ENTITY
,	
and	
there	
may	
be	
a	
disruption	ENTITY
of	
the	
normal	ENTITY
sleep	ENTITY
pattern	ENTITY
,	
with	
frequent	ENTITY
awakenings	ENTITY
.	

REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
may	
be	
present	
.	

About	
45	
%	
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
cases	ENTITY
have	
been	
reported	
to	
be	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
0602	ENTITY
positive	ENTITY
,	
compared	
with	
12	
%	
to	
38	
%	
of	
controls	ENTITY
.	

Whereas	
essentially	
all	
patients	ENTITY
who	
have	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
will	
be	
positive	ENTITY
,	
about	
25	
%	
of	
those	
with	
normal	ENTITY
levels	ENTITY
will	
also	
be	
positive	ENTITY
.	

Assuming	
that	
24	
%	
of	
patients	ENTITY
with	
narcolepsy	ENTITY
but	
no	
cataplexy	ENTITY
will	
have	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
,	
the	
probability	ENTITY
that	
an	
HLA-	ENTITY
positive	ENTITY
patient	ENTITY
will	
have	
low	
Hcrt-1	ENTITY
levels	ENTITY
is	
only	
0.56	
.	

Therefore	
the	
HLA	ENTITY
status	ENTITY
of	
a	
patient	ENTITY
can	
not	
be	
used	
to	
diagnose	ENTITY
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
nor	
to	
predict	
with	
high	
probability	ENTITY
the	
patient	ENTITY
’s	
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
.	

However	
,	
if	
lumbar	ENTITY
puncture	ENTITY
is	
contemplated	
to	
measure	ENTITY
CSF	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
,	
HLA	ENTITY
typing	ENTITY
should	
be	
performed	
first	
;	
if	
the	
patient	ENTITY
is	
HLA	ENTITY
negative	ENTITY
,	
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
will	
almost	
certainly	
be	
normal	ENTITY
and	
the	
lumbar	ENTITY
puncture	ENTITY
will	
be	
unnecessary	
.	

Approximately	
24	
%	
of	
narcoleptic	ENTITY
patients	ENTITY
without	
cataplexy	ENTITY
have	
a	
low	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
concentration	ENTITY
and	
another	
8	
%	
have	
intermediate	ENTITY
levels	ENTITY
(	
>	
110	
pg	
/	
mL	ENTITY
but	
≤	
200	
pg/	
mL	
)	
.	

If	
the	
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
of	
such	
patients	ENTITY
are	
known	
to	
be	
low	ENTITY
,	
they	
are	
classified	
as	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
,	
but	
the	
CSF	ENTITY
Hcrt-1	ENTITY
status	ENTITY
will	
not	
be	
known	
for	
most	
of	
these	
patients	ENTITY
.	

Possible	
indications	ENTITY
for	
considering	
measuring	ENTITY
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
as	
a	
diag-	
nostic	ENTITY
procedure	ENTITY
would	
be	
the	
presence	ENTITY
of	
disorders	ENTITY
such	
as	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
or	
the	
use	
of	
psychotropic	ENTITY
medications	ENTITY
that	
may	
complicate	
interpretation	ENTITY
of	
an	
MSLT	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Narcolepsy	ENTITY
type	ENTITY
1	ENTITY
is	
diagnosed	ENTITY
if	
cataplexy	ENTITY
is	
present	
or	
the	
CSF	ENTITY
hypocretin	ENTITY
levels	ENTITY
are	
known	
to	
be	
low	ENTITY
even	
in	
the	
absence	ENTITY
of	
cataplexy	ENTITY
.	

Patients	ENTITY
with	
idiopathic	ENTITY
hyper-	
somnia	ENTITY
may	
have	
mean	
sleep	ENTITY
latencies	ENTITY
on	
MSLT	ENTITY
similar	
to	
those	
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
,	
but	
have	
fewer	
than	
two	
SOREMPs	ENTITY
on	
MSLT	ENTITY
and	
the	
preceding	
polysomnogram	ENTITY
combined	ENTITY
.	

In	
contrast	
to	
narcolepsy	ENTITY
,	
patients	ENTITY
with	
idiopathic	ENTITY
hypersomnia	ENTITY
generally	
have	
high	
sleep	
efficiency	ENTITY
,	
sleep	ENTITY
drunkenness	ENTITY
,	
and	
long	ENTITY
,	
unrefreshing	ENTITY
naps	ENTITY
.	

Sleepiness	ENTITY
may	
be	
secondary	ENTITY
to	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
OSA	ENTITY
)	
,	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
shift	
work	
,	
the	
effects	ENTITY
of	ENTITY
substances	ENTITY
or	
medications	ENTITY
,	
or	
other	
sleep	ENTITY
disorders	ENTITY
.	

Many	
of	
these	
conditions	ENTITY
can	
result	
in	
early	ENTITY
-	
onset	ENTITY
REM	ENTITY
sleep	ENTITY
,	
so	
their	
clinical	ENTITY
and	
polysomnographic	ENTITY
exclusion	ENTITY
is	
essential	ENTITY
before	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
made	
.	

However	
,	
the	
presence	ENTITY
of	
other	
sleep	ENTITY
disorders	ENTITY
does	
not	
preclude	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
if	
daytime	ENTITY
sleepiness	ENTITY
and	
REM	ENTITY
abnormalities	ENTITY
persist	
after	
adequate	ENTITY
treatment	ENTITY
of	
the	
initial	
disorder	ENTITY
.	

Chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
and	
depression	ENTITY
may	
mimic	
narcolepsy	ENTITY
but	
do	
not	
show	
the	
typical	
MSLT	ENTITY
findings	ENTITY
.	

Malingering	ENTITY
and	
substance	ENTITY
abuse	ENTITY
disorder	ENTITY
should	
be	
considered	
in	
patients	ENTITY
who	
try	
to	
mislead	
the	
clinician	ENTITY
in	
order	
to	
obtain	
stimulant	ENTITY
medications	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Excluding	
the	
minority	ENTITY
of	
patients	ENTITY
with	
definite	
hypocretin	ENTITY
deficiency	ENTITY
,	
the	
underlying	
biology	ENTITY
of	
narcolepsy	ENTITY
without	
the	
presence	ENTITY
of	
cataplexy	ENTITY
is	
unknown	
.	

It	
is	
not	
estab-	
lished	ENTITY
whether	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
a	
homogeneous	ENTITY
or	
heterogeneous	ENTITY
condition	ENTITY
.	

It	
is	
uncertain	
whether	
or	
not	
some	
patients	ENTITY
have	
partial	ENTITY
hypocretin	ENTITY
deficiency	ENTITY
not	
iden-	
tifiable	ENTITY
from	
CSF	ENTITY
measurements	ENTITY
.	

Further	
advances	
in	
classification	ENTITY
will	
depend	
on	
answers	ENTITY
to	
these	
unknowns	ENTITY
.	

Further	
studies	ENTITY
on	
the	
natural	ENTITY
history	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
are	
needed	
to	
determine	
the	
cause	ENTITY
of	
the	
hypersomnolence	ENTITY
and	
the	
risk	ENTITY
of	
development	ENTITY
of	
cataplexy	ENTITY
over	
time	ENTITY
.	

Bibliography	ENTITY
Andlauer	ENTITY
O	ENTITY
,	
Moore	
IV	
H	
,	
Hong	
SC	ENTITY
,	
et	
al	
.	

Predictors	ENTITY
of	
hypocretin	ENTITY
(	
orexin	
)	
deficiency	
in	
narcolepsy	ENTITY
without	
cataplexy	ENTITY
.	

Sleep	ENTITY
2012;35:1247–55	
.	

Bourgin	ENTITY
P	ENTITY
,	
Zeitzer	ENTITY
JM	
,	
Mignot	ENTITY
E.	ENTITY
CSF	ENTITY
hypocretin-1	ENTITY
assessment	ENTITY
in	
sleep	ENTITY
and	
neurological	ENTITY
disorders	ENTITY
.	

Lancet	ENTITY
Neurol	ENTITY
2008;7:649–62	ENTITY
.	

Mignot	ENTITY
E	ENTITY
,	
Lin	
L	
,	
Finn	ENTITY
L	ENTITY
,	
et	
al	
.	

Correlates	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
REM	ENTITY
periods	ENTITY
during	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
in	
community	ENTITY
adults	ENTITY
.	

Brain	ENTITY
2006;129:1609–23	
.	

Oka	ENTITY
Y	ENTITY
,	
Inoue	ENTITY
Y	ENTITY
,	
Kanbayashi	ENTITY
T	ENTITY
,	
et	
al	
.	

Narcolepsy	ENTITY
without	
cataplexy	ENTITY
:	
2	
subtypes	ENTITY
based	
on	
CSF	ENTITY
hypocretin-1/	ENTITY
orexin	ENTITY
-	
A	
findings	ENTITY
.	

Sleep	ENTITY
2006;29:1439–43	
.	

Sasai	ENTITY
T	ENTITY
,	
Inoue	ENTITY
Y	ENTITY
,	
Komada	ENTITY
Y	ENTITY
,	
Sugiura	ENTITY
T	ENTITY
,	
Matsushima	
E.	
Comparison	ENTITY
of	
clinical	ENTITY
characteristics	ENTITY
among	
narcolepsy	ENTITY
with	
and	
without	
cataplexy	ENTITY
and	
idiopathic	ENTITY
hypersomnia	ENTITY
without	
long	ENTITY
sleep	ENTITY
time	ENTITY
,	
focusing	
on	
HLA	ENTITY
-	
DRB1(*)1501	ENTITY
/	
DQB1(*)0602	ENTITY
finding	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2009;10:961–6	ENTITY
.	

Silber	ENTITY
MH	ENTITY
,	
Krahn	ENTITY
LE	ENTITY
,	
Olson	ENTITY
EJ	ENTITY
,	
Pankratz	
VS	ENTITY
.	

The	
epidemiology	ENTITY
of	
narcolepsy	ENTITY
in	
Olmsted	ENTITY
County	ENTITY
,	ENTITY
Minnesota	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2002;25:197–202	
.	

Takei	ENTITY
Y	ENTITY
,	
Komada	ENTITY
Y	ENTITY
,	
Namba	ENTITY
K	ENTITY
,	
et	
al	
.	

Differences	ENTITY
in	
findings	ENTITY
of	
nocturnal	ENTITY
polysomnography	ENTITY
and	
multiple	ENTITY
sleep	ENTITY
latency	ENTITY
test	ENTITY
between	
narcolepsy	ENTITY
and	
idiopathic	ENTITY
hypersomnia	ENTITY
.	

Clin	ENTITY
Neurophysiol	ENTITY
2012;123:137–41	ENTITY
.	

Thannickal	ENTITY
TC	ENTITY
,	
Nienhuis	ENTITY
R	ENTITY
,	
Siegel	
JM	ENTITY
.	

Localized	ENTITY
loss	ENTITY
of	
hypocretin	
(	
orexin	
)	
cells	
in	
narcolepsy	ENTITY
without	
cataplexy	ENTITY
.	

Sleep	ENTITY
2009;32:993–8	
.	

Idiopathic	ENTITY
Hypersomnia	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.11	
Alternate	ENTITY
Names	ENTITY
Idiopathic	ENTITY
CNS	ENTITY
hypersomnolence	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
F	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.11	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
occurring	
for	
at	
least	
three	
months.1	ENTITY
B.	ENTITY
Cataplexy	ENTITY
is	
absent	ENTITY
.	

C.	ENTITY
An	
MSLT	ENTITY
performed	
according	
to	
standard	ENTITY
techniques	ENTITY
shows	
fewer	
than	
two	
sleep	ENTITY
onset	
REM	ENTITY
periods	ENTITY
or	
no	ENTITY
sleep	ENTITY
onset	
REM	ENTITY
periods	ENTITY
if	
the	
REM	ENTITY
latency	ENTITY
on	
the	
preceding	
polysomnogram	ENTITY
was	
less	
than	
or	
equal	
to	
15	
minutes.2	
D.	
The	
presence	ENTITY
of	
at	
least	
one	
of	
the	
following	
:	
.	

The	
MSLT	ENTITY
shows	
a	
mean	
sleep	ENTITY
latency	ENTITY
of	
≤	
8	
minutes	ENTITY
.	
.	

Total	
24	
-	
hour	ENTITY
sleep	ENTITY
time	ENTITY
is	
≥	
660	
minutes	ENTITY
(	
typically	
12–14	
hours)3	ENTITY
on	
24	
-	
hour	ENTITY
polysomnographic	ENTITY
monitoring	
(	
performed	
after	
correction	ENTITY
of	
chronic	ENTITY
sleep	ENTITY
deprivation	ENTITY
)	
,	
or	
by	
wrist	ENTITY
actigraphy	ENTITY
in	
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
association	ENTITY
with	
a	
sleep	ENTITY
log	ENTITY
(	
averaged	
over	
at	
least	
seven	
days	ENTITY
with	
unrestricted	
sleep).4	ENTITY
E.	ENTITY
Insufficient	
sleep	
syndrome	
is	
ruled	
out	
(	
if	
deemed	
necessary	
,	
by	
lack	
of	
improvement	ENTITY
of	
sleepiness	ENTITY
after	
an	
adequate	ENTITY
trial	ENTITY
of	
increased	ENTITY
nocturnal	ENTITY
time	ENTITY
in	
bed	ENTITY
,	
preferably	
confirmed	
by	
at	
least	
a	
week	ENTITY
of	
wrist	ENTITY
actigraphy	ENTITY
)	
.	

F.	

The	
hypersomnolence	ENTITY
and/or	
MSLT	ENTITY
findings	ENTITY
are	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
other	
medical	ENTITY
or	
psychiatric	ENTITY
disorder	ENTITY
,	
or	
use	
of	
drugs	ENTITY
or	
medications	ENTITY
.	

Notes	ENTITY
.	

Severe	ENTITY
and	
prolonged	ENTITY
sleep	ENTITY
inertia	ENTITY
,	
known	
as	
sleep	ENTITY
drunkenness	ENTITY
(	
defined	
as	
prolonged	ENTITY
difficulty	ENTITY
waking	ENTITY
up	
with	
repeated	
returns	
to	
sleep	ENTITY
,	
irritability	ENTITY
,	
automatic	ENTITY
behavior	ENTITY
,	
and	
confusion	ENTITY
)	
and/or	
long	ENTITY
(	
>	
1	
hour	ENTITY
)	
,	
unrefreshing	ENTITY
naps	ENTITY
are	
additional	
supportive	
clinical	ENTITY
features	ENTITY
.	
.	

A	
high	ENTITY
sleep	ENTITY
efficiency	ENTITY
(	
≥	
90	
%	
)	
on	
the	
preceding	
polysomnogram	ENTITY
is	
a	
supportive	ENTITY
finding	ENTITY
(	
as	
long	
as	
sleep	ENTITY
insufficiency	ENTITY
is	
ruled	
out	
)	
.	
.	

The	
total	
24	
-	
hour	ENTITY
sleep	ENTITY
time	ENTITY
required	
for	
diagnosis	ENTITY
may	
need	
to	
be	
adapted	
to	
account	
for	
normal	
changes	ENTITY
in	
sleep	ENTITY
time	ENTITY
associated	ENTITY
with	ENTITY
stages	ENTITY
of	
development	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
as	
well	
as	
for	
variability	ENTITY
across	
cultures	ENTITY
in	
all	
age	ENTITY
groups	ENTITY
.	
.	

Occasionally	
,	
patients	ENTITY
fulfilling	
other	
criteria	ENTITY
may	
have	
an	
MSLT	ENTITY
mean	
sleep	ENTITY
latency	ENTITY
longer	
than	
8	
minutes	ENTITY
and	
total	
24	
-	
hour	ENTITY
sleep	ENTITY
time	ENTITY
shorter	
than	
660	
minutes	ENTITY
.	

Clinical	ENTITY
judgment	ENTITY
should	
be	
used	
in	
deciding	
if	
these	
patients	ENTITY
should	
be	
considered	
to	
have	
idiopathic	ENTITY
hypersomnia	ENTITY
(	
IH	ENTITY
)	
.	

Great	ENTITY
caution	
should	
be	
exercised	
to	
exclude	
other	
conditions	ENTITY
that	
might	
mimic	
the	
disorder	ENTITY
.	

A	
repeat	
MSLT	ENTITY
at	
a	
later	
date	
is	
advisable	
if	
the	
clinical	ENTITY
suspicion	ENTITY
for	
IH	ENTITY
remains	
high	
.	

Essential	ENTITY
Features	ENTITY
IH	ENTITY
is	
characterized	ENTITY
by	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
that	
occurs	
in	
the	
absence	ENTITY
of	
cat-	ENTITY
aplexy	ENTITY
,	
is	
accompanied	
by	
no	
more	
than	
one	
SOREMP	ENTITY
on	
MSLT	ENTITY
and	
preceding	
poly-	
somnogram	ENTITY
combined	ENTITY
,	
and	
is	
not	
adequately	
explained	
by	
another	
disorder	ENTITY
.	

Other	
dis-	
orders	
causing	
sleepiness	ENTITY
must	
be	
carefully	
considered	
and	
excluded	ENTITY
,	
especially	
insuf-	
ficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
.	

Objective	ENTITY
evidence	ENTITY
of	
hypersomnolence	ENTITY
must	
be	
demonstrated	
by	
an	
MSLT	ENTITY
showing	
a	
mean	
sleep	ENTITY
latency	ENTITY
of	
≤	
8	
minutes	ENTITY
or	
by	
polysomnography	ENTITY
or	
wrist	ENTITY
actigraphy	ENTITY
showing	
a	
total	
24	
-	
hour	ENTITY
sleep	ENTITY
time	ENTITY
of	
≥	
660	
minutes	ENTITY
.	

A	
prolonged	ENTITY
and	
severe	ENTITY
form	
of	
sleep	ENTITY
inertia	ENTITY
,	
historically	
known	
as	
sleep	ENTITY
drunkenness	ENTITY
,	
consists	
of	
prolonged	ENTITY
difficulty	ENTITY
waking	ENTITY
up	
with	
repeated	
returns	
to	
sleep	ENTITY
,	
irritability	ENTITY
,	
automatic	ENTITY
behavior	ENTITY
,	
and	
confusion	ENTITY
.	

It	
is	
reported	
in	
36	
%	
to	
66	
%	
of	
patients	ENTITY
with	
IH	ENTITY
in	
differ-	
ent	
series	ENTITY
.	

Subjects	ENTITY
typically	
do	
not	
easily	
awaken	
to	
alarm	ENTITY
clocks	ENTITY
and	
frequently	
use	
special	ENTITY
devices	ENTITY
or	
procedures	ENTITY
to	
wake	ENTITY
up	ENTITY
.	

Naps	ENTITY
are	
generally	
long	
,	
often	
more	
than	
60	
minutes	ENTITY
,	
and	
described	
as	
unrefreshing	ENTITY
by	
46	
%	
to	
78	
%	
of	
patients	ENTITY
.	

Sleep	ENTITY
efficiency	ENTITY
on	
polysomnogram	ENTITY
is	
usually	
high	ENTITY
(	
mean	
90	
%	
to	
94	
%	
)	
.	

Self	ENTITY
-	
reported	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
is	
longer	
than	
in	
controls	ENTITY
and	
is	
≥	
10	
hours	
in	
at	
least	
30	
%	
of	
patients	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Associated	ENTITY
symptoms	ENTITY
which	
suggest	
a	
dysfunction	ENTITY
of	
the	
autonomic	ENTITY
nervous	ENTITY
system	ENTITY
may	
be	
present	
.	

These	
symptoms	ENTITY
include	
headache	ENTITY
,	
orthostatic	ENTITY
disturbance	ENTITY
,	
perception	ENTITY
of	
temperature	ENTITY
dysregulation	ENTITY
,	
and	
peripheral	ENTITY
vascular	ENTITY
complaints	ENTITY
(	
Raynaud	ENTITY
-	
type	ENTITY
phe-	
nomena	
with	
cold	ENTITY
hands	ENTITY
and	
feet	ENTITY
)	
.	

Sleep	ENTITY
paralysis	ENTITY
and	
hypnagogic	ENTITY
hallucinations	ENTITY
may	
also	
be	
reported	
,	
but	
the	
frequency	ENTITY
is	
uncertain	
(	
4	
%	
to	
40	
%	
in	
different	
series	
)	
.	

Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
The	
2005	
2nd	
edition	
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
divided	
IH	ENTITY
into	
two	
disorders	ENTITY
:	
IH	ENTITY
with	
long	ENTITY
sleep	ENTITY
time	ENTITY
,	
and	
IH	ENTITY
without	
long	ENTITY
sleep	ENTITY
time	ENTITY
.	

IH	ENTITY
is	
likely	
a	
heterogeneous	ENTITY
condition	
,	
the	
pathophysiology	ENTITY
of	
which	
is	
currently	
unknown	
.	

However	
,	
recent	
studies	ENTITY
suggest	
that	
a	
division	ENTITY
of	
the	
disorder	ENTITY
based	
on	
the	
length	ENTITY
of	
nocturnal	ENTITY
sleep	ENTITY
lacks	
validity	ENTITY
.	

Comparison	ENTITY
of	
patients	ENTITY
with	
≥	
10	
hours	
of	
sleep	ENTITY
to	
those	
with	
<	
10	
hours	
show	
no	
differences	
in	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
scores	ENTITY
,	
MSLT	ENTITY
mean	
sleep	ENTITY
latencies	ENTITY
,	
or	
percentage	ENTITY
with	
sleep	ENTITY
drunkenness	ENTITY
,	
unrefreshing	ENTITY
naps	ENTITY
,	
hypnago-	
gic	ENTITY
hallucinations	ENTITY
,	
or	
sleep	ENTITY
paralysis	ENTITY
.	

The	
only	
reported	
differences	ENTITY
are	
that	
the	
group	ENTITY
with	
long	ENTITY
sleep	ENTITY
is	
somewhat	
younger	ENTITY
and	
thinner	ENTITY
,	
with	
lower	
Horne	ENTITY
-	
Ostberg	ENTITY
scores	ENTITY
and	
marginally	ENTITY
higher	ENTITY
sleep	ENTITY
efficiency	ENTITY
.	

If	
MSLT	ENTITY
mean	
sleep	ENTITY
latencies	ENTITY
are	
not	
used	
as	
a	
diagnostic	ENTITY
criterion	ENTITY
,	
the	
distribution	ENTITY
of	
latencies	ENTITY
is	
unimodal	ENTITY
,	
suggesting	
no	
sepa-	
rate	ENTITY
subtypes	ENTITY
.	

In	
addition	
,	
an	
actigraphy	ENTITY
study	ENTITY
has	
shown	
that	
patients	ENTITY
with	
IH	ENTITY
tend	
to	
overestimate	ENTITY
their	
sleep	ENTITY
time	ENTITY
by	
a	
mean	
of	
0.99	
hours	ENTITY
,	
thus	
making	
the	
fundamental	ENTITY
criterion	ENTITY
for	
distinguishing	
between	
patients	ENTITY
with	
long	ENTITY
and	
shorter	ENTITY
sleep	ENTITY
inaccurate	ENTITY
.	

Clinicians	ENTITY
may	
wish	
to	
continue	
to	
note	
sleep	ENTITY
duration	ENTITY
as	
an	
important	
clinical	ENTITY
feature	ENTITY
,	
but	
the	
caveats	ENTITY
discussed	
above	
should	
be	
clearly	
considered	
.	

Any	
future	
separation	ENTITY
of	
IH	ENTITY
into	
distinct	
conditions	ENTITY
must	
await	
advances	
in	
understanding	
the	
underlying	
biology	ENTITY
.	

Demographics	ENTITY
Prevalence	ENTITY
and	
incidence	ENTITY
of	
IH	ENTITY
are	
not	
known	
.	

Some	
studies	ENTITY
have	
suggested	
a	
higher	
prevalence	ENTITY
in	
women	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY

In	
contrast	
to	
narcolepsy	ENTITY
,	
the	
disorder	ENTITY
is	
not	
known	
to	
be	
HLA	ENTITY
associated	
,	
and	
no	
con-	ENTITY
sistent	ENTITY
precipitating	ENTITY
factor	ENTITY
has	
been	
identified	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

A	
familial	ENTITY
predisposition	ENTITY
to	
hypersomnia	ENTITY
has	
been	
reported	
but	
rigorous	
studies	
have	
not	
been	
performed	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
mean	
age	ENTITY
of	
onset	
of	
IH	ENTITY
in	
different	
series	ENTITY
is	
16.6–21.2	
years	ENTITY
.	

Once	
established	
,	
the	
disorder	ENTITY
is	
generally	
stable	ENTITY
in	
severity	ENTITY
and	
long	ENTITY
lasting	ENTITY
,	
although	
a	
spontaneous	ENTITY
remission	
rate	
of	
14	
%	
has	
been	
reported	
in	
one	
series	
.	

Complications	ENTITY
are	
mostly	
social	ENTITY
and	
professional	ENTITY
,	
and	
include	
poor	ENTITY
work	ENTITY
or	
school	ENTITY
performance	ENTITY
,	
reduced	ENTITY
earnings	ENTITY
,	
and	
loss	ENTITY
of	ENTITY
employment	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
IH	ENTITY
frequently	
develops	
in	
adolescence	ENTITY
.	

Exclusion	ENTITY
of	
other	
causes	
of	
hypersomno-	
lence	ENTITY
in	
that	
age	ENTITY
group	ENTITY
,	
including	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
,	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
and	
use	
of	
recreational	ENTITY
drugs	ENTITY
,	
is	
essential	ENTITY
.	

Early	ENTITY
in	
the	
development	ENTITY
of	
narcolepsy	ENTITY
,	
SOREMPs	ENTITY
may	
not	
be	
present	
on	
MSLT	ENTITY
;	
therefore	
,	
some	
patients	ENTITY
may	
need	
to	
be	
reclassified	
later	
as	
narcolepsy	ENTITY
type	ENTITY
2	ENTITY
.	

If	
the	
24	
-	
hour	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
is	
used	
to	
confirm	
the	
diagnosis	ENTITY
of	
IH	ENTITY
in	
a	
child	ENTITY
or	
adolescent	ENTITY
,	
normal	ENTITY
values	ENTITY
may	
need	
to	
be	
adapted	
to	
account	
for	
changes	ENTITY
in	
sleep	ENTITY
time	ENTITY
associated	ENTITY
with	ENTITY
stages	ENTITY
of	ENTITY
development	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
pathophysiology	ENTITY
of	
IH	ENTITY
is	
unknown	
.	

Neurochemical	ENTITY
studies	ENTITY
measuring	ENTITY
monoamine	ENTITY
metabolites	ENTITY
in	
the	
CSF	ENTITY
have	
been	
inconclusive	ENTITY
.	

CSF	ENTITY
hypocretin-1	ENTITY
concentrations	ENTITY
in	
patients	ENTITY
with	
IH	ENTITY
are	
normal	ENTITY
.	

CSF	ENTITY
histamine	ENTITY
levels	ENTITY
have	
been	
reported	
to	
be	
low	ENTITY
in	
patients	ENTITY
with	
narcolepsy	ENTITY
and	
IH	ENTITY
,	
but	
a	
recent	
study	ENTITY
did	
not	
confirm	
these	
findings	ENTITY
.	

Objective	
Findings	ENTITY
Polysomnographic	ENTITY
monitoring	ENTITY
generally	
demonstrates	
NREM	ENTITY
and	
REM	ENTITY
sleep	ENTITY
in	
expected	
proportions	ENTITY
with	
normal	ENTITY
REM	ENTITY
latency	ENTITY
.	

Total	ENTITY
sleep	ENTITY
time	ENTITY
is	
often	
prolonged	ENTITY
.	

Sleep	ENTITY
apnea	ENTITY
should	
be	
either	
absent	ENTITY
or	
adequately	
treated	ENTITY
before	
diagnosing	ENTITY
this	
disor-	ENTITY
der	ENTITY
,	
with	
special	
attention	
paid	
to	
excluding	
significant	
respiratory	ENTITY
effort	
related	
arous-	
als	
.	

The	
MSLT	ENTITY
should	
not	
show	
more	
than	
one	
SOREMP	ENTITY
(	
or	
none	
if	
a	
SOREMP	ENTITY
was	
observed	
on	
the	
preceding	
night	ENTITY
’s	
polysomnogram	
(	
PSG	ENTITY
)	
)	
.	

The	
mean	ENTITY
sleep	ENTITY
latency	ENTITY
on	
the	
MSLT	ENTITY
is	
usually	
shorter	ENTITY
than	
in	
controls	ENTITY
but	
longer	
than	
in	
most	
patients	ENTITY
with	
nar-	
colepsy	ENTITY
,	
averaging	
8.3	
and	
7.8	
minutes	ENTITY
in	
two	
large	
studies	ENTITY
.	

In	
patients	ENTITY
with	
MSLT	ENTITY
mean	
latencies	ENTITY
>	
8	
minutes	ENTITY
,	
prolonged	ENTITY
sleep	ENTITY
monitoring	ENTITY
should	
be	
performed	
by	
polysomnography	ENTITY
(	
24	
hours	
)	
or	
wrist	ENTITY
actigraphy	ENTITY
(	
7	
days	ENTITY
with	
unre-	
stricted	ENTITY
sleep	ENTITY
)	
after	
correction	ENTITY
of	
sleep	ENTITY
deprivation	ENTITY
,	
exclusion	ENTITY
of	
other	
sleep	ENTITY
disorders	ENTITY
,	
and	
discontinuation	ENTITY
of	
sedating	ENTITY
medication	ENTITY
as	
required	
for	
an	
MSLT	ENTITY
(	
see	
Narcolepsy	ENTITY
–	
Objective	ENTITY
Findings	ENTITY
)	
.	

Total	
24	
-	
hour	ENTITY
sleep	ENTITY
time	ENTITY
in	
adults	ENTITY
(	
major	
sleep	ENTITY
episode	ENTITY
plus	
naps	ENTITY
)	
must	
be	
≥	
660	
minutes	ENTITY
(	
note	
that	
the	
use	
of	
24	
-	
hour	ENTITY
PSG	ENTITY
monitoring	ENTITY
for	
the	
diagnosis	ENTITY
of	
IH	ENTITY
has	
been	
validated	
against	
controls	ENTITY
,	
but	
the	
use	
of	
seven	
days	ENTITY
of	
actigraphic	ENTITY
mon-	ENTITY
itoring	ENTITY
still	
awaits	
validation	ENTITY
)	
.	

Differential	ENTITY
Diagnosis	ENTITY
IH	ENTITY
may	
be	
confused	
with	
OSA	ENTITY
,	
especially	
when	
respiratory	ENTITY
-	
related	ENTITY
arousals	ENTITY
(	
rather	
than	
apneas	ENTITY
or	
hypopneas	ENTITY
)	
are	
present	
.	

Narcolepsy	ENTITY
type	ENTITY
2	ENTITY
is	
distinguished	
from	
IH	ENTITY
by	
the	
presence	ENTITY
of	
two	
or	
more	
sleep	ENTITY
onset	
REM	ENTITY
periods	ENTITY
on	
the	
MSLT	ENTITY
or	
preceding	
PSG	ENTITY
.	

Insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
must	
be	
carefully	
excluded	
by	
extending	
the	
patient	ENTITY
’s	
sleep	
before	
testing	ENTITY
.	

Historical	ENTITY
information	ENTITY
,	
physical	ENTITY
examination	ENTITY
,	
and	
,	
if	
indicated	
,	
laboratory	ENTITY
testing	ENTITY
including	
brain	ENTITY
imaging	ENTITY
should	
help	
rule	
out	
hypersomnolence	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
.	

In	
particular	
,	
posttraumatic	ENTITY
hypersomnolence	ENTITY
,	
residual	ENTITY
hyper-	
somnolence	ENTITY
following	
adequate	ENTITY
treatment	ENTITY
of	
sleep	ENTITY
apnea	ENTITY
,	
and	
sleep	ENTITY
fragmentation	ENTITY
due	
to	
pain	ENTITY
may	
mimic	
IH	ENTITY
.	

Hypersomnolence	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
must	
be	
considered	
and	
ruled	
out	
by	
discontinuation	ENTITY
of	
possible	
causative	ENTITY
agents	ENTITY
,	
if	
clinically	ENTITY
appropriate	
.	

Hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
psychiatric	ENTITY
disorder	ENTITY
should	
be	
consid-	
ered	ENTITY
in	
patients	ENTITY
with	
a	
psychiatric	ENTITY
condition	ENTITY
,	
most	
typically	
depression	ENTITY
.	

The	
complaint	ENTITY
of	
excessive	ENTITY
sleepiness	ENTITY
and	
prolonged	ENTITY
sleep	ENTITY
may	
be	
rather	
similar	
to	
that	
of	
patients	ENTITY
with	
IH	ENTITY
,	
except	
that	
it	
may	
vary	
from	
day	ENTITY
to	
day	ENTITY
and	
is	
often	
associated	ENTITY
with	ENTITY
poor	ENTITY
sleep	ENTITY
at	
night	ENTITY
.	

The	
MSLT	ENTITY
in	
hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
psychiatric	ENTITY
disorder	ENTITY
does	
not	
demonstrate	
a	
short	ENTITY
mean	ENTITY
sleep	ENTITY
latency	ENTITY
.	

Chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
is	
character-	
ized	ENTITY
by	
persistent	ENTITY
or	
relapsing	ENTITY
fatigue	ENTITY
that	
does	
not	
resolve	
with	
sleep	ENTITY
or	
rest	ENTITY
.	

Patients	ENTITY
clearly	
complain	ENTITY
of	
fatigue	ENTITY
rather	
than	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
and	
the	
mean	
MSLT	ENTITY
sleep	
latency	
is	
normal	
.	

Long	ENTITY
sleepers	ENTITY
feel	ENTITY
fully	
refreshed	
and	
do	
not	
experience	
daytime	ENTITY
sleepiness	ENTITY
if	
they	
are	
allowed	
to	
sleep	ENTITY
as	
long	
as	
they	
need	
,	
in	
contrast	
with	
patients	ENTITY
with	
IH	ENTITY
who	
continue	
to	
feel	
sleepy	ENTITY
regardless	
of	
prior	ENTITY
sleep	ENTITY
duration	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

There	
is	
a	
paucity	
of	
knowledge	ENTITY
regarding	
the	
neurobiology	ENTITY
of	
IH	ENTITY
.	

Further	
research	ENTITY
in	
this	
area	ENTITY
,	
as	
well	
as	
more	
precise	
characterization	ENTITY
of	
clinical	ENTITY
characteristics	ENTITY
and	
treat-	
ment	ENTITY
response	ENTITY
,	
is	
required	
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Bibliography	ENTITY
Ali	ENTITY
M	ENTITY
,	
Auger	ENTITY
RR	ENTITY
,	
Slocumb	ENTITY
NL	ENTITY
,	
Morgenthaler	ENTITY
TI	ENTITY
.	

Idiopathic	ENTITY
hypersomnia	ENTITY
:	
clinical	ENTITY
features	ENTITY
and	
response	ENTITY
to	ENTITY
treatment	ENTITY
.	

J	
Clin	
Sleep	
Med	
2009;5:562–8	
.	

Anderson	ENTITY
KN	ENTITY
,	
Pilsworth	ENTITY
S	ENTITY
,	
Sharples	ENTITY
RD	ENTITY
,	
Smith	ENTITY
IE	ENTITY
,	
Shneerson	
JM	ENTITY
.	

Idiopathic	ENTITY
hypersomnia	ENTITY
:	
a	
study	ENTITY
of	
77	
cases	ENTITY
.	

Sleep	ENTITY
2007;30:1274–81	
.	

Bassetti	ENTITY
C	ENTITY
,	
Aldrich	ENTITY
MS	ENTITY
.	

Idiopathic	ENTITY
hypersomnia	ENTITY
:	
a	
series	
of	
42	
patients	ENTITY
.	

Brain	ENTITY
1997;120:1423–35	ENTITY
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Delallee	ENTITY
N	ENTITY
,	
Jaussent	ENTITY
I	ENTITY
,	
et	
al	
.	

Normal	ENTITY
cerebrospinal	ENTITY
fluid	ENTITY
histamine	ENTITY
and	
tele	ENTITY
-	
methylhistamine	ENTITY
levels	ENTITY
in	
hypersomnia	ENTITY
conditions	ENTITY
.	

Sleep	ENTITY
2012;35:1359–66	
.	

Kanbayashi	ENTITY
T	ENTITY
,	
Kodama	ENTITY
T	ENTITY
,	ENTITY
Kondo	ENTITY
H	ENTITY
,	
et	
al	
.	

CSH	ENTITY
histamine	ENTITY
contents	ENTITY
in	
narcolepsy	ENTITY
,	
idiopathic	ENTITY
hypersomnia	ENTITY
and	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
.	

Sleep	ENTITY
2009;32:181–7	
.	

Vernet	ENTITY
C	ENTITY
,	
Arnulf	
I.	
Idiopathic	ENTITY
hypersomnia	ENTITY
with	
and	
without	
long	ENTITY
sleep	ENTITY
time	ENTITY
:	
a	
controlled	ENTITY
series	ENTITY
of	
75	
patients	ENTITY
.	

Sleep	ENTITY
2009;32:753–9	
.	

Vernet	ENTITY
C	ENTITY
,	
Leu	ENTITY
-	
Semenescu	ENTITY
S	ENTITY
,	
Buzare	ENTITY
MA	ENTITY
,	
Arnulf	
I.	
Subjective	ENTITY
sleepiness	ENTITY
in	
idiopathic	ENTITY
hypersomnia	ENTITY
:	
beyond	
excessive	ENTITY
sleepiness	ENTITY
.	

J	
Sleep	
Res	
2010;19:525–34	
.	

Kleine	ENTITY
-	
Levin	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.13	
Alternate	ENTITY
Names	ENTITY
Recurrent	ENTITY
hypersomnia	ENTITY
,	
periodic	ENTITY
hypersomnolence	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.13	
A.	

The	
patient	ENTITY
experiences	ENTITY
at	
least	
two	
recurrent	ENTITY
episodes	ENTITY
of	
excessive	ENTITY
sleepiness	ENTITY
and	
sleep	ENTITY
duration	ENTITY
,	
each	
persisting	
for	
two	
days	ENTITY
to	
five	
weeks	ENTITY
.	

B.	ENTITY
Episodes	ENTITY
recur	
usually	
more	
than	
once	
a	
year	ENTITY
and	
at	
least	
once	
every	
18	
months	ENTITY
.	

C.	

The	
patient	ENTITY
has	
normal	ENTITY
alertness	ENTITY
,	
cognitive	ENTITY
function	ENTITY
,	
behavior	ENTITY
,	
and	
mood	ENTITY
between	
episodes	ENTITY
.	

D.	

The	
patient	ENTITY
must	
demonstrate	
at	
least	
one	
of	
the	
following	
during	
episodes	ENTITY
:	
.	

Cognitive	ENTITY
dysfunction	ENTITY
.	
.	

Altered	ENTITY
perception	ENTITY
.	
.	

Eating	ENTITY
disorder	ENTITY
(	
anorexia	ENTITY
or	
hyperphagia	ENTITY
)	
.	
.	

Disinhibited	ENTITY
behavior	ENTITY
(	
such	
as	
hypersexuality	ENTITY
)	
.	

E.	

The	
hypersomnolence	ENTITY
and	
related	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
other	
medical	ENTITY
,	
neurologic	ENTITY
,	
or	
psychiatric	ENTITY
disorder	ENTITY
(	
especially	
bipolar	ENTITY
disorder	ENTITY
)	
,	
or	
use	
of	
drugs	ENTITY
or	
medications	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
is	
characterized	
by	
relapsing	ENTITY
-	
remitting	ENTITY
episodes	ENTITY
of	
severe	ENTITY
hypersomnolence	ENTITY
in	
association	ENTITY
with	ENTITY
cognitive	ENTITY
,	
psychiatric	ENTITY
,	
and	
behavioral	ENTITY
distur-	
bances	ENTITY
.	

A	
typical	
episode	ENTITY
lasts	
a	
median	ENTITY
10	
days	ENTITY
(	
range	
,	
2.5–80	
days	ENTITY
)	
,	
with	
rare	
epi-	
sodes	ENTITY
lasting	
several	
weeks	ENTITY
to	
months	ENTITY
.	

The	
first	
episode	ENTITY
is	
often	
triggered	
by	
an	
infec-	
tion	ENTITY
or	
alcohol	ENTITY
intake	ENTITY
,	
with	
further	
episodes	ENTITY
recurring	
every	
1–12	
months	ENTITY
(	
median	
three	
months	ENTITY
)	
for	
years	ENTITY
.	

During	
episodes	ENTITY
,	
patients	ENTITY
may	
sleep	ENTITY
as	
long	
as	
16	
to	
20	
hours	
per	
day	ENTITY
,	
waking	ENTITY
or	
getting	
up	
only	
to	
eat	ENTITY
and	
void	ENTITY
(	
incontinence	ENTITY
is	
not	
observed	
)	
.	

They	
remain	
rousable	ENTITY
,	
but	
are	
irritable	ENTITY
if	
prevented	
from	
sleeping	ENTITY
.	

When	
they	
are	
awake	ENTITY
during	
episodes	ENTITY
,	
most	
patients	ENTITY
are	
exhausted	ENTITY
,	
apathetic	ENTITY
,	
confused	
,	
and	
slow	ENTITY
in	
speaking	ENTITY
and	
answering	ENTITY
.	

Anterograde	ENTITY
amnesia	ENTITY
is	
typical	
.	

Almost	
all	
report	
a	
dreamlike	ENTITY
,	
altered	
perception	ENTITY
of	
the	
environment	ENTITY
(	
derealization	ENTITY
)	
.	

Less	
commonly	
,	
patients	ENTITY
eat	
ravenously	ENTITY
(	
66	
%	
,	
although	
one	
third	
eat	
less	
)	
,	
are	
hypersexual	ENTITY
(	
53	
%	
,	
principally	
men	ENTITY
)	
,	
childish	ENTITY
,	
depressed	ENTITY
(	
53	
%	
,	
predominantly	
women	ENTITY
)	
,	
and	
anxious	ENTITY
at	
being	
left	
alone	
and	
seeing	ENTITY
strangers	ENTITY
,	
and	
experience	
hallucinations	ENTITY
and	
delusions	ENTITY
(	
30	
%	
)	
.	

Patients	ENTITY
are	
remark-	
ably	
normal	
between	
episodes	ENTITY
with	
regard	
to	
sleep	ENTITY
,	
cognition	ENTITY
,	
mood	ENTITY
,	
and	
eating	ENTITY
.	

The	
disease	ENTITY
typically	
resolves	
after	
a	
median	ENTITY
of	
14	
years	ENTITY
,	
except	
in	
adult	ENTITY
-	
onset	ENTITY
cases	ENTITY
,	
when	
the	
course	ENTITY
may	
be	
more	
prolonged	ENTITY
.	

The	
simultaneous	ENTITY
occurrence	ENTITY
of	
all	
these	
symp-	
toms	ENTITY
is	
the	
exception	
rather	
than	
the	
rule	
,	
with	
hypersomnolence	ENTITY
being	
more	
char-	
acteristic	ENTITY
at	
the	
disease	ENTITY
onset	ENTITY
and	
during	
the	
first	
part	
of	
the	
episodes	ENTITY
,	
and	
disinhib-	
ited	ENTITY
behaviors	ENTITY
being	
evident	
during	
only	
a	
few	
episodes	ENTITY
.	

In	
occasional	
cases	ENTITY
,	
isolated	ENTITY
recurrent	ENTITY
hypersomnolence	ENTITY
may	
be	
the	
only	
symptom	ENTITY
.	

Amnesia	ENTITY
,	
transient	ENTITY
dysphoria	ENTITY
,	
or	
elation	ENTITY
with	
insomnia	ENTITY
may	
signal	ENTITY
the	
termination	ENTITY
of	
an	
episode	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Physical	ENTITY
examination	ENTITY
is	
unremarkable	ENTITY
,	
except	
for	
general	ENTITY
psychomotor	ENTITY
slowing	ENTITY
.	

Social	ENTITY
and	
occupational	ENTITY
impairment	ENTITY
during	
attacks	ENTITY
is	
often	
severe	ENTITY
,	
with	
teenagers	ENTITY
bedridden	ENTITY
for	
days	ENTITY
,	
but	
can	
be	
variable	ENTITY
depending	
on	
the	
frequency	ENTITY
,	
severity	ENTITY
,	
and	
duration	ENTITY
of	
episodes	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Menstrual	ENTITY
-	
related	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
(	
alternate	
name	
:	
menstrual	ENTITY
-	
related	ENTITY
hyper-	
somnia	ENTITY
):	

This	
descriptor	ENTITY
is	
used	
when	
episodes	ENTITY
are	
exclusively	
associated	ENTITY
with	ENTITY
men-	
struation	ENTITY
(	
occurring	
just	
before	
or	
during	
menses	ENTITY
)	
,	
a	
condition	ENTITY
reported	
in	
only	
18	
women	ENTITY
worldwide	
.	

Hypersomnolence	ENTITY
episodes	ENTITY
in	
these	
cases	ENTITY
have	
been	
associated	ENTITY
with	ENTITY
compulsive	ENTITY
eating	ENTITY
in	
65	
%	
,	
sexual	ENTITY
disinhibition	ENTITY
in	
29	
%	
,	
and	
depressive	ENTITY
mood	ENTITY
in	
35	
%	
.	

Episodes	ENTITY
last	
3	
to	
15	
days	ENTITY
and	
recur	
less	
than	
three	
times	
a	
year	ENTITY
.	

One	
boy	ENTITY
with	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
is	
reported	
to	
have	
a	
sister	ENTITY
affected	ENTITY
by	
menstrual	ENTITY
-	
related	ENTITY
hypersomnolence	ENTITY
.	

Menstrual	ENTITY
-	
related	ENTITY
hypersomnia	ENTITY
may	
be	
a	
variant	ENTITY
of	
Kleine	ENTITY
-	
Levin	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
syndrome	ENTITY
,	
although	
response	ENTITY
to	
contraceptive	ENTITY
doses	ENTITY
of	
estrogen	ENTITY
and	
progesterone	ENTITY
,	
reported	
in	
some	
cases	ENTITY
,	
suggests	
a	
reproductive	ENTITY
endocrine	ENTITY
disturbance	ENTITY
.	

Demographics	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
is	
rare	ENTITY
,	
with	
a	
prevalence	ENTITY
estimated	ENTITY
around	
1	
to	
2	
cases	ENTITY
per	
million	
.	

Roughly	
500	
cases	ENTITY
have	
been	
reported	
to	
date	
in	
the	
literature	ENTITY
,	
from	
all	
countries	ENTITY
in	
which	
the	
disease	ENTITY
has	
been	
investigated	ENTITY
.	

The	
disease	ENTITY
starts	
during	
the	
second	
decade	
in	
81	
%	
of	
patients	ENTITY
,	
with	
a	
male	ENTITY
/	
female	ENTITY
ratio	ENTITY
of	
2:1	
.	

Adults	ENTITY
and	
younger	ENTITY
children	ENTITY
may	
also	
be	
affected	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Birth	ENTITY
and	
developmental	ENTITY
problems	ENTITY
,	
as	
well	
as	
Jewish	ENTITY
heritage	ENTITY
,	
are	
risk	ENTITY
factors	ENTITY
for	
devel-	
oping	ENTITY
the	
syndrome	ENTITY
.	

The	
frequency	ENTITY
of	
the	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
02	ENTITY
was	
increased	ENTITY
compared	
with	
controls	ENTITY
in	
a	
retrospective	ENTITY
,	
multicenter	ENTITY
series	ENTITY
of	
30	
patients	ENTITY
with	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
,	
but	
not	
in	
another	
larger	
prospective	ENTITY
series	ENTITY
(	
n	
=	
108	
)	
.	

A	
flu	ENTITY
-	
like	
illness	ENTITY
or	
an	
infection	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
(	
and	
more	
rarely	ENTITY
gastroenteritis	ENTITY
)	
is	
often	
reported	
imme-	
diately	
prior	
to	
the	
onset	
of	
the	
first	
episode	ENTITY
,	
and	
more	
rarely	
before	
relapses	ENTITY
.	

Other	
less	
frequently	
reported	
triggering	ENTITY
events	ENTITY
include	
alcohol	ENTITY
consumption	ENTITY
,	
head	ENTITY
trauma	ENTITY
,	
travel	ENTITY
,	
or	
exposure	ENTITY
to	ENTITY
anesthesia	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
cases	ENTITY
of	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
are	
found	
in	
5	
%	
of	
patients	ENTITY
,	
including	
twins	ENTITY
,	
parent	ENTITY
-	
child	ENTITY
,	
siblings	ENTITY
,	
and	
uncle	ENTITY
-	
nephew	ENTITY
associations	ENTITY
.	

There	
is	
no	
increased	ENTITY
history	ENTITY
of	ENTITY
mood	ENTITY
disorders	ENTITY
in	
family	ENTITY
members	ENTITY
of	
patients	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Early	ENTITY
adolescence	ENTITY
(	
second	
decade	
)	
is	
the	
usual	
age	ENTITY
of	
onset	ENTITY
.	

The	
course	ENTITY
of	
Kleine-	

Levin	ENTITY
syndrome	ENTITY
is	
characterized	
by	
recurrent	ENTITY
episodes	ENTITY
of	
severe	ENTITY
sleepiness	ENTITY
,	
lasting	
up	
to	
several	
weeks	ENTITY
,	
with	
normal	ENTITY
functioning	ENTITY
between	
episodes	ENTITY
.	

Several	
long	ENTITY
-	
term	ENTITY
studies	ENTITY
suggest	
an	
often	ENTITY
-	
benign	ENTITY
course	ENTITY
,	
with	
episodes	ENTITY
lessening	ENTITY
in	
duration	ENTITY
,	
severity	ENTITY
,	
and	
fre-	
quency	ENTITY
over	
a	
median	ENTITY
course	ENTITY
of	
14	
years	ENTITY
.	

Male	ENTITY
sex	ENTITY
,	
age	ENTITY
at	
onset	ENTITY
younger	ENTITY
than	
12	
years	ENTITY
or	
older	ENTITY
than	
20	
years	ENTITY
,	
as	
well	
as	
the	
presence	ENTITY
of	
hypersexuality	ENTITY
during	
episodes	ENTITY
,	
predict	
longer	
disease	ENTITY
duration	ENTITY
.	

Complications	ENTITY
are	
mainly	
social	ENTITY
and	
occupational	ENTITY
.	

In	
rare	
cases	ENTITY
,	
subjects	ENTITY
have	
been	
reported	
to	
choke	ENTITY
while	
eating	ENTITY
voraciously	ENTITY
,	
to	
have	
suicidal	ENTITY
thoughts	ENTITY
,	
or	
to	
be	
involved	
in	
a	
car	ENTITY
accident	ENTITY
.	

A	
reduced	ENTITY
long	ENTITY
-	
term	ENTITY
working	ENTITY
memory	ENTITY
capacity	ENTITY
following	
episodes	ENTITY
was	
reported	
in	
eight	
patients	ENTITY
with	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Adolescents	ENTITY
are	
affected	ENTITY
in	
most	
cases	ENTITY
.	

However	
,	
the	
onset	
of	
the	
condition	ENTITY
has	
been	
reported	
in	
children	ENTITY
as	
young	ENTITY
as	
four	
years	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Postmortem	ENTITY
examination	ENTITY
of	
the	
central	ENTITY
nervous	ENTITY
system	ENTITY
has	
been	
performed	
in	
only	
four	
cases	ENTITY
,	
with	
inconsistent	ENTITY
findings	ENTITY
.	

One	
subject	ENTITY
showed	
significant	
perivascular	ENTITY
lymphocytic	
infiltrations	
in	
the	
hypothalamus	ENTITY
,	
amygdala	ENTITY
,	
and	
the	
grey	ENTITY
matter	ENTITY
of	
the	
temporal	ENTITY
lobes	ENTITY
;	
a	
second	
demonstrated	
similar	
infiltrations	ENTITY
in	
the	
thalamus	ENTITY
;	
and	
a	
third	
in	
the	
diencephalon	ENTITY
and	
the	
midbrain	ENTITY
with	
a	
suggestion	
of	
mild	ENTITY
localized	
encephali-	
tis	
.	

In	
the	
fourth	
case	ENTITY
,	
a	
smaller	
locus	ENTITY
coeruleus	ENTITY
and	
decreased	ENTITY
pigmentation	ENTITY
in	
the	
substantia	ENTITY
nigra	ENTITY
were	
reported	
.	

Magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
was	
unremarkable	
.	

In	
contrast	
,	
functional	ENTITY
brain	ENTITY
imaging	ENTITY
studies	
during	
episodes	ENTITY
are	
frequently	
abnormal	ENTITY
,	
showing	
hypometabolism	ENTITY
in	
the	
thalamus	ENTITY
,	
hypothalamus	ENTITY
,	
mesial	ENTITY
temporal	ENTITY
lobe	ENTITY
,	
and	
frontal	ENTITY
lobe	ENTITY
.	

Some	
of	
these	
abnormalities	ENTITY
persist	
during	
asymptomatic	ENTITY
periods	ENTITY
in	
half	
of	
the	
patients	ENTITY
.	

An	
autoimmune	ENTITY
basis	ENTITY
for	
the	
disorder	ENTITY
is	
suggested	
clinically	ENTITY
(	
onset	
occurs	
during	
adolescence	ENTITY
,	
often	
in	
conjunction	ENTITY
with	
an	
infection	ENTITY
)	
and	
by	
the	
occa-	
sional	ENTITY
association	ENTITY
with	
HLA	ENTITY
DQB1	ENTITY
*	ENTITY
02	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Routine	ENTITY
electroencephalograms	ENTITY
obtained	
during	
episodes	ENTITY
have	
shown	
general	
slowing	
of	
background	
electroencephalographic	ENTITY
activity	ENTITY
and	
often	
paroxysmal—0.5	ENTITY
-	
2.0	
-	
sec-	
ond	
—	
bursts	ENTITY
of	
bisynchronous	ENTITY
,	
generalized	ENTITY
,	
moderate-	
to	
high	ENTITY
-	
voltage	ENTITY
5-	
to	
7	
-	
Hz	
waves	ENTITY
.	

Polysomnography	ENTITY
studies	ENTITY
are	
often	
difficult	
to	
interpret	ENTITY
,	
and	
results	ENTITY
are	
depen-	
dent	ENTITY
on	
the	
duration	ENTITY
of	
recording	ENTITY
(	
overnight	ENTITY
vs.	
24	
-	
hour	ENTITY
monitoring	ENTITY
)	
as	
well	
as	
the	
timing	ENTITY
(	
at	
the	
beginning	ENTITY
versus	
the	
end	
of	
episodes	ENTITY
or	
at	
onset	
of	
the	
disease	ENTITY
or	
later	
in	
its	
course	ENTITY
)	
.	

Twenty	ENTITY
-	
four	ENTITY
-	
hour	ENTITY
polysomnography	ENTITY
demonstrates	
prolonged	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
(	
a	
mean	
11–12	
hours	ENTITY
)	
,	
and	
18	
hours	ENTITY
or	
more	
in	
some	
reports	ENTITY
.	

During	
nocturnal	ENTITY
polysomnography	ENTITY
in	
17	
children	ENTITY
,	
nighttime	ENTITY
slow	ENTITY
wave	ENTITY
sleep	ENTITY
percentage	ENTITY
was	
decreased	ENTITY
during	
the	
first	
half	
of	
the	
episodes	ENTITY
,	
and	
REM	ENTITY
sleep	ENTITY
decreased	ENTITY
during	
the	
second	
half	
.	

Results	ENTITY
of	
the	
MSLT	ENTITY
are	
highly	
dependent	
on	
the	
subjects	ENTITY
’	
willingness	ENTITY
to	
comply	
with	
the	
procedure	ENTITY
,	
and	
may	
either	
be	
normal	ENTITY
or	
abnormal	ENTITY
,	
showing	
short	ENTITY
latencies	ENTITY
or	
mul-	
tiple	
SOREMPs	ENTITY
.	

CSF	ENTITY
cytology	ENTITY
and	
protein	ENTITY
are	
normal	
.	

CSF	ENTITY
levels	ENTITY
of	
hypocretin-1	ENTITY
were	
within	
normal	
range	
in	
16	
patients	ENTITY
,	
although	
intraepisodic	ENTITY
levels	ENTITY
are	
lower	
than	
interepisodic	ENTITY
levels	ENTITY
.	

Computed	ENTITY
tomography	ENTITY
scans	ENTITY
and	
magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
are	
normal	
.	

Brain	ENTITY
functional	ENTITY
imaging	ENTITY
is	
abnormal	ENTITY
in	
most	
cases	ENTITY
,	
with	
hypoperfusion	ENTITY
of	
the	
left	ENTITY
or	
right	ENTITY
temporal	ENTITY
and	
frontal	ENTITY
lobes	ENTITY
as	
well	
as	
the	
diencephalon	ENTITY
.	

These	
abnor-	
malities	ENTITY
are	
present	
during	
the	
episode	ENTITY
of	
hypersomnolence	ENTITY
and	
sometimes	
between	
episodes	ENTITY
.	

Hormone	ENTITY
levels	ENTITY
are	
normal	ENTITY
,	
as	
are	
24	
-	
hour	ENTITY
secretory	ENTITY
patterns	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Recurrent	ENTITY
waxing	ENTITY
and	
waning	ENTITY
episodes	ENTITY
of	
sleepiness	ENTITY
may	
be	
secondary	ENTITY
to	ENTITY
struc-	
tural	ENTITY
insults	ENTITY
of	
the	
central	ENTITY
nervous	ENTITY
system	ENTITY
.	

Tumors	ENTITY
within	
the	
third	ENTITY
ventricle	ENTITY
(	
such	
as	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
colloid	ENTITY
cysts	ENTITY
,	
pedunculated	ENTITY
astrocytomas	ENTITY
,	
or	
,	
in	
some	
cases	ENTITY
,	
craniopharyngiomas	ENTITY
)	
may	
produce	
intermittent	ENTITY
obstructions	ENTITY
of	
ventricular	ENTITY
flow	ENTITY
,	
leading	
to	
headaches	ENTITY
,	
vomiting	ENTITY
,	
vague	ENTITY
sensorial	ENTITY
disturbances	ENTITY
,	
and	
a	
paroxysmal	ENTITY
impairment	ENTITY
of	
alertness	ENTITY
.	

Encephalitis	ENTITY
,	
hyperammonemic	ENTITY
encephalopathy	ENTITY
,	
multiple	ENTITY
sclerosis	ENTITY
,	
head	ENTITY
trauma	ENTITY
,	
porphyria	ENTITY
,	
Lyme	ENTITY
disease	ENTITY
,	
basilar	ENTITY
migraine	ENTITY
,	
and	
complex	ENTITY
partial	ENTITY
status	ENTITY
epilepticus	ENTITY
less	
frequently	
mimic	
symptoms	ENTITY
of	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
.	

Recurrent	ENTITY
episodes	ENTITY
of	
sleepiness	ENTITY
also	
are	
reported	
in	
the	
context	ENTITY
of	
psychiatric	ENTITY
disorders	ENTITY
,	
such	
as	
depression	ENTITY
,	
bipolar	ENTITY
disorder	ENTITY
,	
seasonal	ENTITY
affective	ENTITY
disorder	ENTITY
,	
and	
somatoform	ENTITY
disorder	ENTITY
.	

However	
,	
the	
onset	ENTITY
and	
offset	ENTITY
of	
symptoms	ENTITY
are	
less	
abrupt	
than	
in	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
and	
persist	
to	
some	
extent	
between	
episodes	ENTITY
.	

Other	
differential	ENTITY
diagnoses	ENTITY
include	
excessive	ENTITY
sleepiness	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
,	
OSA	ENTITY
,	
narcolepsy	ENTITY
,	
IH	ENTITY
,	
and	
insufficient	ENTITY
sleep	ENTITY
.	

In	
these	
disor-	
ders	ENTITY
,	
however	
,	
the	
complaint	ENTITY
of	
excessive	ENTITY
sleepiness	ENTITY
occurs	
daily	ENTITY
and	
is	
usually	
not	
recurrent	
or	
periodic	ENTITY
.	

There	
is	
no	
evidence	ENTITY
that	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
occurs	
as	
a	
result	
of	
a	
seizure	ENTITY
disorder	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

The	
pathophysiology	ENTITY
of	
this	
disorder	ENTITY
is	
not	
known	
.	

Evidence	ENTITY
to	
date	
suggests	
that	
a	
localized	ENTITY
but	
multifocal	ENTITY
encephalopathy	ENTITY
occurs	
during	
episodes	ENTITY
of	
Kleine	ENTITY
-	
Levin	ENTITY
syn-	ENTITY
drome	ENTITY
,	
as	
functional	ENTITY
imaging	ENTITY
and	
electroencephalography	ENTITY
(	
EEG	ENTITY
)	
slowing	
indicate	
tha-	
lamic	ENTITY
,	
temporal	ENTITY
,	
and	
frontal	ENTITY
lobe	ENTITY
involvement	ENTITY
.	

The	
cause	
of	
these	
episodic	ENTITY
abnormali-	
ties	ENTITY
may	
be	
genetic	ENTITY
,	
autoimmune	ENTITY
,	
inflammatory	ENTITY
,	
or	
metabolic	ENTITY
.	

Bibliography	ENTITY
Arnulf	ENTITY
I	ENTITY
,	
Lin	
L	
,	
Gadoth	ENTITY
N	ENTITY
,	
et	
al	
.	

Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
:	
a	
systematic	ENTITY
study	ENTITY
of	
108	
patients	ENTITY
.	

Ann	
Neurol	
2008;63:482–93	
.	

Arnulf	ENTITY
I	ENTITY
,	
Zeitzer	ENTITY
JM	ENTITY
,	
File	
J	
,	
Farber	ENTITY
N	ENTITY
,	ENTITY
Mignot	ENTITY
E.	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
:	
a	
systematic	ENTITY
review	ENTITY
of	
186	
cases	ENTITY
in	
the	
literature	ENTITY
.	

Brain	ENTITY
2005;128:2763–76	
.	

Billiard	ENTITY
M	ENTITY
,	
Jaussent	ENTITY
I	ENTITY
,	
Dauvilliers	ENTITY
Y	ENTITY
,	
Besset	ENTITY
A.	ENTITY
Recurrent	ENTITY
hypersomnia	ENTITY
:	
a	
review	ENTITY
of	
339	
cases	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2011;15:247–57	ENTITY
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Mayer	ENTITY
G	ENTITY
,	
Lecendreux	ENTITY
M	ENTITY
,	
et	
al	
.	

Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
.	

An	
autoimmune	ENTITY
hypothesis	ENTITY
based	
on	
clinical	ENTITY
and	
genetic	ENTITY
analyses	ENTITY
.	

Neurology	ENTITY
2002;59:1739–45	
.	

Engström	ENTITY
M	ENTITY
,	
Vigren	ENTITY
P	ENTITY
,	
Karlsson	ENTITY
T	ENTITY
,	
Landtblom	
A.	
Working	ENTITY
memory	ENTITY
in	
8	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
patients	ENTITY
:	
An	
fMRI	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2009;32:681–8	ENTITY
.	

Gadoth	ENTITY
N	ENTITY
,	
Kesler	ENTITY
A	ENTITY
,	
Vainstein	ENTITY
G	ENTITY
,	
Peled	ENTITY
R	ENTITY
,	
Lavie	
P.	
Clinical	
and	
polysomnographic	ENTITY
characteristics	ENTITY
of	
34	
patients	ENTITY
with	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
.	

J	
Sleep	
Res	
2001;10:337–41	
.	

Huang	ENTITY
Y	ENTITY
,	
Lin	
Y	
,	
Guilleminault	ENTITY
C.	ENTITY
Polysomnography	ENTITY
in	
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
.	

Neurology	ENTITY
2008;70:795–801	
.	

Huang	ENTITY
Y	ENTITY
,	
Guilleminault	ENTITY
C	ENTITY
,	
Lin	ENTITY
K	ENTITY
,	
Hwang	ENTITY
F	ENTITY
,	
Liu	ENTITY
F	ENTITY
,	
Kung	
Y.	
Relationship	ENTITY
between	
Kleine	ENTITY
-	
Levin	ENTITY
Syndrome	ENTITY
and	
upper	ENTITY
respiratory	ENTITY
infection	ENTITY
in	
Taiwan	ENTITY
.	

Sleep	ENTITY
2012;35:123–9	
.	

Hypersomnia	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.14	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.14	ENTITY
Alternate	ENTITY
Names	ENTITY
Not	
applicable	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
occurring	
for	
at	
least	
three	
months	ENTITY
.	

B.	ENTITY
The	
daytime	ENTITY
sleepiness	ENTITY
occurs	
as	
a	
consequence	
of	
a	
significant	
underlying	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
.	

C.	

If	
an	
MSLT	ENTITY
is	
performed	
,	
the	
mean	ENTITY
sleep	ENTITY
latency	ENTITY
is	
≤	
8	
minutes	ENTITY
,	
and	
fewer	
than	
two	
sleep	ENTITY
onset	
REM	ENTITY
periods	
(	
SOREMPs	ENTITY
)	
are	
observed.1	ENTITY
D.	ENTITY
The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
untreated	ENTITY
sleep	ENTITY
disorder,2	ENTITY
a	
mental	ENTITY
disorder	ENTITY
,	
or	
the	
effects	ENTITY
of	ENTITY
medications	ENTITY
or	
drugs	ENTITY
.	

Notes	ENTITY
.	

In	
the	
subtype	ENTITY
of	
residual	ENTITY
hypersomnolence	ENTITY
after	
treatment	ENTITY
of	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
the	
MSLT	ENTITY
mean	
latency	ENTITY
may	
be	
>	
8	
minutes	ENTITY
.	
.	

Should	
criteria	ENTITY
for	
narcolepsy	ENTITY
be	
fulfilled	
,	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
or	
type	
2	
due	
to	
a	
medical	ENTITY
condition	ENTITY
should	
be	
used	
rather	
than	
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
condition	ENTITY
.	
.	

In	
patients	ENTITY
with	
severe	ENTITY
neurological	ENTITY
or	
medical	ENTITY
disorders	ENTITY
in	
whom	
it	
is	
not	
possible	
or	
desirable	
to	
perform	
sleep	ENTITY
studies	ENTITY
,	
the	
diagnosis	ENTITY
can	
be	
made	
by	
clinical	ENTITY
criteria	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Patients	ENTITY
with	
this	
disorder	ENTITY
have	
excessive	ENTITY
nocturnal	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
sleepiness	ENTITY
,	
or	
excessive	ENTITY
napping	ENTITY
that	
is	
attributable	
to	
a	
coexisting	ENTITY
medical	ENTITY
or	
neurological	ENTITY
disor-	ENTITY
der	ENTITY
.	

Daytime	ENTITY
sleepiness	ENTITY
may	
be	
of	
variable	ENTITY
severity	ENTITY
and	
may	
resemble	
that	
of	
narco-	
lepsy	ENTITY
(	
i.e.	
,	
refreshing	ENTITY
naps	ENTITY
)	
or	
idiopathic	ENTITY
hypersomnia	ENTITY
(	
i.e.	
,	
long	ENTITY
periods	ENTITY
of	
unrefresh-	
ing	
sleep	ENTITY
)	
.	

Sleep	ENTITY
paralysis	ENTITY
,	
hypnagogic	ENTITY
hallucinations	ENTITY
,	
or	
automatic	ENTITY
behavior	ENTITY
may	
be	
present	
,	
but	
if	
the	
patient	ENTITY
has	
cataplexy	ENTITY
,	
the	
MSLT	ENTITY
shows	
two	
or	
more	
SOREMPs	ENTITY
,	
or	
CSF	ENTITY
Hcrt-1	ENTITY
levels	ENTITY
are	
low	ENTITY
,	
then	
narcolepsy	ENTITY
(	
type	
1	
or	
type	
2	
)	
due	
to	
a	
medical	ENTITY
condi-	
tion	ENTITY
should	
be	
diagnosed	ENTITY
.	

In	
patients	ENTITY
with	
both	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
and	
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
,	
the	
latter	
diagnosis	ENTITY
should	
be	
made	
only	
if	
the	
hypersomnolence	ENTITY
persists	
after	
adequate	ENTITY
treatment	ENTITY
of	
the	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
.	

Hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
is	
only	
diagnosed	ENTITY
if	
the	
medical	ENTITY
condition	ENTITY
is	
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
judged	
to	
be	
directly	
causing	
the	
excessive	ENTITY
sleepiness	ENTITY
.	

Hypersomnolence	ENTITY
has	
been	
described	
in	
association	ENTITY
with	
a	
large	
range	
of	
conditions	ENTITY
,	
including	
metabolic	ENTITY
enceph-	
alopathy	ENTITY
,	
head	ENTITY
trauma	ENTITY
,	
stroke	ENTITY
,	
brain	ENTITY
tumors	ENTITY
,	
encephalitis	ENTITY
,	
systemic	ENTITY
inflammation	ENTITY
(	
e.g.	
,	
chronic	ENTITY
infections	ENTITY
,	
rheumatologic	ENTITY
disorders	ENTITY
,	
cancer	ENTITY
)	
,	
genetic	ENTITY
disorders	ENTITY
,	
and	
neurode-	
generative	ENTITY
diseases	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Not	
applicable	
or	
known	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Many	
medical	ENTITY
conditions	ENTITY
can	
cause	ENTITY
hypersomnolence	ENTITY
.	

Hypersomnia	ENTITY
secondary	
to	
Parkinson	ENTITY
disease	ENTITY
:	
Significant	ENTITY
hypersomnolence	ENTITY
docu-	
mented	ENTITY
by	
MSLT	ENTITY
has	
been	
reported	
in	
some	
cases	ENTITY
of	
Parkinson	ENTITY
disease	ENTITY
.	

Hypersomnia	ENTITY
in	
Parkinson	ENTITY
disease	ENTITY
may	
be	
due	
to	
insufficient	ENTITY
control	
of	
nocturnal	ENTITY
symptoms	ENTITY
,	
result-	
ing	
in	
insufficient	ENTITY
sleep	ENTITY
and	
daytime	ENTITY
sleepiness	ENTITY
.	

If	
so	
,	
the	
diagnosis	ENTITY
should	
be	
insomnia	ENTITY
disorder	ENTITY
.	

Cases	ENTITY
of	
hypersomnolence	ENTITY
that	
are	
due	
to	
the	
side	ENTITY
effects	ENTITY
of	
dopaminergic	ENTITY
agents	ENTITY
should	
be	
coded	
as	
hypersomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
.	

In	
other	
cases	ENTITY
,	
however	
,	
hypersomnolence	ENTITY
is	
likely	
of	
central	ENTITY
origin	ENTITY
and	
should	
be	
classified	
in	
this	
section	ENTITY
.	

Parkinson	ENTITY
disease	ENTITY
patients	ENTITY
with	
an	
MSLT	ENTITY
profile	
consistent	ENTITY
with	ENTITY
narco-	
lepsy	ENTITY
should	
be	
coded	
as	
narcolepsy	ENTITY
due	
to	
a	
medical	ENTITY
condition	ENTITY
.	

Posttraumatic	ENTITY
hypersomnia	ENTITY
:	
Hypersomnolence	ENTITY
appears	
to	
be	
common	
after	
trau-	
matic	ENTITY
brain	ENTITY
injury	ENTITY
(	
TBI	ENTITY
)	
,	
with	
one	
meta	ENTITY
-	
analysis	ENTITY
suggesting	
a	
frequency	ENTITY
of	
28	
%	
of	
TBI	ENTITY
patients	ENTITY
.	

In	
some	
cases	ENTITY
this	
may	
be	
caused	
by	
injury	ENTITY
to	
the	
hypocretin	ENTITY
/	
orexin	ENTITY
neurons	ENTITY
or	
other	
wake	ENTITY
-	
promoting	ENTITY
neural	ENTITY
systems	ENTITY
.	

However	
,	
the	
prevalence	ENTITY
of	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
(	
SRBD	ENTITY
)	
in	
patients	ENTITY
with	
head	ENTITY
trauma	ENTITY
is	
high	ENTITY
(	
frequency	ENTITY
23	
%	
to	
25	
%	
)	
.	

The	
nature	ENTITY
of	
the	
relationship	ENTITY
between	
TBI	ENTITY
and	
OSA	ENTITY
remains	
undefined	
.	

Therefore	
,	
control	
of	
other	
potential	ENTITY
sleep	ENTITY
disorders	ENTITY
is	
necessary	
prior	
to	
making	
a	
diagnosis	ENTITY
of	
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
(	
posttraumatic	ENTITY
hypersomnia	ENTITY
)	
.	

Genetic	ENTITY
disorders	ENTITY
associated	ENTITY
with	ENTITY
primary	ENTITY
central	ENTITY
nervous	ENTITY
system	ENTITY
somnolence	ENTITY
:	
Genetic	ENTITY
disorders	ENTITY
such	
as	
Niemann	ENTITY
Pick	ENTITY
type	ENTITY
C	ENTITY
disease	ENTITY
and	
Norrie	ENTITY
disease	ENTITY
have	
been	
associated	ENTITY
with	ENTITY
daytime	ENTITY
somnolence	ENTITY
.	

Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
,	
myotonic	ENTITY
dystrophy	ENTITY
,	
Moebius	ENTITY
syndrome	ENTITY
,	
and	
fragile	ENTITY
X	ENTITY
syndrome	ENTITY
are	
other	
examples	
of	
centrally	ENTITY
mediated	ENTITY
sleepiness	ENTITY
.	

A	
number	
of	
genetic	ENTITY
disorders	ENTITY
have	
been	
reported	
to	
be	
associated	ENTITY
with	ENTITY
both	
sleep	ENTITY
disordered	
breathing	
and	
hypersomnolence	ENTITY
(	
e.g.	
,	
myotonic	ENTITY
dystrophy	ENTITY
and	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
)	
.	

In	
these	
cases	ENTITY
,	
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
should	
be	
diagnosed	ENTITY
only	
if	
the	
excessive	ENTITY
sleepiness	ENTITY
is	
still	
present	
after	
adequate	ENTITY
treatment	ENTITY
of	
the	
SRBD	ENTITY
.	

Smith	ENTITY
-	
Magenis	ENTITY
syndrome	ENTITY
is	
a	
neurodevelopmental	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
dysmorphic	ENTITY
facial	ENTITY
features	
,	
behavioral	ENTITY
disturbance	ENTITY
with	
onset	
in	
early	ENTITY
childhood	ENTITY
,	
daytime	ENTITY
somnolence	ENTITY
,	
and	
night	ENTITY
awakenings	ENTITY
in	
association	ENTITY
with	ENTITY
reversal	ENTITY
in	
the	
timing	ENTITY
of	
the	
melatonin	ENTITY
secretion	
pattern	
(	
i.e.	
,	
the	
serum	ENTITY
levels	ENTITY
of	
melatonin	ENTITY
are	
high	
during	
the	
daytime	ENTITY
and	
low	ENTITY
at	
night	ENTITY
)	
.	

Hypersomnia	ENTITY
secondary	
to	
brain	ENTITY
tumors	ENTITY
,	
infections	ENTITY
,	
or	
other	
central	ENTITY
nervous	ENTITY
system	ENTITY
lesions	ENTITY
:	
Strokes	ENTITY
,	
infections	ENTITY
,	
tumors	ENTITY
,	
sarcoidosis	ENTITY
,	
or	
neurodegenerative	ENTITY
lesions	ENTITY
of	
the	
brain	ENTITY
,	
especially	
in	
the	
hypothalamus	ENTITY
or	
rostral	ENTITY
midbrain	ENTITY
,	
may	
produce	
daytime	ENTITY
sleepi-	
ness	ENTITY
.	

In	
patients	ENTITY
with	
brain	ENTITY
tumors	ENTITY
,	
the	
sleepiness	ENTITY
may	
be	
due	
to	
the	
tumor	ENTITY
itself	
or	
the	
effects	ENTITY
of	ENTITY
treatment	ENTITY
.	

Hypersomnia	ENTITY
secondary	
to	
endocrine	ENTITY
disorder	ENTITY
:	
Hypothyroidism	ENTITY
is	
the	
most	
recog-	
nized	ENTITY
example	
of	
this	
condition	ENTITY
.	

Hypersomnia	ENTITY
secondary	
to	
metabolic	ENTITY
encephalopathy	ENTITY
:	
Hepatic	ENTITY
encephalopathy	ENTITY
,	
chronic	ENTITY
renal	ENTITY
insufficiency	ENTITY
,	
adrenal	ENTITY
or	
pancreatic	ENTITY
insufficiency	ENTITY
,	
exposure	ENTITY
to	ENTITY
toxins	ENTITY
,	
and	
certain	
inherited	ENTITY
metabolic	ENTITY
disorders	ENTITY
in	
childhood	ENTITY
may	
result	
in	
hypersomnolence	ENTITY
.	

Residual	ENTITY
hypersomnia	ENTITY
in	
patients	ENTITY
with	
adequately	
treated	ENTITY
OSA	ENTITY
:	
Some	
patients	ENTITY
with	
SRBDs	ENTITY
report	ENTITY
persistent	ENTITY
sleepiness	ENTITY
despite	
apparently	
adequate	ENTITY
amounts	
of	
sleep	ENTITY
and	
optimal	ENTITY
treatment	ENTITY
of	
their	
sleep	ENTITY
apnea	ENTITY
and	
other	
known	
sleep	ENTITY
disorders	ENTITY
.	

They	
may	
have	
moderately	
elevated	
Epworth	
Sleepiness	
Scale	
scores	
,	
but	
most	
have	
mean	ENTITY
sleep	ENTITY
laten-	
cies	ENTITY
>	
8	
minutes	
on	
MSLT	ENTITY
.	

They	
also	
report	ENTITY
more	
fatigue	ENTITY
,	
apathy	ENTITY
,	
and	
depression	ENTITY
.	

It	
is	
essential	
that	
sleep	ENTITY
disordered	
breathing	
be	
fully	
treated	ENTITY
for	
at	
least	
three	
months	ENTITY
,	
and	
that	
control	
of	
the	
SRBD	ENTITY
be	
confirmed	
by	
:	
(	
1	
)	
a	
download	
of	
positive	ENTITY
airway	ENTITY
pressure	ENTITY
(	
PAP	
)	
machine	
compliance	ENTITY
data	ENTITY
demonstrating	
optimal	ENTITY
usage	ENTITY
(	
preferably	
at	
least	
7	
hours	
a	
night	ENTITY
)	
;	
and	
(	
2	
)	
a	
polysomnogram	ENTITY
demonstrating	
elimination	ENTITY
of	
essentially	
all	
sleep	ENTITY
disordered	
breathing	ENTITY
.	

Other	
causes	
of	
sleepiness	ENTITY
,	
such	
as	
insufficient	ENTITY
sleep	ENTITY
syn-	ENTITY
drome	ENTITY
,	
psychiatric	ENTITY
disorders	ENTITY
,	
or	
hypersomnolence	ENTITY
related	
to	
medications	ENTITY
or	
drugs	ENTITY
must	
be	
eliminated	ENTITY
.	

Animal	ENTITY
studies	ENTITY
have	
suggested	
this	
residual	ENTITY
sleepiness	ENTITY
could	
be	
caused	
by	
hypoxic	ENTITY
injury	ENTITY
to	
monoamine	ENTITY
systems	ENTITY
.	

Obesity	ENTITY
itself	
may	
also	
contribute	
,	
and	
more	
research	ENTITY
is	
needed	
to	
understand	
the	
underlying	
mechanism	ENTITY
.	

Demographics	ENTITY
Demographics	ENTITY
reflect	
those	
of	
the	
underlying	
condition	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
and	
precipitating	ENTITY
factors	ENTITY
reflect	
those	
of	
the	
underlying	
condition	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
patterns	ENTITY
reflect	
those	
of	
the	
underlying	
condition	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
,	
course	ENTITY
,	
and	
complications	ENTITY
reflect	
those	
of	
the	
underlying	
condition	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Daytime	ENTITY
naps	ENTITY
are	
normal	
in	
children	ENTITY
younger	ENTITY
than	
3	
-	
4	
years	ENTITY
;	
thus	
,	
it	
is	
difficult	
to	
dif-	
ferentiate	ENTITY
physiologic	
napping	
from	
hypersomnolence	ENTITY
in	
children	ENTITY
younger	ENTITY
than	
this	
age	ENTITY
.	

Inattentiveness	ENTITY
,	
mood	ENTITY
swings	ENTITY
,	
and	
learning	ENTITY
difficulties	ENTITY
often	
accompany	
child-	
hood	ENTITY
daytime	ENTITY
sleepiness	ENTITY
.	

Reference	ENTITY
values	ENTITY
for	
the	
MSLT	ENTITY
in	
children	ENTITY
differ	
from	
those	
of	
adults	ENTITY
,	
and	
this	
issue	ENTITY
should	
be	
considered	
during	
the	
evaluation	ENTITY
process	ENTITY
.	

Special	ENTITY
attention	ENTITY
should	
be	
paid	
to	
genetic	ENTITY
disorders	ENTITY
in	
children	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Pathology	ENTITY
and	
pathophysiology	ENTITY
reflect	
those	
of	
the	
underlying	
condition	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Nocturnal	ENTITY
polysomnography	ENTITY
may	
show	
normal	ENTITY
or	
moderately	
disturbed	ENTITY
sleep	ENTITY
.	

In	
patients	ENTITY
with	
a	
metabolic	ENTITY
encephalopathy	ENTITY
,	
EEG	ENTITY
abnormalities	ENTITY
may	
be	
present	
,	
such	
as	
an	
increase	ENTITY
in	
the	
amount	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

MSLT	ENTITY
must	
show	
fewer	
than	
2	
SOREMPs	ENTITY
and	
usually	
will	
show	
a	
mean	
sleep	ENTITY
latency	ENTITY
less	
than	
eight	
minutes	ENTITY
.	

If	
clin-	
ically	ENTITY
significant	
sleep	ENTITY
disordered	ENTITY
breathing	
or	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
are	
present	
,	
they	
should	
be	
treated	ENTITY
prior	
to	
diagnosing	ENTITY
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
See	
the	
differential	ENTITY
diagnosis	ENTITY
in	
previous	
hypersomnolence	ENTITY
sections	ENTITY
.	

The	
major	
chal-	
lenge	ENTITY
in	
establishing	
a	
diagnosis	ENTITY
of	
hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
is	
deter-	
mining	ENTITY
whether	
the	
associated	ENTITY
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
is	
truly	
causing	
the	
hypersomnolence	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

This	
area	ENTITY
is	
understudied	
.	

Multiple	ENTITY
complex	ENTITY
neurological	ENTITY
,	
metabolic	ENTITY
,	
endocrine	ENTITY
,	
and	
medication	ENTITY
-	
related	ENTITY
interactions	ENTITY
may	
be	
present	
.	

Further	
studies	ENTITY
are	
needed	
to	
define	
the	
reciprocal	ENTITY
relationships	ENTITY
between	
sleep	ENTITY
disorders	ENTITY
and	
other	
diseases	ENTITY
.	

Bibliography	ENTITY
Bruin	ENTITY
VM	ENTITY
,	
Bittencourt	ENTITY
LR	ENTITY
,	
Tufik	
S.	
Sleep	
-	
wake	ENTITY
disturbances	ENTITY
in	
Parkinson	ENTITY
’s	ENTITY
disease	ENTITY
:	
current	
evidence	ENTITY
regarding	
diagnostic	ENTITY
and	
therapeutic	ENTITY
decisions	ENTITY
.	

Eur	
Neurol	
2012;67:257–67	
.	

Castriotti	ENTITY
RJ	ENTITY
,	
Wilde	
MC	ENTITY
,	
Lai	ENTITY
JM	ENTITY
,	ENTITY
Atanasov	ENTITY
S	ENTITY
,	
Masel	ENTITY
BE	ENTITY
,	
Kuna	ENTITY
ST	ENTITY
.	
Prevalence	ENTITY
and	
consequences	ENTITY
of	ENTITY
sleep	ENTITY
disorders	ENTITY
in	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
.	

J	
Clin	
Sleep	
Med	
2007;3:349–56	
.	

Guilleminault	ENTITY
C	ENTITY
,	
Yuen	
KM	
,	
Gulevich	ENTITY
MG	ENTITY
,	
Karadeniz	ENTITY
D	ENTITY
,	
Leger	ENTITY
D	ENTITY
,	
Philip	ENTITY
D.	ENTITY
Hypersomnia	ENTITY
after	
head	ENTITY
-	
neck	ENTITY
trauma	ENTITY
:	
a	
medico	ENTITY
-	
legal	ENTITY
dilemma	ENTITY
.	

Neurology	ENTITY
2000;54:653–9	
.	

Kempf	ENTITY
J	ENTITY
,	ENTITY
Werth	ENTITY
E	ENTITY
,	
Kaiser	ENTITY
PR	ENTITY
,	
et	
al	
.	

Sleep	ENTITY
-	
wake	ENTITY
disturbances	ENTITY
3	
years	ENTITY
after	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
.	

J	
Neurol	
Neurosurg	
Psychiatry	
2010;81:1402–5	
.	

Martinez	ENTITY
-	
Rodriguez	ENTITY
JE	ENTITY
,	
Lin	ENTITY
L	ENTITY
,	ENTITY
Iranzo	ENTITY
A	ENTITY
,	
et	
al	
.	

Decreased	ENTITY
hypocretin-1	ENTITY
(	
orexin	ENTITY
-	
A	ENTITY
)	
levels	ENTITY
in	
the	
cerebrospinal	ENTITY
fluid	ENTITY
of	
patients	ENTITY
with	
myotonic	ENTITY
dystrophy	ENTITY
and	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
.	

Sleep	ENTITY
2003;26:287–90	ENTITY
.	

Mathias	ENTITY
JL	ENTITY
,	
Alvaro	
PK	ENTITY
.	

Prevalence	ENTITY
of	
sleep	ENTITY
disturbances	ENTITY
,	
disorders	ENTITY
,	
and	
problems	ENTITY
following	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
:	
a	
meta	ENTITY
-	
analysis	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2012;13:898–905	
.	

Panossian	ENTITY
L	ENTITY
,	
Veasey	
S.	
Daytime	
sleepiness	
in	
obesity	ENTITY
:	
mechanisms	ENTITY
beyond	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
--	
a	
review	ENTITY
.	

Sleep	ENTITY
2012;35:605–15	
.	

Vernet	ENTITY
C	ENTITY
,	
Redolfi	ENTITY
S	ENTITY
,	
Attali	
,	
V	
,	
et	
al	
.	

Residual	ENTITY
sleepiness	ENTITY
in	
obstructive	ENTITY
sleep	ENTITY
apnoea	ENTITY
:	
phenotype	ENTITY
and	
related	
symptoms	ENTITY
.	

Eur	
Respir	
J	
2011;38:98–105	
.	

Wienecke	ENTITY
M	ENTITY
,	
Werth	ENTITY
E	ENTITY
,	
Poryazova	ENTITY
R	ENTITY
,	
et	
al	
.	

Progressive	ENTITY
dopamine	ENTITY
and	
hypocretin	ENTITY
deficiencies	ENTITY
in	
Parkinson	ENTITY
’s	ENTITY
disease	ENTITY
:	
is	
there	
an	
impact	ENTITY
on	
sleep	ENTITY
and	
wakefulness	ENTITY
?	

J	
Sleep	
Res	
2012;21:710–7	
.	

Zhu	ENTITY
Y	ENTITY
,	
Fenik	
P	
,	
Zhan	
G	
,	
et	
al	
.	

Selective	
loss	
of	
catecholaminergic	ENTITY
wake	ENTITY
active	
neurons	ENTITY
in	
a	
murine	ENTITY
sleep	ENTITY
apnea	ENTITY
model	ENTITY
.	

J	
Neurosci	
2007;27:10060–71	
.	

Hypersomnia	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
292.85	
(	
drug	ENTITY
-	
induced	ENTITY
)	
;	
291.82	
(	
alcohol	ENTITY
-	
induced	ENTITY
)	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F11	ENTITY
-	
F19	ENTITY
(	
see	
table	
in	
Appendix	ENTITY
B	ENTITY
for	
detailed	
coding	ENTITY
instructions	ENTITY
)	

Alternate	ENTITY
Names	ENTITY
Hypersomnia	ENTITY
due	
to	
substance	ENTITY
abuse	ENTITY
,	
hypersomnia	ENTITY
due	
to	
stimulant	ENTITY
withdrawal	ENTITY
,	
hyper-	
somnia	ENTITY
due	
to	
sedative	ENTITY
abuse	ENTITY
,	
toxic	ENTITY
hypersomnia	ENTITY
,	
toxic	ENTITY
encephalopathy	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
.	

B.	ENTITY
The	
daytime	ENTITY
sleepiness	ENTITY
occurs	
as	
a	
consequence	ENTITY
of	ENTITY
current	ENTITY
medication	ENTITY
or	
substance	ENTITY
use	ENTITY
or	
withdrawal	ENTITY
from	
a	
wake	ENTITY
-	
promoting	ENTITY
medication	ENTITY
or	
substance	ENTITY
.	

C.	

The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
untreated	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
mental	ENTITY
disorder	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Essential	ENTITY
Features	ENTITY
Patients	ENTITY
with	
this	
disorder	ENTITY
have	
excessive	ENTITY
nocturnal	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
sleepiness	ENTITY
,	
or	
excessive	ENTITY
napping	ENTITY
that	
is	
attributable	
to	
sedating	ENTITY
medications	ENTITY
,	
alcohol	ENTITY
,	
or	
drugs	ENTITY
of	
abuse	ENTITY
.	

This	
diagnosis	ENTITY
also	
includes	
hypersomnolence	ENTITY
associated	ENTITY
with	ENTITY
withdrawal	ENTITY
from	
amphetamines	ENTITY
and	
other	
drugs	ENTITY
.	

If	
narcolepsy	ENTITY
or	
hypersomnolence	ENTITY
existed	
prior	
to	
stimulant	ENTITY
abuse	ENTITY
,	
the	
diagnosis	ENTITY
of	
hypersomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
should	
not	
be	
used	
.	

Associated	ENTITY
Features	ENTITY
Associated	
features	
reflect	
those	
of	
the	
medications	ENTITY
or	
substances	ENTITY
responsible	
.	

Clinical	ENTITY
and	
Pathological	ENTITY
Subtypes	ENTITY
Hypersomnia	ENTITY
due	
to	
sedating	ENTITY
medications	ENTITY
:	
Sedation	ENTITY
is	
a	
common	
side	ENTITY
effect	ENTITY
of	
many	
prescription	ENTITY
medications	ENTITY
including	
benzodiazepines	ENTITY
,	
nonbenzodiazepine	ENTITY
hypnot-	
ics	ENTITY
,	
opioids	ENTITY
,	
barbiturates	ENTITY
,	
anticonvulsants	ENTITY
,	
antipsychotics	ENTITY
,	
anticholinergics	ENTITY
,	
and	
some	
antidepressants	ENTITY
and	
antihistamines	ENTITY
.	

Sleepiness	ENTITY
also	
can	
occur	
with	
some	
dopamine	ENTITY
agonists	ENTITY
such	
as	
pramipexole	ENTITY
or	
ropinirole	ENTITY
,	
and	
with	
many	
antiseizure	ENTITY
medications	ENTITY
.	

Though	
less	
common	
,	
sleepiness	ENTITY
can	
also	
occur	
with	
nonsteroidal	ENTITY
anti	ENTITY
-	
inflammatory	ENTITY
drugs	ENTITY
,	
some	
antibiotics	ENTITY
,	
antispasmodics	ENTITY
,	
antiarryhthmics	ENTITY
,	
and	
beta	ENTITY
-	
blockers	ENTITY
.	

Over	ENTITY
-	
the-	
counter	
medications	ENTITY
,	
such	
as	
valerian	ENTITY
and	
melatonin	ENTITY
,	
can	
produce	
sedation	ENTITY
.	

Excessive	ENTITY
sleepiness	ENTITY
is	
especially	
common	
when	
these	
drugs	ENTITY
are	
used	
in	
elderly	ENTITY
patients	ENTITY
or	
those	
with	
multiple	ENTITY
medical	
conditions	
,	
or	
in	
combination	ENTITY
.	

Some	
tolerance	ENTITY
to	
the	
sedative	ENTITY
effects	ENTITY
can	
occur	
with	
time	ENTITY
.	

Hypersomnia	ENTITY
due	
to	
substance	ENTITY
abuse	ENTITY
:	
Daytime	ENTITY
sleepiness	ENTITY
can	
occur	
with	
abuse	ENTITY
of	ENTITY
alcohol	ENTITY
,	
benzodiazepines	ENTITY
,	
barbiturates	ENTITY
,	
gamma	ENTITY
hydroxybutyrate	ENTITY
,	
opiates	ENTITY
,	
and	
marijuana	ENTITY
.	

Hypersomnia	ENTITY
due	
to	
stimulant	ENTITY
withdrawal	ENTITY
:	
Daytime	ENTITY
sleepiness	ENTITY
is	
common	
with	
abrupt	
discontinuation	ENTITY
of	
stimulants	ENTITY
.	

In	
chronically	ENTITY
heavy	ENTITY
amphetamine	
users	
,	
sleepiness	ENTITY
is	
most	
severe	ENTITY
in	
the	
first	
week	ENTITY
of	
withdrawal	ENTITY
and	
can	
persist	
for	
up	
to	
three	
weeks	ENTITY
;	
indi-	
viduals	ENTITY
may	
have	
an	
increase	ENTITY
in	
total	ENTITY
sleep	ENTITY
and	
daytime	ENTITY
napping	ENTITY
,	
but	
sleep	ENTITY
may	
seem	
fragmented	
and	
nonrestorative	ENTITY
.	

Significant	ENTITY
depression	ENTITY
often	
accompanies	
the	
hyper-	ENTITY
somnolence	ENTITY
.	

Infrequently	ENTITY
,	
sleepiness	ENTITY
may	
be	
a	
residual	ENTITY
complaint	ENTITY
in	
those	
who	
have	
used	
stimulants	ENTITY
in	
the	
past	
but	
have	
been	
abstinent	ENTITY
for	
many	
years	ENTITY
.	

In	
people	ENTITY
who	
regularly	ENTITY
consume	ENTITY
coffee	ENTITY
or	
other	
sources	ENTITY
of	
caffeine	ENTITY
,	
discontinuation	ENTITY
can	
produce	
sleepiness	ENTITY
,	
fatigue	ENTITY
,	
and	
inattentiveness	ENTITY
for	
two	
to	
nine	
days	ENTITY
.	

Demographics	ENTITY
Patients	ENTITY
of	
any	
age	ENTITY
can	
experience	ENTITY
sleepiness	ENTITY
from	
sedating	ENTITY
medications	ENTITY
.	

Stimulant	ENTITY
abuse	ENTITY
and	
the	
consequent	ENTITY
sleepiness	ENTITY
during	
withdrawal	ENTITY
are	
most	
common	
in	
adoles-	
cents	ENTITY
and	
young	ENTITY
adults	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Sleepiness	ENTITY
from	
sedating	ENTITY
medications	ENTITY
may	
be	
more	
common	
in	
older	ENTITY
patients	ENTITY
and	
in	
those	
with	
multiple	ENTITY
medical	ENTITY
problems	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
,	
course	ENTITY
,	
and	
complications	ENTITY
reflect	
those	
of	
the	
medications	ENTITY
or	
substances	ENTITY
responsible	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Not	
applicable	
or	
known	
.	

Objective	ENTITY
Findings	ENTITY
Polysomnography	ENTITY
is	
generally	
unnecessary	
unless	
a	
concomitant	ENTITY
sleep	ENTITY
disorder	ENTITY
is	
sus-	ENTITY
pected	ENTITY
.	

Polysomnography	ENTITY
and	
MSLT	ENTITY
results	ENTITY
vary	
depending	
on	
the	
specific	
substance	ENTITY
in	
question	ENTITY
and	
the	
timing	ENTITY
of	
the	
most	
recent	
intake	ENTITY
.	

With	
stimulant	ENTITY
withdrawal	ENTITY
,	
noc-	
turnal	ENTITY
polysomnography	ENTITY
may	
show	
normal	ENTITY
sleep	ENTITY
,	
whereas	
the	
MSLT	ENTITY
typically	
demon-	
strates	ENTITY
a	
short	ENTITY
mean	ENTITY
sleep	ENTITY
latency	ENTITY
with	
or	
without	
multiple	
SOREMPs	ENTITY
.	

A	
urine	ENTITY
tox-	
icology	
screen	ENTITY
may	
be	
positive	ENTITY
for	
the	
suspected	ENTITY
substance	ENTITY
.	

The	
diagnosis	ENTITY
is	
often	
confirmed	
if	
symptoms	ENTITY
resolve	
after	
the	
causal	ENTITY
agent	ENTITY
is	
removed	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Major	
sleep	ENTITY
disorders	ENTITY
that	
are	
associated	ENTITY
with	ENTITY
excessive	ENTITY
sleepiness	ENTITY
,	
especially	
SRBDs	ENTITY
,	
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
,	
narcolepsy	ENTITY
,	
IH	ENTITY
,	
and	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
should	
be	
ruled	
out	
.	

A	
urine	ENTITY
drug	ENTITY
screen	ENTITY
should	
routinely	
accompany	
an	
MSLT	ENTITY
as	
the	
use	
of	
or	
withdrawal	ENTITY
from	
some	
medications	ENTITY
or	
substances	ENTITY
may	
affect	
MSLT	ENTITY
test	ENTITY
results	ENTITY
.	

Although	
many	
psychotropic	ENTITY
medications	ENTITY
may	
result	
in	
daytime	ENTITY
sleepiness	ENTITY
,	
it	
is	
import-	
ant	ENTITY
for	
clinicians	ENTITY
to	
recognize	
that	
many	
psychiatric	ENTITY
disorders	ENTITY
also	
are	
associated	ENTITY
with	ENTITY
increased	ENTITY
prevalence	ENTITY
of	
other	
sleep	ENTITY
disorders	ENTITY
(	
e.g.	
,	
insomnia	ENTITY
,	
SRBD	ENTITY
,	
circadian	ENTITY
disor-	
ders	ENTITY
,	
and	
movement	ENTITY
disorders	ENTITY
)	
.	

Although	
sedative	ENTITY
effects	ENTITY
of	
the	
psychotropic	ENTITY
agents	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
may	
contribute	
to	
sleepiness	ENTITY
,	
clinicians	ENTITY
must	
maintain	
a	
high	ENTITY
index	ENTITY
of	
suspicion	ENTITY
for	
other	
sleep	ENTITY
related	
etiologies	ENTITY
.	

When	
other	
sleep	ENTITY
disorders	ENTITY
are	
identified	ENTITY
,	
multiple	
diag-	
noses	ENTITY
may	
be	
appropriate	
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY
Sedatives	ENTITY
can	
worsen	ENTITY
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
,	
and	
more	
research	ENTITY
is	
needed	
to	
understand	
and	
manage	
this	
interaction	ENTITY
.	

Bibliography	ENTITY
Ancoli	ENTITY
-	
Israel	ENTITY
S.	ENTITY
Sleep	ENTITY
and	
its	
disorders	ENTITY
in	
aging	ENTITY
populations	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2009;10	ENTITY
Suppl	ENTITY
1	ENTITY
:	
S7–11	ENTITY
.	

España	
RA	ENTITY
,	
Scammell	ENTITY
TE	ENTITY
.	

Sleep	ENTITY
neurobiology	ENTITY
from	
a	
clinical	ENTITY
perspective	ENTITY
.	

Sleep	ENTITY
2011;34:845–58	
.	

Gillin	ENTITY
JC	ENTITY
,	
Smith	ENTITY
TL	ENTITY
,	
Irwin	ENTITY
M	ENTITY
,	
Butters	ENTITY
N	ENTITY
,	
Demodena	ENTITY
A	ENTITY
,	
Schuckit	ENTITY
M.	ENTITY
Increased	ENTITY
pressure	ENTITY
for	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
sleep	
at	
time	
of	
hospital	ENTITY
admission	ENTITY
predicts	
relapse	ENTITY
in	
nondepressed	ENTITY
patients	ENTITY
with	
primary	ENTITY
alcoholism	ENTITY
at	
3	
-	
month	ENTITY
follow	ENTITY
-	
up	
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
1994;51:189–97	ENTITY
.	

Guilleminault	ENTITY
C	ENTITY
,	
Brooks	ENTITY
SN	ENTITY
.	

Excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
:	
a	
challenge	
for	
the	
practicing	ENTITY
neurologist	ENTITY
.	

Brain	ENTITY
2001;124:1482–91	
.	

Juliano	ENTITY
LM	ENTITY
,	
Griffiths	ENTITY
RR	ENTITY
.	

A	
critical	
review	
of	
caffeine	ENTITY
withdrawal	ENTITY
:	
empirical	ENTITY
validation	ENTITY
of	
symptoms	ENTITY
and	
signs	ENTITY
,	
incidence	ENTITY
,	
severity	ENTITY
,	
and	
associated	
features	ENTITY
.	

Psychopharmacology	ENTITY
(	
Berl	
)	
2004	
;	
176:1–29	
.	

McGregor	ENTITY
C	ENTITY
,	
Srisurapanont	ENTITY
M	ENTITY
,	
Jittiwutikarn	ENTITY
J	ENTITY
,	
Laobhripatr	ENTITY
S	ENTITY
,	
Wongtan	ENTITY
T	ENTITY
,	
White	ENTITY
JM	ENTITY
.	

The	
nature	ENTITY
,	
time	ENTITY
course	ENTITY
and	
severity	ENTITY
of	
methamphetamine	ENTITY
withdrawal	ENTITY
.	

Addiction	ENTITY
2005;100:1320–9	
.	

Mogri	ENTITY
M	ENTITY
,	
Desai	ENTITY
H	ENTITY
,	
Webster	ENTITY
L	ENTITY
,	ENTITY
Grant	ENTITY
BJ	ENTITY
,	ENTITY
Mador	ENTITY
MJ	ENTITY
.	

Hypoxemia	ENTITY
in	
patients	ENTITY
on	
chronic	ENTITY
opiate	ENTITY
therapy	ENTITY
with	
and	
without	
sleep	ENTITY
apnea	ENTITY
.	

Sleep	ENTITY
Breath	ENTITY
2009;13:49–57	
.	

Punjabi	ENTITY
NM	ENTITY
.	

The	
epidemiology	ENTITY
of	
adult	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

Proc	ENTITY
Am	ENTITY
Thorac	ENTITY
Soc	ENTITY
2008;5:136–43	ENTITY
.	

Qureshi	ENTITY
A	ENTITY
,	
Lee	
-	
Chiong	ENTITY
T.	ENTITY
Medications	ENTITY
and	
their	
effects	ENTITY
on	
sleep	ENTITY
.	

Med	ENTITY
Clin	ENTITY
North	ENTITY
Am	ENTITY
2004;88:751–66	ENTITY
.	

Roehrs	ENTITY
T	ENTITY
,	
Roth	
T.	ENTITY
Sleep	ENTITY
,	
sleepiness	ENTITY
,	
and	
alcohol	ENTITY
use	ENTITY
.	

Alcohol	ENTITY
Res	ENTITY
Health	ENTITY
2001;25:101–9	ENTITY
.	

Roehrs	ENTITY
T	ENTITY
,	
Bonahoom	ENTITY
A	ENTITY
,	
Pedrosi	ENTITY
B	ENTITY
,	
Zorick	ENTITY
F	ENTITY
,	
Roth	
T.	
Nighttime	
versus	
daytime	ENTITY
hypnotic	ENTITY
self-	ENTITY
administration	ENTITY
.	

Psychopharmacology	ENTITY
2002;161:137–42	
.	

Schweitzer	ENTITY
P.	ENTITY
Drugs	ENTITY
that	
disturb	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

St	ENTITY
Louis	ENTITY
:	
Elsevier	ENTITY
Saunders	ENTITY
,	
2011:542–60	
.	

William	ENTITY
Ishak	ENTITY
W	ENTITY
,	
Ugochukwu	ENTITY
C	ENTITY
,	
Bagot	ENTITY
K	ENTITY
,	
Khalili	ENTITY
D	ENTITY
,	
Zaky	ENTITY
C.	ENTITY
Energy	ENTITY
drinks	
:	
psychological	ENTITY
effects	ENTITY
and	
impact	ENTITY
on	
well	ENTITY
-	ENTITY
being	ENTITY
and	
quality	ENTITY
of	ENTITY
life	ENTITY
-	
a	
literature	ENTITY
review	ENTITY
.	

Innov	ENTITY
Clin	
Neurosci	
2012;9:25–34	
.	

Hypersomnia	ENTITY
Associated	ENTITY
with	ENTITY
a	
Psychiatric	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.15	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F51.13	ENTITY
Alternate	ENTITY
Names	ENTITY
Hypersomnia	ENTITY
not	
due	
to	
substance	ENTITY
or	
known	
physiological	ENTITY
condition	ENTITY
,	
nonorganic	ENTITY
hypersomnia	ENTITY
,	
pseudohypersomnia	ENTITY
,	
or	
pseudonarcolepsy	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
occurring	
for	
at	
least	
three	
months	ENTITY
.	

B.	ENTITY
The	
daytime	ENTITY
sleepiness	ENTITY
occurs	
in	
association	ENTITY
with	
a	
concurrent	ENTITY
psychiatric	ENTITY
disorder	ENTITY
.	

C.	

The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
untreated	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
a	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
the	
effects	ENTITY
of	ENTITY
medications	ENTITY
or	
drugs	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Patients	ENTITY
with	
hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
psychiatric	ENTITY
disorder	ENTITY
may	
report	
excessive	
nocturnal	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
sleepiness	ENTITY
,	
or	
excessive	ENTITY
napping	ENTITY
.	

In	
addition	
,	
they	
often	
feel	
their	
sleep	ENTITY
is	
of	
poor	ENTITY
quality	ENTITY
and	
nonrestorative	ENTITY
.	

Patients	ENTITY
are	
often	
intensely	
focused	
on	
their	
hypersomnolence	ENTITY
,	
and	
psychiatric	ENTITY
symptoms	ENTITY
may	
become	
apparent	ENTITY
only	
after	
prolonged	ENTITY
interviews	ENTITY
or	
psychometric	ENTITY
testing	ENTITY
.	

Associated	ENTITY
psychiatric	ENTITY
conditions	ENTITY
include	
mood	ENTITY
disorders	ENTITY
,	
conversion	ENTITY
or	
undifferentiated	ENTITY
somatoform	ENTITY
disorder	ENTITY
,	
and	
less	
frequently	
other	
mental	ENTITY
disorders	ENTITY
such	
as	
schizoaffective	ENTITY
disorder	ENTITY
,	
adjustment	ENTITY
disor-	ENTITY
der	ENTITY
,	
or	
personality	ENTITY
disorders	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Poor	
work	ENTITY
attendance	ENTITY
,	
spending	
full	
days	ENTITY
in	
bed	
several	
times	
a	
week	ENTITY
,	
or	
abruptly	
leaving	
work	
because	
of	
a	
perceived	ENTITY
need	
to	
sleep	ENTITY
are	
common	
symptoms	ENTITY
.	

Patients	ENTITY
may	
also	
have	
social	ENTITY
withdrawal	ENTITY
,	
apathy	ENTITY
,	
and	
feelings	ENTITY
of	
low	ENTITY
energy	ENTITY
.	

Clinical	ENTITY
and	
Pathological	ENTITY
Subtypes	ENTITY
Hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
mood	ENTITY
disorder	ENTITY
:	

Hypersomnolence	ENTITY
in	
the	
context	ENTITY
of	
depression	ENTITY
is	
a	
frequent	ENTITY
feature	
of	
atypical	ENTITY
depression	ENTITY
and	
bipolar	ENTITY
II	ENTITY
disorder	ENTITY
(	
recur-	
rent	
major	
depressive	ENTITY
episodes	ENTITY
with	
hypomanic	ENTITY
episodes	ENTITY
)	
.	

In	
seasonal	ENTITY
affective	ENTITY
disor-	ENTITY
der	ENTITY
,	
daytime	ENTITY
fatigue	ENTITY
,	
loss	ENTITY
of	ENTITY
concentration	ENTITY
,	
increased	ENTITY
appetite	ENTITY
for	
carbohydrates	ENTITY
,	
and	
weight	ENTITY
gain	ENTITY
are	
reported	
.	

MSLT	ENTITY
results	ENTITY
are	
usually	
normal	ENTITY
,	
but	
long	ENTITY
hours	ENTITY
spent	
in	
bed	ENTITY
are	
reported	
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
conversion	ENTITY
disorder	ENTITY
or	
somatic	ENTITY
symptom	ENTITY
disorder	ENTITY
:	
Pseudohypersomnia	ENTITY
or	
pseudonarcolepsy	ENTITY
,	
sometimes	
with	
pseudocataplexy	ENTITY
,	
has	
been	
described	
.	

Demographics	ENTITY
Hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
psychiatric	ENTITY
disorder	ENTITY
accounts	
for	
5	
%	
to	
7	
%	
of	
hyper-	
somnolence	ENTITY
cases	ENTITY
.	

Women	ENTITY
are	
more	
susceptible	ENTITY
than	
men	ENTITY
,	
and	
the	
typical	
age	ENTITY
range	
is	
between	
20	
and	
50	
years	ENTITY
.	

In	
patients	ENTITY
with	
major	ENTITY
depression	ENTITY
,	
the	
prevalence	ENTITY
of	
hypersom-	
nolence	ENTITY
ranges	ENTITY
from	
5	
%	
to	
over	
50	
%	
depending	
on	
how	
hypersomnolence	ENTITY
is	
defined	
.	

Hypersomnolence	ENTITY
affects	
over	
50	
%	
of	
patients	ENTITY
with	
seasonal	ENTITY
affective	ENTITY
disorder	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Not	
applicable	
or	
known	
.	

Familial	ENTITY
Patterns	ENTITY
Not	
known	
,	
except	
for	
the	
familial	ENTITY
patterns	ENTITY
of	
certain	
psychiatric	ENTITY
disorders	ENTITY
(	
e.g.	
,	
bipolar	ENTITY
II	ENTITY
disorder	ENTITY
)	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
mean	
age	ENTITY
of	
onset	ENTITY
is	
usually	
in	
the	
third	
decade	
in	
both	
sexes	ENTITY
.	

With	
major	
depres-	
sion	ENTITY
,	
hypersomnolence	ENTITY
may	
persist	
even	
after	
the	
depressive	ENTITY
episode	ENTITY
improves	ENTITY
,	
and	
persistent	ENTITY
hypersomnolence	ENTITY
is	
associated	ENTITY
with	ENTITY
increased	ENTITY
risk	ENTITY
of	
recurrent	ENTITY
depression	ENTITY
.	

Complications	ENTITY
are	
mostly	
social	ENTITY
and	
occupational	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Hypersomnolence	ENTITY
occurs	
in	
10	
%	
to	
20	
%	
of	
children	ENTITY
with	
major	
depression	ENTITY
,	
some-	
times	
in	
combination	ENTITY
with	
insomnia	ENTITY
,	
but	
sleep	ENTITY
quality	ENTITY
appears	
normal	
.	

Although	
sleep	ENTITY
problems	ENTITY
may	
develop	
at	
any	
stage	ENTITY
of	
depression	ENTITY
,	
they	
are	
most	
pronounced	
during	
the	
acute	ENTITY
phase	ENTITY
.	

Children	ENTITY
and	
adolescents	ENTITY
with	
depression	ENTITY
who	
manifest	ENTITY
either	
insomnia	ENTITY
or	
hypersomnolence	ENTITY
generally	
manifest	ENTITY
more	
pronounced	
symptoms	ENTITY
,	
such	
as	
anhedo-	
nia	ENTITY
and	
weight	ENTITY
loss	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
underlying	
cause	ENTITY
is	
unknown	
.	

Although	
patients	ENTITY
with	
this	
disorder	ENTITY
report	ENTITY
sleep-	
iness	
,	
sleep	ENTITY
studies	ENTITY
reveal	
little	
or	
no	
evidence	ENTITY
of	
increased	ENTITY
propensity	
to	
sleep	ENTITY
.	

In	
some	
patients	ENTITY
,	
fragmented	
nighttime	ENTITY
sleep	ENTITY
may	
contribute	
to	
their	
daytime	ENTITY
sleepiness	ENTITY
.	

Because	
of	
uncertainty	ENTITY
about	
the	
nature	ENTITY
of	
the	
relationship	ENTITY
,	
the	
term	ENTITY
“	
hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
a	
psychiatric	ENTITY
disorder	ENTITY
”	
is	
preferred	
to	
“	
hypersomnia	ENTITY
due	
to	
a	
psychi-	
atric	ENTITY
disorder	ENTITY
.	
”	

Objective	ENTITY
Findings	ENTITY
Nocturnal	ENTITY
polysomnography	ENTITY
typically	
shows	
a	
prolonged	ENTITY
total	ENTITY
time	ENTITY
in	
bed	ENTITY
with	ENTITY
frag-	
mented	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
latency	ENTITY
is	
prolonged	ENTITY
,	
wake	ENTITY
time	ENTITY
after	
sleep	ENTITY
onset	ENTITY
is	
increased	ENTITY
,	
awakenings	ENTITY
may	
be	
frequent	ENTITY
and	
prolonged	ENTITY
,	
and	
sleep	ENTITY
efficiency	ENTITY
is	
low	ENTITY
.	

REM	ENTITY
sleep	ENTITY
latency	ENTITY
may	
be	
shortened	ENTITY
in	
the	
case	ENTITY
of	
untreated	ENTITY
depression	ENTITY
.	

Sleep	ENTITY
latencies	ENTITY
on	
the	
MSLT	ENTITY
are	
often	
within	
normal	ENTITY
limits	ENTITY
,	
a	
result	
contrasting	
with	
the	
subjective	ENTITY
complaint	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
and	
an	
elevated	ENTITY
score	ENTITY
on	
the	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
.	

24	
-	
hour	ENTITY
continuous	ENTITY
sleep	ENTITY
-	
recording	ENTITY
studies	ENTITY
typically	
show	
considerable	
time	
spent	
in	
bed	ENTITY
during	
day	ENTITY
and	
night	ENTITY
,	
a	
behavior	ENTITY
sometime	
referred	
to	
as	
clinophilia	ENTITY
.	

Psychiatric	ENTITY
inter-	
views	ENTITY
and	
evaluations	ENTITY
are	
essential	ENTITY
to	
diagnose	ENTITY
the	
underlying	
psychiatric	ENTITY
condition	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
As	
there	
are	
no	
definitive	
tests	
for	
diagnosing	ENTITY
hypersomnolence	ENTITY
associated	ENTITY
with	ENTITY
a	
psy-	ENTITY
chiatric	ENTITY
disorder	ENTITY
,	
it	
is	
essential	
to	
rule	
out	
other	
common	
causes	
of	
sleepiness	ENTITY
such	
as	
insufficient	ENTITY
sleep	ENTITY
,	
sedation	ENTITY
from	
medications	ENTITY
or	
substances	ENTITY
,	
SRBD	ENTITY
,	
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
,	
and	
IH	ENTITY
.	

Chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
is	
characterized	
by	
persistent	ENTITY
or	
relapsing	ENTITY
fatigue	ENTITY
that	
does	
not	
resolve	
with	
sleep	ENTITY
or	
rest	ENTITY
,	
but	
the	
main	
complaint	ENTITY
is	
usually	
fatigue	ENTITY
rather	
than	
sleepiness	ENTITY
.	

Insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
is	
associated	ENTITY
with	ENTITY
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
impaired	ENTITY
concentration	ENTITY
,	
and	
lowered	ENTITY
energy	ENTITY
level	ENTITY
,	
but	
a	
detailed	
history	ENTITY
of	
the	
subject	ENTITY
’s	
current	
sleep	ENTITY
schedule	ENTITY
reveals	
chronic	ENTITY
sleep	ENTITY
deprivation	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

The	
lack	ENTITY
of	
concordance	
between	
subjective	ENTITY
and	
objective	
findings	ENTITY
raises	
multiple	
issues	ENTITY
.	

It	
is	
unclear	
to	
what	
extent	
these	
patients	ENTITY
are	
objectively	ENTITY
sleepy	ENTITY
or	
,	
instead	
,	
suffer	
from	
decreased	ENTITY
energy	ENTITY
and	
lack	ENTITY
of	
interest	
that	
confines	
them	
to	
bed	ENTITY
.	

More	
research	ENTITY
is	
needed	
to	
create	
an	
effective	ENTITY
definition	ENTITY
of	
hypersomnolence	ENTITY
in	
this	
population	ENTITY
and	
to	
develop	
tools	ENTITY
for	
measuring	ENTITY
it	
.	

Finally	
,	
future	
efforts	
should	
define	
the	
mechanism	ENTITY
through	
which	
some	
patients	ENTITY
express	ENTITY
their	
psychiatric	ENTITY
symptoms	ENTITY
as	
excessive	ENTITY
sleepiness	ENTITY
.	

Bibliography	ENTITY
Guilleminault	ENTITY
C	ENTITY
,	
Brooks	ENTITY
SN	ENTITY
.	

Excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
:	
a	
challenge	
for	
the	
practicing	ENTITY
neurologist	ENTITY
.	

Brain	ENTITY
2001;124:1282–91	
.	

Kaplan	ENTITY
KA	ENTITY
,	
Harvey	ENTITY
AG	ENTITY
.	

Hypersomnia	ENTITY
across	
mood	ENTITY
disorders	ENTITY
:	
a	
review	ENTITY
and	
synthesis	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2009;13:275–85	
.	

Kotagal	ENTITY
S.	ENTITY
Hypersomnia	ENTITY
in	
children	ENTITY
:	
interface	
with	
psychiatric	ENTITY
disorders	ENTITY
.	

Child	ENTITY
Adolesc	
Psychiatr	
Clin	
N	
Am	
2009;18:967–77	
.	

Liu	ENTITY
X	ENTITY
,	
Buysse	ENTITY
DJ	ENTITY
,	
Gentzler	ENTITY
AL	ENTITY
,	
et	
al	
.	

Insomnia	ENTITY
and	
hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
depressive	ENTITY
phenomenology	ENTITY
and	
comorbidity	ENTITY
in	
childhood	ENTITY
depression	ENTITY
.	

Sleep	ENTITY
2007;30:83–90	
.	

Nofzinger	ENTITY
EA	ENTITY
,	
Thase	ENTITY
ME	ENTITY
,	
Reynolds	ENTITY
CF	ENTITY
3rd	ENTITY
,	ENTITY
et	
al	
.	

Hypersomnia	ENTITY
in	
bipolar	ENTITY
depression	ENTITY
:	
a	
comparison	ENTITY
with	
narcolepsy	ENTITY
using	
the	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
.	

Am	ENTITY
J	ENTITY
Psychiatry	ENTITY
1991;148:1177–81	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Partonen	ENTITY
T	ENTITY
,	
Lönnqvist	
J.	
Seasonal	ENTITY
affective	ENTITY
disorder	ENTITY
.	

Lancet	ENTITY
1998;352:1369–74	ENTITY
.	

van	
den	
Berg	
JF	ENTITY
,	
Luijendijk	
HJ	
,	
Tulen	ENTITY
JH	ENTITY
,	
Hofman	ENTITY
A	ENTITY
,	
Neven	
AK	
,	
Tiemeier	
H.	
Sleep	
in	
depression	ENTITY
and	
anxiety	ENTITY
disorders	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
study	ENTITY
of	
elderly	ENTITY
persons	ENTITY
.	

J	
Clin	
Psychiatry	
2009;70:1105–13	
.	

Vgontzas	ENTITY
AN	ENTITY
,	
Bixler	ENTITY
EO	ENTITY
,	
Kales	ENTITY
A	ENTITY
,	
Criley	ENTITY
C	ENTITY
,	
Vela	ENTITY
-	
Bueno	
A.	
Differences	ENTITY
in	
nocturnal	ENTITY
and	
daytime	ENTITY
sleep	ENTITY
between	
primary	ENTITY
and	
psychiatric	ENTITY
hypersomnia	ENTITY
:	
diagnosis	ENTITY
and	
treatment	ENTITY
implications	
.	

Psychosom	ENTITY
Med	ENTITY
2000;62:220–6	ENTITY
.	

Insufficient	ENTITY
Sleep	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.44	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

F51.12	ENTITY
Alternate	ENTITY
Names	ENTITY
Behaviorally	ENTITY
induced	ENTITY
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
,	
insufficient	ENTITY
nocturnal	ENTITY
sleep	ENTITY
,	
chronic	ENTITY
sleep	ENTITY
deprivation	ENTITY
,	
sleep	ENTITY
restriction	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
F	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
has	
daily	ENTITY
periods	
of	
irrepressible	ENTITY
need	
to	
sleep	ENTITY
or	
daytime	ENTITY
lapses	ENTITY
into	
sleep	ENTITY
or	
,	
in	
the	
case	ENTITY
of	
prepubertal	ENTITY
children	ENTITY
,	
there	
is	
a	
complaint	ENTITY
of	
behavioral	ENTITY
abnormalities	ENTITY
attributable	
to	
sleepiness	ENTITY
.	

B.	ENTITY
The	
patient	ENTITY
’s	ENTITY
sleep	ENTITY
time	ENTITY
,	
established	
by	
personal	ENTITY
or	
collateral	ENTITY
history	ENTITY
,	
sleep	ENTITY
logs	ENTITY
,	
or	
actigraphy1	ENTITY
is	
usually	
shorter	ENTITY
than	
expected	
for	
age.2	ENTITY
C.	

The	
curtailed	ENTITY
sleep	ENTITY
pattern	ENTITY
is	
present	
most	
days	ENTITY
for	
at	
least	
three	
months	ENTITY
.	

D.	

The	
patient	ENTITY
curtails	
sleep	ENTITY
time	ENTITY
by	
such	
measures	ENTITY
as	
an	
alarm	ENTITY
clock	ENTITY
or	
being	
awakened	
by	
another	
person	ENTITY
and	
generally	
sleeps	ENTITY
longer	ENTITY
when	
such	
measures	ENTITY
are	
not	
used	
,	
such	
as	
on	
weekends	ENTITY
or	
vacations	ENTITY
.	

E.	ENTITY
Extension	ENTITY
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
results	ENTITY
in	
resolution	ENTITY
of	
the	
symptoms	ENTITY
of	
sleepiness	ENTITY
.	

F.	

The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
untreated	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
the	
effects	ENTITY
of	ENTITY
medications	ENTITY
or	
drugs	ENTITY
,	
or	
other	
medical	ENTITY
,	
neurologic	ENTITY
,	
or	
mental	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

If	
there	
is	
doubt	
about	
the	
accuracy	ENTITY
of	
personal	ENTITY
history	ENTITY
or	
sleep	ENTITY
logs	ENTITY
,	
then	
actigraphy	ENTITY
should	
be	
performed	
,	
preferably	
for	
at	
least	
two	
weeks	ENTITY
.	
.	

In	
the	
case	ENTITY
of	
long	ENTITY
sleepers	ENTITY
,	
reported	
habitual	ENTITY
sleep	
periods	ENTITY
may	
be	
normal	
based	
on	
age	ENTITY
.	

However	
,	
these	
sleep	ENTITY
periods	ENTITY
may	
be	
insufficient	ENTITY
for	
these	
patients	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Insufficient	
sleep	ENTITY
syndrome	ENTITY
occurs	
when	
an	
individual	ENTITY
persistently	ENTITY
fails	
to	
obtain	
the	
amount	ENTITY
of	
sleep	ENTITY
required	
to	
maintain	
normal	
levels	ENTITY
of	
alertness	ENTITY
and	
wakefulness	ENTITY
.	

The	
individual	ENTITY
is	
chronically	ENTITY
sleep	ENTITY
deprived	
as	
a	
result	
of	
failure	ENTITY
to	
achieve	
necessary	
sleep	ENTITY
time	ENTITY
due	
to	
reduced	ENTITY
time	ENTITY
in	
bed	ENTITY
.	

There	
is	
a	
U	ENTITY
-	
shaped	ENTITY
relationship	ENTITY
between	
age	ENTITY
and	
average	ENTITY
sleep	ENTITY
time	ENTITY
,	
with	
the	
minimum	ENTITY
in	
middle	ENTITY
-	
aged	ENTITY
individuals	ENTITY
.	

Examination	ENTITY
reveals	
unimpaired	
or	
above	
-	
average	ENTITY
ability	
to	
initiate	ENTITY
and	
maintain	
sleep	ENTITY
,	
with	
little	
or	
no	
psychopathology	ENTITY
.	

Physical	ENTITY
examination	ENTITY
reveals	
no	
medical	
explanation	
for	
the	
patient	ENTITY
’s	
sleepiness	ENTITY
.	

A	
detailed	
history	ENTITY
of	
the	
sleep	ENTITY
pattern	ENTITY
reveals	
a	
substantial	
dis-	
parity	ENTITY
between	
the	
need	
for	
sleep	ENTITY
and	
the	
amount	ENTITY
actually	
obtained	
.	

The	
significance	ENTITY
of	
this	
disparity	ENTITY
often	
goes	
unappreciated	
by	
the	
patient	ENTITY
.	

Sleep	ENTITY
time	ENTITY
that	
is	
markedly	
extended	
on	
weekend	ENTITY
nights	ENTITY
or	
during	
holidays	ENTITY
compared	
to	
weekday	ENTITY
nights	ENTITY
is	
also	
suggestive	
of	
this	
disorder	ENTITY
.	

A	
therapeutic	ENTITY
trial	ENTITY
of	
a	
longer	
major	
sleep	ENTITY
episode	ENTITY
can	
reverse	
the	
symptoms	ENTITY
.	

In	
individuals	ENTITY
with	
physiologic	ENTITY
sleep	ENTITY
requirements	ENTITY
significantly	
in	
excess	ENTITY
of	
seven	
to	
eight	
hours	ENTITY
,	
reported	
“	
average	ENTITY
”	
amounts	
of	
sleep	ENTITY
(	
e.g.	
,	
seven	
hours	ENTITY
/	
night	ENTITY
)	
may	
,	
in	
fact	
,	
be	
insufficient	ENTITY
.	

Additional	
symptoms	ENTITY
such	
as	
sleep	ENTITY
paralysis	ENTITY
and	
hypnagogic	ENTITY
hallucinations	ENTITY
may	
occur	
.	

Associated	ENTITY
Features	ENTITY
Depending	
upon	
chronicity	ENTITY
and	
extent	ENTITY
of	
sleep	ENTITY
loss	ENTITY
,	
individuals	ENTITY
with	
this	
condition	ENTITY
may	
show	
irritability	ENTITY
,	
concentration	ENTITY
and	
attention	ENTITY
deficits	ENTITY
,	
reduced	ENTITY
vigilance	ENTITY
,	
distract-	
ibility	ENTITY
,	
reduced	ENTITY
motivation	ENTITY
,	
anergia	ENTITY
,	
dysphoria	ENTITY
,	
fatigue	ENTITY
,	
restlessness	ENTITY
,	
uncoordination	ENTITY
,	
and	
malaise	ENTITY
.	

Secondary	ENTITY
symptoms	ENTITY
may	
become	
the	
main	
focus	
of	
the	
patient	ENTITY
,	
serving	
to	
obscure	ENTITY
the	
primary	
cause	
of	
the	
difficulties	ENTITY
.	

Psychologically	ENTITY
and	
somatically	ENTITY
normal	
individuals	ENTITY
who	
chronically	ENTITY
obtain	ENTITY
less	
sleep	ENTITY
than	
they	
physiologically	ENTITY
require	
typi-	
cally	
experience	
daytime	ENTITY
sleepiness	ENTITY
.	

Situational	ENTITY
factors	ENTITY
such	
as	
demands	ENTITY
of	
the	
family	ENTITY
and	
work	ENTITY
schedule	ENTITY
may	
,	
on	
occasion	ENTITY
,	
make	
it	
very	
difficult	
to	
obtain	
adequate	ENTITY
sleep	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiologic	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
Insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
affects	
all	
ages	ENTITY
and	
both	
sexes	ENTITY
.	

It	
may	
be	
more	
frequent	ENTITY
in	
adolescence	ENTITY
,	
when	
sleep	ENTITY
need	
is	
high	
,	
but	
social	ENTITY
pressure	ENTITY
and	
tendency	
to	
delay	ENTITY
sleep	ENTITY
often	
lead	
to	
chronic	ENTITY
restricted	ENTITY
sleep	ENTITY
.	

Cultural	ENTITY
factors	ENTITY
may	
also	
influence	ENTITY
sleep	ENTITY
dura-	
tion	ENTITY
,	
with	
students	ENTITY
from	
different	
countries	ENTITY
reporting	
sleep	ENTITY
time	ENTITY
varying	
between	
six	
and	
eight	
hours	
per	
night	ENTITY
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	
Hypersomnolence	ENTITY
Predisposing	ENTITY
and	

Precipitating	ENTITY
Factors	ENTITY
Social	ENTITY
and	
psychological	ENTITY
factors	ENTITY
may	
impact	ENTITY
nocturnal	ENTITY
sleep	ENTITY
length	
and	
daytime	ENTITY
sleep-	ENTITY
iness	ENTITY
.	

Cultural	ENTITY
habits	ENTITY
such	
as	
the	
siesta	ENTITY
may	
enhance	
evening	ENTITY
alertness	ENTITY
at	
the	
expense	
of	
reducing	ENTITY
nocturnal	ENTITY
sleep	ENTITY
efficiency	ENTITY
.	

Also	
,	
the	
evening	ENTITY
preference	ENTITY
chronotype	ENTITY
predis-	
poses	
to	
complaints	ENTITY
of	
insomnia	ENTITY
and	
insufficient	ENTITY
sleep	ENTITY
.	

The	
association	ENTITY
of	
eveningness	ENTITY
with	
insufficient	ENTITY
sleep	ENTITY
persists	
after	
controlling	ENTITY
for	
variables	ENTITY
such	
as	
sex	ENTITY
,	
age	ENTITY
,	
and	
sleep	ENTITY
duration	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
This	
condition	ENTITY
results	ENTITY
in	
increased	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
concentration	ENTITY
problems	ENTITY
,	
lowered	ENTITY
energy	ENTITY
level	ENTITY
,	
and	
malaise	ENTITY
.	

If	
unchecked	
,	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
may	
predispose	
to	
depression	ENTITY
and	
other	
psychological	ENTITY
difficulties	ENTITY
,	
as	
well	
as	
poor	
work	ENTITY
performance	ENTITY
and	
withdrawal	ENTITY
from	
family	ENTITY
and	
social	ENTITY
activities	ENTITY
.	

Abuse	ENTITY
of	ENTITY
stimulants	ENTITY
may	
also	
occur	
.	

Traffic	ENTITY
accidents	ENTITY
or	
injury	ENTITY
at	
work	
may	
result	
.	

Developmental	ENTITY
Issues	ENTITY
Insufficient	
sleep	
syndrome	
is	
a	
common	
problem	ENTITY
in	
adolescents	ENTITY
.	

It	
should	
be	
differ-	
entiated	
from	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
,	
the	
effects	ENTITY
of	ENTITY
recreational	ENTITY
drug	ENTITY
use	ENTITY
,	
and	
school	ENTITY
avoidance	ENTITY
behavior	ENTITY
.	

Increased	ENTITY
predisposition	ENTITY
to	
substance	ENTITY
use	ENTITY
and	
accidents	ENTITY
in	
teens	ENTITY
may	
be	
consequent	
to	
insufficient	ENTITY
sleep	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Symptoms	ENTITY
are	
due	
to	
normal	
physiological	ENTITY
and	
psychological	ENTITY
responses	ENTITY
to	
sleep	ENTITY
depri-	ENTITY
vation	ENTITY
.	

Sleep	ENTITY
restriction	ENTITY
studies	ENTITY
in	
normal	ENTITY
volunteers	ENTITY
have	
shown	
that	
even	
mild	ENTITY
sleep	ENTITY
restriction	ENTITY
(	
for	
example	
,	
six	
hours	
of	
nocturnal	ENTITY
sleep	ENTITY
per	
night	
)	
results	ENTITY
in	
a	
correspond-	
ing	
decrease	ENTITY
in	
performance	ENTITY
and	
increased	ENTITY
sleepiness	ENTITY
.	

Sleep	ENTITY
restriction	ENTITY
to	
four	
hours	
per	
night	ENTITY
(	
i.e.	
,	
extension	ENTITY
of	
wakefulness	ENTITY
to	
20	
hours	
per	
day	ENTITY
)	
will	
likely	
lead	
to	
greater	
buildup	ENTITY
of	
homeostatic	ENTITY
sleep	ENTITY
drive	
during	
the	
waking	ENTITY
hours	ENTITY
and	
greater	
likelihood	ENTITY
of	
impaired	ENTITY
performance	ENTITY
on	
a	
psychomotor	ENTITY
vigilance	ENTITY
task	ENTITY
.	

The	
effects	ENTITY
of	ENTITY
sleep	ENTITY
depriva-	ENTITY
tion	ENTITY
on	
neurobehavioral	ENTITY
performance	ENTITY
measures	ENTITY
may	
vary	
with	
the	
nature	ENTITY
of	
the	
task	ENTITY
being	
considered	
.	

In	
some	
long	ENTITY
sleepers	ENTITY
,	
it	
is	
important	
to	
be	
aware	
that	
extending	
sleep	ENTITY
to	
nine	
or	
more	
hours	
often	
results	ENTITY
in	
improved	ENTITY
performance	ENTITY
.	

The	
diagnosis	ENTITY
of	
insufficient	ENTITY
sleep	ENTITY
syn-	ENTITY
drome	ENTITY
may	
be	
especially	
difficult	
to	
make	
in	
subjects	ENTITY
who	
have	
a	
physiologic	ENTITY
need	
for	
unusually	
large	
amounts	
of	
sleep	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Actigraphy	ENTITY
combined	
with	
sleep	ENTITY
diaries	ENTITY
maintained	ENTITY
for	
a	
2-	
to	
3	
-	
week	ENTITY
period	ENTITY
may	
be	
helpful	
by	
documenting	
total	ENTITY
time	ENTITY
in	
bed	ENTITY
,	
sleep	ENTITY
latency	ENTITY
,	
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
and	
sleep	ENTITY
efficiency	ENTITY
.	

Polysomnography	ENTITY
and	
MSLT	ENTITY
are	
not	
required	
to	
establish	
a	
diagnosis	ENTITY
of	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
.	

Rather	
,	
sleep	ENTITY
time	ENTITY
is	
extended	
first	
,	
and	
the	
patient	ENTITY
is	
reevaluated	
.	

If	
a	
therapeutic	ENTITY
trial	ENTITY
with	
a	
longer	ENTITY
sleep	ENTITY
episode	ENTITY
eliminates	
the	
symptoms	ENTITY
,	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
is	
diagnosed	ENTITY
.	

Polysomnography	ENTITY
,	
when	
performed	
,	
reveals	
reduced	ENTITY
sleep	ENTITY
onset	ENTITY
latency	
,	
and	
high	ENTITY
(	
greater	
than	
90	
%	
)	
sleep	ENTITY
efficiency	ENTITY
.	

When	
extended	ENTITY
sleep	ENTITY
is	
permitted	
,	
prolonged	ENTITY
sleep	ENTITY
time	ENTITY
with	
slow	ENTITY
wave	ENTITY
rebound	ENTITY
may	
be	
seen	
.	

Noting	
a	
disparity	ENTITY
between	
reported	
sleep	ENTITY
at	
home	ENTITY
and	
observed	
total	ENTITY
sleep	ENTITY
time	ENTITY
in	
the	
sleep	ENTITY
laboratory	ENTITY
can	
be	
helpful	
.	

The	
MSLT	ENTITY
reveals	
excessive	ENTITY
sleepiness	ENTITY
,	
with	
stage	ENTITY
N1	ENTITY
sleep	ENTITY
occurring	
in	
most	
naps	ENTITY
,	
with	
short	ENTITY
sleep	ENTITY
latency	ENTITY
.	

Stage	ENTITY
N2	ENTITY
sleep	
occurs	
in	
more	
than	
80	
%	
of	
MSLT	ENTITY
naps	ENTITY
.	

SOREMPs	ENTITY
can	
occur	
.	

Differential	ENTITY
Diagnosis	ENTITY
Insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
may	
be	
confused	
with	
narcolepsy	ENTITY
or	
other	
hypersom-	
nolence	ENTITY
disorders	ENTITY
because	
an	
abnormal	ENTITY
MSLT	ENTITY
(	
even	
with	
two	
SOREMPs	ENTITY
)	
can	
be	
observed	
as	
the	
result	
of	
acute	ENTITY
or	
chronic	ENTITY
sleep	ENTITY
deprivation	ENTITY
.	

The	
confusion	ENTITY
may	
be	
most	
frequently	
encountered	
in	
adolescents	ENTITY
or	
young	ENTITY
adults	ENTITY
.	

The	
differential	
diagno-	
sis	ENTITY
of	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
includes	
numerous	
other	
conditions	ENTITY
that	
may	
result	
in	
daytime	ENTITY
sleepiness	ENTITY
or	
shortening	ENTITY
of	
nocturnal	ENTITY
sleep	ENTITY
duration	ENTITY
.	

These	
include	
other	
central	ENTITY
disorders	ENTITY
of	
hypersomnolence	ENTITY
,	
long	ENTITY
sleeper	ENTITY
or	
short	ENTITY
sleeper	ENTITY
,	
SRBD	ENTITY
,	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
disorders	ENTITY
,	
insomnia	ENTITY
disorder	ENTITY
,	
affective	ENTITY
disorder	ENTITY
,	
and	
periodic	ENTITY
limb	ENTITY
move-	
ment	ENTITY
disorder	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

The	
correlation	ENTITY
between	
subjectively	ENTITY
reported	ENTITY
sleepiness	ENTITY
,	
performance	ENTITY
-	
test	ENTITY
decre-	
ments	ENTITY
,	
and	
MSLT	ENTITY
-	
measured	ENTITY
sleepiness	ENTITY
after	
sleep	ENTITY
deprivation	ENTITY
is	
poor	ENTITY
.	

Short	ENTITY
sleepers	ENTITY
often	
have	
a	
higher	
NREM	ENTITY
sleep	ENTITY
pressure	ENTITY
,	
as	
measured	
by	
EEG	ENTITY
delta	
power	
,	
than	
long	ENTITY
sleepers	ENTITY
,	
even	
if	
they	
do	
not	
complain	
of	
daytime	ENTITY
sleepiness	ENTITY
.	

There	
is	
interindividual	ENTITY
susceptibility	ENTITY
to	
sleep	ENTITY
deprivation	ENTITY
,	
with	
some	
people	ENTITY
being	
consistently	
more	
tired	ENTITY
and	
experiencing	
greater	
performance	ENTITY
decrement	ENTITY
after	
even	
a	
mild	ENTITY
degree	ENTITY
of	
sleep	ENTITY
deprivation	ENTITY
.	

Bibliography	ENTITY
Carskadon	ENTITY
MA	ENTITY
,	
Dement	ENTITY
WC	ENTITY
.	

Effects	ENTITY
of	ENTITY
total	ENTITY
sleep	ENTITY
loss	ENTITY
on	
sleep	ENTITY
tendency	
.	

Percept	ENTITY
Mot	ENTITY
Skills	ENTITY
1979;48:495–506	
.	

Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Habeck	ENTITY
C	ENTITY
,	
Rakitin	ENTITY
BC	ENTITY
,	
Moeller	
J	
,	
et	
al	
.	

An	
event	ENTITY
related	
fMRI	ENTITY
study	ENTITY
of	
the	
neurobehavioral	ENTITY
impact	ENTITY
of	
sleep	ENTITY
deprivation	ENTITY
on	
performance	ENTITY
of	
a	
delayed	ENTITY
match	ENTITY
to	
sample	ENTITY
task	ENTITY
.	

Cogn	ENTITY
Brain	ENTITY
Res	ENTITY
2004;18:306–21	ENTITY
.	

Merikanto	ENTITY
I	ENTITY
,	
Kronholm	ENTITY
E	ENTITY
,	
Peltonen	ENTITY
M	ENTITY
,	
Laatikainen	ENTITY
T	ENTITY
,	
Lahti	ENTITY
T	ENTITY
,	
Partonen	ENTITY
T.	
Relation	ENTITY
of	
chronotype	ENTITY
to	
sleep	ENTITY
complaints	ENTITY
in	
the	
general	
Finnish	ENTITY
population	ENTITY
.	

Chronobiol	ENTITY
Int	ENTITY
2012;29:311–7	ENTITY
.	

Mont	ENTITY
TH	ENTITY
,	
Buysse	ENTITY
DJ	ENTITY
,	
Carrier	ENTITY
J	ENTITY
,	
Bart	ENTITY
BD	ENTITY
,	
Rose	ENTITY
LR	ENTITY
.	

Effects	ENTITY
of	ENTITY
afternoon	ENTITY
“	
siesta	ENTITY
”	
naps	
on	
sleep	ENTITY
,	
alertness	ENTITY
,	
performance	ENTITY
,	
and	
circadian	ENTITY
rhythms	ENTITY
in	
the	
elderly	ENTITY
.	

Sleep	ENTITY
2001;24:680–7	
.	

Mu	ENTITY
Q	ENTITY
,	
Mishory	ENTITY
A	ENTITY
,	
Johnson	ENTITY
KA	ENTITY
,	
et	
al	
.	

Decreased	ENTITY
brain	ENTITY
activation	ENTITY
during	
a	
working	ENTITY
memory	ENTITY
task	
at	
rested	
wakefulness	ENTITY
is	
associated	ENTITY
with	ENTITY
vulnerability	ENTITY
to	
sleep	ENTITY
deprivation	ENTITY
.	

Sleep	ENTITY
2005;28:433–46	
.	

Roehrs	ENTITY
T	ENTITY
,	
Zorick	ENTITY
F	ENTITY
,	
Sicklesteel	ENTITY
J	ENTITY
,	
Wittig	ENTITY
R	ENTITY
,	ENTITY
Roth	ENTITY
T.	ENTITY
Excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
associated	ENTITY
with	ENTITY
insufficient	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
1983;6:319–25	
.	

Taylor	ENTITY
DJ	ENTITY
,	
Bramoweth	ENTITY
AD	ENTITY
.	

Patterns	ENTITY
and	
consequences	ENTITY
of	
inadequate	ENTITY
sleep	ENTITY
among	
college	ENTITY
students	ENTITY
:	
substance	ENTITY
use	ENTITY
and	
motor	ENTITY
vehicle	ENTITY
accidents	ENTITY
.	

J	
Adolesc	
Health	
2010;46:610–2	
.	

Tucker	ENTITY
AM	ENTITY
,	
Whitney	ENTITY
P	ENTITY
,	
Belenky	ENTITY
G	ENTITY
,	
Hinson	ENTITY
JM	ENTITY
,	
Van	
Dongen	
HPA	
.	

Effects	ENTITY
of	ENTITY
sleep	ENTITY
deprivation	ENTITY
on	
dissociated	ENTITY
components	ENTITY
of	
executive	ENTITY
functioning	ENTITY
.	

Sleep	ENTITY
2010;33:47–57	
.	

Van	ENTITY
Dongen	ENTITY
HP	ENTITY
,	
Maislin	ENTITY
G	ENTITY
,	
Mullington	ENTITY
JM	ENTITY
,	
Dinges	ENTITY
DF	ENTITY
.	

The	
cumulative	ENTITY
cost	ENTITY
of	
additional	
wakefulness	ENTITY
:	
dose	ENTITY
-	
response	ENTITY
effects	ENTITY
on	
neurobehavioral	ENTITY
functions	ENTITY
and	
sleep	ENTITY
physiology	ENTITY
from	
chronic	ENTITY
sleep	ENTITY
restriction	ENTITY
and	
total	ENTITY
sleep	ENTITY
deprivation	ENTITY
.	

Sleep	ENTITY
2003;26:117–26	
.	

Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Long	ENTITY
Sleeper	ENTITY

A	
long	ENTITY
sleeper	ENTITY
is	
an	
individual	ENTITY
who	
consistently	
sleeps	ENTITY
substantially	
more	
in	
24	
hours	
than	
does	
the	
typical	
person	ENTITY
of	
his	
or	
her	
age	ENTITY
group	ENTITY
.	

For	
adults	ENTITY
,	
the	
usually	
accepted	ENTITY
figure	
is	
10	
hours	ENTITY
or	
more	
,	
but	
many	
epidemiologic	ENTITY
studies	ENTITY
have	
used	
sleep	ENTITY
times	ENTITY
of	
8–10	
hours	ENTITY
.	

For	
children	ENTITY
and	
adolescents	ENTITY
,	
the	
entity	ENTITY
should	
be	
considered	
if	
sleep	ENTITY
time	ENTITY
is	
more	
than	
two	
hours	
longer	
than	
age	ENTITY
-	
specific	ENTITY
norms	ENTITY
.	

Sleep	ENTITY
,	
although	
long	
,	
is	
basi-	
cally	
normal	
in	
architecture	ENTITY
and	
physiology	ENTITY
.	

Sleep	ENTITY
efficiency	ENTITY
and	
timing	ENTITY
are	
normal	ENTITY
.	

A	
consistent	
daily	
pattern	
,	
documented	ENTITY
by	
a	
carefully	
kept	
sleep	ENTITY
log	ENTITY
(	
preferably	
con-	ENTITY
firmed	ENTITY
by	ENTITY
actigraphy	ENTITY
)	
,	
showing	
10	
or	
more	
hours	
of	
sleep	ENTITY
per	ENTITY
night	ENTITY
over	
a	
minimum	
of	
seven	
days	ENTITY
is	
desirable	
for	
the	
identification	ENTITY
of	
the	
long	ENTITY
sleeper	ENTITY
.	

In	
general	
,	
long	ENTITY
sleepers	ENTITY
seek	
medical	ENTITY
help	ENTITY
when	
they	
develop	
sleepiness	ENTITY
as	
a	
result	
of	
being	
forced	ENTITY
to	
curtail	ENTITY
their	
sleep	ENTITY
time	ENTITY
to	
less	
than	
their	
required	
amounts	
.	

Usually	
,	
the	
long	ENTITY
sleep	ENTITY
pattern	ENTITY
began	
in	
childhood	ENTITY
,	
is	
well	
established	
by	
early	ENTITY
adolescence	ENTITY
,	
and	
persists	
throughout	
life	ENTITY
.	

Many	
long	ENTITY
sleepers	ENTITY
,	
because	
of	
occupational	ENTITY
or	
educational	ENTITY
demands	ENTITY
,	
function	ENTITY
with	
reasonable	
success	ENTITY
on	
nine	
hours	
of	
sleep	ENTITY
per	
night	ENTITY
during	
the	
work	ENTITY
or	
school	ENTITY
week	ENTITY
,	
with	
increases	ENTITY
to	
12	
or	
more	
hours	
on	
weekends	ENTITY
and	
holidays	ENTITY
.	

About	
2	
%	
of	
men	ENTITY
and	
1.5	
%	
of	
women	ENTITY
report	ENTITY
sleeping	ENTITY
at	
least	
10	
hours	
per	
night	ENTITY
.	

Epidemiologic	ENTITY
studies	ENTITY
have	
consistently	
found	
an	
increased	ENTITY
mortality	ENTITY
(	
and	
sometimes	
increased	ENTITY
body	ENTITY
mass	ENTITY
index	ENTITY
,	
lower	ENTITY
glucose	ENTITY
tolerance	ENTITY
,	
higher	ENTITY
prevalence	ENTITY
of	
type	ENTITY
2	ENTITY
dia-	ENTITY
betes	ENTITY
and	
coronary	ENTITY
heart	ENTITY
disease	ENTITY
)	
associated	ENTITY
with	ENTITY
long	ENTITY
sleep	ENTITY
,	
compared	
to	
average	ENTITY
-	
du-	ENTITY
ration	ENTITY
sleep	ENTITY
,	
but	
it	
is	
not	
clear	
whether	
most	
of	
the	
subjects	ENTITY
were	
naturally	
long	ENTITY
sleep-	ENTITY
ers	ENTITY
or	
had	
disorders	ENTITY
resulting	
in	
excessive	ENTITY
duration	ENTITY
of	ENTITY
sleep	ENTITY
.	

In	
subjects	ENTITY
older	
than	
60	
years	ENTITY
,	
sleep	ENTITY
duration	ENTITY
longer	
than	
9.5	
hours	ENTITY
is	
associated	ENTITY
with	ENTITY
male	ENTITY
sex	ENTITY
,	
low	ENTITY
education	ENTITY
,	
no	
physical	ENTITY
exercise	ENTITY
,	
and	
more	
physical	ENTITY
diseases	ENTITY
.	

Long	ENTITY
(	
>	
nine	
hours	
)	
sleep	ENTITY
duration	ENTITY
has	
a	
high	
heritability	ENTITY
(	
44	
%	
)	
and	
concordance	ENTITY
between	
monozygotic	ENTITY
twins	ENTITY
,	
which	
is	
higher	ENTITY
if	
they	
live	ENTITY
together	
.	

Genomewide	ENTITY
studies	ENTITY
favor	
a	
polygenic	ENTITY
origin	ENTITY
of	
sleep	ENTITY
duration	ENTITY
,	
with	
influence	ENTITY
of	
clock	ENTITY
and	
other	
genes	ENTITY
(	
DEC2	ENTITY
,	
K+	ENTITY
channel	ENTITY
regulatory	ENTITY
pro-	ENTITY
teins	ENTITY
genes	ENTITY
)	
.	

Long	ENTITY
sleepers	ENTITY
presumably	
represent	
the	
extreme	
high	
end	
of	
the	
normal	ENTITY
sleep	ENTITY
duration	ENTITY
continuum	ENTITY
.	

Long	ENTITY
sleepers	ENTITY
,	
like	
short	ENTITY
sleepers	ENTITY
,	
have	
normal	
absolute	ENTITY
amounts	
of	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
,	
unless	
there	
is	
chronic	ENTITY
sleep	ENTITY
restriction	ENTITY
preceding	
polysomnography	ENTITY
,	
in	
which	
case	
the	
absolute	ENTITY
amount	
of	
N3	ENTITY
stage	ENTITY
is	
increased	ENTITY
.	

Amounts	ENTITY
of	
stages	ENTITY
N2	ENTITY
and	
REM	ENTITY
sleep	ENTITY
are	
somewhat	
higher	
than	
normal	ENTITY
.	

The	
individual	ENTITY
has	
no	
problem	
with	
time	ENTITY
distortion	ENTITY
or	
ability	
to	
be	
accurate	ENTITY
about	
the	
quantity	ENTITY
or	
quality	ENTITY
of	ENTITY
sleep	ENTITY
.	

Assuming	
that	
individuals	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
Central	ENTITY
Disorders	ENTITY
of	ENTITY
Hypersomnolence	ENTITY
have	
obtained	
their	
usual	
sleep	ENTITY
amounts	ENTITY
for	
several	
nights	ENTITY
before	
the	
procedure	ENTITY
,	
no	ENTITY
sleepiness	ENTITY
is	
evident	
on	
the	
MSLT	ENTITY
.	

It	
is	
important	
to	
differentiate	ENTITY
the	
long	ENTITY
sleeper	ENTITY
from	
patients	ENTITY
with	
narcolepsy	ENTITY
,	
idiopathic	ENTITY
hypersomnia	ENTITY
,	
sleep	ENTITY
disordered	ENTITY
breathing	ENTITY
,	
or	
medical	ENTITY
causes	ENTITY
of	
hypersomnolence	ENTITY
.	

Many	
pathologic	ENTITY
causes	
of	
increased	ENTITY
sleep	ENTITY
have	
an	
acute	ENTITY
or	
subacute	ENTITY
onset	ENTITY
,	
may	
not	
be	
present	
since	
childhood	ENTITY
,	
and	
rarely	ENTITY
show	
the	
stable	ENTITY
course	ENTITY
of	
the	
long	ENTITY
sleeper	ENTITY
.	

Nevertheless	
,	
differentiation	ENTITY
from	
pathologic	ENTITY
con-	
ditions	ENTITY
of	
hypersomnolence	ENTITY
may	
be	
difficult	
in	
the	
child	ENTITY
or	
adolescent	ENTITY
because	
the	
normal	
continuum	ENTITY
of	
sleep	ENTITY
duration	ENTITY
is	
somewhat	
higher	ENTITY
in	
these	
age	ENTITY
groups	ENTITY
than	
in	
adults	ENTITY
.	

The	
correct	
determination	ENTITY
is	
often	
made	
by	
exclusion	ENTITY
of	
specific	
diagnostic	ENTITY
features	ENTITY
associated	ENTITY
with	ENTITY
other	
conditions	ENTITY
and	
by	
the	
absence	ENTITY
of	
complaints	ENTITY
concerning	
the	
quality	ENTITY
of	
the	
individual	ENTITY
’s	
awake	ENTITY
-	
state	ENTITY
functioning	ENTITY
when	
adequate	ENTITY
sleep	ENTITY
is	
obtained	
(	
e.g.	
,	
during	
prolonged	ENTITY
holidays	ENTITY
)	
.	

In	
particular	
,	
the	
differentiation	ENTITY
of	
a	
genuine	
long	ENTITY
sleeper	ENTITY
from	
a	
patient	ENTITY
with	
idiopathic	ENTITY
hypersomnia	ENTITY
may	
be	
difficult	
.	

In	
the	
genuine	
long	ENTITY
sleeper	ENTITY
,	
sleeping	ENTITY
long	ENTITY
hours	ENTITY
is	
refreshing	ENTITY
,	
and	
sleepiness	ENTITY
disappears	ENTITY
when	
long	ENTITY
hours	ENTITY
of	
nocturnal	ENTITY
sleep	ENTITY
are	
enforced	
.	

Bibliography	ENTITY
Aeschbach	ENTITY
D	ENTITY
,	
Cajochen	ENTITY
C	ENTITY
,	
Landolt	ENTITY
H	ENTITY
,	
Borbély	ENTITY
AA	ENTITY
.	

Homeostatic	ENTITY
sleep	ENTITY
regulation	ENTITY
in	
habitual	ENTITY
short	
sleepers	ENTITY
and	
long	ENTITY
sleepers	ENTITY
.	

Am	
J	
Physiol	
1996;270	
:	
R41–53	ENTITY
.	

Hartmann	ENTITY
E	ENTITY
,	
Baekeland	ENTITY
F	ENTITY
,	
Zwilling	ENTITY
GR	ENTITY
.	

Psychological	ENTITY
differences	
between	
long	ENTITY
and	
short	ENTITY
sleepers	ENTITY
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
1972;26:463–8	ENTITY
.	

Kripke	ENTITY
DF	ENTITY
,	
Garfinkel	ENTITY
L	ENTITY
,	
Wingard	ENTITY
DL	ENTITY
,	
Klauber	ENTITY
MR	ENTITY
,	
Marler	ENTITY
MR	ENTITY
.	

Mortality	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
duration	ENTITY
and	
insomnia	ENTITY
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
2002;59:131–6	ENTITY
.	

Kripke	ENTITY
DF	ENTITY
,	
Simons	ENTITY
RN	ENTITY
,	
Garfinkel	
L	
,	
Hammond	ENTITY
EC	ENTITY
.	

Short	ENTITY
and	
long	ENTITY
sleep	ENTITY
and	
sleeping	ENTITY
pills	ENTITY
.	

Is	
increased	ENTITY
mortality	ENTITY
associated	
?	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
1979;36:103–16	ENTITY
.	

Webb	ENTITY
WB	ENTITY
.	

Are	
short	ENTITY
and	
long	ENTITY
sleepers	ENTITY
different	
?	

Psychol	ENTITY
Rep	ENTITY
1979;44:259–64	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Delayed	
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder	ENTITY
191	ENTITY
Advanced	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder	ENTITY
198	
Irregular	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder204	ENTITY
Non-24	ENTITY
-	
Hour	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder	ENTITY
209	ENTITY
Shift	ENTITY
Work	ENTITY
Disorder	ENTITY
215	ENTITY
Jet	ENTITY
Lag	ENTITY
Disorder	ENTITY
220	ENTITY
Circadian	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorder	ENTITY
Not	
Otherwise	
Specified	
(	
NOS	ENTITY
)	
224	

Circadian	ENTITY
rhythms	ENTITY
are	
endogenous	ENTITY
,	
near-24	ENTITY
-	
hour	ENTITY
biological	ENTITY
rhythms	ENTITY
that	
exist	
in	
all	
living	ENTITY
organisms	ENTITY
.	

The	
internal	ENTITY
near-24	ENTITY
-	
hour	ENTITY
circadian	ENTITY
clock	
is	
entrained	ENTITY
or	
synchro-	
nized	ENTITY
to	
the	
24	
-	
hour	ENTITY
light	ENTITY
-	
dark	ENTITY
cycle	ENTITY
.	

In	
humans	ENTITY
,	
the	
endogenous	ENTITY
period	ENTITY
of	
the	
circa-	
dian	
oscillation	ENTITY
is	
genetically	ENTITY
determined	
and	
typically	
is	
slightly	
longer	
than	
24	
hours	ENTITY
.	

In	
order	
to	
maintain	
entrainment	ENTITY
,	
the	
endogenous	ENTITY
rhythm	ENTITY
must	
be	
reset	
each	
day	ENTITY
to	
the	
24	
-	
hour	ENTITY
clock	ENTITY
time	ENTITY
.	

For	
optimal	ENTITY
sleep	ENTITY
,	
the	
actual	ENTITY
sleep	ENTITY
time	ENTITY
should	
match	
the	
timing	ENTITY
of	
the	
circadian	ENTITY
rhythm	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
propensity	ENTITY
.	

Therefore	
,	
a	
recurrent	ENTITY
or	
chronic	ENTITY
pattern	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
disturbance	ENTITY
may	
result	
from	
disruption	ENTITY
of	
the	
internal	ENTITY
circa-	ENTITY
dian	ENTITY
timing	
system	ENTITY
or	
a	
misalignment	ENTITY
between	
the	
timing	ENTITY
of	
the	
individual	ENTITY
’s	
circadian	
sleep	
-	
wake	ENTITY
propensity	ENTITY
and	
the	
24	
-	
hour	ENTITY
social	ENTITY
and	
physical	ENTITY
environments	ENTITY
(	
e.g.	
,	
sleep	ENTITY
episodes	ENTITY
scheduled	ENTITY
entirely	
or	
in	
part	
during	
a	
phase	ENTITY
of	
circadian	ENTITY
alertness	
promotion	
)	
.	

As	
used	
herein	
,	
a	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorder	ENTITY
(	
CRSWD	ENTITY
)	
is	
defined	
by	
the	
following	
criterion	ENTITY
:	
The	
disorder	ENTITY
is	
caused	
by	
alterations	ENTITY
of	
the	
circadian	ENTITY
time	ENTITY
-	
keeping	ENTITY
system	ENTITY
,	
its	
entrainment	ENTITY
mechanisms	ENTITY
,	
or	
a	
misalignment	ENTITY
of	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
and	
the	
external	ENTITY
environment	ENTITY
.	

Most	
CRSWDs	ENTITY
arise	
when	
a	
substantial	
misalignment	ENTITY
exists	
between	
the	
internal	ENTITY
rhythm	ENTITY
and	
the	
required	
timing	ENTITY
of	
the	
patient	ENTITY
’s	ENTITY
school	ENTITY
,	
work	
,	
or	
social	ENTITY
activities	ENTITY
.	

Therefore	
,	
measurement	ENTITY
of	
endogenous	ENTITY
circadian	ENTITY
timing	ENTITY
is	
important	
for	
the	
accu-	
rate	ENTITY
diagnosis	ENTITY
of	
CRSWDs	ENTITY
.	

In	
addition	
to	
the	
history	ENTITY
,	
multiple	
tools	ENTITY
are	
available	
to	
assess	ENTITY
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
.	

Sleep	ENTITY
log	ENTITY
and	
actigraphy	ENTITY
are	
essential	
instruments	ENTITY
in	
the	
evaluation	ENTITY
of	
CRSWDs	ENTITY
and	
should	
be	
conducted	
for	
at	
least	
seven	
days	ENTITY
,	
preferably	
for	
14	
days	ENTITY
,	
to	
capture	
work	
and	
non	ENTITY
-	
work	ENTITY
days	ENTITY
.	

Circadian	ENTITY
chronotype	ENTITY
(	
Morningness-	
Eveningness	ENTITY
Questionnaires	ENTITY
)	
and	
physiological	ENTITY
measures	ENTITY
of	
endogenous	ENTITY
circadian	ENTITY
timing	ENTITY
(	
salivary	ENTITY
or	
plasma	ENTITY
dim	ENTITY
light	ENTITY
melatonin	ENTITY
onset	

and	
urinary	ENTITY
6	
-	
sulfatoxymelatonin	ENTITY
)	
also	
can	
provide	
important	
diagnostic	ENTITY
information	ENTITY
.	

Circadian	ENTITY
chronotype	ENTITY
is	
a	
reflec-	
tion	ENTITY
of	
an	
individual	ENTITY
’s	
optimal	ENTITY
timing	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
propensity	ENTITY
,	
as	
well	
as	
other	
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
physiological	ENTITY
and	
mental	ENTITY
functions	ENTITY
.	

Several	
questionnaires	ENTITY
can	
be	
used	
to	
assess	ENTITY
chro-	
notype	ENTITY
of	
“	
eveningness	ENTITY
”	
or	
“	
morningness	ENTITY
”	
(	
e.g.	
,	
Munich	ENTITY
Chronotype	ENTITY
Questionnaire	ENTITY
,	
or	
Morningness	ENTITY
-	
Eveningness	ENTITY
Questionnaire	ENTITY
)	
.	

The	
most	
common	
presenting	
symptoms	ENTITY
of	
CRSWDs	ENTITY
are	
difficulty	
initiating	
and	
maintaining	
sleep	ENTITY
,	
and	
excessive	ENTITY
sleepiness	ENTITY
,	
but	
their	
impact	ENTITY
extends	
to	
adverse	ENTITY
health	ENTITY
outcomes	
,	
impairments	ENTITY
in	
social	ENTITY
,	
occupational	ENTITY
and	
educational	ENTITY
performance	ENTITY
,	
and	
safety	ENTITY
concerns	ENTITY
.	

Important	
advances	ENTITY
have	
been	
made	
in	
the	
identification	ENTITY
of	
clin-	
ical	ENTITY
CRSWD	ENTITY
subtypes	ENTITY
,	
particularly	
in	
the	
area	ENTITY
of	ENTITY
pediatrics	ENTITY
.	

However	
,	
the	
challenge	
remains	
to	
develop	
more	
precise	
and	
clinically	ENTITY
practical	ENTITY
tools	ENTITY
to	
improve	
diagnostic	ENTITY
accuracy	ENTITY
for	
CRSWDs	ENTITY
.	

General	ENTITY
Criteria	ENTITY
for	
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorder	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY
A	ENTITY
chronic	ENTITY
or	
recurrent	ENTITY
pattern	ENTITY
of	
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disruption	ENTITY
primarily	
due	
to	
alteration	ENTITY
of	
the	
endogenous	ENTITY
circadian	ENTITY
timing	
system	
or	
misalignment	ENTITY
between	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
and	
the	
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
desired	
or	
required	
by	
an	
individual	ENTITY
’s	
physical	ENTITY
environment	ENTITY
or	
social	ENTITY
/	
work	ENTITY
schedules	ENTITY
.	

B.	ENTITY
The	
circadian	ENTITY
rhythm	ENTITY
disruption	ENTITY
leads	
to	
insomnia	ENTITY
symptoms	ENTITY
,	
excessive	ENTITY
sleepiness	ENTITY
,	
or	
both	
.	

C.	

The	
sleep	ENTITY
and	
wake	ENTITY
disturbances	ENTITY
cause	
clinically	ENTITY
significant	ENTITY
distress	ENTITY
or	
impairment	ENTITY
in	
mental	ENTITY
,	
physical	ENTITY
,	
social	ENTITY
,	
occupational	ENTITY
,	
educational	ENTITY
,	
or	
other	
important	
areas	
of	
functioning	ENTITY
.	

All	
disorders	ENTITY
described	
in	
the	
ensuing	
section	ENTITY
imply	
a	
sleep	ENTITY
difficulty	ENTITY
that	
meets	
each	
of	
the	
above	
criteria	ENTITY
.	

The	
specific	
features	ENTITY
that	
characterize	ENTITY
each	
type	
of	
CRSWD	ENTITY
are	
included	
within	
the	
individual	ENTITY
diagnostic	ENTITY
criteria	ENTITY
.	

Delayed	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.31	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.21	ENTITY
Alternate	ENTITY
Names	ENTITY
Delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
,	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
pattern	
,	
motivated	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
A.	ENTITY

There	
is	
a	
significant	
delay	ENTITY
in	
the	
phase	ENTITY
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
in	
relation	
to	
the	
desired	
or	
required	
sleep	ENTITY
time	ENTITY
and	
wake	ENTITY
-	
up	
time	ENTITY
,	
as	
evidenced	
by	
a	
chronic	ENTITY
or	
recurrent	ENTITY
complaint	ENTITY
by	
the	
patient	ENTITY
or	
a	
caregiver	ENTITY
of	
inability	
to	
fall	ENTITY
asleep	ENTITY
and	
difficulty	ENTITY
awakening	ENTITY
at	
a	
desired	
or	
required	
clock	ENTITY
time	ENTITY
.	

B.	ENTITY
The	
symptoms	ENTITY
are	
present	
for	
at	
least	
three	
months	ENTITY
.	

C.	ENTITY
When	
patients	ENTITY
are	
allowed	
to	
choose	
their	
ad	ENTITY
libitum	ENTITY
schedule	ENTITY
,	
they	
will	
exhibit	
improved	ENTITY
sleep	ENTITY
quality	ENTITY
and	
duration	ENTITY
for	
age	ENTITY
and	
maintain	
a	
delayed	ENTITY
phase	
of	
the	
24	
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
.	

D.	ENTITY
Sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
monitoring	ENTITY
for	
at	
least	
seven	
days	ENTITY
(	
preferably	
14	
days	ENTITY
)	
demonstrate	
a	
delay	ENTITY
in	
the	
timing	ENTITY
of	
the	
habitual	ENTITY
sleep	ENTITY
period	ENTITY
.	

Both	
work	ENTITY
/	
school	ENTITY
days	ENTITY
and	
free	ENTITY
days	ENTITY
must	
be	
included	
within	
this	
monitoring	ENTITY
.	

E.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Standardized	ENTITY
chronotype	ENTITY
questionnaires	
are	
useful	
tools	ENTITY
to	
assess	
the	
chronotype	ENTITY
of	
eveningness	ENTITY
and	
morningness	ENTITY
.	

Individuals	ENTITY
with	
this	
disorder	ENTITY
typically	
score	ENTITY
as	
evening	ENTITY
types	ENTITY
.	

This	
tool	ENTITY
can	
also	
be	
useful	
in	
determining	
whether	
an	
eveningness	ENTITY
circadian	ENTITY
preference	ENTITY
contributes	
to	
sleep	ENTITY
initiation	ENTITY
difficulties	ENTITY
among	
those	
who	
do	
not	
meet	
full	
criteria	ENTITY
for	
the	
disorder	ENTITY
.	
.	

Demonstration	ENTITY
of	
a	
delay	ENTITY
in	
the	
timing	ENTITY
of	
other	
circadian	ENTITY
rhythms	ENTITY
,	
such	
as	
melatonin	ENTITY
(	
measured	
by	
dim	ENTITY
light	ENTITY
melatonin	ENTITY
onset	ENTITY
or	
urinary	ENTITY
6	
-	
sulfatoxymelatonin	ENTITY
sampled	ENTITY
across	
a	
24	
-	
hour	ENTITY
period	ENTITY
)	
,	
is	
desirable	
to	
confirm	
the	
delayed	ENTITY
circadian	
phase	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Essential	ENTITY
Features	ENTITY
Delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
(	
DSWPD	ENTITY
)	
is	
characterized	
by	
habitual	ENTITY
sleep-	
wake	
timing	ENTITY
that	
is	
delayed	ENTITY
,	
usually	
more	
than	
two	
hours	ENTITY
,	
relative	
to	
conventional	ENTITY
or	
socially	ENTITY
acceptable	
timing	ENTITY
.	

Affected	ENTITY
individuals	ENTITY
complain	ENTITY
of	
difficulty	ENTITY
falling	ENTITY
asleep	ENTITY
at	
a	
socially	ENTITY
acceptable	
time	
,	
as	
required	
to	
obtain	
sufficient	ENTITY
sleep	ENTITY
duration	ENTITY
on	
a	
school	ENTITY
or	
work	ENTITY
night	ENTITY
.	

Once	
sleep	ENTITY
onset	ENTITY
occurs	
,	
it	
is	
reportedly	
of	
normal	ENTITY
duration	ENTITY
.	

These	
individ-	
uals	ENTITY
also	
experience	
difficulty	
arising	
at	
a	
socially	ENTITY
acceptable	ENTITY
wake	ENTITY
time	ENTITY
,	
as	
required	
to	
prepare	
for	
school	ENTITY
or	
work	
.	

When	
allowed	
to	
follow	
his	
or	
her	
preferred	
schedule	ENTITY
,	
the	
patient	ENTITY
’s	
timing	ENTITY
of	
sleep	ENTITY
is	
delayed	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Individuals	ENTITY
with	
DSWPD	ENTITY
may	
demonstrate	
excessive	ENTITY
sleep	ENTITY
inertia	ENTITY
(	
extreme	
difficulty	
awakening	ENTITY
and	
confusion	ENTITY
)	
in	
the	
morning	ENTITY
as	
a	
result	
of	
curtailed	ENTITY
sleep	ENTITY
time	ENTITY
and	
awak-	
ening	
during	
a	
circadian	ENTITY
phase	ENTITY
of	
high	ENTITY
sleep	ENTITY
propensity	
.	

Individuals	ENTITY
with	
this	
disor-	ENTITY
der	ENTITY
as	
well	
as	
normal	ENTITY
sleepers	ENTITY
with	
evening	ENTITY
chronotypes	ENTITY
may	
have	
increased	ENTITY
rates	ENTITY
of	
mental	ENTITY
disturbances	ENTITY
,	
such	
as	
Diagnostic	ENTITY
and	
Statistical	
Manual	
of	
Mental	
Disorders	
(	
DSM	ENTITY
)	

Axis	ENTITY
I	ENTITY
disorders	ENTITY
or	
symptoms	ENTITY
(	
e.g.	
,	
mood	ENTITY
disorders	ENTITY
or	
depressive	ENTITY
symptoms	ENTITY
)	
.	

In	
some	
individuals	ENTITY
with	
DSWPD	ENTITY
,	
there	
may	
be	
an	
overlap	ENTITY
with	
non-24	ENTITY
-	
hour	ENTITY
sleep-	
wake	ENTITY
disorder	ENTITY
,	
or	
an	
alternation	ENTITY
between	
symptoms	ENTITY
of	
the	
two	
disorders	ENTITY
.	

Attempts	
to	
cope	ENTITY
with	
the	
inability	
to	
fall	ENTITY
asleep	ENTITY
earlier	
may	
result	
in	
the	
development	ENTITY
of	
insomnia	ENTITY
disorder	ENTITY
.	

Individuals	ENTITY
may	
use	
alcohol	
,	
sedatives	ENTITY
,	
hypnotics	ENTITY
,	
or	
stimulant	ENTITY
substances	ENTITY
to	
alleviate	
symptoms	ENTITY
of	
insomnia	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
,	
thereby	
perpetuating	
their	
underlying	
sleep	ENTITY
disorder	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Motivated	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
is	
a	
subtype	ENTITY
typically	
composed	
of	
ado-	
lescents	ENTITY
who	
have	
little	
intrinsic	ENTITY
motivation	ENTITY
to	
successfully	
complete	ENTITY
treatment	ENTITY
and	
thereby	
resume	ENTITY
a	
normal	ENTITY
lifestyle	ENTITY
(	
regular	ENTITY
school	ENTITY
attendance	ENTITY
,	
developmentally	
appro-	
priate	ENTITY
peer	ENTITY
interactions	ENTITY
,	
etc	
)	
.	

A	
history	ENTITY
of	ENTITY
mood	ENTITY
or	
anxiety	ENTITY
disorder	ENTITY
(	
especially	
school	ENTITY
phobia	ENTITY
and	
separation	ENTITY
and	
social	ENTITY
anxiety	ENTITY
)	
or	
other	
factors	ENTITY
(	
e.g.	
,	
learning	ENTITY
disabilities	ENTITY
,	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
)	
are	
often	
present	
and	
may	
motivate	
the	
patient	ENTITY
(	
sometimes	
unconsciously	ENTITY
)	
to	
avoid	
a	
return	ENTITY
to	ENTITY
normal	
adolescent	ENTITY
activities	ENTITY
,	
espe-	
cially	
regular	
school	
attendance	
.	

It	
is	
not	
uncommon	
that	
ill	ENTITY
-	
defined	ENTITY
medical	ENTITY
issues	ENTITY
(	
e.g.	
,	
chronic	ENTITY
fatigue	ENTITY
,	
recurrent	ENTITY
mononucleosis	ENTITY
episodes	ENTITY
,	
pain	ENTITY
syndromes	ENTITY
)	
trigger	ENTITY
the	
onset	ENTITY
or	
complicate	ENTITY
the	
course	ENTITY
of	
the	
disorder	ENTITY
.	

Important	
clues	
,	
in	
addition	
to	
the	
exis-	
tence	
of	
premorbid	ENTITY
mental	ENTITY
disorders	ENTITY
,	
include	
exaggerated	ENTITY
presenting	ENTITY
symptoms	ENTITY
(	
e.g.	
,	
“	
ca	
n’t	ENTITY
wake	
up	
even	
if	
I	
throw	
cold	
water	
on	
him	
”	
)	
and	
failure	ENTITY
to	
comply	
with	
basic	
straightforward	
treatment	ENTITY
recommendations	ENTITY
(	
e.g.	
,	
refusal	ENTITY
or	
inability	
to	
stop	ENTITY
napping	ENTITY
during	
the	
day	ENTITY
)	
.	

Although	
social	ENTITY
,	
psychological	ENTITY
,	
and	
environmental	ENTITY
factors	ENTITY
may	
play	
a	
significant	
role	
in	
the	
development	ENTITY
of	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
,	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
has	
chosen	
to	
list	
only	
a	
single	
delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
diag-	
nosis	ENTITY
,	
with	
the	
recognition	ENTITY
that	
most	
cases	ENTITY
reflect	
variable	ENTITY
chronobiologic	ENTITY
and	
behav-	
ioral	ENTITY
contributions	ENTITY
.	

Demographics	ENTITY
The	
exact	
prevalence	ENTITY
of	
DSWPD	ENTITY
in	
the	
general	ENTITY
population	ENTITY
is	
unknown	
.	

The	
condition	ENTITY
is	
more	
common	
among	
adolescents	ENTITY
and	
young	ENTITY
adults	ENTITY
,	
with	
a	
reported	
prevalence	ENTITY
of	
7	
%	
to	
16	
%	
.	

It	
is	
estimated	
that	
DSWPD	ENTITY
is	
seen	
in	
approximately	
10	
%	
of	
patients	ENTITY
pre-	
senting	ENTITY
in	
sleep	ENTITY
clinics	ENTITY
with	
recurrent	ENTITY
insomnia	ENTITY
complaints	ENTITY
.	

There	
have	
been	
no	
studies	
assessing	
racial	ENTITY
/	
ethnic	ENTITY
differences	ENTITY
in	
DSWPD	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Most	
individuals	ENTITY
with	
DSWPD	ENTITY
are	
evening	ENTITY
chronotypes	ENTITY
.	

Many	
adolescents	ENTITY
experi-	
ence	ENTITY
a	
biological	ENTITY
endogenous	ENTITY
shift	
towards	
later	
bedtimes	ENTITY
beginning	
around	
puberty	ENTITY
.	

Genetic	ENTITY
factors	ENTITY
such	
as	
polymorphism	ENTITY
in	
the	
circadian	ENTITY
clock	
gene	ENTITY
hPer3	ENTITY
are	
associated	ENTITY
with	ENTITY
DSWPD	ENTITY
.	

Environmental	ENTITY
factors	ENTITY
,	
including	
decreased	ENTITY
exposure	ENTITY
to	ENTITY
light	
during	
the	
phase	ENTITY
advance	ENTITY
region	ENTITY
of	
the	
phase	ENTITY
response	ENTITY
curve	ENTITY
(	
PRC	ENTITY
)	
(	
i.e.	
,	
in	
the	
morning	ENTITY
on	
days	ENTITY
with	
early	ENTITY
wake	
times	
)	
or	
increased	ENTITY
exposure	ENTITY
to	ENTITY
bright	ENTITY
light	ENTITY
during	
the	
phase	ENTITY
delay	ENTITY
portion	ENTITY
of	
the	
PRC	ENTITY
(	
i.e.	
,	
late	
in	
the	
evening	ENTITY
)	
may	
exacerbate	ENTITY
the	
delayed	ENTITY
circa-	
dian	
phase	ENTITY
.	

Individuals	ENTITY
may	
have	
increased	ENTITY
sensitivity	ENTITY
in	
the	
phase	ENTITY
delay	ENTITY
region	ENTITY
or	
decreased	ENTITY
sensitivity	ENTITY
in	
the	
phase	ENTITY
advance	ENTITY
region	ENTITY
of	
the	
phase	ENTITY
response	ENTITY
curve	ENTITY
to	
light	
.	

Maladjustment	ENTITY
to	
changes	ENTITY
in	
work	ENTITY
and	
social	ENTITY
schedules	ENTITY
,	
travel	ENTITY
across	
time	ENTITY
zones	ENTITY
,	
and	
shift	
work	
can	
precipitate	ENTITY
this	
disorder	ENTITY
.	

Individuals	ENTITY
may	
consume	
excessive	ENTITY
caffeine	ENTITY
and	
other	
stimulants	ENTITY
,	
which	
may	
further	
delay	ENTITY
sleep	ENTITY
onset	ENTITY
and	
thus	
exacerbate	ENTITY
the	
delayed	ENTITY
sleep	ENTITY
time	ENTITY
.	

Social	ENTITY
and	
behavioral	ENTITY
factors	ENTITY
play	
an	
important	
role	
in	
the	
development	ENTITY
and	
mainte-	
nance	ENTITY
of	
the	
delayed	ENTITY
sleep	ENTITY
patterns	ENTITY
for	
many	
affected	ENTITY
individuals	ENTITY
.	

Personal	ENTITY
,	
social	ENTITY
,	
and	
occupational	ENTITY
activities	ENTITY
that	
continue	
into	
the	
late	
evening	ENTITY
may	
perpetuate	ENTITY
and	
exacerbate	ENTITY
the	
sleep	ENTITY
phase	ENTITY
delay	
.	

In	
adolescents	ENTITY
,	
the	
role	
of	
school	ENTITY
avoidance	ENTITY
,	
social	ENTITY
maladjustment	ENTITY
,	
and	
family	ENTITY
dysfunction	ENTITY
should	
be	
considered	
as	
contributing	
factors	ENTITY
.	

Individuals	ENTITY
with	
a	
psychiatric	ENTITY
disorder	ENTITY
,	
such	
as	
a	
mood	ENTITY
disorder	ENTITY
(	
major	
depression	ENTITY
or	
bipolar	ENTITY
disorder	ENTITY
)	
,	
severe	ENTITY
obsessive	ENTITY
-	
compulsive	ENTITY
disorder	ENTITY
,	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
,	
or	
other	
neurodevelopmental	ENTITY
disorders	ENTITY
may	
have	
a	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Familial	ENTITY
Patterns	ENTITY

A	
positive	ENTITY
family	ENTITY
history	ENTITY
has	
been	
reported	
in	
approximately	
40	
%	
of	
individuals	ENTITY
with	
DSWPD	ENTITY
.	

In	
one	
pedigree	ENTITY
,	
DSWPD	ENTITY
was	
suggested	
to	
segregate	
as	
an	
autosomal	ENTITY
domi-	
nant	ENTITY
trait	ENTITY
.	

Polymorphisms	ENTITY
in	
hPer3	ENTITY
,	
arylalkylamine	ENTITY
N	ENTITY
-	
acetyltransferase	ENTITY
,	
human	ENTITY
leuko-	
cyte	ENTITY
antigen	ENTITY
,	
and	
Clock	ENTITY
have	
been	
suggested	
to	
be	
associated	ENTITY
with	ENTITY
DSWPD	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
A	
delayed	ENTITY
sleep	ENTITY
pattern	ENTITY
typically	
begins	
during	
adolescence	ENTITY
.	

Onset	ENTITY
in	
early	ENTITY
childhood	ENTITY
is	
also	
described	
,	
especially	
in	
familial	ENTITY
cases	ENTITY
;	
the	
onset	
may	
follow	
psychological	ENTITY
,	
medical	ENTITY
,	
or	
environmental	ENTITY
stressors	ENTITY
.	

Without	
treatment	ENTITY
,	
DSWPD	ENTITY
is	
a	
chronic	ENTITY
condition	ENTITY
that	
may	
last	
into	
late	ENTITY
life	ENTITY
.	

However	
,	
with	
increasing	ENTITY
age	ENTITY
across	
adulthood	ENTITY
,	
the	
timing	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
may	
advance	
,	
thereby	
decreasing	ENTITY
the	
propensity	
to	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
.	

Phototherapy	ENTITY
,	
as	
well	
as	
behavioral	ENTITY
and	
pharmacologic	ENTITY
treatments	ENTITY
,	
can	
advance	
the	
timing	ENTITY
of	
sleep	ENTITY
hours	ENTITY
,	
but	
there	
is	
usually	
a	
continual	
tendency	
and	
prefer-	
ence	ENTITY
for	
delayed	ENTITY
sleep	ENTITY
hours	ENTITY
,	
and	
recurrence	ENTITY
is	
high	
.	

Use	ENTITY
of	ENTITY
alcohol	
,	
sedatives	ENTITY
,	
hypnot-	
ics	ENTITY
,	
or	
stimulants	ENTITY
to	
treat	ENTITY
symptoms	ENTITY
of	
insomnia	ENTITY
and	
sleepiness	ENTITY
during	
normal	ENTITY
waking	ENTITY
hours	
may	
lead	
to	
substance	ENTITY
abuse	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
DSWPD	ENTITY
may	
be	
encountered	
in	
any	
age	ENTITY
group	ENTITY
but	
is	
especially	
prevalent	ENTITY
among	
ado-	
lescents	ENTITY
and	
young	ENTITY
adults	ENTITY
.	

In	
addition	
to	
the	
clinical	ENTITY
features	ENTITY
described	
elsewhere	
,	
DSWPD	ENTITY
may	
present	
in	
older	ENTITY
children	ENTITY
and	
adolescents	ENTITY
with	
chief	ENTITY
complaints	ENTITY
of	
truancy	ENTITY
,	
repeated	
school	ENTITY
absences	ENTITY
,	
chronic	ENTITY
tardiness	ENTITY
and/or	
school	ENTITY
failure	ENTITY
,	
rather	
than	
sleep	ENTITY
complaints	ENTITY
per	
se	
.	

In	
severe	ENTITY
cases	ENTITY
,	
school	ENTITY
attendance	ENTITY
is	
completely	
curtailed	ENTITY
and	
the	
patient	ENTITY
may	
have	
failed	
to	
attend	ENTITY
school	ENTITY
regularly	ENTITY
for	
many	
months	ENTITY
.	

Extreme	ENTITY
diffi-	
culty	
in	
morning	ENTITY
awakening	ENTITY
,	
requiring	
intensive	
parental	ENTITY
involvement	ENTITY
,	
may	
also	
be	
the	
presenting	
concern	
.	

An	
increased	ENTITY
risk	ENTITY
of	
motor	ENTITY
vehicle	ENTITY
accidents	ENTITY
has	
been	
associated	ENTITY
with	ENTITY
delayed	ENTITY
sleep	ENTITY
onset	ENTITY
and	
resultant	ENTITY
insufficient	ENTITY
sleep	ENTITY
in	
adolescents	ENTITY
;	
thus	
,	
the	
occur-	
rence	ENTITY
of	
a	
car	ENTITY
crash	ENTITY
or	
“	
near	ENTITY
-	
miss	ENTITY
”	
incident	ENTITY
should	
alert	
the	
clinician	ENTITY
to	
probe	ENTITY
for	
addi-	
tional	ENTITY
evidence	ENTITY
of	
circadian	ENTITY
pathology	ENTITY
.	

Adolescents	ENTITY
may	
also	
present	
primarily	
with	
mood	ENTITY
complaints	ENTITY
(	
depression	ENTITY
,	
suicidal	ENTITY
ideation	ENTITY
)	
.	

Chronic	ENTITY
insomnia	ENTITY
is	
commonly	
asso-	
ciated	ENTITY
with	
and	
may	
be	
the	
chief	ENTITY
presenting	ENTITY
complaint	
in	
adolescents	ENTITY
with	
DSWPD	ENTITY
as	
a	
result	
of	
repeated	
attempts	ENTITY
and	
failures	ENTITY
to	
achieve	
sleep	ENTITY
onset	ENTITY
at	
their	
desired	
bedtime	ENTITY
.	

In	
younger	ENTITY
children	ENTITY
,	
the	
condition	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
delays	ENTITY
in	
other	
markers	ENTITY
of	
circadian	ENTITY
phase	ENTITY
,	
including	
the	
typical	
presleep	ENTITY
surge	ENTITY
in	
alertness	ENTITY
referred	
to	
as	
the	
“	
for-	
bidden	ENTITY
zone	ENTITY
”	
or	
“	
second	
wind	ENTITY
phenomenon	ENTITY
.	
”	

Thus	
,	
especially	
in	
younger	ENTITY
children	ENTITY
,	
DSWPD	ENTITY
may	
present	
primarily	
as	
bedtime	ENTITY
resistance	ENTITY
,	
as	
caregivers	ENTITY
attempt	
to	
establish	
bedtimes	ENTITY
that	
directly	
conflict	ENTITY
with	
the	
child	ENTITY
’s	
circadian	ENTITY
-	
mediated	ENTITY
readiness	ENTITY
for	
sleep	ENTITY
.	

Several	
pediatric	ENTITY
populations	ENTITY
appear	
to	
have	
an	
increased	ENTITY
vulnerability	ENTITY
to	
DSWPD	ENTITY
and	
sleep	ENTITY
disturbances	ENTITY
,	
likely	
of	
multifactorial	ENTITY
etiology	ENTITY
.	

These	
include	
children	ENTITY
with	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
(	
ADHD	ENTITY
)	
and	
autism	ENTITY
spectrum	ENTITY
disorder	ENTITY
(	
ASD	ENTITY
)	
.	

Several	
studies	ENTITY
have	
examined	
melatonin	ENTITY
onset	ENTITY
in	
children	ENTITY
with	
ADHD	ENTITY
and	
reported	
significant	
delays	ENTITY
in	
comparison	ENTITY
with	
typically	
developing	
children	ENTITY
,	
as	
well	
as	
suc-	ENTITY
cessful	ENTITY
treatment	ENTITY
with	
melatonin	ENTITY
.	

Children	ENTITY
with	
ASD	ENTITY
have	
a	
high	
prevalence	ENTITY
(	
up	
to	
80	
%	
)	
of	
sleep	ENTITY
disturbances	ENTITY
,	
including	
delayed	ENTITY
sleep	ENTITY
onset	ENTITY
,	
night	ENTITY
and	
early	ENTITY
morning	ENTITY
awakenings	ENTITY
,	
and	
irregular	ENTITY
sleep	
patterns	
,	
at	
least	
some	
of	
which	
appear	
associated	ENTITY
with	ENTITY
circadian	ENTITY
abnormalities	ENTITY
.	

These	
children	ENTITY
reportedly	
have	
a	
number	
of	
alterations	ENTITY
in	
mel-	ENTITY

atonin	ENTITY
synthesis	ENTITY
,	
levels	ENTITY
,	
amplitude	ENTITY
,	
and	
patterns	ENTITY
of	
secretion	ENTITY
.	

Little	
is	
known	
about	
the	
natural	ENTITY
history	ENTITY
of	
the	
clinical	ENTITY
entity	ENTITY
of	
DSWPD	ENTITY
in	
the	
pediat-	
ric	ENTITY
population	ENTITY
,	
including	
the	
impact	ENTITY
of	
various	
treatment	ENTITY
modalities	ENTITY
,	
the	
likelihood	ENTITY
of	
spontaneous	ENTITY
resolution	ENTITY
of	ENTITY
symptoms	ENTITY
,	
or	
long	ENTITY
-	
term	ENTITY
consequences	ENTITY
.	

There	
is	
increasing	ENTITY
evidence	ENTITY
to	
suggest	
that	
the	
evening	ENTITY
chronotype	ENTITY
is	
associated	
in	
both	
children	ENTITY
and	
adolescents	ENTITY
with	
a	
number	
of	
adverse	ENTITY
consequences	ENTITY
,	
including	
decreased	ENTITY
health	ENTITY
-	
related	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
,	
higher	
rates	ENTITY
of	
behavioral	ENTITY
/	
emotional	ENTITY
problems	
including	
depression	ENTITY
and	
suicidality	ENTITY
,	
decreased	ENTITY
sleep	ENTITY
duration	ENTITY
and	
increased	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
more	
sleep	ENTITY
complaints	ENTITY
,	
impairments	ENTITY
in	
academic	ENTITY
functioning	ENTITY
,	
and	
increased	ENTITY
likelihood	ENTITY
of	
substance	ENTITY
use	ENTITY
.	

Thus	
,	
eveningness	ENTITY
may	
confer	
an	
increased	ENTITY
risk	ENTITY
for	
physical	ENTITY
and	
mental	ENTITY
health	ENTITY
problems	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
exact	
mechanisms	ENTITY
responsible	
for	
DSWPD	ENTITY
are	
unknown	
.	

An	
abnormal	ENTITY
interac-	
tion	ENTITY
between	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
and	
the	
sleep	ENTITY
homeostatic	ENTITY
process	ENTITY
that	
regulates	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
may	
play	
an	
essential	
role	
in	
the	
pathophysiology	ENTITY
of	
DSWPD	ENTITY
.	

Early	ENTITY
studies	ENTITY
reported	
an	
altered	
phase	ENTITY
relationship	ENTITY
between	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
and	
circadian	ENTITY
phase	ENTITY
,	
whereas	
more	
recent	
studies	ENTITY
have	
failed	
to	
support	
this	
finding	ENTITY
.	

In	
these	
patients	ENTITY
,	
sleep	ENTITY
onset	ENTITY
,	
sleep	ENTITY
offset	ENTITY
,	
and	
phase	ENTITY
of	
circadian	ENTITY
markers	ENTITY
such	
as	
core	ENTITY
body	ENTITY
temperature	ENTITY
and	
melatonin	ENTITY
are	
delayed	ENTITY
relative	
to	
clock	ENTITY
time	ENTITY
when	
com-	
pared	ENTITY
with	
controls	ENTITY
.	

Although	
this	
condition	ENTITY
may	
be	
predominantly	
due	
to	
a	
misalign-	
ment	ENTITY
between	
circadian	ENTITY
timing	ENTITY
and	
the	
external	ENTITY
environment	ENTITY
,	
alterations	ENTITY
in	
the	
length	ENTITY
of	
the	
circadian	ENTITY
period	ENTITY
or	
an	
altered	
homeostatic	ENTITY
process	ENTITY
(	
indicated	
by	
decreased	ENTITY
sleep	ENTITY
propensity	
in	
response	ENTITY
to	ENTITY
sleep	ENTITY
deprivation	ENTITY
)	
also	
may	
be	
contributing	
factors	ENTITY
.	

In	
chil-	
dren	ENTITY
and	
adults	ENTITY
,	
voluntary	ENTITY
behaviors	ENTITY
such	
as	
staying	ENTITY
awake	ENTITY
late	
at	
night	ENTITY
and	
waking	ENTITY
up	
late	
in	
the	
morning	ENTITY
or	
afternoon	ENTITY
may	
result	
in	
an	
abnormal	ENTITY
relationship	ENTITY
between	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
and	
the	
sleep	ENTITY
homeostatic	ENTITY
process	ENTITY
that	
regulates	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
.	

Delayed	ENTITY
bedtimes	ENTITY
and	
wake	ENTITY
times	ENTITY
may	
increase	ENTITY
exposure	ENTITY
to	ENTITY
bright	ENTITY
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
light	ENTITY
in	
the	
late	ENTITY
evening	ENTITY
(	
a	
delay	ENTITY
signal	ENTITY
for	
the	
circadian	ENTITY
clock	ENTITY
)	
and	
decrease	ENTITY
expo-	
sure	
to	
light	
in	
the	
early	ENTITY
morning	ENTITY
(	
an	
advance	
signal	ENTITY
for	
the	
circadian	ENTITY
clock	ENTITY
)	
,	
thereby	
promoting	ENTITY
and	
perpetuating	
the	
delay	ENTITY
in	
the	
circadian	ENTITY
sleep	ENTITY
phase	ENTITY
.	

Given	
a	
sufficient	
discrepancy	ENTITY
between	
early	ENTITY
and	
late	ENTITY
wake	ENTITY
times	ENTITY
,	
early	ENTITY
wake	ENTITY
times	
may	
be	
associated	ENTITY
with	ENTITY
bright	ENTITY
light	ENTITY
exposure	ENTITY
during	
the	
maximal	ENTITY
phase	
delay	
region	
,	
perpetuating	
the	
cir-	ENTITY
cadian	ENTITY
phase	ENTITY
delay	
and	
the	
disorder	ENTITY
.	

Individuals	ENTITY
may	
have	
alterations	ENTITY
in	
sensitivity	ENTITY
to	
the	
phase	ENTITY
shifting	
effects	ENTITY
of	ENTITY
light	ENTITY
.	

For	
example	
,	
partial	ENTITY
sleep	
deprivation	
encountered	
with	
this	
disorder	ENTITY
can	
also	
attenuate	ENTITY
the	
ability	
to	
phase	ENTITY
-	
advance	ENTITY
the	
circadian	ENTITY
system	ENTITY
,	
further	
perpetuating	
the	
delayed	ENTITY
circadian	
phase	
.	

Objective	ENTITY
Findings	ENTITY
Recordings	ENTITY
of	
sleep	ENTITY
logs	ENTITY
and	
actigraphy	ENTITY
over	
an	
interval	ENTITY
of	
at	
least	
seven	
(	
and	
pref-	
erably	
fourteen	
)	
consecutive	ENTITY
days	ENTITY
demonstrate	
delayed	ENTITY
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
offset	ENTITY
(	
typically	
greater	
than	
two	
hours	
)	
relative	
to	
socially	ENTITY
acceptable	
times	
.	

Though	
clock	ENTITY
times	ENTITY
may	
be	
culture	ENTITY
dependent	ENTITY
,	
for	
many	
affected	ENTITY
individuals	ENTITY
sleep	ENTITY
onset	ENTITY
is	
typi-	
cally	
delayed	ENTITY
until	
1:00	
a.m.	
to	
6:00	
a.m.	
,	
(	
though	
may	
be	
earlier	
based	
on	
age	ENTITY
and	
developmental	ENTITY
status	ENTITY
)	
,	
and	
wake	ENTITY
time	ENTITY
occurs	
in	
the	
late	ENTITY
morning	ENTITY
or	
afternoon	ENTITY
.	

Daily	ENTITY
demands	ENTITY
and	
schedules	ENTITY
may	
result	
in	
an	
earlier	
than	
desired	
wake	ENTITY
-	
up	
time	ENTITY
during	
work	ENTITY
or	
school	ENTITY
days	ENTITY
,	
but	
a	
delay	ENTITY
in	
bedtime	ENTITY
and	
wake	ENTITY
-	
up	
time	ENTITY
is	
almost	
always	
seen	
during	
free	ENTITY
days	ENTITY
and	
vacation	ENTITY
.	

Polysomnography	ENTITY
(	
though	
not	
routinely	
indicated	
nor	
required	
for	
the	
diagnosis	ENTITY
)	
,	
when	
performed	
at	
preferred	ENTITY
(	
delayed	
)	
sleep	
times	
,	
is	
essentially	
normal	
for	
age	ENTITY
.	

If	
a	
conventional	ENTITY
bedtime	ENTITY
and	
wake	ENTITY
-	
up	
time	ENTITY
are	
enforced	ENTITY
,	
however	
,	
polysomnographic	ENTITY
recording	ENTITY
may	
show	
prolonged	ENTITY
sleep	ENTITY
latency	ENTITY
and	
decreased	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

Laboratory	ENTITY
measures	ENTITY
of	
circadian	ENTITY
timing	ENTITY
generally	
show	
the	
expected	
phase	ENTITY
delay	ENTITY
in	
the	
timing	ENTITY
of	
the	
nadir	ENTITY
of	
the	
core	ENTITY
body	ENTITY
temperature	
rhythm	
and	
dim-	ENTITY
light	ENTITY
melatonin	ENTITY
onset	ENTITY
(	
DLMO	ENTITY
)	
.	

Several	
questionnaires	ENTITY
are	
useful	
in	
assessing	
the	
chro-	
notype	ENTITY
,	
the	
degree	ENTITY
of	
eveningness	ENTITY
or	
morningness	ENTITY
(	
e.g.	
,	
“	
Morningness	ENTITY
-	
Eveningness	ENTITY
Questionnaire	ENTITY
,	
”	
“	
Munich	ENTITY
Chronotype	ENTITY
Questionnaire	ENTITY
”	
)	
.	

Individuals	ENTITY
with	
DSWPD	ENTITY
,	
typ-	
ically	ENTITY
score	ENTITY
high	
as	
evening	ENTITY
types	
,	
though	
normal	ENTITY
sleepers	ENTITY
can	
also	
score	ENTITY
high	ENTITY
on	
eve-	ENTITY
ningness	ENTITY
.	

Elevations	ENTITY
are	
expected	
in	
self	ENTITY
-	
report	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
,	
such	
as	
on	
the	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
.	

The	
results	ENTITY
of	
polysomnography	ENTITY
and	
other	
diagnostic	ENTITY
tools	ENTITY
in	
younger	ENTITY
age	ENTITY
groups	
are	
similar	
to	
those	
seen	
in	
adults	ENTITY
.	

Actigraphy	ENTITY
and/or	
sleep	ENTITY
logs	ENTITY
are	
useful	
in	
the	
diagnosis	ENTITY
of	
DSWPD	ENTITY
in	
the	
pediatric	ENTITY
population	ENTITY
.	

Several	
validated	
instruments	ENTITY
are	
available	
for	
assessing	ENTITY
phase	ENTITY
preference	ENTITY
in	
the	
pediatric	ENTITY
and	
adolescent	ENTITY
pop-	
ulations	ENTITY
.	

These	
include	
the	
Children	ENTITY
’s	
Chronotype	
Questionnaire	
(	
CCTQ	ENTITY
)	
(	
par-	ENTITY
ent	ENTITY
-	
report	ENTITY
)	
,	
the	
Morningness	ENTITY
-	
Eveningness	ENTITY
Scale	ENTITY
for	ENTITY
Children	ENTITY
(	
self	ENTITY
-	
report	ENTITY
)	
,	
and	
the	
Morningness	ENTITY
-	
Eveningness	ENTITY
Questionnaire	ENTITY
for	
Children	ENTITY
and	
Adolescents	ENTITY
.	

These	
surveys	ENTITY
have	
been	
used	
to	
assess	ENTITY
chronotype	ENTITY
in	
the	
pediatric	ENTITY
population	ENTITY
and	
may	
be	
useful	
in	
clinical	ENTITY
settings	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
must	
be	
distinguished	
from	
“	
normal	ENTITY
”	
sleep	
pat-	
terns	ENTITY
,	
particularly	
in	
adolescents	ENTITY
and	
young	ENTITY
adults	ENTITY
who	
maintain	
delayed	ENTITY
schedules	ENTITY
regularly	
or	
intermittently	ENTITY
,	
without	
distress	ENTITY
or	
impaired	ENTITY
functioning	ENTITY
.	

DSWPD	ENTITY
must	
be	
distinguished	
from	
other	
causes	
of	
difficulty	ENTITY
initiating	ENTITY
sleep	
,	
including	
chronic	ENTITY
insom-	
nia	ENTITY
disorder	ENTITY
.	

In	
DSWPD	ENTITY
,	
sleep	ENTITY
initiation	ENTITY
and	
maintenance	ENTITY
are	
improved	ENTITY
when	
the	
patient	ENTITY
is	
allowed	
to	
sleep	ENTITY
on	
the	
preferred	
schedule	ENTITY
.	

When	
individuals	ENTITY
with	
DSWPD	ENTITY
must	
arise	
before	
the	
desired	
wake	
time	
,	
excessive	ENTITY
sleep	ENTITY
inertia	ENTITY
and	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
may	
be	
evident	
.	

Other	
forms	
of	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
from	
which	
this	
must	
be	
distinguished	
,	
do	
not	
generally	
exhibit	
the	
pronounced	
circadian	ENTITY
pattern	
and	
do	
not	
abate	ENTITY
with	
alterations	ENTITY
in	
the	
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
.	

The	
development	ENTITY
of	
DSWPD	ENTITY
may	
be	
influenced	ENTITY
by	
alterations	ENTITY
in	
circadian	ENTITY
physiology	ENTITY
as	
well	
as	
behavioral	ENTITY
factors	ENTITY
.	

Inadequate	ENTITY
sleep	ENTITY
hygiene	ENTITY
and	
insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
must	
also	
be	
considered	
in	
the	
differential	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
is	
limited	
knowledge	ENTITY
of	
the	
underlying	
pathophysiology	ENTITY
of	
DSWPD	ENTITY
.	

Recent	
evidence	ENTITY
suggests	
that	
alteration	ENTITY
in	
the	
homeostatic	ENTITY
regulation	ENTITY
of	
sleep	ENTITY
and	
alertness	ENTITY
may	
play	
an	
important	
role	
.	

The	
intrinsic	ENTITY
circadian	
period	ENTITY
may	
be	
abnormally	ENTITY
long	ENTITY
.	

Recent	
advances	
in	
the	
understanding	
of	
the	
molecular	ENTITY
basis	ENTITY
for	
the	
generation	ENTITY
and	
entrainment	ENTITY
of	
circadian	ENTITY
rhythms	ENTITY
,	
together	
with	
the	
identification	ENTITY
of	
a	
familial	ENTITY
form	ENTITY
of	
DSWPD	ENTITY
,	
will	
lead	
to	
improved	
understanding	
of	
the	
mechanisms	ENTITY
responsible	
for	
this	
condition	ENTITY
,	
as	
well	
as	
targeted	ENTITY
,	
evidence	ENTITY
-	
based	ENTITY
therapies	ENTITY
.	

Bibliography	ENTITY
Ancoli	ENTITY
-	
Israel	ENTITY
S	ENTITY
,	
Schnierow	ENTITY
B	ENTITY
,	
Kelsoe	ENTITY
J	ENTITY
,	ENTITY
Fink	ENTITY
R.	ENTITY
A	ENTITY
pedigree	ENTITY
of	
one	
family	ENTITY
with	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Chronobiol	ENTITY
Int	ENTITY
2001;18:831–41	ENTITY
.	

Archer	
SN	ENTITY
,	
Carpen	ENTITY
JD	ENTITY
,	
Gibson	ENTITY
M	ENTITY
,	
et	
al	
.	

Polymorphism	ENTITY
in	
the	
PER3	ENTITY
promoter	
associates	
with	
diurnal	ENTITY
preference	ENTITY
and	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
2010;33:695–701	
.	

Bijlenga	ENTITY
D	ENTITY
,	
Van	
Someren	
EJW	
,	
Gruber	ENTITY
R	ENTITY
,	
et	
al	
.	

Body	ENTITY
temperature	ENTITY
,	
activity	ENTITY
,	
and	
melatonin	ENTITY
profiles	ENTITY
in	
adults	ENTITY
with	
attention	ENTITY
-	
deficit	ENTITY
/	
hyperactivity	ENTITY
disorder	ENTITY
and	
delayed	ENTITY
sleep	ENTITY
:	
a	
case	ENTITY
-	
control	ENTITY
study	ENTITY
.	

J	
Sleep	
Res	
2013	
;	
22:607–16	
.	

Dagan	ENTITY
Y	ENTITY
,	
Stein	ENTITY
D	ENTITY
,	
Steinbock	ENTITY
M	ENTITY
,	
Yovel	ENTITY
I	ENTITY
,	
Hallis	ENTITY
D.	ENTITY
Frequency	ENTITY
of	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
among	
hospitalized	ENTITY
adolescent	ENTITY
psychiatric	ENTITY
patients	ENTITY
.	

Psychosom	ENTITY
Res	ENTITY
1998;45:15–20	ENTITY
.	

Gruber	ENTITY
R	ENTITY
,	
Sheshko	ENTITY
D.	
Circadian	ENTITY
sleep	ENTITY
disorders	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
.	

In	
Ivanenko	ENTITY
A.	ENTITY
(	ENTITY
ed	ENTITY
)	ENTITY
,	
Sleep	ENTITY
and	
psychiatric	ENTITY
disorders	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
.	

USA	ENTITY
:	
Informa	ENTITY
Healthcare	ENTITY
,	
2008	
;	
61	
-	
78	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Gruber	ENTITY
R	ENTITY
,	
Fontil	ENTITY
L	ENTITY
,	
Bergmame	ENTITY
L	ENTITY
,	
et	
al	
.	

Contributions	ENTITY
of	
circadian	ENTITY
tendencies	ENTITY
and	
behavioural	ENTITY
problems	ENTITY
to	
sleep	ENTITY
onset	ENTITY
problems	ENTITY
of	
children	ENTITY
with	
ADHD	ENTITY
.	

BMC	ENTITY
Psychiat	ENTITY
2012;12:212	
.	

Kripke	ENTITY
DF	ENTITY
,	
Rex	ENTITY
KM	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S	
,	
Nievergelt	ENTITY
CM	ENTITY
,	
Klimecki	ENTITY
W	ENTITY
,	ENTITY
Kelsoe	ENTITY
JR	ENTITY
.	

Delayed	ENTITY
sleep	ENTITY
phase	ENTITY
cases	ENTITY
and	
controls	ENTITY
.	

J	
Circadian	ENTITY
Rhythms	ENTITY
2008;6:6	
.	

Marchetti	ENTITY
LM	ENTITY
,	
Biello	ENTITY
SM	ENTITY
,	
Broomfield	ENTITY
NM	ENTITY
,	
Macmahon	ENTITY
KM	ENTITY
,	
Espie	ENTITY
CA	ENTITY
.	

Who	
is	
pre	ENTITY
-	
occupied	ENTITY
with	
sleep	ENTITY
?	

A	
comparison	ENTITY
of	
attention	ENTITY
bias	ENTITY
in	
people	ENTITY
with	
psychophysiological	ENTITY
insomnia	ENTITY
,	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
and	
good	ENTITY
sleepers	ENTITY
using	
the	
induced	ENTITY
change	
blindness	ENTITY
paradigm	ENTITY
.	

J	
Sleep	
Res	
2006;15:212–21	
.	

Rahman	ENTITY
SA	ENTITY
,	
Kayumov	ENTITY
L	ENTITY
,	
Tchmoutina	ENTITY
EA	ENTITY
,	
Shapiro	ENTITY
CM	ENTITY
.	

Clinical	ENTITY
efficacy	ENTITY
of	
dim	ENTITY
light	ENTITY
melatonin	ENTITY
onset	ENTITY
testing	ENTITY
in	
diagnosing	ENTITY
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2009;10:549–55	ENTITY
.	

Reid	ENTITY
KJ	ENTITY
,	
Jaksa	ENTITY
AA	ENTITY
,	
Eisengart	ENTITY
JB	ENTITY
,	
et	
al	
.	

Systematic	ENTITY
evaluation	ENTITY
of	
Axis	ENTITY
-	
I	ENTITY
DSM	
diagnoses	ENTITY
in	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
and	
evening	ENTITY
-	
type	ENTITY
circadian	ENTITY
preference	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2012;13:1171–7	
.	

Shibui	ENTITY
K	ENTITY
,	
Uchiyama	ENTITY
M	ENTITY
,	
Okawa	ENTITY
M.	ENTITY
Melatonin	ENTITY
rhythms	ENTITY
in	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

J	
Biol	
Rhythms	
1999;14:72–6	
.	

Uchiyama	ENTITY
M	ENTITY
,	
Okawa	ENTITY
M	ENTITY
,	
Shibui	ENTITY
K	ENTITY
,	
et	
al	
.	

Poor	ENTITY
compensatory	ENTITY
function	ENTITY
for	
sleep	ENTITY
loss	ENTITY
as	
a	
pathogenic	ENTITY
factor	ENTITY
in	
patients	ENTITY
with	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Sleep	ENTITY
2000;23:553–8	ENTITY
.	

Weitzman	ENTITY
E	ENTITY
,	
Czeisler	ENTITY
C	ENTITY
,	
Coleman	ENTITY
R	ENTITY
,	
Spielman	ENTITY
,	
et	
al	
.	

Delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
:	
a	
chronobiological	ENTITY
disorder	ENTITY
with	
sleep	ENTITY
onset	ENTITY
insomnia	ENTITY
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
1981;38:737–46	ENTITY
.	

Wyatt	ENTITY
JK	ENTITY
,	
Stepanski	ENTITY
EJ	ENTITY
,	
Kirkby	
J.	
Circadian	
phase	
in	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
:	
predictors	ENTITY
and	
temporal	ENTITY
stability	ENTITY
across	
multiple	
assessments	ENTITY
.	

Sleep	ENTITY
2006;29:1075–80	
.	

Advanced	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Phase	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.32	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.22	ENTITY
Alternate	ENTITY
Names	ENTITY
Advanced	ENTITY
sleep	ENTITY
phase	ENTITY
type	ENTITY
,	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
,	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
A.	ENTITY

There	
is	
an	
advance	ENTITY
(	
early	ENTITY
timing	ENTITY
)	
in	
the	
phase	ENTITY
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
in	
relation	
to	
the	
desired	
or	
required	
sleep	ENTITY
time	ENTITY
and	
wake	ENTITY
-	
up	
time	ENTITY
,	
as	
evidenced	
by	
a	
chronic	ENTITY
or	
recurrent	ENTITY
complaint	ENTITY
of	
difficulty	ENTITY
staying	ENTITY
awake	ENTITY
until	
the	
required	
or	
desired	
conventional	ENTITY
bedtime	ENTITY
,	
together	
with	
an	
inability	
to	
remain	
asleep	ENTITY
until	
the	
required	
or	
desired	
time	ENTITY
for	
awakening	ENTITY
.	

B.	ENTITY
Symptoms	ENTITY
are	
present	
for	
at	
least	
three	
months	ENTITY
.	

C.	ENTITY
When	
patients	ENTITY
are	
allowed	
to	
sleep	ENTITY
in	
accordance	
with	
their	
internal	ENTITY
biological	ENTITY
clock	ENTITY
,	
sleep	ENTITY
quality	ENTITY
and	
duration	ENTITY
are	
improved	ENTITY
with	
a	
consistent	
but	
advanced	
timing	ENTITY
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
.	

D.	ENTITY
Sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
monitoring	ENTITY
for	
at	
least	
seven	
days	ENTITY
(	
preferably	
14	
days	ENTITY
)	
demonstrate	
a	
stable	ENTITY
advance	
in	
the	
timing	ENTITY
of	
the	
habitual	ENTITY
sleep	ENTITY
period	ENTITY
.	

Both	
work	ENTITY
/	
school	ENTITY
days	ENTITY
and	
free	ENTITY
days	ENTITY
must	
be	
included	
within	
this	
monitoring	ENTITY
.	

E.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Standardized	ENTITY
chronotype	ENTITY
questionnaires	
are	
useful	
tools	ENTITY
to	
assess	
the	
chronotype	ENTITY
of	
eveningness	ENTITY
and	
morningness	ENTITY
.	

Individuals	ENTITY
with	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
score	ENTITY
as	
morning	ENTITY
types	ENTITY
.	
.	

Demonstration	ENTITY
of	
an	
advance	ENTITY
(	
typically	
greater	
than	
two	
hours	
)	
in	
the	
timing	ENTITY
of	
other	
circadian	ENTITY
rhythms	ENTITY
such	
as	
DLMO	ENTITY
or	
urinary	ENTITY
6	
-	
sulfatoxymelatonin	ENTITY
is	
desirable	
to	
confirm	
the	
advanced	ENTITY
circadian	ENTITY
phase	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Advanced	
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
(	
ASWPD	ENTITY
)	
is	
characterized	ENTITY
by	
a	
stable	ENTITY
advance	ENTITY
(	
earlier	
timing	ENTITY
)	
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
,	
such	
that	
habitual	ENTITY
sleep	ENTITY
onset	ENTITY
and	
offset	
occur	
typically	
two	
or	
more	
hours	
prior	
to	
required	
or	
desired	
times	ENTITY
.	

Affected	ENTITY
individ-	
uals	ENTITY
complain	ENTITY
of	
early	ENTITY
morning	ENTITY
or	
maintenance	ENTITY
insomnia	ENTITY
and	
excessive	ENTITY
evening	
sleep-	
iness	
.	

When	
affected	ENTITY
individuals	ENTITY
are	
allowed	
to	
maintain	
an	
advanced	ENTITY
schedule	ENTITY
,	
sleep	ENTITY
quality	ENTITY
and	
quantity	ENTITY
are	
improved	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Individuals	ENTITY
with	
ASWPD	ENTITY
may	
experience	
chronic	ENTITY
partial	ENTITY
sleep	ENTITY
loss	ENTITY
due	
to	
early	ENTITY
morning	ENTITY
and	
maintenance	ENTITY
insomnia	ENTITY
,	
particularly	
if	
sleep	ENTITY
is	
resisted	
during	
early	ENTITY
evening	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Familial	ENTITY
patterns	ENTITY
are	
discussed	
below	
.	

Demographics	ENTITY
The	
prevalence	ENTITY
of	
ASWPD	ENTITY
in	
the	
general	ENTITY
population	ENTITY
is	
unknown	
.	

In	
one	
large	
survey	ENTITY
study	ENTITY
involving	
middle	ENTITY
-	
aged	ENTITY
adults	ENTITY
(	
40	
-	
64	
years	ENTITY
)	
,	
the	
population	ENTITY
prevalence	ENTITY
was	
esti-	
mated	ENTITY
at	
1	
%	
,	
although	
it	
is	
unclear	
what	
proportion	ENTITY
of	
these	
subjects	ENTITY
would	
deem	
their	
schedule	ENTITY
to	
be	
significantly	
troublesome	
so	
as	
to	
warrant	
clinical	ENTITY
attention	ENTITY
.	

Until	
the	
identification	ENTITY
of	
familial	ENTITY
cohorts	ENTITY
(	
see	
below	
)	
,	
only	
four	
cases	ENTITY
were	
described	
in	
the	
lit-	
erature	ENTITY
.	

There	
is	
no	
known	
sex	ENTITY
difference	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Advanced	ENTITY
age	ENTITY
appears	
to	
be	
a	
risk	ENTITY
factor	ENTITY
.	

Among	
a	
cohort	ENTITY
aged	
20	
to	
59	
years	ENTITY
,	
older	ENTITY
age	ENTITY
was	
associated	ENTITY
with	ENTITY
increased	ENTITY
morningness	ENTITY
,	
which	
was	
determined	
to	
be	
a	
sig-	
nificant	
mediator	
of	
numerous	
age	ENTITY
-	
sleep	ENTITY
relationships	ENTITY
.	

A	
patient	ENTITY
’s	ENTITY
ability	
to	
sleep	ENTITY
at	
an	
abnormal	ENTITY
circadian	
phase	
(	
phase	ENTITY
tolerance	ENTITY
)	
also	
impacts	ENTITY
the	
degree	ENTITY
to	
which	
adverse	ENTITY
symptoms	ENTITY
are	
experienced	ENTITY
,	
and	
this	
adaptability	ENTITY
varies	
among	
individuals	ENTITY
.	

Conflicting	
results	
have	
been	
obtained	
with	
respect	
to	
the	
relationship	ENTITY
between	
age	ENTITY
and	
phase	ENTITY
tolerance	ENTITY
,	
with	
some	
suggesting	
that	
age	ENTITY
decreases	
phase	ENTITY
tolerance	ENTITY
,	
and	
others	
suggesting	
that	
age	ENTITY
may	
actually	
be	
protective	ENTITY
.	

Methodological	ENTITY
differences	ENTITY
preclude	
direct	
comparisons	ENTITY
of	
the	
investigations	ENTITY
,	
as	
do	
wide	
variations	ENTITY
in	
the	
age	ENTITY
groups	ENTITY
studied	
.	

Genetic	ENTITY
factors	ENTITY
also	
can	
influence	ENTITY
the	
development	ENTITY
of	
the	
condition	ENTITY
,	
as	
has	
been	
definitively	
demonstrated	
among	
select	
familial	ENTITY
cohorts	ENTITY
(	
see	
Pathology	ENTITY
and	
Pathophysiology	ENTITY
section	ENTITY
)	
.	

Environmental	ENTITY
influences	ENTITY
may	
precipitate	ENTITY
,	
maintain	ENTITY
,	
or	
exacerbate	ENTITY
the	
advanced	ENTITY
circadian	ENTITY
phase	ENTITY
,	
but	
this	
has	
not	
been	
proven	
.	

ASWPD	ENTITY
has	
been	
reported	
in	
children	ENTITY
with	
neurodevelopmental	ENTITY
disorders	ENTITY
.	

In	
particular	
,	
studies	ENTITY
in	
children	ENTITY
with	
autism	ENTITY
spectrum	ENTITY
disorders	ENTITY
and	
Smith	ENTITY
-	
Magenis	ENTITY
syndrome	ENTITY
have	
shown	
profound	
alterations	ENTITY
in	
melatonin	ENTITY
secretion	ENTITY
profiles	ENTITY
,	
which	
may	
manifest	ENTITY
as	
a	
phase	ENTITY
advance	
with	
very	
early	
morning	ENTITY
waking	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Various	
groups	ENTITY
have	
described	
kindreds	ENTITY
with	
familial	ENTITY
ASWPD	ENTITY
.	

These	
cases	ENTITY
may	
be	
characterized	ENTITY
by	
an	
earlier	
age	ENTITY
of	
onset	ENTITY
.	

It	
is	
not	
clear	
whether	
the	
familial	ENTITY
or	
non-	
familial	ENTITY
variety	
of	
the	
condition	ENTITY
is	
more	
common	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Repetitive	ENTITY
attempts	ENTITY
to	
resume	ENTITY
sleep	ENTITY
with	
awakenings	ENTITY
may	
result	
in	
the	
development	ENTITY
of	
a	
comorbid	ENTITY
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Individuals	ENTITY
may	
use	
alcohol	
,	
other	
sedatives	ENTITY
,	
and/or	
stimulants	ENTITY
to	
alleviate	
symptoms	ENTITY
,	
potentially	
exacerbating	ENTITY
the	
underlying	
sleep/	ENTITY
wake	ENTITY
disorder	ENTITY
.	

The	
impact	ENTITY
on	
caregivers	ENTITY
of	
children	ENTITY
with	
neurodevelopmental	ENTITY
disor-	
ders	ENTITY
and	
ASWPD	ENTITY
may	
be	
particularly	
profound	
.	

Developmental	ENTITY
Issues	ENTITY
ASWPD	ENTITY
is	
most	
frequently	
encountered	
among	
older	ENTITY
age	ENTITY
groups	ENTITY
.	

An	
early	ENTITY
age	ENTITY
of	
onset	
of	
ASWPD	ENTITY
should	
prompt	
further	
probing	
for	
a	
familial	ENTITY
pattern	ENTITY
.	

Caregivers	ENTITY
may	
report	
that	
a	
child	ENTITY
wakes	ENTITY
“	
too	
early	ENTITY
”	
in	
the	
morning	ENTITY
,	
which	
is	
disruptive	
to	
the	
house-	
hold	
routine	ENTITY
and	
may	
curtail	ENTITY
parental	ENTITY
sleep	ENTITY
.	

This	
is	
particularly	
true	
for	
younger	ENTITY
chil-	
dren	ENTITY
,	
who	
may	
require	
adult	ENTITY
supervision	ENTITY
once	
they	
are	
awake	ENTITY
.	

However	
,	
this	
complaint	ENTITY
regarding	
the	
waking	ENTITY
pattern	ENTITY
is	
often	
more	
related	
to	
unrealistic	
caregiver	ENTITY
expecta-	
tions	ENTITY
regarding	
an	
“	
appropriate	ENTITY
”	
wake	ENTITY
time	ENTITY
for	
a	
young	ENTITY
child	ENTITY
and/or	
a	
developmentally	
inappropriate	
early	ENTITY
bedtime	ENTITY
resulting	
in	
prolonged	ENTITY
time	
in	
bed	ENTITY
,	
rather	
than	
to	
a	
true	
advance	
in	
sleep	ENTITY
onset	ENTITY
and	
offset	ENTITY
.	

In	
some	
cases	ENTITY
,	
children	ENTITY
are	
motivated	
to	
wake	
up	
earlier	
than	
desired	
because	
they	
are	
reinforced	ENTITY
for	
this	
behavior	ENTITY
by	
parental	ENTITY
attention	ENTITY
or	
the	
opportunity	
to	
watch	ENTITY
television	ENTITY
or	
utilize	
other	
media	ENTITY
upon	
waking	ENTITY
.	

The	
com-	ENTITY
plaint	ENTITY
that	
a	
child	ENTITY
“	
falls	ENTITY
asleep	ENTITY
too	
early	ENTITY
”	
in	
the	
evening	ENTITY
,	
especially	
in	
adolescence	ENTITY
,	
is	
rare	ENTITY
and	
should	
raise	
concerns	
regarding	
the	
possibility	
of	
chronically	ENTITY
insufficient	ENTITY
sleep	ENTITY
and/or	
a	
sleep	ENTITY
disorder	ENTITY
resulting	
in	
increased	ENTITY
sleep	ENTITY
needs	
.	

The	
rarity	ENTITY
of	
observa-	
tions	ENTITY
of	
advanced	ENTITY
sleep	ENTITY
onset	ENTITY
and	
offset	
times	
among	
young	ENTITY
children	ENTITY
may	
also	
be	
due	
in	
part	
to	
societal	ENTITY
expectations	ENTITY
of	
earlier	
bed	ENTITY
and	
wake	ENTITY
times	ENTITY
for	
this	
age	ENTITY
group	ENTITY
;	
thus	
,	
a	
misalignment	ENTITY
with	
circadian	ENTITY
preference	ENTITY
is	
less	
likely	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Possible	
etiologies	ENTITY
include	
:	
(	
1	
)	
an	
alteration	ENTITY
in	
the	
ability	
of	
the	
circadian	ENTITY
clock	
to	
phase	ENTITY
delay	ENTITY
;	
(	
2	
)	
a	
dominant	ENTITY
phase	
advance	
region	
of	
the	
light	ENTITY
phase	ENTITY
response	ENTITY
curve	ENTITY
to	
entraining	ENTITY
agents	ENTITY
;	
(	
3	
)	
altered	
strength	ENTITY
of	
entraining	ENTITY
agents	ENTITY
,	
such	
as	
light	
exposure	ENTITY
at	
the	
appropriate	
circadian	ENTITY
time	ENTITY
(	
voluntarily	ENTITY
or	
involuntarily	ENTITY
induced	ENTITY
)	
;	
or	
(	
4	
)	
a	
shortened	ENTITY
endogenous	ENTITY
circadian	ENTITY
period	ENTITY
of	
the	
pacemaker	ENTITY
.	

Among	
these	
proposed	
mechanisms	ENTITY
,	
only	
the	
latter	
has	
been	
definitively	
demonstrated	
among	
select	
familial	ENTITY
ASWPD	ENTITY
sub-	
jects	ENTITY
.	

Genetic	ENTITY
analyses	ENTITY
revealed	
a	
missense	ENTITY
mutation	ENTITY
in	
a	
casein	ENTITY
kinase	ENTITY
(	
CK1ε	
)	
binding	ENTITY
region	ENTITY
of	
a	
Period	ENTITY
gene	ENTITY
(	
hPer2	ENTITY
)	
,	
culminating	
in	
hypophosphorylation	ENTITY
by	
CK1ε	ENTITY
in	ENTITY
vitro	ENTITY
.	

Hypophosphorylation	ENTITY
of	
the	
Period	ENTITY
protein	ENTITY
results	ENTITY
in	
promotion	ENTITY
of	
its	
transcription	ENTITY
and	
,	
ultimately	
,	
a	
decrease	ENTITY
in	
the	
period	ENTITY
length	
of	
the	
clock	ENTITY
.	

However	
,	
genetic	ENTITY
het-	
erogeneity	ENTITY
is	
apparent	ENTITY
within	
familial	ENTITY
ASWPD	ENTITY
,	
as	
demonstrated	
by	
the	
fact	
that	
other	
cohorts	ENTITY
from	
this	
same	
study	ENTITY
and	
another	
study	ENTITY
did	
not	
reveal	
mutations	ENTITY
in	
hPer2	ENTITY
.	

A	
separate	
report	ENTITY
of	
a	
Japanese	ENTITY
familial	ENTITY
ASWPD	ENTITY
cohort	ENTITY
described	
a	
missense	ENTITY
mutation	ENTITY
in	
a	
different	
casein	ENTITY
kinase	ENTITY
gene	ENTITY
(	
CKIδ	ENTITY
)	
,	
which	
also	
resulted	
in	
decreased	ENTITY
enzymatic	ENTITY
activity	ENTITY
in	ENTITY
vitro	ENTITY
.	

Yet	
another	
group	ENTITY
described	
associations	ENTITY
between	
hPer1	ENTITY
and	
hPer2	ENTITY
polymorphisms	ENTITY
and	
extreme	
morningness	
circadian	
preferences	ENTITY
(	
questionnaire	ENTITY
-	
based	ENTITY
)	
,	
in	
the	
absence	ENTITY
of	
discrete	ENTITY
ASWPD	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Among	
patients	ENTITY
with	
familial	ENTITY
ASWPD	ENTITY
,	
laboratory	ENTITY
measures	ENTITY
to	
determine	
the	
phase	ENTITY
of	
circadian	ENTITY
rhythms	ENTITY
reliably	
show	
the	
expected	
phase	
advance	
in	
the	
timing	ENTITY
of	
the	
nadir	ENTITY
of	
the	
temperature	ENTITY
rhythm	ENTITY
and	
the	
dim	ENTITY
light	ENTITY
melatonin	ENTITY
onset	ENTITY
,	
in	
comparison	ENTITY
with	
unaf-	
fected	ENTITY
controls	ENTITY
.	

Among	
those	
with	
nonfamilial	ENTITY
ASWPD	ENTITY
,	
a	
wider	
range	
of	
timing	ENTITY
of	
circadian	ENTITY
markers	ENTITY
is	
found	
,	
with	
some	
values	ENTITY
approaching	
those	
of	
unaffected	
controls	ENTITY
.	

Polysomnography	ENTITY
(	
though	
not	
routinely	
indicated	
nor	
required	
for	
the	
diagnosis	ENTITY
)	
,	
when	
performed	
at	
preferred	ENTITY
(	
advanced	
)	
sleep	
times	
,	
is	
essentially	
normal	
for	
age	ENTITY
.	

If	
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
a	
conventional	ENTITY
bedtime	ENTITY
and	
wake	ENTITY
-	
up	
time	ENTITY
is	
enforced	ENTITY
,	
however	
,	
polysomnographic	ENTITY
recording	ENTITY
may	
show	
short	ENTITY
sleep	ENTITY
latency	ENTITY
and	
early	ENTITY
awakening	
with	
curtailment	ENTITY
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
ASWPD	ENTITY
must	
be	
distinguished	
from	
“	
normal	ENTITY
”	
sleep	
patterns	
,	
particularly	
among	
the	
elderly	ENTITY
or	
very	
young	ENTITY
,	
who	
often	
maintain	
advanced	ENTITY
schedules	ENTITY
without	
distress	ENTITY
or	
impaired	ENTITY
functioning	ENTITY
.	

ASWPD	ENTITY
must	
also	
be	
distinguished	
from	
other	
causes	
of	
early	ENTITY
awakening	ENTITY
,	
including	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
practices	
,	
partic-	
ularly	ENTITY
evening	ENTITY
napping	ENTITY
among	
the	
elderly	ENTITY
,	
and	
irregularity	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
should	
also	
be	
considered	
.	

The	
possibility	
of	
a	
“	
free	ENTITY
-	
running	ENTITY
”	
(	
nonentrained	
)	
circadian	ENTITY
rhythm	ENTITY
also	
merits	
consideration	
,	
but	
patients	ENTITY
with	
this	
condition	ENTITY
are	
most	
commonly	
blind	ENTITY
and	
report	ENTITY
only	
periodic	ENTITY
complaints	ENTITY
of	
insomnia	ENTITY
depending	
on	
the	
relative	
rela-	
tionship	ENTITY
between	
the	
internal	ENTITY
rhythm	ENTITY
and	
that	
of	
the	
light	ENTITY
/	
dark	ENTITY
cycle	ENTITY
.	

Major	
depressive	ENTITY
disorder	ENTITY
is	
a	
common	
cause	
of	
early	ENTITY
awakening	ENTITY
that	
must	
be	
considered	
.	

These	
patients	ENTITY
do	
not	
typically	
manifest	ENTITY
the	
early	ENTITY
evening	ENTITY
sleepiness	ENTITY
that	
is	
characteristic	
of	
ASWPD	ENTITY
.	

As	
with	
any	
sleep	ENTITY
disturbances	ENTITY
that	
persists	
over	
time	ENTITY
,	
insomnia	ENTITY
can	
develop	
second-	
arily	ENTITY
.	

The	
Horne	ENTITY
-	
Östberg	ENTITY
questionnaire	ENTITY
(	
or	
other	
chronotype	ENTITY
questionnaire	ENTITY
)	
may	
assist	
in	
determining	
the	
contribution	ENTITY
of	
a	
morningness	ENTITY
circadian	ENTITY
preference	ENTITY
to	
the	
presenting	ENTITY
sleep	ENTITY
/	
wake	ENTITY
complaint	ENTITY
.	

The	
presence	ENTITY
of	
more	
than	
one	
contributing	
variable	ENTITY
seems	
to	
be	
the	
norm	ENTITY
,	
and	
each	
entity	ENTITY
needs	
to	
be	
treated	ENTITY
accordingly	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
existing	
literature	ENTITY
suggests	
that	
clinicians	ENTITY
are	
unlikely	
to	
encounter	
patients	ENTITY
with	
stringently	
defined	
ASWPD	ENTITY
.	

Until	
the	
identification	ENTITY
of	
familial	ENTITY
cohorts	ENTITY
,	
only	
four	
cases	ENTITY
were	
described	
.	

Various	
treatment	ENTITY
trials	ENTITY
also	
support	
this	
contention	
with	
demon-	
stration	ENTITY
of	
objectively	ENTITY
conventional	ENTITY
sleep	ENTITY
and	
wake	ENTITY
times	ENTITY
despite	
study	ENTITY
entry	ENTITY
based	
on	
subjective	ENTITY
reports	ENTITY
of	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
.	

Select	ENTITY
studies	ENTITY
of	
patients	ENTITY
with	
sole	
complaints	ENTITY
of	
maintenance	ENTITY
insomnia	ENTITY
/	
early	ENTITY
-	
morning	ENTITY
awakenings	ENTITY
have	
demonstrated	
marked	
advances	ENTITY
(	
earlier	
timing	ENTITY
)	
of	
physiologically	ENTITY
measured	
circadian	ENTITY
rhythms	ENTITY
.	

The	
absence	ENTITY
of	
the	
early	ENTITY
evening	
sleepiness	ENTITY
complaint	ENTITY
may	
be	
due	
to	
the	
fact	
that	
the	
timing	ENTITY
of	
sleep	ENTITY
onset	ENTITY
can	
be	
more	
readily	
modified	
than	
wake	ENTITY
time	ENTITY
,	
and	
is	
likely	
to	
be	
more	
actively	
resisted	
due	
to	
its	
propensity	
to	
conflict	ENTITY
with	
social	ENTITY
or	
family	ENTITY
obligations	ENTITY
.	

Alternatively	
,	
evening	ENTITY
sleep	ENTITY
that	
occurs	
prior	
to	
entering	
the	
bed	ENTITY
/	
bedroom	ENTITY
may	
not	
be	
reported	
as	
such	
.	

If	
it	
is	
definitively	
demonstrated	
that	
the	
evening	ENTITY
sleepiness	ENTITY
complaint	ENTITY
is	
not	
present	
or	
is	
not	
prominent	
,	
the	
term	
advance	ENTITY
-	
related	ENTITY
sleep	ENTITY
complaints	ENTITY
may	
be	
used	
in	
lieu	
of	
ASWPD	ENTITY
.	

If	
this	
broader	
term	
is	
used	
,	
the	
condition	ENTITY
is	
observed	
more	
commonly	
(	
~7	
%	
of	
respondents	ENTITY
in	
a	
study	ENTITY
of	
individuals	ENTITY
aged	ENTITY
40	
-	
64	
years	ENTITY
)	
.	

There	
is	
limited	
knowledge	ENTITY
of	
the	
pathophysiology	ENTITY
of	
ASWPD	ENTITY
(	
or	
advance	ENTITY
-	
related	ENTITY
sleep	ENTITY
complaints	ENTITY
)	
beyond	
those	
associated	ENTITY
with	ENTITY
select	
cases	ENTITY
of	
familial	ENTITY
ASWPD	ENTITY
.	

Increased	ENTITY
use	
of	
physiologic	ENTITY
circadian	
assessments	ENTITY
will	
require	
the	
development	ENTITY
of	
normative	ENTITY
values	ENTITY
to	
guide	
practitioners	ENTITY
.	

Knowledge	ENTITY
gaps	ENTITY
are	
even	
more	
prominent	
within	
pediat-	
ric	ENTITY
and	
adolescent	ENTITY
populations	ENTITY
.	

Bibliography	ENTITY
Ando	ENTITY
K	ENTITY
,	
Kripke	ENTITY
DF	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S.	
Delayed	ENTITY
and	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
symptoms	ENTITY
.	

Isr	ENTITY
J	ENTITY
Psychiatry	ENTITY
Relat	ENTITY
Sci	ENTITY
2002;39:11–8	ENTITY
.	

Auger	ENTITY
R.	ENTITY
Advance	ENTITY
-	
related	ENTITY
sleep	ENTITY
complaints	ENTITY
and	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Clin	ENTITY
2009;4:219–27	ENTITY
.	

Campbell	ENTITY
SS	ENTITY
,	
Dawson	ENTITY
D	ENTITY
,	
Anderson	ENTITY
MW	ENTITY
.	

Alleviation	ENTITY
of	
sleep	ENTITY
maintenance	ENTITY
insomnia	ENTITY
with	
timed	ENTITY
exposure	ENTITY
to	ENTITY
bright	ENTITY
light	ENTITY
.	

J	
Am	
Geriatr	
Soc	
1993;41:829–36	
.	

Carpen	ENTITY
JD	ENTITY
,	
Archer	
SN	ENTITY
,	
Skene	ENTITY
DJ	ENTITY
,	
Smits	ENTITY
M	ENTITY
,	

von	
Schantz	
M.	
A	
single	ENTITY
-	
nucleotide	ENTITY
polymorphism	ENTITY
in	
the	
5’-untranslated	ENTITY
region	ENTITY
of	
the	
hPER2	ENTITY
gene	ENTITY
is	
associated	ENTITY
with	ENTITY
diurnal	ENTITY
preference	ENTITY
.	

J	
Sleep	
Res	
2005;14:293–7	
.	

Carpen	ENTITY
JD	ENTITY
,	
von	
Schantz	
M	
,	
Smits	ENTITY
M	ENTITY
,	
Skene	ENTITY
DJ	ENTITY
,	
Archer	
SN	ENTITY
.	

A	
silent	ENTITY
polymorphism	ENTITY
in	
the	
PER1	ENTITY
gene	ENTITY
associates	
with	
extreme	
diurnal	ENTITY
preference	ENTITY
in	
humans	ENTITY
.	

J	
Hum	
Genet	
2006;51:1122–5	
.	

Carrier	ENTITY
J	ENTITY
,	
Monk	ENTITY
TH	ENTITY
,	
Buysse	ENTITY
DJ	ENTITY
,	
Kupfer	ENTITY
DJ	ENTITY
.	

Sleep	ENTITY
and	
morningness	ENTITY
-	
eveningness	ENTITY
in	
the	
‘	
middle	ENTITY
’	ENTITY
years	ENTITY
of	ENTITY
life	ENTITY
(	
20	
-	
59	
y	
)	
.	

J	
Sleep	
Res	
1997;6:230–7	
.	

Horne	ENTITY
JA	ENTITY
,	
Ostberg	ENTITY
O.	ENTITY
A	ENTITY
self	ENTITY
-	
assessment	ENTITY
questionnaire	ENTITY
to	
determine	
morningness	ENTITY
-	
eveningness	ENTITY
in	
human	ENTITY
circadian	ENTITY
rhythms	ENTITY
.	

Int	ENTITY
J	ENTITY
Chronobiol	ENTITY
1976;4:97–110	
.	

Jones	ENTITY
C	ENTITY
,	
Campbell	ENTITY
SS	ENTITY
,	
Zone	ENTITY
SE	ENTITY
,	
et	
al	
.	

Familial	ENTITY
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
:	

A	
short	ENTITY
-	
period	ENTITY
circadian	ENTITY
rhythm	ENTITY
variant	ENTITY
in	
humans	ENTITY
.	

Nature	ENTITY
Med	ENTITY
1999;5:1062–5	ENTITY
.	

Kamei	ENTITY
R	ENTITY
,	
Hughes	
L	ENTITY
,	
Miles	ENTITY
L	ENTITY
,	
et	
al	
.	

Advanced	ENTITY
-	
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
studied	
in	
a	
time	
isolation	ENTITY
facility	ENTITY
.	

Chronobiologia	ENTITY
1979;6:115	
.	

Moldofsky	ENTITY
H	ENTITY
,	
Musisi	ENTITY
S	ENTITY
,	
Phillipson	ENTITY
EA	ENTITY
.	

Treatment	ENTITY
of	
a	
case	ENTITY
of	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
by	
phase	ENTITY
advance	ENTITY
chronotherapy	ENTITY
.	

Sleep	ENTITY
1986;9:61–5	ENTITY
.	

Palmer	ENTITY
CR	ENTITY
,	
Kripke	ENTITY
DF	ENTITY
,	
Savage	ENTITY
HC	ENTITY
Jr	ENTITY
,	
Cindrich	ENTITY
LA	ENTITY
,	
Loving	ENTITY
RT	ENTITY
,	
Elliott	ENTITY
JA	ENTITY
.	

Efficacy	ENTITY
of	
enhanced	ENTITY
evening	ENTITY
light	ENTITY
for	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Behav	ENTITY
Sleep	ENTITY
Med	ENTITY
2003;1:213–26	ENTITY
.	

Sack	ENTITY
RL	ENTITY
,	
Auckley	ENTITY
D	ENTITY
,	
Auger	ENTITY
RR	ENTITY
,	
et	
al	
.	
,	
Circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
disorders	ENTITY
:	
part	ENTITY
II	ENTITY
,	
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
,	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
disorder	ENTITY
,	
free	ENTITY
-	
running	ENTITY
disorder	ENTITY
,	
and	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
.	

An	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
review	ENTITY
.	

Sleep	ENTITY
2007;30:1484–501	
.	

Satoh	ENTITY
K	ENTITY
,	
Mishima	ENTITY
K	ENTITY
,	
Inoue	ENTITY
Y	ENTITY
,	ENTITY
Ebisawa	ENTITY
T	ENTITY
,	
Shimizu	
T.	
Two	
pedigrees	ENTITY
of	
familial	ENTITY
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
in	
Japan	ENTITY
.	

Sleep	ENTITY
2003;26:416–7	
.	

Singer	ENTITY
CM	ENTITY
,	
Lewy	ENTITY
AJ	ENTITY
.	

Case	ENTITY
report	ENTITY
:	
use	
of	
the	
dim	ENTITY
light	ENTITY
melatonin	ENTITY
onset	ENTITY
in	
the	
treatment	ENTITY
of	
ASPS	ENTITY
with	
bright	ENTITY
light	ENTITY

[	
abstract	ENTITY
]	
.	

Sleep	ENTITY
Res	ENTITY
1989;18:445	ENTITY
.	

Toh	ENTITY
K	ENTITY
,	
Jones	ENTITY
CR	ENTITY
,	
He	
Y	
,	
et	
al	
.	

An	
hPer2	ENTITY
phosphorylation	ENTITY
site	
mutation	ENTITY
in	
familial	ENTITY
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Science	ENTITY
2001;291:1040–3	
.	

Xu	ENTITY
Y	ENTITY
,	
Padiath	ENTITY
QS	ENTITY
,	
Shapiro	
RE	ENTITY
,	
et	
al	
.	

Functional	ENTITY
consequences	ENTITY
of	
a	
CKIdelta	ENTITY
mutation	ENTITY
causing	
familial	ENTITY
advanced	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
.	

Nature	ENTITY
2005;434:640–4	
.	

Yoon	
IY	ENTITY
,	
Kripke	ENTITY
DF	ENTITY
,	
Elliott	ENTITY
JA	ENTITY
,	
Youngstedt	ENTITY
SD	ENTITY
,	
Rex	ENTITY
KM	ENTITY
,	
Hauger	
RL	ENTITY
.	

Age	ENTITY
-	
related	ENTITY
changes	ENTITY
of	
circadian	ENTITY
rhythms	ENTITY
and	
sleep	ENTITY
-	
wake	ENTITY
cycles	ENTITY
.	

J	
Am	
Geriatr	
Soc	
2003;51:1085–91	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Irregular	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.33	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.23	ENTITY
Alternate	ENTITY
Names	ENTITY
Irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
disorder	ENTITY
,	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	
type	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
or	
caregiver	ENTITY
reports	ENTITY
a	
chronic	ENTITY
or	
recurrent	ENTITY
pattern	ENTITY
of	
irregular	ENTITY
sleep	ENTITY
and	
wake	ENTITY
episodes	ENTITY
throughout	
the	
24	
-	
hour	ENTITY
period	ENTITY
,	
characterized	ENTITY
by	
symptoms	ENTITY
of	
insomnia	ENTITY
during	
the	
scheduled	ENTITY
sleep	ENTITY
period	ENTITY
(	
usually	
at	
night	ENTITY
)	
,	
excessive	ENTITY
sleepiness	
(	
napping	ENTITY
)	
during	
the	
day	ENTITY
,	
or	
both	
.	

B.	ENTITY
Symptoms	ENTITY
are	
present	
for	
at	
least	
three	
months	ENTITY
.	

C.	ENTITY
Sleep	ENTITY
log	ENTITY
and	
,	
whenever	
possible	
,	
actigraphy	ENTITY
monitoring	ENTITY
for	
at	
least	
seven	
days	ENTITY
,	
preferably	
14	
days	ENTITY
,	
demonstrate	
no	
major	
sleep	ENTITY
period	ENTITY
and	
multiple	ENTITY
irregular	ENTITY
sleep	
bouts	
(	
at	
least	
three	
)	
during	
a	
24	
-	
hour	ENTITY
period	ENTITY
.	

D.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disorder	ENTITY
(	
ISWRD	ENTITY
)	
is	
characterized	
by	
lack	ENTITY
of	
a	
clearly	
defined	
circadian	ENTITY
rhythm	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
.	

The	
chronic	ENTITY
or	
recurring	
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
is	
temporally	
disorganized	ENTITY
so	
that	
sleep	ENTITY
and	
wake	ENTITY
episodes	ENTITY
are	
variable	ENTITY
throughout	
the	
24	
-	
hour	ENTITY
cycle	ENTITY
.	

Individuals	ENTITY
have	
symptoms	ENTITY
of	
insomnia	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
,	
depending	
on	
the	
time	ENTITY
of	
day	ENTITY
and	
their	
particular	
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
.	

Associated	
Features	
ISWRD	ENTITY
is	
more	
commonly	
observed	
in	
neurodegenerative	ENTITY
disorders	ENTITY
,	
such	
as	
demen-	
tia	ENTITY
,	
and	
in	
children	ENTITY
with	
developmental	ENTITY
disorders	ENTITY
.	

Individuals	ENTITY
typically	
present	
with	
insomnia	ENTITY
or	
excessive	ENTITY
sleepiness	ENTITY
,	
depending	
on	
the	
time	
of	
day	ENTITY
.	

Sleep	ENTITY
and	
wake	ENTITY
epi-	
sodes	ENTITY
across	
the	
24	
-	
hour	ENTITY
cycle	ENTITY
are	
fragmented	
,	
with	
the	
longest	ENTITY
sleep	ENTITY
bout	ENTITY
being	
typi-	
cally	ENTITY
less	ENTITY
than	
four	
hours	ENTITY
.	

Individuals	ENTITY
or	
caregivers	ENTITY
report	
frequent	
naps	ENTITY
throughout	
the	
daytime	ENTITY
.	

Total	ENTITY
sleep	ENTITY
time	ENTITY
across	
the	
24	
hours	ENTITY
may	
be	
normal	
for	
age	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Older	ENTITY
adults	ENTITY
with	
Alzheimer	ENTITY
disease	ENTITY
who	
experience	ENTITY
sundowning	ENTITY
may	
represent	
a	
clin-	
ical	ENTITY
subtype	ENTITY
with	
more	
severe	ENTITY
sleep	ENTITY
fragmentation	ENTITY
and	
lower	
circadian	ENTITY
rhythm	ENTITY
ampli-	
tude	ENTITY
than	
those	
who	
do	
not	
experience	
sundowning	ENTITY
.	

Demographics	ENTITY
Demographic	ENTITY
patterns	ENTITY
generally	
parallel	
those	
of	
associated	ENTITY
risk	ENTITY
factors	ENTITY
such	
as	
neuro-	ENTITY
developmental	ENTITY
and	
neurodegenerative	ENTITY
disorders	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Neurodegenerative	ENTITY
disorders	ENTITY
such	
as	
Alzheimer	ENTITY
disease	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
and	
Huntington	ENTITY
disease	ENTITY
increase	ENTITY
the	
risk	ENTITY
for	
ISWRD	ENTITY
.	

Children	ENTITY
with	
developmental	ENTITY
disor-	
ders	ENTITY
also	
are	
at	
increased	ENTITY
risk	ENTITY
for	
ISWRD	ENTITY
.	

Poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
and	
lack	ENTITY
of	
exposure	ENTITY
to	ENTITY
external	
synchronizing	ENTITY
agents	ENTITY
such	
as	
light	ENTITY
,	
activity	ENTITY
,	
and	
social	ENTITY
schedules	ENTITY
may	
be	
predisposing	ENTITY
as	
well	
as	
precipitating	
factors	ENTITY
involved	
in	
the	
development	ENTITY
of	
ISWRD	ENTITY
,	
particularly	
in	
the	
institutionalized	ENTITY
elderly	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	
of	
the	
condition	ENTITY
may	
occur	
at	
any	
age	ENTITY
.	

Little	
is	
known	
regarding	
the	
course	ENTITY
and	
complications	ENTITY
of	
ISWRD	ENTITY
in	
adults	ENTITY
.	

Due	
to	
the	
multiple	ENTITY
awakenings	ENTITY
and	
,	
in	
the	
elderly	ENTITY
,	
nocturnal	ENTITY
wandering	ENTITY
,	
falls	ENTITY
can	
be	
an	
indirect	ENTITY
complication	ENTITY
.	

In	
addition	
to	
the	
patient	ENTITY
’s	
sleep	
-	
wake	ENTITY
dysfunction	ENTITY
,	
the	
caregiver	ENTITY
’s	ENTITY
sleep	
is	
often	
disrupted	ENTITY
.	

The	
sleep	ENTITY
and	
wake	
disruption	ENTITY
associated	ENTITY
with	ENTITY
ISWRD	ENTITY
is	
a	
common	
cause	
of	
institutionalization	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Caregivers	ENTITY
may	
report	ENTITY
that	
a	
child	ENTITY
with	
ISWRD	ENTITY
has	
difficulty	ENTITY
falling	ENTITY
asleep	ENTITY
at	
the	
desired	
bedtime	ENTITY
or	
“	
falls	ENTITY
asleep	ENTITY
too	
early	ENTITY
”	
in	
the	
evening	ENTITY
,	
wakes	ENTITY
“	
too	
early	ENTITY
”	
or	
has	
dif-	
ficulty	ENTITY
waking	ENTITY
in	
the	
morning	ENTITY
,	
and/or	
exhibits	
developmentally	
inappropriate	ENTITY
napping	ENTITY
behavior	ENTITY
during	
the	
day	ENTITY
.	

Parents	ENTITY
may	
complain	ENTITY
that	
their	
child	ENTITY
sleeps	ENTITY
too	
much	
or	
too	
little	
or	
at	
inappropriate	ENTITY
times	
.	

Attempts	
to	
keep	
the	
child	ENTITY
awake	ENTITY
during	
the	
day	ENTITY
,	
especially	
during	
sedentary	ENTITY
activities	ENTITY
,	
are	
often	
unsuccessful	
.	

The	
key	
characteristics	ENTITY
that	
distinguish	
ISWRD	ENTITY
from	
other	
sleep	ENTITY
complaints	ENTITY
or	
circadian	ENTITY
sleep	ENTITY
wake	ENTITY
disor-	
ders	ENTITY
are	
the	
lack	ENTITY
of	
prolonged	ENTITY
consolidated	ENTITY
sleep	ENTITY
periods	ENTITY
,	
the	
often	
seemingly	
random	ENTITY
distribution	ENTITY
in	
sleep	ENTITY
periods	ENTITY
across	
the	
24	
-	
hour	ENTITY
day	ENTITY
,	
and	
the	
marked	
day	ENTITY
-	
to	
-	
day	ENTITY
and	
week	ENTITY
-	
to	
-	
week	ENTITY
variability	ENTITY
with	
little	
in	
the	
way	
of	
a	
clearly	
predictable	
major	
sleep-	
wake	ENTITY
pattern	ENTITY
.	

The	
impact	ENTITY
on	
caregivers	ENTITY
’	
sleep	ENTITY
and	
daytime	ENTITY
functioning	ENTITY
is	
likely	
to	
be	
particularly	
profound	
.	

There	
may	
be	
phenotypes	ENTITY
of	
ISWRD	ENTITY
in	
children	ENTITY
,	
with	
differences	
regarding	
symptom	ENTITY
presentation	ENTITY
and	
severity	ENTITY
and	
chronicity	ENTITY
that	
are	
related	
to	
the	
underlying	
condition	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
For	
example	
,	
it	
is	
possible	
that	
children	ENTITY
with	
chronic	ENTITY
neurologic	ENTITY
conditions	ENTITY
such	
as	
autism	ENTITY
or	
chromosomal	ENTITY
syndromes	ENTITY
characterized	ENTITY
by	
developmental	ENTITY
delays	ENTITY
may	
have	
a	
more	
intractable	ENTITY
and	
treatment	ENTITY
resistant	ENTITY
pattern	ENTITY
compared	
with	
children	ENTITY
with	
more	
self	ENTITY
-	
limited	ENTITY
conditions	ENTITY
(	
e.g.	
,	
postconcussion	ENTITY
)	
.	

Although	
ISWRD	ENTITY
appears	
to	
be	
rare	ENTITY
in	
typically	
developing	
children	ENTITY
,	
it	
may	
be	
envi-	
ronmentally	ENTITY
or	
behaviorally	ENTITY
induced	ENTITY
.	

This	
may	
be	
seen	
in	
children	ENTITY
with	
irregular	ENTITY
or	
fragmented	ENTITY
sleep	ENTITY
and	
wake	ENTITY
schedules	ENTITY
because	
of	
a	
chaotic	ENTITY
household	ENTITY
.	

Children	ENTITY
with	
developmental	ENTITY
disorders	ENTITY
are	
at	
increased	ENTITY
risk	ENTITY
for	
ISWRD	ENTITY
.	

For	
example	
,	
children	ENTITY
with	
autism	ENTITY
,	
Asperger	ENTITY
syndrome	ENTITY
,	
or	
pervasive	
developmental	ENTITY
disorder	ENTITY
not	
otherwise	
spec-	
ified	
often	
have	
highly	
irregular	ENTITY
sleep	ENTITY
patterns	ENTITY
.	

In	
addition	
,	
these	
children	ENTITY
often	
have	
circadian	ENTITY
rhythm	ENTITY
abnormalities	
which	
are	
both	
more	
severe	ENTITY
and	
chronic	ENTITY
and	
they	
are	
at	
increased	ENTITY
risk	ENTITY
for	
relapse	ENTITY
.	

Both	
ISWRD	ENTITY
and	
non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disorder	ENTITY
are	
also	
common	
in	
Angelman	ENTITY
syndrome	ENTITY
,	
a	
neurodevelopmental	ENTITY
disorder	ENTITY
associated	ENTITY
with	ENTITY
an	
abnormality	ENTITY
of	
chromosome	ENTITY
15q11	ENTITY
-	ENTITY
q13	ENTITY
,	
and	
have	
been	
reported	
in	
children	ENTITY
with	
Williams	ENTITY
syndrome	ENTITY
,	
a	
neurodevelopmental	ENTITY
genetic	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
physical	ENTITY
abnormalities	ENTITY
and	
a	
dis-	
tinctive	ENTITY
cognitive	ENTITY
profile	ENTITY
with	
intellectual	ENTITY
disabilities	ENTITY
and	
learning	ENTITY
difficulties	ENTITY
.	

Studies	ENTITY
in	
children	ENTITY
and	
adults	ENTITY
with	
autism	ENTITY
spectrum	ENTITY
disorders	ENTITY
and	
in	
children	ENTITY
with	
Smith	ENTITY
-	
Magenis	ENTITY
syndrome	ENTITY
have	
shown	
profound	
alterations	ENTITY
in	
melatonin	ENTITY
secretion	ENTITY
profiles	ENTITY
.	

Smith-	

Magenis	ENTITY
syndrome	ENTITY
is	
a	
developmental	ENTITY
disorder	ENTITY
caused	
by	
an	
abnormality	ENTITY
in	
the	
short	ENTITY
(	
p	
)	
arm	
of	
chromosome	
17	
.	

It	
is	
characterized	
by	
mild	ENTITY
to	
moderate	ENTITY
intellectual	ENTITY
disabil-	
ity	ENTITY
,	
distinctive	
facial	ENTITY
features	ENTITY
,	
sleep	ENTITY
disturbances	ENTITY
,	
and	
behavioral	ENTITY
problems	ENTITY
.	

Decreased	ENTITY
concentrations	ENTITY
of	
melatonin	ENTITY
and	
its	
metabolites	ENTITY
and	
daytime	ENTITY
elevation	ENTITY
and	
abnormal	ENTITY
rhythm	ENTITY
/	
decreased	ENTITY
amplitude	ENTITY
of	
melatonin	ENTITY
secretion	ENTITY
have	
been	
reported	
in	
these	
popu-	
lations	ENTITY
.	

These	
findings	ENTITY
may	
be	
due	
to	
polymorphisms	ENTITY
in	
melatonin	ENTITY
enzymes	ENTITY
synthesis	ENTITY
or	
variants	ENTITY
in	
genes	ENTITY
coding	ENTITY
for	
melatonin	ENTITY
receptors	ENTITY
.	

Other	
postulated	
mechanisms	ENTITY
for	
circadian	ENTITY
rhythm	ENTITY
disturbances	ENTITY
,	
particularly	
ISWRD	ENTITY
,	
in	
these	
populations	ENTITY
include	
clock	ENTITY
gene	ENTITY
polymorphisms	ENTITY
and	
decreased	ENTITY
levels	ENTITY
of	
entrainment	ENTITY
by	
social	ENTITY
/	
environmental	ENTITY
cues	ENTITY
.	

There	
may	
also	
be	
medical	ENTITY
conditions	ENTITY
that	
predispose	
typically	
developing	
children	ENTITY
and	
adolescents	ENTITY
to	
ISWRD	ENTITY
.	

These	
include	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
and	
chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
.	

Brain	ENTITY
tumor	ENTITY
survivors	ENTITY
,	
especially	
patients	ENTITY
who	
have	
experienced	
disrup-	
tion	ENTITY
in	
the	
hypothalamic	ENTITY
-	
pituitary	ENTITY
axis	ENTITY
,	
may	
have	
an	
increased	ENTITY
prevalence	ENTITY
of	
circadian	ENTITY
rhythm	ENTITY
disorders	ENTITY
,	
including	
ISWRD	ENTITY
.	

There	
is	
very	
little	
literature	ENTITY
on	
ISWRD	ENTITY
in	
the	
pediatric	ENTITY
population	ENTITY
;	
prevalence	ENTITY
,	
sex	ENTITY
,	
and	
racial	ENTITY
/	
ethnic	ENTITY
differences	ENTITY
are	
unknown	
.	

Little	
is	
known	
about	
the	
natural	ENTITY
history	ENTITY
of	
the	
clinical	ENTITY
entity	ENTITY
of	
ISWRD	ENTITY
in	
the	
pediatric	ENTITY
population	
,	
including	
the	
impact	ENTITY
of	
various	
treatment	ENTITY
modalities	ENTITY
,	
the	
likelihood	ENTITY
of	
spontaneous	ENTITY
resolution	ENTITY
of	ENTITY
symptoms	ENTITY
,	
or	
long	ENTITY
-	
term	ENTITY
consequences	ENTITY
.	

The	
impact	ENTITY
on	
caregivers	ENTITY
of	
children	ENTITY
with	
neurodevelopmen-	
tal	ENTITY
disorders	ENTITY
and	
ISWRD	ENTITY
may	
be	
particularly	
profound	
.	

The	
prevalence	ENTITY
of	
ISWRD	ENTITY
increases	ENTITY
with	
advancing	
age	ENTITY
,	
but	
it	
is	
likely	
that	
age	ENTITY
-	
re-	ENTITY
lated	ENTITY
increase	ENTITY
in	
neurodegenerative	ENTITY
disorders	ENTITY
,	
rather	
than	
aging	ENTITY
per	
se	
,	
explains	
this	
relationship	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
etiology	ENTITY
of	
ISWRD	ENTITY
is	
likely	
multifactorial	ENTITY
.	

Anatomic	ENTITY
or	
functional	ENTITY
abnormal-	
ities	ENTITY
of	
the	
circadian	ENTITY
clock	
can	
result	
in	
an	
arrhythmic	ENTITY
pattern	ENTITY
of	
rest	ENTITY
and	
activity	ENTITY
.	

Decreased	ENTITY
exposure	ENTITY
to	ENTITY
environmental	ENTITY
-	
entraining	ENTITY
agents	ENTITY
,	
such	
as	
light	ENTITY
and	
structured	ENTITY
physical	ENTITY
and	
social	ENTITY
activities	ENTITY
(	
common	
in	
institutionalized	ENTITY
elderly	ENTITY
,	
and	
children	ENTITY
with	
developmental	ENTITY
disorders	ENTITY
)	
,	
also	
can	
contribute	
to	
the	
development	ENTITY
of	
an	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

In	
addition	
to	
a	
careful	
sleep	ENTITY
history	ENTITY
,	
sleep	ENTITY
log	ENTITY
and	
actigraphy	ENTITY
monitoring	ENTITY
show	
the	
expected	
lack	
of	
a	
clearly	
defined	
circadian	ENTITY
rhythm	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
,	
which	
,	
instead	
,	
is	
characterized	
by	
multiple	
irregular	ENTITY
sleep	
and	
wake	ENTITY
bouts	ENTITY
throughout	
the	
24	
-	
hour	ENTITY
period	ENTITY
.	

The	
use	
of	
sleep	ENTITY
log	ENTITY
and	
actigraphy	ENTITY
is	
indicated	
for	
the	
identification	ENTITY
of	
irregular	ENTITY
sleep	ENTITY
wake	ENTITY
rhythm	ENTITY
.	

The	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
is	
defined	
as	
having	
multiple	ENTITY
sleep	ENTITY
bouts	ENTITY
(	
typically	
2–4	
hours	ENTITY
)	
during	
a	
24	
-	
hour	ENTITY
period	ENTITY
.	

The	
pattern	ENTITY
may	
vary	
from	
day	ENTITY
to	
day	ENTITY
,	
thus	
monitoring	ENTITY
for	
at	
least	
seven	
days	ENTITY
and	
preferably	
14	
days	ENTITY
may	
be	
needed	
to	
differentiate	ENTITY
the	
irregular	ENTITY
pattern	ENTITY
from	
other	
circadian	ENTITY
rhythm	ENTITY
sleep-	
wake	ENTITY
disorders	ENTITY
.	

Polysomnography	ENTITY
is	
not	
required	
to	
establish	
the	
diagnosis	ENTITY
.	

Polysomnography	ENTITY
may	
be	
useful	
for	
the	
diagnosis	ENTITY
of	
other	
comorbid	ENTITY
sleep	ENTITY
disorders	ENTITY
.	

Monitoring	ENTITY
of	
other	
circa-	
dian	
rhythms	ENTITY
,	
such	
as	
core	ENTITY
body	ENTITY
temperature	ENTITY
and	
melatonin	ENTITY
for	
at	
least	
24	
hours	ENTITY
,	
may	
also	
show	
a	
loss	ENTITY
of	
clear	
circadian	ENTITY
rhythmicity	ENTITY
or	
a	
low	ENTITY
amplitude	ENTITY
rhythm	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
and	
voluntary	ENTITY
maintenance	ENTITY
of	
irregular	ENTITY
sleep	ENTITY
schedules	ENTITY
should	
be	
distinguished	
from	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
.	

Individuals	ENTITY
with	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythms	ENTITY
may	
present	
with	
complaints	ENTITY
of	
insomnia	ENTITY
.	

Careful	
analysis	ENTITY
of	
sleep	ENTITY
logs	ENTITY
or	
actigraphy	ENTITY
will	
demonstrate	
multiple	
irregular	ENTITY
periods	ENTITY
of	
sleep	ENTITY
throughout	
the	
24	
-	
hour	ENTITY
cycle	ENTITY
.	

In	
both	
adults	ENTITY
and	
children	ENTITY
,	
other	
causes	
of	
sleep	ENTITY
fragmentation	ENTITY
and	
daytime	ENTITY
Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
napping	ENTITY
,	
including	
comorbid	ENTITY
medical	ENTITY
and	
psychiatric	ENTITY
disorders	ENTITY
,	
other	
sleep	ENTITY
disorders	ENTITY
,	
or	
medication	ENTITY
should	
be	
identified	ENTITY
and	
treated	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
is	
limited	
knowledge	ENTITY
of	
the	
pathophysiology	ENTITY
and	
natural	ENTITY
history	ENTITY
,	
response	ENTITY
to	ENTITY
treatment	ENTITY
,	
and	
complications	ENTITY
of	
the	
disorder	ENTITY
in	
adults	ENTITY
and	
children	ENTITY
.	

Further	
research	ENTITY
into	
the	
relative	
contribution	ENTITY
of	
alterations	ENTITY
in	
environmental	ENTITY
synchronizing	ENTITY
agents	ENTITY
,	
such	
as	
light	ENTITY
and	
activity	ENTITY
,	
versus	
a	
dysfunction	ENTITY
of	
the	
endogenous	ENTITY
circadian	ENTITY
clock	ENTITY
in	
the	
development	ENTITY
of	
irregular	ENTITY
sleep	
and	
wake	ENTITY
patterns	ENTITY
will	
lead	
to	
improved	
understanding	
of	
this	
condition	ENTITY
.	

Bibliography	ENTITY
Hopkins	ENTITY
R	ENTITY
,	
Rindlisbacher	ENTITY
P.	ENTITY
Fragmentation	ENTITY
of	
activity	ENTITY
periods	
in	
Alzheimer	ENTITY
’s	ENTITY
disease	ENTITY
.	

Int	ENTITY
J	ENTITY
Geriatr	ENTITY
Psychiatry	ENTITY
1992;7:805–12	
.	

McCurry	ENTITY
SM	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S.	ENTITY
Sleep	ENTITY
dysfunction	ENTITY
in	
Alzheimer	ENTITY
’s	ENTITY
disease	ENTITY
and	
other	
dementias	ENTITY
.	

Curr	ENTITY
Treat	ENTITY
Options	ENTITY
Neurol	
2003;5:261–72	
.	

Okawa	ENTITY
M	ENTITY
,	
Mishima	ENTITY
K	ENTITY
,	
Hishikawa	ENTITY
Y	ENTITY
,	
Hozumi	ENTITY
S	ENTITY
,	
Hori	
H	
,	
Takahashi	
K.	
Circadian	
rhythm	
disorders	
in	
sleep	ENTITY
-	
waking	ENTITY
and	
body	ENTITY
temperature	ENTITY
in	
elderly	ENTITY
patients	ENTITY
with	
dementia	ENTITY
and	
their	
treatment	ENTITY
.	

Sleep	ENTITY
1991;14:478–85	ENTITY
.	

Pillar	ENTITY
G	ENTITY
,	
Shahar	ENTITY
E	ENTITY
,	
Peled	ENTITY
N	ENTITY
,	
Ravid	ENTITY
S	ENTITY
,	
Lavie	ENTITY
P	ENTITY
,	
Etzioni	ENTITY
A.	ENTITY
Melatonin	ENTITY
improves	ENTITY
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
in	
psychomotor	ENTITY
retarded	ENTITY
children	ENTITY
.	

Pediatr	ENTITY
Neurol	ENTITY
2000;23:225–8	ENTITY
.	

Pollack	ENTITY
C	ENTITY
,	
Stokes	ENTITY
P.	ENTITY
Circadian	ENTITY
rest	ENTITY
-	
activity	ENTITY
rhythms	ENTITY
in	
demented	ENTITY
and	
non	ENTITY
-	
demented	ENTITY
older	ENTITY
community	ENTITY
residents	ENTITY
and	
their	
caregivers	ENTITY
.	

J	
Am	
Geriatr	
Soc	
1997;45:446	
-	
52	
.	

Shochat	ENTITY
T	ENTITY
,	
Martin	
J	
,	
Marler	ENTITY
M	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S.	
Illumination	ENTITY
levels	
in	
nursing	ENTITY
home	ENTITY
patients	ENTITY
:	
Effects	ENTITY
on	
sleep	ENTITY
and	
activity	ENTITY
rhythms	ENTITY
.	

J	
Sleep	
Res	
2000;9:373–9	
.	

Volicer	ENTITY
L	ENTITY
,	
Harper	ENTITY
DG	ENTITY
,	
Manning	ENTITY
BC	ENTITY
,	
Goldstein	ENTITY
R	ENTITY
,	ENTITY
Satlin	ENTITY
A.	ENTITY
Sundowning	ENTITY
and	
circadian	ENTITY
rhythms	ENTITY
in	
Alzheimer	ENTITY
’s	ENTITY
disease	ENTITY
.	

Am	ENTITY
J	ENTITY
Psychiatry	ENTITY
2001;158:704–11	ENTITY
.	

Witting	ENTITY
W	ENTITY
,	
Kwa	ENTITY
I	ENTITY
,	
Eikelenboom	ENTITY
P	ENTITY
,	
Mirmiran	ENTITY
M	ENTITY
,	
Swaab	
D.	
Alterations	ENTITY
in	
the	
circadian	ENTITY
rest	ENTITY
-	
activity	ENTITY
rhythm	ENTITY
in	
aging	ENTITY
and	
Alzheimer	ENTITY
’s	ENTITY
disease	ENTITY
.	

Biol	ENTITY
Psychiatry	ENTITY
1990;27:563–72	ENTITY
.	

Zee	ENTITY
PC	ENTITY
,	
Vitiello	ENTITY
MV	ENTITY
.	

Circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
disorder	ENTITY
:	
irregular	ENTITY
sleep	ENTITY
wake	ENTITY
rhythm	ENTITY
type	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Clin	ENTITY
2009;4:213–8	ENTITY
.	

Non-24	ENTITY
-	
Hour	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Rhythm	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.34	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.24	ENTITY
Alternate	ENTITY
Names	ENTITY
Free	ENTITY
-	
running	ENTITY
disorder	ENTITY
,	
nonentrained	ENTITY
disorder	ENTITY
,	
hypernychthemeral	ENTITY
syndrome	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

There	
is	
a	
history	ENTITY
of	
insomnia	ENTITY
,	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
or	
both	
,	
which	
alternate	
with	
asymptomatic	ENTITY
episodes	ENTITY
,	
due	
to	
misalignment	ENTITY
between	
the	
24	
-	
hour	ENTITY
light	ENTITY
-	
dark	ENTITY
cycle	ENTITY
and	
the	
non	ENTITY
-	
entrained	ENTITY
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
of	
sleep	ENTITY
-	
wake	ENTITY
propensity	ENTITY
.	

B.	ENTITY
Symptoms	ENTITY
persist	
over	
the	
course	ENTITY
of	
at	
least	
three	
months	ENTITY
.	

C.	ENTITY
Daily	ENTITY
sleep	
logs	
and	
actigraphy	ENTITY
for	
at	
least	
14	
days	ENTITY
,	
preferably	
longer	
for	
blind	ENTITY
persons	ENTITY
,	
demonstrate	
a	
pattern	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
times	ENTITY
that	
typically	
delay	ENTITY
each	
day	ENTITY
,	
with	
a	
circadian	ENTITY
period	ENTITY
that	
is	
usually	
longer	
than	
24	
hours	ENTITY
.	

D.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Patients	ENTITY
may	
present	
with	
a	
progressively	
delaying	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
and	
intermittent	ENTITY
insomnia	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
.	

Individual	ENTITY
symptoms	ENTITY
will	
depend	
on	
when	
an	
individual	ENTITY
tries	
to	
sleep	ENTITY
in	
relation	
to	
the	
circadian	ENTITY
rhythm	ENTITY
of	
sleep	ENTITY
-	
wake	ENTITY
propensity	ENTITY
.	

The	
magnitude	ENTITY
of	
the	
daily	ENTITY
delay	ENTITY
will	
depend	
on	
the	
endogenous	ENTITY
circadian	ENTITY
period	ENTITY
,	
and	
may	
range	
from	
less	
than	
30	
minutes	ENTITY
(	
when	
the	
period	ENTITY
is	
close	
to	
24	
hours	ENTITY
)	
to	
more	
than	
an	
hour	ENTITY
(	
when	
the	
period	ENTITY
is	
longer	
than	
25	
hours	ENTITY
)	
.	
.	

The	
symptomatic	ENTITY
episode	ENTITY
will	
typically	
begin	
with	
a	
gradual	
increase	ENTITY
in	
sleep	ENTITY
latency	ENTITY
and	
delayed	ENTITY
sleep	ENTITY
onset	ENTITY
.	

As	
the	
sleep	ENTITY
propensity	ENTITY
rhythm	ENTITY
shifts	
into	
the	
daytime	ENTITY
,	
patients	ENTITY
will	
have	
difficulty	ENTITY
falling	ENTITY
asleep	ENTITY
at	
night	ENTITY
and	
staying	ENTITY
awake	ENTITY
during	
the	
day	ENTITY
.	

As	
the	
sleep	ENTITY
-	
wake	ENTITY
propensity	ENTITY
rhythm	ENTITY
drifts	ENTITY
further	
,	
patients	ENTITY
will	
eventually	
complain	ENTITY
of	
late	ENTITY
afternoon	ENTITY
and	
evening	ENTITY
sleepiness	ENTITY
and	
naps	ENTITY
as	
well	
as	
an	
early	ENTITY
sleep	ENTITY
onset	ENTITY
time	ENTITY
and	
short	ENTITY
sleep	ENTITY
latency	ENTITY
.	
.	

Other	
circadian	ENTITY
rhythms	ENTITY
,	
such	
as	
the	
DLMO	ENTITY
or	
urinary	ENTITY
6	
-	
sulfatoxy-	
melatonin	ENTITY
rhythm	ENTITY
obtained	
at	
two	
time	
points	
2	
-	
4	
weeks	ENTITY
apart	
(	
i.e.	
,	
to	
allow	
sufficient	
time	
for	
the	
drift	
to	
be	
apparent	ENTITY
)	
is	
desirable	
to	
confirm	
the	
nonentrained	ENTITY
rhythm	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Essential	ENTITY
Features	ENTITY
Non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorder	ENTITY
(	
N24SWD	ENTITY
)	
is	
characterized	
by	
symptoms	ENTITY
of	
insomnia	ENTITY
or	
excessive	ENTITY
sleepiness	ENTITY
that	
occur	
because	
the	
intrinsic	ENTITY
circadian	ENTITY
pace-	
maker	ENTITY
is	
not	
entrained	ENTITY
to	
a	
24	
-	
hour	ENTITY
light	ENTITY
/	
dark	ENTITY
cycle	ENTITY
.	

The	
non-24	ENTITY
-	
hour	ENTITY
period	ENTITY
can	
be	
shorter	ENTITY
or	
,	
more	
typically	
,	
longer	
than	
24	
hours	ENTITY
.	

Because	
the	
endogenous	ENTITY
circadian	ENTITY
rhythm	ENTITY
is	
not	
aligned	
to	
the	
external	
24	
-	
hour	ENTITY
environment	ENTITY
,	
symptoms	ENTITY
will	
depend	
on	
when	
an	
individual	ENTITY
tries	
to	
sleep	ENTITY
in	
relation	
to	
the	
circadian	ENTITY
rhythm	ENTITY
of	
sleep	ENTITY
and	
wake	ENTITY
propensity	ENTITY
.	

Individuals	ENTITY
typically	
present	
with	
episodes	ENTITY
of	
difficulty	ENTITY
falling	ENTITY
asleep	
or	
staying	ENTITY
asleep	ENTITY
,	
excessive	ENTITY
sleepiness	ENTITY
or	
both	
,	
alternating	ENTITY
with	
short	
asymp-	
tomatic	ENTITY
periods	ENTITY
.	

The	
severity	ENTITY
of	
individual	ENTITY
sleep	ENTITY
-	
wake	ENTITY
symptoms	ENTITY
can	
be	
variable	ENTITY
.	

Starting	
with	
the	
asymptomatic	ENTITY
period	ENTITY
when	
the	
individual	ENTITY
’s	
endogenous	ENTITY
rhythm	ENTITY
is	
aligned	
to	
the	
external	ENTITY
environment	ENTITY
and	
required	
sleep	ENTITY
-	
wake	ENTITY
times	ENTITY
,	
sleep	ENTITY
latency	ENTITY
will	
gradually	
increase	ENTITY
and	
the	
individual	ENTITY
will	
complain	ENTITY
of	
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
.	

As	
the	
sleep	ENTITY
phase	ENTITY
continues	
to	
drift	
so	
that	
maximal	ENTITY
endogenous	ENTITY
sleep	ENTITY
propensity	
is	
now	
in	
the	
daytime	ENTITY
,	
individuals	ENTITY
will	
have	
trouble	
staying	ENTITY
awake	ENTITY
during	
the	
day	ENTITY
(	
exhibiting	
multiple	ENTITY
daytime	ENTITY
naps	ENTITY
)	
and	
complain	ENTITY
of	
sleepiness	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Most	
individuals	ENTITY
with	
nonentrained	ENTITY
circadian	ENTITY
rhythms	ENTITY
are	
totally	
blind	ENTITY
,	
and	
the	
failure	ENTITY
to	
entrain	ENTITY
circadian	ENTITY
rhythms	ENTITY
is	
related	
to	
the	
lack	ENTITY
of	
photic	ENTITY
input	ENTITY
to	
the	
cir-	ENTITY
cadian	ENTITY
pacemaker	ENTITY
.	

A	
small	
proportion	
of	
totally	
blind	ENTITY
people	ENTITY
may	
retain	
functional	ENTITY
circadian	ENTITY
photoreception	ENTITY
and	
entrained	ENTITY
rhythms	ENTITY
if	
their	
blindness	ENTITY
is	
due	
exclusively	
to	
an	
outer	ENTITY
retina	ENTITY
disorder	ENTITY
(	
rod	ENTITY
and	
cone	ENTITY
layer	ENTITY
)	
with	
retention	ENTITY
of	
functional	ENTITY
,	
intrin-	
sically	ENTITY
photosensitive	ENTITY
retinal	ENTITY
ganglion	ENTITY
cells	ENTITY
and	
the	
retinohypothalamic	ENTITY
pathway	ENTITY
.	

Some	
blind	ENTITY
people	ENTITY
may	
also	
be	
able	
to	
entrain	ENTITY
to	
nonphotic	ENTITY
cues	ENTITY
(	
e.g.	
,	
the	
timing	ENTITY
of	
physical	ENTITY
activity	ENTITY
)	
,	
producing	
entrainment	ENTITY
at	
an	
adverse	ENTITY
phase	ENTITY
in	
some	
cases	ENTITY
.	

In	
sighted	ENTITY
people	ENTITY
,	
social	ENTITY
and	
behavioral	ENTITY
factors	ENTITY
also	
play	
an	
important	
role	
in	
the	
development	ENTITY
and	
maintenance	ENTITY
of	
the	
disorder	ENTITY
,	
as	
there	
is	
an	
increased	ENTITY
incidence	ENTITY
of	
psychiatric	ENTITY
disorders	ENTITY
.	

Occasionally	
,	
the	
disorder	ENTITY
is	
associated	ENTITY
with	ENTITY
developmental	ENTITY
intellectual	ENTITY
disability	ENTITY
or	
dementia	ENTITY
.	

In	
sighted	ENTITY
individuals	ENTITY
,	
there	
is	
often	
a	
history	ENTITY
of	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
,	
and	
decreased	ENTITY
exposure	ENTITY
to	ENTITY
light	ENTITY
and	
structured	ENTITY
social	ENTITY
and	
phys-	
ical	ENTITY
activity	ENTITY
.	

Some	
sighted	ENTITY
individuals	ENTITY
with	
N24SWD	ENTITY
also	
demonstrate	
increased	ENTITY
sleep	ENTITY
duration	ENTITY
.	

Demographics	ENTITY
It	
is	
thought	
that	
over	
half	
of	
totally	
blind	ENTITY
individuals	ENTITY
have	
non-24	ENTITY
-	
hour	ENTITY
circa-	
dian	
rhythms	ENTITY
;	
50	
%	
to	
80	
%	
of	
blind	ENTITY
individuals	ENTITY
complain	ENTITY
of	
sleep	ENTITY
disturbances	ENTITY
.	

The	
prevalence	ENTITY
,	
sex	ENTITY
,	
and	
racial	ENTITY
/	
ethnic	ENTITY
differences	ENTITY
of	
N24SWD	ENTITY
in	
adults	ENTITY
and	
children	ENTITY
are	
unknown	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Total	ENTITY
blindness	ENTITY
is	
the	
most	
common	
predisposing	ENTITY
condition	ENTITY
.	

In	
sighted	ENTITY
people	ENTITY
,	
the	
dis-	
order	
can	
be	
induced	ENTITY
by	
certain	
environmental	ENTITY
conditions	ENTITY
,	
such	
as	
decreased	ENTITY
or	
inap-	
propriately	ENTITY
timed	ENTITY
exposure	ENTITY
to	ENTITY
circadian	ENTITY
entraining	ENTITY
agents	ENTITY
,	
particularly	
light	
.	

Delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
may	
predispose	
to	
N24SWD	ENTITY
in	
sighted	ENTITY
persons	ENTITY
.	

The	
con-	
dition	ENTITY
has	
developed	
after	
chronotherapy	ENTITY
for	
DSWPD	ENTITY
.	

This	
disorder	ENTITY
has	
also	
been	
reported	
in	
adults	ENTITY
following	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Developmental	ENTITY
Issues	ENTITY
Caregivers	ENTITY
may	
report	ENTITY
that	
a	
child	ENTITY
has	
difficulty	ENTITY
falling	ENTITY
asleep	ENTITY
at	
the	
desired	
bedtime	ENTITY
or	
“	
falls	ENTITY
asleep	ENTITY
too	
early	ENTITY
”	
in	
the	
evening	ENTITY
,	
wakes	ENTITY
“	
too	
early	ENTITY
”	
or	
has	
difficulty	ENTITY
waking	ENTITY
in	
the	
morning	ENTITY
and	
staying	ENTITY
awake	ENTITY
during	
the	
day	ENTITY
.	

Parents	ENTITY
may	
complain	ENTITY
that	
their	
child	ENTITY
sleeps	ENTITY
too	
much	
or	
too	
little	
or	
at	
inappropriate	ENTITY
times	
.	

The	
key	
characteristics	ENTITY
that	
distinguish	
N24SWD	ENTITY
from	
other	
sleep	ENTITY
complaints	ENTITY
or	
circadian	ENTITY
sleep	ENTITY
wake	ENTITY
dis-	
orders	ENTITY
are	
twofold	
:	
(	
1	
)	
the	
predictable	
pattern	
of	
misalignment	ENTITY
between	
the	
child	ENTITY
’s	ENTITY
sleep	ENTITY
patterns	ENTITY
and	
the	
light	ENTITY
-	
dark	ENTITY
24	
-	
hour	ENTITY
cycle	ENTITY
(	
progressive	ENTITY
delay	ENTITY
in	
sleep	ENTITY
onset	ENTITY
-	
offset	ENTITY
across	
days	ENTITY
to	
weeks	ENTITY
)	
;	
and	
(	
2	
)	
periods	ENTITY
of	
apparent	ENTITY
“	
symptom	ENTITY
remission	ENTITY
”	
during	
those	
transient	ENTITY
intervals	ENTITY
when	
the	
child	ENTITY
’s	
circadian	
sleep	
-	
wake	ENTITY
propensity	ENTITY
coincides	
with	
the	
desired	
bed	ENTITY
and	
wake	ENTITY
times	ENTITY
.	

The	
impact	ENTITY
on	
caregivers	ENTITY
’	
sleep	ENTITY
and	
daytime	ENTITY
functioning	ENTITY
is	
often	
profound	
.	

Although	
N24SWD	ENTITY
is	
extremely	
rare	ENTITY
in	
typically	
developing	
or	
sighted	ENTITY
children	ENTITY
,	
it	
has	
been	
reported	
with	
some	
frequency	ENTITY
in	
children	ENTITY
with	
intellectual	ENTITY
disabilities	ENTITY
and	
blindness	ENTITY
.	

For	
example	
,	
children	ENTITY
with	
optic	ENTITY
nerve	ENTITY
hypoplasia	ENTITY
due	
to	
a	
variety	
of	
under-	
lying	
causes	
,	
especially	
those	
children	ENTITY
with	
hypoplastic	ENTITY
corpus	ENTITY
callosum	ENTITY
and	
comor-	
bid	ENTITY
severe	
intellectual	ENTITY
and	
visual	ENTITY
impairments	ENTITY
,	
have	
been	
reported	
to	
have	
features	ENTITY
of	
N24SWD	ENTITY
.	
N24SWD	ENTITY
has	
also	
been	
described	
in	
pediatric	ENTITY
patients	ENTITY
with	
Rett	ENTITY
syndrome	ENTITY
(	
a	
genetic	ENTITY
disorder	ENTITY
occurring	
almost	
exclusively	
in	
girls	ENTITY
,	
characterized	
by	
severe	ENTITY
developmental	ENTITY
regression	ENTITY
,	
language	ENTITY
delays	ENTITY
,	
and	
limited	ENTITY
social	ENTITY
interactions	ENTITY
)	
,	
autism	ENTITY
spectrum	ENTITY
disorders	ENTITY
,	
and	
Angelman	ENTITY
syndrome	ENTITY
,	
a	
neurodevelopmental	ENTITY
disorder	ENTITY
asso-	
ciated	ENTITY
with	
an	
abnormality	ENTITY
of	
chromosome	ENTITY
15q11	ENTITY
-	ENTITY
q13	ENTITY
.	

The	
common	
mechanism	ENTITY
in	
all	
of	
these	
disorders	ENTITY
is	
postulated	
to	
be	
lack	ENTITY
of	
entrainment	ENTITY
to	
the	
24	
-	
hour	ENTITY
day	ENTITY
that	
results	ENTITY
from	
the	
failure	ENTITY
to	
perceive	ENTITY
and/or	
attend	ENTITY
to	
social	ENTITY
/	
environmental	ENTITY
zeitgebers	ENTITY
(	
time	ENTITY
cues	ENTITY
)	
.	

There	
have	
also	
been	
several	
case	ENTITY
reports	ENTITY
which	
describe	
the	
emergence	ENTITY
of	
N24SWD	ENTITY
in	
intellectually	ENTITY
normal	ENTITY
sighted	ENTITY
children	ENTITY
or	
adolescents	ENTITY
who	
have	
limited	ENTITY
or	
inappropriate	ENTITY
exposure	ENTITY
to	ENTITY
environmental	ENTITY
and	
other	
entraining	ENTITY
cues	ENTITY
(	
e.g.	
,	
decreased	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
light	ENTITY
during	
the	
day	ENTITY
and/or	
excessive	ENTITY
light	
exposure	ENTITY
in	
the	
evening	ENTITY
)	
.	

These	
individuals	ENTITY
are	
likely	
to	
have	
significant	
psychiatric	ENTITY
impairments	ENTITY
that	
predispose	
them	
to	
avoid-	
ance	ENTITY
of	
social	ENTITY
interactions	ENTITY
(	
e.g.	
,	
anxiety	ENTITY
)	
or	
medical	ENTITY
conditions	ENTITY
that	
involve	
enforced	
prolonged	ENTITY
periods	ENTITY
of	
inactivity	ENTITY
(	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
,	
chronic	ENTITY
fatigue	ENTITY
)	
.	

Little	
is	
known	
about	
the	
natural	ENTITY
history	ENTITY
of	
the	
clinical	ENTITY
entity	ENTITY
of	
N24SWD	ENTITY
in	
the	
pedi-	
atric	ENTITY
population	ENTITY
,	
including	
the	
impact	ENTITY
of	
various	
treatment	ENTITY
modalities	ENTITY
,	
the	
likelihood	ENTITY
of	
spontaneous	ENTITY
resolution	ENTITY
of	ENTITY
symptoms	ENTITY
,	
or	
long	ENTITY
-	
term	ENTITY
consequences	ENTITY
.	

There	
may	
be	
varying	
phenotypes	ENTITY
of	
N24SWD	ENTITY
in	
children	ENTITY
,	
with	
differences	
in	
regard	
to	
symptom	ENTITY
presentation	ENTITY
,	
severity	ENTITY
,	
and	
chronicity	ENTITY
that	
are	
related	
to	
the	
underlying	
condition	ENTITY
.	

For	
example	
,	
it	
is	
likely	
that	
children	ENTITY
with	
chronic	ENTITY
neurologic	ENTITY
conditions	ENTITY
such	
as	
blindness	ENTITY
or	
neurodevelopmental	ENTITY
disabilities	ENTITY
have	
a	
more	
intractable	ENTITY
and	
treat-	
ment	ENTITY
resistant	ENTITY
pattern	ENTITY
compared	
to	
children	ENTITY
with	
more	
self	ENTITY
-	
limited	ENTITY
conditions	ENTITY
(	
e.g.	
,	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
)	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
may	
occur	
at	
any	
age	ENTITY
in	
blind	ENTITY
individuals	ENTITY
,	
coincident	ENTITY
with	ENTITY
loss	ENTITY
of	ENTITY
light	ENTITY
percep-	
tion	ENTITY
,	
and	
,	
in	
congenitally	ENTITY
blind	ENTITY
children	ENTITY
,	
onset	
can	
occur	
from	
birth	ENTITY
or	
during	
infancy	ENTITY
.	

If	
untreated	ENTITY
,	
the	
course	ENTITY
is	
chronic	ENTITY
.	

Attempts	
to	
regulate	ENTITY
sleep	ENTITY
and	
wake	ENTITY
times	ENTITY
may	
involve	
the	
use	
of	
alcohol	ENTITY
,	
sedatives	ENTITY
-	
hypnotics	ENTITY
,	
and	
stimulants	ENTITY
,	
which	
in	
turn	
can	
exac-	
erbate	
the	
underlying	
sleep	ENTITY
disorder	ENTITY
.	

Depressive	ENTITY
symptoms	ENTITY
and	
mood	ENTITY
disorders	ENTITY
can	
be	
comorbid	ENTITY
conditions	ENTITY
,	
particularly	
in	
sighted	ENTITY
patients	ENTITY
.	

The	
adverse	ENTITY
effects	ENTITY
on	
school	ENTITY
or	
work	ENTITY
performance	ENTITY
,	
as	
well	
as	
other	
psychosocial	ENTITY
complications	ENTITY
,	
due	
to	
a	
lack	ENTITY
of	
pre-	
dictable	ENTITY
sleep	ENTITY
and	
wake	ENTITY
times	ENTITY
and	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
are	
key	
motivations	ENTITY
for	
seeking	ENTITY
treatment	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
intrinsic	ENTITY
period	ENTITY
of	
the	
human	ENTITY
circadian	ENTITY
pacemaker	ENTITY
is	
usually	
longer	
than	
24	
hours	ENTITY
and	
requires	
daily	ENTITY
input	ENTITY
from	
the	
environment	ENTITY
to	
maintain	
synchrony	ENTITY
to	
the	
24	
-	
hour	ENTITY
day	ENTITY
.	

The	
light	ENTITY
-	
dark	ENTITY
cycle	ENTITY
is	
the	
most	
important	
environmental	ENTITY
time	ENTITY
cue	
(	
zeitgeber	ENTITY
)	
in	
humans	ENTITY
(	
as	
in	
other	
species	ENTITY
)	
,	
although	
nonphotic	ENTITY
time	ENTITY
cues	ENTITY
also	
play	
a	
role	
in	
normal	ENTITY
entrainment	ENTITY
.	

A	
lack	
of	
photic	ENTITY
input	ENTITY
to	
the	
circadian	ENTITY
pacemaker	ENTITY
is	
clearly	
the	
cause	
of	
nonentrained	ENTITY
rhythms	ENTITY
in	
totally	
blind	ENTITY
people	ENTITY
.	

It	
has	
been	
suggested	
that	
,	
in	
sighted	ENTITY
individuals	ENTITY
,	
a	
systematic	ENTITY
delay	ENTITY
due	
to	
inadequate	ENTITY
exposure	ENTITY
to	ENTITY
light	
may	
contribute	
to	
the	
development	ENTITY
of	
N24SWD	ENTITY
.	

In	
addition	
,	
the	
disorder	ENTITY
may	
be	
caused	
by	
an	
extremely	
prolonged	ENTITY
endogenous	ENTITY
circadian	ENTITY
period	ENTITY
that	
is	
outside	
of	
the	
range	
for	
entrainment	ENTITY
to	
the	
24	
-	
hour	ENTITY
cycle	ENTITY
or	
by	
an	
alteration	ENTITY
in	
the	
response	ENTITY
of	
the	
circadian	ENTITY
clock	
to	
the	
entraining	ENTITY
effects	ENTITY
of	ENTITY
light	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Sleep	ENTITY
studies	ENTITY
yield	
different	
results	ENTITY
depending	
on	
the	
degree	ENTITY
of	
synchrony	ENTITY
between	
sleep	ENTITY
times	ENTITY
and	
the	
circadian	ENTITY
pacemaker	ENTITY
at	
the	
time	
when	
the	
sleep	ENTITY
study	ENTITY
is	
performed	
.	

Recording	ENTITY
of	
sleep	ENTITY
log	ENTITY
and	
actigraphy	ENTITY
over	
prolonged	ENTITY
periods	ENTITY
(	
at	
least	
14	
days	ENTITY
,	
but	
ideally	
longer	
in	
blind	ENTITY
individuals	ENTITY
)	
demonstrate	
the	
lack	ENTITY
of	
a	
stable	ENTITY
relationship	ENTITY
between	
the	
timing	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
and	
the	
24	
-	
hour	ENTITY
day	ENTITY
.	

When	
sleep	ENTITY
sched-	
ules	
follow	
the	
endogenous	ENTITY
circadian	ENTITY
propensity	
for	
sleep	ENTITY
and	
wake	ENTITY
,	
sleep	ENTITY
onset	ENTITY
and	
wake	ENTITY
times	ENTITY
are	
typically	
delayed	ENTITY
each	
day	ENTITY
.	

Serial	ENTITY
measurements	ENTITY
of	
circadian	ENTITY
rhythms	ENTITY
,	
such	
as	
melatonin	ENTITY
,	
usually	
show	
a	
progressive	ENTITY
daily	ENTITY
delay	
of	
the	
phase	ENTITY
of	
the	
rhythm	ENTITY
consistent	ENTITY
with	ENTITY
a	
period	ENTITY
that	
is	
longer	
than	
24	
hours	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiologic	ENTITY
Subtypes	ENTITY
Totally	
blind	ENTITY
patients	ENTITY
with	
N24SWD	ENTITY
are	
clinically	ENTITY
different	
than	
sighted	ENTITY
patients	ENTITY
.	

In	
sighted	ENTITY
patients	ENTITY
with	
N24SWD	ENTITY
,	
the	
circadian	ENTITY
period	ENTITY
is	
often	
25	
hours	ENTITY
or	
longer	ENTITY
,	
whereas	
in	
totally	
blind	ENTITY
patients	ENTITY
with	
the	
disorder	ENTITY
,	
the	
circadian	ENTITY
period	ENTITY
follows	
an	
average	ENTITY
period	ENTITY
length	ENTITY
which	
is	
often	
closer	
to	
24	
hours	ENTITY
and	
rarely	ENTITY
may	
be	
shorter	
than	
24	
hours	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

Some	
individuals	ENTITY
with	
severe	ENTITY
DSWPD	ENTITY
may	
demonstrate	
progressive	ENTITY
delay	ENTITY
of	
their	
sleep	ENTITY
period	ENTITY
by	
30	
minutes	ENTITY
or	
more	
for	
several	
days	ENTITY
,	
and	
their	
symptoms	ENTITY
may	
be	
con-	
fused	ENTITY
with	
N24SWD	ENTITY
.	

Behavioral	ENTITY
factors	ENTITY
and	
psychiatric	ENTITY
disorders	ENTITY
,	
as	
well	
as	
medical	ENTITY
and	
neurological	ENTITY
dis-	
orders	ENTITY
(	
especially	
blindness	ENTITY
,	
but	
also	
dementia	ENTITY
or	
mental	ENTITY
retardation	ENTITY
)	
,	
may	
play	
a	
role	
in	
the	
development	ENTITY
of	
N24SWD	ENTITY
.	

In	
many	
of	
these	
cases	ENTITY
,	
however	
,	
multiple	ENTITY
physio-	ENTITY
logic	ENTITY
,	
behavioral	ENTITY
,	
and	
environmental	ENTITY
factors	ENTITY
contribute	
to	
the	
condition	ENTITY
.	

In	
the	
major-	ENTITY
ity	ENTITY
of	
these	
cases	ENTITY
,	
the	
disorder	ENTITY
should	
be	
coded	
as	
N24SWD	ENTITY
.	

This	
includes	
non-24-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
that	
are	
associated	ENTITY
with	ENTITY
blindness	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
is	
only	
limited	
knowledge	ENTITY
of	
the	
underlying	
pathophysiology	ENTITY
of	
sighted	ENTITY
persons	ENTITY
with	
N24SWD	ENTITY
.	

The	
primary	ENTITY
risk	ENTITY
factor	ENTITY
in	
sighted	ENTITY
persons	ENTITY
appears	
to	
be	
a	
long	ENTITY
circa-	ENTITY
dian	
period	ENTITY
that	
is	
beyond	
the	
range	
of	
entrainment	ENTITY
to	
a	
24	
-	
hour	ENTITY
cycle	ENTITY
or	
a	
progressive	ENTITY
delay	ENTITY
due	
to	
inappropriate	ENTITY
exposure	ENTITY
to	ENTITY
light	
.	

This	
risk	ENTITY
may	
explain	
the	
overlap	ENTITY
between	
DSWPD	ENTITY
and	
N24SWD	ENTITY
.	

Future	
studies	ENTITY
are	
needed	
to	
understand	
the	
role	
of	
genetic	ENTITY
predisposition	ENTITY
,	
environmental	ENTITY
or	
social	ENTITY
cues	ENTITY
and	
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
in	
the	
develop-	
ment	ENTITY
of	
N24SWD	ENTITY
,	
and	
to	
delineate	
other	
health	ENTITY
consequences	ENTITY
of	
the	
condition	ENTITY
.	

There	
are	
substantial	
knowledge	ENTITY
gaps	ENTITY
regarding	
the	
prevalence	ENTITY
,	
pathophysiology	ENTITY
,	
clinical	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
presentation	ENTITY
,	
natural	ENTITY
history	ENTITY
,	
effective	ENTITY
treatment	ENTITY
strategies	ENTITY
,	
and	
prognosis	ENTITY
of	
N24SWD	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
compared	
with	
adults	ENTITY
.	

Bibliography	ENTITY
Ayalon	ENTITY
L	ENTITY
,	
Borodkin	ENTITY
K	ENTITY
,	
Dishon	ENTITY
L	ENTITY
,	
Kanety	
H	
,	
Dagan	
Y.	
Circadian	
rhythm	
sleep	ENTITY
disorders	ENTITY
following	
mild	ENTITY
traumatic	ENTITY
brain	ENTITY
injury	ENTITY
.	

Neurology	ENTITY
2007;68:1136–40	
.	

Boivin	ENTITY
DB	ENTITY
,	
James	ENTITY
FO	ENTITY
,	ENTITY
Santo	ENTITY
JB	ENTITY
,	
Caliyurt	ENTITY
O	ENTITY
,	
Chalk	ENTITY
C.	ENTITY
Non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
syndrome	ENTITY
following	
a	
car	ENTITY
accident	ENTITY
.	

Neurology	ENTITY
2003;60:1841–3	
.	

Czeisler	ENTITY
CA	ENTITY
,	
Shanahan	ENTITY
TL	ENTITY
,	
Klerman	ENTITY
EB	ENTITY
,	
et	
al	
.	

Suppression	ENTITY
of	
melatonin	ENTITY
secretion	ENTITY
in	
some	
blind	ENTITY
patients	ENTITY
by	
exposure	ENTITY
to	ENTITY
bright	ENTITY
light	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
1995;332:6–11	ENTITY
.	

Hayakawa	ENTITY
T	ENTITY
,	
Uchiyama	ENTITY
M	ENTITY
,	
Kamei	ENTITY
Y	ENTITY
,	
et	
al	
.	

Clinical	ENTITY
analyses	ENTITY
of	
sighted	ENTITY
patients	ENTITY
with	
non-24	ENTITY
-	
hour	ENTITY
sleep-	ENTITY
wake	ENTITY
syndrome	ENTITY
:	
A	
study	ENTITY
of	
57	
consecutively	
diagnosed	ENTITY
cases	ENTITY
.	

Sleep	ENTITY
2005;28:945–52	
.	

Lewy	ENTITY
AJ	
,	
Newsome	ENTITY
DA	ENTITY
.	

Different	
types	
of	
melatonin	ENTITY
circadian	ENTITY
secretory	ENTITY
rhythms	ENTITY
in	
some	
blind	ENTITY
subjects	ENTITY
.	

J	
Clin	
Endocrinol	
Metab	
1983;56:1103–7	
.	

Lockley	ENTITY
SW	ENTITY
,	
Arendt	
J	
,	
Skene	ENTITY
DJ	ENTITY
.	

Visual	ENTITY
impairment	ENTITY
and	
circadian	ENTITY
rhythm	ENTITY
disorders	ENTITY
.	

Dialogues	ENTITY
Clin	
Neurosci	
2007;9:301–14	
.	

Lockley	ENTITY
SW	ENTITY
,	
Dijk	
DJ	
,	
Kosti	ENTITY
O	ENTITY
,	
Skene	ENTITY
DJ	ENTITY
,	
Arendt	
J.	
Alertness	
,	
mood	ENTITY
and	
performance	ENTITY
rhythm	
disturbances	ENTITY
associated	ENTITY
with	ENTITY
circadian	ENTITY
sleep	ENTITY
disorders	ENTITY
in	
the	
blind	ENTITY
.	

J	
Sleep	
Res	
2008;17:207–16	
.	

Lockley	ENTITY
SW	ENTITY
,	
Skene	ENTITY
DJ	ENTITY
,	
Butler	ENTITY
LJ	ENTITY
,	
Arendt	ENTITY
J.	ENTITY
Sleep	ENTITY
and	
activity	ENTITY
rhythms	ENTITY
are	
related	
to	
circadian	ENTITY
phase	ENTITY
in	
the	
blind	ENTITY
.	

Sleep	ENTITY
1999;22:616–23	
.	

McArthur	ENTITY
A	ENTITY
,	
Lewy	ENTITY
A	ENTITY
,	
Sack	ENTITY
R.	ENTITY
Non-24	ENTITY
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
syndrome	ENTITY
in	
a	
sighted	ENTITY
man	ENTITY
:	
circadian	ENTITY
rhythm	ENTITY
studies	ENTITY
and	
efficacy	ENTITY
of	
melatonin	ENTITY
treatment	ENTITY
.	

Sleep	ENTITY
1996;19:544–53	
.	

Morgenthaler	ENTITY
TI	ENTITY
,	
Lee	ENTITY
-	
Chiong	ENTITY
T	ENTITY
,	ENTITY
Alessi	ENTITY
C	ENTITY
,	
et	
al	
.	

Practice	ENTITY
parameters	ENTITY
for	
the	
clinical	ENTITY
evaluation	ENTITY
and	
treatment	ENTITY
of	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
disorders	ENTITY
:	
An	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
report	ENTITY
.	

Sleep	ENTITY
2007;30:1445–59	
.	

Sack	ENTITY
RL	ENTITY
,	
Lewy	ENTITY
AJ	ENTITY
,	
Blood	ENTITY
ML	ENTITY
,	
Keith	ENTITY
LD	ENTITY
,	
Nakagawa	ENTITY
H.	
Circadian	
rhythm	
abnormalities	
in	
totally	
blind	ENTITY
people	ENTITY
:	
incidence	ENTITY
and	
clinical	ENTITY
significance	ENTITY
.	

J	
Clin	
Endocrinol	
Metab	
1992;75:127–34	
.	

Uchiyama	ENTITY
M	ENTITY
,	
Lockley	ENTITY
SW	ENTITY
.	

Non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
syndrome	ENTITY
in	
sighted	ENTITY
and	
blind	ENTITY
patients	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Clin	ENTITY
2009;4:195–211	ENTITY
.	

Uchiyama	ENTITY
M	ENTITY
,	
Okawa	ENTITY
M	ENTITY
,	
Shibui	ENTITY
K	ENTITY
,	
et	
al	
.	

Altered	
phase	ENTITY
relation	
between	
sleep	ENTITY
timing	ENTITY
and	
core	ENTITY
body	ENTITY
temperature	
rhythm	ENTITY
in	
delayed	ENTITY
sleep	ENTITY
phase	ENTITY
syndrome	ENTITY
and	
non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
syndrome	ENTITY
in	
humans	ENTITY
.	

Neurosci	ENTITY
Lett	ENTITY
2000;294:101–4	ENTITY
.	

Uchiyama	ENTITY
M	ENTITY
,	
Shibui	ENTITY
K	ENTITY
,	
Hayakawa	ENTITY
T	ENTITY
,	
et	
al	
.	

Larger	ENTITY
phase	ENTITY
angle	ENTITY
between	
sleep	ENTITY
propensity	
and	
melatonin	ENTITY
rhythms	ENTITY
in	
sighted	ENTITY
humans	ENTITY
with	
non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
syndrome	ENTITY
.	

Sleep	ENTITY
2002;25:83–8	
.	

Zaidi	ENTITY
FH	ENTITY
,	
Hull	ENTITY
JT	ENTITY
,	
Peirson	
SN	ENTITY
,	
et	
al	
.	

Short	ENTITY
-	
wavelength	ENTITY
light	ENTITY
sensitivity	ENTITY
of	
circadian	ENTITY
,	
pupillary	ENTITY
,	
and	
visual	ENTITY
awareness	ENTITY
in	
humans	ENTITY
lacking	ENTITY
an	
outer	ENTITY
retina	ENTITY
.	

Curr	ENTITY
Biol	ENTITY
2007;17:2122–8	ENTITY
.	

Shift	ENTITY
Work	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.36	
Alternate	ENTITY
Names	ENTITY
Shift	
work	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.26	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY

A.	ENTITY

There	
is	
a	
report	ENTITY
of	
insomnia	ENTITY
and/or	
excessive	ENTITY
sleepiness	ENTITY
,	
accompanied	
by	
a	
reduction	ENTITY
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
which	
is	
associated	ENTITY
with	ENTITY
a	
recurring	
work	ENTITY
schedule	ENTITY
that	
overlaps	
the	
usual	ENTITY
time	ENTITY
for	
sleep	ENTITY
.	

B.	ENTITY
The	
symptoms	ENTITY
have	
been	
present	
and	
associated	ENTITY
with	ENTITY
the	
shift	
work	ENTITY
schedule	ENTITY
for	
at	
least	
three	
months	ENTITY
.	

C.	ENTITY
Sleep	ENTITY
log	ENTITY
and	
actigraphy	ENTITY
monitoring	ENTITY
(	
whenever	
possible	
and	
preferably	
with	
concurrent	ENTITY
light	
exposure	
measurement	ENTITY
)	
for	
at	
least	
14	
days	ENTITY
(	
work	
and	
free	ENTITY
days	ENTITY
)	
demonstrate	
a	
disturbed	ENTITY
sleep	ENTITY
and	
wake	ENTITY
pattern	ENTITY
.	

D.	

The	
sleep	ENTITY
and/or	
wake	ENTITY
disturbance	ENTITY
are	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Shift	ENTITY
work	ENTITY
disorder	ENTITY
is	
characterized	
by	
complaints	ENTITY
of	
insomnia	ENTITY
or	
excessive	ENTITY
sleepi-	
ness	ENTITY
that	
occur	
in	
association	ENTITY
with	
work	
hours	
that	
occur	
,	
at	
least	
in	
part	
,	
during	
the	
usual	
sleep	ENTITY
episode	ENTITY
.	

There	
are	
several	
types	
of	
shift	ENTITY
-	
work	ENTITY
schedules	ENTITY
,	
including	
evening	ENTITY
shifts	ENTITY
,	
night	ENTITY
shifts	ENTITY
,	
early	ENTITY
morning	ENTITY
shifts	
,	
rotating	ENTITY
shifts	ENTITY
,	
split	ENTITY
shifts	ENTITY
,	
on	
-	
call	ENTITY
overnight	ENTITY
duty	
,	
and	
long	ENTITY
duration	ENTITY
work	ENTITY
shifts	
that	
include	
work	
hours	
at	
night	ENTITY
.	

The	
sleep	ENTITY
distur-	
bance	ENTITY
is	
most	
commonly	
reported	
in	
association	ENTITY
with	ENTITY
night	ENTITY
shifts	ENTITY
,	
early	ENTITY
morning	ENTITY
shifts	
,	
and	
rotating	ENTITY
shifts	ENTITY
.	

Total	ENTITY
sleep	ENTITY
time	ENTITY
is	
typically	
curtailed	ENTITY
by	
one	
to	
four	
hours	ENTITY
,	
and	
sleep	ENTITY
quality	ENTITY
is	
perceived	
as	
unsatisfactory	ENTITY
in	
night	ENTITY
,	
early	ENTITY
morning	ENTITY
,	
and	
rotating	ENTITY
shift	ENTITY
workers	ENTITY
as	
well	
as	
in	
those	
who	
work	
long	ENTITY
-	
duration	ENTITY
shifts	ENTITY
.	

In	
addition	
to	
impairment	ENTITY
of	
performance	ENTITY
at	
work	
,	
reduced	ENTITY
alertness	ENTITY
may	
also	
be	
associated	ENTITY
with	ENTITY
consequences	ENTITY
for	
safety	ENTITY
during	
the	
work	ENTITY
schedule	ENTITY
and	
on	
the	
commute	ENTITY
to	
and	
from	
work	
.	

The	
sleep	ENTITY
disorder	ENTITY
occurs	
despite	
attempts	
to	
optimize	
environmental	ENTITY
conditions	ENTITY
for	
sleep	ENTITY
.	

The	
condition	ENTITY
usually	
persists	
only	
for	
the	
duration	ENTITY
of	
the	
shift	
work	ENTITY
schedule	ENTITY
.	

However	
,	
in	
some	
individuals	ENTITY
,	
the	
sleep	ENTITY
disturbance	ENTITY
may	
persist	
beyond	
the	
duration	ENTITY
of	
shift	
work	
.	

Associated	ENTITY
Features	ENTITY
Early	ENTITY
morning	ENTITY
work	
shifts	
starting	
between	
4:00	
a.m.	
and	
7:00	
a.m.	
can	
also	
be	
asso-	
ciated	ENTITY
with	
complaints	ENTITY
of	
difficulty	ENTITY
in	
sleep	ENTITY
initiation	ENTITY
as	
well	
as	
difficulty	ENTITY
awakening	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Permanent	ENTITY
evening	
shifts	
may	
be	
primarily	
associated	ENTITY
with	ENTITY
sleep	ENTITY
maintenance	ENTITY
dif-	
ficulty	ENTITY
.	

Excessive	ENTITY
sleepiness	ENTITY
usually	
occurs	
during	
work	
shifts	
(	
mainly	
night	ENTITY
,	
early	ENTITY
morning	ENTITY
,	
and	
rotating	ENTITY
shifts	ENTITY
)	
,	
often	
accompanied	
by	
the	
need	
to	
nap	ENTITY
and	
by	
impaired	ENTITY
mental	ENTITY
ability	ENTITY
due	
to	
the	
reduced	ENTITY
alertness	ENTITY
.	

Reduced	ENTITY
alertness	ENTITY
and	
increased	ENTITY
fatigue	ENTITY
throughout	
the	
waking	ENTITY
period	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
reduced	ENTITY
performance	ENTITY
capacity	ENTITY
,	
and	
with	
consequences	ENTITY
for	ENTITY
safety	ENTITY
.	

Also	
,	
major	
portions	ENTITY
of	
free	ENTITY
time	ENTITY
may	
have	
to	
be	
used	
for	
recovery	ENTITY
of	
sleep	ENTITY
,	
resulting	
in	
adverse	ENTITY
social	ENTITY
consequences	ENTITY
.	

When	
compared	ENTITY
with	
shift	ENTITY
workers	ENTITY
without	
shift	
work	ENTITY
disorder	ENTITY
,	
patients	ENTITY
with	
shift	
work	
disorder	
report	ENTITY
greater	
mood	ENTITY
problems	ENTITY
,	
such	
as	
impatience	ENTITY
,	
avoidance	ENTITY
of	
interaction	ENTITY
with	
coworkers	ENTITY
,	
a	
higher	ENTITY
risk	ENTITY
of	
depression	ENTITY
,	
impaired	ENTITY
social	ENTITY
functioning	ENTITY
,	
and	
lower	
coping	ENTITY
skills	ENTITY
.	

Patients	ENTITY
with	
shift	
work	ENTITY
disorder	ENTITY
also	
have	
a	
higher	ENTITY
risk	ENTITY
of	
subjective	ENTITY
health	ENTITY
complaints	ENTITY
,	
ulcers	ENTITY
,	
and	
substance	ENTITY
abuse	ENTITY
.	

Risk	ENTITY
for	
sleepiness	ENTITY
-	
related	ENTITY
errors	ENTITY
and	
accidents	ENTITY
are	
highest	ENTITY
at	
night	ENTITY
,	
especially	
in	
the	
early	ENTITY
morning	ENTITY
hours	
.	

Drowsy	ENTITY
driving	ENTITY
accident	
risk	ENTITY
is	
highest	
in	
the	
morning	ENTITY
hours	ENTITY
when	
night	ENTITY
shift	ENTITY
workers	ENTITY
commute	ENTITY
home	ENTITY
and	
early	ENTITY
morning	
workers	ENTITY
commute	ENTITY
to	
work	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
There	
are	
substantial	
individual	
differences	
in	
the	
ability	
to	
adjust	
to	
shift	
work	
.	

However	
,	
mechanisms	ENTITY
underlying	
these	
individual	ENTITY
differences	
are	
not	
known	
.	

Requirement	ENTITY
of	
extended	
work	ENTITY
hours	ENTITY
,	
such	
as	
on	
-	
call	ENTITY
overnight	ENTITY
duty	ENTITY
and	
long	ENTITY
-	
duration	ENTITY
work	
shifts	
that	
include	
work	
hours	
at	
night	ENTITY
,	
represents	
a	
specific	
clinical	ENTITY
subtype	
.	

In	
addition	
to	
the	
circadian	ENTITY
misalignment	ENTITY
(	
having	
to	
work	
during	
the	
night	ENTITY
)	
,	
sleep	ENTITY
loss	ENTITY
and	
fatigue	ENTITY
associated	ENTITY
with	ENTITY
prolonged	ENTITY
continuous	ENTITY
work	ENTITY
may	
increase	ENTITY
the	
severity	ENTITY
of	
excessive	ENTITY
sleepiness	ENTITY
and	
performance	ENTITY
impairments	ENTITY
.	

Demographics	ENTITY
The	
prevalence	ENTITY
of	
shift	
work	
disorder	
depends	
on	
the	
prevalence	ENTITY
of	
shift	
work	
in	
the	
population	ENTITY
.	

It	
has	
been	
estimated	ENTITY
that	
approximately	
20	
%	
of	
the	
workforce	ENTITY
in	
indus-	
trialized	ENTITY
countries	ENTITY
is	
employed	
in	
a	
job	ENTITY
that	
requires	
shift	
work	
.	

Although	
the	
actual	ENTITY
prevalence	ENTITY
of	
clinically	ENTITY
significant	ENTITY
sleep	ENTITY
disturbance	ENTITY
and	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
due	
to	
work	ENTITY
schedules	ENTITY
is	
unknown	
,	
the	
total	
number	
of	
night	ENTITY
-	
shift	ENTITY
workers	ENTITY
suggests	
that	
an	
estimated	ENTITY
prevalence	ENTITY
of	
2	
%	
to	
5	
%	
of	
the	
general	ENTITY
population	ENTITY
is	
reasonable	
.	

The	
prevalence	ENTITY
of	
shift	
work	ENTITY
disorder	ENTITY
among	
rotating-	
and	
night	ENTITY
-	
shift	ENTITY
workers	ENTITY
has	
been	
estimated	
to	
be	
between	
~10	
%	
and	
38	
%	
.	

These	
figures	ENTITY
do	
not	
,	
however	
,	
include	
individuals	ENTITY
with	
early	ENTITY
morning	ENTITY
or	
split	
shift	
work	
,	
which	
may	
be	
other	
at	
-	
risk	ENTITY
groups	ENTITY
.	

There	
is	
no	
known	
sex	ENTITY
or	
racial	ENTITY
difference	ENTITY
in	
vulnerability	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Depending	
on	
the	
type	
of	
shift	
,	
circadian	ENTITY
preference	ENTITY
may	
influence	ENTITY
the	
ability	
to	
adjust	
to	
or	
tolerate	
shift	
work	
.	

For	
example	
,	
individuals	ENTITY
described	
as	
morning	ENTITY
types	
obtain	
shorter	ENTITY
daytime	ENTITY
sleep	ENTITY
after	
a	
night	ENTITY
shift	
.	

Persons	ENTITY
with	
comorbid	ENTITY
medical	ENTITY
,	
psychiat-	
ric	
,	
and	
other	
sleep	ENTITY
disorders	ENTITY
such	
as	
sleep	ENTITY
apnea	ENTITY
and	
individuals	ENTITY
with	
a	
strong	
need	
for	
stable	ENTITY
hours	
of	
sleep	ENTITY
may	
be	
at	
particular	
risk	ENTITY
.	

Social	ENTITY
pressures	ENTITY
before	
and	
after	
a	
work	
shift	
also	
contribute	
to	
short	ENTITY
sleep	ENTITY
durations	ENTITY
in	
shift	ENTITY
workers	ENTITY
(	
e.g.	
,	
social	ENTITY
inter-	
actions	ENTITY
with	
family	ENTITY
and	
friends	ENTITY
,	
domestic	ENTITY
obligations	ENTITY
,	
a	
second	
job	ENTITY
,	
and	
leisure	ENTITY
activ-	
ities	ENTITY
)	
.	

Social	ENTITY
pressures	ENTITY
also	
diminish	
the	
desire	ENTITY
or	
willingness	ENTITY
to	
maintain	
a	
consis-	
tent	ENTITY
daytime	ENTITY
sleep	
schedule	
on	
days	ENTITY
off	
,	
thereby	
reducing	ENTITY
the	
likelihood	ENTITY
of	
circadian	ENTITY
adjustment	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY

The	
condition	ENTITY
is	
closely	
linked	
to	
work	ENTITY
schedules	ENTITY
and	
typically	
remits	ENTITY
when	
the	
major	
sleep	ENTITY
episode	ENTITY
is	
scheduled	ENTITY
at	
a	
conventional	ENTITY
time	ENTITY
.	

Because	
there	
are	
so	
many	
different	
work	ENTITY
schedules	ENTITY
,	
ranging	
from	
an	
occasional	
overnight	
shift	
to	
regular	ENTITY
night	ENTITY
work	ENTITY
,	
the	
course	ENTITY
is	
quite	ENTITY
variable	ENTITY
.	

Because	
shift	
work	
is	
often	
combined	
with	
extended	
hours	
of	
duty	ENTITY
,	
fatigue	ENTITY
can	
be	
a	
complicating	ENTITY
factor	ENTITY
.	

Circadian	ENTITY
adaptation	ENTITY
is	
often	
counteracted	
by	
exposure	ENTITY
to	ENTITY
light	
at	
the	
wrong	
time	
of	
the	
day	ENTITY
and	
the	
tendency	
of	
most	
workers	ENTITY
to	
resume	ENTITY
full	
daytime	ENTITY
activities	ENTITY
and	
nighttime	ENTITY
sleep	ENTITY
during	
weekends	ENTITY
and	
vacations	ENTITY
.	

It	
has	
been	
hypothesized	
that	
in	
some	
individuals	ENTITY
,	
the	
condition	ENTITY
may	
lead	
to	
chronic	ENTITY
sleep	ENTITY
disturbances	ENTITY
.	

Complications	ENTITY
may	
include	
exacerbation	ENTITY
of	
gastrointestinal	ENTITY
,	
met-	ENTITY
abolic	ENTITY
,	
reproductive	ENTITY
,	
neoplastic	ENTITY
,	
and	
cardiovascular	ENTITY
disorders	ENTITY
.	

Disruptions	ENTITY
of	
social	ENTITY
and	
family	ENTITY
life	ENTITY
are	
frequent	ENTITY
.	

Drug	ENTITY
and	
alcohol	ENTITY
dependency	ENTITY
may	
result	
from	
attempts	
to	
improve	ENTITY
the	
sleep	ENTITY
and	
wakefulness	ENTITY
disturbances	ENTITY
produced	
by	
shift	
work	
.	

Fatigue	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
due	
to	
the	
combination	ENTITY
of	
sleep	ENTITY
loss	ENTITY
and	
circadian	ENTITY
misalignment	ENTITY
pose	
important	
safety	ENTITY
concerns	ENTITY
.	

The	
level	ENTITY
of	
alertness	ENTITY
required	
of	
the	
worker	ENTITY
,	
in	
addi-	
tion	ENTITY
to	
the	
intensity	ENTITY
of	
symptoms	ENTITY
,	
needs	
to	
be	
taken	
into	
account	
when	
evaluating	ENTITY
the	
disorder	ENTITY
.	

For	
example	
,	
the	
threshold	ENTITY
for	
intervention	ENTITY
may	
be	
lower	
for	
workers	ENTITY
whose	
performance	ENTITY
is	
critical	
for	
personal	ENTITY
or	
public	ENTITY
safety	ENTITY
(	
for	
example	
,	
health	ENTITY
care	ENTITY
workers	ENTITY
or	
nuclear	ENTITY
power	ENTITY
plant	ENTITY
or	
public	ENTITY
transport	ENTITY
operators	ENTITY
)	
.	

Developmental	ENTITY
Issues	ENTITY
Not	
applicable	
or	
known	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Pathology	ENTITY
and	
Pathophysiology	ENTITY

The	
condition	ENTITY
is	
thought	
to	
be	
directly	
related	
to	
circadian	ENTITY
misalignment	ENTITY
and	
sleep	ENTITY
loss	ENTITY
.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
generated	
by	
a	
circadian	ENTITY
alerting	ENTITY
process	ENTITY
that	
corre-	
sponds	ENTITY
with	
the	
time	ENTITY
that	
the	
worker	ENTITY
needs	
to	
sleep	ENTITY
.	

The	
excessive	ENTITY
sleepiness	ENTITY
during	
the	
night	ENTITY
and	
early	ENTITY
morning	ENTITY
appears	
to	
be	
partly	
related	
to	
cumulative	ENTITY
sleep	ENTITY
loss	ENTITY
and	
partly	
due	
to	
a	
decreased	ENTITY
circadian	ENTITY
alerting	ENTITY
signal	ENTITY
that	
corresponds	
with	
the	
work	ENTITY
time	ENTITY
and	
the	
commute	ENTITY
to	
and	
from	
work	
.	

Tolerance	ENTITY
to	
night	ENTITY
work	
varies	
considerably	
and	
may	
involve	
differences	
in	
the	
degree	ENTITY
of	
circadian	ENTITY
adaptation	ENTITY
(	
“	
clock	ENTITY
resetting	ENTITY
”	
)	
to	
a	
night	ENTITY
-	
work	ENTITY
,	
day	ENTITY
-	
sleep	ENTITY
schedule	ENTITY
.	

Alternatively	
,	
tolerance	ENTITY
may	
be	
related	
to	
individual	
differences	
in	
response	ENTITY
to	
circadian	ENTITY
and	
homeostatic	ENTITY
influences	ENTITY
on	
sleep	ENTITY
and	
wakeful-	
ness	ENTITY
regulation	ENTITY
.	

Environmental	ENTITY
and	
social	ENTITY
factors	ENTITY
may	
exacerbate	ENTITY
sleep	ENTITY
loss	ENTITY
associated	ENTITY
with	ENTITY
shift	
work	ENTITY
schedules	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

The	
condition	ENTITY
can	
usually	
be	
diagnosed	ENTITY
by	
history	ENTITY
.	

Sleep	ENTITY
logs	ENTITY
and	
actigraphy	ENTITY
are	
rec-	
ommended	
to	
demonstrate	
a	
disrupted	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
consistent	ENTITY
with	ENTITY
shift	
work	ENTITY
disorder	ENTITY
.	

Polysomnographic	ENTITY
recordings	ENTITY
,	
while	
not	
required	
for	
the	
diagnosis	ENTITY
,	
are	
useful	
if	
the	
etiology	ENTITY
of	
the	
sleep	ENTITY
disturbance	ENTITY
is	
in	
question	
(	
for	
example	
to	
rule	
out	
sleep	ENTITY
apnea	ENTITY
or	
narcolepsy	ENTITY
)	
.	

Polysomnography	ENTITY
during	
a	
typical	
daytime	ENTITY
sleep	ENTITY
episode	
after	
a	
work	
shift	
also	
can	
be	
useful	
to	
determine	
the	
severity	ENTITY
of	
the	
sleep	ENTITY
disruption	ENTITY
,	
although	
this	
is	
undertaken	
almost	
exclusively	
for	
research	ENTITY
studies	ENTITY
of	
shift	
work	
disor-	
der	
.	

Polysomnography	ENTITY
may	
demonstrate	
impaired	ENTITY
sleep	ENTITY
quality	ENTITY
,	
with	
prolonged	ENTITY
sleep	ENTITY
latency	ENTITY
,	
sleep	ENTITY
maintenance	ENTITY
difficulty	ENTITY
,	
or	
shortened	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
depending	
on	
the	
timing	ENTITY
of	
the	
sleep	ENTITY
episode	ENTITY
in	
relation	
to	
the	
underlying	
phase	ENTITY
of	
the	
circadian	ENTITY
timing	ENTITY
system	ENTITY
.	

The	
sleep	ENTITY
episode	ENTITY
may	
be	
fragmented	
,	
with	
frequent	ENTITY
arousals	ENTITY
and	
awaken-	
ings	ENTITY
.	

The	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
(	ENTITY
MSLT	ENTITY
)	
may	
demonstrate	
excessive	ENTITY
sleepiness	ENTITY
during	
the	
time	ENTITY
of	
the	
work	
shift	
.	

If	
available	
,	
measures	ENTITY
of	
the	
unmasked	
melatonin	ENTITY
rhythm	ENTITY
are	
useful	
to	
indicate	
the	
degree	ENTITY
of	
circadian	ENTITY
misalignment	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
excessive	ENTITY
sleepiness	ENTITY
should	
be	
differentiated	
from	
that	
caused	
by	
other	
primary	ENTITY
sleep	ENTITY
disorders	ENTITY
such	
as	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
or	
narcolepsy	ENTITY
.	

Insufficient	ENTITY
sleep	ENTITY
related	
to	
conflicting	
daytime	ENTITY
activities	ENTITY
(	
for	
example	
,	
child	ENTITY
care	ENTITY
)	
or	
from	
environmental	ENTITY
interference	ENTITY
with	
sleep	ENTITY
(	
for	
example	
,	
daytime	ENTITY
noise	ENTITY
)	
often	
contributes	
to	
sleepiness	ENTITY
.	

Sometimes	
patients	ENTITY
with	
DSWPD	ENTITY
may	
adopt	
a	
night	ENTITY
-	
work	ENTITY
schedule	ENTITY
that	
is	
more	
con-	
gruent	ENTITY
with	
their	
sleep	ENTITY
preferences	ENTITY
.	

Insomnia	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
may	
also	
suggest	
other	
persistent	ENTITY
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
.	

However	
,	
historical	ENTITY
informa-	
tion	ENTITY
on	
the	
relation	
between	
the	
occurrence	ENTITY
of	
disturbed	ENTITY
sleep	ENTITY
and	
work	ENTITY
-	
hour	ENTITY
distribu-	
tion	ENTITY
should	
provide	
sufficient	
information	ENTITY
to	
indicate	
the	
correct	
diagnosis	ENTITY
.	

Increasing	ENTITY
frustration	ENTITY
,	
negative	ENTITY
expectations	ENTITY
,	
and	
poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
may	
predispose	
the	
person	ENTITY
to	
the	
development	ENTITY
of	
coexisting	ENTITY
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
that	
could	
persist	
beyond	
the	
shift	
work	ENTITY
schedule	ENTITY
(	
i.e.	
,	
shift	
work	
may	
represent	
a	
precipitating	ENTITY
event	ENTITY
that	
leads	
to	
chronic	ENTITY
problems	ENTITY
with	
insomnia	ENTITY
)	
.	

Drug	ENTITY
and	
alcohol	ENTITY
abuse	ENTITY
or	
dependency	ENTITY
may	
result	
from	
efforts	
to	
treat	ENTITY
the	
sleep	ENTITY
disturbance	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Although	
there	
is	
sufficient	
information	ENTITY
regarding	
the	
prevalence	ENTITY
of	
shift	
work	
in	
indus-	
trialized	ENTITY
populations	ENTITY
,	
less	
information	ENTITY
is	
available	
regarding	
the	
actual	ENTITY
prevalence	ENTITY
of	
shift	
work	ENTITY
disorder	ENTITY
and	
its	
impact	ENTITY
on	
health	ENTITY
and	
safety	ENTITY
.	

Further	
research	ENTITY
is	
needed	
to	
improve	ENTITY
the	
definition	ENTITY
of	
what	
constitutes	
shift	
work	ENTITY
disorder	ENTITY
,	
to	
develop	
diagnostic	ENTITY
tools	ENTITY
for	
shift	
work	ENTITY
disorder	ENTITY
,	
to	
determine	
the	
prevalence	ENTITY
of	
shift	
work	ENTITY
disorder	ENTITY
using	
diagnostic	ENTITY
criteria	ENTITY
,	
to	
elucidate	
the	
burden	ENTITY
of	
shift	
work	ENTITY
disorder	ENTITY
over	
and	
above	
that	
which	
may	
be	
due	
to	
shift	
work	
in	
general	
,	
to	
investigate	ENTITY
mechanisms	ENTITY
underlying	
the	
health	ENTITY
and	
safety	ENTITY
consequences	ENTITY
of	ENTITY
shift	
work	ENTITY
disorder	ENTITY
,	
and	
to	
determine	
which	
shift	ENTITY
workers	ENTITY
are	
at	
greatest	
risk	ENTITY
of	
shift	
work	ENTITY
disorder	ENTITY
.	

Furthermore	
,	
there	
is	
limited	
information	ENTITY
on	
the	
role	
of	
age	ENTITY
,	
sex	ENTITY
,	
and	
circadian	ENTITY
chronotype	ENTITY
on	
the	
vulnerability	ENTITY
to	
shift	
work	ENTITY
disorder	ENTITY
.	

Bibliography	ENTITY
Akerstedt	ENTITY
T.	
Shift	
work	
and	
disturbed	ENTITY
sleep	ENTITY
/	
wakefulness	ENTITY
.	

Occup	ENTITY
Med	ENTITY
2003;53:89–94	ENTITY
.	

Ancoli	ENTITY
-	
Israel	ENTITY
S	
,	
Cole	ENTITY
R	ENTITY
,	
Alessi	
C	
,	
Chambers	ENTITY
M	ENTITY
,	
Moorcroft	ENTITY
W	ENTITY
,	
Pollak	ENTITY
C.	ENTITY

The	
role	
of	
actigraphy	ENTITY
in	
the	
study	ENTITY
of	
sleep	ENTITY
and	
circadian	ENTITY
rhythms	ENTITY
.	

Sleep	ENTITY
2003;26:342–92	
.	

Boggild	ENTITY
H	ENTITY
,	
Knutsson	
A.	
Shift	
work	
,	
risk	ENTITY
factors	ENTITY
and	
cardiovascular	ENTITY
disease	ENTITY
.	

Scand	
J	
Work	
Environ	
Health	
1999;25:85–99	
.	

Costa	ENTITY
G.	
Shift	
work	
and	
occupational	ENTITY
medicine	ENTITY
:	
an	
overview	ENTITY
.	

Occup	ENTITY
Med	ENTITY
2003;53:83–8	ENTITY
.	

Drake	ENTITY
CL	ENTITY
,	
Roehrs	ENTITY
T	ENTITY
,	
Richardson	ENTITY
G	ENTITY
,	
Walsh	
JK	
,	
Roth	
T.	
Shift	
work	ENTITY
sleep	ENTITY
disorder	ENTITY
:	
prevalence	ENTITY
and	
consequences	ENTITY
beyond	
that	
of	
symptomatic	ENTITY
day	ENTITY
workers	ENTITY
.	

Sleep	ENTITY
2004;27:1453–62	
.	

Drake	ENTITY
CL	ENTITY
,	
Wright	ENTITY
KP	ENTITY
Jr.	ENTITY
Shift	ENTITY
work	ENTITY
,	
shift	
work	ENTITY
disorder	ENTITY
,	
and	
jet	ENTITY
lag	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

Philadelphia	ENTITY
:	
Elsevier	
Saunders	
,	
2011:784–98	
.	

Flo	ENTITY
E	ENTITY
,	
Pallesen	ENTITY
S	ENTITY
,	
Magerøy	ENTITY
N	ENTITY
,	
et	
al	
.	

Shift	ENTITY
work	ENTITY
disorder	ENTITY
in	
nurses	ENTITY
--	
assessment	ENTITY
,	
prevalence	ENTITY
and	
related	
health	ENTITY
problems	ENTITY
.	

PLoS	ENTITY
One	
2012;7	
:	
e33981	ENTITY
.	

Folkard	ENTITY
S	ENTITY
,	
Tucker	
P.	
Shift	
work	
,	
safety	ENTITY
and	
productivity	ENTITY
.	

Occup	ENTITY
Med	ENTITY
2003;53:95–101	
.	

Horne	
J	
,	
Reyner	
L.	
Vehicle	
accidents	
related	
to	
sleep	ENTITY
:	
a	
review	ENTITY
.	

Occup	ENTITY
Environ	ENTITY
Med	ENTITY
1999;56:289–94	ENTITY
.	

Knutsson	ENTITY
A.	ENTITY
Health	ENTITY
disorders	ENTITY
of	
shift	ENTITY
workers	ENTITY
.	

Occup	ENTITY
Environ	ENTITY
Med	ENTITY
2003;53:103–8	ENTITY
.	

Swanson	ENTITY
LM	ENTITY
,	
Arnedt	ENTITY
JT	ENTITY
,	
Rosekind	ENTITY
MR	ENTITY
,	
Belenky	ENTITY
G	ENTITY
,	
Balkin	ENTITY
TJ	ENTITY
,	
Drake	ENTITY
C.	ENTITY
Sleep	ENTITY
disorders	ENTITY
and	
work	ENTITY
performance	ENTITY
:	
findings	ENTITY
from	
the	
2008	
National	ENTITY
Sleep	ENTITY
Foundation	ENTITY
Sleep	ENTITY
in	
America	ENTITY
poll	ENTITY
.	

J	
Sleep	
Res	
2011;20:487–94	
.	

Waage	ENTITY
S	ENTITY
,	
Moen	ENTITY
BE	ENTITY
,	
Pallesen	ENTITY
S	ENTITY
,	
et	
al	
.	

Shift	ENTITY
work	ENTITY
disorder	ENTITY
among	
oil	ENTITY
rig	ENTITY
workers	ENTITY
in	
the	
North	ENTITY
Sea	ENTITY
.	

Sleep	ENTITY
2009;32:558–65	
.	

Wright	ENTITY
KP	ENTITY
Jr	ENTITY
,	
Bogan	ENTITY
RK	ENTITY
,	
Wyatt	ENTITY
JK	ENTITY
.	

Shift	ENTITY
work	ENTITY
and	
the	
assessment	ENTITY
and	
management	ENTITY
of	
shift	ENTITY
work	ENTITY
disorder	ENTITY
(	
SWD	ENTITY
)	
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2013;17:41–54	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	
-	
Wake	ENTITY
Disorders	ENTITY
Jet	ENTITY
Lag	ENTITY
Disorder	ENTITY
Jet	
lag	
,	
time	ENTITY
zone	ENTITY
change	ENTITY
syndrome	ENTITY
,	
jet	ENTITY
lag	ENTITY
syndrome	ENTITY
,	
jet	ENTITY
lag	ENTITY
type	ENTITY
.	

ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.35	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.25	ENTITY
Alternate	ENTITY
Names	ENTITY
Diagnostic	ENTITY
Criteria	ENTITY
Criteria	
A	
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

There	
is	
a	
complaint	ENTITY
of	
insomnia	ENTITY
or	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
accompanied	
by	
a	
reduction	ENTITY
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
associated	ENTITY
with	ENTITY
transmeridian	ENTITY
jet	ENTITY
travel	ENTITY
across	
at	
least	
two	
time	ENTITY
zones	ENTITY
.	

B.	ENTITY
There	
is	
associated	ENTITY
impairment	ENTITY
of	
daytime	ENTITY
function	ENTITY
,	
general	ENTITY
malaise	ENTITY
,	
or	
somatic	ENTITY
symptoms	ENTITY
(	
e.g.	
,	
gastrointestinal	ENTITY
disturbance	ENTITY
)	
within	
one	
to	
two	
days	ENTITY
after	
travel	ENTITY
.	

C.	

The	
sleep	ENTITY
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Jet	ENTITY
lag	ENTITY
disorder	ENTITY
is	
characterized	
by	
a	
temporary	ENTITY
mismatch	ENTITY
between	
the	
timing	ENTITY
of	
the	
sleep	ENTITY
and	
wake	ENTITY
cycle	ENTITY
generated	
by	
the	
endogenous	ENTITY
circadian	ENTITY
clock	ENTITY
and	
that	
of	
the	
sleep	ENTITY
and	
wake	ENTITY
pattern	ENTITY
required	
by	
a	
change	
in	
time	ENTITY
zone	ENTITY
.	

Individuals	ENTITY
complain	ENTITY
of	
disturbed	ENTITY
sleep	ENTITY
,	
sleepiness	ENTITY
and	
fatigue	ENTITY
,	
and	
impaired	ENTITY
daytime	ENTITY
function	ENTITY
.	

The	
severity	ENTITY
and	
duration	ENTITY
of	
symptoms	ENTITY
is	
dependent	
on	
the	
number	
of	
time	ENTITY
zones	ENTITY
traveled	ENTITY
,	
the	
ability	
to	
sleep	ENTITY
while	
traveling	ENTITY
,	
exposure	ENTITY
to	ENTITY
appropriate	
circadian	ENTITY
times	
cues	ENTITY
in	
the	
new	
environment	ENTITY
,	
tolerance	ENTITY
to	
circadian	ENTITY
misalignment	ENTITY
when	
awake	ENTITY
during	
the	
bio-	
logical	ENTITY
night	ENTITY
,	
and	
the	
direction	ENTITY
of	
the	
travel	ENTITY
.	

Eastward	ENTITY
travel	ENTITY
(	
requiring	
advancing	
circadian	ENTITY
rhythms	ENTITY
and	
sleep	ENTITY
-	
wake	ENTITY
hours	ENTITY
)	
is	
usually	
more	
difficult	
to	
adjust	
to	
than	
westward	ENTITY
travel	ENTITY
.	

Associated	
Features	

In	
addition	
to	
sleep	ENTITY
disturbance	ENTITY
and	
decreased	ENTITY
daytime	ENTITY
alertness	ENTITY
,	
associated	ENTITY
features	ENTITY
may	
include	
general	ENTITY
malaise	ENTITY
and	
gastrointestinal	ENTITY
symptoms	ENTITY
.	

Numerous	
other	
variables	ENTITY
related	
to	
travel	ENTITY
,	
such	
as	
sleep	ENTITY
loss	ENTITY
,	
decreased	ENTITY
mobility	ENTITY
,	
and	
alcohol	ENTITY
and/or	
caffeine	ENTITY
intake	ENTITY
,	
contribute	
to	
the	
overall	ENTITY
fatigue	ENTITY
.	

Daytime	ENTITY
sleepiness	ENTITY
can	
lead	
to	
memory	ENTITY
diffi-	
culties	ENTITY
,	
problems	ENTITY
concentrating	
,	
driving	ENTITY
and	
flying	ENTITY
,	
and	
to	
impaired	ENTITY
decision	ENTITY
-	
making	ENTITY
.	

Sleepiness	ENTITY
,	
sleep	ENTITY
disturbance	ENTITY
and	
circadian	ENTITY
misalignment	ENTITY
associated	ENTITY
with	ENTITY
jet	
lag	
may	
also	
impair	ENTITY
athletic	ENTITY
performance	ENTITY
.	

Effects	ENTITY
of	ENTITY
jet	ENTITY
lag	ENTITY
not	
only	
affect	
travelers	ENTITY
,	
but	
also	
can	
have	
significant	
consequences	ENTITY
for	
airline	ENTITY
pilots	ENTITY
and	
flight	ENTITY
attendants	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
There	
are	
individual	
differences	
in	
the	
ability	
to	
adjust	
to	
rapid	
shifts	
in	
time	ENTITY
zones	ENTITY
;	
however	
,	
specific	
clinical	ENTITY
subtypes	ENTITY
have	
not	
been	
identified	ENTITY
.	

Demographics	ENTITY
Jet	ENTITY
lag	ENTITY
affects	
all	
age	ENTITY
,	
sex	ENTITY
,	
and	
racial	ENTITY
groups	ENTITY
.	

Limited	ENTITY
available	
data	ENTITY
suggest	
that	
older	ENTITY
individuals	ENTITY
may	
experience	
fewer	
jet	ENTITY
lag	ENTITY
symptoms	ENTITY
compared	
with	
younger	ENTITY
individu-	
als	
.	

However	
,	
the	
data	ENTITY
have	
limitations	ENTITY
and	
further	
research	ENTITY
is	
needed	
to	
better	
define	
the	
relationship	ENTITY
between	
age	ENTITY
and	
the	
development	ENTITY
of	
jet	ENTITY
lag	ENTITY
disorder	ENTITY
.	

There	
are	
no	
studies	
on	
the	
prevalence	ENTITY
of	
jet	ENTITY
lag	ENTITY
disorder	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Disturbed	ENTITY
sleep	ENTITY
and/or	
shortened	ENTITY
sleep	ENTITY
duration	ENTITY
before	
and	
during	
travel	ENTITY
contribute	
to	
jet	ENTITY
lag	ENTITY
symptoms	ENTITY
.	

Prolonged	ENTITY
uncomfortable	ENTITY
sitting	ENTITY
positions	ENTITY
,	
air	ENTITY
quality	ENTITY
and	
pressure	ENTITY
,	
stress	ENTITY
,	
and	
excessive	ENTITY
caffeine	ENTITY
and	
alcohol	ENTITY
consumption	ENTITY
may	
increase	ENTITY
the	
severity	ENTITY
of	
insomnia	ENTITY
and	
impaired	ENTITY
alertness	ENTITY
and	
function	ENTITY
associated	ENTITY
with	ENTITY
transmeridian	ENTITY
travel	ENTITY
.	

Eastward	ENTITY
travel	ENTITY
often	
leads	
to	
difficulties	ENTITY
with	
sleep	ENTITY
onset	ENTITY
as	
attempts	ENTITY
to	ENTITY
sleep	ENTITY
are	
made	
at	
an	
earlier	
internal	ENTITY
circadian	ENTITY
time	
when	
the	
travelers	ENTITY
’	
biological	ENTITY
clock	ENTITY
is	
pro-	ENTITY
moting	ENTITY
alertness	ENTITY
(	
i.e.	
,	
biological	ENTITY
day	ENTITY
)	
.	

Difficulty	ENTITY
awakening	ENTITY
and	
daytime	ENTITY
sleepiness	ENTITY
and	
fatigue	ENTITY
occur	
because	
wake	ENTITY
time	ENTITY
also	
occurs	
at	
an	
earlier	
biological	ENTITY
time	ENTITY
when	
the	
circadian	ENTITY
clock	
is	
still	
promoting	ENTITY
sleep	ENTITY
(	
i.e.	
,	
during	
the	
travelers	ENTITY
’	
biological	ENTITY
night	ENTITY
)	
.	

Westward	ENTITY
jet	ENTITY
travel	ENTITY
often	
leads	
to	
sleepiness	ENTITY
and	
fatigue	ENTITY
in	
the	
evening	ENTITY
hours	ENTITY
of	
the	
new	
time	ENTITY
zone	ENTITY
as	
the	
internal	ENTITY
circadian	ENTITY
clock	ENTITY
of	
the	
traveler	ENTITY
is	
promoting	ENTITY
sleep	ENTITY
(	
i.e.	
,	
biological	ENTITY
night	ENTITY
)	
.	

Sleep	ENTITY
disturbance	ENTITY
in	
the	
new	
time	ENTITY
zone	ENTITY
is	
typically	
manifest	ENTITY
as	
a	
sleep	ENTITY
maintenance	ENTITY
issue	ENTITY
with	
early	ENTITY
morning	ENTITY
awakenings	ENTITY
and	
difficulty	ENTITY
returning	ENTITY
to	
sleep	ENTITY
because	
the	
internal	ENTITY
circadian	ENTITY
clock	ENTITY
of	
the	
traveler	ENTITY
is	
promoting	ENTITY
wakefulness	ENTITY
during	
the	
sleep	ENTITY
episode	ENTITY
(	
i.e.	
,	
biological	ENTITY
day	ENTITY
)	
.	

Basic	ENTITY
circadian	ENTITY
science	ENTITY
principles	ENTITY
suggest	
that	
inappropriately	ENTITY
timed	ENTITY
exposure	ENTITY
to	ENTITY
light	ENTITY
and	
darkness	ENTITY
during	
and	
immediately	
after	
jet	ENTITY
travel	ENTITY
can	
shift	
the	
circadian	ENTITY
clock	
in	
the	
wrong	
direction	ENTITY
,	
thereby	
increasing	ENTITY
the	
duration	ENTITY
of	
jet	
lag	
symptoms	ENTITY
.	

Time	ENTITY
at	
destina-	
tion	ENTITY
upon	
arrival	ENTITY
may	
also	
influence	ENTITY
jet	ENTITY
lag	ENTITY
symptoms	ENTITY
with	
fewer	
symptoms	ENTITY
reported	
following	
midday	ENTITY
arrivals	ENTITY
after	
eastward	ENTITY
travel	ENTITY
.	

An	
individual	ENTITY
’s	
innate	
circadian	
preference	ENTITY
may	
also	
confer	
a	
greater	ENTITY
or	
lesser	
ability	
to	
adjust	
to	
a	
particular	
time	ENTITY
shift	ENTITY
,	
but	
this	
finding	ENTITY
has	
not	
been	
systematically	ENTITY
assessed	ENTITY
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	
-	
Wake	ENTITY
Disorders	ENTITY
Jet	
lag	
is	
often	
reported	
to	
be	
worse	ENTITY
after	
eastward	ENTITY
than	
westward	ENTITY
travel	ENTITY
.	

Westward	ENTITY
travel	ENTITY
may	
generally	
be	
easier	
because	
the	
genetically	ENTITY
determined	
period	ENTITY
of	
the	
cir-	ENTITY
cadian	ENTITY
clock	ENTITY
in	
humans	ENTITY
is	
on	
average	ENTITY
longer	
than	
24	
hours	ENTITY
.	

A	
circadian	ENTITY
period	ENTITY
longer	
than	
24	
hours	ENTITY
is	
associated	ENTITY
with	ENTITY
a	
circadian	ENTITY
drive	
or	
physiological	ENTITY
tendency	
for	
bed	ENTITY
and	
wake	ENTITY
times	ENTITY
to	
be	
later	
,	
thus	
making	
it	
easier	
to	
shift	
the	
circadian	ENTITY
clock	
during	
west-	
ward	ENTITY
travel	ENTITY
to	
more	
delayed	ENTITY
sleep	ENTITY
and	
wake	ENTITY
times	ENTITY
.	

However	
,	
20	
%	
to	
25	
%	
of	
humans	ENTITY
have	
circadian	ENTITY
periods	ENTITY
that	
are	
near	
to	
,	
or	
shorter	ENTITY
than	
,	
24	
hours	ENTITY
,	
and	
these	
individuals	ENTITY
may	
find	
it	
easier	
to	
adapt	
to	
eastward	ENTITY
travel	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Jet	ENTITY
lag	ENTITY
is	
usually	
a	
temporary	ENTITY
condition	ENTITY
.	

Symptoms	ENTITY
begin	
approximately	
one	
to	
two	
days	ENTITY
after	
air	ENTITY
travel	ENTITY
across	
at	
least	
two	
time	
zones	ENTITY
and	
are	
self	ENTITY
-	
limited	ENTITY
.	

The	
severity	ENTITY
and	
duration	ENTITY
of	
symptoms	ENTITY
are	
usually	
in	
proportion	ENTITY
to	
the	
number	
of	
time	ENTITY
zones	ENTITY
trav-	
eled	ENTITY
and	
the	
direction	ENTITY
of	
travel	ENTITY
.	

It	
is	
estimated	
that	
it	
takes	
one	
day	ENTITY
per	
time	ENTITY
zone	ENTITY
for	
circadian	ENTITY
rhythms	ENTITY
to	
adjust	
to	
the	
local	ENTITY
time	ENTITY
.	

However	
,	
if	
traveling	ENTITY
more	
than	
six	
time	ENTITY
zones	ENTITY
,	
circadian	ENTITY
rhythms	ENTITY
may	
shift	
in	
the	
opposite	
direction	ENTITY
,	
resulting	
in	
a	
prolonged	ENTITY
period	ENTITY
of	
adjustment	ENTITY
that	
may	
last	
up	
to	
several	
weeks	ENTITY
and	
increased	ENTITY
severity	ENTITY
of	
jet	ENTITY
-	
lag	ENTITY
symptoms	ENTITY
.	

Exposure	ENTITY
to	ENTITY
light	
at	
inappropriate	ENTITY
times	
may	
prolong	
the	
time	ENTITY
of	
adjust-	
ment	ENTITY
by	
shifting	
the	
circadian	ENTITY
rhythms	ENTITY
in	
the	
opposite	
direction	ENTITY
.	

Menstrual	ENTITY
and	
repro-	
ductive	ENTITY
problems	
have	
been	
associated	ENTITY
with	ENTITY
frequent	ENTITY
transmeridian	ENTITY
travel	ENTITY
in	
female	ENTITY
airline	ENTITY
personnel	ENTITY
.	

Poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
practices	
may	
perpetuate	ENTITY
sleep	ENTITY
/	
wake	ENTITY
complaints	ENTITY
,	
and	
repetitive	ENTITY
failed	ENTITY
attempts	
to	
initiate	ENTITY
or	
maintain	
sleep	ENTITY
at	
desired	
times	
may	
predis-	
pose	
to	
the	
development	ENTITY
of	
insomnia	ENTITY
disorder	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY

The	
effect	ENTITY
of	
age	ENTITY
on	
the	
development	ENTITY
or	
severity	ENTITY
of	
jet	ENTITY
lag	ENTITY
disorder	ENTITY
symptoms	ENTITY
is	
unknown	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
symptoms	ENTITY
of	
jet	ENTITY
lag	ENTITY
disorder	ENTITY
are	
due	
to	
both	
desynchronization	ENTITY
of	
endogenous	ENTITY
circadian	ENTITY
rhythms	ENTITY
with	
local	ENTITY
time	ENTITY
and	
sleep	ENTITY
disturbance	ENTITY
.	

The	
severity	ENTITY
of	
symptoms	ENTITY
can	
be	
influenced	ENTITY
by	
the	
environment	ENTITY
and	
behaviors	ENTITY
of	
the	
traveler	ENTITY
.	

Factors	ENTITY
inherent	ENTITY
to	
jet	ENTITY
travel	ENTITY
,	
including	
prolonged	ENTITY
time	ENTITY
spent	ENTITY
sitting	ENTITY
in	
a	
confined	
space	ENTITY
,	
ability	
to	
sleep	ENTITY
on	
long	ENTITY
-	
haul	ENTITY
flights	ENTITY
,	
decreased	ENTITY
physical	ENTITY
activity	ENTITY
,	
and	
a	
low	ENTITY
oxygen	ENTITY
environment	ENTITY
,	
may	
influence	ENTITY
severity	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Objective	
laboratory	ENTITY
testing	ENTITY
usually	
is	
not	
indicated	
.	

When	
performed	ENTITY
,	
polysomnogra-	
phy	ENTITY
or	
actigraphy	ENTITY
shows	
disturbed	ENTITY
sleep	ENTITY
and	
a	
loss	ENTITY
of	
a	
normal	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
or	
a	
mismatch	ENTITY
between	
the	
timing	ENTITY
of	
sleep	ENTITY
and	
wakefulness	ENTITY
with	
the	
desired	
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
of	
the	
local	ENTITY
time	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
A	
thorough	
history	ENTITY
and	
physical	ENTITY
examination	ENTITY
should	
be	
performed	
to	
exclude	
other	
mental	ENTITY
,	
physical	ENTITY
,	
or	
sleep	ENTITY
disorders	ENTITY
.	

Somatic	ENTITY
complaints	ENTITY
of	
gastrointestinal	ENTITY
symptoms	ENTITY
may	
indicate	
an	
underlying	
medical	ENTITY
condition	ENTITY
.	

When	
jet	ENTITY
lag	ENTITY
symptoms	ENTITY
persist	
,	
increas-	
ing	
frustration	ENTITY
,	
negative	ENTITY
expectations	ENTITY
,	
and	
poor	ENTITY
sleep	ENTITY
hygiene	ENTITY
may	
predispose	
the	
indi-	
vidual	
to	
the	
development	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Understanding	
mechanisms	ENTITY
of	
individual	
differences	
in	
vulnerability	ENTITY
and	
tolerance	ENTITY
to	
disturbed	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
during	
jet	ENTITY
lag	ENTITY
is	
necessary	
.	

Development	ENTITY
of	
effective	ENTITY
and	
practical	ENTITY
strategies	ENTITY
to	
combat	ENTITY
jet	ENTITY
-	
lag	ENTITY
symptoms	ENTITY
and	
improve	ENTITY
sleep	ENTITY
,	
performance	ENTITY
and	
safety	ENTITY
are	
needed	
.	

It	
is	
unknown	
how	
expression	ENTITY
of	
the	
disorder	ENTITY
varies	
across	
the	
life	ENTITY
span	ENTITY
.	

Bibliography	ENTITY
Auger	ENTITY
RR	ENTITY
,	
Morgenthaler	ENTITY
TI	ENTITY
.	

Jet	ENTITY
lag	
and	
other	
sleep	ENTITY
disorders	ENTITY
relevant	
to	
the	
traveler	ENTITY
.	

Travel	ENTITY
Med	ENTITY
Infect	ENTITY
Dis	ENTITY
2009;7:60–8	ENTITY
.	

Burgess	ENTITY
HJ	ENTITY
,	
Crowley	ENTITY
SJ	ENTITY
,	
Gazda	ENTITY
CJ	ENTITY
,	
Fogg	ENTITY
LF	ENTITY
.	

Eastman	ENTITY
CI	ENTITY
.	

Preflight	ENTITY
adjustment	ENTITY
to	
eastward	ENTITY
travel	ENTITY
:	
3	
days	ENTITY
of	
advancing	ENTITY
sleep	ENTITY
with	
and	
without	
morning	ENTITY
bright	ENTITY
light	ENTITY
.	

J	
Biol	
Rhythms	
2003;18:318–28	
.	

Daan	ENTITY
S	ENTITY
,	
Lewy	ENTITY
AJ	ENTITY
.	

Scheduled	ENTITY
exposure	ENTITY
to	ENTITY
daylight	
:	
a	
potential	
strategy	
to	
reduce	ENTITY
“	
jet	ENTITY
lag	ENTITY
”	
following	
transmeridian	ENTITY
flight	ENTITY
.	

Psychopharmacol	ENTITY
Bull	ENTITY
1984;20:566–8	ENTITY
.	

Dawson	ENTITY
D	ENTITY
,	
Campbell	ENTITY
SS	ENTITY
.	

Timed	ENTITY
exposure	ENTITY
to	ENTITY
bright	ENTITY
light	ENTITY
improves	ENTITY
sleep	ENTITY
and	
alertness	ENTITY
during	
simulated	ENTITY
night	ENTITY
shifts	ENTITY
.	

Sleep	ENTITY
1991;14:511–6	
.	

Drake	ENTITY
CL	ENTITY
,	
Wright	ENTITY
KP	ENTITY
Jr.	ENTITY
Shift	ENTITY
work	ENTITY
,	
shift	
work	ENTITY
disorder	ENTITY
,	
and	
jet	ENTITY
lag	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

Philadelphia	ENTITY
:	
Elsevier	
Saunders	
,	
2011	
;	
784–98	
.	

Eastman	ENTITY
CI	ENTITY
,	
Gazda	ENTITY
CJ	ENTITY
,	
Burgess	
HJ	
,	
Crowley	ENTITY
SJ	ENTITY
,	
Fogg	ENTITY
LF	ENTITY
.	

Advancing	
circadian	ENTITY
rhythms	ENTITY
before	
eastward	ENTITY
flight	
:	
a	
strategy	
to	
prevent	ENTITY
or	
reduce	ENTITY
jet	ENTITY
lag	ENTITY
.	

Sleep	ENTITY
2005;28:33–44	
.	

Moline	ENTITY
ML	ENTITY
,	
Pollak	ENTITY
CP	ENTITY
,	
Monk	ENTITY
TH	ENTITY
,	
et	
al	
.	

Age	ENTITY
-	
related	ENTITY
differences	ENTITY
in	
recovery	ENTITY
from	
simulated	ENTITY
jet	
lag	
.	

Sleep	ENTITY
1992;15:28–40	
.	

Muhm	ENTITY
,	
JM	ENTITY
,	
Rock	ENTITY
PB	ENTITY
,	
McMullin	ENTITY
DL	ENTITY
,	
et	
al	
.	

Effect	ENTITY
of	
aircraft	ENTITY
-	
cabin	ENTITY
altitude	ENTITY
on	
passenger	ENTITY
discomfort	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2007;357:18–27	ENTITY
.	

Sack	ENTITY
R	ENTITY
,	
Auckley	ENTITY
D	ENTITY
,	
Auger	ENTITY
RR	ENTITY
,	
et	
al	
.	

Circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
disorders	ENTITY
:	
part	
i	
,	
basic	
principles	
,	
shift	
work	
and	
jet	ENTITY
lag	ENTITY
:	
An	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
Review	ENTITY
.	

Sleep	ENTITY
2007;30:1456–79	
.	

Suhner	ENTITY
A	ENTITY
,	
Schlagenhauf	
P	
,	
Höfer	ENTITY
I	ENTITY
,	
Johnson	ENTITY
R	ENTITY
,	
Tschopp	ENTITY
A	ENTITY
,	
Steffen	ENTITY
R.	ENTITY
Effectiveness	ENTITY
and	
tolerability	ENTITY
of	
melatonin	ENTITY
and	
zolpidem	ENTITY
for	
the	
alleviation	ENTITY
of	
jet	ENTITY
lag	ENTITY
.	

Aviat	ENTITY
Space	ENTITY
Environ	
Med	
2001;72:638–46	
.	

Circadian	ENTITY
Rhythm	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorders	ENTITY
Circadian	ENTITY
Rhythm	
Sleep	
-	
Wake	ENTITY
Disorders	ENTITY
Tresguerres	ENTITY
JA	ENTITY
,	
Ariznavarreta	ENTITY
C	ENTITY
,	
Granados	ENTITY
B	ENTITY
,	
et	
al	
.	

Circadian	ENTITY
urinary	ENTITY
6	
-	
sulphatoxymelatonin	ENTITY
,	
cortisol	ENTITY
excretion	ENTITY
and	
locomotor	ENTITY
activity	ENTITY
in	
airline	ENTITY
pilots	ENTITY
during	
transmeridian	ENTITY
flights	ENTITY
.	

J	
Pineal	ENTITY
Res	ENTITY
2001;31:16–22	ENTITY
.	

Waterhouse	ENTITY
J	ENTITY
,	
Edwards	ENTITY
B	ENTITY
,	ENTITY
Nevill	ENTITY
A	ENTITY
,	
et	
al	
.	

Identifying	
some	
determinants	ENTITY
of	
“	
jet	ENTITY
lag	ENTITY
”	
and	
its	
symptoms	ENTITY
:	
a	
study	ENTITY
of	
athletes	ENTITY
and	
other	
travellers	ENTITY
.	

Br	ENTITY
J	ENTITY
Sports	ENTITY
Med	ENTITY
2002;36:54–60	
.	

Circadian	ENTITY
Sleep	ENTITY
-	
Wake	ENTITY
Disorder	ENTITY
Not	
Otherwise	
Specified	
(	
NOS	ENTITY
)	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.30	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.20	ENTITY
Patients	ENTITY
who	
meet	
all	
of	
the	
general	
diagnostic	ENTITY
criteria	ENTITY
for	
a	
CRSWD	ENTITY
but	
do	
not	
meet	
criteria	ENTITY
for	
one	
of	
the	
specific	
types	
of	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
are	
clas-	
sified	ENTITY
here	
.	

This	
diagnosis	ENTITY
is	
intended	
primarily	
for	
patients	ENTITY
with	
alterations	ENTITY
in	
circa-	
dian	
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
due	
to	
underlying	
medical	ENTITY
,	
neurologic	ENTITY
,	
and	
psychiatric	ENTITY
dis-	
orders	ENTITY
.	

The	
underlying	
neurological	ENTITY
,	
psychiatric	ENTITY
,	
or	
medical	ENTITY
condition	ENTITY
is	
typically	
the	
precipitating	ENTITY
factor	ENTITY
.	

Patients	ENTITY
may	
present	
with	
a	
variety	
of	
symptoms	ENTITY
,	
including	
dis-	
turbed	ENTITY
nocturnal	ENTITY
sleep	ENTITY
and	
excessive	ENTITY
sleepiness	ENTITY
.	

The	
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
may	
range	
from	
alterations	ENTITY
in	
the	
phase	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
to	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
pattern	ENTITY
.	

Recordings	ENTITY
of	
sleep	
logs	
and	
actigraphy	ENTITY
over	
a	
period	ENTITY
of	
at	
least	
seven	
days	ENTITY
,	
preferably	
for	
14	
days	ENTITY
or	
longer	ENTITY
,	
demonstrate	
sleep	ENTITY
onsets	ENTITY
and	
sleep	ENTITY
offsets	ENTITY
that	
may	
be	
delayed	ENTITY
or	
advanced	ENTITY
relative	
to	
conventional	ENTITY
times	ENTITY
,	
irregular	ENTITY
or	
non-24	ENTITY
-	
hour	ENTITY
.	

Sleep	ENTITY
-	
wake	ENTITY
disturbances	ENTITY
are	
common	
in	
patients	ENTITY
with	
neurodegenerative	ENTITY
disorders	ENTITY
(	
Alzheimer	ENTITY
disease	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
Huntington	ENTITY
disease	ENTITY
)	
,	
as	
well	
as	
neurodevelop-	
mental	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
-	
wake	ENTITY
disturbances	ENTITY
associated	ENTITY
with	ENTITY
these	
disorders	ENTITY
may	
exhibit	
some	
features	ENTITY
of	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
patterns	ENTITY
,	
but	
do	
not	
have	
a	
consistent	
pattern	ENTITY
of	
at	
least	
three	
sleep	ENTITY
periods	
per	
day	ENTITY
.	

The	
particular	
features	ENTITY
of	
this	
disorder	ENTITY
vary	
with	
the	
type	
of	
underlying	
medical	ENTITY
,	
psychiatric	ENTITY
,	
or	
neurological	ENTITY
condition	ENTITY
.	

The	
disruption	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
has	
been	
implicated	
in	
the	
etiology	ENTITY
of	
sundowning	ENTITY
and	
noc-	
turnal	ENTITY
wandering	
in	
older	ENTITY
adults	ENTITY
with	
dementia	ENTITY
.	

Patients	ENTITY
with	
Parkinson	ENTITY
disease	ENTITY
may	
exhibit	
various	
types	
of	
circadian	ENTITY
-	
rhythm	ENTITY
alterations	ENTITY
.	

In	
addition	
,	
motor	ENTITY
fluctuations	ENTITY
can	
exhibit	
marked	
diurnal	ENTITY
fluctuation	ENTITY
in	
patients	ENTITY
with	
Parkinson	ENTITY
disease	ENTITY
.	

Parasomnias	ENTITY
NREM	ENTITY
-	
Related	ENTITY
Parasomnias	ENTITY
Disorders	ENTITY
of	
Arousal	ENTITY
(	
From	
NREM	ENTITY
Sleep)228	

Confusional	ENTITY
Arousals229	ENTITY
Sleepwalking	ENTITY
229	ENTITY
Sleep	ENTITY
Terrors	ENTITY
230	ENTITY
Sleep	ENTITY
Related	ENTITY
Eating	ENTITY
Disorder	ENTITY
240	ENTITY
REM	ENTITY
-	
Related	ENTITY
Parasomnias	ENTITY
REM	ENTITY
Sleep	ENTITY
Behavior	ENTITY
Disorder246	ENTITY

Recurrent	ENTITY
Isolated	ENTITY
Sleep	ENTITY
Paralysis	ENTITY
254	ENTITY
Nightmare	ENTITY
Disorder	ENTITY
257	
Other	
Parasomnias	ENTITY
Exploding	ENTITY
Head	ENTITY
Syndrome264	ENTITY
Sleep	ENTITY
Related	ENTITY
Hallucinations267	ENTITY
Sleep	ENTITY
Enuresis	ENTITY
270	
Parasomnia	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder276	ENTITY
Parasomnia	ENTITY

Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
276	ENTITY
Parasomnia	ENTITY
,	
Unspecified	
278	
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Sleep	ENTITY
Talking	ENTITY
279	ENTITY
Parasomnias	ENTITY
are	
undesirable	
physical	ENTITY
events	ENTITY
or	
experiences	ENTITY
that	
occur	
during	
entry	ENTITY
into	
sleep	ENTITY
,	
within	
sleep	ENTITY
,	
or	
during	
arousal	ENTITY
from	
sleep	ENTITY
.	

Parasomnias	ENTITY
may	
occur	
during	
non	ENTITY
-	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
sleep	ENTITY
(	
NREM	ENTITY
)	
,	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
sleep	ENTITY
(	
REM	ENTITY
)	
,	
or	
during	
transitions	ENTITY
to	
and	
from	
sleep	ENTITY
.	

Parasomnias	ENTITY
encompass	
abnormal	ENTITY
sleep	
related	
complex	ENTITY
movements	ENTITY
,	
behaviors	ENTITY
,	
emo-	
tions	ENTITY
,	
perceptions	ENTITY
,	
dreams	ENTITY
,	
and	
autonomic	ENTITY
nervous	ENTITY
system	ENTITY
activity	ENTITY
.	

Parasomnias	ENTITY
are	
clinical	ENTITY
disorders	ENTITY
because	
of	
the	
resulting	
injuries	ENTITY
,	
sleep	ENTITY
disruption	ENTITY
,	
adverse	ENTITY
health	ENTITY
effects	ENTITY
,	
and	
untoward	
psychosocial	ENTITY
effects	ENTITY
.	

The	
clinical	ENTITY
consequences	ENTITY
of	
the	
parasom-	
nias	ENTITY
can	
affect	
the	
patient	ENTITY
,	
the	
bed	ENTITY
partner	ENTITY
,	
or	
both	
.	

Human	ENTITY
consciousness	ENTITY
consists	
of	
three	
essential	ENTITY
states	
:	
Wake	ENTITY
,	
NREM	ENTITY
sleep	ENTITY
,	
and	
REM	ENTITY
sleep	ENTITY
.	

The	
three	
states	ENTITY
are	
modulated	ENTITY
by	
a	
host	ENTITY
of	
influences	ENTITY
including	
the	
degree	ENTITY
of	
ami-	ENTITY
nergic	ENTITY
and	
cholinergic	ENTITY
neurochemical	ENTITY
bias	ENTITY
,	
central	ENTITY
nervous	ENTITY
system	ENTITY
(	
CNS	
)	
activation	ENTITY
,	
Parasomnias	ENTITY
and	
the	
degree	ENTITY
of	
endogenous	ENTITY
versus	
exogenous	ENTITY
input	ENTITY
.	

Under	
normal	ENTITY
physiologic	ENTITY
conditions	
,	
which	
include	
homeostatic	ENTITY
drive	
and	
circadian	ENTITY
rhythmicity	ENTITY
,	
the	
process	ENTITY
of	
state	ENTITY
declaration	ENTITY
is	
maintained	ENTITY
in	
a	
stable	ENTITY
and	
predictable	
fashion	
throughout	
a	
24	
-	
hour	ENTITY
period	ENTITY
.	

However	
,	
as	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
oscillates	ENTITY
,	
the	
normally	
distinct	
states	ENTITY
of	
con-	
sciousness	ENTITY
may	
be	
rendered	
into	
a	
state	ENTITY
that	
is	
not	
fully	
declared	
,	
resulting	
in	
a	
tempo-	
rary	ENTITY
unstable	
state	
of	
dissociation	ENTITY
.	

Thus	
,	
sleep	ENTITY
and	
wake	ENTITY
can	
be	
viewed	
as	
occurring	
on	
a	
spectrum	ENTITY
rather	
than	
being	
entirely	
dichotomous	ENTITY
states	ENTITY
.	

Parasomnias	ENTITY
are	
the	
result	
of	
such	
state	ENTITY
dissociation	ENTITY
.	

Recent	
research	ENTITY
has	
shown	
that	
com-	
binations	ENTITY
of	
one	
or	
more	
of	
these	
states	ENTITY
do	
occur	
and	
may	
result	
in	
unstable	ENTITY
states	ENTITY
of	
altered	
consciousness	ENTITY
manifesting	
as	
parasomnias	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
,	
such	
as	
sleepwalking	ENTITY
,	
sleep	ENTITY
terrors	ENTITY
,	
and	
confusional	ENTITY
arousals	ENTITY
are	
an	
admixture	ENTITY
of	
wakefulness	ENTITY
and	
NREM	ENTITY
sleep	ENTITY
.	

Higher	ENTITY
cognitive	ENTITY
function	ENTITY
is	
severely	ENTITY
impaired	ENTITY
,	
if	
not	
absent	
,	
while	
the	
potential	ENTITY
for	
motor	ENTITY
capacity	ENTITY
has	
,	
for	
the	
most	
part	
,	
been	
retained	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
)	
is	
an	
admixture	ENTITY
of	
REM	ENTITY
sleep	ENTITY
coupled	
with	
waking	ENTITY
or	
NREM	ENTITY
sleep	
levels	
of	
tonic	ENTITY
EMG	
activity	
.	

All	
three	
states	ENTITY
may	
be	
present	
in	
the	
same	
individual	ENTITY
as	
an	
overlap	ENTITY
of	
disorders	ENTITY
.	

The	
comingling	ENTITY
of	
basic	
states	ENTITY
of	
consciousness	ENTITY
is	
the	
result	
of	
different	
forms	
of	
pathophysiology	ENTITY
.	

In	
disorders	ENTITY
of	
arousal	ENTITY
,	
no	
identifiable	
neuropathology	ENTITY
is	
present	
,	
but	
functional	ENTITY
changes	ENTITY
in	
cerebral	ENTITY
activity	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
are	
present	
,	
essentially	
resulting	
in	
a	
brain	ENTITY
in	
which	
certain	
areas	
are	
deactivated	
(	
asleep	ENTITY
)	
and	
others	
remain	
activated	ENTITY
(	
awake	ENTITY
)	
.	

This	
CNS	ENTITY
activation	ENTITY
,	
with	
concomitant	ENTITY
skeletal	ENTITY
muscle	ENTITY
and	
auto-	
nomic	ENTITY
nervous	ENTITY
system	ENTITY
activation	ENTITY
,	
is	
believed	
to	
reflect	
a	
functional	ENTITY
disabling	ENTITY
of	
,	
or	
damage	ENTITY
to	
,	
brain	ENTITY
areas	ENTITY
usually	
responsible	
for	
the	
inhibition	ENTITY
of	
these	
activities	ENTITY
during	
sleep	ENTITY
.	

Additionally	
,	
sleep	ENTITY
inertia	ENTITY
,	
sleep	ENTITY
state	ENTITY
instability	ENTITY
,	
and	
locomotor	ENTITY
/	
central	ENTITY
pattern	ENTITY
generators	ENTITY
are	
thought	
to	
contribute	
to	
the	
occurrence	ENTITY
of	
NREM	ENTITY
parasomnias	ENTITY
.	

NREM	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
frequently	
appear	
to	
involve	
the	
disinhibition	ENTITY
of	
“	
basic	
drive	
states	ENTITY
”	
such	
as	
feeding	ENTITY
,	
sex	ENTITY
,	
and	
aggression	ENTITY
.	

Here	
,	
it	
has	
been	
postulated	
that	
central	ENTITY
pattern	ENTITY
generators	ENTITY
elicit	
primal	ENTITY
fixed	ENTITY
action	ENTITY
patterns	
that	
would	
otherwise	
have	
been	
inhibited	ENTITY
by	
the	
prefrontal	ENTITY
cortex	ENTITY
during	
wake	ENTITY
.	

In	
this	
regard	
,	
aggression	ENTITY
is	
typ-	
ically	ENTITY
abrupt	ENTITY
in	
onset	
and	
characterized	ENTITY
by	
apparent	ENTITY
instinctual	
defensive	ENTITY
posturing	ENTITY
as	
opposed	
to	
behaviors	ENTITY
that	
are	
complex	ENTITY
and	
procedural	ENTITY
.	

These	
can	
emerge	
in	
pathologic	ENTITY
forms	
with	
the	
parasomnias	ENTITY
,	
as	
seen	
with	
sleep	ENTITY
related	
aggression	ENTITY
and	
locomotion	ENTITY
,	
sleep	ENTITY
related	ENTITY
eating	ENTITY
disorder	ENTITY
(	
SRED	ENTITY
)	
,	
and	
abnormal	ENTITY
sleep	ENTITY
related	
sexual	ENTITY
behaviors	ENTITY
.	

In	
contrast	
,	
RBD	ENTITY
often	
results	
from	
serious	
neuropathology	ENTITY
.	

Initially	
,	
this	
neuropathology	ENTITY
affects	
the	
area	ENTITY
of	
the	
brain	ENTITY
responsible	
for	
inhibiting	ENTITY
muscle	ENTITY
tone	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

As	
a	
result	ENTITY
,	
dreams	ENTITY
may	
be	
enacted	
.	

In	
the	
case	ENTITY
of	
REM	ENTITY
-	
related	ENTITY
behaviors	ENTITY
,	
the	
experience	ENTITY
and	
activity	ENTITY
reflect	
the	
actual	ENTITY
,	
often	
aggressive	ENTITY
content	ENTITY
of	
a	
dream	ENTITY
.	

It	
is	
frequently	
pos-	
sible	ENTITY
to	
correlate	
observed	ENTITY
movements	ENTITY
with	
later	
descriptions	ENTITY
of	
the	
dream	ENTITY
.	

The	
initial	
appearance	ENTITY
of	
RBD	ENTITY
symptoms	ENTITY
is	
often	
followed	
years	ENTITY
later	
by	
the	
development	ENTITY
of	
neu-	ENTITY
rodegenerative	ENTITY
disorders	ENTITY
,	
particularly	
Parkinson	ENTITY
disease	ENTITY
and	
related	
synucleinopathies	ENTITY
.	

Abnormal	ENTITY
sleep	ENTITY
related	
movements	ENTITY
comprise	
a	
separate	
category	
of	
disorders	ENTITY
,	
which	
is	
detailed	
in	
the	
sleep	ENTITY
related	
movement	
disorders	
section	ENTITY
.	

Unlike	
the	
parasomnias	ENTITY
,	
which	
typ-	
ically	ENTITY
entail	
more	
complex	ENTITY
movements	ENTITY
and	
behavior	ENTITY
,	
the	
movement	ENTITY
disorders	ENTITY
encompass	
a	
broad	
range	
of	
predominantly	
simple	
motoric	ENTITY
activities	ENTITY
:	
myoclonic	ENTITY
,	
repetitive	ENTITY
,	
rocking	ENTITY
,	
rhythmic	ENTITY
,	
grinding	ENTITY
,	
cramping	ENTITY
,	
fragmentary	ENTITY
,	
dystonic	ENTITY
,	
or	
dyskinetic	ENTITY
movements	ENTITY
or	
tremors	ENTITY
,	
which	
are	
not	
usually	
associated	ENTITY
with	ENTITY
dream	ENTITY
mentation	ENTITY
or	
experiential	ENTITY
concomitants	ENTITY
.	

Parasomnias	ENTITY
involve	
sleep	ENTITY
related	
behaviors	ENTITY
and	
experiences	ENTITY
over	
which	
there	
is	
no	
conscious	
deliberate	ENTITY
control	ENTITY
.	

There	
are	
ten	
core	
categories	ENTITY
of	
parasomnias	ENTITY
listed	
in	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
.	

Only	
one	
of	
the	
core	ENTITY
cat-	
egories	ENTITY
,	
RBD	ENTITY
,	
requires	
video	ENTITY
-	
polysomnographic	ENTITY
documentation	ENTITY
as	
one	
of	
the	
essen-	
tial	ENTITY
diagnostic	ENTITY
criteria	ENTITY
.	

However	
,	
for	
most	
of	
the	
other	
parasomnias	ENTITY
,	
polysomnographic	ENTITY
monitoring	ENTITY
can	
provide	
corroborative	ENTITY
documentation	ENTITY
in	
support	
of	
the	
clinical	ENTITY
diagnosis	ENTITY
.	

Considerable	
advances	
have	
taken	
place	
in	
understanding	
the	
neurophysiologic	ENTITY
aspects	
of	
abnormal	ENTITY
arousals	ENTITY
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
associated	ENTITY
with	ENTITY
the	
disorders	ENTITY
of	
arousal	ENTITY
.	

Advances	ENTITY
in	
the	
clinical	ENTITY
understanding	
of	
these	
NREM	ENTITY
sleep	ENTITY
parasomnias	ENTITY
have	
occurred	
as	
well	
,	
particularly	
in	
regard	
to	
their	
prevalence	ENTITY
and	
severity	ENTITY
in	
adults	ENTITY
.	

In	
regard	
to	
RBD	ENTITY
,	
long	ENTITY
-	
term	ENTITY
delayed	ENTITY
emergence	ENTITY
of	
neurodegeneration	ENTITY
has	
frequently	
been	
found	
in	
middle	ENTITY
-	
aged	ENTITY
and	
older	ENTITY
adults	ENTITY
following	
onset	
of	
RBD	ENTITY
.	

When	
combined	
with	
thorough	
clinical	ENTITY
interviews	ENTITY
,	
video	ENTITY
-	
polysomnography	ENTITY
a	
powerful	
discriminating	
tool	
for	
identifying	ENTITY
the	
cause	
of	
sleep	
related	
injury	ENTITY
in	
adults	ENTITY
.	

Bibliography	ENTITY
Cramer	ENTITY
Bornemann	ENTITY
MA	ENTITY
,	
Mahowald	ENTITY
MW	ENTITY
.	

Sleep	ENTITY
forensics	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

Philadelphia	ENTITY
:	
Elsevier	
Saunders	
,	
2010	
.	

Hobson	ENTITY
JA	ENTITY
.	

REM	ENTITY
sleep	ENTITY
and	
dreaming	ENTITY
:	
towards	
a	
theory	ENTITY
of	
protoconsciousness	ENTITY
.	

Nat	ENTITY
Rev	ENTITY
Neurosci	ENTITY
2009;10:803–13	ENTITY
.	

Ohayon	ENTITY
M	ENTITY
,	
Caulet	ENTITY
M	ENTITY
,	
Priest	
R.	
Violent	ENTITY
behavior	ENTITY
during	
sleep	ENTITY
.	

J	
Clin	
Psychiatry	
1997;58:369–76	
.	

Ohayon	ENTITY
M	ENTITY
,	
Mahowald	ENTITY
M	ENTITY
,	
Dauvilliers	ENTITY
Y	ENTITY
,	
Krystal	ENTITY
A	ENTITY
,	
Leger	ENTITY
D.	
Prevalence	ENTITY
and	
comorbidity	ENTITY
of	
nocturnal	ENTITY
wandering	ENTITY
in	
the	
US	ENTITY
adult	ENTITY
general	ENTITY
population	ENTITY
.	

Neurology	ENTITY
2012;78:1583–9	
.	

Schenck	ENTITY
C	ENTITY
,	
Milner	ENTITY
D	ENTITY
,	
Hurwitz	ENTITY
T	ENTITY
,	
Bundlie	ENTITY
S	ENTITY
,	
Mahowald	
M.	
A	
polysomnographic	ENTITY
and	
clinical	ENTITY
report	ENTITY
on	
sleep	ENTITY
related	ENTITY
injury	ENTITY
in	
100	
adult	ENTITY
patients	ENTITY
.	

Am	ENTITY
J	ENTITY
Psychiatry	ENTITY
1989;146:1166–73	ENTITY
.	

Siclari	ENTITY
F	ENTITY
,	
Khatami	ENTITY
R	ENTITY
,	
Urbaniok	ENTITY
F	ENTITY
,	
et	
al	
.	

Violence	ENTITY
in	
sleep	ENTITY
.	

Brain	ENTITY
2010;133:3494–509	
.	

Tassinari	ENTITY
C	ENTITY
,	
Rubboli	ENTITY
G	ENTITY
,	
Gardella	ENTITY
E	ENTITY
,	
et	
al	
.	

Central	ENTITY
pattern	ENTITY
generators	ENTITY
for	
a	
common	
semiology	ENTITY
in	
fronto-	
limbic	ENTITY
seizures	ENTITY
and	
in	
parasomnias	ENTITY
.	

A	
neuroethologic	ENTITY
approach	ENTITY
.	

Neurol	ENTITY
Sci	ENTITY
2005;26	ENTITY
:	
s225–32	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
NREM	ENTITY
-	
Related	ENTITY
Parasomnias	ENTITY
Disorders	ENTITY
of	
Arousal	ENTITY
(	
From	
NREM	ENTITY
Sleep	ENTITY
)	

This	
group	ENTITY
of	
NREM	ENTITY
-	
related	ENTITY
disorders	ENTITY
,	
which	
includes	
confusional	ENTITY
arousals	ENTITY
,	
sleep-	ENTITY
walking	ENTITY
,	
and	
sleep	ENTITY
terrors	ENTITY
,	
arise	
as	
a	
result	
of	
incomplete	ENTITY
arousals	ENTITY
from	
deep	ENTITY
sleep	ENTITY
.	

The	
conditions	ENTITY
share	
:	
(	
1	
)	
similar	
genetic	ENTITY
and	
familial	ENTITY
patterns	ENTITY
;	
(	
2	
)	
similar	
pathophysiology	ENTITY
of	
partial	ENTITY
arousals	ENTITY
from	
deep	ENTITY
sleep	ENTITY
;	
and	
(	
3	
)	
similar	
priming	ENTITY
by	
sleep	ENTITY
deprivation	ENTITY
and	
biopsychosocial	ENTITY
stressors	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
are	
:	
(	
1	
)	
not	
secondary	
to	
psychiatric	ENTITY
disorders	ENTITY
;	
(	
2	
)	
not	
generally	
secondary	ENTITY
to	ENTITY
neuropathology	ENTITY
or	
head	ENTITY
injury	ENTITY
;	
(	
3	
)	
associated	ENTITY
with	ENTITY
absent	ENTITY
or	
minimal	ENTITY
cognitive	ENTITY
functioning	ENTITY
;	
(	
4	
)	
associated	ENTITY
with	ENTITY
amnesia	ENTITY
for	
the	
prior	
episode	ENTITY
;	
and	
(	
5	
)	
may	
be	
triggered	ENTITY
by	ENTITY
sound	ENTITY
,	
touch	ENTITY
,	
or	
other	
stimuli	ENTITY
.	

General	ENTITY
Diagnostic	ENTITY
Criteria	ENTITY
for	ENTITY
Disorders	ENTITY
of	ENTITY
Arousal	ENTITY
Criteria	ENTITY
A	ENTITY
-	
E	ENTITY
must	
be	
met	
A.	ENTITY
Recurrent	ENTITY
episodes	ENTITY
of	
incomplete	ENTITY
awakening	ENTITY
from	
sleep.1	ENTITY
B.	ENTITY
Inappropriate	ENTITY
or	
absent	ENTITY
responsiveness	ENTITY
to	
efforts	
of	
others	
to	
intervene	ENTITY
or	
redirect	
the	
person	ENTITY
during	
the	
episode	ENTITY
.	

C.	ENTITY
Limited	ENTITY
(	
e.g.	
,	
a	
single	ENTITY
visual	ENTITY
scene	ENTITY
)	
or	
no	
associated	
cognition	ENTITY
or	
dream	ENTITY
imagery	ENTITY
.	

D.	
Partial	ENTITY
or	
complete	
amnesia	ENTITY
for	
the	
episode	ENTITY
.	

E.	

The	
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
condition	ENTITY
,	
medication	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

Notes	ENTITY
.	

The	
events	ENTITY
usually	
occur	
during	
the	
first	
third	
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
.	
.	

The	
individual	ENTITY
may	
continue	
to	
appear	
confused	
and	
disoriented	ENTITY
for	
several	
minutes	
or	
longer	
following	
the	
episode	ENTITY
.	

Confusional	ENTITY
Arousals	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.41	
Alternate	ENTITY
Names	ENTITY
Elpenor	ENTITY
syndrome	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.51	ENTITY
Sleepwalking	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.46	
Alternate	ENTITY
Names	ENTITY
Somnambulism	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F51.3	ENTITY
Parasomnias	ENTITY
A.	ENTITY
The	
disorder	ENTITY
meets	
general	
criteria	
for	
NREM	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
.	

B.	ENTITY
The	
episodes	ENTITY
are	
characterized	ENTITY
by	
mental	ENTITY
confusion	ENTITY
or	
confused	
behavior	ENTITY
that	
occurs	
while	
the	
patient	ENTITY
is	
in	
bed	ENTITY
.	

C.	ENTITY
There	
is	
an	
absence	ENTITY
of	
terror	ENTITY
or	
ambulation	ENTITY
outside	
of	
the	
bed	ENTITY
.	

Notes	ENTITY
.	

There	
is	
typically	
a	
lack	ENTITY
of	
autonomic	ENTITY
arousal	ENTITY
such	
as	
mydriasis	ENTITY
,	
tachycardia	ENTITY
,	
tachypnea	ENTITY
,	
and	
diaphoresis	ENTITY
during	
an	
episode	ENTITY
.	

A.	ENTITY

The	
disorder	ENTITY
meets	
general	
criteria	
for	
NREM	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
.	

B.	ENTITY
The	
arousals	ENTITY
are	
associated	ENTITY
with	ENTITY
ambulation	ENTITY
and	
other	
complex	ENTITY
behaviors	ENTITY
out	
of	
bed	ENTITY
.	

Parasomnias	ENTITY
Sleep	ENTITY
Terrors	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.46	
Alternate	ENTITY
Names	ENTITY
Night	ENTITY
terrors	ENTITY
,	
pavor	ENTITY
nocturnus	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

F51.4	ENTITY
A.	
The	
disorder	ENTITY
meets	
general	
criteria	
for	
NREM	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
.	

B.	ENTITY
The	
arousals	ENTITY
are	
characterized	ENTITY
by	
episodes	ENTITY
of	
abrupt	ENTITY
terror	ENTITY
,	
typically	
beginning	
with	
an	
alarming	ENTITY
vocalization	ENTITY
such	
as	
a	
frightening	
scream	ENTITY
.	

C.	ENTITY
There	
is	
intense	
fear	ENTITY
and	
signs	ENTITY
of	
autonomic	ENTITY
arousal	ENTITY
,	
including	
mydriasis	ENTITY
,	
tachycardia	ENTITY
,	
tachypnea	ENTITY
,	
and	
diaphoresis	ENTITY
during	
an	
episode	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Disorders	ENTITY
of	
arousal	ENTITY
consist	
of	
complex	ENTITY
behaviors	ENTITY
that	
are	
usually	
initiated	
during	
partial	ENTITY
arousals	ENTITY
from	
slow	ENTITY
wave	ENTITY
(	
N3	
)	
sleep	
.	

Most	
episodes	ENTITY
are	
brief	
,	
but	
they	
may	
last	
as	
long	
as	
30	
to	
40	
minutes	ENTITY
in	
some	
children	ENTITY
.	

Sleep	ENTITY
talking	ENTITY
and	
shouting	ENTITY
may	
accompany	
these	
events	ENTITY
.	

The	
eyes	ENTITY
are	
usually	
open	
during	
an	
episode	ENTITY
and	
,	
not	
uncom-	
monly	ENTITY
,	
are	
wide	
open	
with	
a	
confused	
“	
glassy	ENTITY
”	
stare	ENTITY
.	

The	
patient	ENTITY
with	
a	
disorder	ENTITY
of	
arousal	ENTITY
may	
be	
very	
difficult	
to	
awaken	
and	
,	
when	
awakened	ENTITY
,	
is	
often	
confused	
.	

There	
is	
usually	
amnesia	ENTITY
for	
these	
episodes	ENTITY
,	
although	
adults	ENTITY
may	
remember	
fragments	ENTITY
of	
episodes	ENTITY
.	

Dream	ENTITY
-	
like	
mentation	ENTITY
is	
sometimes	
reported	
in	
adults	ENTITY
.	

Other	
high	ENTITY
-	
level	ENTITY
cog-	
nitive	ENTITY
functions	ENTITY
such	
as	
attention	ENTITY
,	
planning	ENTITY
,	
social	ENTITY
interaction	ENTITY
,	
and	
intent	ENTITY
are	
absent	ENTITY
.	

Because	
disorders	ENTITY
of	
arousal	ENTITY
usually	
originate	
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
,	
they	
most	
often	
emerge	
in	
the	
first	
third	
or	
first	
half	
of	
the	
typical	ENTITY
sleep	ENTITY
period	
.	

They	
may	
occur	
during	
other	
times	
of	
increased	ENTITY
slow	ENTITY
wave	ENTITY
sleep	ENTITY
,	
such	
as	
during	
recovery	ENTITY
sleep	ENTITY
following	
sleep	ENTITY
deprivation	ENTITY
.	

They	
rarely	
arise	
from	
a	
daytime	ENTITY
nap	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
are	
encountered	
most	
commonly	
in	
children	ENTITY
and	
typically	
resolve	
by	
puberty	ENTITY
but	
may	
persist	
(	
or	
,	
infrequently	
,	
arise	
de	ENTITY
novo	ENTITY
)	
in	
adolescence	ENTITY
or	
adulthood	ENTITY
.	

Confusional	ENTITY
Arousals	ENTITY
:	
Confusional	ENTITY
arousals	ENTITY
,	
unlike	
sleepwalking	ENTITY
,	
occur	
with	
the	
patient	ENTITY
in	
bed	ENTITY
.	

When	
the	
patient	ENTITY
leaves	
the	
bed	ENTITY
,	
sleepwalking	ENTITY
has	
been	
initiated	
.	

Confusional	ENTITY
arousals	ENTITY
often	
start	
with	
the	
individual	ENTITY
sitting	ENTITY
up	
in	
bed	ENTITY
and	
looking	
about	
in	
a	
confused	
manner	
.	

Sleepwalking	ENTITY
:	
Sleepwalking	ENTITY
episodes	ENTITY
typically	
begin	
as	
confusional	ENTITY
arousals	ENTITY
.	

Sleepwalking	ENTITY
episodes	ENTITY
can	
also	
begin	
with	
the	
individual	ENTITY
immediately	
leaving	
the	
bed	ENTITY
and	
walking	ENTITY
or	
even	
“	
bolting	ENTITY
”	
from	
the	
bed	ENTITY
and	
running	ENTITY
.	

Highly	
inappropriate	ENTITY
,	
agitated	ENTITY
,	
resistive	ENTITY
,	
belligerent	ENTITY
,	
or	
violent	ENTITY
behavior	ENTITY
can	
also	
occur	
.	

Behaviors	ENTITY
can	
be	
simple	
and	
non	ENTITY
–	
goal	ENTITY
-	
directed	ENTITY
,	
or	
complex	ENTITY
and	
protracted	ENTITY
,	
and	
may	
involve	
inappro-	
priate	ENTITY
sexual	ENTITY
activity	ENTITY
with	
oneself	ENTITY
or	
an	
individual	ENTITY
in	
close	
proximity	ENTITY
such	
as	
a	
bed	ENTITY
partner	ENTITY
.	

The	
ambulation	ENTITY
may	
terminate	ENTITY
spontaneously	ENTITY
,	
at	
times	
in	
inappropriate	ENTITY
places	
,	
or	
the	
sleepwalker	ENTITY
may	
return	ENTITY
to	ENTITY
bed	ENTITY
,	
lie	
down	
,	
and	
continue	
to	
sleep	ENTITY
without	
reach-	
ing	
conscious	ENTITY
awareness	ENTITY
at	
any	
point	
.	

The	
sleepwalking	ENTITY
individual	ENTITY
is	
disoriented	ENTITY
in	
time	ENTITY
and	
place	ENTITY
,	
with	
slow	ENTITY
speech	ENTITY
,	
with	
severely	
diminished	ENTITY
mentation	ENTITY
,	
and	
blunted	ENTITY
response	ENTITY
to	
questions	ENTITY
or	
requests	ENTITY
.	

There	
is	
often	
prominent	
anterograde	ENTITY
and	
retrograde	ENTITY
memory	
impairment	
.	

Despite	
diminished	ENTITY
external	ENTITY
perception	ENTITY
as	
a	
result	
of	
blockade	ENTITY
of	
sensory	ENTITY
input	ENTITY
,	
the	
individual	ENTITY
may	
appear	
to	
be	
awake	ENTITY
during	
some	
or	
most	
of	
a	
disorder	ENTITY
of	
arousal	ENTITY
with	
reduced	ENTITY
vigilance	ENTITY
and	
impaired	ENTITY
cognitive	ENTITY
response	ENTITY
.	

Sleep	ENTITY
Terrors	ENTITY
:	
Sleep	ENTITY
terrors	ENTITY
differ	
from	
other	
disorders	ENTITY
of	
arousal	ENTITY
in	
that	
the	
events	ENTITY
are	
often	
accompanied	
by	
a	
cry	ENTITY
or	
piercing	ENTITY
scream	ENTITY
,	
accompanied	
by	
autonomic	ENTITY
nervous	ENTITY
system	ENTITY
and	
behavioral	ENTITY
manifestations	ENTITY
of	
intense	ENTITY
fear	ENTITY
.	

There	
is	
often	
intense	
autonomic	ENTITY
discharge	ENTITY
,	
with	
tachycardia	ENTITY
,	
tachypnea	ENTITY
,	
flushing	ENTITY
of	
the	
skin	ENTITY
,	
diaphoresis	ENTITY
,	
mydriasis	ENTITY
,	
and	
increased	ENTITY
muscle	ENTITY
tone	ENTITY
.	

The	
person	ENTITY
usually	
sits	
up	
in	
bed	ENTITY
;	
is	
unresponsive	
to	
exter-	
nal	ENTITY
stimuli	ENTITY
;	
and	
,	
if	
awakened	
,	
is	
confused	
and	
disoriented	ENTITY
.	

However	
,	
bolting	ENTITY
out	
of	
bed	ENTITY
and	
running	ENTITY
is	
not	
uncommon	
in	
adults	ENTITY
and	
also	
can	
be	
associated	ENTITY
with	ENTITY
violent	ENTITY
behav-	ENTITY
iors	ENTITY
,	
particularly	
if	
attempts	ENTITY
are	
made	
to	
block	ENTITY
or	
restrain	
the	
individual	ENTITY
.	

The	
sleep	ENTITY
terror	ENTITY
episode	ENTITY
may	
be	
accompanied	
by	
incoherent	ENTITY
vocalizations	ENTITY
.	

Sometimes	
there	
is	
prolonged	ENTITY
inconsolability	ENTITY
associated	ENTITY
with	ENTITY
a	
sleep	ENTITY
terror	ENTITY
in	
children	ENTITY
or	
adults	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Disorders	ENTITY
of	
arousal	ENTITY
are	
devoid	
of	
higher	ENTITY
cognitive	ENTITY
functions	ENTITY
such	
as	
planning	ENTITY
,	
memory	ENTITY
from	
before	
an	
incident	ENTITY
,	
formation	ENTITY
of	
a	
memory	ENTITY
during	
an	
incident	ENTITY
,	
true	ENTITY
social	ENTITY
inter-	
action	ENTITY
,	
or	
recognition	ENTITY
of	
others	
.	

Patients	ENTITY
exhibiting	
disorders	ENTITY
of	
arousal	ENTITY
are	
not	
con-	
sciously	ENTITY
aware	
and	
behaviors	ENTITY
are	
often	
thought	
to	
be	
“	
automatic	ENTITY
”	
in	
nature	ENTITY
.	

Self	ENTITY
-	
injury	ENTITY
may	
occur	
as	
well	
as	
injury	ENTITY
to	
others	
in	
close	
proximity	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
,	
in	
particular	
sleepwalking	ENTITY
,	
can	
involve	
normal	ENTITY
,	
routine	ENTITY
behav-	
iors	ENTITY
that	
are	
inappropriate	ENTITY
only	
in	
regard	
to	
their	
timing	ENTITY
.	

More	
often	
,	
however	
,	
sleep-	ENTITY
walking	ENTITY
involves	
inappropriate	ENTITY
behaviors	ENTITY
,	
such	
as	
urinating	ENTITY
in	
a	
wastebasket	ENTITY
,	
moving	ENTITY
furniture	ENTITY
around	
haphazardly	ENTITY
,	
or	
climbing	ENTITY
out	
a	
window	ENTITY
.	

Sleepwalkers	ENTITY
are	
sometimes	
able	
to	
navigate	
in	
familiar	
surroundings	ENTITY
,	
but	
are	
prone	
to	
bumping	ENTITY
into	
objects	ENTITY
or	
falling	ENTITY
down	ENTITY
.	

A	
sudden	ENTITY
arousal	ENTITY
consistent	ENTITY
with	ENTITY
sleep	ENTITY
terrors	ENTITY
may	
segue	ENTITY
rapidly	
into	
agitated	ENTITY
sleepwalking	ENTITY
and	
panicky	ENTITY
running	ENTITY
and	
other	
potentially	
dangerous	
behav-	
iors	ENTITY
.	

Self	ENTITY
-	
injury	ENTITY
is	
not	
unusual	
and	
when	
resulting	
in	
death	ENTITY
has	
been	
given	
the	
term	
of	
Parasomnias	ENTITY
Parasomnias	ENTITY
“	
parasomnia	ENTITY
pseudosuicide	ENTITY
.	
”	

Cuts	ENTITY
,	
bruises	ENTITY
,	
and	
other	
injuries	ENTITY
may	
occur	
—	
often	
to	
the	
surprise	
of	
the	
sleepwalker	
once	
awake	ENTITY
.	

Sleepwalkers	ENTITY
are	
reported	
to	
have	
a	
high	
tol-	
erance	ENTITY
for	
pain	ENTITY
.	

Knife	ENTITY
cuts	ENTITY
,	
burns	ENTITY
,	
and	
other	
self	ENTITY
-	
injury	ENTITY
sustained	ENTITY
during	
sleepwalking	ENTITY
may	
not	
awaken	
them	
.	

Violence	ENTITY
to	
others	
also	
can	
occur	
with	
adult	ENTITY
sleepwalking	ENTITY
,	
especially	
in	
men	ENTITY
.	

The	
sleepwalker	ENTITY
does	
not	
generally	
seek	
out	
the	
eventual	ENTITY
victim	ENTITY
of	
violence	ENTITY
.	

More	
typi-	

cally	ENTITY
,	
a	
person	ENTITY
attempting	
to	
block	ENTITY
,	
grab	ENTITY
,	
restrain	ENTITY
,	
redirect	ENTITY
or	
awaken	
a	
sleepwalker	
during	
an	
episode	ENTITY
may	
be	
violently	
attacked	ENTITY
,	
even	
if	
they	
are	
family	ENTITY
members	ENTITY
or	
friends	ENTITY
.	

This	
may	
result	
in	
a	
form	
of	
primitive	
defensive	ENTITY
aggression	ENTITY
including	
pushing	ENTITY
,	
hitting	ENTITY
,	
kicking	ENTITY
,	
or	
throwing	ENTITY
objects	ENTITY
.	

This	
pattern	ENTITY
also	
has	
been	
reported	
in	
the	
sleep	ENTITY
laboratory	ENTITY
when	
technical	ENTITY
personnel	ENTITY
have	
attempted	
to	
return	ENTITY
sleepwalking	ENTITY
patients	ENTITY
to	
bed	ENTITY
.	

In	
extreme	
cases	ENTITY
,	
victims	ENTITY
have	
been	
stabbed	ENTITY
with	
knives	ENTITY
or	
blunt	ENTITY
objects	ENTITY
.	

Such	
inappropriate	ENTITY
and	
antisocial	ENTITY
behaviors	ENTITY
have	
legal	ENTITY
and	
forensic	ENTITY
implications	
,	
as	
sleep-	ENTITY
walkers	ENTITY
have	
been	
arrested	ENTITY
and	
charged	ENTITY
with	ENTITY
assault	ENTITY
and	
battery	ENTITY
,	
attempted	
homicide	ENTITY
,	
homicide	ENTITY
,	
and	
sexual	ENTITY
assault	ENTITY
with	
indecency	ENTITY
.	

The	
child	ENTITY
with	
calm	ENTITY
sleepwalking	ENTITY
may	
quietly	ENTITY
walk	ENTITY
toward	
a	
light	ENTITY
or	
to	
the	
parents	ENTITY
’	
bedroom	ENTITY
.	

Occasionally	
,	
children	ENTITY
will	
walk	
toward	
a	
window	ENTITY
or	
door	ENTITY
or	
even	
go	
outside	ENTITY
,	
with	
obvious	
attendant	ENTITY
risk	ENTITY
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
Sleep	ENTITY
related	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
are	
primarily	
classified	
as	
confusional	ENTITY
arous-	
als	
in	
that	
they	
typically	
occur	
without	
any	
behaviors	ENTITY
outside	
of	
the	
bed	ENTITY
(	
or	
chosen	
sleep-	
ing	
accommodation	ENTITY
)	
,	
but	
have	
also	
been	
less	
commonly	
associated	ENTITY
with	ENTITY
sleepwalking	ENTITY
.	

Other	
terms	
for	
this	
condition	ENTITY
include	
“	
atypical	ENTITY
sexual	ENTITY
behavior	ENTITY
during	
sleep	ENTITY
,	
”	
“	
sexsom-	
nia	ENTITY
,	
”	
and	
“	
sleep	ENTITY
sex	ENTITY
.	
”	

Sleep	ENTITY
related	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
often	
have	
major	
inter-	
personal	ENTITY
,	
clinical	ENTITY
,	
and	
occasional	
criminal	ENTITY
consequences	ENTITY
.	

The	
set	
of	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
during	
disordered	ENTITY
arousals	ENTITY
includes	
prolonged	ENTITY
or	
violent	ENTITY
masturbation	ENTITY
,	
sexual	ENTITY
molestation	ENTITY
and	
assaults	ENTITY
(	
of	
minors	ENTITY
and	
adults	ENTITY
)	
,	
initiation	ENTITY
of	
sexual	ENTITY
intercourse	ENTITY
irre-	
spective	ENTITY
of	
the	
menstrual	ENTITY
status	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
(	
in	
contrast	
to	
waking	ENTITY
intercourse	ENTITY
for	
those	
individuals	ENTITY
)	
,	
and	
loud	ENTITY
(	
sexual	
)	
vocalizations	
during	
sleep	ENTITY
—	
followed	
by	
morning	ENTITY
amnesia	ENTITY
.	

The	
preponderance	
of	
patients	ENTITY
have	
also	
been	
diagnosed	ENTITY
with	
a	
NREM	ENTITY
sleep	ENTITY
parasomnia	ENTITY
,	
most	
often	
confusional	ENTITY
arousals	ENTITY
alone	
but	
on	
occasion	
with	
sleepwalking	ENTITY
,	
sleep	ENTITY
related	ENTITY
driving	ENTITY
,	
or	
sleep	ENTITY
related	
eating	ENTITY
disorder	ENTITY
.	

Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
OSA	ENTITY
)	
is	
another	
recognized	
precipitant	ENTITY
of	
sleep	
related	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
.	

The	
presence	ENTITY
of	
an	
overlap	ENTITY
disorder	ENTITY
,	
in	
which	
RBD	ENTITY
and	
a	
partial	ENTITY
arousal	ENTITY
disorder	ENTITY
(	
sleepwalking	ENTITY
or	
sleep	ENTITY
terrors	ENTITY
)	
are	
comorbid	ENTITY
in	
a	
patient	ENTITY
,	
may	
complicate	
diagnosis	ENTITY
of	
each	
condition	ENTITY
.	

Careful	
review	ENTITY
of	
history	ENTITY
and	
use	
of	
polysomnography	ENTITY
may	
facilitate	
identification	ENTITY
of	
this	
presentation	ENTITY
.	

Demographics	ENTITY
There	
is	
no	ENTITY
sex	ENTITY
difference	ENTITY
with	
disorders	ENTITY
of	ENTITY
arousals	ENTITY
.	

They	
are	
especially	
prevalent	ENTITY
among	
children	ENTITY
and	
adults	ENTITY
younger	ENTITY
than	
35	
years	ENTITY
.	

The	
prevalence	ENTITY
rate	ENTITY
of	
confusional	ENTITY
arousals	ENTITY
and	
sleepwalking	ENTITY
are	
similar	
.	

The	
prevalence	ENTITY
of	
confusional	ENTITY
arousals	ENTITY
in	
children	ENTITY
three	
to	
13	
years	ENTITY
of	
age	ENTITY
in	
a	
large	
population	ENTITY
-	
based	ENTITY
study	ENTITY
was	
17.3	
%	
.	

Lifetime	ENTITY
prevalence	ENTITY
of	
confusional	ENTITY
arousals	ENTITY
has	
recently	
been	
reported	
as	
18.5	
%	
(	
16.1	
-	
20.9	
confidence	ENTITY
interval	ENTITY
)	
.	

The	
prevalence	ENTITY
among	
adults	ENTITY
older	
than	
15	
years	ENTITY
is	
2.9	
%	
to	
4.2	
%	
.	

The	
lifetime	ENTITY
prevalence	ENTITY
of	
sleepwalking	ENTITY
is	
as	
high	
as	
18.3	
%	
.	

A	
recent	
study	ENTITY
of	
“	
noctur-	
nal	ENTITY
wandering	ENTITY
”	
that	
likely	
included	
a	
large	
percentage	ENTITY
of	
sleepwalkers	ENTITY
reported	
a	
life-	ENTITY
time	ENTITY
prevalence	
of	
29.2	
%	
.	

A	
Swedish	ENTITY
study	ENTITY
of	
children	ENTITY
aged	ENTITY
6	
-	
16	
years	ENTITY
found	
the	
inci-	ENTITY
dence	ENTITY
of	
sleepwalking	ENTITY
to	
be	
40	
%	
.	

Up	
to	
4.3	
%	
of	
adults	ENTITY
sleepwalk	ENTITY
.	

In	
one	
series	
,	
one	
third	
of	
54	
adult	ENTITY
patients	ENTITY
with	
injurious	ENTITY
sleepwalking	ENTITY
(	
with	
or	
without	
night	ENTITY
terrors	ENTITY
)	
began	
sleepwalking	ENTITY
after	
16	
years	ENTITY
of	
age	ENTITY
.	

The	
prevalence	ENTITY
of	
sleep	ENTITY
terrors	ENTITY
has	
not	
been	
studied	
as	
thoroughly	
.	

Prevalence	ENTITY
rates	ENTITY
of	
1	
%	
to	
6.5	
%	
in	
children	ENTITY
and	
2.2	
%	
in	
adults	ENTITY
have	
been	
reported	
,	
with	
a	
virtually	
constant	
prevalence	ENTITY
rate	ENTITY
of	
2.3	
%	
to	
2.6	
%	
in	
the	
15	
-	
year	ENTITY
-	
old	ENTITY
to	
64	
-	
year	ENTITY
-	
old	ENTITY
age	ENTITY
group	ENTITY
,	
before	
falling	
to	
1	
%	
in	
the	
older	ENTITY
than	
65	
years	ENTITY
age	ENTITY
group	ENTITY
.	

Other	
studies	ENTITY
have	
reported	
the	
intermittent	ENTITY
appearance	ENTITY
of	
sleep	ENTITY
terrors	ENTITY
in	
25	
%	
of	
children	ENTITY
younger	ENTITY
than	
five	
years	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Disorders	ENTITY
of	
arousal	ENTITY
are	
most	
often	
evaluated	ENTITY
in	
terms	
of	
predisposing	ENTITY
,	
priming	ENTITY
,	
and	
precipitating	ENTITY
(	
triggering	
)	
factors	
.	

Most	
often	
a	
simultaneous	ENTITY
co	ENTITY
-	
occurrence	ENTITY
of	
these	
factors	ENTITY
is	
thought	
necessary	
in	
order	
for	
a	
disorder	ENTITY
of	
arousal	ENTITY
occur	
.	

However	
,	
the	
reason	
a	
disorder	ENTITY
of	
arousal	ENTITY
occurs	
on	
one	
night	ENTITY
and	
not	
others	
is	
not	
fully	
understood	
.	

A	
genetic	ENTITY
predisposition	ENTITY
has	
been	
hypothesized	ENTITY
and	
several	
studies	ENTITY
have	
identified	
dif-	
ferent	ENTITY
genetic	ENTITY
loci	ENTITY
and	
modes	ENTITY
of	
inheritance	ENTITY
(	
see	
Familial	ENTITY
Pattern	ENTITY
,	
below	
)	
.	

In	ENTITY
childhood	ENTITY
,	
disorder	ENTITY
of	
arousal	ENTITY
can	
usually	
be	
considered	
an	
expected	
and	
normal	ENTITY
developmental	ENTITY
sleep	ENTITY
phenomenon	
,	
apart	
from	
those	
cases	ENTITY
with	
clinical	ENTITY
consequences	ENTITY
.	

However	
,	
dis-	
orders	
of	
arousal	ENTITY
that	
persist	
beyond	
adolescence	ENTITY
or	
begin	
in	ENTITY
adulthood	ENTITY
can	
often	
be	
problematic	ENTITY
and	
may	
require	
clinical	ENTITY
attention	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Many	
priming	ENTITY
factors	ENTITY
for	
disorders	ENTITY
of	
arousal	ENTITY
,	
in	
particular	
sleepwalking	ENTITY
,	
have	
been	
identified	ENTITY
.	

Sleep	ENTITY
deprivation	ENTITY
and	
situational	ENTITY
stress	ENTITY
are	
the	
most	
potent	
factors	ENTITY
.	

Hyperthyroidism	ENTITY
,	
migraines	ENTITY
,	
head	ENTITY
injury	ENTITY
,	
encephalitis	ENTITY
,	
stroke	ENTITY
,	
and	
other	
conditions	ENTITY
have	
also	
been	
reported	
much	
more	
rarely	
as	
potential	
priming	ENTITY
factors	ENTITY
.	

OSA	ENTITY
and	
other	
sleep	ENTITY
related	
respiratory	ENTITY
events	ENTITY
are	
increasingly	
recognized	
precipitants	ENTITY
of	
disorders	ENTITY
of	
arousal	ENTITY
in	
both	
children	ENTITY
and	
adults	ENTITY
.	

Treatment	ENTITY
of	
these	
comorbid	ENTITY
con-	
ditions	ENTITY
may	
reduce	ENTITY
or	
eliminate	
the	
occurrence	ENTITY
of	
disorders	ENTITY
of	
arousal	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
may	
also	
be	
triggered	
by	
environmental	ENTITY
stimuli	ENTITY
such	
as	
telephone	ENTITY
calls	ENTITY
,	
pagers	ENTITY
,	
messaging	ENTITY
from	
electronic	ENTITY
devices	ENTITY
,	
and	
a	
host	ENTITY
of	
other	
stimuli	ENTITY
.	

It	
is	
clinically	ENTITY
important	
to	
note	
that	
first	
responders	ENTITY
,	
physicians	ENTITY
,	
and	
others	
on	
call	
may	
be	
vulnerable	ENTITY
to	
such	
stimuli	ENTITY
,	
increasing	ENTITY
the	
potential	ENTITY
for	
inappropriate	ENTITY
responses	ENTITY
and	
behavior	ENTITY
.	

Travel	ENTITY
,	
sleeping	ENTITY
in	
unfamiliar	
surroundings	ENTITY
,	
febrile	ENTITY
states	ENTITY
in	
children	ENTITY
,	
physical	ENTITY
or	
emo-	
tional	ENTITY
stress	ENTITY
in	
adults	ENTITY
,	
the	
premenstrual	ENTITY
period	ENTITY
in	
women	ENTITY
,	
as	
well	
as	
the	
use	
of	
psycho-	
tropic	ENTITY
medications	ENTITY
such	
as	
lithium	ENTITY
carbonate	ENTITY
,	
phenothiazines	ENTITY
,	
anticholinergic	ENTITY
agents	ENTITY
,	
and	
sedative	ENTITY
/	
hypnotic	ENTITY
agents	ENTITY
have	
been	
associated	ENTITY
with	ENTITY
the	
onset	ENTITY
of	ENTITY
sleepwalking	ENTITY
,	
but	
a	
causal	
relationship	ENTITY
has	
yet	
to	
be	
established	
.	

Alcohol	ENTITY
has	
been	
identified	ENTITY
in	
previous	
reports	ENTITY
as	
a	
potential	ENTITY
sleepwalking	ENTITY
trigger	ENTITY
.	

However	
,	
the	
amnesia	ENTITY
associated	ENTITY
with	ENTITY
dis-	
orders	
of	
arousal	ENTITY
makes	
these	
reports	ENTITY
unreliable	ENTITY
.	

More	
recent	
evidence	ENTITY
-	
based	ENTITY
reviews	ENTITY
have	
found	
no	
compelling	
relationship	ENTITY
between	
alcohol	ENTITY
and	
disorders	ENTITY
of	
arousal	ENTITY
.	

Internal	ENTITY
stimuli	ENTITY
,	
such	
as	
a	
distended	ENTITY
bladder	ENTITY
,	
or	
external	ENTITY
stimuli	ENTITY
,	
such	
as	
noise	ENTITY
or	
light	ENTITY
,	
can	
also	
precipitate	ENTITY
episodes	ENTITY
.	

There	
is	
no	ENTITY
significant	ENTITY
association	ENTITY
between	
childhood	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
and	
psycho-	
pathology	ENTITY
.	

In	
adult	ENTITY
sleepwalking	ENTITY
,	
although	
a	
considerable	
number	
of	
patients	ENTITY
may	
have	
a	
past	
or	
current	
history	ENTITY
of	
nonpsychotic	ENTITY
depressive	ENTITY
and	
anxiety	ENTITY
disorders	ENTITY
,	
it	
does	
not	
appear	
that	
the	
psychiatric	ENTITY
disorder	ENTITY
and	
sleepwalking	ENTITY
,	
in	
particular	
,	
are	
tightly	
linked	
.	

In	
addition	
,	
when	
the	
two	
conditions	ENTITY
emerge	
in	
close	
temporal	ENTITY
proximity	ENTITY
,	
control	ENTITY
of	
the	
psychiatric	ENTITY
disorder	ENTITY
often	
does	
not	
control	
the	
parasomnia	ENTITY
,	
for	
which	
separate	ENTITY
treatment	ENTITY
is	
required	
.	

Familial	ENTITY
Pattern	ENTITY
Genetic	ENTITY
factors	ENTITY
appear	
to	
play	
an	
important	
role	
in	
all	
of	
the	
disorders	ENTITY
of	
arousal	ENTITY
.	

However	
,	
published	ENTITY
research	ENTITY
data	ENTITY
exist	
primarily	
for	
patients	ENTITY
who	
sleepwalk	ENTITY
.	

Sleepwalking	ENTITY
has	
a	
familial	ENTITY
pattern	ENTITY
.	

The	
rate	ENTITY
of	
childhood	ENTITY
sleepwalking	ENTITY
increases	ENTITY
in	
relation	
to	
the	
number	
of	
affected	ENTITY
parents	ENTITY
:	
22	
%	
when	
neither	
parent	ENTITY
has	
the	
disor-	ENTITY
der	ENTITY
,	
45	
%	
if	
one	
parent	ENTITY
is	
affected	ENTITY
,	
and	
60	
%	
when	
both	
are	
affected	ENTITY
.	

Population	ENTITY
-	
based	ENTITY
studies	ENTITY
of	
monozygotic	ENTITY
and	
dizygotic	ENTITY
twins	ENTITY
suggest	
that	
genetic	ENTITY
factors	ENTITY
play	
a	
role	
in	
65	
%	
of	
cases	ENTITY
of	
sleepwalking	ENTITY
.	

Different	ENTITY
models	ENTITY
of	
modes	ENTITY
of	
inheritance	ENTITY
includ-	
ing	
multifactorial	ENTITY
,	
recessive	ENTITY
with	ENTITY
incomplete	ENTITY
penetrance	ENTITY
,	
and	
autosomal	ENTITY
dominant	ENTITY
trait	ENTITY
with	
reduced	ENTITY
penetrance	ENTITY
have	
been	
proposed	
,	
based	
primarily	
on	
analysis	ENTITY
of	
family	ENTITY
histories	ENTITY
.	

However	
,	
these	
finding	ENTITY
are	
not	
sufficiently	
specific	
to	
be	
used	
for	
diagnostic	ENTITY
testing	ENTITY
.	

Further	
,	
the	
mechanisms	ENTITY
by	
which	
a	
genetic	ENTITY
predisposition	ENTITY
for	
confusional	ENTITY
arousal	ENTITY
or	
other	
related	
disorders	ENTITY
contributes	
to	
their	
occurrence	ENTITY
are	
not	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Confusional	ENTITY
arousals	ENTITY
most	
often	
appear	
in	
early	ENTITY
childhood	ENTITY
around	
the	
age	ENTITY
of	
two	
years	ENTITY
.	

This	
childhood	ENTITY
form	
of	
confusional	ENTITY
arousals	ENTITY
is	
typically	
benign	ENTITY
,	
but	
may	
cause	
concern	
in	
parents	ENTITY
.	

Confusional	ENTITY
arousals	ENTITY
of	
early	ENTITY
childhood	ENTITY
diminish	ENTITY
in	
occurrence	ENTITY
after	
the	
age	ENTITY
of	
five	
years	ENTITY
.	

Sleepwalking	ENTITY
can	
begin	
as	
soon	
as	
a	
child	ENTITY
is	
able	
to	
walk	ENTITY
but	
may	
begin	
at	
almost	
any	
time	ENTITY
in	
the	
life	ENTITY
cycle	ENTITY
,	
including	
as	
late	
as	
the	
seventh	
decade	
.	

Sleepwalking	ENTITY
is	
often	
preceded	
by	
confusional	ENTITY
arousals	ENTITY
.	

Childhood	ENTITY
sleepwalking	ENTITY
usually	
disappears	
sponta-	
neously	ENTITY
around	
puberty	ENTITY
but	
may	
persist	
into	
adolescence	ENTITY
.	

Episodes	ENTITY
can	
occur	
sporad-	
ically	ENTITY
or	
with	
high	
frequency	ENTITY
,	
such	
as	
multiple	ENTITY
times	
nightly	ENTITY
for	
several	
consecutive	ENTITY
nights	ENTITY
.	

Sleepwalking	ENTITY
may	
occur	
for	
the	
first	
time	
in	ENTITY
adulthood	ENTITY
or	
may	
recur	
in	
adult-	
hood	ENTITY
during	
periods	ENTITY
of	
sleep	ENTITY
deprivation	ENTITY
or	
stress	ENTITY
.	

Sleep	ENTITY
terrors	ENTITY
usually	
emerge	
in	
children	ENTITY
aged	ENTITY
four	
to	
12	
years	ENTITY
(	
but	
can	
also	
emerge	
in	ENTITY
adulthood	ENTITY
)	
and	
tend	
to	
resolve	
spontaneously	ENTITY
by	
early	ENTITY
adolescence	ENTITY
,	
as	
does	
sleep-	ENTITY
walking	ENTITY
.	

Social	ENTITY
embarrassment	ENTITY
over	
the	
sleep	ENTITY
terrors	ENTITY
can	
impair	ENTITY
social	ENTITY
relationships	ENTITY
in	
children	ENTITY
and	
adults	ENTITY
.	

Serious	ENTITY
or	
even	
lethal	ENTITY
injuries	ENTITY
can	
occur	
.	

Developmental	ENTITY
Issues	ENTITY
As	
noted	
above	
,	
disorders	ENTITY
of	
arousal	ENTITY
most	
often	
occur	
initially	
in	
childhood	ENTITY
and	
decrease	ENTITY
in	
occurrence	ENTITY
steadily	
until	
young	ENTITY
adulthood	ENTITY
.	

However	
,	
they	
may	
occur	
for	
the	
first	
time	
in	ENTITY
adulthood	ENTITY
or	
reappear	
after	
many	
asymptomatic	ENTITY
years	ENTITY
,	
often	
related	
to	
stress	ENTITY
,	
sleep	ENTITY
deprivation	ENTITY
,	
or	
development	ENTITY
of	
another	
sleep	ENTITY
disorder	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
overwhelming	
majority	
of	
individuals	ENTITY
with	
disorders	ENTITY
of	
arousal	ENTITY
do	
not	
have	
neuro-	ENTITY
logical	ENTITY
or	
psychological	ENTITY
pathology	ENTITY
.	

There	
are	
rare	ENTITY
reported	
cases	ENTITY
of	
confusional	ENTITY
arous-	
als	
associated	ENTITY
with	ENTITY
brain	ENTITY
lesions	ENTITY
in	
areas	
subserving	
arousal	ENTITY
,	
such	
as	
the	
posterior	ENTITY
hypothalamus	ENTITY
,	
midbrain	ENTITY
reticular	ENTITY
area	ENTITY
,	
and	
periventricular	ENTITY
gray	ENTITY
matter	ENTITY
.	

However	
,	
data	ENTITY
from	
a	
single	
patient	ENTITY
with	
confusional	ENTITY
arousals	ENTITY
suggest	
that	
they	
may	
be	
due	
to	
a	
func-	
tional	ENTITY
abnormality	ENTITY
in	
the	
brain	ENTITY
that	
leaves	ENTITY
some	
regions	ENTITY
,	
such	
as	
hippocampus	ENTITY
and	
Parasomnias	ENTITY
Parasomnias	ENTITY
frontal	ENTITY
associative	ENTITY
cortices	ENTITY
,	
asleep	ENTITY
,	
while	
other	
parts	
of	
the	
brain	ENTITY
such	
as	
motor	ENTITY
,	
cingu-	
late	
,	
insular	ENTITY
,	
amygdala	ENTITY
,	
and	
temporopolar	ENTITY
cortices	ENTITY
,	
are	
active	ENTITY
or	
awake	ENTITY
.	

It	
is	
generally	
considered	
that	
disorders	ENTITY
of	
arousal	ENTITY
represent	
a	
dissociation	ENTITY
of	
different	
regions	ENTITY
of	
the	
brain	ENTITY
in	
addition	
to	
activation	ENTITY
of	
locomotor	ENTITY
centers	ENTITY
/	
central	ENTITY
pattern	ENTITY

gen-	
erators	ENTITY
,	
accompanied	
by	
sleep	ENTITY
inertia	ENTITY
and	
sleep	ENTITY
state	ENTITY
instability	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

Although	
not	
routinely	
indicated	
for	
the	
evaluation	ENTITY
of	
typical	
,	
uncomplicated	ENTITY
,	
and	
non-	
injurious	ENTITY
parasomnias	ENTITY
,	
polysomnographic	ENTITY
studies	ENTITY
demonstrate	
that	
disorders	ENTITY
of	
arousal	ENTITY
typically	
begin	
after	
an	
arousal	ENTITY
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
,	
most	
commonly	
toward	
the	
end	
of	
the	
first	
or	
second	
episode	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

Occasionally	
,	
disorders	ENTITY
of	
arousal	ENTITY
can	
emerge	
from	
stage	ENTITY
N2	ENTITY
sleep	ENTITY
.	

Heart	ENTITY
rate	ENTITY
acceleration	ENTITY
,	
increased	ENTITY
muscle	ENTITY
tone	ENTITY
,	
and	
muscle	ENTITY
twitching	ENTITY
may	
rarely	
be	
observed	
before	
a	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
arousal	ENTITY
.	

Diagnostic	ENTITY
polysomnography	ENTITY
may	
note	
high	ENTITY
-	
amplitude	ENTITY
hypersynchronous	
delta	
waves	
and	
frequent	ENTITY
arousals	ENTITY
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

However	
,	
these	
findings	ENTITY
have	
a	
low	ENTITY
spec-	
ificity	ENTITY
and	
have	
been	
reported	
to	
occur	
in	
other	
disorders	ENTITY
such	
as	
OSA	ENTITY
and	
in	
asymp-	
tomatic	ENTITY
individuals	ENTITY
.	

On	
rare	
occasions	ENTITY
,	
polysomnography	ENTITY
can	
provide	
support	
for	
the	
clinical	ENTITY
diagnosis	ENTITY
by	
documenting	
arousals	ENTITY
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
accompanied	
by	
behaviors	ENTITY
typical	
of	
confusional	ENTITY
arousals	ENTITY
.	

Out	
-	
of	
-	
bed	ENTITY
behaviors	ENTITY
are	
very	
rare	
in	
the	
sleep	ENTITY
laboratory	ENTITY
.	

Changes	ENTITY
between	
the	
home	ENTITY
and	
sleep	ENTITY
laboratory	ENTITY
environment	ENTITY
,	
timing	ENTITY
,	
habits	ENTITY
,	
and	
other	
factors	ENTITY
may	
serve	
to	
decrease	ENTITY
the	
likelihood	ENTITY
of	
sleepwalking	ENTITY
in	
the	
laboratory	ENTITY
.	

Time	ENTITY
-	
synchronized	ENTITY
video	ENTITY
-	
polysomnographic	ENTITY
(	
vPSG	ENTITY
)	
recording	ENTITY
is	
essen-	
tial	ENTITY
if	
polysomnography	
(	
PSG	ENTITY
)	
is	
to	
be	
used	
as	
support	
for	
the	
diagnosis	ENTITY
.	

However	
,	
a	
normal	
PSG	ENTITY
does	
not	
rule	
out	
the	
diagnosis	ENTITY
of	
a	
disorder	ENTITY
of	
arousal	ENTITY
.	

In	
adults	ENTITY
in	
whom	
there	
are	
only	
one	
or	
two	
episodes	ENTITY
per	ENTITY
year	ENTITY
,	
there	
is	
a	
very	
low	
likelihood	ENTITY
of	
occurrence	ENTITY
in	
the	
sleep	ENTITY
laboratory	ENTITY
.	

However	
,	
the	
sleep	ENTITY
study	ENTITY
may	
assist	
in	
ruling	
out	
disorders	ENTITY
with	
similar	
presentations	ENTITY
,	
such	
as	
RBD	ENTITY
or	
nocturnal	ENTITY
epilepsy	ENTITY
.	

PSG	ENTITY
may	
further	
be	
useful	
by	
identifying	
potential	ENTITY
triggers	ENTITY
,	
such	
as	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
or	
peri-	
odic	ENTITY
leg	ENTITY
movements	ENTITY
that	
are	
currently	
present	
.	

Provocative	ENTITY
sleep	ENTITY
studies	ENTITY
using	
sleep	ENTITY
deprivation	ENTITY
and	
acoustic	ENTITY
stimuli	ENTITY
have	
been	
used	
for	
research	ENTITY
purposes	ENTITY
,	
with	
success	ENTITY
.	

However	
,	
the	
sensitivity	ENTITY
and	
specificity	ENTITY
of	
these	
techniques	ENTITY
for	
clinical	ENTITY
purposes	ENTITY
are	
unknown	
.	

Postarousal	ENTITY
EEG	ENTITY
recordings	ENTITY
in	
children	ENTITY
and	
adults	ENTITY
with	
sleepwalking	ENTITY
often	
demon-	

strate	ENTITY
a	
partial	ENTITY
or	
virtually	
complete	
persistence	ENTITY
of	ENTITY
sleep	ENTITY
,	
with	
diffuse	ENTITY
,	
rhythmic	ENTITY
delta	ENTITY
activity	ENTITY
;	
diffuse	ENTITY
delta	ENTITY
and	
theta	ENTITY
activity	ENTITY
;	
mixed	ENTITY
delta	ENTITY
,	
theta	ENTITY
,	
alpha	ENTITY
,	
and	
beta	ENTITY
activity	ENTITY
;	
or	
at	
times	
alpha	
and	
beta	ENTITY
activity	ENTITY
.	

PSG	ENTITY
also	
may	
be	
helpful	
in	
excluding	
the	
diagnosis	ENTITY
of	
RBD	ENTITY
by	
demonstration	
of	
normal	ENTITY
muscle	ENTITY
atonia	ENTITY
in	
REM	ENTITY
sleep	ENTITY
(	
assuming	
adequate	ENTITY
amounts	
of	
REM	ENTITY
sleep	ENTITY
are	
observed	ENTITY
)	
.	

Although	
the	
“	
macrostructure	ENTITY
”	
of	
sleep	ENTITY
(	
i.e.	
,	
the	
cycling	ENTITY
of	
various	
NREM	ENTITY
and	
REM	ENTITY
sleep	ENTITY
stages	ENTITY
and	
the	
relative	
distributions	ENTITY
of	
these	
sleep	ENTITY
stages	ENTITY
)	
is	
generally	
preserved	
with	
sleepwalking	ENTITY
,	
the	
“	
microstructure	ENTITY
”	
of	
sleep	ENTITY
can	
be	
perturbed	ENTITY
.	

Power	ENTITY
spectral	ENTITY
analyses	ENTITY
of	
slow	ENTITY
wave	ENTITY
activity	ENTITY
in	
adult	ENTITY
sleepwalkers	ENTITY
have	
revealed	
several	
forms	
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
dysregulation	ENTITY
,	
including	
high	
amounts	
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
fragmentation	ENTITY
(	
particularly	
during	
the	
first	
NREM	ENTITY
-	
REM	ENTITY
sleep	ENTITY
cycle	ENTITY
)	
,	
a	
significant	
increase	ENTITY
in	
delta	
power	
just	
prior	
to	
an	
arousal	ENTITY
,	
and	
increased	ENTITY
slow	ENTITY
wave	ENTITY
activity	ENTITY
across	
all	
NREM	ENTITY
sleep	ENTITY
cycles	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Disorders	ENTITY
of	
arousal	ENTITY
should	
be	
carefully	
distinguished	
from	
other	
disorders	ENTITY
with	
similar	
presentations	ENTITY
,	
but	
different	
pathophysiologies	ENTITY
,	
courses	ENTITY
,	
and	
treatments	ENTITY
.	

Other	
disorders	ENTITY
to	
be	
considered	
include	
RBD	ENTITY
,	
sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
,	
sleep	ENTITY
related	
dissocia-	
tive	ENTITY
disorders	ENTITY
,	
alcohol	ENTITY
and	
drug	ENTITY
related	ENTITY
behaviors	ENTITY
,	
and	
OSA	ENTITY
.	

RBD	ENTITY
typically	
presents	
as	
dream	ENTITY
-	
enacting	ENTITY
behaviors	ENTITY
during	
the	
second	
half	
of	
the	
night	ENTITY
and	
usually	
affects	
middle	ENTITY
-	
aged	ENTITY
men	ENTITY
,	
but	
also	
can	
affect	
women	ENTITY
and	
virtually	
any	
age	ENTITY
group	ENTITY
.	

Because	
sleepwalking	ENTITY
in	
adults	ENTITY
can	
also	
present	
as	
dream	ENTITY
-	
enacting	ENTITY
behaviors	ENTITY
that	
emerge	
during	
any	
time	
of	
the	
night	ENTITY
,	
vPSG	ENTITY
may	
be	
necessary	
to	
distinguish	
sleep-	ENTITY
walking	ENTITY
from	
RBD	ENTITY
.	

In	
contrast	
to	
disorders	ENTITY
of	
arousal	ENTITY
,	
signs	ENTITY
of	
RBD	ENTITY
,	
particularly	
tonic	ENTITY
/	
phasic	ENTITY
EMG	ENTITY
activity	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
are	
almost	
always	
present	
during	
sleep	ENTITY
studies	ENTITY
.	

If	
sleepwalking	ENTITY
(	
or	
sleep	ENTITY
terrors	ENTITY
)	
occurs	
with	
RBD	ENTITY
in	
the	
same	
patient	ENTITY
,	
both	
should	
be	
diagnosed	ENTITY
.	

This	
has	
been	
referred	
to	
as	
a	
parasomnia	ENTITY
overlap	
disorder	ENTITY
.	

Other	
sleep	ENTITY
disorders	ENTITY
,	
such	
as	
OSA	ENTITY
,	
can	
precipitate	ENTITY
disorders	ENTITY
of	
arousal	ENTITY
.	

Therefore	
,	
a	
careful	
history	ENTITY
must	
be	
obtained	
to	
identify	
other	
sleep	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
can	
manifest	ENTITY
with	
wandering	ENTITY
behavior	ENTITY
or	
with	
frenzied	
walking	ENTITY
or	
running	ENTITY
.	

In	
adults	ENTITY
,	
a	
diagnosis	ENTITY
of	
malingering	ENTITY
also	
should	
be	
considered	
.	

If	
a	
neurologic	ENTITY
or	
medical	ENTITY
disor-	ENTITY
der	ENTITY
is	
identified	ENTITY
as	
the	
precipitant	ENTITY
of	
a	
disorder	ENTITY
of	
arousal	ENTITY
,	
then	
the	
sleepwalking	ENTITY
should	
be	
diagnosed	ENTITY
as	
parasomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
should	
not	
be	
diagnosed	ENTITY
in	
the	
presence	ENTITY
of	
alcohol	ENTITY
intoxication	ENTITY
.	

The	
behavior	ENTITY
of	
the	
alcohol	ENTITY
-	
intoxicated	ENTITY
individual	ENTITY
may	
superficially	
resemble	
that	
of	
the	
sleepwalker	ENTITY
.	

However	
,	
the	
sleepwalker	ENTITY
is	
typically	
severely	
cognitively	ENTITY
impaired	ENTITY
,	
but	
with	
only	
limited	
motor	ENTITY
impairment	ENTITY
.	

The	
alcohol	ENTITY
-	
intoxicated	ENTITY
individual	ENTITY
’s	
level	ENTITY
of	
cognitive	ENTITY
functioning	ENTITY
may	
be	
reduced	ENTITY
,	
but	
not	
absent	
,	
whereas	
motor	ENTITY
behavior	ENTITY
is	
often	
severely	ENTITY
impaired	ENTITY
.	

In	
alcoholic	ENTITY
blackouts	ENTITY
,	
where	
anterograde	ENTITY
amnesia	ENTITY
is	
,	
by	
definition	ENTITY
,	
Parasomnias	ENTITY
Parasomnias	ENTITY
the	
cardinal	
manifestation	ENTITY
,	
it	
is	
important	
to	
note	
that	
outward	ENTITY
motor	ENTITY
behavior	ENTITY
and	
cog-	
nitive	ENTITY
function	ENTITY
may	
not	
be	
impaired	ENTITY
and	
may	
be	
perceived	ENTITY
as	
normal	ENTITY
.	

Thus	
,	
the	
impor-	ENTITY
tance	ENTITY
of	
appreciating	
the	
neuroscience	ENTITY
of	
alcoholic	ENTITY
blackouts	ENTITY
and	
its	
potential	
role	
in	
the	
explanation	
of	
unusual	ENTITY
and	
bizarre	ENTITY
nocturnal	ENTITY
behaviors	ENTITY
can	
not	
be	
understated	
because	
these	
can	
mimic	
parasomnias	ENTITY
.	

The	
former	
are	
exponentially	
more	
prevalent	ENTITY
and	
thus	
should	
be	
given	
appropriate	
weight	
when	
attributing	
likely	
causation	ENTITY
in	
cases	ENTITY
with	
criminal	ENTITY
allegations	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
With	
the	
development	ENTITY
of	
sophisticated	
genetic	ENTITY
testing	ENTITY
and	
neuroimaging	ENTITY
,	
direct	
research	ENTITY
into	
the	
causes	ENTITY
and	
mechanisms	ENTITY
of	
disorders	ENTITY
or	
arousals	ENTITY
is	
anticipated	ENTITY
.	

Further	
investigations	ENTITY
that	
aid	
in	
the	
characterization	ENTITY
of	
the	
pathophysiology	ENTITY
are	
necessary	
.	

Further	
development	ENTITY
of	
sleep	ENTITY
laboratory	ENTITY
-	
based	ENTITY
techniques	ENTITY
for	
provoking	
episodes	ENTITY
of	
sleepwalking	ENTITY
would	
improve	
diagnostic	ENTITY
accuracy	ENTITY
.	

Bibliography	ENTITY
Achermann	
P	
,	
Werth	ENTITY
E	ENTITY
,	
Dijk	
DJ	
,	
Borbély	ENTITY
AA	ENTITY
.	

Time	ENTITY
course	ENTITY
of	
sleep	ENTITY
inertia	ENTITY
after	
nighttime	ENTITY
and	
daytime	ENTITY
sleep	ENTITY
episodes	ENTITY
.	

Arch	ENTITY
Ital	ENTITY
Biol	ENTITY
1995;134:109–19	ENTITY
.	

Broughton	ENTITY
RJ	ENTITY
.	

Sleep	ENTITY
disorders	ENTITY
:	
disorders	ENTITY
of	
arousal	ENTITY
?	

Science	ENTITY
1968;159:1070–8	ENTITY
.	

Fisher	ENTITY
C	ENTITY
,	
Kahn	ENTITY
E	ENTITY
,	
Edwards	ENTITY
A	ENTITY
,	
Davis	ENTITY
D	ENTITY
,	
Fine	
J.	
A	
psychophysiological	ENTITY
study	ENTITY
of	
nightmares	ENTITY
and	
night	ENTITY
terrors	ENTITY
.	

III	
.	

Mental	ENTITY
content	ENTITY
and	
recall	ENTITY
of	
stage	
4	
night	ENTITY
terrors	ENTITY
.	

J	
Nerv	
Ment	
Dis	
1974;158:174–88	
.	

Fisher	ENTITY
C	ENTITY
,	
Kahn	ENTITY
E	ENTITY
,	
Edwards	ENTITY
D	ENTITY
,	
Davis	
D.	
A	
psychophysiological	ENTITY
study	ENTITY
of	
nightmares	ENTITY
and	
night	ENTITY
terrors	ENTITY
:	
physiological	ENTITY
aspects	ENTITY
of	
the	
stage	ENTITY
4	
night	ENTITY
terror	ENTITY
.	

J	
Nerv	
Ment	
Dis	
1973;157:75–98	
.	

Gastaut	ENTITY
H	ENTITY
,	ENTITY
Broughton	ENTITY
R.	ENTITY
A	ENTITY
clinical	ENTITY
and	
polygraphic	ENTITY
study	ENTITY
of	
episodic	ENTITY
phenomena	ENTITY
during	
sleep	ENTITY
.	

In	
:	
Wortis	ENTITY
J	ENTITY
,	ENTITY
ed	
.	

Recent	
advances	
in	
biological	ENTITY
psychiatry	ENTITY
,	
Volume	ENTITY
7	ENTITY
.	

New	ENTITY
York	ENTITY
:	
Plenum	ENTITY
Press	ENTITY
,	
1965:197–223	
.	

Guilleminault	ENTITY
C	ENTITY
,	
Moscovitch	ENTITY
A	ENTITY
,	
Yuen	ENTITY
K	ENTITY
,	
Poyares	ENTITY
D.	
Atypical	ENTITY
sexual	ENTITY
behavior	ENTITY
during	
sleep	ENTITY
.	

Psychosom	ENTITY
Med	ENTITY
2002;64:328–36	ENTITY
.	

Guilleminault	ENTITY
C	ENTITY
,	
Silvestri	ENTITY
JM	ENTITY
.	

Disorders	
of	
arousal	ENTITY
and	
epilepsy	ENTITY
during	
sleep	ENTITY
.	

In	
:	
Sterman	ENTITY
M	ENTITY
,	
Shouse	ENTITY
M	ENTITY
,	
Passouant	ENTITY
P	ENTITY
,	
eds	
.	

Sleep	ENTITY
and	
epilepsy	ENTITY
.	

New	ENTITY
York	ENTITY
:	
Academic	ENTITY
Press	ENTITY
,	
1983:513–31	
.	

Hublin	ENTITY
C	ENTITY
,	
Kaprio	ENTITY
J	ENTITY
,	
Partinen	ENTITY
M	ENTITY
,	
Heikkila	ENTITY
K	ENTITY
,	
Koskenvuo	ENTITY
M.	ENTITY
Parasomnias	ENTITY
:	
co	ENTITY
-	
occurrence	ENTITY
and	
genetics	ENTITY
.	

Psychiatr	ENTITY
Genet	ENTITY
2001;11:65–70	ENTITY
.	

Hublin	ENTITY
C	ENTITY
,	
Kaprio	ENTITY
J	ENTITY
,	
Partinen	ENTITY
M	ENTITY
,	
Heikkila	ENTITY
K	ENTITY
,	
Koskenvuo	ENTITY
M.	ENTITY
Prevalence	ENTITY
and	
genetics	ENTITY
of	
sleepwalking	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
twin	ENTITY
study	ENTITY
.	

Neurology	ENTITY
1997;48:177–81	
.	

Iranzo	ENTITY
A	ENTITY
,	
Santamaria	ENTITY
J.	ENTITY
Severe	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
/	
hypopnea	ENTITY
mimicking	ENTITY
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
2005;28:203–6	
.	

Kales	ENTITY
A	ENTITY
,	
Soldatos	ENTITY
C	ENTITY
,	
Bixler	ENTITY
E	ENTITY
,	
et	
al	
.	

Hereditary	ENTITY
factors	ENTITY
in	
sleepwalking	ENTITY
and	
night	ENTITY
terrors	ENTITY
.	

Br	ENTITY
J	ENTITY
Psychiatry	ENTITY
1980;137:111–8	ENTITY
.	

Klackenberg	ENTITY
G.	
Somnambulism	
in	
childhood	ENTITY
—	
prevalence	ENTITY
,	
course	ENTITY
and	
behavioral	ENTITY
correlations	ENTITY
:	
a	
prospective	ENTITY
longitudinal	ENTITY
study	ENTITY
(	
3	
-	
16	
years	ENTITY
)	
.	

Acta	
Paediatr	
Scand	
1982;71:495–9	
.	

Mahowald	ENTITY
M	ENTITY
,	
Schenck	ENTITY
C	ENTITY
,	
Goldner	ENTITY
M	ENTITY
,	
Bachelder	ENTITY
V	ENTITY
,	
Cramer	
Bornemann	
M.	
Parasomnia	
pseudo	ENTITY
-	
suicide	ENTITY
.	

J	
Forensic	
Sci	
2003;48:1158–62	
.	

Nino	ENTITY
-	
Murcia	ENTITY
G	ENTITY
,	
Dement	ENTITY
W.	
Psychophysiological	ENTITY
and	
pharmacological	ENTITY
aspects	ENTITY
of	
somnambulism	ENTITY
and	
night	ENTITY
terrors	ENTITY
in	
children	ENTITY

.	

In	
:	
Meltzer	ENTITY
H	ENTITY
,	
ed	
.	

Psychopharmacology	ENTITY
:	
the	
third	
generation	
of	
progress	ENTITY
.	

New	ENTITY
York	ENTITY
:	
Raven	ENTITY
Press	ENTITY
,	
1987:873–9	
.	

Ohayon	ENTITY
M	ENTITY
,	
Guilleminault	ENTITY
C	ENTITY
,	
Priest	
R.	
Night	ENTITY
terrors	ENTITY
,	
sleepwalking	ENTITY
,	
and	
confusional	ENTITY
arousals	ENTITY
in	
the	
general	ENTITY
population	ENTITY
:	
their	
frequency	ENTITY
and	
relationship	ENTITY
to	
other	
sleep	ENTITY
and	
mental	ENTITY
disorders	ENTITY
.	

J	
Clin	
Psychiatry	
1999;60:268–76	
.	

Ohayon	ENTITY
M	ENTITY
,	
Priest	ENTITY
R	ENTITY
,	ENTITY
Zulley	ENTITY
J	ENTITY
,	
Smirne	ENTITY
S.	

The	
place	
of	
confusional	ENTITY
arousals	ENTITY
in	
sleep	ENTITY
and	
mental	ENTITY
disorders	ENTITY
:	
findings	ENTITY
in	
a	
general	ENTITY
population	ENTITY
sample	ENTITY
of	
13,057	
subjects	ENTITY
.	

J	
Nerv	
Ment	
Dis	
2000;188:340–8	
.	

Pilon	ENTITY
M	ENTITY
,	
Zadra	ENTITY
A	ENTITY
,	
Joncas	ENTITY
S	ENTITY
,	
Montplaisir	
J.	
Hypersynchronous	
delta	
waves	
and	
somnambulism	ENTITY
:	
brain	ENTITY
topography	ENTITY
and	
effect	ENTITY
of	
sleep	ENTITY
deprivation	ENTITY
.	

Sleep	ENTITY
2006;29:77–84	
.	

Pressman	ENTITY
M	ENTITY
,	
Mahowald	ENTITY
M	ENTITY
,	
Schenck	ENTITY
C	ENTITY
,	ENTITY
Cramer	ENTITY
Bornemann	ENTITY
M.	ENTITY
Alcohol	ENTITY
-	
induced	ENTITY
sleepwalking	ENTITY
or	
confusional	ENTITY
arousal	ENTITY
as	
a	
defense	ENTITY
to	
criminal	ENTITY
behavior	ENTITY
:	
a	
review	ENTITY
of	
scientific	ENTITY
evidence	ENTITY
,	
methods	ENTITY
and	
forensic	ENTITY
considerations	ENTITY
.	

J	
Sleep	
Rev	
2007;16:198–212	
.	

Pressman	ENTITY
M.	ENTITY
Factors	ENTITY
that	
predispose	ENTITY
,	
prime	ENTITY
and	
precipitate	ENTITY
NREM	ENTITY
parasomnias	ENTITY
in	
adults	ENTITY
:	
clinical	ENTITY
and	
forensic	ENTITY
implications	
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2007;11:5–30	ENTITY
.	

Pressman	ENTITY
MR	ENTITY
.	

Hypersynchronous	ENTITY
delta	ENTITY
sleep	ENTITY
EEG	
activity	ENTITY
and	
sudden	ENTITY
arousals	ENTITY
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
in	
adults	ENTITY
without	
a	
history	ENTITY
of	
parasomnias	ENTITY
:	
clinical	ENTITY
and	
forensic	ENTITY
implications	
.	

Sleep	ENTITY
2004	
;	
27:706–10	
.	

Schenck	ENTITY
C	ENTITY
,	
Arnulf	ENTITY
I	ENTITY
,	
Mahowald	ENTITY
M.	ENTITY
Sleep	ENTITY
and	
sex	ENTITY
:	
what	
can	
go	
wrong	
?	

A	
review	ENTITY
of	
the	
literature	ENTITY
on	
sleep	ENTITY
related	
disorders	ENTITY
and	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
and	
experiences	ENTITY
.	

Sleep	ENTITY
2007;30:683–702	
.	

Schenck	ENTITY
C	ENTITY
,	
Boyd	
J	
,	
Mahowald	
M.	
A	
parasomnia	ENTITY
overlap	
disorder	ENTITY
involving	
sleepwalking	ENTITY
,	
sleep	ENTITY
terrors	ENTITY
,	
and	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
in	
33	
polysomnographically	ENTITY
confirmed	
cases	ENTITY
.	

Sleep	ENTITY
1997;20:972–81	
.	

Schenck	ENTITY
C	ENTITY
,	
Mahowald	
M.	

On	
the	
reported	
association	ENTITY
of	
psychopathology	ENTITY
with	
sleep	ENTITY
terrors	ENTITY
in	
adults	ENTITY
.	

Sleep	ENTITY
2000;23:448–9	
.	

Simonds	ENTITY
J	ENTITY
,	
Parraga	
H.	
Prevalence	ENTITY
of	
sleep	ENTITY
disorders	ENTITY
and	
sleep	ENTITY
behaviors	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
.	

J	
Am	
Acad	
Child	
Adolesc	
Psychiatry	
1982;21:383–8	
.	

Zadra	ENTITY
A	ENTITY
,	
Desautels	ENTITY
A	ENTITY
,	
Petit	ENTITY
D	ENTITY
,	
Montplaisir	ENTITY
J.	ENTITY
Somnambulism	ENTITY
:	
clinical	ENTITY
aspects	ENTITY
and	
pathophysiological	ENTITY
hypotheses	ENTITY
.	

Lancet	ENTITY
Neurol	ENTITY
2013;12:285–94	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Sleep	ENTITY
Related	ENTITY
Eating	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.40	
Alternate	ENTITY
Names	ENTITY
Sleep	ENTITY
eating	ENTITY
Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
D	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.59	ENTITY
A.	ENTITY
Recurrent	ENTITY
episodes	ENTITY
of	
dysfunctional	ENTITY
eating	ENTITY
that	
occur	
after	
an	
arousal	ENTITY
during	
the	
main	
sleep	ENTITY
period	ENTITY
.	

B.	ENTITY
The	
presence	ENTITY
of	
at	
least	
one	
of	
the	
following	
in	
association	ENTITY
with	ENTITY
the	
recurrent	ENTITY
episodes	ENTITY
of	
involuntary	ENTITY
eating	ENTITY
:	
.	

Consumption	ENTITY
of	
peculiar	
forms	
or	
combinations	ENTITY
of	
food	ENTITY
or	
inedible	ENTITY
or	
toxic	ENTITY
substances	ENTITY
.	
.	

Sleep	ENTITY
related	
injurious	ENTITY
or	
potentially	
injurious	ENTITY
behaviors	ENTITY
performed	
while	
in	
pursuit	
of	
food	ENTITY
or	
while	
cooking	ENTITY
food	ENTITY
.	
.	

Adverse	ENTITY
health	ENTITY
consequences	ENTITY
from	
recurrent	ENTITY
nocturnal	ENTITY
eating	ENTITY
.	

C.	

There	
is	
partial	ENTITY
or	
complete	
loss	ENTITY
of	
conscious	ENTITY
awareness	ENTITY
during	
the	
eating	ENTITY
episode	ENTITY
,	
with	
subsequent	
impaired	ENTITY
recall	ENTITY
.	

D.	

The	
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
disorder	ENTITY
,	
medication	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

Essential	ENTITY
Features	ENTITY
SRED	ENTITY
consists	
of	
recurrent	ENTITY
episodes	ENTITY
of	
involuntary	ENTITY
eating	ENTITY
and	
drinking	ENTITY
during	
arous-	
als	
from	
sleep	ENTITY
,	
associated	ENTITY
with	ENTITY
diminished	ENTITY
levels	ENTITY
of	
consciousness	ENTITY
and	
subsequent	
recall	ENTITY
,	
with	
problematic	
consequences	ENTITY
.	

The	
episodes	ENTITY
of	
eating	ENTITY
always	
occur	
in	
an	
involuntary	ENTITY
or	
“	
out	
of	
control	ENTITY
”	
manner	
after	
an	
interval	ENTITY
of	
sleep	ENTITY
.	

Typically	
,	
they	
occur	
during	
partial	ENTITY
arousals	ENTITY
from	
sleep	ENTITY
with	
subsequent	
partial	ENTITY
recall	ENTITY
.	

On	
the	
one	
hand	
,	
some	
patients	ENTITY
can	
not	
be	
easily	
brought	
to	
full	
consciousness	ENTITY
during	
an	
episode	ENTITY
of	
eating	ENTITY
,	
as	
is	
the	
case	ENTITY
with	
sleepwalking	ENTITY
,	
and	
may	
have	
no	
recall	
of	
having	
eaten	ENTITY
during	
the	
night	ENTITY
.	

On	
the	
other	
hand	
,	
some	
patients	ENTITY
seemingly	
have	
considerable	
alertness	ENTITY
during	
an	
episode	ENTITY
and	
have	
substantial	
recall	
in	
the	
morning	ENTITY
.	

There	
may	
be	
variability	ENTITY
of	
awareness	ENTITY
and	
subsequent	
recall	ENTITY
within	
one	
night	ENTITY
,	
and	
across	
the	
evolution	ENTITY
of	
the	
disorder	ENTITY
in	
individual	ENTITY
patients	ENTITY
.	

The	
recurrent	ENTITY
episodes	ENTITY
of	
involuntary	ENTITY
eating	ENTITY
and	
drinking	ENTITY
during	
the	
main	
sleep	ENTITY
period	ENTITY
are	
typically	
associated	ENTITY
with	ENTITY
a	
feeling	
of	
lack	ENTITY
of	
control	
over	
eating	ENTITY
.	

Problematic	ENTITY
features	ENTITY
of	
the	
recurrent	ENTITY
sleep	ENTITY
related	ENTITY
eating	ENTITY
include	
the	
following	
:	
con-	
sumption	ENTITY
of	
peculiar	
forms	
or	
combinations	ENTITY
of	
food	ENTITY
,	
or	
of	
inedible	ENTITY
or	
toxic	ENTITY
substances	ENTITY
(	
e.g.	
,	
frozen	ENTITY
pizzas	ENTITY
,	
raw	ENTITY
bacon	ENTITY
,	
buttered	ENTITY
cigarettes	ENTITY
,	
cat	ENTITY
food	ENTITY
and	
salt	ENTITY
sandwiches	ENTITY
,	
coffee	ENTITY
grounds	ENTITY
,	
ammonia	ENTITY
cleaning	ENTITY
solutions	ENTITY
)	
;	
sleep	ENTITY
related	ENTITY
injury	ENTITY
(	
e.g.	
,	
lacerations	ENTITY
from	
care-	
less	
manipulation	ENTITY
of	
kitchen	ENTITY
utensils	ENTITY
;	
internal	ENTITY
or	
external	
burns	
from	
consuming	ENTITY
or	
spilling	ENTITY
hot	ENTITY
foods	ENTITY
or	
beverages	ENTITY
;	
or	
poisoning	ENTITY
and	
internal	ENTITY
injuries	ENTITY
from	
ingesting	ENTITY
toxic	ENTITY
substances	ENTITY
)	
;	
adverse	ENTITY
health	ENTITY
consequences	ENTITY
(	
e.g.	
,	
dental	ENTITY
caries	ENTITY
and	
tooth	ENTITY
chipping	ENTITY
from	
biting	ENTITY
frozen	ENTITY
foods	ENTITY
)	
;	
weight	ENTITY
gain	ENTITY
;	
obesity	ENTITY
(	
including	
morbid	ENTITY
obesity	ENTITY
resulting	
in	
bar-	
iatric	ENTITY
surgery	ENTITY
)	
;	
various	
metabolic	ENTITY
problems	ENTITY
,	
such	
as	
destabilization	ENTITY
or	
precipitation	ENTITY
of	
diabetes	ENTITY
mellitus	ENTITY
,	
hypertriglyceridemia	ENTITY
,	
and	
hypercholesterolemia	ENTITY
;	
nonrestorative	ENTITY
sleep	ENTITY
from	
sleep	ENTITY
disruption	ENTITY
;	
morning	ENTITY
anorexia	ENTITY
and	
abdominal	ENTITY
distention	ENTITY
.	

SRED	ENTITY
carries	
the	
risk	ENTITY
of	
consuming	ENTITY
foods	ENTITY
to	
which	
one	
is	
allergic	ENTITY
.	

Also	
,	
overnight	ENTITY
fasting	ENTITY
prior	
to	
next	
-	
day	ENTITY
surgery	ENTITY
or	
testing	ENTITY
can	
be	
compromised	ENTITY
.	

Secondary	ENTITY
depressive	ENTITY
disorders	ENTITY
may	
emerge	
from	
longstanding	
personal	ENTITY
dejection	ENTITY
and	
a	
sense	ENTITY
of	ENTITY
failure	ENTITY
over	
the	
inability	
to	
control	
the	
nocturnal	ENTITY
eating	ENTITY
.	

Secondary	ENTITY
food	ENTITY
restriction	ENTITY
,	
prompted	
by	
despair	ENTITY
over	
not	
being	
able	
to	
stop	
the	
nocturnal	ENTITY
eating	ENTITY
,	
often	
occurs	
at	
some	
point	
during	
the	
course	ENTITY
of	
the	
disorder	ENTITY
.	

Patients	ENTITY
may	
engage	
in	
potentially	
hazardous	ENTITY
(	
and	
expensive	ENTITY
)	
weight	ENTITY
-	
loss	ENTITY
regimens	ENTITY
.	

Insomnia	ENTITY
can	
also	
be	
a	
complication	ENTITY
.	

Associated	ENTITY
Features	
Nightly	ENTITY
eating	ENTITY
,	
including	
multiple	ENTITY
episodes	ENTITY
nightly	ENTITY
,	
is	
reported	
by	
a	
majority	
of	
affected	ENTITY
individuals	ENTITY
.	

The	
episodes	ENTITY
of	
eating	ENTITY
occur	
during	
any	
time	ENTITY
in	
the	
sleep	ENTITY
cycle	ENTITY
.	

High	ENTITY
-	
caloric	ENTITY
foods	ENTITY
are	
typically	
preferred	
.	

The	
foods	ENTITY
preferentially	
consumed	
during	
sleep	ENTITY
related	
eating	ENTITY
are	
not	
typically	
consumed	
with	
preference	ENTITY
during	
the	
daytime	ENTITY
.	

Paradoxically	
,	
to	
the	
extent	
that	
there	
is	
recall	ENTITY
,	
hunger	ENTITY
and	
thirst	ENTITY
are	
notably	
absent	
during	
episodes	ENTITY
of	
compulsive	ENTITY
eating	ENTITY
with	
SRED	ENTITY
.	

The	
episodes	ENTITY
of	
eating	ENTITY
are	
some-	
times	
experienced	ENTITY
as	
food	ENTITY
-	
related	ENTITY
enactment	ENTITY
of	
a	
dream	ENTITY
.	

Simple	ENTITY
foods	ENTITY
or	
entire	
hot	ENTITY
or	
cold	ENTITY
meals	ENTITY
may	
be	
prepared	ENTITY
and	
consumed	ENTITY
.	

Careless	ENTITY
food	ENTITY
handling	
often	
occurs	
.	

Alcoholic	ENTITY
beverages	ENTITY
are	
almost	
never	
consumed	
.	

The	
usual	
response	ENTITY
to	
interference	ENTITY
during	
an	
eating	ENTITY
episode	ENTITY
is	
irritability	ENTITY
and	
agitation	ENTITY
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
The	
following	
rates	ENTITY
of	
SRED	ENTITY
,	
as	
determined	
by	
self	ENTITY
-	
administered	ENTITY
questionnaire	ENTITY
,	
have	
been	
reported	
:	
16.7	
%	
in	
an	
inpatient	ENTITY
eating	
disorders	
group	ENTITY
;	
8.7	
%	
in	
an	
outpatient	ENTITY
eating	
disorders	
group	ENTITY
;	
and	
4.6	
%	
in	
an	
unselected	ENTITY
university	ENTITY
student	ENTITY
group	ENTITY
.	

This	
study	ENTITY
would	
indicate	
a	
high	
prevalence	ENTITY
of	
SRED	ENTITY
,	
although	
confirmatory	ENTITY
studies	ENTITY
across	
Parasomnias	ENTITY
Parasomnias	ENTITY
different	
clinical	ENTITY
and	
nonclinical	ENTITY
population	
groups	
are	
needed	
.	

Females	ENTITY
comprise	
60	
%	
to	
83	
%	
of	
patients	ENTITY
in	
reported	
series	
.	

Mean	
age	ENTITY
of	
onset	
of	
SRED	ENTITY
is	
reported	
to	
be	
22	
-	
39	
years	ENTITY
.	

In	
the	
reported	
series	ENTITY
,	
the	
mean	
duration	ENTITY
of	
SRED	ENTITY
prior	
to	
clinical	ENTITY
presen-	
tation	ENTITY
ranged	
from	
four	
to	
15	
years	ENTITY
,	
suggesting	
that	
SRED	ENTITY
often	
is	
a	
chronic	ENTITY
disorder	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
SRED	ENTITY
can	
be	
idiopathic	ENTITY
,	
but	
it	
appears	
to	
be	
most	
commonly	
associated	ENTITY
with	ENTITY
a	
primary	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
another	
clinical	ENTITY
condition	ENTITY
,	
or	
use	
of	
a	
sedative	ENTITY
-	
hypnotic	ENTITY
medication	ENTITY
.	

Sleepwalking	ENTITY
is	
the	
most	
common	
sleep	ENTITY
disorder	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	ENTITY
eating	ENTITY
,	
although	
once	
eating	ENTITY
becomes	
part	
of	
the	
behavioral	ENTITY
repertoire	ENTITY
,	
it	
quickly	
becomes	
the	
predominant	ENTITY
,	
if	
not	
the	
exclusive	
,	
nocturnal	ENTITY
“	
sleepwalking	ENTITY
”	
behavior	ENTITY
.	

This	
would	
indi-	
cate	ENTITY
that	
SRED	ENTITY
is	
most	
often	
a	
“	
sleepwalking	ENTITY
variant	ENTITY
disorder	ENTITY
.	
”	

A	
history	ENTITY
of	
sleepwalk-	
ing	
during	
childhood	ENTITY
appears	
to	
be	
a	
predisposing	ENTITY
factor	ENTITY
in	
many	
cases	ENTITY
.	

A	
recent	
retro-	
spective	ENTITY
controlled	ENTITY
study	ENTITY
of	
SRED	ENTITY
patients	ENTITY
,	
sleepwalking	ENTITY
patients	ENTITY
,	
and	
controls	ENTITY
found	
that	
SRED	ENTITY
patients	ENTITY
were	
mainly	
women	ENTITY
with	
onset	
of	
the	
disturbance	ENTITY
in	
adulthood	ENTITY
.	

They	
typically	
experienced	
nightly	ENTITY
episodes	ENTITY
and	
had	
more	
frequent	ENTITY
eating	ENTITY
problems	ENTITY
in	
childhood	ENTITY
and	
higher	ENTITY
current	ENTITY
anorexia	ENTITY
scores	ENTITY
than	
sleepwalking	ENTITY
patients	ENTITY
or	
controls	ENTITY
.	

They	
also	
shared	
commonalities	
with	
sleepwalking	ENTITY
patients	ENTITY
,	
including	
a	
high	ENTITY
(	
66	
%	
)	
frequency	ENTITY
of	
past	
or	
current	
sleepwalking	ENTITY
,	
a	
similar	
timing	ENTITY
of	
parasomnia	ENTITY
episodes	ENTITY
(	
in	
the	
first	
half	
of	
the	
night	ENTITY
)	
,	
and	
numerous	
arousals	ENTITY
from	
stage	ENTITY
N3	
.	

On	
video	ENTITY
-	
polysom-	
nography	ENTITY
,	
eating	ENTITY
episodes	ENTITY
occurred	
mostly	
within	
one	
minute	
after	
awakening	ENTITY
from	
stage	ENTITY
N2	ENTITY
or	
N3	
.	

The	
frequencies	ENTITY
of	
RLS	ENTITY
,	
PLMs	ENTITY
,	
and	
sleep	ENTITY
apnea	ENTITY
were	
similar	
across	
the	
three	
groups	ENTITY
.	

Other	
sleep	ENTITY
disorders	ENTITY
that	
can	
be	
closely	
associated	ENTITY
with	ENTITY
SRED	ENTITY
include	
:	
RLS	ENTITY
,	
PLMD	ENTITY
,	
OSA	ENTITY
,	
and	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
,	
particularly	
irregular	ENTITY
sleep/	ENTITY
wake	ENTITY
pattern	ENTITY
.	

Multiple	ENTITY
sleep	ENTITY
disorders	ENTITY
in	
the	
same	
patient	ENTITY
have	
been	
reported	
with	
SRED	ENTITY
,	
including	
sexsomnia	ENTITY
and	
a	
variant	ENTITY
of	
confusional	ENTITY
arousals	ENTITY
and	
sleepwalking	ENTITY
.	

Medication	ENTITY
-	
induced	ENTITY
SRED	ENTITY
has	
been	
reported	
with	
zolpidem	ENTITY
,	
in	
particular	
,	
but	
also	
with	
a	
broad	
range	
of	
sedative	ENTITY
hypnotics	ENTITY
,	
including	
benzodiazepines	ENTITY
,	
benzodiazepine	ENTITY
receptor	ENTITY
agonists	ENTITY
,	
mirtazapine	ENTITY
,	
risperidone	ENTITY
,	
quetiapine	ENTITY
,	
lithium	ENTITY
carbonate	ENTITY
,	
anticholin-	
ergics	ENTITY
,	
and	
various	
other	
psychotropic	ENTITY
agents	ENTITY
.	

Onset	ENTITY
of	
SRED	ENTITY
also	
has	
been	
reported	
with	
cessation	ENTITY
of	
cigarette	ENTITY
smoking	ENTITY
,	
cessation	ENTITY
of	
alcohol	ENTITY
and	
substance	ENTITY
abuse	ENTITY
,	
acute	ENTITY
stress	ENTITY
(	
usually	
involving	
major	
separation	
reactions	
)	
,	
after	
daytime	ENTITY
dieting	ENTITY
,	
and	
with	
onset	
of	
narcolepsy	ENTITY
,	
autoimmune	ENTITY
hepatitis	ENTITY
,	
encephalitis	ENTITY
,	
and	
other	
conditions	ENTITY
.	

SRED	ENTITY
can	
also	
be	
associated	ENTITY
with	ENTITY
daytime	ENTITY
eating	ENTITY
disorders	ENTITY
,	
and	
with	
nocturnal	ENTITY
dissocia-	
tive	ENTITY
disorder	ENTITY
.	

In	
a	
controlled	ENTITY
study	ENTITY
of	
65	
patients	ENTITY
with	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
,	
32	
%	
of	
patients	ENTITY
had	
SRED	ENTITY
vs.	
2	
%	
of	
controls	ENTITY
.	

Nocturnal	ENTITY
smoking	ENTITY
was	
present	
in	
33	
%	
of	
SRED	ENTITY
-	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
patients	ENTITY
and	
in	
16	
%	
of	
narcolepsy	ENTITY
-	
cataplexy	ENTITY
patients	ENTITY
without	
SRED	ENTITY
.	

(	
A	
link	
between	
SRED	ENTITY
and	
nocturnal	ENTITY
smoking	ENTITY
had	
previously	
been	
identified	ENTITY
when	
nocturnal	ENTITY
smoking	ENTITY
was	
first	
reported	
in	
2008	
)	
.	

A	
study	ENTITY
of	
88	
patients	ENTITY
with	
RLS	ENTITY
and	
42	
patients	ENTITY
with	
insomnia	ENTITY
who	
were	
systematically	ENTITY
questioned	
for	
the	
presence	ENTITY
of	
SRED	ENTITY
or	
other	
nocturnal	ENTITY
eating	ENTITY
demonstrated	
that	
36	
%	
of	
patients	ENTITY
with	
RLS	ENTITY
versus	
zero	ENTITY
patients	ENTITY
with	
insomnia	ENTITY
had	
SRED	ENTITY
,	
and	
the	
very	
significant	
difference	
was	
not	
related	
to	
arousal	ENTITY
frequency	ENTITY
.	

In	
that	
study	ENTITY
,	
patients	ENTITY
with	
RLS	ENTITY
who	
were	
taking	
hypnotic	ENTITY
medications	ENTITY
were	
at	
additional	
risk	ENTITY
for	
SRED	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
A	
familial	ENTITY
basis	ENTITY
for	
SRED	ENTITY
is	
not	
uncommon	
,	
including	
co	ENTITY
-	
occurrence	ENTITY
in	
fraternal	ENTITY
twins	ENTITY
,	
although	
detailed	
genetic	ENTITY
studies	ENTITY
have	
not	
been	
carried	
out	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
onset	
of	
SRED	ENTITY
can	
be	
insidious	ENTITY
and	
sporadic	ENTITY
,	
or	
it	
can	
be	
precipitous	ENTITY
and	
fulmi-	
nant	ENTITY
with	
rapid	
development	
of	
nightly	ENTITY
episodes	ENTITY
of	
eating	ENTITY
,	
related	
or	
unrelated	
to	
the	
start	
of	
hypnotic	ENTITY
medication	ENTITY
therapy	ENTITY
of	
insomnia	ENTITY
.	

The	
course	ENTITY
is	
usually	
unremitting	
.	

Fires	ENTITY
can	
occur	
when	
the	
individual	ENTITY
with	
SRED	ENTITY
begins	
to	
cook	ENTITY
foods	ENTITY
on	
the	
stove	ENTITY
or	
in	
the	
oven	ENTITY
,	
and	
then	
abandons	
them	
.	

A	
variety	
of	
other	
complications	ENTITY
have	
been	
described	
previously	
.	

Developmental	ENTITY
Issues	ENTITY
SRED	ENTITY
can	
emerge	
in	
childhood	ENTITY
,	
either	
associated	ENTITY
or	ENTITY
unassociated	
with	
a	
family	ENTITY
history	ENTITY
of	
SRED	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
underlying	
pathophysiology	ENTITY
of	
SRED	ENTITY
is	
unclear	ENTITY
.	

Despite	
the	
broad	
range	
of	
pre-	
disposing	ENTITY
and	
precipitating	
factors	ENTITY
in	
SRED	ENTITY
,	
the	
relatively	
homogeneous	
set	
of	
clinical	ENTITY
features	ENTITY
suggests	
the	
presence	ENTITY
of	
a	
“	
final	
common	
pathway	ENTITY
”	
that	
can	
be	
accessed	
by	
a	
variety	
of	
factors	ENTITY
.	

Although	
SRED	ENTITY
has	
prominent	
features	ENTITY
of	
both	
a	
sleep	ENTITY
disorder	ENTITY
and	
an	
eating	ENTITY
disorder	ENTITY
,	
its	
relatively	
homogeneous	
presentation	ENTITY
supports	
its	
classification	ENTITY
as	
a	
separate	
diagnostic	ENTITY
entity	ENTITY
.	

More	
than	
half	
of	
patients	ENTITY
with	
SRED	ENTITY
have	
a	
history	ENTITY
of	
another	
parasomnia	ENTITY
that	
preceded	
the	
onset	
of	
nocturnal	ENTITY
eating	ENTITY
,	
suggesting	
that	
the	
presence	ENTITY
of	
another	
parasomnia	ENTITY
is	
a	
major	
risk	ENTITY
factor	ENTITY
for	
SRED	ENTITY
.	

However	
,	
the	
female	ENTITY
predominance	ENTITY
in	
SRED	ENTITY
is	
more	
consistent	ENTITY
with	ENTITY
eating	ENTITY
disorders	ENTITY
,	
which	
are	
female	ENTITY
pre-	
dominant	
,	
than	
with	
sleepwalking	ENTITY
or	
movement	ENTITY
disorders	ENTITY
(	
RLS	ENTITY
/	
PLMD	ENTITY
)	
which	
have	
slight	
to	
no	
female	ENTITY
bias	ENTITY
.	

Thus	
it	
appears	
that	
two	
basic	
drive	
states	ENTITY
—	
sleeping	ENTITY
and	
eating	ENTITY
—	
are	
pathologically	ENTITY
intertwined	
in	
SRED	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	
Objective	
Findings	ENTITY
Although	
not	
routinely	
indicated	
in	
the	
assessment	ENTITY
of	
SRED	ENTITY
,	
vPSG	ENTITY
evaluations	ENTITY
have	
often	
reported	
positive	ENTITY
findings	ENTITY
.	

The	
most	
common	
finding	
consists	
of	
multiple	ENTITY
confu-	
sional	ENTITY
arousals	ENTITY
,	
with	
or	
without	
eating	ENTITY
,	
arising	
from	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

However	
,	
abnor-	
mal	ENTITY
arousals	ENTITY
have	
been	
documented	ENTITY
from	
all	
stages	ENTITY
of	
NREM	ENTITY
sleep	ENTITY
and	
also	
occasion-	
ally	
from	
REM	ENTITY
sleep	ENTITY
.	

The	
level	ENTITY
of	
consciousness	ENTITY
has	
typically	
spanned	
the	
range	
from	
virtual	ENTITY
unconsciousness	ENTITY
to	
various	
levels	ENTITY
of	
partial	ENTITY
consciousness	ENTITY
despite	
a	
concurrent	ENTITY
EEG	ENTITY
pattern	ENTITY
that	
is	
often	
predominantly	
awake	ENTITY
,	
suggesting	
dissociation	ENTITY
between	
the	
EEG	ENTITY
and	
the	
level	ENTITY
of	
consciousness	ENTITY
.	

This	
dissociation	ENTITY
also	
can	
be	
found	
in	
adult	ENTITY
sleep-	ENTITY
walking	ENTITY
without	
associated	ENTITY
eating	ENTITY
.	

In	
contrast	
,	
classic	
sleepwalking	ENTITY
in	
childhood	ENTITY
is	
usually	
associated	ENTITY
with	ENTITY
the	
persistence	ENTITY
of	
high	ENTITY
-	
voltage	ENTITY
delta	ENTITY
waves	ENTITY
or	
the	
admixture	ENTITY
of	
delta	ENTITY
,	
theta	ENTITY
,	
and	
alpha	ENTITY
activity	ENTITY
.	

A	
predominant	ENTITY
wake	ENTITY
pattern	ENTITY
is	
rare	ENTITY
in	
childhood	ENTITY
sleep-	
walking	
.	

PLMs	ENTITY
and	
OSA	ENTITY
may	
be	
observed	
in	
polysomnographic	ENTITY
monitoring	ENTITY
of	
SRED	ENTITY
patients	ENTITY
.	

In	
one	
recent	
study	ENTITY
that	
addressed	
the	
boundaries	ENTITY
between	
SRED	ENTITY
and	
fully	
conscious	ENTITY
abnormal	ENTITY
nocturnal	ENTITY
eating	ENTITY
,	
22	
of	
35	
patients	ENTITY
had	
PLMs	ENTITY
,	
5	
of	
35	
had	
RLS	ENTITY
,	
and	
29	
of	
35	
had	
recurring	
chewing	ENTITY
and	
swallowing	ENTITY
movements	ENTITY
during	
sleep	ENTITY
that	
were	
associated	ENTITY
with	ENTITY
nearly	
half	
of	
the	
total	
number	
of	
EEG	ENTITY
arousals	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
SRED	ENTITY
must	
be	
distinguished	
primarily	
from	
night	ENTITY
eating	ENTITY
syndrome	ENTITY
(	
NES	ENTITY
)	
,	
which	
is	
characterized	ENTITY
by	
excessive	ENTITY
eating	ENTITY
between	
dinner	ENTITY
and	
bedtime	ENTITY
and	
during	
full	
awaken-	
ings	ENTITY
during	
the	
sleep	ENTITY
period	ENTITY
.	

In	
contrast	
to	
daytime	ENTITY
eating	ENTITY
disorders	ENTITY
(	
bulimia	ENTITY
nervosa	ENTITY
,	
anorexia	ENTITY
nervosa	ENTITY
)	
,	
inappropriate	
compensatory	ENTITY
behavior	ENTITY
,	
such	
as	
self	ENTITY
-	
induced	ENTITY
vom-	
iting	ENTITY
,	
enemas	ENTITY
,	
misuse	ENTITY
of	ENTITY
laxatives	ENTITY
,	
diuretics	ENTITY
,	
or	
other	
medications	ENTITY
,	
or	
other	
purging	ENTITY
activity	ENTITY
,	
are	
not	
present	
in	
SRED	ENTITY
,	
although	
the	
two	
conditions	ENTITY
may	
be	
comorbid	ENTITY
.	

A	
person	ENTITY
with	
a	
daytime	ENTITY
eating	ENTITY
disorder	ENTITY
may	
also	
have	
a	
coexisting	ENTITY
SRED	ENTITY
that	
is	
asso-	
ciated	ENTITY
with	
confusional	ENTITY
arousals	ENTITY
but	
not	
associated	ENTITY
with	ENTITY
purging	ENTITY
behaviors	ENTITY
during	
the	
night	ENTITY
or	
upon	
arising	
in	
the	
morning	ENTITY
.	

Patients	ENTITY
with	
longstanding	
SRED	ENTITY
and	
excessive	ENTITY
weight	ENTITY
gain	ENTITY
may	
eventually	
fast	
during	
the	
daytime	ENTITY
and/or	
engage	ENTITY
in	
excessive	ENTITY
exer-	
cise	
to	
prevent	ENTITY
obesity	ENTITY
from	
the	
SRED	ENTITY
.	

Likewise	
,	
patients	ENTITY
who	
otherwise	
fulfill	
crite-	
ria	ENTITY
for	
SRED	ENTITY
may	
consciously	ENTITY
eat	
during	
the	
prebedtime	ENTITY
period	ENTITY
in	
a	
futile	
attempt	
to	
suppress	ENTITY
the	
compulsion	ENTITY
to	
eat	ENTITY
after	
subsequently	
falling	
asleep	ENTITY
.	

SRED	ENTITY
appears	
to	
be	
considerably	
more	
female	ENTITY
predominant	ENTITY
that	
NES	ENTITY
(	
which	
has	
<	
60	
%	
female	ENTITY
prevalence	ENTITY
)	
,	
and	
mood	ENTITY
disorders	ENTITY
are	
more	
common	
with	
NES	ENTITY
than	
with	
SRED	ENTITY
.	

Nevertheless	
,	
SRED	ENTITY
and	
NES	ENTITY
share	
a	
considerable	
number	
of	
overlapping	
features	ENTITY
and	
may	
exist	
along	
a	
common	
spectrum	ENTITY
of	
pathophysiology	ENTITY
.	

SRED	ENTITY
should	
also	
be	
distinguished	
from	
nocturnal	ENTITY
(	ENTITY
sleep	ENTITY
related	ENTITY
)	
extensions	ENTITY
of	
bulimia	ENTITY
nervosa	ENTITY
,	
binge	ENTITY
-	
eating	ENTITY
disorder	ENTITY
,	
and	
anorexia	ENTITY
nervosa	ENTITY
,	
binge	ENTITY
/	
purge	ENTITY
type	ENTITY
.	

The	
nocturnal	ENTITY
eating	ENTITY
(	
drinking	
)	
syndrome	
described	
in	
the	
original	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
is	
primarily	
a	
disorder	ENTITY
of	
infancy	ENTITY
that	
is	
characterized	ENTITY
by	
recurrent	ENTITY
awakenings	ENTITY
with	
the	
inability	
to	
resume	ENTITY
sleep	
without	
eating	ENTITY
or	
drinking	ENTITY
.	

Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
(	
periodic	ENTITY
hypersomnia	ENTITY
)	
can	
present	
with	
inappropriate	ENTITY
noctur-	
nal	ENTITY
eating	ENTITY
,	
but	
its	
predominance	
in	
adolescent	ENTITY
males	ENTITY
and	
its	
hallmark	
symptom	ENTITY
complex	ENTITY
of	
periodic	ENTITY
hypersomnia	ENTITY
,	
hypersexuality	ENTITY
,	
and	
hyperphagia	ENTITY
lasting	
days	ENTITY
to	
weeks	ENTITY
should	
easily	
distinguish	
it	
from	
SRED	ENTITY
.	

Medical	ENTITY
and	
neurologic	ENTITY
disorders	ENTITY
that	
could	
be	
asso-	
ciated	ENTITY
with	
abnormal	ENTITY
recurrent	ENTITY
eating	ENTITY
during	
the	
main	
sleep	
period	
(	
usually	
with	
full	
or	
almost	
full	
alertness	ENTITY
)	
should	
also	
be	
excluded	
.	

These	
include	
:	
hypoglycemic	ENTITY
states	ENTITY
,	
peptic	ENTITY
ulcer	ENTITY
disease	ENTITY
,	
reflux	ENTITY
esophagitis	ENTITY
,	
and	
Kluver	ENTITY
-	
Bucy	ENTITY
syndrome	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

The	
extent	
of	
overlap	ENTITY
and	
divergence	ENTITY
between	
SRED	ENTITY
and	
NES	ENTITY
needs	
to	
be	
further	
elucidated	
.	

Bibliography	ENTITY
Brion	ENTITY
A	ENTITY
,	
Flamand	ENTITY
M	ENTITY
,	
Oudiette	ENTITY
D	ENTITY
,	
Voillery	ENTITY
D	ENTITY
,	
Golmard	ENTITY
JL	ENTITY
,	
Arnulf	
I.	
Sleep	
related	
eating	
disorder	
versus	
sleepwalking	ENTITY
:	
a	
controlled	ENTITY
study	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2012	ENTITY
;	
3:1094–101	
.	

Howell	ENTITY
MJ	ENTITY
,	
Schenck	ENTITY
CH	ENTITY
,	
Crow	ENTITY
SJ	ENTITY
.	

A	
review	ENTITY
of	
nighttime	ENTITY
eating	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2009;13:23–-34	ENTITY
.	

Howell	ENTITY
MJ	ENTITY
,	
Schenck	ENTITY
CH	ENTITY
.	

Restless	ENTITY
nocturnal	ENTITY
eating	ENTITY
:	
a	
common	
feature	
of	
Willis	ENTITY
-	
Ekbom	ENTITY
syndrome	ENTITY
(	
RLS	ENTITY
)	
.	

J	
Clin	
Sleep	
Med	
2012;8:413–9	
.	

Palaia	ENTITY
V	ENTITY
,	
Poli	ENTITY
F	ENTITY
,	
Pizz	ENTITY
F	ENTITY
,	
et	
al	
.	

Narcolepsy	ENTITY
with	
cataplexy	ENTITY
associated	ENTITY
with	ENTITY
nocturnal	ENTITY
compulsive	ENTITY
behaviors	ENTITY
:	
a	
case	ENTITY
-	
control	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2011;34:1365–71	
.	

Schenck	ENTITY
CH	ENTITY
,	
Hurwitz	
TD	ENTITY
,	
Bundlie	ENTITY
SR	ENTITY
,	
Mahowald	ENTITY
MW	ENTITY
.	

Sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorders	ENTITY
:	
polysomnographic	ENTITY
correlates	
of	
a	
heterogeneous	ENTITY
syndrome	ENTITY
distinct	
from	
daytime	ENTITY
eating	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
1991;14:419–31	
.	

Schenck	ENTITY
CH	ENTITY
,	
Hurwitz	
TD	ENTITY
,	
O’Connor	ENTITY
KA	ENTITY
,	
Mahowald	ENTITY
MW	ENTITY
.	

Additional	
categories	ENTITY
of	
sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorders	ENTITY
and	
the	
current	ENTITY
status	ENTITY
of	
treatment	ENTITY
.	

Sleep	ENTITY
1993;16:457–66	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Manconi	ENTITY
M	ENTITY
,	
Ferini	ENTITY
-	
Strambi	ENTITY
L	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Montagna	
P.	
Nocturnal	ENTITY
eating	ENTITY
:	
sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorder	ENTITY
or	
night	ENTITY
eating	ENTITY
syndrome	ENTITY
?	

A	
videopolysomnographic	ENTITY
study	ENTITY
.	

Sleep	ENTITY
2006;29:949–54	
.	

Vinai	ENTITY
P	ENTITY
,	
Ferri	ENTITY
R	ENTITY
,	
Ferini	ENTITY
-	
Strambi	ENTITY
L	
,	
et	
al	
.	

Defining	
the	
borders	ENTITY
between	
sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorder	ENTITY
and	
night	ENTITY
eating	ENTITY
syndrome	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2012;13:686–90	
.	

Winkelman	ENTITY
JW	
.	

Clinical	ENTITY
and	
polysomnographic	ENTITY
features	ENTITY
of	
sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorder	ENTITY
.	

J	
Clin	
Psychiatry	
1998;59:14–9	
.	

Winkelman	ENTITY
JW	
,	
Herzog	ENTITY
DB	ENTITY
,	ENTITY
Fava	
M.	

The	
prevalence	ENTITY
of	
sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorder	ENTITY
in	
psychiatric	ENTITY
and	
non	ENTITY
-	
psychiatric	ENTITY
populations	ENTITY
.	

Psychol	ENTITY
Med	ENTITY
1999;29:1461–6	ENTITY
.	

Winkelman	ENTITY
JW	
.	

Sleep	ENTITY
-	
related	ENTITY
eating	ENTITY
disorder	ENTITY
and	
night	ENTITY
eating	ENTITY
syndrome	ENTITY
:	
sleep	ENTITY
disorders	ENTITY
,	
eating	ENTITY
disorders	ENTITY
,	
or	
both	
?	

Sleep	ENTITY
2006;29:876–7	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
REM	ENTITY
-	
Related	ENTITY
Parasomnias	ENTITY
REM	ENTITY
Sleep	ENTITY
Behavior	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.42	
Alternate	ENTITY
Names	ENTITY
None	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.52	ENTITY
A.	ENTITY
Repeated	
episodes	ENTITY
of	
sleep	
related	
vocalization	ENTITY
and/or	
complex	ENTITY
motor	

behaviors.1,2	
B.	

These	
behaviors	ENTITY
are	
documented	ENTITY
by	
polysomnography	ENTITY
to	
occur	
during	
REM	ENTITY
sleep	ENTITY
or	
,	
based	
on	
clinical	ENTITY
history	ENTITY
of	
dream	ENTITY
enactment	ENTITY
,	
are	
presumed	
to	
occur	
during	
REM	ENTITY
sleep	ENTITY
.	

C.	ENTITY
Polysomnographic	ENTITY
recording	
demonstrates	
REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
(	
RWA)3	
D.	

The	
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

Notes	ENTITY
.	

This	
criterion	ENTITY
can	
be	
fulfilled	
by	
observation	ENTITY
of	
repetitive	ENTITY
episodes	ENTITY
during	
a	
single	
night	ENTITY
of	
video	ENTITY
polysomnography	ENTITY
.	
.	

The	
observed	
vocalizations	ENTITY
or	
behaviors	ENTITY
often	
correlate	
with	
simultaneously	ENTITY
occurring	
dream	ENTITY
mentation	ENTITY
,	
leading	
to	
the	
frequent	ENTITY
report	ENTITY
of	
“	
acting	
out	
one	
’s	
dreams	ENTITY
.	
”	
.	

As	
defined	
by	
the	
guidelines	ENTITY
for	
scoring	ENTITY
PSG	ENTITY
features	ENTITY
of	
RBD	ENTITY
in	
the	
most	
recent	
version	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
(	
AASM	ENTITY
)	
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	
.	

Upon	
awakening	ENTITY
,	
the	
individual	ENTITY
is	
typically	
awake	ENTITY
,	
alert	
,	
coherent	ENTITY
,	
and	
oriented	ENTITY
.	
.	

On	
occasion	ENTITY
,	
there	
may	
be	
patients	ENTITY
with	
a	
typical	
clinical	ENTITY
history	ENTITY
of	
RBD	ENTITY
with	
dream	ENTITY
-	
enacting	ENTITY
behaviors	ENTITY
,	
who	
also	
exhibit	
typical	
RBD	ENTITY
behaviors	ENTITY
during	
vPSG	ENTITY
,	
but	
do	
not	
demonstrate	
sufficient	ENTITY
RWA	ENTITY
,	
based	
on	
the	
current	
evidence	ENTITY
-	
based	ENTITY
data	ENTITY
,	
to	
satisfy	
the	
PSG	ENTITY
criteria	ENTITY
for	
diagnosing	ENTITY
RBD	ENTITY
.	

In	
such	
patients	ENTITY
,	
RBD	ENTITY
may	
be	
provisionally	
diagnosed	ENTITY
,	
based	
on	
clinical	ENTITY
judgment	ENTITY
.	

The	
same	
rule	
applies	
when	
vPSG	ENTITY
is	
not	
readily	
available	
.	

6	
.	

Medications	ENTITY
may	
unmask	
latent	ENTITY
RBD	ENTITY
with	
preexisting	ENTITY
RWA	ENTITY
,	
according	
to	
current	
expert	ENTITY
opinion	ENTITY
.	

Therefore	
,	
medication	ENTITY
-	
induced	ENTITY
RBD	ENTITY
can	
be	
diagnosed	ENTITY
as	
RBD	ENTITY
,	
using	
clinical	ENTITY
judgment	ENTITY
,	
pending	
future	
longitudinal	ENTITY
studies	ENTITY
.	

Essential	ENTITY
Features	ENTITY
RBD	ENTITY
is	
characterized	
by	
abnormal	ENTITY
behaviors	ENTITY
emerging	
during	
REM	ENTITY
sleep	ENTITY
that	
may	
cause	
injury	ENTITY
or	
sleep	ENTITY
disruption	ENTITY
.	

RBD	ENTITY
is	
also	
associated	ENTITY
with	ENTITY
EMG	ENTITY
abnormalities	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

The	
EMG	ENTITY
demonstrates	
an	
excess	ENTITY
of	
muscle	ENTITY
tone	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
and/or	
an	
excess	ENTITY
of	
phasic	ENTITY
EMG	ENTITY
twitch	ENTITY
activity	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

A	
complaint	ENTITY
of	
sleep	
related	
injury	ENTITY
is	
common	
with	
RBD	ENTITY
,	
which	
usually	
manifests	
as	
an	
attempted	
enactment	ENTITY
of	
unpleasant	ENTITY
,	
action	ENTITY
-	
filled	ENTITY
,	
and	
violent	ENTITY
dreams	ENTITY
in	
which	
the	
individual	ENTITY
is	
being	
confronted	ENTITY
,	
attacked	ENTITY
,	
or	
chased	ENTITY
by	
unfamiliar	ENTITY
people	ENTITY
or	
animals	ENTITY
.	

Typically	
,	
at	
the	
end	
of	
an	
episode	ENTITY
,	
the	
individual	ENTITY
awakens	ENTITY
quickly	
,	
becomes	
rapidly	
alert	
,	
and	
reports	ENTITY
a	
dream	
with	
a	
coherent	ENTITY
story	ENTITY
.	

The	
dream	ENTITY
action	ENTITY
corresponds	
closely	
to	
the	
observed	ENTITY
sleep	ENTITY
behaviors	ENTITY
.	

Sleep	ENTITY
and	
dream	ENTITY
-	
related	ENTITY
behaviors	ENTITY
reported	
by	
history	ENTITY
and	
documented	ENTITY
during	
vPSG	ENTITY
include	
both	
violent	ENTITY
and	
(	
less	
commonly	
)	
nonviolent	ENTITY
behaviors	ENTITY
:	
talking	ENTITY
(	
including	
giving	
speeches	ENTITY
)	
,	
smiling	ENTITY
,	
laughing	ENTITY
,	
singing	ENTITY
,	
whistling	ENTITY
,	
shouting	ENTITY
,	
swearing	ENTITY
profan-	
ities	ENTITY
,	
crying	ENTITY
,	
chewing	ENTITY
,	
gesturing	ENTITY
,	
reaching	
,	
grabbing	ENTITY
,	
arm	ENTITY
flailing	ENTITY
,	
clapping	ENTITY
,	
slap-	
ping	ENTITY
,	
punching	ENTITY
,	
kicking	ENTITY
,	
sitting	ENTITY
up	ENTITY
,	
leaping	ENTITY
from	
bed	ENTITY
,	
crawling	ENTITY
,	
running	ENTITY
,	
or	
dancing	ENTITY
.	

Walking	ENTITY
,	
however	
,	
is	
quite	
uncommon	ENTITY
with	
RBD	ENTITY
,	
and	
leaving	
the	
room	ENTITY
is	
especially	
rare	ENTITY
,	
because	
the	
eyes	ENTITY
are	
usually	
closed	ENTITY
,	
precluding	
attention	
to	
the	
environment	ENTITY
.	

There	
can	
be	
rare	ENTITY
occurrences	
of	
smoking	ENTITY
a	
fictive	ENTITY
cigarette	ENTITY
,	
masturbation	ENTITY
-	
like	
behav-	
ior	ENTITY
,	
pelvic	ENTITY
thrusting	ENTITY
,	
and	
mimics	ENTITY
of	
eating	ENTITY
,	
drinking	ENTITY
,	
urinating	ENTITY
,	
and	
defecating	ENTITY
.	

The	
eyes	ENTITY
usually	
remain	
closed	ENTITY
during	
an	
RBD	ENTITY
episode	ENTITY
,	
with	
the	
person	ENTITY
attending	ENTITY
to	
the	
dream	ENTITY
action	ENTITY
and	
not	
to	
the	
actual	ENTITY
environment	ENTITY
.	

Medical	ENTITY
attention	ENTITY
is	
usually	
sought	
after	
sleep	ENTITY
related	
injury	ENTITY
has	
occurred	
to	
either	
the	
person	ENTITY
or	
the	
bed	ENTITY
partner	ENTITY
,	
and	
rarely	
because	
of	
sleep	ENTITY
disruption	ENTITY
.	

Because	
RBD	ENTITY
occurs	
during	
REM	ENTITY
sleep	ENTITY
,	
it	
usually	
appears	
at	
least	
90	
minutes	ENTITY
after	
sleep	ENTITY
onset	ENTITY
,	
unless	
there	
is	
coexisting	ENTITY
narcolepsy	ENTITY
,	
in	
which	
case	ENTITY
RBD	ENTITY
can	
emerge	
shortly	
after	
sleep	ENTITY
onset	ENTITY
during	
a	
sleep	ENTITY
onset	ENTITY
rapid	
eye	
movement	
period	
(	
SOREMP	ENTITY
)	
.	

There	
is	
an	
acute	ENTITY
form	ENTITY
of	
RBD	ENTITY
that	
emerges	
during	
intense	ENTITY
REM	ENTITY
sleep	ENTITY
rebound	ENTITY
states	ENTITY
,	
such	
as	
during	
withdrawal	ENTITY
from	
alcohol	ENTITY
and	
sedative	ENTITY
-	
hypnotic	ENTITY
agents	ENTITY
,	
or	
in	
association	ENTITY
with	ENTITY
certain	
medication	ENTITY
use	ENTITY
,	
drug	ENTITY
intoxication	ENTITY
,	
or	
relapsing	ENTITY
multiple	ENTITY
sclerosis	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Associated	
Features	
PLMs	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
are	
very	
common	
with	
RBD	ENTITY
and	
may	
disturb	
the	
sleep	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
.	

Daytime	ENTITY
tiredness	ENTITY
or	
sleepiness	ENTITY
is	
uncommon	ENTITY
,	
unless	
narcolepsy	ENTITY
is	
also	
present	
.	

There	
is	
typically	
no	
history	
of	
irritable	ENTITY
,	
aggressive	ENTITY
,	
or	
violent	ENTITY
behav-	ENTITY
ior	ENTITY
during	
the	
day	ENTITY
.	

There	
may	
be	
a	
longstanding	
prodromal	ENTITY
history	ENTITY
of	
sleep	ENTITY
talking	ENTITY
,	
yelling	ENTITY
,	
limb	ENTITY
twitching	ENTITY
,	
and	
jerking	ENTITY
during	
sleep	ENTITY
that	
may	
or	
may	
not	
be	
dream	
related	
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
Parasomnia	ENTITY
overlap	ENTITY
disorder	ENTITY
is	
a	
condition	ENTITY
in	
which	
patients	ENTITY
have	
both	
RBD	ENTITY
and	
either	
a	
disorder	ENTITY
of	
arousal	ENTITY
,	
sleep	ENTITY
related	
eating	ENTITY
disorder	ENTITY
,	
sexsomnia	ENTITY
,	
or	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
.	

This	
condition	ENTITY
is	
male	ENTITY
predominant	ENTITY
,	
but	
less	
so	
than	
isolated	ENTITY
RBD	ENTITY
.	

Most	
cases	ENTITY
begin	
during	
childhood	ENTITY
or	
adolescence	ENTITY
.	

Virtually	
all	
age	ENTITY
groups	ENTITY
can	
be	
affected	ENTITY
.	

It	
can	
be	
idiopathic	ENTITY
or	
symptomatic	ENTITY
of	
a	
broad	
set	
of	
disorders	ENTITY
,	
including	
narcolepsy	ENTITY
,	
mul-	
tiple	ENTITY
sclerosis	ENTITY
,	
brain	ENTITY
tumor	ENTITY
(	
and	
therapy	ENTITY
)	
,	
rhombencephalitis	ENTITY
(	
right	ENTITY
pontine	ENTITY
tegmen-	ENTITY
tum	ENTITY
/	
medulla	ENTITY
lesion	ENTITY
)	
,	
brain	ENTITY
trauma	ENTITY
,	
congenital	ENTITY
Moebius	ENTITY
syndrome	ENTITY
,	
agrypnia	ENTITY
excitata	ENTITY
,	
Machado	ENTITY
-	
Joseph	ENTITY
disease	ENTITY
,	
various	
psychiatric	ENTITY
disorders	ENTITY
and	
their	
pharmacotherapies	ENTITY
,	
and	
substance	ENTITY
abuse	ENTITY
disorders	ENTITY
and	
withdrawal	ENTITY
states	ENTITY
.	

Status	ENTITY
dissociatus	ENTITY
can	
be	
classified	
as	
a	
subtype	ENTITY
of	
RBD	ENTITY
that	
manifests	
as	
an	
extreme	
form	
of	
state	ENTITY
dissociation	ENTITY
without	
identifiable	ENTITY
sleep	ENTITY
stages	ENTITY
,	
but	
with	
sleep	ENTITY
and	
dream	ENTITY
-	
related	ENTITY
behaviors	ENTITY
that	
closely	
resemble	
RBD	ENTITY
.	

Status	ENTITY
dissociatus	ENTITY
represents	
a	
major	
breakdown	ENTITY
of	
the	
polysomnographic	ENTITY
markers	
for	
REM	ENTITY
sleep	ENTITY
,	
NREM	ENTITY
sleep	ENTITY
,	
and	
wakefulness	ENTITY
,	
with	
admixtures	ENTITY
of	
these	
states	ENTITY
being	
present	
,	
but	
with	
conventional	ENTITY
sleep	ENTITY
stages	ENTITY
not	
being	
identifiable	
during	
polysomnographic	ENTITY
monitoring	ENTITY
.	

There	
is	
abnormal	ENTITY
behavioral	ENTITY
release	
that	
can	
be	
associated	ENTITY
with	ENTITY
disturbed	ENTITY
dreaming	ENTITY
,	
strongly	
suggestive	
of	
dream	ENTITY
-	
enacting	ENTITY
behaviors	ENTITY
that	
closely	
resemble	
RBD	ENTITY
.	

Not	
uncommonly	
,	
the	
indi-	
vidual	
thinks	
he	
is	
awake	ENTITY
when	
observers	ENTITY
presume	
he	
is	
asleep	ENTITY
and	
attempting	
to	
act	
out	
a	
dream	ENTITY
,	
or	
vice	
versa	
.	

An	
underlying	
neurologic	ENTITY
or	
medical	ENTITY
condition	ENTITY
,	
spanning	
a	
broad	
range	
of	
pathology	ENTITY
,	
is	
virtually	
always	
present	
.	

Dream	ENTITY
enactment	ENTITY
(	
“	
oneirism	ENTITY
”	
)	
that	
is	
REM	ENTITY
sleep	ENTITY
related	
or	
related	
to	
a	
dissociated	ENTITY
REM	ENTITY
sleep	ENTITY
-	
wakefulness	ENTITY
state	ENTITY
can	
be	
a	
core	ENTITY
feature	ENTITY
of	
a	
pathologic	ENTITY
condition	ENTITY
called	
agrypnia	ENTITY
excitata	ENTITY
that	
is	
characterized	ENTITY
by	
generalized	ENTITY
motor	ENTITY
overactivity	ENTITY
,	
impaired	ENTITY
ability	
to	
initiate	ENTITY
and	
maintain	
sleep	ENTITY
(	
with	
“	
wakeful	ENTITY
dreaming	ENTITY
”	
)	
,	
loss	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
,	
and	
marked	
motor	ENTITY
and	
autonomic	ENTITY
sympathetic	ENTITY
activation	ENTITY
.	

Agrypnia	ENTITY
excitata	ENTITY
is	
found	
with	
such	
diverse	ENTITY
conditions	ENTITY
as	
delirium	ENTITY
tremens	ENTITY
,	
Morvan	ENTITY
syndrome	ENTITY
,	
and	
fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
.	

Thus	
,	
agrypnia	ENTITY
excitata	ENTITY
manifests	
as	
both	
a	
severe	ENTITY
parasomnia	ENTITY
and	
a	
severe	ENTITY
insomnia	ENTITY
.	

Demographics	ENTITY
RBD	ENTITY
is	
a	
male	ENTITY
predominant	
disorder	ENTITY
that	
usually	
emerges	
after	
age	ENTITY
50	
years	ENTITY
.	

Cases	ENTITY
of	
RBD	ENTITY
from	
early	ENTITY
childhood	ENTITY
up	
to	
age	ENTITY
88	
years	ENTITY
have	
been	
reported	
.	

RBD	ENTITY
emerging	
in	
adults	ENTITY
before	
age	ENTITY
50	
years	ENTITY
tends	
to	
have	
different	
demographics	ENTITY
and	
associated	ENTITY
features	ENTITY
,	
including	
greater	
sex	ENTITY
parity	ENTITY
and	
increased	ENTITY
rates	ENTITY
of	
idiopathic	ENTITY
RBD	ENTITY
and	
para-	
somnia	ENTITY
overlap	ENTITY
disorder	ENTITY
(	
POD	ENTITY
)	
,	
comorbid	ENTITY
narcolepsy	ENTITY
,	
antidepressant	ENTITY
medication	ENTITY
use	
,	
and	
possibly	
autoimmune	ENTITY
diseases	ENTITY
.	

In	
addition	
,	
the	
clinical	ENTITY
presentation	ENTITY
of	
RBD	ENTITY
in	
younger	ENTITY
adults	ENTITY
differs	
from	
that	
in	
older	ENTITY
adults	ENTITY
in	
being	
less	
aggressive	ENTITY
and	
violent	ENTITY
,	
presumably	
due	
to	
greater	
female	ENTITY
representation	ENTITY
and	
higher	ENTITY
rates	ENTITY
of	
comorbid	ENTITY
narco-	
lepsy	ENTITY
(	
which	
manifests	
with	
milder	
RBD	ENTITY
behaviors	ENTITY
)	
.	

RBD	ENTITY
associated	ENTITY
with	ENTITY
neurologic	ENTITY
disorders	ENTITY
and	
other	
symptomatic	ENTITY
forms	
of	
RBD	ENTITY
are	
as	
male	ENTITY
predominant	ENTITY
as	
idiopathic	ENTITY
RBD	ENTITY
,	
with	
the	
exception	
of	
narcolepsy	ENTITY
(	
as	
described	
below	
)	
and	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
.	

Of	
note	
,	
RBD	ENTITY
may	
not	
be	
the	
presenting	
com-	ENTITY
plaint	ENTITY
to	
a	
sleep	ENTITY
disorders	ENTITY
center	ENTITY
.	

Therefore	
,	
systematic	ENTITY
questioning	ENTITY
for	
RBD	ENTITY
should	
be	
included	
for	
all	
newly	
evaluated	
patients	ENTITY
at	
a	
sleep	ENTITY
center	ENTITY
.	

RBD	ENTITY
in	
children	ENTITY
is	
virtually	
never	
idiopathic	ENTITY
and	
is	
usually	
associated	ENTITY
with	ENTITY
narcolepsy	ENTITY
(	
at	
times	
emerging	
months	ENTITY
before	
the	
emergence	ENTITY
of	
narcoleptic	ENTITY
symptoms	ENTITY
)	
,	
brainstem	ENTITY
tumors	ENTITY
,	
antidepressant	ENTITY
medications	ENTITY
,	
neurodevelopmental	ENTITY
disorders	ENTITY
,	
and	
various	
rare	ENTITY
conditions	ENTITY
.	

The	
prevalence	ENTITY
is	
not	
known	
with	
much	
certainty	ENTITY
,	
although	
a	
prevalence	ENTITY
of	
0.38	
%	
to	
0.5	
%	
is	
reported	
in	
the	
elderly	ENTITY
and	
the	
general	ENTITY
population	ENTITY
.	

A	
2.1	
%	
prevalence	ENTITY
of	
current	ENTITY
sleep	ENTITY
related	
violence	ENTITY
has	
been	
reported	
;	
38	
%	
of	
these	
events	ENTITY
have	
associated	
dream	
enactment	ENTITY
,	
suggesting	
a	
prevalence	ENTITY
of	
RBD	ENTITY
as	
high	
as	
0.8	
%	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY

The	
major	
predisposing	ENTITY
factors	ENTITY
are	
male	ENTITY
sex	ENTITY
,	
age	ENTITY
50	
years	ENTITY
or	
older	ENTITY
,	
and	
an	
under-	
lying	ENTITY
neurological	ENTITY
disorder	ENTITY
,	
particularly	
Parkinson	ENTITY
disease	ENTITY
,	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
,	
dementia	ENTITY
with	
Lewy	ENTITY
bodies	ENTITY
,	
narcolepsy	ENTITY
,	
or	
stroke	ENTITY
.	

A	
recent	
multicenter	ENTITY
case	ENTITY
-	
control	ENTITY
study	ENTITY
of	
environmental	ENTITY
risk	ENTITY
factors	ENTITY
of	
RBD	ENTITY
found	
that	
smoking	ENTITY
,	
head	ENTITY
injury	ENTITY
,	
pesticide	ENTITY
exposure	ENTITY
,	
and	
farming	ENTITY
were	
significant	
risk	ENTITY
factors	ENTITY
.	

Medications	ENTITY
,	
particularly	
the	
anti-	ENTITY
depressants	ENTITY
venlafaxine	ENTITY
,	
serotonin	ENTITY
-	
specific	ENTITY
reuptake	ENTITY
inhibitors	ENTITY
(	
SSRIs	ENTITY
)	
,	
mirtazapine	ENTITY
,	
and	
other	
antidepressant	ENTITY
agents	ENTITY
(	
but	
not	
bupropion	ENTITY
)	
are	
an	
increasingly	
recognized	
precipitating	
factor	ENTITY
.	

Beta	ENTITY
-	
blockers	ENTITY
(	
bisoprolol	ENTITY
,	
atenolol	ENTITY
)	
,	
anticholinesterase	ENTITY
inhibitors	ENTITY
,	
and	
selegiline	ENTITY
can	
also	
trigger	
RBD	ENTITY
.	

Psychiatric	ENTITY
disorders	ENTITY
involving	
depression	ENTITY
(	
that	
require	
antidepressant	ENTITY
pharmacotherapy	ENTITY
)	
may	
comprise	
a	
predisposing	ENTITY
factor	ENTITY
,	
particu-	
larly	
in	
adults	ENTITY
younger	ENTITY
than	
50	
years	ENTITY
.	

RBD	ENTITY
may	
also	
be	
associated	ENTITY
with	ENTITY
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	
Familial	
Pattern	
A	
recent	
multicenter	ENTITY
controlled	ENTITY
study	ENTITY
revealed	
a	
significantly	
increased	ENTITY
positive	ENTITY
family	ENTITY
history	ENTITY
of	
dream	ENTITY
enactment	ENTITY
,	
raising	
the	
possibility	
of	
a	
genetic	ENTITY
contribution	ENTITY
to	
RBD	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
of	
chronic	ENTITY
RBD	ENTITY
can	
be	
gradual	ENTITY
or	
rapid	ENTITY
,	
and	
the	
course	ENTITY
is	
often	
progressive	ENTITY
.	

Complications	ENTITY
include	
sleep	ENTITY
related	ENTITY
injuries	ENTITY
to	
self	
and/or	
bed	ENTITY
partner	ENTITY
that	
at	
times	
are	
life	ENTITY
threatening	ENTITY
,	
and	
disruption	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
’s	ENTITY
sleep	ENTITY
that	
can	
be	
severe	ENTITY
.	

Marital	ENTITY
discord	ENTITY
due	
to	
the	
RBD	ENTITY
is	
uncommon	ENTITY
but	
can	
be	
severe	ENTITY
when	
present	ENTITY
,	
due	
to	
repeated	
injury	ENTITY
and/or	
disruption	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
’s	ENTITY
sleep	ENTITY
.	

Delayed	ENTITY
emergence	ENTITY
of	
a	
neurodegenerative	ENTITY
disorder	ENTITY
,	
often	
more	
than	
a	
decade	
after	
the	
onset	
of	
idiopathic	ENTITY
RBD	ENTITY
,	
is	
very	
common	
in	
men	ENTITY
50	
years	ENTITY
of	
age	ENTITY
and	
older	ENTITY
.	

These	
dis-	
orders	ENTITY
include	
Parkinson	ENTITY
disease	ENTITY
(	
PD	ENTITY
)	
,	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
(	
MSA	ENTITY
)	
,	
and	
dementia	ENTITY
with	
Lewy	ENTITY
bodies	ENTITY
(	
DLB	ENTITY
)	
.	

Two	
recently	
reported	
series	
found	
81	
%	
and	
82	
%	
eventual	ENTITY
conversion	ENTITY
rates	ENTITY
from	
idiopathic	ENTITY
RBD	ENTITY
to	
parkinsonism	ENTITY
/	
dementia	ENTITY
(	
and	
also	
mild	ENTITY
cog-	
nitive	ENTITY
impairment	ENTITY
in	
the	
latter	
study	ENTITY
)	
.	

Conversely	
,	
RBD	ENTITY
is	
present	
in	
>	
90	
%	
of	
reported	
cases	ENTITY
of	
MSA	ENTITY
,	
in	
approximately	
50	
%	
of	
reported	
cases	ENTITY
of	
DLB	ENTITY
,	
and	
in	
up	
to	
46	
%	
of	
reported	
patients	ENTITY
with	
PD	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
As	
stated	
previously	
,	
RBD	ENTITY
can	
emerge	
in	
children	ENTITY
,	
usually	
in	
association	ENTITY
with	ENTITY
narco-	
lepsy	ENTITY
-	
cataplexy	ENTITY
,	
brainstem	ENTITY
tumors	ENTITY
,	
or	
antidepressant	ENTITY
medications	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Current	ENTITY
evidence	ENTITY
suggests	
a	
selective	
association	ENTITY
between	
RBD	ENTITY
and	
neurodegenera-	
tive	ENTITY
disorders	ENTITY
.	

The	
synucleinopathies	ENTITY
comprise	
a	
set	
of	
neurodegenerative	ENTITY
disorders	ENTITY
that	
share	
a	
common	
pathologic	ENTITY
lesion	ENTITY
composed	
of	
aggregates	ENTITY
of	
insoluble	ENTITY
α	ENTITY
-	ENTITY
synu-	ENTITY
clein	ENTITY
protein	ENTITY
in	
selectively	
vulnerable	ENTITY
populations	ENTITY
of	
neurons	ENTITY
and	
glial	ENTITY
cells	ENTITY
.	

These	
pathologic	ENTITY
aggregates	ENTITY
appear	
to	
be	
closely	
linked	
to	
the	
onset	ENTITY
and	
progression	ENTITY
of	
clin-	
ical	ENTITY
symptoms	ENTITY
and	
the	
degeneration	ENTITY
of	
affected	
brain	ENTITY
regions	ENTITY
in	
neurodegenerative	ENTITY
disorders	ENTITY
.	

The	
major	
synucleinopathies	ENTITY
include	
PD	ENTITY
,	
DLB	ENTITY
,	
and	
MSA	ENTITY
.	

RBD	ENTITY
can	
be	
strongly	
linked	
with	
narcolepsy	ENTITY
(	
almost	
always	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
)	ENTITY
,	
rep-	ENTITY
resenting	ENTITY
another	
form	
of	
REM	ENTITY
sleep	ENTITY
motor	ENTITY
-	
behavioral	ENTITY
dyscontrol	ENTITY
.	

The	
RBD	ENTITY
may	
be	
precipitated	ENTITY
or	
worsened	ENTITY
by	
the	
pharmacologic	ENTITY
treatment	ENTITY
of	
cataplexy	ENTITY
.	

RBD	ENTITY
associ-	
ated	ENTITY
with	
narcolepsy	ENTITY
is	
now	
considered	
to	
be	
a	
distinct	
phenotype	ENTITY
of	
RBD	ENTITY
,	
character-	
ized	ENTITY
by	
lack	ENTITY
of	
sex	
predominance	ENTITY
,	
less	
complex	ENTITY
and	
more	
elementary	ENTITY
movements	ENTITY
in	
REM	ENTITY
sleep	ENTITY
,	
less	
violent	ENTITY
behavior	ENTITY
in	
REM	ENTITY
sleep	ENTITY
,	
earlier	
age	ENTITY
of	
onset	ENTITY
,	
and	
hypocretin	ENTITY
deficiency	ENTITY
(	
that	
is	
characteristic	
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
)	
.	

The	
presence	ENTITY
of	
RBD	ENTITY
in	
pediat-	
ric	
patients	ENTITY
may	
be	
an	
initial	
manifestation	ENTITY
of	
narcolepsy	ENTITY
type	ENTITY
1	ENTITY
.	

Other	
reported	
etiologic	ENTITY
associations	ENTITY
of	
RBD	ENTITY
with	
neurologic	ENTITY
disorders	ENTITY
include	
isch-	
emic	ENTITY
or	
hemorrhagic	ENTITY
cerebrovascular	ENTITY
disease	ENTITY
,	
multiple	ENTITY
sclerosis	ENTITY
,	
progressive	ENTITY
supranu-	
clear	ENTITY
palsy	ENTITY
,	
Guillain	ENTITY
-	
Barré	ENTITY
syndrome	ENTITY
,	
brainstem	ENTITY
neoplasms	ENTITY
(	
including	
cerebellopon-	
tine	ENTITY
angle	ENTITY
tumors	ENTITY
)	
,	
Machado	ENTITY
-	
Joseph	ENTITY
disease	ENTITY
(	
spinocerebellar	ENTITY
ataxia	ENTITY
type	ENTITY
3	ENTITY
)	
,	
mitochon-	
drial	ENTITY
encephalomyopathy	ENTITY
,	
normal	ENTITY
pressure	ENTITY
hydrocephalus	ENTITY
,	
Tourette	ENTITY
syndrome	ENTITY
,	
group	ENTITY
A	ENTITY
xeroderma	ENTITY
,	
and	
autism	ENTITY
.	

The	
pathophysiology	ENTITY
of	
human	ENTITY
RBD	ENTITY
is	
presumed	
to	
correspond	
to	
the	
findings	ENTITY
from	
an	
animal	ENTITY
model	ENTITY
of	
RBD	ENTITY
with	
respect	
to	
interruption	ENTITY
of	
the	
REM	ENTITY
atonia	ENTITY
pathway	ENTITY
and/	
or	
disinhibition	ENTITY
of	
brainstem	ENTITY
motor	ENTITY
pattern	ENTITY
generators	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Polysomnography	ENTITY
demonstrates	
an	
excessive	ENTITY
amount	ENTITY
of	
sustained	ENTITY
or	
intermittent	ENTITY
loss	
of	
REM	ENTITY
atonia	ENTITY
and/or	
excessive	ENTITY
phasic	ENTITY
muscle	ENTITY
twitch	
activity	ENTITY
of	
the	
submental	ENTITY
and/or	
limb	ENTITY
EMGs	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

Some	
patients	ENTITY
have	
almost	
exclusively	
arm	ENTITY
and	
hand	ENTITY
behaviors	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
indicating	
the	
need	
for	
both	
upper	ENTITY
and	
lower	ENTITY
extremity	ENTITY
EMG	ENTITY
monitoring	ENTITY
in	
fully	
evaluating	ENTITY
for	
RBD	ENTITY
.	

Some	
patients	ENTITY
preserve	
most	
of	
their	
REM	ENTITY
atonia	ENTITY
but	
have	
excessive	
EMG	ENTITY
twitching	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

The	
most	
current	
evidence	ENTITY
-	
based	ENTITY
data	ENTITY
for	
detecting	ENTITY
RWA	ENTITY
in	
the	
evaluation	ENTITY
of	
RBD	ENTITY
indicate	
that	
any	
(	
tonic	ENTITY
/	
phasic	ENTITY
)	
chin	
EMG	ENTITY
activity	ENTITY
combined	
with	
bilateral	ENTITY
phasic	ENTITY
activity	ENTITY
of	
the	
flexor	ENTITY
digitorum	ENTITY
superficialis	ENTITY
muscles	ENTITY
in	
>	
27	
%	
of	
REM	ENTITY
sleep	ENTITY
(	
scored	ENTITY
in	
30	
-	
second	ENTITY
epochs	ENTITY
)	
reliably	
distinguishes	
RBD	ENTITY
patients	ENTITY
from	
controls	ENTITY
.	

Autonomic	ENTITY
nervous	ENTITY
system	ENTITY
activa-	
tion	ENTITY
(	
such	
as	
tachycardia	ENTITY
)	
is	
uncommon	
during	
REM	ENTITY
sleep	ENTITY
motor	ENTITY
activation	ENTITY
in	
RBD	ENTITY
,	
in	
contrast	
to	
the	
disorders	ENTITY
of	
arousal	ENTITY
.	

Approximately	
75	
%	
of	
patients	ENTITY
have	
PLMs	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
;	
a	
low	
percentage	
of	
these	
movements	ENTITY
is	
associated	ENTITY
with	ENTITY
EEG	ENTITY
signs	ENTITY
of	
arousal	ENTITY
.	

Increased	ENTITY
percentages	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
and	
increased	ENTITY
delta	
power	
in	
RBD	ENTITY
have	
been	
found	
in	
controlled	ENTITY
and	
uncontrolled	ENTITY
studies	ENTITY
,	
but	
this	
can	
be	
a	
highly	
vari-	
able	
finding	ENTITY
in	
RBD	ENTITY
,	
depending	
on	
the	
clinical	ENTITY
population	ENTITY
.	

Sleep	ENTITY
architecture	ENTITY
and	
the	
customary	ENTITY
cycling	ENTITY
among	
REM	ENTITY
and	
NREM	ENTITY
sleep	ENTITY
stages	ENTITY
are	
usually	
preserved	
in	
RBD	ENTITY
,	
although	
some	
patients	ENTITY
show	
a	
shift	
toward	
N1	ENTITY
sleep	ENTITY
.	

Validated	ENTITY
RBD	ENTITY
screening	
questionnaires	
that	
can	
assist	
in	
the	
process	ENTITY
of	
diagnosing	ENTITY
RBD	ENTITY
are	
currently	
available	
.	

Parasomnias	ENTITY
Parasomnias	
Differential	ENTITY
Diagnosis	ENTITY
RBD	ENTITY
is	
one	
of	
several	
disorders	ENTITY
that	
can	
manifest	ENTITY
as	
complex	ENTITY
,	
injurious	ENTITY
,	
and	
violent	ENTITY
sleep	ENTITY
related	
and	
dream	ENTITY
-	
related	ENTITY
behaviors	ENTITY
in	
adults	ENTITY
.	

Other	
disorders	ENTITY
that	
can	
mimic	
RBD	ENTITY
in	
adults	ENTITY
and/or	
children	ENTITY
include	
sleepwalking	ENTITY
,	
sleep	ENTITY
terrors	ENTITY
,	
OSA	ENTITY
,	
nocturnal	ENTITY
seizures	ENTITY
(	
nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
;	
nocturnal	ENTITY
complex	ENTITY
partial	ENTITY
seizures	ENTITY
)	
;	
rhyth-	
mic	ENTITY
movement	ENTITY
disorders	ENTITY
;	
sleep	ENTITY
related	
dissociative	ENTITY
disorders	ENTITY
,	
frightening	
hypnopom-	
pic	ENTITY
hallucinations	ENTITY
,	
and	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
;	
a	
diagnosis	ENTITY
of	
malingering	ENTITY
also	
should	
be	
considered	
.	

In	
general	
,	
RBD	ENTITY
involves	
attempted	
enactment	ENTITY
of	
unpleasant	ENTITY
,	
aggressive	ENTITY
dreams	ENTITY
that	
usually	
occurs	
two	
or	
more	
hours	
after	
sleep	ENTITY
onset	ENTITY
,	
with	
rapid	
awakening	ENTITY
from	
an	
episode	ENTITY
.	

In	
contrast	
,	
sleepwalking	ENTITY
and	
sleep	ENTITY
terror	ENTITY
episodes	ENTITY
often	
emerge	
within	
two	
hours	
after	
sleep	ENTITY
onset	ENTITY
,	
are	
not	
usually	
associated	ENTITY
with	ENTITY
rapid	
alertness	ENTITY
,	
and	
are	
rarely	
associated	ENTITY
with	ENTITY
dreaming	ENTITY
in	
children	ENTITY
.	

Adults	ENTITY
can	
have	
dreams	ENTITY
associated	ENTITY
with	ENTITY
disor-	
ders	ENTITY
of	
arousal	ENTITY
,	
but	
they	
are	
usually	
more	
fragmentary	
and	
limited	
than	
RBD	ENTITY
dreams	ENTITY
.	

Sleep	ENTITY
related	
seizures	ENTITY
usually	
present	
with	
repetitive	ENTITY
,	
stereotypical	ENTITY
behaviors	ENTITY
.	

Parasomnia	ENTITY
overlap	
disorder	ENTITY
can	
be	
distinguished	
from	
status	ENTITY
dissociatus	ENTITY
in	
several	
ways	
:	
if	
there	
is	
an	
awakening	ENTITY
after	
an	
episode	ENTITY
of	
RBD	ENTITY
,	
sleepwalking	ENTITY
,	
or	
sleep	ENTITY
terror	ENTITY
,	
there	
is	
the	
realization	ENTITY
of	
having	
just	
been	
asleep	ENTITY
;	
status	ENTITY
dissociatus	ENTITY
,	
however	
,	
is	
more	
likely	
to	
manifest	ENTITY
with	
confusion	ENTITY
over	
whether	
one	
is	
asleep	ENTITY
,	
awake	ENTITY
,	
or	
dreaming	ENTITY
.	

vPSG	ENTITY
in	
overlap	ENTITY
conditions	ENTITY
shows	
the	
typical	
findings	ENTITY
for	
both	
RBD	ENTITY
and	
disorders	ENTITY
of	
arousal	ENTITY
,	
whereas	
with	
status	ENTITY
dissociatus	ENTITY
,	
there	
is	
an	
inability	
to	
discern	
sleep	ENTITY
stages	ENTITY
.	

Also	
,	
patients	ENTITY
with	
status	ENTITY
dissociatus	ENTITY
do	
not	
walk	
far	
during	
an	
episode	ENTITY
,	
and	
their	
behavioral	ENTITY
repertoire	ENTITY
more	
closely	
resembles	
that	
of	
RBD	ENTITY
than	
that	
of	
the	
disorders	ENTITY
of	
arousal	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY
Numerous	
questions	
related	
to	
the	
vPSG	ENTITY
evaluation	ENTITY
of	
RBD	ENTITY
remain	
unresolved	
.	

These	
include	
issues	ENTITY
of	
defining	
and	
quantifying	ENTITY
RWA	ENTITY
and	
RBD	ENTITY
activity	ENTITY
such	
as	
:	
(	
1	
)	
What	
is	
the	
minimum	ENTITY
REM	ENTITY
sleep	ENTITY
percentage	ENTITY
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
(	
and	
minimum	ENTITY
absolute	ENTITY
REM	ENTITY
sleep	ENTITY
time	ENTITY
)	
needed	
to	
diagnose	ENTITY
RWA	ENTITY
or	
rule	
out	
RWA	ENTITY
?	

(	
2	
)	
What	
is	
the	
minimum	
number	
of	
REM	ENTITY
sleep	ENTITY
epochs	ENTITY
and	
minimum	ENTITY
duration	ENTITY
of	
REM	ENTITY
sleep	ENTITY
epochs	ENTITY
necessary	
to	
diagnose	ENTITY
RWA	ENTITY
or	
rule	
out	
RWA	ENTITY
?	

(	
3	
)	
What	
guidelines	ENTITY
can	
be	
developed	
for	
diag-	
nosing	ENTITY
or	
ruling	
out	
RWA	ENTITY
in	
the	
setting	
of	
disrupted	ENTITY
REM	ENTITY
sleep	ENTITY
continuity	ENTITY
associated	ENTITY
with	ENTITY
conditions	ENTITY
such	
as	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
with	
medications	ENTITY
?	

(	
4	
)	
What	
are	
the	
minimal	
amounts	
of	
true	ENTITY
RBD	ENTITY
behaviors	ENTITY
documented	ENTITY
by	
vPSG	ENTITY
needed	
to	
identify	
RBD	ENTITY
in	
patients	ENTITY
without	
sufficient	ENTITY
RWA	ENTITY
?	

It	
is	
unclear	
why	
there	
is	
a	
male	ENTITY
predominance	ENTITY
of	
this	
disorder	ENTITY
in	
middle	ENTITY
-	
aged	ENTITY
and	
older	ENTITY
adults	ENTITY
.	

It	
is	
unknown	
if	
RBD	ENTITY
subgroups	ENTITY
other	
than	
men	ENTITY
age	ENTITY
50	
years	ENTITY
or	
older	ENTITY
demon-	
strate	ENTITY
increased	ENTITY
risk	ENTITY
for	
development	ENTITY
of	
parkinsonism	ENTITY
or	
dementia	ENTITY
.	

One	
such	
subgroup	ENTITY
comprises	
patients	ENTITY
with	
antidepressant	ENTITY
-	
triggered	ENTITY
RBD	ENTITY
for	
whom	
the	
potential	ENTITY
risk	ENTITY
for	
future	
parkinsonism	ENTITY
and	
dementia	ENTITY
is	
unclear	ENTITY
.	

New	
antidepressant	ENTITY
or	
other	
psychotro-	
pic	ENTITY
agents	ENTITY
being	
developed	
for	
clinical	ENTITY
use	ENTITY
should	
be	
assessed	ENTITY
for	
their	
immediate	ENTITY
and	
long	ENTITY
-	
term	ENTITY
effects	ENTITY
on	
REM	ENTITY
atonia	ENTITY
,	
REM	ENTITY
phasic	ENTITY
activity	ENTITY
,	
REM	ENTITY
sleep	ENTITY
behavioral	
release	
,	
and	
proclivity	ENTITY
to	
precipitate	ENTITY
dream	ENTITY
-	
enacting	ENTITY
behaviors	ENTITY
.	

Bibliography	ENTITY
Boeve	ENTITY
BF	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
:	
Updated	ENTITY
review	ENTITY
of	
the	
core	ENTITY
features	ENTITY
,	
the	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
-	
neurodegenerative	ENTITY
disease	ENTITY
association	ENTITY
,	
evolving	ENTITY
concepts	ENTITY
,	
controversies	ENTITY
,	
and	
future	
directions	ENTITY
.	

Ann	ENTITY
N	ENTITY
Y	ENTITY
Acad	ENTITY
Sci	ENTITY
2010;1184:15–54	ENTITY
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Jennum	ENTITY
P	ENTITY
,	
Plazzi	
G.	ENTITY
REM	ENTITY
sleep	ENTITY
behaviour	ENTITY
disorder	ENTITY
and	
REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
in	
narcolepsy	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2013;14:775–81	ENTITY
.	

Frauscher	ENTITY
B	ENTITY
,	
Gschliesser	ENTITY
V	ENTITY
,	
Brandauer	ENTITY
E	ENTITY
,	
et	
al	
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
in	
703	
sleep	ENTITY
-	
disorder	ENTITY
patients	ENTITY
:	
the	
importance	
of	
eliciting	
a	
comprehensive	ENTITY
sleep	ENTITY
history	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:167–71	ENTITY
.	

Frauscher	ENTITY
B	ENTITY
,	
Iranzo	
A	
,	
Gaig	
C	
,	
et	
al	
.	

Normative	ENTITY
EMG	ENTITY
values	
during	
REM	ENTITY
sleep	ENTITY
for	
the	
diagnosis	ENTITY
of	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
2012;35:835–47	ENTITY
.	

Iranzo	ENTITY
A	ENTITY
,	
Santamaria	ENTITY
J.	ENTITY
Severe	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
/	
hypopnea	ENTITY
mimicking	ENTITY
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
2005;28:203–6	
.	

Iranzo	ENTITY
A	ENTITY
,	
Santamaria	ENTITY
J	ENTITY
,	ENTITY
Tolosa	ENTITY
E.	ENTITY

The	
clinical	ENTITY
and	
pathophysiological	ENTITY
relevance	ENTITY
of	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
in	
neurodegenerative	ENTITY
diseases	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2009;13:385–401	ENTITY
.	

Iranzo	ENTITY
A	ENTITY
,	
Tolosa	ENTITY
E	ENTITY
,	
Gelpi	ENTITY
E	ENTITY
,	
et	
al	
.	

Neurodegenerative	ENTITY
disease	ENTITY
status	ENTITY
and	
post	ENTITY
-	
mortem	ENTITY
pathology	ENTITY
in	
isolated	ENTITY
rapid	ENTITY
-	
eye	ENTITY
-	
movement	ENTITY
sleep	ENTITY
behaviour	ENTITY
disorder	ENTITY
:	
an	
observational	ENTITY
cohort	ENTITY
study	ENTITY
.	

Lancet	ENTITY
Neurol	ENTITY
2013;12:443–53	ENTITY
.	

Ju	ENTITY
YE	ENTITY
.	

Rapid	ENTITY
eye	ENTITY
movement	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
in	
adults	ENTITY
younger	ENTITY
than	
50	
years	ENTITY
of	
age	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2013;14:768–74	ENTITY
.	

Lloyd	ENTITY
R	ENTITY
,	
Tippman	ENTITY
-	
Peikert	ENTITY
M	ENTITY
,	
Slocumb	ENTITY
N	ENTITY
,	
Kotagal	
S.	
Characteristics	ENTITY
of	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
in	
childhood	ENTITY
.	

J	
Clin	
Sleep	
Med	
2012:15:127–31	
.	

Olson	ENTITY
E	ENTITY
,	
Boeve	ENTITY
B	ENTITY
,	
Silber	
M.	
Rapid	
eye	
movement	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
:	
demographic	ENTITY
,	
clinical	ENTITY
,	
and	
laboratory	ENTITY
findings	ENTITY
in	
93	
cases	ENTITY
.	

Brain	ENTITY
2000;123:331–9	
.	

Oudiette	ENTITY
D	ENTITY
,	
De	ENTITY
Cock	ENTITY
VC	ENTITY
,	
Lavault	ENTITY
S	ENTITY
,	
Leu	ENTITY
S	ENTITY
,	
Vidailhet	ENTITY
M	ENTITY
,	
Arnulf	
I.	
Non	ENTITY
-	
violent	ENTITY
elaborate	ENTITY
behaviors	ENTITY
may	
also	
occur	
in	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
.	

Neurology	ENTITY
2009;72:551–7	
.	

Postuma	ENTITY
RB	ENTITY
,	
Gagnon	ENTITY
JF	ENTITY
,	
Vendette	ENTITY
M	ENTITY
,	
Fantini	ENTITY
ML	ENTITY
,	
Massicotte	ENTITY
-	
Marquez	
J	
,	
Montplaisir	
J.	
Quantifying	ENTITY
the	
risk	ENTITY
of	
neurodegenerative	ENTITY
disease	ENTITY
in	
idiopathic	ENTITY
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
.	

Neurology	ENTITY
2009;72:1296–300	ENTITY
.	

Schenck	ENTITY
CH	ENTITY
,	
Mahowald	ENTITY
MW	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
:	
clinical	ENTITY
,	
developmental	ENTITY
,	
and	
neuroscience	ENTITY
perspectives	
16	
years	ENTITY
after	
its	
formal	
identification	ENTITY
in	
SLEEP	ENTITY
.	

Sleep	ENTITY
2002;25:120–38	ENTITY
.	

Schenck	ENTITY
CH	ENTITY
,	
Boeve	ENTITY
BF	ENTITY
,	
Mahowald	ENTITY
MW	ENTITY
.	

Delayed	ENTITY
emergence	ENTITY
of	
a	
parkinsonian	ENTITY
disorder	ENTITY
or	
dementia	ENTITY
in	
81	
%	
of	
older	ENTITY
males	ENTITY
initially	
diagnosed	ENTITY
with	
idiopathic	ENTITY
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
):	
16	
year	ENTITY
update	ENTITY
on	
a	
previously	
reported	
series	
.	

Sleep	ENTITY
Med	ENTITY
2013;14:744–8	ENTITY
.	

Schenck	ENTITY
CH	ENTITY
,	
Howell	ENTITY
MJ	ENTITY
.	

Spectrum	ENTITY
of	
RBD	ENTITY
(	
overlap	ENTITY
between	
RBD	ENTITY
and	
other	
parasomnias	ENTITY
)	
.	

Sleep	ENTITY
and	
Biological	ENTITY
Rhythms	ENTITY
2013;11(Supplement	
1):27–34	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Recurrent	
Isolated	ENTITY
Sleep	ENTITY
Paralysis	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.43	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.53	ENTITY
Alternate	ENTITY
Names	ENTITY
Hypnagogic	ENTITY
and	
hypnopompic	ENTITY
paralysis	ENTITY
,	
predormital	ENTITY
and	
postdormital	ENTITY
paralysis	ENTITY
,	
kanashibari	ENTITY
(	
Japan	ENTITY
)	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY
A	ENTITY
recurrent	ENTITY
inability	
to	
move	
the	
trunk	ENTITY
and	
all	
of	
the	
limbs	ENTITY
at	
sleep	ENTITY
onset	ENTITY
or	
upon	
awakening	ENTITY
from	
sleep	ENTITY
.	

B.	ENTITY
Each	
episode	ENTITY
lasts	
seconds	
to	
a	
few	
minutes	ENTITY
.	

C.	

The	
episodes	ENTITY
cause	
clinically	ENTITY
significant	ENTITY
distress	ENTITY
including	
bedtime	ENTITY
anxiety	ENTITY
or	
fear	ENTITY
of	ENTITY
sleep	ENTITY
.	

D.	
The	
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
(	
especially	
narcolepsy	ENTITY
)	
,	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
condition	ENTITY
,	
medication	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Recurrent	ENTITY
isolated	ENTITY
sleep	ENTITY
paralysis	ENTITY
is	
characterized	ENTITY
by	
an	
inability	
to	
perform	
voluntary	ENTITY
movements	ENTITY
at	
sleep	ENTITY
onset	ENTITY
(	
hypnagogic	ENTITY
or	
predormital	ENTITY
form	
)	
or	
on	
waking	ENTITY
from	
sleep	ENTITY
(	
hypnopompic	ENTITY
or	
postdormital	
form	
)	
in	
the	
absence	ENTITY
of	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
.	

The	
event	ENTITY
consists	
of	
an	
inability	
to	
speak	
or	
to	
move	
the	
limbs	ENTITY
,	
trunk	ENTITY
,	
and	
head	ENTITY
.	

Respiration	ENTITY
is	
usually	
unaffected	
.	

Consciousness	ENTITY
is	
preserved	
,	
and	
full	
recall	ENTITY
is	
present	
.	

An	
episode	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
lasts	
seconds	
to	
minutes	ENTITY
.	

It	
usually	
resolves	
spontaneously	ENTITY
but	
can	
be	
aborted	ENTITY
by	
sensory	ENTITY
stimulation	ENTITY
,	
such	
as	
being	
touched	
or	
spoken	ENTITY
to	
,	
or	
by	
the	
patient	ENTITY
making	
intense	ENTITY
efforts	
to	
move	
.	

Associated	ENTITY
Features	ENTITY
At	
least	
during	
the	
initial	ENTITY
episodes	ENTITY
,	
intense	ENTITY
anxiety	ENTITY
is	
usually	
present	
.	

Hallucinatory	ENTITY
experiences	ENTITY
accompany	
the	
paralysis	ENTITY
in	
about	
25	
%	
to	
75	
%	
of	
patients	ENTITY
.	

These	
may	
include	
auditory	ENTITY
,	
visual	ENTITY
,	
or	
tactile	ENTITY
hallucinations	ENTITY
,	
or	
the	
sense	
of	
a	
presence	ENTITY
in	
the	
room	ENTITY
.	

Some	
patients	ENTITY
experience	ENTITY
predormital	ENTITY
or	
postdormital	ENTITY
hallucinations	ENTITY
at	
separate	
times	
from	
episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
A	
familial	ENTITY
form	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
has	
been	
described	
(	
see	
below	
)	
.	

Demographics	ENTITY
Estimates	ENTITY
of	
the	
prevalence	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
vary	
widely	
due	
to	
differences	
in	
the	
definition	ENTITY
used	
,	
the	
age	ENTITY
of	
the	
population	ENTITY
sampled	ENTITY
,	
and	
possibly	
cultural	ENTITY
and	
ethnic	ENTITY
factors	ENTITY
.	

Most	
prevalence	ENTITY
studies	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
(	
usually	
of	
students	ENTITY
younger	ENTITY
than	
30	
years	ENTITY
)	
have	
investigated	ENTITY
the	
occurrence	ENTITY
of	
one	
or	
more	
episodes	ENTITY
without	
require-	
ment	ENTITY
of	
recurrence	ENTITY
or	
distress	ENTITY
.	

These	
suggest	
a	
15	
%	
to	
40	
%	
prevalence	ENTITY
of	
at	
least	
one	
episode	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
.	

Two	
notable	
exceptions	
are	
a	
1962	
study	ENTITY
of	
mostly	
college	ENTITY
students	ENTITY
that	
reported	
a	
prevalence	ENTITY
of	
5	
%	
,	
and	
a	
1999	
study	ENTITY
of	
all	
adult	ENTITY
ages	ENTITY
that	
found	
a	
prevalence	ENTITY
of	
6	
%	
.	

No	
consistent	
sex	
differences	ENTITY
have	
emerged	
from	
multiple	
studies	ENTITY
.	

The	
mean	
age	ENTITY
of	
onset	
is	
14	
to	
17	
years	ENTITY
,	
although	
onset	
earlier	
and	
later	
in	
life	ENTITY
has	
been	
reported	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Sleep	ENTITY
deprivation	ENTITY
and	
irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
schedules	ENTITY
have	
been	
identified	ENTITY
as	
predis-	
posing	
factors	ENTITY
to	
episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
.	

Mental	ENTITY
stress	ENTITY
has	
been	
reported	
as	
a	
precipitating	ENTITY
factor	ENTITY
in	
some	
but	
not	
other	
studies	ENTITY
.	

Sleep	ENTITY
paralysis	ENTITY
appears	
to	
be	
more	
common	
with	
sleep	ENTITY
in	
the	
supine	ENTITY
position	ENTITY
.	

Personality	ENTITY
factors	ENTITY
have	
not	
been	
shown	
to	
play	
a	
major	
role	
,	
although	
one	
study	ENTITY
found	
a	
higher	
score	ENTITY
on	
the	
paranoia	ENTITY
scale	ENTITY
of	
the	
Minnesota	ENTITY
Multiphasic	ENTITY
Personality	ENTITY
Inventory	ENTITY
in	
patients	ENTITY
with	
sleep	ENTITY
paralysis	ENTITY
com-	
pared	
to	
controls	ENTITY
.	

Other	
factors	ENTITY
that	
have	
been	
noted	
on	
regression	ENTITY
analysis	ENTITY
include	
an	
association	ENTITY
with	
bipolar	ENTITY
disorder	ENTITY
,	
the	
use	
of	
anxiolytic	ENTITY
medication	ENTITY
,	
and	
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
Two	
families	ENTITY
with	
apparent	ENTITY
familial	ENTITY
sleep	ENTITY
paralysis	ENTITY
occurring	
over	
three	
and	
four	
gen-	
erations	ENTITY
have	
been	
reported	
.	

A	
maternal	ENTITY
form	ENTITY
of	
transmission	ENTITY
has	
been	
postulated	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
is	
usually	
in	
adolescence	ENTITY
.	

Most	
events	ENTITY
appear	
to	
occur	
in	
the	
second	
and	
third	
decades	ENTITY
,	
but	
may	
continue	
later	
in	
life	ENTITY
.	

There	
are	
no	
known	
complications	ENTITY
,	
apart	
from	
anxiety	ENTITY
over	
the	
episodes	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Though	
sleep	ENTITY
paralysis	ENTITY
may	
be	
present	
as	
part	
of	
the	
narcolepsy	ENTITY
tetrad	ENTITY
in	
children	ENTITY
,	
there	
is	
no	
information	
currently	
available	
about	
childhood	ENTITY
presentation	ENTITY
of	
recurrent	ENTITY
isolated	ENTITY
sleep	ENTITY
paralysis	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Pathology	ENTITY
and	
Pathophysiology	ENTITY
Episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
elicited	
by	
awakening	ENTITY
patients	ENTITY
from	
nocturnal	ENTITY
sleep	ENTITY
appear	
to	
arise	
from	
REM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
paralysis	ENTITY
is	
an	
example	
of	
state	ENTITY
dissociation	ENTITY
with	
ele-	
ments	ENTITY
of	
REM	ENTITY
sleep	ENTITY
persisting	
into	
wakefulness	ENTITY
.	

Early	ENTITY
-	
onset	ENTITY
REM	ENTITY
sleep	ENTITY
after	
forced	ENTITY
awakenings	ENTITY
has	
been	
shown	
to	
predispose	
an	
individual	ENTITY
to	
having	
sleep	ENTITY
paralysis	ENTITY
.	

It	
may	
be	
that	
subjects	ENTITY
with	
less	
tolerance	ENTITY
to	
sleep	ENTITY
disruption	ENTITY
are	
more	
likely	
to	
experi-	
ence	ENTITY
the	
phenomenon	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Analysis	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
after	
forced	ENTITY
awakenings	ENTITY
during	
PSG	ENTITY
studies	ENTITY
reveals	
the	
event	ENTITY
to	
be	
a	
dissociated	ENTITY
state	ENTITY
with	
the	
persistence	ENTITY
of	
REM	ENTITY
-	
related	ENTITY
electromyographic	ENTITY
atonia	ENTITY
into	
conscious	ENTITY
wakefulness	ENTITY
.	

Hallucinatory	ENTITY
experiences	ENTITY
may	
be	
present	
but	
are	
not	
essential	
for	
the	
diagnosis	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Cataplexy	ENTITY
produces	
similar	
generalized	ENTITY
paralysis	ENTITY
of	
skeletal	ENTITY
muscles	ENTITY
but	
occurs	
during	
wakefulness	ENTITY
and	
is	
precipitated	
by	
emotion	ENTITY
.	

Atonic	ENTITY
seizures	ENTITY
occur	
during	
wakefulness	ENTITY
.	

Nocturnal	ENTITY
panic	ENTITY
attacks	ENTITY
are	
not	
usually	
associated	ENTITY
with	ENTITY
paralysis	ENTITY
.	

Familial	ENTITY
periodic	ENTITY
paralysis	ENTITY
syndromes	ENTITY
,	
especially	
hypokalemic	ENTITY
periodic	ENTITY
paralysis	ENTITY
,	
may	
occur	
at	
rest	ENTITY
and	
on	
awakening	ENTITY
.	

However	
,	
the	
episodes	ENTITY
usually	
last	
hours	
,	
may	
be	
associated	ENTITY
with	ENTITY
car-	
bohydrate	ENTITY
intake	ENTITY
,	
and	
are	
usually	
accompanied	
by	
hypokalemia	ENTITY
.	

There	
are	
also	
hyper-	
kalemic	ENTITY
and	
normokalemic	ENTITY
periodic	
paralysis	
syndromes	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Not	
applicable	
or	
known	
.	

Bibliography	ENTITY
Fukuda	ENTITY
K.	ENTITY
Sleep	ENTITY
paralysis	ENTITY
and	
sleep	ENTITY
-	
onset	ENTITY
REM	ENTITY
period	ENTITY
in	
normal	ENTITY
individuals	ENTITY
.	

In	
:	
Olgilvie	ENTITY
R	ENTITY
,	
Harsh	ENTITY
J	ENTITY
,	
eds	
.	

Sleep	ENTITY
onset	ENTITY
:	
normal	ENTITY
and	
abnormal	ENTITY
processes	ENTITY
.	

Washington	ENTITY
:	
American	ENTITY
Psychological	ENTITY
Association	ENTITY
,	
1994:161–81	
.	

Goode	ENTITY
G.	ENTITY
Sleep	ENTITY
paralysis	ENTITY
.	

Arch	ENTITY
Neurol	ENTITY
1962;6:228–34	ENTITY
.	

Hishikawa	ENTITY
Y.	ENTITY
Sleep	ENTITY
paralysis	ENTITY
.	

In	
:	
Guilleminault	ENTITY
C	ENTITY
,	
Dement	ENTITY
W	ENTITY
,	
Passouant	ENTITY
P	ENTITY
,	
eds	
.	

Narcolepsy	ENTITY
.	

New	ENTITY
York	ENTITY
:	
Spectrum	ENTITY
,	
1976:97–124	
.	

Ohayon	ENTITY
M	ENTITY
,	
Zulley	ENTITY
J	ENTITY
,	
Guilleminault	ENTITY
C	ENTITY
,	
Smirne	ENTITY
S.	ENTITY
Prevalence	ENTITY
and	
pathologic	ENTITY
associations	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

Neurology	ENTITY
1999;52:1194–200	
.	

Takeuchi	ENTITY
T	ENTITY
,	
Fukuda	ENTITY
K	ENTITY
,	
Sasaki	ENTITY
Y	ENTITY
,	
Inugami	ENTITY
M	ENTITY
,	
Murphy	
T.	ENTITY
Factors	ENTITY
related	
to	
the	
occurrence	ENTITY
of	
isolated	ENTITY
sleep	ENTITY
paralysis	ENTITY
elicited	
during	
a	
multi	ENTITY
-	
phasic	ENTITY
sleep	ENTITY
-	
wake	ENTITY
schedule	ENTITY
.	

Sleep	ENTITY
2002;25:89–96	
.	

Takeuchi	ENTITY
T	ENTITY
,	
Miyasita	ENTITY
A	ENTITY
,	
Sasaki	ENTITY
Y	ENTITY
,	
Inugami	ENTITY
M	ENTITY
,	
Fukuda	ENTITY
K.	ENTITY
Isolated	ENTITY
sleep	ENTITY
paralysis	ENTITY
elicited	
by	
sleep	ENTITY
interruption	ENTITY
.	

Sleep	ENTITY
1992;15:217–25	
.	

Nightmare	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
307.47	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

F51.5	
Alternate	ENTITY
Names	ENTITY
Nightmares	ENTITY
,	
REM	ENTITY
nightmares	ENTITY
,	
recurrent	ENTITY
nightmares	ENTITY
,	
dream	ENTITY
anxiety	ENTITY
disorder	ENTITY
,	
anxiety	ENTITY
dreams	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	
Repeated	ENTITY
occurrences	
of	
extended	ENTITY
,	
extremely	
dysphoric	ENTITY
,	
and	
well-	
remembered	
dreams	ENTITY
that	
usually	
involve	
threats	ENTITY
to	
survival	ENTITY
,	
security	ENTITY
,	
or	
physical	ENTITY
integrity	ENTITY
.	

B.	ENTITY
On	
awakening	ENTITY
from	
the	
dysphoric	ENTITY
dreams	ENTITY
,	
the	
person	ENTITY
rapidly	
becomes	
oriented	ENTITY
and	
alert	ENTITY
.	

C.	ENTITY
The	
dream	
experience	ENTITY
,	
or	
the	
sleep	ENTITY
disturbance	ENTITY
produced	
by	
awakening	ENTITY
from	
it	
,	
causes	
clinically	ENTITY
significant	ENTITY
distress	ENTITY
or	
impairment	ENTITY
in	
social	ENTITY
,	
occupational	ENTITY
,	
or	
other	
important	
areas	
of	
functioning	ENTITY
as	
indicated	
by	
the	
report	ENTITY
of	
at	
least	
one	
of	
the	
following	
:	
.	

Mood	ENTITY
disturbance	ENTITY
(	
e.g.	
,	
persistence	ENTITY
of	
nightmare	ENTITY
affect	ENTITY
,	
anxiety	ENTITY
,	
dysphoria	ENTITY
)	
.	
.	

Sleep	ENTITY
resistance	ENTITY
(	
e.g.	
,	
bedtime	ENTITY
anxiety	ENTITY
,	
fear	ENTITY
of	ENTITY
sleep	ENTITY
/	
subsequent	ENTITY
nightmares	ENTITY
)	
.	
.	

Cognitive	ENTITY
impairments	ENTITY
(	
e.g.	
,	
intrusive	ENTITY
nightmare	
imagery	ENTITY
,	
impaired	ENTITY
concentration	ENTITY
,	
or	
memory	ENTITY
)	
.	
.	

Negative	ENTITY
impact	ENTITY
on	
caregiver	ENTITY
or	
family	ENTITY
functioning	ENTITY
(	
e.g.	
,	
nighttime	ENTITY
disruption	ENTITY
)	
.	
.	

Behavioral	ENTITY
problems	
(	
e.g.	
,	
bedtime	ENTITY
avoidance	ENTITY
,	
fear	ENTITY
of	ENTITY
the	ENTITY
dark	ENTITY
)	
.	
.	

Daytime	ENTITY
sleepiness	ENTITY
.	
.	

Fatigue	ENTITY
or	
low	ENTITY
energy	ENTITY
.	
.	

Impaired	ENTITY
occupational	ENTITY
or	
educational	ENTITY
function	ENTITY
.	
.	

Impaired	ENTITY
interpersonal	ENTITY
/	
social	ENTITY
function	ENTITY
Notes	ENTITY
.	

Nightmare	ENTITY
disorder	ENTITY
in	
children	ENTITY
is	
most	
likely	
to	
occur	
in	
those	
exposed	ENTITY
to	ENTITY
severe	ENTITY
psychosocial	ENTITY
stressors	ENTITY
.	

Because	
childhood	ENTITY
nightmares	ENTITY
often	
resolve	
spontaneously	ENTITY
,	
the	
diagnosis	ENTITY
should	
be	
given	
only	
if	
there	
is	
persistent	ENTITY
distress	ENTITY
or	
impairment	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	
Essential	
Features	
Nightmare	
disorder	
is	
characterized	ENTITY
by	
recurrent	ENTITY
,	
highly	
dysphoric	ENTITY
dreams	ENTITY
,	
which	
are	
disturbing	
mental	ENTITY
experiences	ENTITY
that	
generally	
occur	
during	
REM	ENTITY
sleep	ENTITY
and	
that	
often	
result	
in	
awakening	ENTITY
.	

Given	
that	
these	
experiences	ENTITY
are	
most	
often	
associated	ENTITY
with	ENTITY
REM	ENTITY
sleep	ENTITY
,	
the	
episodes	ENTITY
have	
a	
greater	
tendency	
to	
occur	
during	
the	
second	
half	
of	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
when	
the	
REM	ENTITY
pressure	ENTITY
is	
most	
pronounced	
.	

Nightmares	ENTITY
involve	
an	
internally	
generated	
conscious	ENTITY
experience	ENTITY
or	
dream	ENTITY
sequence	ENTITY
that	
seems	
vivid	ENTITY
and	
real	ENTITY
.	

They	
have	
a	
tendency	
to	
become	
increasingly	
more	
disturbing	
as	
they	
unfold	
.	

Emotions	ENTITY
are	
characteristically	
negative	ENTITY
and	
most	
frequently	
involve	
anxiety	ENTITY
,	
fear	ENTITY
,	
or	
terror	ENTITY
but	
may	
also	
involve	
anger	ENTITY
,	
rage	ENTITY
,	
embarrassment	ENTITY
,	
and	
disgust	ENTITY
.	

Nightmare	ENTITY
content	ENTITY
most	
often	
focuses	
on	
imminent	ENTITY
physical	ENTITY
danger	ENTITY
to	
the	
individual	ENTITY
but	
may	
also	
involve	
other	
distressing	
themes	ENTITY
.	

Ability	ENTITY
to	
detail	
the	
nightmare	ENTITY
’s	
contents	ENTITY
upon	
awakening	ENTITY
is	
common	
in	
nightmare	ENTITY
disorder	ENTITY
.	

Multiple	ENTITY
nightmares	ENTITY
within	
a	
single	ENTITY
sleep	ENTITY
episode	ENTITY
may	
occur	
and	
may	
bear	
similar	
themes	ENTITY
.	

Because	
nightmares	ENTITY
typically	
arise	
during	
REM	ENTITY
sleep	ENTITY
,	
they	
may	
occur	
at	
any	
moment	ENTITY
that	
REM	ENTITY
pressure	ENTITY
is	
high	
.	

Nightmares	ENTITY
are	
very	
common	
in	
children	ENTITY
.	

They	
typically	
occur	
in	
the	
last	
third	
of	
the	
night	ENTITY
and	
result	ENTITY
in	
a	
complete	ENTITY
awakening	ENTITY
,	
after	
which	
the	
child	ENTITY
can	
often	
provide	
a	
detailed	
description	ENTITY
of	
the	
frightening	
scenario	ENTITY
.	

However	
,	
clear	
distinction	
from	
con-	
fusional	ENTITY
arousals	ENTITY
and	
sleep	ENTITY
terrors	ENTITY
in	
young	ENTITY
children	ENTITY
is	
often	
not	
possible	
.	

Associated	
Features	ENTITY
Postawakening	
anxiety	ENTITY
and	
difficulty	ENTITY
returning	
to	
sleep	ENTITY
may	
be	
present	
.	

Nightmares	ENTITY
are	
more	
common	
in	
those	
with	
higher	
levels	ENTITY
of	
anxiety	ENTITY
.	

Additionally	
,	
nightmares	ENTITY
are	
commonly	
seen	
in	
those	
who	
have	
been	
physically	ENTITY
or	
sexually	ENTITY
abused	ENTITY
and	
in	
those	
suf-	
fering	
from	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
.	

Nightmares	ENTITY
arising	
either	
immediately	
following	
a	
trauma	ENTITY
(	
acute	ENTITY
stress	ENTITY
disorder	ENTITY
[	
ASD	ENTITY
]	
)	
or	
one	
month	ENTITY
or	
more	
after	
a	
trauma	ENTITY
(	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
[	
PTSD	ENTITY
]	
)	
have	
been	
described	
during	
NREM	ENTITY
sleep	ENTITY
,	
especially	
N2	ENTITY
,	
as	
well	
as	
during	
REM	ENTITY
sleep	ENTITY
and	
at	
sleep	ENTITY
onset	ENTITY
.	

Posttraumatic	ENTITY
nightmares	ENTITY
may	
take	
the	
form	
of	
a	
realistic	
reliving	
of	
a	
traumatic	ENTITY
event	ENTITY
or	
may	
depict	
only	
some	
of	
its	
elements	ENTITY
or	
emotional	ENTITY
content	ENTITY
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
Occasional	ENTITY
nightmares	ENTITY
are	
very	
common	
in	
children	ENTITY
,	
occurring	
in	
60	
%	
to	
75	
%	
of	
chil-	
dren	ENTITY
,	
beginning	
as	
young	ENTITY
as	
2.5	
years	ENTITY
of	
age	ENTITY
.	

The	
occurrence	ENTITY
of	
occasional	ENTITY
nightmares	ENTITY
in	
children	ENTITY
does	
not	
constitute	
a	
nightmare	ENTITY
disorder	ENTITY
.	

However	
,	
frequent	ENTITY
nightmares	ENTITY
are	
uncommon	ENTITY
,	
occurring	
in	
1	
%	
to	
5	
%	
of	
preadolescent	ENTITY
children	ENTITY
.	

It	
is	
estimated	
that	
10	
%	
to	
50	
%	
of	
children	ENTITY
aged	ENTITY
three	
to	
five	
years	ENTITY
have	
at	
least	
occasional	ENTITY
nightmares	ENTITY
severe	ENTITY
enough	
to	
disturb	ENTITY
their	
parents	ENTITY
.	

Nightmares	ENTITY
appear	
to	
be	
a	
trait	ENTITY
-	
like	
characteristic	
that	
persists	ENTITY
over	
time	
during	
childhood	ENTITY
.	

The	
best	
predictor	ENTITY
of	
recurrent	ENTITY
nightmares	ENTITY
at	
an	
older	ENTITY
age	ENTITY
is	
recurrent	ENTITY
nightmares	ENTITY
in	
childhood	ENTITY
.	

Approximately	
2	
%	
to	
8	
%	
of	
the	
general	ENTITY
population	ENTITY
has	
a	
current	
problem	ENTITY
with	
nightmares	ENTITY
,	
and	
this	
frequency	ENTITY
is	
higher	ENTITY
in	
clini-	
cal	
populations	ENTITY
.	

Trauma	ENTITY
-	
related	ENTITY
nightmares	ENTITY
are	
the	
most	
consistent	
problem	ENTITY
reported	
by	
patients	ENTITY
with	
PTSD	ENTITY
.	

Nightmares	ENTITY
beginning	
within	
three	
months	ENTITY
of	
a	
trauma	ENTITY
are	
present	
in	
up	
to	
80	
%	
of	
patients	ENTITY
with	
PTSD	ENTITY
.	

Although	
approximately	
50	
%	
of	
PTSD	ENTITY
cases	ENTITY
resolve	
within	
three	
months	ENTITY
,	
posttraumatic	ENTITY
nightmares	ENTITY
may	
persist	
throughout	
life	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Frequent	ENTITY
nightmares	ENTITY
are	
associated	ENTITY
with	ENTITY
enduring	
personality	ENTITY
characteristics	ENTITY
and	
psy-	
chopathologies	ENTITY
;	
they	
are	
inversely	
correlated	ENTITY
with	
measures	ENTITY
of	
well	ENTITY
-	ENTITY
being	ENTITY
.	

Associations	ENTITY
with	
psychopathology	ENTITY
have	
been	
identified	ENTITY
for	
adults	ENTITY
and	
adolescents	ENTITY
,	
but	
research	ENTITY
on	
children	ENTITY
is	
largely	
absent	
other	
than	
for	
assessments	ENTITY
of	
PTSD	ENTITY
.	

Measures	ENTITY
of	
nightmare	ENTITY
distress	ENTITY
are	
much	
more	
robustly	
associated	ENTITY
with	ENTITY
psychopathology	ENTITY
than	
are	
measures	ENTITY
of	
nightmare	ENTITY
frequency	ENTITY
.	

The	
clinical	ENTITY
use	
of	
pharmacologic	ENTITY
agents	ENTITY
affecting	ENTITY
the	
neurotransmitters	ENTITY
norepinephrine	ENTITY
,	
serotonin	ENTITY
,	
and	
dopamine	ENTITY
is	
associated	ENTITY
with	ENTITY
the	
complaint	ENTITY
of	
night-	
mares	ENTITY
.	

A	
majority	
of	
these	
agents	ENTITY
are	
antidepressants	ENTITY
,	
antihypertensives	ENTITY
,	
and	
dopa-	
mine	ENTITY
-	
receptor	ENTITY
agonists	ENTITY
.	

Agents	ENTITY
affecting	ENTITY
the	
neurotransmitters	ENTITY
gamma	
-	
aminobutyric	ENTITY
acid	ENTITY
(	
GABA	ENTITY
)	
,	
acetylcholine	ENTITY
,	
and	
histamine	ENTITY
,	
and	
the	
withdrawal	ENTITY
of	
REM	ENTITY
sleep	ENTITY
sup-	ENTITY
pressive	ENTITY
agents	ENTITY
also	
can	
be	
associated	ENTITY
with	ENTITY
the	
complaint	ENTITY
of	
nightmares	ENTITY
.	

Of	
note	
,	
nightmares	ENTITY
are	
a	
common	
reaction	ENTITY
in	
varenicline	ENTITY
,	
which	
is	
an	
agent	ENTITY
that	
blocks	ENTITY
α-4	ENTITY
-	
β-2	ENTITY
nicotinic	ENTITY
acetylcholine	ENTITY
receptors	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
Twin	ENTITY
-	
based	ENTITY
studies	ENTITY
have	
identified	ENTITY
persistent	ENTITY
genetic	ENTITY
predisposition	ENTITY
to	
nightmares	ENTITY
in	
childhood	ENTITY
(	
reported	
retrospectively	ENTITY
by	
adults	ENTITY
)	
and	
adulthood	ENTITY
as	
well	
as	
genetic	ENTITY
influ-	
ences	ENTITY
on	
the	
co	ENTITY
-	
occurrence	ENTITY
of	
nightmares	ENTITY
and	
some	
other	
parasomnias	ENTITY
,	
such	
as	
sleep	ENTITY
talking	ENTITY
(	
somniloquy	ENTITY
)	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Nightmares	ENTITY
usually	
start	
between	
ages	ENTITY
three	
years	ENTITY
and	
six	
years	ENTITY
.	

The	
proportion	ENTITY
of	
children	ENTITY
reporting	
nightmares	ENTITY
reaches	
a	
peak	
between	
six	
and	
ten	
years	ENTITY
of	
age	ENTITY
and	
decreases	ENTITY
thereafter	
.	

A	
subgroup	ENTITY
of	
children	ENTITY
continue	
to	
have	
nightmares	ENTITY
into	
Parasomnias	ENTITY
Parasomnias	ENTITY
adolescence	ENTITY
or	
adulthood	ENTITY
and	
may	
become	
lifelong	ENTITY
nightmare	ENTITY
sufferers	ENTITY
.	

Nightmares	ENTITY
generally	
diminish	ENTITY
in	
frequency	ENTITY
and	
intensity	ENTITY
over	
the	
course	ENTITY
of	
decades	ENTITY
,	
but	
some	
patients	ENTITY
still	
describe	
frequent	ENTITY
episodes	ENTITY
at	
the	
age	ENTITY
of	
60	
or	
70	
years	ENTITY
.	

Nightmare	ENTITY
dis-	
order	
can	
lead	
to	
sleep	ENTITY
avoidance	ENTITY
and	
deprivation	ENTITY
,	
and	
thereby	
to	
more	
intense	ENTITY
night-	
mares	ENTITY
,	
which	
can	
produce	
insomnia	ENTITY
.	

ASD	ENTITY
and	
PTSD	ENTITY
associated	
nightmares	ENTITY
can	
develop	
at	
any	
age	ENTITY
after	
physical	ENTITY
or	
emo-	
tional	ENTITY
trauma	ENTITY
.	

Individuals	ENTITY
with	
PTSD	ENTITY
are	
at	
risk	ENTITY
for	
developing	ENTITY
mood	ENTITY
disorders	ENTITY
and	
depression	ENTITY
,	
social	ENTITY
and	
employment	ENTITY
consequences	ENTITY
,	
self	ENTITY
-	
destructive	ENTITY
and	
impulsive	ENTITY
behavior	ENTITY
,	
and	
substance	ENTITY
abuse	ENTITY
;	
it	
is	
not	
known	
to	
what	
extent	
the	
nightmares	ENTITY
symp-	
tomatic	ENTITY
of	
PTSD	ENTITY
contribute	
to	
these	
complications	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
As	
stated	
above	
,	
nightmares	ENTITY
are	
very	
common	
in	
children	ENTITY
but	
the	
occurrence	ENTITY
of	
occa-	
sional	ENTITY
nightmares	ENTITY
does	
not	
constitute	
nightmare	ENTITY
disorder	ENTITY
.	

Population	ENTITY
studies	ENTITY
have	
revealed	
that	
the	
prevalence	ENTITY
and	
frequency	ENTITY
of	
nightmares	ENTITY
increases	ENTITY
through	
childhood	ENTITY
into	
adolescence	ENTITY
.	

For	
example	
,	
preschoolers	ENTITY
seldom	
report	ENTITY
“	
bad	ENTITY
dreams	ENTITY
.	
”	

Furthermore	
,	
in	
regard	
to	
the	
prevalence	ENTITY
of	
nightmares	ENTITY
,	
children	ENTITY
appear	
to	
exhibit	
a	
sex	ENTITY
divergence	ENTITY
over	
time	ENTITY
,	
with	
girls	ENTITY
demonstrating	
higher	
prevalence	ENTITY
by	
late	ENTITY
adolescence	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Not	
applicable	
or	
known	
.	

Objective	
Findings	ENTITY
PSG	ENTITY
recordings	ENTITY
during	
actual	ENTITY
nightmares	ENTITY
are	
few	
in	
number	
and	
,	
in	
some	
instances	ENTITY
,	
have	
shown	
abrupt	
awakenings	ENTITY
from	
REM	ENTITY
sleep	ENTITY
preceded	
by	
accelerated	ENTITY
heart	ENTITY
and	
respiratory	ENTITY
rates	ENTITY
.	

Highly	
disturbing	
dream	
content	ENTITY
frequently	
contrasts	
strikingly	
with	
relatively	
minor	
autonomic	ENTITY
changes	ENTITY
.	

Distinctive	ENTITY
anomalies	ENTITY
in	
nightly	ENTITY
sleep	ENTITY
architec-	
ture	ENTITY
have	
not	
been	
demonstrated	
;	
brainstem	ENTITY
and	
auditory	ENTITY
-	
evoked	ENTITY
potentials	ENTITY
appear	
normal	
.	

Recordings	ENTITY
during	
posttraumatic	ENTITY
nightmares	ENTITY
are	
few	
but	
have	
been	
recorded	
from	
both	
REM	ENTITY
and	
NREM	ENTITY
sleep	ENTITY
.	

PSG	ENTITY
recordings	ENTITY
of	
sleep	ENTITY
in	
patients	ENTITY
with	
PTSD	ENTITY
have	
provided	
widely	
variable	ENTITY
results	ENTITY
.	

PSG	ENTITY
evaluation	ENTITY
is	
not	
routinely	
performed	
but	
may	
be	
indicated	
in	
some	
circumstances	
to	
exclude	
other	
parasomnias	ENTITY
such	
as	
disorders	ENTITY
of	
arousal	ENTITY
and	
sleep	ENTITY
-	
associated	ENTITY
sei-	ENTITY
zures	ENTITY
.	

A	
PSG	ENTITY
is	
particularly	
appropriate	
if	
patients	ENTITY
report	ENTITY
nightmares	ENTITY
in	
conjunction	ENTITY
with	
sleep	ENTITY
behaviors	ENTITY
that	
are	
repetitive	ENTITY
or	
stereotyped	ENTITY
or	
are	
injurious	ENTITY
to	
self	
or	
others	
.	

Differential	ENTITY
Diagnosis	ENTITY
Nightmare	ENTITY
disorder	ENTITY
must	
be	
distinguished	
from	
dream	ENTITY
disturbances	ENTITY
associated	ENTITY
with	ENTITY
certain	
other	
neurological	ENTITY
and	
sleep	ENTITY
disorders	ENTITY
.	

Rare	ENTITY
cases	ENTITY
of	
seizures	ENTITY
presenting	
only	
as	
“	
nightmares	ENTITY
”	
have	
been	
reported	
and	
should	
be	
considered	
in	
the	
differential	
diagno-	
sis	ENTITY
,	
particularly	
in	
those	
patients	ENTITY
who	
present	
with	
a	
history	ENTITY
of	
central	ENTITY
nervous	ENTITY
system	ENTITY
disease	ENTITY
.	

PSG	ENTITY
or	
continuous	ENTITY
video	ENTITY
EEG	ENTITY
may	
be	
necessary	
to	
identify	
nightmares	ENTITY
asso-	
ciated	ENTITY
with	
nocturnal	ENTITY
seizures	ENTITY
.	

Nightmares	ENTITY
differ	
from	
sleep	ENTITY
terrors	ENTITY
in	
having	
detailed	
recollection	ENTITY
of	
dreaming	ENTITY
in	
contrast	
to	
fragments	ENTITY
of	
dreams	ENTITY
or	
no	
dream	
recall	ENTITY
,	
pre-	
senting	ENTITY
no	
or	
minimal	
overt	ENTITY
movement	ENTITY
or	
autonomic	ENTITY
activity	ENTITY
,	
occurring	
late	
in	
the	
night	ENTITY
,	
being	
followed	
by	
rapid	
awakening	ENTITY
and	
difficulty	ENTITY
returning	
to	
sleep	ENTITY
,	
and	
most	
often	
arising	
from	
REM	ENTITY
sleep	ENTITY
.	

RBD	ENTITY
occurs	
more	
often	
in	
late	ENTITY
middle	ENTITY
-	
aged	ENTITY
men	ENTITY
and	
is	
more	
often	
associated	ENTITY
with	ENTITY
violent	ENTITY
explosive	ENTITY
movements	ENTITY
and	
a	
history	ENTITY
of	
nocturnal	ENTITY
injuries	ENTITY
.	

The	
dream	ENTITY
disturbance	ENTITY
of	
RBD	ENTITY
usually	
involves	
being	
threatened	ENTITY
or	
attacked	
by	
unfamiliar	ENTITY
people	ENTITY
or	
animals	ENTITY
and	
is	
controlled	ENTITY
in	
tandem	
with	
the	
sleep	ENTITY
behavioral	ENTITY
disturbance	ENTITY
by	
appropriate	
medication	ENTITY
.	

Nightmares	ENTITY
occur	
at	
any	
age	ENTITY
and	
are	
not	
typ-	
ically	ENTITY
associated	ENTITY
with	ENTITY
movements	ENTITY
,	
overt	ENTITY
behaviors	ENTITY
,	
or	
injuries	ENTITY
.	

Anxiety	ENTITY
may	
accom-	
pany	ENTITY
episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
occurring	
either	
at	
sleep	ENTITY
onset	ENTITY
(	
hypnagogic	ENTITY
)	
or	
offset	ENTITY
(	
hypnopompic	ENTITY
)	
,	
when	
the	
individual	ENTITY
feels	
conscious	ENTITY
but	
unable	
to	
move	
,	
speak	ENTITY
,	
and	
,	
at	
times	
,	
breathe	ENTITY
properly	
.	

Anxiety	ENTITY
may	
be	
further	
worsened	ENTITY
if	
disturbing	
hypnago-	
gic	ENTITY
hallucinations	ENTITY
or	
dream	ENTITY
sequences	ENTITY
accompany	
the	
paralysis	ENTITY
.	

Nightmares	ENTITY
,	
although	
they	
may	
involve	
some	
degree	ENTITY
of	
movement	ENTITY
inhibition	ENTITY
or	
some	
degree	ENTITY
of	
apparent	ENTITY
wakefulness	ENTITY
,	
are	
usually	
not	
accompanied	
by	
feelings	ENTITY
of	
either	
total	ENTITY
paralysis	ENTITY
or	
com-	
plete	ENTITY
waking	
consciousness	
.	

Patients	ENTITY
with	
narcolepsy	ENTITY
often	
report	ENTITY
nightmares	ENTITY
;	
these	
may	
occur	
at	
sleep	ENTITY
onset	ENTITY
.	

However	
,	
narcolepsy	ENTITY
and	
nightmare	ENTITY
disorder	ENTITY
are	
clearly	
distinguishable	
by	
other	
clinical	ENTITY
symptoms	ENTITY
.	

Nocturnal	ENTITY
panic	ENTITY
attacks	ENTITY
occur	
either	
during	
or	
immediately	
after	
nocturnal	ENTITY
awakenings	ENTITY
from	
NREM	ENTITY
sleep	ENTITY
,	
usually	
in	
the	
first	
four	
hours	ENTITY
of	
the	
sleep	ENTITY
episode	ENTITY
.	

Although	
frequency	ENTITY
of	
panic	ENTITY
attacks	ENTITY
is	
correlated	ENTITY
with	
frequency	ENTITY
of	
night-	
mares	ENTITY
and	
many	
patients	ENTITY
report	ENTITY
that	
dysphoric	ENTITY
dreams	ENTITY
precede	
their	
attacks	ENTITY
,	
there	
may	
be	
no	
dream	
recall	ENTITY
reported	
on	
awakening	ENTITY
with	
a	
panic	ENTITY
attack	ENTITY
.	

Sleep	ENTITY
related	
dissociative	ENTITY
disorders	ENTITY
comprise	
a	
sleep	ENTITY
related	
variant	ENTITY
of	
the	
dissociative	ENTITY
disorders	ENTITY
as	
defined	
by	
the	
Diagnostic	ENTITY
and	ENTITY
Statistical	ENTITY
Manual	ENTITY
of	ENTITY
Mental	ENTITY
Disorders	ENTITY
,	
Fifth	
Edition	
(	
DSM	ENTITY
-	
V	ENTITY
)	
.	

These	
include	
dissociative	ENTITY
identity	ENTITY
disorder	ENTITY
(	
formerly	
called	
multi-	
ple	ENTITY
personality	ENTITY
disorder	ENTITY
)	
and	
dissociative	ENTITY
fugue	ENTITY
,	
in	
which	
individuals	ENTITY
meeting	
waking	ENTITY
criteria	ENTITY
for	
these	
diagnoses	ENTITY
may	
at	
times	
experience	ENTITY
the	
recall	ENTITY
of	
actual	ENTITY
physical	ENTITY
or	
emotional	ENTITY
trauma	ENTITY
as	
a	
“	
dream	ENTITY
”	
during	
periods	ENTITY
of	
EEG	ENTITY
-	
documented	ENTITY
nocturnal	ENTITY
waking	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Nightmares	ENTITY
that	
occur	
intermittently	
during	
the	
course	ENTITY
of	
ASD	ENTITY
or	
PTSD	ENTITY
are	
an	
expected	
symptom	ENTITY
of	
those	
mental	ENTITY
disorders	ENTITY
and	
do	
not	
always	
require	
independent	ENTITY
coding	ENTITY
as	
nightmare	ENTITY
disorder	ENTITY
.	

However	
,	
as	
is	
often	
the	
case	ENTITY
,	
when	
the	
frequency	ENTITY
and/or	
severity	ENTITY
of	
posttraumatic	ENTITY
nightmares	ENTITY
is	
such	
that	
they	
require	
independent	
clinical	ENTITY
attention	ENTITY
,	
then	
a	
diagnosis	ENTITY
of	
nightmare	ENTITY
disorder	ENTITY
should	
be	
applied	
.	

In	
some	
cases	ENTITY
,	
other	
symp-	
toms	ENTITY
of	
PTSD	ENTITY
may	
have	
largely	
resolved	ENTITY
while	
the	
nightmares	ENTITY
persist	
.	

Nightmare	ENTITY
disorder	ENTITY
should	
be	
coded	
in	
these	
cases	ENTITY
as	
well	
.	

It	
is	
clinically	ENTITY
important	
to	
establish	
whether	
nightmares	ENTITY
are	
associated	ENTITY
with	ENTITY
PTSD	ENTITY
or	
ASD	ENTITY
because	
the	
evaluation	ENTITY
,	
course	ENTITY
,	
complications	ENTITY
,	
and	
treatment	ENTITY
differ	
significantly	
for	
these	
groups	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

Basic	
pathophysiologic	ENTITY
studies	
are	
still	
needed	
,	
especially	
studies	ENTITY
contrasting	
“	
idio-	
pathic	ENTITY
”	
nightmare	
disorder	ENTITY
and	
nightmares	ENTITY
associated	ENTITY
with	ENTITY
PTSD	ENTITY
.	

In	
particular	
,	
deter-	
mining	ENTITY
whether	
posttraumatic	ENTITY
nightmares	ENTITY
arise	
from	
sleep	ENTITY
or	
primarily	
from	
wakeful-	
ness	ENTITY
would	
be	
an	
important	
distinguishing	
feature	
particularly	
when	
determining	
effec-	
tive	ENTITY
clinical	
interventions	
.	

The	
PSG	ENTITY
correlates	ENTITY
of	
nightmare	ENTITY
disorder	ENTITY
and	
posttraumatic	ENTITY
nightmares	ENTITY
as	
well	
as	
the	
variables	ENTITY
affecting	ENTITY
dream	ENTITY
mentation	ENTITY
and	
recall	ENTITY
require	
further	
definition	ENTITY
and	
delineation	ENTITY
.	

The	
distinction	
between	
nightmares	ENTITY
and	
sleep	ENTITY
terrors	ENTITY
is	
difficult	
when	
assessed	ENTITY
only	
by	
questionnaires	ENTITY
.	

It	
still	
remains	
unclear	
to	
what	
degree	ENTITY
and	
level	ENTITY
of	
complexity	ENTITY
sleep	ENTITY
mentation	ENTITY
is	
associated	ENTITY
with	ENTITY
sleep	ENTITY
terrors	ENTITY
.	

The	
topic	
of	
NREM	ENTITY
sleep	ENTITY
dream	ENTITY
distur-	
bances	ENTITY
(	
other	
than	
disturbed	
mentation	ENTITY
that	
may	
occur	
with	
sleep	ENTITY
terrors	ENTITY
)	
also	
needs	
formal	
investigation	ENTITY
,	
including	
whether	
or	
not	
the	
term	
NREM	ENTITY
sleep	
nightmare	ENTITY
should	
be	
utilized	
.	

The	
optimal	ENTITY
methods	ENTITY
for	
assessing	
nightmare	ENTITY
frequency	ENTITY
and	
nightmare	ENTITY
distress	ENTITY
are	
still	
unclear	ENTITY
.	

Standardized	ENTITY
scales	ENTITY
assessing	
nightmare	ENTITY
distress	ENTITY
should	
be	
developed	
and	
utilized	
.	

Retrospective	ENTITY
questionnaire	ENTITY
-	
based	ENTITY
evaluations	ENTITY
of	
nightmares	ENTITY
are	
problematic	
inasmuch	
as	
they	
underestimate	
nightmare	ENTITY
frequencies	ENTITY
relative	
to	
home	ENTITY
logs	ENTITY
,	
whereas	
home	ENTITY
logs	ENTITY
may	
selectively	
increase	ENTITY
recall	ENTITY
of	
nightmares	ENTITY
.	

Bibliography	ENTITY
Germain	ENTITY
A	ENTITY
,	
Nielsen	
T.	
Sleep	
pathophysiology	ENTITY
in	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
and	
idiopathic	ENTITY
nightmare	ENTITY
sufferers	ENTITY
.	

Biol	ENTITY
Psychiatry	ENTITY
2003;54:1092–8	ENTITY
.	

Hobson	
J.	
REM	ENTITY
sleep	ENTITY
and	
dreaming	ENTITY
:	
towards	
a	
theory	ENTITY
of	
protoconsciousness	ENTITY
.	

Nat	ENTITY
Rev	ENTITY
Neurosci	ENTITY
2009;10:803–13	ENTITY
.	

Hublin	ENTITY
C	ENTITY
,	
Kaprio	ENTITY
J	ENTITY
,	
Partinen	ENTITY
M	ENTITY
,	
Koskenvuo	ENTITY
M.	ENTITY
Nightmares	ENTITY
:	
familial	ENTITY
aggregation	ENTITY
and	
association	ENTITY
with	
psychiatric	ENTITY
disorders	ENTITY
in	
a	
nationwide	
twin	ENTITY
cohort	ENTITY
.	

Am	
J	
Med	
Genet	
1999;88:329–36	
.	

Lavie	ENTITY
P.	ENTITY
Sleep	ENTITY
disturbances	
in	
the	
wake	
of	
traumatic	ENTITY
events	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2001;345:1825–32	ENTITY
.	

Levin	ENTITY
R	ENTITY
,	
Fireman	
G.	
Nightmare	
prevalence	ENTITY
,	
nightmare	ENTITY
distress	ENTITY
,	
and	
self	ENTITY
-	
reported	ENTITY
psychological	ENTITY
disturbance	ENTITY
.	

Sleep	ENTITY
2002;25:205–12	
.	

Muzur	ENTITY
A	ENTITY
,	
Pace	ENTITY
-	
Schott	ENTITY
EF	
,	
Hobson	
J.	
The	
prefrontal	ENTITY
cortex	ENTITY
in	
sleep	ENTITY
.	

Trends	ENTITY
Cogn	ENTITY
Sci	ENTITY
2002;6:475–81	ENTITY
.	

Nielsen	ENTITY
T	ENTITY
,	
Zadra	
A.	
Idiopathic	ENTITY
nightmares	ENTITY
and	
dream	ENTITY
disturbances	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
-	
wake	ENTITY
transitions	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

Philadelphia	ENTITY
:	
Elsevier	
Saunders	
,	
2010:1106–15	
.	

Pagel	ENTITY
J	ENTITY
,	ENTITY
Helfter	ENTITY
P.	ENTITY
Drug	ENTITY
induced	ENTITY
nightmares	ENTITY
—	
an	
etiology	ENTITY
based	
review	ENTITY
.	

Hum	
Psychopharmacol	
2003;18:59–67	
.	

Zadra	ENTITY
A	ENTITY
,	
Donderi	
D.	
Nightmares	
and	
bad	
dreams	ENTITY
:	
their	
prevalence	ENTITY
and	
relationship	ENTITY
to	
well	
-	
being	
.	

J	
Abnorm	
Psychol	
2000;109:273–81	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Other	
Parasomnias	ENTITY
Exploding	ENTITY
Head	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.49	
Alternate	ENTITY
Names	ENTITY
Sensory	ENTITY
sleep	ENTITY
starts	ENTITY
,	
sensory	ENTITY
sleep	ENTITY
shocks	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.59	ENTITY
A.	ENTITY
There	
is	
a	
complaint	ENTITY
of	
a	
sudden	ENTITY
loud	ENTITY
noise	ENTITY
or	
sense	ENTITY
of	ENTITY
explosion	ENTITY
in	
the	
head	ENTITY
either	
at	
the	
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
or	
upon	
waking	ENTITY
during	
the	
night	ENTITY
.	

B.	ENTITY
The	
individual	ENTITY
experiences	ENTITY
abrupt	ENTITY
arousal	ENTITY
following	
the	
event	ENTITY
,	
often	
with	
a	
sense	ENTITY
of	ENTITY
fright	ENTITY
.	

C.	

The	
experience	ENTITY
is	
not	
associated	ENTITY
with	ENTITY
significant	
complaints	ENTITY
of	
pain	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Exploding	
head	ENTITY
syndrome	ENTITY
is	
characterized	
by	
a	
sudden	ENTITY
,	
loud	ENTITY
imagined	
noise	ENTITY
or	
sense	
of	
a	
violent	ENTITY
explosion	ENTITY
in	
the	
head	ENTITY
occurring	
as	
the	
patient	ENTITY
is	
falling	ENTITY
asleep	ENTITY
or	
waking	ENTITY
during	
the	
night	ENTITY
.	

The	
event	ENTITY
is	
variously	
described	
as	
a	
painless	ENTITY
loud	ENTITY
bang	ENTITY
,	
an	
explosion	ENTITY
,	
a	
clash	
of	
cymbals	ENTITY
,	
or	
a	
bomb	ENTITY
exploding	ENTITY
,	
but	
occasionally	
may	
be	
a	
less	
alarming	
sound	ENTITY
.	

It	
is	
usually	
associated	ENTITY
with	ENTITY
a	
sense	ENTITY
of	ENTITY
fright	ENTITY
,	
and	
many	
patients	ENTITY
believe	
they	
are	
having	
a	
stroke	ENTITY
.	

In	
a	
minority	ENTITY
of	
cases	ENTITY
a	
flash	ENTITY
of	ENTITY
light	ENTITY
or	
myoclonic	ENTITY
jerk	ENTITY
may	
accompany	
the	
event	ENTITY
.	

The	
abnormal	ENTITY
sensation	ENTITY
lasts	
a	
few	
seconds	
and	
may	
recur	
during	
further	
attempts	ENTITY
at	ENTITY
sleeping	ENTITY
.	

The	
number	
of	
attacks	ENTITY
varies	
—	
from	
many	
on	
a	
single	
night	ENTITY
to	
infrequent	ENTITY
—	
with	
some	
patients	ENTITY
reporting	
clustering	ENTITY
of	
attacks	ENTITY
over	
several	
nights	ENTITY
fol-	
lowed	ENTITY
by	
a	
gap	ENTITY
of	
weeks	ENTITY
to	
months	ENTITY
.	

A	
high	
level	ENTITY
of	
clinical	ENTITY
distress	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
recurrent	ENTITY
attacks	ENTITY
,	
with	
concern	
about	
their	
underlying	
cause	ENTITY
.	

Associated	
Features	ENTITY
A	
flash	ENTITY
of	ENTITY
light	ENTITY
may	
accompany	
the	
sound	ENTITY
,	
and	
a	
myoclonic	ENTITY
jerk	ENTITY
may	
sometimes	
occur	
.	

Although	
the	
event	ENTITY
is	
typically	
painless	ENTITY
,	
a	
simultaneous	ENTITY
stab	ENTITY
of	
pain	ENTITY
in	
the	
head	ENTITY
has	
occasionally	
been	
reported	
.	

An	
insomnia	ENTITY
complaint	ENTITY
may	
develop	
as	
a	
result	
of	
the	
recurring	
arousals	ENTITY
and	
anxiety	ENTITY
regarding	
the	
events	ENTITY
.	

Clinical	ENTITY
or	
Pathophysiological	ENTITY
Subtypes	ENTITY
None	
known	
.	

Demographics	ENTITY
The	
prevalence	ENTITY
is	
unknown	
.	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
is	
reported	
to	
be	
more	
common	
in	
women	ENTITY
than	
in	
men	ENTITY
.	

The	
median	
age	ENTITY
of	
onset	
is	
58	
years	ENTITY
,	
but	
onset	
at	
all	
ages	ENTITY
has	
been	
reported	
,	
including	
the	
first	
and	
eighth	
decades	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Most	
patients	ENTITY
do	
not	
detect	ENTITY
precipitating	
factors	ENTITY
,	
but	
some	
report	ENTITY
increased	ENTITY
numbers	
of	
attacks	ENTITY
when	
under	
personal	ENTITY
stress	ENTITY
or	
overtired	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
Occasional	ENTITY
cases	ENTITY
of	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
occurring	
in	
the	
same	
family	ENTITY
have	
been	
reported	
,	
although	
it	
is	
not	
clear	
whether	
this	
represents	
a	
true	
familial	ENTITY
pattern	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complication	ENTITY
The	
course	ENTITY
is	
benign	ENTITY
with	
no	
reported	
neurologic	ENTITY
sequelae	ENTITY
.	

Frequent	ENTITY
events	ENTITY
on	
a	
single	
night	ENTITY
can	
result	
in	
insomnia	ENTITY
.	

Clinical	ENTITY
levels	ENTITY
of	
anxiety	ENTITY
may	
result	
from	
patient	ENTITY
concern	
about	
a	
serious	
medical	ENTITY
basis	ENTITY
for	
the	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
.	

The	
condition	ENTITY
may	
also	
exacerbate	ENTITY
a	
comorbid	ENTITY
migraine	ENTITY
disorder	ENTITY
.	

In	
many	
patients	ENTITY
,	
the	
symptoms	ENTITY
appear	
to	
remit	ENTITY
spontaneously	ENTITY
over	
some	
years	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
or	
applicable	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
events	ENTITY
occur	
most	
frequently	
during	
a	
period	ENTITY
of	
drowsiness	ENTITY
preceding	
sleep	ENTITY
.	

Some	
events	ENTITY
are	
reported	
to	
occur	
upon	
waking	ENTITY
during	
the	
night	ENTITY
,	
but	
may	
actually	
be	
occur-	
ring	
during	
reinitiating	ENTITY
sleep	ENTITY
.	

The	
condition	ENTITY
appears	
to	
be	
a	
sensory	ENTITY
variant	ENTITY
of	
the	
better	ENTITY
-	
known	ENTITY
transient	ENTITY
motor	ENTITY
phenomenon	ENTITY
of	
sleep	ENTITY
starts	ENTITY
or	
hypnic	ENTITY
jerks	ENTITY
occurring	
at	
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
.	

The	
neurophysiologic	ENTITY
mechanisms	ENTITY
underlying	
these	
hypnago-	
gic	ENTITY
phenomena	ENTITY
are	
unknown	
.	

Objective	
Findings	ENTITY
VPSG	ENTITY
in	
a	
small	
sample	ENTITY
of	
patients	ENTITY
found	
that	
events	ENTITY
arose	
from	
early	ENTITY
drowsiness	
with	
predominant	ENTITY
alpha	ENTITY
rhythm	ENTITY
interspersed	
with	
some	
theta	ENTITY
activity	ENTITY
.	

In	
one	
patient	ENTITY
,	
events	ENTITY
arose	
during	
transition	ENTITY
from	
N1	ENTITY
sleep	ENTITY
,	
in	
another	
patient	ENTITY
from	
N1	ENTITY
sleep	ENTITY
to	
wakeful-	
ness	ENTITY
,	
and	
in	
a	
third	
patient	ENTITY
from	
N2	ENTITY
sleep	ENTITY
to	
wakefulness	ENTITY
.	

Events	ENTITY
occurring	
in	
the	
N1/	ENTITY
Parasomnias	ENTITY
Parasomnias	ENTITY
N2	ENTITY
to	
wake	
transition	ENTITY
have	
been	
recorded	
during	
both	
nocturnal	ENTITY
vPSG	ENTITY
and	
MSLTs	ENTITY
.	

Slow	ENTITY
eye	ENTITY
movements	ENTITY
were	
present	
in	
the	
only	
tracing	
reproduced	
in	
the	
report	ENTITY
of	
a	
patient	ENTITY
with	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
emerging	
during	
wake	
to	
N1	ENTITY
sleep	ENTITY
transition	ENTITY
.	

Arousals	ENTITY
occurred	
immediately	
following	
the	
episodes	ENTITY
.	

No	
epileptiform	ENTITY
discharges	ENTITY
accompany	
the	
event	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
should	
be	
distinguished	
from	
sudden	ENTITY
onset	ENTITY
-	
headache	ENTITY
syn-	ENTITY
dromes	ENTITY
.	

“	
Idiopathic	ENTITY
stabbing	ENTITY
headache	ENTITY
”	
(	
ice	ENTITY
-	
pick	ENTITY
headache	ENTITY
)	
is	
a	
benign	ENTITY
syndrome	ENTITY
of	
brief	ENTITY
stabs	ENTITY
of	
pain	ENTITY
on	
the	
side	
of	
the	
head	ENTITY
.	

Although	
they	
can	
occur	
at	
sleep	ENTITY
onset	ENTITY
,	
they	
are	
more	
common	
during	
wakefulness	ENTITY
.	

“	
Thunderclap	ENTITY
headache	ENTITY
”	
is	
a	
very	
severe	ENTITY
sudden	ENTITY
onset	ENTITY
headache	ENTITY
characteristic	
of	
subarachnoid	ENTITY
hemorrhage	ENTITY
but	
also	
resulting	
from	
other	
causes	
and	
occasionally	
occurring	
as	
a	
benign	ENTITY
symptom	ENTITY
.	

It	
does	
not	
usually	
occur	
at	
sleep	ENTITY
onset	ENTITY
.	

“	
Hypnic	ENTITY
headache	ENTITY
syndrome	ENTITY
”	
affects	
older	ENTITY
people	ENTITY
who	
regularly	
awaken	
4	
-	
6	
hours	ENTITY
after	
sleep	ENTITY
onset	ENTITY
,	
with	
a	
diffuse	ENTITY
headache	ENTITY
that	
lasts	
30	
-	
60	
minutes	ENTITY
and	
is	
often	
associated	ENTITY
with	ENTITY
nausea	ENTITY
but	
no	
autonomic	ENTITY
symptoms	ENTITY
.	

Other	
conditions	ENTITY
to	
be	
con-	ENTITY
sidered	ENTITY
include	
sleep	ENTITY
related	ENTITY
migraines	ENTITY
,	
cluster	ENTITY
headaches	ENTITY
,	
and	
nocturnal	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
.	

In	
contrast	
to	
headache	ENTITY
syndromes	ENTITY
,	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
is	
usually	
painless	ENTITY
.	

Simple	ENTITY
partial	ENTITY
seizures	ENTITY
can	
present	
with	
sensory	ENTITY
phenomena	ENTITY
but	
do	
not	
usually	
occur	
predominantly	
at	
sleep	ENTITY
onset	ENTITY
.	

Nocturnal	ENTITY
panic	ENTITY
attacks	ENTITY
can	
waken	
a	
person	ENTITY
from	
sleep	ENTITY
,	
but	
are	
not	
usually	
associated	ENTITY
with	ENTITY
a	
sense	ENTITY
of	ENTITY
noise	ENTITY
or	
explosion	ENTITY
.	

Recurrent	ENTITY
night-	
mares	ENTITY
are	
characterized	ENTITY
by	
recall	ENTITY
of	
more	
complex	ENTITY
and	
longer	ENTITY
-	
lasting	ENTITY
visual	ENTITY
imagery	ENTITY
.	

Sleep	ENTITY
starts	
occur	
at	
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
but	
are	
predominantly	
a	
motor	ENTITY
phenomenon	ENTITY
with	
sudden	ENTITY
myoclonic	ENTITY
jerks	ENTITY
rather	
than	
an	
emphasis	
on	
sensory	ENTITY
symptoms	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY

The	
neurophysiologic	ENTITY
basis	
of	
these	
events	ENTITY
requires	
further	
study	ENTITY
.	

Bibliography	ENTITY
Chakravarty	ENTITY
A.	ENTITY
Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
:	
report	ENTITY
of	
two	
new	
cases	ENTITY
.	

Cephalalgia	
2008;28:399–400	
.	

Evans	ENTITY
RW	ENTITY
.	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
followed	
by	
sleep	ENTITY
paralysis	ENTITY
:	
a	
rare	ENTITY
migraine	ENTITY
aura	ENTITY
.	

Headache	ENTITY
2006;46:682–3	
.	

Kallweit	ENTITY
U	ENTITY
,	
Khatami	ENTITY
R	ENTITY
,	ENTITY
Bassetti	ENTITY
CL	ENTITY
.	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
-	
more	
than	
“	
snapping	ENTITY
of	
the	
brain	ENTITY
”	
?	

Sleep	ENTITY
Med	ENTITY
2008;9:589	
.	

Palikh	ENTITY
GM	ENTITY
,	
Vaughn	ENTITY
BV	ENTITY
.	

Topiramate	ENTITY
responsive	ENTITY
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
.	

J	
Clin	
Sleep	
Med	
2010;6:382–3	
.	

Pearce	
JM	ENTITY
.	

Clinical	ENTITY
features	ENTITY
of	
the	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
.	

J	
Neurol	
Neurosurg	
Psychiatry	
1989;52:907–10	
.	

Sachs	ENTITY
C	ENTITY
,	
Svanborg	ENTITY
E.	ENTITY

The	
exploding	ENTITY
head	ENTITY
syndrome	ENTITY
:	
polysomnographic	ENTITY
recordings	ENTITY
and	
therapeutic	ENTITY
suggestions	ENTITY
.	

Sleep	ENTITY
1991;14:263–6	
.	

Sleep	ENTITY
Related	ENTITY
Hallucinations	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
368.16	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

H53.16	ENTITY
Alternate	ENTITY
Names	
Hypnagogic	ENTITY
hallucinations	ENTITY
,	
hypnopompic	ENTITY
hallucinations	ENTITY
,	
complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

There	
is	
a	
complaint	ENTITY
of	
recurrent	ENTITY
hallucinations	ENTITY
that	
are	
experienced	
just	
prior	
to	
sleep	ENTITY
onset	ENTITY
or	
upon	
awakening	ENTITY
during	
the	
night	ENTITY
or	
in	
the	
morning	ENTITY
.	

B.	ENTITY
The	
hallucinations	ENTITY
are	
predominantly	
visual	ENTITY
.	

C.	

The	
disturbance	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
(	
especially	
narcolepsy	ENTITY
)	
,	
mental	ENTITY
disorder	ENTITY
,	
medical	ENTITY
disorder	ENTITY
,	
medication	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
hallucinations	ENTITY
are	
hallucinatory	ENTITY
experiences	ENTITY
that	
occur	
at	
sleep	ENTITY
onset	ENTITY
or	
on	
awakening	ENTITY
from	
sleep	ENTITY
.	

Sleep	ENTITY
related	
hallucinations	ENTITY
are	
predominantly	
visual	ENTITY
but	
may	
include	
auditory	ENTITY
,	
tactile	ENTITY
,	
or	
kinetic	ENTITY
phenomena	ENTITY
.	

Hallucinations	ENTITY
at	
sleep	
onset	
(	
hypnagogic	ENTITY
hallucinations	ENTITY
)	
may	
be	
difficult	
to	
differentiate	ENTITY
from	
sleep	ENTITY
onset	ENTITY
dream-	
ing	
.	

Hallucinations	ENTITY
on	
waking	ENTITY
in	
the	
morning	ENTITY
(	
hypnopompic	ENTITY
hallucinations	ENTITY
)	
may	
arise	
out	
of	
a	
period	ENTITY
of	
REM	ENTITY
sleep	ENTITY
,	
and	
patients	ENTITY
also	
may	
be	
uncertain	
whether	
they	
rep-	ENTITY
resent	ENTITY
waking	ENTITY
or	
dream	ENTITY
-	
related	ENTITY
experiences	ENTITY
.	

Complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
may	
represent	
a	
distinct	
form	
of	
sleep	ENTITY
related	
hallucinations	ENTITY
.	

They	
typically	
occur	
fol-	
lowing	ENTITY
a	
sudden	ENTITY
awakening	ENTITY
,	
without	
recall	ENTITY
of	
a	
preceding	
dream	ENTITY
.	

They	
usually	
take	
the	
form	
of	
complex	ENTITY
,	
vivid	ENTITY
,	
relatively	
immobile	
images	ENTITY
of	
people	ENTITY
or	
animals	ENTITY
,	
sometimes	
distorted	ENTITY
in	
shape	ENTITY
or	
size	ENTITY
.	

These	
hallucinations	ENTITY
may	
remain	
present	
for	
many	
minutes	ENTITY
but	
usually	
disappear	
if	
ambient	ENTITY
illumination	ENTITY
is	
increased	ENTITY
.	

Patients	ENTITY
are	
clearly	
awake	ENTITY
but	
often	
initially	
perceive	
the	
hallucinations	ENTITY
as	
real	
and	
frightening	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Sleep	
related	
hallucinations	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
,	
either	
at	
the	
same	
time	ENTITY
or	
on	
different	
nights	ENTITY
.	

Patients	ENTITY
with	
complex	ENTITY
nocturnal	ENTITY
visual	
hal-	
lucinations	ENTITY
may	
jump	
out	
of	
the	
bed	ENTITY
in	
terror	ENTITY
,	
sometimes	
injuring	ENTITY
themselves	
.	

Some	
patients	ENTITY
may	
experience	
other	
parasomnias	ENTITY
,	
such	
as	
sleep	ENTITY
talking	ENTITY
or	
sleepwalking	ENTITY
,	
sep-	
arate	ENTITY
from	
the	
hallucinations	ENTITY
;	
some	
patients	ENTITY
may	
also	
experience	
similar	
complex	ENTITY
hal-	
lucinations	ENTITY
during	
the	
day	ENTITY
,	
unassociated	ENTITY
with	ENTITY
sleep	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	
Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Dream	ENTITY
-	
like	
hypnagogic	ENTITY
and	
hypnopompic	ENTITY
hallucinations	ENTITY
appear	
to	
differ	
in	
clini-	
cal	
features	ENTITY
and	
pathogenesis	ENTITY
from	
complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
arising	
in	
wakefulness	ENTITY
after	
sudden	ENTITY
arousals	ENTITY
during	
the	
night	ENTITY
.	

Sleep	ENTITY
related	
hallucinations	ENTITY
are	
common	
in	
narcolepsy	ENTITY
and	
also	
occur	
as	
occasional	
phenomena	ENTITY
in	
a	
high	
per-	
centage	ENTITY
of	
the	
general	ENTITY
population	ENTITY
.	

In	
contrast	
,	
complex	ENTITY
nocturnal	
visual	
hallucina-	
tions	ENTITY
appear	
to	
be	
rare	ENTITY
and	
occur	
in	
the	
setting	
of	
a	
range	
of	
neurologic	ENTITY
and	
visual	ENTITY
disorders	ENTITY
(	
see	
Differential	ENTITY
Diagnosis	ENTITY
)	
as	
well	
as	
in	
an	
idiopathic	ENTITY
form	ENTITY
.	

However	
,	
further	
work	
is	
needed	
to	
establish	
whether	
or	
not	
these	
forms	
of	
hallucinations	ENTITY
represent	
different	
entities	ENTITY
.	

Demographics	ENTITY
In	
large	
European	ENTITY
population	
studies	
,	
sleep	ENTITY
related	ENTITY
hallucinations	ENTITY
have	
been	
reported	
to	
occur	
with	
a	
prevalence	ENTITY
of	
25	
%	
to	
37	
%	
for	
hypnagogic	ENTITY
hallucinations	ENTITY
,	
whereas	
the	
equivalent	ENTITY
reported	
prevalence	ENTITY
for	
hypnopompic	ENTITY
hallucinations	ENTITY
is	
7	
%	
to	
13	
%	
.	

Both	
hypnagogic	ENTITY
and	
hypnopompic	ENTITY
hallucinations	ENTITY
are	
more	
common	
in	
younger	ENTITY
persons	ENTITY
and	
occur	
slightly	
more	
frequently	
in	
women	ENTITY
than	
in	
men	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Multivariate	ENTITY
analyses	ENTITY
in	
large	
population	ENTITY
studies	ENTITY
have	
suggested	
that	
sleep	ENTITY
related	
hal-	
lucinations	ENTITY
are	
associated	ENTITY
with	ENTITY
younger	ENTITY
age	ENTITY
,	
current	
drug	ENTITY
use	ENTITY
,	
past	ENTITY
alcohol	ENTITY
use	ENTITY
,	
anxiety	ENTITY
,	
mood	ENTITY
disorder	ENTITY
,	
sleep	ENTITY
onset	ENTITY
insomnia	ENTITY
,	
and	
perceived	ENTITY
insufficient	ENTITY
sleep	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Sleep	
related	
hallucinations	ENTITY
appear	
to	
be	
more	
common	
in	
adolescence	ENTITY
and	
early	ENTITY
adult-	
hood	ENTITY
.	

In	
many	
patients	ENTITY
,	
the	
frequency	ENTITY
appears	
to	
decrease	ENTITY
with	
age	ENTITY
.	

The	
natural	ENTITY
history	ENTITY
of	
complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
depends	
on	
the	
underlying	
cause	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
or	
applicable	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
It	
is	
presumed	
that	
most	
sleep	ENTITY
related	
hallucinations	ENTITY
are	
due	
to	
dream	ENTITY
ideation	ENTITY
of	
REM	ENTITY
sleep	ENTITY
intruding	
into	
wakefulness	ENTITY
,	
but	
this	
has	
not	
been	
firmly	
established	
.	

Infrequent	ENTITY
hallucinations	ENTITY
of	
this	
type	ENTITY
may	
be	
within	
the	
limits	
of	
normal	ENTITY
sleep	ENTITY
-	
wake	ENTITY
transition	ENTITY
.	

Complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
may	
in	
some	
cases	ENTITY
be	
release	ENTITY
phenomena	ENTITY
in	
which	
loss	ENTITY
of	
visual	ENTITY
input	ENTITY
or	
decreased	ENTITY
reticular	
activating	
system	
activity	
results	
in	
the	
visual	ENTITY
cortex	ENTITY
generating	
aberrant	ENTITY
images	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Hypnagogic	ENTITY
hallucinations	ENTITY
appear	
to	
arise	
predominantly	
from	
sleep	ENTITY
onset	ENTITY
REM	ENTITY
periods	ENTITY
.	

However	
,	
the	
very	
few	
reports	ENTITY
of	
polysomnography	ENTITY
in	
complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
suggest	
an	
onset	
from	
NREM	ENTITY
sleep	ENTITY
.	

MRI	ENTITY
scans	ENTITY
of	
the	
brain	ENTITY
,	
PSG	ENTITY
,	
EEG	ENTITY
,	
and	
neuropsychological	ENTITY
testing	ENTITY
may	
help	
in	
the	
differential	ENTITY
diagnosis	ENTITY
and	
in	
identifying	
underlying	
disorders	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Nightmares	ENTITY
are	
frightening	
dreams	ENTITY
awakening	ENTITY
the	
patient	ENTITY
from	
sleep	ENTITY
.	

They	
are	
clearly	
recognized	
as	
dreams	ENTITY
and	
do	
not	
persist	
into	
wakefulness	ENTITY
.	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
consists	
of	
a	
sudden	ENTITY
sensation	ENTITY
of	
an	
explosion	ENTITY
in	
the	
head	ENTITY
,	
usually	
at	
sleep	ENTITY
onset	ENTITY
and	
sometimes	
accompanied	
by	
a	
noise	ENTITY
or	
flash	ENTITY
of	ENTITY
light	ENTITY
.	

It	
does	
not	
involve	
complex	ENTITY
visual	ENTITY
imagery	ENTITY
and	
lasts	
only	
seconds	
.	

In	
RBD	ENTITY
,	
the	
patient	ENTITY
acts	
out	
dreams	ENTITY
during	
REM	ENTITY
sleep	ENTITY
.	

If	
not	
awakened	
by	
an	
observer	ENTITY
,	
the	
person	ENTITY
usually	
has	
little	
recollection	ENTITY
of	
dream	ENTITY
content	ENTITY
.	

Sleepwalking	ENTITY
may	
occasionally	
be	
associated	ENTITY
with	ENTITY
dream	ENTITY
ideation	ENTITY
,	
but	
the	
patient	ENTITY
recognizes	
that	
the	
dream	ENTITY
occurred	
during	
sleep	ENTITY
.	

Visual	ENTITY
hallucinations	ENTITY
can	
be	
due	
to	
epileptic	ENTITY
seizures	ENTITY
but	
are	
usually	
brief	ENTITY
,	
stereotyped	ENTITY
,	
and	
fragmentary	
in	
such	
cases	ENTITY
.	

Occasionally	
,	
complex	ENTITY
visual	ENTITY
hallucinations	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
migraine	ENTITY
but	
are	
usually	
followed	
by	
a	
headache	ENTITY
.	

Complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
may	
be	
seen	
in	
patients	ENTITY
with	
narcolepsy	ENTITY
,	
PD	ENTITY
,	
DLB	ENTITY
,	
visual	ENTITY
loss	ENTITY
(	
Charles	
Bonnet	ENTITY
hallucinations	ENTITY
)	
,	
and	
midbrain	ENTITY
and	
diencephalic	ENTITY
pathology	ENTITY
(	
peduncular	ENTITY
hallucinosis	ENTITY
)	
,	
as	
well	
as	
with	
the	
use	
of	
β	ENTITY
-	
adrenergic	ENTITY
receptor-	ENTITY
blocking	ENTITY
medications	ENTITY
.	

Anxiety	ENTITY
disorders	ENTITY
have	
been	
noted	
in	
some	
patients	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

In	
contrast	
to	
the	
extensive	
study	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
,	
little	
work	
has	
been	
reported	
on	
sleep	ENTITY
related	
hallucinations	ENTITY
.	

It	
is	
uncertain	
whether	
they	
represent	
normal	ENTITY
variants	ENTITY
or	
pathologic	ENTITY
entities	ENTITY
.	

It	
is	
unclear	
whether	
they	
are	
always	
associated	ENTITY
with	ENTITY
REM	ENTITY
sleep	ENTITY
intruding	
into	
wakefulness	ENTITY
.	

It	
is	
uncertain	
how	
frequently	
complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
are	
an	
independent	
entity	ENTITY
,	
as	
opposed	
to	
representing	
a	
final	
common	
pathway	ENTITY
of	
a	
range	
of	
other	
disorders	ENTITY
.	

Further	
work	
is	
needed	
to	
determine	
from	
which	
stages	ENTITY
of	
sleep	ENTITY
they	
arise	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Bibliography	ENTITY
Barnes	
J	
,	
David	
AS	
.	

Visual	ENTITY
hallucinations	ENTITY
in	
Parkinson	ENTITY
’s	ENTITY
disease	ENTITY
:	
a	
review	ENTITY
and	
phenomenological	ENTITY
survey	ENTITY
.	

J	
Neurol	
Neurosurg	
Psychiatry	
2001;70:727–33	
.	

Kavey	ENTITY
N	ENTITY
,	
Whyte	
J.	
Somnambulism	
associated	ENTITY
with	ENTITY
hallucinations	ENTITY
.	

Psychosomatics	ENTITY
1993;34:86–90	
.	

Mahowald	ENTITY
M	ENTITY
,	
Woods	ENTITY
S	ENTITY
,	
Schenck	ENTITY
C.	ENTITY
Sleeping	ENTITY
dreams	
,	
waking	ENTITY
hallucinations	ENTITY
,	
and	
the	
central	ENTITY
nervous	ENTITY
system	ENTITY
.	

Dreaming	ENTITY
1998;8:89–102	
.	

Manford	ENTITY
M	ENTITY
,	
Andermann	ENTITY
F.	ENTITY
Complex	ENTITY
visual	ENTITY
hallucinations	ENTITY
.	

Clinical	ENTITY
and	
neurobiological	ENTITY
insights	
.	

Brain	ENTITY
1998;121:1819–40	ENTITY
.	

Ohayon	ENTITY
M.	
Prevalence	ENTITY
of	
hallucinations	ENTITY
and	
their	
pathological	ENTITY
associations	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

Psychiatry	ENTITY
Res	ENTITY
2000;97:153–64	ENTITY
.	

Ohayon	ENTITY
M	ENTITY
,	
Priest	ENTITY
R	ENTITY
,	
Caulet	ENTITY
M	ENTITY
,	
Guilleminault	ENTITY
C.	ENTITY
Hypnagogic	ENTITY
and	
hypnopompic	ENTITY
hallucinations	ENTITY
:	
pathological	ENTITY
phenomena	ENTITY
?	

Br	ENTITY
J	ENTITY
Psychiatry	ENTITY
1996;169:459–67	ENTITY
.	

Silber	ENTITY
MH	ENTITY
,	
Hansen	ENTITY
M	ENTITY
,	
Girish	
M.	
Complex	
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2005;6:363–6	ENTITY
.	

Sleep	ENTITY
Enuresis	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
788.36	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

N39.44	ENTITY
Alternate	
Names	
Enuresis	ENTITY
nocturna	ENTITY
;	
nocturnal	ENTITY
bedwetting	ENTITY
;	
primary	ENTITY
,	
familial	ENTITY
,	
functional	ENTITY
,	
idiopathic	ENTITY
,	
monosymptomatic	ENTITY
,	
or	
essential	ENTITY
enuresis	ENTITY
;	
night	ENTITY
wetting	ENTITY
;	
sleep	ENTITY
related	ENTITY
enuresis	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Primary	ENTITY
Sleep	ENTITY
Enuresis	ENTITY
–	
Criteria	ENTITY
A	
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
is	
older	
than	
five	
years	ENTITY
.	

B.	ENTITY
The	
patient	ENTITY
exhibits	
recurrent	ENTITY
involuntary	ENTITY
voiding	ENTITY
during	
sleep	ENTITY
,	
occurring	
at	
least	
twice	
a	
week	ENTITY
.	

C.	

The	
condition	ENTITY
has	
been	
present	
for	
at	
least	
three	
months	ENTITY
.	

D.	

The	
patient	ENTITY
has	
never	
been	
consistently	
dry	ENTITY
during	
sleep	ENTITY
.	

Secondary	ENTITY
Sleep	ENTITY
Enuresis	ENTITY
–	
Criteria	ENTITY
A	
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
is	
older	
than	
five	
years	ENTITY
.	

B.	ENTITY
The	
patient	ENTITY
exhibits	
recurrent	ENTITY
involuntary	ENTITY
voiding	ENTITY
during	
sleep	ENTITY
,	
occurring	
at	
least	
twice	
a	
week	ENTITY
.	

C.	

The	
condition	ENTITY
has	
been	
present	
for	
at	
least	
three	
months	ENTITY
.	

D.	

The	
patient	ENTITY
has	
previously	
been	
consistently	
dry	ENTITY
during	
sleep	ENTITY
for	
at	
least	
six	
months	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
enuresis	
(	
SE	ENTITY
)	
is	
characterized	ENTITY
by	
recurrent	ENTITY
involuntary	ENTITY
voiding	ENTITY
that	
occurs	
during	
sleep	ENTITY
.	

In	
primary	ENTITY
SE	ENTITY
,	
recurrent	ENTITY
involuntary	ENTITY
voiding	ENTITY
occurs	
at	
least	
twice	
a	
week	ENTITY
during	
sleep	ENTITY
after	
five	
years	ENTITY
of	
age	ENTITY
in	
a	
patient	ENTITY
who	
has	
never	
been	
consistently	
dry	ENTITY
during	
sleep	ENTITY
for	
six	
consecutive	ENTITY
months	ENTITY
.	

SE	ENTITY
is	
considered	
secondary	ENTITY
in	
a	
child	ENTITY
or	
adult	ENTITY
who	
had	
previously	
been	
dry	ENTITY
for	
six	
consecutive	ENTITY
months	ENTITY
and	
then	
began	
wetting	ENTITY
at	
least	
twice	
a	
week	ENTITY
.	

Both	
primary	ENTITY
and	
secondary	ENTITY
enuresis	ENTITY
must	
be	
present	
for	
a	
period	ENTITY
of	
at	
least	
three	
months	ENTITY
.	

Though	
primary	ENTITY
and	
secondary	ENTITY
enuresis	ENTITY
share	
the	
common	
symptom	ENTITY
of	
voiding	ENTITY
during	
sleep	ENTITY
,	
they	
are	
understood	
as	
distinct	
phenomena	ENTITY
with	
different	
etiologies	ENTITY
.	

SE	ENTITY
is	
associated	ENTITY
with	ENTITY
difficulty	ENTITY
arousing	
from	
sleep	ENTITY
in	
response	ENTITY
to	
an	
urge	
to	
urinate	ENTITY
and	
may	
occur	
during	
any	
sleep	ENTITY
stage	ENTITY
.	

Sleep	ENTITY
disorders	ENTITY
that	
fragment	ENTITY
sleep	ENTITY
such	
as	
sleep	ENTITY
apnea	ENTITY
are	
associated	ENTITY
with	ENTITY
SE	ENTITY
,	
and	
treatment	ENTITY
of	
these	
disorders	ENTITY
may	
cure	ENTITY
or	
reduce	ENTITY
their	
incidence	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Involuntary	ENTITY
voiding	ENTITY
during	
wakefulness	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
SE	ENTITY
and	
,	
if	
present	
,	
generally	
points	
toward	
a	
physiological	ENTITY
etiology	ENTITY
.	

Psychosocial	ENTITY
problems	
are	
consid-	
ered	
a	
relatively	
rare	
cause	ENTITY
in	
primary	ENTITY
SE	ENTITY
,	
though	
it	
does	
occur	
more	
commonly	
in	
children	ENTITY
with	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
and	
in	
children	ENTITY
living	ENTITY
in	
disorga-	
nized	ENTITY
families	ENTITY
.	

Secondary	ENTITY
SE	ENTITY
is	
seen	
more	
commonly	
in	
children	ENTITY
who	
have	
recently	
experienced	
a	
significant	ENTITY
psychosocial	ENTITY
stress	ENTITY
,	
such	
as	
parental	ENTITY
divorce	ENTITY
,	
physical	ENTITY
or	
sexual	ENTITY
abuse	ENTITY
,	
or	
neglect	ENTITY
.	

Chronic	ENTITY
constipation	ENTITY
and	
encopresis	ENTITY
(	
fecal	ENTITY
soiling	ENTITY
)	
often	
occur	
in	
children	ENTITY
with	
secondary	ENTITY
SE	ENTITY
.	

SE	ENTITY
can	
occur	
in	
association	ENTITY
with	ENTITY
diabetes	ENTITY
and	
urinary	ENTITY
tract	ENTITY
infection	ENTITY
.	

It	
may	
occur	
in	
individuals	ENTITY
with	
nocturnal	ENTITY
epilepsy	ENTITY
.	

Among	
older	ENTITY
adults	ENTITY
,	
SE	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
symptoms	ENTITY
of	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
OSA	ENTITY
,	
depression	ENTITY
,	
and	
dementia	ENTITY
.	

SRBD	ENTITY
is	
reported	
in	
8	
%	
to	
47	
%	
of	
children	ENTITY
with	
enuresis	ENTITY
,	
compared	
to	
an	
overall	ENTITY
prev-	
alence	
of	
1	
%	
to	
2	
%	
.	

PLMS	ENTITY
have	
been	
reported	
in	
patients	ENTITY
with	
refractory	ENTITY
SE	ENTITY
.	

A	
large	
epidemiology	ENTITY
study	ENTITY
of	
children	ENTITY
aged	ENTITY
6	
-	
10	
years	ENTITY
found	
that	
a	
current	
complaint	
of	
SE	ENTITY
was	
significantly	
associated	ENTITY
with	ENTITY
increased	ENTITY
ORs	ENTITY
(	
2.7	
-	
3.4	
)	
for	
subjectively	ENTITY
high	
arousal	ENTITY
threshold	ENTITY
,	
night	ENTITY
terrors	ENTITY
,	
nocturia	ENTITY
,	
and	
confusion	ENTITY
when	
awakened	
from	
sleep	ENTITY
.	

Other	
studies	ENTITY
have	
found	
mouth	ENTITY
breathing	ENTITY
,	
nasal	ENTITY
congestion	ENTITY
,	
snoring	ENTITY
,	
and	
restless	ENTITY
sleep	ENTITY
to	
be	
highly	
related	
to	
enuresis	ENTITY
in	
children	ENTITY
.	

Parasomnias	ENTITY
Parasomnias	
Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
The	
most	
important	
distinction	ENTITY
is	
between	
primary	ENTITY
and	
secondary	ENTITY
SE	ENTITY
.	

Demographics	ENTITY
SE	ENTITY
occurs	
in	
15	
%	
to	
20	
%	
of	
5	
-	
year	ENTITY
-	
olds	ENTITY
.	

It	
is	
three	
times	
more	
common	
in	
boys	ENTITY
than	
in	
girls	ENTITY
.	

SE	ENTITY
is	
reported	
by	
2.1	
%	
of	
community	ENTITY
-	
dwelling	ENTITY
older	ENTITY
adults	ENTITY
and	
is	
more	
common	
among	
women	ENTITY
than	
men	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
etiology	ENTITY
of	
SE	ENTITY
is	
complex	ENTITY
.	

The	
factors	ENTITY
that	
precipitate	ENTITY
SE	ENTITY
on	
a	
particular	
night	ENTITY
and	
at	
a	
particular	
time	ENTITY
remain	
unknown	
.	

One	
popular	
model	ENTITY
hypothesizes	
that	
SE	ENTITY
consists	
of	
three	
interrelated	
factors	
:	
large	
nocturnal	ENTITY
urine	ENTITY
volume	ENTITY
production	ENTITY
,	
noc-	
turnal	ENTITY
bladder	ENTITY
overactivity	ENTITY
,	
and	
difficulty	ENTITY
arousing	
from	
sleep	ENTITY
.	

Several	
studies	ENTITY
suggest	
difficulty	
arousing	
from	
sleep	ENTITY
is	
most	
important	
in	
primary	ENTITY
enuresis	ENTITY
,	
whereas	
bladder	ENTITY
instability	ENTITY
/	
overactivity	ENTITY
is	
more	
important	
in	
secondary	ENTITY
enuresis	ENTITY
.	

Children	ENTITY
with	
enuresis	ENTITY
are	
often	
described	
by	
their	
families	ENTITY
as	
“	
deep	ENTITY
sleepers	ENTITY
”	
and	
very	
difficult	
to	
arouse	
.	

A	
high	ENTITY
arousal	ENTITY
threshold	ENTITY
has	
been	
objectively	ENTITY
confirmed	
in	
these	
children	ENTITY
.	

It	
has	
been	
reported	
that	
fragmentation	ENTITY
of	
sleep	
by	
disorders	ENTITY
such	
as	
sleep	ENTITY
apnea	ENTITY
is	
highly	
correlated	ENTITY
with	
SE	ENTITY
.	

Sleep	ENTITY
fragmenting	ENTITY
disorders	ENTITY
such	
as	
sleep	ENTITY
apnea	ENTITY
and	
PLMS	ENTITY
have	
been	
previously	
reported	
to	
be	
proximal	ENTITY
triggers	ENTITY
for	
the	
occurrence	ENTITY
of	
disorders	ENTITY
of	
arousal	ENTITY
—	
sleepwalking	ENTITY
,	
confusional	ENTITY
arousals	ENTITY
,	
and	
night	ENTITY
terrors	ENTITY
.	

Successful	
treatment	ENTITY
of	
sleep	ENTITY
apnea	ENTITY
in	
these	
disorders	ENTITY
has	
been	
reported	
to	
result	
in	
reduction	ENTITY
or	
elimination	ENTITY
of	
disorders	ENTITY
of	
arousal	ENTITY
.	

Similarly	
,	
surgical	ENTITY
treatment	ENTITY
of	
sleep	ENTITY
apneas	ENTITY
by	
adenotonsillec-	
tomy	ENTITY
has	
been	
reported	
to	
cure	ENTITY
nocturnal	ENTITY
enuresis	ENTITY
in	
60	
%	
or	
more	
of	
patients	ENTITY
,	
although	
this	
is	
not	
a	
consistent	
result	
.	

Several	
studies	ENTITY
have	
noted	
the	
presence	ENTITY
of	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
in	
>	
40	
%	
of	
enuresis	ENTITY
patients	ENTITY
studied	
.	

However	
,	
not	
all	
sleep	ENTITY
studies	ENTITY
have	
noted	
SRBD	ENTITY
in	
patients	ENTITY
with	
enuresis	ENTITY
.	

Those	
without	
SRBD	ENTITY
were	
still	
found	
to	
have	
high	
arousal	ENTITY
threshold	ENTITY
from	
sleep	ENTITY
.	

Primary	ENTITY
SE	ENTITY
is	
a	
disorder	ENTITY
that	
occurs	
when	
an	
individual	ENTITY
fails	
to	
arouse	
from	
sleep	ENTITY
in	
response	ENTITY
to	
bladder	ENTITY
sensations	ENTITY
or	
fails	
to	
inhibit	ENTITY
a	
bladder	ENTITY
contraction	ENTITY
.	

These	
are	
devel-	
opmentally	
acquired	
skills	
,	
and	
,	
as	
such	
,	
there	
is	
a	
range	
in	
the	
ages	ENTITY
of	
their	
acquisition	ENTITY
.	

A	
small	
proportion	ENTITY
of	
children	ENTITY
with	
primary	ENTITY
SE	ENTITY
lack	
the	
normal	
increase	ENTITY
in	
vasopressin	ENTITY
release	ENTITY
during	
sleep	ENTITY
,	
leading	
to	
a	
high	
urinary	ENTITY
volume	ENTITY
that	
exceeds	
the	
bladder	ENTITY
capac-	
ity	ENTITY
.	

If	
these	
children	ENTITY
do	
not	
arouse	
to	
the	
sensation	ENTITY
of	
a	
full	
bladder	ENTITY
,	
primary	ENTITY
SE	ENTITY
is	
the	
result	ENTITY
.	

Secondary	ENTITY
SE	ENTITY
can	
be	
caused	
by	
,	
or	
be	
associated	ENTITY
with	ENTITY
,	
any	
one	
of	
the	
following	
identifiable	ENTITY
problems	ENTITY
:	
(	
1	
)	
an	
inability	
to	
concentrate	ENTITY
urine	ENTITY
due	
to	
diabetes	ENTITY
mellitus	ENTITY
,	
diabetes	ENTITY
insipidus	ENTITY
,	
nephrogenic	ENTITY
diabetes	ENTITY
insipidus	ENTITY
(	
idiopathic	ENTITY
or	
pharmacologic	ENTITY

[	
e.g.	
,	
secondary	
to	
the	
use	
of	
lithium	ENTITY
carbonate	ENTITY
]	
)	
,	
or	
sickle	ENTITY
cell	ENTITY
disease	ENTITY
;	
(	
2	
)	
increased	ENTITY
urine	ENTITY
production	ENTITY
secondary	
to	
the	
ingestion	ENTITY
of	
caffeine	ENTITY
,	
diuretics	ENTITY
,	
or	
other	
agents	ENTITY
;	
(	
3	
)	
urinary	ENTITY
tract	ENTITY
pathology	ENTITY
,	
such	
as	
urinary	ENTITY
tract	ENTITY
infections	ENTITY
,	
irritable	ENTITY
bladder	ENTITY
,	
malformations	ENTITY
of	
the	
genitourinary	ENTITY
tract	ENTITY
(	
e.g.	
,	
ectopic	ENTITY
ureter	ENTITY
)	
;	
(	
4	
)	
chronic	ENTITY
constipation	ENTITY
and	
encopresis	ENTITY
;	
(	
5	
)	
neurologic	ENTITY
pathology	ENTITY
,	
such	
as	
seizures	ENTITY
or	
neurogenic	ENTITY
bladder	ENTITY
;	
or	
(	
6	
)	
psychosocial	ENTITY
stressors	ENTITY
,	
such	
as	
parental	ENTITY
divorce	ENTITY
,	
neglect	ENTITY
,	
physical	ENTITY
or	
sexual	ENTITY
abuse	ENTITY
,	
and	
institution-	
alization	ENTITY
.	

The	
mechanisms	ENTITY
by	
which	
secondary	ENTITY
SE	ENTITY
is	
associated	ENTITY
with	ENTITY
these	
problems	ENTITY
are	
often	
not	
understood	
.	

Familial	ENTITY
Patterns	ENTITY
Hereditary	ENTITY
factors	ENTITY
are	
suspected	ENTITY
in	
children	ENTITY
with	
primary	ENTITY
enuresis	ENTITY
.	

There	
is	
often	
a	
high	
prevalence	ENTITY
of	
enuresis	ENTITY
among	
the	
parents	ENTITY
,	
siblings	ENTITY
,	
and	
other	
relatives	ENTITY
of	
the	
child	ENTITY
with	
primary	ENTITY
enuresis	ENTITY
.	

The	
reported	
prevalence	ENTITY
is	
77	
%	
when	
both	
parents	ENTITY
were	
enuretic	ENTITY
as	
children	ENTITY
and	
44	
%	
when	
one	
parent	ENTITY
has	
a	
history	ENTITY
of	
enuresis	ENTITY
.	

Recent	
linkage	ENTITY
studies	ENTITY
support	
the	
hypothesis	ENTITY
of	
genetic	ENTITY
and	
phenotypic	ENTITY
heterogeneity	ENTITY
of	
SE	ENTITY
.	

A	
putative	
linkage	
of	
SE	ENTITY
to	
a	
region	ENTITY
on	
chromosomes	ENTITY
22q	ENTITY
,	
13q	ENTITY
,	
and	
12q	ENTITY
across	
different	
families	ENTITY
has	
been	
reported	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Voiding	ENTITY
is	
a	
spinal	ENTITY
reflex	ENTITY
during	
wakefulness	ENTITY
and	
sleep	ENTITY
during	
infancy	ENTITY
,	
until	
about	
18	
months	ENTITY
of	
age	ENTITY
.	

Between	
18	
months	ENTITY
and	
three	
years	ENTITY
of	
age	ENTITY
,	
the	
child	ENTITY
is	
able	
to	
delay	ENTITY
voiding	ENTITY
with	
a	
full	
bladder	ENTITY
,	
first	
during	
wakefulness	ENTITY
and	
at	
a	
later	
age	ENTITY
during	
sleep	ENTITY
.	

The	
primary	
determinant	
of	
the	
age	ENTITY
at	
which	
this	
skill	ENTITY
is	
acquired	
is	
developmental	ENTITY
matura-	
tion	ENTITY
.	

Somewhat	
arbitrarily	
,	
primary	ENTITY
SE	ENTITY
is	
defined	
as	
a	
problem	ENTITY
if	
it	
persists	
beyond	
five	
years	ENTITY
of	
age	ENTITY
.	

The	
spontaneous	ENTITY
cure	ENTITY
rate	ENTITY
is	
15	
%	
per	
year	ENTITY
.	

The	
primary	ENTITY
complication	ENTITY
of	
SE	ENTITY
is	
to	
the	
child	ENTITY
’s	
self	
-	
esteem	ENTITY
.	

How	
well	
the	
child	ENTITY
’s	
family	
deals	
with	
the	
symptom	ENTITY
is	
an	
important	
determinant	ENTITY
of	
whether	
complications	ENTITY
develop	
.	

Secondary	ENTITY
SE	ENTITY
can	
occur	
at	
any	
age	ENTITY
.	

Complications	ENTITY
of	
secondary	ENTITY
SE	ENTITY
are	
determined	
by	
the	
problem	ENTITY
leading	
to	
the	
enuresis	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
The	
developmental	ENTITY
pattern	
of	
enuresis	ENTITY
is	
similar	
to	
NREM	ENTITY
parasomnias	ENTITY
,	
although	
its	
first	
occurrence	ENTITY
in	ENTITY
adulthood	ENTITY
is	
uncommon	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
SE	ENTITY
is	
a	
heterogeneous	ENTITY
disorder	ENTITY
with	
various	
underlying	
pathophysiological	ENTITY
mecha-	
nisms	ENTITY
,	
resulting	
in	
a	
mismatch	ENTITY
between	
nocturnal	ENTITY
bladder	
capacity	ENTITY
and	
the	
amount	ENTITY
of	
Parasomnias	ENTITY
Parasomnias	
urine	ENTITY
produced	
during	
sleep	ENTITY
,	
in	
association	ENTITY
with	
a	
simultaneous	ENTITY
failure	ENTITY
of	
arousal	ENTITY
from	
sleep	ENTITY
in	
response	ENTITY
to	
the	
sensation	ENTITY
of	
bladder	ENTITY
fullness	ENTITY
.	

SE	ENTITY
can	
be	
seen	
in	
association	ENTITY
with	ENTITY
sleep	ENTITY
fragmentation	ENTITY
disorders	ENTITY
including	
SRBD	ENTITY
,	
which	
in	
children	ENTITY
is	
most	
often	
secondary	
to	
adenotonsillar	ENTITY
hypertrophy	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
In	
primary	ENTITY
and	
secondary	ENTITY
SE	ENTITY
,	
enuretic	ENTITY
episodes	ENTITY
can	
occur	
in	
all	
sleep	ENTITY
stages	ENTITY
,	
during	
nocturnal	ENTITY
wakefulness	ENTITY
,	
and	
in	
association	ENTITY
with	
transient	ENTITY
arousals	ENTITY
.	

Sleep	ENTITY
stages	ENTITY
have	
not	
been	
found	
to	
be	
different	
on	
nights	ENTITY
when	
enuresis	ENTITY
occurs	ENTITY
versus	
nights	ENTITY
on	
which	
it	
does	
not	
occur	
.	

The	
results	ENTITY
of	
polysomnographic	ENTITY
studies	ENTITY
of	
children	ENTITY
with	
enuresis	ENTITY
com-	
pared	
to	
normal	ENTITY
controls	ENTITY
have	
been	
inconsistent	ENTITY
.	

A	
computerized	ENTITY
power	ENTITY
analysis	ENTITY
of	
sleep	ENTITY
data	ENTITY
suggested	
an	
increase	ENTITY
in	
delta	
power	
,	
whereas	
the	
majority	
of	
other	
studies	ENTITY
have	
reported	
no	
differences	
.	

However	
,	
a	
recent	
study	ENTITY
found	
those	
age	ENTITY
6	
-	
14	
years	ENTITY
had	
elevated	ENTITY
light	ENTITY
stage	ENTITY
N1	ENTITY
sleep	ENTITY
and	
reduced	ENTITY
N3	ENTITY
sleep	ENTITY
and	
REM	ENTITY
sleep	ENTITY
compared	
to	
normal	ENTITY
controls	ENTITY
.	

The	
population	ENTITY
with	
enuresis	ENTITY
had	
a	
significantly	
elevated	ENTITY
arousal	ENTITY
index	ENTITY
.	

SRBD	ENTITY
has	
been	
reported	
in	
8	
%	
to	
47	
%	
of	
children	ENTITY
with	
SE	ENTITY
.	

SE	ENTITY
and	
sleep	ENTITY
apnea	ENTITY
are	
highly	
correlated	ENTITY
with	
an	
increasing	ENTITY
prevalence	ENTITY
of	
enuresis	ENTITY
as	
the	
respiratory	ENTITY
distur-	
bance	
index	
(	
RDI	ENTITY
)	
increases	ENTITY
.	

In	
addition	
to	
SRBD	ENTITY
,	
PLMS	ENTITY
(	
range	
of	
3.9	
to	
38.6	
per	
hour	
of	
sleep	ENTITY
)	
have	
been	
reported	
in	
a	
group	ENTITY
of	
children	ENTITY
with	
treatment	ENTITY
-	
resistant	ENTITY
SE	ENTITY
.	

Recent	
studies	
have	
demonstrated	
that	
patients	ENTITY
with	
enuresis	ENTITY
are	
subjectively	ENTITY
sleepier	ENTITY
than	
normal	ENTITY
controls	ENTITY
.	

This	
has	
been	
hypothesized	
to	
result	
from	
fragmented	
nocturnal	ENTITY
sleep	ENTITY
and	
is	
consistent	ENTITY
with	ENTITY
a	
large	
body	
of	
sleep	ENTITY
research	ENTITY
in	
other	
areas	
.	

Differential	ENTITY
Diagnosis	ENTITY
Enuresis	ENTITY
may	
be	
caused	
by	
a	
variety	
of	
medical	ENTITY
or	
neurological	ENTITY
disorders	ENTITY
such	
as	
diabetes	ENTITY
mellitus	ENTITY
,	
diabetes	ENTITY
insipidus	ENTITY
,	
epilepsy	ENTITY
,	
sickle	ENTITY
cell	ENTITY
disease	ENTITY
,	
bowel	ENTITY
or	
bladder	ENTITY
dysfunction	ENTITY
,	
anatomical	ENTITY
abnormalities	ENTITY
or	
infection	ENTITY
of	
the	
urinary	ENTITY
tract	ENTITY
,	
neurological/	ENTITY
developmental	ENTITY
disorders	ENTITY
or	
other	
sleep	ENTITY
disorders	ENTITY
,	
especially	
OSA	ENTITY
.	

Organic	ENTITY
pathology	ENTITY
of	
the	
urinary	ENTITY
tract	ENTITY
is	
more	
prevalent	ENTITY
in	
children	ENTITY
who	
,	
in	
addition	
to	
sleep	ENTITY
enuresis	ENTITY
,	
also	
exhibit	
daytime	ENTITY
enuresis	ENTITY
,	
abnormalities	ENTITY
in	
the	
initiation	ENTITY
of	
micturition	ENTITY
,	
or	
abnormal	ENTITY
urinary	ENTITY
flow	ENTITY
.	

Evaluation	ENTITY
of	
sleep	ENTITY
enuresis	ENTITY
should	
include	
complete	ENTITY
enuresis	ENTITY
history	ENTITY
,	
sleep	ENTITY
history	ENTITY
,	
physical	ENTITY
examination	ENTITY
and	
laboratory	ENTITY
studies	ENTITY
(	
as	
indicated	
)	
to	
exclude	
these	
etiol-	
ogies	ENTITY
.	

When	
signs	ENTITY
and	
symptoms	ENTITY
of	
sleep	ENTITY
apnea	ENTITY
are	
present	
—	
mouth	ENTITY
breathing	ENTITY
,	
snoring	ENTITY
,	
adenotonsillar	ENTITY
hypertrophy	ENTITY
,	
daytime	ENTITY
sleepiness	ENTITY
,	
hyperactivity	ENTITY
—	
a	
sleep	ENTITY
study	ENTITY
should	
be	
conducted	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Recent	
advances	
suggest	
that	
the	
terms	
primary	ENTITY
and	
secondary	ENTITY
enuresis	ENTITY
may	
be	
overly	
simplistic	ENTITY
.	

Further	
work	
is	
necessary	
to	
understand	
the	
genetic	ENTITY
and	
clinical	ENTITY
aspects	ENTITY
of	
SE	ENTITY
.	

Other	
sleep	ENTITY
disorders	ENTITY
are	
common	
in	
children	ENTITY
with	
SE	ENTITY
.	

Though	
it	
may	
be	
possible	
that	
the	
apneas	ENTITY
,	
hypopneas	ENTITY
,	
and	
snoring	ENTITY
-	
related	ENTITY
arousals	ENTITY
in	
children	ENTITY
with	
SRBD	ENTITY
could	
be	
the	
trigger	ENTITY
of	
SE	ENTITY
,	
many	
children	ENTITY
with	
SE	ENTITY
do	
not	
have	
a	
sleep	ENTITY
disorder	ENTITY
.	

In	
such	
cases	ENTITY
,	
the	
underlying	
bladder	ENTITY
overactivity	ENTITY
may	
be	
the	
stimulus	ENTITY
for	
arousal	ENTITY
.	

Studies	ENTITY
of	
the	
relationship	ENTITY
of	
sleep	ENTITY
,	
sleep	ENTITY
disorders	ENTITY
,	
and	
sleep	ENTITY
fragmentation	ENTITY
to	
SE	ENTITY
performed	
to	
date	
have	
been	
inconsistent	ENTITY
.	

This	
is	
likely	
due	
to	
differing	
definitions	ENTITY
of	
enuresis	ENTITY
and	
varying	
research	ENTITY
methodologies	ENTITY
.	

Further	
sophisticated	
sleep	
laboratory	
studies	
are	
necessary	
to	
elucidate	
the	
relationship	ENTITY
.	

In	
particular	
,	
the	
proximal	ENTITY
trigger	ENTITY
for	
episodes	ENTITY
of	
SE	ENTITY
has	
not	
been	
determined	
.	

Some	
studies	ENTITY
suggest	
enuresis	ENTITY
is	
sponta-	
neous	
,	
whereas	
others	
suggest	
a	
relationship	ENTITY
to	
sleep	ENTITY
disorders	ENTITY
that	
result	
in	
arousals	ENTITY
—	
similar	
to	
findings	ENTITY
in	
disorders	ENTITY
of	
arousal	ENTITY
.	

Bibliography	ENTITY
Burgio	ENTITY
K	ENTITY
,	
Locher	
J	
,	
Ives	ENTITY
D	ENTITY
,	
Hardin	ENTITY
J	ENTITY
,	
Newman	ENTITY
A	ENTITY
,	
Kuller	ENTITY
L.	ENTITY
Nocturnal	ENTITY
enuresis	ENTITY
in	
community	ENTITY
-	
dwelling	ENTITY
older	ENTITY
adults	ENTITY
.	

J	
Am	
Geriatr	
Soc	
1996;44:139–43	
.	

Brooks	ENTITY
LJ	ENTITY
,	
Topol	ENTITY
HI	ENTITY
.	

Enuresis	ENTITY
in	
children	ENTITY
with	
sleep	ENTITY
apnea	ENTITY
.	

J	
Pediatr	
2003;142:515–8	
.	

Chandra	ENTITY
M	ENTITY
,	
Saharia	ENTITY
R	ENTITY
,	
Hill	ENTITY
V	ENTITY
,	
Shi	
QH	
.	

Prevalence	ENTITY
of	
diurnal	ENTITY
voiding	ENTITY
symptoms	ENTITY
and	
difficult	
arousal	ENTITY
from	
sleep	ENTITY
in	
children	ENTITY
with	
nocturnal	ENTITY
enuresis	ENTITY
.	

J	
Urol	
2004;172:311–6	
.	

Cohen	ENTITY
-	
Zrubavel	ENTITY
V	ENTITY
,	
Kushnir	ENTITY
B	ENTITY
,	
Kushnir	
J	
,	
Sadeh	
A.	
Sleep	
and	
sleepiness	ENTITY
in	
children	ENTITY
with	
nocturnal	ENTITY
enuresis	ENTITY
.	

Sleep	ENTITY
2011;34:191–4	
.	

Dhondt	ENTITY
K	ENTITY
,	
Raes	ENTITY
A	ENTITY
,	
Hoebeke	ENTITY
P	ENTITY
,	
Van	
Laecke	ENTITY
E	ENTITY
,	
Van	
Herzeele	ENTITY
C	ENTITY
,	
Vande	
Walle	
J.	
Abnormal	ENTITY
sleep	ENTITY
architecture	
and	
refractory	ENTITY
nocturnal	ENTITY
enuresis	ENTITY
.	

J	
Urol	
2009;182:1961–5	
.	

Jeyakumar	ENTITY
A	ENTITY
,	
Rahman	ENTITY
SI	ENTITY
,	
Armbrecht	ENTITY
ES	ENTITY
,	
Mitchell	
R.	
The	
association	ENTITY
between	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
and	
enuresis	ENTITY
in	
children	ENTITY
.	

Laryngoscope	
2012	
Aug;122:1873–7	ENTITY
.	

Neveus	ENTITY
T.	ENTITY
The	
role	
of	
sleep	ENTITY
and	
arousal	ENTITY
in	
nocturnal	ENTITY
enuresis	ENTITY
.	

Acta	
Paediatr	
2003;92:1118–23	
.	

Kalorin	ENTITY
CM	ENTITY
,	
Mouzakes	ENTITY
J	ENTITY
,	
Gavin	ENTITY
JP	ENTITY
,	
et	
al	
.	

Tonsillectomy	ENTITY
does	
not	
improve	
bedwetting	ENTITY
:	
results	ENTITY
of	
a	
prospective	ENTITY
controlled	ENTITY
trial	ENTITY
.	

J	
Urol	
2010;184:2527	
.	

Neveus	ENTITY
T	ENTITY
,	
Stenberg	ENTITY
A	ENTITY
,	
Lackgren	ENTITY
G	ENTITY
,	
Tuvemo	
T	
,	
Hetta	
J.	
Sleep	
of	
children	ENTITY
with	
enuresis	ENTITY
:	
A	
polysomnographic	ENTITY
study	ENTITY
.	

Pediatrics	ENTITY
1999;103:1193–7	
.	

Norgaard	ENTITY
JP	ENTITY
,	
Hansen	ENTITY
JH	ENTITY
,	
Nielsen	ENTITY
JB	ENTITY
,	
Petersen	ENTITY
BS	ENTITY
,	
Knudsen	ENTITY
N	ENTITY
,	ENTITY
Djurhuus	ENTITY
JC	ENTITY
.	

Simultaneous	ENTITY
registration	ENTITY
of	
sleep	ENTITY
-	
stages	ENTITY
and	
bladder	ENTITY
activity	ENTITY
in	
enuresis	ENTITY
.	

Urology	ENTITY
1985;26:316–9	
.	

Sakellaropoulou	ENTITY
AV	ENTITY
,	
Hatzistilianou	ENTITY
MN	ENTITY
,	
Emporiadou	ENTITY
MN	ENTITY
,	
et	
al	
.	
Association	ENTITY
between	
primary	ENTITY
nocturnal	ENTITY
enuresis	ENTITY
and	
habitual	ENTITY
snoring	ENTITY
in	
children	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnoea	ENTITY
-	
hypopnoea	ENTITY
syndrome	ENTITY
.	

Arch	ENTITY
Med	ENTITY
Sci	ENTITY
2012;8:521–7	ENTITY
.	

Stone	ENTITY
J	ENTITY
,	
Malone	ENTITY
PS	ENTITY
,	
Atwill	ENTITY
D	ENTITY
,	
et	
al	
.	

Symptoms	ENTITY
of	
sleep	ENTITY
-	
disordered	ENTITY
breathing	ENTITY
in	
children	ENTITY
with	
nocturnal	ENTITY
enuresis	ENTITY
.	

J	
Pediatr	
Urol	
2008;4:197	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Weissbach	ENTITY
A	ENTITY
,	
Leiberman	ENTITY
A	ENTITY
,	
Tarasiuk	ENTITY
A	ENTITY
,	
Goldbart	ENTITY
A	ENTITY
,	
Tal	
A.	
Adenotonsillectomy	
improves	
enuresis	ENTITY
in	
children	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
syndrome	ENTITY
.	

Int	ENTITY
J	ENTITY
Pediatr	ENTITY
Otorhinolaryngol	ENTITY
2006;70:1351–6	ENTITY
.	

Wolfish	ENTITY
N.	ENTITY
Sleep	ENTITY
arousal	ENTITY
function	ENTITY
in	
enuretic	ENTITY
males	ENTITY
.	

Scand	
J	
Urol	
Nephrol	
Suppl	
1999;202:24–6	
.	

Wolfish	ENTITY
NM	ENTITY
,	
Pivik	ENTITY
RT	ENTITY
,	
Busby	ENTITY
KA	ENTITY
.	

Elevated	ENTITY
sleep	ENTITY
arousal	ENTITY
thresholds	ENTITY
in	
enuretic	ENTITY
boys	ENTITY
:	
clinical	ENTITY
implications	
.	

Acta	
Paediatr	
1997;86:381–4	
.	

Yeung	ENTITY
CK	ENTITY
,	
Chiu	ENTITY
HN	ENTITY
,	
Sit	ENTITY
FK	ENTITY
.	

Sleep	ENTITY
disturbance	ENTITY
and	
bladder	ENTITY
dysfunction	ENTITY
in	
enuretic	ENTITY
children	ENTITY
with	
treatment	ENTITY
failure	ENTITY
:	
fact	
or	
fiction	ENTITY
?	

Scand	
J	
Urol	
Nephrol	
Suppl	
1999;202:20–3	
.	

Yeung	ENTITY
CK	ENTITY
,	
Diao	ENTITY
M	ENTITY
,	
Sreedhar	ENTITY
B.	ENTITY
Cortical	ENTITY
arousal	ENTITY
in	
children	ENTITY
with	
severe	ENTITY
enuresis	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2008;359;22–4	ENTITY
.	

Parasomnia	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.44	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.54	ENTITY
The	
essential	
feature	
of	
this	
diagnosis	ENTITY
is	
the	
presence	ENTITY
of	
a	
parasomnia	ENTITY
that	
is	
attrib-	
utable	ENTITY
to	
an	
underlying	
neurological	ENTITY
or	
medical	ENTITY
condition	ENTITY
.	

RBD	ENTITY
is	
the	
parasomnia	ENTITY
most	
commonly	
associated	ENTITY
with	ENTITY
an	
underlying	
neurological	ENTITY
condition	ENTITY
(	
“	
symptomatic	ENTITY
RBD	ENTITY
”	
)	
.	

However	
,	
when	
diagnostic	ENTITY
criteria	ENTITY
for	
RBD	ENTITY
are	
met	
,	
the	
more	
specific	
diagno-	
sis	ENTITY
of	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
should	
be	
made	
.	

Complex	ENTITY
nocturnal	ENTITY
sleep	ENTITY
related	
(	
hypnagogic	ENTITY
and	
hypnopompic	ENTITY
)	ENTITY
visual	ENTITY
hallucina-	ENTITY
tions	ENTITY
can	
occur	
with	
neurological	ENTITY
disorders	ENTITY
such	
as	
narcolepsy	ENTITY
,	
PD	ENTITY
,	
DLB	ENTITY
,	
visual	ENTITY
loss	ENTITY
(	
Charles	
Bonnet	ENTITY
hallucinations	ENTITY
)	
,	
and	
midbrain	ENTITY
and	
diencephalic	ENTITY
pathology	ENTITY
(	
pedun-	
cular	ENTITY
hallucinosis	ENTITY
)	
.	

Dreaming	ENTITY
and	
sleep	ENTITY
paralysis	ENTITY
may	
or	
may	
not	
be	
associated	ENTITY
with	ENTITY
these	
hallucinations	ENTITY
.	

Parasomnia	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
292.85	
(	
drug	ENTITY
-	
induced	ENTITY
)	
;	
291.82	
(	
alcohol	ENTITY
-	
induced	ENTITY
)	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F11	ENTITY
-	
F19	ENTITY
(	
see	
table	
in	
Appendix	ENTITY
B	ENTITY
for	
detailed	
coding	ENTITY
instructions	ENTITY
)	

The	
essential	
feature	
of	
this	
diagnosis	ENTITY
is	
the	
close	
temporal	ENTITY
relationship	ENTITY
between	
expo-	
sure	
to	
a	
drug	ENTITY
,	
medication	ENTITY
,	
or	
biological	ENTITY
substance	ENTITY
and	
the	
onset	
of	
the	
signs	ENTITY
and	
symp-	
toms	ENTITY
of	
that	
disorder	ENTITY
.	

A	
likely	
causal	
relationship	ENTITY
can	
be	
inferred	
if	
signs	ENTITY
and	
symp-	
toms	ENTITY
of	
the	
parasomnia	ENTITY
disappear	
when	
the	
drug	ENTITY
or	
substance	ENTITY
is	
withdrawn	ENTITY
.	

The	
emergent	ENTITY
parasomnia	ENTITY
can	
be	
a	
de	ENTITY
novo	ENTITY
parasomnia	ENTITY
,	
the	
aggravation	ENTITY
of	
a	
chronic	ENTITY
intermittent	
parasomnia	
,	
or	
the	
reactivation	ENTITY
of	
a	
previous	
parasomnia	ENTITY
.	

As	
discussed	
previously	
,	
a	
variety	
of	
medications	ENTITY
and	
biological	ENTITY
substances	ENTITY
,	
including	
selective	
serotonin	ENTITY
reuptake	ENTITY
inhibitors	ENTITY
,	
venlafaxine	ENTITY
,	
tricyclic	ENTITY
antidepressants	ENTITY
,	
mono-	
amine	ENTITY
oxidase	ENTITY
inhibitors	ENTITY
,	
mirtazapine	ENTITY
,	
bisoprolol	ENTITY
,	
selegiline	ENTITY
,	
or	
cholinergic	ENTITY
treatment	ENTITY
for	
Alzheimer	ENTITY
disease	ENTITY
,	
have	
been	
reported	
to	
be	
associated	ENTITY
with	ENTITY
acute	ENTITY
or	
chronic	ENTITY
RBD	ENTITY
.	

Acute	ENTITY
RBD	ENTITY
can	
also	
be	
seen	
during	
states	ENTITY
of	
withdrawal	ENTITY
from	ENTITY
cocaine	ENTITY
,	
amphetamine	ENTITY
,	
alcohol	ENTITY
,	
barbiturate	ENTITY
,	
and	
meprobamate	ENTITY
abuse	ENTITY
.	

Caffeine	ENTITY
and	
chocolate	ENTITY
abuse	ENTITY
have	
been	
implicated	
in	
causing	
or	
unmasking	ENTITY
RBD	ENTITY
.	

However	
,	
when	
diagnostic	ENTITY
criteria	ENTITY
for	
RBD	ENTITY
are	
met	
,	
the	
more	
specific	
diagnosis	ENTITY
of	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
should	
be	
made	
.	

The	
use	
of	
medications	ENTITY
such	
as	
β	
-	
adrenergic	ENTITY
receptor	ENTITY
-	
blocking	ENTITY
agents	ENTITY
can	
be	
associ-	
ated	ENTITY
with	ENTITY
sleep	ENTITY
related	
hallucinations	ENTITY
.	

When	
the	
clinical	ENTITY
presentation	ENTITY
suggests	
a	
direct	
relationship	ENTITY
between	
a	
drug	ENTITY
or	
substance	ENTITY
and	
sleep	ENTITY
related	
hallucinations	ENTITY
,	
a	
diagnosis	ENTITY
of	
parasomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
should	
be	
employed	
.	

Sedative	ENTITY
-	
hypnotics	ENTITY
such	
as	
zolpidem	ENTITY
and	
zopiclone	ENTITY
have	
been	
associated	ENTITY
with	ENTITY
apparent	ENTITY
NREM	ENTITY
parasomnias	ENTITY
including	
SRED	ENTITY
and	
sleep	ENTITY
driving	ENTITY
.	

It	
has	
been	
suggested	
that	
sleep	ENTITY
driving	ENTITY
is	
an	
overlap	ENTITY
behavior	ENTITY
in	
which	
the	
sedative	ENTITY
-	
hypnotic	ENTITY
increases	ENTITY
the	
arousal	ENTITY
threshold	ENTITY
during	
sleep	ENTITY
at	
the	
beginning	
of	
the	
behavior	ENTITY
,	
while	
later	
behavior	ENTITY
is	
due	
to	
the	
CNS	ENTITY
depressing	ENTITY
effects	ENTITY
of	
the	
drug	ENTITY
while	
awake	ENTITY
.	

It	
has	
not	
been	
determined	
if	
drug	ENTITY
-	
re-	ENTITY
lated	ENTITY
NREM	ENTITY
parasomnias	ENTITY
are	
associated	ENTITY
with	ENTITY
the	
same	
genetic	ENTITY
predisposition	ENTITY
,	
priming	ENTITY
factors	ENTITY
,	
and	
triggers	ENTITY
observed	
in	
disorders	ENTITY
of	
arousal	ENTITY
.	

When	
clinical	ENTITY
presentation	ENTITY
sug-	ENTITY
gests	ENTITY
a	
direct	
relationship	ENTITY
between	
disorders	ENTITY
of	
arousal	ENTITY
and	
use	
of	
a	
drug	ENTITY
or	
substance	ENTITY
,	
a	
diagnosis	ENTITY
of	
parasomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
should	
be	
employed	
.	

Alcohol	ENTITY
has	
often	
appeared	
on	
lists	
of	
potential	ENTITY
sleepwalking	ENTITY
triggers	ENTITY
without	
a	
basis	
in	
reliable	
empirical	ENTITY
scientific	ENTITY
research	ENTITY
.	

Recent	
evidence	ENTITY
-	
based	ENTITY
reviews	ENTITY
have	
found	
no	
relationship	ENTITY
between	
alcohol	ENTITY
and	
sleepwalking	ENTITY
.	

The	
behavior	ENTITY
of	
the	
alcohol	ENTITY
-	
in-	
toxicated	ENTITY
individual	ENTITY
may	
superficially	
resemble	
that	
of	
the	
sleepwalker	ENTITY
.	

However	
,	
the	
sleepwalker	ENTITY
is	
typically	
severely	
cognitively	ENTITY
impaired	ENTITY
,	
but	
with	
only	
limited	
motor	ENTITY
impairment	ENTITY
.	

The	
alcohol	ENTITY
-	
intoxicated	ENTITY
individual	ENTITY
’s	
level	ENTITY
of	
cognitive	ENTITY
functioning	ENTITY
may	
be	
reduced	ENTITY
,	
but	
not	
absent	
,	
whereas	
motor	ENTITY
behavior	ENTITY
is	
severely	ENTITY
impaired	ENTITY
.	

Proponents	ENTITY
of	
the	
theory	ENTITY
of	
alcohol	ENTITY
related	ENTITY
sleepwalking	ENTITY
suggest	
that	
the	
effects	ENTITY
of	ENTITY
alcohol	ENTITY
are	
similar	
to	
that	
of	
sleep	ENTITY
deprivation	ENTITY
—	
that	
is	
,	
alcohol	ENTITY
increases	ENTITY
deep	ENTITY
sleep	ENTITY
.	

However	
,	
this	
claim	
in	
not	
substantiated	
by	
sleep	ENTITY
laboratory	ENTITY
-	
based	ENTITY
studies	ENTITY
in	
normal	ENTITY
controls	ENTITY
,	
and	
no	
empirical	ENTITY
sleep	ENTITY
studies	ENTITY
of	
alcohol	ENTITY
and	
sleepwalking	ENTITY
have	
ever	
been	
conducted	
.	

There	
is	
no	
scientific	
evidence	ENTITY
that	
complex	ENTITY
behaviors	ENTITY
occurring	
during	
the	
sleep	ENTITY
period	ENTITY
following	
alcohol	ENTITY
ingestion	ENTITY
are	
anything	
other	
than	
the	
nocturnal	ENTITY
wandering	ENTITY
of	
Parasomnias	ENTITY
Parasomnias	ENTITY
an	
alcohol	ENTITY
-	
intoxicated	ENTITY
individual	ENTITY
.	

Unconsciousness	ENTITY
,	
intoxication	ENTITY
,	
and	
sleep	ENTITY
are	
very	
different	
states	ENTITY
of	
consciousness	ENTITY
.	

Parasomnias	ENTITY
should	
be	
easily	
distinguished	
from	
alcohol	ENTITY
intoxication	ENTITY
by	
the	
presence	ENTITY
of	
significant	ENTITY
alcohol	ENTITY
ingestion	ENTITY
prior	
to	
bedtime	ENTITY
.	

The	
association	ENTITY
of	
therapeutic	ENTITY
doses	ENTITY
of	
sedative	ENTITY
hypnotic	ENTITY
drugs	ENTITY
and	
apparent	ENTITY
para-	
somnias	ENTITY
should	
be	
carefully	
distinguished	
from	
the	
expected	
effects	ENTITY
of	
drug	ENTITY
abuse	ENTITY
or	
misuse	ENTITY
that	
result	
in	
CNS	ENTITY
depression	ENTITY
.	

Investigations	ENTITY
of	
drivers	ENTITY
who	
had	
accidents	ENTITY
attributed	
to	
drug	ENTITY
-	
related	ENTITY
sleep	ENTITY
driving	ENTITY
are	
reported	
to	
show	
that	
(	
1	
)	
blood	ENTITY
levels	ENTITY
of	
prescribed	ENTITY
sedative	ENTITY
hypnotics	ENTITY
exceeded	
therapeutic	ENTITY
ranges	ENTITY
;	
(	
2	
)	
the	
individuals	ENTITY
failed	
to	
take	
the	
medication	ENTITY
at	
the	
correct	
time	ENTITY
or	
remain	
in	
bed	
for	
sufficient	
time	
follow-	
ing	
ingestion	ENTITY
;	
and/or	
(	
3	
)	
the	
individuals	ENTITY
combined	
sedative	ENTITY
-	
hypnotics	ENTITY
with	
other	
CNS	ENTITY
depressants	ENTITY
and/or	
alcohol	ENTITY
.	

Driving	ENTITY
with	
a	
high	ENTITY
blood	ENTITY
level	
of	
a	
sedative	ENTITY
-	
hypnotic	ENTITY
can	
result	
in	
significant	ENTITY
cognitive	ENTITY
and	
motor	ENTITY
impairment	ENTITY
.	

Serious	ENTITY
accidents	ENTITY
can	
result	
.	

Sleep	ENTITY
driving	ENTITY
and	
other	
complex	ENTITY
behaviors	ENTITY
in	
this	
population	ENTITY
are	
more	
likely	
to	
have	
resulted	
from	
drug	ENTITY
misuse	ENTITY
and	
abuse	ENTITY
rather	
than	
true	ENTITY
parasomnias	ENTITY
.	

Parasomnia	ENTITY
,	
Unspecified	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.40	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.50	
This	
diagnosis	ENTITY
is	
intended	
for	
parasomnias	ENTITY
that	
can	
not	
be	
classified	
elsewhere	
or	
for	
cases	ENTITY
in	
which	
the	
physician	ENTITY
has	
a	
clinical	ENTITY
suspicion	ENTITY
of	
a	
parasomnia	ENTITY
but	
is	
unable	
to	
establish	
a	
specific	
diagnosis	ENTITY
.	

In	
many	
cases	ENTITY
,	
“	
parasomnia	ENTITY
,	
unspecified	
”	
will	
be	
a	
tem-	
porary	ENTITY
diagnosis	ENTITY
.	

However	
,	
in	
other	
patients	ENTITY
,	
an	
underlying	
condition	ENTITY
may	
not	
ever	
be	
established	ENTITY
,	
and	
in	
those	
patients	ENTITY
,	
“	
parasomnia	ENTITY
,	
unspecified	ENTITY
”	
should	
remain	
an	
ongoing	
diagnosis	ENTITY
.	

Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Sleep	ENTITY
Talking	
Alternate	ENTITY
Names	ENTITY
Somniloquy	ENTITY
.	

The	
essential	
feature	
is	
talking	ENTITY
,	
with	
varying	
degrees	ENTITY
of	
comprehensibility	ENTITY
,	
during	
sleep	ENTITY
.	

Sleep	ENTITY
talking	ENTITY
may	
occur	
during	
REM	ENTITY
or	
NREM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
talking	ENTITY
can	
be	
idiopathic	ENTITY
or	
associated	ENTITY
with	ENTITY
parasomnias	ENTITY
such	
as	
RBD	ENTITY
or	
disorders	ENTITY
of	
arousal	ENTITY
such	
as	
confusional	ENTITY
arousal	ENTITY
.	

Sleep	ENTITY
talking	ENTITY
may	
follow	
arousals	ENTITY
from	
sleep	ENTITY
or	
more	
rarely	
cause	
them	
.	

Sleep	ENTITY
talking	ENTITY
is	
highly	
prevalent	ENTITY
.	

A	
recent	
cross	ENTITY
-	
sectional	ENTITY
epidemiologic	ENTITY
study	ENTITY
found	
the	
life-	ENTITY
time	ENTITY
prevalence	ENTITY
of	
sleep	ENTITY
talking	ENTITY
to	
be	
66	
%	
and	
current	ENTITY
prevalence	ENTITY
—	
in	
the	
past	
three	
months	ENTITY
—	
to	
be	
17	
%	
.	

There	
is	
no	
apparent	ENTITY
sex	ENTITY
difference	
.	

Onset	ENTITY
and	
course	ENTITY
are	
unknown	
.	

Complications	ENTITY
usually	
arise	
when	
sleep	ENTITY
talking	ENTITY
is	
very	
frequent	ENTITY
or	
loud	ENTITY
or	
if	
the	
content	ENTITY
is	
objectionable	
to	
others	
.	

Sleep	ENTITY
talking	ENTITY
is	
usually	
reported	
by	
the	
bed	ENTITY
partner	ENTITY
or	
someone	ENTITY
sleeping	ENTITY
in	
the	
same	
room	ENTITY
or	
sleeping	ENTITY
area	ENTITY
as	
the	
affected	ENTITY
individual	ENTITY
.	

Sleep	ENTITY
talking	ENTITY
can	
disrupt	ENTITY
the	
sleep	ENTITY
of	
a	
bed	ENTITY
partner	ENTITY
,	
roommate	ENTITY
,	
or	
others	
in	
a	
group	ENTITY
-	
sleeping	ENTITY
situation	ENTITY
(	
such	
as	
college	ENTITY
dormitories	ENTITY
,	
military	ENTITY
barracks	ENTITY
,	
fire	ENTITY
stations	ENTITY
,	
or	
a	
tent	ENTITY
while	
camping	ENTITY
)	
.	

The	
content	ENTITY
of	
sleep	ENTITY
talking	ENTITY
has	
not	
been	
shown	
to	
reflect	
actual	ENTITY
prior	
waking	ENTITY
behavior	ENTITY
or	
memories	ENTITY
.	

The	
sleep	ENTITY
talker	ENTITY
is	
rarely	
aware	
of	
his	
or	
her	
sleep	ENTITY
talking	ENTITY
.	

Nocturnal	ENTITY
vocalization	ENTITY
,	
including	
frank	ENTITY
sleep	ENTITY
talking	ENTITY
,	
is	
often	
seen	
in	
patients	ENTITY
with	
RBD	ENTITY
and	
subclinical	ENTITY
RBD	ENTITY
.	

A	
recent	
report	
notes	
that	
sleep	ENTITY
talking	ENTITY
may	
be	
a	
useful	
diagnostic	ENTITY
marker	ENTITY
for	
differentiating	
DLB	ENTITY
from	
Alzheimer	ENTITY
disease	ENTITY
and	
other	
types	
of	
dementia	ENTITY
.	

The	
vocalizations	ENTITY
of	
RBD	ENTITY
may	
be	
loud	ENTITY
,	
emotional	ENTITY
,	
profane	ENTITY
,	
and	
associated	ENTITY
with	ENTITY
behav-	
iors	ENTITY
that	
correlate	ENTITY
with	
remembered	
dream	ENTITY
mentation	ENTITY
.	

Nocturnal	ENTITY
seizures	ENTITY
may	
be	
asso-	
ciated	ENTITY
with	
vocalization	ENTITY
that	
tends	
to	
be	
stereotypic	ENTITY
.	

The	
vocalizations	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
terrors	ENTITY
are	
emotionally	
laden	ENTITY
and	
associated	ENTITY
with	ENTITY
behaviors	ENTITY
of	
intense	ENTITY
arousal	ENTITY
and	
agitation	ENTITY
.	

In	
PTSD	ENTITY
,	
increased	ENTITY
vocalizations	ENTITY
during	
sleep	ENTITY
have	
been	
described	
.	

Bibliography	ENTITY
Arkin	ENTITY
AM	ENTITY
,	
Toth	ENTITY
MF	ENTITY
,	
Baker	ENTITY
J	ENTITY
,	
Hastey	ENTITY
JM	ENTITY
.	

The	
frequency	ENTITY
of	
sleep	ENTITY
talking	ENTITY
in	
the	
laboratory	ENTITY
among	
chronic	ENTITY
sleep	ENTITY
talkers	ENTITY
and	
good	
dream	ENTITY
recallers	ENTITY
.	

J	
Nerv	
Ment	
Dis	
1970;151:369–74	
.	

Bjorvatn	ENTITY
B	ENTITY
,	
Grønli	ENTITY
J	ENTITY
,	
Pallesen	
S.	
Prevalence	
of	
different	
parasomnias	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:1031–4	
.	

Parasomnias	ENTITY
Parasomnias	ENTITY
Honda	ENTITY
K	ENTITY
,	ENTITY
Hashimoto	ENTITY
M	ENTITY
,	
Yatabe	ENTITY
Y	ENTITY
,	
et	
al	
.	

The	
usefulness	ENTITY
of	
monitoring	ENTITY
sleep	ENTITY
talking	ENTITY
for	
the	
diagnosis	ENTITY
of	
Dementia	ENTITY
with	
Lewy	ENTITY
bodies	ENTITY
.	

Int	ENTITY
Psychogeriatr	ENTITY
2013;25:851–8	
.	

Hublin	ENTITY
C	ENTITY
,	
Kaprio	ENTITY
J	ENTITY
,	
Partinen	ENTITY
M	ENTITY
,	
Koskenvuo	ENTITY
M.	ENTITY
Sleeptalking	ENTITY
in	
twins	ENTITY
:	
epidemiology	ENTITY
and	
psychiatric	ENTITY
comorbidity	ENTITY
.	

Behav	ENTITY
Genet	ENTITY
1998;28:289–98	ENTITY
.	

Reimao	ENTITY
RN	ENTITY
,	
Lefevre	ENTITY
AB	ENTITY
.	

Prevalence	ENTITY
of	
sleep	ENTITY
-	
talking	ENTITY
in	
childhood	ENTITY
.	

Brain	ENTITY
Dev	ENTITY
1980;2:353–7	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Restless	ENTITY
Legs	ENTITY
Syndrome282	
Periodic	
Limb	
Movement	
Disorder	
292	
Sleep	
Related	
Leg	
Cramps	

299	
Sleep	ENTITY
Related	ENTITY
Bruxism303	ENTITY
Sleep	ENTITY
Related	ENTITY
Rhythmic	ENTITY
Movement	ENTITY
Disorder312	ENTITY
Benign	ENTITY
Sleep	ENTITY
Myoclonus	ENTITY
of	ENTITY
Infancy	ENTITY
317	
Propriospinal	ENTITY
Myoclonus	ENTITY
at	
Sleep	ENTITY
Onset321	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder325	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
.....	
326	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
,	
Unspecified327	ENTITY
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Excessive	ENTITY
Fragmentary	ENTITY
Myoclonus	ENTITY
328	ENTITY
Hypnagogic	ENTITY
Foot	ENTITY
Tremor	ENTITY
and	
Alternating	ENTITY
Leg	ENTITY
Muscle	ENTITY
Activation	
330	
Sleep	
Starts	
(	
Hypnic	ENTITY
Jerks)335	ENTITY

Sleep	ENTITY
related	ENTITY
movement	ENTITY
disorders	ENTITY
are	
primarily	
characterized	ENTITY
by	
relatively	
simple	
,	
usually	
stereotyped	ENTITY
,	
movements	ENTITY
that	
disturb	ENTITY
sleep	ENTITY
or	
its	
onset	
.	

Restless	ENTITY
legs	ENTITY
syndrome	ENTITY
(	
RLS	ENTITY
)	
is	
an	
exception	
in	
that	
patients	ENTITY
typically	
engage	
in	
walking	ENTITY
or	
nonstereotypic	ENTITY
limb	ENTITY
movement	ENTITY
to	
reduce	ENTITY
leg	ENTITY
discomfort	ENTITY
.	

However	
,	
RLS	ENTITY
is	
closely	
associated	ENTITY
with	ENTITY
periodic	ENTITY
limb	ENTITY
movements	ENTITY
(	
PLMs	ENTITY
)	
,	
which	
are	
usually	
simple	
and	
stereotyped	ENTITY
within	
a	
series	ENTITY
.	

Nocturnal	ENTITY
sleep	ENTITY
disturbance	ENTITY
or	
complaints	ENTITY
of	
daytime	ENTITY
sleepiness	ENTITY
or	
fatigue	ENTITY
are	
a	
prerequisite	
for	
a	
diagnosis	ENTITY
of	
a	
sleep	ENTITY
related	
movement	ENTITY
disorder	ENTITY
.	

For	
example	
,	
many	
normal	ENTITY
sleepers	ENTITY
exhibit	
episodes	ENTITY
of	
periodic	ENTITY
limb	ENTITY
movements	
of	
sleep	
(	
PLMS	ENTITY
)	
but	
have	
no	ENTITY
complaint	ENTITY
of	
a	
sleep	ENTITY
disturbance	ENTITY
,	
nor	
do	
they	
show	
a	
significant	
objective	ENTITY
dis-	
turbance	ENTITY
of	
their	
sleep	ENTITY
as	
a	
result	
of	
the	
movements	ENTITY
.	

Such	
persons	ENTITY
should	
not	
be	
classi-	
fied	ENTITY
as	
having	
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
(	
PLMD	ENTITY
)	
,	
but	
instead	
,	
the	
presence	ENTITY
of	
PLMS	ENTITY
should	
simply	
be	
noted	
.	

Similar	
considerations	ENTITY
relate	
to	
the	
distinction	
between	
rhythmic	ENTITY
movement	
disorder	
and	
the	
presence	ENTITY
of	
rhythmic	ENTITY
movements	ENTITY
.	

Body	ENTITY
movements	ENTITY
that	
disturb	ENTITY
sleep	ENTITY
also	
are	
seen	
in	
many	
other	
sleep	ENTITY
disorder	ENTITY
categories	ENTITY
(	
e.g.	
,	
in	
parasomnias	ENTITY
such	
as	
sleepwalking	ENTITY
,	
sleep	ENTITY
terrors	ENTITY
,	
and	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
(	
REM	
)	
sleep	
behavior	
disorder	
(	
RBD	ENTITY
)	
)	
.	

However	
,	
these	
parasomnias	ENTITY
differ	
from	
the	
simple	
ste-	
reotyped	ENTITY
movements	
categorized	
as	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
in	
that	
they	
involve	
complex	ENTITY
behaviors	ENTITY
during	
the	
sleep	ENTITY
period	ENTITY
.	

Parasomnia	ENTITY
-	
related	ENTITY
movements	ENTITY
may	
appear	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
purposeful	ENTITY
and	
goal	ENTITY
directed	
,	
but	
are	
outside	
the	
conscious	ENTITY
awareness	ENTITY
of	
the	
individual	ENTITY
.	

Parasomnias	ENTITY
are	
listed	
in	
a	
separate	
section	ENTITY
from	
the	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
.	

Although	
the	
history	ENTITY
may	
be	
diagnostic	ENTITY
,	
polysomnography	ENTITY
is	
sometimes	
necessary	
to	
make	
a	
firm	
diagnosis	ENTITY
of	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
and	
distinguish	
them	
from	
parasomnias	ENTITY
.	

In	
these	
cases	ENTITY
,	
it	
is	
necessary	
to	
add	
all	
-	
night	ENTITY
video	ENTITY
recording	ENTITY
to	
the	
poly-	
somnographic	ENTITY
recording	ENTITY
and	
to	
correlate	ENTITY
the	
documented	ENTITY
movements	ENTITY
with	
the	
techni-	
cian	
’s	
description	ENTITY
of	
the	
patient	ENTITY
’s	ENTITY
behavior	ENTITY
and	
level	ENTITY
of	
consciousness	ENTITY
in	
order	
to	
estab-	
lish	ENTITY
a	
diagnosis	ENTITY
.	

There	
are	
some	
movement	ENTITY
disorders	ENTITY
that	
may	
occur	
during	
both	
sleep	ENTITY
and	
wakefulness	ENTITY
.	

If	
the	
presentation	ENTITY
during	
sleep	ENTITY
is	
significantly	
different	
from	
that	
during	
wakefulness	ENTITY
,	
or	
if	
the	
movement	ENTITY
is	
entirely	
confined	
to	
sleep	ENTITY
,	
then	
the	
move-	
ment	ENTITY
disorder	ENTITY
is	
classified	
here	
(	
e.g.	
,	
the	
occurrence	ENTITY
of	
bruxism	ENTITY
exclusively	
in	
sleep	ENTITY
)	
.	

Restless	ENTITY
Legs	ENTITY
Syndrome	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
333.94	
Alternate	ENTITY
Names	ENTITY
Willis	ENTITY
-	
Ekbom	ENTITY
disease	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G25.81	ENTITY
A.	
An	
urge	ENTITY
to	
move	
the	
legs	ENTITY
,	
usually	
accompanied	
by	
or	
thought	
to	
be	
caused	
by	
uncomfortable	ENTITY
and	
unpleasant	ENTITY
sensations	ENTITY
in	
the	
legs.1,2	ENTITY
These	
symptoms	ENTITY
must	
:	
.	

Begin	ENTITY
or	
worsen	ENTITY
during	
periods	ENTITY
of	
rest	ENTITY
or	
inactivity	ENTITY
such	
as	
lying	
down	
or	
sitting	ENTITY
;	
.	

Be	ENTITY
partially	ENTITY
or	
totally	
relieved	
by	
movement	ENTITY
,	
such	
as	
walking	ENTITY
or	
stretching	ENTITY
,	
at	
least	
as	
long	
as	
the	
activity	ENTITY
continues;3	
and	
.	

Occur	ENTITY
exclusively	
or	
predominantly	
in	
the	
evening	ENTITY
or	
night	ENTITY
rather	
than	
during	
the	
day.4	
B.	
The	
above	
features	ENTITY
are	
not	
solely	
accounted	
for	
as	
symptoms	ENTITY
of	
another	
medical	ENTITY
or	
a	
behavioral	ENTITY
condition	
(	
e.g.	
,	
leg	ENTITY
cramps	ENTITY
,	
positional	ENTITY
discomfort	ENTITY
,	
myalgia	ENTITY
,	
venous	ENTITY
stasis	ENTITY
,	
leg	ENTITY
edema	ENTITY
,	
arthritis	ENTITY
,	
habitual	ENTITY
foot	ENTITY
tapping	ENTITY
)	
.	

C.	

The	
symptoms	ENTITY
of	
RLS	ENTITY
cause	
concern	
,	
distress	ENTITY
,	
sleep	ENTITY
disturbance	ENTITY
,	
or	
impairment	ENTITY
in	
mental	ENTITY
,	
physical	ENTITY
,	
social	ENTITY
,	
occupational	ENTITY
,	
educational	ENTITY
,	
behavioral	ENTITY
,	
or	
other	
important	
areas	
of	
functioning.5	ENTITY
Notes	ENTITY
.	

Sometimes	
the	
urge	ENTITY
to	
move	
the	
legs	ENTITY
is	
present	
without	
the	
uncomfortable	ENTITY
sensations	ENTITY
,	
and	
sometimes	
the	
arms	ENTITY
or	
other	
parts	
of	
the	
body	ENTITY
are	
involved	
in	
addition	
to	
the	
legs	ENTITY
.	
.	

For	
children	ENTITY
,	
the	
description	ENTITY
of	
these	
symptoms	ENTITY
should	
be	
in	
the	
child	ENTITY
’s	
own	
words	ENTITY
.	
.	

When	
symptoms	ENTITY
are	
very	
severe	ENTITY
,	
relief	ENTITY
by	
activity	ENTITY
may	
not	
be	
noticeable	
but	
must	
have	
been	
previously	
present	
.	
.	

As	
a	
result	
of	
severity	ENTITY
,	
treatment	ENTITY
intervention	ENTITY
,	
or	
treatment	ENTITY
-	
induced	ENTITY
augmentation	ENTITY
,	
the	
worsening	ENTITY
in	
the	
evening	ENTITY
or	
night	ENTITY
may	
not	
be	
noticeable	
but	
must	
have	
been	
previously	
present	
.	
.	

For	
certain	
research	ENTITY
applications	
,	
such	
as	
genetic	ENTITY
or	
epidemiological	ENTITY
studies	ENTITY
,	
it	
may	
be	
appropriate	
to	
omit	
criterion	ENTITY
C.	

If	
so	
,	
this	
should	
be	
clearly	
stated	
in	
the	
research	ENTITY
report	ENTITY
.	

Essential	ENTITY
Features	ENTITY
RLS	ENTITY
is	
a	
sensorimotor	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
a	
complaint	ENTITY
of	
a	
strong	ENTITY
,	
nearly	
irresist-	
ible	ENTITY
urge	ENTITY
to	
move	
the	
limbs	ENTITY
.	

This	
urge	
to	
move	
is	
often	
but	
not	
always	
accompanied	
by	
other	
uncomfortable	ENTITY
sensations	ENTITY
felt	
deep	ENTITY
inside	ENTITY
the	
limbs	ENTITY
or	
by	
a	
feeling	
that	
is	
simply	
difficult	
or	
impossible	
to	
describe	
.	

Although	
the	
legs	ENTITY
are	
most	
prominently	
affected	ENTITY
,	
“	
restless	ENTITY
legs	ENTITY
”	
is	
a	
misnomer	
,	
in	
that	
21	
%	
to	
57	
%	
of	
individuals	ENTITY
with	
RLS	ENTITY
describe	
some	
arm	ENTITY
sensations	ENTITY
.	

The	
most	
common	
adult	ENTITY
RLS	ENTITY
descriptors	ENTITY
in	
English	ENTITY
are	
“	
rest-	ENTITY
less	ENTITY
,	
”	
“	
uncomfortable	ENTITY
,	
”	
“	
twitchy	ENTITY
,	
”	
“	
need	
to	
stretch	ENTITY
,	
”	
“	
urge	ENTITY
to	
move	
,	
”	
and	
“	
legs	ENTITY
want	
to	
move	
on	
their	
own	
.	
”	

About	
half	
express	ENTITY
their	
RLS	ENTITY
sensations	ENTITY
as	
painful	ENTITY
.	

“	
Numb	ENTITY
”	
and	
“	
cold	ENTITY
”	
are	
very	
uncommon	ENTITY
descriptors	ENTITY
for	
RLS	ENTITY
.	

Criteria	ENTITY
A1	ENTITY
-	
3	
specify	
the	
necessary	
characteristics	ENTITY
of	
the	
RLS	ENTITY
sensations	ENTITY
:	
worse	ENTITY
at	
rest	ENTITY
,	
better	
with	
movement	ENTITY
,	
and	
predominant	ENTITY
occurrence	ENTITY
in	
the	
evening	ENTITY
or	
night	ENTITY
.	

The	
separation	ENTITY
of	
worsening	ENTITY
at	
rest	ENTITY
(	
criterion	ENTITY
A1	ENTITY
)	
from	
worsening	ENTITY
in	
the	
evening/	ENTITY
night	ENTITY
(	
criterion	ENTITY
A3	
)	
is	
based	
on	
circadian	ENTITY
rhythm	ENTITY
studies	
that	
show	
an	
increase	ENTITY
at	
night	ENTITY
,	
independent	
of	
activity	ENTITY
level	ENTITY
.	

RLS	ENTITY
must	
be	
differentiated	
from	
other	
condi-	
tions	ENTITY
that	
can	
mimic	
RLS	ENTITY
(	
criterion	ENTITY
B	ENTITY
)	
.	

Clinically	ENTITY
significant	ENTITY
RLS	ENTITY
is	
defined	
by	
RLS	ENTITY
symptoms	ENTITY
causing	
substantial	ENTITY
distress	ENTITY
,	
sleep	ENTITY
disturbance	ENTITY
,	
or	
impairment	ENTITY
of	ENTITY
function	ENTITY
(	
criterion	ENTITY
C	ENTITY
)	
.	

Associated	ENTITY
Features	ENTITY
Disturbed	ENTITY
sleep	ENTITY
is	
a	
common	
,	
prominent	ENTITY
,	
and	
distressing	ENTITY
aspect	ENTITY
of	
RLS	ENTITY
.	

Sleep	ENTITY
onset	ENTITY
and	
maintenance	ENTITY
complaints	ENTITY
in	
individuals	ENTITY
with	
RLS	ENTITY
are	
notably	
higher	
than	
in	
con-	ENTITY
trols	ENTITY
,	
with	
odds	ENTITY
ratios	ENTITY
(	
OR	ENTITY
)	
between	
1.7	
and	
3.5	
.	

In	
clinical	ENTITY
populations	ENTITY
,	
disturbed	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
sleep	
is	
reported	
in	
60	
%	
to	
90	
%	
of	
individuals	ENTITY
with	
RLS	ENTITY
,	
is	
typically	
the	
most	
trou-	
bling	ENTITY
symptom	ENTITY
,	
and	
is	
often	
the	
primary	
reason	
for	
seeking	
medical	ENTITY
care	ENTITY
.	

The	
Medical	ENTITY
Outcomes	ENTITY
Study	ENTITY
Sleep	ENTITY
Questionnaire	ENTITY
scores	ENTITY
for	
sleep	ENTITY
quantity	ENTITY
,	
sleep	ENTITY
disturbance	ENTITY
,	
sleep	ENTITY
adequacy	ENTITY
,	
and	
sleep	ENTITY
problems	ENTITY
are	
significantly	
worse	
for	
RLS	ENTITY
patients	ENTITY
than	
con-	ENTITY
trols	ENTITY
.	

Daytime	ENTITY
fatigue	ENTITY
and	
daytime	ENTITY
sleepiness	ENTITY
are	
also	
common	
complaints	ENTITY
;	
however	
,	
the	
sleepiness	ENTITY
is	
not	
as	
severe	ENTITY
as	
expected	
for	
the	
degree	ENTITY
of	
sleep	ENTITY
disruption	ENTITY
,	
implying	
hyperarousal	ENTITY
in	
RLS	ENTITY
.	

In	
contrast	
to	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
scores	ENTITY
in	
RLS	ENTITY
are	
typically	
in	
the	
normal	ENTITY
range	ENTITY
,	
and	
either	
no	
different	
or	
marginally	
elevated	ENTITY
when	
compared	ENTITY
to	
normal	ENTITY
controls	ENTITY
.	

Clinical	ENTITY
sleep	ENTITY
disturbance	ENTITY
correlates	
with	
both	
severity	ENTITY
of	
RLS	ENTITY
and	
health	ENTITY
impact	ENTITY
of	
RLS	ENTITY
.	

Some	
individuals	ENTITY
with	
RLS	ENTITY
may	
choose	
to	
work	
at	
night	ENTITY
,	
thereby	
shifting	
quiet	
activities	ENTITY
and	
their	
sleep	ENTITY
schedule	ENTITY
away	
from	
the	
circadian	ENTITY
peak	ENTITY
of	
their	
RLS	ENTITY
symptoms	ENTITY
.	

PLMs	ENTITY
,	
a	
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
,	
and	
response	ENTITY
to	
dopaminergic	ENTITY
therapy	ENTITY
are	
supportive	
of	
the	
diagnosis	ENTITY
.	

Periodic	ENTITY
limb	ENTITY
movements	ENTITY
can	
occur	
in	
sleep	ENTITY
(	
PLMS	ENTITY
)	
or	
wakeful-	
ness	ENTITY
(	
PLMW	ENTITY
)	
.	

PLMW	ENTITY
occur	
during	
quiet	
rest	ENTITY
and	
frequently	
at	
the	
transition	ENTITY
between	
waking	ENTITY
and	
sleep	ENTITY
,	
disrupting	ENTITY
sleep	ENTITY
onset	ENTITY
or	
the	
return	ENTITY
to	ENTITY
sleep	ENTITY
.	

PLMS	ENTITY
are	
frequently	
associated	ENTITY
with	ENTITY
arousal	ENTITY
from	
sleep	ENTITY
.	

RLS	ENTITY
sensory	ENTITY
and	
motor	ENTITY
features	ENTITY
respond	
initially	
to	
treatment	ENTITY
with	
dopaminergic	ENTITY
therapy	ENTITY
in	
almost	
all	
cases	ENTITY
.	

Multiple	ENTITY
clinic	ENTITY
-	
based	ENTITY
and	
population	ENTITY
-	
based	ENTITY
studies	ENTITY
have	
shown	
an	
increased	ENTITY
preva-	
lence	
of	
mood	ENTITY
and	
anxiety	ENTITY
disorders	ENTITY
in	
individuals	ENTITY
with	
RLS	ENTITY
.	

Most	
controlled	ENTITY
studies	ENTITY
using	
validated	
assessments	ENTITY
have	
shown	
significantly	
increased	ENTITY
ORs	ENTITY
for	
moderately	ENTITY
or	
highly	
elevated	ENTITY
depressive	ENTITY
symptoms	ENTITY
(	
OR	ENTITY
1.95	
and	
3.67	
)	
,	
major	ENTITY
depression	ENTITY
(	
OR	ENTITY
2.6	
)	
,	
major	ENTITY
depressive	ENTITY
disorder	ENTITY
(	
OR	ENTITY
2.57	
and	
4.7	
)	
,	
generalized	ENTITY
anxiety	ENTITY
disorder	ENTITY
(	
OR	ENTITY
3.5	
)	
,	
panic	ENTITY
disorder	ENTITY
(	
OR	ENTITY
4.7	
,	
12.9	
,	
and	
18.9	
)	
,	
and	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
(	
OR	ENTITY
3.76	
)	
.	

In	
addition	
,	
a	
positive	ENTITY
correlation	ENTITY
has	
been	
found	
between	
the	
severity	ENTITY
of	
RLS	ENTITY
and	
depression	ENTITY
/	
anxiety	ENTITY
symptoms	ENTITY
.	

Relevant	ENTITY
to	
the	
RLS	ENTITY
-	
depression	ENTITY
relationship	ENTITY
is	
the	
emerging	
evidence	ENTITY
that	
treatment	ENTITY
of	
RLS	ENTITY
improves	
depressive	ENTITY
symptoms	ENTITY
.	

Similarly	
,	
increased	ENTITY
rates	ENTITY
of	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
(	
ADHD	ENTITY
)	
have	
been	
found	
in	
RLS	ENTITY
,	
both	
in	
pediatric	ENTITY
and	
adult	ENTITY
studies	ENTITY
.	

Emerging	
data	ENTITY
indicate	
that	
about	
one	
fourth	
of	
individuals	ENTITY
with	
RLS	ENTITY
have	
ADHD	ENTITY
symptoms	ENTITY
,	
and	
conversely	
,	
that	
12	
%	
to	
35	
%	
of	
those	
with	
ADHD	ENTITY
meet	
criteria	ENTITY
for	
RLS	ENTITY
.	

Other	
medical	ENTITY
condi-	
tions	ENTITY
for	
which	
there	
is	
some	
evidence	ENTITY
for	
greater	ENTITY
-	
than	
-	
chance	ENTITY
association	ENTITY
include	
narcolepsy	ENTITY
,	
migraine	ENTITY
,	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
multiple	ENTITY
sclerosis	ENTITY
,	
peripheral	ENTITY
neuropathy	ENTITY
,	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
diabetes	ENTITY
melli-	
tus	ENTITY
,	
fibromyalgia	ENTITY
,	
rheumatoid	ENTITY
arthritis	ENTITY
,	
nocturnal	ENTITY
eating	ENTITY
,	
obesity	ENTITY
,	
thyroid	ENTITY
disease	ENTITY
,	
and	
heart	ENTITY
disease	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Evidence	ENTITY
in	
the	
literature	ENTITY
is	
not	
sufficient	
to	
support	
well	
-	
defined	
subtypes	ENTITY
of	
RLS	ENTITY
.	

Early	ENTITY
-	
onset	ENTITY
RLS	ENTITY
(	
prior	
to	
age	ENTITY
45	
years	ENTITY
)	
is	
more	
familial	ENTITY
and	
associated	ENTITY
with	ENTITY
slower	
progression	ENTITY
than	
late	ENTITY
-	
onset	ENTITY
RLS	ENTITY
.	

In	
addition	
,	
the	
classification	ENTITY
of	
“	
secondary	ENTITY
”	
RLS	ENTITY
has	
been	
suggested	
when	
the	
condition	ENTITY
occurs	
in	
association	ENTITY
with	
iron	ENTITY
deficiency	ENTITY
,	
preg-	
nancy	
,	
and	
chronic	ENTITY
renal	ENTITY
failure	ENTITY
,	
but	
this	
construct	ENTITY
has	
been	
challenged	
based	
on	
patho-	
physiological	ENTITY
,	
family	ENTITY
history	ENTITY
,	
genetic	ENTITY
,	
and	
clinical	ENTITY
course	ENTITY
data	ENTITY
.	

Demographics	ENTITY
The	
overall	ENTITY
prevalence	ENTITY
of	
RLS	ENTITY
has	
been	
estimated	ENTITY
at	
5	
%	
to	
10	
%	
in	
European	ENTITY
and	
North	ENTITY
American	ENTITY
population	ENTITY
-	
based	ENTITY
studies	ENTITY
.	

However	
,	
in	
Asian	ENTITY
countries	ENTITY
,	
studies	ENTITY
thus	
far	
indicate	
a	
lower	
prevalence	ENTITY
.	

Prevalence	ENTITY
is	
about	
twice	
as	
high	
in	
women	ENTITY
than	
in	
men	ENTITY
.	

In	
most	
studies	ENTITY
,	
prevalence	ENTITY
increases	ENTITY
with	
age	ENTITY
up	
to	
60	
-	
70	
years	ENTITY
,	
except	
in	
Asian	ENTITY
populations	ENTITY
where	
an	
age	ENTITY
-	
related	ENTITY
increase	ENTITY
has	
not	
been	
found	
.	

Various	
measures	ENTITY
of	
clinical	ENTITY
significance	ENTITY
such	
as	
frequency	ENTITY
(	
1	
-	
2	
times	ENTITY
/	
week	ENTITY
)	
,	
severity	ENTITY
(	
moderate	ENTITY
to	
severe	ENTITY
distress	ENTITY
)	
,	
differential	ENTITY
diagnosis	ENTITY
,	
and	
impact	ENTITY
have	
been	
applied	
to	
population	ENTITY
-	
based	ENTITY
studies	ENTITY
.	

These	
analyses	ENTITY
indicate	
the	
prevalence	ENTITY
of	
clinically	ENTITY
significant	ENTITY
RLS	ENTITY
to	
be	
2	
%	
to	
3	
%	
in	
Europe	ENTITY
and	
North	ENTITY
America	ENTITY
,	
but	
lower	
in	
Asia	ENTITY
.	

Annual	ENTITY
incidence	ENTITY
rates	ENTITY
have	
been	
reported	
as	
0.8	
%	
to	
2.2	
%	
.	

Pediatric	ENTITY
prevalence	ENTITY
rates	ENTITY
are	
2	
%	
to	
4	
%	
in	
UK	ENTITY
/	
US	ENTITY
and	
Turkish	ENTITY
studies	ENTITY
,	
with	
moderate	ENTITY
to	
severe	ENTITY
RLS	ENTITY
in	
about	
0.5	
%	
to	
1	
%	
.	

Adolescents	ENTITY
are	
more	
likely	
to	
have	
moderate	ENTITY
to	
severe	ENTITY
RLS	ENTITY
symptoms	ENTITY
than	
younger	ENTITY
children	ENTITY
—	
one	
half	
of	
12-	
to	
17	
-	
year	ENTITY
-	
olds	ENTITY
com-	
pared	
to	
one	
fourth	
of	
8-	
to	
11	
-	
year	ENTITY
-	
olds	ENTITY
with	
RLS	ENTITY
.	

Boys	ENTITY
are	
affected	ENTITY
as	
often	
as	
girls	ENTITY
,	
with	
the	
sex	ENTITY
difference	ENTITY
not	
emerging	
until	
the	
late	ENTITY
teens	ENTITY
or	
twenties	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
A	
positive	ENTITY
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
,	
the	
genetic	ENTITY
variants	ENTITY
noted	
below	
,	
and	
female	ENTITY
sex	ENTITY
confer	
increased	ENTITY
risk	ENTITY
for	
RLS	ENTITY
.	

The	
best	
characterized	
precipitating	ENTITY
factors	ENTITY
are	
iron	ENTITY
deficiency	ENTITY
,	
certain	
medications	ENTITY
,	
pregnancy	ENTITY
,	
chronic	ENTITY
renal	ENTITY
failure	ENTITY
,	
and	
prolonged	ENTITY
immo-	
bility	ENTITY
.	

Mild	ENTITY
iron	ENTITY
deficiency	ENTITY
,	
characterized	
by	
serum	ENTITY
ferritin	ENTITY
below	
50	
μg	
/	
L	ENTITY
,	
has	
been	
associated	ENTITY
with	ENTITY
increased	ENTITY
severity	ENTITY
of	
RLS	ENTITY
,	
and	
repletion	ENTITY
of	
iron	ENTITY
stores	ENTITY
from	
below	
50	
-	
75	
μg	
/	
L	ENTITY
has	
been	
found	
to	
diminish	
RLS	ENTITY
symptoms	ENTITY
.	

Medications	ENTITY
that	
may	
precip-	
itate	ENTITY
or	
aggravate	ENTITY
RLS	ENTITY
and/or	
PLMS	ENTITY
include	
sedating	ENTITY
antihistamines	ENTITY
,	
some	
centrally	
active	
dopamine	ENTITY
receptor	ENTITY
antagonists	ENTITY
,	
and	
most	
antidepressants	ENTITY
.	

An	
exception	ENTITY
is	
the	
antidepressant	ENTITY
bupropion	ENTITY
,	
with	
its	
dopamine	ENTITY
-	
promoting	ENTITY
activity	ENTITY
.	

The	
prevalence	ENTITY
of	
RLS	ENTITY
during	
pregnancy	ENTITY
is	
two	
to	
three	
times	
greater	
than	
in	
the	
general	ENTITY
population	ENTITY
.	

There	
is	
a	
peak	
in	
the	
number	
of	
women	ENTITY
affected	ENTITY
by	
RLS	ENTITY
in	
the	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
third	ENTITY
trimester	ENTITY
,	
with	
resolution	ENTITY
of	
symptoms	ENTITY
for	
most	
,	
but	
not	
all	
,	
by	
one	
month	ENTITY
after	
delivery	ENTITY
.	

Independent	ENTITY
predictors	ENTITY
of	
RLS	ENTITY
during	
pregnancy	ENTITY
are	
a	
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
(	
OR	ENTITY
8.43	
)	
,	
a	
history	ENTITY
of	
RLS	ENTITY
in	
prior	
pregnancy	ENTITY
(	
OR	ENTITY
53.74	
)	
,	
a	
history	ENTITY
of	
RLS	ENTITY
in	
the	
past	
(	
OR	ENTITY
12.91	
)	
,	
and	
hemoglobin	ENTITY
≤11	
g	ENTITY
/	
dL	ENTITY
(	
OR	ENTITY
2.05	
)	
.	

Parity	ENTITY
,	
the	
number	
of	
previous	
pregnancies	ENTITY
,	
appears	
to	
account	
for	
the	
2:1	
sex	ENTITY
difference	
between	
women	ENTITY
and	
men	ENTITY
in	
the	
general	ENTITY
population	ENTITY
prevalence	ENTITY
of	
RLS	ENTITY
.	

In	
chronic	ENTITY
renal	ENTITY
failure	ENTITY
patients	ENTITY
,	
the	
prevalence	ENTITY
of	
RLS	ENTITY
is	
two	
to	
five	
times	
greater	
than	
in	
the	
general	ENTITY
population	ENTITY
.	

This	
represents	
prevalence	ENTITY
rates	ENTITY
of	
11	
%	
to	
58	
%	
in	
US	ENTITY
and	
European	ENTITY
chronic	ENTITY
renal	ENTITY
failure	ENTITY
clinics	ENTITY
.	

Compared	
to	
patients	ENTITY
with	
chronic	ENTITY
renal	ENTITY
failure	ENTITY
without	
RLS	ENTITY
,	
those	
with	
RLS	ENTITY
have	
greater	
sleep	ENTITY
disturbance	ENTITY
,	
report	ENTITY
poorer	
quality	ENTITY
of	ENTITY
life	ENTITY
,	
and	
more	
frequently	
discontinue	ENTITY
dialysis	ENTITY
prematurely	
.	

Typically	
,	
RLS	ENTITY
symptoms	ENTITY
improve	ENTITY
dramatically	
within	
one	
month	ENTITY
after	
kidney	ENTITY
transplantation	ENTITY
but	
become	
severe	ENTITY
again	
with	
transplant	ENTITY
failure	ENTITY
.	

There	
is	
limited	
or	
contradictory	
evidence	ENTITY
for	
sleep	ENTITY
deprivation	ENTITY
,	
peripheral	ENTITY
neuropathy	ENTITY
,	
radiculopathy	ENTITY
,	
pain	ENTITY
,	
caffeine	ENTITY
,	
tobacco	ENTITY
,	
or	
alcohol	
as	
exacerbating	ENTITY
factors	ENTITY
for	
RLS	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Early	ENTITY
-	
onset	ENTITY
RLS	ENTITY
is	
highly	
familial	ENTITY
,	
with	
40	
%	
to	
92	
%	
of	
cases	ENTITY
reporting	
affected	ENTITY
family	ENTITY
members	ENTITY
.	

High	
concordance	ENTITY
rates	ENTITY
are	
observed	
in	
monozygotic	ENTITY
twins	ENTITY
.	

The	
risk	ENTITY
of	
RLS	ENTITY
is	
two	
to	
six	
times	
greater	
for	
first	
-	
degree	ENTITY
relatives	ENTITY
of	
patients	ENTITY
with	
RLS	ENTITY
than	
for	
those	
from	
the	
general	ENTITY
population	ENTITY
.	

Although	
an	
autosomal	ENTITY
dominant	ENTITY
model	ENTITY
of	
RLS	ENTITY
is	
sug-	ENTITY
gested	
by	
many	
family	ENTITY
studies	ENTITY
,	
recent	
genomewide	ENTITY
linkage	ENTITY
and	
association	ENTITY
studies	ENTITY
suggest	
a	
more	
complex	ENTITY
gene	ENTITY
-	
environment	ENTITY
pattern	ENTITY
.	

Linkage	ENTITY
analyses	ENTITY
have	
reported	
several	
different	
gene	ENTITY
loci	ENTITY
associated	ENTITY
with	ENTITY
RLS	ENTITY
but	
,	
to	
date	
,	
no	
single	
causative	ENTITY
gene	ENTITY
.	

However	
,	
genomewide	ENTITY
association	
studies	
have	
identified	
single	ENTITY
nucleotide	ENTITY
poly-	ENTITY
morphisms	
in	
RLS	ENTITY
,	
four	
of	
which	
have	
been	
replicated	
:	
BTBD9	ENTITY
,	
MEIS1	ENTITY
,	
MAP2K5/	ENTITY
LBXCOR	ENTITY
,	
and	
PTPRD	ENTITY
.	

Nonetheless	
,	
the	
relationship	ENTITY
between	
familial	ENTITY
RLS	ENTITY
and	
these	
findings	ENTITY
remains	
to	
be	
determined	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
of	
RLS	ENTITY
symptoms	ENTITY
occurs	
at	
all	
ages	ENTITY
,	
from	
childhood	ENTITY
to	
late	ENTITY
adult	ENTITY
life	ENTITY
.	

Mean	
age	ENTITY
of	
onset	
for	
familial	ENTITY
RLS	ENTITY
is	
in	
the	
third	
or	
fourth	
decade	
,	
with	
onset	
prior	
to	
age	ENTITY
21	
years	ENTITY
in	
about	
one	
third	
of	
cases	ENTITY
.	

The	
clinical	ENTITY
course	ENTITY
of	
RLS	ENTITY
differs	
based	
on	
age	ENTITY
of	
onset	ENTITY
.	

In	
early	ENTITY
-	
onset	ENTITY
RLS	ENTITY
(	
before	
age	ENTITY
45	
years	ENTITY
)	
,	
slow	ENTITY
progression	ENTITY
of	
symptoms	ENTITY
is	
found	
in	
about	
two	
thirds	
of	
cases	ENTITY
.	

Most	
of	
the	
remaining	
one	
third	
report	
stable	ENTITY
symp-	
toms	ENTITY
over	
time	ENTITY
,	
although	
remission	ENTITY
has	
been	
described	
.	

In	
late	ENTITY
-	
onset	ENTITY
RLS	ENTITY
,	
rapid	
pro-	ENTITY
gression	ENTITY
is	
typical	
and	
aggravating	ENTITY
factors	ENTITY
are	
common	
.	

Significant	ENTITY
impairment	ENTITY
of	
health	ENTITY
-	
related	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
(	
HRQoL	ENTITY
)	
has	
been	
found	
in	
moderate	ENTITY
to	
severe	ENTITY
RLS	ENTITY
.	

Both	
physical	ENTITY
health	ENTITY
and	
mental	ENTITY
health	ENTITY
scores	ENTITY
have	
consis-	
tently	
been	
found	
to	
be	
lower	
for	
individuals	ENTITY
with	
RLS	ENTITY
,	
using	
standard	ENTITY
QoL	ENTITY
assess-	
ment	ENTITY
tools	ENTITY
.	

The	
HRQoL	ENTITY
impairments	ENTITY
are	
strongly	
associated	ENTITY
with	ENTITY
severity	ENTITY
of	
RLS	ENTITY
and	
remain	
after	
controlling	ENTITY
for	
age	ENTITY
,	
sex	ENTITY
,	
and	
disease	ENTITY
comorbidity	ENTITY
.	

In	
addition	
,	
patients	ENTITY
with	
cancer	ENTITY
,	
type	ENTITY
2	ENTITY
diabetes	ENTITY
,	
or	
renal	ENTITY
failure	ENTITY
who	
also	
have	
RLS	ENTITY
have	
been	
shown	
to	
have	
poorer	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
than	
those	
without	
RLS	ENTITY
.	

Overall	
,	
RLS	ENTITY
accounts	
for	
a	
major	
disease	ENTITY
burden	ENTITY
on	
those	
who	
suffer	
from	
it	
,	
demonstrated	
to	
be	
similar	
to	
or	
worse	
than	
that	
associated	ENTITY
with	ENTITY
osteoarthritis	ENTITY
,	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
depression	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
or	
stroke	ENTITY
.	

Large	ENTITY
population	ENTITY
-	
based	ENTITY
studies	ENTITY
have	
found	
positive	ENTITY
associations	ENTITY
between	
RLS	ENTITY
and	
cardiovascular	ENTITY
disease	ENTITY
,	
including	
coronary	ENTITY
heart	ENTITY
disease	ENTITY
and	
stroke	ENTITY
.	

Repetitive	ENTITY
surges	ENTITY
in	
heart	ENTITY
rate	ENTITY
and	
blood	ENTITY
pressure	ENTITY
associated	ENTITY
with	ENTITY
PLMS	ENTITY
are	
a	
potential	
mediator	
in	
the	
physiology	ENTITY
of	
these	
relationships	ENTITY
.	

Only	
limited	
mortality	ENTITY
data	ENTITY
are	
available	
,	
suggesting	
increased	ENTITY
risk	ENTITY
of	
mortality	ENTITY
in	
women	ENTITY
and	
in	
chronic	ENTITY
renal	ENTITY
failure	ENTITY
patients	ENTITY
with	
RLS	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
The	
accurate	ENTITY
diagnosis	ENTITY
of	
RLS	ENTITY
in	
children	ENTITY
and	
adolescents	ENTITY
requires	
understanding	
of	
developmental	ENTITY
language	ENTITY
and	
cognitive	ENTITY
skills	ENTITY
.	

Adequate	ENTITY
verbal	ENTITY
skills	ENTITY
are	
needed	
for	
children	ENTITY
to	
communicate	
the	
sensory	ENTITY
component	ENTITY
of	
RLS	ENTITY
and	
description	ENTITY
must	
be	
in	
“	
the	
child	ENTITY
’s	
own	
words	ENTITY
,	
”	
rather	
than	
by	
a	
parent	ENTITY
or	
caretaker	ENTITY
.	

For	
criterion	ENTITY
A	
,	
children	ENTITY
rarely	
use	
or	
understand	
the	
word	ENTITY
“	
urge	ENTITY
.	
”	

Instead	
they	
describe	
that	
their	
legs	ENTITY
“	
need	
to	
”	
“	
have	
to	
”	
or	
“	
got	
to	
”	
move	
.	

Descriptors	ENTITY
for	
the	
discomfort	ENTITY
include	
:	
bugs	ENTITY
,	
ants	ENTITY
,	
weird/	
funny	
feelings	ENTITY
,	
tingle	ENTITY
,	
wiggly	ENTITY
,	
and	
shaky	ENTITY
.	

Younger	ENTITY
children	ENTITY
often	
use	
the	
word	ENTITY
“	
kick	ENTITY
”	
rather	
than	
“	
move	
,	
”	
e.g.	
,	
“	
my	
legs	ENTITY
want	
to	
kick	ENTITY
.	
”	

Similar	
to	
adults	ENTITY
,	
children	ENTITY
report	ENTITY
arm	ENTITY
involvement	ENTITY
in	
almost	
half	
of	
cases	ENTITY
.	

Sitting	ENTITY
in	
class	ENTITY
,	
lying	ENTITY
in	
bed	ENTITY
,	
reading	ENTITY
a	
book	ENTITY
,	
and	
riding	ENTITY
in	
a	
car	ENTITY
are	
situations	ENTITY
where	
children	ENTITY
report	
onset	
or	
worsening	ENTITY
of	
their	
symp-	
toms	ENTITY
.	

Relief	ENTITY
is	
typically	
achieved	
by	
moving	ENTITY
around	
,	
walking	ENTITY
,	
rubbing	ENTITY
,	
kicking	ENTITY
,	
or	
distraction	ENTITY
.	

Perhaps	
as	
a	
result	
of	
prolonged	ENTITY
periods	ENTITY
of	
sitting	ENTITY
in	
class	ENTITY
,	
two	
thirds	
of	
children	ENTITY
and	
adolescents	ENTITY
with	
RLS	ENTITY
report	ENTITY
daytime	ENTITY
leg	ENTITY
sensations	ENTITY
.	

Because	
of	
this	
,	
for	
diagnostic	ENTITY
criterion	ENTITY
A3	ENTITY
(	
worse	
in	
the	
evening	ENTITY
/	
night	ENTITY
)	
,	
it	
is	
important	
to	
compare	ENTITY
equal	
duration	ENTITY
of	
sitting	ENTITY
or	
lying	ENTITY
down	ENTITY
in	
the	
day	ENTITY
to	
sitting	ENTITY
or	
lying	ENTITY
down	ENTITY
in	
the	
evening/	ENTITY
night	ENTITY
.	

However	
,	
even	
with	
such	
comparisons	ENTITY
,	
a	
significant	
subset	
of	
children	ENTITY
do	
not	
report	
worsening	ENTITY
at	
evening	ENTITY
/	
night	ENTITY
,	
yet	
meet	
all	
other	
diagnostic	ENTITY
criteria	ENTITY
and	
have	
sup-	ENTITY
portive	ENTITY
features	ENTITY
for	
RLS	ENTITY
,	
including	
a	
positive	ENTITY
family	ENTITY
history	ENTITY
.	

Children	ENTITY
who	
are	
age	ENTITY
six	
years	ENTITY
or	
older	ENTITY
and	
developmentally	ENTITY
normal	ENTITY
have	
been	
shown	
to	
report	ENTITY
detailed	
,	
ade-	
quate	ENTITY
descriptors	ENTITY
for	
RLS	ENTITY
symptoms	ENTITY
.	

For	
children	ENTITY
who	
are	
too	
young	ENTITY
to	
adequately	
describe	
RLS	ENTITY
sensations	ENTITY
or	
are	
developmentally	
delayed	
,	
a	
PLMD	ENTITY
diagnosis	ENTITY
may	
be	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
the	
initial	
diagnosis	ENTITY
,	
with	
full	
RLS	ENTITY
symptomatology	ENTITY
evident	
over	
time	ENTITY
.	

Diagnosis	ENTITY
by	
observational	ENTITY
techniques	ENTITY
has	
been	
suggested	
but	
not	
yet	
validated	
.	

The	
differential	ENTITY
diagnosis	ENTITY
of	
pediatric	ENTITY
RLS	ENTITY
includes	
positional	ENTITY
discomfort	ENTITY
,	
sore	ENTITY
leg	ENTITY
muscles	ENTITY
,	
joint	ENTITY
/	
tendon	ENTITY
injury	ENTITY
,	
and	
bruises	ENTITY
,	
all	
of	
which	
are	
common	
mimics	ENTITY
.	

In	
child-	ENTITY
hood	ENTITY
,	
RLS	ENTITY
is	
frequently	
misdiagnosed	ENTITY
as	
“	
growing	ENTITY
pains	ENTITY
.	
”	

Four	
specific	
domains	ENTITY
that	
are	
affected	ENTITY
in	
pediatric	ENTITY
RLS	ENTITY
are	
sleep	ENTITY
,	
daily	ENTITY
activities	ENTITY
,	
mood	ENTITY
,	
and	
energy	ENTITY
/	
vital-	
ity	ENTITY
.	

Difficulties	ENTITY
with	
sleep	ENTITY
onset	ENTITY
,	
sleep	ENTITY
maintenance	ENTITY
,	
and	
sleep	ENTITY
quality	ENTITY
are	
common	
.	

Negative	ENTITY
influence	ENTITY
of	
RLS	ENTITY
on	
waking	ENTITY
activities	ENTITY
includes	
academic	ENTITY
impact	
due	
to	
dis-	
ruption	ENTITY
of	
schoolwork	ENTITY
,	
homework	ENTITY
,	
and	
ability	
to	
concentrate	ENTITY
.	

Severity	ENTITY
assessment	ENTITY
of	
pediatric	ENTITY
RLS	ENTITY
has	
thus	
far	
been	
limited	
to	
simple	
measures	ENTITY
of	
self	ENTITY
-	
reported	ENTITY
frequency	ENTITY
and	
intensity	ENTITY
.	

Because	
pediatric	ENTITY
RLS	ENTITY
is	
highly	
familial	ENTITY
,	
the	
presence	ENTITY
of	
RLS	ENTITY
in	
a	
first	
-	
degree	ENTITY
rela-	
tive	ENTITY
helps	
to	
increase	ENTITY
diagnostic	ENTITY
certainty	ENTITY
in	
childhood	ENTITY
RLS	ENTITY
.	

Similarly	
,	
the	
presence	ENTITY
of	
PLMS	ENTITY
or	
a	
history	ENTITY
of	
PLMD	ENTITY
is	
quite	
helpful	
in	
supporting	
an	
RLS	ENTITY
diagnosis	ENTITY
in	
chil-	
dren	ENTITY
.	

As	
in	
adults	ENTITY
,	
approximately	
70	
%	
of	
children	ENTITY
with	
RLS	ENTITY
demonstrate	
PLMS	ENTITY
≥	
5/	
hour	ENTITY
on	
a	
single	
night	ENTITY
and	
nearly	
90	
%	
when	
multiple	ENTITY
nights	ENTITY
are	
sampled	ENTITY
.	

PLMS	ENTITY
≥	
5/	
hour	ENTITY
are	
uncommon	
in	
pediatric	ENTITY
normative	ENTITY
samples	ENTITY
.	

As	
noted	
above	
,	
pediatric	ENTITY
RLS	ENTITY
is	
comorbid	ENTITY
with	
ADHD	ENTITY
in	
about	
one	
fourth	
of	
cases	ENTITY
,	
and	
,	
as	
in	
adults	ENTITY
,	
higher	
rates	ENTITY
of	
anxiety	ENTITY
and	
depressive	ENTITY
symptoms	ENTITY
are	
found	
.	

RLS	ENTITY
is	
common	
in	
pediatric	ENTITY
chronic	ENTITY
kidney	ENTITY
disease	ENTITY
.	

Prevalence	ENTITY
rates	ENTITY
of	
RLS	ENTITY
increase	ENTITY
with	
age	ENTITY
until	
late	ENTITY
adulthood	ENTITY
then	
stabilize	ENTITY
or	
decrease	ENTITY
slightly	
in	
the	
elderly	ENTITY
.	

However	
,	
strong	
associations	ENTITY
with	ENTITY
anxiety	ENTITY
,	
mood	ENTITY
disorders	ENTITY
,	
and	
decreased	ENTITY
QoL	ENTITY
measures	ENTITY
remain	
in	
the	
elderly	ENTITY
.	

Diagnostic	ENTITY
criteria	ENTITY
for	
RLS	ENTITY
in	
the	
cog-	
nitive	ENTITY
-	
impaired	ENTITY
elderly	ENTITY
have	
been	
suggested	
but	
not	
validated	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Brain	
iron	
deficiency	
,	
central	ENTITY
nervous	ENTITY
system	ENTITY
dopamine	ENTITY
regulation	ENTITY
,	
and	
genetics	ENTITY
appear	
to	
be	
primary	ENTITY
factors	ENTITY
in	
the	
pathophysiology	ENTITY
of	
RLS	ENTITY
.	

Iron	ENTITY
is	
important	
in	
brain	ENTITY
dopa-	ENTITY
mine	ENTITY
production	ENTITY
and	
synaptic	ENTITY
density	ENTITY
,	
as	
well	
as	
in	
myelin	ENTITY
synthesis	ENTITY
and	
energy	ENTITY
pro-	ENTITY
duction	ENTITY
.	

A	
connection	ENTITY
between	
RLS	ENTITY
and	
low	ENTITY
brain	ENTITY
iron	ENTITY
is	
supported	
by	
autopsy	ENTITY
data	ENTITY
,	
MRI	ENTITY
,	
brain	ENTITY
sonography	ENTITY
,	
and	
cerebrospinal	ENTITY
fluid	ENTITY
analysis	ENTITY
.	

Evidence	ENTITY
for	
central	ENTITY
nervous	ENTITY
system	ENTITY
dopaminergic	ENTITY
system	ENTITY
involvement	ENTITY
comes	
mainly	
from	
multiple	
randomized	ENTITY
clinical	ENTITY
trials	ENTITY
that	
have	
clearly	
demonstrated	
the	
effect	ENTITY
of	
dopaminergic	ENTITY
drugs	ENTITY
for	
RLS	ENTITY
and	
PLMS	ENTITY
.	

In	
addition	
,	
an	
altered	
dopaminergic	ENTITY
profile	ENTITY
in	
RLS	ENTITY
is	
supported	
by	
func-	
tional	ENTITY
MRI	ENTITY
,	
positron	ENTITY
emission	ENTITY
tomography	ENTITY
,	
and	
autopsy	ENTITY
data	ENTITY
.	

Association	ENTITY
of	
gene	
vari-	
ants	ENTITY
BTBD9	ENTITY
,	
MEIS1	ENTITY
,	
MAP2K5	ENTITY
/	
LBXCOR	ENTITY
,	
and	
PTPRD	ENTITY
with	
RLS	ENTITY
has	
been	
replicated	ENTITY
,	
indicating	
a	
genetic	ENTITY
substrate	ENTITY
upon	
which	
environmental	ENTITY
factors	ENTITY
might	
act	
.	

BTBD9	ENTITY
is	
estimated	
to	
confer	
a	
population	ENTITY
attributable	
risk	
(	
PAR	ENTITY
)	
of	
50	
%	
for	
RLS	ENTITY
.	

Together	
,	
BTBD9	ENTITY
,	
MEIS1	ENTITY
,	
and	
MAP2K5	ENTITY
/	
LBXCOR	ENTITY
account	
for	
70	
%	
of	
the	
PAR	ENTITY
for	
RLS	ENTITY
in	
indi-	
viduals	ENTITY
with	
European	ENTITY
ancestry	ENTITY
.	

Thus	
far	
,	
two	
of	
the	
variants	ENTITY
,	
BTBD9	ENTITY
and	
MEIS1	ENTITY
,	
appear	
to	
influence	ENTITY
expression	ENTITY
of	
PLMS	ENTITY
,	
as	
well	
as	
iron	ENTITY
homeostasis	ENTITY
.	

However	
,	
the	
full	
role	
of	
RLS	ENTITY
gene	ENTITY
variants	ENTITY
has	
not	
been	
adequately	
defined	
.	

Objective	ENTITY
Findings	ENTITY

Although	
polysomnography	ENTITY
is	
not	
routinely	
indicated	
in	
the	
evaluation	ENTITY
of	
RLS	ENTITY
,	
poly-	
somnographic	ENTITY
studies	ENTITY
demonstrate	
significant	
objective	ENTITY
sleep	ENTITY
abnormalities	ENTITY
in	
RLS	ENTITY
,	
with	
increased	ENTITY
latency	ENTITY
to	
persistent	ENTITY
sleep	ENTITY
and	
higher	ENTITY
arousal	ENTITY
index	ENTITY
as	
the	
most	
consis-	
tent	ENTITY
differences	ENTITY
in	
sleep	ENTITY
architecture	ENTITY
.	

PLMS	ENTITY
≥5	
/	
hour	ENTITY
occur	
in	
70	
%	
to	
80	
%	
of	
adults	ENTITY
with	
RLS	ENTITY
on	
single	ENTITY
-	
night	ENTITY
testing	ENTITY
but	
in	
>	
90	
%	
when	
multiple	ENTITY
nights	ENTITY
are	
sampled	ENTITY
.	

In	
adult	ENTITY
RLS	ENTITY
,	
PLMS	ENTITY
are	
more	
prominent	
during	
the	
first	
half	
of	
the	
night	ENTITY
and	
vary	
in	
frequency	ENTITY
from	
night	ENTITY
to	
night	ENTITY
.	

About	
one	
third	
of	
PLMS	ENTITY
are	
associated	ENTITY
with	ENTITY
cortical	ENTITY
arousals	ENTITY
,	
and	
most	
have	
associated	
autonomic	ENTITY
arousals	ENTITY
.	

PLMS	ENTITY
are	
not	
influenced	
by	
placebo	ENTITY
effect	ENTITY
.	

PLMS	ENTITY
arousals	ENTITY
contribute	
to	
the	
primary	ENTITY
RLS	ENTITY
morbidity	ENTITY
of	
sleep	ENTITY
dis-	
turbance	ENTITY
.	

Furthermore	
,	
RLS	ENTITY
sensory	ENTITY
symptoms	ENTITY
impair	ENTITY
return	ENTITY
to	ENTITY
sleep	ENTITY
,	
and	
thereby	
result	
in	
more	
prolonged	ENTITY
awakening	ENTITY
.	

The	
Suggested	
Immobilization	
Test	
(	
SIT	ENTITY
)	
evaluates	
PLMW	ENTITY
and	
related	
sensory	ENTITY
com-	
ponents	
of	
RLS	ENTITY
during	
resting	ENTITY
wakefulness	ENTITY
.	

A	
standard	
polysomnogram	ENTITY
recording	
without	
respiratory	ENTITY
measures	ENTITY
is	
used	
for	
one	
hour	ENTITY
before	
the	
usual	ENTITY
bedtime	ENTITY
while	
the	
subject	ENTITY
sits	
comfortably	ENTITY
awake	ENTITY
and	
upright	ENTITY
in	
bed	ENTITY
with	ENTITY
the	
legs	ENTITY
outstretched	ENTITY
.	

RLS	ENTITY
diagnosis	ENTITY
is	
supported	
by	
a	
finding	ENTITY
of	
more	
than	
40	
PLMW	ENTITY
/	
hour	ENTITY
.	

Activity	ENTITY
monitors	ENTITY
with	
high	ENTITY
-	
frequency	ENTITY
sampling	ENTITY
and	
body	ENTITY
-	
position	ENTITY
monitoring	ENTITY
may	
be	
attached	
to	
the	
ankle	ENTITY
or	
foot	ENTITY
to	
provide	
an	
alternate	
measure	ENTITY
of	
PLMs	ENTITY
.	

Recordings	ENTITY
assess	
the	
frequency	ENTITY
and	
variability	ENTITY
of	
PLMs	ENTITY
from	
night	ENTITY
to	
night	ENTITY
,	
typically	
over	
three	
to	
five	
nights	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
differentiation	ENTITY
of	
RLS	ENTITY
from	
other	
conditions	ENTITY
that	
may	
have	
characteristics	ENTITY
of	
RLS	ENTITY
is	
essential	ENTITY
,	
because	
approximately	
40	
%	
of	
individuals	ENTITY
without	
RLS	ENTITY
will	
report	
some	
urge	ENTITY
or	
need	
to	
move	
the	
legs	ENTITY
while	
at	
rest	ENTITY
.	

Fulfilling	ENTITY
diagnostic	ENTITY
criteria	ENTITY
A2	
(	
better	
with	
movement	ENTITY
)	
and	
A3	ENTITY
(	
worse	
in	
the	
evening	ENTITY
/	
night	ENTITY
)	
improves	ENTITY
specificity	ENTITY
for	
an	
RLS	ENTITY
diagnosis	ENTITY
to	
only	
about	
70	
%	
,	
based	
on	
studies	ENTITY
that	
have	
used	
structured	ENTITY
diagnostic	ENTITY
interviews	ENTITY
.	

However	
,	
differentiating	
RLS	ENTITY
from	
leg	ENTITY
cramps	ENTITY
and	
positional	ENTITY
discomfort	ENTITY
improves	
specificity	ENTITY
to	
94	
%	
,	
emphasizing	
the	
importance	
of	
differential	ENTITY
diagnosis	ENTITY
.	

The	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
most	
important	
“	
mimics	ENTITY
”	
of	
RLS	ENTITY
are	
leg	ENTITY
cramps	ENTITY
,	
positional	ENTITY
discomfort	ENTITY
,	
arthralgias/	ENTITY
arthritis	ENTITY
,	
myalgias	ENTITY
,	
leg	ENTITY
edema	ENTITY
,	
peripheral	ENTITY
neuropathy	ENTITY
,	
radiculopathy	ENTITY
,	
and	
habitual	ENTITY
foot	ENTITY
tapping	ENTITY
.	

Not	
characteristic	
of	
RLS	ENTITY
are	
:	
“	
knotting	ENTITY
”	
of	
the	
muscle	
(	
cramps	ENTITY
)	
,	
relief	ENTITY
with	
a	
single	ENTITY
postural	ENTITY
shift	ENTITY
(	
positional	ENTITY
discomfort	ENTITY
)	
,	
limitation	
to	
joints	ENTITY
(	
arthritis	ENTITY
)	
,	
sore-	
ness	
to	
palpation	ENTITY
(	
myalgias	ENTITY
)	
,	
and	
other	
abnormalities	ENTITY
on	
physical	ENTITY
examination	ENTITY
.	

Less	
common	
conditions	ENTITY
to	
be	
differentiated	
from	
RLS	ENTITY
include	
neuroleptic	ENTITY
-	
induced	ENTITY
akathi-	

sia	
,	
myelopathy	ENTITY
,	
symptomatic	ENTITY
venous	ENTITY
insufficiency	ENTITY
,	
peripheral	ENTITY
artery	ENTITY
disease	ENTITY
,	
eczema	ENTITY
,	
orthopedic	ENTITY
problems	ENTITY
,	
painful	ENTITY
legs	
and	
moving	ENTITY
toes	ENTITY
,	
and	
anxiety	ENTITY
-	
induced	ENTITY
restlessness	ENTITY
.	

Neuroleptic	ENTITY
-	
induced	ENTITY
akathisia	ENTITY
differs	
from	
RLS	ENTITY
in	
that	
akathisia	ENTITY
is	
associated	ENTITY
with	ENTITY
the	
need	
to	
move	
the	
entire	ENTITY
body	ENTITY
and	
occurs	
in	
association	ENTITY
with	ENTITY
use	
of	
dopamine	ENTITY
-	
receptor	ENTITY
antagonists	ENTITY
.	

Painful	ENTITY
legs	ENTITY
and	
moving	ENTITY
toes	ENTITY
have	
neither	
a	
clear	
circadian	ENTITY
pattern	
nor	
the	
sense	
of	
an	
urge	ENTITY
to	
move	
.	

Pain	ENTITY
involving	
the	
legs	ENTITY
occurs	
with	
numerous	
conditions	ENTITY
,	
including	
arthritis	ENTITY
,	
vascular	ENTITY
problems	ENTITY
,	
sports	ENTITY
/	
orthopedic	ENTITY
injuries	ENTITY
,	
and	
neuropathy	ENTITY
.	

These	
pains	ENTITY
can	
have	
a	
nocturnal	ENTITY
presentation	ENTITY
and	
may	
be	
worse	ENTITY
at	
rest	ENTITY
,	
but	
improvement	ENTITY
with	
movement	ENTITY
either	
does	
not	
occur	
or	
entails	
more	
exercise	ENTITY
than	
simple	
movement	ENTITY
of	
the	
leg	ENTITY
.	

The	
urge	ENTITY
to	
move	
,	
if	
present	
at	
all	
,	
usually	
stems	ENTITY
from	
awareness	ENTITY
that	
movement	ENTITY
produces	
relief	ENTITY
rather	
than	
the	
strong	
primary	ENTITY
urgency	ENTITY
of	
movement	ENTITY
felt	
with	
RLS	ENTITY
.	

The	
presence	ENTITY
of	
pain	ENTITY
,	
however	
,	
does	
not	
exclude	
a	
diagnosis	ENTITY
of	
RLS	ENTITY
,	
because	
about	
50	
%	
of	
patients	ENTITY
with	
RLS	ENTITY
report	ENTITY
their	
RLS	ENTITY
symptoms	ENTITY
as	
painful	ENTITY
.	

Although	
it	
is	
important	
that	
RLS	ENTITY
symptoms	ENTITY
not	
be	
attributable	
solely	
to	
another	
medical	ENTITY
or	
behavioral	ENTITY
condition	ENTITY
,	
it	
should	
also	
be	
appreciated	
that	
any	
of	
these	
mimics	ENTITY
can	
occur	
in	
an	
individual	ENTITY
who	
also	
has	
RLS	ENTITY
.	

For	
example	
,	
some	
subjects	ENTITY
may	
have	
both	
RLS	ENTITY
and	
leg	ENTITY
cramps	ENTITY
.	

When	
the	
diagnosis	ENTITY
of	
RLS	ENTITY
is	
not	
certain	
,	
evaluation	ENTITY
for	
the	
supportive	ENTITY
features	ENTITY
such	
as	
the	
presence	ENTITY
of	
PLMS	ENTITY
or	
a	
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
may	
be	
helpful	
.	

Diagnostic	ENTITY
interviews	ENTITY
that	
include	
differential	ENTITY
diagnosis	ENTITY
have	
been	
validated	
for	
RLS	ENTITY
.	

These	
demonstrate	
sensitivity	ENTITY
and	
specificity	ENTITY
of	
>	
90	
%	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
diagnosis	ENTITY
of	
RLS	ENTITY
relies	
on	
the	
subjective	ENTITY
report	ENTITY
of	
sensory	ENTITY
symptoms	ENTITY
that	
lie	
outside	
the	
range	
of	
common	
sensory	ENTITY
experience	ENTITY
.	

Many	
patients	ENTITY
have	
difficulty	ENTITY
describing	
the	
sensations	ENTITY
.	

Further	
studies	ENTITY
of	
the	
biological	ENTITY
bases	ENTITY
for	
RLS	ENTITY
may	
lead	
to	
better	
classification	ENTITY
of	
RLS	ENTITY
and	
possibly	
to	
objective	
tests	ENTITY
for	
diagnosis	ENTITY
.	

Iron	ENTITY
,	
dopa-	ENTITY
mine	ENTITY
,	
and	
genetic	ENTITY
research	ENTITY
hold	
particular	
promise	
.	

Additional	
epidemiological	ENTITY
and	
genetic	ENTITY
studies	ENTITY
outside	
the	
US	ENTITY
and	
Europe	ENTITY
are	
needed	
to	
explore	
apparent	ENTITY
population	ENTITY
differences	
.	

The	
diagnostic	ENTITY
standards	ENTITY
and	
severity	ENTITY
assessment	ENTITY
for	
children	ENTITY
and	
cogni-	
tively	
impaired	ENTITY
adults	ENTITY
require	
further	
development	ENTITY
.	

Clarification	ENTITY
of	
the	
natural	ENTITY
course	ENTITY
and	
potential	ENTITY
exacerbating	ENTITY
factors	ENTITY
is	
needed	
.	

Better	
understanding	
of	
RLS	ENTITY
with	
comor-	
bidities	ENTITY
such	
as	
mood	ENTITY
disorders	ENTITY
and	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
might	
lead	
to	
improved	
outcomes	ENTITY
in	
those	
disorders	ENTITY
.	

Further	
evaluation	ENTITY
of	
long	ENTITY
-	
term	ENTITY
complica-	
tions	ENTITY
is	
important	
,	
including	
clarification	ENTITY
of	
associations	ENTITY
with	ENTITY
hypertension	ENTITY
,	
cardiovas-	
cular	ENTITY
disease	ENTITY
,	
and	
stroke	ENTITY
.	

Bibliography	ENTITY
Allen	ENTITY
R	ENTITY
,	ENTITY
Picchietti	ENTITY
D	ENTITY
,	
Hening	
W	
,	
et	
al	
.	

Restless	ENTITY
legs	ENTITY
syndrome	ENTITY
:	
diagnostic	ENTITY
criteria	ENTITY
,	
special	
considerations	
,	
and	
epidemiology	ENTITY
.	

A	
report	ENTITY
from	
the	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
diagnosis	ENTITY
and	
epidemiology	ENTITY
workshop	ENTITY
at	
the	
National	ENTITY
Institutes	ENTITY
of	ENTITY
Health	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2003;4:101–19	ENTITY
.	

Allen	ENTITY
RP	ENTITY
,	
Stillman	ENTITY
P	ENTITY
,	
Myers	ENTITY
AJ	ENTITY
.	

Physician	ENTITY
-	
diagnosed	ENTITY
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
in	
a	
large	
sample	ENTITY
of	
primary	ENTITY
medical	ENTITY
care	ENTITY
patients	ENTITY
in	
western	ENTITY
Europe	ENTITY
:	
Prevalence	ENTITY
and	
characteristics	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:31–7	
.	

Dauvilliers	ENTITY
Y	ENTITY
,	
Winkelmann	
J.	
Restless	
legs	
syndrome	
:	
update	ENTITY
on	
pathogenesis	ENTITY
.	

Curr	
Opin	
Pulm	
med	
2013;19:594	
-	
600	
.	

Earley	ENTITY
CJ	ENTITY
,	
Silber	ENTITY
MH	ENTITY
.	

Restless	ENTITY
legs	ENTITY
syndrome	ENTITY
:	
Understanding	
its	
consequences	ENTITY
and	
the	
need	
for	
better	
treatment	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2010;11:807–15	ENTITY
.	

Ekbom	ENTITY
K.	
Restless	
legs	
:	
a	
clinical	ENTITY
study	ENTITY
.	

Acta	
Med	
Scand	
1945;158:1–122	
.	

Ferini	ENTITY
-	
Strambi	ENTITY
L	ENTITY
,	
Walters	ENTITY
AS	ENTITY
,	
Sica	
D.	

The	
relationship	ENTITY
among	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
(	
Willis	ENTITY
-	
Ekbom	ENTITY
Disease	ENTITY
)	
,	
hypertension	ENTITY
,	
cardiovascular	ENTITY
disease	ENTITY
,	
and	
cerebrovascular	ENTITY
disease	ENTITY
.	

J	
Neurol	
2013	

Aug	
21	
.	

[	
Epub	
ahead	
of	
print	
]	
Hening	ENTITY
WA	ENTITY
,	
Allen	ENTITY
RP	ENTITY
,	
Washburn	ENTITY
M	ENTITY
,	
Lesage	ENTITY
SR	ENTITY
,	
Earley	ENTITY
CJ	ENTITY
.	

The	
four	
diagnostic	ENTITY
criteria	ENTITY
for	
Restless	ENTITY
Legs	ENTITY
Syndrome	ENTITY
are	
unable	
to	
exclude	
confounding	ENTITY
conditions	ENTITY
(	
“	
mimics	ENTITY
”	
)	
.	

Sleep	ENTITY
Med	ENTITY
2009;10:976–81	ENTITY
.	

Ohayon	ENTITY
MM	ENTITY
,	
O’Hara	ENTITY
R	ENTITY
,	
Vitiello	ENTITY
MV	ENTITY
.	

Epidemiology	ENTITY
of	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
:	
A	
synthesis	ENTITY
of	
the	
literature	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2012;16:283–95	ENTITY
.	

Picchietti	ENTITY
DL	ENTITY
,	
Arbuckle	ENTITY
RA	ENTITY
,	
Abetz	ENTITY
L	ENTITY
,	
et	
al	
.	

Pediatric	ENTITY
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
:	
analysis	ENTITY
of	
symptom	ENTITY
descriptions	ENTITY
and	
drawings	ENTITY
.	

J	
Child	
Neurol	
2011;26:1365–76	
.	

Picchietti	ENTITY
DL	ENTITY
,	
Bruni	ENTITY
O	ENTITY
,	
de	
Weerd	
A	
,	
et	
al	
.	

Pediatric	ENTITY
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
diagnostic	ENTITY
criteria	ENTITY
:	
An	
update	ENTITY
by	
the	
International	ENTITY
Restless	ENTITY
Legs	ENTITY
Syndrome	ENTITY
Study	ENTITY
Group	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2013;14:1253	ENTITY
-	ENTITY
9	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Periodic	ENTITY
Limb	ENTITY
Movement	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.51	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.61	ENTITY
Alternate	ENTITY
Names	ENTITY

Periodic	ENTITY
movement	ENTITY
disorder	ENTITY
of	ENTITY
sleep	ENTITY
,	
sleep	ENTITY
myoclonus	ENTITY
syndrome	ENTITY
,	
nocturnal	ENTITY
myoclo-	ENTITY
nus	ENTITY
syndrome	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY
Polysomnography	ENTITY
demonstrates	
PLMS	ENTITY
,	
as	
defined	
in	
the	
most	
recent	
version	ENTITY
of	
the	
American	ENTITY
Academy	ENTITY
of	ENTITY
Sleep	ENTITY
Medicine	ENTITY
(	
AASM	ENTITY
)	

Manual	ENTITY
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

B.	ENTITY
The	
frequency	ENTITY
is	
>	
5	
/	
hour	ENTITY
in	
children	ENTITY
or	
>	
15	
/	
hour	ENTITY
in	
adults.1	ENTITY

C.	ENTITY
The	
PLMS	ENTITY
cause	
clinically	ENTITY
significant	ENTITY
sleep	ENTITY
disturbance	ENTITY
or	
impairment	ENTITY
in	
mental	ENTITY
,	
physical	ENTITY
,	
social	ENTITY
,	
occupational	ENTITY
,	
educational	ENTITY
,	
behavioral	ENTITY
,	
or	
other	
important	
areas	
of	
functioning.2,3	ENTITY
D.	ENTITY
The	
PLMS	ENTITY
and	
the	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
current	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
mental	ENTITY
disorder	ENTITY
(	
e.g.	
,	
PLMS	ENTITY
occurring	
with	
apneas	ENTITY
or	
hypopneas	ENTITY
should	
not	
be	
scored).4,5	
Notes	ENTITY
.	

The	
PLMS	ENTITY
Index	ENTITY
must	
be	
interpreted	ENTITY
in	
the	
context	ENTITY
of	
a	
patient	ENTITY
’s	
sleep	
related	
complaint	ENTITY
.	

In	
adults	ENTITY
,	
normative	ENTITY
values	ENTITY
greater	
than	
five	
per	
hour	ENTITY
have	
been	
found	
in	
studies	ENTITY
that	
did	
not	
exclude	
respiratory	ENTITY
event	ENTITY
-	
related	ENTITY
arousals	ENTITY
(	
using	
sensitive	ENTITY
respiratory	ENTITY
monitoring	ENTITY
)	
and	
other	
causes	
for	
PLMS	ENTITY
.	

Data	ENTITY
suggest	
a	
partial	ENTITY
overlap	ENTITY
of	
PLMS	ENTITY
Index	ENTITY
values	ENTITY
between	
symptomatic	ENTITY
and	
asymptomatic	ENTITY
individuals	ENTITY
,	
emphasizing	
the	
importance	
of	
clinical	ENTITY
context	ENTITY
over	
an	
absolute	ENTITY
cutoff	ENTITY
value	ENTITY
.	
.	

If	
PLMS	ENTITY
are	
present	
without	
clinical	ENTITY
sleep	
disturbance	
or	
daytime	ENTITY
impairment	ENTITY
,	
the	
PLMS	ENTITY
can	
be	
noted	
as	
a	
polysomnographic	ENTITY
finding	ENTITY
,	
but	
criteria	ENTITY
are	
not	
met	
for	
a	
diagnosis	ENTITY
of	
PLMD	ENTITY
.	
.	

The	
presence	ENTITY
of	
insomnia	ENTITY
or	
hypersomnia	ENTITY
with	
PLMS	ENTITY
is	
not	
sufficient	
to	
establish	
the	
diagnosis	ENTITY
of	
PLMD	ENTITY
.	

Studies	ENTITY
have	
shown	
that	
in	
most	
cases	ENTITY
the	
cause	ENTITY
of	
the	
accompanying	
insomnia	ENTITY
or	
hypersomnia	ENTITY
is	
something	
other	
than	
the	
PLMS	ENTITY
.	

To	
establish	
the	
diagnosis	ENTITY
of	
PLMD	ENTITY
,	
it	
is	
essential	
to	
establish	
a	
reasonable	
cause	ENTITY
-	
and	
-	
effect	ENTITY
relationship	ENTITY
between	
the	
insomnia	ENTITY
or	
hypersomnia	ENTITY
and	
the	
PLMS	ENTITY
.	

This	
requires	
that	
other	
causes	
of	
insomnia	ENTITY
such	
as	
anxiety	ENTITY
or	
other	
causes	
of	
hypersomnia	ENTITY
such	
as	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
or	
narcolepsy	ENTITY
are	
ruled	
out	
.	

PLMS	ENTITY
are	
common	
,	
but	
PLMD	ENTITY
is	
thought	
to	
be	
rare	ENTITY
in	
adults	ENTITY
.	
.	

PLMD	ENTITY
can	
not	
be	
diagnosed	ENTITY
in	
the	
context	ENTITY
of	
RLS	ENTITY
,	
narcolepsy	ENTITY
,	
untreated	ENTITY
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
or	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
;	
PLMS	ENTITY
occur	
commonly	
in	
these	
conditions	ENTITY
but	
the	
sleep	ENTITY
complaint	ENTITY
is	
more	
readily	
ascribed	
to	
the	
accompanying	
disorder	ENTITY
.	

The	
diagnosis	ENTITY
of	
RLS	ENTITY
takes	
precedence	
over	
that	
of	
PLMD	ENTITY
when	
potentially	
sleep-	
disrupting	ENTITY
PLMS	ENTITY
occur	
in	
the	
context	ENTITY
of	
RLS	ENTITY
.	

In	
such	
cases	ENTITY
,	
the	
diagnosis	ENTITY
of	
RLS	ENTITY
is	
made	
and	
the	
PLMS	ENTITY
are	
noted	
.	
.	

When	
it	
is	
reasonably	
certain	
that	
the	
PLMS	ENTITY
have	
been	
induced	ENTITY
by	
medication	ENTITY
,	
and	
full	
criteria	ENTITY
for	
PLMD	ENTITY
are	
met	
,	
it	
is	
preferred	
that	
the	
more	
specific	
diagnosis	ENTITY
of	
PLMD	ENTITY
be	
used	
,	
rather	
than	
“	
Sleep	ENTITY
related	
movement	
disorder	
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
.	
”	

Essential	ENTITY
Features	
PLMD	ENTITY
is	
characterized	
by	
periodic	ENTITY
episodes	ENTITY
of	
repetitive	ENTITY
,	
highly	
stereotyped	ENTITY
limb	ENTITY
movements	ENTITY
that	
occur	
during	
sleep	ENTITY
(	
PLMS	ENTITY
)	
,	
in	
conjunction	ENTITY
with	
clinical	ENTITY
sleep	ENTITY
dis-	
turbance	ENTITY
or	
fatigue	ENTITY
that	
can	
not	
be	
accounted	
for	
by	
another	
primary	ENTITY
sleep	ENTITY
disorder	ENTITY
or	
other	
etiology	ENTITY
.	

PLMS	ENTITY
occur	
most	
frequently	
in	
the	
lower	ENTITY
extremities	ENTITY
.	

They	
typically	
involve	
exten-	
sion	ENTITY
of	
the	
big	ENTITY
toe	ENTITY
,	
often	
in	
combination	ENTITY
with	
partial	ENTITY
flexion	ENTITY
of	
the	
ankle	ENTITY
,	
the	
knee	ENTITY
,	
and	
sometimes	ENTITY
,	
the	
hip	ENTITY
.	

Similar	
movements	ENTITY
can	
occur	
in	
the	
upper	ENTITY
limbs	ENTITY
.	

Individual	ENTITY
movements	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
an	
autonomic	ENTITY
arousal	ENTITY
,	
a	
cortical	ENTITY
arousal	ENTITY
,	
or	
an	
awakening	ENTITY
.	

Typically	
,	
the	
patient	ENTITY
is	
unaware	
of	
the	
limb	ENTITY
movements	ENTITY
or	
the	
frequent	ENTITY
sleep	ENTITY
disruption	ENTITY
.	

An	
arousal	ENTITY
may	
precede	
,	
coincide	
with	
,	
or	
follow	
the	
limb	ENTITY
movement	ENTITY
,	
suggesting	
that	
a	
central	ENTITY
generator	ENTITY
may	
give	
rise	
to	
both	
the	
periodic	ENTITY
movements	ENTITY
and	
the	
related	
sleep	ENTITY
disturbance	ENTITY
.	

A	
clinical	ENTITY
history	ENTITY
of	
sleep	ENTITY
onset	ENTITY
problems	
,	
sleep	ENTITY
maintenance	ENTITY
problems	ENTITY
,	
or	
unrefresh-	
ing	
sleep	ENTITY
attributable	
to	
the	
PLMS	ENTITY
is	
needed	
for	
a	
diagnosis	ENTITY
of	
PLMD	ENTITY
.	

These	
symp-	
toms	ENTITY
have	
most	
consistently	
been	
associated	ENTITY
with	ENTITY
PLMS	ENTITY
,	
and	
the	
presence	ENTITY
of	
these	
clinical	ENTITY
symptoms	ENTITY
differentiates	
PLMD	ENTITY
from	
asymptomatic	ENTITY
PLMS	ENTITY
.	

Although	
exces-	ENTITY
sive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
has	
been	
reported	
with	
PLMD	ENTITY
in	
the	
past	
,	
newer	
data	ENTITY
do	
not	
find	
significantly	
elevated	
Epworth	
Sleepiness	
Scale	
scores	
or	
Multiple	ENTITY
Sleep	ENTITY
Latency	ENTITY
Test	ENTITY
(	ENTITY
MSLT	
)	
values	
in	
subjects	ENTITY
with	
PLMS	ENTITY
.	

If	
the	
only	
complaint	ENTITY
is	
sleep	ENTITY
disruption	ENTITY
for	
the	
bed	ENTITY
partner	ENTITY
,	
then	
PLMD	ENTITY
should	
not	
be	
diagnosed	ENTITY
but	
the	
sleep	ENTITY
disturbance	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
can	
be	
noted	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
The	
PLMS	ENTITY
index	
should	
exceed	
five	
per	
hour	
in	
children	ENTITY
and	
15	
per	
hour	
in	
adult	ENTITY
cases	ENTITY
for	
a	
diagnosis	ENTITY
of	
PLMD	ENTITY
.	

This	
is	
based	
on	
substantial	
normative	ENTITY
data	ENTITY
in	
children	ENTITY
.	

In	
adults	ENTITY
,	
there	
is	
a	
significant	
increase	ENTITY
in	
sleep	ENTITY
disturbance	ENTITY
symptoms	ENTITY
with	
PLMS	ENTITY
>	
15	
/	
hour	ENTITY
.	

The	
PLMS	ENTITY
and	
the	
symptoms	ENTITY
of	
sleep	ENTITY
disturbance	ENTITY
or	
nonrestorative	ENTITY
sleep	ENTITY
should	
not	
be	
better	
explained	
by	
another	
etiology	ENTITY
.	

Most	
important	
in	
the	
differential	ENTITY
diagnosis	ENTITY
are	
RLS	ENTITY
,	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
)	
,	
and	
narcolepsy	ENTITY
.	

Research	ENTITY
studies	ENTITY
indicate	
that	
five	
or	
more	
PLMS	ENTITY
per	
hour	
occur	
in	
80	
%	
to	
90	
%	
of	
patients	ENTITY
with	
RLS	ENTITY
,	
in	
about	
70	
%	
with	
RBD	ENTITY
,	
and	
in	
45	
%	
to	
65	
%	
with	
narcolepsy	ENTITY
.	

In	
RBD	ENTITY
,	
PLMS	ENTITY
are	
often	
present	
without	
arousals	ENTITY
during	
nonrapid	ENTITY
eye	ENTITY
movement	ENTITY
sleep	ENTITY
(	
NREM	
)	
sleep	
but	
can	
also	
con-	
tinue	ENTITY
into	
REM	ENTITY
sleep	ENTITY
,	
which	
is	
unusual	ENTITY
in	
all	
other	
settings	
.	

If	
significant	
daytime	
sleep-	
iness	
and	
PLMS	ENTITY
are	
present	
,	
a	
diagnosis	ENTITY
of	
narcolepsy	ENTITY
should	
be	
considered	
.	

PLMD	ENTITY
should	
not	
be	
diagnosed	ENTITY
when	
criteria	ENTITY
for	
one	
of	
these	
three	
disorders	ENTITY
is	
met	
.	

However	
,	
the	
primary	ENTITY
disorder	ENTITY
“	
with	
PLMS	ENTITY
”	
can	
be	
specified	
(	
e.g.	
,	
“	
RLS	ENTITY
with	
PLMS	ENTITY
”	
)	
.	

A	
sensitive	ENTITY
technique	ENTITY
,	
such	
as	
pressure	ENTITY
transducer	ENTITY
airflow	ENTITY
monitoring	ENTITY
or	
esophageal	ENTITY
manometry	ENTITY
,	
should	
be	
used	
to	
monitor	ENTITY
breathing	ENTITY
during	
polysomnography	ENTITY
to	
rea-	
sonably	ENTITY
exclude	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
(	
SRBDs	ENTITY
)	
as	
the	
direct	
cause	
of	
the	
PLMS	ENTITY
.	

When	
independent	ENTITY
PLMS	ENTITY
are	
present	
in	
patients	ENTITY
with	
SRBDs	ENTITY
,	
a	
separate	
diag-	
nosis	ENTITY
of	
PLMD	ENTITY
may	
be	
considered	
if	
the	
PLMS	ENTITY
persist	
despite	
adequate	ENTITY
treatment	ENTITY
of	
the	
SRBD	ENTITY
and	
otherwise	
unexplained	ENTITY
sleep	ENTITY
disturbance	ENTITY
remains	
.	

Ideally	
,	
polysom-	
nography	ENTITY
for	
the	
diagnosis	ENTITY
of	
PLMD	ENTITY
should	
be	
performed	
after	
the	
biologic	ENTITY
effect	ENTITY
of	
a	
medication	ENTITY
or	
substance	ENTITY
,	
such	
as	
an	
antidepressant	ENTITY
known	
to	
induce	ENTITY
or	
aggravate	ENTITY
PLMS	ENTITY
,	
has	
ended	
.	

Associated	ENTITY
Features	ENTITY
Higher	
rates	ENTITY
of	
mood	ENTITY
disorders	ENTITY
,	
anxiety	ENTITY
,	
attention	ENTITY
deficits	ENTITY
,	
oppositional	ENTITY
behaviors	ENTITY
,	
and	
parasomnias	ENTITY
have	
been	
reported	
in	
some	
studies	ENTITY
of	
patients	ENTITY
with	
PLMD	ENTITY
.	

In	
children	ENTITY
with	
PLMD	ENTITY
,	
a	
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
is	
common	
.	

A	
sustained	ENTITY
clinical	ENTITY
response	ENTITY
to	
dopa-	
minergic	ENTITY
therapy	ENTITY
is	
supportive	
of	
the	
diagnosis	ENTITY
of	
PLMD	ENTITY
.	

Although	
PLMD	ENTITY
symptoms	ENTITY
may	
be	
responsive	ENTITY
to	
benzodiazepines	ENTITY
,	
benzodiazepine	ENTITY
responsiveness	ENTITY
is	
not	
support-	
i	
ve	
of	
the	
diagnosis	ENTITY
due	
to	
the	
nonspecific	ENTITY
effect	ENTITY
of	
benzodiazepines	ENTITY
on	
sleep	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
Although	
PLMD	ENTITY
is	
thought	
to	
be	
rare	ENTITY
,	
the	
exact	
prevalence	ENTITY
is	
not	
known	
.	

PLMD	ENTITY
has	
been	
reported	
in	
both	
children	ENTITY
and	
adults	ENTITY
.	

PLMS	ENTITY
>	
5	
/	
hour	ENTITY
are	
very	
uncommon	ENTITY
in	
children	ENTITY
and	
adults	ENTITY
younger	ENTITY
than	
the	
age	ENTITY
of	
40	
years	ENTITY
,	
but	
then	
increase	ENTITY
markedly	
with	
advancing	
age	ENTITY
,	
occurring	
in	
over	
45	
%	
of	
the	
elderly	ENTITY
.	

The	
population	ENTITY
prevalence	ENTITY
of	
PLMS	ENTITY
>	
15	
/	
hour	ENTITY
has	
been	
estimated	ENTITY
at	
7.6	
%	
of	
18-	
to	
65	
-	
year	ENTITY
-	
olds	ENTITY
,	
with	
4.5	
%	
of	
the	
total	ENTITY
population	ENTITY
also	
reporting	
sleep	ENTITY
disturbance	ENTITY
or	
excessive	ENTITY
sleepiness	ENTITY
.	

However	
,	
RLS	ENTITY
and	
medication	ENTITY
-	
induced	ENTITY
PLMS	ENTITY
were	
not	
exclusionary	ENTITY
criteria	ENTITY
in	
this	
popula-	
tion	ENTITY
,	
suggesting	
much	
lower	
rates	ENTITY
for	
PLMD	ENTITY
.	

The	
increase	ENTITY
in	
PLMS	ENTITY
with	
age	ENTITY
may	
occur	
as	
a	
partial	ENTITY
expression	ENTITY
of	
familial	ENTITY
or	
genetic	ENTITY
factors	ENTITY
associated	ENTITY
with	ENTITY
RLS	ENTITY
,	
based	
on	
data	ENTITY
that	
show	
very	
little	
increase	ENTITY
in	
PLMS	ENTITY
with	
age	ENTITY
when	
individuals	ENTITY
who	
have	
RLS	ENTITY
or	
first	ENTITY
-	
degree	ENTITY
relatives	ENTITY
with	
RLS	ENTITY
are	
excluded	
.	

PLMS	ENTITY
are	
less	
common	
in	
black	ENTITY
adults	ENTITY
and	
children	ENTITY
than	
in	
whites	ENTITY
.	

No	ENTITY
sex	ENTITY
difference	ENTITY
has	
been	
described	
for	
PLMS	ENTITY
or	
PLMD	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
A	
positive	ENTITY
family	ENTITY
history	ENTITY
of	
RLS	ENTITY
confers	
increased	ENTITY
risk	ENTITY
for	
PLMS	ENTITY
and	
PLMD	ENTITY
.	

The	
genetic	ENTITY
variants	ENTITY
noted	
below	
may	
be	
a	
mediator	
of	
this	
risk	ENTITY
.	

Precipitation	ENTITY
or	
aggrava-	
tion	ENTITY
of	
PLMS	ENTITY
has	
been	
reported	
with	
the	
use	
of	
several	
medications	ENTITY
.	

Selective	
sero-	
tonin	
reuptake	
inhibitor	
antidepressants	ENTITY
,	
tricyclic	ENTITY
antidepressants	ENTITY
,	
lithium	ENTITY
,	
and	
dopa-	
mine	ENTITY
receptor	ENTITY
antagonists	ENTITY
have	
most	
often	
been	
associated	ENTITY
with	ENTITY
this	
effect	ENTITY
.	

Low	ENTITY
brain	ENTITY
iron	ENTITY
,	
as	
reflected	
by	
serum	ENTITY
ferritin	ENTITY
level	ENTITY
,	
may	
worsen	ENTITY
PLMS	ENTITY
via	
the	
role	
of	
iron	ENTITY
in	
dopamine	ENTITY
function	ENTITY
.	

Less	
evidence	ENTITY
is	
available	
for	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
OSA	ENTITY
)	
,	
alcohol	ENTITY
,	
pain	ENTITY
,	
and	
sleep	ENTITY
deprivation	ENTITY
as	
factors	ENTITY
that	
worsen	ENTITY
PLMS	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

The	
familial	ENTITY
pattern	ENTITY
of	
PLMD	ENTITY
has	
not	
been	
studied	
in	
detail	
.	

Families	ENTITY
with	
RLS	ENTITY
have	
been	
found	
to	
include	
first	
-	
degree	ENTITY
relatives	ENTITY
without	
RLS	ENTITY
but	
with	
increased	ENTITY
rates	ENTITY
of	
PLMS	ENTITY
or	
PLMD	ENTITY
,	
raising	
the	
possibility	
that	
PLMD	ENTITY
is	
an	
attenuated	ENTITY
manifestation	ENTITY
or	
a	
precursor	ENTITY
to	
RLS	ENTITY
.	

The	
gene	ENTITY
variants	ENTITY
BTBD9	ENTITY
and	
MEIS1	ENTITY
,	
which	
were	
found	
in	
genome-	
wide	
studies	
of	
RLS	ENTITY
,	
appear	
to	
influence	ENTITY
the	
expression	ENTITY
of	
PLMS	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Although	
the	
typical	
age	ENTITY
of	
onset	ENTITY
is	
not	
known	
,	
PLMD	ENTITY
occurs	
in	
both	
children	ENTITY
and	
adults	ENTITY
,	
with	
onset	
as	
early	
as	
infancy	ENTITY
.	

The	
natural	ENTITY
history	ENTITY
has	
not	
been	
described	
in	
detail	
,	
but	
some	
pediatric	ENTITY
cases	ENTITY
of	
PLMD	ENTITY
progress	ENTITY
to	
RLS	ENTITY
.	

Incidence	ENTITY
and	
remission	ENTITY
rates	ENTITY
are	
unknown	
.	

Impaired	ENTITY
performance	ENTITY
in	
a	
simulated	ENTITY
driving	
task	ENTITY
has	
been	
found	
in	
patients	ENTITY
with	
PLMD	ENTITY
.	

Increased	ENTITY
PLMS	ENTITY
have	
been	
associated	ENTITY
with	ENTITY
a	
higher	ENTITY
risk	ENTITY
of	
cardiovascular	ENTITY
disease	ENTITY
,	
stroke	ENTITY
,	
and	
mortality	ENTITY
in	
some	
studies	ENTITY
.	

PLMS	ENTITY
-	
related	ENTITY
overac-	
tivity	ENTITY
of	
the	
sympathetic	ENTITY
nervous	ENTITY
system	ENTITY
is	
postulated	
to	
be	
a	
potential	ENTITY
mechanism	ENTITY
for	
these	
associations	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Developmental	ENTITY
Issues	ENTITY
Given	
the	
low	ENTITY
background	
rates	
of	
PLMS	ENTITY
in	
children	ENTITY
,	
PLMD	ENTITY
has	
emerged	
as	
a	
useful	
diagnostic	ENTITY
category	ENTITY
in	
pediatric	ENTITY
sleep	ENTITY
medicine	ENTITY
.	

Pediatric	ENTITY
PLMD	ENTITY
has	
important	

clini-	

cal	

and	
polysomnographic	ENTITY
correlates	ENTITY
that	
are	
comparable	
in	
severity	ENTITY
to	
pediatric	ENTITY
OSA	ENTITY
.	

However	
,	
PLMS	ENTITY
and	
PLMD	ENTITY
normative	ENTITY
data	ENTITY
remain	
sparse	
for	
children	ENTITY
younger	ENTITY
than	
two	
years	ENTITY
.	

In	
the	
elderly	ENTITY
,	
frequent	ENTITY
occurrence	ENTITY
of	
other	
conditions	ENTITY
that	
can	
account	
for	
sleep	ENTITY
dis-	

turbance	ENTITY
and	
fatigue	ENTITY
makes	
application	ENTITY
of	
PLMD	ENTITY
criteria	ENTITY
difficult	ENTITY
,	
even	
though	
PLMS	ENTITY
are	
common	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Dopaminergic	ENTITY
impairment	ENTITY
has	
been	
implicated	
in	
the	
pathophysiology	ENTITY
of	
PLMS	ENTITY
and	
PLMD	ENTITY
.	

The	
study	ENTITY
of	
PLMS	ENTITY
in	
RLS	ENTITY
and	
in	
children	ENTITY
also	
suggests	
genetic	ENTITY
diathesis	ENTITY
and	
iron	ENTITY
status	ENTITY
as	
factors	ENTITY
.	

Cyclic	ENTITY
alternating	
pattern	
,	
a	
marker	ENTITY
of	
nonrestorative	ENTITY
sleep	ENTITY
,	
is	
increased	ENTITY
in	
individuals	ENTITY
with	
PLMS	ENTITY
and	
may	
influence	ENTITY
the	
periodicity	ENTITY
of	
PLMS	ENTITY
.	

Cortical	ENTITY
arousals	ENTITY
can	
precede	
,	
coincide	
with	
,	
or	
follow	
PLMS	ENTITY
,	
indicating	
that	
PLMS	ENTITY
do	
not	
cause	
the	
arousals	ENTITY
.	

In	
addition	
,	
PLMS	ENTITY
can	
be	
dissociated	ENTITY
from	
arousals	ENTITY
pharma-	
cologically	ENTITY
,	
suggesting	
an	
indirect	ENTITY
relation	ENTITY
,	
possibly	
mediated	
by	
a	
central	ENTITY
generator	ENTITY
.	

The	
autonomic	ENTITY
arousals	ENTITY
associated	ENTITY
with	ENTITY
PLMS	ENTITY
are	
characterized	ENTITY
by	
significant	
heart	ENTITY
rate	ENTITY
and	
blood	ENTITY
pressure	ENTITY
surges	ENTITY
,	
a	
mechanism	ENTITY
for	
possible	
increased	ENTITY
cardiovascular	ENTITY
and	
cerebrovascular	ENTITY
disease	ENTITY
risk	ENTITY
.	

Objective	
Findings	ENTITY
PLMS	ENTITY
can	
appear	
immediately	
with	
the	
onset	ENTITY
of	ENTITY
stage	ENTITY
N1	ENTITY
sleep	ENTITY
,	
are	
frequent	ENTITY
during	
stage	ENTITY
N2	ENTITY
sleep	ENTITY
,	
decrease	ENTITY
in	
frequency	ENTITY
in	
stage	ENTITY
N3	ENTITY
,	
and	
are	
usually	
absent	ENTITY
during	
stage	ENTITY
R	ENTITY
sleep	ENTITY
.	

PLMS	ENTITY
typically	
occur	
in	
discrete	
episodes	ENTITY
that	
last	
from	
a	
few	
minutes	
to	
an	
hour	ENTITY
.	

Both	
lower	ENTITY
limbs	ENTITY
should	
be	
monitored	ENTITY
for	
the	
presence	ENTITY
of	
limb	ENTITY
movements	ENTITY
.	

Movements	ENTITY
of	
the	
upper	ENTITY
limbs	ENTITY
may	
be	
sampled	ENTITY
if	
clinically	ENTITY
indicated	
.	

The	
anterior	ENTITY
tibialis	ENTITY
electro-	ENTITY
myogram	ENTITY
(	
EMG	ENTITY
)	
shows	
repetitive	ENTITY
contractions	ENTITY
,	
each	
lasting	
0.5	
to	
10	
seconds	
.	

The	
movements	ENTITY
may	
affect	
one	
or	
,	
more	
typically	
,	
both	
of	
the	
lower	ENTITY
limbs	ENTITY
,	
but	
not	
neces-	
sarily	
in	
a	
symmetric	ENTITY
or	
simultaneous	ENTITY
pattern	ENTITY
.	

Specific	
scoring	ENTITY
criteria	ENTITY
for	
PLMS	ENTITY
are	
described	
in	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Self	ENTITY
-	
reports	ENTITY
,	
bed	ENTITY
partner	ENTITY
observations	ENTITY
,	
or	
parental	ENTITY
reports	ENTITY
for	
children	ENTITY
have	
not	
been	
found	
to	
have	
sufficient	
specificity	ENTITY
or	
sensitivity	ENTITY
to	
replace	
objective	
testing	ENTITY
for	
PLMS	ENTITY
.	

Care	ENTITY
must	
be	
taken	
to	
discriminate	ENTITY
PLMS	ENTITY
from	
other	
movements	ENTITY
such	
as	
a	
simple	
change	
in	
body	ENTITY
position	ENTITY
,	
stretching	ENTITY
of	
a	
limb	ENTITY
,	
or	
a	
muscle	ENTITY
cramp	ENTITY
.	

PLMS	ENTITY
are	
longer	
in	
duration	ENTITY
than	
myoclonic	ENTITY
jerks	ENTITY
,	
which	
,	
by	
definition	ENTITY
,	
are	
typically	
50	
to	
150	
millisec-	
onds	
long	
.	

Movements	ENTITY
associated	ENTITY
with	ENTITY
respiratory	ENTITY
events	ENTITY
,	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
,	
or	
alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
during	
sleep	ENTITY
(	
ALMA	ENTITY
)	
should	
not	
be	
included	
in	
the	
PLMS	ENTITY
index	
.	

PLMS	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
electroencephalographic	ENTITY
(	
cortical	
)	
arousals	
or	
with	
awakenings	ENTITY
.	

Autonomic	ENTITY
arousals	ENTITY
—	
measured	ENTITY
by	
a	
change	
in	
heart	ENTITY
rate	ENTITY
,	
blood	ENTITY
pressure	ENTITY
,	
or	
pulse	ENTITY
transit	ENTITY
time	ENTITY
—	
have	
been	
shown	
to	
be	
more	
frequent	ENTITY
than	
cortical	ENTITY
arousals	ENTITY
.	

In	
some	
cases	ENTITY
,	
periodic	ENTITY
arousals	ENTITY
may	
persist	
even	
though	
the	
PLMS	ENTITY
have	
subsided	
.	

The	
arousals	ENTITY
are	
typically	
more	
difficult	
to	
measure	ENTITY
than	
are	
the	
PLMS	ENTITY
,	
and	
their	
clinical	ENTITY
significance	ENTITY
is	
a	
topic	
of	
ongoing	
debate	ENTITY
.	

As	
with	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
the	
associated	
cortical	ENTITY
arousal	ENTITY
index	ENTITY
has	
not	
proven	
more	
useful	
than	
the	
PLMS	ENTITY
index	
in	
making	
clini-	
cal	
decisions	ENTITY
.	

Although	
a	
subjective	ENTITY
report	ENTITY
of	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
is	
present	
in	
some	
patients	ENTITY
with	
PLMD	ENTITY
,	
mean	ENTITY
sleep	ENTITY
latency	ENTITY
measured	
by	
MSLT	ENTITY
has	
not	
been	
found	
to	
be	
consistently	
abnormal	ENTITY
or	
to	
correlate	
with	
the	
PLMS	ENTITY
cortical	ENTITY
arousal	ENTITY
index	ENTITY
.	

The	
movements	ENTITY
should	
be	
reported	
as	
an	
index	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
called	
the	
PLMS	ENTITY
index	
.	

The	
PLMS	ENTITY
index	
is	
the	
number	
of	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
per	
hour	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
,	
as	
determined	
by	
polysomnography	ENTITY
.	

The	
PLMS	ENTITY
arousal	ENTITY
index	ENTITY
is	
the	
number	
of	
PLMS	ENTITY
associated	ENTITY
with	ENTITY
a	
cortical	ENTITY
arousal	ENTITY
,	
expressed	ENTITY
per	
hour	
of	
total	ENTITY
sleep	ENTITY
time	ENTITY
.	

Other	
parameters	ENTITY
for	
the	
description	ENTITY
of	
PLMS	ENTITY
include	
periodicity	ENTITY
index	ENTITY
,	
intermove-	
ment	ENTITY
interval	ENTITY
distribution	ENTITY
,	
and	
time	ENTITY
of	
night	ENTITY
distribution	ENTITY
.	

These	
features	ENTITY
have	
been	
shown	
to	
help	
differentiate	
PLMS	ENTITY
patterns	ENTITY
in	
different	
conditions	ENTITY
(	
e.g.	
,	
a	
finding	ENTITY
of	
the	
highest	ENTITY
periodicity	ENTITY
indices	ENTITY
in	
adult	ENTITY
RLS	ENTITY
and	
PLMD	ENTITY
)	
.	

Leg	ENTITY
actigraphy	ENTITY
has	
been	
validated	
against	
PSG	ENTITY
for	
the	
measurement	ENTITY
of	
PLMS	ENTITY
and	
provides	
a	
methodology	ENTITY
to	
assess	
PLMS	ENTITY
in	
large	
populations	ENTITY
,	
as	
well	
as	
night	ENTITY
-	
to	
-	
night	ENTITY
variability	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
As	
described	
in	
the	
essential	ENTITY
features	ENTITY
section	ENTITY
,	
PLMD	ENTITY
is	
a	
diagnosis	ENTITY
of	
exclusion	ENTITY
and	
it	
is	
important	
to	
differentiate	ENTITY
it	
from	
other	
conditions	ENTITY
in	
which	
PLMS	ENTITY
occur	
,	
particularly	
RLS	ENTITY
,	
RBD	ENTITY
,	
narcolepsy	ENTITY
,	
and	
SRBDs	ENTITY
.	

Increased	ENTITY
rates	ENTITY
of	
PLMS	ENTITY
have	
also	
been	
reported	
in	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
,	
dopa	ENTITY
-	
responsive	ENTITY
dystonia	ENTITY
,	
sleep	ENTITY
related	
eating	ENTITY
disorder	ENTITY
,	
spinal	ENTITY
cord	ENTITY
injury	ENTITY
,	
end	ENTITY
-	
stage	ENTITY
renal	ENTITY
disease	ENTITY
,	
congestive	ENTITY
heart	ENTITY
failure	ENTITY
,	
Parkinson	ENTITY
disease	ENTITY
,	
sickle	ENTITY
cell	ENTITY
disease	ENTITY
,	
posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
,	
Asperger	ENTITY
syndrome	ENTITY
,	
Williams	ENTITY
syn-	ENTITY
drome	ENTITY
,	
and	
multiple	ENTITY
sclerosis	ENTITY
.	

Dopaminergic	ENTITY
impairment	ENTITY
and/or	
diminished	ENTITY
inhibition	ENTITY
of	
the	
central	ENTITY
pattern	ENTITY
generator	ENTITY
for	
PLMS	ENTITY
have	
been	
proposed	
as	
common	
factors	ENTITY
linking	
various	
disorders	ENTITY
and	
PLMS	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
starts	ENTITY
(	
hypnic	ENTITY
jerks	ENTITY
)	
need	
to	
be	
differentiated	
from	
PLMS	ENTITY
.	

Sleep	ENTITY
starts	
typically	
are	
limited	
to	
the	
transition	ENTITY
from	
wakefulness	ENTITY
to	
sleep	ENTITY
,	
are	
not	
periodic	
,	
and	
are	
briefer	ENTITY
(	
20	
to	
100	
milliseconds	ENTITY
)	
than	
PLMS	ENTITY
.	

Normal	ENTITY
phasic	ENTITY
REM	ENTITY
activity	ENTITY
is	
limited	
to	
REM	ENTITY
sleep	ENTITY
,	
typically	
occurs	
in	
5-	
to	
15	
-	
second	ENTITY
clusters	ENTITY
,	
and	
is	
usually	
associated	ENTITY
with	ENTITY
bursts	ENTITY
of	
REMs	ENTITY
.	

Phasic	ENTITY
REM	ENTITY
EMG	ENTITY
twitches	ENTITY
are	
more	
variable	ENTITY
in	
duration	ENTITY
and	
do	
not	
have	
the	
periodicity	ENTITY
of	
PLMS	ENTITY
.	

Fragmentary	ENTITY
myoclonus	ENTITY
is	
characterized	
by	
EMG	ENTITY
activity	ENTITY
that	
is	
briefer	ENTITY
(	
75	
to	
150	
milliseconds	ENTITY
)	
,	
more	
variable	ENTITY
in	
duration	ENTITY
,	
less	
periodic	ENTITY
than	
PLMS	ENTITY
,	
and	
has	
little	
or	
no	
associated	
visible	
movement	
.	

Also	
,	
PLMS	ENTITY
must	
be	
differentiated	
from	
movements	ENTITY
associated	ENTITY
with	ENTITY
nocturnal	ENTITY
epileptic	ENTITY
seizures	ENTITY
and	
myoclonic	ENTITY
epilepsy	ENTITY
and	
from	
a	
number	
of	
forms	
of	
myoclonus	ENTITY
seen	
while	
awake	ENTITY
,	
such	
as	
in	
Alzheimer	ENTITY
disease	ENTITY
,	
Creutzfeldt	ENTITY
-	
Jakob	ENTITY
disease	ENTITY
,	
and	
other	
neuropathologic	ENTITY
conditions	ENTITY
.	

However	
,	
in	
these	
disorders	ENTITY
,	
the	
involuntary	ENTITY
movements	ENTITY
are	
prominent	
during	
the	
daytime	ENTITY
,	
often	
do	
not	
disappear	
with	
activity	ENTITY
,	
are	
prominent	
in	
the	
arms	ENTITY
and	
other	
body	ENTITY
parts	ENTITY
in	
addition	
to	
the	
legs	ENTITY
,	
and	
do	
not	
display	
the	
periodicity	ENTITY
seen	
with	
PLMS	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
has	
been	
controversy	
over	
the	
clinical	ENTITY
significance	ENTITY
of	
PLMS	ENTITY
.	

To	
date	
,	
the	
inter-	
pretation	ENTITY
of	
most	
studies	ENTITY
has	
been	
confounded	
by	
multiple	
factors	
that	
include	
:	
impre-	
cise	ENTITY
diagnostic	ENTITY
criteria	ENTITY
;	
confusion	ENTITY
between	
PLMS	ENTITY
and	
PLMD	ENTITY
;	
inadequate	ENTITY
monitoring	ENTITY
for	
subtle	
SRBDs	ENTITY
;	
a	
lack	
of	
consideration	
of	
medications	ENTITY
known	
to	
induce	ENTITY
,	
worsen	ENTITY
,	
or	
suppress	ENTITY
PLMS	ENTITY
;	
and	
inadequate	ENTITY
measurement	ENTITY
of	
the	
known	
night	ENTITY
-	
to	
-	
night	ENTITY
vari-	
ability	
of	
PLMS	ENTITY
.	

Newer	
respiratory	ENTITY
monitoring	ENTITY
techniques	ENTITY
for	
polysomnography	ENTITY
and	
the	
use	
of	
actigraphy	ENTITY
monitors	ENTITY
over	
several	
nights	ENTITY
should	
help	
address	
a	
number	
of	
these	
issues	ENTITY
.	

The	
role	
of	
associated	ENTITY
arousals	ENTITY
in	
relation	
to	
clinical	ENTITY
symptoms	ENTITY
is	
yet	
to	
be	
determined	
,	
but	
the	
appreciation	
of	
autonomic	ENTITY
arousals	ENTITY
as	
well	
as	
cortical	ENTITY
arousals	ENTITY
might	
be	
critical	
.	

It	
is	
possible	
that	
PLMS	ENTITY
are	
a	
measurable	
marker	ENTITY
of	
unstable	ENTITY
sleep	ENTITY
,	
related	
to	
genetic	ENTITY
diathesis	ENTITY
and	
dopaminergic	ENTITY
impairment	ENTITY
.	

Bibliography	ENTITY
Ferri	ENTITY
R.	ENTITY
The	
time	ENTITY
structure	ENTITY
of	
leg	ENTITY
movement	ENTITY
activity	ENTITY
during	
sleep	ENTITY
:	
The	
theory	ENTITY
behind	
the	
practice	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2012;13:433–41	
.	

Gingras	ENTITY
JL	ENTITY
,	
Gaultney	ENTITY
JF	ENTITY
,	
Picchietti	ENTITY
DL	ENTITY
.	

Pediatric	ENTITY
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
:	
sleep	ENTITY
symptom	ENTITY
and	
polysomnographic	ENTITY
correlates	ENTITY
compared	
to	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Clin	
Sleep	
Med	
2011;7:603–9	
.	

Hornyak	ENTITY
M	ENTITY
,	
Feige	ENTITY
B	ENTITY
,	
Riemann	ENTITY
D	ENTITY
,	
Voderholzer	
U.	
Periodic	
leg	ENTITY
movements	ENTITY
in	
sleep	ENTITY
and	
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
:	
prevalence	ENTITY
,	
clinical	ENTITY
significance	ENTITY
and	
treatment	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2006;10:169–77	ENTITY
.	

Koo	ENTITY
BB	ENTITY
,	
Blackwell	ENTITY
T	ENTITY
,	
Ancoli	ENTITY
-	
Israel	ENTITY
S	
,	
Stone	ENTITY
KL	ENTITY
,	
Stefanick	ENTITY
ML	ENTITY
,	
Redline	ENTITY
S.	
Association	
of	
incident	ENTITY
cardiovascular	ENTITY
disease	ENTITY
with	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
during	
sleep	ENTITY
in	
older	ENTITY
men	ENTITY
:	
Outcomes	ENTITY
of	
Sleep	ENTITY
Disorders	ENTITY
in	
Older	ENTITY
Men	ENTITY
(	
MrOS	ENTITY
)	
Study	ENTITY
.	

Circulation	ENTITY
2011;124:1223–31	
.	

Pennestri	ENTITY
MH	ENTITY
,	
Whittom	ENTITY
S	ENTITY
,	ENTITY
Adam	ENTITY
B	ENTITY
,	
Petit	ENTITY
D	ENTITY
,	
Carrier	ENTITY
J	ENTITY
,	ENTITY
Montplaisir	ENTITY
J.	ENTITY
PLMS	ENTITY
and	
PLMW	ENTITY
in	
healthy	ENTITY
subjects	ENTITY
as	
a	
function	ENTITY
of	
age	ENTITY
:	
prevalence	ENTITY
and	
interval	ENTITY
distribution	ENTITY
.	

Sleep	ENTITY
2006;29:1183–7	ENTITY
.	

Picchietti	ENTITY
DL	ENTITY
,	
Rajendran	ENTITY
RR	ENTITY
,	
Wilson	ENTITY
MP	ENTITY
,	
Picchietti	ENTITY
MA	ENTITY
.	

Pediatric	ENTITY
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
and	
periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
:	
parent	ENTITY
-	
child	ENTITY
pairs	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2009;10:925–31	ENTITY
.	

Picchietti	ENTITY
D.	ENTITY
Periodic	ENTITY
limb	ENTITY
movements	ENTITY
in	
sleep	ENTITY
:	
irrelevant	ENTITY
epiphenomenon	ENTITY
,	
marker	ENTITY
for	
a	
potential	ENTITY
problem	ENTITY
,	
or	
a	
disorder	ENTITY
?	

J	
Clin	
Sleep	
Med	
2006;2:446–7	
.	

Scofield	ENTITY
H	ENTITY
,	ENTITY
Roth	ENTITY
T	ENTITY
,	
Drake	
C.	
Periodic	
limb	
movements	ENTITY
during	
sleep	ENTITY
:	
population	ENTITY
prevalence	ENTITY
,	
clinical	ENTITY
correlates	ENTITY
,	
and	
racial	ENTITY
differences	ENTITY
.	

Sleep	ENTITY
2008;31:1221–7	ENTITY
.	

Stefansson	ENTITY
H	ENTITY
,	
Rye	
DB	
,	
Hicks	ENTITY
A	ENTITY
,	
et	
al	
.	

A	
genetic	ENTITY
risk	ENTITY
factor	ENTITY
for	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
in	
sleep	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2007;357:639–47	ENTITY
.	

Walters	ENTITY
AS	ENTITY
,	
Rye	
DB	
.	

Review	ENTITY
of	
the	
relationship	ENTITY
of	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
and	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
in	
sleep	ENTITY
to	
hypertension	ENTITY
,	
heart	ENTITY
disease	ENTITY
,	
and	
stroke	ENTITY
.	

Sleep	ENTITY
2009;32:589–97	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Leg	ENTITY
Cramps	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.52	
Alternate	ENTITY
names	ENTITY
Leg	ENTITY
cramps	ENTITY
,	
“	
charley	ENTITY
horse	ENTITY
,	
”	
nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.62	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY

Disorders	
A.	

A	
painful	ENTITY
sensation	ENTITY
in	
the	
leg	ENTITY
or	
foot	ENTITY
associated	ENTITY
with	ENTITY
sudden	ENTITY
,	
involuntary	ENTITY
muscle	ENTITY
hardness	ENTITY
or	
tightness	ENTITY
,	
indicating	
a	
strong	
muscle	ENTITY
contraction	ENTITY
.	

B.	ENTITY
The	
painful	ENTITY
muscle	ENTITY
contractions	ENTITY
occur	
during	
the	
time	ENTITY
in	
bed	ENTITY
,	
although	
they	
may	
arise	
from	
either	
wakefulness	ENTITY
or	
sleep	ENTITY
.	

C.	

The	
pain	ENTITY
is	
relieved	
by	
forceful	
stretching	ENTITY
of	
the	
affected	ENTITY
muscles	ENTITY
,	
thus	
releasing	
the	
contraction	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
leg	ENTITY
cramps	ENTITY
are	
painful	ENTITY
sensations	ENTITY
caused	
by	
sudden	ENTITY
and	
intense	ENTITY
involun-	
tary	ENTITY
contractions	ENTITY
of	
muscles	ENTITY
or	
muscle	ENTITY
groups	ENTITY
during	
which	
there	
is	
muscle	ENTITY
spasm	ENTITY
and	
hardness	ENTITY
for	
several	
seconds	
.	

These	
painful	ENTITY
sensations	ENTITY
are	
usually	
in	
the	
calf	ENTITY
or	
small	ENTITY
muscle	ENTITY
of	
the	
foot	ENTITY
.	

Occurring	ENTITY
during	
the	
time	ENTITY
in	
bed	ENTITY
,	
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
may	
arise	
from	
either	
wakefulness	ENTITY
or	
sleep	ENTITY
.	

Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
usually	
start	
abruptly	
but	
may	
in	
some	
cases	ENTITY
be	
preceded	
by	
a	
less	
painful	ENTITY
warning	ENTITY
sensation	ENTITY
.	

The	
muscle	ENTITY
contractions	ENTITY
last	
for	
a	
few	
seconds	
up	
to	
several	
minutes	ENTITY
and	
then	
remit	ENTITY
spontaneously	ENTITY
.	

The	
frequency	ENTITY
of	
sleep	
related	
leg	ENTITY
cramps	ENTITY
varies	
considerably	
from	
less	
than	
yearly	
to	
multiple	ENTITY
episodes	ENTITY
every	
night	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY

The	
cramps	ENTITY
can	
be	
relieved	
by	
strongly	
stretching	ENTITY
the	
affected	ENTITY
muscle	ENTITY
and	
sometimes	
also	
by	
local	ENTITY
massage	ENTITY
,	
application	ENTITY
of	
heat	ENTITY
,	
or	
movement	ENTITY
of	
the	
affected	ENTITY
limb	ENTITY
.	

Leg	ENTITY
cramps	ENTITY
can	
be	
present	
primarily	
during	
the	
daytime	ENTITY
.	

Associated	ENTITY
Features	ENTITY
The	
muscle	ENTITY
cramp	ENTITY
affects	
sleep	ENTITY
.	

The	
pain	ENTITY
from	
the	
cramp	ENTITY
itself	
and	
from	
the	
activities	ENTITY
used	
to	
relieve	
it	
commonly	
disturb	ENTITY
sleep	ENTITY
onset	ENTITY
or	
cause	
an	
awakening	ENTITY
from	
sleep	ENTITY
.	

Often	
the	
presenting	ENTITY
complaint	ENTITY
is	
insomnia	ENTITY
,	
at	
times	
severe	ENTITY
.	

Tenderness	ENTITY
and	
discomfort	ENTITY
in	
the	
muscle	ENTITY
may	
persist	
for	
several	
hours	
after	
the	
cramp-	
ing	
.	

Persisting	ENTITY
discomfort	ENTITY
after	
the	
cramping	ENTITY
episode	ENTITY
often	
delays	ENTITY
subsequent	
return	ENTITY
to	ENTITY
sleep	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
are	
known	
to	
be	
either	
idiopathic	ENTITY
or	
secondary	ENTITY
to	
other	
medical	ENTITY
conditions	ENTITY
,	
but	
there	
have	
been	
no	
indications	ENTITY
of	
significant	
differences	
in	
the	
clinical	ENTITY
features	ENTITY
of	
the	
disorder	ENTITY
related	
to	
the	
cause	ENTITY
.	

Demographics	ENTITY
Sleep	
related	
leg	ENTITY
cramps	ENTITY
are	
common	
.	

It	
has	
been	
suggested	
that	
nearly	
every	
adult	ENTITY
older	
than	
50	
years	ENTITY
has	
experienced	
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
at	
least	
once	
.	

Both	
the	
prevalence	ENTITY
and	
the	
frequency	ENTITY
of	
the	
events	ENTITY
increase	ENTITY
with	
age	ENTITY
.	

Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
have	
been	
reported	
to	
occur	
at	
least	
occasionally	
in	
about	
7	
%	
of	
children	ENTITY
and	
adoles-	
cents	ENTITY
,	
33	
%	
in	
adults	ENTITY
older	
than	
60	
years	ENTITY
,	
and	
50	
%	
in	
adults	ENTITY
older	
than	
80	
years	ENTITY
,	
with	
both	
older	ENTITY
groups	ENTITY
reporting	
a	
symptom	ENTITY
frequency	ENTITY
of	
at	
least	
once	
every	
two	
months	ENTITY
.	

Nightly	ENTITY
leg	ENTITY
cramps	ENTITY
have	
been	
reported	
in	
6	
%	
of	
adults	ENTITY
older	
than	
60	
years	ENTITY
.	

No	ENTITY
defin-	
itive	ENTITY
sex	ENTITY
information	ENTITY
has	
been	
reported	
,	
though	
a	
single	
study	
reported	
a	
higher	ENTITY
prev-	
alence	
in	
women	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
factors	ENTITY
include	
diabetes	ENTITY
mellitus	ENTITY
,	
amyotrophic	ENTITY
lateral	ENTITY
sclerosis	ENTITY
,	
cramp	ENTITY
fasciculation	ENTITY
syndrome	ENTITY
,	
peripheral	ENTITY
vascular	ENTITY
disease	ENTITY
,	
hypokalemia	ENTITY
,	
hypocalcemia	ENTITY
,	
hypomagnesemia	ENTITY
,	
and	
metabolic	ENTITY
disorders	ENTITY
.	

The	
disorder	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
prior	
vigorous	ENTITY
exercise	ENTITY
,	
prolonged	ENTITY
standing	ENTITY
at	
work	ENTITY
,	
dehydration	ENTITY
,	
fluid	ENTITY
and	
electrolyte	ENTITY
distur-	
bances	ENTITY
,	
endocrine	ENTITY
disorders	ENTITY
,	
neuromuscular	ENTITY
disorders	ENTITY
,	
disorders	ENTITY
of	
reduced	ENTITY
mobility	ENTITY
,	
vascular	ENTITY
disease	ENTITY
,	
cirrhosis	ENTITY
,	
and	
hemodialysis	ENTITY
.	

Medications	ENTITY
that	
have	
been	
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
include	
oral	ENTITY
contraceptives	ENTITY
,	
intravenous	ENTITY
iron	ENTITY
sucrose	ENTITY
,	
teriparatide	ENTITY
,	
raloxifene	ENTITY
,	
diuretics	ENTITY
,	
long	ENTITY
-	
acting	ENTITY
β	ENTITY
-	
agonists	ENTITY
,	
and	
statins	ENTITY
.	

Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
occur	
in	
about	
40	
%	
of	
pregnant	ENTITY
women	ENTITY
and	
generally	
resolve	
after	
delivery	ENTITY
.	

Familial	ENTITY
Pattern	ENTITY
Not	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
and	
Complications	ENTITY
Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
have	
not	
been	
reported	
in	
infancy	ENTITY
,	
nor	
in	
children	ENTITY
younger	ENTITY
than	
eight	
years	ENTITY
.	

The	
peak	ENTITY
onset	ENTITY
is	
usually	
in	ENTITY
adulthood	ENTITY
,	
but	
the	
condition	ENTITY
may	
be	
seen	
for	
the	
first	
time	
in	
old	ENTITY
age	ENTITY
.	

The	
natural	ENTITY
history	ENTITY
of	
leg	ENTITY
cramps	ENTITY
is	
not	
well	
under-	
stood	
.	

Many	
patients	ENTITY
describe	
a	
waxing	ENTITY
and	
waning	ENTITY
course	ENTITY
of	
many	
years	ENTITY
’	
duration	ENTITY
.	

Complications	ENTITY
include	
muscle	ENTITY
tenderness	ENTITY
,	
insomnia	ENTITY
,	
and	
occasional	ENTITY
daytime	ENTITY
fatigue	
due	
to	
interrupted	ENTITY
sleep	ENTITY
.	

No	ENTITY
marked	ENTITY
mental	ENTITY
or	
social	ENTITY
dysfunction	ENTITY
has	
been	
described	
due	
to	
sleep	ENTITY
related	
leg	ENTITY
cramps	ENTITY
alone	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Many	
sleep	ENTITY
related	
leg	ENTITY
cramps	ENTITY
appear	
to	
be	
idiopathic	ENTITY
.	

Although	
leg	ENTITY
cramps	ENTITY
involve	
abnormal	ENTITY
muscle	ENTITY
tone	ENTITY
,	
they	
are	
generally	
considered	
not	
to	
involve	
agonist	ENTITY
-	
antagonist	ENTITY
co	ENTITY
-	
contractions	ENTITY
and	
,	
thus	
,	
are	
not	
classified	
as	
dystonias	ENTITY
.	

Some	
nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
,	
particularly	
those	
in	
the	
feet	ENTITY
,	
may	
resemble	
dystonias	ENTITY
but	
,	
unlike	
classic	
dystonias	ENTITY
,	
sleep	ENTITY
related	ENTITY
leg	ENTITY
and	
foot	ENTITY
cramps	ENTITY
are	
relieved	
by	
stretching	ENTITY
the	
affected	ENTITY
muscle	ENTITY
or	
muscles	ENTITY
.	

Electrophysiologic	ENTITY
recordings	ENTITY
show	
that	
the	
cramps	ENTITY
typically	
start	
with	
spontaneous	ENTITY
firing	ENTITY
of	
anterior	ENTITY
horn	ENTITY
cells	ENTITY
followed	
by	
motor	ENTITY
unit	ENTITY
discharges	ENTITY
for	
contractions	ENTITY
at	
rates	ENTITY
up	
to	
300	
Hz	
(	
considerably	
more	
than	
with	
voluntary	ENTITY
muscle	ENTITY
contractions	ENTITY
)	
.	

The	
pain	ENTITY
may	
result	
from	
local	ENTITY
metabolite	ENTITY
accumulations	ENTITY
or	
from	
local	ENTITY
ischemia	ENTITY
.	

Muscle	ENTITY
and	
tendon	ENTITY
shortening	ENTITY
due	
to	
age	ENTITY
or	
lack	ENTITY
of	
stretching	ENTITY
exercise	ENTITY
is	
thought	
to	
contribute	
to	
the	
development	ENTITY
of	
sleep	ENTITY
related	
leg	ENTITY
cramps	ENTITY
.	

Exercise	ENTITY
involving	
stretch-	
ing	
the	
affected	ENTITY
muscles	ENTITY
is	
thought	
to	
help	
prevent	ENTITY
or	
reduce	ENTITY
the	
occurrence	ENTITY
of	
sleep	ENTITY
related	
leg	ENTITY
cramps	ENTITY
.	

Objective	
Findings	ENTITY
Polysomnographic	ENTITY
studies	ENTITY
of	
patients	ENTITY
with	
chronic	ENTITY
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
reveal	
non-	
periodic	ENTITY
bursts	ENTITY
of	
gastrocnemius	ENTITY
EMG	ENTITY
activity	ENTITY
.	

Episodes	ENTITY
arise	
from	
sleep	ENTITY
without	
any	
specific	
preceding	
physiologic	ENTITY
changes	
during	
sleep	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Sleep	
related	
leg	ENTITY
cramps	ENTITY
are	
common	
in	
chronic	ENTITY
myelopathy	ENTITY
,	
peripheral	ENTITY
neuropathy	ENTITY
,	
muscular	ENTITY
pain	ENTITY
fasciculation	ENTITY
syndrome	ENTITY
,	
and	
disorders	ENTITY
of	
calcium	ENTITY
metabolism	ENTITY
.	

These	
causes	
should	
be	
differentiated	
by	
clinical	ENTITY
history	ENTITY
and	
physical	ENTITY
examination	ENTITY
.	

RLS	ENTITY
is	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
sometimes	
confused	
with	
sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
because	
both	
can	
present	
with	
leg	ENTITY
discomfort	ENTITY
during	
the	
sleep	ENTITY
period	ENTITY
and	
RLS	ENTITY
patients	ENTITY
sometimes	
complain	ENTITY
of	
a	
cramping	ENTITY
sensation	ENTITY
.	

However	
,	
if	
patients	ENTITY
meet	
the	
diagnostic	ENTITY
criteria	ENTITY
for	
RLS	ENTITY
and	
do	
not	
describe	
an	
actual	ENTITY
cramp	ENTITY
or	
hardening	ENTITY
of	
the	
muscle	ENTITY
,	
the	
diagnosis	ENTITY
should	
be	
RLS	ENTITY
.	

Because	
leg	ENTITY
cramps	ENTITY
can	
mimic	
RLS	ENTITY
and	
meet	
all	
the	
criteria	ENTITY
for	
RLS	ENTITY
,	
the	
description	ENTITY
of	
an	
actual	ENTITY
spasm	ENTITY
or	
hardening	ENTITY
of	
the	
muscle	ENTITY
is	
a	
critical	
differentiating	
factor	
.	

A	
leg	ENTITY
cramp	ENTITY
is	
also	
a	
much	
briefer	ENTITY
event	ENTITY
than	
the	
typical	
symptoms	ENTITY
of	
RLS	ENTITY
,	
which	
can	
persist	
for	
hours	ENTITY
.	

However	
,	
RLS	ENTITY
and	
leg	ENTITY
cramps	ENTITY
may	
sometimes	
be	
seen	
in	
the	
same	
individual	ENTITY
.	

Dystonia	ENTITY
is	
ongoing	
daily	ENTITY
spasm	ENTITY
of	
muscles	ENTITY
and	
is	
distinguished	
electrophysiologi-	
cally	
from	
leg	ENTITY
cramps	ENTITY
by	
ongoing	
co	ENTITY
-	
contraction	ENTITY
of	
agonist	ENTITY
and	
antagonist	ENTITY
muscles	ENTITY
.	

Dystonia	ENTITY
can	
be	
focal	ENTITY
,	
as	
in	
the	
case	ENTITY
of	
muscles	ENTITY
of	
the	
neck	
(	
torticollis	ENTITY
)	
or	
hand	ENTITY
(	
writer	
’s	
cramp	
)	
,	
or	
generalized	
as	
in	
the	
case	ENTITY
of	
torsion	ENTITY
dystonia	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Sleep	
related	
leg	ENTITY
cramps	ENTITY
are	
common	
and	
can	
affect	ENTITY
sleep	ENTITY
.	

Their	
association	ENTITY
with	ENTITY
other	
disorders	ENTITY
and	
different	
medications	ENTITY
hinder	
accurate	ENTITY
epidemiological	ENTITY
data	ENTITY
and	
under-	
estimate	ENTITY
their	
effect	ENTITY
on	
sleep	ENTITY
and	
on	
quality	ENTITY
of	ENTITY
life	ENTITY
.	

Instruments	ENTITY
to	
quantify	ENTITY
the	
sever-	
ity	ENTITY
of	
the	
disorder	ENTITY
and	
its	
impact	ENTITY
are	
needed	
to	
adequately	
address	
clinical	ENTITY
relevance	ENTITY
,	
treatment	ENTITY
,	
and	
the	
potential	ENTITY
occupational	ENTITY
hazards	ENTITY
.	

Effective	ENTITY
treatments	ENTITY
for	
sleep	ENTITY
related	
leg	ENTITY
cramps	ENTITY
have	
yet	
to	
be	
developed	
.	

The	
prophylactic	ENTITY
benefits	ENTITY
of	
stretching	ENTITY
exercises	ENTITY
remain	
to	
be	
adequately	
validated	
.	

Bibliography	ENTITY
Allen	ENTITY
RE	ENTITY
,	
Kirby	
KA	ENTITY
.	

Nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
.	

Am	ENTITY
Fam	ENTITY
Physician	ENTITY
2012;86:350–5	
.	

Bahk	ENTITY
JW	ENTITY
,	
Kim	
H	
,	
Jung	
-	
Choi	ENTITY
K	ENTITY
,	
Jung	ENTITY
MC	ENTITY
,	
Lee	
I.	
Relationship	ENTITY
between	
prolonged	ENTITY
standing	ENTITY
and	
symptoms	ENTITY
of	
varicose	ENTITY
veins	ENTITY
and	
nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
among	
women	ENTITY
and	
men	ENTITY
.	

Ergonomics	ENTITY
2012;55:133–9	
.	

Butler	
J	
,	
Mulkerrin	ENTITY
E	ENTITY
,	
O’Keeffe	ENTITY
S.	ENTITY
Nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
in	
older	ENTITY
people	ENTITY
.	

Postgrad	ENTITY
Med	ENTITY
J	ENTITY
2002;78:596–8	ENTITY
.	

Garrison	ENTITY
SR	ENTITY
,	
Dormuth	ENTITY
CR	ENTITY
,	
Morrow	
RL	ENTITY
,	
Carney	ENTITY
GA	ENTITY
,	
Khan	ENTITY
KM	ENTITY
.	

Nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
and	
prescription	ENTITY
use	
that	
precedes	ENTITY
them	
:	
a	
sequence	ENTITY
symmetry	ENTITY
analysis	ENTITY
.	

Arch	ENTITY
Intern	ENTITY
Med	ENTITY
2012;172:120–6	ENTITY
.	

Hawke	ENTITY
F	ENTITY
,	
Chuter	ENTITY
V	ENTITY
,	
Burns	
J.	
Factors	
associated	ENTITY
with	ENTITY
night	ENTITY
-	
time	ENTITY
calf	ENTITY
muscle	ENTITY
cramps	ENTITY
;	
a	
case	ENTITY
control	ENTITY
study	ENTITY
.	

Muscle	ENTITY
Nerve	ENTITY
2013;47:339–43	ENTITY
.	

Hawke	ENTITY
F	ENTITY
,	
Chuter	ENTITY
V	ENTITY
,	
Burns	ENTITY
J.	
Impact	ENTITY
of	
nocturnal	ENTITY
calf	ENTITY
cramping	ENTITY
on	
quality	ENTITY
of	ENTITY
sleep	ENTITY
and	
health	ENTITY
-	
related	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
.	

Qual	ENTITY
Life	ENTITY
Res	ENTITY
2013;22:1281–6	
.	

Heimisdottir	ENTITY
F	ENTITY
,	
Guddnason	ENTITY
V	ENTITY
,	
Sigurdsson	ENTITY
G	ENTITY
,	
Benediktsson	ENTITY
R.	ENTITY
[	
Foot	ENTITY
disease	ENTITY
in	
Icelandic	ENTITY
patients	ENTITY
with	
established	
type	ENTITY
2	ENTITY
diabetes	ENTITY
]	
.	

Laeknabladid	ENTITY
2008;94:109–14	
.	

Hudson	ENTITY
AJ	ENTITY
,	
Brown	ENTITY
WF	ENTITY
,	
Gilbert	ENTITY
JJ	ENTITY
.	

The	
muscular	ENTITY
pain	ENTITY
-	
fasciculation	ENTITY
syndrome	ENTITY
.	

Neurology	ENTITY
1978;28:1105–9	
.	

Jacobsen	ENTITY
J	ENTITY
,	ENTITY
Rosenberg	ENTITY
R	ENTITY
,	
Huttenlocher	
P	
,	
Spire	ENTITY
J.	
Familial	ENTITY
nocturnal	ENTITY
cramping	ENTITY
.	

Sleep	ENTITY
1986;9:54–60	
.	

Kleopa	ENTITY
KA	ENTITY
,	
Zamba	ENTITY
-	
Papanicolaou	ENTITY
E	ENTITY
,	
Kyriakides	ENTITY
T.	
Compressive	ENTITY
lumbar	ENTITY
myelopathy	ENTITY
presenting	
as	
segmental	ENTITY
motor	ENTITY
neuron	ENTITY
disease	ENTITY
.	

Muscle	ENTITY
Nerve	ENTITY
2003;28:69–73	
.	

Leung	ENTITY
AK	ENTITY
,	
Wong	ENTITY
BE	ENTITY
,	
Chan	ENTITY
PY	ENTITY
,	
Cho	
HY	
.	

Nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
in	
children	ENTITY
:	
incidence	ENTITY
and	
clinical	ENTITY
characteristics	ENTITY
.	

J	
Natl	
Med	
Assoc	
1999;91:329–32	
.	

Matsumoto	ENTITY
M	ENTITY
,	
Watanabe	ENTITY
K	ENTITY
,	
Tsuji	ENTITY
T	ENTITY
,	
et	
al	
.	

Nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
:	
a	
common	
complaint	ENTITY
in	
patients	ENTITY
with	
lumbar	ENTITY
spinal	ENTITY
canal	ENTITY
stenosis	ENTITY
.	

Spine	ENTITY
(	
Phila	ENTITY
Pa	ENTITY
1976	ENTITY
)	
2009;34	
:	
E189–94	ENTITY
.	

Norris	ENTITY
FJ	ENTITY
,	
Gasteiger	ENTITY
E	ENTITY
,	
Chatfield	ENTITY
P.	ENTITY

An	
electromyographic	ENTITY
study	ENTITY
of	
induced	ENTITY
and	
spontaneous	ENTITY
muscle	ENTITY
cramps	ENTITY
.	

Electroencephalogr	ENTITY
Clin	
Neurophysiol	
1957;9:139–47	
.	

Parisi	ENTITY
L	ENTITY
,	
Serrao	ENTITY
M	ENTITY
,	
Rossi	
P	
,	
et	
al	
.	

Afterdischarge	ENTITY
activity	ENTITY
in	
neuropathic	ENTITY
patients	ENTITY
with	
frequent	ENTITY
muscle	ENTITY
cramps	ENTITY
.	

Acta	
Neurol	
Scand	
2000;102:359–62	
.	

Pitkin	ENTITY
RM	ENTITY
.	

Endocrine	ENTITY
regulation	ENTITY
of	
calcium	ENTITY
homeostasis	ENTITY
during	
pregnancy	ENTITY
.	

Clin	
Perinatol	
1983;10:575–92	
.	

Saskin	ENTITY
P	ENTITY
,	
Whelton	ENTITY
C	ENTITY
,	
Moldofsky	
H	
,	
Akin	ENTITY
F.	ENTITY
Sleep	ENTITY
and	
nocturnal	ENTITY
leg	ENTITY
cramps	ENTITY
.	

Sleep	ENTITY
1988;11:307–8	
.	

Weiner	ENTITY
I	ENTITY
,	
Weiner	
H.	
Nocturnal	
leg	
muscle	ENTITY
cramps	ENTITY
.	

JAMA	ENTITY
1980;244:2332–3	
.	

Sleep	ENTITY
Related	ENTITY
Bruxism	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.53	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.63	ENTITY
Alternate	ENTITY
Names	ENTITY
Nocturnal	ENTITY
bruxism	ENTITY
,	
nocturnal	ENTITY
tooth	ENTITY
grinding	ENTITY
,	
tooth	ENTITY
clenching	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
and	
B	ENTITY
must	
be	
met	
A.	ENTITY

The	
presence	ENTITY
of	
regular	ENTITY
or	
frequent	ENTITY
tooth	ENTITY
grinding	ENTITY
sounds	
occurring	
during	
sleep	ENTITY
.	

B.	ENTITY
The	
presence	ENTITY
of	
one	
or	
more	
of	
the	
following	
clinical	ENTITY
signs	ENTITY
:	
.	

Abnormal	ENTITY
tooth	ENTITY
wear	ENTITY
consistent	ENTITY
with	ENTITY
above	
reports	ENTITY
of	
tooth	ENTITY
grinding	ENTITY
during	
sleep	ENTITY
.	
.	

Transient	ENTITY
morning	ENTITY
jaw	ENTITY
muscle	ENTITY
pain	ENTITY
or	
fatigue	ENTITY
;	
and/or	
temporal	ENTITY
headache	ENTITY
;	
and/or	
jaw	ENTITY
locking	ENTITY
upon	
awakening	ENTITY
consistent	ENTITY
with	ENTITY
above	
reports	ENTITY
of	
tooth	ENTITY
grinding	ENTITY
during	
sleep	ENTITY
.	

Notes	ENTITY
.	

Although	
polysomnography	ENTITY
is	
not	
required	
for	
the	
diagnosis	ENTITY
,	
sleep	ENTITY
bruxism	ENTITY
,	
as	
described	
in	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
,	
is	
ideally	
recorded	
with	
masseter	ENTITY
muscle	ENTITY
activity	ENTITY
with	
audio	ENTITY
-	
video	ENTITY
signal	ENTITY
to	
increase	ENTITY
diagnostic	ENTITY
reliability	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Bruxism	ENTITY
is	
defined	
as	
a	
repetitive	ENTITY
jaw	ENTITY
-	
muscle	ENTITY
activity	ENTITY
characterized	ENTITY
by	
clenching	ENTITY
or	
grinding	ENTITY
of	
the	
teeth	ENTITY
and/or	
by	
bracing	ENTITY
or	
thrusting	ENTITY
of	
the	
mandible	ENTITY
.	

Bruxism	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
has	
been	
divided	
into	
its	
two	
distinct	
circadian	ENTITY
manifestations	ENTITY
:	
sleep	ENTITY
bruxism	ENTITY
and	
awake	ENTITY
bruxism	ENTITY
.	

In	
sleep	ENTITY
,	
jaw	ENTITY
muscle	ENTITY
contractions	ENTITY
are	
frequently	
repeated	
over	
time	ENTITY
and	
are	
termed	
rhythmic	ENTITY
masticatory	ENTITY
muscle	ENTITY
activity	ENTITY
(	
RMMA	ENTITY
)	
.	

These	
contractions	ENTITY
can	
take	
two	
forms	
on	
electromyographic	ENTITY
traces	ENTITY
:	
a	
series	
of	
repetitive	ENTITY
activity	ENTITY
(	
phasic	ENTITY
muscle	ENTITY
contractions	ENTITY
)	
or	
isolated	ENTITY
sustained	ENTITY
jaw	ENTITY
clenching	ENTITY
(	
tonic	ENTITY
contractions	ENTITY
)	
.	

These	
contractions	ENTITY
during	
sleep	ENTITY
produce	
tooth	ENTITY
-	
grinding	ENTITY
sounds	ENTITY
and	
are	
referred	
to	
as	
sleep	ENTITY
related	
bruxism	ENTITY
.	

Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
can	
lead	
to	
abnormal	ENTITY
tooth	ENTITY
wear	ENTITY
,	
tooth	ENTITY
pain	ENTITY
,	
jaw	ENTITY
muscle	ENTITY
pain	ENTITY
,	
and	
temporal	ENTITY
headache	ENTITY
.	

Severe	ENTITY
sleep	
related	
bruxism	ENTITY
may	
also	
result	
in	
sleep	ENTITY
dis-	
ruption	ENTITY
.	

This	
may	
involve	
not	
only	
the	
individual	ENTITY
affected	ENTITY
,	
but	
also	
the	
bed	ENTITY
partner	ENTITY
,	
because	
the	
sounds	ENTITY
made	
by	
the	
friction	ENTITY
of	
the	
teeth	ENTITY
are	
usually	
perceived	ENTITY
as	
being	
unpleasant	ENTITY
and	
can	
be	
quite	
loud	ENTITY
and	
disturbing	
to	
those	
nearby	
.	

The	
disorder	ENTITY
is	
typically	
brought	
to	
dental	ENTITY
or	
medical	ENTITY
attention	ENTITY
because	
of	
the	
tooth	ENTITY
damage	ENTITY
,	
pain	ENTITY
,	
or	
disturbing	
sounds	ENTITY
.	

Less	
commonly	
,	
it	
may	
present	
as	
a	
cause	ENTITY
of	
dis-	
turbed	ENTITY
sleep	ENTITY
.	

Young	ENTITY
and	
otherwise	
healthy	ENTITY
individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
appear	
to	
have	
normal	ENTITY
sleep	ENTITY
structure	ENTITY
and	
homeostasis	ENTITY
.	

The	
majority	
of	
RMMA	ENTITY
epi-	
sodes	ENTITY
during	
sleep	ENTITY
occur	
in	
association	ENTITY
with	ENTITY
sleep	ENTITY
arousal	ENTITY
.	

Jaw	ENTITY
muscle	ENTITY
pain	ENTITY
,	
tenderness	ENTITY
in	
the	
masseter	ENTITY
and	
temporalis	ENTITY
muscle	ENTITY
regions	ENTITY
,	
morning	ENTITY
headache	ENTITY
,	
or	
fatigue	ENTITY
can	
arise	
due	
to	
sleep	ENTITY
related	
bruxism	ENTITY
.	

Associated	ENTITY
Features	
Additional	
symptoms	ENTITY
include	
a	
variety	
of	
unpleasant	ENTITY
muscle	ENTITY
and	
tooth	ENTITY
sensations	ENTITY
,	
lim-	
itation	ENTITY
of	
jaw	ENTITY
movements	ENTITY
,	
orofacial	ENTITY
pain	ENTITY
,	
and	
temporal	ENTITY
/	
tension	ENTITY
headaches	ENTITY
.	

Tooth	ENTITY
wear	ENTITY
,	
fractured	ENTITY
teeth	ENTITY
,	
and	
buccal	ENTITY
lacerations	ENTITY
also	
can	
occur	
.	

These	
symptoms	ENTITY
may	
be	
induced	ENTITY
by	
sleep	ENTITY
related	
bruxism	ENTITY
,	
but	
the	
connection	ENTITY
may	
not	
be	
apparent	ENTITY
to	
the	
affected	ENTITY
indi-	
vidual	ENTITY
and	
diagnostic	ENTITY
discrimination	ENTITY
is	
weak	ENTITY
.	

Headaches	ENTITY
are	
frequently	
reported	
by	
both	
adults	ENTITY
and	
children	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
.	

The	
headache	ENTITY
usually	
involves	
the	
temporal	ENTITY
regions	ENTITY
and	
it	
has	
the	
charac-	
teristics	
of	
a	
tension	ENTITY
headache	ENTITY
.	

It	
is	
reported	
either	
in	
the	
morning	ENTITY
(	
more	
frequently	
)	
or	
during	
the	
day	ENTITY
(	
with	
wake	ENTITY
bruxism	ENTITY
)	
.	

The	
estimated	
OR	ENTITY
for	
headache	ENTITY
in	
individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
is	
>	
4	
compared	ENTITY
to	
controls	ENTITY
.	

There	
is	
high	
individual	ENTITY
variability	ENTITY
in	
the	
intensity	ENTITY
and	
duration	ENTITY
of	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
,	
but	
in	
the	
most	
severe	ENTITY
cases	ENTITY
,	
hundreds	
of	
events	ENTITY
can	
occur	
during	
a	
night	ENTITY
of	
sleep	ENTITY
.	

However	
,	
no	
direct	
relationship	ENTITY
has	
been	
observed	
between	
the	
severity	ENTITY
of	
sleep	ENTITY
related	
bruxism	ENTITY
and	
the	
appearance	ENTITY
of	
clinical	ENTITY
signs	ENTITY
and	
symptoms	ENTITY
.	

Indeed	
,	
indi-	
viduals	ENTITY
with	
a	
mild	ENTITY
to	
moderate	ENTITY
index	ENTITY
of	
sleep	ENTITY
bruxism	ENTITY
(	
2	
to	
4	
RMMA	ENTITY
episodes	ENTITY
/	
hour	ENTITY
of	
sleep	ENTITY
)	
have	
a	
higher	ENTITY
risk	ENTITY
of	
reporting	ENTITY
painful	ENTITY
jaw	
upon	
awakening	ENTITY
(	
OR	ENTITY
3.9	
)	
,	
and	
masticatory	ENTITY
muscle	ENTITY
fatigue	ENTITY
(	
OR	ENTITY
5.1	
)	
compared	
to	
individuals	ENTITY
with	
severe	ENTITY
sleep	
related	
bruxism	ENTITY
(	
>	
4	
RMMA	ENTITY
episodes	ENTITY
/	
hour	ENTITY
of	
sleep	ENTITY
)	
.	

Psychosocial	ENTITY
components	ENTITY
may	
also	
be	
linked	
to	
sleep	ENTITY
related	
bruxism	ENTITY
.	

The	
psycholog-	
ical	
assessment	ENTITY
of	
otherwise	
healthy	ENTITY
adults	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
suggests	
a	
cor-	ENTITY
relation	ENTITY
(	
not	
yet	
proven	
as	
a	
causality	ENTITY
)	
between	
bruxism	ENTITY
and	
stress	ENTITY
/	
anxiety	ENTITY
.	

Moreover	
,	
both	
children	ENTITY
and	
adults	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
seem	
to	
have	
higher	
scores	ENTITY
in	
stress	ENTITY
,	
anxiety	ENTITY
,	
and	
psychiatric	ENTITY
scales	ENTITY
compared	
to	
control	ENTITY
individuals	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
without	
clear	
cause	ENTITY
is	
termed	
primary	ENTITY
or	
idiopathic	ENTITY
.	

Forms	ENTITY
of	
sleep	
related	
bruxism	ENTITY
associated	ENTITY
with	ENTITY
the	
use	
of	
psychoactive	ENTITY
medications	ENTITY
,	
recreational	ENTITY
drugs	ENTITY
,	
or	
a	
variety	
of	
medical	ENTITY
disorders	ENTITY
(	
e.g.	
,	
Parkinson	ENTITY
disease	ENTITY
,	
RBD	ENTITY
,	
Down	ENTITY
syndrome	ENTITY
)	
are	
defined	
as	
secondary	ENTITY
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
.	

Treatment	ENTITY
-	
induced	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
is	
also	
termed	
iatrogenic	ENTITY
.	

Although	
the	
primary	
form	
of	
sleep	ENTITY
related	
bruxism	ENTITY
is	
most	
often	
reported	
in	
healthy	ENTITY
children	ENTITY
and	
adults	ENTITY
,	
secondary	ENTITY
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
is	
observed	
in	
children	ENTITY
with	
cere-	
bral	ENTITY
palsy	ENTITY
and	
mental	ENTITY
retardation	ENTITY
and	
in	
adult	ENTITY
patients	ENTITY
with	
abnormal	ENTITY
movements	ENTITY
such	
as	
in	
oromandibular	ENTITY
myoclonus	ENTITY
/	
facio	ENTITY
-	
mandibular	ENTITY
myoclonus	ENTITY
or	
with	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
.	

OSA	ENTITY
and	
sleep	ENTITY
related	
bruxism	ENTITY
commonly	
co	ENTITY
-	
occur	ENTITY
.	

Tooth	ENTITY
grinding	ENTITY
and	
clenching	ENTITY
also	
can	
occur	
during	
wakefulness	ENTITY
,	
as	
an	
oral	ENTITY
parafunc-	
tional	ENTITY
activity	ENTITY
known	
as	
awake	ENTITY
bruxism	ENTITY
.	

Awake	ENTITY
bruxism	ENTITY
is	
considered	
a	
different	
dis-	
order	
,	
probably	
with	
different	
diagnostic	ENTITY
criteria	ENTITY
and	
pathophysiology	ENTITY
;	
its	
association	ENTITY
with	ENTITY
sleep	ENTITY
bruxism	ENTITY
is	
still	
under	
debate	ENTITY
.	

However	
,	
the	
two	
oral	ENTITY
activities	ENTITY
may	
coexist	
in	
the	
same	
individual	ENTITY
.	

Demographics	ENTITY
The	
prevalence	ENTITY
of	
sleep	ENTITY
related	
bruxism	ENTITY
,	
based	
on	
reports	ENTITY
from	
parents	ENTITY
or	
sleep	ENTITY
partner	ENTITY
,	
is	
highest	
in	
childhood	ENTITY
(	
approximately	
14	
%	
to	
17	
%	
)	
and	
then	
decreases	ENTITY
over	
the	
life	ENTITY
span	ENTITY
.	

In	
teenagers	ENTITY
to	
young	ENTITY
adults	ENTITY
,	
prevalence	ENTITY
is	
in	
the	
12	
%	
range	ENTITY
.	

In	
young	ENTITY
to	
middle	ENTITY
-	
aged	ENTITY
adults	ENTITY
,	
it	
is	
approximately	
8	
%	
but	
as	
little	
as	
3	
%	
in	
older	ENTITY
persons	ENTITY
.	

The	
reported	
reduction	ENTITY
in	
tooth	ENTITY
grinding	ENTITY
in	
the	
elderly	ENTITY
probably	
overestimates	ENTITY
the	
actual	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
reduction	ENTITY
,	
because	
edentulism	ENTITY
,	
use	
of	
dentures	ENTITY
,	
and	
changes	ENTITY
in	
sleeping	ENTITY
behaviors	ENTITY
(	
i.e.	
,	
in	
isolation	ENTITY
)	
may	
influence	ENTITY
reporting	ENTITY
.	

There	
is	
no	
reported	
sex	ENTITY
difference	ENTITY
for	
the	
prev-	
alence	
of	
sleep	ENTITY
related	
bruxism	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
factors	ENTITY
include	
personality	ENTITY
types	ENTITY
;	
for	
example	
,	
individuals	ENTITY
who	
are	
highly	
motivated	ENTITY
or	
characteristically	
maintain	
high	
vigilance	ENTITY
may	
have	
an	
increased	ENTITY
preva-	
lence	
of	
sleep	ENTITY
related	
bruxism	ENTITY
.	

Genetic	ENTITY
predisposition	ENTITY
is	
plausible	
but	
still	
under	
investigation	ENTITY
.	

As	
described	
below	
,	
there	
is	
some	
familial	ENTITY
predisposition	ENTITY
due	
to	
environmental	ENTITY
or	
shared	
genetic	ENTITY
factors	ENTITY
.	

Recently	
,	
a	
serotonin	ENTITY
gene	ENTITY
was	
described	
in	
bruxism	ENTITY
patients	ENTITY
but	
the	
absence	ENTITY
of	
distinction	
between	
the	
wake	ENTITY
and	
sleep	ENTITY
forms	ENTITY
in	
this	
report	ENTITY
preclude	
firm	
conclusions	ENTITY
.	

Precipitating	ENTITY
factors	ENTITY
can	
include	
anxiety	ENTITY
related	
to	
current	ENTITY
life	ENTITY
events	ENTITY
,	
tasks	
requir-	
ing	
high	
levels	
of	
performance	ENTITY
,	
and	
repetitive	ENTITY
tasks	ENTITY
with	
short	ENTITY
deadlines	ENTITY
.	

The	
use	
of	
cigarettes	ENTITY
or	
caffeine	ENTITY
in	
the	
hours	ENTITY
before	
sleep	ENTITY
also	
can	
contribute	
to	
the	
occur-	
rence	ENTITY
of	
sleep	
related	
bruxism	ENTITY
(	
probably	
due	
to	
the	
increased	ENTITY
arousals	ENTITY
and	
sleep	ENTITY
instability	ENTITY
)	
.	

The	
role	
of	
dental	ENTITY
morphologic	ENTITY
“	
defects	ENTITY
”	
(	
occlusal	ENTITY
interferences	ENTITY
)	
remains	
controver-	
sial	ENTITY
in	
the	
etiology	ENTITY
of	
sleep	ENTITY
related	
bruxism	ENTITY
.	

Tooth	ENTITY
contacts	ENTITY
do	
not	
usually	
set	
in	
motion	ENTITY
a	
bruxism	ENTITY
episode	ENTITY
;	
they	
are	
usually	
late	
in	
the	
series	
of	
events	ENTITY
occurring	
during	
sleep	ENTITY
related	
bruxism	ENTITY
/	

tooth	ENTITY
grinding	ENTITY
.	

Hence	
,	
the	
causality	
link	
between	
tooth	ENTITY
contact	ENTITY
and	
sleep	ENTITY
related	
bruxism	ENTITY
is	
not	
supported	
by	
the	
temporal	ENTITY
sequence	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
tends	
to	
occur	
in	
families	ENTITY
;	
approximately	
20	
%	
to	
50	
%	
of	
affected	ENTITY
individuals	ENTITY
have	
at	
least	
one	
direct	
family	ENTITY
member	ENTITY
with	
a	
history	ENTITY
of	
tooth	ENTITY
grinding	ENTITY
,	
and	
childhood	ENTITY
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
appears	
to	
persist	
into	
adulthood	ENTITY
in	
two	
thirds	
of	
reported	
cases	ENTITY
.	

However	
,	
no	
genetic	ENTITY
variants	ENTITY
or	
genetic	ENTITY
inheritance	ENTITY
patterns	
so	
far	
have	
been	
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
onset	ENTITY
of	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
may	
occur	
during	
childhood	ENTITY
,	
adolescence	ENTITY
,	
or	
adulthood	ENTITY
.	

It	
is	
difficult	
to	
establish	
the	
time	ENTITY
of	
onset	ENTITY
with	ENTITY
precision	ENTITY
because	
it	
is	
mainly	
based	
on	
the	
awareness	ENTITY
of	
the	
individual	ENTITY
or	

his	
/	
her	
family	ENTITY
members	ENTITY
who	
report	ENTITY
the	
disorder	ENTITY
.	

Sleep	ENTITY
related	
bruxism	ENTITY
in	
childhood	ENTITY
has	
been	
reported	
by	
parents	ENTITY
to	
begin	
as	
soon	
as	
both	
upper	ENTITY
and	
lower	ENTITY
teeth	ENTITY
have	
erupted	ENTITY
.	

Secondary	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
may	
occur	
at	
any	
age	ENTITY
,	
but	
is	
more	
common	
in	
younger	ENTITY
and	
middle	ENTITY
-	
aged	ENTITY
adults	ENTITY
.	

Even	
without	
a	
tooth	ENTITY
grinding	ENTITY
history	ENTITY
or	
complaints	ENTITY
,	
RMMA	ENTITY
may	
be	
observed	
in	
most	
normal	ENTITY
sleepers	ENTITY
(	
on	
average	ENTITY
,	
one	
episode	ENTITY
per	
hour	
of	
sleep	ENTITY
)	
across	
the	
life	ENTITY
span	ENTITY
.	

However	
,	
in	
individuals	ENTITY
with	
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
,	
jaw	ENTITY
-	
muscle	ENTITY
contractions	ENTITY
are	
more	
frequent	ENTITY
and	
more	
intense	ENTITY
.	

This	
may	
explain	
the	
secondary	ENTITY
tooth	ENTITY
damage	ENTITY
and	
the	
occurrence	ENTITY
of	
pain	ENTITY
and	
other	
symptoms	ENTITY
.	

The	
night	ENTITY
-	
to	
-	
night	ENTITY
variability	ENTITY
in	
episodes	ENTITY
of	
audible	ENTITY
tooth	ENTITY
grinding	ENTITY
sounds	ENTITY
is	
large	
(	
greater	
than	
50	
%	
coefficient	ENTITY
of	ENTITY
variation	ENTITY
)	
.	

In	
-	
laboratory	ENTITY
polysomnographic	ENTITY
record-	
ings	
indicate	
that	
the	
corresponding	
variability	ENTITY
in	
frequency	ENTITY
of	
RMMA	ENTITY
is	
smaller	
(	
approximately	
25	
%	
)	
,	
although	
ambulatory	ENTITY
recording	ENTITY
has	
suggested	
somewhat	
higher	
RMMA	ENTITY
variability	ENTITY
.	

First	ENTITY
-	
night	ENTITY
effect	ENTITY
on	
RMMA	ENTITY
index	
is	
minimal	ENTITY
.	

Dental	ENTITY
damage	ENTITY
and	
abnormal	ENTITY
tooth	ENTITY
wear	ENTITY
are	
the	
most	
frequent	ENTITY
signs	ENTITY
of	
the	
disorder	ENTITY
.	

However	
,	
they	
are	
not	
a	
direct	
proof	
of	
current	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
and	
many	
contrib-	
uting	
factors	ENTITY
have	
to	
be	
ruled	
out	
(	
e.g.	
,	
type	
of	
diet	ENTITY
in	
the	
occurrence	ENTITY
of	
abnormal	ENTITY
tooth	ENTITY
wear	ENTITY
)	
.	

Diagnostic	ENTITY
discriminative	ENTITY
strength	ENTITY
of	
these	
dental	ENTITY
findings	ENTITY
is	
weak	ENTITY
;	
severity	ENTITY
of	
wear	ENTITY
can	
not	
account	
for	
the	
index	ENTITY
(	
i.e.	
,	
frequency	ENTITY
of	
RMMA	ENTITY
)	
.	

Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
could	
lead	
to	
temporomandibular	ENTITY
joint	ENTITY
disorders	ENTITY
(	
e.g.	
,	
pain	ENTITY
,	
joint	ENTITY
sound	ENTITY
[	
click	
]	
,	
or	
jaw	ENTITY
movement	ENTITY
limitations	ENTITY
)	
,	
although	
recent	
evidence	ENTITY
does	
not	
support	
this	
association	ENTITY
.	

Transient	ENTITY
morning	ENTITY
orofacial	ENTITY
pain	ENTITY
,	
including	
temporal	ENTITY
headaches	ENTITY
,	
is	
not	
uncommon	
,	
as	
described	
above	
.	

Hypertrophy	ENTITY
of	
the	
masseter	ENTITY
and	
temporalis	ENTITY
muscles	ENTITY
can	
occur	
,	
but	
the	
diagnostic	ENTITY
specificity	ENTITY
of	
this	
finding	ENTITY
for	
sleep	ENTITY
related	
bruxism	ENTITY
is	
also	
weak	ENTITY
.	

The	
natural	ENTITY
course	ENTITY
of	
this	
sleep	ENTITY
disorder	ENTITY
is	
usually	
benign	ENTITY
.	

Many	
individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
remain	
asymptomatic	ENTITY
for	
most	
of	
their	
lives	ENTITY
.	

Others	
can	
experi-	
ence	ENTITY
associated	
symptoms	ENTITY
(	
i.e.	
,	
pain	ENTITY
)	
that	
may	
interfere	ENTITY
with	ENTITY
their	
quality	ENTITY
of	ENTITY
life	ENTITY
and/	ENTITY
or	
sleep	ENTITY
and	
may	
require	
treatments	ENTITY
.	

Further	
diagnostic	ENTITY
investigations	ENTITY
and	
assessment	ENTITY
are	
recommended	
if	
sleep	ENTITY
related	
bruxism	ENTITY
is	
associated	ENTITY
with	ENTITY
other	
more	
severe	ENTITY
sleep	ENTITY
or	
medical	ENTITY
disorders	ENTITY
(	
e.g.	
,	
SRBD	ENTITY
,	
RBD	ENTITY
,	
epilepsy	ENTITY
)	
.	

Developmental	ENTITY
Issues	ENTITY
Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
is	
frequently	
reported	
in	
childhood	ENTITY
but	
decreases	ENTITY
with	
age	ENTITY
.	

However	
,	
some	
individuals	ENTITY
may	
experience	
it	
every	
night	ENTITY
for	
most	
of	
their	
lives	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Conceptualizations	ENTITY
of	
sleep	
related	
bruxism	ENTITY
in	
children	ENTITY
vary	
.	

Some	
consider	
this	
a	
physiological	ENTITY
oral	ENTITY
parafunction	ENTITY
while	
teeth	ENTITY
are	
erupting	ENTITY
or	
exfoliating	ENTITY
,	
whereas	
others	
view	
this	
as	
a	
sleep	ENTITY
disorder	ENTITY
with	
many	
associated	
signs	
and	
symptoms	ENTITY
.	

Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
,	
especially	
in	
children	ENTITY
,	
has	
been	
associated	ENTITY
with	ENTITY
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
,	
parasomnias	ENTITY
,	
SRBD	ENTITY
,	
snoring	ENTITY
,	
and	
many	
psychological	ENTITY
and	
medical	ENTITY
conditions	ENTITY
.	

In	
the	
elderly	ENTITY
,	
sleep	ENTITY
related	
bruxism	ENTITY
has	
been	
observed	
in	
association	ENTITY
with	ENTITY
movement	ENTITY
disorders	ENTITY
(	
e.g.	
,	
Parkinson	ENTITY
disease	ENTITY
or	
oral	ENTITY
tardive	ENTITY
dyskinesia	ENTITY
persisting	
during	
sleep	ENTITY
)	
,	
RBD	ENTITY
,	
and	
dementia	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
majority	
of	
RMMA	ENTITY
episodes	ENTITY
during	
sleep	ENTITY
(	
up	
to	
80	
%	
)	
occur	
in	
association	ENTITY
with	ENTITY
sleep	ENTITY
arousals	ENTITY
.	

Sleep	ENTITY
related	
bruxism	ENTITY
episodes	ENTITY
typically	
follow	
a	
clear	
arousal	ENTITY
sequence	ENTITY
,	
starting	
with	
increased	ENTITY
sympathetic	ENTITY
-	
cardiac	ENTITY
activity	ENTITY
and	
fast	ENTITY
electroenceph-	ENTITY
alographic	ENTITY
(	ENTITY
EEG	
)	
waves	
in	
the	
minutes	
to	
seconds	
preceding	
the	
onset	
of	
an	
RMMA	ENTITY
episode	ENTITY
.	

The	
jaw	ENTITY
muscle	ENTITY
contractions	ENTITY
are	
then	
followed	
by	
,	
or	
are	
concomitant	ENTITY
with	
,	
an	
increase	ENTITY
in	
blood	ENTITY
pressure	ENTITY
and	
ventilation	ENTITY
.	

RMMA	ENTITY
episodes	ENTITY
sometimes	
conclude	
with	
swallowing	ENTITY
.	

Other	
causes	
of	
sleep	ENTITY
bruxism	ENTITY
onset	
are	
unknown	
,	
although	
potential	
candidates	
include	
airway	ENTITY
resistance	ENTITY
and	
oropharyngeal	ENTITY
dryness	ENTITY
.	

In	
the	
majority	
of	
individuals	ENTITY
with	
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
,	
the	
frequency	ENTITY
of	
sleep	ENTITY
arous-	ENTITY
als	ENTITY
is	
within	
the	
normal	ENTITY
range	ENTITY
.	

However	
,	
they	
may	
have	
an	
exaggerated	ENTITY
responsiveness	ENTITY
to	
ongoing	
sleep	ENTITY
arousals	ENTITY
or	
an	
increased	ENTITY
magnitude	ENTITY
of	
arousal	ENTITY
.	

Individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
show	
more	
CAP	ENTITY
phase	ENTITY
A3	ENTITY
(	
as	
described	
by	
the	
scoring	ENTITY
and	
analysis	ENTITY
of	
cyclic	ENTITY
alternating	ENTITY
pattern	ENTITY
(	
CAP	ENTITY
)	
during	
sleep	ENTITY
)	
than	
controls	ENTITY
,	
an	
expression	ENTITY
of	
increased	ENTITY
arousal	ENTITY
pressure	ENTITY
and	
increased	ENTITY
sleep	ENTITY
instability	ENTITY
.	

This	
increased	ENTITY
sleep	ENTITY
instability	ENTITY
seems	
to	
be	
the	
“	
permissive	ENTITY
window	ENTITY
”	
for	
occurrence	ENTITY
of	
RMMA	ENTITY
during	
sleep	ENTITY
.	

Objective	
Findings	ENTITY
Polysomnographic	ENTITY
(	
PSG	ENTITY
)	
monitoring	ENTITY
of	
individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
demonstrates	
increased	ENTITY
masseter	ENTITY
and	
temporalis	ENTITY
muscle	ENTITY
activity	ENTITY
during	
sleep	ENTITY
,	
along	
with	
grinding	ENTITY
sounds	ENTITY
.	

RMMA	ENTITY
episodes	ENTITY
can	
occur	
during	
all	
sleep	ENTITY
stages	ENTITY
,	
but	
are	
most	
common	
in	
sleep	ENTITY
stages	ENTITY
N1	
and	
N2	ENTITY
(	
more	
than	
80	
%	
of	
episodes	ENTITY
)	
,	
whereas	
fewer	
than	
10	
%	
of	
RMMA	ENTITY
episodes	ENTITY
occur	
during	
REM	ENTITY
sleep	ENTITY
.	

However	
,	
in	
some	
individuals	ENTITY
,	
sleep	ENTITY
related	
bruxism	ENTITY
occurs	
predominantly	
in	
REM	ENTITY
sleep	ENTITY
.	

As	
described	
above	
,	
the	
majority	
of	
sleep	ENTITY
related	
bruxism	ENTITY
episodes	ENTITY
are	
temporally	
associated	ENTITY
with	ENTITY
sleep	ENTITY
arousal	ENTITY
and	
are	
preceded	
by	
signs	ENTITY
of	
autonomic	ENTITY
/	
cardiac	ENTITY
activa-	
tion	ENTITY
(	
e.g.	
,	
increased	ENTITY
heart	ENTITY
rate	ENTITY
and	
blood	ENTITY
pressure	ENTITY
)	
.	

Three	
subtypes	ENTITY
of	
the	
EMG	ENTITY
pattern	ENTITY
of	
sleep	ENTITY
related	
bruxism	ENTITY
have	
been	
described	
:	
phasic	ENTITY
activity	ENTITY
at	
1	
Hz	
frequency	ENTITY
with	
EMG	ENTITY
bursts	ENTITY
lasting	
0.25	
to	
2	
seconds	
;	
sustained	ENTITY
tonic	ENTITY
activity	ENTITY
lasting	
longer	
than	
2	
seconds	
;	
or	
a	
mixed	
pattern	
.	

An	
episode	ENTITY
begins	
after	
at	
least	
a	
three	
-	
second	ENTITY
interval	ENTITY
with	
no	
muscle	
activity	
.	

Polysomnography	ENTITY
is	
not	
usually	
performed	
in	
otherwise	
healthy	ENTITY
individuals	ENTITY
with	
sleep	ENTITY
related	
bruxism	ENTITY
in	
routine	
clinical	ENTITY
settings	ENTITY
.	

However	
,	
PSG	ENTITY
may	
be	
indicated	
to	
demon-	
strate	ENTITY
the	
disorder	ENTITY
and	
to	
rule	
out	
associated	
respiratory	ENTITY
disturbances	ENTITY
,	
gastroesophageal	ENTITY
reflux	ENTITY
,	
RBD	ENTITY
,	
night	ENTITY
terrors	ENTITY
,	
faciomandibular	ENTITY
myoclonus	ENTITY
,	
or	
epilepsy	ENTITY
.	

The	
sensitivity	ENTITY
of	
polysomnographic	ENTITY
study	ENTITY
in	
detecting	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
in	
severe	ENTITY
cases	ENTITY
is	
moderate	ENTITY
to	
high	ENTITY
;	
in	
milder	
cases	ENTITY
,	
however	
,	
it	
may	
be	
low	ENTITY
due	
to	
the	
night	ENTITY
-	
to	
-	
night	ENTITY
variability	ENTITY
in	
RMMA	ENTITY
and	
tooth	ENTITY
grinding	ENTITY
.	

Ambulatory	ENTITY
home	ENTITY
monitoring	ENTITY
may	
be	
used	
for	
screening	ENTITY
,	
diagnosis	ENTITY
,	
and	
treatment	ENTITY
outcome	ENTITY
assessment	ENTITY
by	
studying	
the	
individual	ENTITY
in	
his	
/	
her	
usual	ENTITY
environment	ENTITY
,	
but	
it	
is	
characterized	
by	
lower	
diagnostic	ENTITY
specificity	ENTITY
due	
to	
the	
absence	ENTITY
of	
audiovisual	ENTITY
record-	ENTITY
ings	ENTITY
(	
i.e.	
,	
20	
%	
overestimation	ENTITY
in	
RMMA	ENTITY
frequency	ENTITY
is	
expected	
due	
to	
poor	ENTITY
capacity	ENTITY
to	
exclude	
concomitant	ENTITY
nonspecific	ENTITY
activities	ENTITY
)	
.	

To	
record	ENTITY
and	
score	ENTITY
sleep	ENTITY
related	
bruxism	ENTITY
activity	ENTITY
(	
i.e.	
,	
RMMA	ENTITY
)	

,	
there	
must	
be	
a	
minimum	
of	
one	
masseter	ENTITY
muscle	ENTITY
monitor	ENTITY
,	
ideally	
with	
audiovisual	ENTITY
recording	ENTITY
,	
to	
associate	
muscular	ENTITY
activity	ENTITY
with	
grinding	ENTITY
sound	ENTITY
production	ENTITY
.	

Video	ENTITY
monitoring	ENTITY
helps	
distinguish	
bruxism	ENTITY
from	
other	
orofacial	ENTITY
and	
masticatory	ENTITY
movements	ENTITY
that	
normally	
occur	
during	
sleep	ENTITY
(	
e.g.	
,	
swallowing	ENTITY
,	
coughing	ENTITY
)	
and	
from	
specific	
movement	
disorders	
(	
RBD	ENTITY
,	
epilepsy	ENTITY
and	
tooth	ENTITY
tapping	ENTITY
,	
oromandibular	ENTITY
myoclonus	ENTITY
)	
.	

For	
the	
best	
level	ENTITY
of	
diagnostic	ENTITY
specificity	ENTITY
and	
sensitivity	ENTITY
,	
bilateral	ENTITY
masseter	ENTITY
and	
tem-	ENTITY
poralis	ENTITY
muscle	ENTITY
EMG	ENTITY
recordings	ENTITY
,	
referenced	
to	
ear	ENTITY
,	
mastoid	ENTITY
,	
or	
zygomatic	ENTITY
bone	ENTITY
,	
are	
advisable	
.	

Differential	ENTITY
Diagnosis	ENTITY

The	
disorder	ENTITY
seldom	ENTITY
poses	
diagnostic	ENTITY
problems	ENTITY
.	

Evaluation	ENTITY
for	
temporomandibular	ENTITY
disorders	ENTITY
and	
damage	ENTITY
to	
dentition	ENTITY
is	
indicated	
.	

Sleep	ENTITY
related	
bruxism	ENTITY
needs	
to	
be	
differentiated	
from	
other	
faciomandibular	ENTITY
activities	ENTITY
occurring	
during	
sleep	ENTITY
,	
such	
as	
faciomandibular	ENTITY
myoclonus	ENTITY
,	
SRBD	ENTITY
,	
RBD	ENTITY
,	
abnormal	ENTITY
swallowing	ENTITY
,	
gastro	ENTITY
-	
esophageal	ENTITY
reflux	ENTITY
,	
night	ENTITY
terrors	ENTITY
,	
confusional	ENTITY
arousals	ENTITY
,	
dyskinetic	ENTITY
jaw	ENTITY
movements	ENTITY
persisting	
in	
sleep	ENTITY
(	
dystonia	ENTITY
,	
tremor	ENTITY
,	
chorea	ENTITY
,	
dyskinesia	ENTITY
)	
,	
and	
,	
rarely	ENTITY
,	
sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Oromandibular	ENTITY
or	
faciomandibular	ENTITY
myoclonus	ENTITY
has	
been	
observed	
in	
approximately	
10	
%	
of	
individuals	ENTITY
with	
severe	ENTITY
sleep	
related	
bruxism	ENTITY
,	
but	
it	
can	
also	
occur	
in	
indi-	
viduals	ENTITY
without	
abnormally	
increased	ENTITY
RMMA	ENTITY
events	ENTITY
.	

As	
opposed	
to	
sleep	ENTITY
related	
bruxism	ENTITY
,	
faciomandibular	ENTITY
myoclonus	ENTITY
consists	
of	
EMG	ENTITY
bursts	ENTITY
of	
brief	ENTITY
duration	ENTITY
(	
less	
than	
250	
milliseconds	
in	
length	ENTITY
)	
in	
the	
facial	ENTITY
muscles	ENTITY
;	
these	
can	
occur	
either	
as	
isolated	ENTITY
bursts	ENTITY
or	
as	
a	
cluster	ENTITY
of	
regularly	ENTITY
or	
irregularly	ENTITY
occurring	
brief	ENTITY
bursts	ENTITY
.	

A	
high	ENTITY
index	ENTITY
of	
oromandibular	ENTITY
myoclonus	ENTITY
in	
sleep	ENTITY
has	
been	
observed	
in	
idiopathic	ENTITY
RBD	ENTITY
patients	ENTITY
.	

Rhythmic	ENTITY
jaw	ENTITY
movements	ENTITY
also	
have	
been	
observed	
in	
association	ENTITY
with	ENTITY
partial	ENTITY
complex	ENTITY
or	
generalized	ENTITY
seizure	ENTITY
disorders	ENTITY
.	

Epilepsy	ENTITY
needs	
to	
be	
considered	
in	
the	
differential	ENTITY
diagnosis	ENTITY
,	
although	
the	
presentation	ENTITY
of	
epilepsy	ENTITY
as	
relatively	
isolated	ENTITY
sleep	
related	
bruxism	ENTITY
is	
very	
rare	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

An	
expert	ENTITY
bruxism	ENTITY
international	ENTITY
group	ENTITY
has	
proposed	
a	
diagnostic	ENTITY
grading	ENTITY
system	ENTITY
of	
“	
possible	ENTITY
,	
”	
“	
probable	ENTITY
,	
”	
and	
“	
definite	ENTITY
”	
for	
both	
sleep	ENTITY
and	
awake	ENTITY
bruxism	ENTITY
.	

Such	
a	
clinical	ENTITY
tool	ENTITY
will	
help	
to	
discriminate	ENTITY
sleep	ENTITY
bruxism	ENTITY
from	
awake	ENTITY
bruxism	ENTITY
,	
although	
further	
validation	ENTITY
is	
required	
for	
clinical	ENTITY
and	
research	ENTITY
purposes	
in	
all	
relevant	ENTITY
dental	ENTITY
and	
medical	ENTITY
domains	ENTITY
.	

In	
summary	
,	
this	
group	ENTITY
suggests	
that	
a	
rating	ENTITY
of	
:	
(	
1	
)	
“	
possible	
”	
is	
given	
if	
based	
on	
self	ENTITY
-	
report	ENTITY
,	
by	
means	
of	
questionnaires	ENTITY
,	
and/or	
the	
anamnestic	ENTITY
part	ENTITY
of	
a	
clinical	ENTITY
examination	ENTITY
;	
(	
2	
)	
“	
probable	ENTITY
”	
sleep	
or	
awake	ENTITY
bruxism	ENTITY
is	
given	
if	
based	
on	
self	ENTITY
-	
report	ENTITY
and	
supportive	ENTITY
physical	ENTITY
findings	ENTITY
;	
(	
3	
)	
“	
definite	ENTITY
”	
sleep	ENTITY
bruxism	ENTITY
if	
based	
on	
self	ENTITY
-	
report	ENTITY
,	
physical	ENTITY
findings	ENTITY
,	
and	
a	
polysomnographic	ENTITY
recording	ENTITY
,	
preferably	
with	
audiovisual	ENTITY
recordings	ENTITY
.	

The	
clinical	ENTITY
relevance	ENTITY
of	
sleep	ENTITY
related	
bruxism	ENTITY
in	
cases	ENTITY
of	
comorbidity	ENTITY
with	
other	
medical	ENTITY
problems	ENTITY
such	
as	
snoring	ENTITY
,	
sleep	ENTITY
related	
breathing	ENTITY
disorder	ENTITY
,	
RBD	ENTITY
,	
attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
,	
headache	ENTITY
,	
and	
orofacial	ENTITY
pain	ENTITY
needs	
to	
be	
assessed	ENTITY
in	
order	
to	
distinguish	
primary	
benign	ENTITY
forms	ENTITY
of	
sleep	
related	
bruxism	ENTITY
from	
those	
that	
rep-	ENTITY
resent	ENTITY
an	
epiphenomenon	ENTITY
of	
other	
more	
severe	ENTITY
sleep	ENTITY
and	
medical	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
related	
bruxism	ENTITY
may	
be	
concomitant	ENTITY
to	
breathing	ENTITY
disorders	ENTITY
,	
including	
any	
level	ENTITY
of	
severity	ENTITY
of	
OSA	ENTITY
;	
further	
research	ENTITY
is	
in	
progress	ENTITY
to	
assess	ENTITY
the	
specificity	ENTITY
and	
validity	ENTITY
of	
this	
association	ENTITY
.	

There	
is	
currently	
no	
evidence	ENTITY
supporting	
the	
possibility	
that	
patients	ENTITY
with	
sleep	ENTITY
related	ENTITY
bruxism	ENTITY
,	
in	
its	
primary	ENTITY
form	ENTITY
,	
are	
at	
increased	ENTITY
risk	ENTITY
of	
neurological	ENTITY
disorders	ENTITY
;	
such	
a	
risk	ENTITY
factor	ENTITY
assessment	ENTITY
needs	
long-	
term	
study	ENTITY
before	
any	
conclusion	ENTITY
can	
be	
drawn	
.	

Investigation	ENTITY
of	
genetic	ENTITY
associations	
to	
sleep	ENTITY
related	
bruxism	ENTITY
require	
large	
sample	ENTITY
sizes	ENTITY
,	
using	
valid	
tools	ENTITY
to	
assess	
the	
specificity	ENTITY
of	
RMMA	ENTITY
versus	
other	
oromandibular	ENTITY
activities	ENTITY
and	
to	
discriminate	ENTITY
gene	ENTITY
candidates	ENTITY
specific	
for	
bruxism	ENTITY
from	
those	
related	
to	
its	
comorbidities	ENTITY
such	
as	
stress	ENTITY
or	
other	
related	
triggers	ENTITY
of	
RMMA	ENTITY
.	

Bibliography	ENTITY
Abe	ENTITY
S	ENTITY
,	
Yamaguchi	
T	
,	
Rompré	ENTITY
PH	ENTITY
,	
De	ENTITY
Grandmont	ENTITY
P	ENTITY
,	
Chen	ENTITY
YJ	ENTITY
,	
Lavigne	ENTITY
GJ	ENTITY
.	

Tooth	ENTITY
wear	ENTITY
in	
young	ENTITY
subjects	ENTITY
:	
a	
discriminator	
between	
sleep	ENTITY
bruxers	ENTITY
and	
controls	ENTITY
?	

Int	ENTITY
J	ENTITY
Prosthodont	ENTITY
2009;22:342–50	ENTITY
.	

Carra	ENTITY
MC	ENTITY
,	
Macaluso	
GM	
,	
Rompre	ENTITY
PH	ENTITY
,	
et	
al	
.	

Clonidine	ENTITY
has	
a	
paradoxical	ENTITY
effect	
on	
cyclic	ENTITY
arousal	ENTITY
and	
sleep	ENTITY
bruxism	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
2010;33:1711–6	
.	

Hublin	ENTITY
C	ENTITY
,	
Kaprio	ENTITY
J	ENTITY
,	
Partinen	ENTITY
M	ENTITY
,	
Koskenvuo	ENTITY
M.	ENTITY
Sleep	ENTITY
bruxism	ENTITY
based	
on	
self	ENTITY
-	
report	ENTITY
in	
a	
nationwide	
twin	ENTITY
cohort	ENTITY
.	

J	
Sleep	
Res	
1998;7:61–7	
.	

Lavigne	ENTITY
G	ENTITY
,	
Guitard	ENTITY
F	ENTITY
,	
Rompre	ENTITY
P	ENTITY
,	
Montplaisir	ENTITY
J.	
Variability	ENTITY
in	
sleep	ENTITY
bruxism	ENTITY
activity	
over	
time	ENTITY
.	

J	
Sleep	
Res	
2001;10:237–44	
.	

Lavigne	ENTITY
G	ENTITY
,	
Manzini	ENTITY
C	ENTITY
,	
Huynh	ENTITY
NT	ENTITY
.	

Sleep	ENTITY
bruxism	ENTITY
.	

In	
:	
Kryger	ENTITY
MH	ENTITY
,	
Roth	ENTITY
T	ENTITY
,	
Dement	ENTITY
WC	ENTITY
,	
eds	
.	

Principles	ENTITY
and	
practice	ENTITY
of	
sleep	ENTITY
medicine	ENTITY
,	
5th	
ed	
.	

St.	ENTITY
Louis	ENTITY
:	
Elsevier	
Saunders	
,	
2011:1129–39	
.	

Lobbezoo	ENTITY
F	ENTITY
,	
Ahlberg	
J	
,	
Glaros	ENTITY
AG	ENTITY
,	
et	
al	
.	

Bruxism	ENTITY
defined	
and	
graded	ENTITY
:	
An	
international	ENTITY
consensus	ENTITY
.	

J	ENTITY
Oral	ENTITY
Rehab	ENTITY
2013;40:2–4	ENTITY
.	

Ohayon	ENTITY
M	ENTITY
,	
Li	ENTITY
K	ENTITY
,	ENTITY
Guilleminault	
C.	
Risk	ENTITY
factors	ENTITY
for	
sleep	ENTITY
bruxism	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

Chest	ENTITY
2001;119:53–61	ENTITY
.	

Rompre	ENTITY
PH	ENTITY
,	
Daigle	ENTITY
-	
Landry	ENTITY
D	ENTITY
,	
Guitard	ENTITY
F	ENTITY
,	
Montplaisir	ENTITY
JY	ENTITY
,	
Lavigne	ENTITY
GJ	ENTITY
.	

Identification	ENTITY
of	
a	
sleep	ENTITY
bruxism	ENTITY
subgroup	ENTITY
with	
a	
higher	ENTITY
risk	ENTITY
of	
pain	ENTITY
.	

J	
Dent	
Res	
2007;86:837–42	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
et	
al	
.	

Familial	ENTITY
nocturnal	ENTITY
facio	ENTITY
-	
mandibular	ENTITY
myoclonus	ENTITY
mimicking	
sleep	ENTITY
bruxism	ENTITY
.	

Neurology	ENTITY
2002;58:644–7	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Rhythmic	ENTITY
Movement	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.59	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.69	ENTITY
Alternate	ENTITY
Names	ENTITY
Body	ENTITY
rocking	ENTITY
,	
head	ENTITY
banging	ENTITY
,	
head	ENTITY
rolling	ENTITY
,	
body	ENTITY
rolling	ENTITY
,	
jactatio	ENTITY
capitis	ENTITY
nocturna	ENTITY
,	
jac-	
tatio	ENTITY
corporis	ENTITY
nocturna	ENTITY
,	
rhythmie	ENTITY
du	
sommeil	
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
D	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
exhibits	
repetitive	ENTITY
,	
stereotyped	ENTITY
,	
and	
rhythmic	ENTITY
motor	ENTITY
behaviors	ENTITY
involving	
large	
muscle	ENTITY
groups	ENTITY
.	

B.	ENTITY
The	
movements	ENTITY
are	
predominantly	
sleep	ENTITY
related	
,	
occurring	
near	ENTITY
nap	ENTITY
or	
bedtime	ENTITY
,	
or	
when	
the	
individual	ENTITY
appears	
drowsy	ENTITY
or	
asleep	ENTITY
.	

C.	

The	
behaviors	ENTITY
result	
in	
a	
significant	
complaint	
as	
manifest	ENTITY
by	
at	
least	
one	
of	
the	
following:1	ENTITY
.	

Interference	ENTITY
with	ENTITY
normal	ENTITY
sleep	ENTITY
.	
.	

Significant	ENTITY
impairment	ENTITY
in	
daytime	ENTITY
function	ENTITY
.	
.	

Self	ENTITY
-	
inflicted	ENTITY
bodily	ENTITY
injury	ENTITY
or	
likelihood	ENTITY
of	
injury	ENTITY
if	
preventive	ENTITY
measures	ENTITY
are	
not	
used	
.	

D.	

The	
rhythmic	ENTITY
movements	ENTITY
are	
not	
better	
explained	
by	
another	
movement	ENTITY
disorder	ENTITY
or	
epilepsy	ENTITY
.	

Notes	ENTITY
.	

When	
there	
are	
no	
clinical	ENTITY
consequences	ENTITY
of	
the	
rhythmic	ENTITY
movements	ENTITY
,	
the	
rhythmic	ENTITY
movements	ENTITY
are	
simply	
noted	
but	
the	
term	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
is	
not	
employed	
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
(	
RMD	ENTITY
)	
is	
characterized	
by	
repetitive	ENTITY
,	
ste-	
reotyped	ENTITY
,	
and	
rhythmic	ENTITY
motor	ENTITY
behaviors	ENTITY
(	
not	
tremors	ENTITY
)	
that	
occur	
predominantly	
during	
drowsiness	ENTITY
or	
sleep	ENTITY
and	
involve	
large	
muscle	ENTITY
groups	ENTITY
.	

The	
occurrence	ENTITY
of	
significant	
clinical	ENTITY
consequences	ENTITY
differentiates	
RMD	ENTITY
from	
developmentally	ENTITY
normal	ENTITY
sleep	ENTITY
related	
movements	ENTITY
.	

Typically	
seen	
in	
infants	ENTITY
and	
children	ENTITY
,	
but	
also	
in	
adults	ENTITY
,	
RMD	ENTITY
comprises	
several	
sub-	
types	
.	

Body	ENTITY
rocking	ENTITY
may	
involve	
the	
entire	ENTITY
body	ENTITY
,	
with	
the	
individual	ENTITY
on	
hands	ENTITY
and	
knees	ENTITY
,	
or	
it	
may	
be	
limited	
to	
the	
torso	ENTITY
,	
with	
the	
individual	ENTITY
sitting	ENTITY
.	

Head	ENTITY
banging	ENTITY
often	
occurs	
with	
the	
person	ENTITY
prone	
,	
repeatedly	
lifting	ENTITY
the	
head	ENTITY
or	
entire	
upper	ENTITY
torso	ENTITY
,	
and	
forc-	
ibly	ENTITY
banging	ENTITY
the	
head	ENTITY
back	ENTITY
down	ENTITY
into	
the	
pillow	ENTITY
or	
mattress	ENTITY
.	

Alternately	
,	
the	
individual	ENTITY
may	
sit	
with	
the	
back	
of	
the	
head	ENTITY
against	
the	
headboard	ENTITY
or	
wall	
,	
repeatedly	
banging	ENTITY
the	
occiput	ENTITY
.	

Combining	
head	ENTITY
banging	ENTITY
and	
body	ENTITY
rocking	ENTITY
,	
they	
may	
rock	ENTITY
on	
hands	ENTITY
and	
knees	ENTITY
,	
banging	ENTITY
the	
vertex	ENTITY
or	
frontal	ENTITY
region	ENTITY
of	
the	
head	ENTITY
into	
the	
headboard	ENTITY
or	
wall	ENTITY
.	

Head	ENTITY
rolling	ENTITY
consists	
of	
side	ENTITY
-	
to	
-	
side	ENTITY
head	ENTITY
movements	
,	
usually	
with	
the	
child	ENTITY
(	
or	
adult	ENTITY
)	
in	
the	
supine	ENTITY
position	ENTITY
.	

Less	
common	
rhythmic	ENTITY
movement	ENTITY
forms	
include	
body	ENTITY
rolling	ENTITY
,	
leg	ENTITY
banging	ENTITY
,	
or	
leg	ENTITY
rolling	ENTITY
.	

Rhythmic	ENTITY
humming	ENTITY
or	
inarticulate	ENTITY
sounds	ENTITY
often	
accompany	
the	
body	ENTITY
,	
head	ENTITY
,	
or	
limb	ENTITY
movements	ENTITY
and	
may	
be	
quite	
loud	ENTITY
.	

Episodes	ENTITY
often	
occur	
near	ENTITY
sleep	ENTITY
onset	ENTITY
,	
although	
they	
also	
may	
occur	
at	
any	
time	
during	
the	
night	ENTITY
and	
even	
during	
quiet	
wakeful	ENTITY
activities	ENTITY
,	
such	
as	
listening	ENTITY
to	
music	ENTITY
or	
trav-	
eling	ENTITY
in	
vehicles	ENTITY
.	

The	
movement	ENTITY
frequency	ENTITY
can	
vary	
,	
but	
the	
rate	ENTITY
is	
usually	
between	
0.5	
per	
second	
and	
two	
per	
second	
.	

Duration	ENTITY
of	
the	
individual	ENTITY
movement	ENTITY
clusters	ENTITY
also	
varies	
but	
generally	
is	
less	
than	
15	
minutes	ENTITY
.	

Cessation	ENTITY
of	
movements	ENTITY
may	
occur	
fol-	
lowing	ENTITY
environmental	
disturbance	
or	
being	
spoken	ENTITY
to	
.	

Children	ENTITY
who	
have	
sufficient	
language	ENTITY
development	ENTITY
to	
be	
asked	
about	
event	ENTITY
recall	ENTITY
in	
the	
morning	ENTITY
are	
typically	
amnestic	ENTITY
for	
the	
episodes	ENTITY
.	

Rarely	ENTITY
,	
adults	ENTITY
will	
report	
a	
volitional	ENTITY
component	ENTITY
.	

Sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
are	
common	
in	
normal	ENTITY
infants	ENTITY
and	
children	ENTITY
.	

Without	
evidence	ENTITY
for	
significant	ENTITY
consequences	ENTITY
,	
the	
movements	ENTITY
alone	
should	
not	
be	
considered	
a	
disorder	ENTITY
.	

Sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
should	
be	
considered	
a	
disorder	ENTITY
only	
if	
the	
behaviors	ENTITY
significantly	
interfere	ENTITY
with	ENTITY
normal	ENTITY
sleep	ENTITY
,	
cause	
significant	
impairment	ENTITY
in	
daytime	ENTITY
function	ENTITY
,	
or	
result	
in	
self	ENTITY
-	
inflicted	ENTITY
bodily	ENTITY
injury	ENTITY
(	
or	
would	
result	
in	
injury	ENTITY
if	
preventive	ENTITY
measures	ENTITY
are	
not	
used	
)	
.	

Associated	ENTITY
Features	ENTITY
The	
vast	
majority	
of	
infants	ENTITY
and	
children	ENTITY
with	
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
are	
otherwise	
developmentally	
and	
intellectually	ENTITY
normal	ENTITY
,	
as	
are	
most	
adolescents	ENTITY
and	
adults	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Body	ENTITY
Rocking	ENTITY
:	
The	
whole	ENTITY
body	ENTITY
is	
rocked	
while	
on	
the	
hands	ENTITY
and	
knees	ENTITY
.	

Head	ENTITY
Banging	ENTITY
:	
The	
head	ENTITY
is	
forcibly	
moved	
,	
striking	
an	
object	ENTITY
.	

Head	ENTITY
Rolling	ENTITY
:	
The	
head	ENTITY
is	
moved	
laterally	ENTITY
,	
typically	
while	
in	
a	
supine	ENTITY
position	ENTITY
.	

Other	
:	
Includes	ENTITY
body	ENTITY
rolling	ENTITY
,	
leg	ENTITY
rolling	ENTITY
,	
and	
leg	ENTITY
banging	ENTITY
.	

Combined	ENTITY
:	
Involves	ENTITY
two	
or	
more	
of	
the	
individual	ENTITY
types	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Demographics	ENTITY

At	
nine	
months	ENTITY
of	
age	ENTITY
,	
59	
%	
of	
all	
infants	ENTITY
have	
been	
reported	
to	
exhibit	
one	
or	
more	
of	
the	
following	
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
:	
body	ENTITY
rocking	ENTITY
(	
43	
%	
)	
,	
head	ENTITY
banging	ENTITY
(	
22	
%	
)	
,	
or	
head	ENTITY
rolling	ENTITY
(	
24	
%	
)	
.	

At	
18	
months	ENTITY
,	
the	
overall	ENTITY
prevalence	ENTITY
has	
been	
reported	
to	
decline	ENTITY
to	
33	
%	
,	
and	
by	
five	
years	ENTITY
,	
to	
only	
5	
%	
.	

Most	
pediatric	ENTITY
studies	ENTITY
have	
found	
no	ENTITY
sex	ENTITY
difference	ENTITY
.	

Over	
50	
cases	ENTITY
of	
RMD	ENTITY
have	
been	
reported	
in	
adolescents	ENTITY
and	
adults	ENTITY
,	
with	
a	
male	ENTITY
pre-	ENTITY
ponderance	ENTITY
found	
in	
adults	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
The	
soothing	ENTITY
effect	ENTITY
of	
vestibular	ENTITY
stimulation	ENTITY
has	
been	
proposed	
as	
the	
initiating	
factor	
in	
infants	ENTITY
and	
toddlers	ENTITY
.	

Environmental	ENTITY
stress	ENTITY
and	
lack	ENTITY
of	
environmental	ENTITY
stimulation	ENTITY
have	
also	
been	
proposed	
as	
factors	ENTITY
.	

One	
study	ENTITY
found	
higher	ENTITY
anxiety	ENTITY
scores	ENTITY
in	
children	ENTITY
with	
body	ENTITY
rocking	ENTITY
than	
in	
controls	ENTITY
.	

Self	ENTITY
-	
stimulation	ENTITY
has	
been	
suggested	
as	
a	
factor	ENTITY
,	
particularly	
in	
intellectually	ENTITY
disabled	ENTITY
,	
autistic	ENTITY
,	
and	
emotionally	
disturbed	
children	ENTITY
.	

Rhythmic	ENTITY
movements	ENTITY
have	
been	
postulated	
to	
be	
a	
calming	ENTITY
technique	ENTITY
employed	
by	
children	ENTITY
to	
combat	ENTITY
insomnia	ENTITY
.	

Rhythmic	ENTITY
movements	ENTITY
have	
been	
reported	
in	
association	ENTITY
with	
RLS	ENTITY
,	
OSA	ENTITY
,	
narcolepsy	ENTITY
,	
RBD	ENTITY
,	
and	
ADHD	ENTITY
.	

Rhythmic	ENTITY
movements	ENTITY
may	
be	
used	
as	
a	
conscious	ENTITY
strategy	ENTITY
to	
relieve	
the	
urge	ENTITY
to	
move	
or	
the	
uncomfortable	ENTITY
sensations	ENTITY
associated	ENTITY
with	ENTITY
RLS	ENTITY
.	
OSA-	

associated	
RMD	ENTITY
often	
improves	ENTITY
with	
positive	ENTITY
airway	
pressure	
.	

Individuals	ENTITY
with	
narco-	
lepsy	ENTITY
may	
initiate	
rhythmic	ENTITY
movements	ENTITY
to	
terminate	ENTITY
episodes	ENTITY
of	
sleep	ENTITY
paralysis	ENTITY
.	

In	
older	ENTITY
children	ENTITY
or	
adults	ENTITY
,	
stereotypic	ENTITY
movements	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
intellectual	ENTITY
disability	ENTITY
or	
autism	ENTITY
spectrum	ENTITY
disorder	ENTITY
.	

However	
,	
in	
most	
of	
these	
cases	ENTITY
,	
the	
movements	ENTITY
are	
not	
predominantly	
sleep	ENTITY
related	
,	
and	
an	
additional	
diagnosis	ENTITY
of	
RMD	ENTITY
is	
not	
indicated	
.	

Familial	ENTITY
Patterns	ENTITY

A	
familial	ENTITY
pattern	ENTITY
has	
been	
reported	
rarely	
,	
as	
has	
occurrence	ENTITY
in	
identical	ENTITY
twins	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
The	
onset	ENTITY
of	ENTITY
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
is	
typically	
in	
early	ENTITY
childhood	ENTITY
.	

Body	ENTITY
rocking	ENTITY
has	
a	
mean	
age	ENTITY
of	
onset	
of	
six	
months	ENTITY
,	
head	ENTITY
banging	ENTITY
of	
nine	
months	ENTITY
,	
and	
head	ENTITY
rolling	ENTITY
of	
ten	
months	ENTITY
.	

The	
condition	ENTITY
may	
rarely	
present	
at	
an	
older	ENTITY
age	ENTITY
following	
central	ENTITY
nervous	ENTITY
system	ENTITY
trauma	ENTITY
.	

Sleep	ENTITY
related	
rhythmic	ENTITY
movements	
commonly	
resolve	
in	
the	
second	
or	
third	
year	
of	
life	
.	

Persistence	ENTITY
at	
five	
years	ENTITY
of	
age	ENTITY
occurs	
in	
about	
5	
%	
of	
children	ENTITY
.	

Sleep	ENTITY
related	
movements	ENTITY
rarely	
continue	
into	
adolescence	ENTITY
and	
adulthood	ENTITY
.	

Worsening	ENTITY
or	
spontaneous	ENTITY
onset	
in	
adults	ENTITY
is	
very	
rare	
.	

In	
some	
adult	ENTITY
cases	ENTITY
the	
chief	ENTITY
concern	ENTITY
is	
disturbance	ENTITY
of	
the	
bed	ENTITY
partner	ENTITY
’s	ENTITY
sleep	ENTITY
.	

Most	
adolescents	ENTITY
and	
adults	ENTITY
have	
one	
form	
of	
RMD	ENTITY
,	
although	
some	
have	
two	
or	
more	
.	

Head	ENTITY
banging	ENTITY
is	
the	
most	
disturbing	
form	
of	
the	
problem	ENTITY
.	

Typical	
cases	ENTITY
in	
infants	ENTITY
and	
toddlers	ENTITY
pose	
little	
risk	ENTITY
of	
serious	ENTITY
injury	ENTITY
.	

Vigorous	ENTITY
rhythmic	ENTITY
movements	ENTITY
can	
produce	
loud	ENTITY
noises	ENTITY
when	
the	
patient	ENTITY
hits	ENTITY
the	
bed	ENTITY
frame	ENTITY
or	
when	
the	
bed	ENTITY
bangs	ENTITY
against	
the	
wall	ENTITY
or	
floor	ENTITY
.	

The	
noises	ENTITY
can	
be	
very	
disturbing	
to	
other	
family	ENTITY
members	ENTITY
.	

Parental	ENTITY
concern	
is	
common	
,	
and	
psychosocial	ENTITY
consequences	ENTITY
in	
the	
older	ENTITY
individual	ENTITY
can	
be	
distressing	ENTITY
.	

It	
is	
important	
to	
discuss	
appropriate	
safety	ENTITY
precautions	ENTITY
with	
the	
patient	ENTITY
’s	
caretak-	
ers	ENTITY
.	

Under	
extraordinary	
circumstances	ENTITY
,	
particularly	
in	
the	
developmentally	ENTITY
disabled	ENTITY
,	
injury	ENTITY
to	
soft	ENTITY
tissues	ENTITY
or	
bone	ENTITY
has	
been	
reported	
.	

Developmental	ENTITY
Issues	ENTITY
Because	
age	ENTITY
-	
related	ENTITY
factors	ENTITY
are	
a	
critical	
dimension	
for	
RMD	ENTITY
,	
developmental	ENTITY
issues	ENTITY
are	
discussed	
under	
Essential	ENTITY
Features	ENTITY
and	
other	
sections	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
In	
infants	ENTITY
and	
young	ENTITY
children	ENTITY
,	
rhythmic	ENTITY
movements	ENTITY
have	
been	
hypothesized	
to	
promote	ENTITY
motor	ENTITY
development	ENTITY
by	
stimulation	ENTITY
of	
the	
vestibular	ENTITY
system	ENTITY
.	

More	
recently	
,	
the	
role	
of	
inhibitory	ENTITY
control	ENTITY
on	
the	
central	ENTITY
motor	ENTITY
pattern	ENTITY
generator	ENTITY
has	
been	
sug-	ENTITY
gested	ENTITY
as	
a	
physiologic	ENTITY
mechanism	ENTITY
to	
explain	
both	
pediatric	ENTITY
and	
adult	ENTITY
forms	
of	
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
.	

Objective	
Findings	ENTITY
Polysomnographic	ENTITY
scoring	ENTITY
rules	
for	
RMD	ENTITY
are	
defined	
in	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Video	ENTITY
-	
polysomnographic	ENTITY
studies	ENTITY
have	
shown	
rhythmic	ENTITY
movements	ENTITY
to	
occur	
most	
often	
in	
association	ENTITY
with	ENTITY
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
sleep	ENTITY
;	
46	
%	
occur	
while	
falling	ENTITY
asleep	ENTITY
or	
during	
NREM	ENTITY
sleep	ENTITY
;	
30	
%	
during	
both	
NREM	ENTITY
and	
REM	ENTITY
sleep	ENTITY
;	
and	
24	
%	
only	
during	
REM	ENTITY
sleep	ENTITY
.	

The	
exclusively	
REM	ENTITY
-	
related	ENTITY
rhythmic	ENTITY
movements	ENTITY
occur	
more	
frequently	
in	
adults	ENTITY
.	

Although	
an	
epileptic	ENTITY
etiology	ENTITY
has	
been	
reported	
in	
one	
individual	ENTITY
,	
most	
EEG	ENTITY
studies	ENTITY
have	
shown	
normal	
activity	ENTITY
between	
epi-	
sodes	ENTITY
of	
rhythmic	ENTITY
behavior	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
RMD	ENTITY
must	
be	
distinguished	
from	
other	
repetitive	ENTITY
movements	ENTITY
involving	
restricted	
small	
muscle	
groups	ENTITY
,	
such	
as	
sleep	ENTITY
related	
bruxism	ENTITY
,	
thumb	ENTITY
sucking	ENTITY
,	
and	
rhythmic	ENTITY
sucking	ENTITY
of	
a	
pacifier	ENTITY
or	
the	
lips	ENTITY
,	
as	
well	
as	
other	
specifically	
defined	
rhythmic	ENTITY
movements	ENTITY
of	
sleep	ENTITY
,	
such	
as	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
In	
adults	ENTITY
,	
RMD	ENTITY
can	
be	
misdiagnosed	ENTITY
as	
RBD	ENTITY
or	
be	
comorbid	ENTITY
with	
RBD	ENTITY
.	

Video	ENTITY
poly-	ENTITY
somnography	ENTITY
is	
particularly	
helpful	
in	
these	
cases	ENTITY
.	

Rhythmic	ENTITY
movements	ENTITY
may	
occur	
as	
a	
conscious	ENTITY
or	
unconscious	ENTITY
strategy	ENTITY
to	
relieve	
RLS	ENTITY
symptoms	ENTITY
.	

If	
the	
rhythmic	ENTITY
move-	
ments	ENTITY
are	
clearly	
in	
response	ENTITY
to	
RLS	ENTITY
sensations	ENTITY
,	
then	
a	
separate	
diagnosis	ENTITY
of	
RMD	ENTITY
is	
not	
needed	
.	

However	
,	
RMD	ENTITY
may	
be	
diagnosed	ENTITY
if	
RMD	ENTITY
criteria	ENTITY
are	
met	
and	
RLS	ENTITY
does	
not	
adequately	
explain	
the	
presence	ENTITY
or	
extent	
of	
rhythmic	ENTITY
movements	ENTITY
.	

Children	ENTITY
with	
autism	ENTITY
spectrum	ENTITY
disorder	ENTITY
often	
exhibit	
repetitive	ENTITY
behaviors	ENTITY
,	
but	
these	
movements	ENTITY
typically	
occur	
during	
wakefulness	ENTITY
and	
are	
not	
predominantly	
sleep	ENTITY
related	
.	

Stereotypic	ENTITY
movement	ENTITY
disorder	ENTITY
is	
a	
Diagnostic	ENTITY
and	
Statistical	
Manual	
of	
Mental	
Disorders	
(	
DSM	
)	
diagnosis	ENTITY
that	
is	
typically	
seen	
with	
intellectual	ENTITY
disability	ENTITY
and	
is	
not	
predominantly	
sleep	ENTITY
related	
.	

In	
children	ENTITY
with	
autism	ENTITY
spectrum	ENTITY
disorder	ENTITY
or	
intellectual	ENTITY
disability	ENTITY
,	
an	
additional	
diagnosis	ENTITY
of	
RMD	ENTITY
should	
be	
made	
only	
if	
the	
movements	ENTITY
are	
predominantly	
sleep	ENTITY
related	
.	

Akathisia	ENTITY
is	
seen	
as	
a	
complication	ENTITY
of	
neuroleptic	ENTITY
medi-	ENTITY
cation	ENTITY
and	
is	
not	
predominantly	
sleep	ENTITY
related	
.	

Autoerotic	ENTITY
or	
masturbatory	ENTITY
behaviors	ENTITY
may	
involve	
body	ENTITY
rocking	ENTITY
or	
other	
repetitive	ENTITY
body	ENTITY
movements	ENTITY
,	
but	
the	
primary	ENTITY
focus	ENTITY
is	
genital	ENTITY
stimulation	ENTITY
as	
is	
evident	
by	
direct	
genital	ENTITY
contact	ENTITY
.	

Rarely	ENTITY
,	
RMD	ENTITY
needs	
to	
be	
differentiated	
from	
epilepsy	ENTITY
,	
tic	ENTITY
disorders	ENTITY
,	
or	
involuntary	ENTITY
movements	ENTITY
associated	ENTITY
with	ENTITY
other	
neurological	ENTITY
conditions	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

There	
is	
controversy	
about	
the	
classification	ENTITY
of	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
as	
a	
separate	
entity	ENTITY
or	
as	
a	
subtype	ENTITY
of	
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
.	

Many	
aspects	
of	
sleep	ENTITY
related	
rhythmic	ENTITY
movements	ENTITY
deserve	
further	
study	ENTITY
,	
including	
the	
relationship	ENTITY
of	
the	
typical	
form	
seen	
in	
otherwise	
normal	ENTITY
infants	ENTITY
and	
young	ENTITY
children	ENTITY
to	
the	
rhythmic	ENTITY
movements	ENTITY
seen	
in	
children	ENTITY
with	
intellectual	ENTITY
disability	ENTITY
and	
autism	ENTITY
spectrum	ENTITY
disorder	ENTITY
.	

The	
pathophysiology	ENTITY
of	
persistent	ENTITY
RMD	ENTITY
is	
poorly	
understood	
,	
as	
is	
the	
association	ENTITY
with	
other	
sleep	ENTITY
disorders	ENTITY
in	
adults	ENTITY
.	

Bibliography	ENTITY
Dyken	ENTITY
M	ENTITY
,	
Lin	ENTITY
-	
Dyken	ENTITY
D	ENTITY
,	
Yamada	
T.	
Diagnosing	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
with	
video	ENTITY
-	
polysomnography	ENTITY
.	

Pediatr	ENTITY
Neurol	ENTITY
1997;16:37–41	ENTITY
.	

Kohyama	ENTITY
J	ENTITY
,	ENTITY
Matsukura	ENTITY
F	ENTITY
,	
Kimura	ENTITY
K	ENTITY
,	ENTITY
Tachibana	ENTITY
N.	ENTITY
Rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
:	
polysomnographic	ENTITY
study	ENTITY
and	
summary	
of	
reported	
cases	ENTITY
.	

Brain	ENTITY
Dev	ENTITY
2002;24:33–8	ENTITY
.	

Laberge	ENTITY
L	ENTITY
,	
Tremblay	ENTITY
R	ENTITY
,	
Vitaro	ENTITY
F	ENTITY
,	
Montplaisir	ENTITY
J.	ENTITY
Development	ENTITY
of	ENTITY
parasomnias	ENTITY
from	
childhood	ENTITY
to	
early	ENTITY
adolescence	ENTITY
.	

Pediatrics	ENTITY
2000;106:67–74	
.	

Manni	ENTITY
R	ENTITY
,	ENTITY
Terzaghi	ENTITY
M.	ENTITY
Rhythmic	ENTITY
movements	
during	
sleep	ENTITY
:	
a	
physiological	ENTITY
and	
pathological	ENTITY
profile	ENTITY
.	

Neurol	ENTITY
Sci	ENTITY
2005;26	ENTITY
:	
s181–5	
.	

Mayer	ENTITY
G	ENTITY
,	
Wilde	
-	
Frenz	
J	
,	
Kurella	ENTITY
B.	ENTITY
Sleep	ENTITY
related	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
revisited	
.	

J	
Sleep	
Res	
2007;16:110–6	
.	

Benign	ENTITY
Sleep	ENTITY
Myoclonus	ENTITY
of	ENTITY
Infancy	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.59	
Alternate	ENTITY
Names	ENTITY
Benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.69	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
A.	
Observation	
of	
repetitive	ENTITY
myoclonic	ENTITY
jerks	ENTITY
that	
involve	
the	
limbs	ENTITY
,	
trunk	ENTITY
,	
or	
whole	ENTITY
body	ENTITY
.	

B.	ENTITY
The	
movements	ENTITY
occur	
in	
early	ENTITY
infancy	ENTITY
,	
typically	
from	
birth	ENTITY
to	
six	
months	ENTITY
of	
age	ENTITY
.	

C.	

The	
movements	ENTITY
occur	
only	
during	
sleep	ENTITY
.	

D.	

The	
movements	ENTITY
stop	ENTITY
abruptly	
and	
consistently	
when	
the	
infant	ENTITY
is	
aroused	
.	

E.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
or	
medication	ENTITY
use	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Benign	ENTITY
sleep	ENTITY
myoclonus	ENTITY
of	
infancy	
(	
BSMI	ENTITY
)	
is	
characterized	
by	
repetitive	ENTITY
myoclonic	ENTITY
jerks	ENTITY
that	
occur	
during	
sleep	ENTITY
in	
neonates	ENTITY
and	
infants	ENTITY
.	

Although	
BSMI	ENTITY
is	
benign	ENTITY
and	
relatively	
rare	
,	
it	
is	
included	
in	
the	
sleep	ENTITY
related	
movement	
disorders	
section	ENTITY
because	
it	
is	
commonly	
confused	
with	
epilepsy	ENTITY
.	

However	
,	
unlike	
the	
jerks	ENTITY
of	
myoclonic	ENTITY
seizures	ENTITY
and	
myoclonic	ENTITY
encephalopathy	ENTITY
,	
the	
jerks	ENTITY
of	
BSMI	ENTITY
occur	
exclusively	
during	
sleep	ENTITY
.	

The	
jerks	ENTITY
are	
often	
bilateral	ENTITY
and	
massive	ENTITY
,	
typically	
involving	
large	
muscle	ENTITY
groups	ENTITY
.	

The	
movements	ENTITY
can	
occur	
in	
the	
whole	ENTITY
body	ENTITY
or	
exclusively	
in	
the	
limbs	ENTITY
,	
the	
trunk	ENTITY
,	
or	
rarely	ENTITY
,	
the	
face	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Not	
applicable	
or	
known	
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Most	
infants	ENTITY
with	
BSMI	ENTITY
are	
neurologically	ENTITY
normal	ENTITY
,	
born	ENTITY
to	
mothers	ENTITY
with	
no	ENTITY
history	ENTITY
of	
illicit	ENTITY
drug	ENTITY
use	ENTITY
.	

However	
,	
BSMI	ENTITY
has	
been	
described	
in	
more	
than	
half	
of	
infants	ENTITY
with	
neonatal	ENTITY
opioid	ENTITY
withdrawal	ENTITY
syndrome	ENTITY
,	
suggesting	
a	
subtype	ENTITY
with	
this	
specific	
etiology	ENTITY
.	

It	
must	
be	
stressed	ENTITY
,	
however	
,	
that	
some	
cases	ENTITY
of	
neonatal	ENTITY
abstinence	ENTITY
syndrome	ENTITY
do	
not	
follow	
a	
benign	ENTITY
clinical	ENTITY
course	ENTITY
.	

Whether	
such	
cases	ENTITY
should	
be	
included	
with	
those	
of	
BSMI	ENTITY
is	
an	
unresolved	
matter	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Demographics	ENTITY

The	
prevalence	ENTITY
is	
unknown	
.	

The	
incidence	ENTITY
has	
been	
estimated	ENTITY
at	
3.7	
per	
10,000	
live	ENTITY
births	ENTITY
.	

More	
than	
200	
cases	ENTITY
have	
been	
described	
in	
the	
literature	ENTITY
.	

Males	ENTITY
are	
affected	ENTITY
more	
than	
females	ENTITY
by	
a	
ratio	ENTITY
of	
about	
2:1	
.	

The	
typical	
age	ENTITY
range	
is	
birth	ENTITY
to	
six	
months	ENTITY
of	
age	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
factors	ENTITY
have	
not	
been	
delineated	
.	

Rocking	ENTITY
or	
repetitive	ENTITY
noises	ENTITY
may	
pre-	
cipitate	ENTITY
individual	ENTITY
episodes	ENTITY
of	
BSMI	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
occurrence	ENTITY
has	
been	
described	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Onset	ENTITY
is	
usually	
noted	
between	
birth	ENTITY
and	
one	
month	ENTITY
of	
age	ENTITY
in	
a	
neurologically	ENTITY
normal	ENTITY
infant	ENTITY
.	

The	
course	ENTITY
is	
self	ENTITY
-	
limited	ENTITY
and	
benign	ENTITY
.	

The	
disorder	ENTITY
may	
be	
present	
for	
only	
a	
few	
days	ENTITY
or	
may	
last	
for	
several	
months	ENTITY
.	

Maximum	ENTITY
expression	ENTITY
is	
typically	
between	
15	
and	
35	
days	ENTITY
of	
age	ENTITY
.	

BSMI	ENTITY
resolves	
by	
three	
months	ENTITY
of	
age	ENTITY
in	
64	
%	
of	
affected	ENTITY
infants	ENTITY
,	
by	
six	
months	ENTITY
in	
95	
%	
,	
and	
by	
12	
months	ENTITY
in	
97	
%	
with	
persistence	ENTITY
rarely	ENTITY
into	
the	
second	
year	
of	
life	
or	
later	
.	

There	
are	
no	
known	
complications	ENTITY
.	

Long	ENTITY
-	
term	ENTITY
follow	ENTITY
-	
up	
in	
a	
limited	
number	
of	
children	ENTITY
has	
shown	
normal	ENTITY
psychomotor	ENTITY
development	ENTITY
and	
normal	ENTITY
cognitive	ENTITY
function	ENTITY
at	
five	
to	
10	
years	ENTITY
of	
age	ENTITY
.	

There	
is	
no	
evidence	ENTITY
for	
an	
increased	ENTITY
risk	ENTITY
of	
seizures	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Because	
age	ENTITY
-	
related	ENTITY
factors	ENTITY
are	
a	
critical	
dimension	
for	
BSMI	ENTITY
,	
developmental	ENTITY
issues	ENTITY
are	
discussed	
throughout	
this	
section	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
presence	ENTITY
of	
a	
generator	ENTITY
in	
the	
cervical	ENTITY
spinal	ENTITY
cord	ENTITY
that	
is	
not	
adequately	
inhibited	ENTITY
due	
to	
immature	ENTITY
myelination	ENTITY
of	
descending	ENTITY
pathways	ENTITY
has	
been	
hypothesized	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Video	ENTITY
-	
polysomnographic	ENTITY
EEG	ENTITY
and	
EMG	ENTITY
monitoring	ENTITY
has	
demonstrated	
paroxysmal	ENTITY
muscle	ENTITY
activity	ENTITY
,	
without	
ictal	ENTITY
or	
interictal	ENTITY
EEG	
abnormalities	ENTITY
.	

BSMI	ENTITY
occurs	
predom-	
inantly	
during	
quiet	ENTITY
sleep	ENTITY
but	
also	
may	
be	
present	
during	
active	ENTITY
sleep	ENTITY
.	

The	
muscle	ENTITY
jerks	ENTITY
are	
usually	
seen	
in	
clusters	ENTITY
of	
four	
or	
five	
jerks	ENTITY
per	
second	
,	
each	
jerk	ENTITY
lasting	
40	
to	
300	
milliseconds	
.	

BSMI	ENTITY
clusters	ENTITY
typically	
repeat	
in	
irregular	ENTITY
series	ENTITY
for	
one	
to	
15	
minutes	ENTITY
,	
but	
,	
in	
some	
cases	ENTITY
,	
the	
clusters	ENTITY
may	
recur	
for	
up	
to	
60	
minutes	ENTITY
or	
longer	ENTITY
and	
be	
mistaken	
for	
status	ENTITY
epilepticus	ENTITY
.	

One	
study	ENTITY
showed	
30	
%	
of	
the	
jerks	ENTITY
to	
involve	
the	
whole	ENTITY
body	ENTITY
,	
20	
%	
to	
involve	
the	
abdominal	ENTITY
or	
proximal	ENTITY
muscles	ENTITY
,	
and	
50	
%	
to	
involve	
only	
the	
arms	ENTITY
or	
the	
legs	ENTITY
.	

The	
arms	ENTITY
are	
usually	
more	
involved	
than	
the	
legs	ENTITY
.	

Activity	ENTITY
is	
symmetrical	
in	
over	
90	
%	
of	
cases	ENTITY
but	
can	
be	
lateralized	ENTITY
.	

The	
myoclonus	ENTITY
is	
not	
associ-	
ated	ENTITY
with	ENTITY
arousals	ENTITY
,	
awakenings	ENTITY
,	
or	
sleep	ENTITY
stage	ENTITY
transitions	ENTITY
.	

Spontaneous	ENTITY
or	
provoked	
awakening	ENTITY
of	
the	
infant	ENTITY
leads	
to	
prompt	ENTITY
,	
abrupt	ENTITY
,	
and	
consis-	
tent	ENTITY
cessation	ENTITY
of	
the	
movements	ENTITY
.	

Gentle	ENTITY
rocking	ENTITY
of	
the	
infant	ENTITY
or	
the	
infant	ENTITY
’s	ENTITY
crib	ENTITY
has	
been	
shown	
to	
provoke	
the	
myoclonus	ENTITY
.	

This	
may	
be	
a	
useful	
maneuver	ENTITY
during	
EEG	ENTITY
monitoring	ENTITY
when	
differentiation	ENTITY
from	
seizures	ENTITY
is	
of	
concern	
.	

In	
contrast	
to	
jitteriness	ENTITY
and	
other	
nonepileptic	ENTITY
etiologies	ENTITY
,	
BSMI	ENTITY
will	
often	
increase	ENTITY
rather	
than	
be	
suppressed	ENTITY
by	
gentle	
restraint	
.	

Neuroimaging	ENTITY
studies	ENTITY
are	
normal	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
BSMI	ENTITY
should	
be	
distinguished	
from	
myoclonic	ENTITY
seizures	ENTITY
;	
misdiagnosis	ENTITY
may	
lead	
to	
unnecessary	
diagnostic	ENTITY
testing	ENTITY
or	
medication	ENTITY
use	ENTITY
.	

The	
absence	ENTITY
of	
episodes	ENTITY
while	
awake	ENTITY
in	
infants	ENTITY
with	
BSMI	ENTITY
is	
the	
single	
most	
helpful	
clinical	ENTITY
feature	ENTITY
.	

In	
addition	
,	
BSMI	ENTITY
will	
stop	
abruptly	
and	
consistently	
when	
the	
infant	ENTITY
is	
aroused	
.	

Neonatal	ENTITY
sei-	
zures	ENTITY
are	
often	
seen	
in	
the	
context	ENTITY
of	
perinatal	ENTITY
disorders	ENTITY
such	
as	
hypoxic	ENTITY
-	
ischemic	ENTITY
encephalopathy	ENTITY
,	
infection	ENTITY
,	
or	
metabolic	ENTITY
abnormalities	ENTITY
,	
whereas	
BSMI	ENTITY
is	
typically	
present	
in	
neurologically	ENTITY
normal	ENTITY
infants	ENTITY
.	

Infantile	ENTITY
spasms	ENTITY
(	
West	ENTITY
syndrome	ENTITY
)	
are	
most	
often	
seen	
after	
the	
first	
month	ENTITY
of	
life	ENTITY
but	
sometimes	
occur	
earlier	
.	

Infantile	ENTITY
spasms	ENTITY
are	
usually	
manifest	ENTITY
by	
sudden	ENTITY
head	ENTITY
flexion	ENTITY
with	ENTITY
arm	ENTITY
extension	ENTITY
and	
lower	ENTITY
extremity	ENTITY
flexion	ENTITY
.	

They	
are	
usually	
associated	ENTITY
with	ENTITY
a	
hypsarrhythmic	ENTITY
EEG	ENTITY
pattern	ENTITY
.	

Pyridoxine-	
dependency	ENTITY
seizures	ENTITY
are	
responsive	ENTITY
to	
treatment	ENTITY
with	
vitamin	ENTITY
B6	ENTITY
.	

In	
cases	ENTITY
that	
are	
dif-	
ficult	ENTITY
to	
differentiate	ENTITY
,	
an	
EEG	ENTITY
obtained	
during	
sleep	ENTITY
will	
show	
normal	
patterns	
when	
BSMI	ENTITY
is	
elicited	
by	
gentle	
rocking	ENTITY
.	

Anticonvulsant	ENTITY
medications	ENTITY
are	
ineffective	ENTITY
and	
unnecessary	
in	
BSMI	ENTITY
.	

BSMI	ENTITY
also	
should	
be	
distinguished	
from	
other	
disorders	ENTITY
that	
occur	
during	
wakeful-	
ness	ENTITY
,	
including	
myoclonic	ENTITY
encephalopathies	ENTITY
,	
hyperekplexia	ENTITY
(	
startle	ENTITY
disease	ENTITY
)	
,	
drug	ENTITY
withdrawal	ENTITY
,	
and	
jitteriness	ENTITY
.	

Benign	ENTITY
myoclonus	ENTITY
of	
early	ENTITY
infancy	ENTITY
usually	
occurs	
after	
the	
third	
month	ENTITY
of	
life	ENTITY
and	
only	
occurs	
during	
wakefulness	ENTITY
.	

PLMD	ENTITY
can	
occur	
in	
infants	ENTITY
but	
typically	
has	
a	
distinctly	
different	
duration	ENTITY
and	
fre-	
quency	ENTITY
.	

The	
muscle	ENTITY
activity	ENTITY
is	
of	
longer	ENTITY
duration	ENTITY
(	
0.5	
to	
10	
seconds	
)	
and	
recurs	ENTITY
at	
a	
more	
regular	ENTITY
and	
longer	ENTITY
interval	ENTITY
(	
typically	
20	
to	
40	
seconds	
)	
.	

PLMD	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
EEG	ENTITY
arousals	ENTITY
,	
whereas	
BSMI	ENTITY
is	
not	
.	

BSMI	ENTITY
is	
more	
often	
seen	
in	
the	
arms	
than	
the	
legs	ENTITY
,	
whereas	
PLMD	ENTITY
predominantly	
occurs	
in	
the	
lower	ENTITY
limbs	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Phasic	ENTITY
-	
REM	ENTITY
muscle	ENTITY
activity	ENTITY
typically	
involves	
smaller	
muscle	ENTITY
groups	ENTITY
and	
can	
be	
linked	
to	
observable	
eye	ENTITY
movements	ENTITY
.	

Sleep	ENTITY
starts	
occur	
at	
the	
wake	ENTITY
-	
sleep	ENTITY
transition	ENTITY
and	
typ-	
ically	ENTITY
are	
not	
repetitive	
.	

Propriospinal	ENTITY
myoclonus	ENTITY
at	
sleep	ENTITY
onset	ENTITY
is	
a	
rare	
disorder	ENTITY
that	
has	
not	
been	
reported	
in	
children	ENTITY
and	
is	
characterized	ENTITY
by	
jerks	ENTITY
involving	
the	
abdominal	ENTITY
and	
truncal	ENTITY
muscles	ENTITY
at	
the	
transition	ENTITY
from	
wakefulness	ENTITY
to	
sleep	ENTITY
.	

Fragmentary	ENTITY
myoclo-	
nus	
has	
been	
described	
in	
adults	ENTITY
and	
is	
primarily	
a	
nonspecific	ENTITY
EMG	ENTITY
finding	ENTITY
with	
little	
or	
no	
visible	
movement	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

The	
prevalence	ENTITY
,	
incidence	ENTITY
,	
and	
pathophysiology	ENTITY
of	
BSMI	ENTITY
warrant	
further	
study	ENTITY
.	

Bibliography	ENTITY
Alfonso	ENTITY
I	ENTITY
,	
Papazian	ENTITY
O	ENTITY
,	
Aicardi	ENTITY
J	ENTITY
,	
Jeffries	ENTITY
HE	ENTITY
.	

A	
simple	
maneuver	ENTITY
to	
provoke	
benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
.	

Pediatrics	ENTITY
1995;96:1161–3	
.	

Di	ENTITY
Capua	ENTITY
M	ENTITY
,	
Fusco	ENTITY
L	ENTITY
,	
Ricci	ENTITY
S	ENTITY
,	
Vigevano	
F.	
Benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
:	
clinical	ENTITY
features	ENTITY
and	
video-	
polygraphic	ENTITY
recordings	ENTITY
.	

Mov	ENTITY
Disord	ENTITY
1993;8:191–4	ENTITY
.	

Held	ENTITY
-	
Egli	ENTITY
K	ENTITY
,	
Rüegger	ENTITY
C	ENTITY
,	
Das	
-	
Kundu	ENTITY
S	ENTITY
,	
Schmitt	ENTITY
B	ENTITY
,	ENTITY
Bucher	ENTITY
HU	ENTITY
.	

Benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
in	
newborn	ENTITY
infants	ENTITY
of	
opioid	ENTITY
dependent	ENTITY
mothers	ENTITY
.	

Acta	
Paediatrica	
2009;98:69–73	
.	

Hrastovec	ENTITY
A	ENTITY
,	
Hostnik	ENTITY
T	ENTITY
,	
Neubauer	ENTITY
D.	ENTITY
Benign	ENTITY
convulsions	ENTITY
in	
newborns	ENTITY
and	
infants	ENTITY
:	
Occurrence	ENTITY
,	
clinical	ENTITY
course	ENTITY
and	
prognosis	ENTITY
.	

Eur	
J	
Paediatr	
Neurol	
2012;16:64–73	
.	

Maurer	ENTITY
VO	ENTITY
,	
Rizzi	ENTITY
M	ENTITY
,	
Bianchetti	ENTITY
MG	ENTITY
,	
Ramelli	ENTITY
GP	ENTITY
.	

Benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
:	
a	
review	ENTITY
of	
the	
literature	ENTITY
.	

Pediatrics	ENTITY
2010;125	
:	
e919–24	
.	

Propriospinal	ENTITY
Myoclonus	ENTITY
at	
Sleep	ENTITY
Onset	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.59	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.69	ENTITY
Alternate	ENTITY
Names	ENTITY

Spinal	ENTITY
myoclonus	ENTITY
,	
plurisegmental	ENTITY
myoclonus	ENTITY
,	
intersegmental	ENTITY
myoclonus	ENTITY
,	
axial	ENTITY
myoclonus	ENTITY
.	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY

A	ENTITY
-	
E	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
complains	ENTITY
of	
sudden	ENTITY
jerks	ENTITY
,	
mainly	
of	
the	
abdomen	ENTITY
,	
trunk	ENTITY
,	
and	
neck	ENTITY
.	

B.	ENTITY
The	
jerks	ENTITY
appear	
during	
relaxed	ENTITY
wakefulness	ENTITY
and	
drowsiness	ENTITY
,	
as	
the	
patient	ENTITY
attempts	
to	
fall	ENTITY
asleep	ENTITY
.	

C.	

The	
jerks	ENTITY
disappear	ENTITY
upon	
mental	ENTITY
activation	ENTITY
and	
with	
onset	
of	
a	
stable	ENTITY
sleep	ENTITY
stage	ENTITY
.	

D.	
The	
jerks	ENTITY
result	ENTITY
in	
difficulty	
initiating	ENTITY
sleep	ENTITY
.	

E.	

The	
disorder	ENTITY
is	
not	
better	
explained	
by	
another	
sleep	ENTITY
disorder	ENTITY
,	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
,	
mental	ENTITY
disorder	ENTITY
,	
medication	ENTITY
use	ENTITY
,	
or	
substance	ENTITY
use	ENTITY
disorder	ENTITY
.	

Notes	ENTITY
.	

Although	
there	
is	
no	
current	
definitive	
evidence	ENTITY
that	
propriospinal	ENTITY
myoclonus	ENTITY
confined	
to	
sleep	ENTITY
onset	ENTITY
is	
associated	ENTITY
with	ENTITY
significant	
structural	ENTITY
lesions	ENTITY
of	
the	
spinal	ENTITY
cord	ENTITY
,	
propriospinal	ENTITY
myoclonus	ENTITY
that	
is	
persistent	ENTITY
during	
the	
day	ENTITY
has	
been	
linked	
to	
structural	ENTITY
spinal	ENTITY
cord	ENTITY
pathology	ENTITY
in	
16	
%	
to	
20	
%	
of	
cases	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Propriospinal	ENTITY
myoclonus	ENTITY
at	
sleep	
onset	
(	
PSM	ENTITY
)	
consists	
of	
sudden	ENTITY
myoclonic	ENTITY
jerks	ENTITY
occurring	
in	
the	
transition	ENTITY
from	
wakefulness	ENTITY
to	
sleep	ENTITY
and	
,	
rarely	ENTITY
,	
during	
intrasleep	ENTITY
wakefulness	ENTITY
and	
upon	
awakening	ENTITY
in	
the	
morning	ENTITY
.	

The	
jerks	ENTITY
arise	
mainly	
in	
the	
axial	ENTITY
muscles	ENTITY
and	
spread	ENTITY
rostrally	ENTITY
and	
caudally	ENTITY
according	
to	
propriospinal	ENTITY
propagation	ENTITY
.	

The	
jerks	ENTITY
may	
be	
of	
variable	ENTITY
intensity	ENTITY
;	
they	
are	
isolated	ENTITY
,	
recurring	
in	
quasi	ENTITY
-	
periodic	ENTITY
fashion	
for	
variable	ENTITY
durations	ENTITY
,	
or	
may	
be	
repeated	
in	
brief	ENTITY
clusters	ENTITY
of	
a	
few	
movements	ENTITY
,	
sepa-	
rated	
by	
longer	ENTITY
intervals	ENTITY
.	

Jerks	ENTITY
involve	
the	
abdominal	ENTITY
and	
truncal	ENTITY
muscles	ENTITY
first	
and	
are	
then	
propagated	
to	
proximal	ENTITY
muscles	ENTITY
of	
the	
limbs	ENTITY
and	
the	
neck	ENTITY
.	

The	
pattern	ENTITY
of	
move-	
ment	ENTITY
is	
usually	
flexor	ENTITY
but	
may	
be	
an	
extension	ENTITY
of	
the	
trunk	ENTITY
.	

Vocalization	ENTITY
rarely	
occurs	
.	

The	
jerks	ENTITY
are	
most	
often	
spontaneous	ENTITY
but	
,	
in	
some	
cases	ENTITY
,	
can	
be	
evoked	
by	
external	
stimulations	ENTITY
.	

The	
jerks	ENTITY
appear	
to	
be	
related	
to	
the	
recumbent	ENTITY
position	ENTITY
and	
a	
state	ENTITY
of	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
relaxed	ENTITY
wakefulness	ENTITY
,	
particularly	
when	
the	
patient	ENTITY
tries	
to	
fall	ENTITY
asleep	ENTITY
.	

Any	
mental	ENTITY
acti-	
vation	ENTITY
makes	
the	
jerks	ENTITY
disappear	ENTITY
.	

The	
jerks	ENTITY
eventually	
disappear	
at	
sleep	ENTITY
onset	ENTITY
and	
remain	
absent	
throughout	
all	
stages	ENTITY
of	
sleep	ENTITY
,	
even	
though	
they	
sometimes	
reappear	
during	
intrasleep	ENTITY
wakefulness	ENTITY
.	

Associated	ENTITY
Features	ENTITY
PSM	ENTITY
often	
is	
associated	ENTITY
with	ENTITY
severe	ENTITY
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
due	
to	
the	
inability	
of	
the	
patient	ENTITY
to	
fall	ENTITY
asleep	ENTITY
because	
of	
the	
recurrent	ENTITY
disturbing	
muscular	ENTITY
activity	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
PSM	ENTITY
may	
be	
considered	
a	
variant	ENTITY
of	
the	
more	
generally	
described	
propriospinal	ENTITY
myoc-	ENTITY
lonus	ENTITY
seen	
during	
the	
daytime	ENTITY
.	

In	
daytime	ENTITY
PSM	ENTITY
,	
myoclonic	ENTITY
jerks	ENTITY
involve	
the	
thoracoab-	
dominal	ENTITY
/	
paraspinal	ENTITY
or	
cervical	ENTITY
muscles	ENTITY
and	
spread	ENTITY
caudally	ENTITY
or	
rostrally	ENTITY
to	
the	
other	
myotomes	ENTITY
.	

The	
jerks	ENTITY
are	
provoked	ENTITY
or	
worsened	ENTITY
by	
the	
recumbent	ENTITY
position	ENTITY
and	
can	
not	
be	
voluntarily	
suppressed	ENTITY
.	

They	
are	
often	
preceded	
by	
premonitory	ENTITY
sensations	ENTITY
,	
are	
stable	ENTITY
over	
time	
,	
and	
respond	
unpredictably	
to	
drug	ENTITY
treatment	ENTITY
.	

The	
frequent	ENTITY
presleep	ENTITY
worsening	ENTITY
of	
daytime	
PSM	ENTITY
(	
around	
50	
%	
of	
the	
cases	ENTITY
)	
suggests	
that	
patients	ENTITY
with	
PSM	ENTITY
may	
have	
a	
milder	ENTITY
or	
variant	ENTITY
form	
of	
a	
single	
clinical	ENTITY
and	
neurophysiologic	ENTITY
entity	ENTITY
.	

Demographics	ENTITY
Epidemiologic	ENTITY
data	ENTITY
are	
lacking	ENTITY
.	

PSM	ENTITY
is	
probably	
a	
rare	ENTITY
condition	ENTITY
.	

A	
higher	ENTITY
prevalence	ENTITY
in	
men	ENTITY
is	
reported	
.	

The	
disorder	ENTITY
affects	
adults	ENTITY
and	
has	
not	
been	
reported	
in	
children	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Not	
applicable	
or	
known	
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
PSM	ENTITY
arises	
in	ENTITY
adulthood	ENTITY
and	
is	
usually	
a	
chronic	ENTITY
,	
unremitting	ENTITY
condition	ENTITY
.	

Patients	ENTITY
may	
develop	
a	
fear	ENTITY
of	ENTITY
falling	ENTITY
asleep	ENTITY
,	
anxiety	ENTITY
,	
and	
depression	ENTITY
.	

Intense	ENTITY
myoclonic	ENTITY
jerks	ENTITY
may	
cause	
injury	ENTITY
to	
the	
patient	ENTITY
or	
the	
bed	ENTITY
partner	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
The	
pathophysiology	ENTITY
of	
PSM	ENTITY
is	
unknown	
.	

PSM	ENTITY
is	
thought	
to	
originate	
from	
a	
focal	ENTITY
spinal	ENTITY
pattern	ENTITY
generator	ENTITY
,	
set	
into	
motion	ENTITY
by	
supraspinal	ENTITY
dysfacilitatory	ENTITY
influences	ENTITY
typical	
of	
the	
state	ENTITY
of	
relaxed	ENTITY
wakefulness	ENTITY
and	
drowsiness	ENTITY
.	

PSM	ENTITY
is	
presumed	
to	
propagate	ENTITY
up	
and	
down	
the	
spinal	ENTITY
cord	ENTITY
via	
slowly	
conducting	
,	
long	ENTITY
propriospinal	ENTITY
(	ENTITY
intersegmental	ENTITY
)	ENTITY
pathways	ENTITY
.	

A	
focal	ENTITY
spinal	ENTITY
generator	ENTITY
thus	
is	
able	
to	
recruit	
muscles	ENTITY
from	
multiple	
segments	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Polysomnography	ENTITY
demonstrates	
brief	
myoclonic	ENTITY
EMG	
bursts	ENTITY
recurring	
nonperiodi-	
cally	
with	
alpha	ENTITY
activity	ENTITY
present	
on	
the	
EEG	ENTITY
and	
,	
in	
particular	
,	
when	
alpha	ENTITY
activity	ENTITY
spreads	ENTITY
from	
the	
posterior	ENTITY
to	
the	
anterior	ENTITY
brain	ENTITY
regions	ENTITY
.	

Epileptic	ENTITY
EEG	
discharges	ENTITY
are	
not	
observed	
in	
PSM	ENTITY
.	

Jerks	ENTITY
disappear	
either	
with	
EEG	ENTITY
desynchronization	ENTITY
,	
due	
to	
mental	ENTITY
activation	ENTITY
,	
or	
with	
appearance	ENTITY
of	
sleep	ENTITY
spindles	ENTITY
and	
K	ENTITY
-	
complexes	ENTITY
.	

Jerks	ENTITY
remain	
absent	
throughout	
sleep	ENTITY
but	
may	
occasionally	
reappear	
upon	
awakening	ENTITY
and	
during	
intrasleep	ENTITY
wakefulness	ENTITY
.	

Polysomnography	ENTITY
with	
extended	
EMG	ENTITY
recording	ENTITY
demonstrates	
that	
the	
jerks	ENTITY
arise	
first	
in	
spinal	ENTITY
innervated	ENTITY
muscles	ENTITY
and	
then	
propagate	ENTITY
to	
more	
caudal	ENTITY
and	
rostral	ENTITY
muscles	ENTITY
according	
to	
a	
propriospinal	ENTITY
pattern	ENTITY
of	
propagation	ENTITY
.	

Detailed	
analysis	ENTITY
of	
the	
jerks	ENTITY
shows	
that	
the	
EMG	ENTITY
activity	ENTITY
originates	
in	
muscles	ENTITY
innervated	ENTITY
by	
thoracic	ENTITY
or	
cervical	ENTITY
spinal	ENTITY
segments	ENTITY
(	
sternocleidomastoid	ENTITY
,	
paraspinalis	ENTITY
,	
rectus	ENTITY
abdominis	ENTITY
)	
and	
then	
spreads	
to	
more	
rostrally	ENTITY
and	
caudally	ENTITY
innervated	ENTITY
muscles	ENTITY
at	
a	
slow	ENTITY
velocity	ENTITY
(	
2	
to	
16	
milliseconds	ENTITY
;	
around	
5	
milliseconds	
on	
average	ENTITY
)	
.	

Back	ENTITY
-	
averaging	ENTITY
of	
the	
EEG	ENTITY
does	
not	
show	
any	
jerk	ENTITY
-	
locked	ENTITY
cortical	ENTITY
activity	ENTITY
.	

MRI	ENTITY
of	
the	
brain	ENTITY
is	
normal	
.	

In	
a	
recent	
review	
of	
PSM	ENTITY
,	
only	
one	
patient	ENTITY
with	
exacerbation	ENTITY
at	
sleep	ENTITY
onset	ENTITY
had	
a	
hypersignal	ENTITY
at	
T10	ENTITY
-	
T11	ENTITY
and	
a	
nonspecific	ENTITY
medullary	ENTITY
cone	ENTITY
lesion	ENTITY
.	

The	
remaining	
patients	ENTITY
had	
no	
signs	
on	
spinal	ENTITY
cord	ENTITY
MRI	ENTITY
at	
sleep	ENTITY
onset	ENTITY
.	

MRI	ENTITY
of	
the	
spine	ENTITY
is	
usually	
normal	ENTITY
but	
demonstrates	
a	
focal	ENTITY
lesion	ENTITY
in	
around	
20	
%	
of	
the	
cases	ENTITY
.	

The	
causal	
relationship	ENTITY
of	
PSM	ENTITY
with	
these	
spinal	ENTITY
lesions	ENTITY
is	
unclear	ENTITY
,	
although	
magnetic	ENTITY
resonance	ENTITY
diffusion	ENTITY
tensor	ENTITY
imaging	ENTITY
with	
fiber	ENTITY
tracking	ENTITY
may	
demonstrate	
spinal	ENTITY
tract	ENTITY
disorganization	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
PSM	ENTITY
shows	
features	ENTITY
similar	
to	
those	
of	
the	
syndrome	ENTITY
of	
intensified	ENTITY
sleep	ENTITY
starts	ENTITY
.	

However	
,	
sleep	ENTITY
starts	ENTITY
(	
hypnic	ENTITY
jerks	ENTITY
)	
usually	
appear	
during	
the	
transition	ENTITY
between	
wakefulness	ENTITY
and	
sleep	ENTITY
and	
during	
light	
NREM	ENTITY
sleep	ENTITY
,	
whereas	
PSM	ENTITY
may	
sometimes	
be	
present	
during	
relaxed	ENTITY
wakefulness	ENTITY
.	

Unlike	
PSM	ENTITY
,	
sleep	ENTITY
starts	ENTITY
(	
hypnic	ENTITY
jerks	ENTITY
)	
some-	
times	
affect	
only	
one	
or	
a	
few	
body	ENTITY
segments	ENTITY
;	
propriospinal	ENTITY
propagation	ENTITY
is	
not	
present	
in	
neurophysiological	ENTITY
studies	ENTITY
of	
sleep	ENTITY
starts	
.	

Phasic	ENTITY
REM	ENTITY
twitches	ENTITY
,	
which	
are	
a	
normal	ENTITY
phenomenon	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
involve	
the	
distal	ENTITY
muscles	ENTITY
of	
the	
hands	ENTITY
and	
face	ENTITY
,	
often	
without	
displacement	ENTITY
of	
the	
body	ENTITY
segment	ENTITY
.	

Fragmentary	ENTITY
myoclonus	ENTITY
resembles	
physiological	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
,	
but	
in	
an	
enhanced	ENTITY
form	
,	
and	
persists	
throughout	
all	
stages	ENTITY
of	
NREM	ENTITY
and	
REM	ENTITY
sleep	ENTITY
.	

Both	
physiological	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
and	
frag-	
mentary	ENTITY
myoclonus	ENTITY
are	
EMG	ENTITY
findings	ENTITY
not	
associated	ENTITY
with	ENTITY
overt	ENTITY
muscular	ENTITY
activity	ENTITY
and	
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
do	
not	
involve	
muscles	ENTITY
acting	
across	
large	
joints	ENTITY
.	

Epileptic	ENTITY
myoclonus	ENTITY
is	
not	
confined	
to	
relaxed	ENTITY
wakefulness	ENTITY
and	
may	
be	
associated	ENTITY
with	ENTITY
epileptic	ENTITY
discharges	ENTITY
on	
the	
EEG	ENTITY
.	

PLMS	ENTITY
are	
longer	
in	
duration	ENTITY
,	
involve	
mainly	
the	
lower	ENTITY
limbs	ENTITY
,	
and	
usually	
spare	
truncal	ENTITY
and	
abdominal	ENTITY
muscles	ENTITY
.	

PLMs	ENTITY
may	
begin	
during	
presleep	ENTITY
wakefulness	ENTITY
but	
generally	
occur	
during	
NREM	ENTITY
sleep	ENTITY
.	

Some	
patients	ENTITY
with	
RLS	ENTITY
may	
have	
prominent	
PLMs	ENTITY
in	
wakefulness	ENTITY
while	
sitting	ENTITY
or	
lying	ENTITY
down	ENTITY
.	

However	
,	
prominent	
leg	ENTITY
discomfort	ENTITY
is	
usually	
present	
in	
these	
patients	ENTITY
.	

Occasionally	
PSM	ENTITY
may	
be	
present	
in	
RLS	ENTITY
/	
PLMS	ENTITY
patients	ENTITY
in	
wake	ENTITY
before	ENTITY
sleep	ENTITY
,	
but	
the	
EMG	ENTITY
morphology	ENTITY
is	
different	
.	

In	
addition	
,	
when	
myoclonic	ENTITY
jerks	ENTITY
involving	
leg	ENTITY
muscles	ENTITY
appear	
,	
the	
PSM	ENTITY
disappears	ENTITY
.	

Psychogenic	ENTITY
myoclonus	ENTITY
may	
simulate	ENTITY
PSM	ENTITY
but	
the	
muscle	ENTITY
recruitment	
pattern	
,	
the	
spread	ENTITY
velocity	ENTITY
,	
and	
the	
record-	
ing	
of	
cortical	ENTITY
premovement	ENTITY
activity	ENTITY
observed	
before	
voluntary	ENTITY
movements	ENTITY
may	
be	
useful	
to	
differentiate	ENTITY
the	
two	
types	
of	
jerks	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Future	
studies	ENTITY
are	
needed	
to	
better	
define	
the	
distinctions	ENTITY
between	
PSM	ENTITY
and	
related	
conditions	ENTITY
such	
as	
sleep	ENTITY
starts	ENTITY
(	
hypnic	ENTITY
jerks	ENTITY
)	
and	
,	
in	
particular	
,	
the	
syndrome	ENTITY
of	
inten-	
sified	ENTITY
sleep	ENTITY
starts	ENTITY
.	

Also	
,	
neuroimaging	ENTITY
and	
possibly	
postmortem	ENTITY
studies	ENTITY
may	
detect	ENTITY
the	
neural	ENTITY
structures	ENTITY
responsible	
for	
the	
initiation	ENTITY
of	
the	
myoclonic	ENTITY
jerks	ENTITY
.	

Bibliography	
Montagna	
P	
,	
Provini	ENTITY
F	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Liguori	ENTITY
R	ENTITY
,	
Lugaresi	
E.	
Propriospinal	ENTITY
myoclonus	ENTITY
upon	
relaxation	ENTITY
and	
drowsiness	ENTITY
:	
a	
cause	
of	
severe	ENTITY
insomnia	ENTITY
.	

Mov	ENTITY
Disord	ENTITY
1997;12:66–72	ENTITY
.	

Montagna	
P	
,	
Provini	ENTITY
F	ENTITY
,	
Vetrugno	
R.	
Propriospinal	ENTITY
myoclonus	ENTITY
at	
sleep	ENTITY
onset	ENTITY
.	

Neurophysiologique	ENTITY
clinique	
2006;36:351–5	
.	

Roze	ENTITY
E	ENTITY
,	
Bounolleau	ENTITY
P	ENTITY
,	
Ducreux	ENTITY
D	ENTITY
,	
et	
al	
.	

Propriospinal	ENTITY
myclonusmyoclonus	ENTITY
revisited	
.	

Clinical	ENTITY
,	
neurophysiologic	ENTITY
,	
and	
neuroradiologic	ENTITY
findings	ENTITY
.	

Neurology	ENTITY
2009;72:1301–9	ENTITY
.	

Tison	ENTITY
F	ENTITY
,	
Arne	
P	
,	
Dousset	ENTITY
V	ENTITY
,	
Paty	
J	
,	
Henry	
P.	ENTITY
Propriospinal	ENTITY
myoclonus	ENTITY
induced	ENTITY
by	
relaxation	ENTITY
and	
drowsiness	ENTITY
.	

Rev	ENTITY
Neurol	ENTITY
(	ENTITY
Paris	ENTITY
)	ENTITY
1998;154:423–5	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Meletti	ENTITY
S	ENTITY
,	
et	
al	
.	

Propriospinal	ENTITY
myoclonus	ENTITY
at	
the	
sleep	ENTITY
-	
wake	ENTITY
transition	ENTITY
:	
a	
new	
type	
of	
parasomnia	ENTITY
.	

Sleep	ENTITY
2001;24:835–43	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
Due	
to	
a	
Medical	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.59	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.69	ENTITY
Diagnostic	ENTITY
Criteria	ENTITY

Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
manifests	
sleep	ENTITY
related	
movements	ENTITY
that	
disturb	ENTITY
sleep	ENTITY
or	
its	
onset	
.	

B.	ENTITY
The	
movement	ENTITY
disorder	ENTITY
occurs	
as	
a	
consequence	
of	
a	
significant	
underlying	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
.	

C.	

The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
sleep	ENTITY
related	
movement	ENTITY
disorder	ENTITY
,	
other	
untreated	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
substance	ENTITY
use	ENTITY
,	
or	
mental	ENTITY
disorder	ENTITY
.	

This	
diagnosis	ENTITY
is	
intended	
for	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
due	
to	
an	
underlying	
medical	ENTITY
or	
neurologic	ENTITY
condition	ENTITY
that	
do	
not	
meet	
criteria	ENTITY
for	
another	
specific	
movement	ENTITY
disorder	ENTITY
.	

Many	
neurological	ENTITY
conditions	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
movement	ENTITY
abnormali-	
ties	ENTITY
that	
are	
evident	
in	
wake	ENTITY
and	
sleep	ENTITY
.	

In	
some	
cases	ENTITY
,	
the	
nocturnal	ENTITY
manifestations	ENTITY
of	
the	
movement	ENTITY
abnormalities	ENTITY
may	
be	
apparent	ENTITY
before	
establishment	ENTITY
of	
a	
firm	
neurolog-	
ical	ENTITY
diagnosis	ENTITY
.	

Thus	
,	
in	
some	
cases	ENTITY
,	
“	
sleep	ENTITY
related	
movement	ENTITY
disorder	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
”	
is	
a	
temporary	ENTITY
diagnosis	ENTITY
,	
given	
when	
a	
sleep	ENTITY
diagnosis	ENTITY
is	
required	
before	
the	
underlying	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
can	
be	
fully	
diagnosed	ENTITY
.	

Once	
the	
pres-	
ence	ENTITY
of	
a	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
is	
clearly	
established	
,	
that	
becomes	
the	
sole	
diagnosis	ENTITY
unless	
the	
sleep	ENTITY
complaint	ENTITY
is	
the	
focus	
of	
independent	
clinical	ENTITY
attention	ENTITY
.	

When	
a	
movement	ENTITY
disorder	ENTITY
that	
is	
listed	
elsewhere	
in	
the	
sleep	ENTITY
related	
movement	
disorder	
section	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
is	
caused	
or	
exacerbated	ENTITY
by	
a	
medical	ENTITY
or	
neurological	ENTITY
condition	ENTITY
(	
e.g.	
,	
restless	ENTITY
legs	ENTITY
syn-	ENTITY
drome	ENTITY
)	
,	
it	
is	
preferred	
that	
the	
more	
specific	
diagnosis	ENTITY
(	
e.g.	
,	
RLS	ENTITY
)	
be	
used	
rather	
than	
“	
sleep	ENTITY
related	
movement	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
,	
”	
with	
annotation	ENTITY
of	
the	
relation-	
ship	ENTITY
to	
the	
medical	ENTITY
or	
neurological	ENTITY
disorder	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
Due	
to	
a	
Medication	ENTITY
or	
Substance	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
292.85	
(	
drug	ENTITY
-	
induced	ENTITY
)	
;	
291.82	
(	
alcohol	ENTITY
-	
induced	ENTITY
)	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
F11	ENTITY
-	
F19	ENTITY
(	
see	
table	
in	
Appendix	ENTITY
B	ENTITY
for	
detailed	
coding	ENTITY
instructions	ENTITY
)	

Diagnostic	ENTITY
Criteria	ENTITY
Criteria	ENTITY
A	ENTITY
-	
C	ENTITY
must	
be	
met	
A.	ENTITY

The	
patient	ENTITY
manifests	
sleep	ENTITY
related	
movements	ENTITY
that	
disturb	ENTITY
sleep	ENTITY
or	
its	
onset	
.	

B.	ENTITY
The	
movement	ENTITY
disorder	ENTITY
occurs	
as	
a	
consequence	ENTITY
of	ENTITY
current	ENTITY
medication	ENTITY
or	
substance	ENTITY
use	ENTITY
or	
withdrawal	ENTITY
from	
a	
wake	ENTITY
-	
promoting	ENTITY
medication	ENTITY
or	
substance	ENTITY
.	

C.	

The	
symptoms	ENTITY
are	
not	
better	
explained	
by	
another	
sleep	ENTITY
related	
movement	ENTITY
disorder	ENTITY
,	
other	
untreated	ENTITY
sleep	ENTITY
disorder	ENTITY
,	
or	
medical	ENTITY
,	
neurological	ENTITY
,	
or	
mental	ENTITY
disorder	ENTITY
.	

This	
diagnosis	ENTITY
is	
intended	
for	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
(	
toxin	ENTITY
or	
other	
bioactive	ENTITY
substance	ENTITY
)	
that	
do	
not	
meet	
criteria	ENTITY
for	
another	
spe-	
cific	ENTITY
movement	
disorder	
.	

Many	
substances	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
movement	ENTITY
abnor-	
malities	ENTITY
that	
are	
evident	
in	
wake	ENTITY
and	
sleep	ENTITY
.	

To	
the	
extent	
that	
the	
movement	ENTITY
abnormal-	
ity	ENTITY
is	
an	
expected	
complication	ENTITY
of	
the	
substance(s	ENTITY
)	ENTITY
involved	
(	
e.g.	
,	
tardive	ENTITY
dyskinesia	ENTITY
or	
akathisia	ENTITY
associated	ENTITY
with	ENTITY
neuroleptic	ENTITY
usage	ENTITY
)	
,	
this	
diagnosis	ENTITY
is	
unnecessary	
unless	
the	
sleep	ENTITY
related	
aspects	
of	
the	
movement	ENTITY
abnormality	ENTITY
or	
its	
sequelae	ENTITY
,	
are	
the	
focus	
of	
independent	
clinical	ENTITY
attention	ENTITY
.	

When	
a	
movement	ENTITY
disorder	ENTITY
that	
is	
listed	
elsewhere	
in	
the	
sleep	ENTITY
related	
movement	
disorder	
section	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
is	
caused	
or	
exacerbated	ENTITY
by	
drugs	ENTITY
or	
substances	ENTITY
(	
e.g.	
,	
restless	ENTITY
legs	ENTITY
syndrome	ENTITY
)	
,	
it	
is	
pre-	
ferred	
that	
the	
more	
specific	
diagnosis	ENTITY
(	
e.g.	
,	
RLS	ENTITY
)	
be	
used	
rather	
than	
“	
Sleep	ENTITY
related	
movement	
disorder	
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
,	
”	
with	
annotation	ENTITY
of	
the	
relation-	
ship	ENTITY
to	
drug	ENTITY
or	
substance	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorder	ENTITY
,	
Unspecified	
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.59	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
G47.69	ENTITY
This	
diagnosis	ENTITY
is	
assigned	
when	
patients	ENTITY
have	
a	
sleep	ENTITY
related	
movement	ENTITY
disorder	ENTITY
that	
can	
not	
be	
classified	
elsewhere	
or	
is	
suspected	ENTITY
to	
be	
associated	ENTITY
with	ENTITY
an	
underlying	
psy-	
chiatric	ENTITY
condition	ENTITY
.	

In	
some	
cases	ENTITY
,	
“	
sleep	ENTITY
related	
movement	
disorder	
,	
unspecified	ENTITY
”	
is	
a	
temporary	ENTITY
diagnosis	ENTITY
prior	
to	
establishment	ENTITY
of	
an	
underlying	
psychiatric	ENTITY
condition	ENTITY
that	
may	
explain	
the	
sleep	ENTITY
related	
movement	ENTITY
(	
e.g.	
,	
movements	ENTITY
associated	ENTITY
with	ENTITY
posttrau-	
matic	ENTITY
stress	ENTITY
disorder	ENTITY
nightmares	ENTITY
prior	
to	
firm	
establishment	ENTITY
of	
the	
psychiatric	ENTITY
diag-	
nosis	ENTITY
)	
.	

Once	
the	
psychiatric	ENTITY
diagnosis	ENTITY
is	
established	
,	
that	
becomes	
the	
sole	
diagnosis	ENTITY
unless	
the	
sleep	ENTITY
complaint	ENTITY
is	
the	
focus	
of	
independent	
clinical	ENTITY
attention	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Isolated	ENTITY
Symptoms	ENTITY
and	
Normal	ENTITY
Variants	ENTITY
Excessive	ENTITY
Fragmentary	ENTITY
Myoclonus	ENTITY
Excessive	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
(	
EFM	ENTITY
)	
is	
a	
largely	
incidental	ENTITY
polysomnographic	ENTITY
finding	ENTITY
on	
EMG	ENTITY
,	
characterized	ENTITY
by	
small	ENTITY
movements	ENTITY
of	
the	
corners	ENTITY
of	
the	
mouth	ENTITY
,	
fingers	ENTITY
,	
or	
toes	ENTITY
,	
or	
by	
no	
visible	
movement	
at	
all	
.	

The	
finding	ENTITY
is	
associated	ENTITY
with	ENTITY
no	
known	
clinical	ENTITY
consequence	
.	

Large	ENTITY
limb	ENTITY
movements	ENTITY
across	
large	
joint	
spaces	ENTITY
are	
not	
characteristic	
of	
EFM	ENTITY
and	
,	
if	
present	
,	
should	
exclude	
the	
diagnosis	ENTITY
of	
EFM	ENTITY
.	

Scoring	ENTITY
of	
EFM	ENTITY
is	
described	
in	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

The	
condition	ENTITY
is	
a	
NREM	ENTITY
phenomenon	ENTITY
and	
the	
move-	
ments	ENTITY
resemble	
the	
phasic	ENTITY
twitches	ENTITY
seen	
in	
normal	ENTITY
REM	ENTITY
sleep	ENTITY
except	
that	
they	
are	
more	
universally	
dispersed	
throughout	
a	
sleep	ENTITY
epoch	ENTITY
than	
phasic	ENTITY
REM	ENTITY
twitches	ENTITY
,	
which	
are	
generally	
clustered	ENTITY
within	
small	ENTITY
groups	ENTITY
in	
a	
sleep	ENTITY
epoch	ENTITY
.	

Its	
importance	
lies	
in	
that	
it	
is	
within	
the	
differential	ENTITY
diagnosis	ENTITY
of	
other	
sleep	ENTITY
related	
movement	ENTITY
disorders	ENTITY
.	

Patients	ENTITY
usually	
are	
not	
aware	
of	
the	
twitch	ENTITY
-	
like	
movements	ENTITY
.	

Patients	ENTITY
may	
have	
other	
coexistent	ENTITY
sleep	ENTITY
disorders	ENTITY
,	
but	
EFM	ENTITY
does	
not	
appear	
to	
contribute	
to	
the	
symptoms	ENTITY
of	
these	
sleep	ENTITY
disorders	ENTITY
.	

EFM	ENTITY
,	
a	
NREM	ENTITY
phenomenon	ENTITY
,	
is	
less	
common	
than	
phasic	ENTITY
REM	ENTITY
twitches	ENTITY
,	
which	
occur	
in	
REM	ENTITY
sleep	ENTITY
in	
normal	ENTITY
individuals	ENTITY
without	
sleep	ENTITY
complaints	ENTITY
.	

Most	
cases	ENTITY
have	
been	
reported	
in	
adults	ENTITY
.	

EFM	ENTITY
is	
predominantly	
found	
in	
males	ENTITY
.	

A	
recent	
study	ENTITY
found	
EFM	ENTITY
in	
100	
%	
of	
62	
patients	ENTITY
with	
a	
variety	
of	
sleep	ENTITY
disorders	ENTITY
,	
bringing	
into	
question	
the	
specificity	ENTITY
of	
EFM	ENTITY
.	

Numerous	
causes	
of	
chronic	ENTITY
sleep	ENTITY
fragmentation	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
EFM	ENTITY
.	

The	
condition	ENTITY
has	
been	
described	
with	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
and	
primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
sleep	ENTITY
related	ENTITY
hypoxemic	ENTITY
/	
hypoventilation	ENTITY
syndromes	ENTITY
,	
narcolepsy	ENTITY
,	
PLMD	ENTITY
,	
and	
various	
causes	
of	
insomnia	ENTITY
.	

In	
apneic	ENTITY
patients	ENTITY
,	
the	
twitching	ENTITY
intensifies	
during	
periods	ENTITY
of	
increased	ENTITY
hypoxemia	ENTITY
.	

One	
report	ENTITY
has	
found	
excessive	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
to	
be	
very	
common	
in	
children	ENTITY
with	
Niemann	ENTITY
-	
Pick	ENTITY
disease	ENTITY
,	
type	
C.	
No	
specific	
precipitating	
factors	ENTITY
have	
been	
reported	
.	

The	
contribution	ENTITY
of	
EFM	ENTITY
to	
the	
symptomatology	ENTITY
of	
any	
of	
these	
disorders	ENTITY
is	
unknown	
.	

The	
course	ENTITY
is	
not	
well	
studied	
but	
appears	
to	
be	
benign	ENTITY
and	
non	ENTITY
-	
progressive	ENTITY
.	

The	
dis-	
order	
may	
be	
the	
sole	
abnormality	ENTITY
in	
some	
cases	ENTITY
of	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
but	
causality	ENTITY
is	
questionable	
.	

No	
other	
serious	
consequences	ENTITY
of	
the	
disorder	ENTITY
have	
been	
described	
when	
it	
occurs	
in	
isolation	ENTITY
.	

In	
some	
cases	ENTITY
,	
EFM	ENTITY
is	
present	
in	
normal	ENTITY
individuals	ENTITY
.	

Its	
relatively	
benign	ENTITY
course	ENTITY
sug-	ENTITY
gests	ENTITY
that	
it	
is	
not	
associated	ENTITY
with	ENTITY
a	
neurodegenerative	ENTITY
process	ENTITY
.	

In	
most	
reported	
cases	ENTITY
,	
there	
have	
been	
associated	
sleep	ENTITY
abnormalities	ENTITY
and	
sleep	ENTITY
disruption	ENTITY
,	
suggesting	
that	
EFM	ENTITY
may	
be	
due	
to	
disruptions	ENTITY
of	
normal	ENTITY
motor	ENTITY
-	
control	ENTITY
mechanisms	ENTITY
during	
sleep	ENTITY
.	

Whether	
there	
is	
a	
genetic	ENTITY
or	
other	
basis	
predisposing	ENTITY
individuals	ENTITY
to	
develop	
the	
condi-	
tion	ENTITY
is	
unknown	
.	

In	
any	
case	ENTITY
,	
it	
would	
appear	
to	
result	
from	
intensification	ENTITY
of	
an	
other-	
wise	
normal	
motor	ENTITY
phenomenon	ENTITY
.	

The	
predominant	
topographic	ENTITY
distribution	ENTITY
of	
EFM	ENTITY
in	
distal	ENTITY
and	
facial	ENTITY
muscles	ENTITY
suggests	
that	
cortical	ENTITY
motor	ENTITY
centers	ENTITY
participate	ENTITY
in	
its	
generation	ENTITY
.	

EFM	ENTITY
is	
detected	ENTITY
as	
isolated	ENTITY
,	
very	
brief	
(	
usually	
75	
to	
150	
milliseconds	
)	
,	
asymmetrical	ENTITY
,	
asynchronous	ENTITY
EMG	ENTITY
potentials	ENTITY
in	
various	
muscles	ENTITY
of	
the	
face	ENTITY
,	
trunk	ENTITY
,	
arms	ENTITY
,	
and	
legs	ENTITY
.	

The	
amplitude	ENTITY
varies	
from	
approximately	
50	
to	
several	
hundred	
microvolts	ENTITY
;	
the	
taller	ENTITY
amplitudes	ENTITY
are	
often	
associated	ENTITY
with	ENTITY
visible	ENTITY
movement	ENTITY
of	
the	
fingers	ENTITY
,	
toes	ENTITY
,	
or	
corners	ENTITY
of	
the	
mouth	ENTITY
,	
whereas	
the	
smaller	
ones	
may	
resemble	
fasciculation	ENTITY
potentials	ENTITY
and	
be	
without	
overt	ENTITY
movement	ENTITY
.	

Large	ENTITY
movements	ENTITY
across	
large	
joint	
spaces	
preclude	
a	
diag-	
nosis	ENTITY
of	
EFM	ENTITY
.	

Small	ENTITY
twitch	ENTITY
-	
like	
movements	ENTITY
may	
be	
observed	
on	
video	ENTITY
recording	ENTITY
.	

Episodes	ENTITY
of	
these	
myoclonic	ENTITY
potentials	ENTITY
typically	
last	
from	
10	
minutes	
to	
several	
hours	
.	

They	
often	
appear	
at	
sleep	ENTITY
onset	ENTITY
and	
continue	
through	
the	
NREM	ENTITY
sleep	ENTITY
stages	ENTITY
,	
includ-	
ing	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
.	

The	
presence	ENTITY
of	
EFM	ENTITY
in	
REM	ENTITY
is	
difficult	
to	
determine	
because	
it	
is	
superimposed	
on	
the	
normal	ENTITY
phasic	ENTITY
clusters	ENTITY
of	
physiological	ENTITY
phasic	ENTITY
REM	ENTITY
twitches	ENTITY
.	

EFM	ENTITY
is	
electromyographically	ENTITY
similar	
to	
the	
latter	
.	

Occasionally	
,	
the	
EMG	ENTITY
activity	ENTITY
also	
persists	
during	
EEG	ENTITY
periods	ENTITY
of	
wakefulness	ENTITY
within	
the	
sleep	ENTITY
period	ENTITY
or	
is	
present	
in	
drowsiness	ENTITY
prior	
to	
sleep	ENTITY
onset	ENTITY
.	

The	
EEG	ENTITY
usually	
shows	
no	
changes	
at	
the	
time	
of	
the	
movements	ENTITY
,	
although	
high	ENTITY
-	
amplitude	ENTITY
EMG	ENTITY
potentials	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
a	
K	ENTITY
complex	ENTITY
or	
even	
with	
transient	ENTITY
EEG	ENTITY
arousal	ENTITY
.	

There	
are	
no	
ocular	ENTITY
or	
autonomic	ENTITY
accom-	ENTITY
paniments	ENTITY
.	

It	
seems	
possible	
that	
,	
depending	
on	
the	
digitalization	ENTITY
rates	ENTITY
,	
digital	ENTITY
systems	ENTITY
may	
record	ENTITY
less	
fragmentary	ENTITY
myoclonus	ENTITY
than	
earlier	
paper	ENTITY
records	ENTITY
.	

No	
laboratory	ENTITY
tests	ENTITY
other	
than	
polysomnography	ENTITY
(	
optimally	
with	
multiple	
EMG	ENTITY
leads	
)	
have	
been	
reported	
to	
be	
helpful	
in	
assessing	
EFM	ENTITY
.	

EFM	ENTITY
generally	
has	
a	
maximum	
burst	ENTITY
duration	ENTITY
of	
only	
150	
milliseconds	ENTITY
and	
does	
not	
recur	
periodically	
.	

It	
can	
be	
distinguished	
from	
PLMS	ENTITY
because	
PLMS	ENTITY
are	
character-	
ized	ENTITY
by	
a	
longer	
burst	ENTITY
duration	ENTITY
(	
typically	
0.5	
to	
10	
seconds	
)	
and	
a	
long	
period	
between	
bursts	ENTITY
(	
5	
-	
90	
seconds	
)	
.	

EFM	ENTITY
,	
which	
occurs	
in	
NREM	ENTITY
,	
must	
also	
be	
differentiated	
from	
normal	
physiological	ENTITY
phasic	ENTITY
REM	ENTITY
twitches	ENTITY
,	
which	
have	
a	
similar	
burst	ENTITY
duration	ENTITY
but	
are	
limited	
to	
the	
REM	ENTITY
state	ENTITY
and	
tend	
to	
occur	
in	
clusters	ENTITY
within	
an	
epoch	ENTITY
,	
as	
opposed	
to	
EFM	ENTITY
in	
which	
bursts	ENTITY
tend	
not	
to	
cluster	ENTITY
within	
a	
particular	
epoch	ENTITY
.	

Larger	ENTITY
body	ENTITY
move-	

ments	ENTITY
across	
the	
large	ENTITY
joints	ENTITY
are	
not	
a	
feature	
of	
excessive	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
.	

The	
presence	ENTITY
of	
such	
movements	ENTITY
suggests	
other	
disorders	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Further	
investigation	ENTITY
is	
necessary	
to	
determine	
whether	
EFM	ENTITY
occurs	
as	
a	
consequence	ENTITY
of	ENTITY
sleep	ENTITY
disruption	ENTITY
or	
whether	
it	
is	
an	
independent	ENTITY
cause	ENTITY
of	
sleep	ENTITY
disruption	ENTITY
and	
daytime	ENTITY
symptoms	ENTITY
in	
its	
own	
right	ENTITY
.	

It	
must	
also	
be	
determined	
whether	
there	
are	
any	
physiolog-	
ical	
differences	
that	
distinguish	
fragmentary	
myoclonus	ENTITY
seen	
in	
many	
normal	ENTITY
individu-	
als	
from	
EFM	ENTITY
.	

It	
is	
not	
known	
whether	
some	
additional	
pathophysiological	ENTITY
element	
is	
required	
to	
increase	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
into	
an	
abnormal	ENTITY
range	ENTITY
.	

The	
current	
thresh-	
old	
for	
the	
diagnosis	ENTITY
of	
EFM	ENTITY
should	
be	
further	
investigated	ENTITY
because	
the	
scoring	ENTITY
criteria	ENTITY
lack	
specificity	ENTITY
.	

The	
apparent	
strong	
predominance	
in	
males	ENTITY
also	
remains	
unexplained	
.	

Bibliography	ENTITY
Broughton	ENTITY
R.	ENTITY
Pathological	ENTITY
fragmentary	
myoclonus	
,	
intensified	
sleep	ENTITY
starts	
and	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
:	
three	
unusual	ENTITY
sleep	ENTITY
-	
related	ENTITY
disorders	ENTITY
.	

In	
:	
Koella	ENTITY
WP	ENTITY
,	
Schulz	
OF	
,	
Visser	
P	
,	
eds	
.	

Sleep	ENTITY
1986	
.	

Stuttgart	ENTITY
:	

Fischer	ENTITY
-	
Verlag	ENTITY
,	
1988:240–3	
.	

Broughton	ENTITY
R	ENTITY
,	ENTITY
Tolentino	ENTITY
MA	ENTITY
.	

Fragmentary	ENTITY
pathological	ENTITY
myoclonus	ENTITY
in	
NREM	ENTITY
sleep	ENTITY
.	

Electroencephalogr	ENTITY
Clin	ENTITY
Neurophysiol	ENTITY
1984;57:303–9	ENTITY
.	

Broughton	ENTITY
R	ENTITY
,	ENTITY
Tolentino	ENTITY
MA	ENTITY
,	
Krelina	ENTITY
M.	
Excessive	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
in	
NREM	ENTITY
sleep	ENTITY
:	
a	
report	ENTITY
of	
38	
cases	ENTITY
.	

Electroencephalogr	ENTITY
Clin	ENTITY
Neurophysiol	ENTITY
1985;61:123–33	
.	

Frauscher	ENTITY
B	ENTITY
,	
Kunz	ENTITY
A	ENTITY
,	
Brandauer	ENTITY
E	ENTITY
,	
Ulmer	ENTITY
H	ENTITY
,	ENTITY
Poewe	ENTITY
W	ENTITY
,	
Hogl	
B.	
Fragmentary	ENTITY
myoclonus	ENTITY
in	
sleep	ENTITY
revisited	
:	
A	
polysomnographic	ENTITY
study	ENTITY
in	
62	
patients	ENTITY
.	

Sleep	ENTITY
Med	
2011;12:410–5	
.	

Goyal	ENTITY
MK	ENTITY
,	
Kumar	ENTITY
G	ENTITY
,	
Sivaraman	
M.	
Sahota	
P.	
Teaching	
neuroimages	ENTITY
:	
excessive	ENTITY
fragmentary	
hypnic	ENTITY
myoclonus	ENTITY
.	

Neurology	ENTITY
2011;77	
:	
e59	ENTITY
–	
e60	ENTITY
.	

Lins	ENTITY
O	ENTITY
,	
Castonguay	ENTITY
M	ENTITY
,	
Dunham	ENTITY
W	ENTITY
,	
Nevsimalova	ENTITY
S	ENTITY
,	
Broughton	
R.	
Excessive	
fragmentary	ENTITY
myoclonus	ENTITY
:	
time	
of	
night	ENTITY
and	
sleep	ENTITY
stage	ENTITY
distributions	ENTITY
.	

Can	
J	
Neurol	
Sci	
1993;20:142–6	
.	

Vankova	ENTITY
J	ENTITY
,	
Stepanova	ENTITY
I	ENTITY
,	
Jech	ENTITY
R	ENTITY
,	
et	
al	
.	

Sleep	ENTITY
disturbances	ENTITY
and	
hypocretin	ENTITY
deficiency	ENTITY
in	
Niemann	ENTITY
-	
Pick	ENTITY
disease	ENTITY
type	ENTITY
C.	ENTITY
Sleep	ENTITY
2003;26:427–30	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Liguori	ENTITY
R	ENTITY
,	
Lugaresi	ENTITY
E	ENTITY
,	
Montagna	
P.	
Excessive	
fragmentary	
hypnic	ENTITY
myoclonus	ENTITY
:	
clinical	ENTITY
and	
neurophysiological	ENTITY
findings	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2002;3:73–6	ENTITY
.	

Montagna	
P	
,	
Liguori	ENTITY
R	ENTITY

et	
al	
.	

Physiological	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
Electroencephalogr	
Clin	
Neurophysiol	
1988;70:172–6	
.	

Hypnagogic	ENTITY
Foot	ENTITY
Tremor	ENTITY
and	
Alternating	ENTITY
Leg	ENTITY
Muscle	ENTITY
Activation	ENTITY
Hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
(	
HFT	ENTITY
)	
is	
rhythmic	ENTITY
movement	ENTITY
of	
the	
feet	ENTITY
or	
toes	ENTITY
that	
occurs	
at	
the	
transition	ENTITY
between	
wake	ENTITY
and	
sleep	ENTITY
or	
during	
light	ENTITY
NREM	ENTITY
sleep	ENTITY
(	
stages	ENTITY
N1	
and	
N2	ENTITY
)	
.	

Alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
(	
ALMA	ENTITY
)	
consists	
of	
brief	ENTITY
activation	ENTITY
of	
the	
ante-	
rior	
tibialis	
in	
one	
leg	ENTITY
in	
alternation	ENTITY
with	
similar	
activation	ENTITY
in	
the	
other	
leg	ENTITY
during	
sleep	ENTITY
or	
arousals	ENTITY
from	
sleep	ENTITY
.	

HFT	ENTITY
may	
be	
a	
relatively	
common	
and	
normal	ENTITY
finding	ENTITY
.	

Affected	ENTITY
individuals	ENTITY
move	
the	
feet	ENTITY
or	
the	
toes	ENTITY
rhythmically	ENTITY
for	
seconds	
to	
minutes	
during	
drowsy	ENTITY
wakefulness	ENTITY
or	
lighter	ENTITY
stages	ENTITY
of	
sleep	ENTITY
.	

It	
can	
be	
pathologically	ENTITY
exagger-	
ated	ENTITY
in	
some	
patients	ENTITY
.	

ALMA	ENTITY
is	
defined	
by	
a	
polysomnographic	ENTITY
pattern	ENTITY
with	
unknown	
clinical	ENTITY
manifestations	ENTITY
,	
but	
frequency	ENTITY
of	
muscle	ENTITY
activations	ENTITY
,	
length	ENTITY
of	ENTITY
activations	ENTITY
,	
and	
occurrence	ENTITY
primarily	
with	
arousals	ENTITY
suggest	
that	
ALMA	ENTITY
may	
be	
similar	
to	
HFT	ENTITY
or	
rep-	ENTITY
resent	
an	
EMG	ENTITY
manifestation	ENTITY
of	
some	
episodes	ENTITY
of	
HFT	ENTITY
.	

The	
original	
case	ENTITY
series	ENTITY
that	
described	
ALMA	ENTITY
did	
not	
link	
it	
with	
movement	ENTITY
of	
the	
lower	ENTITY
extremity	ENTITY
,	
but	
a	
subse-	
quent	ENTITY
report	ENTITY
did	
.	

HFT	ENTITY
and	
ALMA	ENTITY
are	
considered	
together	
because	
the	
relationship	ENTITY
between	
them	
remains	
to	
be	
clarified	
,	
and	
the	
similarity	ENTITY
in	
a	
number	
of	
their	
features	ENTITY
suggests	
they	
may	
not	
be	
fully	
independent	ENTITY
entities	ENTITY
.	

Associated	ENTITY
features	ENTITY
of	
HFT	ENTITY
and	
ALMA	ENTITY
are	
similar	
.	

Most	
cases	ENTITY
of	
HFT	ENTITY
have	
been	
reported	
in	
persons	ENTITY
with	
other	
sleep	ENTITY
disorders	ENTITY
,	
such	
as	
RLS	ENTITY
or	
SRBDs	ENTITY
.	

ALMA	ENTITY
has	
been	
identified	ENTITY
mainly	
in	
patients	ENTITY
with	
SRBD	ENTITY
or	
PLMs	ENTITY
.	

Seventy	ENTITY
-	
five	
percent	
of	
patients	ENTITY
with	
ALMA	ENTITY
in	
the	
original	
series	
used	
antidepressant	ENTITY
medication	ENTITY
.	

In	
that	
study	ENTITY
,	
patients	ENTITY
with	
ALMA	ENTITY
complained	
of	
sleepiness	ENTITY
,	
insomnia	ENTITY
,	
or	
restless	ENTITY
of	
the	
legs	ENTITY
,	
but	
only	
one	
reported	
patient	ENTITY
had	
more	
specific	
complaints	ENTITY
of	
sudden	ENTITY
nocturnal	ENTITY
muscle	ENTITY
contractions	ENTITY
in	
his	
legs	ENTITY
and	
a	
sensation	ENTITY
that	
his	
legs	ENTITY
were	
vibrating	ENTITY
.	

A	
separately	
reported	
case	
of	
a	
patient	ENTITY
with	
ALMA	ENTITY
documented	ENTITY
absence	ENTITY
of	
any	
SRBD	ENTITY
,	
PLMs	ENTITY
,	
or	
use	
of	
antidepressant	ENTITY
medication	ENTITY
.	

This	
patient	ENTITY
complained	
of	
frequent	ENTITY
and	
easily	
provoked	
awakenings	ENTITY
,	
as	
well	
as	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
.	

The	
ALMA	ENTITY
and	
symptoms	ENTITY
responded	
to	
treat-	
ment	ENTITY
with	
pramipexole	ENTITY
.	

The	
single	
series	
in	
which	
HFT	ENTITY
was	
studied	
found	
that	
it	
occurs	
in	
7.5	
%	
of	
patients	ENTITY
in	
whom	
a	
polysomnogram	ENTITY
was	
performed	
for	
other	
reasons	ENTITY
.	

Affected	ENTITY
individuals	ENTITY
range	
in	
age	ENTITY
from	
14	
to	
72	
years	ENTITY
,	
with	
a	
majority	
in	
the	
middle	ENTITY
-	
age	ENTITY
range	
(	
40	
to	
65	
years	ENTITY
)	
.	

Men	ENTITY
and	
women	ENTITY
are	
equally	
affected	ENTITY
.	

It	
is	
possible	
that	
the	
frequency	ENTITY
of	
these	
move-	
ments	ENTITY
may	
be	
increased	ENTITY
in	
individuals	ENTITY
with	
disorders	ENTITY
such	
as	
RLS	ENTITY
or	
SRBD	ENTITY
,	
but	
it	
can	
occur	
in	
individuals	ENTITY
with	
otherwise	
normal	ENTITY
sleep	ENTITY
.	

The	
prevalence	ENTITY
of	
the	
condition	ENTITY
in	
the	
general	ENTITY
population	ENTITY
and	
its	
frequency	ENTITY
in	
affected	ENTITY
individuals	ENTITY
remains	
uncertain	
.	

The	
initial	
series	
reporting	
ALMA	ENTITY
found	
that	
it	
occurs	
in	
1.1	
%	
of	
unselected	
studies	ENTITY
from	
a	
sleep	ENTITY
disorder	ENTITY
center	ENTITY
.	

Patients	ENTITY
with	
ALMA	ENTITY
were	
mostly	
male	ENTITY
(	
11:5	
)	
and	
ranged	
in	
age	ENTITY
from	
12	
to	
70	
years	ENTITY
,	
with	
most	
aged	ENTITY
35	
to	
55	
years	ENTITY
(	
mean	
age	ENTITY
41	
years	ENTITY
)	
.	

Therefore	
,	
the	
age	ENTITY
ranges	ENTITY
of	
both	
conditions	ENTITY
are	
similar	
,	
with	
both	
males	ENTITY
and	
females	ENTITY
affected	ENTITY
.	

These	
distributions	ENTITY
may	
be	
due	
to	
the	
incidental	ENTITY
discovery	ENTITY
of	
both	
entities	ENTITY
during	
routine	ENTITY
sleep	ENTITY
studies	ENTITY
for	
other	
sleep	ENTITY
complaints	ENTITY
.	

No	
predisposing	ENTITY
factors	ENTITY
are	
known	
for	
HFT	ENTITY
.	

The	
use	
of	
antidepressant	ENTITY
medication	ENTITY
may	
increase	ENTITY
risk	ENTITY
for	
ALMA	ENTITY
.	

No	ENTITY
longitudinal	ENTITY
studies	ENTITY
have	
been	
performed	
for	
either	
entity	ENTITY
.	

In	
some	
individuals	ENTITY
,	
HFT	ENTITY
is	
an	
occasional	
finding	
,	
but	
others	
appear	
to	
manifest	ENTITY
the	
rhythmic	ENTITY
movements	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
on	
many	
nights	ENTITY
and	
over	
a	
span	
of	
at	
least	
months	ENTITY
.	

ALMA	ENTITY
showed	
some	
tendency	
to	
persist	
between	
two	
different	
recordings	ENTITY
in	
the	
originally	
reported	
series	
.	

Because	
most	
individuals	ENTITY
are	
unaware	
of	
the	
presence	ENTITY
of	
the	
HFT	ENTITY
movements	ENTITY
,	
and	
patients	ENTITY
with	
ALMA	ENTITY
may	
have	
no	
associated	ENTITY
complaint	ENTITY
or	
awareness	ENTITY
of	
the	
phenomenon	ENTITY
,	
the	
evo-	
lution	ENTITY
of	
HFT	ENTITY
and	
ALMA	ENTITY
may	
be	
difficult	
to	
follow	
except	
in	
the	
sleep	ENTITY
laboratory	ENTITY
or	
with	
home	ENTITY
monitoring	ENTITY
.	

Although	
usually	
an	
incidental	ENTITY
and	
benign	ENTITY
finding	ENTITY
,	
HFT	ENTITY
may	
cause	
sleep	ENTITY
disruption	ENTITY
and	
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
if	
sufficiently	
prolonged	ENTITY
or	
severe	ENTITY
.	

In	
HFT	ENTITY
,	
the	
patient	ENTITY
typically	
reports	ENTITY
foot	ENTITY
movements	ENTITY
(	
directly	
experienced	
or	
observed	ENTITY
by	
others	
)	
that	
occur	
at	
the	
transition	ENTITY
between	
wake	ENTITY
and	
sleep	ENTITY
or	
during	
light	ENTITY
sleep	ENTITY
.	

On	
occasion	
,	
movement	ENTITY
has	
not	
been	
observed	ENTITY
but	
HFT	ENTITY
is	
seen	
as	
an	
incidental	ENTITY
finding	
on	
sleep	ENTITY
study	ENTITY
conducted	
for	
other	
indications	ENTITY
.	

Polysomnography	ENTITY
demonstrates	
a	
pattern	ENTITY
of	
brief	
,	
repeated	
activation	ENTITY
of	
the	
anterior	ENTITY
tibialis	ENTITY
in	
one	
leg	ENTITY
.	

The	
minimum	ENTITY
frequency	ENTITY
is	
0.3	
Hz	
;	
the	
maximum	ENTITY
4.0	
Hz	
.	

Multiple	ENTITY
leg	ENTITY
activations	ENTITY
in	
a	
single	
leg	ENTITY
occur	
in	
a	
train	
of	
at	
least	
four	
movements	ENTITY
.	

EMG	ENTITY
recordings	ENTITY
of	
the	
foot	ENTITY
or	
leg	ENTITY
muscles	ENTITY
or	
video	ENTITY
record-	
ings	
of	
movement	ENTITY
may	
show	
trains	
of	
recurrent	ENTITY
1	
-	
Hz	
to	
2	
-	
Hz	
EMG	ENTITY
potentials	ENTITY
or	
move-	
ments	ENTITY
.	

Typical	
associated	
EMG	ENTITY
bursts	ENTITY
are	
300	
to	
700	
milliseconds	
in	
duration	ENTITY
,	
and	
the	
typical	
duration	ENTITY
of	
trains	ENTITY
is	
10	
to	
15	
seconds	
,	
although	
longer	
bursts	ENTITY
and	
trains	ENTITY
have	
been	
reported	
.	

In	
morbid	ENTITY
conditions	ENTITY
,	
trains	ENTITY
may	
persist	
much	
longer	ENTITY
.	

Events	ENTITY
are	
recorded	
at	
the	
transition	ENTITY
into	
sleep	ENTITY
and	
during	
stages	ENTITY
N1	ENTITY
and	
N2	ENTITY
sleep	ENTITY
.	

Distribution	ENTITY
over	
the	
night	ENTITY
has	
not	
been	
fully	
investigated	ENTITY
.	

Persistent	ENTITY
HFT	ENTITY
has	
been	
found	
in	
about	
half	
of	
the	
indi-	
viduals	ENTITY
who	
have	
had	
multiple	
studies	ENTITY
.	

Alternation	ENTITY
between	
legs	ENTITY
has	
not	
been	
described	
,	
but	
its	
potential	ENTITY
occurrence	ENTITY
is	
suggested	
in	
two	
published	ENTITY
studies	ENTITY
of	
HFT	ENTITY
.	

In	
ALMA	ENTITY
,	
polysomnography	ENTITY
demonstrates	
a	
pattern	ENTITY
of	
brief	
,	
repeated	
activation	ENTITY
of	
the	
anterior	ENTITY
tibialis	ENTITY
in	
one	
leg	ENTITY
alternating	ENTITY
with	
similar	
activation	ENTITY
in	
the	
other	
leg	ENTITY
.	

At	
a	
minimum	ENTITY
,	
a	
single	
leg	
muscle	
activation	ENTITY
in	
one	
leg	ENTITY
is	
followed	
sequentially	
by	
a	
similar	
single	
activation	ENTITY
in	
the	
other	
leg	ENTITY
,	
reactivation	ENTITY
in	
the	
original	ENTITY
leg	ENTITY
,	
and	
then	
reactivation	ENTITY
in	
the	
alternate	ENTITY
leg	ENTITY
,	
with	
some	
continued	
alternation	ENTITY
beyond	
this	
minimal	
sequence	ENTITY
in	
most	
instances	ENTITY
.	

The	
minimum	ENTITY
frequency	ENTITY
of	
alternating	ENTITY
EMG	ENTITY
bursts	ENTITY
is	
0.5	
Hz	
,	
and	
the	
maximum	ENTITY
frequency	ENTITY
is	
3.0	
Hz	
.	

The	
patient	ENTITY
may	
report	ENTITY
foot	ENTITY
movements	
(	
directly	
experi-	
enced	ENTITY
or	
observed	ENTITY
by	
others	
)	
that	
occur	
at	
the	
transition	ENTITY
between	
wake	ENTITY
and	
sleep	ENTITY
or	
during	
light	ENTITY
sleep	ENTITY
.	

As	
noted	
above	
,	
there	
is	
frequently	
no	
observation	
of	
movement	ENTITY
reported	
but	
alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
is	
recorded	
as	
an	
incidental	ENTITY
finding	
on	
polysomnography	ENTITY
.	

ALMA	ENTITY
can	
be	
demonstrated	
by	
polysomnography	ENTITY
if	
the	
surface	ENTITY
EMG	ENTITY
is	
recorded	
inde-	
pendently	
from	
both	
right	ENTITY
and	
left	ENTITY
anterior	ENTITY
tibialis	ENTITY
muscles	ENTITY
.	

A	
sequence	
of	
ALMA	ENTITY
may	
begin	
with	
one	
to	
several	
lengthy	
activations	ENTITY
(	
one	
to	
two	
seconds	
)	
in	
one	
or	
both	
legs	ENTITY
.	

Some	
patients	ENTITY
show	
unilateral	ENTITY
activity	ENTITY
at	
times	
.	

ALMA	ENTITY
usually	
closely	
precedes	ENTITY
or	
follows	
an	
arousal	ENTITY
or	
awakening	ENTITY
and	
gradually	
diminishes	
as	
sleep	ENTITY
returns	
.	

However	
,	
ALMA	ENTITY
can	
also	
emerge	
without	
arousals	ENTITY
from	
any	
sleep	ENTITY
stage	ENTITY
.	

Proclivity	ENTITY
for	
any	
spe-	
cific	ENTITY
portion	
of	
the	
nocturnal	ENTITY
sleep	ENTITY
cycle	ENTITY
has	
not	
been	
identified	ENTITY
.	

Leg	ENTITY
muscle	ENTITY
activa-	
tions	ENTITY
during	
REM	ENTITY
sleep	ENTITY
,	
in	
comparison	ENTITY
to	
NREM	ENTITY
sleep	ENTITY
,	
are	
often	
briefer	ENTITY
and	
some-	

what	
less	
regular	ENTITY
.	

Sequences	ENTITY
of	
ALMA	ENTITY
sometimes	
recur	
at	
intervals	ENTITY
similar	
to	
those	
of	
PLMs	ENTITY
.	

Extensor	ENTITY
forearm	ENTITY
EMG	ENTITY
study	ENTITY
may	
suggest	
alternating	ENTITY
muscle	ENTITY
activity	ENTITY
in	
the	
upper	ENTITY
extremities	ENTITY
,	
though	
it	
is	
less	
prominent	
than	
activation	ENTITY
in	
the	
legs	ENTITY
.	

ALMA	ENTITY
shows	
some	
night	ENTITY
-	
to	
-	
night	ENTITY
consistency	ENTITY
.	

Repeat	
studies	ENTITY
are	
likely	
to	
show	
persistent	ENTITY
ALMA	ENTITY
.	

The	
number	
of	
sequences	ENTITY
recorded	
,	
on	
average	ENTITY
,	
and	
the	
timing	ENTITY
of	
ALMA	ENTITY
with	
respect	
to	
arousals	ENTITY
tends	
to	
remain	
constant	ENTITY
.	

The	
specific	
polysomnographic	ENTITY
criteria	ENTITY
for	
HFT	ENTITY
during	
sleep	ENTITY
and	
ALMA	ENTITY
are	
defined	
in	
the	
most	
recent	
version	ENTITY
of	
the	
AASM	ENTITY
Manual	
for	
the	
Scoring	ENTITY
of	ENTITY
Sleep	ENTITY
and	
Associated	ENTITY
Events	ENTITY
.	

Presentation	ENTITY
of	
HFT	ENTITY
or	
ALMA	ENTITY
with	
other	
concurrent	ENTITY
sleep	ENTITY
disorders	ENTITY
is	
common	
.	

Because	
of	
the	
similar	
frequency	ENTITY
,	
duration	ENTITY
,	
and	
body	ENTITY
part	ENTITY
involvement	ENTITY
of	
the	
move-	
ments	ENTITY
,	
HFT	ENTITY
and	
ALMA	ENTITY
may	
represent	
variants	ENTITY
of	
the	
same	
disorder	ENTITY
.	

Insufficient	ENTITY
sci-	

entific	ENTITY
evidence	ENTITY
has	
accumulated	
to	
make	
this	
a	
certainty	ENTITY
.	

Thus	
,	
these	
entities	ENTITY
are	
listed	
sequentially	
but	
separately	
.	

Of	
note	
,	
some	
have	
questioned	
whether	
HFT	ENTITY
and	
ALMA	ENTITY
might	
represent	
a	
variant	ENTITY
of	
rhythmic	ENTITY
movement	ENTITY
disorder	ENTITY
in	
which	
movements	ENTITY
are	
confined	
to	
the	
legs	ENTITY
and	
an	
older	ENTITY
population	ENTITY
is	
affected	ENTITY
.	

HFT	ENTITY
and	
ALMA	ENTITY
should	
be	
distinguished	
from	
other	
sleep	ENTITY
-	
onset	ENTITY
movements	ENTITY
:	
PLMD	ENTITY
(	
especially	
the	
polyclonic	ENTITY
form	ENTITY
)	
,	
PSM	ENTITY
,	
and	
sleep	ENTITY
related	
RMD	ENTITY
.	

Movement	ENTITY
disorders	ENTITY
that	
should	
be	
distinguished	
from	
HFT	ENTITY
and	
ALMA	ENTITY
include	
dyskinetic	ENTITY
movements	ENTITY
of	
the	
foot	ENTITY
,	
such	
as	
painful	ENTITY
legs	
and	
moving	ENTITY
toes	ENTITY
;	
tremors	ENTITY
or	
rhythmic	ENTITY
movements	ENTITY
of	
other	
cause	ENTITY
(	
Parkinson	ENTITY
disease	ENTITY
,	
clonus	ENTITY
)	
;	
and	
neuroleptic	ENTITY
-	
induced	ENTITY
akathisia	ENTITY
.	

None	
of	
these	
conditions	ENTITY
involves	
regular	
alternation	ENTITY
between	
sides	ENTITY
,	
as	
seen	
in	
ALMA	ENTITY
,	
or	
an	
associ-	
ation	ENTITY
with	
the	
use	
of	
antidepressant	ENTITY
medication	ENTITY
.	

Whether	
HFT	ENTITY
should	
be	
distinguished	
from	
ALMA	ENTITY
is	
not	
known	
.	

Potential	
differences	
based	
on	
existing	
reports	ENTITY
include	
the	
presence	ENTITY
of	
clear	
movement	ENTITY
in	
HFT	ENTITY
as	
opposed	
to	
some	
uncertainty	
whether	
ALMA	ENTITY
must	
involve	
movement	ENTITY
.	

ALMA	ENTITY
,	
in	
contrast	
to	
HFT	ENTITY
,	
alternates	
between	
sides	ENTITY
,	
occurs	
in	
any	
sleep	ENTITY
stage	ENTITY
,	
can	
occur	
without	
arousal	ENTITY
,	
and	
is	
associated	ENTITY
with	ENTITY
the	
use	
of	
antidepressants	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
High	ENTITY
-	
frequency	ENTITY
leg	ENTITY
movements	ENTITY
(	
HFLM	ENTITY
)	
also	
have	
been	
described	
as	
a	
repetitive	ENTITY
ante-	ENTITY
rior	ENTITY
tibialis	ENTITY
,	
polysomnographic	ENTITY
activation	ENTITY
phenomenon	ENTITY
,	
possibly	
showing	
some	
asso-	
ciation	ENTITY
with	
RLS	ENTITY
,	
and	
with	
potential	ENTITY
overlap	ENTITY
with	
HFT	ENTITY
and	
ALMA	ENTITY
.	

In	
contrast	
to	
HFT	ENTITY
,	
however	
,	
HFLM	ENTITY
occur	
in	
all	
sleep	ENTITY
stages	ENTITY
,	
and	
are	
mostly	
unilateral	ENTITY
rather	
than	
bilateral	ENTITY
.	

In	
contrast	
to	
ALMA	ENTITY
,	
HFLM	ENTITY
are	
mostly	
unilateral	ENTITY
rather	
than	
alternating	ENTITY
,	
and	
often	
show	
sequences	ENTITY
that	
last	
longer	
than	
those	
reported	
for	
ALMA	ENTITY
.	

The	
reported	
HFLM	ENTITY
may	
be	
more	
common	
than	
ALMA	ENTITY
,	
and	
the	
possibility	
exists	
that	
ALMA	ENTITY
rep-	ENTITY
resents	ENTITY
a	
subtype	ENTITY
of	
HFLM	ENTITY
in	
which	
leg	ENTITY
alternation	ENTITY
occurs	
.	

The	
degree	ENTITY
to	
which	
these	
movements	ENTITY
are	
quasi	ENTITY
-	
voluntary	ENTITY
remains	
to	
be	
determined	
because	
some	
are	
suppressible	ENTITY
.	

Whether	
HFT	ENTITY
and	
ALMA	ENTITY
are	
merely	
alternate	
forms	
of	
the	
same	
underlying	
motor	ENTITY
mechanism	ENTITY
is	
also	
unclear	
.	

As	
reports	ENTITY
of	
these	
move-	
ments	ENTITY
have	
arisen	
from	
reviews	ENTITY
of	
sleep	ENTITY
center	ENTITY
records	ENTITY
,	
nothing	
is	
known	
about	
their	
manifestation	ENTITY
in	
the	
general	ENTITY
population	ENTITY
.	

The	
associations	ENTITY
noted	
may	
be	
due	
to	
biased	
sampling	ENTITY
caused	
by	
a	
skewing	ENTITY
of	
the	
population	ENTITY
toward	
those	
with	
sleep	ENTITY
disorders	ENTITY
,	
especially	
respiratory	ENTITY
disorders	ENTITY
.	

The	
degree	ENTITY
to	
which	
HFT	ENTITY
and	
ALMA	ENTITY
have	
clinical	ENTITY
significance	ENTITY
remains	
uncertain	
.	

Bibliography	ENTITY
Berry	ENTITY
RB	ENTITY
.	

A	
woman	ENTITY
with	
rhythmic	ENTITY
foot	ENTITY
movements	ENTITY
.	

J	
Clin	
Sleep	
Med	
2007;3:749–51	
.	

Broughton	ENTITY
R.	ENTITY
Pathological	ENTITY
fragmentary	
myoclonus	
,	
intensified	
sleep	ENTITY
starts	
and	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
:	
three	
unusual	ENTITY
sleep	ENTITY
-	
related	ENTITY
disorders	ENTITY
.	

In	
:	
Koella	ENTITY
WP	ENTITY
,	
Schulz	
OF	
,	
Visser	
P	
,	
eds	
.	

Sleep	ENTITY
1986	
.	

Stuttgart	ENTITY
:	

Fischer	ENTITY
-	
Verlag	ENTITY
,	
1988:240–3	
.	

Chervin	ENTITY
RD	ENTITY
,	
Consens	ENTITY
FB	ENTITY
,	
Kutluay	ENTITY
E.	ENTITY
Alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
during	
sleep	ENTITY
and	
arousals	ENTITY
:	
a	
new	
sleep	ENTITY
-	
related	ENTITY
motor	ENTITY
phenomenon	ENTITY
?	

Mov	ENTITY
Disord	ENTITY
2003;18:551–9	ENTITY
.	

Consentino	ENTITY
FI	ENTITY
,	
Iero	ENTITY
I	ENTITY
,	
Lanuzza	ENTITY
B	ENTITY
,	
Tripodi	ENTITY
M	ENTITY
,	
Ferri	ENTITY
R.	ENTITY
The	
neurophysiology	ENTITY
of	
the	
alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
(	
ALMA	ENTITY
)	
during	
sleep	ENTITY
:	
Study	ENTITY
of	
one	
patient	ENTITY
before	
and	
after	
treatment	ENTITY
with	
pramipexole	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2006;7:63–71	ENTITY
.	

Cunningham	ENTITY
SL	ENTITY
,	
Winkelman	ENTITY
JW	ENTITY
,	
Dorsey	ENTITY
CM	ENTITY
,	
et	
al	
.	

An	
electromyographic	ENTITY
marker	ENTITY
for	
neuroleptic	ENTITY
-	
induced	ENTITY
akathisia	ENTITY
:	
preliminary	ENTITY
measures	ENTITY
of	
sensitivity	ENTITY
and	
specificity	ENTITY
.	

Clin	ENTITY
Neuropharmacol	ENTITY
1996;19:321–32	ENTITY
.	

Wichniak	ENTITY
A	ENTITY
,	
Tracik	ENTITY
F	ENTITY
,	
Geisler	ENTITY
P	ENTITY
,	
Ebersbach	ENTITY
G	ENTITY
,	
Morrissey	ENTITY
SP	ENTITY
,	
Zulley	
J.	
Rhythmic	
feet	
movements	ENTITY
while	
falling	ENTITY
asleep	ENTITY
.	

Mov	ENTITY
Disord	ENTITY
2001;16:1164–70	
.	

Yang	ENTITY
C	ENTITY
,	
Winkelman	ENTITY
JW	ENTITY
,	
White	ENTITY
DP	ENTITY
.	

The	
effects	ENTITY
of	ENTITY
antidepressants	ENTITY
on	
leg	ENTITY
movements	ENTITY
(	
abstract	
)	
Sleep	
2004;27(Abst	
Suppl):A311–2	ENTITY
.	

Yang	ENTITY
C	ENTITY
,	
Winkelman	ENTITY
JW	
.	

Clinical	ENTITY
and	
polysomnographic	ENTITY
characteristics	ENTITY
of	
high	ENTITY
frequency	ENTITY
leg	ENTITY
movements	ENTITY
.	

J	
Clin	
Sleep	
Med	
2010;6:431–8	
.	

Sleep	ENTITY
Starts	ENTITY
(	
Hypnic	ENTITY
Jerks	ENTITY
)	

Sleep	ENTITY
starts	
,	
also	
known	
as	
hypnic	ENTITY
jerks	ENTITY
,	
are	
sudden	ENTITY
,	
brief	
,	
simultaneous	ENTITY
contractions	ENTITY
of	
the	
body	ENTITY
or	
one	
or	
more	
body	ENTITY
segments	ENTITY
occurring	
at	
sleep	ENTITY
onset	ENTITY
.	

Sleep	ENTITY
starts	ENTITY
(	
or	
hypnic	ENTITY
jerks	ENTITY
)	
usually	
consist	
of	
a	
single	
contraction	ENTITY
that	
often	
affects	
the	
body	ENTITY
asymmetrically	ENTITY
.	

The	
jerks	ENTITY
may	
be	
either	
spontaneous	ENTITY
or	
induced	ENTITY
by	
stimuli	ENTITY
.	

The	
motor	ENTITY
activity	ENTITY
is	
often	
associated	ENTITY
with	ENTITY
a	
sensory	ENTITY
component	ENTITY
,	
which	
may	
be	
somesthetic	ENTITY
,	
often	
an	
impression	ENTITY
of	
falling	
or	
less	
commonly	
pain	ENTITY
or	
tingling	ENTITY
;	
auditory	ENTITY
,	
such	
as	
banging	ENTITY
,	
snapping	ENTITY
or	
crackling	ENTITY
noises	ENTITY
;	
or	
visual	ENTITY
,	
including	
flashing	ENTITY
lights	ENTITY
,	
hypnagogic	ENTITY
dreams	ENTITY
,	
or	
hallucina-	
tions	ENTITY
.	

A	
sharp	ENTITY
cry	ENTITY
may	
occur	
.	

The	
patient	ENTITY
may	
not	
recall	
a	
jerk	ENTITY
that	
was	
noted	
by	
a	
bed	ENTITY
partner	ENTITY
if	
the	
sleep	ENTITY
start	
does	
not	
cause	
awakening	ENTITY
.	

Multiple	ENTITY
jerks	ENTITY
occasionally	
occur	
in	
succession	ENTITY
,	
usually	
early	
in	
the	
sleep	ENTITY
period	ENTITY
.	

When	
sleep	ENTITY
starts	ENTITY
or	
hypnic	ENTITY
jerks	ENTITY
are	
frequent	ENTITY
,	
intense	ENTITY
,	
or	
repetitive	ENTITY
,	
they	
may	
lead	
to	
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
.	

Purely	ENTITY
sensory	ENTITY
sleep	ENTITY
starts	
are	
subjective	ENTITY
,	
localized	ENTITY
,	
sensory	ENTITY
impressions	ENTITY
that	
occur	
at	
sleep	ENTITY
onset	ENTITY
and	
are	
not	
associated	ENTITY
with	ENTITY
motor	ENTITY
activity	ENTITY
.	

The	
term	ENTITY
“	
Intensified	ENTITY
sleep	ENTITY
starts	
”	
has	
been	
applied	
to	
both	
the	
motor	ENTITY
and	
purely	
sensory	ENTITY
forms	ENTITY
when	
a	
complaint	ENTITY
of	
difficulty	ENTITY
falling	ENTITY
asleep	
as	
a	
result	
of	
the	
starts	
is	
present	
.	

A	
prevalence	ENTITY
of	
60	
%	
to	
70	
%	
has	
been	
reported	
,	
but	
with	
a	
highly	
sporadic	ENTITY
occurrence	ENTITY
.	

Sleep	ENTITY
starts	
affect	
all	
ages	ENTITY
and	
both	
sexes	ENTITY
.	

Excessive	ENTITY
caffeine	ENTITY
or	
other	
stimulant	ENTITY
intake	ENTITY
,	
prior	
intense	
physical	ENTITY
work	ENTITY
or	
exercise	ENTITY
,	
sleep	ENTITY
deprivation	ENTITY
,	
and	
emotional	ENTITY
stress	ENTITY
can	
increase	ENTITY
the	
frequency	ENTITY
and	
severity	ENTITY
of	
sleep	ENTITY
starts	ENTITY
.	

Sleep	ENTITY
starts	
are	
an	
essentially	
universal	ENTITY
component	ENTITY
of	
the	
sleep	ENTITY
-	
onset	ENTITY
process	ENTITY
,	
although	
they	
are	
often	
not	
recalled	
.	

Hypnic	ENTITY
jerks	ENTITY
may	
occur	
at	
any	
age	ENTITY
,	
as	
a	
subjective	
com-	ENTITY
plaint	ENTITY
;	
however	
,	
they	
are	
usually	
encountered	
in	ENTITY
adulthood	ENTITY
.	

The	
course	ENTITY
is	
usually	
benign	ENTITY
.	

Intensified	ENTITY
sleep	ENTITY
starts	
may	
lead	
to	
avoidance	ENTITY
/	
delay	ENTITY
of	
sleep	
,	
a	
fear	ENTITY
of	ENTITY
falling	ENTITY
asleep	
and	
chronic	ENTITY
anxiety	ENTITY
.	

As	
a	
result	ENTITY
,	
acute	ENTITY
and	
chronic	ENTITY
sleep	ENTITY
deprivation	ENTITY
may	
occur	
.	

Sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
may	
result	
either	
from	
repeated	
awakenings	ENTITY
induced	ENTITY
by	
the	
starts	
or	
from	
anxiety	ENTITY
about	
falling	ENTITY
asleep	ENTITY
.	

Injury	ENTITY
,	
such	
as	
bruising	ENTITY
a	
foot	ENTITY
against	
a	
bedstead	ENTITY
or	
kicking	ENTITY
a	
sleeping	ENTITY
companion	ENTITY
,	
may	
occasionally	
occur	
.	

The	
physiological	ENTITY
mechanisms	ENTITY
underlying	
sleep	ENTITY
starts	ENTITY
are	
uncertain	
.	

No	
pathologic	ENTITY
finding	ENTITY
has	
been	
described	
except	
for	
a	
single	
case	
of	
auditory	ENTITY
sleep	ENTITY
starts	
associated	ENTITY
with	ENTITY
a	
brainstem	ENTITY
lesion	ENTITY
.	

Hypnic	ENTITY
jerks	ENTITY
are	
hypothetically	
caused	
by	
sudden	ENTITY
descending	ENTITY
volleys	ENTITY
originating	
in	
the	
brainstem	ENTITY
reticular	ENTITY
formation	ENTITY
activated	ENTITY
by	
the	
system	ENTITY
insta-	
bility	ENTITY
at	
the	
transition	ENTITY
between	
wake	ENTITY
and	
sleep	ENTITY
.	

However	
,	
the	
similarity	ENTITY
between	
sleep	ENTITY
starts	
and	
the	
startle	ENTITY
response	ENTITY
has	
led	
some	
to	
postulate	
that	
abnormalities	ENTITY
of	
sensory	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
processing	ENTITY
are	
primary	ENTITY
,	
with	
secondary	ENTITY
motor	ENTITY
manifestations	ENTITY
involving	
the	
reticulo-	
spinal	
tract	
.	

Sleep	ENTITY
starts	
are	
a	
prominent	
symptom	ENTITY
in	
hereditary	ENTITY
hyperekplexia	ENTITY
,	
some	
cases	ENTITY
of	
which	
are	
caused	
by	
mutations	ENTITY
in	
the	
glycine	ENTITY
receptor	ENTITY
.	

It	
has	
also	
been	
postu-	
lated	ENTITY
that	
sleep	ENTITY
starts	
are	
a	
response	ENTITY
to	
hypnagogic	ENTITY
imagery	ENTITY
.	

Polysomnographic	ENTITY
monitoring	ENTITY
shows	
that	
hypnic	ENTITY
jerks	ENTITY
occur	
during	
transitions	ENTITY
from	
wakefulness	ENTITY
to	
sleep	ENTITY
,	
mainly	
at	
the	
beginning	
of	
the	
sleep	ENTITY
episode	ENTITY
.	

Superficial	ENTITY
EMG	ENTITY
recordings	ENTITY
of	
the	
involved	
muscles	ENTITY
show	
brief	
(	
generally	
75	
-	
millisecond	ENTITY
to	
250	
-	
mil-	
lisecond	ENTITY
)	
high	ENTITY
-	
amplitude	ENTITY
potentials	ENTITY
,	
either	
singly	ENTITY
or	
in	
succession	ENTITY
.	

The	
EEG	ENTITY
typically	
shows	
drowsiness	ENTITY
or	
stage	ENTITY
N1	ENTITY
sleep	ENTITY
patterns	ENTITY
,	
sometimes	
with	
a	
negative	ENTITY
-	
vertex	ENTITY
sharp	ENTITY
wave	ENTITY
occurring	
at	
the	
time	
of	
the	
jerk	ENTITY
.	

Autonomic	ENTITY
activation	ENTITY
,	
including	
tachycardia	ENTITY
,	
tachypnea	ENTITY
or	
irregular	ENTITY
breathing	ENTITY
,	
and	
sudomotor	ENTITY
activation	ENTITY
may	
follow	
an	
intense	ENTITY
jerk	ENTITY
.	

After	
the	
jerk	ENTITY
,	
a	
brief	
arousal	ENTITY
or	
a	
return	
to	
sustained	ENTITY
wakefulness	ENTITY
may	
occur	
.	

Physical	ENTITY
and	
neurological	ENTITY
examinations	ENTITY
and	
routine	ENTITY
laboratory	ENTITY
tests	ENTITY
are	
otherwise	
normal	
.	

Although	
polysomnography	ENTITY
is	
not	
necessary	
for	
diagnosis	ENTITY
in	
most	
individuals	ENTITY
,	
it	
may	
be	
indicated	
in	
occasional	
cases	ENTITY
with	
complaints	ENTITY
of	
insomnia	ENTITY
and	
frequent	ENTITY
movements	ENTITY
.	

Hypnic	ENTITY
jerks	ENTITY
must	
be	
differentiated	
from	
a	
number	
of	
physiological	ENTITY
or	
pathologic	ENTITY
movements	ENTITY
that	
occur	
at	
sleep	ENTITY
onset	ENTITY
or	
during	
sleep	ENTITY
.	

Physiological	ENTITY
partial	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
consists	
of	
small	ENTITY
,	
isolated	ENTITY
contractions	ENTITY
of	
a	
muscle	ENTITY
or	
part	
thereof	
,	
occur-	
ring	
sporadically	
in	
distal	ENTITY
muscles	ENTITY
and	
resembling	
fasciculation	ENTITY
potentials	ENTITY
.	

The	
con-	
tractions	ENTITY
are	
particularly	
evident	
during	
stage	ENTITY
N1	ENTITY
and	
REM	ENTITY
sleep	ENTITY
.	

Fragmentary	ENTITY
myoclonus	ENTITY
consists	
of	
profuse	ENTITY
,	
brief	ENTITY
,	
small	ENTITY
-	
amplitude	ENTITY
muscle	
twitches	ENTITY
that	
occur	
in	
an	
asynchronous	ENTITY
,	
symmetrical	ENTITY
,	
and	
bilateral	ENTITY
manner	
,	
especially	
in	
distal	ENTITY
muscles	ENTITY
.	

Fragmentary	ENTITY
myoclonus	ENTITY
occurs	
at	
sleep	ENTITY
onset	ENTITY
as	
well	
as	
within	
all	
sleep	ENTITY
stages	ENTITY
.	

Contrary	
to	
the	
massive	ENTITY
jerks	ENTITY
of	
the	
sleep	ENTITY
starts	ENTITY
or	
hypnic	ENTITY
jerks	ENTITY
,	
the	
small	ENTITY
muscle	ENTITY
twitches	ENTITY
of	
physiological	ENTITY
partial	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
and	
of	
fragmentary	ENTITY
myoclonus	ENTITY
often	
represent	
only	
an	
EMG	ENTITY
finding	ENTITY
and	
are	
not	
associated	ENTITY
with	ENTITY
overt	ENTITY
movements	ENTITY
at	
the	
joints	ENTITY
.	

Normal	ENTITY
body	ENTITY
movements	
are	
complex	ENTITY
,	
with	
body	ENTITY
postural	ENTITY
shifts	ENTITY
usually	
at	
the	
transition	ENTITY
between	
one	
sleep	ENTITY
stage	ENTITY
and	
another	
.	

Benign	ENTITY
sleep	ENTITY
myoclonus	ENTITY
of	
infancy	ENTITY
consists	
of	
myoclonic	ENTITY
jerks	ENTITY
at	
the	
elbow	ENTITY
,	
fingers	ENTITY
,	
toes	ENTITY
,	
and	
face	
during	
sleep	ENTITY
in	
infants	ENTITY
.	

PSM	ENTITY
is	
characterized	
by	
jerks	ENTITY
,	
usually	
spontaneous	ENTITY
,	
but	
sometimes	
also	
evoked	ENTITY
,	
arising	
first	
in	
spinal	ENTITY
innervated	ENTITY
axial	ENTITY
muscles	ENTITY
of	
the	
trunk	ENTITY
,	
neck	ENTITY
,	
or	
abdomen	ENTITY
and	
then	
prop-	
agated	ENTITY
at	
slow	ENTITY
velocity	ENTITY
to	
more	
rostral	ENTITY
and	
caudal	ENTITY
muscles	ENTITY
.	

PSM	ENTITY
is	
present	
during	
relaxed	ENTITY
wakefulness	ENTITY
,	
characterized	ENTITY
by	
diffuse	
EEG	ENTITY
alpha	ENTITY
activity	ENTITY
,	
and	
disappears	
with	
sleep	ENTITY
onset	ENTITY
or	
mental	ENTITY
activation	ENTITY
.	

PSM	ENTITY
is	
usually	
a	
chronic	ENTITY
condition	ENTITY
associated	ENTITY
with	ENTITY
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
.	

Excessive	ENTITY
startling	ENTITY
and	
hypnic	ENTITY
jerks	ENTITY
may	
occur	
as	
part	
of	
the	
hyperekplexia	ENTITY
syndrome	ENTITY
,	
in	
which	
generalized	ENTITY
myoclonus	ENTITY
is	
readily	
elicited	
by	
stimuli	ENTITY
during	
either	
wakeful-	
ness	ENTITY
or	
sleep	ENTITY
.	

The	
major	
form	
of	
this	
condition	ENTITY
is	
also	
characterized	ENTITY
by	
stiffness	ENTITY
and	
falls	ENTITY
.	

Brief	ENTITY
epileptic	ENTITY
myoclonus	ENTITY
can	
be	
differentiated	
by	
coexistent	ENTITY
EEG	ENTITY
discharge	ENTITY
,	
the	
presence	ENTITY
of	
other	
features	ENTITY
of	
epileptic	ENTITY
seizures	ENTITY
,	
and	
the	
occurrence	ENTITY
of	
the	
myoclonus	ENTITY
in	
both	
wakefulness	ENTITY
and	
during	
sleep	ENTITY
rather	
than	
only	
at	
sleep	ENTITY
onset	ENTITY
.	

The	
muscle	ENTITY
contractions	ENTITY
of	
PLMD	ENTITY
are	
much	
longer	
in	
duration	ENTITY
,	
involve	
mainly	
the	
feet	ENTITY
and	
lower	ENTITY
legs	ENTITY
,	
show	
periodicity	ENTITY
,	
and	
occur	
within	
sleep	ENTITY
.	

RLS	ENTITY
consists	
of	
slower	ENTITY
and	
repetitive	ENTITY
semivoluntary	ENTITY
movements	ENTITY
at	
sleep	ENTITY
onset	ENTITY
that	
are	
associated	ENTITY
with	ENTITY
deep	ENTITY
,	
unpleasant	ENTITY
,	
and	
sometimes	
unbearable	
sensations	ENTITY
,	
which	
are	
temporarily	
relieved	
by	
getting	
up	
and	
exercising	ENTITY
.	

Bibliography	ENTITY
Broughton	ENTITY
R.	ENTITY
Pathological	ENTITY
fragmentary	
myoclonus	
,	
intensified	
sleep	ENTITY
starts	
and	
hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
:	
three	
unusual	ENTITY
sleep	ENTITY
-	
related	ENTITY
disorders	ENTITY
.	

In	
:	
Koella	ENTITY
WP	ENTITY
,	
Schulz	
OF	
,	
Visser	
P	
,	
eds	
.	

Sleep	ENTITY
1986	
.	

Stuttgart	ENTITY
:	
Fisher	ENTITY
Verlag	ENTITY
;	
1988:240–3	
.	

Kennard	ENTITY
MA	ENTITY
,	
Schwartzman	ENTITY
AE	ENTITY
,	
Millar	ENTITY
TP	ENTITY
.	

Sleep	ENTITY
,	
consciousness	ENTITY
,	
and	
the	
alpha	ENTITY
electroencephalographic	ENTITY
rhythm	ENTITY
.	

Arch	ENTITY
Neurol	ENTITY
Psychiatry	ENTITY
1958;79:328–35	ENTITY
.	

Montagna	
P	
,	
Liguori	ENTITY
R	ENTITY
,	
Zucconi	ENTITY
M	ENTITY
,	
et	
al	
.	

Physiological	ENTITY
hypnic	ENTITY
myoclonus	ENTITY
.	

Electroencephalgr	ENTITY
Clin	ENTITY
Neurophysiol	ENTITY
1988;70:172–6	ENTITY
.	

Oswald	ENTITY
I.	ENTITY
Sudden	ENTITY
bodily	ENTITY
jerks	ENTITY
on	
falling	ENTITY
asleep	ENTITY
.	

Brain	ENTITY
1959;82:92–103	
.	

Salih	ENTITY
F	ENTITY
,	
Klingebiel	ENTITY
R	ENTITY
,	
Zschenderlein	ENTITY
R	ENTITY
,	
et	
al	
.	

Acoustic	ENTITY
sleep	ENTITY
starts	
with	
sleep	ENTITY
-	
onset	ENTITY
insomnia	ENTITY
related	
to	
a	
brainstem	ENTITY
lesion	ENTITY
.	

Neurology	ENTITY
2008;70:1935–7	
.	

Sander	ENTITY
HW	ENTITY
,	
Geisse	ENTITY
H	ENTITY
,	
Quinto	ENTITY
C	ENTITY
,	
Sachdeo	ENTITY
R	ENTITY
,	
Chokroverty	ENTITY
S.	
Sensory	ENTITY
sleep	ENTITY
starts	
.	

J	
Neurol	
Neurosurg	
Psychiatry	
1998;64:690	
.	

Vetrugno	ENTITY
R	ENTITY
,	
Montagna	
P.	
Sleep	
-	
to	
-	
wake	ENTITY
transition	ENTITY
movement	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2011;12	ENTITY
:	
S11–6	
.	

Sleep	ENTITY
Related	ENTITY
Movement	ENTITY
Disorders	ENTITY
Other	
Sleep	ENTITY
Disorder	ENTITY
ICD-9	ENTITY
-	
CM	ENTITY
code	ENTITY
:	
327.8	
ICD-10	ENTITY
-	
CM	ENTITY
code	ENTITY
:	

G47.8	ENTITY
Sleep	ENTITY
disorders	ENTITY
that	
can	
not	
be	
classified	
elsewhere	
in	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
are	
listed	
here	
.	

This	
may	
be	
due	
to	
the	
fact	
that	
the	
sleep	ENTITY
disorder	ENTITY
overlaps	
more	
than	
one	
category	
or	
,	
more	
often	
,	
when	
insufficient	ENTITY
data	ENTITY
have	
been	
collected	
to	
firmly	
establish	
another	
diagnosis	ENTITY
.	

It	
is	
also	
possible	
that	
new	
sleep	ENTITY
disorders	ENTITY
that	
do	
not	
fall	
within	
any	
of	
the	
current	
major	
categories	ENTITY
will	
be	
dis-	
covered	
during	
the	
lifetime	ENTITY
of	
the	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
3rd	
Edition	
.	

When	
a	
specific	
diagnosis	ENTITY
can	
not	
yet	
be	
determined	
but	
the	
presenting	
problem	
clearly	
falls	
into	
a	
specific	
category	ENTITY
(	
e.g.	
,	
a	
circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
dis-	
order	
)	
,	
the	
“	
unspecified	ENTITY
”	
diagnosis	ENTITY
within	
that	
category	ENTITY
(	
e.g.	
,	
circadian	ENTITY
rhythm	ENTITY
sleep-	
wake	ENTITY
disorder	ENTITY
,	
unspecified	ENTITY
)	
is	
preferred	
.	

The	
International	ENTITY
Classification	ENTITY
of	ENTITY
Sleep	ENTITY
Disorders	ENTITY
,	
2nd	
Edition	
included	
a	
specific	
diagnosis	ENTITY
of	
environmental	ENTITY
sleep	ENTITY
disorder	ENTITY
within	
this	
section	ENTITY
.	

This	
diagnosis	ENTITY
is	
infre-	
quently	ENTITY
employed	
in	
the	
clinical	ENTITY
setting	ENTITY
and	
significant	
controversy	
exists	
regarding	
whether	
environmentally	ENTITY
induced	ENTITY
sleep	ENTITY
disturbance	ENTITY
represents	
a	
clinical	ENTITY
disorder	ENTITY
per	
se	
.	

The	
condition	ENTITY
is	
typically	
characterized	ENTITY
by	
complaints	ENTITY
of	
sleep	ENTITY
initiation	ENTITY
and/or	
maintenance	ENTITY
that	
are	
the	
direct	
result	
of	
an	
environmental	ENTITY
factor	ENTITY
.	

Associated	ENTITY
daytime	
symptoms	
such	
as	
sleepiness	ENTITY
,	
fatigue	ENTITY
,	
or	
cognitive	ENTITY
or	
emotional	ENTITY
disturbance	ENTITY
may	
be	
present	
.	

The	
environmental	ENTITY
disturbance	ENTITY
may	
be	
a	
physical	ENTITY
stimulus	ENTITY
such	
as	
noise	ENTITY
(	
e.g.	
,	
vehicular	ENTITY
traffic	ENTITY
,	
aircraft	ENTITY
,	
bed	ENTITY
partner	ENTITY
snoring	ENTITY
)	
,	
light	ENTITY
,	
temperature	ENTITY
,	
movement	ENTITY
(	
e.g.	
,	
bed	ENTITY
partner	ENTITY
movement	ENTITY
disorder	ENTITY
or	
parasomnia	ENTITY
)	
,	
an	
emotional	ENTITY
stimulus	ENTITY
such	
as	
environ-	
mental	ENTITY
danger	ENTITY
(	
e.g.	
,	
combat	ENTITY
setting	ENTITY
or	
disaster	ENTITY
area	ENTITY
)	
,	
or	
an	
environmental	ENTITY
requirement	ENTITY
(	
such	
as	
caring	ENTITY
for	
an	
infant	ENTITY
or	
elderly	ENTITY
family	ENTITY
member	ENTITY
)	
.	

Hospitalization	ENTITY
is	
often	
cited	
as	
a	
precipitant	ENTITY
of	
environmental	ENTITY
sleep	ENTITY
disturbance	ENTITY
although	
many	
additional	
factors	ENTITY
(	
e.g.	
,	
anxiety	ENTITY
or	
pain	ENTITY
)	
may	
also	
contribute	
to	
sleep	ENTITY
disturbance	ENTITY
in	
this	
setting	
.	

If	
the	
clinician	ENTITY
determines	
that	
an	
environmental	ENTITY
factor	ENTITY
is	
the	
primary	
cause	
of	
a	
sleep	ENTITY
distur-	
bance	ENTITY
,	
a	
diagnosis	ENTITY
of	
Other	
Sleep	ENTITY
Disorder	ENTITY
may	
be	
employed	
.	

It	
is	
the	
physical	ENTITY
aspects	ENTITY
of	
the	
environment	ENTITY
,	
rather	
than	
their	
psychological	ENTITY
meaning	ENTITY
,	
which	
account	
for	
the	
sleep	ENTITY
complaint	ENTITY
.	

Unlike	
insomnia	ENTITY
disorder	ENTITY
,	
the	
sleep	ENTITY
disturbance	ENTITY
is	
dependent	
on	
the	
presence	ENTITY
of	
the	
environmental	ENTITY
factor	ENTITY
.	

In	
the	
absence	ENTITY
of	
the	
stimu-	
lus	
,	
sleep	ENTITY
is	
normal	
.	

The	
prevalence	ENTITY
of	
environmentally	ENTITY
induced	ENTITY
sleep	ENTITY
disturbances	ENTITY
is	
not	
known	
although	
,	
as	
noted	
,	
the	
diagnosis	ENTITY
is	
not	
commonly	
reported	
in	
sleep	ENTITY
centers	ENTITY
.	

Some	
individuals	ENTITY
Other	
Sleep	ENTITY
Disorder	ENTITY
may	
be	
more	
susceptible	ENTITY
to	
environmental	ENTITY
disturbances	ENTITY
but	
little	
is	
known	
about	
spe-	
cific	ENTITY
characteristics	ENTITY
that	
might	
predispose	
to	
this	
condition	ENTITY
.	

Although	
environmental	ENTITY
factors	ENTITY
may	
play	
a	
contributing	
role	
in	
some	
cases	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
,	
multiple	
other	
factors	ENTITY
account	
for	
that	
condition	ENTITY
,	
which	
is	
typically	
evident	
even	
in	
the	
absence	ENTITY
of	
the	
offending	ENTITY
environmental	ENTITY
stimulus	ENTITY
.	

Distinguishing	
an	
insomnia	ENTITY
disorder	ENTITY
from	
an	
environmentally	ENTITY
induced	ENTITY
sleep	ENTITY
disturbance	ENTITY
may	
pose	
a	
challenge	
in	
certain	
clinical	ENTITY
encounters	ENTITY
and	
providers	ENTITY
must	
use	
clinical	ENTITY
judgment	ENTITY
in	
establishing	
the	
diagnosis	ENTITY
.	

In	
behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
,	
the	
child	ENTITY
may	
require	
certain	
environmental	ENTITY
cir-	
cumstances	ENTITY
in	
order	
to	
sleep	ENTITY
(	
e.g.	
,	
a	
pacifier	ENTITY
,	
music	ENTITY
,	
lights	ENTITY
,	
television	ENTITY
,	
or	
a	
parent	ENTITY
)	
.	

It	
is	
the	
absence	ENTITY
of	
these	
circumstances	
that	
results	ENTITY
in	
sleep	ENTITY
initiation	ENTITY
or	
maintenance	ENTITY
prob-	
lems	ENTITY
.	

In	
such	
cases	ENTITY
,	
a	
diagnosis	ENTITY
of	
chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
(	
behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
–	
sleep	ENTITY
-	
onset	ENTITY
association	ENTITY
type	ENTITY
)	
is	
indicated	
.	

Bibliography	ENTITY
Basner	ENTITY
M	ENTITY
,	
Griefahn	ENTITY
B	ENTITY
,	
Berg	ENTITY
MV	ENTITY
.	

Aircraft	ENTITY
noise	
effects	
on	
sleep	ENTITY
:	
mechanisms	ENTITY
,	
mitigation	ENTITY
and	
research	ENTITY
needs	
.	

Noise	ENTITY
Health	ENTITY
2010;12:95–109	ENTITY
.	

Hume	ENTITY
KI	ENTITY
,	
Brink	ENTITY
M	ENTITY
,	
Basner	
M.	
Effects	
of	
environmental	ENTITY
noise	ENTITY
on	
sleep	ENTITY
.	

Noise	ENTITY
Health	ENTITY
.	

2012;14:297–302	
.	

Thiessen	ENTITY
G	ENTITY
,	
Lapointe	
A.	
Effect	
of	
continuous	ENTITY
traffic	ENTITY
noise	ENTITY
on	
percentage	ENTITY
of	
deep	ENTITY
sleep	ENTITY
,	
waking	ENTITY
,	
and	
sleep	ENTITY
latency	ENTITY
.	

J	
Acoust	
Soc	
Amer	
1983;73:225–9	
.	

Yilmaz	ENTITY
M	ENTITY
,	
Sayin	ENTITY
Y	ENTITY
,	ENTITY
Gurler	ENTITY
H.	ENTITY
Sleep	ENTITY
quality	ENTITY
of	
hospitalized	ENTITY
patients	ENTITY
in	
surgical	ENTITY
units	ENTITY
.	

Nurs	ENTITY
Forum	ENTITY
2012;47:183–92	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Fatal	ENTITY
Familial	ENTITY
Insomnia342	ENTITY
Sleep	ENTITY
Related	ENTITY
Epilepsy	ENTITY
345	ENTITY
Sleep	ENTITY
Related	ENTITY
Headaches350	ENTITY
Sleep	ENTITY
Related	ENTITY
Laryngospasm	ENTITY
355	ENTITY
Sleep	ENTITY
Related	ENTITY
Gastroesophageal	ENTITY
Reflux	ENTITY
358	ENTITY
Sleep	ENTITY
Related	ENTITY
Myocardial	ENTITY
Ischemia	ENTITY
363	ENTITY
The	
disorders	ENTITY
presented	
in	
this	
section	ENTITY
may	
have	
a	
unique	ENTITY
presentation	ENTITY
during	
the	
sleep	ENTITY
period	ENTITY
or	
may	
present	
exclusively	
in	
association	ENTITY
with	ENTITY
sleep	ENTITY
.	

Some	
of	
these	
disorders	ENTITY
(	
e.g.	
,	
sleep	ENTITY
related	
epilepsy	ENTITY
and	
sleep	ENTITY
related	ENTITY
headache	ENTITY
)	
may	
be	
encountered	
during	
evaluation	ENTITY
for	
other	
sleep	ENTITY
disorders	ENTITY
.	

In	
addition	
,	
some	
of	
these	
disorders	ENTITY
are	
in	
the	
dif-	
ferential	ENTITY
diagnosis	ENTITY
of	
other	
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
.	

Sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
must	
be	
con-	ENTITY
sidered	ENTITY
in	
the	
differential	ENTITY
diagnosis	ENTITY
of	
certain	
movement	ENTITY
disorders	ENTITY
and	
parasomnias	ENTITY
.	

Sleep	ENTITY
related	
headaches	ENTITY
may	
be	
a	
clue	
to	
the	
presence	ENTITY
of	
sleep	ENTITY
apnea	ENTITY
.	

Sleep	ENTITY
related	
gastroesophageal	ENTITY
reflux	ENTITY
may	
either	
be	
a	
precipitant	ENTITY
of	
a	
sleep	ENTITY
apnea	ENTITY
episode	ENTITY
or	
be	
trig-	
gered	ENTITY
by	
sleep	ENTITY
apnea	ENTITY
with	
aspiration	ENTITY
pneumonia	ENTITY
as	
its	
most	
serious	
consequence	ENTITY
.	

Sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
is	
an	
important	
consideration	
because	
myocardial	ENTITY
infarc-	
tion	ENTITY
has	
a	
predilection	ENTITY
for	
the	
early	ENTITY
morning	ENTITY
hours	
during	
the	
latter	
phase	ENTITY
of	
the	
sleep	ENTITY
period	ENTITY
and	
may	
be	
precipitated	
by	
episodes	ENTITY
of	
sleep	ENTITY
apnea	ENTITY
.	

It	
is	
important	
to	
be	
aware	
of	
sleep	ENTITY
related	
laryngospasm	ENTITY
as	
a	
potentially	
life	ENTITY
-	
threatening	ENTITY
consequence	ENTITY
of	
neurode-	
generative	ENTITY
diseases	ENTITY
such	
as	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
.	

Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
,	
although	
rare	ENTITY
,	
presents	
with	
severe	ENTITY
insomnia	ENTITY
and	
has	
a	
well	
-	
understood	ENTITY
neuropathology	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Fatal	ENTITY
Familial	ENTITY
Insomnia	ENTITY
Alternate	ENTITY
Names	ENTITY
Fatal	ENTITY
progressive	ENTITY
insomnia	ENTITY
with	
dysautonomia	ENTITY
,	
familial	ENTITY
thalamic	ENTITY
degeneration	ENTITY
of	
the	
anterior	ENTITY
and	
dorsomedial	ENTITY
thalamic	ENTITY
nuclei	ENTITY
,	
thalamic	ENTITY
insomnia	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
is	
a	
very	
rare	
,	
progressive	ENTITY
disorder	ENTITY
characterized	ENTITY
by	
initial	
dif-	
ficulties	ENTITY
in	
falling	ENTITY
asleep	ENTITY
and	
maintaining	
sleep	ENTITY
,	
spontaneous	ENTITY
lapses	ENTITY
from	
quiet	ENTITY
wake-	
fulness	ENTITY
into	
a	
sleep	ENTITY
state	ENTITY
with	
enacted	ENTITY
dreams	ENTITY
(	
oneiric	ENTITY
stupor	ENTITY
)	
,	
and	
loss	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
features	
.	

In	
later	
stages	ENTITY
of	
the	
disease	ENTITY
,	
it	
may	
not	
be	
possible	
to	
identify	
any	
dis-	
tinct	ENTITY
sleep	ENTITY
stages	ENTITY
.	

Although	
loss	ENTITY
of	
temporal	ENTITY
and	
spatial	ENTITY
orientation	
develops	ENTITY
,	
cognitive	ENTITY
function	ENTITY
is	
retained	
until	
impaired	ENTITY
alertness	ENTITY
makes	
testing	ENTITY
impossible	
.	

The	
disorder	ENTITY
progresses	
to	
unarousable	ENTITY
coma	ENTITY
,	
and	
finally	
,	
death	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Bronchopulmonary	
and	
other	
infections	ENTITY
may	
also	
be	
present	
.	

There	
is	
a	
loss	ENTITY
of	
the	
circadian	ENTITY
rhythmicity	ENTITY
of	
endocrine	ENTITY
rhythms	ENTITY
.	

Autonomic	ENTITY
hyperactivity	ENTITY
(	
e.g.	
,	
pyrexia	ENTITY
,	
salivation	ENTITY
,	
hyperhidrosis	ENTITY
,	
tachycardia	ENTITY
,	
tachypnea	ENTITY
,	
and	
dyspnea	ENTITY
)	
is	
present	
.	

The	
disor-	ENTITY
der	ENTITY
includes	
somatomotor	ENTITY
disturbances	
,	
with	
dysarthria	ENTITY
,	
dysphagia	ENTITY
,	
tremor	ENTITY
,	
sponta-	
neous	ENTITY
and	
reflex	ENTITY
myoclonus	ENTITY
,	
dystonic	ENTITY
posturing	ENTITY
,	
ataxia	ENTITY
,	
and	
a	
positive	ENTITY
Babinski	ENTITY
sign	ENTITY
.	

Hallucinations	ENTITY
may	
be	
present	
.	

Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
None	
.	

Demographics	ENTITY
Age	ENTITY
of	
onset	ENTITY
is	
usually	
in	ENTITY
adulthood	ENTITY
,	
between	
36	
and	
62	
years	ENTITY
of	
age	ENTITY
.	

The	
disorder	ENTITY
is	
rare	ENTITY
.	

There	
are	
no	
sex	
differences	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Not	
known	
or	
applicable	
.	

Familial	ENTITY
Patterns	ENTITY
Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
(	
FFI	ENTITY
)	
is	
transmitted	ENTITY
according	
to	
an	
autosomal	ENTITY
dominant	ENTITY
pattern	
.	

Patients	ENTITY
harbor	
a	
missense	ENTITY
GAC	ENTITY
to	
AAC	ENTITY
mutation	ENTITY
at	
codon	ENTITY
178	
of	
the	
prion	ENTITY
protein	ENTITY
gene	
PRNP	ENTITY
located	
on	
chromosome	ENTITY
20	ENTITY
,	
cosegregating	ENTITY
with	
the	
methionine	ENTITY
Appendix	ENTITY
A	ENTITY
:	ENTITY
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
polymorphism	ENTITY
at	
codon	ENTITY
129	
of	
the	
same	
gene	ENTITY
on	
the	
mutated	ENTITY
allele	ENTITY
(	ENTITY
D178N	ENTITY
129	ENTITY
M	ENTITY
)	
.	

The	
clinical	ENTITY
syndrome	ENTITY
varies	
by	
the	
M129V	ENTITY
genotype	ENTITY
.	

Patients	ENTITY
who	
are	
methionine	ENTITY
homozygous	ENTITY
at	
the	
129	
codon	ENTITY
are	
younger	ENTITY
and	
display	ENTITY
a	
shorter	ENTITY
disease	ENTITY
course	
than	
do	
patients	ENTITY
who	
are	
methionine	ENTITY
-	
valine	ENTITY
heterozygous	ENTITY
at	
codon	ENTITY
129	ENTITY
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY

The	
disorder	ENTITY
is	
always	
fatal	ENTITY
,	
usually	
within	
eight	
to	
72	
months	ENTITY
.	

The	
course	ENTITY
is	
one	
of	
relentless	
worsening	ENTITY
of	
symptoms	ENTITY
.	

Patients	ENTITY
may	
die	ENTITY
after	
a	
short	ENTITY
(	
less	
than	
12	
months	ENTITY
)	
or	
long	ENTITY
(	
12	
to	
72	
months	ENTITY
)	
disease	ENTITY
course	ENTITY
.	

The	
younger	ENTITY
age	ENTITY
at	
disease	ENTITY
onset	ENTITY
and	
,	
conse-	
quently	ENTITY
,	
a	
lower	
rate	ENTITY
of	
comorbidity	ENTITY
,	
may	
explain	
the	
generally	
more	
prolonged	ENTITY
disease	ENTITY
course	ENTITY
in	
FFI	ENTITY
in	
comparison	ENTITY
to	
other	
prion	ENTITY
diseases	ENTITY
.	

Complications	ENTITY
include	
infections	ENTITY
(	
in	
particular	
of	
the	
lungs	ENTITY
and	
bladder	ENTITY
)	
that	
develop	
during	
the	
course	ENTITY
of	
the	
disease	ENTITY
,	
especially	
in	
the	
late	ENTITY
stages	ENTITY
,	
and	
represent	
the	
usual	
cause	ENTITY
of	ENTITY
death	ENTITY
.	

Other	
frequent	ENTITY
com-	
plications	ENTITY
include	
skin	ENTITY
ulcers	ENTITY
when	
patients	ENTITY
become	
bedridden	ENTITY
and	
aspiration	ENTITY
of	
food	ENTITY
due	
to	
the	
severe	ENTITY
dysphagia	ENTITY
;	
the	
latter	
may	
require	
nasogastric	ENTITY
or	
gastrostomy	ENTITY
feeding	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
Severe	ENTITY
bilateral	ENTITY
loss	ENTITY
of	
neurons	ENTITY
,	
with	
reactive	ENTITY
gliosis	ENTITY
of	
the	
anterior	ENTITY
and	
dorsomedial	ENTITY
thalamic	ENTITY
nuclei	ENTITY
and	
severe	ENTITY
neuronal	ENTITY
loss	ENTITY
and	
reactive	ENTITY
astrogliosis	ENTITY
in	
the	
inferior	ENTITY
olives	ENTITY
,	
are	
found	
.	

Spongiform	ENTITY
changes	ENTITY
in	
cortical	ENTITY
layers	ENTITY
in	
cases	ENTITY
with	
a	
prolonged	ENTITY
course	ENTITY
have	
been	
described	
.	

Deposition	ENTITY
of	
proteinase	ENTITY
K	ENTITY
-	
resistant	ENTITY
prion	ENTITY
protein	ENTITY
type	ENTITY
2	ENTITY
in	
the	
grey	ENTITY
matter	ENTITY
but	
not	
the	
white	ENTITY
matter	ENTITY
occurs	ENTITY
in	
both	
familial	ENTITY
and	
sporadic	ENTITY
fatal	ENTITY
insomnia	ENTITY
.	

Both	
familial	ENTITY
and	
sporadic	ENTITY
fatal	ENTITY
insomnia	ENTITY
have	
been	
transmitted	ENTITY
to	
transgenic	ENTITY
animals	ENTITY
by	
intracerebral	ENTITY
inoculum	ENTITY
of	
brain	ENTITY
homogenates	ENTITY
.	

Objective	ENTITY
Findings	ENTITY

In	
early	ENTITY
stages	ENTITY
of	
FFI	ENTITY
,	
periods	ENTITY
of	
relaxed	ENTITY
wakefulness	ENTITY
alternate	
with	
episodes	ENTITY
of	
elec-	
troencephalographic	ENTITY
(	
EEG	
)	
desynchronization	ENTITY
,	
rapid	ENTITY
eye	ENTITY
movement	ENTITY
(	
REM	
)	
bursts	
,	
loss	ENTITY
of	
antigravity	ENTITY
muscle	ENTITY
tone	ENTITY
,	
and	
irregular	ENTITY
myoclonic	ENTITY
and	
tremor	ENTITY
-	
like	
limb	ENTITY
-	
muscle	ENTITY
activities	ENTITY
associated	ENTITY
with	ENTITY
vivid	ENTITY
dreams	ENTITY
(	
oneiric	ENTITY
stupor	ENTITY
)	
.	

Sleep	ENTITY
spindles	ENTITY
and	
features	ENTITY
of	
slow	ENTITY
wave	ENTITY
sleep	ENTITY
are	
absent	ENTITY
or	
progressively	
lost	ENTITY
throughout	
the	
course	ENTITY
of	
the	
illness	ENTITY
.	

In	
the	
final	
stages	ENTITY
of	
the	
disorder	ENTITY
,	
the	
EEG	ENTITY
becomes	
unreactive	ENTITY
and	
progressively	
flattens	
until	
death	ENTITY
occurs	ENTITY
;	
it	
may	
display	
periodic	
spike	ENTITY
discharges	ENTITY
.	

Positron	ENTITY
emission	ENTITY
tomography	ENTITY
(	
PET	ENTITY
)	
with	
(	
18F)-2	
-	
fluorodeoxy	ENTITY
-	
d	ENTITY
-	
glucose	ENTITY
shows	
tha-	
lamic	ENTITY
hypometabolism	ENTITY
.	

Magnetic	ENTITY
resonance	ENTITY
spectroscopy	ENTITY
with	
multisequences	ENTITY
can	
detect	ENTITY
prion	ENTITY
-	
induced	ENTITY
gliosis	ENTITY
in	ENTITY
vivo	ENTITY
.	

Circadian	ENTITY
rhythms	ENTITY
of	
body	ENTITY
temperature	ENTITY
,	
systemic	ENTITY
blood	ENTITY
pressure	ENTITY
,	
and	
heart	ENTITY
and	
respiratory	ENTITY
rate	ENTITY
and	
endocrine	ENTITY
rhythms	ENTITY
of	
growth	ENTITY
hormone	ENTITY
,	
prolactin	ENTITY
,	
luteinizing	ENTITY
hormone	ENTITY
,	
follicle	ENTITY
-	
stimulating	ENTITY
hormone	ENTITY
,	
and	
adrenocorticotropic	ENTITY
Appendix	ENTITY
A	ENTITY
:	ENTITY
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	ENTITY
Neurological	ENTITY
Disorders	ENTITY
hormone	ENTITY
may	
be	
lost	ENTITY
.	

Serum	ENTITY
catecholamine	ENTITY
and	
cortisol	ENTITY
values	ENTITY
are	
elevated	ENTITY
,	
with	
low	ENTITY
or	
undetectable	ENTITY
adrenocorticotropic	ENTITY
hormone	ENTITY
levels	ENTITY
.	

Pathologic	ENTITY
examination	ENTITY
demon-	
strates	ENTITY
degeneration	ENTITY
of	
the	
anterior	ENTITY
and	
dorsomedial	ENTITY
thalamic	ENTITY
nuclei	ENTITY
and	
atrophy	ENTITY
of	
the	
inferior	ENTITY
olivary	ENTITY
nucleus	ENTITY
.	

Deposition	ENTITY
of	
proteinase	ENTITY
K	ENTITY
-	
resistant	ENTITY
prion	ENTITY
protein	ENTITY
type	ENTITY
2	ENTITY
is	
found	
in	
the	
brain	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY

This	
disorder	ENTITY
must	
be	
differentiated	
from	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
)	
,	
which	
is	
not	
associated	ENTITY
with	ENTITY
autonomic	ENTITY
hyperactivity	ENTITY
or	
a	
familial	ENTITY
pattern	ENTITY
.	

The	
differential	ENTITY
diagnosis	ENTITY
includes	
dementia	ENTITY
,	
familial	ENTITY
Creutzfeldt	ENTITY
-	
Jakob	ENTITY
disease	ENTITY
with	
the	
178	
codon	ENTITY
mutation	ENTITY
in	
the	
PRNP	ENTITY
cosegregating	
with	
the	
valine	ENTITY
polymorphism	ENTITY
at	
codon	ENTITY
129	
on	
the	
mutated	ENTITY
allele	ENTITY
,	
Morvan	ENTITY
fibrillary	ENTITY
chorea	ENTITY
,	
delirium	ENTITY
tremens	ENTITY
,	
or	
even	
schizophrenia	ENTITY
.	

A	
sporadic	ENTITY
form	
of	
fatal	ENTITY
insomnia	ENTITY
has	
also	
been	
reported	
.	

Unresolved	
Issues	ENTITY
and	
Future	ENTITY
Directions	ENTITY
Not	
applicable	
or	
known	
.	

Bibliography	ENTITY
Cortelli	ENTITY
P	ENTITY
,	
Perani	ENTITY
D	ENTITY
,	
Parchi	ENTITY
P	ENTITY
,	
et	
al	
.	

Cerebral	ENTITY
metabolism	ENTITY
in	
fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
:	
relation	
to	
duration	ENTITY
,	
neuropathology	ENTITY
,	
and	
distribution	ENTITY
of	
protease	ENTITY
-	
resistant	ENTITY
prion	ENTITY
protein	ENTITY
.	

Neurology	ENTITY
1997;49:126–33	
.	

Goldfarb	ENTITY
L	ENTITY
,	
Petersen	ENTITY
R	ENTITY
,	
Tabaton	ENTITY
M	ENTITY
,	
et	
al	
.	

Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
and	
familial	ENTITY
Creutzfeldt	ENTITY
-	
Jakob	ENTITY
disease	ENTITY
:	
disease	ENTITY
phenotype	ENTITY
determined	
by	
a	
DNA	ENTITY
polymorphism	ENTITY
.	

Science	ENTITY
1992;258:806–8	
.	

Haik	ENTITY
S	ENTITY
,	
Galanaud	
D	
,	
Linguraru	ENTITY
MG	ENTITY
,	
et	
al	
.	

In	ENTITY
vivo	ENTITY
detection	ENTITY
of	
thalamic	ENTITY
gliosis	ENTITY
.	

A	
pathoradiologic	
demonstration	
in	
familial	ENTITY
fatal	ENTITY
insomnia	ENTITY
.	

Arch	ENTITY
Neurol	ENTITY
2008;65:545–9	ENTITY
.	

Krasnianski	ENTITY
A	ENTITY
,	
Bartl	ENTITY
M	ENTITY
,	
Sanchez	ENTITY
Juan	ENTITY
PJ	ENTITY
,	
et	
al	
.	

Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
:	
clinical	ENTITY
features	ENTITY
and	
early	ENTITY
identification	ENTITY
.	

Ann	
Neurol	
2008;63:658–61	
.	

Lugaresi	ENTITY
E	ENTITY
,	
Medori	ENTITY
R	ENTITY
,	
Montagna	
P	
,	
et	
al	
.	

Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
and	
dysautonomia	ENTITY
with	
selective	ENTITY
degeneration	ENTITY
of	
thalamic	ENTITY
nuclei	ENTITY
.	

N	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
1986;315:997–1003	ENTITY
.	

Monari	ENTITY
L	ENTITY
,	
Chen	ENTITY
S	ENTITY
,	
Brown	ENTITY
P	ENTITY
,	
et	
al	
.	

Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
and	
familial	ENTITY
Creutzfeldt	ENTITY
-	
Jakob	ENTITY
disease	ENTITY
:	
different	
prion	ENTITY
proteins	ENTITY
determined	
by	
a	
DNA	ENTITY
polymorphism	ENTITY
.	

Proc	ENTITY
Natl	ENTITY
Acad	ENTITY
Sci	ENTITY
U	ENTITY
S	ENTITY
A	ENTITY
1994;91:2839–42	ENTITY
.	

Montagna	
P	
,	
Cortelli	ENTITY
P	ENTITY
,	
Gambetti	
P	
,	
Lugaresi	
E.	
Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
:	
sleep	ENTITY
,	
neuroendocrine	ENTITY
and	
vegetative	ENTITY
alterations	ENTITY
.	

Adv	ENTITY
Neuroimmunol	
1995;5:13–21	
.	

Montagna	
P	
,	
Gambetti	
P	
,	
Cortelli	
P	
,	
Lugaresi	
E.	ENTITY
Familial	ENTITY
and	
sporadic	ENTITY
fatal	ENTITY
insomnia	ENTITY
.	

Lancet	ENTITY
Neurol	ENTITY
2003;2:167–76	ENTITY
.	

Sforza	ENTITY
E	ENTITY
,	
Montagna	
P	
,	
Tinuper	ENTITY
P	ENTITY
,	
et	
al	
.	

Sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
abnormalities	ENTITY
in	
fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
.	

Evidence	ENTITY
of	
the	
role	
of	
the	
thalamus	ENTITY
in	
sleep	ENTITY
regulation	ENTITY
.	

Electroencephalogr	ENTITY
Clin	
Neurophysiol	
1995;94:398–405	
.	

Telling	ENTITY
G	ENTITY
,	
Parchi	ENTITY
P	ENTITY
,	
DeArmond	ENTITY
S	ENTITY
,	
et	
al	
.	

Evidence	ENTITY
for	
the	
conformation	ENTITY
of	
the	
pathologic	ENTITY
isoform	ENTITY
of	
the	
prion	ENTITY
protein	ENTITY
enciphering	ENTITY
and	
propagating	
prion	ENTITY
diversity	ENTITY
.	

Science	ENTITY
1996;274:2079–82	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Epilepsy	ENTITY
Alternate	ENTITY
Names	ENTITY
Sleep	ENTITY
epilepsy	ENTITY
,	
nocturnal	ENTITY
seizure	ENTITY
,	
sleep	ENTITY
related	ENTITY
seizures	ENTITY
.	

Essential	ENTITY
Features	ENTITY
A	
seizure	ENTITY
is	
a	
paroxysmal	ENTITY
event	ENTITY
resulting	
from	
a	
sudden	ENTITY
excessive	ENTITY
discharge	ENTITY
of	
the	
neurons	ENTITY
of	
the	
cerebral	ENTITY
cortex	ENTITY
,	
whereas	
epilepsy	ENTITY
is	
a	
condition	ENTITY
of	
recurrent	ENTITY
unpro-	
voked	ENTITY
seizures	ENTITY
.	

Sleep	ENTITY
facilitates	
epileptic	ENTITY
activity	ENTITY
and	
seizures	ENTITY
.	

The	
characteristics	ENTITY
of	
specific	
subtypes	ENTITY
of	
sleep	ENTITY
related	
epilepsy	ENTITY
are	
discussed	
in	
the	
Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
section	ENTITY
below	
.	

Associated	ENTITY
Features	ENTITY
The	
different	
types	
of	
nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
(	
NFLE	ENTITY
)	
may	
cause	
severe	ENTITY
sleep	ENTITY
disruption	ENTITY
,	
affecting	ENTITY
both	
macrostructure	ENTITY
and	
microstructure	ENTITY
of	
sleep	ENTITY
,	
resulting	
in	
poor	ENTITY
sleep	ENTITY
quality	ENTITY
,	
daytime	ENTITY
fatigue	ENTITY
,	
and	
sleepiness	ENTITY
in	
some	
patients	ENTITY
.	

The	
movements	ENTITY
also	
may	
be	
so	
severe	ENTITY
that	
injuries	ENTITY
can	
occur	
.	

From	
one	
third	
to	
one	
half	
of	
patients	ENTITY
with	
sleep	ENTITY
related	
epilepsy	ENTITY
also	
have	
occasional	
attacks	ENTITY
during	
the	
day	ENTITY
,	
although	
these	
are	
not	
necessarily	
of	
the	
same	
type	ENTITY
as	
those	
occurring	ENTITY
at	
night	ENTITY
.	

Neurocognitive	ENTITY
impairment	ENTITY
is	
typically	
diagnosed	ENTITY
in	
almost	
all	
cases	ENTITY
of	
continuous	ENTITY
spike	ENTITY
waves	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
(	
CSWS	ENTITY
)	
.	

Motor	ENTITY
impairment	ENTITY
in	
the	
form	
of	
a	
unilat-	
eral	ENTITY
deficit	ENTITY
is	
sometimes	
seen	
as	
an	
associated	ENTITY
feature	ENTITY
of	
CSWS	ENTITY
.	

Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
Clinical	ENTITY
and	
EEG	ENTITY
criteria	ENTITY
are	
used	
to	
define	
a	
variety	
of	
sleep	ENTITY
related	
epilepsy	ENTITY
subtypes	ENTITY
.	

Several	
types	
of	
epileptic	ENTITY
syndromes	ENTITY
have	
a	
marked	
tendency	
to	
manifest	ENTITY
only	
or	
pre-	ENTITY
dominantly	
during	
sleep	ENTITY
,	
or	
after	
arousal	ENTITY
from	
sleep	ENTITY
.	

These	
include	
NFLE	ENTITY
,	
benign	ENTITY
epilepsy	ENTITY
of	
childhood	ENTITY
with	
centrotemporal	ENTITY
spikes	ENTITY
(	
BECT	ENTITY
)	
,	
benign	ENTITY
epilepsy	ENTITY
with	
occip-	
ital	ENTITY
paroxysms	ENTITY
(	
BEOP	ENTITY
)	
,	
early	ENTITY
-	
onset	ENTITY
or	
late	ENTITY
-	
onset	ENTITY
childhood	ENTITY
occipital	ENTITY
epilepsy	ENTITY
,	
juvenile	ENTITY
myoclonic	ENTITY
epilepsy	ENTITY
(	
JME	ENTITY
)	
,	
generalized	
tonic	ENTITY
-	
clonic	ENTITY
seizures	ENTITY
on	
awakening	ENTITY
,	
certain	
forms	
of	
temporal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
,	
tonic	ENTITY
seizure	ENTITY
(	
as	
a	
component	
of	
Lennox	ENTITY
-	
Gastaut	ENTITY
syndrome	ENTITY
)	
,	
Landau	ENTITY
-	
Kleffner	ENTITY
syndrome	ENTITY
,	
and	
continuous	
spike	ENTITY
waves	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
(	
CSWS	ENTITY
)	
.	

NFLE	ENTITY
may	
present	
in	
three	
distinct	
ways	
:	
(	
1	
)	
nocturnal	ENTITY
paroxysmal	ENTITY
arousal	ENTITY
,	
(	
2	
)	
noc-	
turnal	ENTITY
paroxysmal	ENTITY
dystonia	ENTITY
,	
or	
(	
3	
)	
episodic	ENTITY
nocturnal	ENTITY
wanderings	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
BECT	ENTITY
can	
present	
with	
focal	ENTITY
clonic	ENTITY
facial	ENTITY
twitching	ENTITY
that	
is	
often	
preceded	
by	
perioral	ENTITY
numbness	ENTITY
.	

These	
seizures	ENTITY
are	
more	
often	
seen	
in	
drowsiness	ENTITY
and	
sleep	ENTITY
than	
wakeful-	
ness	ENTITY
.	

The	
clinical	ENTITY
course	ENTITY
is	
often	
benign	ENTITY
with	
disappearance	ENTITY
of	
the	
seizures	ENTITY
in	ENTITY
adulthood	ENTITY
.	

BEOP	ENTITY
is	
characterized	
by	
focal	ENTITY
seizures	ENTITY
marked	
by	
deviation	ENTITY
of	
the	
eyes	ENTITY
and	
vom-	
iting	ENTITY
.	

Sleep	ENTITY
is	
the	
main	
precipitating	
factor	
,	
with	
most	
of	
the	
seizures	ENTITY
occurring	
soon	
after	
sleep	ENTITY
onset	ENTITY
or	
in	
the	
early	ENTITY
hours	ENTITY
of	
the	
morning	ENTITY
.	

There	
is	
frequent	ENTITY
evolution	ENTITY
to	
secondary	ENTITY
generalized	ENTITY
attacks	ENTITY
.	

The	
clinical	ENTITY
evolution	ENTITY
of	
the	
early	ENTITY
-	
onset	ENTITY
type	ENTITY
is	
benign	ENTITY
,	
whereas	
in	
the	
late	ENTITY
-	
onset	ENTITY
type	
with	
visual	ENTITY
seizures	ENTITY
,	
the	
prognosis	ENTITY
is	
uncertain	
.	

JME	ENTITY
is	
characterized	
by	
massive	ENTITY
bilaterally	ENTITY
synchronous	ENTITY
myoclonic	ENTITY
jerks	ENTITY
,	
which	
are	
most	
frequently	
noted	
on	
awakening	ENTITY
.	

CSWS	ENTITY
(	
formerly	
known	
as	
electrical	ENTITY
status	ENTITY
epilepticus	ENTITY
of	ENTITY
sleep	ENTITY
[	
ESES	ENTITY
]	
)	
is	
charac-	
terized	
by	
continuous	ENTITY
and	
diffuse	ENTITY
slow	ENTITY
spike	
-	
and	
-	
wave	ENTITY
complexes	ENTITY
persisting	
through	
NREM	ENTITY
sleep	ENTITY
(	
at	
least	
85	
%	
of	
the	
duration	ENTITY
)	
,	
as	
well	
as	
neuropsychological	ENTITY
and	
motor	ENTITY
impairment	ENTITY
.	

Despite	
the	
continuous	ENTITY
presence	ENTITY
of	
epileptic	ENTITY
spike	ENTITY
-	
wave	ENTITY
activity	ENTITY
on	
EEG	ENTITY
in	
sleep	ENTITY
,	
there	
may	
be	
no	
associated	
visible	ENTITY
sleep	ENTITY
related	
movement	ENTITY
.	

However	
,	
clinical	ENTITY
epileptic	ENTITY
seizures	ENTITY
are	
sometimes	
seen	
in	
the	
daytime	ENTITY
.	

Demographics	ENTITY
There	
is	
no	ENTITY
significant	ENTITY
sex	ENTITY
predominance	ENTITY
.	

Predisposing	ENTITY
and	
Participating	ENTITY
Factors	ENTITY
Stress	ENTITY
,	
sleep	ENTITY
deprivation	ENTITY
,	
irregularities	ENTITY
of	
the	
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
,	
other	
sleep	ENTITY
patholo-	ENTITY
gies	ENTITY
,	
and	
the	
use	
of	
stimulant	ENTITY
drugs	ENTITY
or	
other	
drugs	ENTITY
that	
modify	ENTITY
sleep	ENTITY
architecture	ENTITY
may	
predispose	
an	
individual	ENTITY
to	
having	
seizures	ENTITY
.	

Perinatal	ENTITY
or	
prenatal	ENTITY
problems	ENTITY
,	
congenital	ENTITY
hemiparesis	ENTITY
,	
and	
prior	
encephalopathy	ENTITY
may	
be	
considered	
antecedents	ENTITY
of	
the	
syndrome	ENTITY
of	
CSWS	ENTITY
.	

OSA	ENTITY
may	
exacerbate	ENTITY
sleep	ENTITY
related	
seizures	ENTITY
and	
complicate	ENTITY
their	
treatment	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY

The	
idiopathic	ENTITY
generalized	ENTITY
epilepsies	ENTITY
form	
the	
largest	
category	
of	
epilepsies	ENTITY
that	
appear	
to	
be	
heritable	ENTITY
but	
show	
no	
clear	
mendelian	ENTITY
mode	ENTITY
of	
transmission	ENTITY
.	

Juvenile	ENTITY
myoclonic	ENTITY
epilepsy	ENTITY
and	
idiopathic	ENTITY
generalized	ENTITY
epilepsy	ENTITY
with	
adolescent	ENTITY
onset	ENTITY
appear	
to	
be	
genet-	
ically	ENTITY
heterogeneous	ENTITY
.	

Among	
the	
partial	ENTITY
epilepsies	
,	
BECT	ENTITY
shows	
a	
familial	ENTITY
pattern	ENTITY
.	

A	
form	
of	
autosomal	ENTITY
dominant	ENTITY
NFLE	ENTITY
with	
70	
%	
to	
80	
%	
penetrance	ENTITY
has	
been	
reported	
in	
many	
countries	ENTITY
,	
and	
a	
genetic	ENTITY
heterogeneity	ENTITY
also	
has	
been	
reported	
.	

Genetic	ENTITY
factors	ENTITY
have	
not	
been	
established	
in	
CSWS	ENTITY
and	
seem	
to	
play	
a	
minor	
role	
.	

Familial	ENTITY
anteced-	
ents	
of	
epilepsy	ENTITY
(	
including	
febrile	ENTITY
convulsions	ENTITY
)	
have	
been	
found	
in	
15	
%	
of	
cases	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Idiopathic	ENTITY
generalized	ENTITY
epilepsies	ENTITY
and	
partial	ENTITY
epilepsy	ENTITY
may	
start	
at	
any	
age	ENTITY
.	

The	
onset	
of	
benign	ENTITY
epilepsies	ENTITY
of	
childhood	ENTITY
with	
centrotemporal	ENTITY
or	
occipital	ENTITY
spikes	ENTITY
is	
between	
4	
and	
12	
years	ENTITY
of	
age	ENTITY
.	

The	
onset	
of	
NFLE	ENTITY
is	
generally	
from	
age	ENTITY
10	
to	
16	
years	ENTITY
,	
mostly	
before	
the	
age	ENTITY
of	
20	
years	ENTITY
.	

The	
average	
age	ENTITY
of	
recognition	ENTITY
of	
CSWS	ENTITY
is	
between	
4	
and	
14	
years	ENTITY
,	
but	
the	
appearance	ENTITY
of	
the	
first	
seizure	ENTITY
is	
early	ENTITY
,	
typically	
between	
two	
months	ENTITY
and	
12	
years	ENTITY
of	
age	ENTITY
.	

Most	
patients	ENTITY
with	
recurrent	ENTITY
sleep	ENTITY
related	ENTITY
epilepsy	ENTITY
continue	
to	
have	
seizures	ENTITY
restricted	
to	
sleep	ENTITY
.	

In	
some	
cases	ENTITY
,	
they	
may	
have	
seizures	ENTITY
during	
both	
sleep	ENTITY
and	
wakefulness	ENTITY
.	

For	
focal	ENTITY
epilepsies	ENTITY
(	
excluding	
BECT	ENTITY
and	
the	
early	ENTITY
-	
onset	ENTITY
type	ENTITY
of	
BEOP	ENTITY
)	
,	
the	
prognosis	ENTITY
is	
less	
favorable	
compared	
to	
generalized	ENTITY
epilepsies	ENTITY
.	

At	
least	
35	
%	
of	
the	
focal	ENTITY
seizures	ENTITY
confined	
to	
sleep	ENTITY
are	
resistant	ENTITY
to	
antiepileptic	ENTITY
drugs	ENTITY
.	

Definitive	ENTITY
data	ENTITY
on	
the	
natural	ENTITY
history	ENTITY
of	
NFLE	ENTITY
are	
not	
available	
,	
although	
a	
high	
prev-	
alence	
of	
parasomnias	ENTITY
has	
been	
documented	ENTITY
in	
NFLE	ENTITY
patients	ENTITY
.	

CSWS	ENTITY
resolves	
in	
many	
cases	ENTITY
within	
three	
years	ENTITY
after	
onset	ENTITY
,	
and	
in	
almost	
all	
cases	ENTITY
by	
the	
mid	ENTITY
-	
teen	ENTITY
years	ENTITY
.	

Despite	
normalization	ENTITY
of	
the	
EEG	ENTITY
and	
elimination	ENTITY
of	
seizures	ENTITY
,	
neuropsychological	ENTITY
impairment	ENTITY
may	
persist	
.	

Interictal	ENTITY
paroxysmal	ENTITY
activity	ENTITY
may	
induce	ENTITY
prolonged	ENTITY
cognitive	ENTITY
and	
motor	ENTITY
impairment	ENTITY
.	

Hyperkinesias	ENTITY
,	
aggressiveness	ENTITY
,	
and	
psy-	
chotic	ENTITY
states	ENTITY
may	
appear	
.	

OSA	ENTITY
may	
exacerbate	ENTITY
sleep	ENTITY
related	
seizures	ENTITY
and	
complicate	ENTITY
their	
treatment	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
In	
idiopathic	ENTITY
generalized	ENTITY
epilepsy	ENTITY
,	
genetic	ENTITY
factors	ENTITY
are	
contributory	ENTITY
.	

Pathogenic	ENTITY
markers	ENTITY
,	
associated	
neurologic	ENTITY
deficits	ENTITY
,	
or	
characteristic	
brain	ENTITY
imaging	ENTITY
findings	ENTITY
have	
not	
been	
identified	ENTITY
.	

However	
,	
microdysgenesis	ENTITY
has	
been	
described	
in	
some	
forms	
of	
idiopathic	ENTITY
generalized	ENTITY
epilepsy	ENTITY
.	

EEG	ENTITY
recordings	ENTITY
with	
sphenoidal	ENTITY
or	
zygomatic	ENTITY
leads	
may	
show	
epileptic	ENTITY
activity	ENTITY
over	
the	
mesiotemporal	ENTITY
regions	ENTITY
in	
partial	ENTITY
complex	
seizures	ENTITY
.	

Video	ENTITY
-	
polysomnographic	ENTITY
(	
vPSG	ENTITY
)	
analysis	ENTITY
confirms	
that	
the	
motor	ENTITY
pattern	ENTITY
of	
NFLE	ENTITY
resembles	
that	
noted	
in	
orbital	ENTITY
and	
mesial	ENTITY
frontal	ENTITY
seizures	ENTITY
.	

Nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
sei-	

zures	ENTITY
involve	
a	
large	
neuronal	ENTITY
network	
,	
and	
some	
of	
their	
clinical	ENTITY
expressions	ENTITY
are	
pos-	
sible	ENTITY
consequences	ENTITY
of	
disinhibition	ENTITY
of	
innate	ENTITY
motor	ENTITY
patterns	ENTITY
produced	
by	
the	
central	ENTITY
pattern	ENTITY
generator	ENTITY
.	

Recent	
reports	
derived	
from	
stereo	ENTITY
-	
EEG	ENTITY
studies	ENTITY
seem	
to	
show	
that	
in	
some	
cases	ENTITY
,	
the	
seizures	ENTITY
(	
in	
particular	
nocturnal	ENTITY
wanderings	ENTITY
)	
may	
arise	
from	
temporal	ENTITY
or	
insular	ENTITY
regions	ENTITY
(	
rather	
than	
frontal	ENTITY
regions	ENTITY
)	
with	
a	
secondary	ENTITY
spread	ENTITY
to	
the	
cingulate	ENTITY
regions	ENTITY
.	

They	
may	
sometimes	
mimic	ENTITY
parasomnias	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Secondary	ENTITY
bilateral	ENTITY
synchrony	ENTITY
is	
the	
mechanism	ENTITY
generating	
CSWS	ENTITY
.	

This	
hypothesis	ENTITY
is	
supported	
by	
EEG	ENTITY
,	
intracranial	ENTITY
recordings	ENTITY
,	
EEG	ENTITY
with	
coherence	ENTITY
computer	ENTITY
-	
assisted	ENTITY
analysis	ENTITY
,	
and	
metabolic	ENTITY
(	
positron	ENTITY
emission	ENTITY
tomography	ENTITY

[	
PET	ENTITY
]	
and	
single	ENTITY
-	
photon	ENTITY
emis-	
sion	ENTITY
computed	ENTITY
tomography	ENTITY
[	
SPECT	ENTITY
]	
)	
studies	ENTITY
.	

CSWS	ENTITY
associated	ENTITY
with	ENTITY
Landau	ENTITY
-	
Kleffner	ENTITY
syndrome	ENTITY
(	
an	
acquired	
epileptic	ENTITY
aphasia	ENTITY
)	
is	
probably	
secondary	
to	
an	
alteration	ENTITY
of	
function	ENTITY
over	
the	
temporal	ENTITY
area	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Patients	ENTITY
with	
suspected	ENTITY
sleep	
related	
epilepsy	ENTITY
often	
need	
to	
be	
evaluated	ENTITY
in	
the	
sleep	ENTITY
laboratory	ENTITY
with	
video	ENTITY
and	
full	ENTITY
-	
head	ENTITY
EEG	ENTITY
monitoring	ENTITY
in	
order	
to	
obtain	
the	
correct	
diagnosis	ENTITY
.	

The	
characteristic	
interictal	ENTITY
epileptiform	
activity	
in	
idiopathic	ENTITY
general-	
ized	
epilepsies	
usually	
increases	ENTITY
during	
NREM	ENTITY
sleep	ENTITY
,	
whereas	
it	
decreases	ENTITY
during	
REM	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
.	

Interictal	ENTITY
epileptiform	ENTITY
activity	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
phasic	ENTITY
arousals	ENTITY
.	

In	
partial	ENTITY
epilepsies	ENTITY
,	
the	
interictal	ENTITY
epileptiform	ENTITY
activity	ENTITY
occurs	
in	
a	
localized	ENTITY
distribu-	
tion	ENTITY
with	
an	
increase	ENTITY
in	
spike	ENTITY
frequency	ENTITY
in	
stages	ENTITY
N2	ENTITY
and	
N3	
compared	
to	
REM	ENTITY
sleep	ENTITY
.	

Most	
of	
the	
seizures	ENTITY
are	
activated	ENTITY
in	
stage	ENTITY
N2	ENTITY
sleep	
.	

Monitoring	ENTITY
may	
also	
detect	ENTITY
tran-	
sient	ENTITY
autonomic	ENTITY
alterations	ENTITY
in	
cardiac	ENTITY
rhythm	ENTITY
,	
blood	ENTITY
pressure	ENTITY
,	
and	
respiration	ENTITY
during	
seizures	ENTITY
.	

If	
epilepsy	ENTITY
is	
suspected	ENTITY
,	
a	
standard	ENTITY
daytime	ENTITY
16	
-	
channel	ENTITY
to	
20	
-	
channel	ENTITY
EEG	ENTITY
(	
with	
partial	ENTITY
or	
total	ENTITY
sleep	ENTITY
deprivation	ENTITY
the	
night	ENTITY
before	
,	
as	
indicated	
)	
should	
be	
per-	
formed	
.	

Ambulatory	ENTITY
24	
-	
hour	ENTITY
EEG	ENTITY
recordings	ENTITY
may	
be	
useful	
to	
detect	ENTITY
distribution	ENTITY
of	
interictal	ENTITY
epileptiform	ENTITY
activity	ENTITY
during	
the	
sleep	ENTITY
-	
wake	ENTITY
cycle	ENTITY
.	

Nocturnal	ENTITY
vPSG	ENTITY
is	
the	
gold	ENTITY
standard	ENTITY
test	ENTITY
for	
NFLE	ENTITY
.	

Most	
of	
the	
seizures	ENTITY
appear	
during	
NREM	ENTITY
sleep	ENTITY
,	
with	
preponderance	
in	
NREM	ENTITY
stages	ENTITY
N1	ENTITY
and	
N2	
(	
greater	
than	
60	
%	
)	
.	

Rarely	ENTITY
do	
they	
emerge	
from	
REM	ENTITY
sleep	ENTITY
.	

In	
some	
cases	ENTITY
,	
particularly	
in	
paroxysmal	ENTITY
arousals	ENTITY
,	
the	
motor	ENTITY
attacks	ENTITY
may	
show	
a	
periodicity	ENTITY
(	
every	
20	
seconds	
to	
two	
minutes	ENTITY
)	
.	

Due	
to	
the	
fact	
that	
the	
discharges	ENTITY
originate	
deep	ENTITY
in	
the	
frontal	ENTITY
lobe	ENTITY
and	
are	
not	
visible	
using	
scalp	ENTITY
EEG	ENTITY
,	
the	
EEG	ENTITY
during	
the	
attacks	ENTITY
is	
uninformative	ENTITY
in	
almost	
half	
of	
the	
cases	ENTITY
.	

In	
a	
few	
cases	ENTITY
,	
recording	ENTITY
using	
intracranial	ENTITY
or	
depth	ENTITY
electrodes	ENTITY
confirms	
the	
paroxysms	ENTITY
during	
or	
preceding	
the	
motor	ENTITY
components	ENTITY
.	

The	
interictal	ENTITY
sleep	ENTITY
EEG	ENTITY
is	
generally	
normal	
,	
but	
in	
30	
%	
to	
40	
%	
of	
subjects	ENTITY
,	
focal	ENTITY
epileptic	ENTITY
abnormalities	ENTITY
are	
seen	
,	
predominantly	
in	
the	
anterior	ENTITY
regions	ENTITY
.	

The	
video	ENTITY
recording	ENTITY
of	
the	
different	
types	
of	
attacks	ENTITY
in	
NFLE	ENTITY
permits	
categorization	ENTITY
of	
the	
seizures	ENTITY
and	
characterization	ENTITY
of	
the	
main	
features	ENTITY
.	

During	
CSWS	ENTITY
,	
diffuse	
spike	ENTITY
waves	ENTITY
at	
two	
to	
2.5	
Hz	
occur	
in	
bursts	ENTITY
,	
with	
or	
without	
clinical	ENTITY
manifestations	ENTITY
.	

The	
discharges	ENTITY
are	
continuous	ENTITY
and	
occupy	
from	
85	
%	
to	
100	
%	
Appendix	
A	
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
of	
NREM	ENTITY
sleep	ENTITY
stages	ENTITY
.	

Abnormalities	ENTITY
arise	
as	
soon	
as	
the	
patients	ENTITY
fall	ENTITY
asleep	ENTITY
and	
dis-	
appear	
abruptly	
on	
awakening	ENTITY
.	

REM	ENTITY
sleep	ENTITY
is	
typically	
preserved	
,	
and	
the	
frequency	ENTITY
of	
spike	ENTITY
-	
wave	ENTITY
discharges	ENTITY
significantly	
decreases	ENTITY
but	
the	
frontal	ENTITY
predominance	ENTITY
of	
the	
infrequent	ENTITY
bursts	ENTITY
may	
become	
more	
prominent	ENTITY
.	

In	
general	
,	
EEG	ENTITY
patterns	ENTITY
during	
REM	ENTITY
sleep	ENTITY
are	
similar	
to	
those	
in	
the	
awake	ENTITY
records	ENTITY
.	

The	
sleep	ENTITY
structure	ENTITY
is	
normal	ENTITY
,	
but	
the	
presence	ENTITY
of	
almost	
continuous	ENTITY
spike	ENTITY
-	
wave	ENTITY
discharges	ENTITY
makes	
the	
recognition	ENTITY
of	
normal	ENTITY
NREM	ENTITY
sleep	ENTITY
EEG	ENTITY
elements	ENTITY
(	
such	
as	
K	ENTITY
complexes	ENTITY
,	
spindles	ENTITY
,	
or	
vertex	ENTITY
sharp	ENTITY
transients	ENTITY
)	
difficult	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
NFLE	ENTITY
may	
be	
mistaken	
for	
a	
disorder	ENTITY
of	
arousal	ENTITY
from	
NREM	ENTITY
such	
as	
sleepwalking	ENTITY
,	
confusional	ENTITY
arousal	ENTITY
,	
or	
sleep	ENTITY
terror	ENTITY
.	

Ictal	ENTITY
and	
interictal	ENTITY
EEGs	ENTITY
are	
often	
normal	
because	
the	
focus	
for	
the	
epileptic	ENTITY
discharge	ENTITY
may	
be	
deep	ENTITY
in	
the	
brain	ENTITY
.	

Disorders	ENTITY
of	
arousal	ENTITY
show	
a	
different	
pattern	ENTITY
of	
episodes	ENTITY
in	
that	
they	
occur	
out	
of	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
,	
are	
not	
ste-	
reotyped	ENTITY
,	
often	
have	
a	
sustained	ENTITY
autonomic	ENTITY
component	ENTITY
,	
and	
are	
frequently	
seen	
during	
the	
first	
part	
of	
the	
night	ENTITY
.	

Partial	ENTITY
arousal	ENTITY
disorders	ENTITY
tend	
to	
disappear	
or	
decrease	ENTITY
in	
fre-	
quency	ENTITY
after	
adolescence	ENTITY
.	

VPSG	ENTITY
is	
often	
useful	
.	

Sleep	ENTITY
talking	ENTITY
,	
bruxism	ENTITY
,	
and	
rhythmic	ENTITY
movement	ENTITY
disorders	ENTITY
can	
be	
differentiated	
from	
nocturnal	ENTITY
seizures	ENTITY
by	
history	ENTITY
and	
vPSG	ENTITY
recordings	ENTITY
.	

Benign	ENTITY
neonatal	ENTITY
sleep	ENTITY
myoclonus	ENTITY
may	
be	
confused	
with	
clonic	ENTITY
or	
myoc-	
lonic	ENTITY
seizures	ENTITY
during	
sleep	ENTITY
.	

In	
the	
elderly	ENTITY
(	
older	
than	
60	
years	ENTITY
)	
,	
the	
main	
differentiation	ENTITY
from	
RBD	ENTITY
is	
by	
vPSG	ENTITY
recording	ENTITY
.	

PLMD	ENTITY
,	
sleep	ENTITY
starts	ENTITY
,	
and	
propriospinal	ENTITY
myoclonus	ENTITY
at	
sleep	ENTITY
onset	ENTITY
do	
not	
show	
EEG	ENTITY
epileptiform	ENTITY
activity	ENTITY
and	
belong	
in	
the	
category	
of	
move-	
ment	ENTITY
disorders	ENTITY
during	
sleep	ENTITY
.	

Jerks	ENTITY
,	
dyskinesias	ENTITY
,	
or	
arousal	ENTITY
on	
resumption	ENTITY
of	
breathing	ENTITY
in	
patients	ENTITY
with	
OSA	ENTITY
also	
enter	
into	
the	
differential	ENTITY
diagnosis	ENTITY
of	
sleep	ENTITY
related	
epilepsy	ENTITY
.	

Rare	ENTITY
cases	ENTITY
of	
anoxic	ENTITY
syncope	ENTITY
with	
some	
clonic	ENTITY
jerks	ENTITY
at	
the	
end	
of	
a	
prolonged	ENTITY
(	
longer	
than	
two	
minutes	
)	
obstructive	ENTITY
event	ENTITY
have	
been	
described	
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Not	
applicable	
or	
known	
.	

Bilbliography	ENTITY
Bazil	ENTITY
C	ENTITY
,	
Malow	ENTITY
B	ENTITY
,	
Sammaritano	ENTITY
M.	
Sleep	
and	
epilepsy	ENTITY
:	
the	
clinical	ENTITY
spectrum	ENTITY
.	

Amsterdam	ENTITY
:	
Elsevier	ENTITY
Science	ENTITY
;	
2002	
.	

Dinner	ENTITY
D	ENTITY
,	
Luders	
H.	
Relationship	
of	
epilepsy	ENTITY
and	
sleep	ENTITY
:	
an	
overview	ENTITY
.	

In	
:	
Dinner	ENTITY
D	ENTITY
,	
Luders	ENTITY
H	ENTITY
,	ENTITY
eds	ENTITY
.	

Epilepsy	ENTITY
and	
sleep	ENTITY
:	
physiological	ENTITY
and	
clinical	ENTITY
relationships	ENTITY
.	

San	ENTITY
Diego	ENTITY
:	
Academic	ENTITY
Press	ENTITY
,	
2001:2–18	
.	

Malow	ENTITY
B.	ENTITY
Paroxysmal	ENTITY
events	ENTITY
in	
sleep	ENTITY
.	

J	
Clin	
Neurophysiol	
2002;19:522–34	
.	

Nobili	ENTITY
L	ENTITY
,	
Cossu	ENTITY
M	ENTITY
,	
Mai	ENTITY
R.	ENTITY
Sleep	ENTITY
-	
related	ENTITY
hyperkinetic	ENTITY
seizures	ENTITY
of	
temporal	ENTITY
lobe	ENTITY
origin	ENTITY
.	

Neurology	ENTITY
2004;62:482–5	
.	

Oldani	ENTITY
A	ENTITY
,	
Zucconi	ENTITY
M	ENTITY
,	
Ferini	ENTITY
-	
Strambi	ENTITY
L	ENTITY
,	ENTITY
Bizzozero	ENTITY
D	ENTITY
,	
Smirne	ENTITY
S.	ENTITY
Autosomal	ENTITY
dominant	
nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
:	
electroclinical	ENTITY
picture	ENTITY
.	

Epilepsia	ENTITY
1996;37:964–76	
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	
Disorders	
Provini	ENTITY
F	ENTITY
,	
Plazzi	ENTITY
G	ENTITY
,	
Tinuper	ENTITY
P	ENTITY
,	
Vandi	ENTITY
S	ENTITY
,	
Lugaresi	ENTITY
E	ENTITY
,	
Montagna	
P.	
Nocturnal	
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
.	

A	
clinical	ENTITY
and	
polygraphic	ENTITY
overview	ENTITY
of	
100	
consecutive	ENTITY
cases	ENTITY
.	

Brain	ENTITY
1999;122:1017–31	
.	

Scheffer	ENTITY
I	ENTITY
,	
Bhatia	ENTITY
K	ENTITY
,	
Lopes	ENTITY
-	
Cendes	ENTITY
I	ENTITY
,	
et	
al	
.	

Autosomal	ENTITY
dominant	ENTITY
nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
.	

A	
distinctive	
clinical	ENTITY
disorder	ENTITY
.	

Brain	ENTITY
1995;118:61–73	
.	

Shouse	ENTITY
M	ENTITY
,	
Martins	ENTITY
da	ENTITY
Silva	ENTITY
A	ENTITY
,	
Sammaritano	ENTITY
M.	
Circadian	ENTITY
rhythm	ENTITY
,	
sleep	ENTITY
,	
and	
epilepsy	ENTITY
.	

J	
Clin	
Neurophysiol	
1996;13:32–50	
.	

Tassinari	ENTITY
C	ENTITY
,	
Dravet	ENTITY
C	ENTITY
,	
Roger	
J.	
CSWS	ENTITY
:	

Encephalography	ENTITY
related	
to	
electrical	ENTITY
status	ENTITY
epilepticus	ENTITY
during	
slow	ENTITY
sleep	ENTITY
.	

Electroencephalogr	ENTITY
Clin	ENTITY
Neurophysiol	ENTITY
1977;43:529–30	ENTITY
.	

Tinuper	ENTITY
P	ENTITY
,	
Provini	ENTITY
F	ENTITY
,	
Bisulli	ENTITY
F	ENTITY
,	
et	
al	
.	

Movements	ENTITY
disorders	ENTITY
in	
sleep	ENTITY
:	
guideline	ENTITY
for	
differentiating	ENTITY
epileptic	ENTITY
from	
non	ENTITY
-	
epileptic	ENTITY
motor	ENTITY
phenomena	ENTITY
arising	
from	
sleep	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Rev	ENTITY
2007;11:255–67	ENTITY
.	

Zucconi	ENTITY
M.	ENTITY
Sleep	ENTITY
-	
related	ENTITY
epilepsy	ENTITY
.	

Handb	ENTITY
Clin	ENTITY
Neurol	ENTITY
2011;99:1109–37	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Headaches	ENTITY
Alternate	ENTITY
Names	ENTITY
Various	
(	
see	
Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
)	
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
headaches	ENTITY
are	
a	
group	ENTITY
of	
unilateral	ENTITY
or	
bilateral	ENTITY
cephalalgias	ENTITY
of	
varying	
severity	ENTITY
and	
duration	ENTITY
that	
occur	
during	
sleep	ENTITY
or	
upon	
awakening	ENTITY
from	
sleep	ENTITY
.	

It	
is	
a	
heterogenous	ENTITY
group	ENTITY
of	
different	
headache	ENTITY
entities	ENTITY
with	
the	
common	
feature	
of	
occur-	
rence	ENTITY
during	
sleep	ENTITY
or	
upon	
awakening	ENTITY
.	

The	
characteristics	ENTITY
of	
specific	
subtypes	ENTITY
of	
sleep	ENTITY
related	
headache	ENTITY
are	
discussed	
in	
the	
Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
section	ENTITY
below	
.	

Associated	ENTITY
Features	ENTITY
Individual	
features	ENTITY
associated	ENTITY
with	ENTITY
specific	
sleep	
related	
headache	ENTITY
types	
are	
discussed	
in	
the	
following	
section	ENTITY
.	

Clinical	ENTITY
and	
Pathologic	ENTITY
Subtypes	ENTITY
Most	
sleep	ENTITY
related	
headaches	ENTITY
are	
daytime	ENTITY
headache	ENTITY
conditions	ENTITY
that	
also	
may	
occur	
during	
sleep	ENTITY
.	

These	
include	
the	
primary	ENTITY
headaches	ENTITY
such	
as	
migraine	ENTITY
,	
cluster	ENTITY
head-	ENTITY
ache	ENTITY
,	
and	
chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
.	

There	
are	
other	
primary	ENTITY
headaches	ENTITY
that	
occur	
solely	
with	
sleep	ENTITY
;	
for	
example	
,	
hypnic	ENTITY
headaches	ENTITY
.	

In	
addition	
,	
secondary	ENTITY
head-	ENTITY
aches	ENTITY
related	
to	
medical	ENTITY
,	
neurological	ENTITY
,	
psychiatric	ENTITY
,	
and	
sleep	ENTITY
disorders	ENTITY
can	
cause	
sleep	ENTITY
related	
headaches	ENTITY
.	

Migraines	ENTITY
are	
common	
recurrent	ENTITY
headaches	ENTITY
of	
moderate	ENTITY
to	
severe	ENTITY
intensity	ENTITY
that	
last	
between	
four	
and	
72	
hours	ENTITY
.	

Pain	ENTITY
is	
typically	
unilateral	ENTITY
and	
pulsating	ENTITY
,	
aggra-	
vated	
by	
routine	ENTITY
physical	ENTITY
activity	ENTITY
and	
associated	ENTITY
with	ENTITY
nausea	ENTITY
,	
and/or	
photophobia	ENTITY
Appendix	
A	
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
or	
phonophobia	ENTITY
.	

They	
occur	
during	
the	
day	ENTITY
or	
during	
sleep	ENTITY
;	
approximately	
50	
%	
of	
migraine	ENTITY
attacks	ENTITY
occur	
between	
4:00	
a.m.	
and	
9:00	
a.m.	

Migraine	ENTITY
headaches	ENTITY
do	
not	
have	
a	
fixed	
association	ENTITY
with	
a	
particular	
sleep	ENTITY
stage	ENTITY
.	

The	
patient	ENTITY
may	
awaken	
with	
a	
migraine	ENTITY
out	
of	
REM	ENTITY
sleep	ENTITY
,	
or	
the	
headaches	ENTITY
may	
occur	
in	
relationship	ENTITY
to	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
.	

A	
“	
classic	ENTITY
migraine	ENTITY
”	
headache	ENTITY
is	
preceded	
by	
an	
aura	ENTITY
(	
if	
the	
patient	ENTITY
is	
awake	ENTITY
)	
,	
which	
usually	
lasts	
four	
to	
60	
minutes	ENTITY
and	
typically	
consists	
of	
homonymous	ENTITY
visual	
field	
defects	ENTITY
and	
scintillating	ENTITY
scotomas	ENTITY
.	

In	
some	
patients	ENTITY
,	
the	
aura	ENTITY
may	
continue	
or	
even	
begin	
during	
the	
headache	ENTITY
phase	ENTITY
.	

In	
contrast	
,	
“	
common	
migraine	ENTITY
”	
does	
not	
start	
with	
an	
aura	ENTITY
.	

Other	
signs	
of	
neurological	ENTITY
dysfunction	ENTITY
may	
include	
unilateral	ENTITY
paresthesias	ENTITY
,	
weakness	ENTITY
,	
and	
aphasia	ENTITY
.	

Features	ENTITY
of	
brainstem	ENTITY
involvement	ENTITY
may	
include	
vertigo	ENTITY
,	
tinni-	
tus	ENTITY
,	
dysarthria	ENTITY
,	
decreased	ENTITY
hearing	ENTITY
,	
diplopia	ENTITY
,	
ataxia	ENTITY
,	
bilateral	ENTITY
paresthesias	ENTITY
,	
and	
impaired	ENTITY
level	
of	
consciousness	ENTITY
.	

A	
familial	ENTITY
syndrome	ENTITY
with	
hemiplegia	ENTITY
is	
well	
described	
.	

The	
hemiplegia	ENTITY
is	
ipsilateral	ENTITY
or	
contralateral	ENTITY
to	
the	
side	
of	
the	
headache	ENTITY
.	

Cluster	ENTITY
headaches	ENTITY
are	
severe	ENTITY
,	
unilateral	ENTITY
,	
periorbital	ENTITY
or	
temporal	ENTITY
headaches	ENTITY
that	
start	
quickly	
and	
peak	
within	
10	
to	
15	
minutes	ENTITY
.	

They	
have	
a	
relatively	
shorter	ENTITY
duration	ENTITY
,	
usually	
lasting	
15	
minutes	ENTITY
to	
three	
hours	ENTITY
(	
mean	
,	
60	
minutes	ENTITY
)	
.	

The	
headaches	ENTITY
occur	
daily	ENTITY
during	
cluster	ENTITY
periods	ENTITY
—	
usually	
one	
to	
three	
attacks	ENTITY
per	
day	ENTITY
over	
a	
period	ENTITY
of	
one	
to	
two	
months	ENTITY
.	

Most	
patients	ENTITY
have	
one	
cluster	ENTITY
period	ENTITY
per	
year	ENTITY
,	
though	
this	
can	
vary	
from	
patient	ENTITY
to	
patient	ENTITY
.	

The	
headaches	ENTITY
tend	
to	
occur	
at	
the	
same	
hour	ENTITY
each	
day	ENTITY
,	
with	
75	
%	
of	
cluster	ENTITY
episodes	ENTITY
reported	
to	
occur	
between	
9:00	
p.m.	
and	
10:00	
a.m.	

One	
or	
more	
cranial	ENTITY
autonomic	
features	
(	
e.g.	
,	
ipsilateral	ENTITY
conjunctival	
injection	
,	
lacrimation	ENTITY
,	
nasal	ENTITY
congestion	ENTITY
,	
rhinorrhea	ENTITY
,	
forehead	ENTITY
and	
facial	ENTITY
sweating	ENTITY
,	
miosis	ENTITY
,	
ptosis	ENTITY
,	
or	
eyelid	ENTITY
edema	ENTITY
)	
invariably	
accompany	
attacks	ENTITY
of	
cluster	ENTITY
headaches	ENTITY
.	

A	
strong	
predilection	ENTITY
for	
attacks	ENTITY
to	
occur	
during	
sleep	ENTITY
is	
well	
recognized	
,	
and	
these	
attacks	ENTITY
are	
strongly	
related	
to	
REM	ENTITY
sleep	ENTITY
.	

Chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
closely	
resembles	
cluster	ENTITY
headaches	ENTITY
and	
consists	
of	
severe	ENTITY
unilateral	ENTITY
orbital	
,	
supraorbital	ENTITY
,	
or	
temporal	ENTITY
pain	ENTITY
associated	ENTITY
with	ENTITY
one	
or	
more	
cranial	ENTITY
autonomic	
features	
.	

However	
,	
the	
attacks	ENTITY
are	
usually	
of	
shorter	ENTITY
duration	ENTITY
(	
lasting	
two	
to	
30	
minutes	ENTITY
)	
and	
occur	
more	
frequently	
,	
most	
often	
at	
a	
frequency	ENTITY
of	
more	
than	
five	
per	
day	ENTITY
.	

In	
contrast	
to	
cluster	ENTITY
headaches	ENTITY
,	
chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
is	
exqui-	
sitely	ENTITY
sensitive	ENTITY
to	
indomethacin	ENTITY
.	

Attacks	ENTITY
are	
also	
strongly	
associated	ENTITY
with	ENTITY
REM	ENTITY
sleep	ENTITY
.	

Hypnic	ENTITY
headaches	ENTITY
are	
an	
uncommon	ENTITY
type	
of	
headache	ENTITY
that	
awakens	
the	
patient	ENTITY
from	
sleep	ENTITY
with	
a	
generalized	ENTITY
or	
lateralized	ENTITY
headache	ENTITY
that	
lasts	
at	
least	
15	
minutes	ENTITY
(	
range	
,	
one	
to	
180	
minutes	ENTITY
)	
with	
a	
frequency	ENTITY
of	
at	
least	
15	
times	
per	
month	ENTITY
.	

Onset	ENTITY
is	
typically	
after	
the	
age	ENTITY
of	
50	
,	
although	
similar	
headaches	ENTITY
are	
described	
rarely	
in	
younger	ENTITY
indi-	
viduals	ENTITY
,	
including	
children	ENTITY
.	

In	
comparison	ENTITY
to	
cluster	ENTITY
headaches	ENTITY
,	
hypnic	ENTITY
headaches	ENTITY
are	
Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
less	
severe	
,	
often	
bilateral	ENTITY
and	
not	
associated	ENTITY
with	ENTITY
cranial	ENTITY
autonomic	
features	
.	

Isolated	ENTITY
nausea	ENTITY
,	
photophobia	ENTITY
,	
or	
phonophobia	ENTITY
may	
be	
present	
.	

They	
may	
occur	
one	
to	
three	
times	
during	
the	
night	ENTITY
,	
with	
many	
patients	ENTITY
reporting	
that	
the	
headaches	ENTITY
occur	
at	
the	
same	
time	
of	
the	
night	ENTITY
.	

The	
headaches	ENTITY
tend	
to	
occur	
during	
REM	ENTITY
sleep	ENTITY
.	

However	
,	
they	
also	
have	
been	
reported	
to	
occur	
during	
stage	ENTITY
N3	
sleep	
.	

A	
positive	ENTITY
therapeutic	ENTITY
response	ENTITY
to	
lithium	ENTITY
,	
indomethacin	ENTITY
,	
and	
caffeine	ENTITY
has	
been	
reported	
in	
many	
patients	ENTITY
.	

Other	
medical	ENTITY
(	
e.g.	
,	
hypertension	ENTITY
)	
,	
neurologic	ENTITY
(	
e.g.	
,	
brain	ENTITY
tumors	ENTITY
,	
arteriovenous	ENTITY
mal-	ENTITY
formations	ENTITY
,	
cerebral	ENTITY
venous	ENTITY
thrombosis	ENTITY
and	
trauma	ENTITY
)	
,	
psychiatric	ENTITY
(	
e.g.	
,	
depression	ENTITY
)	
,	
and	
sleep	ENTITY
disorders	ENTITY
(	
e.g.	
,	
snoring	ENTITY
and	
OSA	ENTITY
)	
also	
can	
give	
rise	
to	
headaches	ENTITY
that	
may	
occur	
during	
sleep	ENTITY
or	
upon	
awakening	ENTITY
from	
sleep	ENTITY
.	

Patients	ENTITY
with	
increased	ENTITY
intracranial	ENTITY
pressure	ENTITY
(	
due	
,	
for	
example	
,	
to	
brain	ENTITY
tumor	ENTITY
,	
hematoma	ENTITY
,	
arteriovenous	ENTITY
malformations	ENTITY
,	
or	
cerebral	ENTITY
venous	ENTITY
thrombosis	ENTITY
)	
may	
complain	ENTITY
of	
headache	ENTITY
in	
the	
morning	ENTITY
or	
head-	
ache	
that	
starts	
after	
recumbence	ENTITY
and	
improves	ENTITY
after	
the	
patient	ENTITY
is	
up	
for	
30	
to	
60	
minutes	ENTITY
.	

Nausea	ENTITY
,	
vomiting	ENTITY
,	
signs	
of	
focal	ENTITY
neurological	ENTITY
deficits	ENTITY
,	
and	
papilledema	ENTITY
may	
be	
present	
.	

The	
headache	ENTITY
may	
worsen	ENTITY
with	
bending	ENTITY
down	ENTITY
or	
sneezing	ENTITY
or	
with	
other	
activities	ENTITY
that	
may	
cause	
further	
increase	ENTITY
in	
intracranial	ENTITY
pressure	ENTITY
.	

Sleep	ENTITY
related	
headaches	ENTITY
can	
disrupt	ENTITY
nocturnal	ENTITY
sleep	ENTITY
,	
although	
the	
exact	
prevalence	ENTITY
of	
this	
complication	ENTITY
is	
unknown	
.	

Demographics	ENTITY
The	
exact	
prevalence	ENTITY
of	
sleep	ENTITY
related	
headaches	ENTITY
is	
not	
known	
.	

One	
study	ENTITY
from	
a	
head-	ENTITY
ache	ENTITY
clinic	ENTITY
suggested	
that	
17	
%	
of	
all	
headache	ENTITY
patients	ENTITY
complain	ENTITY
of	
nocturnal	ENTITY
or	
early	ENTITY
morning	ENTITY
headaches	ENTITY
,	
and	
roughly	
half	
of	
these	
were	
related	
to	
an	
identifiable	ENTITY
sleep	ENTITY
disorder	ENTITY
.	

However	
,	
many	
primary	ENTITY
headache	ENTITY
disorders	ENTITY
can	
occur	
during	
sleep	ENTITY
as	
well	
.	

Sleep	ENTITY
related	ENTITY
migraines	ENTITY
have	
been	
reported	
to	
increase	ENTITY
in	
frequency	ENTITY
with	
age	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Migraine	ENTITY
headaches	ENTITY
have	
several	
predisposing	ENTITY
factors	ENTITY
that	
vary	
from	
patient	ENTITY
to	
patient	ENTITY
.	

However	
,	
stress	ENTITY
,	
relaxation	ENTITY
,	
changes	ENTITY
in	
weather	ENTITY
and	
barometric	ENTITY
pressure	ENTITY
,	
changes	ENTITY
in	
sleep	ENTITY
pattern	ENTITY
,	
hypoglycemia	ENTITY
,	
and	
specific	ENTITY
foods	ENTITY
(	
e.g.	
,	
chocolate	ENTITY
,	
Chinese	ENTITY
food	ENTITY
,	
alcohol	ENTITY
)	
have	
been	
known	
to	
trigger	ENTITY
migraine	ENTITY
headaches	ENTITY
.	

Alcohol	ENTITY
can	
also	
predispose	
an	
indi-	
vidual	
to	
having	
cluster	ENTITY
headache	ENTITY
and	
chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
.	

OSA	ENTITY
and	
atten-	ENTITY
dant	ENTITY
hypoxia	ENTITY
have	
been	
reported	
to	
be	
a	
trigger	ENTITY
for	
cluster	ENTITY
headache	ENTITY
.	

However	
,	
sleep	ENTITY
apnea	ENTITY
may	
also	
predispose	
a	
person	ENTITY
to	
having	
other	
types	
of	
headache	ENTITY
and	
may	
inde-	
pendently	
lead	
to	
morning	ENTITY
headaches	ENTITY
.	

Change	ENTITY
of	
sleep	ENTITY
pattern	ENTITY
and	
insomnia	ENTITY
can	
pre-	ENTITY
dispose	ENTITY
the	
patient	ENTITY
to	
developing	
headaches	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Familial	ENTITY
Patterns	ENTITY
There	
is	
a	
positive	ENTITY
family	ENTITY
history	ENTITY
for	
migraine	ENTITY
in	
up	
to	
80	
%	
of	
patients	ENTITY
with	
this	
disor-	ENTITY
der	ENTITY
.	

Familial	ENTITY
hemiplegic	ENTITY
migraine	ENTITY
is	
inherited	ENTITY
in	
an	
autosomal	ENTITY
dominant	ENTITY
pattern	ENTITY
with	
a	
variety	
of	
genetic	ENTITY
mutations	ENTITY
identified	ENTITY
on	
chromosomes	ENTITY
1	ENTITY
and	
19	
.	

Cluster	ENTITY
headache	ENTITY
does	
not	
have	
as	
strong	
of	
a	
familial	ENTITY
disposition	ENTITY
as	
migraine	ENTITY
headache	ENTITY
,	
but	
first	
-	
degree	ENTITY
relatives	ENTITY
of	
probands	ENTITY
with	
cluster	ENTITY
headache	ENTITY
are	
seven	
times	
more	
likely	
to	
develop	
cluster	ENTITY
headaches	ENTITY
,	
and	
the	
concordance	ENTITY
rates	ENTITY
in	
monozygotic	ENTITY
twins	ENTITY
is	
100	
%	
.	

The	
inheritance	ENTITY
patterns	ENTITY
of	
hypnic	ENTITY
headache	ENTITY
are	
not	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Migraine	ENTITY
headache	ENTITY
usually	
starts	
in	
the	
second	
or	
third	
decade	
of	
life	ENTITY
,	
with	
a	
slightly	
earlier	
onset	
in	
men	ENTITY
than	
in	
women	ENTITY
.	

The	
mean	
age	ENTITY
of	
onset	ENTITY
of	ENTITY
cluster	ENTITY
headache	ENTITY
is	
28	
years	ENTITY
.	

Chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
has	
a	
wide	
range	
of	
onset	
,	
from	
childhood	ENTITY
to	
old	
age	ENTITY
.	

Most	
patients	ENTITY
with	
hypnic	ENTITY
headache	ENTITY
are	
elderly	ENTITY
,	
with	
the	
age	ENTITY
of	
onset	
from	
40	
to	
82	
years	ENTITY
.	

Brain	ENTITY
tumors	ENTITY
are	
more	
prevalent	ENTITY
in	
the	
elderly	ENTITY
,	
most	
occurring	
from	
the	
fifth	
decade	
to	
late	ENTITY
life	ENTITY
.	

Most	
sleep	ENTITY
related	
headaches	ENTITY
are	
benign	ENTITY
and	
tend	
to	
decrease	ENTITY
in	
frequency	ENTITY
with	
age	ENTITY
.	

There	
may	
be	
spontaneous	ENTITY
remissions	ENTITY
that	
last	
from	
months	ENTITY
to	
years	ENTITY
.	

Pregnancy	ENTITY
has	
a	
variable	ENTITY
effect	ENTITY
on	
these	
headaches	ENTITY
.	

Migraines	ENTITY
tend	
to	
decrease	ENTITY
with	
age	ENTITY
and	
,	
in	
women	ENTITY
,	
may	
stop	ENTITY
after	
menopause	ENTITY
.	

Cluster	ENTITY
headaches	ENTITY
,	
as	
the	
name	
suggests	
,	
occur	
in	
clusters	ENTITY
and	
are	
accompanied	
by	
pain	ENTITY
-	
free	ENTITY
intervals	ENTITY
lasting	
months	ENTITY
to	
a	
couple	
of	
years	ENTITY
.	

They	
also	
tend	
to	
decrease	ENTITY
with	
age	ENTITY
.	

Hypnic	ENTITY
headache	ENTITY
occurs	
infrequently	
.	

Headaches	ENTITY
in	
patients	ENTITY
with	
brain	ENTITY
tumors	ENTITY
are	
related	
to	
an	
increase	ENTITY
in	
intracranial	ENTITY
pressure	ENTITY
and	
tend	
to	
improve	ENTITY
with	
treatment	ENTITY
of	
the	
primary	ENTITY
lesion	ENTITY
and	
a	
decrease	ENTITY
in	
intracranial	ENTITY
pres-	
sure	
.	

Some	
patients	ENTITY
with	
OSA	ENTITY
report	
improvement	ENTITY
of	
the	
headache	ENTITY
after	
treatment	ENTITY
of	
the	
apnea	ENTITY
.	

The	
sleep	ENTITY
related	
headaches	ENTITY
can	
cause	
sleep	ENTITY
disruption	ENTITY
and	
insomnia	ENTITY
with	
decreased	ENTITY
sleep	ENTITY
efficiency	ENTITY
.	

Cluster	ENTITY
headaches	ENTITY
occurring	
regularly	
in	
sleep	ENTITY
can	
also	
lead	
to	
tran-	
sient	ENTITY
situational	ENTITY
insomnia	ENTITY
that	
may	
resolve	
after	
the	
remission	ENTITY
or	
the	
treatment	ENTITY
of	
the	
cluster	ENTITY
headache	ENTITY
.	

Depending	
on	
the	
etiology	ENTITY
of	
the	
sleep	ENTITY
related	ENTITY
headache	ENTITY
(	
e.g.	
,	
brain	ENTITY
tumor	ENTITY
)	
,	
other	
complications	ENTITY
may	
occur	
.	

Developmental	ENTITY
Issues	ENTITY
Not	
applicable	
or	
known	
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Pathology	ENTITY
and	
Pathophysiology	ENTITY
Several	
anatomic	ENTITY
areas	ENTITY
are	
common	
to	
the	
physiology	ENTITY
of	
both	
sleep	ENTITY
and	
headaches	ENTITY
;	
these	
include	
the	
brainstem	ENTITY
and	
diencephalon	ENTITY
,	
specifically	
the	
ventrolateral	ENTITY
periaque-	
ductal	ENTITY
gray	ENTITY
and	
the	
posterior	ENTITY
hypothalamus	ENTITY
.	

From	
a	
neurochemical	ENTITY
perspective	ENTITY
,	
ade-	
nosine	ENTITY
,	
melatonin	ENTITY
,	
and	
orexin	ENTITY
also	
are	
involved	
in	
both	
the	
regulation	ENTITY
of	ENTITY
sleep	ENTITY
and	
the	
evolution	ENTITY
of	
headaches	ENTITY
.	

Dysfunction	ENTITY
of	
REM	ENTITY
sleep	ENTITY
and	
arousal	ENTITY
mechanisms	ENTITY
are	
common	
to	
many	
headache	ENTITY
disorders	ENTITY
.	

Data	ENTITY
from	
transgenic	ENTITY
models	ENTITY
indicate	
that	
dis-	
ruption	ENTITY
of	
sleep	ENTITY
occurs	
in	
two	
forms	
of	
familial	ENTITY
migraine	ENTITY
.	

However	
,	
current	
mechanis-	
tic	ENTITY
explanations	
of	
the	
relationship	ENTITY
between	
sleep	ENTITY
and	
headache	ENTITY
are	
speculative	
.	

Objective	
Findings	ENTITY
Polysomnographic	ENTITY
aspects	ENTITY
of	
sleep	ENTITY
related	
headaches	ENTITY
need	
to	
be	
better	
defined	
.	

Migraine	ENTITY
headache	ENTITY
is	
reported	
to	
occur	
in	
association	ENTITY
with	
REM	ENTITY
sleep	ENTITY
or	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
.	

An	
excess	ENTITY
of	
stage	ENTITY
N3	ENTITY
sleep	ENTITY
also	
has	
been	
reported	
in	
patients	ENTITY
with	
migraine	ENTITY
.	

However	
,	
large	
controlled	ENTITY
studies	ENTITY
are	
not	
available	
.	

Fifty	
percent	
of	
cluster	ENTITY
headaches	ENTITY
and	
a	
majority	
of	
chronic	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
are	
associated	ENTITY
with	ENTITY
REM	ENTITY
sleep	ENTITY
.	

OSA	ENTITY
and	
hypoxia	ENTITY
during	
sleep	ENTITY
may	
aggravate	ENTITY
other	
sleep	ENTITY
related	
headaches	ENTITY
or	
may	
be	
an	
independent	ENTITY
cause	ENTITY
of	
headache	ENTITY
.	

Hypnic	ENTITY
headache	ENTITY
occurs	
during	
sleep	ENTITY
,	
with	
recent	
reports	ENTITY
of	
headache	ENTITY
during	
REM	ENTITY
sleep	ENTITY
and	
uncommonly	
during	
stage	ENTITY
N3	
sleep	
.	

Thus	
,	
the	
majority	
of	
sleep	ENTITY
related	
headaches	ENTITY
seem	
to	
have	
some	
relationship	ENTITY
with	
REM	ENTITY
sleep	ENTITY
,	
but	
there	
are	
no	
defining	
or	
pathognomonic	ENTITY
polysomnographic	
aspects	
of	
indi-	ENTITY
vidual	ENTITY
headache	ENTITY
syndromes	ENTITY
.	

Neuroimaging	ENTITY
studies	ENTITY
(	
computed	ENTITY
tomography	ENTITY
or	
magnetic	ENTITY
resonance	ENTITY
imaging	ENTITY
head	ENTITY
scans	ENTITY
or	
angiography	ENTITY
)	
may	
be	
performed	
to	
rule	
out	
structural	ENTITY
,	
vascular	ENTITY
,	
or	
infectious	ENTITY
disease	ENTITY
processes	
that	
may	
cause	ENTITY
headaches	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Sleep	
related	
headaches	ENTITY
are	
a	
heterogeneous	ENTITY
group	ENTITY
of	
different	
headache	ENTITY
entities	ENTITY
with	
a	
common	
expression	ENTITY
of	
occurrence	
during	
sleep	ENTITY
.	

They	
need	
to	
be	
differentiated	
from	
other	
headache	ENTITY
conditions	ENTITY
that	
are	
not	
sleep	ENTITY
related	
.	

These	
include	
tension	ENTITY
-	
type	ENTITY
head-	ENTITY
aches	ENTITY
and	
headaches	ENTITY
associated	ENTITY
with	ENTITY
paranasal	ENTITY
sinus	ENTITY
inflammation	ENTITY
,	
tooth	ENTITY
infection	ENTITY
,	
ear	ENTITY
infection	ENTITY
,	
febrile	ENTITY
illness	ENTITY
,	
benign	ENTITY
intracranial	ENTITY
hypertension	ENTITY
,	
intracranial	ENTITY
hypoten-	
sion	ENTITY
,	
vasculitis	ENTITY
,	
head	ENTITY
trauma	ENTITY
,	
alcohol	ENTITY
intoxication	ENTITY
,	
or	
bruxism	ENTITY
.	

Although	
the	
initial	
presentation	ENTITY
may	
be	
one	
of	
headache	ENTITY
,	
detailed	
history	ENTITY
and	
examination	ENTITY
will	
identify	
one	
of	
these	
contributing	
conditions	ENTITY
.	

Tension	ENTITY
-	
type	ENTITY
headaches	ENTITY
are	
bilateral	ENTITY
headaches	ENTITY
with	
a	
feeling	
of	
a	
band	ENTITY
-	
like	
tighten-	
ing	
sensation	ENTITY
around	
the	
head	ENTITY
.	

In	
patients	ENTITY
older	
than	
50	
years	ENTITY
,	
giant	ENTITY
cell	ENTITY
arteritis	ENTITY
may	
Appendix	
A	
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
present	
with	
lateralized	ENTITY
or	
bilateral	ENTITY
headache	ENTITY
with	
tenderness	ENTITY
over	
the	
temporal	ENTITY
area	ENTITY
,	
accompanied	
by	
polymyalgia	ENTITY
rheumatica	ENTITY
and	
visual	ENTITY
problems	ENTITY
,	
including	
loss	ENTITY
of	ENTITY
vision	ENTITY
.	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
is	
in	
the	
differential	ENTITY
diagnosis	ENTITY
of	
headache	ENTITY
because	
it	
may	
occur	
in	
association	ENTITY
with	ENTITY
the	
sleep	ENTITY
period	ENTITY
.	

Patients	ENTITY
report	ENTITY
hearing	ENTITY
an	
explosion	ENTITY
in	
the	
head	ENTITY
which	
is	
unaccompanied	
by	
pain	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Not	
applicable	
or	
known	
.	

Bibliography	ENTITY
Brennan	ENTITY
KC	ENTITY
,	
Charles	ENTITY
A.	ENTITY
Sleep	ENTITY
and	
headache	ENTITY
.	

Semin	ENTITY
Neurol	ENTITY
2009;29:406–17	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Laryngospasm	ENTITY
Alternate	ENTITY
Names	ENTITY
Stridor	ENTITY
,	
laryngeal	ENTITY
dysfunction	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
laryngospasm	ENTITY
is	
a	
disorder	ENTITY
in	
which	
tracheal	ENTITY
muscle	ENTITY
dysfunction	ENTITY
or	
para-	
tracheal	ENTITY
soft	ENTITY
-	
tissue	ENTITY
swelling	ENTITY
causes	
stridor	ENTITY
or	
interruption	ENTITY
of	
airflow	ENTITY
,	
with	
associated	
awakening	ENTITY
from	
sleep	ENTITY
.	

Patients	ENTITY
may	
have	
total	
or	
near	ENTITY
-	
total	ENTITY
cessation	ENTITY
of	
airflow	ENTITY
while	
asleep	ENTITY
,	
and	
suddenly	
arouse	
.	

This	
brief	ENTITY
respiratory	ENTITY
blockage	ENTITY
(	
lasting	
an	
estimated	ENTITY
five	
to	
45	
seconds	
)	
is	
often	
followed	
by	
a	
period	ENTITY
of	
stridor	ENTITY
that	
lasts	
several	
minutes	ENTITY
and	
gradually	
evolves	
to	
normal	ENTITY
breathing	ENTITY
.	

Episodes	ENTITY
are	
associated	ENTITY
with	ENTITY
panic	ENTITY
and	
fear	ENTITY
of	
suffocation	ENTITY
;	
cyanosis	ENTITY
may	
be	
observed	ENTITY
.	

In	
some	
cases	ENTITY
of	
laryngospasm	ENTITY
during	
sleep	ENTITY
,	
patients	ENTITY
may	
have	
frequent	ENTITY
laryngeal	ENTITY
stridor	ENTITY
(	
which	
may	
be	
difficult	
for	
families	ENTITY
to	
dif-	
ferentiate	ENTITY
from	
snoring	ENTITY
)	
,	
associated	
tachypnea	ENTITY
,	
and	
intermittent	ENTITY
upper	
airway	
blockage	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Fear	ENTITY
and	
panic	ENTITY
upon	
awakening	ENTITY
often	
accompany	
events	ENTITY
and	
may	
,	
at	
times	
,	
lead	
to	
insomnia	ENTITY
.	

In	
some	
cases	ENTITY
of	
sleep	ENTITY
related	
laryngospasm	ENTITY
,	
gastroesophageal	ENTITY
reflux	ENTITY
has	
been	
identified	ENTITY
.	

Less	
commonly	
,	
sleep	ENTITY
related	
laryngospasm	ENTITY
has	
been	
related	
to	
underlying	
OSA	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiological	ENTITY
Subtypes	ENTITY
Sleep	ENTITY
related	ENTITY
laryngospasm	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
multisystem	ENTITY
atrophy	ENTITY
,	
a	
neurode-	
generative	ENTITY
disorder	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Demographics	ENTITY
Prevalence	ENTITY
data	ENTITY
do	
not	
exist	
.	

Typical	
age	ENTITY
of	
onset	
is	
unknown	
,	
although	
when	
the	
con-	ENTITY
dition	ENTITY
is	
due	
to	
multisystem	ENTITY
atrophy	ENTITY
,	
affected	ENTITY
individuals	ENTITY
are	
typically	
older	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Sleep	ENTITY
related	ENTITY
laryngospasm	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
.	

Laryngeal	ENTITY
dysfunction	ENTITY
seen	
in	
other	
disorders	ENTITY
,	
including	
laryngeal	ENTITY
tumors	ENTITY
and	
multisystem	ENTITY
atrophy	ENTITY
,	
may	
cause	
sleep	ENTITY
related	
stridor	ENTITY
and	
intermittent	ENTITY
laryngospasm	ENTITY
.	

Precipitating	ENTITY
factors	ENTITY
include	
use	
of	
hypnotic	ENTITY
or	
other	
central	ENTITY
nervous	ENTITY
system	ENTITY
depressant	ENTITY
medications	ENTITY
.	

Tonic	ENTITY
-	
clonic	ENTITY
seizures	ENTITY
may	
be	
a	
rare	
cause	ENTITY
of	
sleep	ENTITY
related	
laryngospasm	ENTITY
in	
children	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
Laryngospasm	ENTITY
is	
a	
common	
cause	
of	
death	ENTITY
in	
multiple	ENTITY
system	ENTITY
atrophy	ENTITY
.	

Developmental	ENTITY
Issues	ENTITY
Not	
known	
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
When	
not	
associated	ENTITY
with	ENTITY
neurodegenerative	ENTITY
disorders	ENTITY
of	
known	
pathology	ENTITY
(	
e.g.	
,	
mul-	ENTITY
tisystem	ENTITY
atrophy	ENTITY
)	
,	
the	
pathology	ENTITY
and	
pathophysiology	ENTITY
is	
uncertain	
.	

Sleep	ENTITY
related	
laryn-	
gospasm	ENTITY
can	
be	
related	
to	
tracheal	ENTITY
muscle	ENTITY
dysfunction	ENTITY
,	
postnasal	ENTITY
drip	ENTITY
,	
or	
reflux	ENTITY
of	
gas-	ENTITY
troesophageal	ENTITY
contents	ENTITY
causing	
irritation	ENTITY
of	
soft	ENTITY
tissue	ENTITY
in	
the	
upper	ENTITY
airway	ENTITY
.	

Laryngeal	ENTITY
tumors	ENTITY
and	
multisystem	ENTITY
atrophy	ENTITY
can	
cause	
laryngeal	ENTITY
dysfunction	ENTITY
,	
resulting	
in	
sleep	ENTITY
related	
laryngospasm	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Sleep	ENTITY
related	ENTITY
laryngospasm	ENTITY
may	
be	
observed	
on	
PSG	ENTITY
with	
accompanying	
audio	
record-	
ing	
.	

It	
is	
seen	
in	
all	
stages	ENTITY
of	
sleep	ENTITY
but	
is	
most	
severe	ENTITY
in	
REM	ENTITY
sleep	ENTITY
.	

Laryngospasm	ENTITY
can	
appear	
to	
be	
similar	
to	
snoring	ENTITY
on	
the	
polysomnographic	ENTITY
snoring	ENTITY
channel	ENTITY
,	
but	
the	
audio	ENTITY
recording	ENTITY
will	
confirm	
the	
high	ENTITY
-	
pitched	ENTITY
inspiratory	ENTITY
sound	
as	
laryngospasm	ENTITY
.	

OSA	ENTITY
has	
also	
been	
detected	ENTITY
in	
some	
cases	ENTITY
.	

Patients	ENTITY
or	
family	ENTITY
members	ENTITY
may	
mistake	
laryngospasm	ENTITY
for	
snoring	ENTITY
or	
sleep	ENTITY
apnea	ENTITY
.	

PSG	ENTITY
evaluation	ENTITY
may	
be	
necessary	
to	
distin-	
guish	ENTITY
these	
disorders	ENTITY
.	

In	
children	ENTITY
,	
PSG	ENTITY
or	
sleep	ENTITY
-	
deprived	ENTITY
EEG	ENTITY
may	
demonstrate	
sei-	
zures	ENTITY
that	
manifest	ENTITY
solely	
as	
nocturnal	ENTITY
laryngospasm	ENTITY
.	

Endoscopy	ENTITY
of	
the	
upper	ENTITY
airway	ENTITY
is	
necessary	
to	
examine	
vocal	ENTITY
cord	ENTITY
function	ENTITY
and	
to	
exclude	
upper	ENTITY
airway	ENTITY
pathology	ENTITY
.	

Gastroesophageal	ENTITY
studies	ENTITY
may	
reveal	
evidence	ENTITY
of	
reflux	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Differential	
Diagnosis	ENTITY
OSA	ENTITY
may	
cause	
awakenings	ENTITY
,	
with	
choking	ENTITY
or	
gasping	ENTITY
for	
air	ENTITY
,	
excessive	ENTITY
daytime	ENTITY
som-	
nolence	ENTITY
,	
restlessness	ENTITY
,	
or	
insomnia	ENTITY
.	

If	
OSA	ENTITY
is	
a	
diagnostic	ENTITY
consideration	ENTITY
,	
sleep	ENTITY
study	ENTITY
is	
warranted	
.	

Sleep	ENTITY
related	
gastroesophageal	ENTITY
reflux	ENTITY
may	
result	
in	
coughing	ENTITY
or	
choking	ENTITY
episodes	ENTITY
during	
the	
night	ENTITY
without	
true	ENTITY
laryngospasm	ENTITY
.	

However	
,	
these	
episodes	ENTITY
usually	
are	
described	
in	
the	
setting	
of	
chest	ENTITY
pain	ENTITY
or	
“	
heartburn	ENTITY
.	
”	

One	
possible	
cause	
of	
sleep	ENTITY
related	
laryngospasm	ENTITY
may	
be	
occult	ENTITY
acid	ENTITY
reflux	ENTITY
into	
the	
upper	ENTITY
airway	ENTITY
,	
causing	
irritation	ENTITY
or	
swelling	ENTITY
.	

Sleep	ENTITY
terrors	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
sensations	ENTITY
of	
impaired	ENTITY
breathing	ENTITY
or	
choking	ENTITY
,	
rapid	
heartbeat	ENTITY
,	
and	
agitation	ENTITY
.	

However	
,	
sleep	ENTITY
terrors	ENTITY
are	
most	
common	
in	
children	ENTITY
,	
and	
most	
patients	ENTITY
do	
not	
focus	
on	
upper	ENTITY
airway	ENTITY
choking	ENTITY
.	

Panic	ENTITY
disorder	ENTITY
can	
involve	
abrupt	
awakening	ENTITY
with	
respiratory	ENTITY
distress	ENTITY
,	
signs	
of	
sympathetic	ENTITY
activity	ENTITY
,	
and	
fear	ENTITY
of	ENTITY
dying	ENTITY
.	

However	
,	
most	
patients	ENTITY
also	
have	
daytime	ENTITY
episodes	ENTITY
of	
panic	ENTITY
.	

Nocturnal	ENTITY
asthma	ENTITY
can	
result	
in	
sleep	ENTITY
related	ENTITY
coughing	ENTITY
,	
wheezing	ENTITY
,	
or	
shortness	ENTITY
of	ENTITY
breath	ENTITY
.	

REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
(	
RBD	ENTITY
)	
may	
be	
in	
the	
differential	ENTITY
diagnosis	ENTITY
of	
laryngospasm	ENTITY
,	
but	
is	
generally	
recognizable	
by	
polysomnographic	ENTITY
features	ENTITY
of	
RBD	ENTITY
and	
a	
history	ENTITY
of	
dream	ENTITY
enactment	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Published	ENTITY
reports	ENTITY
generally	
have	
been	
limited	
to	
case	ENTITY
series	ENTITY
.	

Clarification	ENTITY
of	
the	
rela-	
tionship	ENTITY
between	
laryngospasm	ENTITY
,	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
,	
and	
gastroesopha-	ENTITY
geal	ENTITY
reflux	ENTITY
is	
needed	
.	

Bibliography	ENTITY
Aloe	ENTITY
F	ENTITY
,	
Thorpy	
M.	
Sleep	
-	
related	ENTITY
laryngospasm	ENTITY
.	

Arq	
Neuropsiquiatr	ENTITY
1995;53:46–52	
.	

Campbell	ENTITY
A	ENTITY
,	
Pierce	ENTITY
R.	ENTITY
Brief	ENTITY
upper	ENTITY
airway	ENTITY
dysfunction	ENTITY
.	

Respir	
Med	
1994;88:125–9	
.	

Guilleminault	ENTITY
C	ENTITY
,	
Eldridge	ENTITY
F	ENTITY
,	
Phillips	ENTITY
J	ENTITY
,	ENTITY
Dement	ENTITY
W.	ENTITY
Two	
occult	ENTITY
causes	
of	
insomnia	ENTITY
and	
their	
therapeutic	ENTITY
problems	ENTITY
.	

Arch	ENTITY
Gen	ENTITY
Psychiatry	ENTITY
1976;33:1241–5	ENTITY
.	

Iriarte	ENTITY
J	ENTITY
,	
Urrestarazu	
E	
,	
Alegre	ENTITY
M	ENTITY
,	
Goni	ENTITY
C	ENTITY
,	
Viteri	ENTITY
C	ENTITY
,	
Artieda	
J.	
Sleep	
-	
related	ENTITY
laryngospasm	ENTITY
:	
A	
video	ENTITY
polysomnographic	
recording	
.	

Epileptic	ENTITY
Disord	ENTITY
2006;8:70–2	ENTITY
.	

Kavey	ENTITY
N	ENTITY
,	
Whyte	
J	
,	
Blitzer	ENTITY
A	ENTITY
,	
Gidro	ENTITY
-	
Frank	ENTITY
S.	ENTITY
Sleep	ENTITY
-	
related	ENTITY
laryngeal	ENTITY
obstruction	ENTITY
presenting	
as	
snoring	ENTITY
or	
sleep	ENTITY
apnea	ENTITY
.	

Laryngoscope	ENTITY
1989;99:851–4	
.	

Roland	ENTITY
MM	ENTITY
,	
Baran	ENTITY
AS	ENTITY
,	
Richert	ENTITY
AC	ENTITY
.	

Sleep	ENTITY
related	
laryngospasm	ENTITY
caused	
by	
gastroesophageal	ENTITY
reflux	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
2008;9:451–3	ENTITY
.	

Thorpy	ENTITY
M	ENTITY
,	
Aloe	ENTITY
F.	ENTITY
Choking	ENTITY
during	
sleep	ENTITY
.	

Sleep	ENTITY
Res	ENTITY
1989;18:314	ENTITY
.	

Thorpy	ENTITY
M	ENTITY
,	
Aloe	ENTITY
F.	ENTITY
Sleep	ENTITY
related	
laryngospasm	ENTITY
.	

Sleep	ENTITY
Res	ENTITY
1989;18:313	ENTITY
.	

Thurnheer	ENTITY
R	ENTITY
,	
Henz	ENTITY
S	ENTITY
,	
Knoblauch	ENTITY
A.	ENTITY
Sleep	ENTITY
-	
related	ENTITY
laryngospasm	ENTITY
.	

Eur	
Respir	
J	
1997;10:2084–6	
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Sleep	ENTITY
Related	ENTITY
Gastroesophageal	ENTITY
Reflux	ENTITY
Alternative	ENTITY
Names	ENTITY
Gastroesophageal	ENTITY
reflux	ENTITY
,	
nocturnal	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
,	
supine	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
,	
nocturnal	ENTITY
heartburn	ENTITY
,	
reflux	ENTITY
esophagitis	ENTITY
,	
esophagitis	ENTITY
,	
heartburn	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
gastroesophageal	
reflux	
(	
GER	ENTITY
)	
occurs	
when	
gastric	ENTITY
contents	ENTITY
cross	
the	
lower	ENTITY
esophageal	ENTITY
sphincter	ENTITY
(	
LES	ENTITY
)	
into	
the	
esophagus	ENTITY
and	
,	
potentially	
,	
into	
more	
prox-	
imal	ENTITY
sites	ENTITY
during	
sleep	ENTITY
time	ENTITY
.	

Symptoms	ENTITY
are	
usually	
noticed	
during	
arousals	ENTITY
or	
awak-	
enings	ENTITY
.	

Symptoms	ENTITY
may	
include	
heartburn	ENTITY
,	
substernal	ENTITY
burning	ENTITY
,	
chest	ENTITY
discomfort	ENTITY
,	
a	
sour	ENTITY
or	
bitter	ENTITY
taste	ENTITY
in	
the	
mouth	ENTITY
,	
regurgitation	ENTITY
,	
water	ENTITY
brash	ENTITY
,	
coughing	ENTITY
,	
choking	ENTITY
,	
or	
unex-	
plained	ENTITY
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
even	
in	
the	
absence	ENTITY
of	
typical	
reflux	ENTITY
symptoms	ENTITY
.	

Sleep	ENTITY
related	
GER	ENTITY
is	
associated	ENTITY
with	ENTITY
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
maintenance	ENTITY
insomnia	ENTITY
,	
early	ENTITY
morning	ENTITY
awakenings	ENTITY
,	
sleep	ENTITY
disturbances	ENTITY
,	
arousals	ENTITY
,	
unrefreshing	ENTITY
sleep	ENTITY
,	
daytime	ENTITY
functioning	ENTITY
difficulties	ENTITY
,	
and	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
.	

GER	ENTITY
is	
a	
potential	
asthma	ENTITY
trigger	ENTITY
,	
predisposes	
to	
aspiration	ENTITY
,	
and	
is	
a	
cause	
of	
cough	ENTITY
.	

GER	ENTITY
commonly	
coexists	
in	
patients	ENTITY
with	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
,	
cystic	ENTITY
fibrosis	ENTITY
,	
idiopathic	ENTITY
pulmo-	
nary	ENTITY
fibrosis	ENTITY
,	
and	
bronchiolitis	ENTITY
obliterans	ENTITY
syndrome	ENTITY
in	
lung	ENTITY
transplant	ENTITY
recipients	ENTITY
.	

Sleep	ENTITY
related	
GER	ENTITY
is	
associated	ENTITY
with	ENTITY
sleep	ENTITY
related	
laryngospasm	ENTITY
and	
is	
prevalent	ENTITY
in	
patients	ENTITY
with	
OSA	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Associated	
features	ENTITY
of	
this	
disorder	ENTITY
include	
dysphagia	ENTITY
,	
odynophagia	ENTITY
,	
laryngopharyn-	
gitis	ENTITY
,	
laryngospasm	ENTITY
,	
epigastric	ENTITY
burning	ENTITY
,	
chronic	ENTITY
cough	ENTITY
,	
wheezing	ENTITY
,	
or	
chest	ENTITY
pain	ENTITY
that	
may	
mimic	ENTITY
angina	ENTITY
.	

Other	
associated	
features	ENTITY
of	
sleep	ENTITY
related	
GER	ENTITY
include	
sleep	ENTITY
onset	ENTITY
and	
sleep	ENTITY
maintenance	ENTITY
insomnia	ENTITY
,	
excessive	ENTITY
daytime	ENTITY
sleepiness	ENTITY
,	
daytime	ENTITY
fatigue	ENTITY
,	
poor	ENTITY
daytime	ENTITY
functioning	ENTITY
,	
and	
reduced	ENTITY
work	
productivity	ENTITY
.	

Patients	ENTITY
with	
sleep	ENTITY
related	
GER	ENTITY
also	
have	
a	
decrease	ENTITY
in	
health	ENTITY
-	
related	ENTITY
quality	ENTITY
of	ENTITY
life	ENTITY
and	
more	
health	ENTITY
care	ENTITY
visits	ENTITY
.	

Clinical	ENTITY
and	
Pathological	ENTITY
Subtypes	ENTITY
Not	
applicable	
or	
known	
.	

Demographics	ENTITY
GER	ENTITY
symptoms	ENTITY
affect	
up	
to	
44	
%	
of	
adults	ENTITY
in	
the	
United	ENTITY
States	ENTITY
monthly	ENTITY
,	
and	
20	
%	
weekly	ENTITY
.	

Among	
patients	ENTITY
with	
weekly	ENTITY
heartburn	ENTITY
,	
79	
%	
report	ENTITY
GER	ENTITY
symptoms	ENTITY
during	
sleep	ENTITY
time	ENTITY
,	
57	
%	
report	ENTITY
waking	ENTITY
up	
during	
sleep	ENTITY
,	
and	
40	
%	
report	ENTITY
that	
GER	ENTITY
during	
sleep	ENTITY
time	ENTITY
affected	ENTITY
their	
ability	
to	
work	
the	
next	
day	
.	

Among	
the	
15,315	
subjects	ENTITY
of	
the	
Sleep	ENTITY
Heart	ENTITY
Health	ENTITY
Study	ENTITY
,	
25	
%	
reported	
heartburn	ENTITY
during	
sleep	ENTITY
.	

In	
a	
review	ENTITY
of	
5	
large	
Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
population	ENTITY
studies	ENTITY
,	
the	
mean	ENTITY
prevalence	ENTITY
of	
heartburn	ENTITY
during	
sleep	ENTITY
time	ENTITY
was	
54	
%	
±	
22	
%	
(	
standard	ENTITY
deviation	ENTITY
)	
.	

In	
patients	ENTITY
with	
OSA	ENTITY
,	
sleep	ENTITY
related	
reflux	ENTITY
symptoms	ENTITY
are	
present	
in	
up	
to	
62	
%	
.	

Furthermore	
,	
in	
a	
trial	ENTITY
examining	
consecutive	ENTITY
asthmatics	ENTITY
,	
50	
%	
had	
awakenings	ENTITY
from	
sleep	ENTITY
because	
of	
heartburn	ENTITY
.	

Thus	
,	
GER	ENTITY
symptoms	ENTITY
during	
sleep	ENTITY
time	ENTITY
are	
common	
.	

There	
is	
no	
known	
predilection	ENTITY
for	
men	ENTITY
or	
women	ENTITY
.	

However	
,	
men	ENTITY
are	
more	
likely	
than	
women	ENTITY
to	
develop	
Barrett	ENTITY
esophagus	ENTITY
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
factors	ENTITY
for	
sleep	ENTITY
related	
GER	ENTITY
include	
eating	ENTITY
within	
two	
hours	
of	
bedtime	ENTITY
,	
an	
elevated	ENTITY
body	ENTITY
mass	ENTITY
index	ENTITY
,	
erosive	ENTITY
esophagitis	ENTITY
,	
and	
hiatal	ENTITY
hernia	ENTITY
.	

Predictors	ENTITY
of	
heart-	
burn	ENTITY
during	
sleep	ENTITY
include	
consumption	ENTITY
of	
alcohol	ENTITY
or	
carbonated	ENTITY
beverages	ENTITY
,	
or	
the	
use	
of	
benzodiazepines	ENTITY
before	
sleep	ENTITY
time	ENTITY
.	

Other	
predictors	ENTITY
of	
heartburn	ENTITY
during	
sleep	ENTITY
include	
the	
presence	ENTITY
of	
insomnia	ENTITY
,	
hypertension	ENTITY
,	
asthma	ENTITY
,	
snoring	ENTITY
,	
or	
daytime	ENTITY
sleepiness	ENTITY
.	

The	
relationship	ENTITY
between	
GER	ENTITY
and	
sleep	ENTITY
disturbance	ENTITY
is	
bidirectional	ENTITY
.	

Sleep	ENTITY
related	
GER	ENTITY
is	
associated	ENTITY
with	ENTITY
short	ENTITY
sleep	ENTITY
duration	ENTITY
,	
difficulty	ENTITY
falling	ENTITY
asleep	
,	
arousals	ENTITY
,	
poor	ENTITY
sleep	ENTITY
quality	ENTITY
,	
and	
early	ENTITY
morning	ENTITY
awakenings	ENTITY
.	

Conversely	
,	
sleep	ENTITY
deprivation	ENTITY
induces	ENTITY
a	
state	ENTITY
of	
esophageal	ENTITY
hyperalgesia	ENTITY
to	
acid	ENTITY
,	
thus	
worsening	ENTITY
heartburn	ENTITY
symptoms	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Not	
applicable	
or	
known	
.	

Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
GER	ENTITY
occurs	
in	
all	
age	ENTITY
groups	ENTITY
,	
including	
infants	ENTITY
and	
children	ENTITY
.	

Sleep	ENTITY
disruption	ENTITY
occurs	
more	
frequently	
in	
infants	ENTITY
and	
children	ENTITY
with	
GER	ENTITY
,	
compared	
to	
infants	ENTITY
and	
children	ENTITY
without	
GER	ENTITY
.	

The	
incidence	ENTITY
of	
GER	ENTITY
increases	ENTITY
with	
age	ENTITY
.	

GER	ENTITY
may	
be	
more	
severe	ENTITY
and	
is	
associated	ENTITY
with	ENTITY
more	
complications	ENTITY
in	
older	ENTITY
adults	ENTITY
.	

GER	ENTITY
is	
a	
chronic	ENTITY
disease	ENTITY
which	
is	
rarely	
cured	
,	
but	
it	
may	
be	
controlled	ENTITY
with	
lifestyle	ENTITY
,	
and	
medical	ENTITY
and/or	
surgical	ENTITY
therapies	ENTITY
.	

In	
patients	ENTITY
with	
sleep	ENTITY
related	
GER	ENTITY
,	
medical	ENTITY
GER	ENTITY
therapy	ENTITY
improved	ENTITY
sleep	ENTITY
disturbances	ENTITY
and	
daytime	ENTITY
functioning	ENTITY
in	
placebo	ENTITY
-	
con-	ENTITY
trolled	ENTITY
trials	ENTITY
.	

Long	ENTITY
-	
term	ENTITY
outcome	ENTITY
data	ENTITY
are	
currently	
lacking	ENTITY
.	

If	
GER	ENTITY
is	
left	ENTITY
untreated	ENTITY
,	
the	
disease	ENTITY
generally	
progresses	ENTITY
and	
can	
be	
associated	ENTITY
with	ENTITY
many	
complications	ENTITY
.	

Esophageal	ENTITY
complications	
include	
esophagitis	ENTITY
,	
esophageal	ENTITY
erosions	ENTITY
,	
esophageal	ENTITY
stric-	
ture	ENTITY
,	
ulcerations	ENTITY
with	
stricture	ENTITY
,	
and	
Barrett	ENTITY
esophagus	ENTITY
,	
which	
is	
thought	
to	
be	
a	
precur-	
sor	ENTITY
to	
esophageal	ENTITY
adenocarcinoma	ENTITY
.	

Reflux	ENTITY
can	
also	
result	
in	
dysphagia	ENTITY
,	
weight	ENTITY
loss	ENTITY
,	
and	
upper	ENTITY
gastrointestinal	ENTITY
bleeding	ENTITY
.	

Sleep	ENTITY
related	
GER	ENTITY
is	
more	
commonly	
associated	ENTITY
with	ENTITY
erosive	ENTITY
esophagitis	ENTITY
,	
stricture	ENTITY
,	
Barrett	ENTITY
esophagitis	ENTITY
,	
and	
esophageal	ENTITY
adenocarci-	
noma	ENTITY
,	
compared	
to	
diurnal	ENTITY
reflux	ENTITY
.	

Extraesophageal	ENTITY
complications	
include	
pulmonary	ENTITY
complications	ENTITY
previously	
discussed	
in	
the	
Essential	ENTITY
Features	ENTITY
section	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Pathology	ENTITY
and	
Pathophysiology	ENTITY
Two	
major	
pathophysiologic	ENTITY
mechanisms	ENTITY
cause	
individual	
reflux	ENTITY
episodes	ENTITY
.	

Transient	ENTITY
LES	
relaxations	
(	
LES	ENTITY
relaxations	ENTITY
occurring	
without	
esophageal	ENTITY
contractions	ENTITY
)	
account	
for	
53	
%	
to	
74	
%	
of	
GER	ENTITY
episodes	ENTITY
.	

Transient	ENTITY
LES	ENTITY
relaxations	ENTITY
decrease	ENTITY
the	
LES	ENTITY
pres-	
sure	
to	
the	
gastric	ENTITY
pressure	ENTITY
gradient	ENTITY
,	
facilitating	
the	
retrograde	ENTITY
flow	
of	
gastric	ENTITY
contents	ENTITY
.	

An	
LES	ENTITY
pressure	ENTITY
of	
10	
mm	
Hg	
or	
less	
is	
the	
second	
mechanism	ENTITY
by	
which	
intra	ENTITY
-	
abdom-	
inal	ENTITY
pressure	ENTITY
overcomes	
the	
LES	ENTITY
pressure	ENTITY
,	
resulting	
in	
the	
retrograde	ENTITY
flow	
of	
gastric	ENTITY
contents	ENTITY
into	
the	
esophagus	ENTITY
.	

Pathophysiology	ENTITY
of	
sleep	ENTITY
related	
GER	ENTITY
is	
similar	
to	
diurnal	ENTITY
GER	ENTITY
(	
i.e.	
,	
transient	ENTITY
LES	ENTITY
relaxations	ENTITY
and	
a	
low	ENTITY
LES	ENTITY
pressure	ENTITY
)	
.	

However	
,	
sleep	ENTITY
impacts	ENTITY
esophageal	ENTITY
physiology	ENTITY
through	
the	
impairment	ENTITY
of	
esophageal	ENTITY
acid	ENTITY
clearance	ENTITY
mechanisms	ENTITY
when	
GER	ENTITY
events	ENTITY
occur	
.	

With	
sleep	ENTITY
onset	ENTITY
,	
the	
upper	ENTITY
esophageal	ENTITY
sphincter	ENTITY
(	
UES	
)	
pressure	ENTITY
decreases	ENTITY
and	
is	
lowest	
during	
N3	ENTITY
sleep	ENTITY
,	
thus	
predisposing	ENTITY
to	
aspiration	ENTITY
.	

The	
UES	ENTITY
contractile	ENTITY
reflex	ENTITY
remains	
intact	ENTITY
during	
sleep	ENTITY
,	
including	
REM	ENTITY
sleep	ENTITY
.	

Lower	ENTITY
esophageal	ENTITY
sphincter	ENTITY
(	
LES	
)	
pressure	
remains	
unchanged	
during	
sleep	ENTITY
.	

Sleep	ENTITY
increases	ENTITY
the	
vagal	ENTITY
threshold	ENTITY
for	
trig-	
gering	
transient	ENTITY
LES	ENTITY
relaxations	ENTITY
,	
so	
they	
usually	
do	
not	
occur	
during	
stable	ENTITY
sleep	ENTITY
and	
are	
usually	
confined	
to	
arousals	ENTITY
.	

When	
GER	ENTITY
events	ENTITY
occur	
during	
sleep	ENTITY
,	
esophageal	ENTITY
refluxate	ENTITY
clearance	ENTITY
is	
prolonged	ENTITY
and	
an	
arousal	ENTITY
is	
required	
.	

Sleep	ENTITY
facilitates	
proxi-	
mal	ENTITY
refluxate	ENTITY
migration	ENTITY
toward	
the	
UES	ENTITY
.	

Saliva	ENTITY
secretion	ENTITY
,	
with	
its	
acid	ENTITY
-	
neutralizing	ENTITY
bicarbonate	ENTITY
,	
ceases	
during	
sleep	ENTITY
.	

Swallowing	ENTITY
,	
required	
for	
esophageal	ENTITY
peristalsis	ENTITY
and	
refluxate	ENTITY
clearance	ENTITY
,	
does	
not	
occur	
during	
sleep	ENTITY
and	
is	
dependent	
on	
an	
arousal	ENTITY
.	

Sleep	ENTITY
also	
delays	ENTITY
gastric	ENTITY
emptying	ENTITY
by	
disrupting	ENTITY
gastromyoelectric	ENTITY
function	ENTITY
.	

Events	ENTITY
causing	
arousals	ENTITY
,	
including	
periodic	ENTITY
limb	ENTITY
movements	ENTITY
and	
apneas	ENTITY
,	
could	
trigger	
transient	ENTITY
LES	ENTITY
relaxations	ENTITY
and	
thus	
GER	ENTITY
events	ENTITY
.	

Because	
refluxate	ENTITY
clearance	ENTITY
requires	
an	
arousal	ENTITY
,	
medications	ENTITY
decreasing	ENTITY
the	
arousal	ENTITY
response	ENTITY
(	
including	
benzodiazepines	ENTITY
and	
zolp-	
idem	
)	
may	
prolong	
refluxate	ENTITY
clearance	ENTITY
and	
increase	ENTITY
the	
risk	ENTITY
of	
aspiration	ENTITY
during	
sleep	ENTITY
.	

The	
pathology	ENTITY
of	
GER	ENTITY
includes	
abnormal	ENTITY
esophageal	
manometry	
,	
endoscopy	ENTITY
,	
and	
esophageal	ENTITY
biopsy	ENTITY
findings	ENTITY
.	

Esophageal	ENTITY
manometry	ENTITY
findings	ENTITY
include	
an	
increased	ENTITY
frequency	ENTITY
of	
transient	ENTITY
LES	ENTITY
relaxations	ENTITY
,	
altered	
or	
decreased	ENTITY
esophageal	ENTITY
peristaltic	ENTITY
contraction	ENTITY
amplitude	ENTITY
,	
and	
a	
decrease	ENTITY
in	
LES	ENTITY
pressure	ENTITY
.	

Endoscopic	ENTITY
findings	ENTITY
include	
changes	ENTITY
ranging	
from	
mild	ENTITY
erythema	ENTITY
,	
erosions	ENTITY
,	
and	
ulcerations	ENTITY
to	
severe	ENTITY
erosions	ENTITY
with	
stricture	ENTITY
.	

Barrett	ENTITY
esophagus	ENTITY
is	
identified	ENTITY
when	
columnar	ENTITY
tissue	ENTITY
replaces	
the	
normal	ENTITY
squamous	ENTITY
epithelium	ENTITY
of	
the	
distal	ENTITY
esophagus	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Diagnostic	ENTITY
testing	ENTITY
is	
not	
required	
for	
sleep	ENTITY
related	
GER	ENTITY
.	

The	
diagnosis	ENTITY
can	
be	
made	
if	
typical	
symptoms	ENTITY
of	
heartburn	ENTITY
and/or	
regurgitation	ENTITY
are	
present	
during	
sleep	ENTITY
time	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
PSG	ENTITY
is	
not	
indicated	
.	

Esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
,	
which	
may	
be	
combined	
with	
esophageal	ENTITY
impedance	ENTITY
,	
objectively	ENTITY
measures	ENTITY
individual	ENTITY
GER	ENTITY
events	ENTITY
.	

Esophageal	ENTITY
monitoring	ENTITY
is	
recommended	
in	
difficult	
,	
refractory	ENTITY
cases	ENTITY
,	
or	
when	
symptoms	ENTITY
continue	
despite	
therapy	ENTITY
.	

Sleep	ENTITY
related	
GER	ENTITY
is	
more	
likely	
to	
occur	
during	
the	
first	
two	
hours	
of	
sleep	ENTITY
time	ENTITY
.	

Furthermore	
,	
in	
studies	ENTITY
using	
combined	
esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
with	
actigraphy	ENTITY
,	
acid	ENTITY
reflux	ENTITY
events	ENTITY
occurred	
primarily	
during	
the	
recumbent	ENTITY
-	
awake	ENTITY
period	ENTITY
,	
versus	
the	
recumbent	ENTITY
-	
asleep	ENTITY
period	ENTITY
.	

Reflux	ENTITY
events	ENTITY
are	
more	
likely	
to	
occur	
in	
the	
right	ENTITY
side	ENTITY
down	ENTITY
and	
supine	ENTITY
positions	ENTITY
than	
in	
the	
left	ENTITY
side	ENTITY
down	ENTITY
position	
.	

PSG	ENTITY
without	
esophageal	ENTITY
pH	ENTITY
or	
impedance	ENTITY
monitoring	ENTITY
reveals	
arousals	ENTITY
that	
are	
often	
associated	ENTITY
with	ENTITY
swallows	ENTITY
and	
a	
notable	
increase	ENTITY
in	
chin	ENTITY
EMG	ENTITY
tone	ENTITY
.	

Esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
detects	
acid	ENTITY
reflux	ENTITY
events	ENTITY
and	
can	
be	
integrated	
with	
PSG	ENTITY
.	

Esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
should	
be	
performed	
over	
a	
24	
-	
hour	ENTITY
period	ENTITY
to	
improve	ENTITY
the	
test	ENTITY
’s	ENTITY
sensitiv-	
ity	ENTITY
and	
specificity	ENTITY
,	
which	
approximate	ENTITY
90	
%	
.	

The	
distal	ENTITY
pH	ENTITY
probe	ENTITY
is	
placed	
5	
cm	
above	
the	
LES	ENTITY
.	

A	
proximal	ENTITY
pH	ENTITY
probe	ENTITY
is	
often	
placed	
near	
the	
UES	ENTITY
.	

An	
acid	ENTITY
reflux	ENTITY
event	ENTITY
is	
defined	
when	
the	
pH	ENTITY
drops	ENTITY
to	
less	
than	
4.0	
,	
and	
this	
variable	ENTITY
is	
reported	
as	
time	ENTITY
(	
%	
)	
where	
pH	ENTITY
is	
less	
than	
4.0	
.	

The	
percent	ENTITY
time	ENTITY
where	
pH	ENTITY
is	
less	
than	
4	
is	
reported	
over	
the	
total	
recording	
time	
,	
upright	ENTITY
time	ENTITY
and	
supine	ENTITY
time	ENTITY
.	

Note	
that	
supine	ENTITY
(	
in	
this	
testing	ENTITY
)	
is	
defined	
as	
the	
period	ENTITY
of	
time	
that	
the	
patient	ENTITY
is	
in	
bed	ENTITY
.	

Symptom	ENTITY
correlation	
is	
also	
helpful	
using	
the	
event	ENTITY
marker	ENTITY
on	
the	
device	ENTITY
or	
diaries	ENTITY
.	

Normal	ENTITY
esophageal	ENTITY
pH	ENTITY
times	
during	
the	
“	
supine	ENTITY
”	
or	
sleep	ENTITY
period	ENTITY
are	
:	
1	
)	
distal	ENTITY
pH	ENTITY
<	
4	
-	
less	ENTITY
than	
3.5	
%	
of	
the	
time	ENTITY
;	
and	
2	
)	
proximal	ENTITY
pH	ENTITY
<	
4	
-	
less	ENTITY
than	
0.6	
%	
of	
the	
time	ENTITY
.	

If	
esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
is	
integrated	
with	
polysomnography	ENTITY
,	
esophageal	ENTITY
acid	ENTITY
events	ENTITY
can	
be	
cor-	ENTITY
related	
with	
sleep	ENTITY
events	ENTITY
,	
including	
arousals	ENTITY
,	
apneas	ENTITY
,	
laryngospasm	ENTITY
,	
and	
increased	ENTITY
chin	ENTITY
EMG	
tone	
.	

Esophageal	ENTITY
pH	ENTITY
monitoring	ENTITY
also	
can	
be	
performed	
simultaneously	ENTITY
with	
actigraphy	ENTITY
to	
correlate	
acid	ENTITY
reflux	ENTITY
events	
with	
sleep	ENTITY
and	
wake	ENTITY
periods	ENTITY
.	

Catheter-	
free	
wireless	
pH	ENTITY
systems	ENTITY
are	
also	
available	
and	
are	
deployed	ENTITY
into	
the	
esophagus	ENTITY
,	
usually	
by	
endoscopy	ENTITY
.	

Esophageal	ENTITY
impedance	ENTITY
monitoring	ENTITY
can	
be	
combined	
with	
pH	ENTITY
probes	ENTITY
detecting	
liquid	ENTITY
,	
gas	ENTITY
,	
or	
liquid	ENTITY
gas	ENTITY
in	
the	
esophagus	ENTITY
,	
and	
can	
assess	ENTITY
both	
acid	ENTITY
and	
nonacid	ENTITY
reflux	
events	
.	

Use	
of	
esophageal	ENTITY
impedance	ENTITY
monitoring	ENTITY
is	
often	
performed	
in	
esophageal	ENTITY
centers	ENTITY
,	
and	
this	
technique	ENTITY
would	
be	
difficult	
to	
integrate	ENTITY
with	
polysomnography	ENTITY
.	

Other	
objective	
measures	ENTITY
include	
esophageal	ENTITY
endoscopy	ENTITY
with	
or	
without	
biopsy	ENTITY
in	
order	
to	
evaluate	ENTITY
for	
esophagitis	ENTITY
and	
other	
esophageal	ENTITY
complications	ENTITY
.	

A	
histologic	ENTITY
evaluation	ENTITY
is	
required	
to	
establish	
a	
diagnosis	ENTITY
of	
Barrett	ENTITY
esophagus	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Differential	ENTITY
Diagnosis	ENTITY
The	
differential	ENTITY
diagnosis	ENTITY
is	
primarily	
with	
peptic	ENTITY
ulcer	ENTITY
disease	ENTITY
and	
angina	ENTITY
.	

The	
chest	ENTITY
pain	ENTITY
associated	ENTITY
with	ENTITY
GER	ENTITY
is	
sometimes	
indistinguishable	ENTITY
from	
that	
of	
angina	ENTITY
.	

Duodenal	ENTITY
ulcer	ENTITY
disease	ENTITY
is	
commonly	
associated	ENTITY
with	ENTITY
a	
burning	ENTITY
epigastric	ENTITY
pain	ENTITY
,	
and	
this	
can	
sometimes	
be	
similar	
to	
the	
pain	ENTITY
experienced	
by	
patients	ENTITY
with	
GER	ENTITY
.	

Other	
conditions	ENTITY
that	
may	
be	
associated	ENTITY
with	ENTITY
GER	ENTITY
include	
OSA	ENTITY
,	
sleep	ENTITY
related	
abnormal	ENTITY
swallowing	ENTITY
,	
and	
sleep	ENTITY
related	
laryngospasm	ENTITY
.	

PSG	ENTITY
evaluation	ENTITY
with	
respiratory	ENTITY
and	
pH	ENTITY
monitoring	ENTITY
can	
differentiate	ENTITY
these	
disorders	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY
Not	
applicable	
or	
known	
.	

Bibliography	ENTITY
Allen	ENTITY
L	ENTITY
,	ENTITY
Poh	ENTITY
CH	ENTITY
,	
Gasiorowska	ENTITY
A	ENTITY
,	
et	
al	
.	

Increased	ENTITY
oesophageal	ENTITY
acid	ENTITY
exposure	ENTITY
at	
the	
beginning	
of	
the	
recumbent	ENTITY
period	
is	
primarily	
a	
recumbent	ENTITY
-	
awake	ENTITY
phenomenon	ENTITY
.	

Aliment	
Pharmacol	
Ther	
2010;32:787–94	
.	

Bajaj	ENTITY
JS	ENTITY
,	
Bajaj	ENTITY
S	ENTITY
,	
Dua	ENTITY
KS	ENTITY
,	
et	
al	
.	

Influence	ENTITY
of	
sleep	ENTITY
stages	ENTITY
on	
esophago	ENTITY
-	
upper	ENTITY
esophageal	ENTITY
sphincter	
contractile	ENTITY
reflex	ENTITY
and	
secondary	ENTITY
esophageal	ENTITY
peristalsis	ENTITY
.	

Gastroenterology	ENTITY
2006;130:17–25	
.	

Fass	ENTITY
R	ENTITY
,	
Johnson	ENTITY
DA	ENTITY
,	
Orr	
WC	ENTITY
,	
et	
al	
.	

The	
effect	ENTITY
of	
dexlansoprazole	ENTITY
MR	ENTITY
on	
nocturnal	ENTITY
heartburn	ENTITY
and	
GERD-	ENTITY
related	ENTITY
sleep	ENTITY
disturbances	ENTITY
in	
patients	ENTITY
with	
symptomatic	ENTITY
GERD	ENTITY
.	

Am	
J	
Gastroenterol	
2011;106:421–31	
.	

Fass	ENTITY
R	ENTITY
,	
Quan	
SF	ENTITY
,	
O’Connor	ENTITY
GT	ENTITY
,	
et	
al	
.	

Predictors	ENTITY
of	
heartburn	ENTITY
during	
sleep	ENTITY
in	
a	
large	
prospective	ENTITY
cohort	ENTITY
study	ENTITY
.	

Chest	ENTITY
2005;127:1654–66	ENTITY
.	

Fujiwara	ENTITY
Y	ENTITY
,	
Arakawa	ENTITY
T	ENTITY
,	
Fass	
R.	
Gastroesophageal	
reflux	
disease	
and	
sleep	ENTITY
disturbances	ENTITY
.	

J	
Gastroenterol	
2012;47:760–9	
.	

Gagliardi	ENTITY
GS	ENTITY
,	
Shah	ENTITY
AP	ENTITY
,	
Goldstein	ENTITY
M	ENTITY
,	
et	
al	
.	

Effect	ENTITY
of	
zolpidem	ENTITY
on	
the	
sleep	ENTITY
arousal	ENTITY
response	ENTITY
to	
nocturnal	ENTITY
esophageal	ENTITY
acid	ENTITY
exposure	ENTITY
.	

Clin	ENTITY
Gastroenterol	ENTITY
Hepatol	ENTITY
2009;7:948–52	ENTITY
.	

Gerson	ENTITY
LB	ENTITY
,	
Fass	
R.	
A	
systematic	ENTITY
review	ENTITY
of	
definitions	ENTITY
,	
prevalence	ENTITY
,	
and	
response	ENTITY
to	ENTITY
treatment	ENTITY
of	
nocturnal	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
disease	ENTITY
.	

Clin	ENTITY
Gastroenterol	ENTITY
Hepatol	ENTITY
2009;7:372–8	ENTITY
.	

Ghaem	ENTITY
M	ENTITY
,	
Armstrong	ENTITY
KL	ENTITY
,	ENTITY
Trocki	ENTITY
O	ENTITY
,	
et	
al	
.	

The	
sleep	ENTITY
patterns	ENTITY
of	
infants	ENTITY
and	
young	ENTITY
children	ENTITY
with	
gastro-	ENTITY
oesophageal	ENTITY
reflux	ENTITY
.	

J	
Paediatr	
Child	
Health	
1998;34:160–3	
.	

Green	ENTITY
BT	ENTITY
,	
Broughton	ENTITY
WA	ENTITY
,	
O’Connor	ENTITY
JB	
.	

Marked	
improvement	ENTITY
in	
nocturnal	ENTITY
gastroesophageal	ENTITY
reflux	ENTITY
in	
a	
large	
cohort	ENTITY
of	
patients	ENTITY
with	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
treated	ENTITY
with	ENTITY
continuous	
positive	
airway	
pressure	
.	

Arch	ENTITY
Intern	ENTITY
Med	ENTITY
2003;163:41–5	ENTITY
.	

Harding	
SM	ENTITY
,	
Richter	ENTITY
JE	ENTITY
,	
Guzzo	ENTITY
MR	ENTITY
,	
et	
al	
.	

Asthma	ENTITY
and	
gastroesophageal	ENTITY
reflux	ENTITY
:	
acid	ENTITY
suppressive	ENTITY
therapy	ENTITY
improves	
asthma	ENTITY
outcome	ENTITY
.	

Am	
J	
Med	
1996;100:395–405	
.	

Harding	
SM	ENTITY
.	

Gastroesophageal	ENTITY
reflux	ENTITY
during	
sleep	ENTITY
.	

Sleep	ENTITY
Med	ENTITY
Clin	ENTITY
2007;2:41–50	
.	

Locke	ENTITY
GR	
3rd	
,	
Talley	ENTITY
NJ	ENTITY
,	
Fett	ENTITY
SL	ENTITY
,	
et	
al	
.	

Prevalence	ENTITY
and	
clinical	ENTITY
spectrum	ENTITY
of	
gastroesophageal	ENTITY
reflux	ENTITY
:	
a	
population	ENTITY
-	
based	ENTITY
study	ENTITY
in	
Olmstead	ENTITY
County	ENTITY
,	ENTITY
Minnesota	ENTITY
.	

Gastroenterology	ENTITY
1997;112:1448–56	
.	

Mainie	ENTITY
I	ENTITY
,	
Tutuian	ENTITY
R	ENTITY
,	
Shay	ENTITY
S	ENTITY
,	
et	
al	
.	

Acid	ENTITY
and	
non	ENTITY
-	
acid	ENTITY
reflux	ENTITY
in	
patients	ENTITY
with	
persistent	ENTITY
symptoms	ENTITY
despite	
acid	ENTITY
suppressive	ENTITY
therapy	ENTITY
:	
a	
multicentre	ENTITY
study	ENTITY
using	
combined	ENTITY
ambulatory	ENTITY
impedance	ENTITY
pH	ENTITY
monitoring	ENTITY
.	

Gut	ENTITY
2006;55:1398–402	
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	
Disorders	
Schey	ENTITY
R	ENTITY
,	
Dickman	ENTITY
R	ENTITY
,	
Parthasarathy	ENTITY
S	ENTITY
,	
et	
al	
.	

Sleep	ENTITY
deprivation	ENTITY
is	
hyperalgesic	ENTITY
in	
patients	ENTITY
with	
gastroesophageal	ENTITY
reflux	ENTITY
disease	ENTITY
.	

Gastroenterology	ENTITY
2007;133:1787–95	
.	

Shaheen	ENTITY
NJ	ENTITY
,	
Weinberg	ENTITY
DS	ENTITY
,	
Denberg	ENTITY
TD	ENTITY
,	
et	
al	
.	

Upper	ENTITY
endoscopy	ENTITY
for	
gastroesophageal	ENTITY
reflux	ENTITY
disease	ENTITY
:	
Best	ENTITY
Practice	ENTITY
Advice	ENTITY
from	
the	
Clinical	ENTITY
Guidelines	ENTITY
Committee	ENTITY
of	
the	
American	ENTITY
College	ENTITY
of	ENTITY
Physicians	ENTITY
.	

Ann	
Intern	
Med	
2012;157:808–16	
.	

Shaker	ENTITY
R.	ENTITY
Castell	ENTITY
DO	ENTITY
,	
Schoenfeld	ENTITY
PS	ENTITY
,	
et	
al	
.	

Nighttime	ENTITY
heartburn	ENTITY
is	
an	
under	
-	
appreciated	
clinical	ENTITY
problem	ENTITY
that	
impacts	ENTITY
sleep	ENTITY
and	
daytime	ENTITY
function	ENTITY
:	
the	
results	ENTITY
of	
a	
Gallup	ENTITY
survey	ENTITY
conducted	
on	
behalf	ENTITY
of	
the	
American	ENTITY
Gastroenterological	ENTITY
Association	ENTITY
.	

Am	
J	
Gastroenterol	
2003;98:1487–93	
.	

Sontag	ENTITY
SJ	ENTITY
,	
O’Connell	ENTITY
S	ENTITY
,	
Miller	
TQ	ENTITY
,	
et	
al	
.	

Asthmatics	ENTITY
have	
more	
nocturnal	ENTITY
gasping	ENTITY
and	
reflux	ENTITY
symptoms	ENTITY
than	
nonasthmatics	ENTITY
,	
and	
they	
are	
related	
to	
bedtime	ENTITY
eating	ENTITY
.	

Am	
J	
Gastroenterol	
2004;99:789–96	
.	

Sleep	ENTITY
Related	ENTITY
Myocardial	ENTITY
Ischemia	ENTITY
Alternate	ENTITY
Names	ENTITY
Unstable	ENTITY
angina	ENTITY
,	
coronary	ENTITY
insufficiency	ENTITY
-	
acute	ENTITY
,	
nocturnal	ENTITY
angina	ENTITY
,	
angina	ENTITY
decubitus	ENTITY
,	
variant	ENTITY
angina	ENTITY
,	
Prinzmetal	ENTITY
angina	ENTITY
,	
vasospastic	ENTITY
angina	ENTITY
,	
angina	ENTITY
pectoris	ENTITY
,	
atherosclerotic	ENTITY
heart	ENTITY
disease	ENTITY
,	
asymptomatic	ENTITY
cardiac	ENTITY
ischemia	ENTITY
,	
silent	ENTITY
ischemia	ENTITY
.	

Essential	ENTITY
Features	ENTITY
Sleep	
related	
myocardial	ENTITY
ischemia	ENTITY
is	
characterized	
by	
nocturnal	ENTITY
reduction	ENTITY
of	
blood	ENTITY
flow	ENTITY
to	
the	
myocardium	ENTITY
,	
typically	
during	
sleep	ENTITY
.	

The	
symptoms	ENTITY
of	
sleep	ENTITY
related	
myo-	
cardial	ENTITY
ischemia	ENTITY
are	
very	
similar	
to	
those	
that	
characterize	
episodes	ENTITY
of	
cardiac	ENTITY
isch-	
emia	ENTITY
during	
the	
daytime	ENTITY
.	

Classically	
,	
there	
is	
a	
feeling	
of	
chest	ENTITY
pressure	ENTITY
or	
pain	ENTITY
that	
awakens	
the	
patient	ENTITY
from	
sleep	ENTITY
and	
may	
be	
described	
as	
a	
“	
viselike	ENTITY
”	ENTITY
discomfort	ENTITY
.	

The	
discomfort	ENTITY
may	
radiate	
to	
the	
chin	ENTITY
and	
jaw	ENTITY
and	
to	
the	
arm	ENTITY
,	
especially	
the	
left	ENTITY
arm	ENTITY
.	

Associated	ENTITY
Features	ENTITY
Acute	ENTITY
episodes	ENTITY
of	
sleep	
related	
myocardial	ENTITY
ischemia	ENTITY
sometimes	
elicit	
atrial	ENTITY
or	
ventric-	
ular	ENTITY
arrhythmias	ENTITY
.	

Other	
associated	
presentations	ENTITY
include	
acute	ENTITY
onset	ENTITY
of	ENTITY
shortness	ENTITY
of	ENTITY
breath	ENTITY
that	
wakes	
the	
patient	ENTITY
from	
sleep	ENTITY
and	
that	
may	
be	
secondary	ENTITY
to	ENTITY
left	ENTITY
ventricular	ENTITY
diastolic	ENTITY
dysfunction	ENTITY
or	
ischemic	ENTITY
mitral	ENTITY
regurgitation	ENTITY
.	

Other	
related	
features	ENTITY
depend	
on	
the	
trigger	ENTITY
for	
the	
cardiac	ENTITY
ischemia	ENTITY
.	

Ischemic	ENTITY
events	ENTITY
related	
to	
OSA	ENTITY
may	
present	
during	
those	
times	
of	
sleep	ENTITY
when	
nocturnal	ENTITY
desaturation	ENTITY
is	
most	
severe	ENTITY
.	

Cardiac	ENTITY
isch-	
emia	ENTITY
related	
to	
hemodynamic	ENTITY
changes	ENTITY
or	
vasospasm	ENTITY
occurring	
during	
REM	ENTITY
sleep	ENTITY
may	
present	
in	
the	
early	ENTITY
hours	ENTITY
of	
the	
morning	ENTITY
,	
around	
the	
time	ENTITY
of	ENTITY
waking	
,	
when	
REM	ENTITY
sleep	ENTITY
is	
most	
likely	
to	
occur	
.	

Ischemia	ENTITY
associated	ENTITY
with	ENTITY
nocturnal	ENTITY
hypotension	ENTITY
is	
most	
likely	
to	
occur	
during	
slow	ENTITY
wave	ENTITY
(	
N3	
)	
sleep	
,	
when	
blood	ENTITY
pressure	ENTITY
is	
lowest	ENTITY
.	

Clinical	ENTITY
and	
Pathophysiologic	ENTITY
Subtypes	ENTITY
None	
known	
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Demographics	ENTITY

The	
specifics	
of	
prevalence	ENTITY
,	
sex	ENTITY
ratios	ENTITY
,	
and	
age	ENTITY
ranges	ENTITY
have	
not	
been	
comprehensively	
evaluated	ENTITY
.	

Some	
insights	
into	
demographics	ENTITY
can	
be	
extrapolated	
,	
depending	
on	
the	
cause	
of	
nocturnal	ENTITY
angina	ENTITY
.	

For	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
triggered	
by	
OSA	ENTITY
,	
the	
preponderance	
of	
OSA	ENTITY
in	
men	ENTITY
suggests	
that	
middle	ENTITY
-	
aged	ENTITY
men	ENTITY
with	
severe	ENTITY
OSA	ENTITY
are	
more	
likely	
to	
experience	ENTITY
nocturnal	ENTITY
angina	ENTITY
,	
particularly	
if	
they	
have	
more	
severe	ENTITY
coronary	ENTITY
artery	ENTITY
disease	ENTITY
.	

Variant	ENTITY
angina	ENTITY
(	
also	
referred	
to	
as	
vasospastic	ENTITY
or	
Prinzmetal	ENTITY
angina	ENTITY
)	
more	
commonly	
affects	
younger	ENTITY
populations	ENTITY
,	
particularly	
women	ENTITY
and	
those	
of	
Asian	ENTITY
descent	ENTITY
.	

Cardiac	ENTITY
ischemia	ENTITY
secondary	ENTITY
to	ENTITY
nocturnal	ENTITY
hypotension	ENTITY
is	
more	
com-	
monly	ENTITY
manifested	
in	
older	ENTITY
individuals	ENTITY
,	
particularly	
those	
with	
severe	ENTITY
vasculopathy	ENTITY
who	
are	
taking	
multiple	
antihypertensive	ENTITY
medications	ENTITY
,	
and	
especially	
those	
in	
whom	
autonomic	ENTITY
dysfunction	ENTITY
(	
related	
to	
either	
age	ENTITY
or	
diabetes	ENTITY
)	
may	
impair	ENTITY
blood	ENTITY
pressure	ENTITY
homeostatic	ENTITY
mechanisms	
.	

Predisposing	ENTITY
and	
Precipitating	ENTITY
Factors	ENTITY
Predisposing	ENTITY
factors	ENTITY
include	
established	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
or	
valvular	ENTITY
disease	ENTITY
such	
as	
aortic	ENTITY
stenosis	ENTITY
.	

Because	
coronary	ENTITY
filling	ENTITY
occurs	
during	
diastole	ENTITY
,	
conditions	ENTITY
associated	ENTITY
with	ENTITY
reduced	ENTITY
diastolic	ENTITY
blood	ENTITY
pressure	ENTITY
,	
such	
as	
severe	ENTITY
aortic	ENTITY
regurgita-	ENTITY
tion	ENTITY
,	
may	
elicit	
nocturnal	ENTITY
angina	ENTITY
,	
particularly	
in	
the	
presence	ENTITY
of	
preexisting	ENTITY
coro-	

nary	ENTITY
artery	ENTITY
disease	ENTITY
.	

Similarly	
,	
any	
predisposition	ENTITY
to	
hypotension	ENTITY
,	
which	
is	
most	
likely	
to	
occur	
during	
slow	ENTITY
wave	ENTITY
(	
N3	
)	
sleep	
,	
may	
heighten	
risk	ENTITY
.	

Usual	ENTITY
risk	ENTITY
factors	ENTITY
for	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
that	
predispose	
an	
individual	ENTITY
to	
the	
development	ENTITY
of	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
include	
hypertension	ENTITY
,	
diabetes	ENTITY
mellitus	ENTITY
,	
cigarette	ENTITY
smoking	ENTITY
,	
and	
hyperlipidemia	ENTITY
.	

Retrospective	ENTITY
and	
prospective	ENTITY
studies	ENTITY
suggest	
that	
OSA	ENTITY
may	
be	
a	
trigger	ENTITY
for	
myo-	
cardial	ENTITY
infarction	ENTITY
and	
sudden	ENTITY
death	ENTITY
that	
occurs	
at	
night	ENTITY
.	

Deeper	ENTITY
oxyhemoglobin	ENTITY
desaturations	ENTITY
,	
which	
may	
be	
encountered	
in	
REM	ENTITY
,	
particularly	
with	
coexisting	ENTITY
pulmonary	ENTITY
disease	ENTITY
or	
truncal	ENTITY
-	
abdominal	ENTITY
obesity	ENTITY
,	
are	
more	
likely	
to	
trigger	ENTITY
cardiac	ENTITY
ischemia	ENTITY
.	

In	
patients	ENTITY
with	
vasospastic	ENTITY
angina	ENTITY
,	
use	
of	
nonselective	ENTITY
β	ENTITY
-	
adrenergic	ENTITY
receptor	ENTITY
-	
blocking	ENTITY
agents	ENTITY
may	
theoretically	
increase	ENTITY
the	
likelihood	ENTITY
of	
vasospasm	ENTITY
.	

In	
patients	ENTITY
with	
nocturnal	ENTITY
angina	ENTITY
secondary	ENTITY
to	ENTITY
hypotension	ENTITY
,	
an	
excess	ENTITY
of	
antihy-	
pertensive	ENTITY
medications	ENTITY
,	
as	
well	
as	
long	ENTITY
-	
acting	ENTITY
nitroglycerin	ENTITY
administered	ENTITY
prior	
to	
sleep	ENTITY
,	
may	
contribute	
.	

Finally	
,	
in	
the	
proper	
clinical	ENTITY
context	ENTITY
,	
abuse	ENTITY
of	ENTITY
drugs	ENTITY
such	
as	
amphetamine	ENTITY
,	
cocaine	ENTITY
,	
and	
other	
stimulants	ENTITY
,	
needs	
to	
be	
considered	
in	
the	
evaluation	ENTITY
of	
myocardial	ENTITY
ischemia	ENTITY
.	

Familial	ENTITY
Patterns	ENTITY
Familial	ENTITY
patterns	ENTITY
reflect	
those	
of	
the	
underlying	
disease	ENTITY
process	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Onset	ENTITY
,	
Course	ENTITY
,	
and	
Complications	ENTITY
For	
angina	ENTITY
related	
to	
OSA	ENTITY
,	
the	
first	
presentation	ENTITY
of	
nocturnal	ENTITY
angina	ENTITY
may	
occur	
only	
when	
the	
severity	ENTITY
of	
both	
the	
sleep	ENTITY
apnea	ENTITY
and	
the	
coronary	ENTITY
artery	ENTITY
disease	ENTITY
are	
suffi-	
cient	ENTITY
to	
elicit	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
.	

This	
is	
likely	
to	
be	
most	
common	
in	
middle	ENTITY
-	
aged	ENTITY
to	
older	ENTITY
men	ENTITY
,	
particularly	
those	
who	
are	
overweight	ENTITY
,	
although	
several	
studies	ENTITY
have	
documented	ENTITY
life	ENTITY
-	
threatening	ENTITY
OSA	ENTITY
related	
cardiac	ENTITY
ischemia	ENTITY
in	
women	ENTITY
.	

It	
is	
notable	
that	
several	
studies	ENTITY
have	
reported	
cardiac	ENTITY
ischemia	ENTITY
in	
patients	ENTITY
with	
OSA	ENTITY
even	
in	
the	
absence	ENTITY
of	
severe	ENTITY
coronary	ENTITY
artery	ENTITY
stenosis	ENTITY
.	

ST	ENTITY
segment	ENTITY
changes	
occur-	
ring	
as	
a	
result	
of	
OSA	ENTITY
would	
be	
expected	
to	
resolve	
with	
treatment	ENTITY
of	
the	
OSA	ENTITY
.	

Regardless	
of	
the	
underlying	ENTITY
etiology	ENTITY
,	
potential	
complications	ENTITY
of	
sleep	ENTITY
related	
myo-	
cardial	ENTITY
ischemia	ENTITY
include	
acute	ENTITY
left	ENTITY
ventricular	ENTITY
dysfunction	ENTITY
,	
ischemic	ENTITY
mitral	ENTITY
regur-	ENTITY
gitation	ENTITY
and	
pulmonary	ENTITY
edema	ENTITY
,	
arrhythmias	ENTITY
,	
and	
even	
progression	ENTITY
to	
myocardial	ENTITY
infarction	ENTITY
and	
death	ENTITY
.	

Pathology	ENTITY
and	
Pathophysiology	ENTITY
For	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
related	
to	
OSA	ENTITY
,	
the	
apnea	ENTITY
-	
related	ENTITY
hypoxemia	ENTITY
and	
surges	ENTITY
in	
blood	ENTITY
pressure	ENTITY
and	
heart	ENTITY
rate	ENTITY
at	
termination	ENTITY
of	ENTITY
apnea	ENTITY
may	
all	
result	
in	
rel-	
ative	ENTITY
myocardial	ENTITY
oxygen	
deficiency	
.	

A	
substrate	ENTITY
of	
preexisting	
severe	ENTITY
coronary	ENTITY
artery	ENTITY
disease	ENTITY
is	
expected	
to	
exacerbate	ENTITY
this	
problem	ENTITY
.	

Variant	ENTITY
angina	ENTITY
may	
be	
more	
likely	
to	
occur	
during	
sleep	ENTITY
because	
of	
the	
significant	ENTITY
and	
abrupt	ENTITY
fluctuations	ENTITY
in	
cardiovascular	ENTITY
neural	
control	
during	
REM	ENTITY
sleep	ENTITY
.	

For	
nocturnal	ENTITY
angina	ENTITY
related	
to	
hypotension	ENTITY
,	
perfu-	
sion	ENTITY
of	
the	
coronary	ENTITY
arteries	ENTITY
during	
diastole	ENTITY
makes	
maintenance	ENTITY
of	
diastolic	ENTITY
pressures	ENTITY
during	
sleep	ENTITY
important	
for	
adequate	ENTITY
myocardial	ENTITY
perfusion	ENTITY
.	

Autonomic	ENTITY
insufficiency	ENTITY
due	
to	
old	
age	ENTITY
,	
diabetes	ENTITY
,	
and	
medication	ENTITY
effects	ENTITY
blunts	ENTITY
the	
ability	
of	
the	
cardiovascular	ENTITY
system	ENTITY
to	
maintain	
adequate	ENTITY
blood	ENTITY
pressure	ENTITY
.	

Objective	ENTITY
Findings	ENTITY
Electrocardiographic	ENTITY
monitoring	ENTITY
during	
sleep	ENTITY
reveals	
horizontal	ENTITY
or	
downsloping	ENTITY
ST	ENTITY
segment	ENTITY
depression	ENTITY
of	
greater	
than	
or	
equal	
to	
1	
mm	
,	
or	
ST	ENTITY
segment	
elevation	ENTITY
of	
1	
mm	
or	
more	
.	

The	
electrocardiographic	ENTITY
evidence	ENTITY
of	
sleep	ENTITY
related	
coronary	ENTITY
artery	ENTITY
ischemia	ENTITY
is	
sometimes	
unaccompanied	
by	
chest	ENTITY
discomfort	ENTITY
or	
other	
symptoms	ENTITY
(	
silent	ENTITY
ischemia	ENTITY
)	
and	
may	
be	
incidentally	ENTITY
noted	
on	
either	
Holter	ENTITY
monitoring	ENTITY
or	
telemetry	ENTITY
.	

In	
general	
,	
ST	ENTITY
segment	ENTITY
abnormalities	ENTITY
indicative	
of	
myocardial	ENTITY
ischemia	ENTITY
are	
1	
mm	
or	
more	
horizontal	ENTITY
or	
down	ENTITY
-	
sloping	ENTITY
depression	ENTITY
or	
ST	ENTITY
segment	
elevation	ENTITY
,	
which	
may	
be	
detected	ENTITY
on	
the	
single	ENTITY
lead	ENTITY
electrocardiogram	ENTITY
(	
ECG	ENTITY
)	
employed	
in	
most	
sleep	ENTITY
labo-	
ratories	ENTITY
.	

However	
,	
because	
the	
sensitivity	ENTITY
of	
single	ENTITY
-	
lead	ENTITY
ECG	ENTITY
in	
detecting	
ischemic	ENTITY
changes	ENTITY
is	
poor	ENTITY
,	
the	
patient	ENTITY
with	
symptoms	ENTITY
compatible	
with	
angina	ENTITY
with	
a	
normal	ENTITY
-	
ap-	
pearing	
single	
ECG	ENTITY
channel	ENTITY
should	
be	
further	
evaluated	ENTITY
with	
multichannel	ENTITY
ECG	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
in	
patients	ENTITY
without	
sleep	ENTITY
related	
breathing	ENTITY
disor-	
ders	ENTITY
may	
be	
associated	ENTITY
with	ENTITY
REM	ENTITY
sleep	ENTITY
.	

Slow	ENTITY
wave	ENTITY
sleep	ENTITY
with	
a	
fall	ENTITY
in	
blood	ENTITY
pressure	ENTITY
and	
heart	ENTITY
rate	ENTITY
can	
be	
associated	ENTITY
with	ENTITY
ischemia	ENTITY
.	

Sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
,	
par-	ENTITY
ticularly	
OSA	ENTITY
,	
may	
elicit	
oxygen	ENTITY
desaturation	ENTITY
and	
consequent	ENTITY
sleep	ENTITY
related	
myocar-	
dial	ENTITY
ischemia	ENTITY
.	

The	
presence	ENTITY
of	
cardiac	ENTITY
arrhythmias	ENTITY
should	
prompt	
an	
evaluation	ENTITY
for	
nocturnal	ENTITY
ischemia	ENTITY
.	

Differential	ENTITY
Diagnosis	ENTITY
Sleep	
related	
myocardial	ENTITY
ischemia	ENTITY
must	
be	
differentiated	
from	
gastroesophageal	ENTITY
reflux	ENTITY
,	
which	
may	
also	
be	
associated	ENTITY
with	ENTITY
chest	ENTITY
discomfort	ENTITY
.	

The	
nature	ENTITY
of	
the	
pain	ENTITY
,	
associated	ENTITY
symptoms	ENTITY
and	
prior	
history	ENTITY
are	
helpful	
in	
making	
a	
distinction	ENTITY
,	
although	
12	
-	
lead	ENTITY
ECG	ENTITY
may	
be	
necessary	
in	
some	
cases	ENTITY
.	

Nocturnal	ENTITY
panic	ENTITY
attacks	ENTITY
may	
be	
asso-	
ciated	ENTITY
with	
chest	ENTITY
wall	ENTITY
pain	ENTITY
and	
respiratory	ENTITY
distress	ENTITY
.	

Although	
the	
majority	
of	
patients	ENTITY
with	
nocturnal	ENTITY
panic	ENTITY
will	
have	
a	
history	ENTITY
of	
daytime	ENTITY
panic	ENTITY
attacks	ENTITY
,	
a	
small	
percentage	
have	
only	
nocturnal	ENTITY
events	ENTITY
.	

Nocturnal	ENTITY
panic	ENTITY
attacks	ENTITY
typically	
occur	
during	
transition	ENTITY
from	
N2	
to	
N3	ENTITY
sleep	ENTITY
.	

Other	
causes	
of	
nocturnal	ENTITY
respiratory	ENTITY
distress	ENTITY
,	
including	
heart	ENTITY
failure	ENTITY
and	
pulmonary	ENTITY
disease	ENTITY
,	
may	
be	
confused	
with	
myocardial	ENTITY
ischemic	ENTITY
episodes	ENTITY
,	
although	
typical	
anginal	ENTITY
chest	ENTITY
pain	ENTITY
is	
not	
evident	
in	
these	
cases	ENTITY
.	

Chest	ENTITY
pain	ENTITY
due	
to	
thoracic	ENTITY
mass	ENTITY
,	
pleuritic	ENTITY
pain	ENTITY
,	
aortic	ENTITY
aneurysm	ENTITY
,	
or	
other	
thoracic	ENTITY
disease	ENTITY
should	
be	
considered	
in	
the	
differential	ENTITY
diagnosis	ENTITY
.	

Chest	ENTITY
wall	ENTITY
pain	ENTITY
may	
be	
sec-	
ondary	ENTITY
to	
a	
variety	
of	
causes	
such	
as	
trauma	ENTITY
,	
muscle	ENTITY
spasm	ENTITY
,	
or	
immobility	ENTITY
.	

Unresolved	
Issues	ENTITY
and	
Further	
Directions	ENTITY

More	
comprehensive	ENTITY
data	ENTITY
are	
needed	
to	
identify	
the	
prevalence	ENTITY
and	
demographics	ENTITY
of	
the	
various	
causes	
of	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
.	

Further	
information	ENTITY
is	
also	
needed	
to	
explore	
the	
relationship	ENTITY
between	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
and	
the	
circadian	ENTITY
variation	ENTITY
in	
myocardial	ENTITY
infarction	ENTITY
and	
sudden	ENTITY
death	ENTITY
,	
particularly	
the	
role	
of	
treatment	ENTITY
on	
outcomes	ENTITY
.	

Bibliography	ENTITY
Caples	ENTITY
S	ENTITY
,	
Rosen	ENTITY
C	ENTITY
,	
Shen	
W	
,	
et	
al	
.	

The	
scoring	ENTITY
of	
cardiac	ENTITY
events	ENTITY
during	
sleep	ENTITY
.	

J	
Clin	
Sleep	
Med	
2007;15:147–54	
.	

Franklin	ENTITY
K	ENTITY
,	
Nilsson	
J	
,	
Sahlin	ENTITY
C	ENTITY
,	
Naslund	ENTITY
U.	ENTITY
Sleep	ENTITY
apnoea	ENTITY
and	
nocturnal	ENTITY
angina	ENTITY
.	

Lancet	
1995;345:1085–7	
.	

Gami	ENTITY
A	ENTITY
,	
Howard	ENTITY
D	ENTITY
,	
Olson	ENTITY
E	ENTITY
,	
Somers	ENTITY
V.	ENTITY
Day	ENTITY
-	
night	ENTITY
pattern	ENTITY
of	
sudden	ENTITY
death	ENTITY
in	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

New	ENTITY
Engl	ENTITY
J	ENTITY
Med	ENTITY
2005;352:1206–14	ENTITY
.	

Appendix	ENTITY
A	ENTITY
:	
Sleep	ENTITY
Related	ENTITY
Medical	ENTITY
and	
Neurological	ENTITY
Disorders	ENTITY
Muller	ENTITY
J	ENTITY
,	
Ludmer	
P	
,	
Willich	
S	
,	
et	
al	
.	

Circadian	ENTITY
variation	ENTITY
and	
the	
frequency	ENTITY
of	
sudden	ENTITY
cardiac	ENTITY
death	ENTITY
.	

Circulation	ENTITY
1987;75:131–8	
.	

Nowlin	ENTITY
J	ENTITY
,	
Troyer	ENTITY
WJ	ENTITY
,	
Collins	ENTITY
W	ENTITY
,	
et	
al	
.	

The	
association	ENTITY
of	
nocturnal	ENTITY
angina	ENTITY
pectoris	ENTITY
with	
dreaming	ENTITY
.	

Ann	
Intern	
Med	
1965;63:1040–6	
.	

Schroeder	ENTITY
J	ENTITY
,	ENTITY
Motta	ENTITY
J	ENTITY
,	ENTITY
Guilleminault	ENTITY
C.	ENTITY
Hemodynamic	ENTITY
studies	ENTITY
in	
sleep	ENTITY
apnea	ENTITY
.	

In	
:	
Guilleminault	ENTITY
C	ENTITY
,	
Dement	
W	
,	
eds	
.	

Sleep	ENTITY
Apnea	ENTITY
Syndromes	ENTITY
.	

New	ENTITY
York	ENTITY
:	

Alan	ENTITY
R.	ENTITY
Liss	ENTITY
,	
1978:177–96	
.	

Sert	ENTITY
Kuniyoshi	ENTITY
F	ENTITY
,	
Garcia	ENTITY
-	
Touchard	ENTITY
A	ENTITY
,	
Gami	ENTITY
A	ENTITY
,	
et	
al	
.	

Day	ENTITY
-	
night	ENTITY
variation	ENTITY
of	
acute	ENTITY
myocardial	ENTITY
infarction	ENTITY
in	
obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
.	

J	
Amer	
Coll	
Cardiol	
2008;52:343–6	
.	

Verrier	ENTITY
R	ENTITY
,	
Muller	ENTITY
J	ENTITY
,	
Hobson	
J.	
Sleep	
,	
dreams	ENTITY
,	
and	
sudden	ENTITY
death	ENTITY
:	
the	
case	ENTITY
for	
sleep	ENTITY
as	
an	
autonomic	ENTITY
stress	ENTITY
test	ENTITY
for	
the	
heart	ENTITY
.	

Cardiovasc	ENTITY
Res	ENTITY
1996;31:181	ENTITY
-	ENTITY
211	ENTITY
.	

Appendix	ENTITY
B	ENTITY
:	
ICD-10	ENTITY
-	
CM	ENTITY
Coding	ENTITY
for	
Substance-	
Induced	
Sleep	
Disorders	
ICD-10	ENTITY
-	
CM	ENTITY
coding	ENTITY
for	
substance	ENTITY
-	
induced	ENTITY
disorders	ENTITY
is	
more	
complex	ENTITY
than	
ICD-9	ENTITY
-	
CM	ENTITY
coding	ENTITY
.	

The	
series	
F10.xxx-F19.xxx	
(	
which	
is	
the	
general	ENTITY
section	ENTITY
for	
substance	ENTITY
-	
in-	
duced	ENTITY
mental	ENTITY
and	
behavioral	ENTITY
disorders	ENTITY
in	
ICD-10	ENTITY
-	
CM	ENTITY
)	
contains	
the	
pertinent	
codes	ENTITY
for	
substance	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorders	ENTITY
.	

There	
are	
specific	
codes	ENTITY
for	
sleep	ENTITY
disorders	ENTITY
induced	ENTITY
by	
alcohol	ENTITY
,	
opioids	ENTITY
,	
sedatives	ENTITY
,	
cocaine	ENTITY
,	
other	
stimulants	ENTITY
and	
other	
psychoactive	ENTITY
sub-	ENTITY
stances	ENTITY
.	

However	
,	
in	
the	
case	ENTITY
of	
cannabis	ENTITY
,	
hallucinogens	ENTITY
,	
nicotine	ENTITY
and	
inhalants	ENTITY
,	
there	
are	
no	
sleep	ENTITY
-	
specific	ENTITY
codes	ENTITY
.	

In	
these	
instances	
,	
the	
coder	ENTITY
must	
use	
an	
“	
unspecified	ENTITY
”	
or	
“	
other	
”	
code	ENTITY
.	

A	
detailed	
list	
of	
the	
appropriate	
codes	ENTITY
for	
substance	ENTITY
-	
induced	ENTITY
sleep	ENTITY
dis-	
orders	ENTITY
is	
included	
in	
the	
table	
below	
.	

Substance	ENTITY
Relevant	ENTITY
ICD-10	ENTITY
-	
CM	ENTITY
Codes	ENTITY
Alcohol	ENTITY
F10.182	ENTITY
Alcohol	ENTITY
abuse	ENTITY
with	
alcohol	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F10.282	ENTITY
Alcohol	
dependence	ENTITY
with	
alcohol	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F10.982	ENTITY
Alcohol	ENTITY
use	ENTITY
,	
unspecified	
with	
alcohol	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Opioid	ENTITY
F11.182	ENTITY
Opioid	ENTITY
abuse	ENTITY
with	
opioid	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F11.282	ENTITY
Opioid	ENTITY
dependence	
with	
opioid	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F11.982	
Opioid	ENTITY
use	
,	
unspecified	
with	
opioid	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Cannabis	ENTITY
F12.188	ENTITY
Cannabis	ENTITY
abuse	ENTITY
with	
other	
cannabis	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F12.288	
Cannabis	ENTITY
dependence	
with	
other	
cannabis	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F12.988	
Cannabis	ENTITY
use	ENTITY
,	
unspecified	
with	
other	
cannabis	ENTITY
-	
induced	ENTITY
disorder	ENTITY
Sedative	ENTITY
,	
Hypnotic	ENTITY
or	
Anxiolytic	ENTITY
F13.182	ENTITY
Sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
abuse	ENTITY
with	
sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F13.282	ENTITY
Sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
dependence	
with	
sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F13.982	ENTITY
Sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
use	ENTITY
,	
unspecified	
with	
sedative	ENTITY
,	
hypnotic	ENTITY
or	
anxiolytic	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Appendix	ENTITY
B	ENTITY
:	
ICD-10	ENTITY
-	
CM	ENTITY
Coding	ENTITY
for	
Substance	ENTITY
-	
Induced	ENTITY
Sleep	ENTITY
Disorders	ENTITY
Substance	

Relevant	ENTITY
ICD-10	ENTITY
-	
CM	ENTITY
Codes	ENTITY
Cocaine	ENTITY
F14.182	ENTITY
Cocaine	ENTITY
abuse	ENTITY
with	
cocaine	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F14.282	ENTITY
Cocaine	ENTITY
dependence	ENTITY
with	
cocaine	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F14.982	
Cocaine	ENTITY
use	ENTITY
,	
unspecified	
with	
cocaine	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Other	
Stimulant	ENTITY
(	
includes	
amphetamine	ENTITY
and	
caffeine	ENTITY
)	

F15.182	ENTITY
Other	
stimulant	ENTITY
abuse	ENTITY
with	
stimulant	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F15.282	ENTITY
Other	
stimulant	ENTITY
dependence	ENTITY
with	
stimulant	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F15.982	ENTITY
Other	
stimulant	ENTITY
use	ENTITY
,	
unspecified	
with	
stimulant	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Hallucinogen	ENTITY
(	
includes	
ecstasy	ENTITY
,	
PCP	ENTITY
,	
phencyclidine	ENTITY
)	

F16.188	ENTITY
Hallucinogen	ENTITY
abuse	ENTITY
with	
other	
hallucinogen	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F16.288	ENTITY
Hallucinogen	ENTITY
dependence	ENTITY
with	
other	
hallucinogen	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F16.988	ENTITY
Hallucinogen	ENTITY
use	ENTITY
,	
unspecified	
with	
other	
hallucinogen-	
induced	ENTITY
disorder	ENTITY
Nicotine	ENTITY
F17.208	ENTITY
Nicotine	ENTITY
dependence	ENTITY
,	
unspecified	ENTITY
,	
with	
other	
nicotine-	
induced	ENTITY
disorders	ENTITY
F17.218	ENTITY
Nicotine	ENTITY
dependence	ENTITY
,	
cigarettes	ENTITY
,	
with	
other	
nicotine	ENTITY
-	
induced	ENTITY
disorders	ENTITY
F17.228	ENTITY
Nicotine	ENTITY
dependence	ENTITY
,	
chewing	ENTITY
tobacco	ENTITY
,	
with	
other	
nicotine-	
induced	ENTITY
disorders	ENTITY
F17.298	
Nicotine	ENTITY
dependence	ENTITY
,	
other	
tobacco	ENTITY
product	ENTITY
,	
with	
other	
nicotine	ENTITY
-	
induced	ENTITY
disorders	ENTITY
Inhalant	ENTITY
(	
includes	
volatile	ENTITY
solvents	ENTITY
)	

F18.188	ENTITY
Inhalant	ENTITY
abuse	ENTITY
with	
other	
inhalant	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F18.288	
Inhalant	ENTITY
dependence	
with	
other	
inhalant	ENTITY
-	
induced	ENTITY
disorder	ENTITY
F18.988	ENTITY
Inhalant	ENTITY
use	
,	
unspecified	
with	
other	
inhalant	ENTITY
-	
induced	ENTITY
disorder	ENTITY
Other	
Psychoactive	ENTITY
Substance	ENTITY
(	
includes	
polysubstance	ENTITY
drug	ENTITY
use	ENTITY
)	

F19.182	ENTITY
Other	
psychoactive	ENTITY
substance	ENTITY
abuse	
with	
psychoactive	ENTITY
substance	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F19.282	ENTITY
Other	
psychoactive	ENTITY
substance	ENTITY
dependence	
with	
psychoactive	ENTITY
substance	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
F19.982	
Other	
psychoactive	ENTITY
substance	ENTITY
use	
,	
unspecified	
with	
psychoactive	ENTITY
substance	ENTITY
-	
induced	ENTITY
sleep	ENTITY
disorder	ENTITY
Glossary	ENTITY
Actigraphy	ENTITY
:	
A	
measurement	ENTITY
of	
physical	ENTITY
activity	ENTITY
,	
typically	
via	
a	
wrist	ENTITY
-	
worn	ENTITY
movement	ENTITY
sensor	ENTITY
,	
employed	
to	
estimate	ENTITY
sleep	ENTITY
and	
wakefulness	ENTITY
based	
on	
relative	
levels	ENTITY
of	
physical	ENTITY
inactivity	ENTITY
and	
activity	ENTITY
.	

Alveolar	ENTITY
Hypoventilation	ENTITY
:	
A	
condition	ENTITY
in	
which	
ventilation	ENTITY
of	
the	
lung	ENTITY
gas	ENTITY
exchanging	
units	ENTITY
is	
decreased	ENTITY
relative	
to	
the	
carbon	ENTITY
dioxide	ENTITY
production	ENTITY
(	
excretion	ENTITY
)	
such	
that	
the	
arterial	ENTITY
partial	
pressure	
of	
carbon	ENTITY
dioxide	ENTITY
is	
increased	ENTITY
.	

Alveolar	ENTITY
ventilation	ENTITY
is	
equal	
to	
the	
minute	ENTITY
ventilation	ENTITY
(	
tidal	ENTITY
volume	ENTITY
×	
respiratory	ENTITY
rate	ENTITY
)	
minus	
the	
dead	ENTITY
space	ENTITY
ventilation	ENTITY
.	

Apneic	ENTITY
Threshold	
:	

The	
value	
of	
PaCO2	ENTITY
below	
which	
central	ENTITY
apnea	ENTITY
occurs	
during	
NREM	ENTITY
sleep	ENTITY
.	

Ataxic	ENTITY
Breathing	ENTITY
:	
A	
breathing	ENTITY
pattern	ENTITY
consisting	
of	
irregular	ENTITY
variation	ENTITY
in	
tidal	ENTITY
volume	ENTITY
and	
respiratory	ENTITY
rate	ENTITY
,	
characteristic	
of	
the	
effects	ENTITY
of	ENTITY
opioids	ENTITY
on	
breathing	ENTITY
.	

Autonomic	ENTITY
Arousal	ENTITY
:	
An	
abrupt	
shift	
in	
autonomic	ENTITY
nervous	ENTITY
system	ENTITY
activity	ENTITY
during	
sleep	ENTITY
characterized	ENTITY
by	
an	
increase	ENTITY
in	
sympathetic	ENTITY
activity	ENTITY
,	
including	
heart	ENTITY
rate	ENTITY
and	
blood	ENTITY
pressure	ENTITY
.	

Biological	ENTITY
Day	ENTITY
/	
Night	ENTITY
:	
In	
humans	ENTITY
,	
biological	ENTITY
day	ENTITY
refers	
to	
the	
internal	ENTITY
circadian	ENTITY
time	
when	
wakefulness	ENTITY
and	
associated	ENTITY
functions	ENTITY
are	
promoted	ENTITY
(	
e.g.	
,	
when	
endogenous	ENTITY
melatonin	ENTITY
levels	ENTITY
are	
low	ENTITY
)	
.	

Biological	ENTITY
night	ENTITY
refers	
to	
the	
internal	ENTITY
circadian	ENTITY
time	
when	
sleep	ENTITY
and	
associated	ENTITY
functions	ENTITY
are	
promoted	ENTITY
(	
e.g.	
,	
when	
endogenous	ENTITY
melatonin	ENTITY
levels	ENTITY
are	
high	
)	
.	

Cataplexy	ENTITY
:	

More	
than	
one	
episode	ENTITY
of	
generally	
brief	
(	
<	
2	
minutes	ENTITY
)	
,	
usually	
bilaterally	ENTITY
symmetrical	ENTITY
sudden	ENTITY
loss	ENTITY
of	
muscle	ENTITY
tone	ENTITY
with	
retained	
consciousness	ENTITY
.	

The	
episodes	ENTITY
are	
precipitated	ENTITY
by	
strong	
emotions	ENTITY
,	
usually	
positive	ENTITY
,	
with	
almost	
all	
patients	ENTITY
reporting	
some	
episodes	ENTITY
precipitated	ENTITY
by	
emotions	ENTITY
associated	ENTITY
with	ENTITY
laughter	ENTITY
.	

Chemosensitivity	ENTITY
:	
The	
sensitivity	ENTITY
of	
the	
chemoreceptors	ENTITY
to	
increases	ENTITY
in	
PCO2	ENTITY
or	
decreases	ENTITY
in	
PO2	ENTITY
.	

In	
humans	ENTITY
this	
is	
measured	ENTITY
by	
increases	ENTITY
in	
ventilation	ENTITY
associated	ENTITY
with	ENTITY
these	
stimuli	ENTITY
.	

Chronotype	ENTITY
:	
Individual	ENTITY
timing	ENTITY
preference	ENTITY
for	
various	
physical	ENTITY
and	
mental	ENTITY
activities	ENTITY
,	
and	
sleep	ENTITY
and	
wakefulness	ENTITY
,	
over	
the	
course	ENTITY
of	
a	
day	ENTITY
.	

“	
Morningness	ENTITY
”	
refers	
to	
preference	ENTITY
for	
earlier	
timing	ENTITY
of	
activities	ENTITY
and	
sleep	ENTITY
initiation	ENTITY
;	
“	
eveningness	ENTITY
”	
refers	
to	
preference	ENTITY
for	
later	
timing	ENTITY
of	
activities	ENTITY
and	
sleep	ENTITY
initiation	ENTITY
.	

Glossary	ENTITY
Circadian	ENTITY
Misalignment	ENTITY
:	

Incorrect	ENTITY
or	
inappropriate	
timing	ENTITY
of	
sleep	ENTITY
and	
wakefulness	ENTITY
with	
respect	
to	
internal	ENTITY
circadian	ENTITY
timing	ENTITY
(	
e.g.	
,	
the	
wake	ENTITY
episode	ENTITY
occurring	
entirely	
or	
partially	
during	
the	
biological	ENTITY
night	ENTITY
and/or	
the	
major	ENTITY
sleep	ENTITY
episode	ENTITY
occurring	
entirely	
or	
partially	
during	
the	
biological	ENTITY
day	ENTITY
)	
.	

Circadian	ENTITY
Period	ENTITY
(	
tau	ENTITY
):	
The	
time	
it	
takes	
to	
complete	
one	
circadian	ENTITY
cycle	ENTITY
(	
e.g.	
,	
time	ENTITY
from	
one	
circadian	ENTITY
phase	ENTITY
on	
day	ENTITY
1	
to	
the	
same	
circadian	ENTITY
phase	ENTITY
on	
day	
2	
)	
.	

Circadian	ENTITY
Phase	ENTITY
:	
The	
time	ENTITY
at	
which	
a	
particular	
event	ENTITY
occurs	
within	
the	
circadian	ENTITY
cycle	ENTITY
(	
e.g.	
,	
onset	ENTITY
,	
offset	ENTITY
,	
trough	
,	
peak	
)	
.	

Circadian	ENTITY
Rhythm	ENTITY
:	
Biological	ENTITY
oscillation	ENTITY
,	
with	
a	
periodicity	ENTITY
near	
24	
hours	ENTITY
,	
which	
is	
clock-	
driven	
(	
i.e.	
,	
not	
caused	
by	
external	ENTITY
or	
non	ENTITY
-	
circadian	ENTITY
clock	
factors	
)	
.	

Comorbid	ENTITY
Insomnia	ENTITY
:	
An	
insomnia	ENTITY
syndrome	ENTITY
thought	
to	
have	
partial	ENTITY
or	
total	
independence	ENTITY
from	
a	
co	ENTITY
-	
occurring	ENTITY
sleep	ENTITY
disorder	ENTITY
or	
sleep	ENTITY
-	
disruptive	ENTITY
medical	ENTITY
,	
psychiatric	ENTITY
,	
substance	ENTITY
dependence	ENTITY
/	
abuse	ENTITY
disorder	ENTITY
.	

Conditioned	ENTITY
Arousal	ENTITY
:	
An	
arousal	ENTITY
response	ENTITY
developed	
by	
the	
repeated	
association	ENTITY
of	
a	
specific	
setting	
such	
as	
the	
bedroom	ENTITY
with	
unsuccessful	
sleep	ENTITY
attempts	ENTITY
.	

Cortical	ENTITY
Arousal	ENTITY
:	
An	
abrupt	
shift	
of	
EEG	ENTITY
frequency	ENTITY
to	
a	
faster	
frequency	ENTITY
lasting	
at	
least	
3	
seconds	
,	
indicating	
cortical	ENTITY
activation	ENTITY
.	

Cyclic	ENTITY
Alternating	ENTITY
Pattern	ENTITY
(	
CAP	ENTITY
):	
The	
occurrence	ENTITY
in	
NREM	ENTITY
sleep	ENTITY
of	
transient	ENTITY
EEG	ENTITY
events	ENTITY
(	
phase	ENTITY
A	ENTITY
,	
subtypes	ENTITY
A1	ENTITY
,	
A2	ENTITY
and	ENTITY
A3	ENTITY
)	
interrupting	ENTITY
the	
background	ENTITY
activity	ENTITY
(	
phase	ENTITY
B	ENTITY
)	
.	

CAP	ENTITY
is	
a	
sensitive	ENTITY
marker	ENTITY
of	
sleep	ENTITY
instability	ENTITY
,	
usually	
increased	ENTITY
in	
sleep	ENTITY
disorders	ENTITY
that	
adversely	ENTITY
affect	
sleep	ENTITY
continuity	ENTITY
.	

Dim	ENTITY
Light	ENTITY
Melatonin	ENTITY
Onset	ENTITY
(	
DLMO	ENTITY
):	
A	
marker	ENTITY
of	
internal	ENTITY
circadian	ENTITY
phase	ENTITY
designated	
by	
the	
rise	
in	
melatonin	ENTITY
above	
low	
daytime	
levels	
,	
typically	
assessed	ENTITY
via	
blood	ENTITY
or	
salivary	ENTITY
melatonin	ENTITY
levels	ENTITY
.	

Melatonin	ENTITY
levels	ENTITY
are	
reduced	ENTITY
by	
exposure	ENTITY
to	ENTITY
light	ENTITY
and	
thus	
need	
to	
be	
assessed	ENTITY
in	
dim	ENTITY
light	ENTITY
to	
be	
accurate	ENTITY
.	

Dopaminergic	ENTITY
:	

Related	
to	
the	
neurotransmitter	ENTITY
dopamine	ENTITY
.	

Dystonia	ENTITY
:	
Involuntary	ENTITY
muscle	ENTITY
contractions	ENTITY
that	
result	
in	
slow	
repetitive	ENTITY
movements	ENTITY
or	
abnormal	ENTITY
postures	ENTITY
.	

Early	ENTITY
Morning	ENTITY
Awakening	ENTITY
:	
The	
termination	ENTITY
of	ENTITY
sleep	ENTITY
at	
least	
30	
minutes	ENTITY
before	
the	
desired	
rising	ENTITY
time	
with	
a	
concomitant	ENTITY
reduced	ENTITY
total	ENTITY
sleep	ENTITY
time	ENTITY
compared	
to	
the	
usual	
premorbid	ENTITY
sleep	
pattern	
.	

Electromyogram	ENTITY
(	
EMG	ENTITY
):	
Physiological	ENTITY
recording	ENTITY
of	
muscle	ENTITY
activity	ENTITY
,	
based	
on	
electrical	ENTITY
activity	ENTITY
that	
accompanies	
muscle	ENTITY
contraction	ENTITY
.	

For	
sleep	ENTITY
monitoring	ENTITY
purposes	
,	
EMG	ENTITY
is	
typically	
recorded	
from	
skin	ENTITY
surface	ENTITY
rather	
than	
intramuscular	ENTITY
electrodes	ENTITY
.	

Entrained	ENTITY
/	
Entrainment	ENTITY
:	
The	
successful	
end	
result	
(	
entrained	ENTITY
)	
or	
process	ENTITY
of	
(	
entrainment	
)	
synchronization	ENTITY
of	
an	
internal	ENTITY
circadian	
clock	
to	
the	
environment	ENTITY
(	
e.g.	
,	
light	ENTITY
dark	ENTITY
cycle	ENTITY
)	
,	
producing	
a	
stable	ENTITY
phase	
relationship	ENTITY
between	
the	
circadian	ENTITY
clock	
and	
environmental	ENTITY
time	ENTITY
.	

Fatigue	ENTITY
:	
A	
lack	
of	
energy	
,	
accompanied	
by	
a	
desire	ENTITY
to	
reduce	ENTITY
or	
limit	
activity	ENTITY
levels	ENTITY
.	

This	
symptom	ENTITY
should	
be	
differentiated	
from	
reports	ENTITY
of	
subjective	ENTITY
sleepiness	ENTITY
as	
well	
as	
from	
unintended	ENTITY
sleep	ENTITY
episodes	ENTITY
.	

Homeostasis	ENTITY
:	

The	
tendency	
of	
a	
living	ENTITY
organism	ENTITY
to	
maintain	
internal	ENTITY
equilibrium	ENTITY
by	
adjusting	
and	
regulating	ENTITY
its	
physiological	ENTITY
processes	ENTITY
.	

Hypercapnia	ENTITY
:	
Elevation	ENTITY
of	
the	
arterial	ENTITY
partial	
pressure	
of	
carbon	ENTITY
dioxide	ENTITY
(	
PaCO2	ENTITY
)	
to	
a	
level	ENTITY
>	
45	
mm	

Hg	
during	
wakefulness	ENTITY
.	

Hypersomnolence	ENTITY
:	
Excessive	ENTITY
sleepiness	ENTITY
during	
the	
normal	ENTITY
wake	ENTITY
period	ENTITY
.	

Hypersomnia	ENTITY
:	
A	
disorder	ENTITY
characterized	ENTITY
by	
excessive	ENTITY
sleepiness	ENTITY
(	
e.g.	
idiopathic	ENTITY
hypersomnia	ENTITY
)	
.	

Hypnagogic	ENTITY
Hallucinations	ENTITY
:	

Vivid	ENTITY
dreamlike	ENTITY
experiences	ENTITY
occurring	
at	
the	
transition	ENTITY
from	
wake	ENTITY
to	ENTITY
sleep	ENTITY
.	

Hypnopompic	ENTITY
Hallucinations	ENTITY
:	

Vivid	ENTITY
dreamlike	ENTITY
experiences	ENTITY
occurring	
at	
the	
transition	ENTITY
from	
sleep	ENTITY
to	
wake	
.	

Myalgia	ENTITY
:	
Muscle	ENTITY
pain	ENTITY
.	

Nonrestorative	ENTITY
Sleep	ENTITY
:	
Sleep	ENTITY
that	
is	
perceived	ENTITY
to	
be	
poor	ENTITY
in	
quality	ENTITY
and	
unrefreshing	ENTITY
,	
resulting	
in	
a	
sense	ENTITY
of	ENTITY
feeling	ENTITY
unrested	ENTITY
upon	
awakening	ENTITY
.	

Glossary	
Glossary	
Odds	ENTITY
Ratio	ENTITY
:	

A	
statistical	ENTITY
term	ENTITY
that	
provides	
a	
measure	ENTITY
of	
the	
strength	ENTITY
of	
relationship	ENTITY
between	
two	
variables	ENTITY
;	
the	
odds	ENTITY
of	
an	
event	ENTITY
occurring	
in	
one	
group	ENTITY
compared	
to	
the	
odds	ENTITY
of	
it	
occurring	
in	
another	
group	ENTITY
.	

Oneirism	ENTITY
:	
Acting	ENTITY
-	
out	
of	
dreams	ENTITY
,	
usually	
from	
REM	ENTITY
sleep	ENTITY
.	

Out	
of	
Center	ENTITY
Sleep	ENTITY
Testing	ENTITY
:	
A	
sleep	ENTITY
study	ENTITY
performed	
outside	
of	
the	
sleep	ENTITY
center	ENTITY
,	
usually	
at	
a	
patient	ENTITY
’s	ENTITY
home	ENTITY
and	
with	
limited	ENTITY
(	
typically	
respiratory	
related	
)	
channels	
(	
parameters	ENTITY
)	
recorded	
.	

Parasomnia	ENTITY
Pseudo	ENTITY
-	
Suicide	ENTITY
:	
A	
death	ENTITY
,	
erroneously	
attributed	
by	
authorities	ENTITY
to	
suicide	ENTITY
,	
which	
results	
from	
complex	ENTITY
parasomnia	ENTITY
,	
usually	
from	
NREM	ENTITY
sleep	ENTITY
.	

Parkinson	ENTITY
Disease	ENTITY
:	
A	
neurodegenerative	ENTITY
movement	ENTITY
disorder	ENTITY
which	
may	
result	
in	
bradykinesia	ENTITY
,	
rigidity	ENTITY
,	
tremor	ENTITY
,	
and/or	
postural	ENTITY
instability	ENTITY
,	
and	
eventually	
cognitive	ENTITY
decline	ENTITY
.	

Phase	ENTITY
Advance	ENTITY
/	
Delay	ENTITY
:	
A	
shift	
in	
the	
timing	ENTITY
of	
the	
internal	ENTITY
circadian	ENTITY
clock	ENTITY
in	
which	
circadian	ENTITY
phase	ENTITY
is	
moved	
earlier	
(	
advance	ENTITY
,	
such	
as	
required	
for	
eastward	ENTITY
jet	ENTITY
travel	ENTITY
or	
to	
assume	
an	
earlier	
sleep	ENTITY
schedule	ENTITY
)	
or	
later	
(	
delay	ENTITY
,	
such	
as	
required	
for	
westward	ENTITY
jet	ENTITY
travel	ENTITY
or	
to	
assume	
a	
later	
sleep	ENTITY
schedule	ENTITY
)	
.	

Phase	ENTITY
Response	ENTITY
Curve	ENTITY
:	
Graphic	ENTITY
representation	ENTITY
that	
describes	
the	
circadian	ENTITY
phase	
shifting	
response	ENTITY
to	
a	
time	ENTITY
cue	ENTITY
(	
e.g.	
,	
light	
)	
as	
a	
function	ENTITY
of	
the	
internal	ENTITY
circadian	ENTITY
time	ENTITY
at	
which	
the	
cue	ENTITY
is	
presented	
.	

Phase	ENTITY
Tolerance	ENTITY
:	

The	
ability	
to	
be	
awake	ENTITY
or	
asleep	ENTITY
at	
an	
inappropriate	ENTITY
internal	ENTITY
circadian	ENTITY
time	
.	

Physiological	ENTITY
Hyperarousal	ENTITY
:	
A	
state	
of	
chronic	ENTITY
physiologic	ENTITY
arousal	ENTITY
as	
reflected	
by	
measures	ENTITY
such	
as	
increased	ENTITY
mean	
latency	ENTITY
on	
MSLT	ENTITY
,	
increased	ENTITY
metabolic	ENTITY
rate	ENTITY
and	
glucose	ENTITY
metabolism	ENTITY
in	
the	
CNS	ENTITY
(	
PET	ENTITY
scan	ENTITY
)	
,	
decreased	ENTITY
heart	ENTITY
rate	ENTITY
variability	ENTITY
and	
increased	ENTITY
heart	ENTITY
rate	ENTITY
.	

PHOX2B	ENTITY
:	

A	
paired	ENTITY
-	
like	
homobox	ENTITY
gene	ENTITY
,	
mutation	ENTITY
of	
which	
is	
the	
defining	
abnormality	ENTITY
of	
Congenital	ENTITY
Central	ENTITY
Hypoventilation	ENTITY
Syndrome	ENTITY
.	

Prevalence	ENTITY
:	

The	
proportion	ENTITY
of	
the	
population	ENTITY
affected	ENTITY
by	
a	
disease	ENTITY
or	
condition	ENTITY
at	
a	
given	
time	ENTITY
;	
prevalence	ENTITY
indicates	
how	
widespread	
a	
disease	ENTITY
or	
condition	ENTITY
is	
,	
thereby	
serving	
as	
a	
measure	ENTITY
of	
its	
burden	ENTITY
on	
society	ENTITY
.	

REM	ENTITY
Sleep	ENTITY
without	
Atonia	ENTITY
,	
REM	ENTITY
-	
without	ENTITY
Atonia	ENTITY
:	
The	
intermittent	ENTITY
or	
continuous	ENTITY
loss	ENTITY
of	
the	
normal	ENTITY
muscle	ENTITY
atonia	ENTITY
of	
REM	ENTITY
sleep	ENTITY
.	

Reverse	ENTITY
First	ENTITY
Night	ENTITY
Effect	
:	
A	
propensity	
to	
sleep	ENTITY
better	
than	
usual	
on	
the	
first	
night	ENTITY
in	
the	
sleep	ENTITY
laboratory	ENTITY
.	

Sleep	ENTITY
Attacks	ENTITY
:	
Inappropriate	ENTITY
falling	ENTITY
asleep	ENTITY
with	
few	
or	
no	
prodromal	ENTITY
symptoms	ENTITY
of	
sleepiness	ENTITY
.	

Sleep	ENTITY
Diary	ENTITY
(	
sleep	ENTITY
log	ENTITY
):	
An	
instrument	ENTITY
used	
by	
individuals	ENTITY
to	
keep	
records	ENTITY
of	
their	
nightly	ENTITY
sleep	ENTITY
duration	ENTITY
and	
quality	ENTITY
over	
a	
period	ENTITY
of	
days	ENTITY
to	
weeks	ENTITY
.	

Sleep	ENTITY
Drunkenness	ENTITY
(	
prolonged	ENTITY
sleep	ENTITY
inertia	ENTITY
):	
Prolonged	ENTITY
difficulty	ENTITY
waking	ENTITY
up	
after	
a	
night	ENTITY
’s	ENTITY
sleep	ENTITY
or	
a	
nap	ENTITY
with	
repeated	
returns	
to	
sleep	ENTITY
,	
irritability	ENTITY
,	
automatic	ENTITY
behavior	ENTITY
and	
confusion	ENTITY
.	

Sleep	ENTITY
Homeostasis	ENTITY
:	
A	
process	ENTITY
which	
describes	
the	
propensity	
for	
sleep	ENTITY
driven	
by	
duration	ENTITY
of	
prior	
time	ENTITY
awake	ENTITY
and	
sleep	ENTITY
history	ENTITY
.	

Sleep	ENTITY
Hygiene	ENTITY
:	
A	
set	
of	
rules	ENTITY
/	
instructions	ENTITY
about	
lifestyle	ENTITY
(	
caffeine	ENTITY
intake	ENTITY
,	
alcohol	ENTITY
and	
tobacco	ENTITY
use	ENTITY
,	
diet	ENTITY
,	
etc	
.	
)	

and	
environmental	ENTITY
factors	ENTITY
(	
light	ENTITY
,	
noise	ENTITY
,	
temperature	ENTITY
)	
that	
affect	
overall	ENTITY
sleep	ENTITY
duration	ENTITY
and	
quality	ENTITY
.	

Sleep	ENTITY
Onset	ENTITY
REM	ENTITY
Period	ENTITY
(	
SOREMP	ENTITY
):	
REM	ENTITY
sleep	ENTITY
occurring	
within	
15	
minutes	
of	
sleep	ENTITY
onset	ENTITY
on	
a	
multiple	ENTITY
sleep	ENTITY
latency	ENTITY
test	ENTITY
or	
overnight	ENTITY
polysomnogram	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Abnormal	ENTITY
Sexual	ENTITY
Behaviors	ENTITY
:	
Any	
of	
a	
spectrum	ENTITY
of	
sexualized	ENTITY
behaviors	ENTITY
which	
arise	
from	
sleep	ENTITY
,	
typically	
NREM	ENTITY
sleep	ENTITY
.	

Sleep	ENTITY
Related	ENTITY
Violence	ENTITY
:	
Violent	ENTITY
behavior	ENTITY
which	
is	
associated	ENTITY
with	ENTITY
a	
NREM	ENTITY
parasomnia	ENTITY
when	
the	
affected	ENTITY
individual	ENTITY
is	
accidentally	
provoked	
by	
another	
person	ENTITY
in	
close	
proximity	ENTITY
–	
usually	
a	
family	ENTITY
member	ENTITY
.	

Suggested	
Immobilization	ENTITY
Test	ENTITY
:	
A	
procedure	ENTITY
for	
evaluation	ENTITY
of	
periodic	ENTITY
leg	ENTITY
movements	ENTITY
and	
related	
sensory	ENTITY
components	ENTITY
of	
RLS	ENTITY
during	
resting	ENTITY
wakefulness	ENTITY
.	

A	
standard	
polysomnogram	ENTITY
recording	
without	
respiratory	ENTITY
measures	ENTITY
is	
used	
for	
one	
hour	ENTITY
while	
the	
subject	ENTITY
sits	
quietly	ENTITY
awake	ENTITY
and	
upright	ENTITY
in	
bed	ENTITY
with	ENTITY
the	
legs	ENTITY
outstretched	ENTITY
.	

Glossary	ENTITY
Index	ENTITY
A	ENTITY
Actigraphy	ENTITY
35	
,	
144	
,	
152	
,	
159	
,	
161–163	
,	
165	
,	
182	
,	
185	
,	
187	
,	
189	
,	
191	
,	
196	
,	
199	
,	
204	
,	
207	
,	
209	
,	
213	
,	
215	
,	
218	
,	
223	
,	
224	
,	
297	
,	
298	
,	
361	
Adenotonsillar	ENTITY
hypertrophy	ENTITY
65	
,	
66	
,	
139	
,	
274	
Advanced	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
198–203	
Agrypnia	ENTITY
excitata	ENTITY
248	ENTITY
Akathisia	ENTITY
290	
,	
316	
,	
326	
,	
333	
Alcohol	
27	
,	
31	
,	
43	
,	
54	
,	
57	
,	
110	
,	
122	
,	
125	
,	
,	
139	
,	
167	
,	
168	
,	
175	
,	
176	
,	
192	
,	
194	
,	
200	
,	
212	
,	
217	
,	
219	
,	
220	
,	
221	
,	
234	
,	
237	
,	
238	
,	
241	
,	
242	
,	
247	
,	
268	
,	
276–278	ENTITY
,	
286	
,	
295	
,	
326	
,	
352	
,	
354	
,	
359	
,	
369	
Alpha-1	
antitrypsin	
129	
,	
130	
,	
136	
Alternating	ENTITY
leg	ENTITY
muscle	ENTITY
activation	ENTITY
330–334	
Alzheimer	ENTITY
disease	ENTITY
204	
,	
205	
,	
224	
,	
277	
,	
279	
,	
Amyotrophic	ENTITY
lateral	ENTITY
sclerosis	ENTITY
300	ENTITY
Angina	ENTITY
61	
,	
358	
,	
362–366	
Antidepressant	ENTITY
148	
,	
153	
,	
176	
,	
249	
,	
250	
,	
,	
259	
,	
277	
,	
285	
,	
294	
,	
295	
,	
331	
,	
333	
Anxiety	ENTITY
disorder	ENTITY
26	ENTITY
,	
28	
,	
31	
,	
38	
,	
148	
,	
192	
,	
,	
257	
,	
269	
,	
284	
Anxiolytic	ENTITY
110	ENTITY
,	
122	
,	
130	
,	
255	
,	
369	
Apneic	ENTITY
threshold	ENTITY
72	
,	
73	
,	
82	
,	
91	
,	
92	
Apparent	ENTITY
life	ENTITY
-	
threatening	ENTITY
event	ENTITY
(	
ALTE	ENTITY
)	
94	
,	
,	
97	
,	
114	
,	
117	
Arrhythmia	ENTITY
58	
,	
65	
,	
101	
,	
110	
,	
122	
,	
126	
,	
,	
136	
,	
363	
,	
365	
,	
366	
Asperger	ENTITY
syndrome	ENTITY
206	
,	
297	
Asthma	ENTITY
61	
,	
357–359	
Ataxic	ENTITY
breathing	ENTITY
74	
,	
76	
,	
85	
,	
87	
,	
88	
,	
105	
,	
,	
125	
,	
127	
,	
128	
Atrial	ENTITY
fibrillation	ENTITY
53	
,	
55	
,	
58	
,	
69	
,	
71	
,	
139	
Attention	ENTITY
deficit	ENTITY
hyperactivity	ENTITY
disorder	ENTITY
66	
,	
192	
,	
193	
,	
195	
,	
271	
,	
284	
,	
288	
,	
291	
,	
308	
,	
310	
,	
314	
Augmentation	ENTITY
59	
,	
283	
Autism	ENTITY
(	
see	
also	
pervasive	
developmental	ENTITY
disorder	ENTITY
)	
119	
,	
195	
,	
200	
,	
206	
,	
211	
,	
251	
,	
314	
,	
316	
B	ENTITY
Barrett	ENTITY
esophagus	ENTITY
359–361	
Behavioral	ENTITY
insomnia	ENTITY
of	
childhood	ENTITY
(	
see	
also	
limit	ENTITY
-	
setting	ENTITY
sleep	ENTITY
disorder	ENTITY
and	
sleep-	ENTITY
onset	ENTITY
association	ENTITY
disorder	ENTITY
)	
21	
,	
27	
,	
29	
,	
340	
Benign	ENTITY
epilepsy	ENTITY
of	
childhood	ENTITY
with	
centrotemporal	ENTITY
spikes	ENTITY
(	
BECT	ENTITY
)	
345–347	
Benign	ENTITY
epilepsy	ENTITY
with	
occipital	ENTITY
paroxysms	ENTITY
(	
BEOP	ENTITY
)	
345–347	
Benign	ENTITY
sleep	ENTITY
myoclonus	ENTITY
of	
infancy	ENTITY
317–320	
Biot	ENTITY
breathing	ENTITY
87	
Blindness	ENTITY
202	
,	
209–213	ENTITY
Body	ENTITY
rocking	ENTITY
312–314	
,	
316	
Breathing	ENTITY
disorders	ENTITY
(	
see	
sleep	ENTITY
related	
breathing	ENTITY
disorders	ENTITY
)	
Bruxism	ENTITY
(	
see	
sleep	
related	
bruxism	ENTITY
)	
C	
Cataplexy	ENTITY
141	
,	
145–162	
,	
171	
,	
242	
,	
250	
,	
256	
Catathrenia	ENTITY
141	
Central	ENTITY
disorders	ENTITY
of	
hypersomnolence	ENTITY
–	ENTITY
188	ENTITY
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
without	
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	ENTITY
75–79	ENTITY
Index	ENTITY
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
85–89	ENTITY
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
syndromes	ENTITY

69–107	
Central	ENTITY
sleep	ENTITY
apnea	ENTITY
with	
Cheyne	ENTITY
-	
Stokes	ENTITY
breathing	ENTITY
69–75	
Cerebrovascular	ENTITY
accident	ENTITY
(	
see	
also	
stroke	ENTITY
)	
,	
78	
,	
93	
Charley	ENTITY
horse	ENTITY
299	ENTITY
Chemoresponsiveness	ENTITY
80	
,	
81	
,	
91	
,	
92	
,	
121	
,	
,	
129	
Chemosensitivity	ENTITY
111	
,	
123	
,	
126	
,	
130	
,	
131	
,	
Chiari	ENTITY
malformation	ENTITY
76–78	
,	
93	
,	
116	
Children	ENTITY
’s	
Chronotype	
Questionnaire	
196	
Choking	ENTITY
(	
see	
also	
sleep	ENTITY
related	
laryngospasm	ENTITY
)	
53	
,	
54	
,	
96	
,	
357	
,	
358	
Chronic	ENTITY
bronchitis	ENTITY
129	
Chronic	ENTITY
fatigue	ENTITY
syndrome	ENTITY
39	
,	
154	
,	
160	
,	
,	
181	
,	
206	
Chronic	ENTITY
insomnia	ENTITY
disorder	ENTITY
21–41	
Chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
(	
see	
also	
lower	
airway	ENTITY
)	
55	
,	
56	
,	
129	
,	
131	
,	
,	
138	
,	
284	
,	
358	
Chronic	ENTITY
pain	ENTITY
22	
,	
31	
,	
86	
,	
87	
Chronic	ENTITY
renal	ENTITY
failure	ENTITY
285	
,	
286	
,	
287	
Chronotype	ENTITY
184	
,	
189–193	ENTITY
,	
195–197	
,	
199	
,	
,	
219	
Circadian	ENTITY
period	ENTITY
195	
,	
197	
,	
201	
,	
209	
,	
212	
,	
,	
222	
Circadian	ENTITY
phase	ENTITY
191–196	
,	
199	
,	
200	
Circadian	ENTITY
rhythm	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorders	ENTITY
–	
224	
Circadian	ENTITY
sleep	ENTITY
-	
wake	ENTITY
disorder	ENTITY
not	
otherwise	
specified	
224	
Cluster	ENTITY
headache	ENTITY
266	
,	
350–354	
Comorbid	ENTITY
insomnia	ENTITY
21	
Complex	ENTITY
nocturnal	ENTITY
visual	ENTITY
hallucinations	ENTITY
–	
269	
Complex	ENTITY
sleep	ENTITY
apnea	ENTITY
(	
see	
also	
treatment-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
)	

102	
Conditioned	ENTITY
arousal	ENTITY
20	
,	
23	
,	
26	
,	
28	
Confusional	ENTITY
arousal	ENTITY

228–239	
Congenital	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
113–117	
Congestive	ENTITY
heart	ENTITY
failure	ENTITY
50	
,	
53	
,	
55	
,	
58	
,	
61	
,	
,	
71	
,	
72	
,	
93	
,	
271	
,	
287	
,	
297	
Continuous	ENTITY
spike	ENTITY
and	
wave	ENTITY
in	
sleep	
(	
CSWS	ENTITY
)	
,	
346	
,	
347	
,	
348	
Coronary	ENTITY
artery	ENTITY
disease	ENTITY
(	
see	
also	
angina	ENTITY
)	
,	
55	
,	
58	
,	
61	
,	
139	
,	
364	
,	
365	
Cor	ENTITY
pulmonale	ENTITY
55	
,	
66	
,	
77	
,	
91	
,	
109	
,	
110	
,	
,	
115	
,	
117	
,	
119	
,	
122	
,	
125	
,	
129	
,	
135	
Cyclic	ENTITY
alternating	
pattern	
296	
,	
308	
Cystic	ENTITY
fibrosis	ENTITY
129	
,	
130	
,	
136	
,	
358	
D	
Delayed	ENTITY
sleep	ENTITY
-	
wake	ENTITY
phase	ENTITY
disorder	ENTITY
191–198	ENTITY
Dementia	ENTITY
with	
Lewy	ENTITY
bodies	ENTITY
249	
,	
250	
Diabetes	ENTITY
53	
,	
55	
,	
58	
,	
62	
,	
118	
,	
119	
,	
187	
,	
241	
,	
,	
273	
,	
274	
,	
284	
,	
287	
,	
300	
,	
364	
,	
365	
Diagnostic	ENTITY
and	
statistical	ENTITY
manual	ENTITY
26	
,	
28	
,	
,	
261	
,	
316	
Dim	ENTITY
-	
light	ENTITY
melatonin	ENTITY
onset	
196	
,	
199	
,	
209	
Disorders	
of	
arousal	ENTITY
(	
from	
NREM	ENTITY
sleep	ENTITY
)	
–	
239	
Dopamine	ENTITY
172	
,	
176	
,	
259	
,	
284	
,	
285	
,	
288	
,	
,	
294–298	
Down	ENTITY
syndrome	ENTITY
57	
,	
65	
,	
305	
Dystonia	ENTITY
297	
,	
301	
,	
302	
,	
309	
,	
345	
E	ENTITY
Early	ENTITY
morning	ENTITY
awakening	ENTITY
24	
,	
33	
,	
37	
,	
45	
,	
195	
,	
202	
,	
221	
,	
358	
,	
359	
Electromyogram	ENTITY
(	
EMG	ENTITY
)	
60	
,	
226	
,	
237	
,	
247	
,	
251	
,	
296	
,	
298	
,	
301	
,	
309	
,	
310	
,	
318	
,	
320	
,	
323	
,	
324	
,	
328	
,	
329	
,	
331–333	
,	
336	
,	
361	
Emphysema	ENTITY
(	
see	
also	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
)	
129	
,	
130	
,	
136	
Entrainment	ENTITY
189	
,	
197	
,	
206	
,	
210–213	
Environmental	ENTITY
sleep	ENTITY
disorder	ENTITY
339	ENTITY
Epilepsy	ENTITY
(	
see	
also	
sleep	ENTITY
related	
epilepsy	ENTITY
and	
seizure	ENTITY
)	
68	
,	
236	
,	
237	
,	
252	
,	
271	
,	
274	
,	
298	
,	
307	
,	
309	
,	
310	
,	
312	
,	
316	
,	
317	
,	
341	
,	
345–349	
Epworth	ENTITY
Sleepiness	ENTITY
Scale	ENTITY
55	
,	
86	
,	
144	
,	
163	
,	
173	
,	
181	
,	
196	
,	
284	
,	
293	
Esophageal	ENTITY
manometry	ENTITY
60	
,	
294	
,	
360	
Esophageal	ENTITY
pH	ENTITY
361	
Excessive	ENTITY
fragmentary	ENTITY
myoclonus	ENTITY
328–330	
Excessive	ENTITY
time	
in	
bed	
47	

Exploding	ENTITY
head	ENTITY
syndrome	ENTITY
264–266	
F	
Fatal	ENTITY
familial	ENTITY
insomnia	ENTITY
342–344	
Ferritin	ENTITY
285	
,	
295	
Fibromyalgia	ENTITY
39	
,	
284	
Free	ENTITY
-	ENTITY
running	ENTITY
(	
see	
non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disorder	ENTITY
)	

G	ENTITY
Gastroesophageal	ENTITY
reflux	ENTITY
(	
see	
also	
sleep	ENTITY
related	
gastroesophageal	ENTITY
reflux	ENTITY
)	
22	
,	
23	
,	
31	
,	
33	
,	
38	
,	
55	
,	
61	
,	
99	
,	
101	
,	
117	
,	
309	
,	
341	
,	
355–358	
,	
362	
,	
363	
,	
366	
H	
Hcrt	ENTITY
149	
,	
156–160	
,	
171	
Headaches	ENTITY
(	
see	
sleep	ENTITY
related	ENTITY
headaches	ENTITY
)	
Head	ENTITY
banging	ENTITY
312–315	
Head	ENTITY
trauma	ENTITY
149	
,	
156	
,	
157	
,	
168	
,	
170	
,	
172	
,	
High	ENTITY
-	
altitude	ENTITY
periodic	ENTITY
breathing	
79–84	
hPer2	ENTITY
(	
clock	ENTITY
gene	ENTITY
)	
201	
hPer3	ENTITY
(	
clock	ENTITY
gene	ENTITY
)	
193	
,	
194	
Human	ENTITY
leukocyte	ENTITY
antigen	ENTITY
149	
,	
150	
,	
152	
,	
153	
,	
157–160	
,	
164	
,	
168	
,	
169	
,	
194	
Huntington	ENTITY
disease	ENTITY
205	
,	
224	
Hypernychthemeral	ENTITY
209	ENTITY
Hypersomnia	ENTITY
associated	ENTITY
with	ENTITY
psychiatric	ENTITY
disorders	ENTITY
179–182	
Hypersomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
–	
175	
Hypersomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
175–178	ENTITY
Hypertension	ENTITY
32	
,	
53	
,	
55	
,	
56	
,	
58	
,	
60	
,	
61	
,	
66	
,	
,	
91	
,	
110	
,	
112	
,	
116	
,	
120	
,	
122–126	ENTITY
,	
128–132	ENTITY
,	
134–137	ENTITY
,	
139	
,	
140	
,	
291	
,	
352	
,	
354	
,	
359	
,	
364	
Hyperthyroidism	ENTITY
234	
Hypnagogic	ENTITY
foot	ENTITY
tremor	ENTITY
330–334	
Hypnagogic	ENTITY
hallucination	ENTITY
148	
,	
150	
,	
151	
,	
,	
158	
,	
163	
,	
171	
,	
183	
,	
261	
,	
267–269	
,	
Hypnic	ENTITY
headache	ENTITY
266	ENTITY
,	
350	
,	
351	
,	
353	
,	
354	
Hypnic	ENTITY
jerks	ENTITY
(	
see	
also	
sleep	ENTITY
starts	ENTITY
)	
335–337	
Hypnopompic	ENTITY
hallucination	ENTITY
148	
,	
252	
,	
267	
,	
,	
276	
Hypnotic	ENTITY
22	ENTITY
,	
33	
,	
110	
,	
122	
,	
130	
,	
176	
,	
178	
,	
,	
194	
,	
212	
,	
234	
,	
242	
,	
243	
,	
247	
,	
277	
,	
,	
356	
,	
369	
Hypocretin	ENTITY
145	
,	
146	
,	
149–156	
,	
158–160	
,	
,	
169	
,	
172	
,	
250	
Hypothyroidism	ENTITY
57	
,	
112	
,	
118	
,	
123	
,	
127	
,	
173	
Hypoventilation	ENTITY
(	
see	
sleep	ENTITY
related	
hypoventilation	ENTITY
disorders	ENTITY
)	

I	
Idiopathic	ENTITY
central	ENTITY
alveolar	ENTITY
hypoventilation	ENTITY

121–124	
Idiopathic	ENTITY
hypersomnia	ENTITY
161–166	
Idiopathic	ENTITY
insomnia	ENTITY
20	
,	
27	
Inadequate	ENTITY
sleep	ENTITY
hygiene	ENTITY
20	
,	
27	
,	
197	
Insomnia	ENTITY
19–48	ENTITY
Index	ENTITY
Index	ENTITY
Insomnia	ENTITY
due	
to	
(	
a	
)	
medical	ENTITY
condition	ENTITY
28	
Insomnia	ENTITY
due	
to	
(	
another	
)	
mental	ENTITY
disorder	ENTITY
Insomnia	ENTITY
due	
to	
drug	ENTITY
or	
substance	ENTITY
28	
Insomnia	ENTITY
with	
objectively	ENTITY
short	ENTITY
sleep	ENTITY
duration	ENTITY
29	

Insufficient	ENTITY
sleep	ENTITY
syndrome	ENTITY
182–186	
Iron	ENTITY
deficiency	ENTITY
285	
,	
288	
Irregular	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disorder	ENTITY
–	
208	
J	
Jet	
lag	
disorder	
220–224	
Juvenile	ENTITY
myoclonic	ENTITY
epilepsy	ENTITY
(	
JME	ENTITY
)	
345	
,	
K	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
166–170	
L	
Laryngospasm	ENTITY
(	
see	
sleep	ENTITY
related	
laryngospasm	ENTITY
)	

Late	ENTITY
-	
onset	ENTITY
central	ENTITY
hypoventilation	ENTITY
with	
hypothalamic	ENTITY
dysfunction	ENTITY
118–120	
Leg	ENTITY
cramps	ENTITY
(	
see	
sleep	
related	
leg	ENTITY
cramps	ENTITY
)	

Limit	ENTITY
-	
setting	ENTITY
sleep	ENTITY
disorder	ENTITY
21	ENTITY
Long	ENTITY
sleeper	ENTITY
187–188	
Lower	ENTITY
airway	ENTITY
(	
lung	ENTITY
disease	ENTITY
)	
(	
see	
also	
chronic	ENTITY
obstructive	ENTITY
pulmonary	ENTITY
disease	ENTITY
,	
emphysema	ENTITY
and	
chronic	ENTITY
bronchitis	ENTITY
)	
52	
,	
129	
,	
135	
M	
Major	
depression	ENTITY
(	
see	
also	
mood	ENTITY
disorder	ENTITY
)	

180	
,	
193	
,	
284	
Melatonin	ENTITY
(	
see	
also	
dim	ENTITY
-	
light	ENTITY
melatonin	ENTITY
onset	
)	

173	
,	
176	
,	
189	
,	
191	
,	
195	
,	
196	
,	
200	
,	
201	
,	
206	
,	
207	
,	
209	
,	
213	
,	
218	
,	
354	
Menopause	ENTITY
57	
,	
353	
Menstrual	ENTITY
-	
related	ENTITY
Kleine	ENTITY
-	
Levin	ENTITY
syndrome	ENTITY
167	ENTITY
Methadone	ENTITY
(	
see	
also	
opioid	ENTITY
)	
86	
,	
87	
,	
105	
,	
126	
Migraine	ENTITY
170	
,	
234	
,	
265	
,	
266	
,	
269	
,	
284	
,	
350–354	
Mood	ENTITY
disorder	ENTITY
(	
see	
also	
major	
depression	ENTITY
)	
28	
,	
53	
,	
168	
,	
179	
,	
192	
,	
193	
,	
212	
,	
244	
,	
260	
,	
268	
,	
288	
,	
291	
,	
294	
Morningness	ENTITY
-	
eveningness	ENTITY
questionnaire	ENTITY
189	
,	
190	
,	
196	
Movement	ENTITY
disorders	ENTITY
(	
see	
sleep	ENTITY
related	
movement	
disorders	
)	

Multiple	ENTITY
sclerosis	ENTITY
34	
,	
156	
,	
170	
,	
247	
,	
248	
,	
251	
,	
284	
,	
297	
Multiple	ENTITY
sleep	ENTITY
latency	ENTITY
test	ENTITY
35	
,	
55	
,	
61	
,	
144	
,	
146	
,	
151–165	
,	
169	
,	
171–174	
,	
177	
,	
179	
,	
181	
,	
185	
,	
188	
,	
218	
,	
266	
,	
293	
,	
297	
Multisystem	ENTITY
atrophy	ENTITY
355	
,	
356	
Munich	ENTITY
Chronotype	ENTITY
Questionnaire	ENTITY
190	
,	
196	
Muscular	ENTITY
dystrophy	ENTITY
67	ENTITY
,	
117	
Myocardial	ENTITY
ischemia	ENTITY
(	
see	
sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
)	

Myotonic	ENTITY
dystrophy	ENTITY
57	ENTITY
,	
156	
,	
172	
,	
175	
N	
Narcolepsy	ENTITY
type	ENTITY
1	ENTITY
146–155	ENTITY
Narcolepsy	ENTITY
type	ENTITY
2	ENTITY
155–161	ENTITY
Negative	ENTITY
expectations	ENTITY
23	
,	
219	
,	
223	
Neuromuscular	ENTITY
(	ENTITY
disease	ENTITY
/	
disorder	ENTITY
)	
52	
,	
64	
,	
,	
66	
,	
67	
,	
93	
,	
112	
,	
121	
,	
123	
,	
126–131	
,	
–	
137	
,	
153	
,	
300	
Night	ENTITY
eating	ENTITY
syndrome	ENTITY
244	
,	
245	
Nightmare	ENTITY
disorder	ENTITY
257–263	
Nocturnal	ENTITY
frontal	ENTITY
lobe	ENTITY
epilepsy	ENTITY
(	
NFLE	ENTITY
)	
,	
345–349	
Nocturnal	ENTITY
paroxysmal	ENTITY
hemicrania	ENTITY
266	ENTITY
Non-24	ENTITY
-	
hour	ENTITY
sleep	ENTITY
-	
wake	ENTITY
rhythm	ENTITY
disorder	ENTITY
–	
214	
Nonrestorative	ENTITY
sleep	ENTITY
23	
,	
33	
,	
39	
,	
43	
,	
53	
,	
69	
,	
75	
,	
79	
,	
85	
,	
89	
,	
241	
,	
294	
,	
296	

O	

Obesity	ENTITY
51	
,	
53	
,	
55	
,	
57	
,	
58	
,	
61	
,	
65	
,	
66	
,	
68	
,	
108–111	
,	
116	
,	
118–121	
,	
123	
,	
124	
,	
126	
,	
128	
,	
139	
,	
148	
,	
151	
,	
173	
,	
241	
,	
244	
,	
284	
,	
364	
Obesity	ENTITY
hypoventilation	ENTITY
syndrome	ENTITY
108–113	
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
adult	ENTITY
53–62	
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
disorders	ENTITY
53–68	ENTITY
Obstructive	ENTITY
sleep	ENTITY
apnea	ENTITY
,	
pediatric	ENTITY
63–68	ENTITY
Oneirism	ENTITY
248	
Opioid	ENTITY
(	
see	
also	
methadone	ENTITY
)	
51	
,	
69	
,	
74	
,	
85–88	
,	
93	
,	
103	
,	
126	
,	
176	
,	
317	
,	
369	
Opioid	ENTITY
withdrawal	ENTITY
88	
,	
317	
Other	
insomnia	ENTITY
disorder	ENTITY
46	
Other	
parasomnias	ENTITY
264–278	
Other	
sleep	ENTITY
disorder	ENTITY
339–340	
Out	
-	
of	
-	
center	ENTITY
sleep	ENTITY
testing	ENTITY
(	
OCST	ENTITY
)	
50	
,	
53	
,	
,	
60	
,	
61	
,	
134	
,	
137	
,	
139	
P	
Paradoxical	ENTITY
insomnia	ENTITY
20	
,	
27	
,	
35	
Parasomnia	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
276	
Parasomnia	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
–	ENTITY
278	ENTITY
Parasomnia	ENTITY
overlap	
disorder	ENTITY
237	
,	
248	
,	
249	
,	
Parasomnias	ENTITY
225–280	
Parasomnia	ENTITY
,	
unspecified	
278	
Parenchymal	ENTITY
(	
lung	ENTITY
disease	ENTITY
)	
52	
,	
93	
,	
109	
,	
,	
121	
,	
123	
,	
124	
,	
127–131	
,	
134–137	
Parkinson	ENTITY
disease	ENTITY
156	
,	
172	
,	
205	
,	
224	
,	
227	
,	
249	
,	
250	
,	
284	
,	
287	
,	
297	
,	
305	
,	
308	
,	
333	
Performance	ENTITY
anxiety	ENTITY
26	
Periodic	ENTITY
breathing	ENTITY
50	
,	
74	
,	
78–83	
,	
87	
,	
92	
,	
,	
95	
,	
98	
,	
101	
Periodic	ENTITY
limb	ENTITY
movement	ENTITY
disorder	ENTITY
292–299	
Periodic	ENTITY
limb	ENTITY
movements	ENTITY
of	
sleep	ENTITY
148	
,	
271	
,	
272	
,	
274	
,	
281	
,	
284	
,	
285	
,	
287–290	
,	
292–298	ENTITY
,	
324	
,	
329	
Periodic	ENTITY
limb	ENTITY
movements	ENTITY
of	
wake	
284	
,	
289	
Pervasive	ENTITY
developmental	ENTITY
disorder	ENTITY
(	
see	
also	
autism	ENTITY
)	
206	
Phase	ENTITY
response	ENTITY
curve	ENTITY
193	
,	
201	
PHOX2B	ENTITY
113	
,	
114	
,	
116	
,	
118–120	ENTITY
,	
123	
Physiological	ENTITY
hyperarousal	ENTITY
33	ENTITY
,	
35	
Posttraumatic	ENTITY
stress	ENTITY
disorder	ENTITY
249	
,	
252	
,	
258	
,	
,	
260	
,	
262	
,	
279	
,	
284	
,	
297	
,	
327	
Prader	ENTITY
-	
Willi	ENTITY
syndrome	ENTITY
120	ENTITY
,	
156	
,	
172	
Pramipexole	ENTITY
176	
,	
331	
Pregnancy	ENTITY
139	
,	
140	
,	
285	
,	
286	
,	
353	
Prematurity	ENTITY
91	
,	
98–101	
Primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
89–94	
Primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
of	
infancy	ENTITY
–	
98	
Primary	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
of	
prematurity	ENTITY
–	
102	
Primary	ENTITY
insomnia	ENTITY
20	
,	
21	
,	
26	
,	
28	
,	
29	
Prion	ENTITY
protein	ENTITY
342–344	
Propriospinal	ENTITY
myoclonus	ENTITY
at	
sleep	ENTITY
onset	ENTITY
–	
324	
Psychophysiological	ENTITY
insomnia	ENTITY
20	
,	
26	
Pulmonary	ENTITY
hypertension	ENTITY
55	
,	
56	
,	
66	
,	
77	
,	
91	
,	
110	
,	
112	
,	
113	
,	
116	
,	
120	
,	
122–124	
,	
126	
,	
128	
,	
130–132	
,	
134	
,	
136	
,	
137	
R	ENTITY
Recurrent	ENTITY
hypersomnia	ENTITY
145	
,	
166	
Recurrent	ENTITY
isolated	ENTITY
sleep	ENTITY
paralysis	ENTITY
254–256	
REM	ENTITY
-	
related	ENTITY
parasomnias	ENTITY
246–263	
REM	ENTITY
sleep	ENTITY
behavior	ENTITY
disorder	ENTITY
246–253	

REM	ENTITY
sleep	ENTITY
without	
atonia	ENTITY
151	
,	
152	
,	
159	
,	
,	
247	
,	
251	
,	
252	
Renal	ENTITY
failure	ENTITY
70–74	
,	
285–287	
Residual	ENTITY
hypersomnia	ENTITY
173	ENTITY
Index	ENTITY
Index	ENTITY
Respiratory	ENTITY
depressant	ENTITY
51	ENTITY
,	
85	
,	
121	
,	
125–127	
Respiratory	ENTITY
effort	
related	
arousal	ENTITY
(	
RERA	ENTITY
)	
53	
,	
54	
,	
56	
,	
60	
,	
61	
,	
65	
,	
102	
,	
139	
,	
164	
Restless	ENTITY
legs	ENTITY
syndrome	ENTITY
282–291	
Reverse	
first	
-	
night	ENTITY
effect	ENTITY
34	
Rhythmic	ENTITY
masticatory	ENTITY
muscle	
activity	
304	
,	
,	
307–311	
S	ENTITY
Secondary	ENTITY
insomnia	ENTITY
20	
,	
21	
,	
28	
,	
29	
Sedating	ENTITY
medication	ENTITY
54	
,	
57	
,	
165	
,	
176	
,	
177	
Sedative	ENTITY
86	ENTITY
,	
125	
,	
175–178	
,	
192	
,	
194	
,	
200	
,	
,	
234	
,	
242	
,	
247	
,	
277	
,	
278	
,	
369	
Seizures	ENTITY
(	
see	
also	
epilepsy	ENTITY
)	
55	
,	
66	
,	
68	
,	
,	
101	
,	
115	
,	
153	
,	
170	
,	
176	
,	
252	
,	
256	
,	
260	
,	
261	
,	
266	
,	
269	
,	
273	
,	
279	
,	
298	
,	
310	
,	
317–319	
,	
337	
,	
345–349	
,	
356	
Sexsomnia	ENTITY
232	
,	
242	
,	
248	
Shift	ENTITY
work	ENTITY
disorder	ENTITY
215–219	
Short	ENTITY
sleeper	ENTITY
47–48	ENTITY
Short	ENTITY
-	
term	ENTITY
insomnia	ENTITY
disorder	ENTITY
41–45	
Sleep	ENTITY
attack	ENTITY
143	
,	
147	
Sleep	ENTITY
drunkenness	ENTITY
154	
,	
160	
,	
162	
,	
163	
Sleep	ENTITY
enuresis	ENTITY
270–276	
Sleep	ENTITY
inertia	ENTITY
162	
,	
192	
,	
197	
,	
226	
,	
236	
Sleep	ENTITY
log	ENTITY
144	
,	
152	
,	
159	
,	
162	
,	
182	
,	
187	
,	
189	
,	
,	
196	
,	
199	
,	
204	
,	
207	
,	
209	
,	
213	
,	
215	
,	
,	
224	
Sleep	ENTITY
-	
onset	ENTITY
association	ENTITY
disorder	ENTITY
21	

Sleep	ENTITY
onset	ENTITY
REM	ENTITY
period	ENTITY
144	
,	
146	
,	
152	
,	
–	
162	
,	
164	
,	
165	
,	
169	
,	
171	
,	
174	
,	
177	
,	
,	
247	
,	
269	
Sleep	ENTITY
paralysis	ENTITY
148	
,	
150	
,	
151	
,	
153	
,	
156	
,	
,	
163	
,	
171	
,	
183	
,	
254–256	
,	
261	
,	
266	
,	
,	
269	
,	
276	
,	
314	
Sleep	ENTITY
related	
abnormal	ENTITY
sexual	ENTITY
behaviors	ENTITY
Sleep	ENTITY
related	ENTITY
breathing	ENTITY
disorders	ENTITY
49–141	
Sleep	ENTITY
related	ENTITY
Sleep	ENTITY
related	ENTITY
Sleep	ENTITY
related	ENTITY
Sleep	ENTITY
related	
–	
363	
Sleep	ENTITY
related	ENTITY
Sleep	ENTITY
related	ENTITY
Sleep	ENTITY
related	
–	
133	
Sleep	ENTITY
related	ENTITY
bruxism	ENTITY
303–311	
eating	ENTITY
disorder	ENTITY
240–245	
epilepsy	ENTITY
345–350	
gastroesophageal	ENTITY
reflux	ENTITY
hallucinations	ENTITY
267–270	ENTITY
headaches	ENTITY
350–355	
hypoventilation	ENTITY
disorders	ENTITY
hypoventilation	ENTITY
due	
to	
a	
medical	ENTITY
disorder	ENTITY
128–133	
Sleep	
related	
hypoventilation	ENTITY
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
124–128	ENTITY
Sleep	ENTITY
related	ENTITY
hypoxemia	ENTITY

134–138	ENTITY
Sleep	ENTITY
related	ENTITY
injury	ENTITY
227	
,	
241	
,	
247	
,	
250	
Sleep	ENTITY
related	
laryngospasm	ENTITY
355–357	
Sleep	ENTITY
related	ENTITY
leg	ENTITY
cramps	ENTITY
299–303	ENTITY
Sleep	ENTITY
related	ENTITY
medical	ENTITY
and	
neurological	ENTITY
disorders	ENTITY
341–367	ENTITY
Sleep	ENTITY
related	
movement	
disorder	
due	
to	
a	
medical	ENTITY
disorder	ENTITY
325	ENTITY
Sleep	ENTITY
related	
movement	
disorder	
due	
to	
a	
medication	ENTITY
or	
substance	ENTITY
326	ENTITY
Sleep	ENTITY
related	ENTITY
movement	ENTITY
disorders	ENTITY
281–337	
Sleep	ENTITY
related	
movement	
disorder	
,	
unspecified	
327	
Sleep	ENTITY
related	
myocardial	ENTITY
ischemia	ENTITY
363–367	ENTITY
Sleep	ENTITY
related	
rhythmic	
movement	
disorder	
–	
316	
Sleep	ENTITY
starts	ENTITY
(	
see	
also	
hypnic	ENTITY
jerks	ENTITY
)	

335–337	
Sleep	ENTITY
talking	ENTITY
279–280	
Sleep	ENTITY
terrors	ENTITY
228–239	
Sleepwalking	ENTITY
228–239	
Smith	ENTITY
-	
Magenis	ENTITY
syndrome	ENTITY
173	
,	
200	
,	
206	
Snoring	ENTITY
139–140	ENTITY

Status	ENTITY
cataplecticus	ENTITY
148	ENTITY
Status	ENTITY
dissociatus	ENTITY
248	ENTITY
,	
252	
Stroke	ENTITY
(	
see	
also	
cerebrovascular	ENTITY
accident	ENTITY
)	
34	
,	
50	
,	
53	
,	
55	
,	
58	
,	
61	
,	
70–74	
,	
76	
,	
140	
,	
172	
,	
173	
,	
234	
,	
249	
,	
264	
,	
287	
,	
291	
,	
295	
Sudden	ENTITY
infant	ENTITY
death	ENTITY
syndrome	ENTITY
(	
SIDS	ENTITY
)	
94	
,	
97	
,	
98	
Suggested	
immobilization	ENTITY
test	ENTITY
289	
Synucleinopathies	ENTITY
(	
see	
also	
Parkinson	ENTITY
disease	ENTITY
and	
multisystem	ENTITY
atrophy	ENTITY
)	
227	
,	
250	
T	ENTITY
Treatment	ENTITY
-	
emergent	ENTITY
central	ENTITY
sleep	ENTITY
apnea	ENTITY
102–107	
V	
Ventilatory	ENTITY
drive	
50	
,	
59	
,	
66	
,	
72	
,	
74	
,	
87	
,	
90	
,	
92	
,	
122	
,	
124	
,	
125	
Violence	ENTITY
(	
in	
sleep	ENTITY
)	
232	
,	
249	
W	
Willis	
-	
Ekbom	ENTITY
disease	ENTITY
282	ENTITY
Index	ENTITY

